Citrus Sinensis ID: 013520

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-
Protein Sequence
MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Secondary Structure (PSIPRED)
ccccccccccEEEEEEEEccccEEEEEEEEcccccEEEEEEEEcHHHccccHHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEEEEccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccHHHHHHHcccccccccccccccccccccEEEccccHHHHHHHHHHHHHHcccEEEEEccEEEEEEccccccccEEEEEEEEEEcccEEEEEEEEccccHHHHHHHHHHHHHHcccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccHHHEEEEEEEEEccccEEEEEEEcccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEEEcccccHccccHHHHHcccccccHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccEEEHHHHHccHHHcccccccccccccccccccccccccccccccccccccccccccccHHHEEEcccccccHHHHHccccccEEEEEEEccccHHHHHHHHHHHHHHcccEEEEcccEEEEEEcccccccEEEEEEEEEEEcccEEEEEEEcccccHHHHHHHHHHHcHHHHHEEEccccccHccccccc
Coil and Loop (DISEMBL)
MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHChskgvyhrdlkpenllldsygnlkvsdfglsalpqqgvellhttcgtpnyvapevlsnrgydgsaadvWSCGVILFVLMAgylpfgetdlptLYKKInaaefscpfwfstgatslihkildpnpktririegirkhpwfrknynpvkcseeeevnlddvhaVFDDIEYVAEqsenkvggpllMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKtrlegvsanktgQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIiwkptegssllrtmsc
Flexible Loop (DISEMBL)
mkkqtrrvakyevgrtigegtfakvrfaqnretgesvaMKVLakstilkhrmvDQIKREIsimkivrhpniVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATslihkildpnpktririegirkhpwfrknynPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRlegvsanktgQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENiiwkptegssllrtmsc
Low Complexity Region (SEG)
MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Disordered region (IsUnstruct)
*********KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKP************
Disordered Region (DISOPRED)
*****RR**KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE*VNLDDVHAV********************MNAFEMITLSQGLNLA***********************VILS********************************FAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWK*************
Disordered Region (DISEMBL)
**********YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGS********
Disordered Region (DISPRO)
****TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK*******************************GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTE**********
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEGSSLLRTMSC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	441	2.2.26 [Sep-21-2011]
Q9LDI3	446	CBL-interacting serine/th	yes	no	0.997	0.986	0.764	0.0
Q69Q47	453	CBL-interacting protein k	yes	no	0.988	0.962	0.743	0.0
Q5JLD8	446	CBL-interacting protein k	no	no	0.970	0.959	0.703	0.0
Q9STV4	445	CBL-interacting serine/th	no	no	0.970	0.961	0.689	0.0
Q6ZLP5	450	CBL-interacting protein k	no	no	0.950	0.931	0.613	1e-159
Q93VD3	482	CBL-interacting serine/th	no	no	0.952	0.871	0.604	1e-156
Q2QY53	438	CBL-interacting protein k	no	no	0.954	0.961	0.604	1e-153
Q2V452	441	CBL-interacting serine/th	no	no	0.956	0.956	0.593	1e-153
Q84VQ3	439	CBL-interacting serine/th	no	no	0.972	0.977	0.590	1e-153
Q2RAX3	454	CBL-interacting protein k	no	no	0.954	0.927	0.582	1e-149

>sp|Q9LDI3|CIPKO_ARATH CBL-interacting serine/threonine-protein kinase 24 OS=Arabidopsis thaliana GN=CIPK24 PE=1 SV=1

 Score =  720 bits (1858), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/445 (76%), Positives = 393/445 (88%), Gaps = 5/445 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M K+ RRV KYEVGRTIGEGTFAKV+FA+N +TG++VA+K++AKSTILK+RMVDQIKREI
Sbjct: 1   MTKKMRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRL+EVLAS +K+YI+LEFVTGGELFD+IVH+GRL E++ R+YFQQL+D
Sbjct: 61  SIMKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVD 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCH KGVYHRDLKPENLLLD+ GNLKVSDFGLSALPQ+GVELL TTCGTPNYVAPEV
Sbjct: 121 AVAHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           LS +GYDGSAAD+WSCGVILFV++AGYLPF ETDLP LY+KINAAEFSCP WFS     L
Sbjct: 181 LSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           IH+ILDPNPKTRI+I+GI+K PWFR NY P++  EEEEVNLDD+ AVFD IE  YVAE  
Sbjct: 241 IHRILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENV 300

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           E    GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S
Sbjct: 301 ERNDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANS 360

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           +  K HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  
Sbjct: 361 MGFKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKL 420

Query: 419 CAKLENIIWKPTEG---SSLLRTMS 440
           C+KLENIIW+ TEG   S +LRT++
Sbjct: 421 CSKLENIIWRATEGIPKSEILRTIT 445

Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Activates the vacuolar H(+)/Ca(2+) antiporter CAX1 and operates in synergy with CBL4/SOS3 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q69Q47|CIPKO_ORYSJ CBL-interacting protein kinase 24 OS=Oryza sativa subsp. japonica GN=CIPK24 PE=1 SV=1

 Score =  695 bits (1794), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/441 (74%), Positives = 381/441 (86%), Gaps = 5/441 (1%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           +RV +YEVGRTIG+GTFAKV+FA + +TG +VAMKVL K TIL HRM+ QIKREISIMKI
Sbjct: 13  KRVGRYEVGRTIGQGTFAKVKFAVDADTGAAVAMKVLDKDTILNHRMLHQIKREISIMKI 72

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           VRHPNIVRL+EVLA +TK+YIILE +TGGELFDKI  QG+L EN+ R+YFQQLIDA+ +C
Sbjct: 73  VRHPNIVRLNEVLAGKTKIYIILELITGGELFDKIARQGKLRENEARKYFQQLIDAINYC 132

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKGVYHRDLKPENLLLDS GNLKVSDFGLS L Q+GV LLHTTCGTPNYVAPEVLSN G
Sbjct: 133 HSKGVYHRDLKPENLLLDSRGNLKVSDFGLSTLAQKGVGLLHTTCGTPNYVAPEVLSNNG 192

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           YDGSAADVWSCGVIL+VLMAGYLPF E DLPTLY KI A +FSCP+WFS GATSLIH+IL
Sbjct: 193 YDGSAADVWSCGVILYVLMAGYLPFEEDDLPTLYDKITAGQFSCPYWFSPGATSLIHRIL 252

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQSENKVG 303
           DPNPKTRI IE IR+  WF+K Y  +K  E+E V+LDDV AVFD+IE  YV+EQ  +  G
Sbjct: 253 DPNPKTRITIEQIREDTWFKKTYVAIKRGEDENVDLDDVQAVFDNIEDKYVSEQVTHNDG 312

Query: 304 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 363
           GPL+MNAFEMITLSQGL+L+ALFDR+Q++VKRQTRFVSR+PA+ I++ IE VAE++ LKV
Sbjct: 313 GPLVMNAFEMITLSQGLDLSALFDRQQEFVKRQTRFVSRKPAKTIVATIEVVAETMGLKV 372

Query: 364 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLE 423
           H++NYK RLEGVS+N+   FAVVL+VFEVAPSLFMVDVRK AGDTLEYH+FYKN C K+E
Sbjct: 373 HSQNYKLRLEGVSSNRMSPFAVVLQVFEVAPSLFMVDVRKVAGDTLEYHRFYKNLCNKME 432

Query: 424 NIIWKPTE---GSSLLRTMSC 441
           +IIW+P E    S+LLRT +C
Sbjct: 433 SIIWRPIEVSAKSALLRTATC 453

Involved in the regulatory pathway for the control of intracellular Na(+) and K(+) homeostasis and salt tolerance. Operates in synergy with CBL4 to activate the plasma membrane Na(+)/H(+) antiporter SOS1. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5JLD8|CIPK8_ORYSJ CBL-interacting protein kinase 8 OS=Oryza sativa subsp. japonica GN=CIPK8 PE=2 SV=1

 Score =  644 bits (1662), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 302/429 (70%), Positives = 357/429 (83%), Gaps = 1/429 (0%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           RRV KYEVGRTIGEGTFAKV+FAQN E+GESVAMKV+ +S+ILKH+M DQIKREISIMK+
Sbjct: 8   RRVGKYEVGRTIGEGTFAKVKFAQNTESGESVAMKVVDRSSILKHKMADQIKREISIMKL 67

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           VRHPN+VRLHEVLASR K++IILEF+TGGELFDKI+  GRL E D RRYFQQLID V  C
Sbjct: 68  VRHPNVVRLHEVLASRKKIFIILEFITGGELFDKIIRHGRLNEADARRYFQQLIDGVDFC 127

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKGVYHRDLKPENLLLDS GNLK+SDFGLSA P QG  LL TTCGTPNYVAPEVLS++G
Sbjct: 128 HSKGVYHRDLKPENLLLDSQGNLKISDFGLSAWPAQGGALLRTTCGTPNYVAPEVLSHKG 187

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           YDG+ AD WSCGVIL+VL+AGYLPF E DL TLY KI +AE+S P WF  GA SLIH+IL
Sbjct: 188 YDGALADTWSCGVILYVLLAGYLPFDEVDLTTLYGKIESAEYSFPAWFPNGAKSLIHRIL 247

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGP 305
           DPNP  RIRIE IR   WF+KNY P +  E EEVNLDDV+A FDD E  A+ + +   GP
Sbjct: 248 DPNPDKRIRIEEIRNDEWFKKNYEPTREIESEEVNLDDVNAAFDDPEEDADHTLDDEAGP 307

Query: 306 LLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHT 365
           L +NAF++I LSQGLNLAALFDRRQDY K Q RF+SR+PA+VI+S++E VA+S+  K H 
Sbjct: 308 LTLNAFDLIILSQGLNLAALFDRRQDYDKLQNRFLSRKPAKVIMSSMEVVAQSMGYKTHI 367

Query: 366 RNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENI 425
           RNYK R+EG++ANKT   AV+LE+FEVAPS+FM+++++AAGDT +Y+KF  N+C+KL++I
Sbjct: 368 RNYKMRVEGLNANKTSHLAVMLEIFEVAPSIFMIELQRAAGDTSDYNKFINNYCSKLDDI 427

Query: 426 IWK-PTEGS 433
           IW  P E S
Sbjct: 428 IWNFPIEKS 436

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9STV4|CIPK8_ARATH CBL-interacting serine/threonine-protein kinase 8 OS=Arabidopsis thaliana GN=CIPK8 PE=1 SV=1

 Score =  639 bits (1647), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 296/429 (68%), Positives = 359/429 (83%), Gaps = 1/429 (0%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R+V KYE+GRTIGEGTFAKV+FAQN ETGESVAMK++ +STI+K +MVDQIKREISIMK+
Sbjct: 4   RKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKL 63

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           VRHP +VRL+EVLASRTK+YIILE++TGGELFDKIV  GRL E++ R+YF QLID V +C
Sbjct: 64  VRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYC 123

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKGVYHRDLKPENLLLDS GNLK+SDFGLSALP+QGV +L TTCGTPNYVAPEVLS++G
Sbjct: 124 HSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLSHKG 183

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           Y+G+ AD+WSCGVIL+VLMAGYLPF E DLPTLY KI+ AEFSCP +F+ GA SLI++IL
Sbjct: 184 YNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRIL 243

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDI-EYVAEQSENKVGG 304
           DPNP+TRI I  IRK  WF K+Y PV+  + E VNLDDV+A FDD  E    Q   +  G
Sbjct: 244 DPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDTG 303

Query: 305 PLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVH 364
           PL +NAF++I LSQGLNLA LFDR +D +K QTRF+S +PA V+LS++E V++S+  K H
Sbjct: 304 PLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFKTH 363

Query: 365 TRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLEN 424
            RNYK R+EG+SANKT  F+V+LEVF+VAPS+ MVD++ AAGD  EY KFYK FC+KL++
Sbjct: 364 IRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCSKLDD 423

Query: 425 IIWKPTEGS 433
           IIWKP + S
Sbjct: 424 IIWKPPDAS 432

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1

 Score =  563 bits (1450), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 264/430 (61%), Positives = 338/430 (78%), Gaps = 11/430 (2%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           RV +YE+GRT+GEGTFAKV+FA+N ++GE+VA+K+L K  +LKH+M+ QIKREIS MK++
Sbjct: 9   RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHPN++R+HEV+AS+TK+YI++E VTGGELFDKI  +GRL E+D R+YFQQLI+AV +CH
Sbjct: 69  RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNR 184
           S+GVYHRDLKPENLLLD+ G LKVSDFGLSAL QQ  E  LLHTTCGTPNYVAPEV++N+
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           GYDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  A+FSCP WFST A  LI KI
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKI 248

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVF----DDIEYVAEQSEN 300
           LDPNP TRI I  +  + WF+K Y P +  E  +VNLDD++++F    D  + V E+ E 
Sbjct: 249 LDPNPSTRITIAELINNEWFKKGYQPPRF-ETADVNLDDINSIFNESGDQTQLVVERREE 307

Query: 301 KVGGPLLMNAFEMITLSQGLNLAALFDRR-QDYVKRQTRFVSRQPAQVILSNIEAVAESL 359
           +   P +MNAFE+I+ SQGLNL  LF+++ Q  VKR+TRF SR PA  ILS IEA A  +
Sbjct: 308 R---PSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRFASRLPANEILSKIEAAAGPM 364

Query: 360 SLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFC 419
              V  RNYK +L+G +  + GQ A+  EVFEV PSL+MV++RK+ GDTLE+HKFY N  
Sbjct: 365 GFNVQKRNYKLKLQGENPGRKGQLAIATEVFEVTPSLYMVELRKSNGDTLEFHKFYHNIS 424

Query: 420 AKLENIIWKP 429
             L++++WKP
Sbjct: 425 NGLKDVMWKP 434

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1

 Score =  553 bits (1425), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 258/427 (60%), Positives = 331/427 (77%), Gaps = 7/427 (1%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           V KYE+GRT+GEGTFAKV+FA+N E G++VA+KV+ K  +LK++M+ QIKREIS MK+++
Sbjct: 28  VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++R+ EV+AS+TK+Y +LEFVTGGELFDKI   GRL E++ R+YFQQLI+AV +CHS
Sbjct: 88  HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG 185
           +GVYHRDLKPENLLLD+ G LKVSDFGLSALPQQ  E  LLHTTCGTPNYVAPEV++N+G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           YDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  AEF+CP WFS  A  LI +IL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDI----EYVAEQSENK 301
           DPNP TRI    + ++ WF+K Y   K  E  +V+LDDV A+FDD       V E+ E  
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKF-ENADVSLDDVDAIFDDSGESKNLVVERREEG 326

Query: 302 VGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSL 361
           +  P+ MNAFE+I+ SQGLNL +LF+++   VKR+TRF S+  A  I++ IEA A  +  
Sbjct: 327 LKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMGF 386

Query: 362 KVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAK 421
            V T NYK +L G  + + GQ AV  EVF+VAPSL+MV++RK+ GDTLE+HKFYKN    
Sbjct: 387 DVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTTG 446

Query: 422 LENIIWK 428
           L++I+WK
Sbjct: 447 LKDIVWK 453

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2

 Score =  541 bits (1395), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 260/430 (60%), Positives = 332/430 (77%), Gaps = 9/430 (2%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  RRV KYE+GRTIGEGTFAKV+FA++ ETG+ VA+K+L K  +LKH+MV+QIKREIS 
Sbjct: 5   KVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREIST 64

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           MK+++HPN+VR++EV+ S+TK+YI+LE+VTGGELFD IV+ GR+ E++ RRYFQQLI+AV
Sbjct: 65  MKLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAV 124

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 180
            +CHS+GVYHRDLKPENLLLDSYGNLKVSDFGLSAL QQ  +  LLHTTCGTPNYVAPEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEV 184

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI+ AEF+ P W S  A  L
Sbjct: 185 LEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRL 244

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           + +ILDPNP TR+ I  I +  WF+K Y   +  E+ +  LDDV+AVF+D E  +V E+ 
Sbjct: 245 LTRILDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKK 304

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           E     P  +NAFE+I++S GLNL  LFD  Q++ KR+TRF S+ P + I+  IE  A+ 
Sbjct: 305 EE----PEALNAFELISMSAGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKP 359

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           L   V  +NYK RLE V A + G   V  E+ +VAPSL MV+VRKA GDTLE+HKFYKN 
Sbjct: 360 LGFDVQKKNYKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVRKAKGDTLEFHKFYKNL 419

Query: 419 CAKLENIIWK 428
              L++++WK
Sbjct: 420 SRTLKDVVWK 429

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2

 Score =  541 bits (1395), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 255/430 (59%), Positives = 328/430 (76%), Gaps = 8/430 (1%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           RRV KYEVGRTIGEGTFAKV+FA+N ETGE VA+K+L K  +LKH+M +QI+REI+ MK+
Sbjct: 9   RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKL 68

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           ++HPN+V+L+EV+AS+TK++IILE+VTGGELFDKIV+ GR+ E++ RRYFQQLI AV +C
Sbjct: 69  IKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYC 128

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSN 183
           HS+GVYHRDLKPENLLLDSYGNLK+SDFGLSAL QQ  +  LLHT+CGTPNYVAPEVL++
Sbjct: 129 HSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLND 188

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 243
           RGYDG+ AD+WSCGV+L+VL+AGYLPF +++L  LYKKI++ EF+CP W S GA  LI +
Sbjct: 189 RGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITR 248

Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQSENK 301
           ILDPNP TR+  + + +  WF+K+Y P    E ++ N+DD+ AVF D E   V E+ E +
Sbjct: 249 ILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREEQ 308

Query: 302 VGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSL 361
              P  +NAFE+I++S+GLNL  LFD  Q++ KR+TR   R  A  I+  IE  A+ L  
Sbjct: 309 ---PAAINAFEIISMSRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKPLGF 364

Query: 362 KVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAK 421
            V  +NYK RLE V A + G   V  E+F+VAPSL MV V K+ GDTLE+HKFYK     
Sbjct: 365 DVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNS 424

Query: 422 LENIIWKPTE 431
           LE ++W   E
Sbjct: 425 LEQVVWTNNE 434

Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2

 Score =  540 bits (1392), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 258/437 (59%), Positives = 327/437 (74%), Gaps = 8/437 (1%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  RRV KYEVG+T+G+GTFAKVR A N ETGE VA+K+L K  +LKH+M +QI+REI  
Sbjct: 5   KVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICT 64

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           MK++ HPN+VRL+EVLAS+TK+YI+LEF TGGELFDKIVH GRL E + R+YFQQLI+AV
Sbjct: 65  MKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAV 124

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV 180
            +CHS+GVYHRDLKPENLLLD+ GNLKVSDFGLSAL +Q  G  LLHT CGTPNY APEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEV 184

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L+++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI A E+ CP W S GA +L
Sbjct: 185 LNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNL 244

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           I +ILDPNP TRI I  +    WF+KNY P    E+EE NLDDV AVF D E  +V E+ 
Sbjct: 245 IVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKK 304

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           E +   P  MNAFE+I++S+ L+L  LF+  + + KR+TRF ++  A  ++  IE  ++ 
Sbjct: 305 EEQ---PTSMNAFELISMSRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKP 360

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           L   +  +NYK RLE V+A + G   V  E+F+V+PSL M++VRK  GDTLE+HKFYK  
Sbjct: 361 LGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420

Query: 419 CAKLENIIWKPTEGSSL 435
              L +++WK  E S L
Sbjct: 421 STSLNDVVWKSGESSGL 437

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1

 Score =  527 bits (1358), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 260/446 (58%), Positives = 330/446 (73%), Gaps = 25/446 (5%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  RRV KYE+GRTIGEGTFAKV+FA++ ETG+ VA+K+L K  +LKH+MV+QIKREIS 
Sbjct: 5   KVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREIST 64

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           MK+++HPN+VR++EV+ S+T +YI+LE+VTGGELFD IV+ GR+ E++ RRYFQQLI+AV
Sbjct: 65  MKLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAV 124

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEV 180
            +CHS+GVYHRDLKPENLLLDSYGNLKVSDFGLSAL QQ  +  LLHTTCGTPNYVAPEV
Sbjct: 125 DYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEV 184

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI+ AEF+ P W S  A  L
Sbjct: 185 LEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRL 244

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           + +ILDPNP TRI I  I +  WF+K Y   +  E+ +  LDDV AVF+D E  +V E+ 
Sbjct: 245 LTRILDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHHVTEKK 304

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           E     P  +NAFE+I++S GLNL  LFD  Q++ KR+TRF S+ P + I+  IE  A+ 
Sbjct: 305 EE----PEALNAFELISMSAGLNLGNLFDSEQEF-KRETRFTSKCPPKEIVRKIEEAAKP 359

Query: 359 LSLKVHTRNYKT----------------RLEGVSANKTGQFAVVLEVFEVAPSLFMVDVR 402
           L   V  +NYK                 RLE V A + G   V  E+ +VAPSL MV+VR
Sbjct: 360 LGFDVQKKNYKICSPCLTTICMNIPFKLRLEKVKAGRKGNLNVATEILQVAPSLHMVEVR 419

Query: 403 KAAGDTLEYHKFYKNFCAKLENIIWK 428
           KA GDTLE+HKFYKN    L++++WK
Sbjct: 420 KAKGDTLEFHKFYKNLSRTLKDVVWK 445

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
147846506	446	hypothetical protein VITISV_043742 [Viti	1.0	0.988	0.849	0.0
225445529	446	PREDICTED: CBL-interacting serine/threon	1.0	0.988	0.849	0.0
255567051	449	CBL-interacting serine/threonine-protein	1.0	0.982	0.849	0.0
224993594	444	CBL-interacting protein kinase 26 [Popul	0.986	0.979	0.853	0.0
229893775	446	serine/threonine protein kinase [Malus x	0.997	0.986	0.840	0.0
224142617	444	predicted protein [Populus trichocarpa]	0.986	0.979	0.848	0.0
350535735	446	calcineurin B-like interacting protein k	0.997	0.986	0.8	0.0
310896475	445	salt overly sensitive protein 2b [Gossyp	0.997	0.988	0.816	0.0
224087128	431	predicted protein [Populus trichocarpa]	0.968	0.990	0.831	0.0
356563005	446	PREDICTED: CBL-interacting protein kinas	0.975	0.964	0.805	0.0

>gi|147846506|emb|CAN83760.1| hypothetical protein VITISV_043742 [Vitis vinifera] gi|229609819|gb|ACQ83525.1| CBL-interacting protein kinase 09 [Vitis vinifera]

 Score =  797 bits (2058), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/446 (84%), Positives = 412/446 (92%), Gaps = 5/446 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR+V KYEVGRTIGEGTFAKV+FA N ETGESVAMKV+AKSTILKHRMVDQIK+EI
Sbjct: 1   MKKVTRKVGKYEVGRTIGEGTFAKVKFAHNTETGESVAMKVMAKSTILKHRMVDQIKQEI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVLAS+T +YIILEFVTGGEL+DKIVHQGRL EN+ RRYFQQLID
Sbjct: 61  SIMKIVRHPNIVRLHEVLASQTTIYIILEFVTGGELYDKIVHQGRLSENESRRYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AV+HCHSKGVYHRDLKPENLLLDS GNLKVSDFGLSALP+QGV LLHTTCGTPNYVAPEV
Sbjct: 121 AVSHCHSKGVYHRDLKPENLLLDSNGNLKVSDFGLSALPKQGVGLLHTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           LSN+GYDG+AADVWSCGVIL+VLMAGYLPF E DLP+LYKKINAAEFSCPFWFS+G+ S 
Sbjct: 181 LSNQGYDGAAADVWSCGVILYVLMAGYLPFNEIDLPSLYKKINAAEFSCPFWFSSGSKSF 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           + +ILDPNPKTRIRIEGI+  PWFRKNY   KC E+EEVNLDD+HAVFDDIE  YV+EQS
Sbjct: 241 LCRILDPNPKTRIRIEGIKNDPWFRKNYVSSKCREDEEVNLDDIHAVFDDIEENYVSEQS 300

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
            N   GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRFVSR+PA+VI+S IEAVAES
Sbjct: 301 GNNDTGPLIMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFVSREPAKVIISTIEAVAES 360

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           ++ KVHTR+YKTRLEG+SANKT QFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF
Sbjct: 361 MNFKVHTRHYKTRLEGISANKTAQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420

Query: 419 CAKLENIIWKPTEG---SSLLRTMSC 441
           CAKLE+IIWKP E    SSLLRTM+C
Sbjct: 421 CAKLEHIIWKPKEAMTNSSLLRTMTC 446

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225445529|ref|XP_002285262.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 24 [Vitis vinifera] gi|297738965|emb|CBI28210.3| unnamed protein product [Vitis vinifera]

 Score =  796 bits (2056), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/446 (84%), Positives = 412/446 (92%), Gaps = 5/446 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR+V KYEVGRTIGEGTFAKV+FA N ETGESVAMKV+AKSTILKHRMVDQIK+EI
Sbjct: 1   MKKVTRKVGKYEVGRTIGEGTFAKVKFAHNTETGESVAMKVMAKSTILKHRMVDQIKQEI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVLAS+T +YIILEFVTGGEL+DKIVHQGRL EN+ RRYFQQLID
Sbjct: 61  SIMKIVRHPNIVRLHEVLASQTTIYIILEFVTGGELYDKIVHQGRLSENESRRYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AV+HCHSKGVYHRDLKPENLLLDS GNLKVSDFGLSALP+QGV LLHTTCGTPNYVAPEV
Sbjct: 121 AVSHCHSKGVYHRDLKPENLLLDSNGNLKVSDFGLSALPKQGVGLLHTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           LSN+GYDG+AADVWSCGVIL+VLMAGYLPF E DLP+LYKKINAAEFSCPFWFS+G+ SL
Sbjct: 181 LSNQGYDGAAADVWSCGVILYVLMAGYLPFNEIDLPSLYKKINAAEFSCPFWFSSGSKSL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           + +ILD NPKTRIRIEGI+  PWFRKNY   KC E+EEVNLDD+HAVFDDIE  YV+EQS
Sbjct: 241 LCRILDSNPKTRIRIEGIKNDPWFRKNYVSSKCREDEEVNLDDIHAVFDDIEENYVSEQS 300

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
            N   GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRFVSR+PA+VI+S IEAVAES
Sbjct: 301 GNNDTGPLIMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFVSREPAKVIISTIEAVAES 360

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           ++ KVHTR+YKTRLEG+SANKT QFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF
Sbjct: 361 MNFKVHTRHYKTRLEGISANKTAQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420

Query: 419 CAKLENIIWKPTEG---SSLLRTMSC 441
           CAKLE+IIWKP E    SSLLRTM+C
Sbjct: 421 CAKLEHIIWKPKEAMTNSSLLRTMTC 446

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255567051|ref|XP_002524508.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223536296|gb|EEF37948.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  795 bits (2054), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/446 (84%), Positives = 414/446 (92%), Gaps = 5/446 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MK  +R+V KYEVGRTIGEGTFAKV+FAQN ETGESVAMKV+AKSTILKHRMVDQIKREI
Sbjct: 4   MKSVSRKVGKYEVGRTIGEGTFAKVKFAQNLETGESVAMKVMAKSTILKHRMVDQIKREI 63

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRH NIVRLHEVLASRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLID
Sbjct: 64  SIMKIVRHNNIVRLHEVLASRTKIYIILEFVTGGELFDKIVHQGRLSENEARRYFQQLID 123

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCHSKGVYHRDLKPENLLLDS+GNLKVSDFGLSALPQQGV LLHTTCGTPNYVAPEV
Sbjct: 124 AVAHCHSKGVYHRDLKPENLLLDSFGNLKVSDFGLSALPQQGVGLLHTTCGTPNYVAPEV 183

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           + ++GYDG+AADVWSCGVIL+VLMAGYLPF E DLPTLY+KINAAE+S PFWFS GA SL
Sbjct: 184 IGHQGYDGAAADVWSCGVILYVLMAGYLPFDEVDLPTLYRKINAAEYSSPFWFSPGAKSL 243

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           I KILDPNPKTRI+IEGI+KH WFRKNY PVK SEEEEVNLDDVHAVF DIE  YVAEQ+
Sbjct: 244 IDKILDPNPKTRIKIEGIKKHLWFRKNYMPVKQSEEEEVNLDDVHAVFGDIEDQYVAEQT 303

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           EN  GGPL+MNAFEMITLSQGLNL+ALFDR+QDY+KRQTRFVSR+PA+ I+S IEAVAES
Sbjct: 304 ENSEGGPLIMNAFEMITLSQGLNLSALFDRQQDYIKRQTRFVSRRPAKDIISTIEAVAES 363

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           +SLKVHTRNYKTRLEG+SANK G FAVVLEVFEVAPSLFMVDVRKA+GDTLEYHKFYK+F
Sbjct: 364 MSLKVHTRNYKTRLEGISANKAGHFAVVLEVFEVAPSLFMVDVRKASGDTLEYHKFYKDF 423

Query: 419 CAKLENIIWKPTEG---SSLLRTMSC 441
           C+KLE+IIW+P +G    +LLR+M+C
Sbjct: 424 CSKLEDIIWRPADGVNACNLLRSMTC 449

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224993594|gb|ACN76476.1| CBL-interacting protein kinase 26 [Populus euphratica]

 Score =  786 bits (2029), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/437 (85%), Positives = 405/437 (92%), Gaps = 2/437 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR+V KYEVGRTIGEGTFAKV+FAQNRETGESVAMK+L+KS ILKHRMVDQIKREI
Sbjct: 2   MKKVTRKVGKYEVGRTIGEGTFAKVKFAQNRETGESVAMKILSKSAILKHRMVDQIKREI 61

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMK+VRHP IVRLHEVLASRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLID
Sbjct: 62  SIMKLVRHPYIVRLHEVLASRTKIYIILEFVTGGELFDKIVHQGRLGENESRRYFQQLID 121

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSALPQ+GV LLHTTCGTPNYVAPEV
Sbjct: 122 AVAHCHCKGVYHRDLKPENLLLDAFGNLKVSDFGLSALPQKGVGLLHTTCGTPNYVAPEV 181

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L N+GYDG+AADVWSCGVILFVLMAGYLPF E DLPTLY+KINAAE+SCPFWFS GA +L
Sbjct: 182 LGNQGYDGAAADVWSCGVILFVLMAGYLPFEEADLPTLYRKINAAEYSCPFWFSPGAKAL 241

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           I KIL+PNP+TRI IEGI+KHPWF+KNY PV   E+EEVNLDDVHAVFDDIE  YVAEQ 
Sbjct: 242 IDKILNPNPRTRIGIEGIKKHPWFQKNYEPVGHREDEEVNLDDVHAVFDDIEDQYVAEQL 301

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           EN VGGPL+MNAFEMITLSQGLNL+ALFDRRQDY+KRQTRFVSR+PA+ I+S IEAVA S
Sbjct: 302 ENSVGGPLVMNAFEMITLSQGLNLSALFDRRQDYIKRQTRFVSRKPAEDIISTIEAVAGS 361

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           ++LKVHTRNYKTRLEGVS NK GQFAVVLEV+EVAPSLFMVD RKA+G+TLEYHKFYKNF
Sbjct: 362 MNLKVHTRNYKTRLEGVSENKAGQFAVVLEVYEVAPSLFMVDARKASGETLEYHKFYKNF 421

Query: 419 CAKLENIIWKPTEGSSL 435
           C KLENIIWKP EG+ L
Sbjct: 422 CTKLENIIWKPPEGAKL 438

Source: Populus euphratica

Species: Populus euphratica

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|229893775|gb|ACQ90245.1| serine/threonine protein kinase [Malus x domestica]

 Score =  778 bits (2008), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 374/445 (84%), Positives = 409/445 (91%), Gaps = 5/445 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK++R V KYEVGRTIGEGTFAKV+FA+N ETGESVAMKVLAKSTILKHRMVDQIKREI
Sbjct: 1   MKKKSRNVGKYEVGRTIGEGTFAKVKFARNCETGESVAMKVLAKSTILKHRMVDQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRL EVLA RTK++IILEFVTGGELFDKIVHQG+L EN+ R+YFQQLID
Sbjct: 61  SIMKIVRHPNIVRLLEVLAGRTKIFIILEFVTGGELFDKIVHQGKLPENESRKYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCHSKGVYHRDLKPENLLLD+YGNLKVSDFGLSALP QG  LLHTTCGTPNY+APEV
Sbjct: 121 AVAHCHSKGVYHRDLKPENLLLDAYGNLKVSDFGLSALPLQGDGLLHTTCGTPNYIAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDGSAAD+WSCGVILFVLMAGYLPF ET+L TLY+KIN A+FSCPFWFS  A  L
Sbjct: 181 LGDQGYDGSAADIWSCGVILFVLMAGYLPFDETNLSTLYRKINDADFSCPFWFSPEANKL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           IHKILDPNPKTRIRI+GIRK PWF+KNY P+   E+EEV+LDDV AVF+DIE  YVAE+S
Sbjct: 241 IHKILDPNPKTRIRIDGIRKDPWFKKNYAPLTYREDEEVSLDDVRAVFEDIEDQYVAERS 300

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           E K GGPLLMNAFEMITLSQGLNL+ALFDRRQDYV RQTRFVSR+PA VI+SN+EAVAES
Sbjct: 301 EIKDGGPLLMNAFEMITLSQGLNLSALFDRRQDYVNRQTRFVSRKPAHVIISNVEAVAES 360

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           + LKVHTRNYKTRLEG+SAN+TGQFAVVLEV+EVAPSLFMVDVRKAAGDTLEYHKFYKNF
Sbjct: 361 MGLKVHTRNYKTRLEGISANRTGQFAVVLEVYEVAPSLFMVDVRKAAGDTLEYHKFYKNF 420

Query: 419 CAKLENIIWKPTEG---SSLLRTMS 440
           CAKLE IIWKP EG   S+LL+TM+
Sbjct: 421 CAKLEEIIWKPKEGMGHSNLLKTMT 445

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142617|ref|XP_002324651.1| predicted protein [Populus trichocarpa] gi|116265968|gb|ABJ91232.1| CBL-interacting protein kinase 26 [Populus trichocarpa] gi|222866085|gb|EEF03216.1| predicted protein [Populus trichocarpa]

 Score =  778 bits (2008), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/437 (84%), Positives = 403/437 (92%), Gaps = 2/437 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR+V KYEVGRTIGEGTFAKV+FAQNRETGESVAMK+L+KS ILKHRMVDQIKREI
Sbjct: 2   MKKVTRKVGKYEVGRTIGEGTFAKVKFAQNRETGESVAMKILSKSAILKHRMVDQIKREI 61

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMK+VRHP IV LHEVLASRTK+YIILEFVTGGELFDKIVHQ RL EN+ RRYFQQLID
Sbjct: 62  SIMKLVRHPYIVMLHEVLASRTKIYIILEFVTGGELFDKIVHQRRLEENESRRYFQQLID 121

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSALPQ+GV LLHTTCGTPNYVAPEV
Sbjct: 122 AVAHCHCKGVYHRDLKPENLLLDAFGNLKVSDFGLSALPQKGVGLLHTTCGTPNYVAPEV 181

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDG+AADVWSCGVILFVLMAGYLPF ETDLPTLY+KINAAE+SCPFWFS GA +L
Sbjct: 182 LGHQGYDGAAADVWSCGVILFVLMAGYLPFEETDLPTLYRKINAAEYSCPFWFSPGAKAL 241

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           I KIL+PNPKTRI IEGI+KHPWF+KNY PV   E+EEVNLDDVHAVFDDIE  YVAEQ 
Sbjct: 242 IDKILNPNPKTRIGIEGIKKHPWFQKNYEPVGHREDEEVNLDDVHAVFDDIEDQYVAEQL 301

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           EN   GPL+MNAFEMITLSQGLNL+ALFDRRQDY+KRQTRFVSR+PA+ I+S IEAVAES
Sbjct: 302 ENSEDGPLVMNAFEMITLSQGLNLSALFDRRQDYIKRQTRFVSRKPAKDIISAIEAVAES 361

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           ++LKVHTRNYKTRLEGVS NK GQFAVVLEV+EVAPSLFMVD RKA+G+TLEYHKFYKNF
Sbjct: 362 MNLKVHTRNYKTRLEGVSENKAGQFAVVLEVYEVAPSLFMVDARKASGETLEYHKFYKNF 421

Query: 419 CAKLENIIWKPTEGSSL 435
           C KLENIIWKP EG+ L
Sbjct: 422 CTKLENIIWKPPEGAKL 438

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350535735|ref|NP_001234210.1| calcineurin B-like interacting protein kinase [Solanum lycopersicum] gi|66765941|emb|CAG30526.1| calcineurin B-like interacting protein kinase [Solanum lycopersicum] gi|149930452|gb|ABR37648.1| putative SOS2-like protein kinase [Solanum lycopersicum]

 Score =  759 bits (1961), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/445 (80%), Positives = 403/445 (90%), Gaps = 5/445 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK  R++ KYEVGRTIGEGTFAKV+FA+N ETGE+VA+KVLAKSTILKHRMV+QIKREI
Sbjct: 1   MKKVKRKLGKYEVGRTIGEGTFAKVKFARNTETGENVAIKVLAKSTILKHRMVEQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHP IVRLHEVLAS+TK+YI+ EFVTGGELFDKIVH GRL E++ RRYFQ+LID
Sbjct: 61  SIMKIVRHPCIVRLHEVLASQTKIYIVQEFVTGGELFDKIVHLGRLSEDEARRYFQELID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+AHCHSKGVYHRDLKPENLLLD  GNLK+SDFGLSALPQQGVELL+TTCGTPNYVAPEV
Sbjct: 121 AIAHCHSKGVYHRDLKPENLLLDFQGNLKISDFGLSALPQQGVELLYTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L NRGYDG+AADVWSCG+IL+VLMAGYLPF ETDLPTLY KI AAEFSCPFWFS GATSL
Sbjct: 181 LGNRGYDGAAADVWSCGIILYVLMAGYLPFDETDLPTLYTKIKAAEFSCPFWFSPGATSL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           I KI+DPNP+TRI+I+GI++ PWFRKNY  VK   +E VNLDD+HAVFDDIE  +V+E+S
Sbjct: 241 IQKIIDPNPQTRIKIDGIKRDPWFRKNYRAVKAKADEVVNLDDIHAVFDDIEDAFVSEKS 300

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           E+   GPL+MNAFEMITLSQGLNL+ALFDRRQDYVKRQTRF+SRQPA+V++  IEA AES
Sbjct: 301 EDSESGPLVMNAFEMITLSQGLNLSALFDRRQDYVKRQTRFISRQPAKVVIETIEAAAES 360

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           L LKVHTR+YKTR+EGV+AN+ GQFAVVLEVF+VAPSLFMVDVRKAAGDTLEYHKFYK F
Sbjct: 361 LGLKVHTRDYKTRIEGVTANRAGQFAVVLEVFQVAPSLFMVDVRKAAGDTLEYHKFYKTF 420

Query: 419 CAKLENIIWKPTEGSS---LLRTMS 440
           C K++++IWKP EG S   LLRT +
Sbjct: 421 CTKIDDVIWKPKEGMSNAVLLRTRT 445

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|310896475|gb|ADP37983.1| salt overly sensitive protein 2b [Gossypium hirsutum]

 Score =  759 bits (1961), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 364/446 (81%), Positives = 405/446 (90%), Gaps = 6/446 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M+K+T  V KYEVGRTIG+GTFAKV+FA+N  +GESVA+KVL K+TILKHRMVDQIKREI
Sbjct: 1   MRKKTATVGKYEVGRTIGQGTFAKVKFARNSVSGESVALKVLPKATILKHRMVDQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVLASRTK+YIILEF++GGELFDKIVH GRL EN+CRRYFQQLID
Sbjct: 61  SIMKIVRHPNIVRLHEVLASRTKIYIILEFISGGELFDKIVHCGRLPENECRRYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCHSKGVYHRDLKPENLLLDSYG+LKVSDFGLSAL QQGV LLHTTCGTPNYVAPEV
Sbjct: 121 AVAHCHSKGVYHRDLKPENLLLDSYGDLKVSDFGLSALLQQGVGLLHTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L N+GYDG+AAD+WSCGVILF +MAGYLPF E D+PTLYKKI+A +FS PFWFS  A SL
Sbjct: 181 LGNQGYDGAAADIWSCGVILFFIMAGYLPFYEIDIPTLYKKISAGQFSSPFWFSPEANSL 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           I KILDPNPKTRI+IEGI+KHPWF+KNY PVK S EEEVNLDDV AVFDDIE  YV+EQS
Sbjct: 241 IKKILDPNPKTRIQIEGIKKHPWFKKNYLPVKPS-EEEVNLDDVRAVFDDIEDQYVSEQS 299

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
             K GGPL+MNAFEMITLSQGLNL++LFDR+QDYVKRQTRFVSR+P + I+S++EAVAES
Sbjct: 300 VAKEGGPLMMNAFEMITLSQGLNLSSLFDRQQDYVKRQTRFVSRKPPRDIISSVEAVAES 359

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           + LKVHTRNYKTRLE +SANK G+FAVVLEVFEVAPSLFM DVRKA+GDTLEYHKFYKNF
Sbjct: 360 MGLKVHTRNYKTRLERISANKVGEFAVVLEVFEVAPSLFMADVRKASGDTLEYHKFYKNF 419

Query: 419 CAKLENIIWKPTE---GSSLLRTMSC 441
           C KLENIIWKPTE     S+LR+++C
Sbjct: 420 CTKLENIIWKPTEDVANPSVLRSLTC 445

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087128|ref|XP_002308077.1| predicted protein [Populus trichocarpa] gi|116265970|gb|ABJ91233.1| CBL-interacting protein kinase 27 [Populus trichocarpa] gi|222854053|gb|EEE91600.1| predicted protein [Populus trichocarpa]

 Score =  751 bits (1938), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 361/434 (83%), Positives = 392/434 (90%), Gaps = 7/434 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK TR V KYEVGRTIGEG FAKV+FAQNRETGESVAMK+LAKSTILKH+MVDQIKREI
Sbjct: 2   MKKVTRMVGKYEVGRTIGEGNFAKVKFAQNRETGESVAMKILAKSTILKHKMVDQIKREI 61

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVL+SRTK+YIILEFVTGGELFDKIVHQGRL EN+ RRYFQQLID
Sbjct: 62  SIMKIVRHPNIVRLHEVLSSRTKIYIILEFVTGGELFDKIVHQGRLSENESRRYFQQLID 121

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AVAHCH KGVYHRDLKPENLLLD++GNLKVSDFGLSAL Q+GV LLHTTCGTPNYVAPEV
Sbjct: 122 AVAHCHRKGVYHRDLKPENLLLDAFGNLKVSDFGLSALRQKGVGLLHTTCGTPNYVAPEV 181

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L ++GYDG+AADVWSCGVILFVLMAGYLPF E DLPTL +K     +SCPFWFS  A +L
Sbjct: 182 LGHQGYDGAAADVWSCGVILFVLMAGYLPFEEIDLPTLCRK-----YSCPFWFSPVAKAL 236

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           I KILDPNPKTRI IEGI+KHPWFRK+Y PV  SEEEEVNLDDVHAVFDDIE  YVAEQ 
Sbjct: 237 IDKILDPNPKTRIGIEGIKKHPWFRKSYEPVGHSEEEEVNLDDVHAVFDDIEDHYVAEQL 296

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           EN  GGPL+MNAFEMI LSQGLNL+ALFDRRQDYVK+QTRFVS +PA+VI+S  EAVAES
Sbjct: 297 ENSEGGPLVMNAFEMIALSQGLNLSALFDRRQDYVKKQTRFVSHKPAKVIISAFEAVAES 356

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           ++LK HT NYKTRLEG+S NK GQFAVVLEV+EV PSLFMVD RKA+G+TLEYH+FYKNF
Sbjct: 357 MNLKFHTHNYKTRLEGISENKAGQFAVVLEVYEVGPSLFMVDARKASGETLEYHEFYKNF 416

Query: 419 CAKLENIIWKPTEG 432
           CA+LENIIWKP EG
Sbjct: 417 CAQLENIIWKPPEG 430

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356563005|ref|XP_003549757.1| PREDICTED: CBL-interacting protein kinase 24-like isoform 1 [Glycine max]

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 348/432 (80%), Positives = 387/432 (89%), Gaps = 2/432 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MKK  R++ KYEVGRTIGEGTFAKV+FA+N ETGESVA+KV+AK+TIL+HRMV+QIKREI
Sbjct: 1   MKKVRRKIGKYEVGRTIGEGTFAKVKFARNSETGESVAIKVMAKTTILQHRMVEQIKREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           SIMKIVRHPNIVRLHEVLAS+TK+YIILEFV GGEL+DKIV  G+L EN+ R YFQQLID
Sbjct: 61  SIMKIVRHPNIVRLHEVLASQTKIYIILEFVMGGELYDKIVQLGKLSENESRHYFQQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AV HCH KGVYHRDLKPENLLLD+YGNLKVSDFGLSAL +QG +LLHTTCGTPNYVAPEV
Sbjct: 121 AVDHCHRKGVYHRDLKPENLLLDAYGNLKVSDFGLSALTKQGADLLHTTCGTPNYVAPEV 180

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           LSNRGYDG+AADVWSCGVIL+VLMAGYLPF E DLPTLY++INAAEF CPFWFS    S 
Sbjct: 181 LSNRGYDGAAADVWSCGVILYVLMAGYLPFEEADLPTLYRRINAAEFVCPFWFSADTKSF 240

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
           I KILDPNPKTR++IE IRK PWF+KNY PVK  E+E+VNLDDV AVFDDIE  YV+E+S
Sbjct: 241 IQKILDPNPKTRVKIEEIRKDPWFKKNYFPVKLGEDEQVNLDDVRAVFDDIEDQYVSERS 300

Query: 299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
           E   GGPL+MNAFEMI LSQGLNL+ LFDR QDYVKRQTRFVSR+PA+VI+S+IEAVAES
Sbjct: 301 EITEGGPLIMNAFEMIALSQGLNLSPLFDRHQDYVKRQTRFVSRKPAKVIISSIEAVAES 360

Query: 359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
           + LKVH+RNYK RLEGVSAN+ GQFAVVLEVFEVAPSLFMVDVRKA GDT +YHKFYKNF
Sbjct: 361 MGLKVHSRNYKVRLEGVSANRVGQFAVVLEVFEVAPSLFMVDVRKATGDTFDYHKFYKNF 420

Query: 419 CAKLENIIWKPT 430
           C KL NIIW+P 
Sbjct: 421 CGKLGNIIWRPA 432

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	441
TAIR|locus:2155233	446	SOS2 "SALT OVERLY SENSITIVE 2"	0.997	0.986	0.764	1.2e-184
TAIR|locus:2135962	445	CIPK8 "CBL-interacting protein	0.970	0.961	0.689	2.7e-162
TAIR|locus:2009812	482	CIPK23 "CBL-interacting protei	0.954	0.873	0.605	2.1e-139
TAIR|locus:1005716172	439	CIPK26 "calcineurin B-like pro	0.972	0.977	0.590	5.1e-138
TAIR|locus:2059279	451	CIPK3 "CBL-interacting protein	0.956	0.935	0.593	1.3e-137
TAIR|locus:2126749	441	SIP3 "SOS3-interacting protein	0.931	0.931	0.503	5.7e-107
TAIR|locus:2152380	439	CIPK20 "CBL-interacting protei	0.911	0.915	0.480	7.5e-105
TAIR|locus:2179260	488	CIPK25 "CBL-interacting protei	0.950	0.858	0.493	9.5e-105
TAIR|locus:2181047	421	CIPK15 "CBL-interacting protei	0.909	0.952	0.511	3.3e-102
TAIR|locus:2007685	432	CIPK17 "CBL-interacting protei	0.927	0.946	0.476	5.4e-102

TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1791 (635.5 bits), Expect = 1.2e-184, P = 1.2e-184
 Identities = 340/445 (76%), Positives = 393/445 (88%)

Query:     1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
             M K+ RRV KYEVGRTIGEGTFAKV+FA+N +TG++VA+K++AKSTILK+RMVDQIKREI
Sbjct:     1 MTKKMRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREI 60

Query:    61 SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
             SIMKIVRHPNIVRL+EVLAS +K+YI+LEFVTGGELFD+IVH+GRL E++ R+YFQQL+D
Sbjct:    61 SIMKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVD 120

Query:   121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
             AVAHCH KGVYHRDLKPENLLLD+ GNLKVSDFGLSALPQ+GVELL TTCGTPNYVAPEV
Sbjct:   121 AVAHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVELLRTTCGTPNYVAPEV 180

Query:   181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
             LS +GYDGSAAD+WSCGVILFV++AGYLPF ETDLP LY+KINAAEFSCP WFS     L
Sbjct:   181 LSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFL 240

Query:   241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
             IH+ILDPNPKTRI+I+GI+K PWFR NY P++  EEEEVNLDD+ AVFD IE  YVAE  
Sbjct:   241 IHRILDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENV 300

Query:   299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
             E    GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S
Sbjct:   301 ERNDEGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANS 360

Query:   359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
             +  K HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  
Sbjct:   361 MGFKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKL 420

Query:   419 CAKLENIIWKPTEG---SSLLRTMS 440
             C+KLENIIW+ TEG   S +LRT++
Sbjct:   421 CSKLENIIWRATEGIPKSEILRTIT 445

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042802 "identical protein binding" evidence=IPI

GO:0009705 "plant-type vacuole membrane" evidence=IDA

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1580 (561.2 bits), Expect = 2.7e-162, P = 2.7e-162
 Identities = 296/429 (68%), Positives = 359/429 (83%)

Query:     6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
             R+V KYE+GRTIGEGTFAKV+FAQN ETGESVAMK++ +STI+K +MVDQIKREISIMK+
Sbjct:     4 RKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKL 63

Query:    66 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             VRHP +VRL+EVLASRTK+YIILE++TGGELFDKIV  GRL E++ R+YF QLID V +C
Sbjct:    64 VRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYC 123

Query:   126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
             HSKGVYHRDLKPENLLLDS GNLK+SDFGLSALP+QGV +L TTCGTPNYVAPEVLS++G
Sbjct:   124 HSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQGVTILKTTCGTPNYVAPEVLSHKG 183

Query:   186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
             Y+G+ AD+WSCGVIL+VLMAGYLPF E DLPTLY KI+ AEFSCP +F+ GA SLI++IL
Sbjct:   184 YNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRIL 243

Query:   246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE-YVAEQSENKVGG 304
             DPNP+TRI I  IRK  WF K+Y PV+  + E VNLDDV+A FDD E     Q   +  G
Sbjct:   244 DPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDTG 303

Query:   305 PLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVH 364
             PL +NAF++I LSQGLNLA LFDR +D +K QTRF+S +PA V+LS++E V++S+  K H
Sbjct:   304 PLTLNAFDLIILSQGLNLATLFDRGKDSMKHQTRFISHKPANVVLSSMEVVSQSMGFKTH 363

Query:   365 TRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLEN 424
              RNYK R+EG+SANKT  F+V+LEVF+VAPS+ MVD++ AAGD  EY KFYK FC+KL++
Sbjct:   364 IRNYKMRVEGLSANKTSHFSVILEVFKVAPSILMVDIQNAAGDAEEYLKFYKTFCSKLDD 423

Query:   425 IIWKPTEGS 433
             IIWKP + S
Sbjct:   424 IIWKPPDAS 432

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=TAS

GO:0010167 "response to nitrate" evidence=IEP;IMP

GO:0048364 "root development" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 1364 (485.2 bits), Expect = 2.1e-139, P = 2.1e-139
 Identities = 259/428 (60%), Positives = 332/428 (77%)

Query:     7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
             RV KYE+GRT+GEGTFAKV+FA+N E G++VA+KV+ K  +LK++M+ QIKREIS MK++
Sbjct:    27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86

Query:    67 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             +HPN++R+ EV+AS+TK+Y +LEFVTGGELFDKI   GRL E++ R+YFQQLI+AV +CH
Sbjct:    87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146

Query:   127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNR 184
             S+GVYHRDLKPENLLLD+ G LKVSDFGLSALPQQ  E  LLHTTCGTPNYVAPEV++N+
Sbjct:   147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206

Query:   185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
             GYDG+ AD+WSCGVILFVLMAGYLPF +++L +LYKKI  AEF+CP WFS  A  LI +I
Sbjct:   207 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRI 266

Query:   245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDI----EYVAEQSEN 300
             LDPNP TRI    + ++ WF+K Y   K  E  +V+LDDV A+FDD       V E+ E 
Sbjct:   267 LDPNPATRITFAEVIENEWFKKGYKAPKF-ENADVSLDDVDAIFDDSGESKNLVVERREE 325

Query:   301 KVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS 360
              +  P+ MNAFE+I+ SQGLNL +LF+++   VKR+TRF S+  A  I++ IEA A  + 
Sbjct:   326 GLKTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRFTSKSSANEIVTKIEAAAAPMG 385

Query:   361 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 420
               V T NYK +L G  + + GQ AV  EVF+VAPSL+MV++RK+ GDTLE+HKFYKN   
Sbjct:   386 FDVKTNNYKMKLTGEKSGRKGQLAVATEVFQVAPSLYMVEMRKSGGDTLEFHKFYKNLTT 445

Query:   421 KLENIIWK 428
              L++I+WK
Sbjct:   446 GLKDIVWK 453

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IPI

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0010107 "potassium ion import" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007584 "response to nutrient" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA;IMP

GO:0009536 "plastid" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 1351 (480.6 bits), Expect = 5.1e-138, P = 5.1e-138
 Identities = 258/437 (59%), Positives = 327/437 (74%)

Query:     3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
             K  RRV KYEVG+T+G+GTFAKVR A N ETGE VA+K+L K  +LKH+M +QI+REI  
Sbjct:     5 KVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICT 64

Query:    63 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
             MK++ HPN+VRL+EVLAS+TK+YI+LEF TGGELFDKIVH GRL E + R+YFQQLI+AV
Sbjct:    65 MKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAV 124

Query:   123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV 180
              +CHS+GVYHRDLKPENLLLD+ GNLKVSDFGLSAL +Q  G  LLHT CGTPNY APEV
Sbjct:   125 DYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEV 184

Query:   181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
             L+++GYDG+ AD+WSCGVILFVL+AGYLPF +++L TLYKKI A E+ CP W S GA +L
Sbjct:   185 LNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNL 244

Query:   241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQS 298
             I +ILDPNP TRI I  +    WF+KNY P    E+EE NLDDV AVF D E  +V E+ 
Sbjct:   245 IVRILDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKK 304

Query:   299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
             E +   P  MNAFE+I++S+ L+L  LF+  + + KR+TRF ++  A  ++  IE  ++ 
Sbjct:   305 EEQ---PTSMNAFELISMSRALDLGNLFEEEEGF-KRETRFAAKGAANDLVQKIEEASKP 360

Query:   359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNF 418
             L   +  +NYK RLE V+A + G   V  E+F+V+PSL M++VRK  GDTLE+HKFYK  
Sbjct:   361 LGFDIQKKNYKMRLENVTAGRKGNLRVATEIFQVSPSLHMIEVRKTKGDTLEFHKFYKKL 420

Query:   419 CAKLENIIWKPTEGSSL 435
                L +++WK  E S L
Sbjct:   421 STSLNDVVWKSGESSGL 437

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1347 (479.2 bits), Expect = 1.3e-137, P = 1.3e-137
 Identities = 255/430 (59%), Positives = 328/430 (76%)

Query:     6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
             RRV KYEVGRTIGEGTFAKV+FA+N ETGE VA+K+L K  +LKH+M +QI+REI+ MK+
Sbjct:    19 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIATMKL 78

Query:    66 VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             ++HPN+V+L+EV+AS+TK++IILE+VTGGELFDKIV+ GR+ E++ RRYFQQLI AV +C
Sbjct:    79 IKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAVDYC 138

Query:   126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSN 183
             HS+GVYHRDLKPENLLLDSYGNLK+SDFGLSAL QQ  +  LLHT+CGTPNYVAPEVL++
Sbjct:   139 HSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEVLND 198

Query:   184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 243
             RGYDG+ AD+WSCGV+L+VL+AGYLPF +++L  LYKKI++ EF+CP W S GA  LI +
Sbjct:   199 RGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKLITR 258

Query:   244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE--YVAEQSENK 301
             ILDPNP TR+  + + +  WF+K+Y P    E ++ N+DD+ AVF D E   V E+ E +
Sbjct:   259 ILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTEKREEQ 318

Query:   302 VGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSL 361
                P  +NAFE+I++S+GLNL  LFD  Q++ KR+TR   R  A  I+  IE  A+ L  
Sbjct:   319 ---PAAINAFEIISMSRGLNLENLFDPEQEF-KRETRITLRGGANEIIEKIEEAAKPLGF 374

Query:   362 KVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAK 421
              V  +NYK RLE V A + G   V  E+F+VAPSL MV V K+ GDTLE+HKFYK     
Sbjct:   375 DVQKKNYKMRLENVKAGRKGNLNVATEIFQVAPSLHMVQVSKSKGDTLEFHKFYKKLSNS 434

Query:   422 LENIIWKPTE 431
             LE ++W   E
Sbjct:   435 LEQVVWTNNE 444

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=IEP

TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1058 (377.5 bits), Expect = 5.7e-107, P = 5.7e-107
 Identities = 215/427 (50%), Positives = 288/427 (67%)

Query:    10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             +YE+GR +G GTFAKV  A+N +TG+SVAMKV+ K  ++K  MVDQIKREIS+M++V+HP
Sbjct:    23 RYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKHP 82

Query:    70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
             NIV LHEV+AS++K+Y  +E V GGELF K+  +GRL E+  R YFQQLI AV  CHS+G
Sbjct:    83 NIVELHEVMASKSKIYFAMELVRGGELFAKVA-KGRLREDVARVYFQQLISAVDFCHSRG 141

Query:   130 VYHRDLKPENLLLDSYGNLKVSDFGLSA----LPQQGVELLHTTCGTPNYVAPEVLSNRG 185
             VYHRDLKPENLLLD  GNLKV+DFGLSA    L Q G  LLHTTCGTP YVAPEV+  +G
Sbjct:   142 VYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDG--LLHTTCGTPAYVAPEVILKKG 199

Query:   186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
             YDG+ AD+WSCGVILFVL+AGYLPF + +L  +Y+KI   +F CP W S+ A  L+ K+L
Sbjct:   200 YDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLL 259

Query:   246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGP 305
             DPNP TRI IE +   PWF+K       S  E V    +    +D++++  +S+ +    
Sbjct:   260 DPNPNTRITIEKVMDSPWFKKQATR---SRNEPVAAT-ITTTEEDVDFLVHKSKEETE-- 313

Query:   306 LLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAE-SLSLKVH 364
               +NAF +I LS+G +L+ LF+ ++   KR+ RF + +PA  ++S++E  A       V 
Sbjct:   314 -TLNAFHIIALSEGFDLSPLFEEKKKEEKREMRFATSRPASSVISSLEEAARVGNKFDVR 372

Query:   365 TRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAK-LE 423
                 + R+EG    + G+ AV  E+F VAPS  +V+V+K  GDTLEY+ F        L+
Sbjct:   373 KSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKKDHGDTLEYNNFCSTALRPALK 432

Query:   424 NIIWKPT 430
             +I W  T
Sbjct:   433 DIFWTST 439

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0007275 "multicellular organismal development" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0010540 "basipetal auxin transport" evidence=IMP

GO:0042538 "hyperosmotic salinity response" evidence=IDA

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 1038 (370.5 bits), Expect = 7.5e-105, P = 7.5e-105
 Identities = 206/429 (48%), Positives = 297/429 (69%)

Query:    10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             KYE+GR +G+GTFAKV  A+N +TGESVA+KV+ K  + K  ++DQIKREIS+M++VRHP
Sbjct:    11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70

Query:    70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
             ++V LHEV+AS+TK+Y  +E+V GGELFDK V +G+L EN  R+YFQQLI A+ +CHS+G
Sbjct:    71 HVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAIDYCHSRG 129

Query:   130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYD 187
             VYHRDLKPENLLLD  G+LK+SDFGLSAL +   +  LLHTTCGTP YVAPEV+  +GYD
Sbjct:   130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189

Query:   188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
             G+ ADVWSCGV+L+VL+AG+LPF E +L  +Y+KI   EF CP WF      L+ +ILDP
Sbjct:   190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249

Query:   248 NPKTRIRIEGIRKHPWFRKNYNPV---KCSEEEEVN--LDDVHAVFDDIEYVAEQSENKV 302
             NP +RI+IE I ++ WF+K +  +   K  E  +++  + DVHA F  ++          
Sbjct:   250 NPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFS-VK---------- 298

Query:   303 GGPLLMNAFEMIT-LSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLS- 360
               P+  NAF++I+ LSQG +L+ LF++ +   + +++F +++ A+ I+S  E +A S   
Sbjct:   299 --PMSYNAFDLISSLSQGFDLSGLFEKEE---RSESKFTTKKDAKEIVSKFEEIATSSER 353

Query:   361 LKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFY-KNFC 419
               +   +   ++E     + G  A+ +E+FEV  S  MV+ +K+ GDT+EY +F  +   
Sbjct:   354 FNLTKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKSGGDTMEYKQFCDRELR 413

Query:   420 AKLENIIWK 428
               L++I+WK
Sbjct:   414 PSLKDIVWK 422

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0005829 "cytosol" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

TAIR|locus:2179260 CIPK25 "CBL-interacting protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
 Identities = 215/436 (49%), Positives = 300/436 (68%)

Query:     2 KKQTRRV--AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
             ++Q  RV  AKYE+GR +G+GTF KV + +   TGESVA+K++ K  + +  M++QIKRE
Sbjct:    32 EQQQLRVLFAKYEMGRLLGKGTFGKVYYGKEITTGESVAIKIINKDQVKREGMMEQIKRE 91

Query:    60 ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
             ISIM++VRHPNIV L EV+A++TK++ I+E+V GGELF KIV +G+L E+  R+YFQQLI
Sbjct:    92 ISIMRLVRHPNIVELKEVMATKTKIFFIMEYVKGGELFSKIV-KGKLKEDSARKYFQQLI 150

Query:   120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVA 177
              AV  CHS+GV HRDLKPENLL+D  G+LKVSDFGLSALP+Q ++  LLHT CGTP YVA
Sbjct:   151 SAVDFCHSRGVSHRDLKPENLLVDENGDLKVSDFGLSALPEQILQDGLLHTQCGTPAYVA 210

Query:   178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 237
             PEVL  +GYDG+  D+WSCG+IL+VL+AG+LPF + +L  +Y+KI  +EF  P WFS  +
Sbjct:   211 PEVLRKKGYDGAKGDIWSCGIILYVLLAGFLPFQDENLMKMYRKIFKSEFEYPPWFSPES 270

Query:   238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PV--KCSEEEEVNLDDVHAVFDDIEYV 294
               LI K+L  +P  RI I  I + PWFRKN N P+  K  E E  N++D           
Sbjct:   271 KRLISKLLVVDPNKRISIPAIMRTPWFRKNINSPIEFKIDELEIQNVEDETPT--TTATT 328

Query:   295 AEQSENKVGGPLLMNAFEMIT-LSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIE 353
             A  +   V  P   NAFE I+ +S G +L++LF+ ++   K ++ F SR  A  I+  +E
Sbjct:   329 ATTTTTPVS-PKFFNAFEFISSMSSGFDLSSLFESKR---KLRSMFTSRWSASEIMGKLE 384

Query:   354 AVAESLSLKV-HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYH 412
              + + +++KV  T+++K +L G +  + GQ AV  EVFEVAP + +V++ K+AGDTLEY+
Sbjct:   385 GIGKEMNMKVKRTKDFKVKLFGKTEGRKGQIAVTAEVFEVAPEVAVVELCKSAGDTLEYN 444

Query:   413 KFYKNFCAK-LENIIW 427
             + Y+      LE I+W
Sbjct:   445 RLYEEHVRPALEEIVW 460

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0050832 "defense response to fungus" evidence=IEP

TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 1013 (361.7 bits), Expect = 3.3e-102, P = 3.3e-102
 Identities = 214/418 (51%), Positives = 287/418 (68%)

Query:     2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
             KK +  + +YEVG+ +G+GTFAKV  A++ +TG+SVA+KV+ K  ILK  M +QIKREIS
Sbjct:     3 KKGSVLMLRYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKREIS 62

Query:    62 IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
              M+++RHPNIV LHEV+A+++K+Y ++E V GGELF+K V  G+L E+  R+YFQQL+ A
Sbjct:    63 AMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNK-VSTGKLREDVARKYFQQLVRA 121

Query:   122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPE 179
             V  CHS+GV HRDLKPENLLLD +GNLK+SDFGLSAL     +  LLHTTCGTP YVAPE
Sbjct:   122 VDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAPE 181

Query:   180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
             V+S  GYDG  ADVWSCGVILFVL+AGYLPF +++L  LYKKI  AE   P W + GA  
Sbjct:   182 VISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAKR 241

Query:   240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDDIEYVAEQS 298
             L+ +ILDPNP TR+  E I K  WFRK     VK S EEE  +D   A   +    AE+ 
Sbjct:   242 LLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVD-AEA---EGNASAEKE 297

Query:   299 ENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAES 358
             + +    + +NAFE+I+LS G +L+ LF++ ++  K + RF S + A  I   +  + + 
Sbjct:   298 KKRC---INLNAFEIISLSTGFDLSGLFEKGEE--KEEMRFTSNREASEITEKLVEIGKD 352

Query:   359 LSLKVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYK 416
             L +KV  + ++ R++ +SA  T    V  EVFE+APS  MV ++K+ GDT EY +  K
Sbjct:   353 LKMKVRKKEHEWRVK-MSAEAT---VVEAEVFEIAPSYHMVVLKKSGGDTAEYKRVMK 406

GO:0004672 "protein kinase activity" evidence=IEA;ISS;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0009788 "negative regulation of abscisic acid mediated signaling pathway" evidence=IMP

TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1011 (360.9 bits), Expect = 5.4e-102, P = 5.4e-102
 Identities = 201/422 (47%), Positives = 289/422 (68%)

Query:     7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
             RV KYE+GRT+GEG  AKV+FA +  TGES A+K++ KS I +  +  QIKREI  +K++
Sbjct:     7 RVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTLKVL 66

Query:    67 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             +HPNIVRLHEVLAS+TK+Y++LE VTGG+LFD+IV +G+L E   R+ FQQLID V++CH
Sbjct:    67 KHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVSYCH 126

Query:   127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNR 184
             +KGV+HRDLK EN+LLD+ G++K++DFGLSAL Q   E  LLHTTCG+PNYVAPEVL+N 
Sbjct:   127 NKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVLANE 186

Query:   185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
             GYDG+A+D+WSCGVIL+V++ G LPF + +L  + +KI   +   P W S GA ++I ++
Sbjct:   187 GYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMIKRM 246

Query:   245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKV-G 303
             LDPNP TR+ I GI+ H WF+ +Y P    ++     DDV+ + +D+  + E  E K   
Sbjct:   247 LDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDD-----DDVYLIQEDVFMMKEYEEEKSPD 301

Query:   304 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSL-- 361
              P ++NAF++I +S  L+L+  F+  +   +RQ RF S   A+ +L NIE +   +    
Sbjct:   302 SPTIINAFQLIGMSSFLDLSGFFETEK-LSERQIRFTSNSLAKDLLENIETIFTEMGFCL 360

Query:   362 -KVHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCA 420
              K H +    + E     + G  +V  EVFE++PSL +V++RK+ GD+  Y + Y+    
Sbjct:   361 QKKHAKLKAIKEESTQKRQCG-LSVTAEVFEISPSLNVVELRKSHGDSSLYKQLYERLLN 419

Query:   421 KL 422
             +L
Sbjct:   420 EL 421

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q5JLD8	CIPK8_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7039	0.9705	0.9596	no	no
Q69Q47	CIPKO_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7437	0.9886	0.9624	yes	no
Q9LDI3	CIPKO_ARATH	2, ., 7, ., 1, 1, ., 1	0.7640	0.9977	0.9865	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: CIPK09 SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (446 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	441
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-106
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-91
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-78
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-75
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-70
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-66
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-66
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-62
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-62
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-62
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-61
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-54
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-54
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-54
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-53
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-53
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-51
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-51
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-51
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-50
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-49
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-49
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-49
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-49
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-49
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-48
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-47
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-47
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-47
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-46
cd12195	116	cd12195, CIPK_C, C-terminal regulatory domain of C	2e-45
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-45
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-44
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-44
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-44
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-44
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-44
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-43
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-43
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-43
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-43
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-43
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-43
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-42
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-42
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-42
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-42
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-42
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-42
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-41
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-41
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-40
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-40
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-39
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-39
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-39
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-39
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-39
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-38
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-38
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-38
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-38
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-38
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-38
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-37
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-37
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-37
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-37
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-37
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-37
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-37
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-36
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-36
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-36
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-36
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-36
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-36
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-35
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-35
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-35
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-35
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-34
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-34
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-34
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-33
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-33
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-33
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-33
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-33
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-33
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-33
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-33
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	9e-33
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-33
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-32
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-32
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-32
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-31
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-31
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-30
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-30
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-30
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-30
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-30
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-30
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-30
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-30
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-29
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-29
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-29
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-29
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-29
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-29
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-29
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-28
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-28
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-28
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-28
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-28
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-28
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-28
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-27
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-27
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-27
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-27
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-27
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-27
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-27
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-27
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-26
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-26
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-26
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-26
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-26
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-25
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-25
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-25
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-24
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-24
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-24
pfam03822	58	pfam03822, NAF, NAF domain	3e-24
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-24
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-24
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-24
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-23
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-23
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-23
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-23
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-23
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-22
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-22
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-22
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-22
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-22
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-22
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-22
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-21
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-21
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-21
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-20
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-20
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-20
cd12120	95	cd12120, AMPKA_C_like, C-terminal regulatory domai	4e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-19
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-19
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-17
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-17
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-17
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-16
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-16
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-15
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-14
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	9e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-08
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	8e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-07
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-06
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.003
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  313 bits (805), Expect = e-106
 Identities = 116/258 (44%), Positives = 169/258 (65%), Gaps = 8/258 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+   +GEG+F KV  A++++TG+ VA+KV+ K  I K R  ++I REI I+K ++HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IVRL++V     K+Y+++E+  GG+LFD +  +GRL E++ R Y +Q++ A+ + HSKG+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRDLKPEN+LLD  G++K++DFGL+     G E L T  GTP Y+APEVL  +GY   A
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLGKGYGK-A 176

Query: 191 ADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILD 246
            D+WS GVIL+ L+ G  PF G+  L  L+KKI   +   P      S  A  LI K+L 
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236

Query: 247 PNPKTRIRIEGIRKHPWF 264
            +P+ R+  E   +HP+F
Sbjct: 237 KDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  275 bits (705), Expect = 9e-91
 Identities = 101/261 (38%), Positives = 149/261 (57%), Gaps = 8/261 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+ R +G G+F  V  A+++ TG+ VA+K+L K +  K +     +REI I++ + HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IVRL +    +  +Y+++E+  GG+LFD +   G L E++ ++   Q++  + + HS G+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRDLKPEN+LLD  G +K++DFGL+    +    L T  GTP Y+APEVL      G  
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----EFSCPFWFSTG--ATSLIHK 243
            DVWS GVIL+ L+ G  PF   ++    + I        EF  P W S    A  LI K
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 244 ILDPNPKTRIRIEGIRKHPWF 264
            L+ +P  R   E I +HPWF
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  243 bits (624), Expect = 1e-78
 Identities = 99/251 (39%), Positives = 149/251 (59%), Gaps = 4/251 (1%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G+F KV   + ++TG+  AMKVL K  I+K + V+    E +I+  + HP IV+LH 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
              +  K+Y++LE+  GGELF  +  +GR  E   R Y  +++ A+ + HS G+ +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           PEN+LLD+ G++K++DFGL+          +T CGTP Y+APEVL  +GY G A D WS 
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSL 179

Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI--- 253
           GV+L+ ++ G  PF   D   +Y+KI       P + S  A  LI  +L  +P  R+   
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239

Query: 254 RIEGIRKHPWF 264
             E I+ HP+F
Sbjct: 240 GAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  237 bits (607), Expect = 1e-75
 Identities = 92/260 (35%), Positives = 157/260 (60%), Gaps = 9/260 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  +T+G G+F +V   +++ +G+  A+K+L+K+ I+K + V+ +  E  I++ +RHP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V L+      + +Y+++E+V GGELF  +   GR  E   R Y  Q++ A+ + HS  +
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPENLLLDS G +K++DFG +   +      +T CGTP Y+APE++ ++GY G A
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT---YTLCGTPEYLAPEIILSKGY-GKA 178

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W+ G++++ ++AGY PF + +   +Y+KI   +   P +FS  A  LI  +L  +  
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238

Query: 251 TRI-----RIEGIRKHPWFR 265
            R+      +  I+ HPWF 
Sbjct: 239 KRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  220 bits (562), Expect = 6e-70
 Identities = 89/248 (35%), Positives = 138/248 (55%), Gaps = 35/248 (14%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +GEG F  V  A++++TG+ VA+K++         +++++ REI I+K + HPNIV+L+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 77  VLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
           V      +Y+++E+  GG L D +  ++G+L E++  R   Q+++ + + HS G+ HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 136 KPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           KPEN+LLDS  G +K++DFGLS L      LL T  GTP Y+APEVL  +GY    +D+W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR 254
           S GVIL+             LP L                     LI K+L  +P+ R  
Sbjct: 179 SLGVILYE------------LPELKD-------------------LIRKMLQKDPEKRPS 207

Query: 255 IEGIRKHP 262
            + I +H 
Sbjct: 208 AKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  212 bits (542), Expect = 3e-66
 Identities = 91/259 (35%), Positives = 141/259 (54%), Gaps = 15/259 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G F +V   + +    + A+K + K  I++    + I  E  I++   HP IV+L+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
               +  +Y+++E+  GGEL+  +  +G   E   R Y   ++ A  + H++G+ +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           PENLLLDS G +K+ DFG  A   +  +   T CGTP YVAPE++ N+GYD  + D WS 
Sbjct: 121 PENLLLDSNGYVKLVDFG-FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWSL 178

Query: 197 GVILFVLMAGYLPFGETDLPTL--YKKINAA----EFSCPFWFSTGATSLIHKILDPNPK 250
           G++L+ L+ G  PFGE D   +  Y  I       EF  P +    A  LI ++L  NP+
Sbjct: 179 GILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRNPE 236

Query: 251 TRI-----RIEGIRKHPWF 264
            R+      I+ I+KH WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  211 bits (540), Expect = 9e-66
 Identities = 89/280 (31%), Positives = 149/280 (53%), Gaps = 28/280 (10%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE-ISIMKIVRHP 69
           ++ G+ IGEG+F+ V  A+ +ET +  A+K+L K  ++K + V  +K E   + ++  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            I++L+        +Y +LE+   GEL   I   G L E   R Y  +++ A+ + HSKG
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFG--------LSALPQQGVELLHTT------------ 169
           + HRDLKPEN+LLD   ++K++DFG         S    +G      +            
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFS 228
            GT  YV+PE+L+     G ++D+W+ G I++ ++ G  PF G  +  T ++KI   E+S
Sbjct: 183 VGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKILKLEYS 240

Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWF 264
            P  F   A  LI K+L  +P+ R+ +    + ++ HP+F
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  202 bits (517), Expect = 1e-62
 Identities = 83/256 (32%), Positives = 140/256 (54%), Gaps = 11/256 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVR 67
           KYE+ + IG+G+F KV   + +  G+   +K   L+  +  K R  +    E+ I+K + 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KER--EDALNEVKILKKLN 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI---VHQGRLL-ENDCRRYFQQLIDAVA 123
           HPNI++ +E    + K+ I++E+  GG+L  KI     +G+   E     +F QL  A+ 
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           + HS+ + HRD+KP+N+ L S G +K+ DFG+S +    V+L  T  GTP Y++PE+  N
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIH 242
           + Y+   +D+WS G +L+ L     PF   +L  L  KI   ++   P  +S+   +L+ 
Sbjct: 178 KPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236

Query: 243 KILDPNPKTRIRIEGI 258
            +L  +P+ R  I  I
Sbjct: 237 SLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  203 bits (519), Expect = 5e-62
 Identities = 100/264 (37%), Positives = 156/264 (59%), Gaps = 9/264 (3%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +++ +E+G T+G G+F +VR A+++ TGE  A+K L K  ILK + V  + +E SI+  +
Sbjct: 16  KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP IV +        +VY +LEFV GGELF  +   GR   +  + Y  +L+ A  + H
Sbjct: 76  SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           SK + +RDLKPENLLLD+ G++KV+DFG +   ++  +   T CGTP Y+APEV+ ++G+
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCGTPEYLAPEVIQSKGH 192

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G A D W+ GV+L+  +AGY PF +     +Y+KI A     P WF   A  L+  +L 
Sbjct: 193 -GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQ 251

Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +   R+      +  ++ HP+F 
Sbjct: 252 TDHTKRLGTLKGGVADVKNHPYFH 275

Length = 329

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  201 bits (513), Expect = 6e-62
 Identities = 85/261 (32%), Positives = 146/261 (55%), Gaps = 14/261 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           I +G + +V  A+ + TG+  A+KV+ K+ +++   VDQ+  E  I+   + P +V+L+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
               +  +Y+++E++ GG+L   + + G L E+  R Y  +++ A+ + HS G+ HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELL--------HTTCGTPNYVAPEVLSNRGYDG 188
           P+N+L+DS G+LK++DFGLS +     ++             GTP+Y+APEV+  +G+  
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--FWFSTGATSLIHKILD 246
              D WS G IL+  + G  PF       +++ I   +   P     S  A  LI K+L 
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239

Query: 247 PNPKTRI---RIEGIRKHPWF 264
           P+P+ R+    IE I+ HP+F
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  198 bits (505), Expect = 8e-61
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++  G  +G G+F  V  A +++TGE +A+K + + +      ++ ++REI I+  ++HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-ELSGDSEEELEALEREIRILSSLQHP 59

Query: 70  NIVRL--HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIVR    E    +  + I LE+V+GG L   +   G+L E   R+Y +Q+++ +A+ HS
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRG 185
            G+ HRD+K  N+L+DS G +K++DFG +         E   +  GTP ++APEV+    
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPF--WFSTGATSLIH 242
           Y G AAD+WS G  +  +  G  P+ E  +      KI ++          S  A   + 
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238

Query: 243 KILDPNPKTRIRIEGIRKHPWF 264
           K L  +PK R   + + +HP+ 
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  184 bits (468), Expect = 1e-54
 Identities = 99/258 (38%), Positives = 149/258 (57%), Gaps = 10/258 (3%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + +G+G+F KV   R     + G+  AMKVL K+T LK R   + K E  I+  V HP I
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT-LKVRDRVRTKMERDILAEVNHPFI 60

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           V+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H HS G+ 
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ RG+   +A
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSA 179

Query: 192 DVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           D WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +   NP  
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN 239

Query: 252 RI-----RIEGIRKHPWF 264
           R+      +E I++HP+F
Sbjct: 240 RLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  185 bits (469), Expect = 3e-54
 Identities = 105/387 (27%), Positives = 169/387 (43%), Gaps = 29/387 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y + R +GEG+F +V  A++R+    VA+KVLAK    K + V++  REI I+  + HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 70  -NIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHC 125
            NIV+L++       +Y+++E+V GG L D +     +G L E++      Q++ A+ + 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 126 HSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSAL------PQQGVELLHTTCGTPNYVAP 178
           HSKG+ HRD+KPEN+LLD  G  +K+ DFGL+ L            L  T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 179 EVLS--NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEF----- 227
           EVL   +  Y  S++D+WS G+ L+ L+ G  PF      +      K I          
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 228 ----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDD 283
               S P   S  A+ L+ K+L  +PK R+       H              +     D 
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQ 343
                     +     +     +  +  ++   +    LA        +        +  
Sbjct: 298 APLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTAS 357

Query: 344 PAQVILSNIEAVAESLSLKVHTRNYKT 370
             +  L  I A +   SL   +R   +
Sbjct: 358 SKRSSLPKISARSSPSSLSSSSRQQAS 384

Length = 384

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  182 bits (463), Expect = 3e-54
 Identities = 86/271 (31%), Positives = 154/271 (56%), Gaps = 14/271 (5%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
              E  +T+G GTF +V   ++R +    A+KV+A   +++ +    +  E  ++K V H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           P I+RL      +  +Y+++E+V GGELF  + + GR   +    Y  +++ A+ + HSK
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + +RDLKPEN+LLD  G++K++DFG +   ++  +   T CGTP Y+APEV+ ++G+  
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVIQSKGH-N 176

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W+ G++++ ++ GY PF + +   +Y+KI A +   P      A  LI K+L   
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV-V 235

Query: 249 PKTRIRI-------EGIRKHPWFRK-NYNPV 271
            +TR R+       + ++ H WF+  +++ V
Sbjct: 236 DRTR-RLGNMKNGADDVKNHRWFKSVDWDDV 265

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  181 bits (460), Expect = 2e-53
 Identities = 96/281 (34%), Positives = 155/281 (55%), Gaps = 22/281 (7%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRM-VDQIKREISIMKIVRHPN 70
           + +G+G + KV   R     +TG+  AMKVL K+TI++++      K E +I++ V+HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L     +  K+Y+ILE+++GGELF  +  +G  +E+    Y  ++  A+ H H +G+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD+ G++K++DFGL         + HT CGT  Y+APE+L   G+ G A
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKA 180

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L  NP 
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS 240

Query: 251 TRI-----RIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHA 286
           +R+         ++ HP+FR             VN DD+ A
Sbjct: 241 SRLGAGPGDAAEVQSHPFFR------------HVNWDDLLA 269

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  177 bits (451), Expect = 7e-53
 Identities = 80/260 (30%), Positives = 139/260 (53%), Gaps = 9/260 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ R IG+G F KV   Q R+T +  AMK + K   ++   V  +  E  I++ + HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V L         +Y++++ + GG+L   +  + +  E   + +  +++ A+ + HSKG+
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KP+N+LLD  G++ ++DF ++        L  +T GTP Y+APEVL  +GY   A
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAPEVLCRQGY-SVA 179

Query: 191 ADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D WS GV  +  + G  P+ G +         K+  A       W ST A   I+K+L+
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATW-STEAIDAINKLLE 238

Query: 247 PNPKTRI--RIEGIRKHPWF 264
            +P+ R+   ++ ++ HP+F
Sbjct: 239 RDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  176 bits (448), Expect = 1e-51
 Identities = 91/260 (35%), Positives = 150/260 (57%), Gaps = 13/260 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
           + +G+G+F KV  A+ + T E  A+KVL K  IL+   V+    E  ++ +  +HP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    ++ +++ ++E+V GG+L   I   GR  E   R Y  +++  +   H +G+ +R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLK +N+LLDS G++K++DFG+    ++G+    TT   CGTP+Y+APE+LS + Y G A
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC---KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPA 176

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W+ GV+L+ ++AG  PF   D   L++ I   E   P W S  A S++   L  NP+
Sbjct: 177 VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPE 236

Query: 251 TRIRI-----EGIRKHPWFR 265
            R+       + I+ HP+FR
Sbjct: 237 KRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 8e-51
 Identities = 89/253 (35%), Positives = 138/253 (54%), Gaps = 4/253 (1%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F KV   + R+T    A+K + K+ I+    V     E +++  V  P IV L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
              S  K+Y++L F+ GGELF  +  +GR   +  R Y  +L+ A+ + H   V +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           PEN+LLD  G++ + DFGL  L  +  +  +T CGTP Y+APE+L   GY   A D W+ 
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWWTL 179

Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           GV+L+ ++ G  PF + ++  +Y+KI       P  F   A  L+  +L  +P  R+   
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239

Query: 257 G---IRKHPWFRK 266
           G   I+ HP+F +
Sbjct: 240 GAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  172 bits (437), Expect = 9e-51
 Identities = 77/208 (37%), Positives = 121/208 (58%), Gaps = 9/208 (4%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           G  IG GTF KV  A N +TGE +A+K +        + + +I  E+ ++++++HPN+V+
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSKGVYH 132
            + V   R KVYI +E+ +GG L + ++  GR+L E+  R Y  QL++ +A+ HS G+ H
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVH 122

Query: 133 RDLKPENLLLDSYGNLKVSDFG----LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
           RD+KP N+ LD  G +K+ DFG    L        E + +  GTP Y+APEV++     G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 189 --SAADVWSCGVILFVLMAGYLPFGETD 214
              AAD+WS G ++  +  G  P+ E D
Sbjct: 183 HGRAADIWSLGCVVLEMATGKRPWSELD 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  173 bits (441), Expect = 2e-50
 Identities = 86/259 (33%), Positives = 141/259 (54%), Gaps = 14/259 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G + +V  A+ ++TGE VA+K + KS + K   V  +  E  I+   +   +V+L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  +Y+ +E+V GG+    + + G L E+  R Y  ++ +AV   H  G  HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           PEN L+D+ G++K++DFGLS      V   ++  G+P+Y+APEVL  +GYD +  D WS 
Sbjct: 129 PENFLIDASGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRGKGYDFT-VDYWSL 184

Query: 197 GVILFVLMAGYLPFG-----ETDLPTLY--KKINAAEFSCP-FWFSTGATSLIHKILDPN 248
           G +L+  + G+ PF      ET     Y  + +    +  P F  S  A  LI K+++ +
Sbjct: 185 GCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIN-D 243

Query: 249 PKTRIR-IEGIRKHPWFRK 266
           P  R   +E I+ HP+F++
Sbjct: 244 PSRRFGSLEDIKNHPFFKE 262

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  169 bits (429), Expect = 1e-49
 Identities = 88/259 (33%), Positives = 140/259 (54%), Gaps = 17/259 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLH 75
           I +G F  V  A+ R TG+  A+KVL KS ++    V  +K E +IM I    P + +L+
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               S+  +Y+++E++ GG+    I   G L E+  ++Y  +++  V   H +G+ HRD+
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KPENLL+D  G+LK++DFGLS    +         GTP+Y+APE +   G D   +D WS
Sbjct: 124 KPENLLIDQTGHLKLTDFGLS----RNGLENKKFVGTPDYLAPETILGVG-DDKMSDWWS 178

Query: 196 CGVILFVLMAGYLPFGETDLP------TLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
            G ++F  + GY PF   + P       L ++IN  E    F  S  A  LI+++L  +P
Sbjct: 179 LGCVIFEFLFGYPPF-HAETPDAVFDNILSRRINWPEEVKEF-CSPEAVDLINRLLCMDP 236

Query: 250 KTRIR---IEGIRKHPWFR 265
             R+     + I+ HP+F+
Sbjct: 237 AKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  171 bits (434), Expect = 1e-49
 Identities = 90/259 (34%), Positives = 138/259 (53%), Gaps = 12/259 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+++  G+  A+KVL K  ILK +    I  E +++ K V+HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L++V GGELF  +  +    E   R Y  ++  A+ + HS  + +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLKPEN+LLDS G++ ++DFGL    ++G+E   TT   CGTP Y+APEVL  + YD   
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RT 176

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W  G +L+ ++ G  PF   D   +Y  I           S  A  L+  +L  +  
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRT 236

Query: 251 TRI----RIEGIRKHPWFR 265
            R+        I+ H +F 
Sbjct: 237 KRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  168 bits (428), Expect = 2e-49
 Identities = 82/265 (30%), Positives = 136/265 (51%), Gaps = 14/265 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            YEV  TIG+G+F  VR  + +  G+ +  K +     +  +   Q+  E++I++ ++HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59

Query: 70  NIVRL--HEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVA 123
           NIVR     +  S   +YI++E+  GG+L   I      +  + E    R   QL+ A+ 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 124 HCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
            CH++      V HRDLKP N+ LD+  N+K+ DFGL+ +         T  GTP Y++P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFSTGA 237
           E L++  YD   +D+WS G +++ L A   PF   +   L  KI   +F   P+ +S+  
Sbjct: 180 EQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHP 262
             +I  +L+ +P  R   E + + P
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  170 bits (432), Expect = 5e-49
 Identities = 98/331 (29%), Positives = 158/331 (47%), Gaps = 48/331 (14%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +EV + IG G F +V   ++++TG+  AMKVL KS ++K   +  ++ E  I+     P 
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV+L+        +Y+++E++ GG+L + ++ +    E   R Y  +L+ A+   H  G 
Sbjct: 63  IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA----------LPQQGVELL-------------- 166
            HRD+KP+N+L+D+ G++K++DFGL                   LL              
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 167 -----HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK 220
                ++T GTP+Y+APEVL    Y     D WS GVIL+ ++ G+ PF  +T   T  K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241

Query: 221 KINAAE-FSCPF--WFSTGATSLIHKILDPNPKTRI-RIEGIRKHPWFRK--------NY 268
            IN  E    P     S  A  LI ++L   P+ R+   E I+ HP+F+           
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFKGIDWENLRETK 300

Query: 269 NPVKCSEEEEVNLDDVHAVFDDIEYVAEQSE 299
            P       E++     + FDD E   + S+
Sbjct: 301 PPFV----PELSSPLDTSNFDDFEDDKDLSD 327

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  166 bits (423), Expect = 9e-49
 Identities = 76/256 (29%), Positives = 128/256 (50%), Gaps = 3/256 (1%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y++G  IG G F  V    N ETG+ VA+K ++   I +  +   I +EI ++K ++HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL-KSIMQEIDLLKNLKHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV+    + +   +YIILE+   G L   I   G   E+    Y  Q++  +A+ H +G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+K  N+L    G +K++DFG++       +   +  GTP ++APEV+   G   +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS-T 178

Query: 190 AADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           A+D+WS G  +  L+ G  P+ +   +  L++ +       P   S      + +    +
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238

Query: 249 PKTRIRIEGIRKHPWF 264
           P  R   + + KHPW 
Sbjct: 239 PNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  164 bits (417), Expect = 6e-48
 Identities = 86/259 (33%), Positives = 140/259 (54%), Gaps = 11/259 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +E+   IG+G F +V  A+++ TG+ VA+KV+ K    + +  ++I  EI I+K  +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKK--EKIINEIQILKKCKHP 57

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NIV+ +     + +++I++EF +GG L D +      L E+      ++L+  + + HS 
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
           G+ HRD+K  N+LL S G +K+ DFGLSA         +T  GTP ++APEV++ + YD 
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDY 176

Query: 189 SAADVWSCGVILFVLMA-GYLPFGE-TDLPTLYK--KINAAEFSCPFWFSTGATSLIHKI 244
             AD+WS G I  + +A G  P+ E   +  L+K           P  +S      + K 
Sbjct: 177 -KADIWSLG-ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC 234

Query: 245 LDPNPKTRIRIEGIRKHPW 263
           L  NP+ R   E + KHP+
Sbjct: 235 LQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  165 bits (419), Expect = 2e-47
 Identities = 92/258 (35%), Positives = 142/258 (55%), Gaps = 12/258 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+ +  G   A+KVL K TILK +  + I  E +++ K ++HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L++V GGELF  +  +   LE   R Y  ++  A+ + HS  + +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLKPEN+LLDS G++ ++DFGL    ++GVE   TT   CGTP Y+APEVL    YD   
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RT 176

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W  G +L+ ++ G  PF   D+  +Y  I       P   +  A  L+  +L  + +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQR 236

Query: 251 TRIRIEG----IRKHPWF 264
            R+  +     I+ H +F
Sbjct: 237 RRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  164 bits (416), Expect = 2e-47
 Identities = 94/272 (34%), Positives = 152/272 (55%), Gaps = 18/272 (6%)

Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV 66
           +E+ R +G G + KV   R     + G+  AMKVL K+TI+ K +  +  + E  +++ V
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 67  RH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           R  P +V LH    + TK+++IL++V GGELF  +  +    E++ R Y  +++ A+ H 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSN 183
           H  G+ +RD+K EN+LLDS G++ ++DFGLS   L ++  E  ++ CGT  Y+APEV+  
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVI-R 179

Query: 184 RGYDG--SAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGA 237
            G  G   A D WS GV+ F L+ G  PF     +     + ++I  ++   P   S  A
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239

Query: 238 TSLIHKILDPNPKTRIRIEG---IRKHPWFRK 266
              I K+L+ +PK R+   G   I+ HP+F+ 
Sbjct: 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  163 bits (416), Expect = 3e-47
 Identities = 87/311 (27%), Positives = 139/311 (44%), Gaps = 86/311 (27%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA---------KSTILKHRMVDQIKREIS 61
           YE    +GEGT+  V  A++++TGE VA+K +           + +          REIS
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL----------REIS 50

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGE-----LFDKIVHQGRLLENDCRRYFQ 116
           ++K ++HPNIV+L +V+ +  K+Y++ E+    +       DK    G L  N  +    
Sbjct: 51  LLKELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMY 105

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-- 174
           QL+  +A+CHS  + HRDLKP+N+L++  G LK++DFGL+              G P   
Sbjct: 106 QLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-----------RAFGIPLRT 154

Query: 175 ---------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK--- 220
                    Y APE+L  ++ Y  +A D+WS G I   ++ G   F G++++  L+K   
Sbjct: 155 YTHEVVTLWYRAPEILLGSKHY-STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213

Query: 221 ----------------KINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRI 253
                                 F  P +                  L+ K+L  NP  RI
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI 271

Query: 254 RIEGIRKHPWF 264
             +   KHP+F
Sbjct: 272 SAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  161 bits (410), Expect = 3e-46
 Identities = 88/259 (33%), Positives = 138/259 (53%), Gaps = 12/259 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG+  AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS  V +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSAA 191
           LK ENL+LD  G++K++DFGL    ++G+    T    CGTP Y+APEVL +  Y G A 
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 176

Query: 192 DVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK 
Sbjct: 177 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQ 236

Query: 252 RI-----RIEGIRKHPWFR 265
           R+       + I +H +F 
Sbjct: 237 RLGGGPEDAKEIMEHRFFA 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases

 Score =  153 bits (388), Expect = 2e-45
 Identities = 56/117 (47%), Positives = 81/117 (69%), Gaps = 2/117 (1%)

Query: 309 NAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRN- 367
           NAF++I+LS GL+L+ LF+  +D VKR+TRF SR+PA+ I+  +E  A+ L  +V  +  
Sbjct: 1   NAFDLISLSSGLDLSGLFEE-EDEVKRETRFTSRKPAEEIIEKLEEAAKKLGFRVRKKKE 59

Query: 368 YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLEN 424
              +LEG    + G+ AV +EVFEV PSL +V+V+K+AGDTLEYHKF+K+    L  
Sbjct: 60  GGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRPLLK 116

CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  156 bits (398), Expect = 6e-45
 Identities = 71/263 (26%), Positives = 129/263 (49%), Gaps = 13/263 (4%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           E  + +G+G+   V   +++ TG+  A+K +      + R   Q+ RE+  ++    P +
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK--QLLRELKTLRSCESPYV 61

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GV 130
           V+ +       ++ I+LE++ GG L D +   G++ E       +Q++  + + H+K  +
Sbjct: 62  VKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHI 121

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KP NLL++S G +K++DFG+S + +  ++  +T  GT  Y++PE +        A
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYA 180

Query: 191 ADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFW----FSTGATSLIHK 243
           AD+WS G+ L     G  PF   G+     L + I   +   P      FS      I  
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--DGPPPSLPAEEFSPEFRDFISA 238

Query: 244 ILDPNPKTRIRIEGIRKHPWFRK 266
            L  +PK R     + +HP+ +K
Sbjct: 239 CLQKDPKKRPSAAELLQHPFIKK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  157 bits (398), Expect = 2e-44
 Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 1/239 (0%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  157 bits (398), Expect = 2e-44
 Identities = 88/258 (34%), Positives = 144/258 (55%), Gaps = 12/258 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+ +  G+  A+KVL K  +L  +    I  E +++ K V+HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L+FV GGELF  +  +    E   R Y  ++  A+ + HS  + +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLKPEN+LLDS G++ ++DFGL    ++G+    TT   CGTP Y+APEV+  + YD + 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC---KEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT- 176

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W  G +L+ ++ G  PF   D+  +Y  I           S  A S++ ++L+ + +
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQ 236

Query: 251 TRIRIEG----IRKHPWF 264
            R+  +     I++HP+F
Sbjct: 237 RRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  157 bits (398), Expect = 2e-44
 Identities = 99/329 (30%), Positives = 176/329 (53%), Gaps = 25/329 (7%)

Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV 66
           +E+ + +G G + KV   R     +TG+  AMKVL K+ ++ K + V+  + E ++++ V
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 67  RH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           R  P +V LH    +  K+++IL++V+GGE+F  +  +    E++ R Y  ++I A+ H 
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 184
           H  G+ +RD+K EN+LLDS G++ ++DFGLS     +  E  ++ CGT  Y+APE++  +
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT-LYKKINAAEFSCPFWFSTGATSL 240
           G  G A D WS G+++F L+ G  PF   GE +  + + ++I   +   P +    A  L
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241

Query: 241 IHKILDPNPKTRI-----RIEGIRKHPWF----------RKNYNPVKCSEEEEVNLDDVH 285
           +HK+L  +PK R+         I++HP+F          RK   P + S   E+++ +  
Sbjct: 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFA 301

Query: 286 AVFDDIEYVAEQSENKVGGPLLMNAFEMI 314
             F ++E V   +     G  +   +  +
Sbjct: 302 EEFTNLEPVYSPAGTPPSGARVFQGYSFV 330

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  157 bits (400), Expect = 3e-44
 Identities = 89/300 (29%), Positives = 139/300 (46%), Gaps = 47/300 (15%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  + IG G F +VR  Q ++TG   AMK L KS +L+   V  ++ E  I+    +P 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V+L+        +Y+I+E++ GG++   ++ +    E + R Y  + I A+   H  G 
Sbjct: 63  VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGL---------------------------SALPQQGV 163
            HRD+KP+NLLLD+ G++K+SDFGL                            + P    
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 164 ELLHT-----------TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
               T           T GTP+Y+APEV    GY     D WS GVI++ ++ GY PF  
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241

Query: 213 TDLPTLYKKI----NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFR 265
            +    Y+KI       +F      S  A  LI ++     + R+   G   I+ HP+F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  156 bits (395), Expect = 5e-44
 Identities = 84/260 (32%), Positives = 140/260 (53%), Gaps = 9/260 (3%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVR 73
           + +G+G+F KV  A+ + T E  A+KVL K  IL+   VD    E  I+ +   HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    ++ +++ ++E+V GG+L  +I    +  E   R Y  ++  A+   H  GV +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD+ G+ K++DFG+            T CGTP+Y+APE+L    Y G + D 
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+++ +MAG  PF   +   L++ I   +   P W S  A S++   +  NP  R+
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239

Query: 254 RI-------EGIRKHPWFRK 266
                    + I++HP+F++
Sbjct: 240 GCVASQGGEDAIKQHPFFKE 259

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  155 bits (392), Expect = 1e-43
 Identities = 82/239 (34%), Positives = 130/239 (54%), Gaps = 1/239 (0%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + +G+  AMK+L K  I+    V     E  ++K  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                ++ ++  ++E+V GGELF  +  +    E+  R Y  +++ A+ + HS  + +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LK ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   +   P   S  A SL+  +L  +P  R+
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  153 bits (388), Expect = 2e-43
 Identities = 85/287 (29%), Positives = 127/287 (44%), Gaps = 37/287 (12%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRH 68
           Y+    IGEGT+  V  A+++ TGE VA+K +                 REI ++K + H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-CRRYFQQLIDAVAHCHS 127
           PNI++L +V   +  +Y++ EF+   +L+  I  + R L     + Y  QL+  +A CHS
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            G+ HRDLKPENLL+++ G LK++DFGL+      V        T  Y APE+L      
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 188 GSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYKKINAAEFS 228
            +  D+WS G I   L++    F                        P         +FS
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236

Query: 229 CPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            P              S  A  L+ ++L  +P  RI  E    HP+F
Sbjct: 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  154 bits (391), Expect = 2e-43
 Identities = 88/267 (32%), Positives = 147/267 (55%), Gaps = 17/267 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
           R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  + +    HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + ++++ ++EFV+GG+L   +  Q +L E   R Y  ++  A+   H +G+ +R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD+ G++K++D+G+     +  +   T CGTPNY+APE+L    Y  S  D 
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFS-VDW 179

Query: 194 WSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFSTGATSLIHKI 244
           W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S  A+S++   
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239

Query: 245 LDPNPKTRI---RIEG---IRKHPWFR 265
           L+ +PK R+      G   I+ HP+FR
Sbjct: 240 LNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  154 bits (390), Expect = 4e-43
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 12/267 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++V   +G G F +V+  + + TG+  AMKV+ KS +L    V   + E  I+ I   P 
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I +L      +  +Y+++E+  GG+L   +  ++ +  E+  + Y  +L+ A+   H  G
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSN-RGYD 187
             HRD+KPEN+L+D  G++K++DFG +A L    +       GTP+Y+APEVL+   G  
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 188 GSAADV----WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATS 239
                V    WS GVI + ++ G  PF E      Y  I   +    F      S+    
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLD 242

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           LI  +L    K R+  EG+  HP+F K
Sbjct: 243 LIQSLL-CGQKERLGYEGLCCHPFFSK 268

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  153 bits (388), Expect = 5e-43
 Identities = 86/258 (33%), Positives = 139/258 (53%), Gaps = 8/258 (3%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVR 73
           R +G+G+F KV  A+ +E+G   A+KVL K  IL+   V+    E  I+ + R HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L+    +  +++ ++EFV GG+L   I    R  E   R Y  ++  A+   H KG+ +R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD  G+ K++DFG+        +   T CGTP+Y+APE+L    Y G + D 
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+L+ ++ G+ PF   +   L++ I   E   P W S  A  ++   +  NP  R+
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239

Query: 254 RI------EGIRKHPWFR 265
                   E I +HP+F+
Sbjct: 240 GSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  151 bits (384), Expect = 9e-43
 Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 40/290 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   IGEG    V  A++RETGE+VA+K +A    L+  + +Q  REI  ++  +HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSK 128
            +V+L +V    +   +++E++    L + +  + R L E   + Y + L+  VA+ H+ 
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-TCGTPNYVAPEVL-SNRGY 186
           G+ HRDLKP NLL+ + G LK++DFGL+ L  +    L++    T  Y APE+L   R Y
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETD------------------------LPTLYK 220
           D    D+W+ G I   L+ G  P   GE D                        LP  Y 
Sbjct: 179 D-PGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP-DYN 235

Query: 221 KINAAEFSCPFW------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
           KI   E             S  A  L+  +L  +P  R+      +HP+F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  152 bits (386), Expect = 1e-42
 Identities = 84/258 (32%), Positives = 138/258 (53%), Gaps = 10/258 (3%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---IVRHPNIVR 73
           IG+GTF +V   + ++T    AMKVL+K  I+  + V     E +I+    +   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L     + + +Y++ ++++GGELF  +  +GR  E+  + Y  +L+ A+ H H   + +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-LSNRGYDGSAAD 192
           DLKPEN+LLD+ G++ + DFGLS       +  +T CGT  Y+APEV L  +GY     D
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVD 179

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKT 251
            WS GV++F +  G+ PF   D   +Y+ I   +   P    S      +  +L+ NP+ 
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQH 239

Query: 252 RI----RIEGIRKHPWFR 265
           R+        +++HP+F 
Sbjct: 240 RLGAHRDAVELKEHPFFA 257

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  151 bits (383), Expect = 2e-42
 Identities = 97/300 (32%), Positives = 144/300 (48%), Gaps = 59/300 (19%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD----QIKREISIMKIV 66
           YE    IGEGT+ +V  A+N++TGE VA+K      I      +       REI +++ +
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55

Query: 67  RHPNIVRLHEVLASRTK--VYIILEFV----TGGELFDKIVHQGRLLENDCRRYFQQLID 120
           RHPNIVRL E++ S+ K  +Y++ E++    TG  L D    + +  E+  + Y +QL++
Sbjct: 56  RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLE 111

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TPNYVAP 178
            + + HS G+ HRD+K  N+L+++ G LK++DFGL A P         T    T  Y  P
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRPP 170

Query: 179 EVL--SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI----------NAA 225
           E+L  + R Y G   D+WS G IL  L  G   F G T+L  L +KI          N  
Sbjct: 171 ELLLGATR-Y-GPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTDENWP 227

Query: 226 EFSCPFWF---------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
             S   WF                        A  L+ K+L  +PK RI  +   +H +F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  152 bits (384), Expect = 2e-42
 Identities = 89/270 (32%), Positives = 149/270 (55%), Gaps = 23/270 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +   HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H +G+ +R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L    Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFS 176

Query: 191 ADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFSTGATSLI 241
            D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S  A S++
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236

Query: 242 HKILDPNPKTRI------RIEGIRKHPWFR 265
              L+ +PK R+          I+ HP+FR
Sbjct: 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  150 bits (381), Expect = 4e-42
 Identities = 92/314 (29%), Positives = 143/314 (45%), Gaps = 66/314 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK----REISIMKI 65
           +YE G+ +GEGT+A V  A+++ETG  VA+K + K    K    D I     REI +++ 
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGERKEAK-DGINFTALREIKLLQE 58

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTG---GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++HPNI+ L +V   ++ + ++ EF+       + DK +    L   D + Y    +  +
Sbjct: 59  LKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTLRGL 115

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-------- 174
            + HS  + HRDLKP NLL+ S G LK++DFGL+            + G+PN        
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-----------RSFGSPNRKMTHQVV 164

Query: 175 ---YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYKKI------- 222
              Y APE+L    + G   D+WS G I   L+    +LP G++D+  L  KI       
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP-GDSDIDQL-GKIFEALGTP 222

Query: 223 ---NAAEFSC-------------PFW--FSTG---ATSLIHKILDPNPKTRIRIEGIRKH 261
              N    +              P    F      A  L+ ++L  NP  RI      +H
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282

Query: 262 PWFRKNYNPVKCSE 275
           P+F  +  P   S+
Sbjct: 283 PYFSNDPAPTPPSQ 296

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  149 bits (378), Expect = 6e-42
 Identities = 91/274 (33%), Positives = 157/274 (57%), Gaps = 20/274 (7%)

Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV 66
           +E+ + +G G + KV   R     ++G+  AMKVL K+TI+ K +  +  + E  +++ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 67  RH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           R  P +V LH    + TK+++IL+++ GGELF  +  + R  E + + Y  +++ A+ H 
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNR 184
           H  G+ +RD+K EN+LLDS G++ ++DFGLS    +  VE  ++ CGT  Y+AP+++  R
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV--R 179

Query: 185 GYDG---SAADVWSCGVILFVLMAGYLPFG----ETDLPTLYKKINAAEFSCPFWFSTGA 237
           G DG    A D WS GV+++ L+ G  PF     +     + ++I  +E   P   S  A
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239

Query: 238 TSLIHKILDPNPKTRI-----RIEGIRKHPWFRK 266
             +I ++L  +PK R+       + I+KHP+F+K
Sbjct: 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  150 bits (381), Expect = 7e-42
 Identities = 83/260 (31%), Positives = 132/260 (50%), Gaps = 16/260 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVR 73
           +G G F KV  A+ ++TGE  A+K L K  I+    V+ +  E  I +     RHP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L     +   V  ++E+  GG+L   I H     E     Y   ++  + + H   + +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DLK +NLLLD+ G +K++DFGL    ++G+     T   CGTP ++APEVL+   Y   A
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRA 181

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D W  GV+++ ++ G  PF   D   ++  I   E   P + S  A S++ ++L  NP+
Sbjct: 182 VDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPE 241

Query: 251 TRI-----RIEGIRKHPWFR 265
            R+       E ++K P+FR
Sbjct: 242 RRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  149 bits (378), Expect = 1e-41
 Identities = 84/254 (33%), Positives = 139/254 (54%), Gaps = 5/254 (1%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVRHPNIV 72
           + +G+G+F KV  A+ + T E  A+K L K  +L+   V+   ++R +  +    HP + 
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLT 59

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
            L     ++  ++ ++E++ GG+L   I   GR  E   R Y  ++I  +   H KG+ +
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLK +N+LLD  G++K++DFG+      G     T CGTP+Y+APE+L  + Y+ S  D
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNES-VD 178

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTR 252
            WS GV+L+ ++ G  PF   D   L+  I       P W S  A   + K+ + +P  R
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238

Query: 253 IRIEG-IRKHPWFR 265
           + ++G IR+HP+FR
Sbjct: 239 LGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  150 bits (379), Expect = 1e-41
 Identities = 86/269 (31%), Positives = 137/269 (50%), Gaps = 10/269 (3%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNR-ETGESVAMKVLAKSTILKHRMVDQIKREI 60
           +K   +   +   RT+G G+F +V  A  + E    VA+K   KS I+K + VD +  E 
Sbjct: 23  RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I+  + HP  V L+      + +Y++LEFV GGE F  +    R   +    Y  Q++ 
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
              +  S  + +RDLKPENLLLD  G +K++DFG + +        +T CGTP Y+APE+
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT---YTLCGTPEYIAPEI 199

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           L N G+ G AAD W+ G+ ++ ++ G  PF   +   +Y+KI       P +       L
Sbjct: 200 LLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258

Query: 241 IHKILDPNPKTRI-----RIEGIRKHPWF 264
           + K+L  +   R        + +++HPWF
Sbjct: 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  147 bits (372), Expect = 1e-40
 Identities = 85/240 (35%), Positives = 130/240 (54%), Gaps = 2/240 (0%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHR 133
                +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K V +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  Y G A D 
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  145 bits (367), Expect = 1e-40
 Identities = 69/257 (26%), Positives = 122/257 (47%), Gaps = 9/257 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++V + +G+G++  V   +     +  A+K +   ++ +    D +  EI I+  V HPN
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLEND-CRRYFQQLIDAVAHCH 126
           I+   E      K+ I++E+   G+L   I     + +L+      R F QL+  +   H
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            + + HRDLK  N+LL +   +K+ D G+S + ++   +  T  GTP+Y+APEV   R Y
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKIL 245
               +D+WS G +L+ +     PF    +  L  K+   ++   P  +S    + I  +L
Sbjct: 179 S-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237

Query: 246 DPNPKTRIRIEGIRKHP 262
              PK R   + I   P
Sbjct: 238 QVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  144 bits (364), Expect = 2e-39
 Identities = 81/255 (31%), Positives = 139/255 (54%), Gaps = 7/255 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLH 75
           +G+G+F KV  A+ + T E  A+K+L K  I++   V+    E  ++ +   P  + +LH
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   HSKG+ +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           K +N++LD+ G++K++DFG+      G +   T CGTP+Y+APE+++ + Y G + D W+
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186

Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
            GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   +L  +P  R+  
Sbjct: 187 FGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246

Query: 256 -----EGIRKHPWFR 265
                  IR+H +FR
Sbjct: 247 GPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  143 bits (363), Expect = 2e-39
 Identities = 88/305 (28%), Positives = 162/305 (53%), Gaps = 8/305 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
           + +G+G+F KV  A+ + T +  A+K L K  +L    V+    E  ++ +   HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L+    ++  ++ ++E++ GG+L   I    +        Y  ++I  +   HSKG+ +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD+ G++K++DFG+      G     T CGTP+Y+APE+L  + Y  ++ D 
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           WS GV+L+ ++ G  PF   D   L++ I       P W +  A  ++ K+    P+ R+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239

Query: 254 RIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD----DIEYVAEQSENKVGGPLL 307
            ++G IR+HP+FR+ +++ ++  E E      V +  D    D E++ E+    V   +L
Sbjct: 240 GVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRML 299

Query: 308 MNAFE 312
           +N+ +
Sbjct: 300 INSMD 304

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  143 bits (362), Expect = 3e-39
 Identities = 84/255 (32%), Positives = 134/255 (52%), Gaps = 6/255 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+++   +  A+KVL K  ILK +    I  E +++ K V+HP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+ + HS  + +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL  + YD    D 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W  G +L+ ++ G  PF   +   +Y  I           +  A  L+  +L  +   R+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239

Query: 254 RIEG----IRKHPWF 264
             +     I+ H +F
Sbjct: 240 GAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  142 bits (359), Expect = 3e-39
 Identities = 86/259 (33%), Positives = 131/259 (50%), Gaps = 17/259 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G+G F KV  AQ++ETG   A K+  +     L+  MV     EI I+   +HPNIV L
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-----EIDILSECKHPNIVGL 67

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGVYHR 133
           +E      K++I++EF  GG L   ++   R L     RY  +Q+++A+   HS  V HR
Sbjct: 68  YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNRGYDG 188
           DLK  N+LL   G++K++DFG+SA  +  ++   T  GTP ++APEV+      +  YD 
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD- 186

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKIL 245
             AD+WS G+ L  L     P  E +   +  KI  +E      P  +S+     +   L
Sbjct: 187 YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCL 246

Query: 246 DPNPKTRIRIEGIRKHPWF 264
             +P  R     + KHP+ 
Sbjct: 247 VKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  141 bits (358), Expect = 7e-39
 Identities = 78/215 (36%), Positives = 115/215 (53%), Gaps = 7/215 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KYEV   +GEG +  V   +N+ TGE VA+K   +S   +        RE+ +++ +RH 
Sbjct: 2   KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK-KTALREVKVLRQLRHE 60

Query: 70  NIVRLHEVLASRTKVYIILEFV--TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIV L E    + ++Y++ E+V  T  EL +     G L  +  R Y  QL+ A+A+CHS
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
             + HRD+KPEN+L+   G LK+ DFG + AL  +    L     T  Y APE+L     
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK 220
            G   DVW+ G I+  L+ G   F G++D+  LY 
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  141 bits (356), Expect = 1e-38
 Identities = 91/287 (31%), Positives = 133/287 (46%), Gaps = 49/287 (17%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVL-------AKSTILKHRMVDQIKREISIMKIVRHP 69
           +GEGT+A V   +NR TGE VA+K +         ST +         REIS+MK ++H 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI---------REISLMKELKHE 58

Query: 70  NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIVRLH+V+ +  K+ ++ E++     +  D    +G L  N  + +  QL+  +A CH 
Sbjct: 59  NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-SNRGY 186
             V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL  +R Y
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----------------NAAEFSCP 230
             S  D+WS G I+  ++ G   F  T+      KI                   E+   
Sbjct: 179 STS-IDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237

Query: 231 F-------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
           F                     L+H++L  NP+ RI      +HPWF
Sbjct: 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  142 bits (358), Expect = 1e-38
 Identities = 82/265 (30%), Positives = 144/265 (54%), Gaps = 15/265 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R IG G++AKV   + ++  +  AMKV+ K  +     +D ++ E  +  +   +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + +++++++E+V GG+L   +  Q +L E   R Y  ++  A+   H +G+ +R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD+ G++K++D+G+        +   T CGTPNY+APE+L    Y G + D 
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179

Query: 194 WSCGVILFVLMAGYLPFG-ETDLPT------LYKKINAAEFSCPFWFSTGATSLIHKILD 246
           W+ GV++F +MAG  PF   TD P       L++ I       P + S  A+ ++   L+
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239

Query: 247 PNPKTRIRIE------GIRKHPWFR 265
            +PK R+  +       I+ H +FR
Sbjct: 240 KDPKERLGCQPQTGFSDIKSHTFFR 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  142 bits (361), Expect = 1e-38
 Identities = 94/306 (30%), Positives = 150/306 (49%), Gaps = 25/306 (8%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   ++V + IG G F +V+  +++ + +  AMK+L+K  ++K         E  IM   
Sbjct: 41  KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA 100

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
               IV+LH        +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIH 159

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           S G  HRD+KP+N+LLD  G+LK++DFG    +   G+    T  GTP+Y++PEVL ++G
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 186 YD---GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
            D   G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAK 279

Query: 239 SLIHKILDPNPKT--RIRIEGIRKHPWF----------RKNYNPVKCSEEEEVNLDDVHA 286
            LI   L        R  ++ I+ HP+F          R+   PV      E++ D   +
Sbjct: 280 DLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVV----PELSSDIDTS 335

Query: 287 VFDDIE 292
            FDDIE
Sbjct: 336 NFDDIE 341

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  142 bits (360), Expect = 1e-38
 Identities = 94/308 (30%), Positives = 161/308 (52%), Gaps = 17/308 (5%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           ++K   +   Y+V + IG G F +V+  +++ + +  AMK+L+K  ++K         E 
Sbjct: 35  IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            IM     P +V+L         +Y+++E++ GG+L + ++    + E   + Y  +++ 
Sbjct: 95  DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVL 153

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPE 179
           A+   HS G+ HRD+KP+N+LLD +G+LK++DFG    + + G+    T  GTP+Y++PE
Sbjct: 154 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPE 213

Query: 180 VLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFW 232
           VL ++   GY G   D WS GV LF ++ G  PF    L   Y KI    N+  F     
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE 273

Query: 233 FSTGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK---NYNPVKCSEE---EEVNLDDV 284
            S  A +LI   L        R  +E I++HP+F+    N++ ++ +      E++ D  
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDID 333

Query: 285 HAVFDDIE 292
            + FDDIE
Sbjct: 334 SSNFDDIE 341

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  139 bits (352), Expect = 2e-38
 Identities = 77/259 (29%), Positives = 129/259 (49%), Gaps = 9/259 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVR 67
           ++  G  +G G+F  V    N + G+  A+K   LA         V Q+++EI+++  ++
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+          +YI LE V GG L   +   G   E   R Y +Q++  + + H 
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEVLSNRG 185
           +   HRD+K  N+L+D+ G +K++DFG++   +Q VE        G+P ++APEV++ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEF-SCPFWFSTGATSLIHK 243
             G AAD+WS G  +  +  G  P+ +   +  ++K   + E    P   S  A   I K
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237

Query: 244 ILDPNPKTRIRIEGIRKHP 262
            L  +P  R     + +HP
Sbjct: 238 CLQRDPSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  140 bits (354), Expect = 2e-38
 Identities = 81/274 (29%), Positives = 139/274 (50%), Gaps = 18/274 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y+    IGEG   +V  A +R TG+ VA+K +    + K    + I  EI IMK  +HP
Sbjct: 20  LYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNK-ELIINEILIMKDCKHP 75

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NIV  ++      ++++++E++ GG L D I  +  R+ E       ++++  + + HS+
Sbjct: 76  NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRD+K +N+LL   G++K++DFG +A   +     ++  GTP ++APEV+  + Y  
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG- 194

Query: 189 SAADVWSCGVILFVLMAGYLP-FGETDLPTLY----KKINAAEFSCPFWFSTGATSLIHK 243
              D+WS G++   +  G  P   E  L  L+    K I       P  +S      ++K
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI--PPLKNPEKWSPEFKDFLNK 252

Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
            L  +P+ R   E + +HP+ +K      C +EE
Sbjct: 253 CLVKDPEKRPSAEELLQHPFLKK-----ACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  139 bits (351), Expect = 3e-38
 Identities = 72/256 (28%), Positives = 137/256 (53%), Gaps = 5/256 (1%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY   + IGEG+F K    +++E G+   +K +  S  +  +  ++ ++E++++  ++HP
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHCHS 127
           NIV+  E       +YI++++  GG+L+ KI  Q  +L  E+    +F Q+  A+ H H 
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + + HRD+K +N+ L   G +K+ DFG++ +    VEL  T  GTP Y++PE+  NR Y+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILD 246
            + +D+W+ G +L+ +      F   ++  L  KI    +      +S    +L+ ++  
Sbjct: 180 -NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238

Query: 247 PNPKTRIRIEGIRKHP 262
            NP+ R  +  I +  
Sbjct: 239 RNPRDRPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 1e-37
 Identities = 70/201 (34%), Positives = 108/201 (53%), Gaps = 21/201 (10%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-REI-SIMKIVRH 68
           Y+V + +G+GTF  V  A+N+ETGE VA+K + K     +   + +  RE+ S+ K+  H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEH 57

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLL-ENDCRRYFQQLIDAVAHCH 126
           PNIV+L EV     ++Y + E++ G  L+  +   +G+   E+  R    Q++  +AH H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGL-----SALPQQGVELLHTT-CGTPNYVAPEV 180
             G +HRDLKPENLL+     +K++DFGL     S  P       +T    T  Y APE+
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-------YTDYVSTRWYRAPEI 169

Query: 181 LSNRGYDGSAADVWSCGVILF 201
           L       S  D+W+ G I+ 
Sbjct: 170 LLRSTSYSSPVDIWALGCIMA 190

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  137 bits (346), Expect = 1e-37
 Identities = 81/262 (30%), Positives = 133/262 (50%), Gaps = 21/262 (8%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR-----EISIMKI 65
           +++ + IG+G F+ V  A     G  VA+K   K  I +  M+D   R     EI ++K 
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALK---KVQIFE--MMDAKARQDCLKEIDLLKQ 58

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDA 121
           + HPN+++         ++ I+LE    G+L   I H   Q RL+ E    +YF QL  A
Sbjct: 59  LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + H HSK + HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +
Sbjct: 119 LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WFSTG 236
              GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +S  
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP-PLPADHYSEE 236

Query: 237 ATSLIHKILDPNPKTRIRIEGI 258
              L+ + ++P+P+ R  I  +
Sbjct: 237 LRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 2e-37
 Identities = 81/218 (37%), Positives = 118/218 (54%), Gaps = 27/218 (12%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REISIMKIVRHP 69
           IGEGT+  V  A+++ TGE VA+K        K R+  + +       REIS++K + HP
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALK--------KIRLETEDEGVPSTAIREISLLKELNHP 58

Query: 70  NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIVRL +V+ S  K+Y++ EF+     +  D     G L     + Y  QL+  +A+CHS
Sbjct: 59  NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHS 117

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTT--CGTPNYVAPEVLSNR 184
             V HRDLKP+NLL+D  G LK++DFGL+ A    GV +   T    T  Y APE+L   
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLARAF---GVPVRTYTHEVVTLWYRAPEILLGS 174

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 220
               +  D+WS G I F  M    P   G++++  L++
Sbjct: 175 RQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFR 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  137 bits (346), Expect = 2e-37
 Identities = 76/259 (29%), Positives = 130/259 (50%), Gaps = 10/259 (3%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVRHPNI 71
           G+ +G+G F +V    + +TG  +A+K +          + V+ ++ EI ++K ++H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           V+ +  L     + I +E++ GG + D++   G L E   R+Y +Q+++ V + HS  + 
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 132 HRDLKPENLLLDSYGNLKVSDFG----LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           HRD+K  N+L DS GN+K+ DFG    L  +   G  +   T GTP +++PEV+S  GY 
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEVISGEGY- 184

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFSTGATSLIHKIL 245
           G  ADVWS G  +  ++    P+ E +      KI         P   S  A + + +  
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244

Query: 246 DPNPKTRIRIEGIRKHPWF 264
             N K R   E + +H + 
Sbjct: 245 VENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  138 bits (349), Expect = 2e-37
 Identities = 78/253 (30%), Positives = 136/253 (53%), Gaps = 3/253 (1%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
           + +G+G+F KV  A+ +  GE  A+K L K  +L    V+    E  ++ +   +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L+    ++  ++ ++EF+ GG+L   I  +GR        Y  +++  +   HSKG+ +R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N++LD  G++K++DFG+      G     T CGTP+Y+APE+L    Y  S  D 
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS-VDW 179

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           WS GV+L+ ++ G  PF   D   L++ I       P W +  +  ++ K+ + +P  R+
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239

Query: 254 RIEG-IRKHPWFR 265
            + G IR HP+F+
Sbjct: 240 GVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  137 bits (347), Expect = 4e-37
 Identities = 79/255 (30%), Positives = 141/255 (55%), Gaps = 7/255 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLH 75
           +G+G+F KV  A+ + T E  A+K+L K  +++   V+    E  ++ +  + P + +LH
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               +  ++Y ++E+V GG+L  +I   GR  E     Y  ++   +   HSKG+ +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           K +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G + D W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186

Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
            GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+  
Sbjct: 187 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246

Query: 256 --EG---IRKHPWFR 265
             EG   I++H +FR
Sbjct: 247 GPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  137 bits (347), Expect = 9e-37
 Identities = 92/296 (31%), Positives = 144/296 (48%), Gaps = 44/296 (14%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  + IG G F +VR  Q ++TG   AMK+L K+ +L+   V  I+ E  I+       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V++      +  +Y+I+EF+ GG++   ++ +  L E   + Y  + + A+   H  G 
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGL---------------------SALPQQGV------ 163
            HRD+KP+NLLLD+ G++K+SDFGL                     S    Q +      
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 164 --------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETD 214
                   +L ++T GTP+Y+APEV    GY+    D WS GVI++ ++ GY PF  ET 
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 215 LPTLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWF 264
             T  K +N  E   F      S  A  LI +    + + RI    +E I+ HP+F
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  136 bits (344), Expect = 1e-36
 Identities = 79/256 (30%), Positives = 140/256 (54%), Gaps = 7/256 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLH 75
           +G+G+F KV  A+ + T E  A+K+L K  +++   V+    E  ++ +  + P + +LH
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   H +G+ +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           K +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G + D W+
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWA 186

Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
            GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   ++  +P  R+  
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246

Query: 256 --EG---IRKHPWFRK 266
             EG   IR+H +FR+
Sbjct: 247 GPEGERDIREHAFFRR 262

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  133 bits (336), Expect = 3e-36
 Identities = 82/248 (33%), Positives = 127/248 (51%), Gaps = 10/248 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVR 67
           +Y V R +GEG+F +    Q+  + +  AMK   L KS+      V+  ++E  ++  ++
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLL-ENDCRRYFQQLIDAVAHC 125
           HPNIV   E   +   +YI++E+  GG+L  KI  Q G+L  E+   ++F Q+   V H 
Sbjct: 57  HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H K V HRD+K +N+ L   G +K+ DFG + L         T  GTP YV PE+  N  
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKI 244
           Y+ + +D+WS G IL+ L     PF       L  K+    +   P  +S    SLI ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235

Query: 245 LDPNPKTR 252
              NP++R
Sbjct: 236 FKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  134 bits (339), Expect = 4e-36
 Identities = 81/280 (28%), Positives = 143/280 (51%), Gaps = 30/280 (10%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  + I  G +  V   +++ET +  AMK + K  ++    + Q+  E  I+    +P 
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V +     ++  + +++E+V GG+    + + G L  +  R YF + + A+ + H+ G+
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT------------------TCGT 172
            HRDLKP+NLL+ S G++K++DFGLS +   G+  L T                   CGT
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF 231
           P Y+APEV+  +GY G   D W+ G+IL+  + G +PF G+T    L+ ++ + +   P 
Sbjct: 180 PEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIEWPE 237

Query: 232 W---FSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFR 265
                   A  LI ++L  NP  R+   G   +++H +F 
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  135 bits (342), Expect = 8e-36
 Identities = 84/305 (27%), Positives = 133/305 (43%), Gaps = 52/305 (17%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +   +TIG G F +V   +  +T    AMK L K+ +L       +K E  I+    +  
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V+L+     +  +Y +++++ GG++   ++  G   E+  R Y  +L  A+   H  G 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS---------------------------------- 156
            HRD+KP+N+L+D  G++K++DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 157 ---------ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
                       Q    L H+  GTPNY+APEVL   GY     D WS GVIL+ ++ G 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241

Query: 208 LPF-GETDLPTLYKKIN-AAEFSCPFW--FSTGATSLIHKILDPNPKTRI---RIEGIRK 260
            PF  +T   T  K IN       P     S  A+ LI + L    + R+     + I+ 
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKA 300

Query: 261 HPWFR 265
           HP+F+
Sbjct: 301 HPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  135 bits (340), Expect = 9e-36
 Identities = 92/302 (30%), Positives = 151/302 (50%), Gaps = 17/302 (5%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM   
Sbjct: 41  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 101 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIH 159

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++ 
Sbjct: 160 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279

Query: 239 SLIHKILDPNPKT--RIRIEGIRKHPWFR------KNYNPVKCSEEEEVNLDDVHAVFDD 290
           +LI   L        R  +E I++H +F+      +           +++ D   + FDD
Sbjct: 280 NLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 339

Query: 291 IE 292
           IE
Sbjct: 340 IE 341

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  132 bits (333), Expect = 9e-36
 Identities = 81/260 (31%), Positives = 136/260 (52%), Gaps = 8/260 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IGEG+F K+  A+ +   E   +K +   T +  +  +  K+E+ ++  ++HP
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEI-DLTKMPVKEKEASKKEVILLAKMKHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND-CRRYFQQLIDAVAHCHS 127
           NIV          +++I++E+  GG+L  +I  Q G L   D    +F Q+   + H H 
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 128 KGVYHRDLKPENLLLDSYGNL-KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + + HRD+K +N+ L   G + K+ DFG++      +EL +T  GTP Y++PE+  NR Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKI 244
           + +  D+WS G +L+ L     PF   +L  L  KI    F+ P    FS    SLI ++
Sbjct: 180 N-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQL 237

Query: 245 LDPNPKTRIRIEGIRKHPWF 264
              +P+ R  I  I K P+ 
Sbjct: 238 FKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  135 bits (341), Expect = 1e-35
 Identities = 87/305 (28%), Positives = 139/305 (45%), Gaps = 56/305 (18%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG+G F +VR  Q ++TG+  AMK L KS + K   +  +K E  ++     P +V L
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           +        +Y+I+EF+ GG+L   ++      E+  R Y  + + A+   H  G  HRD
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126

Query: 135 LKPENLLLDSYGNLKVSDFGLS------------------------ALPQQGVE------ 164
           +KP+N+L+D  G++K+SDFGLS                           +  V       
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186

Query: 165 -----------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
                            + ++T GTP+Y+APE+   +GY G   D WS G I+F  + G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245

Query: 208 LPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEG---IRK 260
            PF   +    Y+KI     +  F      S  A  LI +++  N + R+   G   I+ 
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304

Query: 261 HPWFR 265
           HP+FR
Sbjct: 305 HPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  134 bits (339), Expect = 1e-35
 Identities = 78/247 (31%), Positives = 123/247 (49%), Gaps = 36/247 (14%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E  + IG G F +VR  Q ++TG   AMK+L K+ +L+   V  I+ E  I+       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V++      +  +Y+I+EF+ GG++   ++ +  L E + + Y  + + A+   H  G 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS-----------------ALPQQGV---------- 163
            HRD+KP+NLLLDS G++K+SDFGL                  +LP              
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 164 --------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL 215
                   +L  +T GTP+Y+APEV    GY+    D WS GVI++ ++ GY PF     
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 216 PTLYKKI 222
              YKK+
Sbjct: 242 QETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  131 bits (332), Expect = 5e-35
 Identities = 82/288 (28%), Positives = 140/288 (48%), Gaps = 38/288 (13%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+G   +V   + + TG+  A+KVL K  ++K   V ++  E  I+  + HP +  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           +    + T + +++++  GGELF  +  Q    L E   R Y  +++ A+ + H  G+ +
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126

Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGV----------ELLHTT------ 169
           RDLKPEN+LL   G++ +SDF LS           + +           +   T      
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186

Query: 170 ------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN 223
                  GT  Y+APEV+S  G+ GSA D W+ G++L+ ++ G  PF  ++    +  I 
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245

Query: 224 AAEFSCP--FWFSTGATSLIHKILDPNPKTRI----RIEGIRKHPWFR 265
             E + P     S+ A  LI K+L  +P  R+        I++HP+FR
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  130 bits (329), Expect = 6e-35
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 13/261 (4%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V   Q + TG+  A K L K  + K +       E  I++ V    IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
              ++  + +++  + GG+L   I + G     E     Y  Q+I  + H H + + +RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPEN+LLD +GN+++SD GL A+  +G + +    GTP Y+APEVL    YD  + D +
Sbjct: 121 LKPENVLLDDHGNVRISDLGL-AVELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVDWF 178

Query: 195 SCGVILFVLMAGYLPFGE----TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
           + G  L+ ++AG  PF +     +   L ++        P  FS  A  L   +L  +P+
Sbjct: 179 ALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE 238

Query: 251 TRI-----RIEGIRKHPWFRK 266
            R+       + +R+HP F+ 
Sbjct: 239 KRLGCRGGSADEVREHPLFKD 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  130 bits (328), Expect = 1e-34
 Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 62/278 (22%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVR- 67
           Y++   IGEGTF++V  AQ+R+TG+  A+K + K      + ++Q+   REI  ++ +  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56

Query: 68  HPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAV 122
           HPNI+RL EVL  R   ++ ++ E +    L++ I  +GR   L E   + Y  QL+ ++
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV------ 176
            H H  G++HRD+KPEN+L+     LK++DFG S                P Y       
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC---------RGIYSKPPYTEYISTR 162

Query: 177 ---APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW 232
              APE L   GY G   D+W+ G + F +++ +  F G  +L  + K            
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK------------ 210

Query: 233 FSTGATSLIHKIL-DPNPKTRIRIEGIRKHPWFRKNYN 269
                   IH +L  P+ +        +       NYN
Sbjct: 211 --------IHDVLGTPDAEV-----LKKFRKSRHMNYN 235

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  129 bits (327), Expect = 2e-34
 Identities = 94/296 (31%), Positives = 132/296 (44%), Gaps = 53/296 (17%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REISI 62
           KYE    IGEGT+  V  A+NRET E VA+K        + R+ D  +       REI +
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICL 52

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 120
           +K ++H NIVRL++VL S  K+ ++ E+      + FD     G +     + +  QL+ 
Sbjct: 53  LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLK 110

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
            +A CHS  V HRDLKP+NLL++  G LK++DFGL+      V        T  Y  P+V
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 170

Query: 181 L-SNRGYDGSAADVWSCGVILFVLMAGYLPF--------------------------GET 213
           L   + Y  S  D+WS G I   L     P                           G +
Sbjct: 171 LFGAKLYSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS 229

Query: 214 DLPT-----LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            LP      +Y    +     P   STG   L+  +L  NP  RI  E   +HP+F
Sbjct: 230 KLPDYKPYPMYPATTSLVNVVPKLNSTG-RDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  128 bits (325), Expect = 2e-34
 Identities = 71/198 (35%), Positives = 106/198 (53%), Gaps = 18/198 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            YE+ + IG GT+  V  A++  TGE VA+KV+    +      + I++EIS++K  RHP
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRHP 60

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL-LEND-----CRRYFQQLIDAVA 123
           NIV        R K++I++E+  GG L D I    R  L        CR   + L    A
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGL----A 115

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           + H  G  HRD+K  N+LL   G++K++DFG+SA     +    +  GTP ++APEV + 
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 184 R---GYDGSAADVWSCGV 198
               GYDG   D+W+ G+
Sbjct: 176 ERKGGYDG-KCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  128 bits (324), Expect = 4e-34
 Identities = 74/191 (38%), Positives = 108/191 (56%), Gaps = 7/191 (3%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66

Query: 77  VLASRTKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
           V+ +  K+Y++ EF+    + F        +     + Y  QL+  +A CHS  V HRDL
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVLSNRGYDGSAADV 193
           KP+NLL+++ G +K++DFGL+     GV +   T    T  Y APE+L    Y  +A D+
Sbjct: 127 KPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184

Query: 194 WSCGVILFVLM 204
           WS G I F  M
Sbjct: 185 WSLGCI-FAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  126 bits (319), Expect = 1e-33
 Identities = 66/219 (30%), Positives = 103/219 (47%), Gaps = 11/219 (5%)

Query: 12  EVGRTIGEGTFAKVR----FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           E+G+ +GEG F +V           T   VA+K L +         ++   E SIMK + 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA--SEEEREEFLEEASIMKKLS 59

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 126
           HPNIVRL  V      +YI+ E++ GG+L D +  H  +L   D  +   Q+   + +  
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
           SK   HRDL   N L+     +K+SDFGLS  + +            P  ++APE L + 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179

Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
            +  S +DVWS GV+L+ +   G  P+       + + +
Sbjct: 180 KFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217

Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  127 bits (320), Expect = 1e-33
 Identities = 80/258 (31%), Positives = 133/258 (51%), Gaps = 10/258 (3%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A ++ TG  VA+K   K  + K +  + +  E+ IM+  +HPNIV ++ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D IV   R+ E         ++ A++  H++GV HRD+K
Sbjct: 84  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL S G +K+SDFG  A   + V    +  GTP ++APEV+S   Y G+  D+WS 
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSL 201

Query: 197 GVILFVLMAGYLP-FGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKILDPNPKTR 252
           G+++  ++ G  P F E  L  + K+I              S    S + ++L  +P  R
Sbjct: 202 GIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR 260

Query: 253 IRIEGIRKHPWFRKNYNP 270
                +  HP+  K   P
Sbjct: 261 ATAAELLNHPFLAKAGPP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  128 bits (322), Expect = 3e-33
 Identities = 71/207 (34%), Positives = 116/207 (56%), Gaps = 16/207 (7%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVL---AKSTILKHRMVDQIKREISIMKIVRH 68
           E    IG G    V    +R TG   A+KV+    + T+ +     QI REI I++ V H
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PN+V+ H++     ++ ++LEF+ GG L    +   + L +  R    Q++  +A+ H +
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---NRG 185
            + HRD+KP NLL++S  N+K++DFG+S +  Q ++  +++ GT  Y++PE ++   N G
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247

Query: 186 -YDGSAADVWSCGVILFVLMAGYLPFG 211
            YDG A D+WS GV +     G  PFG
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFG 274

Length = 353

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  125 bits (315), Expect = 4e-33
 Identities = 74/257 (28%), Positives = 122/257 (47%), Gaps = 9/257 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   R +G+G F +    +  E    V  K +  +  L  +       EI I+ +++HPN
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHCHSK 128
           I+  +        + I +E+  GG L+DKIV Q   L  E     Y  Q++ AV++ H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--TTCGTPNYVAPEVLSNRGY 186
           G+ HRD+K  N+ L   G +K+ DFG+S     G E     T  GTP Y++PE+     Y
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISK--ILGSEYSMAETVVGTPYYMSPELCQGVKY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKIL 245
           +   +D+W+ G +L+ L+     F  T+   L  KI    ++     +S+   SL+H +L
Sbjct: 179 N-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLL 237

Query: 246 DPNPKTRIRIEGIRKHP 262
             +P+ R   + +   P
Sbjct: 238 QQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  124 bits (314), Expect = 5e-33
 Identities = 76/262 (29%), Positives = 131/262 (50%), Gaps = 17/262 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ----IKREISIMKI 65
           KYE  R +G G F  V   + +   + V +K      I   +M        + E  ++K+
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIK-----QIPVEQMTKDERLAAQNECQVLKL 55

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVA 123
           + HPNI+  +E       + I++E+  GG L + I  +   L  E+    +F Q++ A+ 
Sbjct: 56  LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115

Query: 124 HCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           H H+K + HRDLK +N+LLD +   +K+ DFG+S +     +  +T  GTP Y++PE+  
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AYTVVGTPCYISPELCE 174

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WFSTGATSL 240
            + Y+   +D+W+ G +L+ L +    F   +LP L  KI +  F+ P    +S     L
Sbjct: 175 GKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-PISDRYSPDLRQL 232

Query: 241 IHKILDPNPKTRIRIEGIRKHP 262
           I  +L+ +P  R ++  I   P
Sbjct: 233 ILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  125 bits (315), Expect = 5e-33
 Identities = 70/209 (33%), Positives = 112/209 (53%), Gaps = 12/209 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHR-----MVDQIKREISIMKIV 66
           G  IG+GT+ +V  A N  TGE +A+K   L  +   +H      MV  ++ EI  +K +
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            H NIV+      +   + I LE+V GG +   +   GR  E   R + +Q+++ +A+ H
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEVLSN- 183
           SKG+ HRDLK +NLL+D+ G  K+SDFG+S       +        G+  ++APEV+ + 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 184 -RGYDGSAADVWSCGVILFVLMAGYLPFG 211
            +GY     D+WS G ++  + AG  P+ 
Sbjct: 186 SQGYSAK-VDIWSLGCVVLEMFAGRRPWS 213

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  125 bits (317), Expect = 5e-33
 Identities = 90/310 (29%), Positives = 139/310 (44%), Gaps = 69/310 (22%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
           R V +YE    I EGT+  V  A++++TGE VA+K              ++K        
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------------KLKMEKEKEGF 47

Query: 58  -----REISIMKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKI-VHQGRLLEN 109
                REI+I+  ++HPNIV + EV+      K+Y+++E+V   +L   +   +   L++
Sbjct: 48  PITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS 106

Query: 110 DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
           + +    QL+  VAH H   + HRDLK  NLLL++ G LK+ DFGL+   + G  L   T
Sbjct: 107 EVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYT 164

Query: 170 CG--TPNYVAPEVLSNRGYDGSAADVWSCGVIL--FVLMAGYLPFGETDLPTLYK----- 220
               T  Y APE+L       +A D+WS G I    +      P G++++  L K     
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKIFKLL 223

Query: 221 -----KINAAEFSCPFW----------------FSTGATS-----LIHKILDPNPKTRIR 254
                KI       P                  F   + S     L++++L  +P  RI 
Sbjct: 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283

Query: 255 IEGIRKHPWF 264
            E   KHP+F
Sbjct: 284 AEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  124 bits (313), Expect = 6e-33
 Identities = 71/245 (28%), Positives = 120/245 (48%), Gaps = 5/245 (2%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   IG+G+F  V     +      AMK +  S  +  R  ++   E  ++  +    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSK 128
           I+R +E    + K+ I++E+   G+L   +  Q    L E+   R+F Q++  +AH HSK
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + HRD+K  NL LD+Y N+K+ D G++ L        +T  GTP Y++PE+  ++ Y+ 
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYN- 179

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILDP 247
             +DVW+ GV+L+    G  PF   +   L  KI    F      +S     LI + L  
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK 239

Query: 248 NPKTR 252
           + + R
Sbjct: 240 DYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (313), Expect = 9e-33
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 15/229 (6%)

Query: 14  GRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           G+ +GEG F +V   +      +    VA+K L +    +     +  RE  IM+ + HP
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIE--EFLREARIMRKLDHP 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSK 128
           N+V+L  V      +YI++E++ GG+L   +  ++ +L  +D   +  Q+   + +  SK
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
              HRDL   N L+     +K+SDFGLS                P  ++APE L    + 
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF- 180

Query: 188 GSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEF-----SCP 230
            S +DVWS GV+L+ +   G  P+       + + +          +CP
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP 229

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  127 bits (320), Expect = 9e-33
 Identities = 91/305 (29%), Positives = 136/305 (44%), Gaps = 56/305 (18%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +T+G G F +V  A+  +T    AMK L K  +L    V  +K E  I+    +  +VRL
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           +     +  +Y +++++ GG++   ++  G   E+  R Y  +L  AV   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 135 LKPENLLLDSYGNLKVSDFGL--------------------------------------- 155
           +KP+N+L+D  G++K++DFGL                                       
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186

Query: 156 --------SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
                    A  Q    L H+  GTPNY+APEVL   GY     D WS GVIL+ ++ G 
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245

Query: 208 LPF-GETDLPTLYKKIN-AAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEG---IRK 260
            PF  +T L T  K IN       P     S  A+ LI K+    P+ R+   G   I+ 
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKA 304

Query: 261 HPWFR 265
           HP+F+
Sbjct: 305 HPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  126 bits (318), Expect = 9e-33
 Identities = 86/323 (26%), Positives = 138/323 (42%), Gaps = 87/323 (26%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVR 67
           +YE+ + IG G +  V  A ++ TG  VA+K ++   +     +D  +I REI +++ +R
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN--VFDDL-IDAKRILREIKLLRHLR 57

Query: 68  HPNIVRLHEVLASRTK-----VYIILEFVTGGELFD----KIVHQGRLLENDCRRYFQ-Q 117
           H NI+ L ++L   +      VYI    VT  EL +    K++   + L +D  +YF  Q
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYI----VT--ELMETDLHKVIKSPQPLTDDHIQYFLYQ 111

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV 176
           ++  + + HS  V HRDLKP N+L++S  +LK+ DFGL+  +     E    T     YV
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT----EYV 167

Query: 177 ------APEV-LSNRGYDGSAADVWSCGVILFVLMAG----------------------- 206
                 APE+ LS+  Y   A D+WS G I   L+                         
Sbjct: 168 VTRWYRAPELLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTP 226

Query: 207 ---------------YL----PFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
                          YL       +  L  L+   +             A  L+ K+L  
Sbjct: 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE-----------AIDLLEKMLVF 275

Query: 248 NPKTRIRIEGIRKHPWFRKNYNP 270
           +PK RI  +    HP+  + ++P
Sbjct: 276 DPKKRITADEALAHPYLAQLHDP 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  124 bits (313), Expect = 1e-32
 Identities = 85/287 (29%), Positives = 136/287 (47%), Gaps = 48/287 (16%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REISIMKIVRHP 69
           IGEGT+  V   +N++TG+ VAMK        K R+  + +       REIS++K ++HP
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMK--------KIRLESEEEGVPSTAIREISLLKELQHP 59

Query: 70  NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIV L +VL   +++Y+I EF++    +  D +     +     + Y  Q++  +  CHS
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V HRDLKP+NLL+D+ G +K++DFGL+      V +      T  Y APEVL      
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 188 GSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK-----------------KINAAEFS 228
            +  D+WS G I F  MA   P   G++++  L++                  +   + +
Sbjct: 180 STPVDIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238

Query: 229 CPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            P W                  L+ K+L  +P  RI  +    HP+F
Sbjct: 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  123 bits (309), Expect = 3e-32
 Identities = 76/254 (29%), Positives = 131/254 (51%), Gaps = 11/254 (4%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +A + + + IG G F++V  A     G  VA+K +    ++  +      +EI ++K + 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDAVA 123
           HPN+++ +       ++ I+LE    G+L   I H   Q RL+ E    +YF QL  A+ 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WFSTGAT 238
            GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +S    
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELR 238

Query: 239 SLIHKILDPNPKTR 252
            L++  ++P+P+ R
Sbjct: 239 QLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  121 bits (307), Expect = 5e-32
 Identities = 62/203 (30%), Positives = 109/203 (53%), Gaps = 7/203 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +++   +GEG++  V  A ++ETG+ VA+KV+     L+     +I +EISI+K    P 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           IV+ +      T ++I++E+   G + D + +    L E +      Q +  + + HS  
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
             HRD+K  N+LL+  G  K++DFG+S      +   +T  GTP ++APEV+   GY+ +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-N 178

Query: 190 AADVWSCGVILFVLMAGYLPFGE 212
            AD+WS G+    +  G  P+ +
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSD 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  122 bits (308), Expect = 7e-32
 Identities = 83/267 (31%), Positives = 136/267 (50%), Gaps = 17/267 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRH 68
           +E+   +G+G F KV  A+N+ETG   A KV+   +   L+  MV     EI I+    H
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-----EIEILATCNH 68

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHS 127
           P IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+ + HS
Sbjct: 69  PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----LS 182
             + HRDLK  N+LL   G++K++DFG+SA   + ++   +  GTP ++APEV     + 
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATS 239
           +  YD   AD+WS G+ L  +     P  E +   +  KI  +E    S P  +S     
Sbjct: 189 DTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
            +   LD +P+TR     + +HP+   
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  121 bits (306), Expect = 1e-31
 Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 33/276 (11%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG G  A V  A      E VA+K   L K        VD++++E+  M    H
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT----SVDELRKEVQAMSQCNH 58

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHC 125
           PN+V+ +       ++++++ +++GG L D +     +G L E       ++++  + + 
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL----LHTTCGTPNYVAPEVL 181
           HS G  HRD+K  N+LL   G++K++DFG+SA    G +       T  GTP ++APEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 182 SN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLPTLYKKINAAEFS 228
               GYD   AD+WS G+    L  G  P+             + D P+L    +  ++S
Sbjct: 179 EQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237

Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
             F        +I   L  +P  R   E + KH +F
Sbjct: 238 KSF------RKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  120 bits (303), Expect = 2e-31
 Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 16/230 (6%)

Query: 14  GRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           G+ +GEG F +V               VA+K L +    +     +  RE  IM+ + HP
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIE--EFLREARIMRKLDHP 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYF-QQLIDAVAHCHS 127
           NIV+L  V      + I++E++ GG+L D +  ++ + L       F  Q+   + +  S
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
           K   HRDL   N L+     +K+SDFGLS                P  ++APE L    +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEF-----SCP 230
             S +DVWS GV+L+ +   G  P+       + + +          +CP
Sbjct: 182 -TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP 230

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  120 bits (304), Expect = 3e-31
 Identities = 73/214 (34%), Positives = 117/214 (54%), Gaps = 6/214 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-REISIMKIVRH 68
           KYE    +GEG++  V   +++ETG+ VA+K   +S     +MV +I  REI ++K +RH
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESE--DDKMVKKIAMREIRMLKQLRH 59

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
            N+V L EV   + ++Y++ EFV    L D   +   L E+  R+Y  Q++  +  CHS 
Sbjct: 60  ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + HRD+KPEN+L+   G +K+ DFG +       E+      T  Y APE+L      G
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 189 SAADVWSCGVILFVLMAG--YLPFGETDLPTLYK 220
            A D+W+ G ++  ++ G    P G++D+  LY 
Sbjct: 180 RAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  118 bits (297), Expect = 1e-30
 Identities = 74/254 (29%), Positives = 129/254 (50%), Gaps = 11/254 (4%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +A +++ + IG G F++V  A      + VA+K +    ++  +      +EI ++K + 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDAVA 123
           HPN+++  +      ++ I+LE    G+L   I +   Q RL+ E    +YF QL  AV 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WFSTGAT 238
            GY+   +D+WS G +L+ + A   PF   + +L +L +KI   ++  P     +S    
Sbjct: 181 NGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP-PLPTEHYSEKLR 238

Query: 239 SLIHKILDPNPKTR 252
            L+   + P+P  R
Sbjct: 239 ELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  118 bits (296), Expect = 2e-30
 Identities = 80/267 (29%), Positives = 133/267 (49%), Gaps = 22/267 (8%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMK------VLAKSTILKHRMVDQIKREISIMKIVR 67
           G  IG G+F  V    N  +GE +A+K      V A S   K  M+D + REI+++K ++
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           H NIV+          + I LE+V GG +   + + G   E   R + +Q++  + + H+
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGT--PN------YVA 177
           +G+ HRD+K  N+L+D+ G +K+SDFG+S    + +E   L T      P+      ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGIS----KKLEANSLSTKTNGARPSLQGSVFWMA 180

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWFSTG 236
           PEV+    Y    AD+WS G ++  ++ G  PF + T L  ++K    A    P   S+ 
Sbjct: 181 PEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239

Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPW 263
           A   + K  + +   R     + KHP+
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  120 bits (303), Expect = 2e-30
 Identities = 76/257 (29%), Positives = 115/257 (44%), Gaps = 49/257 (19%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +T+G G F +V  A   +T    AMK L K  +L    V  +K E  I+    +  +V+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           +     +  +Y +++++ GG++   ++      E   R Y  +L  A+   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 135 LKPENLLLDSYGNLKVSDFGL----------------SALPQQGVE-------------- 164
           +KP+N+L+D  G++K++DFGL                S + Q  +E              
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 165 -----------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
                            L H+  GTPNY+APEVL  +GY     D WS GVILF ++ G 
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245

Query: 208 LPF-GETDLPTLYKKIN 223
            PF   T   T  K IN
Sbjct: 246 PPFLAPTPTETQLKVIN 262

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  118 bits (298), Expect = 2e-30
 Identities = 89/312 (28%), Positives = 140/312 (44%), Gaps = 68/312 (21%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------R 58
           R V K+++   IGEGT+ +V  A++++TGE VA+K        K R+ ++ +       R
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALK--------KVRLDNEKEGFPITAIR 55

Query: 59  EISIMKIVRHPNIVRLHEVLASRTKV----------YIILEFVTG---GELFDKIVHQGR 105
           EI I++ + H NIV L E++  +             Y++ E++     G L   +VH   
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH--- 112

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
             E+  + + +QL++ + +CH K   HRD+K  N+LL++ G +K++DFGL+ L       
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 166 LHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL--------------------- 203
            +T    T  Y  PE+L      G A DVWSCG IL  L                     
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232

Query: 204 MAGY-----------LPFGETDLPT-LYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           + G            LP+  T  P   Y++    EFS   +  T A  L+  +L  +P  
Sbjct: 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS---FIPTPALDLLDHMLTLDPSK 289

Query: 252 RIRIEGIRKHPW 263
           R   E     PW
Sbjct: 290 RCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 3e-30
 Identities = 76/283 (26%), Positives = 137/283 (48%), Gaps = 44/283 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRH 68
            +E+   IGEGT+ KV  A++++TG+ VA+K++     +     ++IK E +I+ K   H
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSNH 62

Query: 69  PNIVRLHEV------LASRTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYF-QQL 118
           PNI   +          +  ++++++E   GG   +L   +  +G+ L+ +   Y  ++ 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +A+ H   V HRD+K +N+LL     +K+ DFG+SA     +   +T  GTP ++AP
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182

Query: 179 EVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGE------------TDLPTLYKK 221
           EV++     +  YD + +DVWS G+    L  G  P  +               PTL   
Sbjct: 183 EVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP 241

Query: 222 IN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 263
            N + +F+            I + L  N + R  +E + +HP+
Sbjct: 242 ENWSKKFN----------DFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 5e-30
 Identities = 74/276 (26%), Positives = 133/276 (48%), Gaps = 22/276 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM--VDQIKREISIMKIVR 67
            + +   IG+G+F +V  A ++ T + VA+KV+     L+     ++ I++EI  +   R
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID----LEEAEDEIEDIQQEIQFLSQCR 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P I + +      +K++II+E+  GG   D ++  G+L E       ++++  + + H 
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           +G  HRD+K  N+LL   G++K++DFG+S      +   +T  GTP ++APEV+   GYD
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD 176

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETD-------LPTLY-KKINAAEFSCPFWFSTGATS 239
              AD+WS G+    L  G  P  +         +P      +   +FS PF        
Sbjct: 177 -EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPF------KD 229

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
            +   L+ +PK R   + + KH + +K       + 
Sbjct: 230 FVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTL 265

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 6e-30
 Identities = 70/210 (33%), Positives = 116/210 (55%), Gaps = 10/210 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA--KSTILKHRMVDQIKREISIMKIVRH 68
           + +G+ +G G F +V    + +TG  +A+K +     +    + V+ ++ EI ++K +RH
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 69  PNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             IV+ +  L      K+ I +E++ GG + D++   G L EN  RRY +Q++  V++ H
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNYVAPEVLS 182
           S  + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSPEVIS 182

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
             GY G  ADVWS    +  ++    P+ E
Sbjct: 183 GEGY-GRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  116 bits (292), Expect = 8e-30
 Identities = 74/265 (27%), Positives = 131/265 (49%), Gaps = 14/265 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLA---KSTILKHRMVDQIKREISIMKIVRHPN 70
           G+ +G G F+    A++ +TG  +A+K +     ++  +  +V+ +++EI +M  + HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+R+       +   + +E++ GG +   +   G   E     Y +QL+  +++ H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 131 YHRDLKPENLLLDSYGN-LKVSDFGLSA-LPQQGV---ELLHTTCGTPNYVAPEVLSNRG 185
            HRD+K  NLL+DS G  L+++DFG +A L  +G    E      GT  ++APEVL    
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEF-SCPFWFSTGATSL 240
           Y G + DVWS G ++  +     P+        L  ++K  +A    S P   S G   +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFR 265
             + L+  P+ R     + KHP FR
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  116 bits (293), Expect = 2e-29
 Identities = 90/330 (27%), Positives = 141/330 (42%), Gaps = 87/330 (26%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
           R V ++E    IGEGT+  V  A++  +GE VA+K        K RM D  +        
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALK--------KVRM-DNERDGIPISSL 54

Query: 58  REISIMKIVRHPNIVRLHEVLASR--TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRY 114
           REI+++  +RHPNIV L EV+  +    +++++E+                LL+N    +
Sbjct: 55  REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE---------QDLASLLDNMPTPF 105

Query: 115 --------FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGV 163
                     QL+  + + H   + HRDLK  NLLL   G LK++DFGL+    LP + +
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165

Query: 164 ELLHTTCGTPN-----YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL- 215
                   TP      Y APE+L       +A D+W+ G IL  L+A    LP G++++ 
Sbjct: 166 --------TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP-GKSEIE 216

Query: 216 -----------------PTLYKKINAAEFSCP----------F-WFSTGATSLIHKILDP 247
                            P         +F+ P          F W S     L++ +L  
Sbjct: 217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY 276

Query: 248 NPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
           +PK R   E   +  +F++   P+ C  E 
Sbjct: 277 DPKKRATAEEALESSYFKE--KPLPCEPEM 304

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  115 bits (290), Expect = 2e-29
 Identities = 83/275 (30%), Positives = 141/275 (51%), Gaps = 20/275 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR---EISIMKIVR 67
           +E+   +G+G F KV  AQN+ETG      VLA + ++  +  ++++    EI I+    
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEIDILASCD 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCH 126
           HPNIV+L +       ++I++EF  GG +   ++   R L E   R   +Q ++A+ + H
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 181
              + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+     
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGAT 238
            +R YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+   
Sbjct: 181 KDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 272
             + K L+ N   R     + +HP+   N N P++
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIR 274

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  114 bits (287), Expect = 3e-29
 Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 9/261 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVR 67
           +Y + + +G+G+F  V   ++++      +KVL +  +  L      Q  +E  ++  + 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI---VHQGRLL-ENDCRRYFQQLIDAVA 123
           HP IV+ H     R    II E+  G +L  K+    H G+ L EN    +F QL+  V 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           + H + + HRDLK +N+ L +   LK+ DFG+S L     +L  T  GTP Y++PE L +
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           +GYD S +D+WS G IL+ +      F G+  L  + + +     S P  +S    S++ 
Sbjct: 180 QGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238

Query: 243 KILDPNPKTRIRIEGIRKHPW 263
            +L+ +P  R     I ++P+
Sbjct: 239 SMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  114 bits (288), Expect = 3e-29
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 34/271 (12%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVL---AKSTILKHRMVDQIKREISIMKIVRHPNI 71
             +G G    V    +R TG+ +A+K +       I K     QI RE+ I+     P I
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK-----QILRELDILHKCNSPYI 61

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCRRYFQQLIDAVAHCHSK- 128
           V  +    +   + I +E++ GG L DKI    QGR+ E    +    ++  + + H K 
Sbjct: 62  VGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + HRD+KP N+L++S G +K+ DFG+S   Q    L  T  GT +Y+APE +    Y  
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSG--QLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 189 SAADVWSCGVILFVLMAGYLPFG------ETDLPTLYKKIN-------AAEFSCPFWFST 235
             +D+WS G+ L  L  G  P+       +     L   +N       + +FS  F    
Sbjct: 179 K-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF---- 233

Query: 236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
                ++  L  +P+ R   + + +HP+ +K
Sbjct: 234 --QDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  114 bits (287), Expect = 6e-29
 Identities = 78/262 (29%), Positives = 131/262 (50%), Gaps = 13/262 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I + G     E     Y  +++  +   H +   +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD YG++++SD GL+    +G E +    GT  Y+APEVL+N+ Y   + D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQRY-TLSPD 183

Query: 193 VWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            W  G +++ ++ G  PF     +     + +++   E      FS  A S+   +L  +
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD 243

Query: 249 PKTRI--RIEG---IRKHPWFR 265
           PK R+  + EG   +++HP+FR
Sbjct: 244 PKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  114 bits (287), Expect = 7e-29
 Identities = 76/226 (33%), Positives = 118/226 (52%), Gaps = 28/226 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--------AKSTILKHRMVDQIKREIS 61
           +YE    IGEGT+  V  A++R T E++A+K +          ST +         REIS
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI---------REIS 53

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL-FDKIVHQGRLLENDCR---RYFQQ 117
           ++K ++H NIVRL +V+ S  ++Y++ E++   +L   K +        + R    Y  Q
Sbjct: 54  LLKEMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQ 110

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           ++  +A+CHS  V HRDLKP+NLL+D   N LK++DFGL+      V        T  Y 
Sbjct: 111 ILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 220
           APE+L    +  +  D+WS G I F  M    P   G++++  L+K
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFK 215

Length = 294

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  114 bits (288), Expect = 8e-29
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 68/312 (21%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK----REISIMKIV 66
           YE+   +GEGTF +V  A+  +TG  VA+K      IL H   D       REI I+K +
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKKL 64

Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +HPN+V L ++   R          VY++  ++     G L +  V    L E+  + Y 
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYM 121

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--------ALPQQGVELLH 167
            QL++ + + H   + HRD+K  N+L+D+ G LK++DFGL+             G     
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 168 TTCG---TPNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK- 220
                  T  Y  PE +L  R Y  +A D+W  G +   +      L  G++D+  L+  
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQ-GKSDIDQLHLI 239

Query: 221 --------KINAAEFS----CPFWFST----------------GATSLIHKILDPNPKTR 252
                   +     +     C    S                     L+ K+L  +P  R
Sbjct: 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKR 299

Query: 253 IRIEGIRKHPWF 264
           +      +HP+F
Sbjct: 300 LTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  113 bits (283), Expect = 1e-28
 Identities = 67/210 (31%), Positives = 116/210 (55%), Gaps = 10/210 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA--KSTILKHRMVDQIKREISIMKIVRH 68
           + +G+ +G+G F +V    + +TG  +A+K +     +    + V+ ++ EI ++K + H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 69  PNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             IV+ +  L       + I +E + GG + D++   G L EN  R+Y +Q+++ V++ H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNYVAPEVLS 182
           S  + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP +++PEV+S
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSPEVIS 182

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
             GY G  AD+WS G  +  ++    P+ E
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  113 bits (284), Expect = 1e-28
 Identities = 74/265 (27%), Positives = 134/265 (50%), Gaps = 19/265 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
           + E+   IG G +  V   ++  TG  VA+K++   T      V  I+RE++++  +R  
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQS 59

Query: 69  --PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             PNI + +       +++II+E+  GG +   ++  G + E       ++++ A+ + H
Sbjct: 60  QPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIH 118

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
             GV HRD+K  N+L+ + GN+K+ DFG++AL  Q      T  GTP ++APEV++  + 
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATSL 240
           YD + AD+WS G+ ++ +  G  P+ + D    ++ +     S P       +S      
Sbjct: 179 YD-TKADIWSLGITIYEMATGNPPYSDVD---AFRAMMLIPKSKPPRLEDNGYSKLLREF 234

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFR 265
           +   LD  PK R+  E + K  W +
Sbjct: 235 VAACLDEEPKERLSAEELLKSKWIK 259

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  112 bits (282), Expect = 1e-28
 Identities = 67/207 (32%), Positives = 116/207 (56%), Gaps = 10/207 (4%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLA--KSTILKHRMVDQIKREISIMKIVRHPNI 71
           G+ +G+G F +V    + +TG  +A K +     +    + V  ++ EI ++K ++H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 72  VRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           V+ +  L  R +  + I +E++ GG + D++   G L E+  R+Y +Q+++ +++ HS  
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQ----QGVELLHTTCGTPNYVAPEVLSNRG 185
           + HRD+K  N+L DS GN+K+ DFG S   Q     G  +   T GTP +++PEV+S  G
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSPEVISGEG 185

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE 212
           Y G  ADVWS G  +  ++    P+ E
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  113 bits (284), Expect = 2e-28
 Identities = 64/194 (32%), Positives = 114/194 (58%), Gaps = 5/194 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A+ + +G  VA+K++    + K +  + +  E+ IM+  +H N+V +++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D IV Q RL E       + ++ A+ + HS+GV HRD+K
Sbjct: 86  SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V    +  GTP ++APEV+S   Y G+  D+WS 
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSL 203

Query: 197 GVILFVLMAGYLPF 210
           G+++  ++ G  P+
Sbjct: 204 GIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 2e-28
 Identities = 81/269 (30%), Positives = 134/269 (49%), Gaps = 17/269 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + + TG+  AMK+L K  +LK       + E  ++       
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H  G
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFG--LSALPQQGVELLHTTCGTPNYVAPEVL----SN 183
             HRD+KP+N+LLD  G+++++DFG  L  L    V+      GTP+Y++PE+L      
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN-VAVGTPDYISPEILQAMEDG 181

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGAT 238
           +G  G   D WS GV ++ ++ G  PF    L   Y KI   +  F  P      S  A 
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAK 241

Query: 239 SLIHKILDPNPKTRIRIEGI---RKHPWF 264
            LI +++   P+TR+   G+   + HP+F
Sbjct: 242 DLIRRLICS-PETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 64/269 (23%), Positives = 107/269 (39%), Gaps = 31/269 (11%)

Query: 15  RTIGEGTFAKVRFA---QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + +GEG F +V              VA+K L +    + R      +E  +MK + HPN+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--------QQLID--- 120
           VRL  V      +Y++LE++ GG+L         L ++              + L+    
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDL------LDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112

Query: 121 ----AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TPN- 174
                + +  SK   HRDL   N L+     +K+SDFGLS            T G  P  
Sbjct: 113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF-SCPFW 232
           ++APE L +  +  S +DVWS GV+L+ +   G  P+       + + +        P +
Sbjct: 173 WMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEY 231

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                  L+      +P+ R     + + 
Sbjct: 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  114 bits (285), Expect = 3e-28
 Identities = 74/267 (27%), Positives = 128/267 (47%), Gaps = 13/267 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + +   +  AMK+L K  +LK       + E  ++    +  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS----NR 184
             HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+L      +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFW---FSTGATS 239
           G  G   D WS GV ++ ++ G  PF    L   Y KI  +   F  P      S  A  
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKD 242

Query: 240 LIHKILDPNPKT--RIRIEGIRKHPWF 264
           LI +++        +  IE  ++HP+F
Sbjct: 243 LIRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  112 bits (282), Expect = 3e-28
 Identities = 81/262 (30%), Positives = 129/262 (49%), Gaps = 14/262 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V   Q R TG+  A K L K  + K +  +    E  I+  V    IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGVYH 132
              ++T + +++  + GG+L   I +         E     Y  Q+I  + H H + + +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD+ GN+++SD GL+   + G        GTP ++APE+L    YD S  D
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS-VD 179

Query: 193 VWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            ++ GV L+ ++A   PF   GE  +   L ++I     + P  FS  + S    +L  +
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239

Query: 249 PKTRI-----RIEGIRKHPWFR 265
           P+ R+       +G+R HP FR
Sbjct: 240 PEKRLGFRDGNCDGLRTHPLFR 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 4e-28
 Identities = 76/265 (28%), Positives = 128/265 (48%), Gaps = 17/265 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I + G     E     Y  ++   +   H + + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD YG++++SD GL+    +G E +    GT  Y+APEV+ N  Y   + D
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNERY-TFSPD 183

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSCPFWFSTGATSLIHKILD 246
            W  G +++ ++ G  PF +       +++      +  E+S    FS  A S+  ++L 
Sbjct: 184 WWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEK--FSEAARSICRQLLT 241

Query: 247 PNPKTRI-----RIEGIRKHPWFRK 266
            +P  R+       E ++ HP+FR 
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRT 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  111 bits (279), Expect = 5e-28
 Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 20/262 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGES-VAMK-------VLAKSTILKHRMVDQIKREISI 62
           Y V   +G G F  V   + +  G++ +A+K          K    + + +  I  E++I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 63  MK-IVRHPNIVRLHEVLASRTKVYIILEFVTG---GELFDKIVHQG-RLLENDCRRYFQQ 117
           +K  +RHPNIVR ++      ++YI+++ + G   GE F+ +  +  R  E      F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 118 LIDAVAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           ++ A+ + H  K + HRDL P N++L     + ++DFGL A  +Q    L +  GT  Y 
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYS 180

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---WF 233
            PE++ N  Y G  ADVW+ G IL+ +     PF  T++ +L  KI  A +  P     +
Sbjct: 181 CPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLPEGMY 238

Query: 234 STGATSLIHKILDPNPKTRIRI 255
           S   T +I   L P+ + R  I
Sbjct: 239 SEDVTDVITSCLTPDAEARPDI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  112 bits (281), Expect = 5e-28
 Identities = 89/298 (29%), Positives = 134/298 (44%), Gaps = 48/298 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
            YE    IGEGT+ KV  A+++ TG+ VA+K   +  + +  +     REIS+++++   
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSES 60

Query: 69  PNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGR-----LLENDCRRYFQQL 118
             IVRL +V     K     +Y++ E++   +L   +   GR     L     + +  QL
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           +  VAHCH  GV HRDLKP+NLL+D     LK++D GL       V+       T  Y A
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA 179

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDL------------------PT 217
           PEVL    +  +  D+WS G I F  M+   P   G+++L                  P 
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCI-FAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238

Query: 218 LYKKINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
           + K  +  EF  P W            S     L+ K+L  +P  RI  +    HP+F
Sbjct: 239 VSKLRDWHEF--PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  111 bits (278), Expect = 1e-27
 Identities = 63/194 (32%), Positives = 111/194 (57%), Gaps = 5/194 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  + TG+ VA+K   K  + K +  + +  E+ IM+   H N+V ++ 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A+++ H++GV HRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL S G +K+SDFG  A   + V    +  GTP ++APEV+S   Y G+  D+WS 
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSL 204

Query: 197 GVILFVLMAGYLPF 210
           G+++  ++ G  P+
Sbjct: 205 GIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  110 bits (277), Expect = 1e-27
 Identities = 82/261 (31%), Positives = 130/261 (49%), Gaps = 15/261 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVRHPNIVR 73
           IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++     P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           +     +  K+  IL+ + GG+L   +   G   E + R Y  ++I  + H H++ V +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RGYDGSAAD 192
           DLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL     YD S+AD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAYD-SSAD 178

Query: 193 VWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
            +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L  + 
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV 238

Query: 250 KTRIRIEG-----IRKHPWFR 265
             R+   G     +++HP+FR
Sbjct: 239 NRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  110 bits (275), Expect = 2e-27
 Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 19/266 (7%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I H G     + R  F   ++   +   H + + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  S  D
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFS-PD 183

Query: 193 VWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
            W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL   +L
Sbjct: 184 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-EEYSEK--FSPDARSLCKMLL 240

Query: 246 DPNPKTRIRIEG-----IRKHPWFRK 266
             +PK R+  +G     +++HP F++
Sbjct: 241 CKDPKERLGCQGGGAREVKEHPLFKQ 266

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  109 bits (273), Expect = 3e-27
 Identities = 73/253 (28%), Positives = 129/253 (50%), Gaps = 6/253 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G++ +V   ++R  G+   +K L        R     ++E  ++  ++HPNIV  
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 75  HEVLASRT-KVYIILEFVTGGELFDKIVHQ-GRLL-ENDCRRYFQQLIDAVAHCHSKGVY 131
            E        +YI++ F  GG+L+ K+  Q G+LL EN    +F Q+  A+ + H K + 
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDLK +N+ L     +KV D G++ + +   ++  T  GTP Y++PE+ SN+ Y+   +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYN-YKS 183

Query: 192 DVWSCGVILFVLMAGYLPFGETDLPTL-YKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
           DVW+ G  ++ +      F   D+ +L Y+ I       P  +S     LI  +L   P+
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPE 243

Query: 251 TRIRIEGIRKHPW 263
            R  ++ I + P+
Sbjct: 244 KRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  114 bits (288), Expect = 3e-27
 Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 14/234 (5%)

Query: 32  ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL-HEVLASRTKVYIILEF 90
            TG  VA+K+L      +     + +RE ++   + HPNIV L     A    ++ + E+
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 91  VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---N 147
           V G  L + +   G L   +  R   Q++DA+A  H++G+ HRDLKP+N+++   G   +
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 148 LKVSDFGLSAL-------PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVIL 200
            KV DFG+  L           +       GTP Y APE L         +D+++ G+I 
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179

Query: 201 FVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWF-STGATSLIHKILDPNPKTR 252
              + G     G +    LY++++  + S P W        ++ K L+ +P+ R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 4e-27
 Identities = 96/306 (31%), Positives = 145/306 (47%), Gaps = 57/306 (18%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHP 69
           Y+    IGEG +  V  A ++ TG  VA+K   K +  +H+   Q   REI I++  +H 
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHE 63

Query: 70  NIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVA 123
           NI+ + +++   +      VYI+ E +   +L+  I  Q   L ND  +YF  Q++  + 
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH--LSNDHIQYFLYQILRGLK 120

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTT-----CGTPNYV 176
           + HS  V HRDLKP NLLL++  +LK+ DFGL   A P+      HT        T  Y 
Sbjct: 121 YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD----HTGFLTEYVATRWYR 176

Query: 177 APEV-LSNRGYDGSAADVWSCGVILFVLMAG--------Y-----LPFGETDLPT---LY 219
           APE+ L+++GY   A D+WS G IL  +++         Y     L  G    P+   L 
Sbjct: 177 APEIMLNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235

Query: 220 KKIN--AAEF--SCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
             I+  A  +  S PF     W          A  L+ K+L  NP  RI +E    HP+ 
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295

Query: 265 RKNYNP 270
            + ++P
Sbjct: 296 EQYHDP 301

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  110 bits (276), Expect = 4e-27
 Identities = 77/267 (28%), Positives = 127/267 (47%), Gaps = 13/267 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + + T    AMK+L K  +LK       + E +++       
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E+  R Y  +++ A+   H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS----NR 184
             HRD+KP+N+LLD  G+++++DFG    + Q G        GTP+Y++PE+L       
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFWF---STGATS 239
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKD 242

Query: 240 LIHKILDPNPKT--RIRIEGIRKHPWF 264
           LI +++    +   +  IE  +KH +F
Sbjct: 243 LIQRLICSRERRLGQNGIEDFKKHAFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  109 bits (275), Expect = 9e-27
 Identities = 99/347 (28%), Positives = 153/347 (44%), Gaps = 75/347 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL---------AKSTILKHRMVDQIKREI 60
           KYE+ + +G+G +  V  A +R T E VA+K +         A+ T           REI
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF----------REI 57

Query: 61  SIMKIVR-HPNIVRLHEVL-ASRTK-VYIILEFVTGGELFDKIVHQGRLLENDCRRY-FQ 116
             ++ +  HPNIV+L  V+ A   K +Y++ E++   E     V +  +LE+  +RY   
Sbjct: 58  MFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM---ETDLHAVIRANILEDVHKRYIMY 114

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQ-QGVELLHTTCG 171
           QL+ A+ + HS  V HRDLKP N+LL+S   +K++DFGL    S L +     +L     
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 172 TPNYVAPEVL--SNRGYDGSAADVWSCGVILFVLMAG----------------------- 206
           T  Y APE+L  S R Y     D+WS G IL  ++ G                       
Sbjct: 175 TRWYRAPEILLGSTR-YT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPP 232

Query: 207 --------YLPFGET---DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
                     PF  T    LP+  +K            S  A  L+ K+L  NP  R+  
Sbjct: 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKA---SDDALDLLKKLLVFNPNKRLTA 289

Query: 256 EGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKV 302
           E   +HP+  + +NP   S+E  +       + D+++    +  NK+
Sbjct: 290 EEALEHPYVAQFHNP---SDEPVLPYPITIPLDDNVKLSVAEYRNKL 333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  109 bits (274), Expect = 9e-27
 Identities = 87/314 (27%), Positives = 134/314 (42%), Gaps = 66/314 (21%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKRE 59
            KY   + IG G +  V  A+N ET E VA+K         + AK T+          RE
Sbjct: 5   TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----------RE 54

Query: 60  ISIMKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ----GRLLEND 110
           I +++ + H N++ + +++    +     VYI+ E      L D  +HQ     + L +D
Sbjct: 55  IKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDD 108

Query: 111 -CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
            C+ +  QL+  + + HS  V HRDLKP NLLL++  +LK+ DFGL+    +  + +   
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEY 168

Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------- 222
             T  Y APE+L N     +A DVWS G I   L+     F   D     K I       
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSP 228

Query: 223 -----------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGI 258
                       A  +  S P+             +  A  L+ K+L  +P  RI +E  
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288

Query: 259 RKHPWFRKNYNPVK 272
             HP+    ++P  
Sbjct: 289 LAHPYLASLHDPSD 302

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  107 bits (269), Expect = 1e-26
 Identities = 72/262 (27%), Positives = 122/262 (46%), Gaps = 14/262 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMK--VLAKSTILK-HRMVDQIKREISIMKIVRHPN 70
           G  +G+G +  V +      G+ +A+K   L  S +L   +  ++++ E+ ++K ++H N
Sbjct: 5   GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV+          + I +EFV GG +   +   G L E    +Y +Q++D VA+ H+  V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS------ALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HRD+K  N++L   G +K+ DFG +       L      +L +  GTP ++APEV++  
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATSLI 241
           GY G  +D+WS G  +F +  G  P    D       I A        P  FS  A   +
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242

Query: 242 HKILDPNPKTRIRIEGIRKHPW 263
              L  +   R     + +H +
Sbjct: 243 TSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  107 bits (268), Expect = 3e-26
 Identities = 74/262 (28%), Positives = 129/262 (49%), Gaps = 18/262 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  + +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V    +  GTP ++APE++S   Y G   D+WS 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSL 202

Query: 197 GVILFVLMAGYLP-FGETDLP-------TLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           G+++  ++ G  P F E  L         L  K+       P          + ++L  +
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPS-----LKGFLDRLLVRD 257

Query: 249 PKTRIRIEGIRKHPWFRKNYNP 270
           P  R     + KHP+  K   P
Sbjct: 258 PAQRATAAELLKHPFLAKAGPP 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  107 bits (268), Expect = 3e-26
 Identities = 72/214 (33%), Positives = 110/214 (51%), Gaps = 8/214 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           K+EV   +GEG +  V   +++ET E VA+K   K +     + +   RE+ +++ ++  
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60

Query: 70  NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIV L E    R K+Y++ E+V     EL ++      +     R Y  QLI A+  CH 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEE--MPNGVPPEKVRSYIYQLIKAIHWCHK 118

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNRGY 186
             + HRD+KPENLL+     LK+ DFG +    +G    +T    T  Y +PE+L    Y
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
            G A D+WS G IL  L  G   F GE+++  L+
Sbjct: 179 -GKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  106 bits (265), Expect = 4e-26
 Identities = 76/260 (29%), Positives = 122/260 (46%), Gaps = 10/260 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG GT+  V  A+N  TGE  A+KV+    +        +++EI +MK  +H N
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV        R K++I +EF  GG L D     G L E+      ++ +  + + HSKG 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV--LSNRGYDG 188
            HRD+K  N+LL   G++K++DFG+SA     +    +  GTP ++APEV  +  +G   
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATSLIHK 243
              D+W+ G+    L     P  +         +  + F  P       +S      +  
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247

Query: 244 ILDPNPKTRIRIEGIRKHPW 263
            L  NPK R   E + +HP+
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 4e-26
 Identities = 69/213 (32%), Positives = 99/213 (46%), Gaps = 34/213 (15%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA---------KSTILKHRMVDQIKREIS 61
           YE    IGEG +  V  A++  TG  VA+K +           ST+          REI+
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL----------REIA 50

Query: 62  IMKIVR---HPNIVRLHEVLA-----SRTKVYIILEFVTG--GELFDKIVHQGRLLENDC 111
           ++K +    HPNIVRL +V          K+ ++ E V         K    G L     
Sbjct: 51  LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETI 109

Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC- 170
           +   +QL+  V   HS  + HRDLKP+N+L+ S G +K++DFGL+ +     E+  T+  
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI--YSFEMALTSVV 167

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL 203
            T  Y APEVL    Y  +  D+WS G I   L
Sbjct: 168 VTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  106 bits (267), Expect = 4e-26
 Identities = 70/217 (32%), Positives = 110/217 (50%), Gaps = 12/217 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS----TILKHRMVDQIKREISIMKI 65
           KYE    IGEG++  V   +NRETG+ VA+K   +S     I K  +     REI ++K 
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIAL-----REIRMLKQ 56

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           ++HPN+V L EV   + K++++ E+     L +   +   + E+  ++   Q + AV  C
Sbjct: 57  LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H     HRD+KPEN+L+   G +K+ DFG + +     +       T  Y APE+L    
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 186 YDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 220
             G   DVW+ G +   L+ G  P   G++D+  LY 
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYL 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  107 bits (268), Expect = 5e-26
 Identities = 79/316 (25%), Positives = 135/316 (42%), Gaps = 69/316 (21%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK------- 57
              V+KYE    IG+GTF +V  A++++T + VA+K        K  M ++ +       
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--------KVLMENEKEGFPITAL 59

Query: 58  REISIMKIVRHPNIVRLHEVLAS--------RTKVYIILEFVT---GGELFDKIVHQGRL 106
           REI I+++++H N+V L E+  +        +   Y++ EF      G L +K V   + 
Sbjct: 60  REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KF 116

Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGV 163
             ++ ++  + L++ + + H   + HRD+K  N+L+   G LK++DFGL+   +L +   
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 164 ELLHTT-CGTPNYVAPEVLSN-RGYDGSAADVWSCGVIL------FVLMAG--------- 206
              +T    T  Y  PE+L   R Y G   D+W  G I+        +M G         
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL 235

Query: 207 ------------------YLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
                                F + +LP   K+        P+     A  LI K+L  +
Sbjct: 236 ISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK-PYVKDPHALDLIDKLLVLD 294

Query: 249 PKTRIRIEGIRKHPWF 264
           P  RI  +    H +F
Sbjct: 295 PAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  105 bits (264), Expect = 6e-26
 Identities = 78/260 (30%), Positives = 127/260 (48%), Gaps = 13/260 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVRHPNIVR 73
           IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++     P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           +     +  K+  IL+ + GG+L   +   G   E + R Y  ++I  + H H++ V +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL       S+AD 
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW 179

Query: 194 WSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
           +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +L  +  
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239

Query: 251 TRIRIEG-----IRKHPWFR 265
            R+   G     +++H +F+
Sbjct: 240 KRLGCLGRGAQEVKEHVFFK 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (262), Expect = 2e-25
 Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 17/201 (8%)

Query: 15  RTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +GEG F KV           TGE VA+K L  S   +HR     +REI I++ + H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR--SDFEREIEILRTLDHEN 67

Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V        + +I+E++  G L D +  H+ ++       +  Q+   + +  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-----YVAPEVLS 182
           +   HRDL   N+L++S   +K+SDFGL+ +  +  +  +     P      + APE L 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--YYYVKEPGESPIFWYAPECLR 185

Query: 183 NRGYDGSAADVWSCGVILFVL 203
              +  SA+DVWS GV L+ L
Sbjct: 186 TSKFS-SASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  105 bits (264), Expect = 3e-25
 Identities = 76/302 (25%), Positives = 133/302 (44%), Gaps = 49/302 (16%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
            +Y+    +G G + +V  A + +TG  VA+K L++   S I   R      RE+ ++K 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR----TYRELRLLKH 70

Query: 66  VRHPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           + H N++ L +V      L     VY++   + G +L + IV   +L ++  +    Q++
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQIL 128

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             + + HS G+ HRDLKP N+ ++    LK+ DFGL+   +   + +     T  Y APE
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPE 185

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA 224
           ++ N  +     D+WS G I+  L+ G   F  +D                  L +KI++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 225 AE---------------FSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 268
                            F   F   +  A  L+ K+L  +P  RI       HP+  + +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305

Query: 269 NP 270
           +P
Sbjct: 306 DP 307

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (258), Expect = 7e-25
 Identities = 75/261 (28%), Positives = 130/261 (49%), Gaps = 12/261 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA+K +      K  +   I  EI +M+  +HP
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKHP 76

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 192

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           L+ + + R   + + +HP+ +
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  102 bits (256), Expect = 1e-24
 Identities = 78/288 (27%), Positives = 130/288 (45%), Gaps = 34/288 (11%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
             +GEG    V   + + TG   A+K +         +   QI RE+ I K  + P IV+
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCKSPYIVK 63

Query: 74  LHE--VLASRTKVYIILEFVTGGEL---FDKIVHQG-RLLENDCRRYFQQLIDAVAHCHS 127
            +   +  S + + I +E+  GG L   + K+  +G R+ E    +  + ++  +++ HS
Sbjct: 64  YYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + + HRD+KP N+LL   G +K+ DFG+S   +    L  T  GT  Y+APE +  + Y 
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAPERIQGKPYS 181

Query: 188 GSAADVWSCGVILFVLMAGYLPF---GETDLP---TLYKKINAAEF---SCP----FWFS 234
            + +DVWS G+ L  +     PF   GE  L     L   +N         P     W S
Sbjct: 182 IT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW-S 239

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLD 282
                 I + L+ +P  R     + +HPW       +K   +++VN+ 
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPW-------IKAQMKKKVNMA 280

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  102 bits (257), Expect = 2e-24
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 40/215 (18%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKRE 59
           ++Y+    IG G +  V  A +  +G+ VA+K          LAK T+          RE
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL----------RE 54

Query: 60  ISIMKIVRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           + I++  +H NI+ + ++L  R        VY++++ +   +L   I+H  + L  +  R
Sbjct: 55  LKILRHFKHDNIIAIRDIL--RPPGADFKDVYVVMDLM-ESDL-HHIIHSDQPLTEEHIR 110

Query: 114 YF-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL------SALPQQGVELL 166
           YF  QL+  + + HS  V HRDLKP NLL++    L++ DFG+      S    +     
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170

Query: 167 HTTCGTPNYVAPEVL-SNRGYDGSAADVWSCGVIL 200
           +    T  Y APE+L S   Y  +A D+WS G I 
Sbjct: 171 YVA--TRWYRAPELLLSLPEYT-TAIDMWSVGCIF 202

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  101 bits (253), Expect = 3e-24
 Identities = 74/261 (28%), Positives = 132/261 (50%), Gaps = 12/261 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA+K +    + K    + I  EI +MK +++P
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNP 76

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   H+  
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 192

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           L+ + + R   + + +HP+ +
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  101 bits (253), Expect = 3e-24
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 3/207 (1%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +GEG++A V    +R  G+ VA+KV++  T  +  +     RE S++K ++H NIV LH+
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
           ++ ++  +  + E++        I H G L   + R +  QL+  +A+ H + + HRDLK
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLK 130

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           P+NLL+   G LK++DFGL+       +   +   T  Y  P+VL       SA D+W  
Sbjct: 131 PQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGA 190

Query: 197 GVILFVLMAGYLPF-GETDLPTLYKKI 222
           G I   ++ G   F G +D+    +KI
Sbjct: 191 GCIFIEMLQGQPAFPGVSDVFEQLEKI 217

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|217748 pfam03822, NAF, NAF domain

 Score = 94.5 bits (236), Expect = 3e-24
 Identities = 26/57 (45%), Positives = 41/57 (71%)

Query: 308 MNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVH 364
           +NAF++I+LS GL+L+ LF+  +   K++TRF SR+PA  I+S +E +A+ L  KV 
Sbjct: 1   LNAFDLISLSSGLDLSGLFEEEKKSKKKETRFTSRKPASEIISKLEEIAKELGFKVK 57

Length = 58

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  100 bits (250), Expect = 4e-24
 Identities = 67/194 (34%), Positives = 105/194 (54%), Gaps = 13/194 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVR 67
           YE+ + +G GT+  V  A+N  TGE  A+K      I+K    D    I++EI ++K  +
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVK------IIKLEPGDDFSLIQQEIFMVKECK 64

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           H NIV       SR K++I +E+  GG L D     G L E       ++ +  +A+ HS
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---NR 184
           KG  HRD+K  N+LL   G++K++DFG++A     +    +  GTP ++APEV +   N 
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184

Query: 185 GYDGSAADVWSCGV 198
           GY+    D+W+ G+
Sbjct: 185 GYN-QLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score =   99 bits (249), Expect = 4e-24
 Identities = 73/254 (28%), Positives = 119/254 (46%), Gaps = 29/254 (11%)

Query: 20  GTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA 79
           G   KV    +  T ++  +K L KS+        + +  I I   V  PN+V LH+ + 
Sbjct: 4   GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTI-IPHCV--PNMVCLHKYIV 55

Query: 80  SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN 139
           S   V+++L+   GG+L+  I     + E   +R+  +++ A+   H +G+  RDL P N
Sbjct: 56  SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115

Query: 140 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGSAADVWSC 196
           +LLD  G+++++ F       +  E+  +  G      Y APEV      +  A D WS 
Sbjct: 116 ILLDDRGHIQLTYFS------RWSEVEDSCDGEAVENMYCAPEV-GGISEETEACDWWSL 168

Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRI-- 253
           G ILF L+      G+T +      IN     + P W S  A SL+ ++L  NP  R+  
Sbjct: 169 GAILFELLT-----GKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223

Query: 254 ---RIEGIRKHPWF 264
               +E I+ HP+F
Sbjct: 224 GVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  100 bits (251), Expect = 5e-24
 Identities = 74/261 (28%), Positives = 129/261 (49%), Gaps = 12/261 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA+K +      K  +   I  EI +M+  ++P
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 77  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 192

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           L+ +   R   + + +HP+ +
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  100 bits (249), Expect = 8e-24
 Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 17/264 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I + G    ++ R  F   +L   +     + + +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD  G++++SD GL+    +G E +    GT  Y+APEV++N  Y  S  D
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEKYTFS-PD 183

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSCPFWFSTGATSLIHKILD 246
            W  G +++ ++ G  PF +       +++      +  E+S    FS  A S+   +L 
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK--FSEDAKSICRMLLT 241

Query: 247 PNPKTRIRIEG-----IRKHPWFR 265
            NPK R+   G     +++HP F+
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  102 bits (255), Expect = 1e-23
 Identities = 80/257 (31%), Positives = 118/257 (45%), Gaps = 24/257 (9%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIV 66
           V    VGR      F   R       G     KV+AK  +L   R     + E+  +   
Sbjct: 70  VLTTLVGRNPTTAAFVATR-------GSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC 122

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAV 122
            H  IV+  +   S  K+ +I+E+ +GG+L  +I  + +      E +    F Q++ A+
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEV 180
              HS+ + HRDLK  N+ L   G +K+ DFG S      V L    + CGTP Y+APE+
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL 242

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFG-----ETDLPTLYKKINAAEFSCPFWFST 235
              + Y    AD+WS GVIL+ L+  + PF      E     LY K +   F CP   S+
Sbjct: 243 WERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP--FPCP--VSS 297

Query: 236 GATSLIHKILDPNPKTR 252
           G  +L+  +L  NP  R
Sbjct: 298 GMKALLDPLLSKNPALR 314

Length = 478

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  103 bits (258), Expect = 2e-23
 Identities = 76/237 (32%), Positives = 124/237 (52%), Gaps = 37/237 (15%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R+ +YEV + IG G F +V   +++ T E    K ++    LK R   Q+  E+++M+ +
Sbjct: 11  RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMREL 69

Query: 67  RHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLID 120
           +H NIVR  +   ++   K+YI++EF   G+L   I       G++ E+      +QL+ 
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 121 AVAHCHS-------KGVYHRDLKPENLLLDS-----------YGNL------KVSDFGLS 156
           A+A+CH+       + V HRDLKP+N+ L +             NL      K+ DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 157 ALPQQGVE-LLHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCGVILFVLMAGYLPF 210
                G+E + H+  GTP Y +PE+L    + YD   +D+W+ G I++ L +G  PF
Sbjct: 190 K--NIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 98.5 bits (245), Expect = 3e-23
 Identities = 64/196 (32%), Positives = 100/196 (51%), Gaps = 4/196 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V   Q + TG+  A K L K  + K         E  I++ V  P IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQG-RLLE-NDCRRYFQQLIDAVAHCHSKGVYHRD 134
              S+T + +++  + GG+L   I + G R LE      Y  Q+   + H HS  + +RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +KPEN+LLD  GN ++SD GL A+  +  + +    GT  Y+APE+L    Y     D +
Sbjct: 121 MKPENVLLDDQGNCRLSDLGL-AVELKDGKTITQRAGTNGYMAPEILKEEPYSYP-VDWF 178

Query: 195 SCGVILFVLMAGYLPF 210
           + G  ++ ++AG  PF
Sbjct: 179 AMGCSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 97.8 bits (243), Expect = 4e-23
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 9/254 (3%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++          ++ I++EI+++     P + + + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G   E       ++++  + + HS+   HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL   G++K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSL 187

Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILDPNPKTRI 253
           G+    L  G  P   +D+  +       + + P     FS      I   L+ +P  R 
Sbjct: 188 GITAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRP 245

Query: 254 RIEGIRKHPWFRKN 267
             + + KH +  KN
Sbjct: 246 TAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 97.9 bits (243), Expect = 7e-23
 Identities = 73/261 (27%), Positives = 129/261 (49%), Gaps = 12/261 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 193

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           LD + + R   + + +H + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 97.8 bits (243), Expect = 8e-23
 Identities = 76/295 (25%), Positives = 127/295 (43%), Gaps = 51/295 (17%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ------IKREISIMK 64
           YE    +GEG++A V   +++  G+ VA+KV+        R+ ++        RE S++K
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVI--------RLQEEEGTPFTAIREASLLK 58

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAV 122
            ++H NIV LH+++ ++  + ++ E+V     +  DK  H G L   + + +  QL+  +
Sbjct: 59  GLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGL 116

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           ++ H + + HRDLKP+NLL+   G LK++DFGL+               T  Y  P+VL 
Sbjct: 117 SYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF--------------------------GETDLP 216
                 +  D+W  G I   ++ G   F                          G   LP
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236

Query: 217 -------TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                  TLY   N  +      +   A  L  K+L   PK R+  +    H +F
Sbjct: 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.7 bits (241), Expect = 8e-23
 Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 8/203 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + + R +G G F +V +    +    VA+K+L    +LK +     ++E+  +K +RH +
Sbjct: 8   FTLERKLGSGYFGEV-WEGLWKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQ-QLIDAVAHCHSK 128
           ++ L  V +    VYII E +  G L   +   +G++L          Q+ + +A+   +
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
              HRDL   N+L+      KV+DFGL+ L ++ V L         + APE  S+  +  
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFS- 182

Query: 189 SAADVWSCGVILFVLMA-GYLPF 210
           + +DVWS G++L+ +   G +P+
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPY 205

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 96.7 bits (240), Expect = 1e-22
 Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 4/196 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++          ++ I++EI+++     P + + + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 187

Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 188 GITAIELAKGEPPHSE 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 14/192 (7%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++G TIG+G F  V     R  G+ VA+K L   +            E S+M  +RHPN+
Sbjct: 9   KLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKG 129
           V+L  V+     +YI+ E++  G L D +  +GR ++    +  F   + + + +   K 
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDG 188
             HRDL   N+L+      KVSDFGL+    QG      +   P  + APE L  + +  
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG----QDSGKLPVKWTAPEALREKKFS- 177

Query: 189 SAADVWSCGVIL 200
           + +DVWS G++L
Sbjct: 178 TKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 95.9 bits (238), Expect = 2e-22
 Identities = 68/252 (26%), Positives = 121/252 (48%), Gaps = 17/252 (6%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T E VA+K++          ++ I++EI+++     P I R + 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL   G++K++DFG++          +T  GTP ++APEV+    YD   AD+WS 
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADIWSL 187

Query: 197 GVILFVLMAGYLPFGETD-------LPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
           G+    L  G  P  +         +P         ++S PF         +   L+ +P
Sbjct: 188 GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPF------KEFVEACLNKDP 241

Query: 250 KTRIRIEGIRKH 261
           + R   + + KH
Sbjct: 242 RFRPTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 99.2 bits (247), Expect = 2e-22
 Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 17/258 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY + R +G G    V  A+    GE  A+KV+     +     ++ + E+  +      
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-MSEADKNRAQAEVCCLLNCDFF 91

Query: 70  NIVRLHEVLASRTK--------VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQ 117
           +IV+ HE  A +          + ++L++   G+L  +I  + +      E++    F Q
Sbjct: 92  SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNY 175
           ++ AV H HSK + HRD+K  N+LL S G +K+ DFG S +    V  ++  T CGTP Y
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFS 234
           VAPE+   + Y    AD++S GV+L+ L+    PF   ++  +  K  A  +   P   S
Sbjct: 212 VAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSIS 270

Query: 235 TGATSLIHKILDPNPKTR 252
                ++  +L  +PK R
Sbjct: 271 PEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 80/294 (27%), Positives = 134/294 (45%), Gaps = 61/294 (20%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVL-------AKSTILKHRMVDQIKREISIMKIVRHP 69
           +GEG++A V   +++ TG+ VA+K +       A  T +         RE S++K ++H 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI---------REASLLKDLKHA 63

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSK 128
           NIV LH+++ ++  + ++ E++   +L   +   G  L  ++ R +  QL+  +A+CH +
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGV--ELLHTTCGTPNYVAPEVLSN 183
            V HRDLKP+NLL+   G LK++DFGL+   ++P +    E++     T  Y  P+VL  
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-----TLWYRPPDVLLG 177

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDL-------------------PTLYKKIN 223
                ++ D+W  G I + +  G   F G TD+                   P +     
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237

Query: 224 AAEFSCPFW-------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
              +S PF+                    L  K L   PK RI      KHP+F
Sbjct: 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 20/217 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HP 69
           +E+  TIG+GT+ KV    N++ G   A+K+L       H + ++I+ E +I+K +  HP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI----HDIDEEIEAEYNILKALSDHP 75

Query: 70  NIVRLHEVLASRTKV-----YIILEFVTGGELFDKI---VHQGRLLENDCRRY-FQQLID 120
           N+V+ + +   +        +++LE   GG + D +   + +G  +E     Y   + + 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
            + H H     HRD+K  N+LL + G +K+ DFG+SA         +T+ GTP ++APEV
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 181 LS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
           ++     +  YD +  DVWS G+    L  G  P  +
Sbjct: 196 IACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 59/189 (31%), Positives = 99/189 (52%), Gaps = 12/189 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++  T E VA+K ++ S    +     I +E+  ++ +RHPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 75  HEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
                     ++++E+  G   ++ +  VH+  L E +        +  +A+ HS    H
Sbjct: 81  KGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL--SNRG-YDGS 189
           RD+K  N+LL   G +K++DFG ++L    V   ++  GTP ++APEV+   + G YDG 
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASL----VSPANSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 190 AADVWSCGV 198
             DVWS G+
Sbjct: 195 -VDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 95.1 bits (236), Expect = 5e-22
 Identities = 69/226 (30%), Positives = 120/226 (53%), Gaps = 21/226 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+  TIG+GT+ KV    N++ G   A+K+L   +     + ++I+ E +I++ +  HP
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHP 79

Query: 70  NIVRLHEVLASRTK-----VYIILEFVTGG---ELFDKIVHQGRLLENDCRRY--FQQLI 119
           N+V+ + +     K     ++++LE   GG   EL   ++  G+ L+     Y  +  L+
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             + H H+  + HRD+K  N+LL + G +K+ DFG+SA         +T+ GTP ++APE
Sbjct: 140 -GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 180 VLS-NRGYDGS---AADVWSCGVILFVLMAGYLPFGETD-LPTLYK 220
           V++  + YD S     DVWS G+    L  G  P  +   + TL+K
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 98.4 bits (245), Expect = 6e-22
 Identities = 45/140 (32%), Positives = 81/140 (57%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           I  G F KV   + +   +  A+KV+ K+ ++   MV Q++ E   + + + P IV L+ 
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            L S   VY+++E++ GG++   +   G   E    +Y  ++  A+ + H  G+ HRDLK
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131

Query: 137 PENLLLDSYGNLKVSDFGLS 156
           P+N+L+ + G++K++DFGLS
Sbjct: 132 PDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 95.3 bits (237), Expect = 7e-22
 Identities = 71/209 (33%), Positives = 108/209 (51%), Gaps = 29/209 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y   + +G G F  V  A+++ TG++VA+K + K   + +L  R      RE+ ++K +
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY----RELKLLKHL 66

Query: 67  RHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQ-QLIDA 121
           RH NI+ L ++  S    +Y    FVT  EL    +H     R LE    +YF  Q++  
Sbjct: 67  RHENIISLSDIFISPLEDIY----FVT--ELLGTDLHRLLTSRPLEKQFIQYFLYQILRG 120

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG---TPNYVAP 178
           + + HS GV HRDLKP N+L++   +LK+ DFGL A  Q          G   T  Y AP
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGL-ARIQD-----PQMTGYVSTRYYRAP 174

Query: 179 EV-LSNRGYDGSAADVWSCGVILFVLMAG 206
           E+ L+ + YD    D+WS G I   ++ G
Sbjct: 175 EIMLTWQKYD-VEVDIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 95.6 bits (238), Expect = 8e-22
 Identities = 87/344 (25%), Positives = 139/344 (40%), Gaps = 64/344 (18%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK--VLAKSTILKHRMVDQIKREISIMKIV 66
           ++Y   R +G G+   V  A + +  + VA+K  VL     +KH +     REI I++ +
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRL 59

Query: 67  RHPNIVRLHEVLASRTK--------------VYIILEFVTGGELFDKIVHQGRLLENDCR 112
            H NIV+++EVL                   VYI+ E++        ++ QG L E   R
Sbjct: 60  DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVE---LLHT 168
            +  QL+  + + HS  V HRDLKP N+ +++    LK+ DFGL+ +          L  
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 169 TCGTPNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFG---------------- 211
              T  Y +P  +LS   Y   A D+W+ G I   ++ G   F                 
Sbjct: 178 GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236

Query: 212 ---ETDLPTLYKKI------NAAEFSCPFW-----FSTGATSLIHKILDPNPKTRIRIEG 257
              E D   L   I      +  E   P        +  A   + +IL  NP  R+  E 
Sbjct: 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEE 296

Query: 258 IRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENK 301
              HP+         C  +E V+L   H + D+++ +   +E  
Sbjct: 297 ALMHPYMS----CYSCPFDEPVSLHPFH-IEDELDDILLMTEIH 335

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 67/213 (31%), Positives = 108/213 (50%), Gaps = 25/213 (11%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRET--GESVAMK----VLAKSTILKHRMVDQIKREISIMK 64
           YE+ + +G+G +  V  A+N ET   E+VA+K    V +K  + K  +     RE+ +++
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56

Query: 65  IVR-HPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQL 118
             R H NI  L+++      +  ++Y+  E +       +I+  G+ L +   + F  Q+
Sbjct: 57  HFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD--LHQIIRSGQPLTDAHFQSFIYQI 114

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL----SALPQQGVELLHTTCGTPN 174
           +  + + HS  V HRDLKP NLL+++   LK+ DFGL    S  P +    +     T  
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 175 YVAPEV-LSNRGYDGSAADVWSCGVILFVLMAG 206
           Y APE+ LS + Y   A DVWS G IL  L+  
Sbjct: 175 YRAPEIMLSFQSYT-KAIDVWSVGCILAELLGR 206

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 57/193 (29%), Positives = 105/193 (54%), Gaps = 8/193 (4%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRL 74
           +GEGT+A V   +++ T   VA+K +     L+H         RE+S++K ++H NIV L
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHR 133
           H+++ +   + ++ E++   +L   + + G L+  ++ + +  QL+  +++CH + + HR
Sbjct: 69  HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLKP+NLL++  G LK++DFGL+       +       T  Y  P+VL       +  D+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187

Query: 194 WSCGVILFVLMAG 206
           W  G IL+ +  G
Sbjct: 188 WGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 60/214 (28%), Positives = 114/214 (53%), Gaps = 19/214 (8%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+   +G GT+ +V   ++ +TG+  A+KV+     +     ++IK EI+++K    H 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73

Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDA 121
           NI   +     ++      ++++++EF   G + D + + +G  L+ D   Y  ++++  
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +AH H+  V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP ++APEV+
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 182 S-----NRGYDGSAADVWSCGVILFVLMAGYLPF 210
           +     +  YD   +D+WS G+    +  G  P 
Sbjct: 194 ACDENPDATYD-YRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 93.1 bits (231), Expect = 4e-21
 Identities = 59/198 (29%), Positives = 105/198 (53%), Gaps = 18/198 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRL 74
           +GEGT+A V   +++ T   VA+K +     L+H         RE+S++K ++H NIV L
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQQLIDAVAHCHSK 128
           H+++ +   + ++ E++      DK + Q     G ++  ++ + +  Q++  +A+CH +
Sbjct: 70  HDIVHTDKSLTLVFEYL------DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRDLKP+NLL++  G LK++DFGL+       +       T  Y  P+VL       
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 189 SAADVWSCGVILFVLMAG 206
           +  D+W  G I F + +G
Sbjct: 184 TQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 91.8 bits (228), Expect = 5e-21
 Identities = 73/251 (29%), Positives = 117/251 (46%), Gaps = 25/251 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+GT+  V  A++  T   +A+K +        R V  +  EI++   ++H NIV+   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQ-GRLL--ENDCRRYFQQLIDAVAHCHSKGVYHR 133
             +      I +E V GG L   +  + G L   E     Y +Q+++ + + H   + HR
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132

Query: 134 DLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSA 190
           D+K +N+L+++Y G +K+SDFG S           T  GT  Y+APEV+    RGY G+ 
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAP 191

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---------FSTGATSLI 241
           AD+WS G  +  +  G  PF E   P       AA F    +          S  A + I
Sbjct: 192 ADIWSLGCTIVEMATGKPPFIELGEP------QAAMFKVGMFKIHPEIPESLSAEAKNFI 245

Query: 242 HKILDPNPKTR 252
            +  +P+P  R
Sbjct: 246 LRCFEPDPDKR 256

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 91.8 bits (228), Expect = 7e-21
 Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 17/272 (6%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           EV   +G+G +  V    +R TG ++AMK +     L     +QI  E+ I+     P I
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYI 61

Query: 72  VRLHEVLASRTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           V  +        VY+ +E++  G   +L+   V    + E+  RR    ++  +     +
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 129 -GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRD+KP N+L++  G +K+ DFG+S        L  T  G  +Y+APE + + G +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVASLAKTNIGCQSYMAPERIKSGGPN 179

Query: 188 GSA-----ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA----AEFSCPFWFSTGAT 238
            +      +DVWS G+ +  +  G  P+       ++ +++A       + P  +S  A 
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             + K L+  P  R     + +HPW  K  N 
Sbjct: 240 DFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 15/206 (7%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + K  +G  IGEG F  V   Q   TG+ VA+K + K  +     ++    E ++M  + 
Sbjct: 5   LQKLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNI-KCDVTAQAFLE----ETAVMTKLH 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--RYFQQLIDAVAHC 125
           H N+VRL  V+     +YI++E ++ G L + +  +GR L +  +  ++   + + + + 
Sbjct: 58  HKNLVRLLGVIL-HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            SK + HRDL   N+L+   G  KVSDFGL+ +   GV+    +     + APE L ++ 
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD---NSKLPVKWTAPEALKHKK 173

Query: 186 YDGSAADVWSCGVILF-VLMAGYLPF 210
           +  S +DVWS GV+L+ V   G  P+
Sbjct: 174 FS-SKSDVWSYGVLLWEVFSYGRAPY 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 77/317 (24%), Positives = 123/317 (38%), Gaps = 60/317 (18%)

Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-----------REIS 61
            G  +GEGT+ KV  A +  TG+ VA+K +    I      D+             RE+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLI 119
           IM  ++H NI+ L +V      + ++++ +     ++ D+ +   RL E+  +    Q++
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCILLQIL 129

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVEL--LHTTCGTPN 174
           + +   H     HRDL P N+ ++S G  K++DFGL+     P     L    T      
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189

Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----------- 214
                    Y APE+L        A D+WS G I   L+ G   F   +           
Sbjct: 190 MTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFEL 249

Query: 215 --------------LP--TLYKKINAAEFSCPFWF-STGATSLIHKILDPNPKTRIRIEG 257
                         LP  T +      +    F   S  A  L+  +L  NP  RI  + 
Sbjct: 250 LGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE 309

Query: 258 IRKHPWFRKNYNPVKCS 274
             KH +F    +P+ C 
Sbjct: 310 ALKHEYF--KSDPLPCD 324

Length = 335

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 57/198 (28%), Positives = 102/198 (51%), Gaps = 18/198 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRL 74
           +GEGT+A V   +++ T   VA+K +     L+H         RE+S++K ++H NIV L
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQQLIDAVAHCHSK 128
           H+++ +   + ++ E++      DK + Q     G  +  ++ + +  QL+  + +CH +
Sbjct: 70  HDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRDLKP+NLL++  G LK++DFGL+       +       T  Y  P++L       
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 189 SAADVWSCGVILFVLMAG 206
           +  D+W  G I + +  G
Sbjct: 184 TQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 71/258 (27%), Positives = 118/258 (45%), Gaps = 22/258 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++  T E VA+K ++ S    +     I +E+  ++ ++HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                     ++++E+  G       VH+  L E +        +  +A+ HS  + HRD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAA 191
           +K  N+LL   G +K++DFG +++        ++  GTP ++APEV   +    YDG   
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASI----ASPANSFVGTPYWMAPEVILAMDEGQYDGK-V 205

Query: 192 DVWSCGVILFVLMAGYLP-FGETDLPTLYK-------KINAAEFSCPFWFSTGATSLIHK 243
           DVWS G+    L     P F    +  LY         + + E+S   +F     S + K
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD--YFRNFVDSCLQK 263

Query: 244 ILDPNPKTRIRIEGIRKH 261
           I    P+ R   E + KH
Sbjct: 264 I----PQDRPTSEELLKH 277

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 64/196 (32%), Positives = 94/196 (47%), Gaps = 19/196 (9%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR----EISIMKIVRHPN 70
             IG+G F  V +    +    VA+K   +ST     +   +KR    E  I+K   HPN
Sbjct: 1   EKIGKGNFGDV-YKGVLKGNTEVAVKT-CRST-----LPPDLKRKFLQEAEILKQYDHPN 53

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---HCHS 127
           IV+L  V   +  +YI++E V GG L   +  +   L    ++  Q  +DA A   +  S
Sbjct: 54  IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT--VKKLLQMSLDAAAGMEYLES 111

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRG 185
           K   HRDL   N L+     LK+SDFG+S   + G+  +       P  + APE L N G
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEAL-NYG 170

Query: 186 YDGSAADVWSCGVILF 201
              S +DVWS G++L+
Sbjct: 171 RYTSESDVWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 26/218 (11%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR---EISIMKIV 66
           +Y+  + IG G    V  A +  TG++VA+K L++      + V   KR   E+ +MK+V
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRP----FQNVTHAKRAYRELVLMKLV 72

Query: 67  RHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQ--GRLLENDCRRYF-QQ 117
            H NI+ L  V   +        VY+++E      L D  + Q     L+++   Y   Q
Sbjct: 73  NHKNIIGLLNVFTPQKSLEEFQDVYLVME------LMDANLCQVIQMDLDHERMSYLLYQ 126

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYV 176
           ++  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y 
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 184

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           APEV+   GY     D+WS G I+  ++ G + F  TD
Sbjct: 185 APEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTD 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 91.0 bits (226), Expect = 3e-20
 Identities = 62/208 (29%), Positives = 110/208 (52%), Gaps = 15/208 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVR 67
           +Y++   IG+G++  V  A +  TGE VA+K +  + + +H + D  +I REI +++++R
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEH-VSDATRILREIKLLRLLR 57

Query: 68  HPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           HP+IV +  ++   ++     +Y++ E +   +L   I     L     + +  QL+ A+
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTT-CGTPNYVAPE 179
            + H+  V+HRDLKP+N+L ++   LK+ DFGL+  A       +  T    T  Y APE
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 180 VL-SNRGYDGSAADVWSCGVILFVLMAG 206
           +  S       A D+WS G I   ++ G
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains

 Score = 84.5 bits (209), Expect = 4e-20
 Identities = 26/94 (27%), Positives = 34/94 (36%), Gaps = 4/94 (4%)

Query: 333 VKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTR--NYKTRLEGV--SANKTGQFAVVLE 388
            K +    SR     I   I  V E     +  R  N+    + V             +E
Sbjct: 2   KKWELEIHSRIDPSEIYEGIHKVLEGWGKNLVFRITNFIITGKLVNDHILFLRSTLFEIE 61

Query: 389 VFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKL 422
           V+EV P LFMVD +K  G T  + K       KL
Sbjct: 62  VYEVGPGLFMVDFKKKTGSTKTFTKLATKIQIKL 95

This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 89.3 bits (221), Expect = 6e-20
 Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 14/201 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-- 67
           +YE    IG G +  V  A++  +G  VA+K +   T      +  + RE++++K +   
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV-REVALLKRLEAF 59

Query: 68  -HPNIVRLHEVLAS-----RTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLI 119
            HPNIVRL +V A+      TKV ++ E V        DK+   G   E   +   +Q +
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET-IKDLMRQFL 118

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y APE
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV-TLWYRAPE 177

Query: 180 VLSNRGYDGSAADVWSCGVIL 200
           VL    Y  +  D+WS G I 
Sbjct: 178 VLLQSTY-ATPVDMWSVGCIF 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 20/217 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G+F  V FA N  T E VA+K ++ S    +     I +E+  ++ ++HPN +    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                   ++++E+  G       VH+  L E +        +  +A+ HS  + HRD+K
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148

Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAADV 193
             N+LL   G +K++DFG ++         ++  GTP ++APEV   +    YDG   DV
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA----NSFVGTPYWMAPEVILAMDEGQYDGK-VDV 203

Query: 194 WSCGVILFVL------------MAGYLPFGETDLPTL 218
           WS G+    L            M+      + D PTL
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 240

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 66/223 (29%), Positives = 107/223 (47%), Gaps = 16/223 (7%)

Query: 11  YEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++M
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVM 56

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDA 121
           K ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  A
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 180
           + +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE 
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176

Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
           L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 177 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 87.5 bits (216), Expect = 2e-19
 Identities = 73/271 (26%), Positives = 132/271 (48%), Gaps = 25/271 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+   +G GT+ +V   ++ +TG+  A+KV+  +   +    ++IK+EI+++K    H 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63

Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDA 121
           NI   +     +       ++++++EF   G + D I + +G  L+ +   Y  ++++  
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           ++H H   V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP ++APEV+
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 182 S-----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFW 232
           +     +  YD   +D+WS G+    +  G  P  +   P     L  +  A       W
Sbjct: 184 ACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW 241

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPW 263
            S    S I   L  N   R   E + KHP+
Sbjct: 242 -SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 71/211 (33%), Positives = 101/211 (47%), Gaps = 27/211 (12%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + IG G F +V   R     +    VA+K L   +  K R       E SIM    HPNI
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNI 67

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAH 124
           +RL  V+     V II E++  G L DK      L END +    QL+         + +
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIASGMKY 121

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TP-NYVAPEVL 181
                  HRDL   N+L++S    KVSDFGLS    +  E  +TT G   P  + APE +
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR-LEDSEATYTTKGGKIPIRWTAPEAI 180

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
           + R +  SA+DVWS G++++ +M+    +GE
Sbjct: 181 AYRKFT-SASDVWSFGIVMWEVMS----YGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 87.8 bits (217), Expect = 3e-19
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 8/187 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                     ++++E+  G       VH+  L E +        +  +A+ HS  + HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAA 191
           +K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV   +    YDG   
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGK-V 195

Query: 192 DVWSCGV 198
           DVWS G+
Sbjct: 196 DVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 64/192 (33%), Positives = 95/192 (49%), Gaps = 14/192 (7%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F +V   + R     VA+K   ++  L   +  +  +E  I+K   HPNIVRL  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---HCHSKGVYHR 133
           V   +  +YI++E V GG+    +  +G  L+   +   Q + +A A   +  SK   HR
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLK--VKELIQMVENAAAGMEYLESKHCIHR 118

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----YVAPEVLSNRGYDGS 189
           DL   N L+     LK+SDFG+S   + GV    +T G       + APE L N G   S
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEAL-NYGRYSS 175

Query: 190 AADVWSCGVILF 201
            +DVWS G++L+
Sbjct: 176 ESDVWSFGILLW 187

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 65/258 (25%), Positives = 121/258 (46%), Gaps = 30/258 (11%)

Query: 19  EGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEV 77
           +G F KV   +++ T      K+  +  I K +  + I  E  + ++++ +PN ++L+  
Sbjct: 26  DGKFGKVSVLKHKPT-----QKLFVQKII-KAKNFNAI--EPMVHQLMKDNPNFIKLYYS 77

Query: 78  LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP 137
           + +     +I++++  G+LFD +  +G+L E + ++  +QL++A+   H   + H D+K 
Sbjct: 78  VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137

Query: 138 ENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
           EN+L D     + + D+GL  +   G    +   GT +Y +PE +    YD S  D W+ 
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD--GTLDYFSPEKIKGHNYDVS-FDWWAV 192

Query: 197 GVILFVLMAGYLPFGETD---------LPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           GV+ + L+ G  PF E +         L    KK+   +       S  A   +  +L  
Sbjct: 193 GVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV-----SKNANDFVQSMLKY 247

Query: 248 NPKTR-IRIEGIRKHPWF 264
           N   R      I KHP+ 
Sbjct: 248 NINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.1 bits (213), Expect = 6e-19
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 15  RTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + IG G F +V   + +  G+    VA+K L      K R       E SIM    HPNI
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR--DFLSEASIMGQFDHPNI 67

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI-------DAVAH 124
           + L  V+     V I+ E++  G L         L ++D +    QL+         + +
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSL------DAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVL 181
               G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE +
Sbjct: 122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 182 SNRGYDGSAADVWSCGVILFVLMA-GYLPFGE 212
           + R +  SA+DVWS G++++ +M+ G  P+ E
Sbjct: 182 AYRKFT-SASDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 6e-19
 Identities = 64/202 (31%), Positives = 95/202 (47%), Gaps = 32/202 (15%)

Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +   G+   VA+K L KS  L   M D + +E +IM  + H N++R
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFL-KEAAIMHSLDHENLIR 60

Query: 74  LHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           L+ V+ +   + ++ E    G L D  +    G  L +    Y  Q+ + + +  SK   
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV------------AP 178
           HRDL   N+LL S   +K+ DFGL  ALPQ             +YV            AP
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQ----------NEDHYVMEEHLKVPFAWCAP 169

Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           E L  R +   A+DVW  GV L
Sbjct: 170 ESLRTRTFS-HASDVWMFGVTL 190

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 48/308 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +   G +VA+K L++          +  RE+ ++K V H 
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHK 80

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAHCH 126
           NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H H
Sbjct: 81  NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   GY
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPEVILGMGY 199

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC----------- 229
             +  D+WS G I+  L+ G + F  TD    + K+       +AEF             
Sbjct: 200 KEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258

Query: 230 --------------PFWF-----------STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                         P W            ++ A  L+ K+L  +P  RI ++   +HP+ 
Sbjct: 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318

Query: 265 RKNYNPVK 272
              Y+P +
Sbjct: 319 TVWYDPAE 326

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 71/253 (28%), Positives = 117/253 (46%), Gaps = 18/253 (7%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V F    +    VA+K   +   L   +  +   E  I+K   HPNIV+L  
Sbjct: 3   LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA---VAHCHSKGVYHR 133
           V   R  +YI++E V GG+    +  +   L+   ++  +  +DA   +A+  SK   HR
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCIHR 117

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN----YVAPEVLSNRGYDGS 189
           DL   N L+     LK+SDFG+S     G+   +++ G       + APE L N G   S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGI---YSSSGLKQIPIKWTAPEAL-NYGRYSS 173

Query: 190 AADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
            +DVWS G++L+   + G  P+ G T+     +       SCP         ++ +  D 
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDY 233

Query: 248 NPKTRIRIEGIRK 260
            P+ R +   ++K
Sbjct: 234 KPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 61/222 (27%), Positives = 106/222 (47%), Gaps = 18/222 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y+    +G G +  V  A +    + VA+K L++   S I   R      RE+ ++K +
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY----RELRLLKHM 71

Query: 67  RHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           +H N++ L +V    T      +VY++   +  G   + IV   +L +   +    QL+ 
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLR 129

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
            + + HS G+ HRDLKP N+ ++    L++ DFGL+   +Q  + +     T  Y APE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADDEMTGYVATRWYRAPEI 186

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           + N  +     D+WS G I+  L+ G   F   D     K+I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 82.7 bits (204), Expect = 9e-18
 Identities = 70/230 (30%), Positives = 103/230 (44%), Gaps = 18/230 (7%)

Query: 15  RTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + IG G F +V     +  G     VA+K L      K R       E SIM    H NI
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNI 68

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           +RL  V+       II E++  G L DK +  H G           + +   + +     
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNRGY 186
             HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE ++ R +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 230
             SA+DVWS G++++ +M+ G  P+ +     + K IN      A   CP
Sbjct: 188 -TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 19/227 (8%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMK 64
            + E  + +G G F  V        GE     VA+KVL + T  K     +I  E  +M 
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMA 64

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVA 123
            V HP++VRL  +  S   V +I + +  G L D +  H+  +       +  Q+   ++
Sbjct: 65  SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVL 181
           +   K + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E +
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
            +R Y    +DVWS GV ++ LM     FG    P  Y+ I A E  
Sbjct: 184 LHRIYT-HKSDVWSYGVTVWELMT----FGA--KP--YEGIPAVEIP 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 83.6 bits (206), Expect = 1e-17
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 18/214 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y+    +G G +  V  A + +TG  VA+K L++   S I   R      RE+ ++K +
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHM 73

Query: 67  RHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           +H N++ L +V            VY++   +  G   + IV   +L ++  +    Q++ 
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILR 131

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
            + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE+
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEI 188

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + N  +     D+WS G I+  L+ G   F  TD
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 78/332 (23%), Positives = 140/332 (42%), Gaps = 60/332 (18%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
            +Y   + +G G +  V  A +R TG  VA+K L +   S +   R      RE+ ++K 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKH 70

Query: 66  VRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           ++H N++ L +V      +      Y+++ F+  G    K++   +L E+  +    Q++
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             + + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y APE
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPE 185

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD------------------------- 214
           V+ N  +     D+WS G I+  ++ G   F   D                         
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245

Query: 215 ---------LPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
                    LP   KK   +        +  A +++ K+L  + ++RI       HP+F 
Sbjct: 246 EDAKNYVKKLPRFRKKDFRSLLP---NANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302

Query: 266 KNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQ 297
           + ++P     E+E         FD+++   E+
Sbjct: 303 EFHDP-----EDETEAPPYDDSFDEVDQSLEE 329

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 38/215 (17%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
            R +G G F +V       T + VA+K L   T+      +   +E  IMK +RH  +V+
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQ 65

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY--FQQLID-------AVAH 124
           L+ V +    +YI+ E+++ G L D        L++   +     QL+D        +A+
Sbjct: 66  LYAVCSEEEPIYIVTEYMSKGSLLD-------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-------PQQGVELLHTTCGTP-NYV 176
             S+   HRDL   N+L+      K++DFGL+ L        ++G +        P  + 
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF-------PIKWT 171

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
           APE  +N G     +DVWS G++L  ++  G +P+
Sbjct: 172 APEA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 22/212 (10%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVL---AKSTILKHRMVDQIKREISIMKIVRH 68
           E    +G G    V   ++  TG  +A KV+   AKS++ K     QI RE+ IM   R 
Sbjct: 8   ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK-----QILRELQIMHECRS 62

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHS 127
           P IV  +    +   + + +EF+  G L D+I  + G +      +    +++ + + ++
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121

Query: 128 K-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLS 182
              + HRD+KP N+L++S G +K+ DFG+S       EL++    T  GT  Y++PE + 
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSG------ELINSIADTFVGTSTYMSPERIQ 175

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
              Y    +DVWS G+ +  L  G  PF  ++
Sbjct: 176 GGKYT-VKSDVWSLGISIIELALGKFPFAFSN 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 10/205 (4%)

Query: 12  EVGRTIGEGTFAKVRFA--QNRETGE-SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            +GR IGEG F  V      + E  + +VA+K     T    R  ++  +E  IM+   H
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDH 66

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           P+IV+L  V+ +   V+I++E    GEL   + V++  L       Y  QL  A+A+  S
Sbjct: 67  PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           K   HRD+   N+L+ S   +K+ DFGLS  L  +             ++APE ++ R +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 187 DGSAADVWSCGVILF-VLMAGYLPF 210
             SA+DVW  GV ++ +LM G  PF
Sbjct: 186 T-SASDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 77/304 (25%), Positives = 130/304 (42%), Gaps = 49/304 (16%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVRHPNIV 72
           R IG G F  V    +   G+ VA+K +     +   +V   ++ RE+ ++   +H N++
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 73  RLHEVLASR-----TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
              ++L         ++Y++ E +   +L   IV    L  +  + +  Q++  + + HS
Sbjct: 63  SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRG 185
            G+ HRD+KP NLL++S   LK+ DFGL+ +  P +   +      T  Y APE+L    
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILMGSR 180

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE----------TDL---PTLYKKINAAE------ 226
           +  SA D+WS G I   L+   + F            TDL   P+L    +A E      
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHI 240

Query: 227 ---------FSCPFWFSTGAT----SLIHKILDPNPKTRIRIEGIRKHPWF---RKNYNP 270
                        +  S+ AT     L+ ++L  +P  RI       HP+    R  Y+ 
Sbjct: 241 LRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHT 300

Query: 271 VKCS 274
             C 
Sbjct: 301 CMCK 304

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 83.6 bits (206), Expect = 3e-17
 Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 24/233 (10%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKV---------------RFAQNRETGESVAMKVLAKS 45
           +K     +A + V   +  G F K+               R   +   G+    +++AK 
Sbjct: 140 LKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKR 199

Query: 46  TILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII---LEFVTGGELFDKIVH 102
                R   Q++ EI  +  + H NI+++ E+L S    Y+I    +F     ++D+   
Sbjct: 200 VKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD 259

Query: 103 -QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP-- 159
            + R L    R   +QL+ AV + H K + HRD+K EN+ L+  G + + DFG +A+P  
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFG-TAMPFE 318

Query: 160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFG 211
           ++     +   GT    +PE+L+  GY     D+WSCG+IL  +++  + P G
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIG 370

Length = 501

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 21/203 (10%)

Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L +    ++      K+EI+I+K + H N
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67

Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDAVAH 124
           IV+     + +    + +I+E+V  G L D +    ++  +LL      + QQ+ + +A+
Sbjct: 68  IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL-----LFAQQICEGMAY 122

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVL 181
            HS+   HRDL   N+LLD+   +K+ DFGL+    +G E         + V   A E L
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 182 SNRGYDGSAADVWSCGVILFVLM 204
               +   A+DVWS GV L+ L+
Sbjct: 183 KENKF-SYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 80.4 bits (198), Expect = 6e-17
 Identities = 75/224 (33%), Positives = 113/224 (50%), Gaps = 18/224 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR- 67
           +YE    IGEG + KV  A++ +  G  VA+K +   T  +   +  I RE+++++ +  
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLET 60

Query: 68  --HPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V   SRT    K+ ++ E V        DK+   G   E   +    QL
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-IKDMMFQL 119

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    +  L +   T  Y AP
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-ALTSVVVTLWYRAP 178

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYK 220
           EVL    Y  +  D+WS G I F  M    P   G +D+  L K
Sbjct: 179 EVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGK 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 12/224 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + +G G F  V              VA+K L +  I   +   +  RE S+M  + HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           VRL  V      + +++E    G L   +  +  +  +D +    Q+   +A+  SK   
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDG 188
           HRDL   N+LL +    K+SDFG+S AL         TT G  P  + APE ++   +  
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS- 176

Query: 189 SAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 230
           S +DVWS GV L+     G  P+GE     +   + + E    P
Sbjct: 177 SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVR 73
           +TIG+G F  V     R  G  VA+K +      K+    Q    E S+M  +RH N+V+
Sbjct: 12  QTIGKGEFGDVMLGDYR--GNKVAVKCI------KNDATAQAFLAEASVMTQLRHSNLVQ 63

Query: 74  LHEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGV 130
           L  V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +  +   
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF 123

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
            HRDL   N+L+      KVSDFGL+    +       T   P  + APE L  + +  +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLT----KEASSTQDTGKLPVKWTAPEALREKKFS-T 178

Query: 190 AADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCP 230
            +DVWS G++L+ + + G +P+    L  +  ++    +   P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 221

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 82.1 bits (203), Expect = 1e-16
 Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 32/231 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++ R IG+G   +V  A +      VA+K + +       +  +  RE  I   + HP
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGEL--FDKIVHQGRLLENDCR---------RYFQQL 118
            IV ++ + +    VY  + ++ G  L    K V Q   L  +             F ++
Sbjct: 63  GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-------------SALPQQGVEL 165
              + + HSKGV HRDLKP+N+LL  +G + + D+G                + ++ +  
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 166 LHTT-----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLPF 210
              T      GTP+Y+APE L   G   S + D+++ GVIL+ ++    P+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 75  HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 134

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 193 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311

Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 312 PYINVWYDPAE 322

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 67/211 (31%), Positives = 96/211 (45%), Gaps = 28/211 (13%)

Query: 17  IGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           IG G F +V   + +  G+    VA+K L      K R       E SIM    HPNI+ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY-- 131
           L  V+     V II EF+  G L D  + Q     ND +    QL+  +    +   Y  
Sbjct: 70  LEGVVTKSRPVMIITEFMENGAL-DSFLRQ-----NDGQFTVIQLVGMLRGIAAGMKYLS 123

Query: 132 -----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT----CGTP-NYVAPEVL 181
                HRDL   N+L++S    KVSDFGLS   +        T       P  + APE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
           + R +  SA+DVWS G++++ +M+    +GE
Sbjct: 184 AYRKFT-SASDVWSYGIVMWEVMS----YGE 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 77/266 (28%), Positives = 130/266 (48%), Gaps = 28/266 (10%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RH--PNIV 72
           IG GT  +V   + ++TG  +A+K + ++        ++ KR +  + +V   H  P IV
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-----NKEENKRILMDLDVVLKSHDCPYIV 77

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           + +    + + V+I +E +      DK++   QG + E+   +    ++ A+ +   K G
Sbjct: 78  KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLHT-TCGTPNYVAPEVL----SN 183
           V HRD+KP N+LLD+ GN+K+ DFG+S    + V+    T + G   Y+APE +     N
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG---RLVDSKAKTRSAGCAAYMAPERIDPPDPN 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF--WFSTGATS 239
             YD   ADVWS G+ L  L  G  P+   +T+   L K +     S P    FS    S
Sbjct: 193 PKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCS 251

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFR 265
            +   L  + + R +   + +HP+ R
Sbjct: 252 FVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 18/199 (9%)

Query: 17  IGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +G+G F  V   +       TGE VA+K L  ST     + D  +REI I+K ++H NIV
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRD-FEREIEILKSLQHDNIV 68

Query: 73  RLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           +   V   A R  + +++E++  G L D +  H+ RL       Y  Q+   + +  SK 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-----YVAPEVLSNR 184
             HRDL   N+L++S   +K+ DFGL+ +  Q  E  +     P      + APE L+  
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE--YYKVREPGESPIFWYAPESLTES 186

Query: 185 GYDGSAADVWSCGVILFVL 203
            +   A+DVWS GV+L+ L
Sbjct: 187 KFS-VASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 6/216 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V H 
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHK 83

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAHCH 126
           NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H H
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   GY
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMGY 202

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
             +  D+WS G I+  ++ G + F  TD    + K+
Sbjct: 203 KEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)

Query: 15  RTIGEGTFAKVRFA-QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V     N  T   VA+K L   T+     V     E ++MK ++H  +VR
Sbjct: 12  KKLGAGQFGEVWMGYYNNST--KVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVR 65

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           L+ V+     +YII E++  G L D +     G++L      +  Q+ + +A+   K   
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSA 190
           HRDL+  N+L+      K++DFGL+ + +            P  + APE + N G     
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGSFTIK 184

Query: 191 ADVWSCGVILF-VLMAGYLPF 210
           +DVWS G++L+ ++  G +P+
Sbjct: 185 SDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 73/263 (27%), Positives = 119/263 (45%), Gaps = 25/263 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQ---NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +GR +G+G F  VR AQ      + + VA+K+L K+ I     +++  RE + MK   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 68  HPNIVRLHEV-LASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID- 120
           HPN+++L  V L SR K       +IL F+  G+L   ++   R+ E       Q L+  
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRF 118

Query: 121 ------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 173
                  + +  SK   HRDL   N +L+    + V+DFGLS     G +     C +  
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG-DYYRQGCASKL 177

Query: 174 --NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAAEFSC 229
              ++A E L++  Y  + +DVW+ GV ++ +M  G  P+   +   +Y   I       
Sbjct: 178 PVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236

Query: 230 PFWFSTGATSLIHKILDPNPKTR 252
           P         L+ +   P PK R
Sbjct: 237 PPDCLEDVYELMCQCWSPEPKCR 259

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 64/208 (30%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 15  RTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           R +G G F +V     N  T   VA+K L   T+           E  IMK +RHP +++
Sbjct: 12  RKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQ 65

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVY- 131
           L+ V      +YI+ E +  G L + +    GR L+        QLID  A   S   Y 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK------LPQLIDMAAQVASGMAYL 119

Query: 132 ------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE-VLSN 183
                 HRDL   N+L+      KV+DFGL+ + ++ +         P  + APE  L N
Sbjct: 120 EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN 179

Query: 184 RGYDGSAADVWSCGVILFVLMA-GYLPF 210
           R    S  DVWS G++L  ++  G +P+
Sbjct: 180 RFSIKS--DVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 78.8 bits (194), Expect = 4e-16
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y   + +G G +  V  A ++ TGE VA+K L++   S I   R      RE++++K +
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY----RELTLLKHM 71

Query: 67  RHPNIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLI 119
           +H N++ L +V  S          Y+++ ++       KI+  G  L  D  +Y   Q++
Sbjct: 72  QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIM--GHPLSEDKVQYLVYQML 127

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             + + HS G+ HRDLKP NL ++    LK+ DFGL+          H       YV   
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------HADAEMTGYVVTR 178

Query: 177 ---APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
              APEV+ N  +     D+WS G I+  ++ G   F   D
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 78.8 bits (194), Expect = 5e-16
 Identities = 53/208 (25%), Positives = 101/208 (48%), Gaps = 16/208 (7%)

Query: 2   KKQTRRVAK---YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR 58
           K++ R V     Y V +T+  G+  +V  A      + V +K+  K T L   M      
Sbjct: 56  KQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM------ 109

Query: 59  EISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQ 117
              +++ V HP+++R+ + L S     ++L   +  +L+  +  +   L  +      +Q
Sbjct: 110 ---LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQ 165

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           +++ + + H++ + HRD+K EN+ ++    + + D G +  P      L    GT    A
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-GLAGTVETNA 224

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMA 205
           PEVL+   Y+ S AD+WS G++LF ++A
Sbjct: 225 PEVLARDKYN-SKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
            + +G G F  V   + R     VA+K++ +  + +    D    E  +M  + HPN+V+
Sbjct: 9   LKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQ 63

Query: 74  LHEVLASRTKVYIILEFVTGGELFD------KIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           L+ V   +  ++I+ E++  G L +        +    LL+  C      + +A+ +  S
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-C----SDVCEAMEYLES 118

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYVAPEVLS 182
            G  HRDL   N L+     +KVSDFGL+   L  Q      ++ GT     +  PEV  
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT----SSQGTKFPVKWAPPEVF- 173

Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPFG 211
           +     S +DVWS GV+++ V   G +P+ 
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFA--QNRETGESVAMKVLAKSTILKHRMVDQIK-REISIMKIV 66
           KYE+   IG GT+ +V  A  +N + G+  A+K   K    ++  + Q   REI++++ +
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLREL 59

Query: 67  RHPNIVRLHEVLASRT--KVYIILEFVTGGELFD--KIVHQGR------LLENDCRRYFQ 116
           +H N+V L EV        VY++ ++       D  +I+   R      +  +  +    
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGN----LKVSDFGLSALPQQGVELLHTTCG- 171
           Q+++ V + HS  V HRDLKP N+L+   G     +K+ D GL+ L    ++ L      
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 172 --TPNYVAPEV-LSNRGYDGSAADVWSCGVIL 200
             T  Y APE+ L  R Y   A D+W+ G I 
Sbjct: 176 VVTIWYRAPELLLGARHYT-KAIDIWAIGCIF 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 31/210 (14%)

Query: 15  RTIGEGTFAKVRFAQNRETGE-SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F  V++ + R  G+  VA+K++ + ++ +    D+   E  +M  + H  +V+
Sbjct: 10  KELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQ 63

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAHCH 126
           L+ V   +  +YI+ E+++ G L + +   G+  +        QL++        +A+  
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP------SQLLEMCKDVCEGMAYLE 117

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYVAPEVL 181
           SK   HRDL   N L+D  G +KVSDFGLS   L  +      ++ G+     +  PEVL
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPEVL 173

Query: 182 SNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
               +  S +DVW+ GV+++ V   G +P+
Sbjct: 174 LYSKFS-SKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V   + R     VA+K + +  + +   +++ K    +M  + HP +V+L
Sbjct: 10  KELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  +YI+ EF+  G L + +   QG+L ++      Q + + + +       HR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 134 DLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           DL   N L+ S G +KVSDFG++   L  +      ++ G      +  PEV +   Y  
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT----SSSGAKFPVKWSPPEVFNFSKYS- 179

Query: 189 SAADVWSCGVILF-VLMAGYLPF 210
           S +DVWS GV+++ V   G +PF
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPF 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 6/203 (2%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V   Q++ +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70

Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +    R+ E    +    ++  +A+   K  + HRD+
Sbjct: 71  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y    +D+WS
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWS 187

Query: 196 CGVILFVLMAGYLPFGETDLPTL 218
            G+ L  L  G  P    D   L
Sbjct: 188 MGLSLVELAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 48/223 (21%)

Query: 10  KYEVGRTIGEGTFAKVR--FAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V    A+    GE    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 7   KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQ 116
                ++VRL  V+++     +++E +  G+L    +   R    +          ++ Q
Sbjct: 65  EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKS-YLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 117 ---QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL---------------SAL 158
              ++ D +A+  +K   HRDL   N ++     +K+ DFG+                 L
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
           P +             ++APE L + G   + +DVWS GV+L+
Sbjct: 184 PVR-------------WMAPESLKD-GVFTTKSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.9 bits (184), Expect = 4e-15
 Identities = 70/271 (25%), Positives = 114/271 (42%), Gaps = 40/271 (14%)

Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
            +G G    V  A +  T   +A+KV+     ++  +  QI  E+ I+     P I+  +
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
                  ++ I  EF+ GG L D      ++ E+   R    ++  + +  S  + HRD+
Sbjct: 66  GAFFVENRISICTEFMDGGSL-DVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121

Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVW 194
           KP N+L+++ G +K+ DFG+S    Q V  +  T  GT  Y+APE +S   Y G  +DVW
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVS---TQLVNSIAKTYVGTNAYMAPERISGEQY-GIHSDVW 177

Query: 195 SCGVILFVLMAGYLPFGE-------------------TDLPTLYKKINAAEFSCPFWFST 235
           S G+    L  G  P+ +                    D P L       +FS  F    
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL----PVGQFSEKF---- 229

Query: 236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
                I + +   PK R   E +  HP+  +
Sbjct: 230 --VHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 23/208 (11%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI-SIMKIVRHPNIVRLH 75
           IG G F  V    ++ +G  +A+K + +ST+ +     ++  ++  +M+    P IV+ +
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQ-KRLLMDLDVVMRSSDCPYIVKFY 69

Query: 76  EVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG----- 129
             L      +I +E +    + F K V+     E       ++++  +A    K      
Sbjct: 70  GALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 130 ----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE-VLSNR 184
               + HRD+KP N+LLD  GN+K+ DFG+S      +         P Y+APE +  + 
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-YMAPERIDPSA 183

Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPF 210
             GYD   +DVWS G+ L+ +  G  P+
Sbjct: 184 RDGYD-VRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 6/209 (2%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 64

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 181

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTL 218
            +D+WS G+ L  +  G  P    D   L
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 13/207 (6%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
              ++ + +G G F +V  A  N+ T   VA+K +   ++     V+    E ++MK ++
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQ 59

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHC 125
           H  +V+LH V+ ++  +YII EF+  G L D  K     +        +  Q+ + +A  
Sbjct: 60  HDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
             +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE + N 
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NF 177

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
           G     +DVWS G++L  ++  G +P+
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 62/240 (25%), Positives = 109/240 (45%), Gaps = 36/240 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           +  +G+ +GEG F +V  A+     N     +VA+K+L K    +  + D +  E+ +MK
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70

Query: 65  IV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFD----------------KIVHQGRLL 107
           ++ +H NI+ L  V      +Y+++E+   G L D                    +  L 
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 108 ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL- 166
           + D   +  Q+   +    SK   HRDL   N+L+     +K++DFGL+    + +  + 
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA----RDIHHID 186

Query: 167 ----HTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK 220
                T    P  ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 13/200 (6%)

Query: 15  RTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV       +   TGE VA+K L   +   H  +  +K+EI I++ + H N
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67

Query: 71  IVRLHEVLASR--TKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +  S
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ--QGVELLHTTCGTPNY-VAPEVLSNR 184
           +   HRDL   N+L++S   +K+ DFGL+   +  +    +     +P +  APE L   
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 185 GYDGSAADVWSCGVILFVLM 204
            +   A+DVWS GV L+ L+
Sbjct: 188 KF-YIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 70/227 (30%), Positives = 110/227 (48%), Gaps = 25/227 (11%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y++G  IG G+F  V  A   +T E VA+K + +    K+R       E+ IMK + H N
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHIN 120

Query: 71  IVRLHEVLAS----RTKVYIILEFVTGGELFDKIVHQ--GRLLEND-------CRRYFQQ 117
           I+ L +   +    + +  I L  V   E   + VH+       N+        + Y  Q
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVM--EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           L  A+A+ HSK + HRDLKP+NLL+D   + LK+ DFG +     G   +   C +  Y 
Sbjct: 179 LCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC-SRFYR 237

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI 222
           APE++       +  D+WS G I+  ++ GY  F G++ +  L + I
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284

Length = 440

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 22/270 (8%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVDQIKREISIMKIVRHP 69
           EV   +G G +  V   ++  TG  +A+K +  +  +  + R++  +  +IS M+ V  P
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDL--DIS-MRSVDCP 60

Query: 70  NIVRLHEVLASRTKVYIILEFV-TGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCH 126
             V  +  L     V+I +E + T  + F K V      + E+   +    ++ A+ + H
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120

Query: 127 SK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPE---- 179
           SK  V HRD+KP N+L++  G +K+ DFG+S      V+ +  T   G   Y+APE    
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINP 177

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAAEFSCPF-WFSTG 236
            L+ +GYD   +DVWS G+ +  L  G  P+    T    L + +       P   FS  
Sbjct: 178 ELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236

Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
               ++K L  N K R     + +HP+F  
Sbjct: 237 FQDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 19  EGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR---EISIMKIVRHPNIVR-L 74
           EGTF ++ +    +       +V  K T+  H    Q+     E  ++  + H NI+  L
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVK-TVKDHASEIQVTLLLQESCLLYGLSHQNILPIL 74

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLID-------AVAHC 125
           H  +      +++  ++  G L    + Q RL E +  +    QQL+         +++ 
Sbjct: 75  HVCIEDGEPPFVLYPYMNWGNL-KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPN----YVAPE 179
           H +GV H+D+   N ++D    +K++D  LS    P       H      N    ++A E
Sbjct: 134 HKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD----YHCLGDNENRPVKWMALE 189

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 214
            L N+ Y  SA+DVWS GV+L+ LM  G  P+ E D
Sbjct: 190 SLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEID 224

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 64/239 (26%), Positives = 109/239 (45%), Gaps = 38/239 (15%)

Query: 13  VGRTIGEGTFAKVRFA-------QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           +G+ +GEG F +V  A          +   +VA+K+L K       + D I  E+ +MK+
Sbjct: 16  LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73

Query: 66  V-RHPNIVRLHEVLASRTKVYIILEFVTGGEL---------------FDKI-VHQGRLLE 108
           + +H NI+ L  V      +Y+I+E+   G L               FD   V + +L  
Sbjct: 74  IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133

Query: 109 NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT 168
            D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+    +GV  +  
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA----RGVHDIDY 189

Query: 169 TCGTPN------YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
              T N      ++APE L +R Y    +DVWS G++++ +   G  P+    +  L+K
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F +V           VA+K L + ++      +    E ++MK ++HP +VRL
Sbjct: 12  KKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRL 66

Query: 75  HEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           + V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    K   H
Sbjct: 67  YAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAA 191
           RDL+  N+L+      K++DFGL+ L +            P  + APE + N G     +
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKS 184

Query: 192 DVWSCGVILF-VLMAGYLPF 210
           DVWS G++L  ++  G +P+
Sbjct: 185 DVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 73/301 (24%), Positives = 126/301 (41%), Gaps = 72/301 (23%)

Query: 37  VAMKVLAKST--ILKHRMV---------DQIKREISIMKIVRHPNIVRLHEVLASRTKVY 85
           V  KVL + +  I+  +++         +QI RE+ ++     P IV  +    S  ++ 
Sbjct: 16  VVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEIS 75

Query: 86  IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLD 143
           I +E + GG L D+++ + GR+ EN   +    ++  + +   K  + HRD+KP N+L++
Sbjct: 76  ICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134

Query: 144 SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL 203
           S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y    +D+WS G+ L  +
Sbjct: 135 SRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEM 191

Query: 204 MAGYLPFGETDLPTLYKKINAAEFSCPF-------------------------------- 231
             G  P     +P    K   A F  P                                 
Sbjct: 192 AIGRYP-----IPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYI 246

Query: 232 -----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN 280
                       FS      + K L  NPK R  ++ + KHP+ ++       +E EEV+
Sbjct: 247 VNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR-------AELEEVD 299

Query: 281 L 281
            
Sbjct: 300 F 300

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 11/212 (5%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IG G F  V      E  + VA+K     TI +  M ++    E  +M  + HP +V+L+
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIK-----TIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
            V   R+ + ++ EF+  G L D +  Q G+  +         + + +A+  S  V HRD
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADV 193
           L   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +DV
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SKSDV 184

Query: 194 WSCGVILF-VLMAGYLPFGETDLPTLYKKINA 224
           WS GV+++ V   G  P+       + + INA
Sbjct: 185 WSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 25/219 (11%)

Query: 12  EVGRTIGEGTFAKVRFAQNR-ETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRH 68
            + R +G G F +V     R   G++V ++V  K+        D+     E  IM    H
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI----DAVAH 124
            NIVRL  V   R   +I+LE + GG+L   +       E       + L+    D    
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 125 CH---SKGVYHRDLKPENLLLDSYGN---LKVSDFGL------SALPQQGVELLHTTCGT 172
           C         HRD+   N LL   G     K++DFG+      ++  ++G   +      
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
           P    PE   + G   S  DVWS GV+L+ + + GY+P+
Sbjct: 189 P----PEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 15  RTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V     N  T   VA+K L   T+     ++    E  IMK +RH  +V+
Sbjct: 12  KKLGNGQFGEVWMGTWNGNT--KVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQ 65

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVY- 131
           L+ V+ S   +YI+ E+++ G L D +   +GR L+         L+D  A   +   Y 
Sbjct: 66  LYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALK------LPNLVDMAAQVAAGMAYI 118

Query: 132 ------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
                 HRDL+  N+L+      K++DFGL+ L +            P  + APE  +  
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALY 177

Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPF 210
           G     +DVWS G++L  L+  G +P+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 34/237 (14%)

Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 77

Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                V + +L
Sbjct: 78  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137

Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 138 SFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197

Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)

Query: 17  IGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           +GEG F KV   +      R +  SVA+K L ++   K +   + ++E  +M  ++HPNI
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIV----HQGRLLEN---------DCRRYFQ-- 116
           V L  V        ++ E++  G+L + +V    H     E+         DC  +    
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 117 -QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-------PQQGVELLHT 168
            Q+   + +  S    HRDL   N L+     +K+SDFGLS           Q   LL  
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190

Query: 169 TCGTPNYVAPE-VLSNRGYDGSAADVWSCGVILF 201
                 ++ PE +L  +    S  D+WS GV+L+
Sbjct: 191 -----RWMPPEAILYGKFTTES--DIWSFGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 21/212 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE G  +G GT+  V  A+ ++  +    K  A   I    +     REI++++ ++HP
Sbjct: 3   EYE-GCKVGRGTYGHVYKAKRKDGKDE---KEYALKQIEGTGISMSACREIALLRELKHP 58

Query: 70  NIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLLENDCRRYFQQLI 119
           N++ L +V  S +  KV+++ ++           H+         +L  +  +    Q++
Sbjct: 59  NVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118

Query: 120 DAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQQGVELLHTTCGT 172
           D + + H+  V HRDLKP N+L+       G +K++D G + L   P + +  L     T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
             Y APE+L    +   A D+W+ G I   L+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 65.3 bits (159), Expect = 7e-12
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 22/208 (10%)

Query: 15  RTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G G F ++     +    RE    VA+  L      K R       E   +    H 
Sbjct: 11  RILGTGRFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRR--GFLAEALTLGQFDHS 66

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NIVRL  V+     + I+ E+++ G L D  +  H+G+L+          L   + +   
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNR 184
            G  H+ L    +L++S    K+S F    L +   E ++TT    + V   APE +   
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAI-QY 182

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGE 212
            +  SA+DVWS G++++ +M+    +GE
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS----YGE 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 32/230 (13%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-----IMKIVRHPNI 71
           IGEG F +V  A  ++ G    +K+ A   +LK    +   R+ +     + K+  HPNI
Sbjct: 10  IGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--------------CRRYFQQ 117
           + L     +R  +YI +E+   G L D  + + R+LE D               ++  Q 
Sbjct: 66  INLLGACENRGYLYIAIEYAPYGNLLD-FLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 118 LIDAVAHCH---SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 173
             D          K   HRDL   N+L+      K++DFGLS    + V +  T    P 
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPV 182

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
            ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 183 RWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.5 bits (159), Expect = 9e-12
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +YE G  +G GT+  V  A+ ++  +    A+K +  + I          REI++++ ++
Sbjct: 3   EYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC-----REIALLRELK 56

Query: 68  HPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLLENDCRRYFQQ 117
           HPN++ L +V  S    KV+++ ++           H+         +L     +    Q
Sbjct: 57  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQQGVELLHTTC 170
           ++D + + H+  V HRDLKP N+L+       G +K++D G + L   P + +  L    
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
            T  Y APE+L    +   A D+W+ G I   L+
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 32/230 (13%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-----IMKIVRHPNI 71
           IGEG F +V  A+ ++ G    +++ A    +K        R+ +     + K+  HPNI
Sbjct: 3   IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-----------------CRRY 114
           + L      R  +Y+ +E+   G L D  + + R+LE D                    +
Sbjct: 59  INLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP- 173
              +   + +   K   HRDL   N+L+      K++DFGLS    Q V +  T    P 
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
            ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 176 RWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 74/269 (27%), Positives = 116/269 (43%), Gaps = 26/269 (9%)

Query: 13  VGRTIGEGTFAKVRFAQ--NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +G+T+GEG F  V   Q    ++   VA+K +  +   +  M D +  E   MK   HPN
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHPN 61

Query: 71  IVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLI--- 119
           ++RL  V     +        +IL F+  G+L   +++  RL   DC +Y   Q L+   
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RL--GDCPQYLPTQMLVKFM 118

Query: 120 ----DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P 173
                 + +  SK   HRDL   N +L+   N+ V+DFGLS     G             
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAA-EFSCPF 231
            ++A E L++R Y  + +DVWS GV ++ +   G  P+   +   +Y  +        P 
Sbjct: 179 KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP 237

Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRK 260
               G  SL+      NPK R   E +R 
Sbjct: 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 13  VGRTIGEGTFAKVRFAQ-NRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +G+ +GEG F  V   Q +++ G    VA+K + K  I  +  +++   E + MK   HP
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61

Query: 70  NIVRLHEV---LASRTKV---YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           N+++L  V    +S  K+    +IL F+  G+L   +++  RL     +   Q L+  + 
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMV 120

Query: 124 -------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP--- 173
                  +  ++   HRDL   N +L     + V+DFGLS     G +            
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG-DYYRQGRIAKMPV 179

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
            ++A E L++R Y  S +DVW+ GV ++ +   G  P+
Sbjct: 180 KWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 68/248 (27%), Positives = 109/248 (43%), Gaps = 12/248 (4%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T + VA+K L   T+    M +   +E  IMK +RH  +V L+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 77  VLASRTKVYIILEFVTGGELFDKIVH-QGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ S   +YI+ EF+  G L D +    G+ L+         Q+ D +A+       HRD
Sbjct: 69  VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADV 193
           L+  N+L+      K++DFGL+ L +            P  + APE  +  G     +DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYGRFTIKSDV 186

Query: 194 WSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           WS G++L  L+  G +P+ G  +   L +        CP         L+      +P  
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDE 246

Query: 252 RIRIEGIR 259
           R   E I+
Sbjct: 247 RPTFEYIQ 254

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 27/206 (13%)

Query: 17  IGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G+G F +V     N  T   VA+K L   T+     +    +E  +MK +RH  +V+L+
Sbjct: 14  LGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLY 67

Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY-- 131
            V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y  
Sbjct: 68  AVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 132 -----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRG 185
                HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYG 178

Query: 186 YDGSAADVWSCGVILFVLMA-GYLPF 210
                +DVWS G++L  L   G +P+
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 8/157 (5%)

Query: 58  REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 117
           REI I+K + H  I+ L      ++ V +++      +LF  +   G L         ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC----GTP 173
           L++A+A+ H +G+ HRD+K EN+ LD   N  + DFG  A  +         C    GT 
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKLDAHPDTPQCYGWSGTL 251

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
              +PE+L+   Y  +  D+WS G++LF +    +  
Sbjct: 252 ETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 5/158 (3%)

Query: 59  EISIMKIVRHPNIVRLHEVLASRTKVYIIL-EFVTGGELFDKIVHQGRLLENDCRRYFQQ 117
           E  I++ + HP+I++L           +IL  + T  +L+  +  +  +   D     + 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GVELLHTTCGTPNYV 176
           ++ A+ + H   + HRD+K EN+ ++  G++ + DFG +  P        +   GT    
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           APE+L+   Y G A D+WS G++LF +   +    E D
Sbjct: 251 APELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKD 287

Length = 391

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 59/238 (24%), Positives = 106/238 (44%), Gaps = 30/238 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 16  KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 73

Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V   +
Sbjct: 74  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY 193

Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 48/270 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES-----VAMKVLAKSTILKHRMVDQIKREISIMK-I 65
             G+T+G G F KV  A      +S     VA+K+L  +     R  + +  E+ IM  +
Sbjct: 38  SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHL 95

Query: 66  VRHPNIVRLHEVLASRTK---VYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLI 119
             H NIV L   L + T    + +I E+   G+L +  + + R   L   D   +  Q+ 
Sbjct: 96  GNHENIVNL---LGACTIGGPILVITEYCCYGDLLN-FLRRKRESFLTLEDLLSFSYQVA 151

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             +A   SK   HRDL   N+LL     +K+ DFGL+       ++++ +    NYV   
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR------DIMNDS----NYVVKG 201

Query: 177 ---------APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT---LYKKI- 222
                    APE + N  Y    +DVWS G++L+ + + G  P+    +P     YK I 
Sbjct: 202 NARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIK 258

Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTR 252
                + P         ++    D +P  R
Sbjct: 259 EGYRMAQPEHAPAEIYDIMKTCWDADPLKR 288

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 63/258 (24%), Positives = 108/258 (41%), Gaps = 27/258 (10%)

Query: 16  TIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQI----KREISIMKIVRHPN 70
           T+G G F +V  A+ +   E      VL K+  L+    + +    +RE+ + + + H N
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKA--LQKTKDENLQSEFRRELDMFRKLSHKN 69

Query: 71  IVRLHEVLASRTKVYIILEFVTGGEL--FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           +VRL  +       Y+ILE+   G+L  F +   + +  +        +   A+    + 
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRA-TKSKDEKLKPPPLSTKQKVALCTQIAL 128

Query: 129 GV--------YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           G+         HRDL   N L+ S   +KVS   LS                P  ++APE
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT 238
            +    +  + +DVWS GV+++ V   G LPF       +  ++ A +   P     G  
Sbjct: 189 AVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGCP 245

Query: 239 SLIHKIL----DPNPKTR 252
           S ++K++      NPK R
Sbjct: 246 SRLYKLMTRCWAVNPKDR 263

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)

Query: 15  RTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE     VA+K L ++T  K     +I  E  +M  V +P+
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 70

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 71  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 190 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/241 (25%), Positives = 108/241 (44%), Gaps = 34/241 (14%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKRE 59
            +  +G+ +GEG F +V  A+         N+    +VA+K+L      K   +  +  E
Sbjct: 12  TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPV--TVAVKMLKDDATDKD--LSDLVSE 67

Query: 60  ISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGEL---------------FDKI-VH 102
           + +MK++ +H NI+ L         +Y+++E+ + G L               FD   + 
Sbjct: 68  MEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 103 QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG 162
           + +L   D      Q+   + +  S+   HRDL   N+L+     +K++DFGL+      
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187

Query: 163 VELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLY 219
                TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246

Query: 220 K 220
           K
Sbjct: 247 K 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 15/218 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE+    VA+KVL ++T  K     +I  E  +M  V  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 70

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V ++ + +  G L D +  ++ R+   D   +  Q+   +++     
Sbjct: 71  VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ S  ++K++DFGL+ L        H   G  P  ++A E + +R + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 188 GSAADVWSCGVILFVLMA----GYLPFGETDLPTLYKK 221
              +DVWS GV ++ LM      Y      ++P L +K
Sbjct: 190 -HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 54/226 (23%), Positives = 101/226 (44%), Gaps = 34/226 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
              +G+T+GEG F KV  A     + R    +VA+K+L ++          +  E +++K
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR--DLLSEFNLLK 58

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGEL----------------FDKIVHQGRLLE 108
            V HP++++L+   +    + +I+E+   G L                 D   +   L  
Sbjct: 59  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118

Query: 109 NDCR--------RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LP 159
            D R         +  Q+   + +     + HRDL   N+L+     +K+SDFGLS  + 
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 160 QQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
           ++   +  +    P  ++A E L +  Y  + +DVWS GV+L+ ++
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 30/229 (13%)

Query: 17  IGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIV 72
           IGEG F +V  A+ ++ G   ++   ++   ++   HR       E+ ++ K+  HPNI+
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 71

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRRYFQQLIDAV 122
            L      R  +Y+ +E+   G L D  + + R+LE D               QQL+   
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 123 A-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 174
           A       +   K   HRDL   N+L+      K++DFGLS    Q V +  T    P  
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 188

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
           ++A E L+   Y  + +DVWS GV+L+ ++  G  P+       LY+K+
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 58.2 bits (140), Expect = 2e-09
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 27/224 (12%)

Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE+V    A+K+L ++T  K  +  +   E  IM  + HP+
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAH 124
           +VRL  V  S T + ++ + +  G L D  VH+       +LL N C     Q+   + +
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLD-YVHEHKDNIGSQLLLNWC----VQIAKGMMY 124

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVL 181
              + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +   G      ++A E +
Sbjct: 125 LEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPIKWMALECI 183

Query: 182 SNRGYDGSAADVWSCGVILFVLMA-GYLPFG---ETDLPTLYKK 221
             R +    +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 184 HYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 29/88 (32%), Positives = 51/88 (57%), Gaps = 3/88 (3%)

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ--QGVELLHTTCGTP 173
           +QL+ A+ + H +G+ HRD+K EN+L++   ++ + DFG +   +        +   GT 
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF 201
           +  APEVL+   Y  S  D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYTPS-VDIWSAGLVIF 353

Length = 461

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 49/242 (20%), Positives = 101/242 (41%), Gaps = 50/242 (20%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL---AKSTILKHRMVDQIKREISIMKIVR 67
             +G+   +     V  A+++ T   VA+K +   + S       +  +++EI   + ++
Sbjct: 4   TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCS----KEDLKLLQQEIITSRQLQ 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDC---------RRYFQQL 118
           HPNI+         +++Y++   +  G   D       LL+                + +
Sbjct: 58  HPNILPYVTSFIVDSELYVVSPLMAYGSCED-------LLKTHFPEGLPELAIAFILKDV 110

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--------------LPQQGVE 164
           ++A+ + HSKG  HR +K  ++LL   G + +S    S                P+  V+
Sbjct: 111 LNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170

Query: 165 LLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-KK 221
            L        +++PEVL    +GY+   +D++S G+    L  G++PF +     +  +K
Sbjct: 171 NL-------PWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222

Query: 222 IN 223
           + 
Sbjct: 223 VR 224

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 10/191 (5%)

Query: 17  IGEGTFAKVR--FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  V+    + +++ ++VA+K+L K+      + D++ RE ++M+ + +P IVR+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             +  + + + +++E    G L +K + + + + E +      Q+   + +       HR
Sbjct: 62  IGICEAESWM-LVMELAELGPL-NKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS AL          T G  P  + APE ++   +  S 
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SK 178

Query: 191 ADVWSCGVILF 201
           +DVWS GV+++
Sbjct: 179 SDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 48/254 (18%)

Query: 15  RTIGEGTFAKVRFAQNRETG-------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           R IG+G F +V   Q R  G         VA+K+L +       M    +RE ++M    
Sbjct: 11  RDIGQGAFGRV--FQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFD 66

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQ---- 116
           HPNIV+L  V A    + ++ E++  G+L +       +         +  R+       
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 117 -----------QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
                      Q+   +A+   +   HRDL   N L+     +K++DFGLS    + +  
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS----RNIYS 182

Query: 166 LHTTCGTPN------YVAPE-VLSNRGYDGSAADVWSCGVILFVLMA-GYLP-FGETDLP 216
                 + N      ++ PE +  NR Y  + +DVW+ GV+L+ + + G  P +G     
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240

Query: 217 TLYKKINAAEFSCP 230
            +Y   +    SCP
Sbjct: 241 VIYYVRDGNVLSCP 254

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 12/222 (5%)

Query: 17  IGEGTFAKVR--FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  V+    + R+    VA+KVL      +  + D++ RE  IM  + +P IVR+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             V  +   + +++E  +GG L   +   +  +  ++      Q+   + +   K   HR
Sbjct: 61  IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS AL          + G  P  + APE ++ R +  S 
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS-SR 178

Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 230
           +DVWS G+ ++     G  P+ +   P +   I   +   CP
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCP 220

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 55/215 (25%), Positives = 103/215 (47%), Gaps = 32/215 (14%)

Query: 10  KYEVGRTIGEGTFAKVR--FAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V    A++   GE+   VA+K + +S  L+ R+  +   E S+MK
Sbjct: 7   KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELF--------DKIVHQGRLLENDCRRYFQ 116
                ++VRL  V++      +++E +  G+L         +   + GR      +   Q
Sbjct: 65  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT-LQEMIQ 123

Query: 117 ---QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELL 166
              ++ D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                   ++APE L + G   +++D+WS GV+L+
Sbjct: 184 PV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 45/203 (22%), Positives = 79/203 (38%), Gaps = 19/203 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVA---MKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           IG G F KV        G S A   +K L  S     ++     +E+   + + HPN+++
Sbjct: 3   IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQL--LFLQEVQPYRELNHPNVLQ 59

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ-----LIDAVAHCHSK 128
                       ++LEF   G+L + +     ++    ++   Q     +   +   H  
Sbjct: 60  CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              H DL   N  L +  ++K+ D+GL     P+              ++APE++  RG 
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 187 DGSAAD------VWSCGVILFVL 203
           D    D      +WS GV ++ L
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 59/224 (26%), Positives = 91/224 (40%), Gaps = 38/224 (16%)

Query: 15  RTIGEGTFAKVRFAQNRE-----TGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
             +G G F +V      +     +G   VA+K L K    + +   +  +E  +M    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFD------KIVHQGRLLENDCRRYFQQLIDAV 122
           PNIV+L  V       YII+E + GG+L               LL    +      +D  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT--LKELLDICLDVA 116

Query: 123 AHCH---SKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSA-------LPQQGVELLH 167
             C         HRDL   N L+   G      +K+ DFGL+          ++G  LL 
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176

Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
                  ++APE L + G   + +DVWS GV+++ +L  G  P+
Sbjct: 177 V-----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 29/218 (13%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           R IG+G F  V       +       A+K L + T L+   V+Q  +E  IMK   HPN+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNV 58

Query: 72  VRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLIDAVAHCH 126
           + L  + L S     ++L ++  G+L + I  +     N    D   +  Q+   + +  
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLA 115

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA--------LPQQGVELLHTTCGTP-NYVA 177
           SK   HRDL   N +LD    +KV+DFGL+                  HT    P  ++A
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN-----HTGAKLPVKWMA 170

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD 214
            E L  + +  + +DVWS GV+L+ LM  G  P+ + D
Sbjct: 171 LESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 53.4 bits (128), Expect = 8e-08
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 27/219 (12%)

Query: 17  IGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           IG G      V  A+ + TGE V ++ +       + MV  ++ E+ + K+  HPNIV  
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPY 64

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
                +  +++++  F+  G   D I       + E       Q ++ A+ + H  G  H
Sbjct: 65  RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQ-----QGVELLHTTCGTPNY-------VAPEV 180
           R +K  ++L+   G + +S  GL +        Q + ++H     P Y       ++PEV
Sbjct: 125 RSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHD---FPKYSVKVLPWLSPEV 179

Query: 181 LSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT 217
           L    +GYD + +D++S G+    L  G++PF   D+P 
Sbjct: 180 LQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 52/214 (24%), Positives = 100/214 (46%), Gaps = 30/214 (14%)

Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 7   KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+        ++  Q 
Sbjct: 65  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124

Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 185 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 39/172 (22%), Positives = 65/172 (37%), Gaps = 29/172 (16%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES----------------VAMKVLAKSTILKHRMVDQ 55
                +GEG F +V   +     +                 VA+KVL       +   D 
Sbjct: 8   NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDF 66

Query: 56  IKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL----------FDKIVHQGR 105
           +K E+ I+  +  PNI RL  V      + +I+E++  G+L             +    +
Sbjct: 67  LK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 106 LLENDCRRYF-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
            L      Y   Q+   + +  S    HRDL   N L+     +K++DFG+S
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 15/219 (6%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS----IMKIVRHP 69
            + +G G F  V        G+S+ + V  K   ++ R   Q  +EI+     M  + H 
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIK--TIQDRSGRQTFQEITDHMLAMGSLDHA 69

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
            IVRL  +      + ++ +    G L D +  H+  L       +  Q+   + +    
Sbjct: 70  YIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
            + HR+L   N+LL S   ++++DFG++  L     +  ++   TP  ++A E +    Y
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGET---DLPTLYKK 221
               +DVWS GV ++ +M+ G  P+      ++P L +K
Sbjct: 189 T-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 50/213 (23%), Positives = 86/213 (40%), Gaps = 34/213 (15%)

Query: 15  RTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +GEG F KV        +     E VA+K L ++     R     +RE  ++   +H 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHE 68

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGEL----------FDKIVHQ----GRLLENDCRRYF 115
           NIV+ + V        ++ E++  G+L             +       G L  +   +  
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHT 168
            Q+   + +  S+   HRDL   N L+     +K+ DFG+S            G  +L  
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                 ++ PE +  R +  + +DVWS GV+L+
Sbjct: 189 -----RWMPPESIMYRKFT-TESDVWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 27/210 (12%)

Query: 15  RTIGEGTFAKVRFAQNRETGES-----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +GEG F KV  A+      +     VA+K L   T+   +     +RE  ++  ++H 
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQHE 67

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRRYFQQLID 120
           +IV+ + V      + ++ E++  G+L            I+  G+  +        Q++ 
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 121 AVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCG 171
             +   S  VY       HRDL   N L+ +   +K+ DFG+S          +   T  
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
              ++ PE +  R +  + +DVWS GVIL+
Sbjct: 188 PIRWMPPESIMYRKFT-TESDVWSFGVILW 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 28/166 (16%)

Query: 17  IGEGTFAKVRFAQ------------NRETGES--VAMKVLAKSTILKHRMVDQIKREISI 62
           +GEG F +V   +                G+   VA+K+L ++ + K    D +K EI I
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKML-RADVTKTARNDFLK-EIKI 70

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGG---------ELFDKIVHQGRLLE---ND 110
           M  +++PNI+RL  V  S   + +I E++  G         E+     H   +      +
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
                 Q+   + +  S    HRDL   N L+ ++  +K++DFG+S
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 43/234 (18%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR----EISIMKI 65
           ++++   +GEGTF KV  A +R+  E  A+K++        R V +  R    EI  M+ 
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--------RNVPKYTRDAKIEIQFMEK 181

Query: 66  VRHPN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           VR  +      ++++     + T    I+    G  L D I+  G        R+  Q+I
Sbjct: 182 VRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPF----SHRHLAQII 237

Query: 120 ----DAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL----LHTTC 170
                A+ + H++  + H DLKPEN+L+++  +  V      ALP     +    L   C
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMET-SDTVVDPVTNRALPPDPCRVRICDLGGCC 296

Query: 171 ----------GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
                      T +Y +PEV+   G+  S  D+WS G I++ L  G L +   D
Sbjct: 297 DERHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHD 349

Length = 467

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 49/218 (22%), Positives = 93/218 (42%), Gaps = 27/218 (12%)

Query: 17  IGEGTFAKVR----FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +GE  F K+     +    +  + VA+K L      +     + ++E S+M  + HPNIV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQW--GEFQQEASLMAELHHPNIV 70

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVH-----------------QGRLLENDCRRYF 115
            L  V+     V ++ E++  G+L + ++                  +  L   D     
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP- 173
            Q+   + +  S    H+DL   N+L+    ++K+SD GLS  +       +      P 
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
            ++ PE +    +  S +D+WS GV+L+ + + G  P+
Sbjct: 191 RWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 15  RTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +GEG F KV  A+       +    VA+K L  ++    +      RE  ++  ++H 
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARK---DFHREAELLTNLQHE 67

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------------RLLENDCRRYFQ 116
           +IV+ + V      + ++ E++  G+L   +   G              L ++      Q
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPN 174
           Q+   + +  S+   HRDL   N L+     +K+ DFG+S          +   T     
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILF 201
           ++ PE +  R +  + +DVWS GV+L+
Sbjct: 188 WMPPESIMYRKFT-TESDVWSLGVVLW 213

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 4/97 (4%)

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP 230
           GTP+Y+APE+L  + + G A D W+ GV LF  + G  PF +     +++ I   +   P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 231 FW---FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                 S  A + I  +L  +P  R  ++ +++HP F
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 24/74 (32%), Positives = 39/74 (52%), Gaps = 10/74 (13%)

Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGV-----EL 165
           +   +Q++ A+   HS G+ HRD+KP+N++     G+ K+ D G +A  + G+     E 
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEF 317

Query: 166 LHTTCGTPNYVAPE 179
           L      P Y APE
Sbjct: 318 LL----DPRYAAPE 327

Length = 566

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 20/203 (9%)

Query: 17  IGEGTFAKVRFAQNRETGESVA---MKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           IG G F KV  ++   T   VA   +K L  +   K +  ++  ++    +I++HPNI++
Sbjct: 3   IGNGWFGKVLLSE-IYTDTGVARVVVKELKANASSKEQ--NEFLQQGDPYRILQHPNILQ 59

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL---IDA-VAHCHSKG 129
                       ++ E+   G+L   +  +     N      Q++   I A V H H   
Sbjct: 60  CLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             H DL   N  L S   +KV D+G+  S   +  +E     C    ++APE++    + 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF-HG 178

Query: 188 G-------SAADVWSCGVILFVL 203
           G         ++VW+ GV L+ L
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)

Query: 16  TIGEGTFAKVRFAQNRETGE-------SVAMKVLAKSTILKHRMVDQIKRE-ISIMKIVR 67
           ++G+GTF K+     RE G+        V +KVL KS    HR   +   E  S+M  + 
Sbjct: 2   SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLS 57

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY--FQQLIDAVAHC 125
           H ++V  + V     +  ++ E+V  G L D  + + + L N   +    +QL  A+   
Sbjct: 58  HKHLVLNYGVCVCGDESIMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFL 116

Query: 126 HSKGVYHRDLKPENLLL-----DSYGN---LKVSDFGLS--ALPQQGVELLHTTCGTPNY 175
             KG+ H ++  +N+LL        GN   +K+SD G+S   LP+   E+L      P +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EIL--LERIP-W 170

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
           V PE + N      AAD WS G  L+ + +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 3/95 (3%)

Query: 89  EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL 148
           EF+  G+     + Q +   N  +   +Q++  +   H  G+ HRD+KPENLL+   G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348

Query: 149 KVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVL 181
           K+ DFG +     G+    L+     P Y  PE L
Sbjct: 349 KIIDFGAAVDMCTGINFNPLYGML-DPRYSPPEEL 382

Length = 507

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           V K+E    +GEG F KV  A+       +    VA+K L +++          +RE  +
Sbjct: 8   VLKWE----LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAEL 60

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRR 113
           + +++H +IVR + V      + ++ E++  G+L           KI+  G  +    + 
Sbjct: 61  LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG-QL 119

Query: 114 YFQQLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVE 164
              Q++   +   S  VY       HRDL   N L+     +K+ DFG+S          
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
           +   T     ++ PE +  R +  + +D+WS GV+L+
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 17  IGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           +GE  F KV           E  ++VA+K L        R  ++ K E  +   ++HPNI
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLR--EEFKHEAMMRSRLQHPNI 70

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRLLENDCRRYF 115
           V L  V+     + +I  + +  +L + +V                 +  L   D     
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTP 173
            Q+   +    S  V H+DL   N+L+    N+K+SD GL          +L+  +    
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            +++PE +   G     +D+WS GV+L+ V   G  P+
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 26/133 (19%), Positives = 53/133 (39%), Gaps = 17/133 (12%)

Query: 31  RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIV-RLHEVLASRTKVYIIL 88
               E   +K+         R     +RE++I++++      V ++     S    Y+++
Sbjct: 18  GTKDEDYVLKINPSREKGADR-----EREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72

Query: 89  EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY---HRDLKPENLLLDSY 145
           E++ G  L         + E +     +QL + +A  H   +    H DL P N+L+D  
Sbjct: 73  EWIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125

Query: 146 GNLKVSDFGLSAL 158
             L + D+  +  
Sbjct: 126 KILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 13/131 (9%)

Query: 37  VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL 96
           VA+K+L +    K+   D +K EI IM  ++ PNI+RL  V  +   + +I E++  G+L
Sbjct: 49  VAVKML-REDANKNARNDFLK-EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 97  ---FDKIVHQGRLLENDCRRY-FQQLIDAVAHCHSKGVY-------HRDLKPENLLLDSY 145
                +   Q    + D     +  LI       S   Y       HRDL   N L+   
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKN 166

Query: 146 GNLKVSDFGLS 156
             +K++DFG+S
Sbjct: 167 YTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 22/197 (11%)

Query: 33  TGESVAMKVLAKSTILKHRMVDQIKREI-SIMKIVRHPNIVRLHEVLASRTKVYIILEFV 91
                 +KV+ K     HR +     E  S+M+ V H +IV L+ V     +  ++ EFV
Sbjct: 27  YSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFV 86

Query: 92  TGGELFDKIVH-QGRLLENDCR-RYFQQLIDAVAHCHSKGVYHRDLKPENLLL-----DS 144
             G L D  +H +  +L    + +  +QL  A+++   K + H ++  +N+LL     D 
Sbjct: 87  EFGPL-DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG 145

Query: 145 YGN--LKVSDFG--LSALP-QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVI 199
                +K+SD G  ++ L  Q+ VE +        ++APE + +      AAD WS G  
Sbjct: 146 ECGPFIKLSDPGIPITVLSRQECVERI-------PWIAPECVEDSKNLSIAADKWSFGTT 198

Query: 200 LF-VLMAGYLPFGETDL 215
           L+ +   G +P  +  L
Sbjct: 199 LWEICYNGEIPLKDKTL 215

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 22/159 (13%)

Query: 59  EISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 118
           EI+ M  ++HPNIV+L  +  S    Y+I E++ G  L         +L N      +++
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL-------SEVLRNLSWERRRKI 785

Query: 119 IDAVA------HCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
              +A      HC  S  V   +L PE +++D        D     L   G+    T C 
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCF 839

Query: 172 TPN-YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP 209
             + YVAPE    +      +D++  G+IL  L+ G  P
Sbjct: 840 ISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 23/87 (26%)

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 176
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGDARLPLK 240

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF 201
             APE + ++ Y  + +DVWS GV+L+
Sbjct: 241 WMAPESIFDKVYT-TQSDVWSFGVLLW 266

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 34/209 (16%)

Query: 15  RTIGEGTFAKVRFAQNRETGE----------SVAMKVLAKSTILKHRMVDQIKREISIMK 64
             +G+GTF  +     R   +          SV +KVL       HR         S+M 
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMS 56

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDAV 122
            + H ++V+L+ V   R +  ++ E+V  G L D  +H +   +    +    +QL  A+
Sbjct: 57  QLSHKHLVKLYGVCV-RDENIMVEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASAL 114

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGN-------LKVSDFG--LSALPQQGVELLHTTCGTP 173
            +   K + H ++  +N+L+  YG        +K+SD G  ++ L ++           P
Sbjct: 115 HYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIP 169

Query: 174 NYVAPEVLSN-RGYDGSAADVWSCGVILF 201
            ++APE + N +     AAD WS G  L 
Sbjct: 170 -WIAPECIRNGQASLTIAADKWSFGTTLL 197

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 64/257 (24%), Positives = 105/257 (40%), Gaps = 58/257 (22%)

Query: 17  IGEGTFAKV--------------RFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREI 60
           +GEG F +V              +F  N   G    VA+K+L +    K+   D +K E+
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY------ 114
            I+  ++ PNI+RL  V      + +I E++  G+L   +     L + +          
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSH-HLDDKEENGNDAVPPA 129

Query: 115 -------FQQLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSA--- 157
                  +  L+       S   Y       HRDL   N L+     +K++DFG+S    
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 158 ----LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF--VLMAGYLPFG 211
                  QG  +L        ++A E +   G   +A+DVW+ GV L+  +++    P+G
Sbjct: 190 AGDYYRIQGRAVLPI-----RWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYG 243

Query: 212 E-TDLPTLYKKINAAEF 227
           E TD   +    NA EF
Sbjct: 244 ELTDEQVIE---NAGEF 257

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 25/134 (18%)

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           L   D   +  Q+   +    SK   HRDL   N+LL     +K+ DFGL+       ++
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR------DI 287

Query: 166 LHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-G 211
           +H +    NYV            APE + +  Y  + +DVWS G++L+ + + G  P+ G
Sbjct: 288 MHDS----NYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPG 342

Query: 212 ETDLPTLYKKINAA 225
                T Y KI + 
Sbjct: 343 MIVDSTFYNKIKSG 356

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 35/220 (15%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           E+GR  G      V  A++  TG  V +++       +  +   ++ E+ +    RHPNI
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61

Query: 72  VRLHEVLASRTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           +    V  + + +++I  F+  G    L      +G + E          +  + + H  
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL----------------PQQGVELLHTTCGT 172
           G  HR++K  ++L+   G + +S  GLS L                PQ    +L      
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVL------ 172

Query: 173 PNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPF 210
             +++PE+L     GY+   +D++S G+    L  G +PF
Sbjct: 173 -PWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 28/87 (32%), Positives = 39/87 (44%), Gaps = 23/87 (26%)

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 176
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGDARLPLK 246

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF 201
             APE + +R Y    +DVWS GV+L+
Sbjct: 247 WMAPETIFDRVYT-IQSDVWSFGVLLW 272

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 23/87 (26%)

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---------- 176
           S+   HRDL   N+LL     +K+ DFGL+                P+YV          
Sbjct: 192 SRKCIHRDLAARNILLSENNVVKICDFGLA----------RDIYKDPDYVRKGSARLPLK 241

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF 201
             APE + ++ Y  + +DVWS GV+L+
Sbjct: 242 WMAPESIFDKVYT-TQSDVWSFGVLLW 267

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	441
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
smart00090	237	RIO RIO-like kinase.	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.68
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.58
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
KOG1243	690	consensus Protein kinase [General function predict	99.55
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.45
PF03822	63	NAF: NAF domain; InterPro: IPR004041 The NAF domai	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.04
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.03
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.02
COG4248	637	Uncharacterized protein with protein kinase and he	98.97
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.85
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.68
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.66
PRK09902	216	hypothetical protein; Provisional	98.62
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.61
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.57
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.54
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.45
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.25
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.25
PLN02876	822	acyl-CoA dehydrogenase	98.21
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.1
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.07
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.0
PF02149	47	KA1: Kinase associated domain 1; InterPro: IPR0017	97.98
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.96
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.88
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.84
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.78
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.7
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.67
PRK10593	297	hypothetical protein; Provisional	97.67
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.64
KOG2270	520	consensus Serine/threonine protein kinase involved	97.61
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.44
PRK05231	319	homoserine kinase; Provisional	97.44
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.38
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.2
PLN02236	344	choline kinase	97.01
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.99
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.76
PLN02756	418	S-methyl-5-thioribose kinase	96.75
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.7
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.49
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.04
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.95
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.92
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.91
PTZ00384	383	choline kinase; Provisional	95.85
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.58
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.54
PRK12396	409	5-methylribose kinase; Reviewed	95.36
PRK11768	325	serine/threonine protein kinase; Provisional	95.26
PRK06148	1013	hypothetical protein; Provisional	94.77

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-65  Score=482.44  Aligned_cols=261  Identities=39%  Similarity=0.699  Sum_probs=235.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH----HHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR----MVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ...+.|.+.++||+|+||.|.+|..+.||+.||||++++.......    -...+.+|+.||++|+|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3456789999999999999999999999999999999987664422    223477999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC---CCeEEeecccccc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSAL  158 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFGls~~  158 (441)
                      ...|+||||++||+|++++..++.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+   ..+||+|||+|+.
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            9999999999999999999999999999999999999999999999999999999999999866   6799999999998


Q ss_pred             CCccccccccccCCCCcCCccccccCCC--CCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCcCCCCC--C-
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFSCPF--W-  232 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~~~--~-  232 (441)
                      .. ....+.+.||||.|+|||++.+.++  ++.++||||+|||||.+|+|++||.+... +.+.++|..+.+.+.+  | 
T Consensus       329 ~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  329 SG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD  407 (475)
T ss_pred             cc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence            76 3467889999999999999976653  44689999999999999999999987554 4589999999987643  4 


Q ss_pred             -CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       233 -~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                       +|+++++||.+||..||++|||++|+|+||||+..
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence             89999999999999999999999999999999854

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-63  Score=467.07  Aligned_cols=261  Identities=38%  Similarity=0.710  Sum_probs=247.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|+++++||+|+||+|++++.++|++.||+|+++|..+.+....+....|..||..++||+||+++..|+++.++
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            35678999999999999999999999999999999999999998887889999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+|+||+.||+|+.+|++.+.++|+.+++|+.+|+.||.|||++||+||||||||||||.+|+++|+|||+|+.......
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999997666666


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-CCCCCCHhHHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHK  243 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~  243 (441)
                      ..++.|||+.|||||++.+.+|+ ..+|+||||+++|+|++|.+||.+.+...++++|..+... .|..+|.+++++|++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~  259 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKK  259 (357)
T ss_pred             ccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHH
Confidence            77889999999999999998886 9999999999999999999999999999999999999854 455599999999999


Q ss_pred             hcCCCCCCCC----ChHhHhcCCCccc
Q 013520          244 ILDPNPKTRI----RIEGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~----t~~eil~hp~f~~  266 (441)
                      +|+.||++|.    ++++|.+||||..
T Consensus       260 LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  260 LLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HhccCHHHhcCCCCChHHhhcCccccc
Confidence            9999999996    6889999999965

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-62  Score=486.34  Aligned_cols=264  Identities=55%  Similarity=0.990  Sum_probs=248.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVR-HPNIVRLHEVLASRT   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~   82 (441)
                      ...++|.+++.||+|+||+|++|.+..+|..||+|++++......  ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            567899999999999999999999999999999998887643312  34577889999999998 999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-CCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~~~~  161 (441)
                      .+|+||||+.||+|++++...+++.|..++++|+||++||+|||++||+||||||||||++.+ +++||+|||++.....
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999 9999999999998854


Q ss_pred             cccccccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCC-CHhHHH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF-STGATS  239 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~~~~  239 (441)
                      ....+.+.|||+.|+|||++.+.. |.+.++|||||||+||.|++|..||++.+...++.+|..+.+.+|.|+ |+++++
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~  253 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARS  253 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHH
Confidence            457789999999999999999988 999999999999999999999999999999999999999999999999 999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCccc-cCC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRK-NYN  269 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~-~~~  269 (441)
                      |+++||.+||.+|+|+.+|+.||||+. ...
T Consensus       254 Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~  284 (370)
T KOG0583|consen  254 LIEKMLVPDPSTRITLLEILEHPWFQKENPL  284 (370)
T ss_pred             HHHHHcCCCcccCCCHHHHhhChhhccCCCC
Confidence            999999999999999999999999998 443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-63  Score=488.93  Aligned_cols=262  Identities=36%  Similarity=0.676  Sum_probs=251.9

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      .+|..++.||+|+|+.||.+++..+|+.||+|++.+..+.+....+.+.+||+|++.|+|||||+++++|++.+++|||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            46999999999999999999999999999999999999888888999999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      |+|+.++|..++++.+.++|.+++.|++||+.||.|||+++|+|||||..|++|+++-++||+|||+|+..........+
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998877677789


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      .||||.|+|||++...++ +..+||||+|||||.||.|++||...+..+.+.+|...++..|..+|.++++||++||++|
T Consensus       178 lCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~  256 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN  256 (592)
T ss_pred             ecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence            999999999999987665 5999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCChHhHhcCCCccccCCCC
Q 013520          249 PKTRIRIEGIRKHPWFRKNYNPV  271 (441)
Q Consensus       249 P~~R~t~~eil~hp~f~~~~~~~  271 (441)
                      |.+|||+++|+.|+||+.++.|.
T Consensus       257 P~~Rpsl~~vL~h~Ff~~g~~p~  279 (592)
T KOG0575|consen  257 PSERPSLDEVLDHPFFKSGFTPA  279 (592)
T ss_pred             cccCCCHHHHhcCHhhhCCCcCC
Confidence            99999999999999998776654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-63  Score=490.58  Aligned_cols=264  Identities=43%  Similarity=0.819  Sum_probs=250.6

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      +...++-|+++++||.|+.|.|.+|++..||+..|||++.+...........+++||.||+.+.|||+++++++++++.+
T Consensus         7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            34568899999999999999999999999999999999998754444456779999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+|+||++||+||+++...++++|.++.+||+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+... +
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-g  165 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-G  165 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC-C
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999987654 4


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ..+.+.||+|.|.|||++.+.+|+|.++||||||||||.||+|.+||++.+...++.+++.|.|..|..+|+++++||++
T Consensus       166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~  245 (786)
T KOG0588|consen  166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR  245 (786)
T ss_pred             ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence            78899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCccccC
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ||..||++|+|.+||++|||+++..
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCC
Confidence            9999999999999999999998754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-62  Score=443.36  Aligned_cols=257  Identities=36%  Similarity=0.718  Sum_probs=246.3

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|+++++||.|+||.|.+++.+.+|..+|+|++++..+.+...++...+|..+|+.+.||+++++++.+.+.+++|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            67889999999999999999999999999999999999999988888999999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||++||+|+.++++.+++++..+++|+.||+.||+|||+++|++|||||||||||++|++||+|||+|.....   .
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---r  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---R  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999986543   3


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhc
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (441)
                      ..+.||||.|+|||+++.++|. .++|+|||||++|||++|.+||.+.+...+|++|..++..+|..+++++++||+++|
T Consensus       198 T~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL  276 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLL  276 (355)
T ss_pred             EEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHH
Confidence            5688999999999999998885 999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCC-----ChHhHhcCCCccc
Q 013520          246 DPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       246 ~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +.|-.+|.     ..++|..||||+.
T Consensus       277 ~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  277 QVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             hhhhHhhhcCcCCCccccccCccccc
Confidence            99999994     6789999999974

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-59  Score=458.16  Aligned_cols=261  Identities=34%  Similarity=0.642  Sum_probs=244.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   83 (441)
                      .....+|.+++.||+|+|++|++|+++.+++.||||++.|..+.++..++-+.+|-.+|.+| .||.|++|+..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            35678999999999999999999999999999999999999988888888899999999999 89999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+|+||+++|+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||||||||.+|++||+|||-|..+....
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998764311


Q ss_pred             c-------------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC
Q 013520          164 E-------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP  230 (441)
Q Consensus       164 ~-------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  230 (441)
                      .             ...+.+||..|++||+|... ..++.+|||+||||||+|++|.+||.+.+..-.+++|..-.+.+|
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            1             11457899999999999764 456999999999999999999999999999999999999999999


Q ss_pred             CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +.+++.+++||+++|..||.+|+|+.+|.+||||..
T Consensus       308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            999999999999999999999999999999999965

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-58  Score=452.53  Aligned_cols=263  Identities=36%  Similarity=0.664  Sum_probs=239.4

Q ss_pred             CcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         2 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ++....+++|++++.||+|+||.||+|+.+.||+.+|+|+++|......+.++.++.|-.+|...++|+||+++..|++.
T Consensus       134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~  213 (550)
T KOG0605|consen  134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK  213 (550)
T ss_pred             ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence            34466789999999999999999999999999999999999999988888899999999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      .++||||||++||++..+|.+.+.++|+.+++|+.+++.|++-+|+.|++||||||+|+|||..|++||+|||||+-...
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999852211


Q ss_pred             ----------------------cc-c------------------------ccccccCCCCcCCccccccCCCCCCCcchh
Q 013520          162 ----------------------GV-E------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVW  194 (441)
Q Consensus       162 ----------------------~~-~------------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~Diw  194 (441)
                                            .. .                        ...+.+|||.|+|||++.+.+|. ..+|+|
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwW  372 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWW  372 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHH
Confidence                                  00 0                        01234699999999999999974 999999


Q ss_pred             hHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCCC--CCCHhHHHHHHHhcCCCCCCCCC---hHhHhcCCCccc
Q 013520          195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF--WFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  266 (441)
Q Consensus       195 SlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~f~~  266 (441)
                      |||||+||||.|++||.+.+..+.+++|...+  +.+|.  .++++++|||.+||. ||++|..   ++||.+||||+.
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence            99999999999999999999999999987665  55554  479999999999999 9999985   899999999986

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-57  Score=431.07  Aligned_cols=263  Identities=39%  Similarity=0.721  Sum_probs=249.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ....+|++.++||+|+||+|.+|.....|+.||||.|.++.+..++..-.+++||.||+.|+||||+.+|++|+..+.+.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv  129 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV  129 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence            34568999999999999999999999999999999999999999888889999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      |||||+++|+|+|+|...+.++|.+++.+|+||++|+.|||+++++|||||.+|||||+|+++||+|||++..+... ..
T Consensus       130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-kf  208 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-KF  208 (668)
T ss_pred             EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-cH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999877654 67


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhc
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (441)
                      +.++||+|.|.+||++.+.+|.|+.+|-|||||+||.|..|..||++.+...+.++|..+.+.-|. -+.++.-||+.||
T Consensus       209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmL  287 (668)
T KOG0611|consen  209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWML  287 (668)
T ss_pred             HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHH
Confidence            899999999999999999999999999999999999999999999999999999999999988776 4678899999999


Q ss_pred             CCCCCCCCChHhHhcCCCccccCCC
Q 013520          246 DPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      -.||++|.|+++|-.|-|..=.|+.
T Consensus       288 mVNP~RRATieDiAsHWWvNwgy~~  312 (668)
T KOG0611|consen  288 MVNPERRATIEDIASHWWVNWGYNM  312 (668)
T ss_pred             hcCcccchhHHHHhhhheeeccccc
Confidence            9999999999999999998765554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-56  Score=420.76  Aligned_cols=257  Identities=28%  Similarity=0.464  Sum_probs=233.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-EE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK-VY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~   85 (441)
                      ..++.+.++.||+|+.|+||+++++.|++.+|+|++....  +....+++.+|+.+++.++|||||.+|+.|.++.. ++
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            4457888999999999999999999999999999995433  44567899999999999999999999999999995 99


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||+||+|.+.+...++++|.....++.++++||.|||+ ++|+||||||+|||++..|.+||||||.|......  
T Consensus       155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999999999988999999999999999999999995 89999999999999999999999999999877654  


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC-----ChHHHHHHhhcCc-CCCCCC-CCHhH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-----DLPTLYKKINAAE-FSCPFW-FSTGA  237 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~~~  237 (441)
                      ...+.+||..|||||.+.+..|. .++||||||+.++|+.+|+.||...     +..++...|..+. ...|.. +|+++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence            66899999999999999988775 8899999999999999999999774     5567777777754 446665 99999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ++||..||++||.+|||+.|+++|||+++..
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            9999999999999999999999999998753

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-56  Score=423.14  Aligned_cols=261  Identities=38%  Similarity=0.667  Sum_probs=239.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|.+.+.||+|+||.||+|+++.++..||||.+.+..+. ....+.+..||.+|+.++|||||+++++..+.+.+
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            45688999999999999999999999999999999999987653 34578899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC------CCeEEeecccccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY------GNLKVSDFGLSAL  158 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~------~~~kL~DFGls~~  158 (441)
                      |+|||||+||+|.++|+..+.++|..++.++.||+.||++||+++|+||||||+||||+.+      -.+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999865      3599999999998


Q ss_pred             CCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC---CCCCCCH
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS---CPFWFST  235 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~  235 (441)
                      ...+ ....+.||+|.|||||++....|+ .|+|+||+|+|||+|++|.+||+..+..++...+..+...   .+.++++
T Consensus       165 L~~~-~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  165 LQPG-SMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN  242 (429)
T ss_pred             CCch-hHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence            8754 567899999999999999888887 8999999999999999999999999999998887766543   4456889


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ...+|+...|..+|..|.+.++-..||+.....
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            999999999999999999999999999997543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-56  Score=445.68  Aligned_cols=260  Identities=33%  Similarity=0.620  Sum_probs=244.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~   83 (441)
                      ...+.+|.++++||+|+||+|++|..+.+++.||||+++|..+.....++....|.+|+...+ ||++++++..|+++++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            456789999999999999999999999999999999999999988888999999999999885 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||+.||++. .++..+.+++..+++|+..++.||.|||++||||||||.+|||||.+|++||+|||+++..-...
T Consensus       444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g  522 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG  522 (694)
T ss_pred             EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence            99999999999954 44555889999999999999999999999999999999999999999999999999998765455


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ....+.||||.|+|||++.+..|. .++|+|||||+||+||.|+.||.+.+.+++.+.|...+..+|.|+|.++.+++++
T Consensus       523 ~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~  601 (694)
T KOG0694|consen  523 DRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR  601 (694)
T ss_pred             CccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence            678899999999999999988874 9999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCh-----HhHhcCCCccc
Q 013520          244 ILDPNPKTRIRI-----EGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t~-----~eil~hp~f~~  266 (441)
                      +|..||++|...     ++|++||||+.
T Consensus       602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  602 LLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HhccCcccccCCCCCCchhhhhCCcccc
Confidence            999999999965     78999999975

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-56  Score=400.08  Aligned_cols=258  Identities=40%  Similarity=0.750  Sum_probs=237.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      .-+.|++.+.||+|.|+.|+++.+..||+.+|+|+++...+..+ ..+.+.+|+.|-+.|+||||+++++.+.+....|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            34679999999999999999999999999999999998777655 46789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC---CCeEEeeccccccCCccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFGls~~~~~~~  163 (441)
                      |+|++.|++|+.-|....-++|..+-.+++||+.||.|||.+||+|||+||+|+|+-..   .-+||+|||++.... ..
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g  166 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG  166 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence            99999999998888777778999999999999999999999999999999999999643   469999999998777 44


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC--C--CCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--W--FSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~~~~  239 (441)
                      .......|||.|+|||++...+| +.++|||++|||||-||.|++||.+.+...+++.|..+.+..|+  |  +++++++
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHH
Confidence            66778899999999999988877 48999999999999999999999999999999999999887664  4  8999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      |+++||..||.+|+|+.|.|+|||+.+.
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999764

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-55  Score=391.80  Aligned_cols=261  Identities=39%  Similarity=0.696  Sum_probs=246.8

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....+++|++++.||+|.||.||+|+.+.++-.||+|++.++.+...+...++++|++|.+.|+||||++++++|.+...
T Consensus        17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r   96 (281)
T KOG0580|consen   17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR   96 (281)
T ss_pred             cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence            45778999999999999999999999999999999999999888877778899999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           84 VYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~--~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      +|+++||+.+|+++..+.  ...++++..+..|+.|++.|+.|||.++|+||||||+|+|++.+|.+|++|||-+-....
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            999999999999999999  677899999999999999999999999999999999999999999999999999876543


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI  241 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li  241 (441)
                        ....+.|||..|.|||...+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|...++.+|..+|.++.|+|
T Consensus       177 --~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  177 --NKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI  253 (281)
T ss_pred             --CCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence              345689999999999999988886 89999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+||..+|.+|.+..|++.|||....
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHhc
Confidence            99999999999999999999998653

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-56  Score=404.10  Aligned_cols=255  Identities=32%  Similarity=0.566  Sum_probs=229.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEE-EEE-eCC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE-VLA-SRT   82 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~-~~~-~~~   82 (441)
                      ...+.+|+++++||+|+||.||++.+..+|..+|.|.++-.... ....+.+..|+.+|++|+|||||++++ .|. ++.
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            45677899999999999999999999999999999999865544 345677889999999999999999998 444 444


Q ss_pred             EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCcEEEccCCCeEEeecc
Q 013520           83 KVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHS--KG--VYHRDLKPENLLLDSYGNLKVSDFG  154 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~--~g--i~HrDlkp~NILl~~~~~~kL~DFG  154 (441)
                      -++||||||.+|+|...|+.    ...++|..+|.|+.|++.||.+||+  ..  |+||||||.||+|+.+|.+||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            49999999999999999865    3469999999999999999999999  44  9999999999999999999999999


Q ss_pred             ccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-CC-CC
Q 013520          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CP-FW  232 (441)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~-~~  232 (441)
                      +++.+.......++.+|||.||+||++.+.+|+ .+|||||+||++|||++-++||.+.+..++.++|..++++ .| ..
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~  252 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH  252 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence            999998877778899999999999999999987 9999999999999999999999999999999999999887 55 45


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +|.++..+|..|+.+||+.||+.     +|++++
T Consensus       253 YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d  281 (375)
T KOG0591|consen  253 YSTDLRELINMCIAVDPEQRPDT-----VPYVQD  281 (375)
T ss_pred             hhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence            89999999999999999999986     555543

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-54  Score=415.91  Aligned_cols=264  Identities=34%  Similarity=0.640  Sum_probs=234.4

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH-----------HHHHHHHHHHHHHhCCCCCcce
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----------MVDQIKREISIMKIVRHPNIVR   73 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~   73 (441)
                      ...+++|++.+.||+|.||+|.+|++..+++.||||++.+.......           -.+.+.+||.||++|.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            45688999999999999999999999999999999999875543211           2358999999999999999999


Q ss_pred             eEEEEEe--CCEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEE
Q 013520           74 LHEVLAS--RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV  150 (441)
Q Consensus        74 l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL  150 (441)
                      ++++..+  .+.+|||+|||+.|.+.+. ..+.. +++.+|+.|+++++.||+|||.+||+||||||.|+||+.+|++||
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI  251 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI  251 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence            9999976  4679999999999988543 33344 899999999999999999999999999999999999999999999


Q ss_pred             eeccccccCC-----ccccccccccCCCCcCCcccccc---CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh
Q 013520          151 SDFGLSALPQ-----QGVELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI  222 (441)
Q Consensus       151 ~DFGls~~~~-----~~~~~~~~~~gt~~Y~aPE~l~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i  222 (441)
                      +|||.+....     .....+...+|||.|+|||.+.+   ..+.+.+.||||+||+||.|+.|+.||-+....+++.+|
T Consensus       252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI  331 (576)
T KOG0585|consen  252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI  331 (576)
T ss_pred             eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH
Confidence            9999988662     23344566889999999999976   457789999999999999999999999999999999999


Q ss_pred             hcCcCCCCCC--CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          223 NAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       223 ~~~~~~~~~~--~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      .+..+.+|..  +.+.++|||.+||++||++|+++.+|..|||......
T Consensus       332 vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  332 VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            9998888866  7999999999999999999999999999999987644

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1e-54  Score=397.98  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=223.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      |++|+.+.++|+|+||.|+++++++||+.||||.+.-.. .+....+-..|||++|++++|||+|.++++|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            568999999999999999999999999999999985432 2233345678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      +|||+..-|.++-....+++++.++.|+.|++.|+.|||+++++|||||||||||+.+|.+||||||+|+....+.....
T Consensus        80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            99998866655555567899999999999999999999999999999999999999999999999999998876667788


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc--C-------------------c
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--A-------------------E  226 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~-------------------~  226 (441)
                      .++.|.+|+|||.+.+...+|.++||||+||++.||++|.+.|.+.+..++.-.|..  +                   .
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            999999999999999977778999999999999999999999998775444332211  1                   1


Q ss_pred             CCCC----------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          227 FSCP----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       227 ~~~~----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ++.|          +.++..+.||+++||+.||.+|++.++++.||||..
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            1111          125778999999999999999999999999999943

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.8e-54  Score=421.54  Aligned_cols=259  Identities=31%  Similarity=0.571  Sum_probs=244.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|.+.+.||+|+||.||+|+.+.|.+.||+|.+.|....+. ....+.+|++|++.++|||||.++++|++..++|+|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            5789999999999999999999999999999999998764433 467899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      .|||.| +|+.++..++.++|+.++.+..|+++||.|||+++|.|||+||.|||++..|.+|+||||+|+....+.....
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999987 9999999999999999999999999999999999999999999999999999999999999998888777788


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~  247 (441)
                      ...|||.|||||++.+.+|+ ..+|+||+|||+|||++|++||......++.+.|.......|...|..+.+|+..+|.+
T Consensus       159 sikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k  237 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK  237 (808)
T ss_pred             eccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence            88999999999999988876 89999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCChHhHhcCCCccccCC
Q 013520          248 NPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      ||.+|.|..+++.|||.+....
T Consensus       238 dP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  238 DPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             ChhhcccHHHHhcChHHhhhhh
Confidence            9999999999999999987543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.5e-52  Score=411.50  Aligned_cols=259  Identities=39%  Similarity=0.726  Sum_probs=237.5

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....+++|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   92 (329)
T PTZ00263         13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR   92 (329)
T ss_pred             CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence            45678999999999999999999999999999999999987654444456778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      .|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999999999999889999999999999999999999999999999999999999999999999998765432 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                        ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....++.+..+....|.+++..+.+||++
T Consensus       172 --~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        172 --TFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             --cceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence              235689999999999987666 48999999999999999999999988888888888888889999999999999999


Q ss_pred             hcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ||+.||.+|++     ++++++||||++
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            99999999997     799999999975

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.4e-53  Score=400.21  Aligned_cols=262  Identities=28%  Similarity=0.477  Sum_probs=236.0

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      +..-+.+|++++.||.|.-|+||+|+.+.++..+|+|++++..+.......++..|..||+.++||.++.+|..|++...
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            34556789999999999999999999999999999999999888777778889999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           84 VYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      .|++||||+||+|..+.+++  +.+++..+++|+.+++.||+|||-.||++||||||||||-++|++-|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999999888764  5799999999999999999999999999999999999999999999999998642100


Q ss_pred             -----------------------------------c---------------------ccccccccCCCCcCCccccccCC
Q 013520          162 -----------------------------------G---------------------VELLHTTCGTPNYVAPEVLSNRG  185 (441)
Q Consensus       162 -----------------------------------~---------------------~~~~~~~~gt~~Y~aPE~l~~~~  185 (441)
                                                         .                     .....+.+||-.|+|||++.+.+
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                               0                     01123457999999999999887


Q ss_pred             CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC--CCCHhHHHHHHHhcCCCCCCCCC----hHhHh
Q 013520          186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--WFSTGATSLIHKILDPNPKTRIR----IEGIR  259 (441)
Q Consensus       186 ~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~t----~~eil  259 (441)
                      . +.++|||+|||+|||||.|.+||.+.+..+...+|......+|.  .++..++|||+++|.+||++|..    +.||+
T Consensus       312 H-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 H-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             C-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            6 59999999999999999999999999999999999888777775  47899999999999999999998    99999


Q ss_pred             cCCCccc
Q 013520          260 KHPWFRK  266 (441)
Q Consensus       260 ~hp~f~~  266 (441)
                      +||||+.
T Consensus       391 ~HpFF~g  397 (459)
T KOG0610|consen  391 RHPFFEG  397 (459)
T ss_pred             cCccccC
Confidence            9999986

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-54  Score=413.40  Aligned_cols=262  Identities=32%  Similarity=0.512  Sum_probs=228.1

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeC
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR   81 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~   81 (441)
                      .+...+.+|.+++.||.|+||.||+|+.+.+|+.||||.+++.....++..  -.||+..|++++ |||||++.+++.+.
T Consensus         4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~--nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM--NLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH--HHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            345567899999999999999999999999999999999987665543322  358999999998 99999999999888


Q ss_pred             C-EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           82 T-KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        82 ~-~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      . .+|+|||||+ .+|+++++.. ..|++..++.|+.||++||+|+|++|+.|||+||||||+..+..+||+|||+|+..
T Consensus        82 ~~~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   82 DRILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             CceEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence            7 9999999995 5899999764 46999999999999999999999999999999999999999999999999999977


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhh----------------
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN----------------  223 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~----------------  223 (441)
                      ... .....++.|.+|+|||+|...++++.+.||||+|||++|+.+-++.|.+.+..+...+|.                
T Consensus       161 ~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  161 RSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             ccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            654 456788999999999999999999999999999999999999999999887655544442                


Q ss_pred             ---cCcCCCCC-----------CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          224 ---AAEFSCPF-----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       224 ---~~~~~~~~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                         ...+.+|.           ..++++.++|.+||.+||.+|||+.++++||||+...
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence               11223332           2688999999999999999999999999999998754

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-53  Score=403.36  Aligned_cols=259  Identities=32%  Similarity=0.555  Sum_probs=222.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--EEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--KVY   85 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--~~~   85 (441)
                      ..+|..++.||+|+||.||++.++++|...|||.+.....   ...+.+.+|+.+|++++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            3468999999999999999999999999999999877622   12678999999999999999999999754444  799


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEeeccccccCCc--
Q 013520           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQ--  161 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~--  161 (441)
                      ++|||++||+|.+.+.+.+ +++|..+++|.+||+.||.|||++||+||||||+|||++. +|.+||+|||++.....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999987 7999999999999999999999999999999999999999 79999999999886653  


Q ss_pred             -cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC-CChHHHHHHhhcC--cCCCCCCCCHhH
Q 013520          162 -GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAA--EFSCPFWFSTGA  237 (441)
Q Consensus       162 -~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~--~~~~~~~~s~~~  237 (441)
                       .........||+.|||||++......+.++||||+||++.||+||.+||.. .......-.+...  .+.+|.++|+++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence             122344678999999999998632333599999999999999999999987 3444433334333  356788899999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      ++||.+||..||++|||++++|+|||.+....
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999987543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-53  Score=410.08  Aligned_cols=263  Identities=39%  Similarity=0.682  Sum_probs=244.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..-+=|.+.++||+|-|+.|.+|++.-||+.||||++++.++... ...++.+|+..|+.++|||||++|++...+..+|
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~-st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly   93 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL-STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY   93 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh-hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence            345679999999999999999999999999999999999876543 3467889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-cCCCeEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+|+-++|+|+|+|-. ..+++|+.++.||.||+.|+.|||+..++|||||||||.+. .-|-+||+|||++..+..+ 
T Consensus        94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-  172 (864)
T KOG4717|consen   94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-  172 (864)
T ss_pred             EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence            99999999999999966 45899999999999999999999999999999999998775 6699999999999887765 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ..+.+.||+..|.|||++.+..|+.+++||||||||||.|.+|++||...+..+....|..-.+..|..+|.++++||..
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s  252 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS  252 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      ||+.||++|.+.++|..|+|+|....+
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCCCCC
Confidence            999999999999999999999976544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-52  Score=406.44  Aligned_cols=261  Identities=30%  Similarity=0.479  Sum_probs=227.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--C
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--T   82 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~   82 (441)
                      +...+.|+.++.||+|+||.||+|++..||+.||+|.+..+... .+......|||.||++|+||||+++.+...+.  .
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~  191 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG  191 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence            45667899999999999999999999999999999999876543 44567788999999999999999999998876  7


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      .+|+|+|||+. +|.-++.. ...|++.+++.|++||+.||+|||++||+|||||.+|||||.+|.+||+|||+|+++..
T Consensus       192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            89999999976 78777766 45899999999999999999999999999999999999999999999999999997766


Q ss_pred             cc-cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc--Cc--------CCCC
Q 013520          162 GV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AE--------FSCP  230 (441)
Q Consensus       162 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~--------~~~~  230 (441)
                      .. ..+...+-|++|+|||.|.+...++.++|+||+||||.||++|++.|.+.+..++..+|..  +.        ...|
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            43 3467778999999999999988889999999999999999999999999887776666521  10        0111


Q ss_pred             -------------------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          231 -------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       231 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                         ..+++.+.+|+..||..||.+|.|+.++|+|+||...
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~  406 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE  406 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence                               1268899999999999999999999999999999543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-51  Score=408.25  Aligned_cols=257  Identities=40%  Similarity=0.735  Sum_probs=236.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...|++.+.||+|.||.||+++.+.||+.+|+|++.+.........+.+.+|+.+|+.+. |||||.++++|++...+|+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            457999999999999999999999999999999999987766556678999999999998 9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC----CCeEEeeccccccCCcc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY----GNLKVSDFGLSALPQQG  162 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~----~~~kL~DFGls~~~~~~  162 (441)
                      |||+|.||+|++.|... .++|..+..++.|++.++.|||+.||+||||||||+|+...    +.+|++|||++..... 
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            99999999999999876 49999999999999999999999999999999999999643    4799999999998776 


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC--CCC--CCHhHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFW--FSTGAT  238 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~--~s~~~~  238 (441)
                      .......||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+.......+..+++.+  ++|  +|..+.
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ak  270 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAK  270 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHH
Confidence            5678899999999999999877774 99999999999999999999999999888888888887654  445  799999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++|++||..||.+|+|+.++|+|||++..
T Consensus       271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999764

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-51  Score=404.63  Aligned_cols=251  Identities=35%  Similarity=0.604  Sum_probs=228.5

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   94 (441)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765444445567889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCC
Q 013520           95 ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (441)
Q Consensus        95 ~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (441)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.............+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            99999998889999999999999999999999999999999999999999999999999998754333334456789999


Q ss_pred             cCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC-
Q 013520          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-  253 (441)
Q Consensus       175 Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-  253 (441)
                      |+|||++.+..+ +.++||||+||++|+|++|..||...+.......+......+|..+++++.++|++||+.||++|| 
T Consensus       161 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05571         161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             ccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            999999987666 489999999999999999999999888888888888888888889999999999999999999999 


Q ss_pred             ----ChHhHhcCCCccc
Q 013520          254 ----RIEGIRKHPWFRK  266 (441)
Q Consensus       254 ----t~~eil~hp~f~~  266 (441)
                          ++.++++||||+.
T Consensus       240 ~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         240 GGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CCCCCHHHHHcCCCcCC
Confidence                8999999999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-53  Score=391.85  Aligned_cols=262  Identities=32%  Similarity=0.592  Sum_probs=247.8

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....+++|+.+++||+|.||+|-+++.+.+|+.||||+++++.+.....+..-..|-++|+..+||++..+...|+..++
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr  242 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR  242 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence            34578999999999999999999999999999999999999988877778888899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||+.||+|+-++.+...++|+.+++|..+|++||.|||+++|++||||.+|+|+|.+|++||+|||+|+..-...
T Consensus       243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998665556


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ....+.||||.|+|||++....| +.++|+|.+||++|+|++|++||...+...++..|...+..+|..+|++++.|+..
T Consensus       323 ~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsG  401 (516)
T KOG0690|consen  323 DTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSG  401 (516)
T ss_pred             ceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHH
Confidence            67889999999999999987766 59999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCC-----ChHhHhcCCCccc
Q 013520          244 ILDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +|.+||.+|.     .+.||.+|+||..
T Consensus       402 LL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  402 LLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            9999999998     4789999999964

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-51  Score=399.44  Aligned_cols=254  Identities=33%  Similarity=0.622  Sum_probs=232.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997755444344567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......   ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~~  157 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TWT  157 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---ccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999998765432   235


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      .+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....++.+..+...+|..+++.++++|++||+.|
T Consensus       158 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d  236 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD  236 (291)
T ss_pred             ccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCC
Confidence            679999999999987665 4899999999999999999999999888888888888888888889999999999999999


Q ss_pred             CCCCCC-----hHhHhcCCCccc
Q 013520          249 PKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       249 P~~R~t-----~~eil~hp~f~~  266 (441)
                      |.+|++     ++++++||||+.
T Consensus       237 p~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         237 RTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHHccCCccCCHHHHhcCccccC
Confidence            999995     999999999974

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.1e-51  Score=404.61  Aligned_cols=259  Identities=32%  Similarity=0.594  Sum_probs=234.8

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETG-ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .....++|++.+.||+|+||.||+|.++.++ ..||+|.+.+.........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            3456789999999999999999999876654 689999998765544445677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ..|+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH  242 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  242 (441)
                         ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+....++.+..+...+|..+++.+.++|+
T Consensus       185 ---~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  260 (340)
T PTZ00426        185 ---TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMK  260 (340)
T ss_pred             ---cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence               246689999999999977655 5899999999999999999999999888888888888888889999999999999


Q ss_pred             HhcCCCCCCCC-----ChHhHhcCCCccc
Q 013520          243 KILDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       243 ~~L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +||+.||++|+     |++++++||||++
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            99999999996     8999999999975

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.9e-53  Score=381.83  Aligned_cols=258  Identities=35%  Similarity=0.649  Sum_probs=231.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   81 (441)
                      ...|+-.+.||+|..+.|.++.++.+|..+|+|++......     ..+..+.-.+|+.||+++ .||+|+++.++++++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            45688889999999999999999999999999999653221     233556778899999998 699999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..+++|+|.|+.|+|||++.....++|...+++++||+.|+.|||.++|+||||||||||+|++-++||+|||+|+..+.
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998877


Q ss_pred             cccccccccCCCCcCCccccccC-----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC--CCCC--
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFW--  232 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~--  232 (441)
                      + ..+...||||+|+|||.+...     +.++..+|+||||||||.||.|.+||-.....-+.+.|..+++.  .|.|  
T Consensus       176 G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad  254 (411)
T KOG0599|consen  176 G-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD  254 (411)
T ss_pred             c-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence            6 456789999999999998532     22358899999999999999999999887777788888888775  4666  


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +|..++|||++||+.||.+|+|++|+|.||||..
T Consensus       255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             ccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            8999999999999999999999999999999954

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.7e-51  Score=371.00  Aligned_cols=258  Identities=33%  Similarity=0.487  Sum_probs=226.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      .+|...+.||+|+||.||+|++..||+.||||.+...... .+......|||+.|+.++|+||+.++++|...+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            5799999999999999999999999999999999876433 334566889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||++. +|...|+... .++..+++.|+.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+++.+........
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99964 8988887644 688999999999999999999999999999999999999999999999999999887766666


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC----------------------
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------------  225 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------------  225 (441)
                      ..+-|.+|+|||.+.+...++..+||||.|||+.||+.|.+-|.+.+.-++...|-..                      
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            6689999999999998888889999999999999999999999888766555544211                      


Q ss_pred             cCCCC------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          226 EFSCP------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       226 ~~~~~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .++.|      +..++++.||+.+||..||.+|+|+.|+++||||+...
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            01111      12478899999999999999999999999999998743

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-51  Score=409.80  Aligned_cols=263  Identities=40%  Similarity=0.755  Sum_probs=249.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...++.|.+.++||+|.|++|.+|++..||..||||++++....... ...+.+|+++|+.++|||||+++.+...+..+
T Consensus        52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l  130 (596)
T KOG0586|consen   52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL  130 (596)
T ss_pred             cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence            45678999999999999999999999999999999999997766554 34489999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||+.+|++++++.+.+++.+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||++..+..+ .
T Consensus       131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-~  209 (596)
T KOG0586|consen  131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-L  209 (596)
T ss_pred             EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc-c
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999988754 6


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      .+.+.||+++|.|||++.+..|+++++|+||+|++||.|+.|.+||++.+..++......+.+.+|..++.++.++|+++
T Consensus       210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~  289 (596)
T KOG0586|consen  210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKF  289 (596)
T ss_pred             cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHHh
Confidence            78999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCccccCC
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      |..+|.+|+++++|++|+|....+.
T Consensus       290 lvl~Pskr~~~dqim~~~W~n~~~~  314 (596)
T KOG0586|consen  290 LVLNPSKRGPCDQIMKDRWRNDLLE  314 (596)
T ss_pred             hccCccccCCHHHhhhhcccchhhh
Confidence            9999999999999999999976543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-50  Score=396.17  Aligned_cols=250  Identities=35%  Similarity=0.631  Sum_probs=227.2

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L   96 (441)
                      ||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999876544444567788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcC
Q 013520           97 FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV  176 (441)
Q Consensus        97 ~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~  176 (441)
                      .+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            99999888999999999999999999999999999999999999999999999999999876443333445678999999


Q ss_pred             CccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC---
Q 013520          177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI---  253 (441)
Q Consensus       177 aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---  253 (441)
                      |||++.+..+ +.++||||+||++|+|++|..||.+.+..+.++.+......+|..+++++.++|.+||..||++||   
T Consensus       161 aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~  239 (312)
T cd05585         161 APELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN  239 (312)
T ss_pred             CHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence            9999987666 489999999999999999999999988888888888888888889999999999999999999997   


Q ss_pred             ChHhHhcCCCcccc
Q 013520          254 RIEGIRKHPWFRKN  267 (441)
Q Consensus       254 t~~eil~hp~f~~~  267 (441)
                      ++.++++||||...
T Consensus       240 ~~~e~l~hp~~~~~  253 (312)
T cd05585         240 GAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHHHcCCCcCCC
Confidence            57899999999763

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.4e-50  Score=397.28  Aligned_cols=251  Identities=34%  Similarity=0.611  Sum_probs=227.7

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   94 (441)
                      +.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999998765544455677889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCC
Q 013520           95 ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (441)
Q Consensus        95 ~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (441)
                      +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            99999988888999999999999999999999999999999999999999999999999998754333333456789999


Q ss_pred             cCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC-
Q 013520          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-  253 (441)
Q Consensus       175 Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-  253 (441)
                      |+|||++.+..+ +.++|||||||++|+|++|..||...+.......+......+|..+++++.++|++||+.||++|+ 
T Consensus       161 y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (328)
T cd05593         161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG  239 (328)
T ss_pred             ccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence            999999977665 589999999999999999999999888888888888788888889999999999999999999997 


Q ss_pred             ----ChHhHhcCCCccc
Q 013520          254 ----RIEGIRKHPWFRK  266 (441)
Q Consensus       254 ----t~~eil~hp~f~~  266 (441)
                          ++.++++||||..
T Consensus       240 ~~~~~~~~il~h~~~~~  256 (328)
T cd05593         240 GGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCCHHHHhcCCCcCC
Confidence                8999999999965

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.1e-50  Score=401.95  Aligned_cols=256  Identities=33%  Similarity=0.600  Sum_probs=223.5

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-----
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-----  163 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-----  163 (441)
                      ||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987542210     


Q ss_pred             ------------------------------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC
Q 013520          164 ------------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (441)
Q Consensus       164 ------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~  213 (441)
                                                    ......+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                          011346899999999999877665 8999999999999999999999988


Q ss_pred             ChHHHHHHhhcC--cCCCCC--CCCHhHHHHHHHhcCCCCC---CCCChHhHhcCCCccc
Q 013520          214 DLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPK---TRIRIEGIRKHPWFRK  266 (441)
Q Consensus       214 ~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~---~R~t~~eil~hp~f~~  266 (441)
                      +..+.+.++...  ...+|+  .+++++.++|.+|+. +|.   .||+++||++||||+.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence            887777777653  344444  378999999999876 444   4689999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.7e-50  Score=393.83  Aligned_cols=256  Identities=32%  Similarity=0.600  Sum_probs=230.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~   88 (441)
                      +|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+.++..++| ++|+++++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999987654444456678889999999976 56889999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++............
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            99999999999998889999999999999999999999999999999999999999999999999998754333334456


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      .+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+.......|..+++++.+++++||..|
T Consensus       161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  239 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH  239 (324)
T ss_pred             ecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            789999999999987666 4899999999999999999999999888888888888888888899999999999999999


Q ss_pred             CCCCCCh-----HhHhcCCCccc
Q 013520          249 PKTRIRI-----EGIRKHPWFRK  266 (441)
Q Consensus       249 P~~R~t~-----~eil~hp~f~~  266 (441)
                      |.+|++.     +++++||||+.
T Consensus       240 P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         240 PAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             HHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999987     89999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.3e-50  Score=394.98  Aligned_cols=251  Identities=34%  Similarity=0.631  Sum_probs=227.0

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|+++.+++.||+|++.+.........+.+..|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876544444456677888888876 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            99999999888999999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+.......|.++++++.++|++||+.||++|+
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  239 (320)
T cd05590         161 DYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL  239 (320)
T ss_pred             cccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence            9999999977665 489999999999999999999999998888888898888888999999999999999999999999


Q ss_pred             Ch------HhHhcCCCccc
Q 013520          254 RI------EGIRKHPWFRK  266 (441)
Q Consensus       254 t~------~eil~hp~f~~  266 (441)
                      ++      +++++||||+.
T Consensus       240 ~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         240 GSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            98      89999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.3e-50  Score=394.61  Aligned_cols=251  Identities=34%  Similarity=0.605  Sum_probs=227.2

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   94 (441)
                      +.||+|+||.||+++++.+|..||+|++.+...........+.+|+.+++.++||||+++++.+...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765444445567788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCC
Q 013520           95 ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (441)
Q Consensus        95 ~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (441)
                      +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            99999988888999999999999999999999999999999999999999999999999998754333333456789999


Q ss_pred             cCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC-
Q 013520          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI-  253 (441)
Q Consensus       175 Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-  253 (441)
                      |+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++++.++|.+||..||++|+ 
T Consensus       161 y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  239 (323)
T cd05595         161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG  239 (323)
T ss_pred             cCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence            999999977666 589999999999999999999999888888888888788888888999999999999999999998 


Q ss_pred             ----ChHhHhcCCCccc
Q 013520          254 ----RIEGIRKHPWFRK  266 (441)
Q Consensus       254 ----t~~eil~hp~f~~  266 (441)
                          ++.++++||||.+
T Consensus       240 ~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         240 GGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CCCCCHHHHHcCCCcCC
Confidence                8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.9e-50  Score=393.23  Aligned_cols=251  Identities=33%  Similarity=0.635  Sum_probs=227.5

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+..|..++..+ +||||+++++++.+++.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999876544444556677899998866 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            99999999888999999999999999999999999999999999999999999999999999875443334445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+ +.++|||||||++|+|++|..||...+....++.+.......|.++++++.++|++||+.||++|+
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~  239 (321)
T cd05591         161 DYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL  239 (321)
T ss_pred             cccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence            9999999977666 489999999999999999999999998888889998888889999999999999999999999999


Q ss_pred             -------ChHhHhcCCCccc
Q 013520          254 -------RIEGIRKHPWFRK  266 (441)
Q Consensus       254 -------t~~eil~hp~f~~  266 (441)
                             +++++++||||..
T Consensus       240 ~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         240 GCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CCCCCCCCHHHHhcCCccCC
Confidence                   8999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-50  Score=382.65  Aligned_cols=260  Identities=30%  Similarity=0.489  Sum_probs=225.5

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      +.-.++|++...||.|..+.||+|+...+++.||||+++.+.+...  .+.+.+|+..|+.++||||++++..|..+..+
T Consensus        22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            4456799999999999999999999999999999999999887653  78899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           85 YIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      |+||.|+.+|++++.+...  .+++|..+..++++++.||.|||++|-+|||||+.||||+.+|.+||+|||.+......
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            9999999999999999763  46999999999999999999999999999999999999999999999999987654432


Q ss_pred             ccc----cccccCCCCcCCccccc-c-CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC------
Q 013520          163 VEL----LHTTCGTPNYVAPEVLS-N-RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP------  230 (441)
Q Consensus       163 ~~~----~~~~~gt~~Y~aPE~l~-~-~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~------  230 (441)
                      ...    .++.+|||+|||||++. . .+|+ .|+||||+|++..||.+|..||.......+.-.-..+.++.+      
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~  258 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD  258 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence            221    26779999999999953 2 4554 999999999999999999999988766554433333333311      


Q ss_pred             ----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          231 ----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       231 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                          ..++..++.+|..||+.||.+|||++++++|+||++.
T Consensus       259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence                1267889999999999999999999999999999864

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-49  Score=398.21  Aligned_cols=256  Identities=34%  Similarity=0.637  Sum_probs=223.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc----
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE----  164 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~----  164 (441)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........    
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999864321100    


Q ss_pred             ----------------------------------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCC
Q 013520          165 ----------------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  210 (441)
Q Consensus       165 ----------------------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf  210 (441)
                                                        .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence                                              1123579999999999987666 48999999999999999999999


Q ss_pred             CCCChHHHHHHhhcCc--CCCCC--CCCHhHHHHHHHhcCCCCCCCCC---hHhHhcCCCccc
Q 013520          211 GETDLPTLYKKINAAE--FSCPF--WFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  266 (441)
Q Consensus       211 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~f~~  266 (441)
                      ...+.......+....  +..|.  .+++++.++|++||. +|.+|++   ++++++||||+.
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9888777666665432  23333  378999999999997 9999998   999999999975

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-49  Score=392.23  Aligned_cols=254  Identities=31%  Similarity=0.593  Sum_probs=225.7

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998765444445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ....
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~  157 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS  157 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCC
Confidence            9999999999999888999999999999999999999999999999999999999999999999999875543   3356


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCCC------CCCHhHHHH
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF------WFSTGATSL  240 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~~~~l  240 (441)
                      .+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...+..+.+..+....  ...|.      .+++++.++
T Consensus       158 ~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~l  236 (333)
T cd05600         158 VVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL  236 (333)
T ss_pred             cccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHH
Confidence            689999999999987765 489999999999999999999999888777666554322  22222      358999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      |.+||..+|.+||+++++++||||..
T Consensus       237 i~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         237 ITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             HHHHhhChhhhcCCHHHHHhCcccCC
Confidence            99999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.9e-50  Score=393.43  Aligned_cols=251  Identities=35%  Similarity=0.608  Sum_probs=227.0

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   94 (441)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999998765544445567788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           95 ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        95 ~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      +|.+++.....+++..+..++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999888899999999999999999999997 7999999999999999999999999999875433333345668999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.++|++||+.||++|+
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~  239 (325)
T cd05594         161 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL  239 (325)
T ss_pred             ccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence            9999999977665 589999999999999999999999888888888888888888888999999999999999999997


Q ss_pred             -----ChHhHhcCCCccc
Q 013520          254 -----RIEGIRKHPWFRK  266 (441)
Q Consensus       254 -----t~~eil~hp~f~~  266 (441)
                           ++.++++||||..
T Consensus       240 ~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         240 GGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             CCCCCCHHHHhcCCCcCC
Confidence                 8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-49  Score=390.43  Aligned_cols=256  Identities=30%  Similarity=0.582  Sum_probs=230.8

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +|++.+.||+|+||.||+|+++.+++.||+|++.+.........+....|..++..+ +||+|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999876544444456677788888877 5899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+++|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999998754433334456


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      .+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+++.+||+.|
T Consensus       161 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~  239 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH  239 (323)
T ss_pred             CCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence            789999999999987766 4899999999999999999999999888888888888888888899999999999999999


Q ss_pred             CCCCCCh-----HhHhcCCCccc
Q 013520          249 PKTRIRI-----EGIRKHPWFRK  266 (441)
Q Consensus       249 P~~R~t~-----~eil~hp~f~~  266 (441)
                      |++|++.     .++++||||+.
T Consensus       240 p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         240 PGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHhcCCCCCCCHHHHhcCCCcCC
Confidence            9999985     89999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-50  Score=375.77  Aligned_cols=263  Identities=32%  Similarity=0.436  Sum_probs=227.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SRTK   83 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~   83 (441)
                      ..++.|+.+..|++|+||.||+|+++.|++.||+|.++.+. .+.+.--.-.|||.+|..++|||||.+.++..  +-+.
T Consensus        73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            45778999999999999999999999999999999997765 23333445678999999999999999999875  4467


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      +|+|||||+. +|..++...+ ++...+++.++.|++.|++|||.+.|+||||||+|+|++..|.+|++|||+|+.+..+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999999976 8888888765 8999999999999999999999999999999999999999999999999999988877


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-----------------
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----------------  225 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-----------------  225 (441)
                      .......+-|.+|+|||.+.+..-++.+.|+||+|||+.||+++.+.|.+.+..+...+|-..                 
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence            666777889999999999998887789999999999999999999999988766655554210                 


Q ss_pred             --cCCCC------------CC-CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          226 --EFSCP------------FW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       226 --~~~~~------------~~-~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                        ...++            .. ++....+|+..+|..||.+|.|++|.|+|+||.+...|
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p  370 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP  370 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence              01111            11 45889999999999999999999999999999876443

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-49  Score=390.77  Aligned_cols=254  Identities=32%  Similarity=0.560  Sum_probs=226.4

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHH---hCCCCCcceeEEEEEeCCEEEEE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---IVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      |++++.||+|+||.||+|.+..+|+.||||++.+.........+.+.+|+.++.   .++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999998765444444567777877664   56799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |||++||+|...+.. +.+++..+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++...........
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999999999988864 6799999999999999999999999999999999999999999999999999875433333445


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~  247 (441)
                      ..+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......|..+++++.++|++||+.
T Consensus       160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~  238 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR  238 (324)
T ss_pred             ccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence            6789999999999987665 589999999999999999999999988888888888888888888999999999999999


Q ss_pred             CCCCCC-----ChHhHhcCCCccc
Q 013520          248 NPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       248 dP~~R~-----t~~eil~hp~f~~  266 (441)
                      ||.+||     ++.++++||||++
T Consensus       239 dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         239 NPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             CHhHcCCCCCCCHHHHhhCCCcCC
Confidence            999999     6899999999975

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-49  Score=389.88  Aligned_cols=251  Identities=30%  Similarity=0.604  Sum_probs=224.1

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|+++.+|+.||+|++.+..............|..++... +||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999999875443333445677788888765 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.....+.+.......|.+++.++.++|++||+.||++|+
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  239 (316)
T cd05620         161 DYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL  239 (316)
T ss_pred             CccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence            9999999987666 489999999999999999999999888888888888888888899999999999999999999999


Q ss_pred             Ch-HhHhcCCCccc
Q 013520          254 RI-EGIRKHPWFRK  266 (441)
Q Consensus       254 t~-~eil~hp~f~~  266 (441)
                      ++ +++++||||+.
T Consensus       240 ~~~~~~~~h~~f~~  253 (316)
T cd05620         240 GVVGNIRGHPFFKT  253 (316)
T ss_pred             CChHHHHcCCCcCC
Confidence            98 58999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-49  Score=399.29  Aligned_cols=257  Identities=32%  Similarity=0.555  Sum_probs=222.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999998765544555678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc------
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------  162 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~------  162 (441)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999997532100      


Q ss_pred             -----------------------------------------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHH
Q 013520          163 -----------------------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF  201 (441)
Q Consensus       163 -----------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~  201 (441)
                                                               .....+.+||+.|+|||++.+.++. .++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~  239 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY  239 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence                                                     0011245799999999999877765 8999999999999


Q ss_pred             HHhcCCCCCCCCChHHHHHHhhcC--cCCCC--CCCCHhHHHHHHHhcCCCCCCCCC---hHhHhcCCCcccc
Q 013520          202 VLMAGYLPFGETDLPTLYKKINAA--EFSCP--FWFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRKN  267 (441)
Q Consensus       202 ~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~f~~~  267 (441)
                      +|++|.+||...+..+....+...  ....|  ..+++++.++|.+|+ .+|++|++   ++++++||||+..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            999999999887766655555432  23333  348999999999987 59999997   9999999999763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.4e-49  Score=398.03  Aligned_cols=257  Identities=31%  Similarity=0.518  Sum_probs=221.7

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            46999999999999999999999999999999998766555556678999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc------
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------  162 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~------  162 (441)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999999998889999999999999999999999999999999999999999999999999997532110      


Q ss_pred             -----------------------------------------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHH
Q 013520          163 -----------------------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF  201 (441)
Q Consensus       163 -----------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~  201 (441)
                                                               .....+.+||+.|+|||++.+..+. .++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~  239 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF  239 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence                                                     0011345799999999999876664 8999999999999


Q ss_pred             HHhcCCCCCCCCChHHHHHHhhc--CcCCCCC--CCCHhHHHHHHHhcC--CCCCCCCChHhHhcCCCccc
Q 013520          202 VLMAGYLPFGETDLPTLYKKINA--AEFSCPF--WFSTGATSLIHKILD--PNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       202 ~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~--~~s~~~~~li~~~L~--~dP~~R~t~~eil~hp~f~~  266 (441)
                      +|++|.+||...+.......+..  .....|.  .+++++.+||.+|+.  .+|..|++++++++||||+.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            99999999988776655555442  2334444  479999999999664  45556999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-50  Score=377.95  Aligned_cols=260  Identities=30%  Similarity=0.453  Sum_probs=222.4

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----CCE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-----RTK   83 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~   83 (441)
                      .+|..++.||+|+||.|+.|.++.||+.||||.+... +...-..++..+|+.+|+.++|+||+.+.+++..     -+.
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            4566689999999999999999999999999998643 3445567889999999999999999999999864     467


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc--
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--  161 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--  161 (441)
                      +|+|+|++ +.+|...|+.+..++++.++.++.||+.||.|+|+.||+||||||.|+|++.+..+|++|||+|+....  
T Consensus       101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999999 668988888877799999999999999999999999999999999999999999999999999987653  


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc-----------------
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-----------------  224 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-----------------  224 (441)
                      ....++.++.|.+|+|||++.+...++.+.||||+|||+.||++|++.|.+.+.....+.|..                 
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence            234567888999999999997766667999999999999999999999988765444333311                 


Q ss_pred             ------CcCCCC--------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          225 ------AEFSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       225 ------~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                            .....|        +..++.+.+|+.+||..||.+|+|++|+|+|||+.....|
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                  011111        2468999999999999999999999999999999876655

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=399.09  Aligned_cols=255  Identities=26%  Similarity=0.489  Sum_probs=227.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      -...|.....||+|+.|.||.|....+++.||||.+++....+   .+.+.+|+.+|+..+|+|||++++.|.-.+.+|+
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            3467899999999999999999999999999999998865443   3568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      ||||++||+|.|.+.. ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..........
T Consensus       348 VMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            9999999999988865 569999999999999999999999999999999999999999999999999999877665566


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhcC--cCCCCCCCCHhHHHHHHH
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAA--EFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~--~~~~~~~~s~~~~~li~~  243 (441)
                      .+.+|||+|||||++....| |+++||||||+++.||+-|++||-..+.- .+|....++  .+..|..+|+.+++||.+
T Consensus       427 ~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             ccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence            78899999999999988777 59999999999999999999999765543 444443444  345677799999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCccc
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ||+.||++|+++.|+|+||||+.
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhhh
Confidence            99999999999999999999954

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-51  Score=428.77  Aligned_cols=260  Identities=33%  Similarity=0.566  Sum_probs=239.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||.|.+++++.|++.||+|+++|....+......+..|-.+|..-+.+.|++++..|+++.++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            45679999999999999999999999999999999999977776666788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc-ccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-~~~  164 (441)
                      +||||++||+|..++...+++||+.|++|+..|+.||.-+|+.|+|||||||+|||||..|++||+|||.|-.... +.-
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            9999999999999999988999999999999999999999999999999999999999999999999999876664 444


Q ss_pred             ccccccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCC--CCCCHh
Q 013520          165 LLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCP--FWFSTG  236 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~  236 (441)
                      .....+|||.|++||+|..    .+.+|..+|+||+||++|||+.|.+||...+..+.|.+|...  .+.+|  ..+|++
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee  311 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE  311 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence            5678899999999999953    356789999999999999999999999999999999999765  67777  458999


Q ss_pred             HHHHHHHhcCCCCCCCCC---hHhHhcCCCccc
Q 013520          237 ATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  266 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t---~~eil~hp~f~~  266 (441)
                      +++||++++. +|+.|.+   +++|..||||.+
T Consensus       312 akdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  312 AKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             HHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            9999999995 5888998   999999999975

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.3e-49  Score=382.92  Aligned_cols=255  Identities=26%  Similarity=0.433  Sum_probs=215.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      .+++|++.+.||.|+||.||+|+++.++..||+|.+......  .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            578999999999999999999999999999999999764322  123457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT  159 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence            9999975 8988887644 5789999999999999999999999999999999999999999999999998765443334


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------------------c
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------E  226 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~  226 (441)
                      .....|++.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+...                   .
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            456678999999999876554568999999999999999999999877654433322110                   0


Q ss_pred             CCC-----------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          227 FSC-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       227 ~~~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      ...           .+.+++++++||++||+.||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            001           12367899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.4e-49  Score=390.28  Aligned_cols=251  Identities=33%  Similarity=0.626  Sum_probs=221.8

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876655555567788999999988 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875333333445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC---------hHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------LPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      .|+|||++.+..+ +.++|+||+||++|+|++|..||+...         .....+.+.......|..++.++.++|++|
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~  239 (329)
T cd05588         161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF  239 (329)
T ss_pred             cccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999987666 489999999999999999999996321         123455667777788889999999999999


Q ss_pred             cCCCCCCCCC------hHhHhcCCCccc
Q 013520          245 LDPNPKTRIR------IEGIRKHPWFRK  266 (441)
Q Consensus       245 L~~dP~~R~t------~~eil~hp~f~~  266 (441)
                      |+.||.+|+|      ++++++||||..
T Consensus       240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         240 LNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             hccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.9e-49  Score=381.66  Aligned_cols=255  Identities=29%  Similarity=0.477  Sum_probs=220.8

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++.+.+..|+|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            48899999999999999999999999999999987654443344567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+++|+|.+.+...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR  159 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence            99999998887643  36899999999999999999999999999999999999999999999999998765332 2234


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH----HHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ...||+.|+|||++.+..+. .++||||+||++|+|++|..||...+..    .....+......++..+++++.+||++
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  238 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRM  238 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHH
Confidence            56799999999999876664 8999999999999999999999875432    233334445556677799999999999


Q ss_pred             hcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ||+.||++||+     ++++++||||+.
T Consensus       239 ~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         239 LLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             HhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            99999999997     899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-49  Score=394.51  Aligned_cols=256  Identities=34%  Similarity=0.652  Sum_probs=227.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999998765544445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-----
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-----  163 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-----  163 (441)
                      ||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999987654432     


Q ss_pred             ------------------------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHH
Q 013520          164 ------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  219 (441)
Q Consensus       164 ------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~  219 (441)
                                              .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                    22345679999999999987765 48999999999999999999999988877777


Q ss_pred             HHhhc--CcCCCCCC--CCHhHHHHHHHhcCCCCCCCCC-hHhHhcCCCccc
Q 013520          220 KKINA--AEFSCPFW--FSTGATSLIHKILDPNPKTRIR-IEGIRKHPWFRK  266 (441)
Q Consensus       220 ~~i~~--~~~~~~~~--~s~~~~~li~~~L~~dP~~R~t-~~eil~hp~f~~  266 (441)
                      .++..  .....|..  +++++.++|.+||. ||.+|++ ++++++||||+.
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            76665  34444443  59999999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.2e-49  Score=387.31  Aligned_cols=251  Identities=33%  Similarity=0.639  Sum_probs=223.4

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|++..+++.||+|++.+.........+....|..++..+ +||||+++++++..+...|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876544334445566677777654 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875544334445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+.......|.+++.++.++|.+||+.||++||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~  239 (316)
T cd05592         161 DYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL  239 (316)
T ss_pred             cccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence            9999999987665 489999999999999999999999988888888888777888889999999999999999999999


Q ss_pred             ChH-hHhcCCCccc
Q 013520          254 RIE-GIRKHPWFRK  266 (441)
Q Consensus       254 t~~-eil~hp~f~~  266 (441)
                      ++. ++++||||+.
T Consensus       240 ~~~~~l~~h~~~~~  253 (316)
T cd05592         240 GVDGDIRQHPFFRG  253 (316)
T ss_pred             CChHHHHcCcccCC
Confidence            875 8999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-49  Score=396.82  Aligned_cols=256  Identities=33%  Similarity=0.616  Sum_probs=221.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999997755444455677899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc----
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE----  164 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~----  164 (441)
                      ||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.......    
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999863211000    


Q ss_pred             -------------------------------------------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHH
Q 013520          165 -------------------------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF  201 (441)
Q Consensus       165 -------------------------------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~  201 (441)
                                                                 .....+||+.|+|||++.+..+ +.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~  239 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF  239 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence                                                       0013579999999999987666 48999999999999


Q ss_pred             HHhcCCCCCCCCChHHHHHHhhcC--cCCCCC--CCCHhHHHHHHHhcCCCCCCC---CChHhHhcCCCccc
Q 013520          202 VLMAGYLPFGETDLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPKTR---IRIEGIRKHPWFRK  266 (441)
Q Consensus       202 ~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R---~t~~eil~hp~f~~  266 (441)
                      +|++|.+||...+..+.+..+...  ....|.  .++.++.+||++||. +|.+|   +|+.+++.||||+.
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            999999999887776766666542  233444  378999999999998 66665   59999999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.3e-49  Score=386.90  Aligned_cols=256  Identities=30%  Similarity=0.586  Sum_probs=229.5

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +|++.+.||+|+||.||+|+++.+|+.||+|++.+.........+.+..|+.++..+. |++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5889999999999999999999999999999998765444444567788999998885 578889999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            99999999999998889999999999999999999999999999999999999999999999999998754333333456


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      .+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+.....+.+.......|..++.++.+++.+||+.|
T Consensus       161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~  239 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH  239 (323)
T ss_pred             ccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence            679999999999987665 4899999999999999999999999888888888888888888899999999999999999


Q ss_pred             CCCCCCh-----HhHhcCCCccc
Q 013520          249 PKTRIRI-----EGIRKHPWFRK  266 (441)
Q Consensus       249 P~~R~t~-----~eil~hp~f~~  266 (441)
                      |.+|++.     +++++||||+.
T Consensus       240 p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         240 PSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             HhhCCCCCCCCHHHHhcCcccCC
Confidence            9999974     78999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.6e-49  Score=394.46  Aligned_cols=262  Identities=31%  Similarity=0.542  Sum_probs=228.1

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      .....++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            34567899999999999999999999999999999999987544444445667889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999999998865 568999999999999999999999999999999999999999999999999987654321


Q ss_pred             -cccccccCCCCcCCccccccCC---CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCCC--CCCH
Q 013520          164 -ELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF--WFST  235 (441)
Q Consensus       164 -~~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~  235 (441)
                       ......+||+.|+|||++.+..   +.+.++|||||||++|+|++|.+||.+.+....+.++....  ..+|.  .+|.
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  276 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISK  276 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCH
Confidence             1234568999999999986532   34689999999999999999999999988877777776533  34444  4799


Q ss_pred             hHHHHHHHhcCCCCCC--CCChHhHhcCCCccc
Q 013520          236 GATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (441)
                      ++.++|++||+.+|.+  |+|++++++||||+.
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            9999999999999988  999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-49  Score=387.62  Aligned_cols=252  Identities=36%  Similarity=0.655  Sum_probs=225.2

Q ss_pred             EeeeeecCcEEEEEEEEC---CCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           14 GRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      ++.||+|+||.||+|++.   .+++.||+|++.+..... ......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999874   478899999998754322 2234567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      |++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            99999999999988899999999999999999999999999999999999999999999999999987544333344567


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCC
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP  249 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP  249 (441)
                      +||+.|+|||++.+..+ +.++|||||||++|+|++|.+||...+.......+..+....|..+++++.++|++||+.||
T Consensus       161 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  239 (323)
T cd05584         161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP  239 (323)
T ss_pred             CCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence            89999999999977665 48999999999999999999999998888888888888888899999999999999999999


Q ss_pred             CCCC-----ChHhHhcCCCccc
Q 013520          250 KTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       250 ~~R~-----t~~eil~hp~f~~  266 (441)
                      ++||     +++++++||||+.
T Consensus       240 ~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         240 SSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             hHcCCCCCCCHHHHhcCCCcCC
Confidence            9999     8999999999975

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.7e-49  Score=396.92  Aligned_cols=256  Identities=30%  Similarity=0.540  Sum_probs=221.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997755444444567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc------
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------  162 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~------  162 (441)
                      ||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|......      
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999997532100      


Q ss_pred             -------------------------------------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc
Q 013520          163 -------------------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA  205 (441)
Q Consensus       163 -------------------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~  205 (441)
                                                           .......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~  239 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence                                                 001123579999999999987766 489999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhhcC--cCCCCC--CCCHhHHHHHHHhcCCCCCCCC---ChHhHhcCCCccc
Q 013520          206 GYLPFGETDLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  266 (441)
Q Consensus       206 g~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~f~~  266 (441)
                      |..||.+.+..+....+...  ....|.  .+++++.++|.+|+ .+|.+|+   |++++++||||+.
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            99999988776665555432  223333  47999999999987 5999999   9999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.2e-49  Score=387.50  Aligned_cols=251  Identities=34%  Similarity=0.590  Sum_probs=222.8

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++.+.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999998765443333445555555 56789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            99999999888999999999999999999999999999999999999999999999999999875433333445668999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+ +.++|||||||++|+|++|..||...+..+.++.+.......++.+++.+.++|++||+.||.+||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (323)
T cd05575         161 EYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL  239 (323)
T ss_pred             hhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence            9999999987665 489999999999999999999999988888888888887788888999999999999999999999


Q ss_pred             Ch----HhHhcCCCccc
Q 013520          254 RI----EGIRKHPWFRK  266 (441)
Q Consensus       254 t~----~eil~hp~f~~  266 (441)
                      ++    .++++||||..
T Consensus       240 ~~~~~~~~il~~~~~~~  256 (323)
T cd05575         240 GAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCHHHHHcCCCcCC
Confidence            98    69999999965

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=4.9e-49  Score=386.29  Aligned_cols=251  Identities=35%  Similarity=0.672  Sum_probs=226.9

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999876544444556778899999888 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            99999999888999999999999999999999999999999999999999999999999999875333333345568999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+. .++||||+||++|+|++|..||.+.+.......+.......|..++.++.++|++||..||++||
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~  239 (318)
T cd05570         161 DYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL  239 (318)
T ss_pred             cccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence            99999999876664 89999999999999999999999888888888888888888888999999999999999999999


Q ss_pred             Ch-----HhHhcCCCccc
Q 013520          254 RI-----EGIRKHPWFRK  266 (441)
Q Consensus       254 t~-----~eil~hp~f~~  266 (441)
                      |+     .+++.||||+.
T Consensus       240 s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         240 GCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             CCCCCCHHHHhcCCCcCC
Confidence            99     99999999976

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.6e-49  Score=382.93  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=212.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|+++.+|+.||+|++.......  ....+.+|+.+++.++||||+++++++.++...|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            3578999999999999999999999999999999987643221  23456789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||||+. ++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            999996 5777777653 57899999999999999999999999999999999999999999999999998754433333


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhc--Cc----------------
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINA--AE----------------  226 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~--~~----------------  226 (441)
                      ....+||+.|+|||++.+....+.++||||+||++|+|++|..||.+.... .....+..  +.                
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            456678999999999876555568899999999999999999999875332 22221110  00                


Q ss_pred             ---CC--CC---------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          227 ---FS--CP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       227 ---~~--~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                         +.  .|         ..+++++.+||++||+.||++|||+.++++||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence               00  00         0135678999999999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=6e-49  Score=385.36  Aligned_cols=251  Identities=31%  Similarity=0.599  Sum_probs=223.1

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|++..+++.||+|++.+..............|..++... +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876433333345566788888764 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+.+.....+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999875433333345668999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+ +.++||||+||++|+|++|..||...+..+..+.+.......|.+++.++.++|.+||+.||++||
T Consensus       161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  239 (316)
T cd05619         161 DYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL  239 (316)
T ss_pred             cccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence            9999999987666 489999999999999999999999888888888887777788889999999999999999999999


Q ss_pred             ChH-hHhcCCCccc
Q 013520          254 RIE-GIRKHPWFRK  266 (441)
Q Consensus       254 t~~-eil~hp~f~~  266 (441)
                      ++. ++++||||+.
T Consensus       240 ~~~~~l~~h~~~~~  253 (316)
T cd05619         240 GVKGDIRQHPFFRE  253 (316)
T ss_pred             CChHHHHcCcccCC
Confidence            996 9999999976

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.4e-49  Score=386.86  Aligned_cols=251  Identities=33%  Similarity=0.615  Sum_probs=221.0

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999886655555567788999998877 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC---------ChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---------DLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      .|+|||++.+..+ +.++|||||||++|+|++|..||...         ......+.+.......|..++..+.++|++|
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~  239 (329)
T cd05618         161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF  239 (329)
T ss_pred             cccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence            9999999987665 48999999999999999999999531         1223455566777788888999999999999


Q ss_pred             cCCCCCCCCC------hHhHhcCCCccc
Q 013520          245 LDPNPKTRIR------IEGIRKHPWFRK  266 (441)
Q Consensus       245 L~~dP~~R~t------~~eil~hp~f~~  266 (441)
                      |+.||++|+|      ++++++||||+.
T Consensus       240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         240 LNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             hcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            9999999998      479999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.8e-49  Score=392.91  Aligned_cols=256  Identities=34%  Similarity=0.628  Sum_probs=223.7

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999998755444445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-----
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-----  163 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-----  163 (441)
                      ||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            999999999999988899999999999999999999999999999999999999999999999999986432110     


Q ss_pred             ------------------------------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC
Q 013520          164 ------------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (441)
Q Consensus       164 ------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~  213 (441)
                                                    ......+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence                                          011245799999999999877765 8999999999999999999999988


Q ss_pred             ChHHHHHHhhcC--cCCCCC--CCCHhHHHHHHHhcCCCCCCCC---ChHhHhcCCCccc
Q 013520          214 DLPTLYKKINAA--EFSCPF--WFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  266 (441)
Q Consensus       214 ~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~f~~  266 (441)
                      +....+.++...  ...+|+  .+++++.++|.+|+. ||.+|+   +++++++||||+.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence            877777776542  233444  378999999999874 999998   4799999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.5e-49  Score=392.76  Aligned_cols=262  Identities=32%  Similarity=0.561  Sum_probs=226.0

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            44567999999999999999999999999999999999875444444456688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      |+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999999999999865 468999999999999999999999999999999999999999999999999997654321 


Q ss_pred             cccccccCCCCcCCccccccCC---CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCCC--CCCHh
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF--WFSTG  236 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~  236 (441)
                      ....+.+||+.|+|||++.+.+   +.+.++||||+||++|+|++|.+||...+....+..+....  +..|.  .++..
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~  277 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH  277 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence            2234678999999999996543   34689999999999999999999999888777777765432  44444  46999


Q ss_pred             HHHHHHHhcCCCCCC--CCChHhHhcCCCcccc
Q 013520          237 ATSLIHKILDPNPKT--RIRIEGIRKHPWFRKN  267 (441)
Q Consensus       237 ~~~li~~~L~~dP~~--R~t~~eil~hp~f~~~  267 (441)
                      +++++.+||..+|.+  |+|++++++||||+..
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999866544  8999999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-48  Score=385.00  Aligned_cols=257  Identities=33%  Similarity=0.629  Sum_probs=222.8

Q ss_pred             CeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      +|++++.||+|+||.||+|++.   .+|+.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5999999999999999999874   47899999999765432 223456788899999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc-c
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-V  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~  163 (441)
                      |+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            999999999999999988888999999999999999999999999999999999999999999999999998764332 2


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC----ChHHHHHHhhcCcCCCCCCCCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET----DLPTLYKKINAAEFSCPFWFSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~~  239 (441)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|..||...    ........+.......|..+++.+.+
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD  240 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            22345689999999999976655568999999999999999999999643    23344555666667777789999999


Q ss_pred             HHHHhcCCCCCCCC-----ChHhHhcCCCccc
Q 013520          240 LIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       240 li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +|.+||+.||++||     +++++++||||+.
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  272 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG  272 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            99999999999999     7889999999976

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.2e-48  Score=377.18  Aligned_cols=254  Identities=31%  Similarity=0.443  Sum_probs=213.7

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999999765432 233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-cccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~~  167 (441)
                      ||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            999998776666555679999999999999999999999999999999999999999999999999998654322 2233


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------------------cCC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EFS  228 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~~  228 (441)
                      ...||+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+..+....+...                   ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07848         160 EYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR  238 (287)
T ss_pred             ccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence            5679999999999987665 48999999999999999999999876543322221110                   000


Q ss_pred             C-------------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 C-------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 ~-------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .             ...+|.++.+||++||++||++|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1             11267889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-49  Score=372.75  Aligned_cols=259  Identities=31%  Similarity=0.477  Sum_probs=223.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeEEEEEeCC----
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRT----   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~----   82 (441)
                      +..|+.+++||+|+||+||+|+++.+|+.||+|.+..+.-. ++.-....+|+.+++.++|+| |+++++++.+.+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            56688899999999999999999999999999999876432 334456789999999999999 999999998877    


Q ss_pred             --EEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           83 --KVYIILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        83 --~~~lv~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                        .+|+|+||++ -+|..++....    .++...++.+++||+.||+|||++||+||||||+||||+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              8999999995 48999987755    5788899999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc------------
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------  224 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------  224 (441)
                      +...-+.......++|..|+|||++.+...++...||||+|||++||+++++.|.+.+..++...|-.            
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            97776666678889999999999999987778999999999999999999999998876655544411            


Q ss_pred             ------CcCCCCCC------------CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          225 ------AEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       225 ------~~~~~~~~------------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                            ....++.|            .+++..+++.+||+.+|.+|.|+..++.||||+...
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                  01122222            245899999999999999999999999999998653

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.6e-49  Score=385.96  Aligned_cols=257  Identities=32%  Similarity=0.568  Sum_probs=224.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998765544445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-cc
Q 013520           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LL  166 (441)
Q Consensus        89 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~  166 (441)
                      ||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999876 6899999999999999999999999999999999999999999999999999976544322 23


Q ss_pred             ccccCCCCcCCcccccc-----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc----CCCCCCCCHhH
Q 013520          167 HTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE----FSCPFWFSTGA  237 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----~~~~~~~s~~~  237 (441)
                      ...+||+.|+|||++..     ....+.++|||||||++|+|++|..||...+....+.++....    ++..+.+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            34579999999999863     2334589999999999999999999998877776666664432    22333579999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .+||++||. ||++|||++++++||||+.
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            999999998 9999999999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-48  Score=384.58  Aligned_cols=251  Identities=34%  Similarity=0.596  Sum_probs=222.1

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||+||+|+++.+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999998764433334455556655 46778999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            99999999888999999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+. .++|||||||++|+|++|.+||...+..+.++.+.......++..+..+.++|++||..||.+||
T Consensus       161 ~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~  239 (325)
T cd05604         161 EYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL  239 (325)
T ss_pred             hhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence            99999999876664 89999999999999999999999888888888888777777778999999999999999999999


Q ss_pred             Ch----HhHhcCCCccc
Q 013520          254 RI----EGIRKHPWFRK  266 (441)
Q Consensus       254 t~----~eil~hp~f~~  266 (441)
                      ++    .++++||||..
T Consensus       240 ~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         240 GAKEDFLEIQEHPFFES  256 (325)
T ss_pred             CCCCCHHHHhcCCCcCC
Confidence            87    58999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-49  Score=387.23  Aligned_cols=250  Identities=33%  Similarity=0.593  Sum_probs=220.7

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      ||+|+||.||+|+++.+|+.||+|++.+..............|..++...   +||||+++++++.+.+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999775544333344555677777655   699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            99999999888999999999999999999999999999999999999999999999999999875444334455678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCC-CCHhHHHHHHHhcCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW-FSTGATSLIHKILDPNPKTR  252 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R  252 (441)
                      .|+|||++.+....+.++|||||||++|+|++|..||...+..+.++.+..+....|.. +++++.++|++||..||.+|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            99999999765545689999999999999999999999988888888888777776654 79999999999999999999


Q ss_pred             C----ChHhHhcCCCccc
Q 013520          253 I----RIEGIRKHPWFRK  266 (441)
Q Consensus       253 ~----t~~eil~hp~f~~  266 (441)
                      |    +++++++||||..
T Consensus       241 ~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         241 LGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             CCCCCCHHHHhcCccccC
Confidence            8    7899999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-48  Score=381.86  Aligned_cols=251  Identities=35%  Similarity=0.609  Sum_probs=222.1

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999998765443333445555654 57889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|...+.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.............+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+. .++|||||||++|+|++|.+||...+....+..+.......|...+.++.++|.+||+.||.+|+
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (321)
T cd05603         161 EYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL  239 (321)
T ss_pred             ccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence            99999999776664 88999999999999999999999988888888888887888888999999999999999999999


Q ss_pred             Ch----HhHhcCCCccc
Q 013520          254 RI----EGIRKHPWFRK  266 (441)
Q Consensus       254 t~----~eil~hp~f~~  266 (441)
                      ++    .++++||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         240 GAKADFLEIKNHVFFSP  256 (321)
T ss_pred             CCCCCHHHHhCCCCcCC
Confidence            76    49999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.1e-48  Score=383.59  Aligned_cols=251  Identities=38%  Similarity=0.662  Sum_probs=224.2

Q ss_pred             EeeeeecCcEEEEEEEE---CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           14 GRTIGEGTFAKVRFAQN---RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~---~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      ++.||+|+||.||++++   +.+|+.||+|++.+..... .....+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            36899999999999986   4578999999998754322 2235577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccccc
Q 013520           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC  170 (441)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~  170 (441)
                      +++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.............+
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            99999999998888899999999999999999999999999999999999999999999999999876544433445678


Q ss_pred             CCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCC
Q 013520          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK  250 (441)
Q Consensus       171 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~  250 (441)
                      ||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++++.++|++||+.||+
T Consensus       160 g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~  238 (318)
T cd05582         160 GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA  238 (318)
T ss_pred             CChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence            9999999999977665 489999999999999999999999888888888888888888888999999999999999999


Q ss_pred             CCCC-----hHhHhcCCCccc
Q 013520          251 TRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       251 ~R~t-----~~eil~hp~f~~  266 (441)
                      +||+     ++++++||||+.
T Consensus       239 ~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         239 NRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HcCCCCCCCHHHHhCCCCcCC
Confidence            9999     677999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-50  Score=364.74  Aligned_cols=255  Identities=36%  Similarity=0.650  Sum_probs=223.1

Q ss_pred             cccccCeEEE-eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe--
Q 013520            5 TRRVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS--   80 (441)
Q Consensus         5 ~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--   80 (441)
                      ....++|.+. ++||-|-.|+|-.+.++.||+.+|+|++.-        ....++|+.++-+. .|||||++++++++  
T Consensus        57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~  128 (400)
T KOG0604|consen   57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSY  128 (400)
T ss_pred             ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence            3456788885 579999999999999999999999998743        24567899987766 69999999999864  


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CCCeEEeec
Q 013520           81 --RTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDF  153 (441)
Q Consensus        81 --~~~~~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DF  153 (441)
                        ...+.+|||.++||+||..|+..+.  ++|.++..+++||..|+.|||+.+|+||||||||+|...   |..+||+||
T Consensus       129 ~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  129 QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccc
Confidence              4568899999999999999998765  999999999999999999999999999999999999975   446999999


Q ss_pred             cccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC----hHHHHHHhhcCcCCC
Q 013520          154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSC  229 (441)
Q Consensus       154 Gls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~  229 (441)
                      |+|+..... ..+.+.|-||.|+|||++....|+ ...|+||+|||+|.||+|++||....    .+.+..+|..+.+.+
T Consensus       209 GFAK~t~~~-~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  209 GFAKETQEP-GDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccccCCC-ccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            999876543 567899999999999999877775 89999999999999999999997643    357788899998877


Q ss_pred             CC--C--CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          230 PF--W--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       230 ~~--~--~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      |.  |  +|+.++|+|+++|..+|.+|.|+++++.|||+.....
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            64  5  8999999999999999999999999999999976544

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.6e-48  Score=381.59  Aligned_cols=251  Identities=31%  Similarity=0.604  Sum_probs=221.3

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||+||+|.++.+++.||+|++.+.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999886655555567788999999888 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC-------ChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-------DLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (441)
                      .|+|||++.+..+ +.++|||||||++|+|++|..||...       ......+.+.......|..++..+.++|++||.
T Consensus       161 ~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  239 (327)
T cd05617         161 NYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN  239 (327)
T ss_pred             ccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999987666 48999999999999999999999532       123445556666677888899999999999999


Q ss_pred             CCCCCCCC------hHhHhcCCCccc
Q 013520          247 PNPKTRIR------IEGIRKHPWFRK  266 (441)
Q Consensus       247 ~dP~~R~t------~~eil~hp~f~~  266 (441)
                      .||++|++      ++++++||||+.
T Consensus       240 ~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         240 KDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             cCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            99999998      469999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.8e-48  Score=381.03  Aligned_cols=251  Identities=33%  Similarity=0.590  Sum_probs=220.6

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||+|+||.||+|++..+++.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            47999999999999999999999999998754433333344444544 56788999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      |+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.............+||+
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            99999999888899999999999999999999999999999999999999999999999999875433333445678999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .|+|||++.+..+. .++|||||||++|+|++|.+||.+.+..+.++.+.......++.+++.+.++|.+||+.||.+|+
T Consensus       161 ~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~  239 (325)
T cd05602         161 EYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL  239 (325)
T ss_pred             cccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence            99999999876654 89999999999999999999999888888888887777777778999999999999999999999


Q ss_pred             ChH----hHhcCCCccc
Q 013520          254 RIE----GIRKHPWFRK  266 (441)
Q Consensus       254 t~~----eil~hp~f~~  266 (441)
                      ++.    ++++|+||..
T Consensus       240 ~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         240 GAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCHHHHhcCcccCC
Confidence            876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.4e-48  Score=385.80  Aligned_cols=262  Identities=32%  Similarity=0.551  Sum_probs=225.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+.+.+
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            44568999999999999999999999999999999999775444444456688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      |+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....... 
T Consensus       119 ~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            999999999999998865 568999999999999999999999999999999999999999999999999987654321 


Q ss_pred             cccccccCCCCcCCccccccCC---CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCC--CCCCHh
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCP--FWFSTG  236 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~  236 (441)
                      ......+||+.|+|||++.+..   ..+.++|||||||++|+|++|.+||...+....+..+....  ..+|  ..++..
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  277 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE  277 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence            2234678999999999986543   34689999999999999999999999988877777776533  3333  358999


Q ss_pred             HHHHHHHhcCCCCCC--CCChHhHhcCCCcccc
Q 013520          237 ATSLIHKILDPNPKT--RIRIEGIRKHPWFRKN  267 (441)
Q Consensus       237 ~~~li~~~L~~dP~~--R~t~~eil~hp~f~~~  267 (441)
                      +.++|.+||..++.+  |++++++++||||++.
T Consensus       278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            999999999854443  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6e-48  Score=371.55  Aligned_cols=249  Identities=31%  Similarity=0.516  Sum_probs=215.4

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L   96 (441)
                      ||+|+||+||++.++.+|+.||+|.+.+.........+.+..|+.+++.++||||+++.+++..++..|+||||++||+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999999876544444456678899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCC
Q 013520           97 FDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (441)
Q Consensus        97 ~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (441)
                      .+.+..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..............||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            887743    3568999999999999999999999999999999999999999999999999987655443334456799


Q ss_pred             CCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh----HHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       173 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      +.|+|||++.+..+. .++|+||+||++|+|++|..||...+.    ......+.......|..+++++.+++.+||+.|
T Consensus       161 ~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  239 (280)
T cd05608         161 PGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD  239 (280)
T ss_pred             cCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence            999999999877664 899999999999999999999976432    233344444555666778999999999999999


Q ss_pred             CCCCC-----ChHhHhcCCCccc
Q 013520          249 PKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       249 P~~R~-----t~~eil~hp~f~~  266 (441)
                      |++||     +++++++||||+.
T Consensus       240 P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         240 PEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             HHHhcCCCCCCHHHHhcChhhhc
Confidence            99999     7899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6e-49  Score=385.26  Aligned_cols=259  Identities=27%  Similarity=0.474  Sum_probs=240.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-EE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK-VY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~   85 (441)
                      .+++|+.++.+|+|+||.+++++++..+..+++|.+......... .....+|+.++++++|||||.+.+.|..++. +|
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            468899999999999999999999999999999999887655443 4478899999999999999999999998887 99


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |||+||+||++.+.|....  -++|+.+..|+.|++.||.|||++.|.|||||+.||+++.++.+||.|||+|+......
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999997654  68999999999999999999999999999999999999999999999999999988876


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIH  242 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~  242 (441)
                      ....+..|||.|+.||++.+.+|. .++|||||||++|||++-+++|.+.+...+..+|..+. .+.|..++.+++.+|+
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK  239 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence            678899999999999999998885 99999999999999999999999999999999988877 5778889999999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCcccc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .||..+|..||++.++|.+|..+..
T Consensus       240 ~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHhhcCCccCCCHHHHhhChhhhhH
Confidence            9999999999999999999988743

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-47  Score=376.22  Aligned_cols=258  Identities=29%  Similarity=0.548  Sum_probs=220.1

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||.||+++++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999998754444445567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-cc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LL  166 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~  166 (441)
                      ||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999976 45799999999999999999999999999999999999999999999999999865443222 22


Q ss_pred             ccccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCC---CCCCHhH
Q 013520          167 HTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCP---FWFSTGA  237 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~~  237 (441)
                      ...+||+.|+|||++..    ....+.++||||+||++|+|++|..||...+..+.+..+....  +..|   ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            33579999999999863    2344689999999999999999999998887777766664432  2333   2479999


Q ss_pred             HHHHHHhcCCCCCC--CCChHhHhcCCCccc
Q 013520          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (441)
                      +++|++||..++++  |++++++++||||..
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            99999999764443  889999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-49  Score=374.62  Aligned_cols=261  Identities=31%  Similarity=0.588  Sum_probs=243.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   83 (441)
                      ..+..+|.++.+||+|+||+|.+|..+.|.+.||||+++++.+.....++.-..|-++|... +-|.+++++..|++-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            45678999999999999999999999999999999999998877666666677788888877 57899999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||+.||+|-..|+.-+++.|..|.+|+.+|+-||-+||++||++||||.+||+||.+|++||+|||++..--...
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998655555


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ....+.||||.|+|||++..++| +.++|+||+||+|||||.|++||++.+..++++.|.....++|..+|.++.++.+.
T Consensus       505 ~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg  583 (683)
T KOG0696|consen  505 VTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKG  583 (683)
T ss_pred             cceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHH
Confidence            67789999999999999988877 59999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCh-----HhHhcCCCccc
Q 013520          244 ILDPNPKTRIRI-----EGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t~-----~eil~hp~f~~  266 (441)
                      .|.+.|.+|...     .+|..||||+.
T Consensus       584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  584 LLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HhhcCCccccCCCCccccchhhCcchhh
Confidence            999999999865     68999999975

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-50  Score=383.66  Aligned_cols=255  Identities=28%  Similarity=0.445  Sum_probs=228.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ..|+..+.||+|+||.||+|.+..+++.||+|+++.+....  .++.+.+|+.++..++++||.++|+.+..+..+|++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            46888899999999999999999999999999999877543  4688999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      |||.||++.+.++....+.|..+..++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||.+...........+
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999877665455589


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHHHHHHhcCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~  247 (441)
                      .+|||.|||||++...+|+ .++||||||++.+||++|.+||...........|-...+ .....+|+.+++|+..||+.
T Consensus       171 fvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k  249 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDK  249 (467)
T ss_pred             ccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhc
Confidence            9999999999999977876 899999999999999999999987766433333333222 12234899999999999999


Q ss_pred             CCCCCCChHhHhcCCCccc
Q 013520          248 NPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       248 dP~~R~t~~eil~hp~f~~  266 (441)
                      ||+.||++.++++|+|++.
T Consensus       250 ~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  250 NPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             CcccCcCHHHHhhhHHHHh
Confidence            9999999999999999987

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-47  Score=367.50  Aligned_cols=255  Identities=29%  Similarity=0.485  Sum_probs=220.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      .|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+++..|+|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999977554433334567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+.||+|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++...... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~  159 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIR  159 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Cccc
Confidence            99999999888653  46899999999999999999999999999999999999999999999999998765432 2234


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH----HHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ..+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....    ...+.......+..+++.+.+++.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQ  238 (285)
T ss_pred             cccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHH
Confidence            5679999999999976655 4889999999999999999999987654332    2334444455666789999999999


Q ss_pred             hcCCCCCCCC-----ChHhHhcCCCccc
Q 013520          244 ILDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      ||..||++||     +++++++||||.+
T Consensus       239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         239 LLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            9999999999     8999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.8e-47  Score=373.64  Aligned_cols=256  Identities=25%  Similarity=0.407  Sum_probs=219.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|++..+|..+|+|++....  .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            4579999999999999999999999999999999997643  23345679999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||||++||+|.+++.....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....  ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  158 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SM  158 (331)
T ss_pred             EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc--cc
Confidence            999999999999999888899999999999999999999986 699999999999999999999999999875533  22


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhh----------------------
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN----------------------  223 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~----------------------  223 (441)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..++...+.                      
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG  237 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence            345679999999999987665 489999999999999999999997665443322211                      


Q ss_pred             ------------------------cCc-CCCC-CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          224 ------------------------AAE-FSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       224 ------------------------~~~-~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                              ... ...+ ..+++++.+||++||+.||++|||++++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                    000 0111 1368899999999999999999999999999999754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.7e-47  Score=376.25  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=209.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----TKV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~   84 (441)
                      +|++.+.||+|+||.||+|+++.+|..||||.+..... .......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            69999999999999999999999999999999875322 222345688999999999999999999988543     358


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999995 6899999888889999999999999999999999999999999999999999999999999987543211 


Q ss_pred             --cccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh---------------hc-
Q 013520          164 --ELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---------------NA-  224 (441)
Q Consensus       164 --~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i---------------~~-  224 (441)
                        ......+||+.|+|||++.+. ...+.++|||||||++|+|++|.+||.+.+.......+               .. 
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence              122456799999999998652 33458999999999999999999999776533221111               00 


Q ss_pred             ----------CcCCC-----CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          225 ----------AEFSC-----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       225 ----------~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                ...+.     -+.+++.+.++|.+||+.||++|||++++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                      00000     02367889999999999999999999999999999764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-49  Score=376.74  Aligned_cols=262  Identities=31%  Similarity=0.499  Sum_probs=237.8

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .++...+.|..-++||+|+||.|+-++.+.||+.||+|.+.+..+.+.........|..+|.+++.++||.+-..|++++
T Consensus       179 ~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  179 LQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             hhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            46778889999999999999999999999999999999999888777666677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           83 KVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      .+|+||..|.||+|.-+|.+.+  .++|..+.+|+.+|+.||++||+.+|++|||||+|||||+.|+++|+|.|+|..+.
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999999999898776  89999999999999999999999999999999999999999999999999998776


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC----hHHHHHHhhcCcCCCCCCCCHh
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTG  236 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~  236 (441)
                      .+ ......+||.+|||||++.+..|+ ...|+|||||+||+|+.|+.||....    ..++-+.+......+|..+|++
T Consensus       339 ~g-~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~e  416 (591)
T KOG0986|consen  339 EG-KPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEE  416 (591)
T ss_pred             CC-CccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHH
Confidence            65 334556999999999999988865 89999999999999999999997643    3455666777777888899999


Q ss_pred             HHHHHHHhcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          237 ATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ++++.+.+|+.||++|..     ++++.+||||+.
T Consensus       417 akslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  417 AKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            999999999999999985     569999999986

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.5e-47  Score=373.43  Aligned_cols=258  Identities=28%  Similarity=0.533  Sum_probs=220.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++.+.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997654444444566888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc-cccc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VELL  166 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~~~  166 (441)
                      ||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999977 467899999999999999999999999999999999999999999999999998654332 1223


Q ss_pred             ccccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCCC---CCCHhH
Q 013520          167 HTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF---WFSTGA  237 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~~  237 (441)
                      ...+||+.|+|||++..    ....+.++|||||||++|+|++|..||...+..+.+.++....  ...|.   .+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            34679999999999862    2334689999999999999999999999888777777775543  23332   479999


Q ss_pred             HHHHHHhcCCCCCC--CCChHhHhcCCCccc
Q 013520          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (441)
                      .+||++||..++.+  |++++++++||||+.
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            99999999765544  789999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.5e-47  Score=369.92  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=216.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|++.+.||+|+||.||+|+++.+++.||+|.+.......  ....+.+|+.+++.++||||+++++++..++..
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            346789999999999999999999999999999999987654222  234567899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          80 TLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            999999975 788877654 458899999999999999999999999999999999999999999999999987654433


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC------------------
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------------------  225 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------  225 (441)
                      .......+|+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+...                  
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            33445678999999999876555568999999999999999999999876654333222110                  


Q ss_pred             -cCCC-----------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          226 -EFSC-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       226 -~~~~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                       ....           .+.+++++.++|.+||..||.+|||++|+++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence             0111           12368899999999999999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-47  Score=373.31  Aligned_cols=249  Identities=27%  Similarity=0.437  Sum_probs=216.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcE-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-KVY   85 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~-vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~   85 (441)
                      ..+..+.+.||+|+||+||.|...  |.. ||+|++......... .+.+.+|+.+|.+++|||||++++++.++. .++
T Consensus        40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            445667778999999999999986  455 999999887655544 778999999999999999999999999888 799


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEccCC-CeEEeeccccccCCc
Q 013520           86 IILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKG-VYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQ  161 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~g-i~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~  161 (441)
                      +||||+++|+|.+++..  ...++...+..++.||+.|+.|||+++ |+||||||+|||++.++ ++||+|||+++....
T Consensus       117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            99999999999999987  678999999999999999999999999 99999999999999998 999999999987655


Q ss_pred             cccccccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh--hcCcCCCCCCCCHhH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFSTGA  237 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s~~~  237 (441)
                      .........||+.|||||++.+  ..| +.++||||||++||||+||..||.+.........+  ......+|..+++.+
T Consensus       197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l  275 (362)
T KOG0192|consen  197 SKTSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHL  275 (362)
T ss_pred             ccccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            3233444789999999999984  455 49999999999999999999999987764444433  344556677799999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ..++.+||..||+.||++.+|+.
T Consensus       276 ~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  276 SSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999999999864

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=9.7e-47  Score=372.06  Aligned_cols=258  Identities=29%  Similarity=0.515  Sum_probs=220.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997754434444566888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-cc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LL  166 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~  166 (441)
                      ||+.||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999987 46799999999999999999999999999999999999999999999999999876543222 22


Q ss_pred             ccccCCCCcCCccccccC----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCCC---CCCHhH
Q 013520          167 HTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF---WFSTGA  237 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~~  237 (441)
                      ...+||+.|+|||++.+.    +..+.++||||+||++|+|++|..||...+..+.+..+....  ++.|.   .++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            346799999999998642    234589999999999999999999998887777777665433  33333   368999


Q ss_pred             HHHHHHhcCCCCCC--CCChHhHhcCCCccc
Q 013520          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (441)
                      .++|.+||..++++  |++++++++||||+.
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            99999999876654  569999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-46  Score=379.56  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=209.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ....+|++++.||+|+||.||+|.+..+++.||+|....         ..+.+|+.+++.++||||+++++++..+...|
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            345689999999999999999999999999999996432         34678999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc-ccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-GVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-~~~  164 (441)
                      +++|++. ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999995 68999998888899999999999999999999999999999999999999999999999999875332 222


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-------hHHHHHHh---------------
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-------LPTLYKKI---------------  222 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------~~~~~~~i---------------  222 (441)
                      .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||....       .......+               
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             ccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            3345689999999999987665 589999999999999999998764321       00111000               


Q ss_pred             -----------hcCcC----CCCC-----CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          223 -----------NAAEF----SCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       223 -----------~~~~~----~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                                 .....    ..|.     .++.++.+||.+||+.||++|||++|+++||||+....+
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                       00000    1111     146789999999999999999999999999999875433

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-47  Score=361.58  Aligned_cols=255  Identities=33%  Similarity=0.497  Sum_probs=214.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   82 (441)
                      ..-.|+-.+.+|+|+||.||.|....+++.||||.+-.+.-.+       .+|+.+|+.++|||||++..+|....    
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            3346899999999999999999999999999999886654332       36999999999999999998886422    


Q ss_pred             -EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-CCeEEeecccc
Q 013520           83 -KVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLS  156 (441)
Q Consensus        83 -~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls  156 (441)
                       ...+||||++. +|.+.++.    +.+++...++-|.+||++||.|||+.||+||||||+|+|+|.+ |.+||||||.|
T Consensus        95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence             35689999965 88888874    5789999999999999999999999999999999999999965 99999999999


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhh------------c
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN------------A  224 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~------------~  224 (441)
                      +....+.. ..++..|..|+|||.+.+...++.+.||||+|||+.||+.|++.|.+.+..++...|.            .
T Consensus       174 K~L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  174 KVLVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeeccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            98877644 3678889999999999998888899999999999999999999999877554433321            1


Q ss_pred             C-----cCCCC------------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          225 A-----EFSCP------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       225 ~-----~~~~~------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      .     +..+|            ...++++.+|+.++|+.+|.+|.++.|++.||||..-..+
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            1     11111            2268999999999999999999999999999999765433

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.2e-47  Score=387.59  Aligned_cols=251  Identities=28%  Similarity=0.378  Sum_probs=206.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR------   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   81 (441)
                      ..+|++++.||+|+||.||+|.+..+++.||||.+....       ....+|+.+++.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            457999999999999999999999999999999886532       2235799999999999999999887432      


Q ss_pred             --CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeecc
Q 013520           82 --TKVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFG  154 (441)
Q Consensus        82 --~~~~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFG  154 (441)
                        ..+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence              257899999975 6666654    346799999999999999999999999999999999999999665 69999999


Q ss_pred             ccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---------
Q 013520          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------  225 (441)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------  225 (441)
                      +|...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+...         
T Consensus       217 la~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        217 SAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             cchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            99865443 22345678999999999876555568999999999999999999999887654433332110         


Q ss_pred             --------cC------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          226 --------EF------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       226 --------~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                              ..            .+|...|+++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence                    00            1233467899999999999999999999999999999764

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.7e-46  Score=361.64  Aligned_cols=254  Identities=36%  Similarity=0.716  Sum_probs=231.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+..|++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999998765544455677899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||+|.||+++.+|.+||+|||++......   ...
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~  157 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYT  157 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCC
Confidence            99999999999998889999999999999999999999999999999999999999999999999998765443   345


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      .+|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.....+.+..+....|..+++.+.++|.+||..|
T Consensus       158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  236 (290)
T cd05580         158 LCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD  236 (290)
T ss_pred             CCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCC
Confidence            578999999999876654 4889999999999999999999988877777777777788888889999999999999999


Q ss_pred             CCCCC-----ChHhHhcCCCccc
Q 013520          249 PKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       249 P~~R~-----t~~eil~hp~f~~  266 (441)
                      |.+|+     +++++++||||+.
T Consensus       237 p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         237 LTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             HHHccCcccCCHHHHHcCccccc
Confidence            99999     9999999999965

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.2e-47  Score=376.70  Aligned_cols=257  Identities=30%  Similarity=0.482  Sum_probs=216.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            34678999999999999999999999999999999986543  2334567899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||+++|+|.+.    ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            99999999998653    34567888899999999999999999999999999999999999999999999866543333


Q ss_pred             cccccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---HHHHHHhh-cCcCCCCCCCCHhH
Q 013520          166 LHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKIN-AAEFSCPFWFSTGA  237 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~-~~~~~~~~~~s~~~  237 (441)
                      .....||+.|+|||++..    ..+.+.++|||||||++|+|++|..||.....   ......+. ......+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            456689999999999743    23455789999999999999999999974332   22222222 22334456689999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .+||.+||..||++|||+.|+++||||.+..
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            9999999999999999999999999998753

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.1e-46  Score=377.69  Aligned_cols=256  Identities=25%  Similarity=0.423  Sum_probs=215.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-----KV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~   84 (441)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            5889999999999999999999999999999986532 22234567889999999999999999999998776     89


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      |+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999996 5888888888889999999999999999999999999999999999999999999999999987654321 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc-------------------
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-------------------  224 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-------------------  224 (441)
                      .......+|+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+..                   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            2234456899999999998765556899999999999999999999987765444333211                   


Q ss_pred             ----CcC---------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          225 ----AEF---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       225 ----~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                          ...         ......++++.+||.+||+.||++|||+.++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                111         1122357899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.3e-46  Score=360.55  Aligned_cols=252  Identities=30%  Similarity=0.420  Sum_probs=206.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeEEEEE-----
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLA-----   79 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~-----   79 (441)
                      .+|++.+.||+|+||.||+|++.. +|..||+|.+....... .......+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999864 56889999987644322 2234556788877766   6999999999885     


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      ....+++||||+. ++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456999999996 5898888653  458999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CC--------
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FS--------  228 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~--------  228 (441)
                      ..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+..+....+.... .+        
T Consensus       159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             eccCC-cccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            65433 33445679999999999977665 489999999999999999999998877655554443210 00        


Q ss_pred             ------------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 ------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 ------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                        ..+.+++.+.+++.+||+.||++|||+.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              112467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-46  Score=373.12  Aligned_cols=259  Identities=29%  Similarity=0.469  Sum_probs=211.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT---   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---   82 (441)
                      ...++|++.+.||+|+||.||+|.+..+|..||+|++.+... .......+.+|+.+++.++||||+++++++....   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            356899999999999999999999999999999999976532 2334567789999999999999999999986443   


Q ss_pred             ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           83 ---KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        83 ---~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                         ..|+||||+.+ +|.+.+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence               57999999976 5666654  45889999999999999999999999999999999999999999999999998754


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhh----------------
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN----------------  223 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~----------------  223 (441)
                      ... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+.                
T Consensus       174 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         174 CTN-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             ccC-ccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            332 233456789999999999877664 88999999999999999999998765432221110                


Q ss_pred             ------cCcCC---------CCC-----------CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          224 ------AAEFS---------CPF-----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       224 ------~~~~~---------~~~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                            .....         .+.           ..++++++||.+||+.||++|||+.|+++||||+..+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence                  00000         011           136789999999999999999999999999999876554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4e-46  Score=362.41  Aligned_cols=260  Identities=25%  Similarity=0.433  Sum_probs=217.4

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|++.+.||+|+||.||+|.++.+++.||+|.+.......  ....+.+|+.+++.++||||+++++++..++..
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            346789999999999999999999999999999999987543222  234567899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+. ++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            99999997 588888765 3568999999999999999999999999999999999999999999999999987654433


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC------------------
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------------------  225 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------  225 (441)
                      .......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+..+....+...                  
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            33345567899999999876555568999999999999999999999877654443322110                  


Q ss_pred             -cCCCC-----------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          226 -EFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       226 -~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                       ....|           ..+++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence             01111           2368889999999999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-46  Score=357.38  Aligned_cols=253  Identities=37%  Similarity=0.640  Sum_probs=215.4

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      |++++.||+|+||.||++.+..+++.||+|++......... .....+|+.+++.++||||+++++++.+....+++|||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999886543332 23345699999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccccc
Q 013520           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC  170 (441)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~  170 (441)
                      +.+++|.+++.....+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+..............
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999888999999999999999999999999999999999999999999999999999875433334456778


Q ss_pred             CCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHH---HHHHhhcCcCCCCC----CCCHhHHHHHHH
Q 013520          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAAEFSCPF----WFSTGATSLIHK  243 (441)
Q Consensus       171 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---~~~~i~~~~~~~~~----~~s~~~~~li~~  243 (441)
                      +++.|+|||++......+.++|+||||+++|+|++|..||...+...   ............+.    ..++.+.++|.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            99999999998734445699999999999999999999999874322   22222222221111    124899999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCc
Q 013520          244 ILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f  264 (441)
                      ||+.||++|||+.++++||||
T Consensus       240 ~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HSSSSGGGSTTHHHHHTSGGG
T ss_pred             HccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.2e-46  Score=359.08  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=216.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+.+.+..|+|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            48899999999999999999999999999999977655444445667889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+.|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~  159 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIK  159 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-cccc
Confidence            99999999988643  35899999999999999999999999999999999999999999999999998754332 2223


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH----HHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ...|++.|+|||++.+..+ +.++||||+||++|+|++|.+||......    .............+..+++++.+|+++
T Consensus       160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05630         160 GRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM  238 (285)
T ss_pred             CCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHH
Confidence            4579999999999977665 48999999999999999999999864322    111112222234456689999999999


Q ss_pred             hcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ||+.||++|||     ++|+++||||+.
T Consensus       239 ~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         239 LLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            99999999999     899999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=352.16  Aligned_cols=251  Identities=30%  Similarity=0.559  Sum_probs=221.6

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      .+.||+|+|+.|-.+.+..||..||||++.|..   .....++.+|+.++..+ .|+||++++++|+++.+.|+|||-+.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            467999999999999999999999999999863   22457899999999999 59999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEEeeccccccCCc-------c
Q 013520           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQ-------G  162 (441)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~~~-------~  162 (441)
                      ||.|..+|+....++|.+|.++.++|+.||.|||.+||+|||+||||||.....   -+||+||.+..-...       .
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            999999999999999999999999999999999999999999999999997654   489999998754322       2


Q ss_pred             ccccccccCCCCcCCccccc----cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC---------------hHHHHHHhh
Q 013520          163 VELLHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKIN  223 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~~~~~~i~  223 (441)
                      ...+.+.||+..|||||+..    ...++..++|.||||||||.||+|++||.+.-               ...++..|+
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence            23456889999999999862    23455689999999999999999999996532               245678899


Q ss_pred             cCcCCCCCC----CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          224 AAEFSCPFW----FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       224 ~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+.+.+|..    +|.+++++|+.+|..|+..|.++.++++|||++..
T Consensus       320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            999999863    89999999999999999999999999999999764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.3e-46  Score=366.59  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=217.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+..+|..+|+|++....  .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            4578999999999999999999999999999999987643  23345678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||||+.||+|.+++...+.+++..+..++.|++.||.|||++ +|+||||||+|||++.+|.+||+|||++.....  ..
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~  158 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SM  158 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh--hc
Confidence            999999999999999888899999999999999999999985 799999999999999999999999999875433  22


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh-----------------------
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-----------------------  222 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i-----------------------  222 (441)
                      ....+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...........+                       
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (333)
T cd06650         159 ANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRP  237 (333)
T ss_pred             cccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccch
Confidence            345679999999999977655 48899999999999999999999765433221111                       


Q ss_pred             ---------------------hcC-cCCCC-CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          223 ---------------------NAA-EFSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       223 ---------------------~~~-~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                                           ... ....+ ..++.++.+||.+||+.||++|||++|++.||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                                 000 01111 13678899999999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=351.02  Aligned_cols=255  Identities=29%  Similarity=0.503  Sum_probs=220.7

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      +.|++.+.||+|++|.||.|.+..+++.||+|.+.......  ......+.+|+.+++.++||||+++++++.++...|+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57999999999999999999999999999999987643322  2234678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc-
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL-  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~-  165 (441)
                      ++||++|++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......... 
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998754332111 


Q ss_pred             --cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc--CcCCCCCCCCHhHHHHH
Q 013520          166 --LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATSLI  241 (441)
Q Consensus       166 --~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li  241 (441)
                        .....|++.|+|||++.+..+ +.++||||+|+++|+|++|..||...+.......+..  .....|..++..+.++|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence              134568899999999987664 5899999999999999999999987665544444332  33456667899999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCc
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      ++||..+|.+|||+.++++||||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.5e-46  Score=356.83  Aligned_cols=248  Identities=29%  Similarity=0.474  Sum_probs=209.1

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L   96 (441)
                      ||+|+||.||+++++.+|+.||+|.+.+...........+..|+.+++.++||||+++++++.++...|+||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999765544333345566799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCC
Q 013520           97 FDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (441)
Q Consensus        97 ~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (441)
                      .+.+....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... .......|++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~  159 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNG  159 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCCCCC
Confidence            98886543  5888899999999999999999999999999999999999999999999998765432 22345679999


Q ss_pred             cCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh----HHHHHHhhcCcCCCC-CCCCHhHHHHHHHhcCCCC
Q 013520          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFSCP-FWFSTGATSLIHKILDPNP  249 (441)
Q Consensus       175 Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~-~~~s~~~~~li~~~L~~dP  249 (441)
                      |+|||++.+..+ +.++|+||+||++|+|++|..||.....    ..............+ ..+++++.++|++||+.||
T Consensus       160 y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P  238 (277)
T cd05607         160 YMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKP  238 (277)
T ss_pred             ccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCH
Confidence            999999987665 5899999999999999999999976432    233333333333332 3479999999999999999


Q ss_pred             CCCCCh----HhHhcCCCccc
Q 013520          250 KTRIRI----EGIRKHPWFRK  266 (441)
Q Consensus       250 ~~R~t~----~eil~hp~f~~  266 (441)
                      ++||++    +++++||||+.
T Consensus       239 ~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         239 EDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             hhCCCCccchhhhhcChhhcC
Confidence            999999    67889999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.9e-46  Score=369.85  Aligned_cols=258  Identities=29%  Similarity=0.448  Sum_probs=212.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   81 (441)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            46899999999999999999999999999999999876432 223356678899999999999999999987543     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ..+|+||||+.+ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             468999999965 67777653  58889999999999999999999999999999999999999999999999997654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------  225 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------------  225 (441)
                      .. .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+.++...               
T Consensus       178 ~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         178 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CC-CcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            32 223456799999999999876664 8999999999999999999999877654444332210               


Q ss_pred             -------cCC--------------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          226 -------EFS--------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       226 -------~~~--------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                             ...                    .+...+..+++||.+||+.||++|||++++++||||...+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  327 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  327 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence                   000                    001135678999999999999999999999999999866544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.8e-46  Score=384.21  Aligned_cols=259  Identities=29%  Similarity=0.463  Sum_probs=224.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   82 (441)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            457999999999999999999999999999999999876543 334567889999999999999999988775332    


Q ss_pred             ----EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecc
Q 013520           83 ----KVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (441)
Q Consensus        83 ----~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (441)
                          .+++||||+++|+|.+.+..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                47899999999999998864    2468999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCcc--ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCC
Q 013520          155 LSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPF  231 (441)
Q Consensus       155 ls~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~  231 (441)
                      ++......  .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+.. +.|.
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~  267 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP  267 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence            98765432  223456789999999999987666 4899999999999999999999998887777777665544 4567


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+++++.+++.+||..||.+||++.++++|||++..
T Consensus       268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            799999999999999999999999999999998753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2e-46  Score=376.27  Aligned_cols=252  Identities=31%  Similarity=0.460  Sum_probs=214.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-----CCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-H-----PNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----pnIv~l~~~~~~   80 (441)
                      .-.+|++.+.||+|+||+|-+|.+..|++.||||+++..    .....+...|+.+|..|+ |     -|+|+++++|..
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f  259 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF  259 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence            344899999999999999999999999999999999764    345677788999999997 4     389999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC--CCeEEeecccc
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLS  156 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~--~~~kL~DFGls  156 (441)
                      .+++|||+|.. +.+|.++|+.+.  +++...++.+++||+.||.+||+.||||+|||||||||.+-  ..+||+|||.|
T Consensus       260 r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  260 RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999998 559999998754  68999999999999999999999999999999999999753  47999999999


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc------------
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------  224 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------  224 (441)
                      +.....   ..+++.+..|+|||++.+.+|+ .+.||||||||++||++|.+.|.+.+..++...|..            
T Consensus       339 c~~~q~---vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  339 CFESQR---VYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccCCc---ceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            876543   3488999999999999999886 899999999999999999999988875554443310            


Q ss_pred             ----------------------------------------CcCCCCCC-----------CCHhHHHHHHHhcCCCCCCCC
Q 013520          225 ----------------------------------------AEFSCPFW-----------FSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       225 ----------------------------------------~~~~~~~~-----------~s~~~~~li~~~L~~dP~~R~  253 (441)
                                                              .+...|..           -...+.|+|++||.+||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                                                    00111200           124579999999999999999


Q ss_pred             ChHhHhcCCCcccc
Q 013520          254 RIEGIRKHPWFRKN  267 (441)
Q Consensus       254 t~~eil~hp~f~~~  267 (441)
                      |+.++++||||...
T Consensus       495 tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  495 TPAQALNHPFLTGT  508 (586)
T ss_pred             CHHHHhcCcccccc
Confidence            99999999999853

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.8e-46  Score=357.08  Aligned_cols=251  Identities=31%  Similarity=0.437  Sum_probs=205.5

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeEEEEEe-----C
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLAS-----R   81 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~-----~   81 (441)
                      +|++.+.||+|+||.||+|+++.+|+.||+|.+....... .......+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            5999999999999999999999999999999987643222 1223456777777665   69999999998864     3


Q ss_pred             CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      ..++++|||+.+ +|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            568999999975 888888653  35899999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--------------
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--------------  225 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--------------  225 (441)
                      ... .......||+.|+|||++.+..+ +.++||||+||++|+|++|.+||...+......++...              
T Consensus       159 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         159 SCQ-MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             cCc-ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            432 22345578999999999977665 58999999999999999999999876654443333210              


Q ss_pred             ----cC---------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          226 ----EF---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       226 ----~~---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                          .+         ...+.++..+.++|.+||++||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                00         0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.5e-45  Score=347.65  Aligned_cols=253  Identities=28%  Similarity=0.529  Sum_probs=219.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RTKVYIIL   88 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~   88 (441)
                      +|++.+.||+|++|.||++.++.+++.||+|.+....... ...+.+.+|+.+++.++|||++++++.+.. ...+|++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5999999999999999999999999999999997654332 235668899999999999999999998864 45689999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           89 EFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        89 E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      ||+++++|.+++...  ..+++.++..++.|++.||.+||++|++||||||+||+++.++.++|+|||++..........
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999999763  458999999999999999999999999999999999999999999999999987665433444


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHHHHHHhc
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L  245 (441)
                      ....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..+..+++.+.+++.+||
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  238 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML  238 (257)
T ss_pred             ccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence            56678999999999977655 4889999999999999999999988776666555555444 445568999999999999


Q ss_pred             CCCCCCCCChHhHhcCCCc
Q 013520          246 DPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (441)
                      +.||++|||+.++++||||
T Consensus       239 ~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         239 SKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             ccCcccCCCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-45  Score=380.72  Aligned_cols=255  Identities=26%  Similarity=0.454  Sum_probs=222.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC-CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...|.+.+.||+|++|.||+|.+..+ +..||+|.+...   .......+.+|+.+++.++||||+++++++..++..|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            44599999999999999999998877 788999977543   23344567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           87 ILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ||||++||+|.+++..    ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999987753    356899999999999999999999999999999999999999999999999999865432


Q ss_pred             c--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHH
Q 013520          163 V--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATS  239 (441)
Q Consensus       163 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~  239 (441)
                      .  ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+....+..+.. +.|..+++++.+
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  301 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA  301 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence            1  22456689999999999977665 5899999999999999999999998887777777665554 355668999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +|.+||..||++||++++++.|||++.
T Consensus       302 li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999964

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1e-45  Score=381.43  Aligned_cols=253  Identities=24%  Similarity=0.380  Sum_probs=204.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC------CCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH------PNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~~~~   81 (441)
                      .++|++++.||+|+||.||+|.+..+++.||||+++...    ........|+.+++.++|      ++++++++++..+
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            468999999999999999999999999999999996532    123445667777777654      4588899988764


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCC-------------
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYG-------------  146 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~-------------  146 (441)
                       ..+|+|||++ |++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++             
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~  282 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP  282 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence             5789999988 78999999888899999999999999999999998 5999999999999998765             


Q ss_pred             ---CeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhh
Q 013520          147 ---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN  223 (441)
Q Consensus       147 ---~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~  223 (441)
                         .+||+|||.+.....   .....+||+.|+|||++.+..|. .++|||||||++|+|++|++||++.+..+....+.
T Consensus       283 ~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~  358 (467)
T PTZ00284        283 DPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME  358 (467)
T ss_pred             CCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence               499999998764322   23467899999999999877664 89999999999999999999998766443322221


Q ss_pred             cCcCCC------------------------C------------------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          224 AAEFSC------------------------P------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       224 ~~~~~~------------------------~------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ...-..                        +                  ...++.+.+||++||+.||++|||++|+++|
T Consensus       359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            100000                        0                  0014567899999999999999999999999


Q ss_pred             CCccccCC
Q 013520          262 PWFRKNYN  269 (441)
Q Consensus       262 p~f~~~~~  269 (441)
                      |||++.+.
T Consensus       439 p~~~~~~~  446 (467)
T PTZ00284        439 PYVLKYYP  446 (467)
T ss_pred             ccccccCC
Confidence            99987543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1e-45  Score=368.11  Aligned_cols=259  Identities=28%  Similarity=0.454  Sum_probs=211.7

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR----   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----   81 (441)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            357899999999999999999999999999999999876432 233456778899999999999999999998643    


Q ss_pred             --CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           82 --TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        82 --~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                        ...|++|||+++ +|.+.+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999975 5666664  35889999999999999999999999999999999999999999999999999765


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc---------------
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---------------  224 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------------  224 (441)
                      ... .......||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+....+..+..               
T Consensus       170 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         170 GTS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCc-cccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            432 233456799999999999877664 899999999999999999999987664333221100               


Q ss_pred             -------Cc-----CC---------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          225 -------AE-----FS---------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       225 -------~~-----~~---------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                             ..     ..               .+...+.++.+||.+||..||++|||++|+++||||+..+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                   00     00               011135678999999999999999999999999999866543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.6e-45  Score=354.09  Aligned_cols=256  Identities=29%  Similarity=0.492  Sum_probs=220.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+..++..|++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            48889999999999999999999999999999977655444445567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+.+++|.+.+...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR  159 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence            99999999888653  36999999999999999999999999999999999999999999999999998654332 2234


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH----HHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ...|++.|+|||++.+..+ +.++|+||+||++|+|++|..||........    ...+.......+..+++++.+|+.+
T Consensus       160 ~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKM  238 (285)
T ss_pred             CCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHH
Confidence            5579999999999977665 4889999999999999999999987654332    2233444445566689999999999


Q ss_pred             hcCCCCCCCCC-----hHhHhcCCCcccc
Q 013520          244 ILDPNPKTRIR-----IEGIRKHPWFRKN  267 (441)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~~  267 (441)
                      ||+.||++||+     +++++.||||+..
T Consensus       239 ~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            99999999999     8899999999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.2e-46  Score=367.90  Aligned_cols=257  Identities=25%  Similarity=0.397  Sum_probs=211.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   81 (441)
                      ..++|++++.||+|+||.||+|.+..+++.||+|.+.+.... ......+.+|+.+++.++||||+++++++...     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            457899999999999999999999999999999998764322 22345677899999999999999999987543     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ...|+++|++ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence             4579999988 778887765 4679999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------  226 (441)
                      .   .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....              
T Consensus       170 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         170 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             C---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            3   23456799999999999775555689999999999999999999998766443333221100              


Q ss_pred             ---------CCCC--------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          227 ---------FSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       227 ---------~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                               ...+        ...++.+.+||.+||..||++|||+.++++||||.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~  306 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHD  306 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCC
Confidence                     0001        124677899999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=348.16  Aligned_cols=262  Identities=31%  Similarity=0.581  Sum_probs=240.7

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      +...+.+|.++++||+|+|++|.+++.++|.+.||+|+++++.+...+.++.+..|..+...- +||++|-++..|++++
T Consensus       245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes  324 (593)
T KOG0695|consen  245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES  324 (593)
T ss_pred             cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence            345678999999999999999999999999999999999999888888889999999998776 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .+++|.||++||+|--.+++..+++|+.|++|..+|+.||.|||++||++||||.+|+|||..|++||+|+|+++.--..
T Consensus       325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999876666


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC--------CChHHHHHHhhcCcCCCCCCCC
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE--------TDLPTLYKKINAAEFSCPFWFS  234 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~--------~~~~~~~~~i~~~~~~~~~~~s  234 (441)
                      ....++.||||.|.|||++.+..| +..+|+|+|||+++||++|+.||+-        .+..-+++.|......+|..+|
T Consensus       405 gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsls  483 (593)
T KOG0695|consen  405 GDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLS  483 (593)
T ss_pred             CcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceee
Confidence            677899999999999999998877 5999999999999999999999953        1223456778888899999999


Q ss_pred             HhHHHHHHHhcCCCCCCCCC------hHhHhcCCCccc
Q 013520          235 TGATSLIHKILDPNPKTRIR------IEGIRKHPWFRK  266 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t------~~eil~hp~f~~  266 (441)
                      -.+..+++..|.+||.+|..      +.++..||||+.
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            99999999999999999974      689999999974

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-45  Score=351.97  Aligned_cols=253  Identities=31%  Similarity=0.479  Sum_probs=210.4

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|++|.||+|.+..+|..||+|.+..... .....+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            58999999999999999999999999999999866432 22234668889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           90 FVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        90 ~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |++ ++|.+++...   ..+++..++.++.||+.||.|||++|++||||||+||+++.+|.++|+|||++..........
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            997 5888887542   468999999999999999999999999999999999999999999999999987654433333


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh-hcC--------------------
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-NAA--------------------  225 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i-~~~--------------------  225 (441)
                      ....+++.|+|||++.+....+.++|+|||||++|+|++|.+||.+.+.......+ ...                    
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            45567899999999876554568999999999999999999999865532221111 000                    


Q ss_pred             --cC------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          226 --EF------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       226 --~~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                        ..      .....+++++.++|++||+.||++|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence              00      0112368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-44  Score=343.10  Aligned_cols=253  Identities=28%  Similarity=0.492  Sum_probs=222.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|++|.||+|.++.+|+.|++|.+...... ......+.+|+.+++.++||||+++++++.+.+..|++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            589999999999999999999999999999998765443 2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999999764  5788999999999999999999999999999999999999999999999999876654433344


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-CCCCCCHhHHHHHHHhcC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILD  246 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~  246 (441)
                      ..+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+..+ .+..++.++.+++.+||+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT  238 (256)
T ss_pred             ccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence            5678999999999977665 48999999999999999999999888876666666655443 334688999999999999


Q ss_pred             CCCCCCCChHhHhcCCCc
Q 013520          247 PNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       247 ~dP~~R~t~~eil~hp~f  264 (441)
                      .+|++||++.++++|||+
T Consensus       239 ~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         239 KDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCcccCcCHHHHhhCCCC
Confidence            999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8e-45  Score=354.68  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=215.9

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||++.+..+|..+|+|.+....  ......++.+|+.+++.++||||+++++.+.+++.+|++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999987542  2334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++......  ...
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~  156 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  156 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccc
Confidence            999999999999988889999999999999999999998 59999999999999999999999999998654332  234


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC----------------------
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------------  225 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------------  225 (441)
                      ..+|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+...                      
T Consensus       157 ~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             cCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            5679999999999876554 58899999999999999999999765533332222110                      


Q ss_pred             ---------------cCCCC-CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          226 ---------------EFSCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       226 ---------------~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                     ....| ..++.++.+++.+||..||++|||+.++++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                           01111 1267889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-45  Score=355.67  Aligned_cols=258  Identities=31%  Similarity=0.536  Sum_probs=225.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++||||+++++.+.+....|++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999998876554445677899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--
Q 013520           89 EFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--  164 (441)
Q Consensus        89 E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--  164 (441)
                      ||+.|++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998753  5789999999999999999999999999999999999999999999999998864422110  


Q ss_pred             ---------------------------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHH
Q 013520          165 ---------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT  217 (441)
Q Consensus       165 ---------------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~  217 (441)
                                                 ......||..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                       1123468899999999977655 589999999999999999999998887776


Q ss_pred             HHHHhhcCcCCCCCC--CCHhHHHHHHHhcCCCCCCCCC----hHhHhcCCCcccc
Q 013520          218 LYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIR----IEGIRKHPWFRKN  267 (441)
Q Consensus       218 ~~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dP~~R~t----~~eil~hp~f~~~  267 (441)
                      .+..+.......+..  ++..+.++|.+||..||++|||    +++++.||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            666666555555544  6999999999999999999999    9999999999763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.3e-45  Score=345.91  Aligned_cols=254  Identities=28%  Similarity=0.497  Sum_probs=219.1

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc------hHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK------HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      +|.+.+.||.|++|.||+|.+..+++.+|+|.+.......      ....+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5889999999999999999999899999999987654322      2234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      .+++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987654211


Q ss_pred             ------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-cCCCCCCCCHh
Q 013520          164 ------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (441)
Q Consensus       164 ------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (441)
                            .......|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+... ....|..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence                  11123468899999999976655 47899999999999999999999876654444444332 33455668999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +.++|++||++||.+||++.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.6e-45  Score=348.21  Aligned_cols=254  Identities=29%  Similarity=0.414  Sum_probs=214.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++.....   .....+.+|+.+++.++||||+++++++..+...|+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i   83 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI   83 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence            34689999999999999999999999999999999865432   234567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..........
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06646          84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR  163 (267)
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987654332223


Q ss_pred             ccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC-----CCCCHhHHH
Q 013520          167 HTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATS  239 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~~~  239 (441)
                      ....|++.|+|||.+..  ....+.++|+||+||++|+|++|..||...+.......+....+..+     ..++..+.+
T Consensus       164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence            45678999999999842  22234789999999999999999999965543333222222222222     236889999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPW  263 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~  263 (441)
                      +|++||..||++|||+++|++|+|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3.9e-45  Score=346.93  Aligned_cols=253  Identities=31%  Similarity=0.587  Sum_probs=224.7

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+......|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999987665554567889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      |+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... .....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~  159 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTST  159 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-ccccc
Confidence            99999999999887789999999999999999999999999999999999999999999999999987654432 33456


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---HHHHHHhhcCcCCCCCCCCHhHHHHHHHhcC
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (441)
                      .|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.   ..............|..++..+.++|.+||.
T Consensus       160 ~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (258)
T cd05578         160 SGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLE  238 (258)
T ss_pred             CCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHcc
Confidence            68899999999977664 5899999999999999999999987663   3333333335566777789999999999999


Q ss_pred             CCCCCCCCh--HhHhcCCCc
Q 013520          247 PNPKTRIRI--EGIRKHPWF  264 (441)
Q Consensus       247 ~dP~~R~t~--~eil~hp~f  264 (441)
                      .||.+||++  .|+++||||
T Consensus       239 ~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         239 RDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CChhHcCCccHHHHhcCCCC
Confidence            999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-45  Score=351.51  Aligned_cols=257  Identities=32%  Similarity=0.463  Sum_probs=221.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|++.+.||.|+||.||+|.+..++..+|+|.+...   .....+.+.+|+.+++.++||||+++++++..+...|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            35799999999999999999999889999999998654   233456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999999999998764 569999999999999999999999999999999999999999999999999987554433333


Q ss_pred             ccccCCCCcCCccccccC----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCCCCCCHhHHH
Q 013520          167 HTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATS  239 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~  239 (441)
                      ....|++.|+|||.+...    ...+.++|+|||||++|+|++|.+||...+......++.....   ..|..++.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            456789999999998532    2234689999999999999999999988776665555554432   345568999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +|.+||+.+|.+||+++++++||||.+.
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-45  Score=354.50  Aligned_cols=253  Identities=33%  Similarity=0.491  Sum_probs=210.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||+|+++.+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            599999999999999999999999999999999764322 2233567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           90 FVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        90 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      |+++ +|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++............
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9975 77777754 567999999999999999999999999999999999999999999999999998765443333445


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCC-CCCChHHHHHHhhcC----------------c---C-
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA----------------E---F-  227 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~----------------~---~-  227 (441)
                      ..+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+.....+.+...                .   + 
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            568899999999876555568999999999999999988875 444443333322110                0   0 


Q ss_pred             ---------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          228 ---------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       228 ---------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                               ...+.+++++.++|++||+.||.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                     0112368899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=370.22  Aligned_cols=260  Identities=34%  Similarity=0.592  Sum_probs=242.0

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++.+.+.+||-|+||.|-++........+|+|+++|..+.+....+.+..|-.||..++.|+||++|..|.+..++
T Consensus       416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            35577889999999999999999988766556999999999998888889999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+.||-|-||+|+..++..+.|.+..+++|...+++|++|||++||++|||||||++|+.+|.+||.|||+|+....+ .
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~  574 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-R  574 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-C
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999988776 3


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCCCCCCHhHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~  242 (441)
                      ..-+.||||.|+|||++.+++.+ .++|+||||+++||||+|.+||.+.+....|..|..+  .+.+|..++..+.+||+
T Consensus       575 KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik  653 (732)
T KOG0614|consen  575 KTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIK  653 (732)
T ss_pred             ceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence            45689999999999999998887 8999999999999999999999999999999988775  45678889999999999


Q ss_pred             HhcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          243 KILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       243 ~~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ++...+|.+|..     +.+|.+|.||..
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            999999999986     899999999964

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.1e-44  Score=348.58  Aligned_cols=255  Identities=30%  Similarity=0.454  Sum_probs=214.5

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++......|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            4799999999999999999999999999999998654321 122356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||++++.|..++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            99999988888777778999999999999999999999999999999999999999999999999999866554333345


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---------------c----CCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------E----FSC  229 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------------~----~~~  229 (441)
                      ..++..|+|||++.+....+.++|+||+||++|+|++|.+||.+.+..+....+...               .    ...
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            568899999999876555568999999999999999999999876543322221110               0    000


Q ss_pred             C------------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          230 P------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       230 ~------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      |            +.++..+.+|+.+||++||++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            1            1357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4e-45  Score=348.64  Aligned_cols=253  Identities=30%  Similarity=0.449  Sum_probs=214.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....   ......+.+|+.+++.++||||+++++.+...+..|++
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            458999999999999999999999999999999987643   22345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999875544333334


Q ss_pred             cccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC-----CCCCHhHHHH
Q 013520          168 TTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-----FWFSTGATSL  240 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-----~~~s~~~~~l  240 (441)
                      ...|++.|+|||++..  ....+.++|+||+||++|+|++|..||...................+     ..++..+.++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            5679999999999742  22235799999999999999999999965443332222222222222     2367889999


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCC
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPW  263 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~  263 (441)
                      |.+||..||++|||++++++|||
T Consensus       245 i~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-44  Score=349.75  Aligned_cols=261  Identities=30%  Similarity=0.445  Sum_probs=220.1

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      +.-..-+.|++++.||.|+||.||+|++..++..+|+|.+....   ....+.+.+|+.+++.++||||+++++.+..++
T Consensus         6 ~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (292)
T cd06644           6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG   82 (292)
T ss_pred             cccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence            33344567999999999999999999999999999999986542   334677889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..|+||||++|++|...+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999999999887754 45789999999999999999999999999999999999999999999999999865433


Q ss_pred             cccccccccCCCCcCCccccccC----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCCCCCC
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFS  234 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s  234 (441)
                      .........+++.|+|||++...    ...+.++|+|||||++|+|++|.+||...+......++.....   ..+..++
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS  242 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccC
Confidence            22233455688999999998532    2224789999999999999999999987765555555443322   2344578


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .++.++|++||..||++||+++++++||||..
T Consensus       243 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         243 MEFRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            89999999999999999999999999999964

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.3e-45  Score=356.95  Aligned_cols=245  Identities=27%  Similarity=0.438  Sum_probs=194.4

Q ss_pred             EeeeeecCcEEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEEEEe
Q 013520           14 GRTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKVYIILE   89 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~lv~E   89 (441)
                      +++||+|+||.||+|+++  .+++.||+|.+.....     ...+.+|+.+++.++||||+++++++..  ...+|++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            568999999999999976  4678999999865432     2446789999999999999999999854  467899999


Q ss_pred             ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----ccCCCeEEeecccc
Q 013520           90 FVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLS  156 (441)
Q Consensus        90 ~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl----~~~~~~kL~DFGls  156 (441)
                      |+. ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            985 5888877532         258999999999999999999999999999999999999    45678999999999


Q ss_pred             ccCCccc---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH---------HHHHHhhc
Q 013520          157 ALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------TLYKKINA  224 (441)
Q Consensus       157 ~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------~~~~~i~~  224 (441)
                      .......   ......+||+.|+|||++.+...++.++||||+||++|+|++|.+||...+..         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            7654321   12345678999999999977665568999999999999999999999643210         11111100


Q ss_pred             ----------------------------CcCCC----------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          225 ----------------------------AEFSC----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       225 ----------------------------~~~~~----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                                  .....          ....+.++.+||++||+.||++|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                        00000          01135678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.7e-44  Score=347.36  Aligned_cols=255  Identities=30%  Similarity=0.472  Sum_probs=217.5

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      -|++.+.||+|+||.||+|.+..++..+++|.+....   ....+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            3788999999999999999999999999999986542   3345678889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           90 FVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        90 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      |+++++|...+.. ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++............
T Consensus        83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            9999999888764 467899999999999999999999999999999999999999999999999998755433233345


Q ss_pred             ccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc---CCCCCCCCHhHHHHH
Q 013520          169 TCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI  241 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li  241 (441)
                      ..|++.|+|||++..    ....+.++|+||+||++|+|++|.+||...+.......+....   ...|..++.++.++|
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL  242 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence            678999999999842    1223478999999999999999999998776655544443332   234555889999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+||+.||.+|||++++++||||+..
T Consensus       243 ~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         243 KKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHccCChhhCcCHHHHhcCCCEecc
Confidence            99999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.4e-44  Score=350.71  Aligned_cols=257  Identities=30%  Similarity=0.579  Sum_probs=222.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.+.........+.+.+|+.+++.++||||+++++.+..++..|+||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998765444445567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc------
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------  162 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~------  162 (441)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......      
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999987632110      


Q ss_pred             ---------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC--
Q 013520          163 ---------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--  231 (441)
Q Consensus       163 ---------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--  231 (441)
                               ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+..+....+.......|.  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                     001123467889999999876555 58999999999999999999999887777777776655443332  


Q ss_pred             -CCCHhHHHHHHHhcCCCCCCCCC---hHhHhcCCCccc
Q 013520          232 -WFSTGATSLIHKILDPNPKTRIR---IEGIRKHPWFRK  266 (441)
Q Consensus       232 -~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~f~~  266 (441)
                       .++.++.++|.+||+.||++||+   +.++++||||..
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence             47899999999999999999998   789999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-44  Score=340.73  Aligned_cols=253  Identities=28%  Similarity=0.579  Sum_probs=221.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            6999999999999999999999999999999987654332 235678999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+.+++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999987643  578999999999999999999999999999999999999999999999999876554333334


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHHHHHHhcC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~  246 (441)
                      ...|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+..+....+..+.. ..+..++.++.++|.+||+
T Consensus       160 ~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  238 (256)
T cd08218         160 TCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK  238 (256)
T ss_pred             hccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence            4568899999999876654 4799999999999999999999988777777666655544 3556689999999999999


Q ss_pred             CCCCCCCChHhHhcCCCc
Q 013520          247 PNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       247 ~dP~~R~t~~eil~hp~f  264 (441)
                      .+|++||++.++++||||
T Consensus       239 ~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         239 RNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CChhhCcCHHHHhhCcCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=372.18  Aligned_cols=255  Identities=30%  Similarity=0.473  Sum_probs=226.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +.|+|+..||.|+||+||+|.++.++-.-|.|+|...   ..+..+.+.-||.||..++||+||++++.|.-++.+||..
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            4689999999999999999999999988899998654   3456788889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |||.||-....+.. ...+.+++++.+++|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...........
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD  188 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD  188 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence            99999988776654 45799999999999999999999999999999999999999999999999999876544434456


Q ss_pred             cccCCCCcCCccccc-----cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC---CCCCCCHhHHH
Q 013520          168 TTCGTPNYVAPEVLS-----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS---CPFWFSTGATS  239 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~-----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~  239 (441)
                      ++.|||+|||||++.     ..+|+ .++||||||++|.+|..+.+|....+.....-+|....++   .|...+..+.|
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D  267 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD  267 (1187)
T ss_pred             cccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence            889999999999974     35665 8999999999999999999999988888887787766553   46667999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++.+||.+||..||+++++++||||++.
T Consensus       268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  268 FLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            9999999999999999999999999853

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.8e-45  Score=349.93  Aligned_cols=255  Identities=29%  Similarity=0.432  Sum_probs=216.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++..++..|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999999999999999986644322 34567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||++++.|..+......+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++............
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99999999888777677999999999999999999999999999999999999999999999999998765544344445


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------------------cC--
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EF--  227 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~--  227 (441)
                      ..++..|+|||++.+....+.++||||+||++|+|++|.+||...+..+....+...                   ..  
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            678899999999876555568899999999999999999999765543322221100                   00  


Q ss_pred             ----------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          228 ----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       228 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                ...+.++..+.+++.+||..+|++||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                      0123468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-44  Score=350.33  Aligned_cols=260  Identities=31%  Similarity=0.436  Sum_probs=219.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+......  .......+..|+.+++.++|+||+++++++.+.+..|+|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999999775543  122345677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++||||+|+||+++.+|.++|+|||++..........
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 999999998766 79999999999999999999999999999999999999999999999999997665543333


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--------------------
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------------  226 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------------  226 (441)
                      ....+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+......++....                    
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            445678899999998655555689999999999999999999987766544433332110                    


Q ss_pred             ---CC-----CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          227 ---FS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       227 ---~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                         ..     .....+..+.++|.+||.+||++|||+.++++||||++...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence               00     012247889999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.7e-44  Score=343.29  Aligned_cols=248  Identities=35%  Similarity=0.675  Sum_probs=220.4

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L   96 (441)
                      ||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.+++..|+++||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            69999999999999999999999999876655445567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcC
Q 013520           97 FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV  176 (441)
Q Consensus        97 ~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~  176 (441)
                      .+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~  159 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV  159 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence            9999888889999999999999999999999999999999999999999999999999987664432 233457899999


Q ss_pred             CccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC--hHHHHHHhh--cCcCCCCCCCCHhHHHHHHHhcCCCCCCC
Q 013520          177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKIN--AAEFSCPFWFSTGATSLIHKILDPNPKTR  252 (441)
Q Consensus       177 aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R  252 (441)
                      |||.+.+..+ +.++|+||+|+++|+|++|..||....  .......+.  ......|...++++.++|.+||..||++|
T Consensus       160 ~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  238 (262)
T cd05572         160 APEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEER  238 (262)
T ss_pred             ChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhC
Confidence            9999876655 488999999999999999999998766  555566655  44566777789999999999999999999


Q ss_pred             CC-----hHhHhcCCCccc
Q 013520          253 IR-----IEGIRKHPWFRK  266 (441)
Q Consensus       253 ~t-----~~eil~hp~f~~  266 (441)
                      |+     ++|+++||||+.
T Consensus       239 ~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         239 LGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             cCCcccCHHHHhcChhhhC
Confidence            99     999999999974

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.7e-44  Score=342.00  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=218.4

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||.|+||.||+|....++..+|+|++.......  ..+.+.+|+.+++.++|+||+++++.+...+..|++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999998899999999987654333  4577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-
Q 013520           89 EFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (441)
Q Consensus        89 E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (441)
                      ||++|++|.+.+...   ..+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++........ 
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   4589999999999999999999999999999999999999999999999999876544322 


Q ss_pred             ---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCC-----CCCCH
Q 013520          165 ---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCP-----FWFST  235 (441)
Q Consensus       165 ---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~-----~~~s~  235 (441)
                         ......|++.|+|||++......+.++|+|||||++|+|++|..||...+.......+..... ..+     ..+++
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence               123456899999999987664456899999999999999999999987766555544433322 111     14678


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .+.+++.+||..||++|||++++++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.9e-44  Score=348.81  Aligned_cols=257  Identities=26%  Similarity=0.430  Sum_probs=219.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ....+|++.+.||+|+||.||+|.+..++..||+|.+......   ..+.+.+|+.+++.++||||+++++.+..+...|
T Consensus        17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~   93 (296)
T cd06654          17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (296)
T ss_pred             CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEE
Confidence            3456999999999999999999999999999999998765432   2466889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus        94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654          94 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             EeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            99999999999998865 56899999999999999999999999999999999999999999999999998765443333


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhh-cC--cCCCCCCCCHhHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN-AA--EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~-~~--~~~~~~~~s~~~~~li~  242 (441)
                      .....|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+. ..  ....+..+++.+.+++.
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             cCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence            345578999999999876555 489999999999999999999998766533222222 22  12234568899999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCcccc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +||..||++|||++++++||||...
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.1e-44  Score=346.86  Aligned_cols=249  Identities=30%  Similarity=0.457  Sum_probs=206.7

Q ss_pred             eeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHH---hCCCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---IVRHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~---~l~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      .||+|+||.||++.+..+|+.+|+|.+.+.............+|..+++   ..+||||+.+++++..++..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999997765433322233344544443   3479999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCC
Q 013520           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (441)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (441)
                      ||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......  ......|+
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~  158 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT  158 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCC
Confidence            9999999988889999999999999999999999999999999999999999999999999998654332  22345799


Q ss_pred             CCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---HHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCC
Q 013520          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP  249 (441)
Q Consensus       173 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP  249 (441)
                      +.|+|||.+.+....+.++|+||+||++|+|++|..||.....   ..............|..+++++.++|++||..||
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999986434345899999999999999999999975432   2222223333445667789999999999999999


Q ss_pred             CCCC-----ChHhHhcCCCccc
Q 013520          250 KTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       250 ~~R~-----t~~eil~hp~f~~  266 (441)
                      ++|+     |+.++++||||+.
T Consensus       239 ~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         239 SKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             HHhcCCCCCCHHHHHhCccccC
Confidence            9999     6999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.4e-44  Score=351.17  Aligned_cols=262  Identities=29%  Similarity=0.416  Sum_probs=216.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKV   84 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~   84 (441)
                      .+++|++.+.||+|+||.||+|.++.+|+.||+|.+....... .......+|+.+++.++|+||+++++++...  +.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            5789999999999999999999999999999999987543222 2233456799999999999999999998754  578


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999975 78887765 3678999999999999999999999999999999999999999999999999987665432


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC------------------
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------------------  225 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------  225 (441)
                      .......+++.|+|||++.+....+.++|+|||||++|+|++|.+||.+.+..+....+...                  
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence            33334456888999999876555568999999999999999999999887766555443321                  


Q ss_pred             -cCCCC-----------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          226 -EFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       226 -~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                       .+..+           .++++++.++|.+||++||++|||+++++.||||++...+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence             11111           2358889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=345.69  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=221.9

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+.....  ......+.+|+.+++.++||||+++++++.+....|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            479999999999999999999999999999999876532  223466889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+++++|.+++... .+++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||++............
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999999764 8999999999999999999999999999999999999999999999999998776544333445


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCCC-CCHhHHHHHHHhcC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFW-FSTGATSLIHKILD  246 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~-~s~~~~~li~~~L~  246 (441)
                      ..|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.... ...+.. +++++.+++.+||.
T Consensus       158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  236 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN  236 (274)
T ss_pred             ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence            678999999999977664 589999999999999999999998766555544444432 233334 78999999999999


Q ss_pred             CCCCCCCChHhHhcCCCcccc
Q 013520          247 PNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+|++|||++++++||||++.
T Consensus       237 ~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         237 KDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             CChhhCcCHHHHhhChhhcCC
Confidence            999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.2e-44  Score=348.53  Aligned_cols=256  Identities=26%  Similarity=0.447  Sum_probs=220.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...+|++.+.||.|+||.||+|.+..+|+.||+|.+.....   ...+.+.+|+.+++.++||||+++++++......|+
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   93 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV   93 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence            34679999999999999999999999999999999876432   234678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |+||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  172 (296)
T cd06655          94 VMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR  172 (296)
T ss_pred             EEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccC
Confidence            9999999999998865 568999999999999999999999999999999999999999999999999987654433333


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---cCCCCCCCCHhHHHHHHH
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~  243 (441)
                      ....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+...   ....+..+++.+.++|++
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence            45578999999999976655 48999999999999999999999887654433333322   223455688999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCcccc
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ||..||++|||+.+++.||||+..
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhc
Confidence            999999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.9e-44  Score=342.30  Aligned_cols=253  Identities=27%  Similarity=0.466  Sum_probs=215.8

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc---chHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      +|++.+.||.|+||.||+|.+ .+|+.+|+|.+......   .......+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999987 47889999998754321   22334678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc-----
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ-----  161 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~-----  161 (441)
                      ++||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....     
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999998888899999999999999999999999999999999999999999999999999865421     


Q ss_pred             -cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---cCCCCCCCCHhH
Q 013520          162 -GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGA  237 (441)
Q Consensus       162 -~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~  237 (441)
                       .........|++.|+|||++.+..+ +.++|+|||||++|+|++|.+||...+.......+...   ....+..++.++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence             1122334568999999999977665 48999999999999999999999876544433333322   223555689999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .++|++||..+|++||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.9e-44  Score=344.74  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=211.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe------C
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS------R   81 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~------~   81 (441)
                      +.|++.+.||+|+||.||+|.+..+++.||+|.+.....    ....+.+|+.+++++ +||||+++++++..      .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            578999999999999999999999999999999875431    235678899999998 79999999999875      3


Q ss_pred             CEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      ..+|++|||+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999998863  46899999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccccccCCCCcCCccccccC----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC--CCCCCC
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF--SCPFWF  233 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~  233 (441)
                      ...........|++.|+|||++.+.    ...+.++|+||+||++|+|++|..||...........+.....  ..+..+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            4433344566799999999998632    1234789999999999999999999976654443333322211  122347


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +.++.+|+.+||..||.+|||+.++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            8899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-44  Score=357.30  Aligned_cols=251  Identities=22%  Similarity=0.375  Sum_probs=204.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   80 (441)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|++....  .......+.+|+.+++.+ +||||+++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            346899999999999999999975     2356789999986543  222346788999999999 89999999998875


Q ss_pred             C-CEEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 013520           81 R-TKVYIILEFVTGGELFDKIVHQ--------------------------------------------------------  103 (441)
Q Consensus        81 ~-~~~~lv~E~~~gg~L~~~i~~~--------------------------------------------------------  103 (441)
                      . ..+|++|||+++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 4689999999999999998652                                                        


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--ccccccCCCCc
Q 013520          104 ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNY  175 (441)
Q Consensus       104 ------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y  175 (441)
                            ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  ......+++.|
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence                  2377788899999999999999999999999999999999999999999999975432211  11233466789


Q ss_pred             CCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChH-HHHHHhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCC
Q 013520          176 VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTR  252 (441)
Q Consensus       176 ~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R  252 (441)
                      +|||++.+..+ +.++|||||||++|+|++ |..||.+.... .....+..+ ....|..+++++.+++.+||+.||++|
T Consensus       243 ~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  321 (338)
T cd05102         243 MAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER  321 (338)
T ss_pred             cCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence            99999977665 489999999999999997 99999875543 333334333 334556689999999999999999999


Q ss_pred             CChHhHhc
Q 013520          253 IRIEGIRK  260 (441)
Q Consensus       253 ~t~~eil~  260 (441)
                      ||+.++++
T Consensus       322 Ps~~el~~  329 (338)
T cd05102         322 PTFSALVE  329 (338)
T ss_pred             cCHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-44  Score=338.79  Aligned_cols=251  Identities=31%  Similarity=0.470  Sum_probs=217.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|++.....   ...+.+.+|+.+++.++||||+++++++.+...+|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            689999999999999999999999999999999976532   24578899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...........
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999999999999776 7899999999999999999999999999999999999999999999999999876554332334


Q ss_pred             cccCCCCcCCccccccC---CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-----CCCCCCHhHHH
Q 013520          168 TTCGTPNYVAPEVLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-----CPFWFSTGATS  239 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~~~  239 (441)
                      ...++..|+|||.+.+.   .+ +.++|+|||||++|+|++|.+||...+.......+....+.     .+..++.++.+
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHD  238 (262)
T ss_pred             cccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHH
Confidence            56789999999998655   44 47899999999999999999999876654444434333222     22335788999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPW  263 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~  263 (441)
                      ++++||..+|..|||+.+++.|||
T Consensus       239 li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         239 FIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-44  Score=355.94  Aligned_cols=254  Identities=21%  Similarity=0.344  Sum_probs=206.4

Q ss_pred             EEEeeeeec--CcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           12 EVGRTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        12 ~i~~~LG~G--~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +++++||+|  +|++||++.++.+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             ChhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            357889999  7889999999999999999999765432 3345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc----
Q 013520           90 FVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----  163 (441)
Q Consensus        90 ~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~----  163 (441)
                      |+++|+|.+++..  ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++++|||.+.......    
T Consensus        80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            9999999999965  3458999999999999999999999999999999999999999999999998654322110    


Q ss_pred             ---cccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-----------
Q 013520          164 ---ELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-----------  228 (441)
Q Consensus       164 ---~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----------  228 (441)
                         .......++..|+|||++.+. ...+.++||||+||++|+|++|..||..............+..+           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE  239 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence               111234577889999999653 22358999999999999999999999765433322221111100           


Q ss_pred             -----------------------------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          229 -----------------------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       229 -----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                                                         ....+++.+.+||++||+.||++|||++++++||||+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                               01124678999999999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.6e-44  Score=344.11  Aligned_cols=250  Identities=26%  Similarity=0.387  Sum_probs=210.9

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|++..+++.||+|.+....  .....+.+.+|+.+++.++||||+++++.+...+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            46899999999999999999999999999999987653  2233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......  ....
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~  152 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKT  152 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccC
Confidence            99999998654    45789999999999999999999999999999999999999999999999998755332  2345


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-------HHHHHHhhcCcCC--CCCCCCHhHHH
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-------PTLYKKINAAEFS--CPFWFSTGATS  239 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~--~~~~~s~~~~~  239 (441)
                      .+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||.....       ....+.+......  .....++++.+
T Consensus       153 ~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (279)
T cd06619         153 YVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH  231 (279)
T ss_pred             CCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHH
Confidence            689999999999987665 5899999999999999999999965321       1222222222211  12347889999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++.+||+.||++||+++++++||||+..
T Consensus       232 li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         232 FITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            9999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-44  Score=342.91  Aligned_cols=255  Identities=27%  Similarity=0.482  Sum_probs=216.2

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc---hHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK---HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      +|+..+.||+|+||.||+|.+..+++.||+|++.......   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            5889999999999999999999999999999997544221   2245778999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeeccccccCCccc--
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGV--  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~--  163 (441)
                      |+||+.|++|.+++...+++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||.+.......  
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998776 59999999987654321  


Q ss_pred             --cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh-----hcCcCCCCCCCCHh
Q 013520          164 --ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-----NAAEFSCPFWFSTG  236 (441)
Q Consensus       164 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i-----~~~~~~~~~~~s~~  236 (441)
                        .......|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+     .......|..++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence              11223468899999999876655 48999999999999999999999765433222222     12233455668999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      +.+++.+||..+|++|||+.++++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999995

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.6e-44  Score=337.13  Aligned_cols=253  Identities=28%  Similarity=0.499  Sum_probs=223.4

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++++.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            6999999999999999999999999999999987655433 335678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999764  4689999999999999999999999999999999999999999999999999876554433345


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-CCCCCCHhHHHHHHHhcC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILD  246 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~  246 (441)
                      ...|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+..+....+..+.+. .+..++.++.+++.+||.
T Consensus       160 ~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ  238 (256)
T ss_pred             ccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence            5679999999999876654 47899999999999999999999887777777776655543 334579999999999999


Q ss_pred             CCCCCCCChHhHhcCCCc
Q 013520          247 PNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       247 ~dP~~R~t~~eil~hp~f  264 (441)
                      .+|++||++.++++|||+
T Consensus       239 ~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         239 QDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cCcccCCCHHHHhhCcCC
Confidence            999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.6e-44  Score=343.77  Aligned_cols=254  Identities=30%  Similarity=0.468  Sum_probs=214.8

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            699999999999999999999999999999999775432 2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-cccc
Q 013520           90 FVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~~  167 (441)
                      |+ +++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....... ....
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 9999999865 3568999999999999999999999999999999999999999999999999988665432 1234


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------------------cCC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EFS  228 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~~  228 (441)
                      ...|+..|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+...                   ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            5678999999999876655568999999999999999999999776544433322110                   000


Q ss_pred             -----------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          229 -----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       229 -----------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                                 ..+..+.++.++|.+||..||++|||++++++||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                       0123578899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-44  Score=345.37  Aligned_cols=255  Identities=33%  Similarity=0.635  Sum_probs=228.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++...+..|++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999998765544455577889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc----
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----  163 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~----  163 (441)
                      |||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.+|+++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999988899999999999999999999999999999999999999999999999999987654322    


Q ss_pred             ----------------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC
Q 013520          164 ----------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF  227 (441)
Q Consensus       164 ----------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~  227 (441)
                                      .......|+..|+|||++.+..+ +.++|+||||++++++++|..||...+.....+.+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  239 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY  239 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence                            12233457899999999876544 5899999999999999999999998877666777777777


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCCh----HhHhcCCCc
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRI----EGIRKHPWF  264 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~----~eil~hp~f  264 (441)
                      ..|..+++.+.++|.+||+.||++|||+    +++++||||
T Consensus       240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            8888899999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.3e-44  Score=344.36  Aligned_cols=250  Identities=31%  Similarity=0.468  Sum_probs=210.0

Q ss_pred             eeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHH---HHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI---SIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei---~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      .||+|+||.||+|.+..+++.||+|.+.+..............|.   ..++..+||||+++++++.+.+..|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999999875443222222233333   34455689999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCC
Q 013520           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (441)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (441)
                      ||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  .....+|+
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~  158 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGT  158 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCCC
Confidence            9999999988888999999999999999999999999999999999999999999999999998755332  22456799


Q ss_pred             CCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC---ChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCC
Q 013520          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP  249 (441)
Q Consensus       173 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP  249 (441)
                      ..|+|||.+.+....+.++||||+||++|+|++|..||...   ........+.......|..+|+++.+++++||..+|
T Consensus       159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p  238 (278)
T cd05606         159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDV  238 (278)
T ss_pred             cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCH
Confidence            99999999975444458899999999999999999999776   333444444445566666789999999999999999


Q ss_pred             CCCC-----ChHhHhcCCCcccc
Q 013520          250 KTRI-----RIEGIRKHPWFRKN  267 (441)
Q Consensus       250 ~~R~-----t~~eil~hp~f~~~  267 (441)
                      .+||     ++.++++||||+..
T Consensus       239 ~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         239 NRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HhccCCCCCCHHHHHhCccccCC
Confidence            9999     99999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-44  Score=384.55  Aligned_cols=266  Identities=29%  Similarity=0.442  Sum_probs=219.9

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--   80 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--   80 (441)
                      .+...+++|++++.||+|+||.||+|.++.++..||+|++...... ......+..|+.+++.++||||++++++|..  
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            4567789999999999999999999999999999999999765443 2345678899999999999999999998854  


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCcEEEcc-----
Q 013520           81 RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-------GVYHRDLKPENLLLDS-----  144 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~-------gi~HrDlkp~NILl~~-----  144 (441)
                      ...+|+||||+++|+|.++|..    .+.+++..++.++.||+.||.|||+.       +|+||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            4579999999999999999865    35799999999999999999999995       4999999999999964     


Q ss_pred             ------------CCCeEEeeccccccCCccccccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCC
Q 013520          145 ------------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFG  211 (441)
Q Consensus       145 ------------~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~  211 (441)
                                  .+.+||+|||++...... ......+||+.|+|||++.+. ...+.++||||||||||+|++|..||.
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                        235899999999765432 223456799999999998643 334689999999999999999999997


Q ss_pred             CCCh-HHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          212 ETDL-PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       212 ~~~~-~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      ..+. ......+...........+.++.+||.+||..+|.+||++.+++.|||++....+
T Consensus       245 ~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        245 KANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             cCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            6544 3344444333222223478999999999999999999999999999999865443

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6e-44  Score=344.98  Aligned_cols=255  Identities=29%  Similarity=0.471  Sum_probs=208.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      .+++|++.+.||+|++|.||+|.++.+++.||+|.+.......  ....+.+|+.+++.++||||+++++++.+....|+
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            4689999999999999999999999999999999987643221  22346689999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||||+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            9999975 899888654 46899999999999999999999999999999999999999999999999998754332222


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-hHHHHHHhhcC-------------------
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKINAA-------------------  225 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~-------------------  225 (441)
                      .....+++.|+|||++.+....+.++||||+||++|+|++|..||...+ ..+....+...                   
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK  239 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence            2344578899999998765444689999999999999999999997655 22222211100                   


Q ss_pred             cCCC-----------CCCCC--HhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          226 EFSC-----------PFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       226 ~~~~-----------~~~~s--~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      ....           ...++  .++.+++.+||.+||++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000           01234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.2e-44  Score=348.66  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=218.8

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ....+|++++.||+|+||.||+|.+..+|+.||+|.+......   ..+.+.+|+.+++.++||||+++++++......|
T Consensus        16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   92 (297)
T cd06656          16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELW   92 (297)
T ss_pred             ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEE
Confidence            3457999999999999999999999999999999998764322   2456789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus        93 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             EeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            99999999999998865 56899999999999999999999999999999999999999999999999998765443333


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc-C--cCCCCCCCCHhHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-A--EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li~  242 (441)
                      .....|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+.. +  ....|..+++.+.+++.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             cCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            345678999999999977655 4899999999999999999999977654332222221 1  12234557889999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCcccc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +||..||++||+++++++||||+..
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             HHccCChhhCcCHHHHhcCchhccc
Confidence            9999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-45  Score=364.47  Aligned_cols=263  Identities=31%  Similarity=0.545  Sum_probs=228.0

Q ss_pred             CcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         2 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      |+..+..+-|..++.||-|+||+|.++...+|...||+|.+.|..+...+.+..++.|..||..-+.+.||+||..|+++
T Consensus       622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk  701 (1034)
T KOG0608|consen  622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK  701 (1034)
T ss_pred             HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence            44556667899999999999999999999999999999999998888888888999999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC-
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~-  160 (441)
                      +.+|+||||++||++-.++.+.+.|.|+.|++|+.++..|+++.|+.|+|||||||+|||||.+|++||+|||||+-+. 
T Consensus       702 dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  702 DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccccee
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999986321 


Q ss_pred             --------ccc---------------------------------cccccccCCCCcCCccccccCCCCCCCcchhhHhHH
Q 013520          161 --------QGV---------------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVI  199 (441)
Q Consensus       161 --------~~~---------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvi  199 (441)
                              .++                                 -..+..+||+.|+|||++...+|. ..+|+||.|||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvi  860 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVI  860 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHH
Confidence                    000                                 011344699999999999988885 89999999999


Q ss_pred             HHHHhcCCCCCCCCChHHHHHHhhc----CcCCCCCCCCHhHHHHHHHhcCCCCCCCC---ChHhHhcCCCccc
Q 013520          200 LFVLMAGYLPFGETDLPTLYKKINA----AEFSCPFWFSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  266 (441)
Q Consensus       200 l~~ll~g~~Pf~~~~~~~~~~~i~~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~f~~  266 (441)
                      ||+|+.|++||-..+..+...++.+    ..+++...+|.++.++|.++. -+++.|.   .++++..||||+.
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence            9999999999977665544333322    233444568999999999976 4678887   4678999999975

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=359.20  Aligned_cols=248  Identities=33%  Similarity=0.652  Sum_probs=222.0

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      -++||+|.||+||-|+++.+|+.||||+|+|..+...+ ..+++.|+.||+.+.||.||.+...|++.+.+++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            46899999999999999999999999999998887654 48899999999999999999999999999999999999965


Q ss_pred             CChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEEeeccccccCCcccccccc
Q 013520           94 GELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        94 g~L~~~i~--~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~~~~~~~~~~  168 (441)
                       +..+.|.  ..+++++...++++.||+.||.|||-+||+|+||||||||+....   .+||||||+|++.... ....+
T Consensus       648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrs  725 (888)
T KOG4236|consen  648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRS  725 (888)
T ss_pred             -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhh
Confidence             6666664  357899999999999999999999999999999999999997543   6999999999988764 34467


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC--C--CCHhHHHHHHHh
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--W--FSTGATSLIHKI  244 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~--~s~~~~~li~~~  244 (441)
                      .+|||.|+|||++.+++|. ..-|+||.|||+|.-|+|..||+..  +++.++|++..+-+|+  |  +++++.|||..+
T Consensus       726 VVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  726 VVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             hcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            8899999999999999997 8899999999999999999999753  4566778877776664  4  899999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCcccc
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      |+..-.+|.|++..+.|||+|+.
T Consensus       803 LqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHhcchHhhccchhhhcc
Confidence            99999999999999999999864

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.2e-43  Score=338.18  Aligned_cols=255  Identities=29%  Similarity=0.498  Sum_probs=215.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~   84 (441)
                      .+|++.+.||+|+||.||.|.+..+|..||+|.+......  .....+.+.+|+.+++.++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5799999999999999999999999999999998653321  22345678999999999999999999999876  3578


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (441)
                      |++|||++|++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            899999999999999988788999999999999999999999999999999999999999999999999998754321  


Q ss_pred             -ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCCCCCCHhHHH
Q 013520          163 -VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATS  239 (441)
Q Consensus       163 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~  239 (441)
                       ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+...  ....|..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence             112234568999999999977655 58999999999999999999999876544443333322  23345567889999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      +|++|+. +|++||+++++++|||+.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-43  Score=342.34  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=213.8

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC---
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR---   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~---   81 (441)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++++ +|||++++++++...   
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            34678999999999999999999999999999999986532    1235678899999998 899999999998653   


Q ss_pred             --CEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           82 --TKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        82 --~~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                        +..|+||||++|++|.+++..    ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~  174 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV  174 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence              468999999999999998753    45789999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccCC----CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc---CC
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRG----YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FS  228 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~----~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~  228 (441)
                      +..............|+..|+|||++....    ..+.++||||+||++|+|++|.+||...+.......+....   ..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  254 (291)
T cd06639         175 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL  254 (291)
T ss_pred             chhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence            876544322334557899999999985432    13579999999999999999999998766544444443332   22


Q ss_pred             CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      .+..++..+.++|.+||+.||++||++.++++||||+
T Consensus       255 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            3445678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-44  Score=345.12  Aligned_cols=256  Identities=26%  Similarity=0.432  Sum_probs=217.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||.||+|.+..+|..||+|.+....  .......+.+|+.+++.++||||+++++.+...+..|+||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47999999999999999999999999999999986542  2233467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           89 EFVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        89 E~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      ||++|++|..++...   ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....  .
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--S  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC--C
Confidence            999999998888763   378999999999999999999997 5999999999999999999999999999875433  2


Q ss_pred             ccccccCCCCcCCccccccCCC-----CCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHH---hhc-CcCCCCCCCCH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK---INA-AEFSCPFWFST  235 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~---i~~-~~~~~~~~~s~  235 (441)
                      ......|++.|+|||.+.+...     .+.++|+|||||++|+|++|..||...+.......   +.. .....|..+++
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD  236 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence            2345678899999999854322     25789999999999999999999976554443332   222 22345566899


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ++.++|.+||..+|++||++++++.||||....
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            999999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.9e-44  Score=344.11  Aligned_cols=248  Identities=31%  Similarity=0.512  Sum_probs=212.9

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L   96 (441)
                      ||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999999875544333445667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCC
Q 013520           97 FDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (441)
Q Consensus        97 ~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (441)
                      .+++....  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+...... .......++..
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~  159 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCCC
Confidence            99997766  7999999999999999999999999999999999999999999999999998755432 22344568889


Q ss_pred             cCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh----HHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCC
Q 013520          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK  250 (441)
Q Consensus       175 Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~  250 (441)
                      |+|||++.+..+ +.++|+||+||++|+|++|..||.....    ......+.......|..+++.+.++|++||+.||+
T Consensus       160 y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (277)
T cd05577         160 YMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPE  238 (277)
T ss_pred             cCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChh
Confidence            999999876664 5899999999999999999999977543    23333334444556666899999999999999999


Q ss_pred             CCC-----ChHhHhcCCCccc
Q 013520          251 TRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       251 ~R~-----t~~eil~hp~f~~  266 (441)
                      +||     ++.+++.||||..
T Consensus       239 ~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         239 KRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             HccCCCcccHHHHHhChhhhc
Confidence            999     8888999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-43  Score=336.14  Aligned_cols=249  Identities=31%  Similarity=0.543  Sum_probs=218.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||++.++.+++.+|+|.+.....  ....+.+.+|+.+++.++||||+++++.+.+++.+|++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            58999999999999999999999999999999875432  2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+++|+|.+++..  ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            9999999998865  34589999999999999999999999999999999999999999999999999876654333334


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHHHHHHhcC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~  246 (441)
                      ...|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.++|.+||+
T Consensus       159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK  237 (255)
T ss_pred             cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence            5678999999999976655 5899999999999999999999998877766666655544 3556689999999999999


Q ss_pred             CCCCCCCChHhHhcC
Q 013520          247 PNPKTRIRIEGIRKH  261 (441)
Q Consensus       247 ~dP~~R~t~~eil~h  261 (441)
                      .||++|||+.+++.-
T Consensus       238 ~~P~~Rp~~~~il~~  252 (255)
T cd08219         238 RNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCCCHHHHhhc
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-44  Score=361.12  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=206.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+|++++.||+|+||.||+|...  .++..||+|.+...        ....+|+.+++.++||||+++++++......|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999764  35678999987653        23457999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (441)
                      ++||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ 
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9999995 68999998778899999999999999999999999999999999999999999999999999875543221 


Q ss_pred             -ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH---HHHHHhhc----------------
Q 013520          165 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLYKKINA----------------  224 (441)
Q Consensus       165 -~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---~~~~~i~~----------------  224 (441)
                       ......||+.|+|||++....+. .++|||||||++|+|++|..||.+....   .....+..                
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence             22356799999999999876664 8999999999999999999999654321   11111100                


Q ss_pred             -------------CcCCCCC-----CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          225 -------------AEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       225 -------------~~~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                   ..+..|.     .++.++.++|++||..||++|||+.+++.||||++.
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                         0011111     246788999999999999999999999999999764

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-43  Score=338.90  Aligned_cols=255  Identities=29%  Similarity=0.486  Sum_probs=214.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~   84 (441)
                      .+|++.+.||+|+||.||+|.+..++..||+|.+......  .......+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3699999999999999999999999999999998764322  22345678899999999999999999998875  4678


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (441)
                      ++++||+++++|.+++...+.+++.....++.|++.||.|||++||+||||+|+||+++.++.+||+|||++......  
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            999999999999999988888999999999999999999999999999999999999999999999999998754321  


Q ss_pred             -ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc--CcCCCCCCCCHhHHH
Q 013520          163 -VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATS  239 (441)
Q Consensus       163 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~  239 (441)
                       ........++..|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+..  .....|..+++.+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD  240 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence             112234568899999999977654 4899999999999999999999987655444333322  234456668899999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      ++ +||..+|++||+++++++||||+
T Consensus       241 li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         241 FL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99 56778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-43  Score=336.56  Aligned_cols=253  Identities=32%  Similarity=0.589  Sum_probs=221.5

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SRTKVYII   87 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv   87 (441)
                      +|++.+.||.|+||.||+|.+..+|..||+|.+...... ....+.+..|+.+++.++||||+++++++.  .+...|++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            599999999999999999999999999999998765443 334567889999999999999999999875  34578999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCH-----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH-----~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                      |||+++++|.+++..    ..++++..+..++.||+.||.|||     +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999875    367899999999999999999999     89999999999999999999999999999987


Q ss_pred             CCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhH
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGA  237 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~  237 (441)
                      ............|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.....+.+..+.. ..|..++..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL  238 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence            6654433445679999999999976554 4889999999999999999999998877777777666554 3555688999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .+++.+||..+|++|||+.+|++|||+
T Consensus       239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         239 NEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.4e-44  Score=344.84  Aligned_cols=246  Identities=15%  Similarity=0.184  Sum_probs=211.7

Q ss_pred             CeEEE--eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCE
Q 013520           10 KYEVG--RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----RTK   83 (441)
Q Consensus        10 ~y~i~--~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~   83 (441)
                      +++..  ..||+|++|.||+|..  +|+.||||.+.+.........+.+.+|+.+|++++||||+++++++.+    ...
T Consensus        19 ~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~   96 (283)
T PHA02988         19 DIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR   96 (283)
T ss_pred             HcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCc
Confidence            34444  6799999999999987  689999999987655444556788899999999999999999999876    457


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      +++||||++||+|.+++.....+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus        97 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~  176 (283)
T PHA02988         97 LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP  176 (283)
T ss_pred             eEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence            899999999999999999888899999999999999999999985 9999999999999999999999999998754332


Q ss_pred             ccccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc--CcCCCCCCCCHhHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATS  239 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~  239 (441)
                         .....|++.|+|||++.+. ...+.++|||||||++|+|++|..||.+.+..+.+..+..  ..++.|..+++.+.+
T Consensus       177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence               2345689999999999652 2335899999999999999999999998887777777643  344556568999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhc
Q 013520          240 LIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~  260 (441)
                      ++.+||+.||++|||++++++
T Consensus       254 li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999975

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-44  Score=357.58  Aligned_cols=247  Identities=25%  Similarity=0.410  Sum_probs=200.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ..+|++++.||+|+||.||+|.+..+++.||+|+..+..         ...|+.+++.++||||+++++++......|+|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            347999999999999999999999999999999754422         34689999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~  213 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAF  213 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-ccc
Confidence            99995 578887754 457899999999999999999999999999999999999999999999999998754332 223


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcC-CCCCCCCChH----------HHHHHhhcCc---CCCC--
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLP----------TLYKKINAAE---FSCP--  230 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~----------~~~~~i~~~~---~~~~--  230 (441)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|+++ .++|......          .+.+.+....   ..+|  
T Consensus       214 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            45679999999999987666 4899999999999999985 4444432210          1111111000   0000  


Q ss_pred             ----------------------------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          231 ----------------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       231 ----------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                                                  ..++.++.+||.+||+.||++|||+.|+++||||++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                        124667888999999999999999999999999974

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.6e-44  Score=343.80  Aligned_cols=253  Identities=32%  Similarity=0.471  Sum_probs=210.8

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||.|++|.||+|+++.+|+.||||.+...... ......+.+|+.++++++||||+++++++.+.+..|++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            489999999999999999999999999999998754322 2233568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+. ++|..++..  ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...........
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 588888865  35689999999999999999999999999999999999999999999999999876544333334


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc-Cc-----------------CC-
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-AE-----------------FS-  228 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-~~-----------------~~-  228 (441)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|..||...+......++.. ..                 .. 
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            456788999999987655556889999999999999999999977654332222110 00                 00 


Q ss_pred             ----------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 ----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 ----------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                ..+.++++++++|.+||+.||++|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                      112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-43  Score=339.28  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=213.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC---
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT---   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~---   82 (441)
                      ..++|++.+.||+|++|.||+|.++.+++.+++|++.....    ..+.+.+|+.+++++ +||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            35799999999999999999999999999999999876432    246788999999999 7999999999997644   


Q ss_pred             ---EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           83 ---KVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        83 ---~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                         .+|++|||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence               58999999999999998865    35789999999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccC----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---C
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---S  228 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~  228 (441)
                      +..............|++.|+|||++...    ...+.++|||||||++|+|++|.+||...+.......+.....   .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd06608         160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK  239 (275)
T ss_pred             ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence            87654433334556789999999998532    2234789999999999999999999986654444444433322   2


Q ss_pred             CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .+..++.++.++|.+||..||++|||++++++|||+
T Consensus       240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            233367899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.2e-43  Score=335.40  Aligned_cols=254  Identities=32%  Similarity=0.572  Sum_probs=217.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++.+.+.+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            699999999999999999999989999999999776543 3456889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc----
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL----  165 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~----  165 (441)
                      |+++++|.+++.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++.........    
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            9999999999988777999999999999999999999999999999999999999999999999998765443221    


Q ss_pred             cccccCCCCcCCccccccCC--CCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhh-cCcCCCCCCC--CHhHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKIN-AAEFSCPFWF--STGATS  239 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~-~~~~~~~~~~--s~~~~~  239 (441)
                      .....+++.|+|||++.+..  ..+.++||||+|+++|+|++|..||..... ......+. ......|.+.  ++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence            22356889999999987544  235899999999999999999999976532 22222222 2233445544  899999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +|.+||+.+|.+|||+++++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=9e-44  Score=342.68  Aligned_cols=255  Identities=32%  Similarity=0.506  Sum_probs=216.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++..++..|++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            479999999999999999999999999999999876432 2334577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-ccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~~  167 (441)
                      ||++++.+.........+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            9999987777776667799999999999999999999999999999999999999999999999999887655432 334


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc----------------C-----c
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA----------------A-----E  226 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~----------------~-----~  226 (441)
                      ...+++.|+|||++.+....+.++|+||+|+++|+|++|.+||.+.+..+....+..                .     .
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            567899999999998764556899999999999999999999987654332222110                0     0


Q ss_pred             C-----------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          227 F-----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       227 ~-----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +           ..+..+++++.++|++||..+|++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0           1233458899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-43  Score=335.13  Aligned_cols=254  Identities=28%  Similarity=0.469  Sum_probs=218.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +|+..+.||+|+||.||+|.+..+++.|++|.+......  .....+.+.+|+.+++.++||||+++++++.+....|++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            588899999999999999999989999999998764321  233457789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      +||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987654432 234


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc--CcCCCCCCCCHhHHHHHHHhc
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~~L  245 (441)
                      ...|++.|+|||.+......+.++|+||+||++|+|++|..||...........+..  .....|..+++.+.+++++||
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  239 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL  239 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHh
Confidence            567899999999987655245899999999999999999999977654433333332  223455668999999999999


Q ss_pred             CCCCCCCCChHhHhcCCCc
Q 013520          246 DPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (441)
                      +.+|++||++.+++.|||+
T Consensus       240 ~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         240 QRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             hcCcccCcCHHHHhcCCCC
Confidence            9999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-44  Score=341.20  Aligned_cols=256  Identities=28%  Similarity=0.487  Sum_probs=218.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l   86 (441)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.....  ....+.+.+|+.+++.++   |||++++++++..+...|+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            58899999999999999999999999999999876432  223567889999999996   9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      +|||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..........
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999998866 578999999999999999999999999999999999999999999999999987665543334


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCC-CCHhHHHHHHHh
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFW-FSTGATSLIHKI  244 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~~~  244 (441)
                      ....|+..|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+..... ..+.. ++.++.+++.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC  238 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence            4567999999999987655456899999999999999999999987765544443333222 22222 788999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCccccC
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      |..||++||++.++++||||++..
T Consensus       239 l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         239 LDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999998754

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3e-43  Score=333.01  Aligned_cols=252  Identities=29%  Similarity=0.502  Sum_probs=219.4

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+....... ...+.+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            5999999999999999999999999999999998755433 345778999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeeccccccCCcccccc
Q 013520           90 FVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        90 ~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~~~~  166 (441)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++...... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-~~~  158 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-SKA  158 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC-ccc
Confidence            99999999999763  3589999999999999999999999999999999999998654 5899999998765443 222


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHHhc
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L  245 (441)
                      ....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.... ...+..+++++.+++.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  237 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSML  237 (256)
T ss_pred             cccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHc
Confidence            34568999999999976554 489999999999999999999998877766666655443 3455668999999999999


Q ss_pred             CCCCCCCCChHhHhcCCCc
Q 013520          246 DPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (441)
                      ..||++|||+.++++||||
T Consensus       238 ~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         238 NLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             cCChhhCCCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.2e-44  Score=336.85  Aligned_cols=250  Identities=28%  Similarity=0.469  Sum_probs=216.4

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.+....     ..+.+.+|+.+++.++||||+++++++.+....|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            57999999999999999999999889999999986542     1577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||+++++|.+++.. ...+++..+..++.|++.|+.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999999999975 45789999999999999999999999999999999999999999999999999886654433334


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc---CcCCCCCCCCHhHHHHHHHh
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---AEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---~~~~~~~~~s~~~~~li~~~  244 (441)
                      ...|+..|+|||++.+..+ +.++||||+||++|+|++|..||...+.......+..   .....+..++.++.++|.+|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC  236 (256)
T ss_pred             cccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence            4568899999999977665 4899999999999999999999987655433333222   12233445788999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCc
Q 013520          245 LDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f  264 (441)
                      |+.||++|||+.+++.||||
T Consensus       237 l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         237 LVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-43  Score=341.58  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=211.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEE------
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA------   79 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~------   79 (441)
                      ..+.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++ +||||+++++++.      
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4578999999999999999999999999999999986642    2345688899999998 7999999999985      


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      .....|++|||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            356799999999999999998753  458888999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccccccCCCCcCCccccccC----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-C-CCC
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-S-CPF  231 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~-~~~  231 (441)
                      .............|++.|+|||.+...    ...+.++|+|||||++|+|++|.+||...........+..... . .+.
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  249 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK  249 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence            554333334556799999999998531    2234789999999999999999999976654333333322211 1 122


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .++.++.++|++||..||.+|||+.+|++||||
T Consensus       250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            478999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-43  Score=338.15  Aligned_cols=255  Identities=30%  Similarity=0.472  Sum_probs=214.3

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc-------hHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-------HRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~-------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      +|.+.+.||.|+||.||+|.+..+|+.+|+|.+.......       ....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            5899999999999999999999999999999886532211       123456889999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ..++||||+.+++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998754331


Q ss_pred             --ccccccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCCC----CC
Q 013520          163 --VELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPF----WF  233 (441)
Q Consensus       163 --~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~----~~  233 (441)
                        ........|+..|+|||.+.... ..+.++|+||||+++|+|++|..||...+.......+...  ....+.    .+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence              11223456889999999987654 2458999999999999999999999765544333332221  222222    35


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +.++.++|.+||.++|++|||++++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.5e-44  Score=344.80  Aligned_cols=256  Identities=32%  Similarity=0.459  Sum_probs=214.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKV   84 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~   84 (441)
                      .+++|++.+.||.|+||.||+|.++.+++.+|+|.+...... ......+.+|+.+++.++||||+++++++...  +..
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            356899999999999999999999999999999999765432 22344567899999999999999999998877  899


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |++|||+.+ +|.+.+.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999999975 8988887643 58999999999999999999999999999999999999999999999999988665543


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC------------------
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------------------  225 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------  225 (441)
                      .......+++.|+|||.+.+....+.++|+||+|+++|+|++|.+||...+......++...                  
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            33445568899999999876555568999999999999999999999876654443332110                  


Q ss_pred             -------------cCCCCCC-CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          226 -------------EFSCPFW-FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       226 -------------~~~~~~~-~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                   ...++.. +++.+.++|++||+.||++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                         0011222 58889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=2.5e-43  Score=340.77  Aligned_cols=254  Identities=30%  Similarity=0.454  Sum_probs=206.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|.+.+.||+|+||.||+|.++.+|..||+|.+.......  ....+.+|+.+++.++|+||+++++++..+...|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999999999999999987653222  234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+. ++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99996 567666654 4567888999999999999999999999999999999999999999999999987544333333


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhc-Cc------------------
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINA-AE------------------  226 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~-~~------------------  226 (441)
                      ....+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+.. +....+.. ..                  
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            45568999999999876544457899999999999999999999765432 11111100 00                  


Q ss_pred             --C--CCC---------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          227 --F--SCP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       227 --~--~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                        .  ..+         ...++++.+++.+||..||++|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence              0  000         0125688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-43  Score=340.74  Aligned_cols=252  Identities=33%  Similarity=0.514  Sum_probs=212.3

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||.|++|.||+|++..+|+.||+|.+......  .....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999999765422  223567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           90 FVTGGELFDKIVHQ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        90 ~~~gg~L~~~i~~~---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..........
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9985 888887654   358999999999999999999999999999999999999999999999999987554433333


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc------------------CC
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE------------------FS  228 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------~~  228 (441)
                      ....+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+..+....+....                  ..
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            455678999999998765555689999999999999999999998776554443322100                  00


Q ss_pred             -----------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 -----------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 -----------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                 ..+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                       112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-43  Score=337.16  Aligned_cols=249  Identities=34%  Similarity=0.635  Sum_probs=220.9

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L   96 (441)
                      ||.|+||.||++++..+|+.+|+|++...........+.+.+|+.++++++||||+++++.+..+...|+++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999999999999999776554445567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--------cccc
Q 013520           97 FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--------LLHT  168 (441)
Q Consensus        97 ~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--------~~~~  168 (441)
                      .+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........        ....
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            99998878899999999999999999999999999999999999999999999999999875433211        2234


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCC--CHhHHHHHHHhcC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF--STGATSLIHKILD  246 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~~L~  246 (441)
                      ..+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+....|...  +..+.+++++||+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (265)
T cd05579         161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV  239 (265)
T ss_pred             cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence            568889999999876654 5899999999999999999999998888777777777666666655  9999999999999


Q ss_pred             CCCCCCCCh---HhHhcCCCccc
Q 013520          247 PNPKTRIRI---EGIRKHPWFRK  266 (441)
Q Consensus       247 ~dP~~R~t~---~eil~hp~f~~  266 (441)
                      .+|++|||+   .++++||||.+
T Consensus       240 ~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         240 PDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             CCHhhcCCCccHHHHhcCccccC
Confidence            999999999   99999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.4e-43  Score=341.23  Aligned_cols=255  Identities=31%  Similarity=0.442  Sum_probs=209.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCE----
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTK----   83 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~----   83 (441)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            4799999999999999999999999999999998664322 223456788999999995 6999999999987665    


Q ss_pred             -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEeecccc
Q 013520           84 -VYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLS  156 (441)
Q Consensus        84 -~~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls  156 (441)
                       .|++|||+++ +|.+++...     ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999986 788887643     35799999999999999999999999999999999999998 899999999998


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc----------
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE----------  226 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----------  226 (441)
                      ..............+++.|+|||++.+....+.++|+||+|+++|+|++|.+||.+.+.......+....          
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            7554332333344678899999998654445689999999999999999999998766544333321100          


Q ss_pred             ---------C-C--------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          227 ---------F-S--------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       227 ---------~-~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                               + .        ..+.+++++.++|.+||.+||.+||++++++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                     0 0        0023788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=364.01  Aligned_cols=250  Identities=30%  Similarity=0.474  Sum_probs=220.6

Q ss_pred             eeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCC
Q 013520           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGE   95 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~   95 (441)
                      +||+|+||+||.|+|+.|....|||.+....   .+..+-+..||.+++.|+|.|||+++|.+..++.+-|+||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            6999999999999999999999999986543   3346779999999999999999999999999999999999999999


Q ss_pred             hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-cCCCeEEeeccccccCCccccccccccC
Q 013520           96 LFDKIVHQ-GRL--LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCG  171 (441)
Q Consensus        96 L~~~i~~~-~~l--~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~~~~~~~~~~g  171 (441)
                      |.++++.. +++  +|...-+|.+||++||.|||++.|+|||||-+|||++ -.|.+||+|||-++....-+....+..|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            99999874 566  7889999999999999999999999999999999997 5799999999999877665567789999


Q ss_pred             CCCcCCccccc-cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH--HHHH-HhhcCcCCCCCCCCHhHHHHHHHhcCC
Q 013520          172 TPNYVAPEVLS-NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYK-KINAAEFSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       172 t~~Y~aPE~l~-~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~-~i~~~~~~~~~~~s~~~~~li~~~L~~  247 (441)
                      |..|||||++- +...+|.++|||||||++.||.||++||-....+  .+++ ...+..+++|..+|.+++.+|.+|+.+
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            99999999994 3344579999999999999999999999764433  2332 244566788888999999999999999


Q ss_pred             CCCCCCChHhHhcCCCccccC
Q 013520          248 NPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ||.+||++.++|.+||++...
T Consensus       819 d~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             CcccCccHHHhccCcccccCC
Confidence            999999999999999998763

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.2e-43  Score=351.14  Aligned_cols=260  Identities=30%  Similarity=0.478  Sum_probs=212.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   81 (441)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            46789999999999999999999999999999999865432 223446677899999999999999999988643     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ...|+||||+.+ +|.+.+...  +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             357999999964 888877643  8999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------  225 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------------  225 (441)
                      .. .......|++.|+|||.+.+..+. .++|||||||++|+|++|..||...+....+..+...               
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (353)
T cd07850         170 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT  247 (353)
T ss_pred             CC-CCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence            32 223455689999999999876664 8999999999999999999999876543333322110               


Q ss_pred             -------cCC--------------C-------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCCCC
Q 013520          226 -------EFS--------------C-------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK  272 (441)
Q Consensus       226 -------~~~--------------~-------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~~~  272 (441)
                             ...              .       +...++.++++|.+||+.||++|||+.|++.||||+..+.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~  322 (353)
T cd07850         248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE  322 (353)
T ss_pred             hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence                   000              0       1123567899999999999999999999999999987776543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.3e-43  Score=339.85  Aligned_cols=254  Identities=27%  Similarity=0.433  Sum_probs=210.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEE-----e
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA-----S   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~   80 (441)
                      ..++|++.+.||+|+||.||+|.++.+++.+|+|++....    .....+.+|+.+++.+ +||||+++++++.     .
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            4579999999999999999999999999999999875422    1235678899999999 7999999999873     4


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           81 RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      .+..|++|||++|++|.+.+..    ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            5679999999999999988753    356889999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccccccCCCCcCCccccccC----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---cCCC
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSC  229 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~  229 (441)
                      ..............|++.|+|||++...    ...+.++||||+||++|+|++|..||...+.......+...   ....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            7654433333455799999999998532    22357899999999999999999999876554433333222   1223


Q ss_pred             CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      |..++..+.++|.+||+.||++|||+.++++||||
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            44468899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.5e-43  Score=338.60  Aligned_cols=249  Identities=33%  Similarity=0.533  Sum_probs=205.9

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeC--CEEEEE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR--TKVYII   87 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~--~~~~lv   87 (441)
                      |++.+.||+|+||.||+|.+..+++.||+|.+.+......  .....+|+.+++++. ||||+++++++.+.  +..|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            7899999999999999999999999999999876432221  223457888888885 99999999999987  889999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+.+ +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++. +.+||+|||++...... ...
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-~~~  155 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-PPY  155 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC-CCc
Confidence            999974 78887765 357899999999999999999999999999999999999999 99999999998765432 222


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc------------------CcCC
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------------AEFS  228 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------~~~~  228 (441)
                      ....+++.|+|||.+......+.++||||+||++|+|++|.+||.+.+..+....+..                  ..+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN  235 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccccc
Confidence            3456889999999876656667899999999999999999999987765444333221                  0111


Q ss_pred             CC-----------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 CP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 ~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .|           ..++.++.++|.+||.+||++|||++++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11           2367899999999999999999999999999998

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-43  Score=335.61  Aligned_cols=247  Identities=33%  Similarity=0.619  Sum_probs=210.5

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      +.||.|+||.||+|.+..+|+.||+|.+.+...........+..|..++ ...+|||++++++++...+..|+++||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999999999999998765433333333445555554 445899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCC
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP  173 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~  173 (441)
                      ++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.....    .....|++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~  157 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTP  157 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999875433    23456889


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHhHHHHHHHhcCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGATSLIHKILDPNP  249 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP  249 (441)
                      .|+|||.+.+..+ +.++||||+|+++|+|++|.+||...+.......+.......+    ..+++++.+++.+||+.||
T Consensus       158 ~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  236 (260)
T cd05611         158 DYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP  236 (260)
T ss_pred             CccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCH
Confidence            9999999977654 5899999999999999999999988877777666655543322    3478999999999999999


Q ss_pred             CCCCC---hHhHhcCCCccc
Q 013520          250 KTRIR---IEGIRKHPWFRK  266 (441)
Q Consensus       250 ~~R~t---~~eil~hp~f~~  266 (441)
                      ++||+   ++|++.||||++
T Consensus       237 ~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         237 AKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             HHccCCCcHHHHHcChHhhc
Confidence            99995   479999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-43  Score=340.28  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=219.1

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +.|+..+.||.|+||.||.|.+..++..||+|++.....  ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468899999999999999999999999999999876432  234577889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||++||+|.+++.. +++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999998875 67899999999999999999999999999999999999999999999999998765443323334


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHHhcCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~  247 (441)
                      ..++..|+|||++.+... +.++|+|||||++|+|++|.+||...+.......+.... ...+..++..+.+++.+||..
T Consensus       161 ~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNK  239 (277)
T ss_pred             ccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHccc
Confidence            568889999999876554 589999999999999999999998766555444443322 223344788999999999999


Q ss_pred             CCCCCCChHhHhcCCCcccc
Q 013520          248 NPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~  267 (441)
                      +|++||+++++++||||.+.
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         240 DPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             CcccCcCHHHHHhChHhhhc
Confidence            99999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-47  Score=345.33  Aligned_cols=252  Identities=25%  Similarity=0.447  Sum_probs=222.2

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      -|.++.+||+|+||.||+|.++.+|..+|||.+..+.     ..+.+..||.||++++.|++|++|+.+.....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            3678999999999999999999999999999886643     46788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           90 FVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        90 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||..|+..|.++. +.+++|.++..+++.-+.||+|||...-+|||||..||||+.+|+.||+|||.+..........++
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            9999999999975 568999999999999999999999999999999999999999999999999999876665555678


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---cCCCCCCCCHhHHHHHHHhc
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L  245 (441)
                      ..|||.|||||++..-+|+ .++||||||++..+|..|++||.+-......-.|-..   .+..|...|.++.|++++||
T Consensus       189 VIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             cccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            8999999999999988887 8999999999999999999999765443322222221   12334457899999999999


Q ss_pred             CCCCCCCCChHhHhcCCCcccc
Q 013520          246 DPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .++|++|.|+-++++|||.++.
T Consensus       268 iK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  268 IKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             cCCHHHHHHHHHHhhhhhhcCC
Confidence            9999999999999999999864

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-43  Score=361.23  Aligned_cols=248  Identities=20%  Similarity=0.327  Sum_probs=203.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||....         ....+|+.++++++||||+++++++...+..|++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4479999999999999999999999999999995322         2356899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc--c
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--E  164 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~  164 (441)
                      ||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99995 6888888654 469999999999999999999999999999999999999999999999999987654321  1


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC-C-------ChHHHHHHhhcCcC---------
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-T-------DLPTLYKKINAAEF---------  227 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~-------~~~~~~~~i~~~~~---------  227 (441)
                      .....+||+.|+|||++.+..+ +.++|||||||+||+|++|..|+-. .       ....+.+.+.....         
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2234579999999999987766 4899999999999999998765422 1       11222222222111         


Q ss_pred             --------------------CCCCC-----CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          228 --------------------SCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       228 --------------------~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                                          ..+.|     ++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                11111     4668999999999999999999999999999974

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.3e-43  Score=334.39  Aligned_cols=253  Identities=28%  Similarity=0.521  Sum_probs=215.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++.+.||+|+||.||+|+++.+++.||||.+.............+.+|+.+++.++||||+++++++.+.+..|++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            46899999999999999999999999999999988764444445556788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +||+++|+|.+++..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988853    3458899999999999999999999999999999999999999999999999988665443


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC--hHHHHHHhhcCcCC-CC-CCCCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINAAEFS-CP-FWFSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~-~~-~~~s~~~~~  239 (441)
                      .......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||....  .......+....++ .+ ..++..+.+
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE  239 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            33445678999999999977665 488999999999999999999996543  23444444443332 22 247889999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++.+||+.+|++|||+.++++.
T Consensus       240 li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         240 LVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHCCCCcccCcCHHHHHHH
Confidence            9999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=9.4e-44  Score=338.40  Aligned_cols=254  Identities=26%  Similarity=0.437  Sum_probs=217.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|.++.+++.+|+|.+......  .....+.+|+.+++.++||||+++++.+...+..|+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            4789999999999999999999999999999998775422  34567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        89 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      ||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||.+.......  .
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~  156 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--A  156 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--h
Confidence            999999999999876 789999999999999999999999 999999999999999999999999999987553321  1


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-----hHHHHHHhhcC-cCCCCCC-CCHhHHH
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----LPTLYKKINAA-EFSCPFW-FSTGATS  239 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~-~~~~~~~-~s~~~~~  239 (441)
                      ....++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+     ..+..+.+... ....+.. ++.++.+
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06605         157 KTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD  235 (265)
T ss_pred             hcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence            23678999999999977655 489999999999999999999996542     22333333322 2233333 7899999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +|.+||..||++|||+.+++.||||++.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.9e-43  Score=333.28  Aligned_cols=253  Identities=30%  Similarity=0.578  Sum_probs=218.3

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||++.++.+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.+.+..|+++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5899999999999999999999999999999997754322 234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC-eEEeeccccccCCcccccc
Q 013520           90 FVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~-~kL~DFGls~~~~~~~~~~  166 (441)
                      |+++++|.+++....  .+++..+..++.|++.||.|||++|++|+||||+||++++++. +||+|||.+..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999997644  4789999999999999999999999999999999999998864 6999999987665443333


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHHHHHHhc
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L  245 (441)
                      ....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..... ..++.++.++.++|.+||
T Consensus       160 ~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  238 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF  238 (257)
T ss_pred             cccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence            45568999999999876655 4899999999999999999999988776665555444333 344557899999999999


Q ss_pred             CCCCCCCCChHhHhcCCCc
Q 013520          246 DPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f  264 (441)
                      ..+|++|||+.++++||||
T Consensus       239 ~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         239 KVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ccChhhCcCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.9e-43  Score=335.29  Aligned_cols=250  Identities=20%  Similarity=0.292  Sum_probs=211.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ..+|++.+.||+|+||.||+|.++   ..+..||+|.++....  ......+.+|+.+++.++||||+++++++..++..
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            467999999999999999999865   3467899999876432  23346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++|+|.+++... +.+++..+..++.||+.||+|||++|++||||||+||+++.++.++++|||.+.......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~  161 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA  161 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence            9999999999999998764 578999999999999999999999999999999999999999999999999876543221


Q ss_pred             c-ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHH
Q 013520          164 E-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (441)
Q Consensus       164 ~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (441)
                      . ......++..|+|||.+.+..+ +.++||||+||++|++++ |..||...+..+..+.+..+ ..+.|..++..+.++
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (266)
T cd05064         162 IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL  240 (266)
T ss_pred             hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            1 1112335678999999977665 489999999999999775 99999888777766666554 335566689999999


Q ss_pred             HHHhcCCCCCCCCChHhHhc
Q 013520          241 IHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (441)
                      +.+||+.+|++||++++|++
T Consensus       241 i~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         241 MLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4e-43  Score=339.89  Aligned_cols=258  Identities=29%  Similarity=0.437  Sum_probs=211.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++.+.||+|++|.||+|.++.+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            46899999999999999999999999999999998664322 22345678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEeeccccccCCcccc
Q 013520           88 LEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~  164 (441)
                      |||++ ++|.+.+.....  +++..+..++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++........
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            99996 578887765443  578889999999999999999999999999999999985 45799999999976543323


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------------------
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------  225 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------  225 (441)
                      ......+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+..+...++...                   
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            3344567899999999876554568999999999999999999999876554433332110                   


Q ss_pred             ----cCC------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          226 ----EFS------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       226 ----~~~------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                          .+.      ..+.+++.+.+++.+||+.+|++||++.++++||||++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                000      123468889999999999999999999999999999753

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.1e-43  Score=345.39  Aligned_cols=245  Identities=26%  Similarity=0.435  Sum_probs=192.8

Q ss_pred             EeeeeecCcEEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE--eCCEEEEEEe
Q 013520           14 GRTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--SRTKVYIILE   89 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~lv~E   89 (441)
                      +..||+|+||.||+|+++.  ++..||+|.+....     ....+.+|+.+++.++||||+++++++.  .+...|++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            4689999999999999754  56899999886543     1245678999999999999999999885  4567899999


Q ss_pred             ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----ccCCCeEEeecccc
Q 013520           90 FVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLS  156 (441)
Q Consensus        90 ~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl----~~~~~~kL~DFGls  156 (441)
                      |+.+ +|.+.+...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            9864 787777421         248899999999999999999999999999999999999    45679999999999


Q ss_pred             ccCCccc---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH---------HHHH----
Q 013520          157 ALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------TLYK----  220 (441)
Q Consensus       157 ~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------~~~~----  220 (441)
                      .......   .......||+.|+|||++.+....+.++||||+||++|+|++|.+||......         ....    
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            7654321   12335578999999999976555568999999999999999999999643211         0000    


Q ss_pred             -----------Hhh-------------cCcC----------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          221 -----------KIN-------------AAEF----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       221 -----------~i~-------------~~~~----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                 .+.             ....          ......+..+.+||.+||+.||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                       000             0000          0011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-43  Score=343.81  Aligned_cols=257  Identities=27%  Similarity=0.472  Sum_probs=218.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ..|.....||+|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.++||||+++++.+...+..|++|
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            45666788999999999999999999999999986533   233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++............
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            99999999998754 57899999999999999999999999999999999999999999999999998755443333345


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---cCCCCCCCCHhHHHHHHHhc
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L  245 (441)
                      ..|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+...   ....+..++..+.+++.+||
T Consensus       178 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         178 LVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             eecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHc
Confidence            678999999999876655 48999999999999999999999876655544444322   12222347889999999999


Q ss_pred             CCCCCCCCChHhHhcCCCccccCCC
Q 013520          246 DPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      ..||++|||++++++||||+....|
T Consensus       257 ~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         257 VREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             cCChhHCcCHHHHhhChhhhccCCc
Confidence            9999999999999999999866543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.4e-43  Score=339.26  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=215.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCC-----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG-----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~-----~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      .+++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   80 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE   80 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence            4678999999999999999999876554     689999886543  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~  145 (441)
                      ...|++|||+++|+|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            9999999999999999999764                457888999999999999999999999999999999999999


Q ss_pred             CCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHh
Q 013520          146 GNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (441)
Q Consensus       146 ~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i  222 (441)
                      +.++|+|||++.......  .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987543221  12334567889999999876665 489999999999999998 99999988877777777


Q ss_pred             hcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          223 NAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       223 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .... ...|..+++++.+|+.+||+.||.+||++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6544 34566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-43  Score=330.89  Aligned_cols=247  Identities=40%  Similarity=0.725  Sum_probs=223.9

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L   96 (441)
                      ||+|+||.||++.+..+++.+|+|++.+...........+..|+.+++.++||||+++++.+.++...|++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999989999999999887665555667899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcC
Q 013520           97 FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV  176 (441)
Q Consensus        97 ~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~  176 (441)
                      .+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..............++..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            99999888899999999999999999999999999999999999999999999999999876654333345567899999


Q ss_pred             CccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCCh-
Q 013520          177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI-  255 (441)
Q Consensus       177 aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~-  255 (441)
                      |||.+.+... +.++|+||||+++|+|++|..||...+.....+.+....++.|..++..+.+++++||..||++||++ 
T Consensus       161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~  239 (250)
T cd05123         161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG  239 (250)
T ss_pred             ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence            9999876554 57899999999999999999999887777777777777788888899999999999999999999999 


Q ss_pred             --HhHhcCCCc
Q 013520          256 --EGIRKHPWF  264 (441)
Q Consensus       256 --~eil~hp~f  264 (441)
                        +++++||||
T Consensus       240 ~~~~l~~~~~f  250 (250)
T cd05123         240 GAEEIKAHPFF  250 (250)
T ss_pred             cHHHHHhCCCC
Confidence              999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.2e-43  Score=332.11  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=222.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      .+|++.+.||+|++|.||+|.+..+|+.||+|.+......  .....+.+|+..+..++||||+++++++......|++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4699999999999999999999999999999998765432  34577899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||+++++|.+++.....+++.....++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++...........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999888889999999999999999999999 9999999999999999999999999999886655433334


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC---ChHHHHHHhhcC-cCCCCCC-CCHhHHHHHH
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAA-EFSCPFW-FSTGATSLIH  242 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~-~~~~~~~-~s~~~~~li~  242 (441)
                      ...++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...   ...+..+.+... ....+.. ++..+.++|.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  237 (264)
T cd06623         159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS  237 (264)
T ss_pred             ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence            5678999999999876644 58999999999999999999999776   344444444432 2334444 7899999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCccc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +||.++|++|||+.++++||||+.
T Consensus       238 ~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         238 ACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHccCChhhCCCHHHHHhCHHHHh
Confidence            999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3e-43  Score=339.21  Aligned_cols=257  Identities=25%  Similarity=0.396  Sum_probs=218.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...+|++++.||+|+||.||++.+..+|..||+|++....  .....+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence            4578999999999999999999999999999999987543  23345778999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++......  .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--I  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--c
Confidence            99999999999999888889999999999999999999997 59999999999999999999999999998654322  2


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-----------HHHHHhhcCc-CCCCCC-
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-----------TLYKKINAAE-FSCPFW-  232 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-----------~~~~~i~~~~-~~~~~~-  232 (441)
                      ....+|+..|+|||++.+..+ +.++|+||+||++|+|++|..||......           +....+.... ...+.. 
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD  237 (284)
T ss_pred             cCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence            235579999999999876554 48999999999999999999999764431           2222222221 222222 


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ++.++.+|+.+||++||++|||++|+++||||.+..
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            788999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=337.87  Aligned_cols=252  Identities=33%  Similarity=0.462  Sum_probs=211.0

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      |++.+.||.|++|.||+|.++.+|..||+|++...... ......+.+|+.+++.++|||++++++++.+.+..|++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            68899999999999999999999999999999765432 22345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           91 VTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        91 ~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      +. ++|.+++....  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++............
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            95 68999887765  7899999999999999999999999999999999999999999999999998765433333334


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-----------------------
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----------------------  225 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-----------------------  225 (441)
                      ..+++.|+|||++.+....+.++|+||||+++|+|++|.+||...+......++...                       
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            467889999999876544458899999999999999999999876653332221110                       


Q ss_pred             c------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          226 E------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       226 ~------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .      ....+.+++.+.++|.+||++||++|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            0      01123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.8e-43  Score=341.18  Aligned_cols=257  Identities=25%  Similarity=0.399  Sum_probs=207.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT---   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---   82 (441)
                      ..+++|++.+.||+|+||.||+|.+..+++.||||.+....... .....+.+|+.+++.++||||+++++++....   
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPY   87 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence            45778999999999999999999999999999999986543222 22345668999999999999999999986543   


Q ss_pred             -----EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           83 -----KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        83 -----~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                           ..|+||||+.+ +|.+.+... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus        88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence                 46999999965 787777654 37899999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccc----cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--c----
Q 013520          157 ALPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--E----  226 (441)
Q Consensus       157 ~~~~~~~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~----  226 (441)
                      .......    .......++..|+|||.+.+....+.++||||+|+++|+|++|.+||.+.+.......+...  .    
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            7554321    11234467889999999866544468999999999999999999999876654332222110  0    


Q ss_pred             -------------CCC-------------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          227 -------------FSC-------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       227 -------------~~~-------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                   ...             +...++.+.++|.+||..||++|||++++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                         000             11135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.7e-43  Score=336.05  Aligned_cols=254  Identities=25%  Similarity=0.416  Sum_probs=219.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      -|++.+.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47889999999999999999998999999999865432  2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      |+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            9999999998865 578999999999999999999999999999999999999999999999999987554432223445


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHHHHHHhcCCC
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~d  248 (441)
                      .|+..|+|||.+.+... +.++|+||+||++|+|++|.+||...+.......+..... ..+..++.++.+++.+||..+
T Consensus       162 ~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (277)
T cd06641         162 VGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKE  240 (277)
T ss_pred             cCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence            68899999999876554 4789999999999999999999987665555555543332 345568899999999999999


Q ss_pred             CCCCCChHhHhcCCCcccc
Q 013520          249 PKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       249 P~~R~t~~eil~hp~f~~~  267 (441)
                      |.+||++.++++||||.+.
T Consensus       241 p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         241 PSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             hhhCcCHHHHHhCHHHhhh
Confidence            9999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-42  Score=327.65  Aligned_cols=253  Identities=30%  Similarity=0.512  Sum_probs=223.2

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|++|.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++|||++++++++.+.+..|++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            589999999999999999999999999999999776533 2345789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      |+++++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.............
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            99999999999888899999999999999999999999999999999999999999999999999998766544434556


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHH-hhcCcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK-INAAEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~-i~~~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      .++..|+|||.+.+.. .+.++|+||+|+++|+|++|..||...+....... ........+..+++.+.+++.+||..+
T Consensus       160 ~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         160 VGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             ccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence            7899999999987665 45899999999999999999999987654433333 334444566678999999999999999


Q ss_pred             CCCCCChHhHhcCCCc
Q 013520          249 PKTRIRIEGIRKHPWF  264 (441)
Q Consensus       249 P~~R~t~~eil~hp~f  264 (441)
                      |++|||+.+++.||||
T Consensus       239 p~~R~~~~~~l~~~~~  254 (254)
T cd06627         239 PNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999998

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-42  Score=335.48  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=218.9

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ..|.-.+.||+|++|.||++.+..+++.+|+|.+....   ....+.+.+|+.+++.++||||+++++++...+..|+++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            35666789999999999999999999999999886432   223456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+.|++|.+++.. .++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence            99999999999887 67999999999999999999999999999999999999999999999999987654433223344


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC---CCCCCCHhHHHHHHHhc
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS---CPFWFSTGATSLIHKIL  245 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~~~~li~~~L  245 (441)
                      ..|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+......   .+..++..+.+++++||
T Consensus       175 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  253 (285)
T cd06648         175 LVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML  253 (285)
T ss_pred             ccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence            578999999999977665 48999999999999999999999877766665555544222   22337889999999999


Q ss_pred             CCCCCCCCChHhHhcCCCccccC
Q 013520          246 DPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ..+|++|||+.++++||||++..
T Consensus       254 ~~~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         254 VRDPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             ccChhhCcCHHHHccCcccccCC
Confidence            99999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-44  Score=306.89  Aligned_cols=257  Identities=35%  Similarity=0.522  Sum_probs=221.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ..|.-.++||+|+||+||+|+++++++.||+|.+..+.- +++......+||.+++.++|.|||+++++..++..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            457778899999999999999999999999999987653 2334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |||.. +|..+... ++.++.+.++.++.|++.||.+||++++.|||+||+|+||+.+|.+||+|||+++-+.-+..-.+
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            99964 67666644 57789999999999999999999999999999999999999999999999999998877666667


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhc--C-----cC------------
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA--A-----EF------------  227 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~--~-----~~------------  227 (441)
                      ..+-|..|++|.++.+...++...|+||.|||+.|+.. |++.|.+.+..+..++|-.  +     .+            
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            77889999999999998888899999999999999985 9999999888777666521  1     11            


Q ss_pred             -CCC---------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          228 -SCP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       228 -~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                       .+|         +.++..-+++++++|.-+|.+|+++++.++||||...
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence             011         1135668899999999999999999999999999754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-44  Score=358.82  Aligned_cols=244  Identities=34%  Similarity=0.619  Sum_probs=217.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~   85 (441)
                      ....|++...+|.|+|+.|..+.+..+++.+++|++.+...       +..+|+.++... +||||+++++++.++...|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            46789999999999999999999999999999999988632       234678776666 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE-ccCCCeEEeeccccccCCcccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL-DSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl-~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||++.|+.|.+.+.....+. ..+..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++.....  
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999999999999998866565 7888899999999999999999999999999999 58899999999999865543  


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                       +.+.|-|..|+|||++...+|+ .++||||||++||+||+|+.||..... .++...+..+.++  .++|.++++||++
T Consensus       470 -~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  470 -CDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQ  545 (612)
T ss_pred             -hcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHH
Confidence             5677889999999999977775 999999999999999999999976444 4677777766655  7899999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCc
Q 013520          244 ILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f  264 (441)
                      ||+.||.+|+++.+++.||||
T Consensus       546 LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hccCChhhCcChhhhccCcch
Confidence            999999999999999999999

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1e-42  Score=332.43  Aligned_cols=251  Identities=27%  Similarity=0.429  Sum_probs=210.1

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      ......||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++|+||+++++++..++..|+++||
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   86 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ   86 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence            344568999999999999999999999999886543   23456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEeeccccccCCcccccc
Q 013520           91 VTGGELFDKIVHQ-GRL--LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        91 ~~gg~L~~~i~~~-~~l--~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      +++++|.+.+... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++..........
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcc
Confidence            9999999999764 445  78889999999999999999999999999999999986 6799999999987654433334


Q ss_pred             ccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCCCChHH--HHHH-hhcCcCCCCCCCCHhHHHHHH
Q 013520          167 HTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPT--LYKK-INAAEFSCPFWFSTGATSLIH  242 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~--~~~~-i~~~~~~~~~~~s~~~~~li~  242 (441)
                      ....|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||.......  .... ........|..+++++.++++
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  246 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL  246 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence            4556899999999986533 24589999999999999999999997644321  1111 222334556678999999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +||+.+|++|||+.+++.||||
T Consensus       247 ~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         247 RCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-43  Score=342.76  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=206.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKVY   85 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~   85 (441)
                      +|++.+.||+|+||.||+|.+..  ++..||+|.+...........+.+.+|+.+++.++||||+++++++.+.  ..+|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  8999999999875433333446678899999999999999999999988  8899


Q ss_pred             EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc----CCCeEEeecccc
Q 013520           86 IILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS----YGNLKVSDFGLS  156 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~----~~~~kL~DFGls  156 (441)
                      +||||+.+ +|.+.+...     ..+++..++.++.|++.||.|||++||+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 677666432     36899999999999999999999999999999999999999    899999999998


Q ss_pred             ccCCcccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHH---------HHHHh--
Q 013520          157 ALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---------LYKKI--  222 (441)
Q Consensus       157 ~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---------~~~~i--  222 (441)
                      ........   .....++++.|+|||++.+....+.++|||||||++|+|++|.+||...+...         ....+  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86543222   22345788999999998765545689999999999999999999997544221         00000  


Q ss_pred             ------------------------hcCcCCCC-----------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          223 ------------------------NAAEFSCP-----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       223 ------------------------~~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                              .......+           ...+.++.++|.+||++||++|||+.|+++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                    00000111           1356789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1e-42  Score=339.48  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=215.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            45699999999999999999999999999999998765444444556788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      +||+.| ++.+.+.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......    
T Consensus        94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----  168 (307)
T cd06607          94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----  168 (307)
T ss_pred             HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence            999974 66666653 457899999999999999999999999999999999999999999999999998754332    


Q ss_pred             ccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCC-CCCCCHhHHHHHH
Q 013520          167 HTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSC-PFWFSTGATSLIH  242 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~-~~~~s~~~~~li~  242 (441)
                      ....|++.|+|||++.+  ....+.++||||+|+++|+|++|.+||...+.......+.... ... +..++..+.++|.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVD  248 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHH
Confidence            34568899999999842  2334579999999999999999999998776655444443322 222 2236889999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCccccC
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      +||..||++||++.+++.||||....
T Consensus       249 ~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         249 SCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHhcCChhhCcCHHHHhcChhhcccC
Confidence            99999999999999999999998654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.9e-43  Score=335.15  Aligned_cols=246  Identities=24%  Similarity=0.459  Sum_probs=205.3

Q ss_pred             ccCeEEEeee--eecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTI--GEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~L--G~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      .++|++.+.+  |+|+||.||++.++.++..+|+|.+.......        .|+.....+ +||||+++++.+...+..
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            4577787776  99999999999999999999999987643221        123233322 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...... 
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-  163 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-  163 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence            99999999999999998878999999999999999999999999999999999999999988 9999999998755432 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH----HHHhhcCcCCCCCCCCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKKINAAEFSCPFWFSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~s~~~~~  239 (441)
                         ....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||........    ...........+..+|+.+.+
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAND  239 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHH
Confidence               24568999999999977666 4889999999999999999999975543221    111223333455568999999


Q ss_pred             HHHHhcCCCCCCCCC-hHhHhcCCCccc
Q 013520          240 LIHKILDPNPKTRIR-IEGIRKHPWFRK  266 (441)
Q Consensus       240 li~~~L~~dP~~R~t-~~eil~hp~f~~  266 (441)
                      +|.+||++||.+|++ ++++++||||++
T Consensus       240 li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        240 FVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHhccChhhCCchHHHHhcCCcccC
Confidence            999999999999996 699999999963

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=349.45  Aligned_cols=244  Identities=27%  Similarity=0.423  Sum_probs=211.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      .+.+++.||+|.||.||+|.... ...||+|.+......    .+.+.+|+++|+.|+|+|||++++++..+..+|||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            34567899999999999999863 347999998765433    2557799999999999999999999999889999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |++.|+|.++++.  ...+...+...++.||++|++||+++++|||||-..|||++++..+||+|||+|+..........
T Consensus       282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            9999999999987  45788899999999999999999999999999999999999999999999999995443322111


Q ss_pred             -cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHHh
Q 013520          168 -TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       168 -~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~  244 (441)
                       ..--..-|.|||.+....+ +.+||||||||+||||+| |+.||.+.+..+..+.+..+ +++.|..+|+++.+++..|
T Consensus       362 ~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC  440 (468)
T ss_pred             CCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence             1222346999999987666 499999999999999998 99999999999999888765 5788899999999999999


Q ss_pred             cCCCCCCCCChHhHh
Q 013520          245 LDPNPKTRIRIEGIR  259 (441)
Q Consensus       245 L~~dP~~R~t~~eil  259 (441)
                      +..+|++|||++.+.
T Consensus       441 W~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  441 WHEDPEDRPTFETLR  455 (468)
T ss_pred             hhCCcccCCCHHHHH
Confidence            999999999999654

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.4e-43  Score=334.92  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=206.5

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|.+........  ...+..|+.+ ++.++||||+++++++...+..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            479999999999999999999999999999999876543222  2345556665 5667999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      |||++ |+|.+.+..    ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 577666643    34689999999999999999999998 9999999999999999999999999998765332


Q ss_pred             ccccccccCCCCcCCccccccC---CCCCCCcchhhHhHHHHHHhcCCCCCCCCC-h-HHHHHHhhcCcCCCC-CCCCHh
Q 013520          163 VELLHTTCGTPNYVAPEVLSNR---GYDGSAADVWSCGVILFVLMAGYLPFGETD-L-PTLYKKINAAEFSCP-FWFSTG  236 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~---~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~-~~~~~~i~~~~~~~~-~~~s~~  236 (441)
                       .......|+..|+|||.+.+.   ...+.++|+||+||++|+|++|..||.... . ......+.......| ..+|.+
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd06617         158 -VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE  236 (283)
T ss_pred             -cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence             122335688999999988542   223578999999999999999999997532 2 222222333333333 247899


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +.++|.+||..+|++||+++++++||||++.
T Consensus       237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         237 FQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            9999999999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-42  Score=327.03  Aligned_cols=253  Identities=32%  Similarity=0.574  Sum_probs=223.5

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||++.+..++..||+|.+...... ......+.+|+.+++.++|||++++.+.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            589999999999999999999999999999999765432 2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           90 FVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        90 ~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      |+++++|.+.+...    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999999764    67999999999999999999999999999999999999999999999999998876554334


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHHh
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~  244 (441)
                      .....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+............ ...|..++..+.+++.+|
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL  238 (258)
T ss_pred             ecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence            456679999999999876665 488999999999999999999998887766666654443 344556899999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCc
Q 013520          245 LDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f  264 (441)
                      |..+|++|||+.++++||||
T Consensus       239 l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         239 LQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             cCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.9e-43  Score=352.99  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=205.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   81 (441)
                      .++|++++.||+|+||.||+|++..+     +..||+|.+......  ...+.+.+|+.+++.+ +||||+++++.+...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            45799999999999999999986443     457999999765422  2356788999999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ----------------------------------------------------------  103 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~----------------------------------------------------------  103 (441)
                      ...|+||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999988542                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--ccccc
Q 013520          104 ------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTT  169 (441)
Q Consensus       104 ------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~  169 (441)
                                  .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .....
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                        2467888999999999999999999999999999999999999999999999875543211  11223


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHH-HHhhcC-cCCCCCCCCHhHHHHHHHhcC
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY-KKINAA-EFSCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~-~~i~~~-~~~~~~~~s~~~~~li~~~L~  246 (441)
                      .+++.|+|||++.+..+ +.++||||+||++|+|++ |..||......... ..+..+ ....|..+++++.+++.+||+
T Consensus       275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            35567999999976655 589999999999999997 99999775543333 323222 344566789999999999999


Q ss_pred             CCCCCCCChHhHhc
Q 013520          247 PNPKTRIRIEGIRK  260 (441)
Q Consensus       247 ~dP~~R~t~~eil~  260 (441)
                      .||++|||+.++++
T Consensus       354 ~dp~~RPs~~~l~~  367 (374)
T cd05106         354 LEPTERPTFSQISQ  367 (374)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.5e-43  Score=339.47  Aligned_cols=250  Identities=21%  Similarity=0.308  Sum_probs=204.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC----------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE----------------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN   70 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn   70 (441)
                      ..++|++.+.||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.+++.++|||
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence            34689999999999999999998532                34579999987643  2334567889999999999999


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 013520           71 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------------------RLLENDCRRYFQQLIDAVAHCHSKGVY  131 (441)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-------------------~l~e~~~~~~~~qll~aL~~LH~~gi~  131 (441)
                      |+++++++.+.+..|++|||+++|+|.+++....                   .++...+..++.||+.||.|||+.||+
T Consensus        81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv  160 (304)
T cd05096          81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV  160 (304)
T ss_pred             eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            9999999999999999999999999999886532                   356778899999999999999999999


Q ss_pred             ecCCCCCcEEEccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc--CC
Q 013520          132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GY  207 (441)
Q Consensus       132 HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~  207 (441)
                      ||||||+|||++.++.+||+|||++.......  .......++..|+|||++.+..+ +.++|||||||++|+|++  +.
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999987543321  12234456788999999876555 589999999999999986  67


Q ss_pred             CCCCCCChHHHHHHhhc--------CcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHh
Q 013520          208 LPFGETDLPTLYKKINA--------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR  259 (441)
Q Consensus       208 ~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  259 (441)
                      .||...+..+....+..        .....|+.+++.+.+++.+||+.||++|||+++|.
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            88887665544433211        11234556789999999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-43  Score=344.64  Aligned_cols=258  Identities=29%  Similarity=0.445  Sum_probs=209.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----C
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----T   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~   82 (441)
                      -++|++.+.||+|+||.||+|.+..+|+.||+|.+....  .......+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            468999999999999999999999999999999986422  223456678899999999999999999887544     3


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ..|+++||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            58999999964 88777754 67999999999999999999999999999999999999999999999999998754332


Q ss_pred             c---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhh---------------c
Q 013520          163 V---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN---------------A  224 (441)
Q Consensus       163 ~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~---------------~  224 (441)
                      .   ......+|++.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+.               .
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            1   122345789999999987654445689999999999999999999997655332221110               0


Q ss_pred             C-----------cCC-----CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          225 A-----------EFS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       225 ~-----------~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      .           ...     ..+..++++.++|.+||+.||++|||+.++++||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence            0           000     01235788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-43  Score=340.77  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=216.9

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +.|+..+.||+|+||.||+|.+..++..||+|.+.....  ....+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            457788999999999999999999999999999875432  234567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+++++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            99999999998864 67899999999999999999999999999999999999999999999999998765443222334


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHHhcCC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~  247 (441)
                      ..|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+.... ...+..++.++.++|.+||..
T Consensus       161 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK  239 (277)
T ss_pred             ccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccC
Confidence            568899999999977655 488999999999999999999997655444433333222 223344788999999999999


Q ss_pred             CCCCCCChHhHhcCCCcccc
Q 013520          248 NPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~  267 (441)
                      +|++|||+.++++||||+..
T Consensus       240 ~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         240 DPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             CcccCcCHHHHHHhHHHHHH
Confidence            99999999999999999753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.9e-43  Score=346.47  Aligned_cols=258  Identities=30%  Similarity=0.439  Sum_probs=213.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----C
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----T   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~   82 (441)
                      ..+|.+.+.||+|+||.||+|++..+|..||||.+...... ......+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            45899999999999999999999999999999998764322 22345677899999999999999999987644     3


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ..|+++||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            5899999995 689999988888999999999999999999999999999999999999999999999999998765443


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc------------------
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------------  224 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------------  224 (441)
                      ........++..|+|||.+.+....+.++|||||||++|+|++|.+||.+.+.......+..                  
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence            33344567899999999986544456899999999999999999999977654322221110                  


Q ss_pred             ------C----cC---CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          225 ------A----EF---SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       225 ------~----~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                            .    ..   ...+.+++++.++|++||+.||++|||++++++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                  0    00   0123478899999999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.9e-43  Score=340.38  Aligned_cols=256  Identities=27%  Similarity=0.476  Sum_probs=218.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      .-|+....||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++.+..++..|+++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            345667789999999999999999999999999865432   23456889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||+++++|...+.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            99999999887754 67899999999999999999999999999999999999999999999999998755443333345


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc---CCCCCCCCHhHHHHHHHhc
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~L  245 (441)
                      .+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+..+....+....   ...+..++..+.++|++||
T Consensus       177 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l  255 (297)
T cd06659         177 LVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML  255 (297)
T ss_pred             eecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence            679999999999976655 589999999999999999999998776555555544322   2223347889999999999


Q ss_pred             CCCCCCCCChHhHhcCCCccccCC
Q 013520          246 DPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      +.+|++||+++++++||||.+...
T Consensus       256 ~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         256 TREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             cCCcccCcCHHHHhhChhhccCCC
Confidence            999999999999999999987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.8e-43  Score=345.99  Aligned_cols=260  Identities=26%  Similarity=0.423  Sum_probs=214.4

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE----eCCEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA----SRTKV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~   84 (441)
                      .+|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.    ....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            689999999999999999999999999999999876432 2234567788999999999999999999875    34578


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      |+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....... 
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999995 5899999887889999999999999999999999999999999999999999999999999987543321 


Q ss_pred             ---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc----------------
Q 013520          164 ---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA----------------  224 (441)
Q Consensus       164 ---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~----------------  224 (441)
                         .......|+..|+|||++.+....+.++||||+||++|+|++|.+||.+.+.......+..                
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence               1123457899999999986644456899999999999999999999977654322211110                


Q ss_pred             --------C--cCCC-----CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          225 --------A--EFSC-----PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       225 --------~--~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                              .  ....     .+..++++.++|++||+.+|++|||+++++.||||.+...+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                    0  0011     12368899999999999999999999999999999865543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.1e-43  Score=338.54  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=218.0

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++.+.||+|+||.||++.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..|
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   92 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW   92 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEE
Confidence            34579999999999999999999999899999999986532   223466889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.........
T Consensus        93 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          93 VVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             EEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999999999998865 46889999999999999999999999999999999999999999999999988765443333


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc-Cc--CCCCCCCCHhHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-AE--FSCPFWFSTGATSLIH  242 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-~~--~~~~~~~s~~~~~li~  242 (441)
                      .....|++.|+|||.+....+ +.++|+|||||++|+|++|..||...+.......+.. ..  +..+..++..+.++|+
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             cccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            345578999999999876555 5899999999999999999999987654333222221 11  2223346888999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCccccC
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      +||..+|++||++++++.||||+...
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-42  Score=338.83  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=209.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEE--EEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESV--AMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v--avK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   81 (441)
                      ....++|++.+.||+|+||.||+|.++.++..+  |+|.+...  ........+.+|+.++.++ +||||+++++++...
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            356789999999999999999999998877654  66665432  2233456788999999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~  145 (441)
                      +..|++|||+++|+|.+++...+                .+++..+..++.|++.||+|||++|++||||||+|||++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            99999999999999999997543                47889999999999999999999999999999999999999


Q ss_pred             CCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhc
Q 013520          146 GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA  224 (441)
Q Consensus       146 ~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~  224 (441)
                      +.+||+|||++....... ......++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+..+.+..
T Consensus       161 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  238 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  238 (303)
T ss_pred             CcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence            999999999986432211 1112234567999999866554 589999999999999998 9999988777666666544


Q ss_pred             C-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          225 A-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       225 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      . ....+..+++++.+++.+||+.+|++||++++++.+
T Consensus       239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3 233445578999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.5e-43  Score=332.05  Aligned_cols=252  Identities=29%  Similarity=0.530  Sum_probs=214.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++.+.||+|+||.||+|++..+|+.+|||.+.............+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            46899999999999999999999999999999988765444444556788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |||+.|++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998864    3468999999999999999999999999999999999999999999999999987665443


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh--HHHHHHhhcCcCC-C-CCCCCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL--PTLYKKINAAEFS-C-PFWFSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~~~~~~-~-~~~~s~~~~~  239 (441)
                      ......+|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+...  ....+.+....++ . +..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ  239 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHH
Confidence            44455679999999999977665 4889999999999999999999965433  3334444433332 2 2347899999


Q ss_pred             HHHHhcCCCCCCCCChHhHhc
Q 013520          240 LIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~  260 (441)
                      ++.+||+.||++|||+.+|++
T Consensus       240 li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         240 LVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHhcCCCcccCCCHHHHHH
Confidence            999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-42  Score=327.23  Aligned_cols=254  Identities=31%  Similarity=0.501  Sum_probs=215.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~   84 (441)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|.+.....  ........+.+|+.+++.++||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            479999999999999999999999999999998864321  1223456789999999999999999999998764  568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (441)
                      ++++||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......  
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            999999999999999988788999999999999999999999999999999999999999999999999998754321  


Q ss_pred             -ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCCCCCCHhHHH
Q 013520          163 -VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATS  239 (441)
Q Consensus       163 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~  239 (441)
                       ........|+..|+|||.+.+... +.++|+|||||++|+|++|..||..........++...  ....|..+++.+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence             112234568999999999977655 48999999999999999999999876554444443322  23457778999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +|.+||+ +|.+|||+.+++.|||.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1e-42  Score=343.62  Aligned_cols=263  Identities=27%  Similarity=0.370  Sum_probs=216.0

Q ss_pred             cccCeEE-EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH-----------HHHHHHHHHHHHHhCCCCCccee
Q 013520            7 RVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----------MVDQIKREISIMKIVRHPNIVRL   74 (441)
Q Consensus         7 ~~~~y~i-~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~hpnIv~l   74 (441)
                      .-++|.. .+.||+|+||.||+|.++.+++.||+|.+.........           ....+.+|+.+++.++||||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3467865 57799999999999999999999999998764332210           11247789999999999999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecc
Q 013520           75 HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (441)
Q Consensus        75 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (441)
                      ++++..++..|++|||+. |+|.+++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence            999999999999999997 5899999888889999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCc--------------cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHH
Q 013520          155 LSALPQQ--------------GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  220 (441)
Q Consensus       155 ls~~~~~--------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~  220 (441)
                      ++.....              .........+++.|+|||.+.+....+.++|+|||||++|+|++|.+||.+.+......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9875541              11222344578899999998765555689999999999999999999998876554443


Q ss_pred             HhhcCc-------C---------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          221 KINAAE-------F---------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       221 ~i~~~~-------~---------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      .+....       +                     ......+.++.++|.+||+.+|++|||+++++.||||+....+
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            332100       0                     0012357889999999999999999999999999999876543

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4e-42  Score=324.46  Aligned_cols=253  Identities=32%  Similarity=0.538  Sum_probs=220.2

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKVYII   87 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv   87 (441)
                      +|++.+.||+|++|.||+|.+..++..|++|++...... ....+.+.+|+.++++++||||+++++.+.+.  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999999999999999775433 33467889999999999999999999999988  899999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--c
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--L  165 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~  165 (441)
                      +||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999886655422  1


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-hHHHHHHhh--cCcCCCCCCCCHhHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKIN--AAEFSCPFWFSTGATSLIH  242 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~--~~~~~~~~~~s~~~~~li~  242 (441)
                      .....++..|+|||.+....+ +.++|+||+|+++|+|++|..||.... .......+.  ......|..++..+.++|.
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence            345678999999999876554 589999999999999999999998765 222233333  2334456667999999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +||..||++||++.++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-42  Score=333.64  Aligned_cols=258  Identities=33%  Similarity=0.604  Sum_probs=218.7

Q ss_pred             CeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~~-~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++....... ....+.+.+|+.+++.+ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999875   478999999987643322 22346688899999999 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999987654321 


Q ss_pred             cccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCC----hHHHHHHhhcCcCCCCCCCCHhHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTGAT  238 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~  238 (441)
                      .......|+..|+|||.+.+. ...+.++||||+|+++|+|++|..||...+    .....+.+.....+.|..+++.+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK  240 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence            223356789999999998643 234578999999999999999999997432    233444455555666777899999


Q ss_pred             HHHHHhcCCCCCCCC-----ChHhHhcCCCcccc
Q 013520          239 SLIHKILDPNPKTRI-----RIEGIRKHPWFRKN  267 (441)
Q Consensus       239 ~li~~~L~~dP~~R~-----t~~eil~hp~f~~~  267 (441)
                      +++++||+.||++|+     ++++++.||||+..
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            999999999999997     88999999999763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.5e-43  Score=350.16  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=206.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   81 (441)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++.....  ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            34899999999999999999974     34677899999865432  22346788999999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC---------------------------------------------------------
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG---------------------------------------------------------  104 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~---------------------------------------------------------  104 (441)
                      +..|+||||++||+|.+++....                                                         
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            99999999999999999986422                                                         


Q ss_pred             ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--
Q 013520          105 ------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--  164 (441)
Q Consensus       105 ------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--  164 (441)
                                        .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                              367788899999999999999999999999999999999999999999999876543211  


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChH-HHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...... ...+.+..+ ....|...+.++.+++
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence            1122335667999999977665 489999999999999997 99999775443 334444433 2334556789999999


Q ss_pred             HHhcCCCCCCCCChHhHhcC
Q 013520          242 HKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+||+.||++|||+.+|++.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.1e-42  Score=327.25  Aligned_cols=251  Identities=29%  Similarity=0.545  Sum_probs=214.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999999999999987654444444677899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           89 EFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        89 E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      ||+++|+|.+++..    ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999998864    34589999999999999999999999999999999999999999999999999876554433


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC--hHHHHHHhhcCcC-CCCC-CCCHhHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINAAEF-SCPF-WFSTGATSL  240 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~~~l  240 (441)
                      ......|++.|+|||.+.+..+. .++|+|||||++|+|++|..||....  .....+.+..+.. +.|. .++..+.++
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL  240 (267)
T ss_pred             ccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence            34456789999999999776654 89999999999999999999996543  2344444444333 2333 578899999


Q ss_pred             HHHhcCCCCCCCCChHhHhc
Q 013520          241 IHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (441)
                      |.+||..+|++|||+.+|++
T Consensus       241 i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         241 VSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-42  Score=334.00  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=213.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ...+|.+.+.||+|+||.||+|.+..     ++..||+|.+.....  ....+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   80 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEG   80 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence            35679999999999999999998753     467899999866432  22457889999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG--------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN  147 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~  147 (441)
                      ...|++|||+++++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            99999999999999999997643              4788899999999999999999999999999999999999999


Q ss_pred             eEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhc
Q 013520          148 LKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA  224 (441)
Q Consensus       148 ~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~  224 (441)
                      +||+|||++.......  .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            9999999987542211  11233446788999999977665 488999999999999998 9999988777777777766


Q ss_pred             CcCC-CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          225 AEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       225 ~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +... .+..++..+.+++++||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6554 34568999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-42  Score=344.22  Aligned_cols=258  Identities=26%  Similarity=0.406  Sum_probs=215.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE---
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK---   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~---   83 (441)
                      ..++|++.+.||+|++|.||+|++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            567899999999999999999999999999999998654322 2334667789999999999999999988765544   


Q ss_pred             ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           84 ---VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        84 ---~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                         .|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence               89999999 6799988875 579999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------------  227 (441)
                      ..   .....+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+.....             
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         170 DE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             cc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            32   34557889999999986544556899999999999999999999987665544443322100             


Q ss_pred             ------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                                        .....+++.+.++|++||+.||++|||+.++++||||++...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                              0012358899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-45  Score=386.17  Aligned_cols=256  Identities=32%  Similarity=0.533  Sum_probs=227.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|+-+.+||.|.||+||.|.+.+||+..|+|-+.-.... +...+.+.+|..++..++|||+|+++++=.....+||.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            677889999999999999999999999999998776554 4567889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc----ccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG----VEL  165 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~----~~~  165 (441)
                      ||+||+|.+.++..+..+|...+.|..|++.|+.|||+.||+||||||+||+|+.+|-+|++|||.|......    ...
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            9999999999999888899999999999999999999999999999999999999999999999998755443    234


Q ss_pred             cccccCCCCcCCccccccCC--CCCCCcchhhHhHHHHHHhcCCCCCCCC--ChHHHHHHhhcCcCCCCCCCCHhHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGET--DLPTLYKKINAAEFSCPFWFSTGATSLI  241 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~~~~~i~~~~~~~~~~~s~~~~~li  241 (441)
                      ++...|||.|||||++.+..  ..+-++||||||||+.||+||+.||...  ++.-+|.--....+++|..+|++.+++|
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            56778999999999997643  2356899999999999999999999764  3455666556667788989999999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCccc
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .+||..||++|+++.||+.|-|-+.
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHHhhcccc
Confidence            9999999999999999999987653

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.6e-42  Score=327.84  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=213.6

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...+|++.+.||+|+||.||+|.++.++..||+|.+..+.    .....+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            3467999999999999999999999999999999986532    224568889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999999998753  3588899999999999999999999999999999999999999999999999876544221


Q ss_pred             c-cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          165 L-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 ~-~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      . .....+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+... ....|..+++++.+++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM  238 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            1 112234567999999876665 478999999999999998 99999888777777766543 4455667899999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||+.||++|||+.++++
T Consensus       239 ~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         239 RACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.2e-43  Score=343.39  Aligned_cols=258  Identities=29%  Similarity=0.417  Sum_probs=218.3

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-----KV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~   84 (441)
                      +|++.+.||.|++|.||+|++..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++....     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            69999999999999999999999999999999876432 2334567889999999999999999999988765     79


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      |++|||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999997 4899999887789999999999999999999999999999999999999999999999999998665432 


Q ss_pred             --cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-------------
Q 013520          164 --ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-------------  228 (441)
Q Consensus       164 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-------------  228 (441)
                        .......+++.|+|||++.+....+.++|+||+|+++|+|++|.+||.+.+..+.+..+....-.             
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence              22345568999999999987644568999999999999999999999887765554443221000             


Q ss_pred             ------------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          229 ------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       229 ------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                        ..+.+++++.++|.+||+.+|++|||++++++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                              11236788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.9e-42  Score=340.93  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=212.6

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   82 (441)
                      ..++|++++.||+|+||.||+|.+..+|..||||.+.+.. ........+.+|+.+++.++||||+++++++....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            4568999999999999999999999999999999986543 22333456889999999999999999999987543    


Q ss_pred             --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           83 --KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        83 --~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                        ..|+||||+ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence              468999998 7788887764 679999999999999999999999999999999999999999999999999987554


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------------  227 (441)
                      ..   .....+++.|+|||.+.+....+.++|+|||||++|+|++|.+||...+.......+.....             
T Consensus       170 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         170 SE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             cC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            32   23456789999999987644456899999999999999999999987665433332211100             


Q ss_pred             ------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                                        .....+++.+.++|.+||..||++|||+.+++.||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence                              01134688899999999999999999999999999998654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-43  Score=346.00  Aligned_cols=257  Identities=26%  Similarity=0.419  Sum_probs=207.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l   86 (441)
                      -..|++++.||+|+.++||++...+. ..||+|.+.... .+...+.-+.+||..|.+| .|.+||++++|-..++.+|+
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34799999999999999999987644 456666554433 2445678899999999999 59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc--
Q 013520           87 ILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e-~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--  163 (441)
                      ||||= ..+|...|.......+ ...++|.+|++.|+.++|+.||+|.||||.|+|+-. |.+||+|||+|.......  
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence            99975 5689988887655443 688999999999999999999999999999999976 999999999998765532  


Q ss_pred             cccccccCCCCcCCccccccCCCC----------CCCcchhhHhHHHHHHhcCCCCCCCCC-hHHHHHHhhcCc--CCCC
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYD----------GSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKINAAE--FSCP  230 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~----------~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~--~~~~  230 (441)
                      -...+.+||+.|||||.+....+.          +.++||||||||||+|+.|++||.... ...-...|....  ..+|
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp  595 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP  595 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence            234678999999999999643332          578999999999999999999997532 222233344332  2444


Q ss_pred             CCCCH-hHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          231 FWFST-GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       231 ~~~s~-~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ..-+. ++.++++.||..||++|||+.++|+|||++...
T Consensus       596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence            43223 399999999999999999999999999998643

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-42  Score=341.95  Aligned_cols=255  Identities=28%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR------   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   81 (441)
                      -++|++.+.||.|+||.||+|.++.+|..||+|.+.....   ...+.+.+|+.+++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            4789999999999999999999999999999999866543   2356788999999999999999999776543      


Q ss_pred             --------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEee
Q 013520           82 --------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSD  152 (441)
Q Consensus        82 --------~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~D  152 (441)
                              ...|++|||++ ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    46899999997 588887754 57999999999999999999999999999999999999984 55789999


Q ss_pred             ccccccCCccc---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC----
Q 013520          153 FGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----  225 (441)
Q Consensus       153 FGls~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----  225 (441)
                      ||++.......   .......|+..|+|||.+.+....+.++|||||||++|+|++|..||...+.......+...    
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99987543211   11233467889999998765445568999999999999999999999776543333222110    


Q ss_pred             ---------------------cCC-----CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          226 ---------------------EFS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       226 ---------------------~~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                           ...     ..+.++.++.++|.+||+.||++|||++++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                 000     112467889999999999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.6e-42  Score=330.65  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=212.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEEC----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNR----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ..+++|++.+.||+|+||.||+|.+.    .++..+|+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            35688999999999999999999853    456789999986532  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ-----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~-----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~  144 (441)
                      ...|++|||+.+++|.+++...                 ..+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999998532                 23778889999999999999999999999999999999999


Q ss_pred             CCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHH
Q 013520          145 YGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK  221 (441)
Q Consensus       145 ~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~  221 (441)
                      ++.+||+|||++.......  .......++..|+|||.+.+..+ +.++|+|||||++|+|++ |.+||.+.+.......
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999997543321  12234446778999999976555 589999999999999998 9999988766665555


Q ss_pred             hhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          222 INAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       222 i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.... .+.+..+++.+.+++.+||+.||++||++.+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            54433 44566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.3e-42  Score=329.43  Aligned_cols=254  Identities=27%  Similarity=0.419  Sum_probs=210.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKVYI   86 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~l   86 (441)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+......  .....+.+|+.+++.++||||+++++++.+  .+.+|+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            4799999999999999999999999999999998765322  345678899999999999999999998864  447899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           87 ILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ||||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887653    346889999999999999999999999999999999999999999999999998754332


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-----hHHHHHHhhcCcC-CCC------
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----LPTLYKKINAAEF-SCP------  230 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~~~~~-~~~------  230 (441)
                      .  .....++..|+|||.+.+..+ +.++|+|||||++|+|++|..||....     ..+....+..... ..+      
T Consensus       159 ~--~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         159 L--AGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             c--cccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            1  224567889999999876665 489999999999999999999997652     2233333332111 111      


Q ss_pred             CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ..+++.+.++|.+||..||++|||+.|+++||||++.
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            1246789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.4e-42  Score=331.22  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=211.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .++|++.+.||+|+||.||+|..+.     .+..||+|.+.....  ......+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            4689999999999999999997652     345899998865432  222345778999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEee
Q 013520           83 KVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (441)
                      ..|++|||+.+|+|.+++....          ..+...+..++.|++.||.|||++||+||||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999999999999997532          245667889999999999999999999999999999999999999999


Q ss_pred             ccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CC
Q 013520          153 FGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FS  228 (441)
Q Consensus       153 FGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~  228 (441)
                      ||++........  ......++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+..+..+.+..+. ..
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD  241 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            999875433211  1122345678999999876555 589999999999999998 899998877777666655443 34


Q ss_pred             CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc------CCCccc
Q 013520          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK------HPWFRK  266 (441)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~------hp~f~~  266 (441)
                      .+...++.+.+++.+||+.||++|||+.++++      ||||+.
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            55667899999999999999999999999986      999964

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-42  Score=325.22  Aligned_cols=244  Identities=25%  Similarity=0.391  Sum_probs=214.3

Q ss_pred             eeeeecCcEEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecc
Q 013520           15 RTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFV   91 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   91 (441)
                      +.||+|+||.||+|.+...   +..||+|.+.......  ..+.+.+|+.+++.++|+||+++++++.+...++++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4799999999999999865   8899999997654322  4678899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           92 TGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        92 ~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ++++|.+++...         ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         78999999999999999999999999999999999999999999999999999866543


Q ss_pred             c--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHH
Q 013520          163 V--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (441)
Q Consensus       163 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (441)
                      .  .......+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+..+..+.+..+ ....|..+|+++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            2  22345567889999999876654 589999999999999998 69999988877777776643 4456777899999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +++.+||..||++|||+.+++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.8e-42  Score=335.89  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=207.5

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC---
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR---   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---   81 (441)
                      -..+++|++.+.||+|+||.||+|.++.+++.+|+|.+....... .......+|+.+++.++||||+++++++...   
T Consensus         4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (311)
T cd07866           4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDK   82 (311)
T ss_pred             CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheeccccc
Confidence            345789999999999999999999999999999999987644322 1234567899999999999999999887543   


Q ss_pred             -----CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           82 -----TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        82 -----~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                           ..+|+++||+.+ +|...+.. ...+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+
T Consensus        83 ~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          83 SKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             ccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence                 357999999965 66666654 45799999999999999999999999999999999999999999999999999


Q ss_pred             cccCCcccc-----------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc
Q 013520          156 SALPQQGVE-----------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA  224 (441)
Q Consensus       156 s~~~~~~~~-----------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~  224 (441)
                      +........           ......|++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            875433211           112335788899999986655456899999999999999999999987766544443321


Q ss_pred             CcC-----------------------CCC-------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          225 AEF-----------------------SCP-------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       225 ~~~-----------------------~~~-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      ...                       ..+       ..+++.+.++|.+||..||++|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            100                       000       1245778999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.7e-42  Score=330.61  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=211.3

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      -.+|.+.+.||+|+||+||++.+.     .++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            357999999999999999999853     345678999886532   334567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeE
Q 013520           83 KVYIILEFVTGGELFDKIVHQG-------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK  149 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~-------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~k  149 (441)
                      ..|++|||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+||++++++.+|
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999999997543             489999999999999999999999999999999999999999999


Q ss_pred             EeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc
Q 013520          150 VSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE  226 (441)
Q Consensus       150 L~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~  226 (441)
                      |+|||++.......  .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+.
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~  239 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  239 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            99999987543321  11223445778999999976555 489999999999999998 999998887777777776655


Q ss_pred             C-CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          227 F-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       227 ~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      . ..+..+++++.+++.+||+.||.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3 345568899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.2e-42  Score=330.77  Aligned_cols=256  Identities=29%  Similarity=0.478  Sum_probs=220.3

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      .....|++.+.||+|++|.||+|.+..++..||+|++.....    ..+.+.+|+.+++.++|+|++++++.+......|
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            345679999999999999999999998999999999976432    3567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +++||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            9999999999999998876 899999999999999999999999999999999999999999999999998865544323


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-C--CCCCCCHhHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-S--CPFWFSTGATSLI  241 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~--~~~~~s~~~~~li  241 (441)
                      ......+++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+..... .  .+..++..+.++|
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             hhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence            3344568899999999876665 4899999999999999999999987665544444433222 1  2223788999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCccc
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ++||+.+|.+|||+.+++.||||++
T Consensus       251 ~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         251 NKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHhccChhhCcCHHHHhhChHhhc
Confidence            9999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=6.3e-42  Score=324.71  Aligned_cols=247  Identities=23%  Similarity=0.384  Sum_probs=209.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|++.+.||+|+||.||+|..+. +..+|+|.+......    .+.+.+|+.+++.++||||+++++++...+..|++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   77 (256)
T cd05114           3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV   77 (256)
T ss_pred             HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence            4679999999999999999998764 567999988654322    35678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc-
Q 013520           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL-  165 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~-  165 (441)
                      |||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999999999875 356899999999999999999999999999999999999999999999999998754332111 


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHK  243 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~  243 (441)
                      .....++..|+|||++.+..+ +.++|+||+|+++|+|++ |..||...+..+....+..+. ...|...+..+.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             cCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            122235568999999976655 489999999999999999 999998888777777776543 33455578899999999


Q ss_pred             hcCCCCCCCCChHhHhc
Q 013520          244 ILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~  260 (441)
                      ||+.||++|||++++++
T Consensus       237 c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         237 CWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HccCCcccCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-42  Score=325.61  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=213.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      .++|++.+.||+|+||.||+|.++.+   ...||+|.+....  .......+.+|+.+++.++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            46799999999999999999998654   4589999886543  233346688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |++|||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            9999999999999998764 478999999999999999999999999999999999999999999999999998764221


Q ss_pred             cc--cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHH
Q 013520          164 EL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (441)
Q Consensus       164 ~~--~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (441)
                      ..  .....+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ..+.+...++.+.+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            21  122345678999999876655 489999999999999998 99999877776666666544 33455668999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++.+||+.+|++||++.+++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.3e-42  Score=334.41  Aligned_cols=258  Identities=29%  Similarity=0.480  Sum_probs=211.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--   82 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--   82 (441)
                      ....++|++.+.||+|+||.||+|.++.+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+..  
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            45678999999999999999999999999999999999764322 223356778999999999999999999987654  


Q ss_pred             --------EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeec
Q 013520           83 --------KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (441)
Q Consensus        83 --------~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (441)
                              .+|+++||+++ ++.+.+... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                    89999999986 666666543 46899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccc-ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cC---
Q 013520          154 GLSALPQQGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EF---  227 (441)
Q Consensus       154 Gls~~~~~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~---  227 (441)
                      |++........ ......++..|+|||.+.+....+.++|||||||++|+|++|++||...+..+....+...  ..   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            99876544322 2223456788999998865544568999999999999999999999876655444333221  00   


Q ss_pred             -------------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          228 -------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       228 -------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                               .....++..+.+++.+||..||++|||+++++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                     0011368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.7e-42  Score=366.45  Aligned_cols=251  Identities=23%  Similarity=0.357  Sum_probs=206.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            57999999999999999999999999999999999765544444567789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           88 LEFVTGGELFDKIVHQ-----------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      |||++||+|.+++...           ...+...+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988641           23455677889999999999999999999999999999999999999999999


Q ss_pred             ccCCccc------------------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH
Q 013520          157 ALPQQGV------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL  218 (441)
Q Consensus       157 ~~~~~~~------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~  218 (441)
                      .......                  ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            7652110                  01123479999999999987665 5899999999999999999999977544332


Q ss_pred             HHHhh-cC--cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHh
Q 013520          219 YKKIN-AA--EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR  259 (441)
Q Consensus       219 ~~~i~-~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  259 (441)
                      ..... ..  .......+++.+.+++.+||..||++|++..+.+
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL  283 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL  283 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            22111 11  1111124788999999999999999998765544

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-42  Score=330.04  Aligned_cols=252  Identities=32%  Similarity=0.486  Sum_probs=211.4

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CEEEEEE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TKVYIIL   88 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~~~lv~   88 (441)
                      |++.+.||+|+||.||+|.+..+|+.+|+|.+.... ........+.+|+.+++.++|||++++++++...  +..|+|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            789999999999999999999999999999998754 2333446688899999999999999999999988  8999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-cc
Q 013520           89 EFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LL  166 (441)
Q Consensus        89 E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~  166 (441)
                      ||+++ +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++........ ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99975 888888765 5799999999999999999999999999999999999999999999999999876544321 22


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-------------------
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------------  227 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------------------  227 (441)
                      ....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.....                   
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            3446788999999886654456899999999999999999999988776544443321100                   


Q ss_pred             ----C--------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          228 ----S--------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       228 ----~--------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                          .        ....+++.+.+++++||..||.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                0        001138889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-41  Score=319.17  Aligned_cols=249  Identities=33%  Similarity=0.526  Sum_probs=215.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|++|.||++.+..+++.+++|++.....   ...+.+.+|+.+++.++|||++++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            58999999999999999999998999999999977543   245778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           90 FVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        90 ~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      |++|++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+........ ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence            99999999999876 5889999999999999999999999999999999999999999999999999876654322 345


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-cCCC--CCCCCHhHHHHHHHhc
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-EFSC--PFWFSTGATSLIHKIL  245 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~~--~~~~s~~~~~li~~~L  245 (441)
                      ..|+..|+|||.+.+.. .+.++|+||+|+++|+|++|..||...+........... ....  +..++..+.++|.+||
T Consensus       157 ~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  235 (253)
T cd05122         157 MVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCL  235 (253)
T ss_pred             eecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHc
Confidence            67899999999987655 458999999999999999999999876544333333222 1122  2224889999999999


Q ss_pred             CCCCCCCCChHhHhcCCC
Q 013520          246 DPNPKTRIRIEGIRKHPW  263 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~  263 (441)
                      +.||++|||+.++++|||
T Consensus       236 ~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         236 QKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             cCChhhCCCHHHHhcCCC
Confidence            999999999999999999

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.5e-42  Score=328.06  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=214.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...+|++++.||.|+||.||+|.++. +..+|+|++.....   .....+.+|+.+++.++||||+++++++.+....|+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            34679999999999999999999987 88999999876532   234578899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||.+........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999999753  4688999999999999999999999999999999999999999999999999876544322


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (441)
                      ......++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+... ..+.+..+++.+.+++.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             cccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence            2234446678999999876655 488999999999999998 89999887766666665543 34556678999999999


Q ss_pred             HhcCCCCCCCCChHhHhc
Q 013520          243 KILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (441)
                      +||+.||++|||+.+|++
T Consensus       239 ~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         239 ECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHcCCCchhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.8e-42  Score=328.02  Aligned_cols=252  Identities=21%  Similarity=0.259  Sum_probs=209.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ..++|++.+.||+|+||.||+|.++.     ++..||+|.+.....  ......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34689999999999999999998642     456899998865321  22345688999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEe
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS  151 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  151 (441)
                      ...++||||+++|+|.+++....          .++...+..++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999987532          24667888999999999999999999999999999999999999999


Q ss_pred             eccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-C
Q 013520          152 DFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-F  227 (441)
Q Consensus       152 DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~  227 (441)
                      |||++........  ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.....+.+.... .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999875433211  1123345778999999976555 589999999999999998 799998877776666655443 3


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..+..++..+.+++.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4556688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.1e-41  Score=331.35  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=213.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +.|...+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++|||++++++++.+....|++|
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            34777889999999999999999999999999997765444445567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||+. |+|.+.+.. ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++.....    ..
T Consensus       101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~  175 (313)
T cd06633         101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----AN  175 (313)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CC
Confidence            9996 577777754 45689999999999999999999999999999999999999999999999999864322    23


Q ss_pred             cccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC--CCCCCCHhHHHHHHH
Q 013520          168 TTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFWFSTGATSLIHK  243 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~  243 (441)
                      ...|+..|+|||.+..  .+..+.++|+|||||++|+|++|..||...+.......+.....+  ....++..+.+++.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  255 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY  255 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence            5678999999999842  233457899999999999999999999876655444444333222  122367889999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCcccc
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ||+.+|.+||++++++.||||+..
T Consensus       256 ~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         256 CLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HccCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=359.58  Aligned_cols=243  Identities=33%  Similarity=0.517  Sum_probs=205.7

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEE-E---eC---
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVL-A---SR---   81 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~-~---~~---   81 (441)
                      +++|.+.|.+|+|+.||+|++...|..||+|.+-..   ++...+.+++||.+|+.|+ |+|||.+++.. .   ..   
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            578899999999999999999988899999987553   4567889999999999995 99999999932 1   11   


Q ss_pred             CEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           82 TKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      -.++|.||||.||.|.|++..  ..+|+|.++.+||.|+++||.+||..+  |||||||-|||||+.+|++||||||.++
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            247899999999999999974  457999999999999999999999997  9999999999999999999999999886


Q ss_pred             cCCccccc------c---ccccCCCCcCCccccc---cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC
Q 013520          158 LPQQGVEL------L---HTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  225 (441)
Q Consensus       158 ~~~~~~~~------~---~~~~gt~~Y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~  225 (441)
                      -.-.....      .   -....|+.|+|||++.   +.+. ++|+|||+|||+||-|+...+||+....    -.|..+
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng  269 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNG  269 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEec
Confidence            43222110      0   1234799999999973   3343 5899999999999999999999987632    246778


Q ss_pred             cCCCCC--CCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          226 EFSCPF--WFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       226 ~~~~~~--~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .|.+|+  .++..+.+||+.||++||.+||++-+++.
T Consensus       270 ~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  270 NYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE  306 (738)
T ss_pred             cccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence            888886  48999999999999999999999998875

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.7e-42  Score=335.18  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=210.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....+|++.+.||+|+||.||+|.+..+++.    ||+|++....  .....+.+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            3457899999999999999999998766654    8999986432  223456788999999999999999999998764


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ..++++||+.+|+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             578999999999999999874 468889999999999999999999999999999999999999999999999998654


Q ss_pred             ccccc--cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHh
Q 013520          161 QGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (441)
Q Consensus       161 ~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (441)
                      .....  .....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+....+....+..+ ..+.|..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            42221  122334678999999977665 489999999999999997 99999887766555444433 34556678999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.+++.+||..||++|||+.+++.+
T Consensus       240 ~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.8e-42  Score=323.13  Aligned_cols=243  Identities=27%  Similarity=0.455  Sum_probs=203.5

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   94 (441)
                      +.||+|+||.||+|.++.+|+.+|+|.+....  .......+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            46999999999999999999999999876432  2334567889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc--ccccC
Q 013520           95 ELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL--HTTCG  171 (441)
Q Consensus        95 ~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~--~~~~g  171 (441)
                      +|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..........  ....+
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            9999997644 58999999999999999999999999999999999999999999999999987543221110  11123


Q ss_pred             CCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhc-CcCCCCCCCCHhHHHHHHHhcCCCC
Q 013520          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-AEFSCPFWFSTGATSLIHKILDPNP  249 (441)
Q Consensus       172 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP  249 (441)
                      +..|+|||.+.+..+ +.++|+|||||++|+|++ |.+||...+.......+.. .....+..++..+.+++.+||+.||
T Consensus       159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            456999999876655 588999999999999997 9999987665555454443 2345556689999999999999999


Q ss_pred             CCCCChHhHhc
Q 013520          250 KTRIRIEGIRK  260 (441)
Q Consensus       250 ~~R~t~~eil~  260 (441)
                      ++|||+.++++
T Consensus       238 ~~Rps~~~~~~  248 (252)
T cd05084         238 GQRPSFSTVHQ  248 (252)
T ss_pred             hhCcCHHHHHH
Confidence            99999999864

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-41  Score=337.70  Aligned_cols=258  Identities=26%  Similarity=0.401  Sum_probs=210.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   81 (441)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            347899999999999999999999999999999998764322 22345678899999999999999999988643     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ...|++++++ |++|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence             3478888887 7889887764 579999999999999999999999999999999999999999999999999987543


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------  226 (441)
                      .   ......|++.|+|||.+.+....+.++||||+||++|+|++|.+||...+.......+....              
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         172 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             c---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            2   23455789999999998764445689999999999999999999997655433322221100              


Q ss_pred             ---------CCCC--------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          227 ---------FSCP--------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       227 ---------~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                               ...|        ...++++.++|.+||+.||.+|||+.+++.||||++...+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                     0000        1257889999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-42  Score=358.49  Aligned_cols=260  Identities=27%  Similarity=0.417  Sum_probs=196.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCC-CcEEEEEE--------------eecccccchHHHHHHHHHHHHHHhCCCCC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKV--------------LAKSTILKHRMVDQIKREISIMKIVRHPN   70 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vavK~--------------i~~~~~~~~~~~~~~~~Ei~il~~l~hpn   70 (441)
                      ...++|++++.||+|+||+||++..+.. +...+.|.              +.+...........+.+|+.+++.++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            4467899999999999999999876543 22223221              11111112234466889999999999999


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC
Q 013520           71 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~  145 (441)
                      |+++++++.+.+..|+++|++. ++|.+++...     .......++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            9999999999999999999985 5777776542     234466788999999999999999999999999999999999


Q ss_pred             CCeEEeeccccccCCccc-cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCC-CCCCCC--h-HHHHH
Q 013520          146 GNLKVSDFGLSALPQQGV-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETD--L-PTLYK  220 (441)
Q Consensus       146 ~~~kL~DFGls~~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~-Pf~~~~--~-~~~~~  220 (441)
                      |.+||+|||++....... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|.. ||....  . ..+.+
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            999999999997664432 22335679999999999987766 489999999999999999875 454322  1 11111


Q ss_pred             Hhh---------------------cCcC-----CCC-----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          221 KIN---------------------AAEF-----SCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       221 ~i~---------------------~~~~-----~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+.                     ...+     ..+     ..++.++.++|.+||+.||++|||+.|++.||||...
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            111                     0000     000     1246678889999999999999999999999999753

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.2e-41  Score=321.85  Aligned_cols=251  Identities=27%  Similarity=0.489  Sum_probs=220.1

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999987654332 234567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           90 FVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        90 ~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......  .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~  157 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M  157 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence            9999999998866    356899999999999999999999999999999999999999999999999998766543  3


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-CCCCCCHhHHHHHHHh
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKI  244 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~  244 (441)
                      .....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+....+. .+..++.++.+++.+|
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM  236 (256)
T ss_pred             cccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence            345668999999999977665 47899999999999999999999988877666666555443 4455889999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCc
Q 013520          245 LDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f  264 (441)
                      |..+|++|||+.++++||++
T Consensus       237 l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         237 LQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             cCCCcccCCCHHHHhcCCCC
Confidence            99999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7e-42  Score=331.52  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=214.8

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      |+-...||+|+||.||++.+..+|+.||+|.+....   ......+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   98 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF   98 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence            333467999999999999999999999999885432   23356788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccccc
Q 013520           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC  170 (441)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~  170 (441)
                      +++++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..............
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657          99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            999999987754 5789999999999999999999999999999999999999999999999998865443322334467


Q ss_pred             CCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc---CCCCCCCCHhHHHHHHHhcCC
Q 013520          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       171 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~L~~  247 (441)
                      |++.|+|||.+.+..+ +.++|+||+|+++|+|++|.+||...........+....   ......+++.+.+++.+||+.
T Consensus       178 ~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         178 GTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             cCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence            8999999999876554 589999999999999999999998766555444443221   222334789999999999999


Q ss_pred             CCCCCCChHhHhcCCCccccCCC
Q 013520          248 NPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      ||.+||++.+++.||||.+...|
T Consensus       257 ~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         257 DPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             CcccCcCHHHHhcChHHhccCCC
Confidence            99999999999999999887643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3e-43  Score=314.73  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=207.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----CC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-----RT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~   82 (441)
                      -+||++.+.||+|+|+.||++++..++..||+|.+....   .+..+...+|+...++++|||+++++++...     ..
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            468999999999999999999999999999999986654   3457888999999999999999999887543     33


Q ss_pred             EEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEccCCCeEEeecccc
Q 013520           83 KVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      ..|++++|...|+|.+.|+..    ..++|.++..|+.++++||++||+..  ++||||||.|||+.+.+.++|.|||.+
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence            499999999999999999753    36999999999999999999999998  999999999999999999999999998


Q ss_pred             ccCCcccc---------ccccccCCCCcCCccccccCCCC--CCCcchhhHhHHHHHHhcCCCCCCCCCh--HHHHHHhh
Q 013520          157 ALPQQGVE---------LLHTTCGTPNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPFGETDL--PTLYKKIN  223 (441)
Q Consensus       157 ~~~~~~~~---------~~~~~~gt~~Y~aPE~l~~~~~~--~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~  223 (441)
                      +...-...         .......|.+|+|||.+.-+.+.  +.++|||||||+||+|+.|..||+..-.  ..+.-.+.
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~  256 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ  256 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence            75432111         11233468999999998644332  6899999999999999999999953110  01111234


Q ss_pred             cCcCCCCCC--CCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          224 AAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       224 ~~~~~~~~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++++++|..  +|+.+.++|+.||+.||.+||++.+++.+
T Consensus       257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            555655543  89999999999999999999999999865

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=325.70  Aligned_cols=251  Identities=21%  Similarity=0.277  Sum_probs=212.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ..++|++.+.||+|+||.||+|.++..     +..||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            457899999999999999999988644     4789999986543  222345678899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEe
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS  151 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~----------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  151 (441)
                      ...|++|||+++|+|.+++....          .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999999986532          36778899999999999999999999999999999999999999999


Q ss_pred             eccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cC
Q 013520          152 DFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EF  227 (441)
Q Consensus       152 DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~  227 (441)
                      |||++.......  .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+..+.+..+ ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            999987543321  12234456789999999876554 589999999999999998 99999887777766666544 34


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ..|..++.++.+++.+||+.+|++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            566678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.3e-41  Score=363.67  Aligned_cols=151  Identities=30%  Similarity=0.572  Sum_probs=141.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      .+++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            36899999999999999999999999999999999987665555566789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      ||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.1e-41  Score=327.01  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=211.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++|+||+++++++.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            34679999999999999999999987     77899999876433  222345688899999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEEe
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVS  151 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~  151 (441)
                      ...|++|||+.|++|.+++....       .+++..+..++.||+.||.|||++|++||||||+||+++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            99999999999999999997653       488899999999999999999999999999999999998765   59999


Q ss_pred             eccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhc-CcC
Q 013520          152 DFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-AEF  227 (441)
Q Consensus       152 DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~-~~~  227 (441)
                      |||++........  ......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.. ...
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999876532211  1112233567999999976665 589999999999999997 9999998777666665543 344


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..|..++..+.+++.+||+.||++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5566789999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2e-41  Score=332.02  Aligned_cols=254  Identities=25%  Similarity=0.390  Sum_probs=215.1

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ..|+..+.||+|+||.||+|++..+|..+|+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34888999999999999999999999999999997654444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||+.| +|.+.+.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....    ..
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~~  179 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----AN  179 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----cc
Confidence            99975 77776654 45789999999999999999999999999999999999999999999999999865433    23


Q ss_pred             cccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-C-CCCCCHhHHHHHHH
Q 013520          168 TTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-C-PFWFSTGATSLIHK  243 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~~~~li~~  243 (441)
                      ...|++.|+|||.+..  .+..+.++|+||+||++|+|++|.+||...+.......+...... . +..+++.+.+++.+
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  259 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS  259 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHH
Confidence            4568999999999742  233458999999999999999999999877665555555443322 2 23478899999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCcccc
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ||+.+|.+||++.++++|||+...
T Consensus       260 ~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         260 CLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             HccCCcccCcCHHHHHhChhhhcc
Confidence            999999999999999999999654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=346.95  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=216.8

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      .|.-++.||.|+||.||.|++..+.+.||||.+....-...+--+.+..|+..|+.++|||+|.+.++|..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            46667899999999999999999999999999977654444445679999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           90 FVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        90 ~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      ||-| +-.|.+.- ..++.|..+..+..+.+.||.|||+.+.||||||..||||++.|.+||+|||.+.+...    .++
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----Ans  181 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANS  181 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hhc
Confidence            9954 66666643 46789999999999999999999999999999999999999999999999999887644    468


Q ss_pred             ccCCCCcCCccccc--cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh-hcCcCCCCC-CCCHhHHHHHHHh
Q 013520          169 TCGTPNYVAPEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-NAAEFSCPF-WFSTGATSLIHKI  244 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~--~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i-~~~~~~~~~-~~s~~~~~li~~~  244 (441)
                      ++|||.|||||++.  ..+.++-++|||||||+..+|.-.++|+-..+.....-.| .+..+..+. ..|..+++|+..|
T Consensus       182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~C  261 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC  261 (948)
T ss_pred             ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence            89999999999985  3344457999999999999999999998776655444444 333333332 3688999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCccccCC
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      |++-|.+|||.+++++|+|....-+
T Consensus       262 LqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  262 LQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             HhhCcccCCcHHHHhhcchhccCCC
Confidence            9999999999999999999976543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-42  Score=329.01  Aligned_cols=252  Identities=33%  Similarity=0.503  Sum_probs=213.4

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      |++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999997754 2233346678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           91 VTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        91 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      +. ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.............
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            97 5899999876 589999999999999999999999999999999999999999999999999987665543334455


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC------------------cCCCC-
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------------------EFSCP-  230 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------------------~~~~~-  230 (441)
                      .++..|+|||.+.+....+.++|+|||||++|+|++|.+||...+......++...                  ....+ 
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            67888999999876645568999999999999999999999887655443332210                  00011 


Q ss_pred             ----------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          231 ----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       231 ----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                                +.++..+.++|++||..||++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                      1247889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.6e-41  Score=329.59  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=207.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~   85 (441)
                      ++|++.+.||+|+||.||+|.++.++.  .+++|.+....  .....+.+.+|+.++.++ +||||+++++++...+..|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999887765  46888775321  223356788999999999 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeE
Q 013520           86 IILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK  149 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~k  149 (441)
                      ++|||+++++|.+++....                .+++..+..++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999996532                478889999999999999999999999999999999999999999


Q ss_pred             EeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cC
Q 013520          150 VSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EF  227 (441)
Q Consensus       150 L~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~  227 (441)
                      |+|||++........ ......+..|+|||++.+..+ +.++|||||||++|+|++ |.+||...+.......+..+ ..
T Consensus       160 l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~  237 (297)
T cd05089         160 IADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRM  237 (297)
T ss_pred             ECCcCCCccccceec-cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC
Confidence            999999864322111 111223457999999876665 489999999999999997 99999888777776666544 23


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..|..++.++.+++.+||..+|.+|||++++++.
T Consensus       238 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         238 EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4555689999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.9e-42  Score=331.11  Aligned_cols=256  Identities=21%  Similarity=0.320  Sum_probs=207.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~l   86 (441)
                      .++|+..+.||+|+||.||++.+..+|+.||+|.+.+....  .....+.+|+.++.++. ||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            35788889999999999999999999999999998764432  33567889999999995 9999999999999999999


Q ss_pred             EEeccCCCChHH---HHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           87 ILEFVTGGELFD---KIV--HQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        87 v~E~~~gg~L~~---~i~--~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      +|||+.+ ++.+   .+.  ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999864 4433   322  236799999999999999999999975 99999999999999999999999999986543


Q ss_pred             ccccccccccCCCCcCCccccccC--CCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCc-CCC----CCC
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAE-FSC----PFW  232 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~-~~~----~~~  232 (441)
                      .. .......|++.|+|||++.+.  ...+.++||||+||++|+|++|.+||..... .+....+..+. ...    +..
T Consensus       160 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         160 DS-IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             cC-CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            32 122344689999999999765  2445899999999999999999999976542 12222222221 111    123


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++.++.+||.+||+.||++|||++++++||||+..
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            78899999999999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-42  Score=323.77  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=209.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ..+|++.+.||+|+||.||+|.++ ++..+|+|++.+....    ...+.+|+.+++.++||||+++++++...+..|++
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            457999999999999999999886 4678999998654322    24577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc-
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL-  165 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~-  165 (441)
                      |||++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999999763 46899999999999999999999999999999999999999999999999998754332111 


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (441)
                      .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |.+||...+..+....+... ....|...++++.+++.+
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence            111223457999999977665 489999999999999998 89999887776666666544 345556689999999999


Q ss_pred             hcCCCCCCCCChHhHhcC
Q 013520          244 ILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (441)
                      ||..+|++|||+.++++.
T Consensus       237 cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-41  Score=322.24  Aligned_cols=242  Identities=22%  Similarity=0.350  Sum_probs=204.9

Q ss_pred             eeeecCcEEEEEEEE--CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           16 TIGEGTFAKVRFAQN--RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      .||+|+||.||+|..  +.++..+|+|++..... .....+.+.+|+.+++.++||||+++++++.. ...+++|||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            689999999999964  45788999999865432 33456778999999999999999999998754 567899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc---ccccc
Q 013520           94 GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL---LHTTC  170 (441)
Q Consensus        94 g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~---~~~~~  170 (441)
                      |+|.+++.....+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++.........   .....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            999999988888999999999999999999999999999999999999999999999999998765443221   12233


Q ss_pred             CCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHHhcCCC
Q 013520          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       171 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      +++.|+|||.+....+ +.++|+|||||++|+|++ |..||...+.......+..+. ...|..+++++.++|.+||+.|
T Consensus       160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~  238 (257)
T cd05116         160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG  238 (257)
T ss_pred             CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence            4678999999865554 479999999999999998 999998877766666666543 4566779999999999999999


Q ss_pred             CCCCCChHhHhc
Q 013520          249 PKTRIRIEGIRK  260 (441)
Q Consensus       249 P~~R~t~~eil~  260 (441)
                      |++||++++|.+
T Consensus       239 p~~Rp~~~~i~~  250 (257)
T cd05116         239 VDERPGFAVVEL  250 (257)
T ss_pred             chhCcCHHHHHH
Confidence            999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.7e-41  Score=322.47  Aligned_cols=248  Identities=21%  Similarity=0.375  Sum_probs=209.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++.++||||+++++.+...+..|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            4578999999999999999999975 566799998765332    24678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+++++|.+++...  ..++......++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999999998653  4678889999999999999999999999999999999999999999999999976543221


Q ss_pred             c-cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          165 L-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 ~-~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      . .....++..|+|||.+....+ +.++|||||||++|+|++ |..||...+.......+... ..+.+..++.++.+++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM  237 (261)
T ss_pred             eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            1 123345678999999876554 478999999999999998 99999887766666655543 2333445789999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||..+|++|||++++.+
T Consensus       238 ~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         238 KTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.6e-41  Score=327.69  Aligned_cols=258  Identities=34%  Similarity=0.600  Sum_probs=217.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      +|++.+.||+|+||.||++.+.   .+++.||+|.+.+.... .....+.+.+|+.++..+ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999864   46789999998764332 223346688999999999 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||+.+|+|.+.+.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            99999999999999998878899999999999999999999999999999999999999999999999999876543221


Q ss_pred             -ccccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCCCC----hHHHHHHhhcCcCCCCCCCCHhHH
Q 013520          165 -LLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTGAT  238 (441)
Q Consensus       165 -~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~~  238 (441)
                       .....+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|..||...+    .....+.+.....+.|..++.++.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR  240 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence             223456899999999986543 24579999999999999999999996432    233444455556667777899999


Q ss_pred             HHHHHhcCCCCCCCCC---hHhHhcCCCcccc
Q 013520          239 SLIHKILDPNPKTRIR---IEGIRKHPWFRKN  267 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t---~~eil~hp~f~~~  267 (441)
                      ++|.+||+.||++|||   +.++++||||+..
T Consensus       241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            9999999999999998   5678999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.5e-42  Score=337.85  Aligned_cols=260  Identities=30%  Similarity=0.406  Sum_probs=212.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC--
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR--   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~--   81 (441)
                      ....++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+.... ......+.+|+.+++.+ +||||+++++++...  
T Consensus         3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            34567899999999999999999999999999999988653222 22345677899999999 999999999998653  


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ...|+||||+. ++|...+... .+++.....++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            46899999997 5999888765 788999999999999999999999999999999999999999999999999876543


Q ss_pred             cc-----cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-----------
Q 013520          162 GV-----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-----------  225 (441)
Q Consensus       162 ~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-----------  225 (441)
                      ..     .......|++.|+|||++.+....+.++|+|||||++|+|++|++||.+.........+...           
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            21     22334568999999999866555568999999999999999999999765543332222110           


Q ss_pred             ----------------cC----CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          226 ----------------EF----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       226 ----------------~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                      ..    ...+.++.++.++|.+||+.||++|||+.++++||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                            00    0112268899999999999999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.6e-41  Score=328.30  Aligned_cols=252  Identities=24%  Similarity=0.398  Sum_probs=212.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   80 (441)
                      ..++|++.+.||+|+||.||++.....     ...+|+|.+.....  ......+.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            346899999999999999999987643     36899999876432  22346688999999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc
Q 013520           81 RTKVYIILEFVTGGELFDKIVH----------------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~----------------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~  144 (441)
                      .+..|++|||+.+|+|.+++..                ...+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence            9999999999999999999864                246888899999999999999999999999999999999999


Q ss_pred             CCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHH
Q 013520          145 YGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK  221 (441)
Q Consensus       145 ~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~  221 (441)
                      ++.+||+|||++........  ......++..|+|||++.+..+ +.++||||+||++|+|++ |..||...+..+..+.
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            99999999999876543211  1122335567999999876555 489999999999999997 9999988877777766


Q ss_pred             hhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          222 INAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       222 i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.... ...|...+.++.+|+.+||..||++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            65543 34566688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.2e-42  Score=337.27  Aligned_cols=252  Identities=18%  Similarity=0.293  Sum_probs=202.9

Q ss_pred             eeeeec--CcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           15 RTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        15 ~~LG~G--~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      ..||+|  +||+||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|+++||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            456666  99999999999999999999987654332 345789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc------
Q 013520           93 GGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE------  164 (441)
Q Consensus        93 gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~------  164 (441)
                      +++|.+++...  ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||.+........      
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999998764  3589999999999999999999999999999999999999999999999986543221100      


Q ss_pred             -ccccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---------------
Q 013520          165 -LLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---------------  227 (441)
Q Consensus       165 -~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---------------  227 (441)
                       ......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||.................               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence             011223567799999986532 235899999999999999999999977654333222211100               


Q ss_pred             --------------------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          228 --------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       228 --------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                                      +.+..+++.+.+||++||+.||++|||++++++||||+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                            0112256789999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.8e-41  Score=330.63  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=211.4

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEV   77 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~   77 (441)
                      ...++|.+.+.||+|+||.||+|.+..       ++..+|+|.+....  .......+.+|+.+++.+ +||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            445789999999999999999998643       23579999987643  223346788899999999 79999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 013520           78 LASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (441)
Q Consensus        78 ~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NIL  141 (441)
                      +...+..|+||||+.+|+|.+++...                ..++...+..++.|++.||+|||++|++||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            99999999999999999999999763                24788899999999999999999999999999999999


Q ss_pred             EccCCCeEEeeccccccCCcccccc--ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHH
Q 013520          142 LDSYGNLKVSDFGLSALPQQGVELL--HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  218 (441)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~~~~~~--~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~  218 (441)
                      ++.++.+||+|||++..........  ....+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||.+.+..+.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            9999999999999987554321111  12234568999999976555 589999999999999998 9999988777777


Q ss_pred             HHHhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          219 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       219 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+.+.... ...|..++.++.+++.+||..+|++|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            66665543 34566689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-41  Score=324.17  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=207.8

Q ss_pred             eEEEeeeeecCcEEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE----
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK----   83 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----   83 (441)
                      |++++.||+|+||.||.|....   ++..||+|.+..+... ....+.+.+|+..++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            6789999999999999998765   3478999998764332 3345678999999999999999999998765443    


Q ss_pred             --EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           84 --VYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        84 --~~lv~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                        .+++|||+.+|+|...+...      ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888442      3689999999999999999999999999999999999999999999999999


Q ss_pred             cccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCC
Q 013520          156 SALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPF  231 (441)
Q Consensus       156 s~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~  231 (441)
                      +........  ......++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||.+.+..+..+.+..+ ....|.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE  238 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            875543211  1222345678999999876555 589999999999999999 99999887776666665543 445667


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .++..+.+++.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2e-41  Score=321.74  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=209.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|++++.||+|+||.||.|.+.. +..+|+|.+.....    ..+.+.+|+.+++.++||||+++++++......|++
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV   77 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence            4689999999999999999998754 45699998865432    135688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-c
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-L  165 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~  165 (441)
                      |||+.+|+|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.+........ .
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999999764 4689999999999999999999999999999999999999999999999999875433211 1


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHK  243 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~  243 (441)
                      .....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+.. ..+...+..+.+++.+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS  236 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            112235567999999976555 489999999999999998 9999988777766666655433 3345578999999999


Q ss_pred             hcCCCCCCCCChHhHhcC
Q 013520          244 ILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (441)
                      ||+.||.+|||+.+|+.+
T Consensus       237 cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         237 CWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HcCCCcccCCCHHHHHHh
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-41  Score=324.59  Aligned_cols=249  Identities=27%  Similarity=0.380  Sum_probs=206.6

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------CC
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------RT   82 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~   82 (441)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.+..... .....+.+.+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4578999999999999999887775  689998876432 33346778899999999999999999997642      23


Q ss_pred             EEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           83 KVYIILEFVTGGELFDKIVH------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      ..+++|||+.+|+|.+++..      ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            57899999999999988743      234789999999999999999999999999999999999999999999999998


Q ss_pred             ccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCC
Q 013520          157 ALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFW  232 (441)
Q Consensus       157 ~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~  232 (441)
                      ........  ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||........+..+..+. ...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            86543221  1123346778999999976655 589999999999999999 899998877777767666544 345566


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++..+.++|.+||+.||++|||+++++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-41  Score=328.20  Aligned_cols=251  Identities=20%  Similarity=0.259  Sum_probs=210.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCC----------------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG----------------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN   70 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~----------------~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn   70 (441)
                      ..++|++++.||+|+||.||+|.+..++                ..||+|.+.....  ....+.+.+|+.+++.++|||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence            3578999999999999999999876544                4689999876542  234677899999999999999


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 013520           71 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN  139 (441)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~N  139 (441)
                      |+++++++..++..+++|||+.+++|.+++....           .+++..+..++.|++.||.|||++||+||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            9999999999999999999999999999997765           68999999999999999999999999999999999


Q ss_pred             EEEccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc--CCCCCCCCCh
Q 013520          140 LLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GYLPFGETDL  215 (441)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~  215 (441)
                      |+++.++.++|+|||++.......  .......+++.|+|||.+.+..+ +.++|||||||++|+|++  |..||...+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            999999999999999987543321  12234456788999999876554 589999999999999997  7889987666


Q ss_pred             HHHHHHhhcC--------cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          216 PTLYKKINAA--------EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       216 ~~~~~~i~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ..........        ....+..++.++.+++.+||+.||++|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            5555544321        12334557899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.6e-42  Score=328.57  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=213.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      .+.+|++.+.||+|+||.||+|.+..+     +..||+|.+....  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~   80 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE   80 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence            456799999999999999999987543     5789999987543  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~  145 (441)
                      ...++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            9999999999999999998532                347888899999999999999999999999999999999999


Q ss_pred             CCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHh
Q 013520          146 GNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (441)
Q Consensus       146 ~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i  222 (441)
                      +.+||+|||++.......  .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+..+....+
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987553321  12234456789999999876555 589999999999999998 99999888777777777


Q ss_pred             hcCcC-CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          223 NAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       223 ~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..... +.|..++..+.+++.+||+.+|++||++.+|+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            66543 4566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.1e-41  Score=330.58  Aligned_cols=255  Identities=25%  Similarity=0.371  Sum_probs=213.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ...|+..+.||+|+||.||+|+++.+++.+|+|.+.............+.+|+.+++.++|||++++++++......|+|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            34588899999999999999999999999999998764443444456788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+. |++.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......    
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence            99996 577776643 456899999999999999999999999999999999999999999999999998754332    


Q ss_pred             ccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC--CCCCCCHhHHHHHH
Q 013520          167 HTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFWFSTGATSLIH  242 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~  242 (441)
                      ....|++.|+|||.+.+  ....+.++|||||||++|+|++|..||...+.......+.....+  .+..++..+.++|+
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  248 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence            34568899999999742  223357899999999999999999999776554443333333222  23347889999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCcccc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +||..+|++||+++++++|||+...
T Consensus       249 ~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         249 SCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=320.11  Aligned_cols=248  Identities=22%  Similarity=0.355  Sum_probs=209.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|++|.||+|.+. +++.||+|.+.....    ..+.+.+|+.++++++||||+++++++...+..|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            3467999999999999999999975 457899999876432    23568889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+.+++|.+++....  .+++.....++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999999997644  689999999999999999999999999999999999999999999999999876543211


Q ss_pred             c-cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          165 L-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 ~-~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      . .....++..|+|||++.+..+ +.++|+||||+++|+|++ |+.||.+.+.......+... ..+.+...+..+.+++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM  237 (261)
T ss_pred             cccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence            1 111223457999999876555 489999999999999999 99999887776666666443 3345566899999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||+.+|++||++.++++
T Consensus       238 ~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         238 LDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHhhcCcccCCCHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1e-41  Score=337.11  Aligned_cols=250  Identities=22%  Similarity=0.384  Sum_probs=204.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe-C
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS-R   81 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-~   81 (441)
                      ++|++.+.||+|+||.||+|.+.     .+++.||+|++.....  ....+.+.+|+.+++++ +||||+++++++.. .
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            48999999999999999999753     3457899999865432  22346678899999999 89999999998764 4


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ----------------------------------------------------------  103 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~----------------------------------------------------------  103 (441)
                      ..+|++|||+++++|.+++...                                                          
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            6789999999999999988542                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--ccccccCCCCcCCc
Q 013520          104 ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAP  178 (441)
Q Consensus       104 ---~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aP  178 (441)
                         ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........  ......++..|+||
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence               2578889999999999999999999999999999999999999999999999976533211  12234466789999


Q ss_pred             cccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHH-HHHHhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCCh
Q 013520          179 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT-LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRI  255 (441)
Q Consensus       179 E~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~-~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~  255 (441)
                      |++.+..+. .++|||||||++|+|++ |..||.+....+ ....+..+ ....|...++++.+++.+||+.+|++||++
T Consensus       245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~  323 (337)
T cd05054         245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF  323 (337)
T ss_pred             HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            999877664 89999999999999997 999997654332 33333332 233455678999999999999999999999


Q ss_pred             HhHhcC
Q 013520          256 EGIRKH  261 (441)
Q Consensus       256 ~eil~h  261 (441)
                      +++++|
T Consensus       324 ~ell~~  329 (337)
T cd05054         324 SELVEI  329 (337)
T ss_pred             HHHHHH
Confidence            999876

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=326.64  Aligned_cols=252  Identities=34%  Similarity=0.501  Sum_probs=212.0

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      |++.+.||+|++|.||+|.+..+|+.+|+|.+...... ......+.+|+.+++.++||||+++++++.+++..|+++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            67889999999999999999999999999998765432 23456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           91 VTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        91 ~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      +++ +|.+.+.. ...+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||.+.............
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            975 88887766 3588999999999999999999999999999999999999999999999999987665443233345


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------------------cCC--
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EFS--  228 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~~--  228 (441)
                      .++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+..+....+...                   ...  
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            68889999999876634568999999999999999999999877655443332111                   000  


Q ss_pred             ---------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 ---------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 ---------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                               ..+.++.++.++|.+||.+||.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                     012367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-41  Score=334.12  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=207.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR------   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   81 (441)
                      ..+|.+.+.||+|+||.||+|++..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            4689999999999999999999999999999999876432 222345678999999999999999999998654      


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..+|+++||+.. +|...+  ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            357999999964 676654  34689999999999999999999999999999999999999999999999999875432


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC----------------
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------  225 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------  225 (441)
                         ......+++.|+|||++.+....+.++|+||+||++|+|++|+.||.+.+.......+...                
T Consensus       170 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         170 ---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             ---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence               2234568899999999876444568999999999999999999999876644333322110                


Q ss_pred             -------cCCC--------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          226 -------EFSC--------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       226 -------~~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                             ....        .+..++.+.++|.+||+.||++||++++++.||||+...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                   0000        123577899999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-41  Score=323.36  Aligned_cols=253  Identities=29%  Similarity=0.507  Sum_probs=213.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +|.+.+.||+|+||.||++.+..++..+++|++......  .......+..|+.+++.++||||+++++++.+....|++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            699999999999999999999888777777776543221  112234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           88 LEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +||+++++|.+.+..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988853    356899999999999999999999999999999999999975 679999999987665443


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIH  242 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~  242 (441)
                      .......|++.|+|||.+.+..+. .++|+||+|+++|+|++|..||...+.......+..+. ...+..++.++.++|.
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ  238 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence            444556789999999998766554 78999999999999999999998776666555554443 3345568899999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +||..||++||+++++++||||
T Consensus       239 ~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         239 SMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=324.27  Aligned_cols=250  Identities=31%  Similarity=0.440  Sum_probs=206.7

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeEEEEEeCCE----
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLASRTK----   83 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~----   83 (441)
                      |++.+.||+|+||.||+|+++.+++.||+|.+..... .......+.+|+.+++.+   +||||+++++++.+...    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7899999999999999999998999999999976443 222334566788877766   59999999999988776    


Q ss_pred             -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           84 -VYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        84 -~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       .|++|||+.+ +|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             9999999975 7888887643  58999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-C------C-----
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-F------S-----  228 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~------~-----  228 (441)
                      .. .......+++.|+|||++.+..+ +.++|+||+||++|+|++|.+||...+..+...++.... .      .     
T Consensus       159 ~~-~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         159 FE-MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             CC-cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            43 22234458899999999977655 589999999999999999999998877665554442210 0      0     


Q ss_pred             ----C-----------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 ----C-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 ----~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                          +           .+.+++.+.++|.+||+.||++||++++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                0           01246778999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=319.37  Aligned_cols=242  Identities=26%  Similarity=0.370  Sum_probs=204.8

Q ss_pred             eeeeecCcEEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecc
Q 013520           15 RTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFV   91 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   91 (441)
                      +.||+|+||.||+|....++   ..+|+|.+......  ...+.+.+|+.+++.++||||+++++++. .+..+++|||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            47999999999999876554   78999998766543  34567889999999999999999999876 45689999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc---c
Q 013520           92 TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH---T  168 (441)
Q Consensus        92 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~---~  168 (441)
                      ++|+|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........   .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            9999999998888899999999999999999999999999999999999999999999999999876544322211   1


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHHhcC
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~  246 (441)
                      ..++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+.... ...|..++..+.++|.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            123467999999876655 589999999999999998 999998877766666665443 35666789999999999999


Q ss_pred             CCCCCCCChHhHhc
Q 013520          247 PNPKTRIRIEGIRK  260 (441)
Q Consensus       247 ~dP~~R~t~~eil~  260 (441)
                      +||++||++.++++
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.7e-41  Score=322.95  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=209.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....+|++.+.||+|+||.||+|.+..+|.    .||+|++....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            345789999999999999999999877776    48999986543  223456788999999999999999999998754


Q ss_pred             CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ..++++||+++|+|.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+|||+++++.+||+|||++....
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             57899999999999999976 3568999999999999999999999999999999999999999999999999987654


Q ss_pred             ccccc--cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHh
Q 013520          161 QGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTG  236 (441)
Q Consensus       161 ~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~  236 (441)
                      .....  .....+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+..+. .+.+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence            32221  112235678999999977665 489999999999999998 999998776665555555443 3445668999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +.+++.+||..||++||++.+++.
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.6e-41  Score=330.61  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=211.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RTKVY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~   85 (441)
                      .-++|++.+.||.|+||.||+|.++.+|+.||+|.+.+.... ....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            456899999999999999999999999999999998764322 2334678899999999999999999999865 56789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +++||+ +++|.+.+.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....   .
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~  161 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q  161 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence            999998 5688877754 5688999999999999999999999999999999999999999999999999875432   2


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc---------------------
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA---------------------  224 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~---------------------  224 (441)
                      .....+++.|+|||.+.+....+.++|+||+||++|+|++|.+||...+.......+..                     
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            23456788999999986544446899999999999999999999977654222111100                     


Q ss_pred             ---C--cCCCC-----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          225 ---A--EFSCP-----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       225 ---~--~~~~~-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                         .  ....|     +.+++.+.++|++||+.+|++|||+++++.||||.....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence               0  00111     2467899999999999999999999999999999866544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.4e-41  Score=321.20  Aligned_cols=247  Identities=23%  Similarity=0.362  Sum_probs=206.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+..+ ..||+|.+......    .+.+.+|+.+++.++||||+++++++.. ...|+
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence            346899999999999999999998765 45999998764321    2467889999999999999999998754 56899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+++|+|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999999763  3578899999999999999999999999999999999999999999999999876543322


Q ss_pred             -ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          165 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 -~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                       ......++..|+|||.+.+..+ +.++|+||+||++|+|++ |.+||.+.+.......+... ..+.+..++..+.+++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  236 (262)
T ss_pred             ccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence             1223346678999999876555 589999999999999999 89999887766666665443 2344556899999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||++||++||++.++++
T Consensus       237 ~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         237 CQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHccCCcccCCCHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-43  Score=342.86  Aligned_cols=235  Identities=24%  Similarity=0.413  Sum_probs=209.1

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      -++-||.|+.|.||+|+.+  ++.||||.++.          .-+.+|+.|++|+||||+.+.++|.....+|||||||.
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            3567999999999999976  78999997632          22357999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCC
Q 013520           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (441)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (441)
                      .|-|...++....+.......|..+|+.|++|||.+.|||||||.-||||+.+..+||+|||-++..... ...-.++||
T Consensus       196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGT  274 (904)
T KOG4721|consen  196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGT  274 (904)
T ss_pred             cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhh
Confidence            9999999999999999999999999999999999999999999999999999999999999998765543 445578999


Q ss_pred             CCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCCCCCCHhHHHHHHHhcCCCCC
Q 013520          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFSTGATSLIHKILDPNPK  250 (441)
Q Consensus       173 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~~dP~  250 (441)
                      ..|||||++.+.+.. .++|||||||||||||||..||.+-+...++..+...  .++.|..++..++=||++||+-.|.
T Consensus       275 VaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpR  353 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPR  353 (904)
T ss_pred             HhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCC
Confidence            999999999987765 9999999999999999999999877665554444333  4567788999999999999999999


Q ss_pred             CCCChHhHhcC
Q 013520          251 TRIRIEGIRKH  261 (441)
Q Consensus       251 ~R~t~~eil~h  261 (441)
                      .||++.+|+.|
T Consensus       354 NRPSFrqil~H  364 (904)
T KOG4721|consen  354 NRPSFRQILLH  364 (904)
T ss_pred             CCccHHHHHHH
Confidence            99999999998

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.8e-41  Score=332.21  Aligned_cols=258  Identities=28%  Similarity=0.384  Sum_probs=208.2

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCC--CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe----CC
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRET--GESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS----RT   82 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----~~   82 (441)
                      +|++.+.||+|+||.||++.+..+  +..||+|.+.... ......+.+.+|+.+++.+ +||||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  8999999986532 2222345678899999999 59999999987543    25


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .+|+++||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            6889999985 689999988888999999999999999999999999999999999999999999999999998754432


Q ss_pred             c----cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc--------------
Q 013520          163 V----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--------------  224 (441)
Q Consensus       163 ~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--------------  224 (441)
                      .    .......||+.|+|||.+.+....+.++||||+||++|+|++|.+||...+.......+..              
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            1    1223457899999999886543345899999999999999999999987553322221110              


Q ss_pred             -C----------c---CC---CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          225 -A----------E---FS---CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       225 -~----------~---~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                       .          .   ..   ..+..+..+.+++.+||+.||++|||+.+++.||||++...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence             0          0   00   11225788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.2e-41  Score=321.18  Aligned_cols=250  Identities=26%  Similarity=0.398  Sum_probs=209.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ..+|++.+.||+|+||.||+|.++.++.   .+|+|.+.....  ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            4689999999999999999999865543   799998865432  23356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |++|||+++++|.+++... +.++...+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999999764 468999999999999999999999999999999999999999999999999987654422


Q ss_pred             ccc---ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHH
Q 013520          164 ELL---HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (441)
Q Consensus       164 ~~~---~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (441)
                      ...   ....++..|+|||.+.+..+ +.++|+|||||++|++++ |..||...+..+....+... ..+.+..+++.+.
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH  239 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence            211   11223567999999976555 589999999999999886 99999887766666655543 2344455789999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +++.+||+.+|.+||++.++++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.7e-41  Score=325.16  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=210.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ...+|.+.+.||+|+||.||+|.+..     ++..+++|.+....   ....+.+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG   79 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence            45689999999999999999998543     45678999875433   22346788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~  145 (441)
                      ...++||||+++++|.+++....                .+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            99999999999999999997542                37889999999999999999999999999999999999999


Q ss_pred             CCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHh
Q 013520          146 GNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (441)
Q Consensus       146 ~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i  222 (441)
                      +.++|+|||++.......  .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+..+.+
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999987543321  12234456788999999877665 478999999999999998 99999887777777666


Q ss_pred             hcCcCC-CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          223 NAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       223 ~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ..+... .+..++..+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            655443 34457899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=324.45  Aligned_cols=250  Identities=32%  Similarity=0.478  Sum_probs=207.8

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEe
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      |++.+.||+|++|.||+|.+..+++.||+|.+.......  ......+|+..+++++ ||||+++++++.+++..|+|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            788999999999999999999999999999986643221  1233457899999998 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           90 FVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |+ +|+|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR-PPYT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC-CCcC
Confidence            99 889999887754  7899999999999999999999999999999999999999999999999998765432 2234


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------------------cCC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------EFS  228 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~~~  228 (441)
                      ...++..|+|||++.+....+.++|+||||+++++|++|.+||...+..+...++...                   ...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            4568899999999865444568999999999999999999999776654433322110                   000


Q ss_pred             C-----------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          229 C-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       229 ~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      .           .+..+..+.++|++||+.||++|||++|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0           11236789999999999999999999999999998

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-41  Score=318.20  Aligned_cols=244  Identities=26%  Similarity=0.468  Sum_probs=211.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...+|++.+.||.|+||.||+|...  |+.||+|.+.....    ..+++.+|+.+++.++|+||+++++++.+.+..|+
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   77 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI   77 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence            4568999999999999999999874  78999999876432    35678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            999999999999998765  68999999999999999999999999999999999999999999999999987653321 


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (441)
                        ....++..|+|||.+....+ +.++|+||||+++|+|++ |..||...+.......+... ....|..+++.+.++|.
T Consensus       157 --~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             --ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHH
Confidence              13345667999999876554 589999999999999997 99999888777666655443 33455668999999999


Q ss_pred             HhcCCCCCCCCChHhHhc
Q 013520          243 KILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (441)
                      +||..+|++|||++++++
T Consensus       234 ~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         234 DCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3e-43  Score=323.56  Aligned_cols=261  Identities=29%  Similarity=0.441  Sum_probs=211.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~   82 (441)
                      +..|++++.||+|+||.||+|..++++.    .+|+|.++.++- -.+......+|+.+++.++|||++.+..+|.+ +.
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            4579999999999999999997766543    789998866532 12334567899999999999999999999977 78


Q ss_pred             EEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC----CCeEEeec
Q 013520           83 KVYIILEFVTGGELFDKIVHQ-----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY----GNLKVSDF  153 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~-----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~----~~~kL~DF  153 (441)
                      .+|+++||++. +|++.|.-.     ..++...++.++.||+.|+.|||++-|+||||||.|||+..+    |.+||+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            89999999976 888888542     468899999999999999999999999999999999999877    89999999


Q ss_pred             cccccCCcccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---------HHHHHH
Q 013520          154 GLSALPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------PTLYKK  221 (441)
Q Consensus       154 Gls~~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------~~~~~~  221 (441)
                      |+++.+...-.   .....+-|.+|+|||.+.+...++++.|+||.|||+.||++-.+.|.+...         .+..++
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            99998776432   234556789999999999988888999999999999999999998854321         111122


Q ss_pred             hhc--C-----cC----CCCC--------------------C------CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          222 INA--A-----EF----SCPF--------------------W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       222 i~~--~-----~~----~~~~--------------------~------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      |-.  +     .+    ..|.                    |      -++.+.+|+.+||..||.+|+|+++.++|+||
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF  340 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF  340 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence            210  0     00    0111                    1      25669999999999999999999999999999


Q ss_pred             cccCCC
Q 013520          265 RKNYNP  270 (441)
Q Consensus       265 ~~~~~~  270 (441)
                      .....|
T Consensus       341 ~~d~lp  346 (438)
T KOG0666|consen  341 TEDPLP  346 (438)
T ss_pred             ccCCCC
Confidence            987554

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.4e-41  Score=319.01  Aligned_cols=247  Identities=24%  Similarity=0.392  Sum_probs=207.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|..+ +++.||+|.+......    ...+.+|+.+++.++||||+++++++. .+..|+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            3568999999999999999999875 5678999998764432    356889999999999999999999874 457899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999999998653  3688899999999999999999999999999999999999999999999999876542211


Q ss_pred             -ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          165 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 -~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                       ......++..|+|||++....+ +.++||||||+++|+|++ |.+||.+.+..+....+... ..+.+...+.++.+++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELM  236 (260)
T ss_pred             ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence             1223345678999999876554 589999999999999998 99999888777766665543 3345556789999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||..+|++|||+++++.
T Consensus       237 ~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         237 RLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHccCChhhCCCHHHHHH
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.3e-41  Score=340.24  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=205.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~   81 (441)
                      .++|++++.||+|+||.||+|.+...     +..||||++....  .....+.+.+|+.+++.++ ||||+++++++.+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            56788999999999999999987433     3479999986543  2233467889999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------------------------------------------------------
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ----------------------------------------------------------  103 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~----------------------------------------------------------  103 (441)
                      +.+|+||||+++|+|.+++...                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            9999999999999999988542                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC
Q 013520          104 --------------------------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus       104 --------------------------------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~  145 (441)
                                                            ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~  273 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence                                                  236777888999999999999999999999999999999999


Q ss_pred             CCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChH-HHHHH
Q 013520          146 GNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYKK  221 (441)
Q Consensus       146 ~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~~~  221 (441)
                      +.+||+|||++........  ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||...... ..+..
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence            9999999999875433211  1223456788999999976655 589999999999999997 99999775433 33344


Q ss_pred             hhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          222 INAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       222 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +..+ ....+..++.++.+++.+||+.||++|||+.++.+
T Consensus       353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            4433 34455668999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.5e-41  Score=319.60  Aligned_cols=247  Identities=23%  Similarity=0.369  Sum_probs=206.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+. .+..+|+|.+......    .+.+.+|+.++++++|||++++++++. ....|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            3568999999999999999999876 5667999998764432    246889999999999999999999875 456899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999999999998753  3589999999999999999999999999999999999999999999999999876543221


Q ss_pred             -ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          165 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 -~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                       ......++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||.+.+..+....+... ..+.+...+..+.+++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELM  236 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence             1122335567999999876554 489999999999999999 99999887766666666543 4455666899999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||.+||++|||++++.+
T Consensus       237 ~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         237 LQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHcccCcccCcCHHHHHH
Confidence            9999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=7.5e-41  Score=325.81  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=208.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA   79 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~   79 (441)
                      ...++|++.+.||+|+||.||+|.+     ..++..||+|.+.....  ....+.+.+|+.+++++ +||||+++++++.
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            4456899999999999999999975     33556899998865432  23356788999999999 7999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      ..+..|++|||+.+|+|.+++....  .+++.+...++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999999997643  38999999999999999999999999999999999999999999999999987


Q ss_pred             cCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHH-HHhhcC-cCCCCCC
Q 013520          158 LPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY-KKINAA-EFSCPFW  232 (441)
Q Consensus       158 ~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~-~~i~~~-~~~~~~~  232 (441)
                      .......  ......+++.|+|||.+.+..+ +.++||||+||++|+|++ |..||......... ..+..+ ....+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  268 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH  268 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence            5543221  1122346778999999876665 489999999999999998 99999876654433 333322 2234556


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .++++.+++.+||.++|++|||+.++++
T Consensus       269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         269 APAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            7899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.7e-41  Score=322.79  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=209.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ..+|.+.+.||+|+||.||++...     .++..+|+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            457899999999999999999753     356789999876432   334567999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC
Q 013520           83 KVYIILEFVTGGELFDKIVHQG---------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN  147 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~---------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~  147 (441)
                      ..|++|||+++|+|.+++....               .+++..+..++.||+.|+.|||++|++||||||+||++++++.
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence            9999999999999999997643               4788999999999999999999999999999999999999999


Q ss_pred             eEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhc
Q 013520          148 LKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA  224 (441)
Q Consensus       148 ~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~  224 (441)
                      +||+|||++.......  .......+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ  239 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence            9999999986543211  11223345788999999877665 488999999999999998 9999987766666555544


Q ss_pred             C-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          225 A-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       225 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      + ....|..+++.+.++|.+||+.||.+||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3 34456678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.4e-41  Score=326.76  Aligned_cols=251  Identities=23%  Similarity=0.382  Sum_probs=209.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVL   78 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~   78 (441)
                      ..++|.+.+.||+|+||.||+|.+..       .+..+|+|.+....  .......+.+|+.+++.+ +||||+++++++
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            45689999999999999999998632       34579999886543  223456788999999999 699999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 013520           79 ASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (441)
Q Consensus        79 ~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl  142 (441)
                      ...+.+|++|||+.+|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999999653                347888899999999999999999999999999999999


Q ss_pred             ccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHH
Q 013520          143 DSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  219 (441)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~  219 (441)
                      +.++.+||+|||++........  ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~  246 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELF  246 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999976543211  1122234568999999976555 589999999999999998 99999887777777


Q ss_pred             HHhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          220 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       220 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ..+.... ...|..++.++.+++.+||..||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         247 KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            6665543 3455668899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=312.13  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=213.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~   84 (441)
                      ..+++.+.+..||.|+-|.|++++.+.+|...|||.+.+..  +.+..+++.+.+.++...+ +|+||+.+++|..+..+
T Consensus        89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV  166 (391)
T KOG0983|consen   89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV  166 (391)
T ss_pred             cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence            34556778889999999999999999999999999998765  3445678888999887774 89999999999999999


Q ss_pred             EEEEeccCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           85 YIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i-~~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ++.||.+.. .+..++ ...++++|..+-.+..-++.||.||.++ ||+|||+||+|||+|..|++||||||++......
T Consensus       167 ~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  167 FICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            999998843 222222 2356899999999999999999999865 9999999999999999999999999999766543


Q ss_pred             ccccccccCCCCcCCcccccc---CCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCcCC-CCC--CCCH
Q 013520          163 VELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFS-CPF--WFST  235 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~-~~~--~~s~  235 (441)
                       .......|.+.|||||.+.-   ..|+ -.+||||||+.|+||.||+.||.+.+. .+...++.+.+.+ .|.  .+|+
T Consensus       246 -kAhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp  323 (391)
T KOG0983|consen  246 -KAHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSP  323 (391)
T ss_pred             -cccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCH
Confidence             33456679999999999853   2344 789999999999999999999988543 4556666654443 222  3899


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+.+|+..||.+|+.+||...++++|||+...
T Consensus       324 ~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  324 DFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             HHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            99999999999999999999999999999754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.2e-41  Score=317.96  Aligned_cols=229  Identities=29%  Similarity=0.463  Sum_probs=194.9

Q ss_pred             cCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHH
Q 013520           20 GTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDK   99 (441)
Q Consensus        20 G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~   99 (441)
                      |++|+||+|+++.+|+.||+|.+.+..        ...+|...+....||||+++++++.+....|++|||++||+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            889999999999999999999987643        123345555556799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcCCcc
Q 013520          100 IVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE  179 (441)
Q Consensus       100 i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE  179 (441)
                      +.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+......   .....++..|+|||
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE  152 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPE  152 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCc
Confidence            988888999999999999999999999999999999999999999999999999987654332   23455678899999


Q ss_pred             ccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCCh----
Q 013520          180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI----  255 (441)
Q Consensus       180 ~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~----  255 (441)
                      .+....+ +.++|+||+||++|+|++|..||.......    -.......|.++++.+.++|.+||+.||++|+++    
T Consensus       153 ~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~  227 (237)
T cd05576         153 VGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAG  227 (237)
T ss_pred             ccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccc
Confidence            9876555 488999999999999999999886432210    0112345677899999999999999999999986    


Q ss_pred             -HhHhcCCCc
Q 013520          256 -EGIRKHPWF  264 (441)
Q Consensus       256 -~eil~hp~f  264 (441)
                       +++++||||
T Consensus       228 ~~~~~~h~~~  237 (237)
T cd05576         228 VEDIKSHPFF  237 (237)
T ss_pred             hHHHHcCCCC
Confidence             999999998

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.5e-41  Score=317.31  Aligned_cols=243  Identities=25%  Similarity=0.437  Sum_probs=206.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEE-EeCCEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVL-ASRTKVY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~   85 (441)
                      .+.+|++.+.||+|+||.||++...  |..+|+|.+....     ..+.+.+|+.+++.++|+|++++++++ ...+..|
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            4578999999999999999999764  7889999885432     245688999999999999999999875 4567799


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      ++|||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... 
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-  155 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  155 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence            9999999999999997644  4788999999999999999999999999999999999999999999999998754332 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                        .....++..|+|||++.+..+ +.++|||||||++|+|++ |.+||...+.......+..+ ....+..+++.+.+++
T Consensus       156 --~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  232 (256)
T cd05082         156 --QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVM  232 (256)
T ss_pred             --CCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence              123345678999999876655 488999999999999997 99999888777766666544 2334556899999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||..+|++|||+.++++
T Consensus       233 ~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         233 KQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-40  Score=324.68  Aligned_cols=254  Identities=22%  Similarity=0.383  Sum_probs=212.5

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEEC-------CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNR-------ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHE   76 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~   76 (441)
                      .....+|++.+.||+|+||.||+|+..       ..+..||+|.+....  .......+.+|+.+++.+ +||||+++++
T Consensus        11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101          11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            345678999999999999999999752       234579999886542  223356788999999999 8999999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 013520           77 VLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL  140 (441)
Q Consensus        77 ~~~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NI  140 (441)
                      ++......|++|||+.+|+|.+++...                ..++...+..++.||+.||.|||++||+||||||+||
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni  168 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV  168 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence            999999999999999999999999763                2467788899999999999999999999999999999


Q ss_pred             EEccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHH
Q 013520          141 LLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  217 (441)
Q Consensus       141 Ll~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~  217 (441)
                      +++.++.+||+|||++........  ......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..+
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~  247 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  247 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence            999999999999999876543211  1223346678999999977655 488999999999999998 899998888877


Q ss_pred             HHHHhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          218 LYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       218 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..+.+.... ...+..++.++.+++.+||..+|++|||+.++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         248 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            777765543 34455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.4e-41  Score=322.78  Aligned_cols=248  Identities=24%  Similarity=0.346  Sum_probs=207.4

Q ss_pred             CeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+.....  ......+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     235789998865432  22346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 013520           85 YIILEFVTGGELFDKIVHQ------------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENL  140 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NI  140 (441)
                      |+++||+.+|+|.+++...                        ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2477888999999999999999999999999999999


Q ss_pred             EEccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHH
Q 013520          141 LLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT  217 (441)
Q Consensus       141 Ll~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~  217 (441)
                      ++++++.+||+|||++........  ......++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||.+.....
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999875433211  1223456778999999876555 489999999999999998 999998877776


Q ss_pred             HHHHhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          218 LYKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       218 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ....+... ....|..++.++.+++.+||++||++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            66655443 34456668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-40  Score=323.17  Aligned_cols=259  Identities=26%  Similarity=0.391  Sum_probs=209.3

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   83 (441)
                      ....++|++.+.||+|+||.||+|.+..+++.||||.+.+....  .....+.+|+.++... .||||+++++++.+...
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            45678999999999999999999999989999999999764322  2234566677777666 59999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           84 VYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      .|++|||+. +.|.+.+.. .+.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            999999985 467666654 4578999999999999999999997 5999999999999999999999999999875543


Q ss_pred             cccccccccCCCCcCCccccccCC---CCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCc-CCCCC--CCC
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAE-FSCPF--WFS  234 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~-~~~~~--~~s  234 (441)
                      .. ......+++.|+|||.+.+..   ..+.++||||||+++|+|++|..||..... .+....+.... ...+.  .++
T Consensus       168 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T cd06618         168 SK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS  246 (296)
T ss_pred             CC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence            21 123345788999999986542   235789999999999999999999976332 23333333322 22222  368


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .++.+++.+||..||++||+++++++||||+..
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.4e-41  Score=328.67  Aligned_cols=247  Identities=20%  Similarity=0.328  Sum_probs=197.7

Q ss_pred             CcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHHH
Q 013520           21 TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI  100 (441)
Q Consensus        21 ~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i  100 (441)
                      ++|.||.+++..+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..|++|||+.+|+|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            4455666777779999999999875332 335678999999999999999999999999999999999999999999999


Q ss_pred             Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-------cccccccC
Q 013520          101 VHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-------ELLHTTCG  171 (441)
Q Consensus       101 ~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-------~~~~~~~g  171 (441)
                      ...  ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||.+.......       .......+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            753  468999999999999999999999999999999999999999999999999876432211       11234457


Q ss_pred             CCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHH-HHhhcCc-----------------------
Q 013520          172 TPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-KKINAAE-----------------------  226 (441)
Q Consensus       172 t~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~-~~i~~~~-----------------------  226 (441)
                      +..|+|||++... ...+.++|+||+||++|+|++|..||......... .++....                       
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            8889999998653 22358899999999999999999999765433221 2221100                       


Q ss_pred             ----------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          227 ----------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       227 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                                ...+..++.++.+++++||..||++|||++++++||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                      000112456789999999999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-41  Score=324.09  Aligned_cols=250  Identities=21%  Similarity=0.304  Sum_probs=204.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCC--------------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcce
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETG--------------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR   73 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~--------------~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~   73 (441)
                      ..+|++.+.||+|+||.||+|++..++              ..||+|.+....  .....+.+.+|+.+++.++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            458999999999999999999875432              358999987543  2334567899999999999999999


Q ss_pred             eEEEEEeCCEEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 013520           74 LHEVLASRTKVYIILEFVTGGELFDKIVHQG------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (441)
Q Consensus        74 l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NIL  141 (441)
                      +++++...+..|+||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil  161 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence            9999999999999999999999999986532            3678888999999999999999999999999999999


Q ss_pred             EccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc--CCCCCCCCChHH
Q 013520          142 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GYLPFGETDLPT  217 (441)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~~  217 (441)
                      ++.++.+||+|||++.......  .......+++.|+|||++.+..+ +.++|+|||||++|+|++  |..||...+..+
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            9999999999999987543321  11223345678999999876555 589999999999999987  778998766554


Q ss_pred             HHHHhhc--------CcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          218 LYKKINA--------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       218 ~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ....+..        .....++.+++.+.+++.+||+.||++|||+++|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            4433211        112234557899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=315.74  Aligned_cols=249  Identities=23%  Similarity=0.362  Sum_probs=210.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++.+.||+|+||.||+|.+. .+..+|+|.+......    .+.+.+|+.+++.++||||+++++++......|
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            34578999999999999999999976 4578999998764432    356889999999999999999999999989999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      ++|||+++++|.+++....  .++...+..++.|++.|+.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999999997643  68999999999999999999999999999999999999999999999999987654321


Q ss_pred             c-ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHH
Q 013520          164 E-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (441)
Q Consensus       164 ~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (441)
                      . ......++..|+|||.+.+..+ +.++|+||+||++|+|++ |+.||.+.+.....+.+... ..+.|...+.++.++
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1 1112234568999999976554 589999999999999998 99999887776666666544 344556678999999


Q ss_pred             HHHhcCCCCCCCCChHhHhc
Q 013520          241 IHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (441)
                      +.+||..+|++||+++++++
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1e-40  Score=319.55  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=212.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .++|++.+.||+|+||.||+|+.+.     +.+.+|+|.+....  .....+.+.+|+.++++++||||+++++++.+.+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            4689999999999999999999754     34679999876533  2224577899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeec
Q 013520           83 KVYIILEFVTGGELFDKIVHQG---------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~---------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (441)
                      ..|+||||+++|+|.+++....         .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++||
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999999998755         6899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcc-ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcC--CC
Q 013520          154 GLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF--SC  229 (441)
Q Consensus       154 Gls~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~  229 (441)
                      |++...... ........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+..  ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV  240 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence            998643221 112234456778999999876554 488999999999999998 8999987766666666664443  33


Q ss_pred             CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +..++..+.+++.+||+.||++|||+.+++.+
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            45688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.5e-40  Score=317.57  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=209.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      .++|++.+.||+|+||.||+|.++.+++   .||+|.+....  .......+..|+.+++.++||||+++++++.+....
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            5679999999999999999999887665   69999986542  233457789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999998763 568999999999999999999999999999999999999999999999999987544321


Q ss_pred             c--cccccc---CCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHh
Q 013520          164 E--LLHTTC---GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (441)
Q Consensus       164 ~--~~~~~~---gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (441)
                      .  ......   .+..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA  239 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence            1  111111   2457999999976665 489999999999999886 99999887766666665433 33445567899


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +.+++.+||..+|++||++++++.
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-40  Score=316.24  Aligned_cols=247  Identities=25%  Similarity=0.382  Sum_probs=205.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.+++.++|||++++++++. .+..|+
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI   77 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence            346899999999999999999998655 4699998765432    2356788999999999999999999875 456899


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+.+++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++........
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            999999999999997633  478899999999999999999999999999999999999999999999999876543221


Q ss_pred             -ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          165 -LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 -~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                       ......++..|+|||.+.+..+ +.++|||||||++|+|++ |.+||.+.+..+....+... ..+.+..++..+.+++
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM  236 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence             1123345678999999876554 589999999999999999 99999887776666665543 3344556889999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      ++||.+||++||+++++++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1e-40  Score=322.11  Aligned_cols=251  Identities=24%  Similarity=0.354  Sum_probs=210.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            35689999999999999999998753     67899999987543  223456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG----------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN  139 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~----------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~N  139 (441)
                      ...|++|||+++|+|.+++....                      .+++..+..++.|++.||.|||++|++||||||+|
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n  160 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN  160 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence            99999999999999999997432                      36788889999999999999999999999999999


Q ss_pred             EEEccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChH
Q 013520          140 LLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP  216 (441)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~  216 (441)
                      |+++.++.++|+|||++.......  .......++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.+..
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999987543221  11223345677999999877665 489999999999999997 88999887777


Q ss_pred             HHHHHhhcCcC-CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          217 TLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       217 ~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +....+..+.. +.|..++.++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77666665543 346668999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-40  Score=319.47  Aligned_cols=250  Identities=19%  Similarity=0.300  Sum_probs=206.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ..++|++++.||+|+||.||+|.+..+|..    +++|.+....  .......+..|+..++.++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~   81 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A   81 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence            457899999999999999999999877764    6667664321  12234667888889999999999999998754 5


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            57899999999999999976 35789999999999999999999999999999999999999999999999999975433


Q ss_pred             ccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhH
Q 013520          162 GVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF-SCPFWFSTGA  237 (441)
Q Consensus       162 ~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~  237 (441)
                      ...  ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.......+.+..+.. +.+...+.++
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDV  240 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHH
Confidence            211  2234456778999999976655 589999999999999998 9999988776665555555443 3344578899


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .+++.+|+..||++|||+.++++
T Consensus       241 ~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         241 YMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.6e-40  Score=315.78  Aligned_cols=241  Identities=24%  Similarity=0.375  Sum_probs=200.8

Q ss_pred             eeeecCcEEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           16 TIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.++||||+++++++.. ...|+||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            4899999999999775  445679999986543  23345678999999999999999999998864 578999999999


Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc---cccc
Q 013520           94 GELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL---LHTT  169 (441)
Q Consensus        94 g~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~---~~~~  169 (441)
                      ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........   ....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999999875 457899999999999999999999999999999999999999999999999998754432211   1112


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHHhcCC
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~  247 (441)
                      .+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+....+..+ ....|...++++.+++.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            23578999999876555 489999999999999996 99999887776666665543 3456677899999999999999


Q ss_pred             CCCCCCChHhHhc
Q 013520          248 NPKTRIRIEGIRK  260 (441)
Q Consensus       248 dP~~R~t~~eil~  260 (441)
                      ||++||++.+|.+
T Consensus       238 ~~~~Rp~~~~i~~  250 (257)
T cd05115         238 KWEDRPNFAKVEE  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.7e-41  Score=320.12  Aligned_cols=239  Identities=25%  Similarity=0.292  Sum_probs=198.3

Q ss_pred             eeeeecCcEEEEEEEECCCCcE-------EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520           15 RTIGEGTFAKVRFAQNRETGES-------VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~-------vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +.||+|+||.||+|.++.++..       +|+|.+....   ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            4699999999999998765543       8888875432   23456788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC--------eEEeecccccc
Q 013520           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--------LKVSDFGLSAL  158 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~--------~kL~DFGls~~  158 (441)
                      |||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997644 5899999999999999999999999999999999999987765        69999998865


Q ss_pred             CCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcC-CCCCCCCChHHHHHHhhcCcCCCCCCCCHhH
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAEFSCPFWFSTGA  237 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~  237 (441)
                      ...    .....+++.|+|||++.+....+.++|||||||++|+|++| .+||...+..... .........|...+.++
T Consensus       158 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  232 (258)
T cd05078         158 VLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTEL  232 (258)
T ss_pred             cCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHH
Confidence            432    23456889999999997655456899999999999999998 5677655543332 23334456666678899


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+++.+||+.||++|||+++|++.
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHh
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.6e-41  Score=331.67  Aligned_cols=251  Identities=23%  Similarity=0.382  Sum_probs=203.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe-
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS-   80 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~-   80 (441)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||++.....  ......+.+|+.++..+ +||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            45899999999999999999984     34678999999975432  23356788999999999 68999999998764 


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc---------------------------------------------------------
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ---------------------------------------------------------  103 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~---------------------------------------------------------  103 (441)
                      ....|++|||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45689999999999999998642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--ccccccC
Q 013520          104 ----------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCG  171 (441)
Q Consensus       104 ----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~g  171 (441)
                                ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........  ......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                      1356777888999999999999999999999999999999999999999999876432211  1123345


Q ss_pred             CCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChH-HHHHHhhc-CcCCCCCCCCHhHHHHHHHhcCCC
Q 013520          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TLYKKINA-AEFSCPFWFSTGATSLIHKILDPN  248 (441)
Q Consensus       172 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~d  248 (441)
                      ++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... .....+.. .....|.+.++++.+++.+||+.|
T Consensus       244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            678999999876655 489999999999999996 99999775433 23333332 334556678999999999999999


Q ss_pred             CCCCCChHhHhcC
Q 013520          249 PKTRIRIEGIRKH  261 (441)
Q Consensus       249 P~~R~t~~eil~h  261 (441)
                      |++|||+.+|++|
T Consensus       323 p~~Rps~~eil~~  335 (343)
T cd05103         323 PSQRPTFSELVEH  335 (343)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-40  Score=315.80  Aligned_cols=250  Identities=26%  Similarity=0.368  Sum_probs=209.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ..+|+..+.||+|+||.||+|.++.++.   .+|+|.+.....  ....+.+.+|+.+++.++||||+++.+++...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            4579999999999999999999876655   799998865432  22356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |++|||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            9999999999999998763 578999999999999999999999999999999999999999999999999987554322


Q ss_pred             ccc---ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHH
Q 013520          164 ELL---HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (441)
Q Consensus       164 ~~~---~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (441)
                      ...   .....++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ..+.+..++.++.
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  240 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY  240 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            111   11223457999999876655 589999999999999997 99999887776666666543 2333445789999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +++.+||+.+|++||++.++++
T Consensus       241 ~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         241 QLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=317.54  Aligned_cols=242  Identities=24%  Similarity=0.359  Sum_probs=200.7

Q ss_pred             eeeeecCcEEEEEEEECCCCc--EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecc
Q 013520           15 RTIGEGTFAKVRFAQNRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFV   91 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~   91 (441)
                      +.||+|+||.||+|.++.++.  .+|+|.+....  .....+.+.+|+.+++++ +||||+++++++...+..|++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            368999999999999988876  45888775422  223456788999999999 7999999999999999999999999


Q ss_pred             CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           92 TGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        92 ~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                      ++|+|.+++....                .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999997532                478889999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCC
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWF  233 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~  233 (441)
                      +...... ........+..|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+..+.+... ....+..+
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  236 (270)
T cd05047         159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC  236 (270)
T ss_pred             ccccchh-hhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcC
Confidence            8633221 11112234567999999876555 589999999999999997 99999887777766666543 23345557


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +.++.+++.+||..||.+|||+++++.
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         237 DDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.8e-40  Score=321.95  Aligned_cols=249  Identities=21%  Similarity=0.323  Sum_probs=203.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECC----------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcc
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRE----------------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV   72 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~----------------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv   72 (441)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|++....  .....+.+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            579999999999999999986432                34578999987543  233456788999999999999999


Q ss_pred             eeEEEEEeCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 013520           73 RLHEVLASRTKVYIILEFVTGGELFDKIVHQG-----------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (441)
Q Consensus        73 ~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-----------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NIL  141 (441)
                      ++++++...+..|++|||+.+|+|.+++....           .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999987642           3667789999999999999999999999999999999


Q ss_pred             EccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc--CCCCCCCCChHH
Q 013520          142 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA--GYLPFGETDLPT  217 (441)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~--g~~Pf~~~~~~~  217 (441)
                      ++.++.++|+|||++.......  .......+++.|+|||...+..+ +.++|+|||||++|+|++  |..||...+..+
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            9999999999999987543321  11122344678999998866554 589999999999999998  789997766544


Q ss_pred             HHHHhh--------cCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          218 LYKKIN--------AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       218 ~~~~i~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ......        ....+.+..+++.+.+++.+||+.||++|||+.+|.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            433221        1123445568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-41  Score=320.12  Aligned_cols=246  Identities=30%  Similarity=0.500  Sum_probs=203.8

Q ss_pred             EEEeeeeecCcEEEEEEEEC----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520           12 EVGRTIGEGTFAKVRFAQNR----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ++.+.||.|+||.||+|...    ..+..|+||.+....  .....+.+.+|+..++.++||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence            57899999999999999987    356789999995422  233467889999999999999999999999988889999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc--cc
Q 013520           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GV  163 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--~~  163 (441)
                      +||+++|+|.+++...  ..++......++.||+.||.|||+++++|+||+|.||+++.++.+||+|||++.....  ..
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999886  6899999999999999999999999999999999999999999999999999876522  11


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li  241 (441)
                      .......+...|+|||.+.+..+ +.++||||||+++|||++ |..||...+..+....+..+. ...|..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence            22334457788999999976654 589999999999999999 789998888777777765544 345566899999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||..||++|||+.+|++
T Consensus       239 ~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.3e-40  Score=313.11  Aligned_cols=247  Identities=26%  Similarity=0.394  Sum_probs=211.1

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETG----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~----~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      +++.+.||.|+||.||++.+..++    ..||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467899999999999999998766    8999999865432  2245788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+++++|.+++.....  +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999976544  99999999999999999999999999999999999999999999999999876544311


Q ss_pred             ccc-cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHH
Q 013520          165 LLH-TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLI  241 (441)
Q Consensus       165 ~~~-~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li  241 (441)
                      ... ...+++.|+|||.+.+..+ +.++|+||||+++|+|++ |.+||...+.....+.+.... ...+..++.++.+++
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM  237 (258)
T ss_pred             cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence            111 2236789999999865444 589999999999999998 899998877777776665443 345566899999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||..||++|||+.++++
T Consensus       238 ~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      238 LQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHCcCChhhCcCHHHHHh
Confidence            9999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-40  Score=316.91  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=211.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ..++|++++.||+|+||.||+|.++.+|+    .+|+|.+.....  ......+.+|+.+++.++||||+++++++.. .
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            45789999999999999999999877665    589998866542  3345678899999999999999999999887 7


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..+++|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            899999999999999999764 4689999999999999999999999999999999999999999999999999976543


Q ss_pred             ccccc--ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhH
Q 013520          162 GVELL--HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGA  237 (441)
Q Consensus       162 ~~~~~--~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~  237 (441)
                      .....  ....++..|+|||.+....+ +.++|+|||||++|++++ |..||.+....+..+.+..+. .+.|...+..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDV  240 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHH
Confidence            32211  12223568999999876555 489999999999999998 999999887777766665543 45566688999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .+++.+||..||+.|||+.++++
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999864

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-40  Score=314.12  Aligned_cols=242  Identities=26%  Similarity=0.439  Sum_probs=205.4

Q ss_pred             eeeeecCcEEEEEEEECC-CCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEecc
Q 013520           15 RTIGEGTFAKVRFAQNRE-TGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFV   91 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~-~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~   91 (441)
                      +.||+|++|.||+|.+.. ++.  .||+|.+......  ...+.+.+|+.++++++||||+++++++.. ...+++|||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999999865 333  6899999876543  456789999999999999999999999988 8999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc---cc
Q 013520           92 TGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---LL  166 (441)
Q Consensus        92 ~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~---~~  166 (441)
                      ++++|.+.+....  .+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++........   ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999997754  689999999999999999999999999999999999999999999999999876544221   11


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhc--CcCCCCCCCCHhHHHHHHH
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA--AEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~--~~~~~~~~~s~~~~~li~~  243 (441)
                      ....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+..  .....+..++..+.+++.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            23457788999999876665 488999999999999998 9999988777666655543  2233455678999999999


Q ss_pred             hcCCCCCCCCChHhHhc
Q 013520          244 ILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~  260 (441)
                      ||..+|++|||+.++++
T Consensus       237 ~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         237 CWAHNPADRPTFAALRE  253 (257)
T ss_pred             HCCCCcccCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-40  Score=318.27  Aligned_cols=248  Identities=28%  Similarity=0.395  Sum_probs=200.0

Q ss_pred             cCe-EEEeeeeecCcEEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--C
Q 013520            9 AKY-EVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--R   81 (441)
Q Consensus         9 ~~y-~i~~~LG~G~~g~V~~a~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~   81 (441)
                      ++| ++.+.||+|+||+||++.    ...++..||+|.+.....  ......+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            566 999999999999998865    345788999999876432  2234667889999999999999999998765  3


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ...|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            468999999999999999876 4699999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH--HH-------------HHHhh
Q 013520          162 GVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TL-------------YKKIN  223 (441)
Q Consensus       162 ~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~-------------~~~i~  223 (441)
                      ...   ......++..|+|||.+.+..+ +.++|||||||++|+|++|..||......  ..             ...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            221   1123345677999999876554 58999999999999999999998653311  00             01111


Q ss_pred             -cCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          224 -AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       224 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                       ....+.|..++.++.+++.+||++||++|||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             1122345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.8e-40  Score=313.08  Aligned_cols=248  Identities=25%  Similarity=0.379  Sum_probs=209.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ..+|++.+.||+|+||.||+|.+. ++..+|+|.+......    ...+.+|+.+++.++||||+++++++......|++
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            358999999999999999999885 4678999998754432    24678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-c
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-L  165 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~  165 (441)
                      |||+++++|.+++... +.++++.+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++........ .
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999998764 4689999999999999999999999999999999999999999999999999875433211 1


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (441)
                      .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.....+.+..+ ....|...+..+.+++.+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH  236 (256)
T ss_pred             cCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence            112234568999999876555 478999999999999998 99999887777777666554 233355578999999999


Q ss_pred             hcCCCCCCCCChHhHhcC
Q 013520          244 ILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (441)
                      ||+.+|++|||+.+++++
T Consensus       237 ~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         237 CWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HcccChhhCCCHHHHHHh
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.3e-40  Score=310.63  Aligned_cols=243  Identities=26%  Similarity=0.440  Sum_probs=203.2

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   94 (441)
                      +.||+|+||.||+|... ++..+|+|.+....  .......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            46899999999999865 68899999986543  2223456889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-ccccccCC
Q 013520           95 ELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLHTTCGT  172 (441)
Q Consensus        95 ~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~~~~~gt  172 (441)
                      +|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ......++
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999998753 4678999999999999999999999999999999999999999999999999865433211 11122346


Q ss_pred             CCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHHhcCCCCC
Q 013520          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNPK  250 (441)
Q Consensus       173 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~  250 (441)
                      +.|+|||++.+..+ +.++||||+|+++|++++ |..||...+.......+... ....+..++..+.+++.+||..+|+
T Consensus       158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (250)
T cd05085         158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE  236 (250)
T ss_pred             ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            67999999876554 488999999999999998 99999887766665555443 3345666899999999999999999


Q ss_pred             CCCChHhHhcC
Q 013520          251 TRIRIEGIRKH  261 (441)
Q Consensus       251 ~R~t~~eil~h  261 (441)
                      +||++.++++.
T Consensus       237 ~Rp~~~~l~~~  247 (250)
T cd05085         237 NRPKFSELQKE  247 (250)
T ss_pred             cCCCHHHHHHH
Confidence            99999998753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.9e-40  Score=326.22  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=209.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRET-------GESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVL   78 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~   78 (441)
                      ...+|++++.||+|+||.||+|++...       +..||+|.+....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            345899999999999999999986432       2368999886532  223456788999999999 799999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 013520           79 ASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (441)
Q Consensus        79 ~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl  142 (441)
                      ...+..|+++||+++|+|.+++....                .++...+..++.|++.||.|||++|++||||||+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill  167 (334)
T cd05100          88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV  167 (334)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence            99999999999999999999997532                36777888999999999999999999999999999999


Q ss_pred             ccCCCeEEeeccccccCCccccc--cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHH
Q 013520          143 DSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  219 (441)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~  219 (441)
                      +.++.+||+|||++.........  .....++..|+|||++.+..+. .++|||||||++|+|++ |..||.+.+..+..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999998755432111  1222345679999999776654 78999999999999998 89999988877777


Q ss_pred             HHhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          220 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       220 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..+.... ...+..++.++.+++.+||+.+|++|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            7665543 34555678999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-40  Score=335.32  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=206.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~   80 (441)
                      ..++|.+++.||+|+||.||+|++.     .++..||+|++.....  ....+.+.+|+.++.++. ||||+++++++..
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            3457888999999999999999864     3557899999976432  223456889999999997 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC--------------------------------------------------------
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQG--------------------------------------------------------  104 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~--------------------------------------------------------  104 (441)
                      .+..|+||||+++|+|.+++....                                                        
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            999999999999999999986532                                                        


Q ss_pred             ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 013520          105 ------------------------------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (441)
Q Consensus       105 ------------------------------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl  142 (441)
                                                                .++...+..++.||+.||.|||++|++||||||+|||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl  272 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI  272 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence                                                      25566778899999999999999999999999999999


Q ss_pred             ccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHH-
Q 013520          143 DSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL-  218 (441)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~-  218 (441)
                      +.++.+||+|||++........  ......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||......+. 
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            9999999999999875433211  1223457889999999976655 589999999999999998 8999977554443 


Q ss_pred             HHHhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          219 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       219 ~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ...+..+ ....|..++.++.+++.+||..+|.+||++++|++.
T Consensus       352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3333333 344566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=311.32  Aligned_cols=242  Identities=26%  Similarity=0.399  Sum_probs=205.2

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   94 (441)
                      +.||+|+||.||+|.+.. ++.||+|.+......  .....+.+|+.+++.++||||+++++++.+....|++|||+.|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            479999999999999987 999999998765432  24567889999999999999999999999999999999999999


Q ss_pred             ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc--ccccC
Q 013520           95 ELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL--HTTCG  171 (441)
Q Consensus        95 ~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~--~~~~g  171 (441)
                      +|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..........  ....+
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99999966 3468899999999999999999999999999999999999999999999999987554221111  12234


Q ss_pred             CCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHHhcCCCC
Q 013520          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDPNP  249 (441)
Q Consensus       172 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP  249 (441)
                      +..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+... ....|..++..+.+++.+||..+|
T Consensus       158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence            567999999876554 589999999999999998 89999887766666655443 344556689999999999999999


Q ss_pred             CCCCChHhHhc
Q 013520          250 KTRIRIEGIRK  260 (441)
Q Consensus       250 ~~R~t~~eil~  260 (441)
                      ++|||++++++
T Consensus       237 ~~Rp~~~ell~  247 (251)
T cd05041         237 ENRPSFSEIYN  247 (251)
T ss_pred             hhCcCHHHHHH
Confidence            99999999976

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9e-40  Score=310.77  Aligned_cols=248  Identities=22%  Similarity=0.400  Sum_probs=206.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++.+.||+|+||.||+|.+. .+..+|+|.+....    ...+.+.+|+.+++.++|+||+++++++.. ...|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            34678999999999999999999865 45679999886532    234678889999999999999999999887 7789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      ++|||+++++|.+++...  ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999763  357788899999999999999999999999999999999999999999999987654321


Q ss_pred             c-ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHH
Q 013520          164 E-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (441)
Q Consensus       164 ~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (441)
                      . ......++..|+|||++....+ +.++|+|||||++|++++ |..||...+.......+..+ ..+.+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence            1 1122335677999999976554 588999999999999998 99999887776666655543 223445688999999


Q ss_pred             HHHhcCCCCCCCCChHhHhc
Q 013520          241 IHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (441)
                      +.+||++||++||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=6.8e-40  Score=313.19  Aligned_cols=251  Identities=27%  Similarity=0.375  Sum_probs=208.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ...+|.+.+.||+|+||.||+|.+...   ...||+|.......  ....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~   80 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP   80 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence            456799999999999999999987644   34789998865431  2345678899999999999999999999876 45


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .|++|||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            789999999999999997644 5899999999999999999999999999999999999999999999999998755432


Q ss_pred             cc-ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHH
Q 013520          163 VE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (441)
Q Consensus       163 ~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (441)
                      .. ......+++.|+|||.+....+ +.++|||||||++|+|++ |..||...+..+....+..+ ..+.|..+++.+.+
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  239 (270)
T ss_pred             cceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            11 1112234568999999876655 489999999999999986 99999887766666665544 34556678999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++.+|+..+|++|||+.+++..
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.4e-40  Score=313.73  Aligned_cols=239  Identities=22%  Similarity=0.245  Sum_probs=194.8

Q ss_pred             eeeeecCcEEEEEEEECC------------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520           15 RTIGEGTFAKVRFAQNRE------------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~------------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      +.||+|+||.||+|....            ....+|+|.+....   ......+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999998532            22358888875532   234457888999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC-------eEEeecc
Q 013520           83 KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-------LKVSDFG  154 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~-------~kL~DFG  154 (441)
                      ..+++|||+++|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999999888865 356899999999999999999999999999999999999987664       8999999


Q ss_pred             ccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHh-cCCCCCCCCChHHHHHHhhcCcCCCCCCC
Q 013520          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKKINAAEFSCPFWF  233 (441)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  233 (441)
                      ++......    ....++..|+|||.+.+....+.++|||||||++|+|+ .|..||......+.. .............
T Consensus       158 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~  232 (262)
T cd05077         158 IPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPS  232 (262)
T ss_pred             CCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCCCC
Confidence            98654322    24568889999999875455568999999999999997 599999776544432 2233333333445


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++++.+++.+||+.||.+||++.+|+++
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            7889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5e-40  Score=316.74  Aligned_cols=249  Identities=25%  Similarity=0.378  Sum_probs=201.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEE----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC--CE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQN----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR--TK   83 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--~~   83 (441)
                      -|++++.||+|+||.||+|..    +.++..||+|.+....  .......+.+|+.+++.++||||+++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            368999999999999999974    4578899999986543  233456789999999999999999999998775  67


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .|++|||++|++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            899999999999999997643 5899999999999999999999999999999999999999999999999998765442


Q ss_pred             cc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---------------HHHHHHhhc
Q 013520          163 VE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA  224 (441)
Q Consensus       163 ~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------------~~~~~~i~~  224 (441)
                      ..   ......++..|+|||++.+..+ +.++|||||||++|+|+++..|+..+..               ......+..
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            21   1234557778999999876655 4899999999999999998776532210               111111222


Q ss_pred             C-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          225 A-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       225 ~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      + ..+.+..+++.+.+|+.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1 233455689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.4e-40  Score=314.24  Aligned_cols=251  Identities=21%  Similarity=0.284  Sum_probs=209.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-C
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-R   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~   81 (441)
                      ..++|++.+.||+|+||.||+|.+..    ++..|++|.+....  .....+.+.+|+.+++.++||||+++++++.. +
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            45789999999999999999999876    35789999876432  33345778899999999999999999998765 5


Q ss_pred             CEEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeec
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ--------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (441)
                      ...++++||+.+++|.+++...        ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            7789999999999999998653        45889999999999999999999999999999999999999999999999


Q ss_pred             cccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCC
Q 013520          154 GLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSC  229 (441)
Q Consensus       154 Gls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~  229 (441)
                      |+++.......  ......++..|+|||.+.+..+ +.++|||||||++|++++ |.+||...+..+....+..+ .+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            99875433211  1122345678999999976655 589999999999999998 99999887766666655443 2334


Q ss_pred             CCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +..+++++.+++.+||..||++|||+.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-40  Score=316.24  Aligned_cols=238  Identities=24%  Similarity=0.279  Sum_probs=194.1

Q ss_pred             eeeecCcEEEEEEEECCC------------------------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc
Q 013520           16 TIGEGTFAKVRFAQNRET------------------------GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI   71 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~------------------------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI   71 (441)
                      .||+|+||.||+|....+                        ...||+|++....   ......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence            699999999999975321                        2358889886532   2234567889999999999999


Q ss_pred             ceeEEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC----
Q 013520           72 VRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----  146 (441)
Q Consensus        72 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~----  146 (441)
                      +++++++.+....|+||||+++|+|..++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++..+    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999998865 46789999999999999999999999999999999999998654    


Q ss_pred             ---CeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHh-cCCCCCCCCChHHHHHHh
Q 013520          147 ---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKKI  222 (441)
Q Consensus       147 ---~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~i  222 (441)
                         .+|++|||++......    ....++..|+|||.+.+....+.++|||||||++|+|+ +|..||...+..+.....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~  234 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFY  234 (274)
T ss_pred             ccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHH
Confidence               3899999987543221    23457889999999876554568999999999999984 799999876654433322


Q ss_pred             hcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       223 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                       ......|...++.+.++|.+||+.+|++|||+.+++++
T Consensus       235 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 -EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             23334455567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=332.19  Aligned_cols=250  Identities=26%  Similarity=0.403  Sum_probs=214.1

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCc---E-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGE---S-VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~---~-vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ++-.+.+.||+|+||.||+|..+..+.   . ||+|....+..........+.+|+++|+.++|||||+++|+...+..+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            455667999999999999998765422   3 899988764444556678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+|||+|.||+|.++++..+. ++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||++...... 
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~-  315 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY-  315 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce-
Confidence            999999999999999998774 999999999999999999999999999999999999999999999999998754311 


Q ss_pred             cccccc-cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcC--CCCCCCCHhHHH
Q 013520          164 ELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF--SCPFWFSTGATS  239 (441)
Q Consensus       164 ~~~~~~-~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~  239 (441)
                      ...... --...|+|||.+....| +.++||||+||++||+++ |..||.+.+..+...++....+  +.|...+.++..
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~  394 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAK  394 (474)
T ss_pred             eeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence            111112 24568999999987655 599999999999999998 8999999999999888855444  455567889999


Q ss_pred             HHHHhcCCCCCCCCChHhHhc
Q 013520          240 LIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~  260 (441)
                      ++.+|+..||++|||+.++.+
T Consensus       395 ~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  395 VMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHhccCChhhccCHHHHHH
Confidence            999999999999999999865

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-39  Score=314.11  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=199.9

Q ss_pred             cCeEEEeeeeecCcEEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CC
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RT   82 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~   82 (441)
                      .+|++.+.||+|+||.||.|.    +..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            479999999999999999997    44578899999986542   3345678899999999999999999998753  45


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      .+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            689999999999999999764 4689999999999999999999999999999999999999999999999999886543


Q ss_pred             cccc---cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHH----------------HHHHh
Q 013520          162 GVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----------------LYKKI  222 (441)
Q Consensus       162 ~~~~---~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----------------~~~~i  222 (441)
                      ....   .....++..|+|||.+.+..+ +.++|||||||++|+|++|..|+.......                ....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            2211   112223456999999976555 589999999999999999987765432110                11111


Q ss_pred             hc-CcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          223 NA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       223 ~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .. ..++.+..++.++.+++.+||..+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11 123344568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-39  Score=309.24  Aligned_cols=242  Identities=27%  Similarity=0.460  Sum_probs=204.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||++.  .+++.||+|.+....     ..+.+.+|+.+++.++||||+++++++..+ ..|+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            45789999999999999999986  468899999986532     235688899999999999999999998764 4799


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|||+.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......  
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            999999999999997643  5789999999999999999999999999999999999999999999999998754321  


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIH  242 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~  242 (441)
                       ......+..|+|||.+.+..+ +.++|+|||||++|+|++ |.+||...+..+....+..+. ...+..++..+.+++.
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHH
Confidence             122334568999999876555 489999999999999997 999998887777666665442 2334557899999999


Q ss_pred             HhcCCCCCCCCChHhHhc
Q 013520          243 KILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (441)
                      +||+.+|++||++++++.
T Consensus       232 ~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         232 SCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.4e-41  Score=354.44  Aligned_cols=254  Identities=28%  Similarity=0.479  Sum_probs=208.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEE--------
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVL--------   78 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--------   78 (441)
                      ...+|+.++.||+||||.||+++++-+|..||||.|....  .......+.+|+..+.+|+|||||+++..+        
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            5678899999999999999999999999999999998765  344567899999999999999999986421        


Q ss_pred             -------------------------------------------------E---------------------e--------
Q 013520           79 -------------------------------------------------A---------------------S--------   80 (441)
Q Consensus        79 -------------------------------------------------~---------------------~--------   80 (441)
                                                                       .                     +        
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                             0                     0        


Q ss_pred             -------------------------C--------CEEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHH
Q 013520           81 -------------------------R--------TKVYIILEFVTGGELFDKIVHQGRL-LENDCRRYFQQLIDAVAHCH  126 (441)
Q Consensus        81 -------------------------~--------~~~~lv~E~~~gg~L~~~i~~~~~l-~e~~~~~~~~qll~aL~~LH  126 (441)
                                               +        ..+||-||||+...|.+.+..+... ....++++|+||+.||.|+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence                                     0        2479999999998888888775544 47889999999999999999


Q ss_pred             HCCceecCCCCCcEEEccCCCeEEeeccccccCC------------------ccccccccccCCCCcCCccccccCC--C
Q 013520          127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ------------------QGVELLHTTCGTPNYVAPEVLSNRG--Y  186 (441)
Q Consensus       127 ~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~------------------~~~~~~~~~~gt~~Y~aPE~l~~~~--~  186 (441)
                      ++||+||||||.||+||.++++||+|||+++...                  .+.....+.+||..|+|||++.+..  .
T Consensus       715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            9999999999999999999999999999998611                  0112345678999999999997665  3


Q ss_pred             CCCCcchhhHhHHHHHHhcCCCCCCC-CChHHHHHHhhcCcCCCCCCC----CHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          187 DGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWF----STGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       187 ~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++.|+|+||||||||||+.   ||+. .........+..+.++.|+.+    -+.-..+|++||+.||++|||+.|+|++
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            4599999999999999984   4643 223445566667777766332    2456789999999999999999999999


Q ss_pred             CCcc
Q 013520          262 PWFR  265 (441)
Q Consensus       262 p~f~  265 (441)
                      .||.
T Consensus       872 ~llp  875 (1351)
T KOG1035|consen  872 ELLP  875 (1351)
T ss_pred             cCCC
Confidence            9996

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-39  Score=316.88  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=207.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ..++|+..+.||+|+||.||+|.+..+|.    .+|+|.+.....  ......+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-   81 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-   81 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence            45689999999999999999999987776    468888765432  22334688999999999999999999998764 


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..++++||+++|+|.+.+.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            4679999999999999987644 688999999999999999999999999999999999999999999999999976543


Q ss_pred             ccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhH
Q 013520          162 GVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (441)
Q Consensus       162 ~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (441)
                      ...  ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.......+.+..+ .++.+...+..+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDV  240 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence            222  1223445778999999876655 488999999999999997 99999876655554444433 234455678999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+++.+|+..+|++||+++++++.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998775

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.3e-39  Score=309.49  Aligned_cols=243  Identities=20%  Similarity=0.259  Sum_probs=193.1

Q ss_pred             eeeeecCcEEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           15 RTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      +.||+|+||.||+|...  .++..+|+|.+.....  ......+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999864  3567899998866432  2233568889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--c
Q 013520           93 GGELFDKIVHQG-----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--L  165 (441)
Q Consensus        93 gg~L~~~i~~~~-----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~  165 (441)
                      +|+|.+++....     ..++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++........  .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999986532     356677889999999999999999999999999999999999999999999865433211  1


Q ss_pred             cccccCCCCcCCccccccCC------CCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHH-hhcCcCC--CC---CC
Q 013520          166 LHTTCGTPNYVAPEVLSNRG------YDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAAEFS--CP---FW  232 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~-i~~~~~~--~~---~~  232 (441)
                      .....|++.|+|||++.+..      ..+.++||||+||++|+|++ |..||...+..+.... +......  .|   ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            22345788899999985422      13579999999999999996 9999987665544332 2222222  12   23


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .++.+.+++.+|+ .+|++|||+++|..
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            6788999999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.3e-39  Score=307.85  Aligned_cols=244  Identities=25%  Similarity=0.326  Sum_probs=197.4

Q ss_pred             eeeeecCcEEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEEEEEEec
Q 013520           15 RTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-SRTKVYIILEF   90 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~   90 (441)
                      +.||+|+||.||+|.+..   .+..+|+|.+....  .....+.+.+|+.+++.++||||+++++++. .++..|++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998753   34579999875422  2334567889999999999999999999765 45668999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc----cc
Q 013520           91 VTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----EL  165 (441)
Q Consensus        91 ~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~----~~  165 (441)
                      +.+|+|.+++... ...++.....++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......    ..
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999999764 346677788899999999999999999999999999999999999999999987543211    11


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHK  243 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~  243 (441)
                      .....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+..+....+..+. ...+..+++.+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            123345778999999876655 489999999999999999 577887766666665554443 33455578999999999


Q ss_pred             hcCCCCCCCCChHhHhcC
Q 013520          244 ILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (441)
                      ||..+|++||++.++++.
T Consensus       238 cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         238 CWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HcCCChhhCCCHHHHHHH
Confidence            999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-39  Score=308.80  Aligned_cols=236  Identities=22%  Similarity=0.259  Sum_probs=194.0

Q ss_pred             eeeeecCcEEEEEEEECCCC----------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520           15 RTIGEGTFAKVRFAQNRETG----------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~----------~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      +.||+|+||.||+|.++.++          ..+++|.+.....    ....+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46999999999999998776          3477787654321    14678899999999999999999999888 778


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-------CeEEeecccc
Q 013520           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-------NLKVSDFGLS  156 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-------~~kL~DFGls  156 (441)
                      |+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998766 789999999999999999999999999999999999999887       7999999998


Q ss_pred             ccCCccccccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcCCCCCCCC
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFWFS  234 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s  234 (441)
                      .....    .....++..|+|||++... ...+.++|||||||++|+|++ |..||...+.......... ....+...+
T Consensus       156 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~  230 (259)
T cd05037         156 ITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMPDC  230 (259)
T ss_pred             ccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCCCc
Confidence            75433    2244577889999998765 344689999999999999999 6888877654333332222 222222234


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ..+.+++.+||..+|.+|||+.++++
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHH
Confidence            78999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2e-39  Score=309.85  Aligned_cols=243  Identities=19%  Similarity=0.278  Sum_probs=192.1

Q ss_pred             eeeeecCcEEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           15 RTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            469999999999996533  44578888775432  22334667889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--c
Q 013520           93 GGELFDKIVHQG-----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--L  165 (441)
Q Consensus        93 gg~L~~~i~~~~-----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--~  165 (441)
                      +|+|.+++....     ..++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999997643     246778899999999999999999999999999999999999999999999865332211  1


Q ss_pred             cccccCCCCcCCccccccC------CCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHH-hhcCcCC-----CCCC
Q 013520          166 LHTTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAAEFS-----CPFW  232 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~------~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~-i~~~~~~-----~~~~  232 (441)
                      .....+++.|+|||++...      ...+.++|||||||++|+|++ |..||......+.... +......     .+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            1233456789999997532      233579999999999999998 8899987665544433 3333222     2234


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +++...+++..|+ .||++|||++++++
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            7888999999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.2e-39  Score=309.39  Aligned_cols=250  Identities=29%  Similarity=0.504  Sum_probs=210.4

Q ss_pred             CeEEEeeeeecCcEEEEEEEECC-CCcEEEEEEeecccc-------cchHHHHHHHHHHHHHHh-CCCCCcceeEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTI-------LKHRMVDQIKREISIMKI-VRHPNIVRLHEVLAS   80 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~-~~~~vavK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~   80 (441)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 788999998864321       122334567788888865 799999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           81 RTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                      .+..|++|||++|++|.+.+..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743    3568999999999999999999996 7899999999999999999999999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC-CC-CC
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PF-WF  233 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~~-~~  233 (441)
                      +....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|.+||...+.......+....... +. .+
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY  238 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccC
Confidence            87655432 3445678999999999976554 589999999999999999999998877766666655544332 22 57


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++.+.+++++||+.||++||++.|+..+
T Consensus       239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         239 SEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            8999999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-39  Score=311.08  Aligned_cols=243  Identities=23%  Similarity=0.355  Sum_probs=201.9

Q ss_pred             eeeeecCcEEEEEEEECCCC------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520           15 RTIGEGTFAKVRFAQNRETG------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~------~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +.||+|+||.||+|.++..+      ..+|+|.+.+...  ......+.+|+.+++.++||||+++++++......|++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            46899999999999986543      6899998865421  223467888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-----CeEEeecccc
Q 013520           89 EFVTGGELFDKIVHQ-------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-----NLKVSDFGLS  156 (441)
Q Consensus        89 E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-----~~kL~DFGls  156 (441)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||++|++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999999642       3477889999999999999999999999999999999999877     8999999998


Q ss_pred             ccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCC
Q 013520          157 ALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFW  232 (441)
Q Consensus       157 ~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~  232 (441)
                      ........  ......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ .+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            75432211  1123345778999999976555 589999999999999998 99999887766666655443 3455666


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +|..+.++|.+||..+|.+||+++++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8999999999999999999999999865

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-40  Score=332.46  Aligned_cols=251  Identities=24%  Similarity=0.473  Sum_probs=218.6

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE--EEEEEe
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK--VYIILE   89 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~lv~E   89 (441)
                      ....||+|+|-+||+|.|..+|-.||---++...+ ...+..+++..|+.+|+.|+||||+++++++.+..+  +-+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            45689999999999999999999998655544333 234456889999999999999999999999987666  888999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEcc-CCCeEEeeccccccCCcccccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--GVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~--gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      ++.+|+|+.+..+.+.++...++.|++||+.||.|||++  .|+|||||-+||+|+. .|.+||+|+|+|+......  .
T Consensus       124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--a  201 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--A  201 (632)
T ss_pred             cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--c
Confidence            999999999999999999999999999999999999998  6999999999999984 5899999999999876542  3


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC-CChHHHHHHhhcCcCCCCC--CCCHhHHHHHHH
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPF--WFSTGATSLIHK  243 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~  243 (441)
                      ....|||.|||||++- ..|+ ..+||||||+.|.||.|+..||.. .+..++|+++..|..+...  --+++++++|.+
T Consensus       202 ksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIek  279 (632)
T KOG0584|consen  202 KSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEK  279 (632)
T ss_pred             ceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHH
Confidence            3478999999999985 5675 999999999999999999999976 5567889998877654322  247899999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCccccC
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ||.. .+.|+|+.|+|+||||..+.
T Consensus       280 Cl~~-~~~R~sa~eLL~d~Ff~~d~  303 (632)
T KOG0584|consen  280 CLAT-KSERLSAKELLKDPFFDEDG  303 (632)
T ss_pred             HhcC-chhccCHHHHhhChhhcccc
Confidence            9999 99999999999999998763

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-41  Score=331.01  Aligned_cols=250  Identities=22%  Similarity=0.333  Sum_probs=212.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...+...++..||+|.||+||+|++..   .||||+++.+..... ..+.+++|+.++++-+|.||+-+.|++..+.. .
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            445667889999999999999999863   599999988776554 68899999999999999999999999998877 9


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc--c
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--G  162 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--~  162 (441)
                      ||.-+|+|.+|..++.- ..+|.....+.|++|++.|+.|||.++|+|||||..||+|.+++.|||+|||+++....  +
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            99999999999998854 35788889999999999999999999999999999999999999999999999975432  3


Q ss_pred             ccccccccCCCCcCCccccccC--CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC-----CCCCCH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-----PFWFST  235 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s~  235 (441)
                      ........|...|||||++...  ..++..+||||+||++|||++|.+||...+.+.+...+..+....     -...+.
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk  623 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK  623 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence            3455677789999999998632  233589999999999999999999999666665555555553222     123577


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ++++|+..|+..++++||.+.+|+.
T Consensus       624 ~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  624 AMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHhcCcccCccHHHHHH
Confidence            9999999999999999999999876

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-41  Score=316.29  Aligned_cols=253  Identities=29%  Similarity=0.474  Sum_probs=206.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--C----CcceeEEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--P----NIVRLHEVL   78 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--p----nIv~l~~~~   78 (441)
                      ...-++|+++.++|+|+||+|-.+.+..++..||+|+++.-    ....+...-|+.++.++++  |    -++.+.++|
T Consensus        85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            34567999999999999999999999999999999998542    1234556679999999942  3    378888999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc------------
Q 013520           79 ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS------------  144 (441)
Q Consensus        79 ~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~------------  144 (441)
                      .-.+++|||+|.+ |-++++.+..++  +++.+.++.+.+||+.+++|||+.+++|-||||||||+.+            
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            9999999999988 669999998754  6889999999999999999999999999999999999942            


Q ss_pred             --------CCCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH
Q 013520          145 --------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP  216 (441)
Q Consensus       145 --------~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~  216 (441)
                              +..++|+|||.|+.....   -++.+.|..|+|||++.+-++. .++||||+||||+||.+|...|...+..
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcH
Confidence                    235899999998865443   2566789999999999999986 8999999999999999999999876533


Q ss_pred             H---HHHHhhc------------------CcCCCCCC-------------------------CCHhHHHHHHHhcCCCCC
Q 013520          217 T---LYKKINA------------------AEFSCPFW-------------------------FSTGATSLIHKILDPNPK  250 (441)
Q Consensus       217 ~---~~~~i~~------------------~~~~~~~~-------------------------~s~~~~~li~~~L~~dP~  250 (441)
                      +   +.+.|..                  +.+..|..                         --.++.|||++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            3   3333321                  11111100                         013488999999999999


Q ss_pred             CCCChHhHhcCCCccc
Q 013520          251 TRIRIEGIRKHPWFRK  266 (441)
Q Consensus       251 ~R~t~~eil~hp~f~~  266 (441)
                      +|+|+.|++.||||..
T Consensus       396 ~RiTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  396 RRITLREALSHPFFAR  411 (415)
T ss_pred             ccccHHHHhcCHHhhc
Confidence            9999999999999975

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=3.3e-39  Score=308.61  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=204.7

Q ss_pred             eEEEeeeeecCcEEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-----   82 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----   82 (441)
                      |++.++||+|+||.||+|.++.   ++..||||++..+... ....+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            6788999999999999998653   5789999999664433 334567889999999999999999999886432     


Q ss_pred             -EEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           83 -KVYIILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        83 -~~~lv~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                       ..++++||+.+|+|.+++...      ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247899999999998877532      2478889999999999999999999999999999999999999999999999


Q ss_pred             cccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCC
Q 013520          156 SALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPF  231 (441)
Q Consensus       156 s~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~  231 (441)
                      +........  ......+++.|++||.+.+..+ +.++|||||||++|+|++ |.+||.+.+..+.+..+... ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP  238 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            876543211  1223345678999999876655 479999999999999999 99999887776666655443 345566


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+++.+.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.8e-39  Score=309.61  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=204.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEEC----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CC
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNR----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RT   82 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~   82 (441)
                      .+|++.+.||+|+||.||+|...    .++..+|+|++......  ...+.+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            57889999999999999999864    35889999999765432  345779999999999999999999999877  66


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..|++|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            7999999999999999997644 589999999999999999999999999999999999999999999999999986653


Q ss_pred             cccc---cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHH---------------HHHHhh
Q 013520          162 GVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---------------LYKKIN  223 (441)
Q Consensus       162 ~~~~---~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~---------------~~~~i~  223 (441)
                      ....   .....++..|+|||.+.+..+ +.++|||||||++|+|++|..||.......               ....+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            2111   112345567999999876654 488999999999999999999986543211               122222


Q ss_pred             c-CcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          224 A-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       224 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      . ...+.+..++.++.+++.+||.++|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2 223445567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-42  Score=307.60  Aligned_cols=262  Identities=26%  Similarity=0.426  Sum_probs=213.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------   80 (441)
                      ..+.|+-+.++|+|.||.||+|+.+.+|+.||+|++-.+. .+.+.-....+|+.+|..++|+|++.+++++.+      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            4567888899999999999999999999999998764322 123344567789999999999999999887743      


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           81 --RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        81 --~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                        ...+|+||++|+. +|+..+... .+++...++.++++++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+++
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence              3358999999975 788887665 689999999999999999999999999999999999999999999999999996


Q ss_pred             cCCccc----cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc--CcCC---
Q 013520          158 LPQQGV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFS---  228 (441)
Q Consensus       158 ~~~~~~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~--~~~~---  228 (441)
                      .+....    ......+-|.+|++||.+.+...++++.|||..|||+.+|.+|.+.+.+.+.......|..  +.+.   
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            554321    1233455699999999999888889999999999999999999999988765444333310  1100   


Q ss_pred             ------------------------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          229 ------------------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       229 ------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                                                    .|..-++++.+|+.+||..||.+|++++++++|.||.+...|
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                                          111235689999999999999999999999999999876544

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-38  Score=308.75  Aligned_cols=250  Identities=14%  Similarity=0.134  Sum_probs=190.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC---CcEEEEEEeecccccc--hHH------HHHHHHHHHHHHhCCCCCcceeEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILK--HRM------VDQIKREISIMKIVRHPNIVRLHE   76 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vavK~i~~~~~~~--~~~------~~~~~~Ei~il~~l~hpnIv~l~~   76 (441)
                      -++|++.+.||+|+||.||+|.+..+   +..+|+|+........  +..      ......+...+..++|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999998877   6677888654322110  000      011223344456678999999998


Q ss_pred             EEEeCC----EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEee
Q 013520           77 VLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (441)
Q Consensus        77 ~~~~~~----~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (441)
                      ......    ..++++|++. .++.+.+......++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D  169 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID  169 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence            765443    4578888774 36666666655678899999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccc-------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-H--------
Q 013520          153 FGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-P--------  216 (441)
Q Consensus       153 FGls~~~~~~~-------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~--------  216 (441)
                      ||+|+......       .......||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+. .        
T Consensus       170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~  248 (294)
T PHA02882        170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC  248 (294)
T ss_pred             cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence            99987653211       11233469999999999987666 5899999999999999999999977632 1        


Q ss_pred             HHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          217 TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       217 ~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +....+..+.... +..++.+.++++.|+..+|++||++++|++
T Consensus       249 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        249 DFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1223344443333 346889999999999999999999999875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=342.78  Aligned_cols=250  Identities=24%  Similarity=0.367  Sum_probs=214.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC-Cc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET-GE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      -..-++.+.||+|+||.||.|..... |.    .||||.+.+.  .+.+....+.+|..+|+.++|||||+++|++.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            34678899999999999999987653 32    3788877653  35566788999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           83 KVYIILEFVTGGELFDKIVHQ-------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~-------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                      ..+|++|||+||+|..+|+..       ..++..+...++.|++.|++||++++++||||...|+||+....+||+|||+
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999999875       3588899999999999999999999999999999999999999999999999


Q ss_pred             cccCCccccccccccC--CCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHH-HhhcCcCCCCC
Q 013520          156 SALPQQGVELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK-KINAAEFSCPF  231 (441)
Q Consensus       156 s~~~~~~~~~~~~~~g--t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~-~i~~~~~~~~~  231 (441)
                      |+.............+  ...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..+... ....+++..|.
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~  927 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS  927 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence            9843332111111112  246999999987554 699999999999999998 999999987766665 56677889999


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .++..+.+++..||+.+|++||++..|++
T Consensus       928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            99999999999999999999999999987

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=316.58  Aligned_cols=263  Identities=27%  Similarity=0.420  Sum_probs=221.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccc----cchHHHHHHHHHHHHHHhCCCCCcceeEEEEE-
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI----LKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-   79 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~----~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-   79 (441)
                      +..-++|-++..||+|+|+.||+|.+...++.||||+-...+.    .+.+..+...+|..|.+.|+||.||++|++|. 
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            3455789999999999999999999999999999999755332    22345567889999999999999999999996 


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEc---cCCCeEEeecc
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--GVYHRDLKPENLLLD---SYGNLKVSDFG  154 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~--gi~HrDlkp~NILl~---~~~~~kL~DFG  154 (441)
                      +.+..|-|+|||+|.+|.-++.....++|.+|+.++.||+.||.||...  .|+|-||||.||||-   ..|.+||+|||
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            5667899999999999999999999999999999999999999999976  699999999999995   45789999999


Q ss_pred             ccccCCcc-------ccccccccCCCCcCCcccccc---CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHH---
Q 013520          155 LSALPQQG-------VELLHTTCGTPNYVAPEVLSN---RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYK---  220 (441)
Q Consensus       155 ls~~~~~~-------~~~~~~~~gt~~Y~aPE~l~~---~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~---  220 (441)
                      ++.+++..       ....+...||.+|++||.+.-   .+..+.++||||.|||+|+++.|+.||+..... ++.+   
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT  698 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT  698 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence            99987652       234567789999999998742   344568999999999999999999999875432 2221   


Q ss_pred             HhhcCcCCCC--CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          221 KINAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       221 ~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+...+..+|  +.+++++.++|++||+.--++|+.+.++-.||||...
T Consensus       699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence            1334444444  5599999999999999999999999999999999753

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-38  Score=302.75  Aligned_cols=243  Identities=19%  Similarity=0.292  Sum_probs=191.6

Q ss_pred             eeeeecCcEEEEEEEECCC--CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           15 RTIGEGTFAKVRFAQNRET--GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      +.||+|+||.||++.....  ...+++|.+.....  ....+.+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            3699999999999975433  23566776654332  2335678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc--ccc
Q 013520           93 GGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELL  166 (441)
Q Consensus        93 gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~~~  166 (441)
                      +|+|.+++...    ...++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......  ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999999764    235667788999999999999999999999999999999999999999999976432211  122


Q ss_pred             ccccCCCCcCCccccccCC------CCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-c-----CCCCCCC
Q 013520          167 HTTCGTPNYVAPEVLSNRG------YDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-E-----FSCPFWF  233 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~-----~~~~~~~  233 (441)
                      ...+|++.|+|||++....      ..+.++|||||||++|+|++ |..||...+..+.+..+... .     ...+..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3557889999999985321      12478999999999999996 67899776665555543222 1     1223347


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ++.+.+++..|+ .+|++||+++++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            888999999999 67999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-39  Score=335.27  Aligned_cols=252  Identities=26%  Similarity=0.382  Sum_probs=216.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA   79 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   79 (441)
                      .....+-+..+.||+|+||+||+|+-..     ....||||.++...  ..++..++++|+.++..++|||||+++|++.
T Consensus       482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            3445677889999999999999998643     34589999987654  3336688999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQG--------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~~--------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~  145 (441)
                      .++.+|+|+||+..|||.+++....              +++..+...++.||+.|+.||-++.++||||-..|+||.++
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence            9999999999999999999996532              27788899999999999999999999999999999999999


Q ss_pred             CCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHh
Q 013520          146 GNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (441)
Q Consensus       146 ~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i  222 (441)
                      -.|||+|||+++..-..+.  ......-...|||||.+....+ +.+|||||+||+|||+++ |..||.+.+.++..+.|
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence            9999999999985433211  1112223458999999987766 489999999999999998 99999999999999888


Q ss_pred             hcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHh
Q 013520          223 NAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIR  259 (441)
Q Consensus       223 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  259 (441)
                      ..++ ++.|..+|.++.+|+..|++.+|++||++.||-
T Consensus       719 ~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  719 RAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            7765 578888999999999999999999999999983

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-40  Score=329.25  Aligned_cols=242  Identities=30%  Similarity=0.516  Sum_probs=199.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC------
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT------   82 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~------   82 (441)
                      .-|..-+.||+|+||.||+++++.||+.||||.+++....+  -.+..-+|+++|++++|||||+++++-++..      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            46788899999999999999999999999999998765333  3577889999999999999999999865443      


Q ss_pred             EEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc--CC--CeEEeeccc
Q 013520           83 KVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--YG--NLKVSDFGL  155 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~--~~--~~kL~DFGl  155 (441)
                      .-.+|||||.||+|+..++.   ..+++|.+...++.++..||.|||++||+||||||+||++-.  +|  ..||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            46799999999999999975   347999999999999999999999999999999999999953  23  489999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-----HHHHHHhh-------
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-----PTLYKKIN-------  223 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-----~~~~~~i~-------  223 (441)
                      |+..+.+ ....+.+||+.|.+||++-.+++++..+|.||+||++|++.||..||.....     ..++..+.       
T Consensus       171 Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  171 ARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             cccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            9987765 4678889999999999997667778999999999999999999999943221     12222221       


Q ss_pred             -------------cCcCCCCCCCCHh----HHHHHHHhcCCCCCCCC
Q 013520          224 -------------AAEFSCPFWFSTG----ATSLIHKILDPNPKTRI  253 (441)
Q Consensus       224 -------------~~~~~~~~~~s~~----~~~li~~~L~~dP~~R~  253 (441)
                                   ...+++|..+++.    +-.++..+|..+|++|.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                         1123344444544    44678889999999999

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=313.34  Aligned_cols=247  Identities=28%  Similarity=0.383  Sum_probs=196.1

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-KVYII   87 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~~lv   87 (441)
                      ++|.-...||+|+||.||+|...+ |..||||.+.......   ..++.+|+.++.+++|||+|+++|+|.+.+ ..++|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            467777899999999999999864 4899999776544221   345999999999999999999999999988 59999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           88 LEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKG---VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~g---i~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      +||+++|+|.+++....  .+++....+|+.+++.||+|||+..   |+||||||+|||||++.+.||+|||+|......
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999997755  7899999999999999999999863   999999999999999999999999999655431


Q ss_pred             ccccccc-cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC------hHHHH-HHhhcCcC------C
Q 013520          163 VELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD------LPTLY-KKINAAEF------S  228 (441)
Q Consensus       163 ~~~~~~~-~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~------~~~~~-~~i~~~~~------~  228 (441)
                      .....+. .||..|+|||++.. +..+.++|||||||+|.||++|+.|.+...      ..+.. ..+..+..      .
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~  309 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR  309 (361)
T ss_pred             ccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence            1222233 89999999999976 444689999999999999999998887532      11111 11222111      1


Q ss_pred             CC-CCCC--Hh---HHHHHHHhcCCCCCCCCChHhHhc
Q 013520          229 CP-FWFS--TG---ATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       229 ~~-~~~s--~~---~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .. ...+  .+   +..+..+|++.+|.+||++.++.+
T Consensus       310 l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  310 LKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            11 1122  12   556888999999999999999743

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-38  Score=333.29  Aligned_cols=256  Identities=18%  Similarity=0.259  Sum_probs=180.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCC----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEE---
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRET----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEV---   77 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~---   77 (441)
                      ....++|++.+.||+|+||.||+|.+..+    +..||+|.+.....     .+....|  .++...+.++..+...   
T Consensus       128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence            44678999999999999999999999988    89999998754221     1111111  1111122222222211   


Q ss_pred             ---EEeCCEEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013520           78 ---LASRTKVYIILEFVTGGELFDKIVHQGR--------------------LLENDCRRYFQQLIDAVAHCHSKGVYHRD  134 (441)
Q Consensus        78 ---~~~~~~~~lv~E~~~gg~L~~~i~~~~~--------------------l~e~~~~~~~~qll~aL~~LH~~gi~HrD  134 (441)
                         .......++|+||+.+++|.+++.....                    ..+..+..++.||+.||.|||++||+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence               2456679999999999999998865321                    12344668999999999999999999999


Q ss_pred             CCCCcEEEcc-CCCeEEeeccccccCCcc-ccccccccCCCCcCCccccccCCC---------------------CCCCc
Q 013520          135 LKPENLLLDS-YGNLKVSDFGLSALPQQG-VELLHTTCGTPNYVAPEVLSNRGY---------------------DGSAA  191 (441)
Q Consensus       135 lkp~NILl~~-~~~~kL~DFGls~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~---------------------~~~~~  191 (441)
                      |||+|||++. ++.+||+|||+|+..... .......+||+.|+|||.+.....                     .+.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999985 689999999999755432 223456789999999997643221                     12456


Q ss_pred             chhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC---------------------CCCCCHhHHHHHHHhcCCCCC
Q 013520          192 DVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC---------------------PFWFSTGATSLIHKILDPNPK  250 (441)
Q Consensus       192 DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~~s~~~~~li~~~L~~dP~  250 (441)
                      ||||+||+||+|+++..|++.. .......+.......                     ....+....+||.+||+.||+
T Consensus       361 DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            9999999999999987775432 112222221111110                     011233456899999999999


Q ss_pred             CCCChHhHhcCCCccccC
Q 013520          251 TRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       251 ~R~t~~eil~hp~f~~~~  268 (441)
                      +|||+.++++||||+...
T Consensus       440 kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        440 QRISAKAALAHPYFDREG  457 (566)
T ss_pred             cCCCHHHHhCCcCcCCCC
Confidence            999999999999998643

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.5e-39  Score=287.75  Aligned_cols=250  Identities=28%  Similarity=0.497  Sum_probs=205.6

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC--E
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRT--K   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~--~   83 (441)
                      ..++|++++++|+|.|+.||.|.+..+++.++||+++.-      ..+.+.+|+.||+.|. ||||++++++..++.  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            457899999999999999999999999999999998542      2467999999999996 999999999987653  4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~  162 (441)
                      ..+++||+.+.+...+.   ..++..+++.|+.||+.||.|||+.||+|||+||.|++||. ...++|+|+|+|.+...+
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            67999999887665544   56888999999999999999999999999999999999995 457999999999877654


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCC-CCChHHHHHHh-------------hc----
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG-ETDLPTLYKKI-------------NA----  224 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~-~~~~~~~~~~i-------------~~----  224 (441)
                       ...+-.+.+..|-.||.+..-..+..+-|+|||||+|..|...+-||- +.+..++.-+|             ..    
T Consensus       187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~  265 (338)
T KOG0668|consen  187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID  265 (338)
T ss_pred             -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence             344567788899999999887777799999999999999999998883 32222221111             10    


Q ss_pred             ---------CcCCCCCC-----------CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          225 ---------AEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       225 ---------~~~~~~~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                               +..+..+|           .++++.||+.++|..|-.+|+|+.|.+.||||..
T Consensus       266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence                     01111112           5799999999999999999999999999999964

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.4e-37  Score=288.47  Aligned_cols=240  Identities=46%  Similarity=0.792  Sum_probs=209.0

Q ss_pred             CcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHHH
Q 013520           21 TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI  100 (441)
Q Consensus        21 ~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i  100 (441)
                      +||.||+|.+..+|+.+|+|++........  .+.+.+|+..++.++|+||+++++.+......++++||+.+++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999998999999999876543221  578899999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcCCccc
Q 013520          101 VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV  180 (441)
Q Consensus       101 ~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~  180 (441)
                      .....++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......++..|+|||.
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~  157 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence            877678999999999999999999999999999999999999999999999999987655432 3456678999999999


Q ss_pred             cccCCCCCCCcchhhHhHHHHHHhcCCCCCCC-CChHHHHHHhhcCcCCCCCC---CCHhHHHHHHHhcCCCCCCCCChH
Q 013520          181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILDPNPKTRIRIE  256 (441)
Q Consensus       181 l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~~L~~dP~~R~t~~  256 (441)
                      +....+ +.++|+||+|+++|+|++|..||.. .+.....+.+..........   ++.++.+++.+||..+|++||++.
T Consensus       158 ~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~  236 (244)
T smart00220      158 LLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAE  236 (244)
T ss_pred             HccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHH
Confidence            976555 4799999999999999999999987 55555555555554443332   889999999999999999999999


Q ss_pred             hHhcCCCc
Q 013520          257 GIRKHPWF  264 (441)
Q Consensus       257 eil~hp~f  264 (441)
                      ++++||||
T Consensus       237 ~~~~~~~~  244 (244)
T smart00220      237 EALQHPFF  244 (244)
T ss_pred             HHhhCCCC
Confidence            99999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-38  Score=320.39  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=219.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEE-----e
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA-----S   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~-----~   80 (441)
                      .-+.|++.+++|.|.+|+||+++++.+|+..|+|+.+...-    .-+.++.|..+++.+ .|||++.++++|.     .
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            34679999999999999999999999999999999876532    336688899999988 6999999999985     3


Q ss_pred             CCEEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520           81 RTKVYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                      .+.+|+|||||.||+.-|++..  ..++.|+.+..+++.++.|+.+||.+.++|||||-.|||++.+|.+||+|||.+..
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ  172 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  172 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence            5689999999999999999876  45788999999999999999999999999999999999999999999999999998


Q ss_pred             CCccccccccccCCCCcCCccccccC-----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCC
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCP  230 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~  230 (441)
                      .........+..|||.|||||++...     .| ...+|+||||++..||..|.+|+-+.......-.|-....   ..|
T Consensus       173 ldsT~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp  251 (953)
T KOG0587|consen  173 LDSTVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP  251 (953)
T ss_pred             eecccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence            87766677899999999999999542     23 3689999999999999999999987766544444433211   123


Q ss_pred             CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ...+.++.++|..||.+|-++||+..++++|||.+.
T Consensus       252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             hhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            346899999999999999999999999999999974

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.8e-37  Score=312.93  Aligned_cols=263  Identities=18%  Similarity=0.263  Sum_probs=191.4

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEEC----------------CCCcEEEEEEeecccccch-----------HHHHHHH
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNR----------------ETGESVAMKVLAKSTILKH-----------RMVDQIK   57 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~----------------~~~~~vavK~i~~~~~~~~-----------~~~~~~~   57 (441)
                      ....++|++.+.||+|+||.||+|...                ..++.||||.+........           ...+...
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            356789999999999999999999752                2456799999865321110           0112233


Q ss_pred             HHHHHHHhCCCCCc-----ceeEEEEEe--------CCEEEEEEeccCCCChHHHHHhcC--------------------
Q 013520           58 REISIMKIVRHPNI-----VRLHEVLAS--------RTKVYIILEFVTGGELFDKIVHQG--------------------  104 (441)
Q Consensus        58 ~Ei~il~~l~hpnI-----v~l~~~~~~--------~~~~~lv~E~~~gg~L~~~i~~~~--------------------  104 (441)
                      .|+..+.+++|.++     +++++++..        .+..|+||||+++++|.+++....                    
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46777777766544     666676643        356899999999999999886421                    


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-ccccccCCCCcCCcc
Q 013520          105 ----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-LLHTTCGTPNYVAPE  179 (441)
Q Consensus       105 ----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-~~~~~~gt~~Y~aPE  179 (441)
                          .++...++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ ......+|+.|+|||
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence                234567888999999999999999999999999999999999999999999865433211 111223588999999


Q ss_pred             ccccCCC--------------------C-CCCcchhhHhHHHHHHhcCCC-CCCCCCh-----------HHHHHHhhcCc
Q 013520          180 VLSNRGY--------------------D-GSAADVWSCGVILFVLMAGYL-PFGETDL-----------PTLYKKINAAE  226 (441)
Q Consensus       180 ~l~~~~~--------------------~-~~~~DiwSlGvil~~ll~g~~-Pf~~~~~-----------~~~~~~i~~~~  226 (441)
                      .+.....                    . ..+.|+||+||++|+|++|.+ ||.....           ...++.+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            9854221                    1 124799999999999999986 7754211           11122233334


Q ss_pred             CCCCC--CCCHhHHHHHHHhcCCCC---CCCCChHhHhcCCCcccc
Q 013520          227 FSCPF--WFSTGATSLIHKILDPNP---KTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       227 ~~~~~--~~s~~~~~li~~~L~~dP---~~R~t~~eil~hp~f~~~  267 (441)
                      +.++.  ..++.++||+.+||..+|   .+|+|++|+|+||||...
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            44443  378999999999999766   689999999999999653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=292.20  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=203.6

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEEEec
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI-VRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      +-+..||.|+||.|++..++.+|+..|||.|.....  +...+++..|.....+ -+.||||++++....++..||.||+
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            446679999999999999999999999999987654  3345778888887554 4799999999999999999999999


Q ss_pred             cCCCChHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           91 VTGGELFDKI------VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        91 ~~gg~L~~~i------~~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      ++- +| |.+      .....++|...-.+.-..+.||.||... .|+|||+||+||||+..|.+||||||++...... 
T Consensus       145 Md~-Sl-DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-  221 (361)
T KOG1006|consen  145 MDI-SL-DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-  221 (361)
T ss_pred             Hhh-hH-HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence            953 33 222      2345799999888989999999999865 9999999999999999999999999998765443 


Q ss_pred             cccccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCcCCC---CC---CCC
Q 013520          164 ELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFSC---PF---WFS  234 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~---~~---~~s  234 (441)
                      -.-....|..+|||||.+..  .+|+ -+||+||||++|||+.||..|+..-+. .+....+..+.++.   +.   .+|
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s  300 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS  300 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence            12245579999999999954  3454 899999999999999999999976433 33444445555432   22   278


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ..+..+|.-||.+|-+.||...+++++||++..
T Consensus       301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            999999999999999999999999999999764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-38  Score=311.08  Aligned_cols=207  Identities=31%  Similarity=0.575  Sum_probs=189.2

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHH-----HHHHHHHHHHhCC---CCCcceeE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-----QIKREISIMKIVR---HPNIVRLH   75 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~-----~~~~Ei~il~~l~---hpnIv~l~   75 (441)
                      ....+.+|..++.||.|+||+|++|.++.+...|+||.|.|+.+....+++     .+-.||+||..++   |+||++++
T Consensus       556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            346678999999999999999999999999999999999998776544433     3678999999997   99999999


Q ss_pred             EEEEeCCEEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecc
Q 013520           76 EVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFG  154 (441)
Q Consensus        76 ~~~~~~~~~~lv~E~~-~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFG  154 (441)
                      ++|++++++|++||-- +|-+||++|.....++|..++.+|+|++.|+++||++||+|||||-||+.++.+|-+||+|||
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence            9999999999999954 578999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC
Q 013520          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  212 (441)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~  212 (441)
                      .+.....  +.....+||..|.|||++.+..|.|.+-|||++|++||.+.....||..
T Consensus       716 saa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9886554  4567889999999999999999999999999999999999999999853

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=291.83  Aligned_cols=256  Identities=30%  Similarity=0.474  Sum_probs=212.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------   80 (441)
                      ...+|.-++.+|.|+- .|..|.|.-++++||+|.+..+ +......++..+|..++..++|+||++++.+|.-      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            3458888999999999 7888999999999999998776 3444456778899999999999999999999853      


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      ....|+||||++. +|...+.  -.++.+....++.|++.|++|||+.||+||||||+||++..++.+|+.|||++....
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence            3468999999954 7888776  457788999999999999999999999999999999999999999999999998655


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------  225 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------------  225 (441)
                      .. -..+.++.|..|.|||++.+.+| ...+||||+|||+.||++|...|.+.+.-+.+.++...               
T Consensus       170 ~~-~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  170 TD-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             cc-cccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            43 35678889999999999998885 58999999999999999999999887654444333100               


Q ss_pred             ---------c---CC----CCCC-----------CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          226 ---------E---FS----CPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       226 ---------~---~~----~~~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                               +   ++    +|.+           -+..+++++.+||..||++|.+++++|+|||++-++.
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~  318 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYD  318 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecc
Confidence                     0   11    1111           1355899999999999999999999999999985543

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.1e-37  Score=303.28  Aligned_cols=254  Identities=26%  Similarity=0.409  Sum_probs=210.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC------CCcceeEEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH------PNIVRLHEVL   78 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h------pnIv~l~~~~   78 (441)
                      ...-++|.+....|+|-||+|..|.+..-|..||||+|....    -+.+.=..|+.||++|+.      -|+++++..|
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            345679999999999999999999999999999999997743    344556789999999962      4899999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-CCeEEeecc
Q 013520           79 ASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFG  154 (441)
Q Consensus        79 ~~~~~~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFG  154 (441)
                      ...+++|+|+|.+. .+|.+.+...+   ++....++.|++||+.||..|...||+|.||||.|||+++. ..+||||||
T Consensus       504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence            99999999999884 58999887754   68889999999999999999999999999999999999864 569999999


Q ss_pred             ccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----
Q 013520          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----  230 (441)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----  230 (441)
                      .|.....+  ....+.-+..|.|||++.+.+|+ ...|+||.||.||||.||...|.+.+...+.+......-++|    
T Consensus       583 SA~~~~en--eitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  583 SASFASEN--EITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             cccccccc--cccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            98765443  23455567789999999999997 899999999999999999999998876555433211110000    


Q ss_pred             -------------------------------------C------------CC-------CHhHHHHHHHhcCCCCCCCCC
Q 013520          231 -------------------------------------F------------WF-------STGATSLIHKILDPNPKTRIR  254 (441)
Q Consensus       231 -------------------------------------~------------~~-------s~~~~~li~~~L~~dP~~R~t  254 (441)
                                                           +            .+       -..+++||.+||..||++|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence                                                 0            01       145889999999999999999


Q ss_pred             hHhHhcCCCccc
Q 013520          255 IEGIRKHPWFRK  266 (441)
Q Consensus       255 ~~eil~hp~f~~  266 (441)
                      +.++|+||||+.
T Consensus       740 ~nqAL~HpFi~~  751 (752)
T KOG0670|consen  740 VNQALKHPFITE  751 (752)
T ss_pred             HHHHhcCCcccC
Confidence            999999999974

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=301.37  Aligned_cols=245  Identities=28%  Similarity=0.445  Sum_probs=205.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCC--Cc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRET--GE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~--~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..++.+.||.|.||.||.|.....  |+  .||||..+.+.-..  ..+.+..|..+|+.++|||||+++|++.+ ...|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W  466 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--DTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW  466 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--hHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence            345567899999999999986432  33  68889886644322  36789999999999999999999999986 5689


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      ||||+++-|+|..+++.+ ..++......|+.||..||.|||+...+||||-..|||+....-+||+|||+++..+....
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y  546 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY  546 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence            999999999999999875 4688889999999999999999999999999999999999999999999999997766422


Q ss_pred             ccccccCC--CCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHH
Q 013520          165 LLHTTCGT--PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (441)
Q Consensus       165 ~~~~~~gt--~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (441)
                      . ....|.  .-|||||-+.-..+ +.+||+|-|||.+||++. |..||.+....+..-.+.++ +++.|+.+|+.+..|
T Consensus       547 Y-kaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYsl  624 (974)
T KOG4257|consen  547 Y-KASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSL  624 (974)
T ss_pred             h-hccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHH
Confidence            2 222333  35999999865554 589999999999999886 99999887766666666554 578999999999999


Q ss_pred             HHHhcCCCCCCCCChHhHh
Q 013520          241 IHKILDPNPKTRIRIEGIR  259 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil  259 (441)
                      +.+||+.+|.+||.+.+|.
T Consensus       625 mskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  625 MSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHhccCcccCCcHHHHH
Confidence            9999999999999988764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=305.16  Aligned_cols=254  Identities=27%  Similarity=0.429  Sum_probs=218.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECC-CCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRE-TGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ++..+.+.||+|+||.|++|.++. +|+  .||||.+.......  ....+.+|+.+|.+|+|||++++|++..+ ..+.
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            355678899999999999998875 343  68999997766443  57889999999999999999999999988 7788


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|||+++.|+|.+.+..  ...|.......|+.||+.|+.||.+++.|||||-..|+||-....+||+|||+.+-...+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999999987  3468888999999999999999999999999999999999999999999999998776654


Q ss_pred             cccc---cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHH
Q 013520          164 ELLH---TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (441)
Q Consensus       164 ~~~~---~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (441)
                      ....   ..--...|+|||.+....+ +.++|+|++||++|||++ |+.||.+..-..+.++|..+ .++.|..+|+++.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY  345 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY  345 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence            3321   1123457999999987766 489999999999999998 89999999988888888754 4678888999999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +++..||..+|++|||+..|...-+.+.
T Consensus       346 ~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  346 QIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             HHHHHhccCCccccccHHHHHHhHHHHh
Confidence            9999999999999999999986655544

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-36  Score=288.38  Aligned_cols=130  Identities=28%  Similarity=0.465  Sum_probs=115.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----C---CCcceeEEEEE-
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----H---PNIVRLHEVLA-   79 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~-   79 (441)
                      ++|.+.++||-|-|++||+|.|..+.+.||+|+.+..    +...+....||.+|+.++     |   .+||++++.|. 
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            7999999999999999999999999999999998653    334567888999999883     3   37999999996 


Q ss_pred             ---eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEc
Q 013520           80 ---SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLD  143 (441)
Q Consensus        80 ---~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~  143 (441)
                         .+.++|+|+|+. |-+|..+|...  ..++...++.+++|++.||.|||+. ||||.||||||||+.
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence               456899999998 77898998764  4799999999999999999999976 999999999999993

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=281.92  Aligned_cols=256  Identities=27%  Similarity=0.423  Sum_probs=211.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-----EE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-----KV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~   84 (441)
                      +.+--+.||-|+||.||.+.|..+|+.||+|.+.. .+.+-...+.+.+|+++|...+|.|++..+++.+-..     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            44556889999999999999999999999998743 2223334577899999999999999999998876543     36


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc-c
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-V  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~  163 (441)
                      |++.|.+. .+|...|.....++.+.++-+++||+.||+|||+.||.||||||.|+|++.|..+||||||+++..+.. .
T Consensus       133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            78888884 588888888889999999999999999999999999999999999999999999999999999876653 2


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhh--------------------
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN--------------------  223 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~--------------------  223 (441)
                      ..+...+-|-+|+|||++.+...++.+.||||.|||+.||+..+..|...+..+..+.|.                    
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence            334566778899999999988877899999999999999999999998776554443331                    


Q ss_pred             ---cCcCCCCC-----------CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          224 ---AAEFSCPF-----------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       224 ---~~~~~~~~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                         .+....|.           .-..+..+++.++|.+||++|++.++.+.|++..+.
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence               11112221           123568899999999999999999999999998653

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-36  Score=295.39  Aligned_cols=246  Identities=26%  Similarity=0.395  Sum_probs=212.4

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      .+.....+||.|.||.||.+.++.-.-.||||.++.+..    .++.+..|..+|+.++|||+|+++++|..+...|||.
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            345567889999999999999999888999999866543    3567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           89 EFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||..|+|.++++...  -++.-....++.||.+|++||..+++|||||-..|.|+.++..+|++|||+++++.......
T Consensus       343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA  422 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA  422 (1157)
T ss_pred             ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence            9999999999998754  36666777888999999999999999999999999999999999999999999876532222


Q ss_pred             cccc-CCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHH
Q 013520          167 HTTC-GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       167 ~~~~-gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (441)
                      +.-. -..-|.|||-|.-..+ +.++|||+|||+|||+.| |-.||.+-+..+.|..+.++ +..-|..+++.+..|++.
T Consensus       423 HAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMra  501 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRA  501 (1157)
T ss_pred             ccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHH
Confidence            2111 2346999999876555 489999999999999998 99999999999888877654 456788899999999999


Q ss_pred             hcCCCCCCCCChHhHh
Q 013520          244 ILDPNPKTRIRIEGIR  259 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil  259 (441)
                      ||+++|.+||+++||-
T Consensus       502 CW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  502 CWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HhcCCcccCccHHHHH
Confidence            9999999999999984

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-37  Score=304.84  Aligned_cols=257  Identities=29%  Similarity=0.445  Sum_probs=223.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      --.+|+++.++|.|+||.||+|+++.+++..|+|+++.+.-.   ...-+.+|+-+++.++||||+.+++.+.....+|+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence            356899999999999999999999999999999999886533   34667889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      .||||.||+|.+.-.-.++++|.++....++.+.|++|||+.|-+|||||-.|||+++.|.+||+|||.+......-...
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence            99999999999988888999999999999999999999999999999999999999999999999999988766544455


Q ss_pred             ccccCCCCcCCccccc---cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC-----CCCHhHH
Q 013520          167 HTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-----WFSTGAT  238 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~s~~~~  238 (441)
                      .+..|||.|||||+-.   ..+| ...+|||++|+...|+---++|-.............+..+..|.     ..++.+.
T Consensus       170 ksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             hcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence            6889999999999863   3344 59999999999999998888886554444444444455554442     3688899


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +|++.+|.++|++|||++.+|.|||....
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc
Confidence            99999999999999999999999998653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=306.51  Aligned_cols=242  Identities=31%  Similarity=0.470  Sum_probs=195.1

Q ss_pred             EeeeeecCcEE-EEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEEecc
Q 013520           14 GRTIGEGTFAK-VRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIILEFV   91 (441)
Q Consensus        14 ~~~LG~G~~g~-V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~   91 (441)
                      -+.+|.|+.|+ ||+|..  .|+.||||.+-.+      ....+.+||..|+.- +|||||++++.-.+....||..|.|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            45689999987 799986  4789999977443      345678999999998 6999999999999999999999999


Q ss_pred             CCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CC--CeEEeeccccccCCcc
Q 013520           92 TGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YG--NLKVSDFGLSALPQQG  162 (441)
Q Consensus        92 ~gg~L~~~i~~~~~----l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~--~~kL~DFGls~~~~~~  162 (441)
                      . .+|.++++..+.    ......+..+.|+++||++||+.+|+||||||.||||+.   ++  .++|+|||+|+....+
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            5 599999987411    111445788999999999999999999999999999985   33  6899999999876653


Q ss_pred             c---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcC-CCCCCCCChHHHHHHhhcCcCCCCC---CCCH
Q 013520          163 V---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAEFSCPF---WFST  235 (441)
Q Consensus       163 ~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~---~~s~  235 (441)
                      .   ....+..||-+|+|||++..... ..++||||+||++|..++| ..||++.-  +...+|..+.+....   .-..
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCchH
Confidence            2   23456779999999999976554 4799999999999998885 99997642  333455555543321   1122


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++.+||.+|+.++|..||++.+++.||+|-..
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            89999999999999999999999999999543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=291.43  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=207.5

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +...++++||+|.||.|.+++-. .+..||+|.++.....  ...+.+.+||++|.+|+||||++++++|..++.+++++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            45678999999999999999864 3689999999776543  34588999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--
Q 013520           89 EFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--  164 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--  164 (441)
                      ||++.|+|.+++..+..  .......+++.||++|++||.+.+++||||.+.|+|++.++++||+|||+++..-.++.  
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~  694 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR  694 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence            99999999999987643  34455678999999999999999999999999999999999999999999985443211  


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHh--cCCCCCCCCChHHHHHHhhc--------CcCCCCCCCC
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM--AGYLPFGETDLPTLYKKINA--------AEFSCPFWFS  234 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll--~g~~Pf~~~~~~~~~~~i~~--------~~~~~~~~~s  234 (441)
                      .-...+-...|||||.+....+ +.+||+|++|+++||++  +...||...+..+..++...        .-++.|.-++
T Consensus       695 vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  695 VQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             eecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence            1112334568999999876555 58999999999999976  58899988877766655421        2245677799


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .++.+++-+|+..+-++||+++++-.
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            99999999999999999999999844

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=324.54  Aligned_cols=237  Identities=20%  Similarity=0.251  Sum_probs=186.7

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ..|...+.||+|+||.||+|+++.+|..||+|.+.....       ....|+.++++++||||+++++++.+....|+||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            345667789999999999999999999999998864321       1134688999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH---SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH---~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||+++|+|.+++.   .+++.....++.|++.|++|||   +.+|+||||||+||+++.++..++. ||.......    
T Consensus       763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----  834 (968)
T PLN00113        763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----  834 (968)
T ss_pred             eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence            9999999999995   4888999999999999999999   6799999999999999998887775 665443221    


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-----HHHHHHhhc---------CcC----
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-----PTLYKKINA---------AEF----  227 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-----~~~~~~i~~---------~~~----  227 (441)
                      .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||+....     .+..+....         ...    
T Consensus       835 ~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        835 DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCC
Confidence            123468899999999987666 4899999999999999999999954211     111111000         000    


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..+.....++.+++.+|++.||++|||+.|+++.
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            0000112356789999999999999999999775

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=297.79  Aligned_cols=252  Identities=27%  Similarity=0.402  Sum_probs=218.6

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ..+.-.|.++||.|.||.|+.|+.+..|+   .||||.++....  +.....+..|+.||-+++||||+++.++......
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            34556788999999999999999987764   799999876543  3345779999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      +.||.|||++|.|..+++. ++.|+..+..-+++.|+.|++||-+.|++||||-..|||++.+-..|++|||+++..+..
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999999999975 567999999999999999999999999999999999999999999999999999987664


Q ss_pred             cccccccc-C--CCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhH
Q 013520          163 VELLHTTC-G--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (441)
Q Consensus       163 ~~~~~~~~-g--t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (441)
                      .....+.. |  ...|.|||.+....+ +.+||+||+||+|||.++ |.-||-+.+..+..+.|..+ +++.|..+|..+
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL  863 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAAL  863 (996)
T ss_pred             CCccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHH
Confidence            43322222 2  247999999977665 589999999999999776 99999888888888888665 566777799999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+|+..|+++|-.+||.+++|..+
T Consensus       864 ~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  864 YQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999998764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=250.06  Aligned_cols=208  Identities=23%  Similarity=0.403  Sum_probs=170.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +..-+..||+|+||.|-+.++..+|...|+|.+.....  .+..+++.+|+.+..+. .+|++|.+++.+..+..+|+.|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34556789999999999999999999999999876442  34567788899987665 7999999999999999999999


Q ss_pred             eccCCCChH----HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           89 EFVTGGELF----DKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        89 E~~~gg~L~----~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |.++- +|.    +.+...+.++|...-+++..++.||.|||++ .|+|||+||+||||+.+|++|+||||.|.......
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi  203 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI  203 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence            99853 442    2345567899999999999999999999987 99999999999999999999999999998665432


Q ss_pred             cccccccCCCCcCCccccc----cCCCCCCCcchhhHhHHHHHHhcCCCCCCCC-ChHHHHHHh
Q 013520          164 ELLHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGET-DLPTLYKKI  222 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i  222 (441)
                       ..+...|..+|+|||.+.    ..+|+ -+|||||||+.+.||.+++.||+.- +..++.+++
T Consensus       204 -Akt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv  265 (282)
T KOG0984|consen  204 -AKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV  265 (282)
T ss_pred             -HHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence             122367889999999984    23554 8999999999999999999999753 333444443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-33  Score=292.14  Aligned_cols=247  Identities=25%  Similarity=0.405  Sum_probs=208.1

Q ss_pred             eEEEeeeeecCcEEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      ..+.+.||+|+||.|++|.-..       ....||||........  ...+.+..|+.+|+.+ .||||+.+.+.+...+
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3567799999999999997431       1457899998765543  4568899999999999 6999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC
Q 013520           83 KVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~  146 (441)
                      .+++|+||+..|+|.++++...                .++..+...++.||+.|++||++.+++||||-..|||+..+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNK  455 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCC
Confidence            9999999999999999998755                388889999999999999999999999999999999999999


Q ss_pred             CeEEeeccccccCCcccccc-ccccCCCC--cCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCC-hHHHHHH
Q 013520          147 NLKVSDFGLSALPQQGVELL-HTTCGTPN--YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD-LPTLYKK  221 (441)
Q Consensus       147 ~~kL~DFGls~~~~~~~~~~-~~~~gt~~--Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~-~~~~~~~  221 (441)
                      .+|++|||+|+......... ....|+.+  |||||.+....| +.++||||+||+|||+++ |..||.+.. ..++++.
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~  534 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF  534 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence            99999999998544432211 22233344  999999987555 589999999999999998 999998744 5566776


Q ss_pred             hhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          222 INAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       222 i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +..+. ...|..+++++.++++.|+..+|++||++.++.+
T Consensus       535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            76654 4788889999999999999999999999999865

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=4.5e-34  Score=273.37  Aligned_cols=251  Identities=30%  Similarity=0.462  Sum_probs=201.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      ....|.++.+||+|+|+.||+|.+..   .++.||+|.+....     ....+..|++.|..+ .+.||+++.+.+..++
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            45678999999999999999999877   78899999886533     245688999999999 5999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-cCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~  161 (441)
                      ...+||||.+..+..++..   .++-..++.|++.++.||.++|.+||+||||||+|+|.+ ..++-.|.|||++...+.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            9999999999988777764   467889999999999999999999999999999999998 467899999999861100


Q ss_pred             -------cc-------c------------------------------ccccccCCCCcCCccccccCCCCCCCcchhhHh
Q 013520          162 -------GV-------E------------------------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCG  197 (441)
Q Consensus       162 -------~~-------~------------------------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlG  197 (441)
                             ..       .                              ......||++|+|||++..-+..++++||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence                   00       0                              001224999999999998877778999999999


Q ss_pred             HHHHHHhcCCCCCCCCCh--------------HHHHH------H---------------------h-----hcCcC---C
Q 013520          198 VILFVLMAGYLPFGETDL--------------PTLYK------K---------------------I-----NAAEF---S  228 (441)
Q Consensus       198 vil~~ll~g~~Pf~~~~~--------------~~~~~------~---------------------i-----~~~~~---~  228 (441)
                      ||+..++++..||-....              .++.+      +                     +     ...+.   .
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            999999999999933210              00000      0                     0     00000   0


Q ss_pred             CC---CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          229 CP---FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       229 ~~---~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      ..   ..++..+.+|+.+||..||.+|+|+++.|+||||.
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            00   11466899999999999999999999999999996

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=5.1e-32  Score=246.00  Aligned_cols=213  Identities=41%  Similarity=0.749  Sum_probs=188.5

Q ss_pred             eeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCCh
Q 013520           17 IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL   96 (441)
Q Consensus        17 LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L   96 (441)
                      ||+|++|.||++.+..+|+.+++|++.......  ..+.+.+|+..++.++|++|+++++++......++++||+.|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999987654321  346789999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEeeccccccCCccccccccccCCCC
Q 013520           97 FDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPN  174 (441)
Q Consensus        97 ~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~~~~~~~~gt~~  174 (441)
                      .+++... ..++...+..++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+..............+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9999875 57899999999999999999999999999999999999999 899999999998766543222345668889


Q ss_pred             cCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCC
Q 013520          175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR  254 (441)
Q Consensus       175 Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  254 (441)
                      |++||.+......+.++|+|++|+++++|                               ..+.+++.+|++.||++||+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~  207 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS  207 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence            99999987653446899999999999999                               57889999999999999999


Q ss_pred             hHhHhcCC
Q 013520          255 IEGIRKHP  262 (441)
Q Consensus       255 ~~eil~hp  262 (441)
                      ++++++|+
T Consensus       208 ~~~l~~~~  215 (215)
T cd00180         208 AKEILEHL  215 (215)
T ss_pred             HHHHhhCC
Confidence            99999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-32  Score=264.32  Aligned_cols=244  Identities=25%  Similarity=0.442  Sum_probs=193.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHH--hCCCCCcceeEEEEEe----C
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK--IVRHPNIVRLHEVLAS----R   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~--~l~hpnIv~l~~~~~~----~   81 (441)
                      -.+-.+.+.||+|.||+||+|.++  |+.||||++....      .....+|.+|.+  .|+|+||+.+++.-..    -
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            346789999999999999999987  8999999996532      355677888776  4599999999976532    2


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEccCCCeEEeec
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDF  153 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~--------gi~HrDlkp~NILl~~~~~~kL~DF  153 (441)
                      ..+|+|.+|-+.|+|+|++.+ ..++.+.+.+++..++.||+|||..        .|+|||||..|||+.++|..-|+|+
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            369999999999999999998 7899999999999999999999952        4999999999999999999999999


Q ss_pred             cccccCCccc----cccccccCCCCcCCccccccCC----CCC-CCcchhhHhHHHHHHhcC----------CCCCCC--
Q 013520          154 GLSALPQQGV----ELLHTTCGTPNYVAPEVLSNRG----YDG-SAADVWSCGVILFVLMAG----------YLPFGE--  212 (441)
Q Consensus       154 Gls~~~~~~~----~~~~~~~gt~~Y~aPE~l~~~~----~~~-~~~DiwSlGvil~~ll~g----------~~Pf~~--  212 (441)
                      |+|-......    -..+..+||..|||||+|...-    +.+ ..+||||||.|+||++..          .+||.+  
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9996554431    2356789999999999995421    111 469999999999998753          678854  


Q ss_pred             ---CChHHHHHHh--hcCcCCCCC-CCCHh----HHHHHHHhcCCCCCCCCChHhHhc
Q 013520          213 ---TDLPTLYKKI--NAAEFSCPF-WFSTG----ATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       213 ---~~~~~~~~~i--~~~~~~~~~-~~s~~----~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                         ++.+++.+-+  ...++++|. |-|.+    +..+++.|+..||.-|.|+--|.+
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence               4445555543  333444444 44433    456889999999999999977754

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-31  Score=246.87  Aligned_cols=218  Identities=42%  Similarity=0.711  Sum_probs=187.3

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      |++.+.||.|++|.||++.+..+++.+|+|.+......  ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999988999999999775433  2467889999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-ccccc
Q 013520           91 VTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-ELLHT  168 (441)
Q Consensus        91 ~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~~~~  168 (441)
                      +.+++|.+++..... +++.....++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999988766 8999999999999999999999999999999999999999999999999987665432 12345


Q ss_pred             ccCCCCcCCcccc-ccCCCCCCCcchhhHhHHHHHHhcCCCCCCC--CChHHHHHHhhcCcCCCCC
Q 013520          169 TCGTPNYVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAAEFSCPF  231 (441)
Q Consensus       169 ~~gt~~Y~aPE~l-~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~--~~~~~~~~~i~~~~~~~~~  231 (441)
                      ..++..|++||.+ ....+ +.++|+||||+++++|++|++||..  .+...+.+.+..+.....+
T Consensus       159 ~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE  223 (225)
T ss_pred             eeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence            6788899999998 44444 4699999999999999999999977  3444677777776644433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-33  Score=253.24  Aligned_cols=253  Identities=26%  Similarity=0.433  Sum_probs=199.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEE-EEeCCEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEV-LASRTKV   84 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~-~~~~~~~   84 (441)
                      ..+.|.|.+.||+|.||++.+++++.++..+++|.+.++..    ....+.+|..---.| .|.||+.-+++ |++.+.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            35689999999999999999999999999999999987643    346788888776666 58999998865 6777888


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc--CCCeEEeeccccccCCcc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~~~~~  162 (441)
                      .+++||++.|+|..-+.. .++-|...+.++.|+++|+.|||+++++|||||.+||||-.  .-++||||||+++..+. 
T Consensus        98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-  175 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-  175 (378)
T ss_pred             EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence            999999999999988876 57889999999999999999999999999999999999953  33799999999864332 


Q ss_pred             ccccccccCCCCcCCccccccC---CC-CCCCcchhhHhHHHHHHhcCCCCCCCCCh----HHHHHHhhcC-cCCCCC--
Q 013520          163 VELLHTTCGTPNYVAPEVLSNR---GY-DGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAA-EFSCPF--  231 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~---~~-~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~-~~~~~~--  231 (441)
                        .....--+..|.|||++...   .+ ..+.+|+|.||+|+|.+|+|.+||.....    ...+.++... ....|.  
T Consensus       176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F  253 (378)
T KOG1345|consen  176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF  253 (378)
T ss_pred             --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence              22233346689999987432   22 14679999999999999999999975322    1122222222 223333  


Q ss_pred             -CCCHhHHHHHHHhcCCCCCCC---CChHhHhcCCCcccc
Q 013520          232 -WFSTGATSLIHKILDPNPKTR---IRIEGIRKHPWFRKN  267 (441)
Q Consensus       232 -~~s~~~~~li~~~L~~dP~~R---~t~~eil~hp~f~~~  267 (441)
                       .+|+.+..+.++-|.++|++|   .++....+.-|....
T Consensus       254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence             379999999999999999999   667777777777543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=2.9e-32  Score=277.39  Aligned_cols=246  Identities=24%  Similarity=0.350  Sum_probs=209.9

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ....++||+|+||+||+|..-..|+    +||+|++......+  ....+.+|+-+|..++|||++++++++.... +.|
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~--~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK--ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch--hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            3446789999999999998755454    78999987765443  3477889999999999999999999998765 889


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      |++|+++|.|.|+++.. ..+-......|..||++|+.|||.++++||||-..|||+..-.++|++|||++.........
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            99999999999999864 46888889999999999999999999999999999999999999999999999987665444


Q ss_pred             cccccC--CCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       166 ~~~~~g--t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      .+...|  .+.|+|=|.+....| +.++||||+||++||++| |..|+.+....++-+.+..+ +++.|+-++.++..++
T Consensus       855 y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            333333  346888888877666 599999999999999998 99999998887777766544 5788999999999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||-.|+..||++.++-.
T Consensus       934 vkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHhccCcccCccHHHHHH
Confidence            9999999999999988653

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.1e-32  Score=263.51  Aligned_cols=242  Identities=24%  Similarity=0.350  Sum_probs=190.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceeEEEEEeCC---
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHPNIVRLHEVLASRT---   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~---   82 (441)
                      +...++.+.+|+|.||.||+|...  ++.||||++...      ..+.+..|..|.+.  ++|+||+++++.-.-.+   
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            445678899999999999999875  699999998653      24556677777664  58999999998865444   


Q ss_pred             -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCceecCCCCCcEEEccCCCeEEee
Q 013520           83 -KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS---------KGVYHRDLKPENLLLDSYGNLKVSD  152 (441)
Q Consensus        83 -~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~---------~gi~HrDlkp~NILl~~~~~~kL~D  152 (441)
                       .+++|+||.+.|+|.+++.. ..++.....+++..++.||+|||+         .+|+|||||..|||+..++..-|+|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence             79999999999999999987 568999999999999999999996         3699999999999999999999999


Q ss_pred             ccccccCCcc--ccccccccCCCCcCCccccccCCCCC-----CCcchhhHhHHHHHHhcCCCC------------CC--
Q 013520          153 FGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDG-----SAADVWSCGVILFVLMAGYLP------------FG--  211 (441)
Q Consensus       153 FGls~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~-----~~~DiwSlGvil~~ll~g~~P------------f~--  211 (441)
                      ||+|..+...  .......+||..|||||+|-+.-...     .+.||||+|.|||||++...-            |.  
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999876552  23455689999999999996532221     368999999999999986433            32  


Q ss_pred             ---CCChHHHHHHh--hcCcCCCCC-C----CCHhHHHHHHHhcCCCCCCCCChHhH
Q 013520          212 ---ETDLPTLYKKI--NAAEFSCPF-W----FSTGATSLIHKILDPNPKTRIRIEGI  258 (441)
Q Consensus       212 ---~~~~~~~~~~i--~~~~~~~~~-~----~s~~~~~li~~~L~~dP~~R~t~~ei  258 (441)
                         .++..++....  .+.++.+|. |    -...+.+.+..|++.||+.|.|+.=+
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence               23344444433  233444443 2    24568899999999999999998643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.1e-32  Score=286.08  Aligned_cols=258  Identities=29%  Similarity=0.490  Sum_probs=209.9

Q ss_pred             Ce-EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecc---cccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520           10 KY-EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS---TILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus        10 ~y-~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~---~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      .| .....+|.|++|.|+.+......+.++.|.....   ..........+..|..+-..+.|||++.....+.+....+
T Consensus       318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~  397 (601)
T KOG0590|consen  318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL  397 (601)
T ss_pred             ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence            35 4578899999999999888777777777765421   1112222333778888889999999988877776666666


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc--
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--  163 (441)
                      -.||||++ +|+..+...+.+...++..+++||+.||+|+|+.||.|||+||+|++++.+|.+|++|||.+..+....  
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            66999999 999999988899999999999999999999999999999999999999999999999999998765532  


Q ss_pred             --cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHH--HHhhcCcC-------CCCCC
Q 013520          164 --ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY--KKINAAEF-------SCPFW  232 (441)
Q Consensus       164 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~--~~i~~~~~-------~~~~~  232 (441)
                        ......+|+.+|+|||++.+..|+....||||+|++++.|.+|+.||..+...+..  ........       ..-..
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  556 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSL  556 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHh
Confidence              34567889999999999999999999999999999999999999999765543221  11111111       11123


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ++...+.+|.+||++||.+|.|+++|++++||+...
T Consensus       557 lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  557 LPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             chhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            788899999999999999999999999999998653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.1e-31  Score=291.32  Aligned_cols=199  Identities=17%  Similarity=0.228  Sum_probs=146.4

Q ss_pred             hCCC-CCcceeEEEE-------EeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 013520           65 IVRH-PNIVRLHEVL-------ASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL  135 (441)
Q Consensus        65 ~l~h-pnIv~l~~~~-------~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDl  135 (441)
                      .++| +||.+++++|       .....++.++||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3345 5777777776       2334577888987 6699999965 356999999999999999999999999999999


Q ss_pred             CCCcEEEccCC-------------------CeEEeeccccccCCccc----------------cccccccCCCCcCCccc
Q 013520          136 KPENLLLDSYG-------------------NLKVSDFGLSALPQQGV----------------ELLHTTCGTPNYVAPEV  180 (441)
Q Consensus       136 kp~NILl~~~~-------------------~~kL~DFGls~~~~~~~----------------~~~~~~~gt~~Y~aPE~  180 (441)
                      ||+||||+..|                   .+|++|||+++......                ......+||+.|+|||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            99999996544                   45556666554321100                00112468999999999


Q ss_pred             cccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-CCCCCCHhHHHHHHHhcCCCCCCCCChHhHh
Q 013520          181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIR  259 (441)
Q Consensus       181 l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  259 (441)
                      +.+..| +.++|||||||+||||++|.+|+....  .....+.....+ .+....+...+++.+||.+||.+||++.|++
T Consensus       187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil  263 (793)
T PLN00181        187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL  263 (793)
T ss_pred             hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence            987776 589999999999999999999875422  111222111111 1111245678999999999999999999999


Q ss_pred             cCCCcccc
Q 013520          260 KHPWFRKN  267 (441)
Q Consensus       260 ~hp~f~~~  267 (441)
                      +||||.+.
T Consensus       264 ~h~~~~~~  271 (793)
T PLN00181        264 QSEFINEP  271 (793)
T ss_pred             hchhhhhh
Confidence            99999763

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=268.91  Aligned_cols=239  Identities=37%  Similarity=0.623  Sum_probs=212.3

Q ss_pred             eeeecCcEEEEEEEE---CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEecc
Q 013520           16 TIGEGTFAKVRFAQN---RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIILEFV   91 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~---~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~   91 (441)
                      ++|+|+||+|++++.   ...|..+|+|+..+......... .-..|..++..++ ||++++++..++.++..|+++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            479999999998753   45688999999988665443322 5567888888886 999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccC
Q 013520           92 TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG  171 (441)
Q Consensus        92 ~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~g  171 (441)
                      .||+|+..+.....+.+.....|...++.|++++|+.||+|||+|++||+++.+|++++.|||+++..-...    ..||
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~----~~cg  155 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK----IACG  155 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh----hccc
Confidence            999999999998899999999999999999999999999999999999999999999999999998654432    2299


Q ss_pred             CCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCC
Q 013520          172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT  251 (441)
Q Consensus       172 t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~  251 (441)
                      |..|||||++.  +. ...+|+||+|+++|+|++|..||..    +....|....+..|..++..++++++.++..+|.+
T Consensus       156 t~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             chhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHH
Confidence            99999999997  33 4899999999999999999999987    67778888899999999999999999999999999


Q ss_pred             CCCh-----HhHhcCCCccc
Q 013520          252 RIRI-----EGIRKHPWFRK  266 (441)
Q Consensus       252 R~t~-----~eil~hp~f~~  266 (441)
                      |...     .+|++|+||+.
T Consensus       229 rLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  229 RLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             HhccCcchhHHHhccchhee
Confidence            9855     79999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=2.5e-27  Score=228.56  Aligned_cols=254  Identities=37%  Similarity=0.601  Sum_probs=213.8

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCEEEEEEe
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP-NIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~lv~E   89 (441)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.............+.+|+.++..+.|+ +|+++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999987   78999999887655544567899999999999988 79999999988888999999


Q ss_pred             ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeeccccccCCcccc-
Q 013520           90 FVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVE-  164 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~~-  164 (441)
                      ++.++++.+.+....   .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+........ 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999998777664   799999999999999999999999999999999999999988 799999999875544321 


Q ss_pred             -----ccccccCCCCcCCccccccC--CCCCCCcchhhHhHHHHHHhcCCCCCCCCCh----HHHHHHhhcCcCC-CCCC
Q 013520          165 -----LLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFS-CPFW  232 (441)
Q Consensus       165 -----~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~-~~~~  232 (441)
                           .....+||..|+|||.+.+.  .+.....|+||+|++++++++|..||.....    ......+.....+ ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 34677899999999999764  4556899999999999999999999877663    4555555444433 2222


Q ss_pred             CC--------HhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          233 FS--------TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       233 ~s--------~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ..        ..+.+++.+++..+|..|.+..+...++|....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            21        478999999999999999999999998776543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=5.2e-29  Score=222.74  Aligned_cols=158  Identities=22%  Similarity=0.238  Sum_probs=128.5

Q ss_pred             CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCC
Q 013520           94 GELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (441)
Q Consensus        94 g~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (441)
                      |+|.+++... .++++..++.++.|++.||.|||+++      ||+|||++.++.+|+  ||++......     ...||
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence            6899999864 56999999999999999999999999      999999999999999  9998765432     23689


Q ss_pred             CCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCcCC-------CCCCCCH--hHHHHHH
Q 013520          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFS-------CPFWFST--GATSLIH  242 (441)
Q Consensus       173 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~-------~~~~~s~--~~~~li~  242 (441)
                      +.|+|||++.+..+. .++||||+||++|+|++|..||..... ......+......       .+..++.  ++.+++.
T Consensus        68 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  146 (176)
T smart00750       68 PYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMR  146 (176)
T ss_pred             ccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHH
Confidence            999999999887764 899999999999999999999976443 2233332221111       1122333  6999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCcc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      +||..||++|||+.++++|+|+.
T Consensus       147 ~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      147 VCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHhcccccccCHHHHHHHHHHH
Confidence            99999999999999999999985

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=2.6e-27  Score=233.27  Aligned_cols=168  Identities=22%  Similarity=0.229  Sum_probs=133.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECC-CCcEEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCCcce-eEEEEEe
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRHPNIVR-LHEVLAS   80 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vavK~i~~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~-l~~~~~~   80 (441)
                      +...++|++.+.||+|+||+||+|+++. +++.+|||.+.....  ........+.+|+.+|+.++|+|++. +++.   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            4567899999999999999999999876 678889998753311  12234567999999999999999985 4432   


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEccCCCeEEeeccccccC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL-KPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDl-kp~NILl~~~~~~kL~DFGls~~~  159 (441)
                       +..|+||||++|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence             46899999999999963 211   11   1468899999999999999999999 999999999999999999999865


Q ss_pred             Ccccc--------ccccccCCCCcCCcccccc
Q 013520          160 QQGVE--------LLHTTCGTPNYVAPEVLSN  183 (441)
Q Consensus       160 ~~~~~--------~~~~~~gt~~Y~aPE~l~~  183 (441)
                      .....        .....++++.|+|||.+..
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            44221        1245678999999999853

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-27  Score=225.64  Aligned_cols=250  Identities=23%  Similarity=0.306  Sum_probs=202.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE-e
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-S   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~   80 (441)
                      ...|+++...+-+|.||.||.|.+++.     .+.|-+|.++....  +-....+..|...+..+.|||+..+.++.. +
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS--~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS--QIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc--HHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            345688888999999999999976542     23455565544321  223567888999999999999999999875 4


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEee
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ--------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~--------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (441)
                      ....++++.+..-|+|..++...        ..++..+...++.|+..|++|||+.||+|.||-..|.+||+.-++||+|
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEecc
Confidence            56678888888889999988732        2466667778899999999999999999999999999999999999999


Q ss_pred             ccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCC
Q 013520          153 FGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFS  228 (441)
Q Consensus       153 FGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~  228 (441)
                      =.+++..-..+.  ......-...||+||.+.+..|. .++|+|||||+||||++ |..|+..-+..++...++.+ ++.
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla  518 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA  518 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence            999875433211  11222234579999999988875 89999999999999998 99999999988888887765 457


Q ss_pred             CCCCCCHhHHHHHHHhcCCCCCCCCChHhHh
Q 013520          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIR  259 (441)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil  259 (441)
                      .|..+|.++..++.-||..+|++||+++|+.
T Consensus       519 QP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  519 QPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence            7888999999999999999999999999975

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=4.6e-27  Score=246.37  Aligned_cols=219  Identities=31%  Similarity=0.578  Sum_probs=177.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      .-.+|+.++++..|+||.||+++++.+.+.+|+| ++++.+.-       ++   ++.....|.+|              
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil-------Rn---ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL-------RN---ILTFAGNPFVV--------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh-------hc---cccccCCccee--------------
Confidence            4568999999999999999999999999999994 54433211       11   44444555555              


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc----
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG----  162 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~----  162 (441)
                             |+-...+...+.++.+.        +.+++|+|+-||+|||+||+|++|+.-|++|++|||++...-..    
T Consensus       136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence                   55556666666666554        78999999999999999999999999999999999998642110    


Q ss_pred             -----------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC
Q 013520          163 -----------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF  231 (441)
Q Consensus       163 -----------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~  231 (441)
                                 .-.....||||.|.|||++..++| |..+|||++|+|+|+.+.|..||.+.+.++++..........|.
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence                       011245599999999999998888 59999999999999999999999999999998887666655554


Q ss_pred             C---CCHhHHHHHHHhcCCCCCCCC---ChHhHhcCCCccc
Q 013520          232 W---FSTGATSLIHKILDPNPKTRI---RIEGIRKHPWFRK  266 (441)
Q Consensus       232 ~---~s~~~~~li~~~L~~dP~~R~---t~~eil~hp~f~~  266 (441)
                      .   ++++++++|.++|+.+|..|.   .+-++.+|+||+.
T Consensus       280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            3   789999999999999999997   4568999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.7e-25  Score=217.35  Aligned_cols=247  Identities=23%  Similarity=0.304  Sum_probs=192.1

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCC----CCcceeEEEE-EeCCE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETG-ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH----PNIVRLHEVL-ASRTK   83 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~-~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----pnIv~l~~~~-~~~~~   83 (441)
                      +|.+.+.||+|+||.||.|.+..++ ..+|+|+.........   ..+..|+.++..+..    +++..+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999998774 6789998766432221   257789999998863    6999999999 58888


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-----CCeEEeecccc
Q 013520           84 VYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-----GNLKVSDFGLS  156 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-----~~~kL~DFGls  156 (441)
                      -|+||+.+ |.+|.++....  +.++...+.+++.|++.+|++||+.|++||||||+|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999988 88999877543  589999999999999999999999999999999999999865     35999999999


Q ss_pred             ccCC--ccc-------cc-cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHH---Hhh
Q 013520          157 ALPQ--QGV-------EL-LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---KIN  223 (441)
Q Consensus       157 ~~~~--~~~-------~~-~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---~i~  223 (441)
                      +...  ...       .. .....||..|+++.+..+... +.+.|+||++.++.+|+.|.+||..........   ...
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            8322  111       01 223459999999999876554 589999999999999999999997655322222   221


Q ss_pred             cCcCC--CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          224 AAEFS--CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       224 ~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .....  .....+.++.++...+-..+...+|....+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11111  223345677777777777888889988877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4.3e-27  Score=246.12  Aligned_cols=412  Identities=25%  Similarity=0.365  Sum_probs=287.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~   85 (441)
                      ...|.+.+.||+|+|+.|-.+.+.. +...+|+|.+.... ........+..|..+.+.+. |+|++++++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            6679999999999999999888754 44567778776554 23345567788999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEccCC-CeEEeeccccccCCc
Q 013520           86 IILEFVTGGELFDKI-VHQG-RLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQ  161 (441)
Q Consensus        86 lv~E~~~gg~L~~~i-~~~~-~l~e~~~~~~~~qll~aL~~LH-~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~  161 (441)
                      ++++|+.|+++++.+ ..+. ..+...+.+++.|+..++.|+| ..++.||||||+|.+++.++ .++++|||+|+....
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999999 6665 7889999999999999999999 99999999999999999999 999999999987655


Q ss_pred             ---cccccccccC-CCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH-HHHhhc--CcCCCCC--C
Q 013520          162 ---GVELLHTTCG-TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL-YKKINA--AEFSCPF--W  232 (441)
Q Consensus       162 ---~~~~~~~~~g-t~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~-~~~i~~--~~~~~~~--~  232 (441)
                         ........|| ++.|+|||...+..|.++..|+||+|+++..+++|.+||........ +.....  ..+...+  .
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence               2345677889 99999999998888999999999999999999999999977654321 111111  2222333  3


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc-cCCCCCCc-ccccCCcccccc----------------ccc-----
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK-NYNPVKCS-EEEEVNLDDVHA----------------VFD-----  289 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~-~~~~~~~~-~~~~~~~~~~~~----------------~~~-----  289 (441)
                      ++....+++.++|..+|..|.+.+++..+||+.. ........ ......+.....                .+.     
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~y~~~~~~~g~ga~g~~~~~  337 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEKYGKPGRVLGSGAYGSVRIA  337 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccccccccccccccccccccccCccccccccCCccceeeecccCceEEE
Confidence            8899999999999999999999999999999987 11111110 000000000000                000     


Q ss_pred             ----chh-hhhhhccc---cCCCCCccch--h-h---hhhcCCCC-------------Cccc-cCccccccccccce--E
Q 013520          290 ----DIE-YVAEQSEN---KVGGPLLMNA--F-E---MITLSQGL-------------NLAA-LFDRRQDYVKRQTR--F  339 (441)
Q Consensus       290 ----~~~-~~~~~~~~---~~~~~~~~~~--~-~---~~~~~~~~-------------~~~~-~~~~~~~~~~~~tr--f  339 (441)
                          +.+ +..+....   ........+.  . +   ..++++..             .... -+-.. ++...+++  |
T Consensus       338 ~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~  416 (601)
T KOG0590|consen  338 KRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK  416 (601)
T ss_pred             EecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc
Confidence                000 00000000   0000000000  0 0   00011110             0000 00011 23345666  8


Q ss_pred             EeCCCHHHHHHHHH---HHHHHcCcEEEeec-ceEEEEeeccCCCccEE----EEEEEEEEcCc---eEEEEEEecCC--
Q 013520          340 VSRQPAQVILSNIE---AVAESLSLKVHTRN-YKTRLEGVSANKTGQFA----VVLEVFEVAPS---LFMVDVRKAAG--  406 (441)
Q Consensus       340 ~s~~~~~~~~~~l~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~----~~~~i~~~~~~---~~~v~f~~~~G--  406 (441)
                      .+..++...++.|.   ..++..|+..+.-+ ..+.+.     .+|.|.    +..+||.++.+   ...++|..+++  
T Consensus       417 ~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~-----~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~  491 (601)
T KOG0590|consen  417 LTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT-----ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYL  491 (601)
T ss_pred             cchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe-----cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCc
Confidence            99999999999999   66788887654322 333321     122232    46677888755   56799999999  


Q ss_pred             -----CchHHHHHHHHHHHhcccce
Q 013520          407 -----DTLEYHKFYKNFCAKLENII  426 (441)
Q Consensus       407 -----d~le~~~~~~~~~~~l~~~v  426 (441)
                           ++.||+.++..+-...-..+
T Consensus       492 apE~~~~~~ydpr~vDiwS~~ii~~  516 (601)
T KOG0590|consen  492 APEVLTGKEYDPRAVDVWSCGIIYI  516 (601)
T ss_pred             CcccccccccCcchhhhhhccceEE
Confidence                 99999999999888854444

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-24  Score=194.19  Aligned_cols=245  Identities=20%  Similarity=0.290  Sum_probs=196.5

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~   83 (441)
                      ....+.|.++++||.|+||.+|+|....+|+.||||+-....-     ..++..|..+.+.|++ ..|..+..+..+...
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            4567899999999999999999999999999999998655331     2457789999999975 788888888999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CCCeEEeeccccccC
Q 013520           84 VYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALP  159 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DFGls~~~  159 (441)
                      -.+|||.. |.+|.++..- ...++...+.-++-|++.-++|+|.++++||||||+|.|..-   ...+.|+|||+|+..
T Consensus        86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999988 7788887764 457899999999999999999999999999999999999963   357999999999865


Q ss_pred             Ccc-------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC---hHHHHHHhhcCcCCC
Q 013520          160 QQG-------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKKINAAEFSC  229 (441)
Q Consensus       160 ~~~-------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~  229 (441)
                      ...       -+......||..|.+--...+... +...|+=|+|.+|..+..|.+||.+..   ..+-+++|.....+.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~  243 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST  243 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence            431       112234569999988766654332 468899999999999999999998754   345677777766665


Q ss_pred             CC-----CCCHhHHHHHHHhcCCCCCCCCChH
Q 013520          230 PF-----WFSTGATSLIHKILDPNPKTRIRIE  256 (441)
Q Consensus       230 ~~-----~~s~~~~~li~~~L~~dP~~R~t~~  256 (441)
                      |.     .+|.++.-.+.-|-..-=++-|...
T Consensus       244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            53     4788888888888766555556543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=2.3e-24  Score=195.35  Aligned_cols=144  Identities=22%  Similarity=0.271  Sum_probs=114.8

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH-----------------------HHHHHHHHHHHHHhCCCCC
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----------------------MVDQIKREISIMKIVRHPN   70 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~hpn   70 (441)
                      ...||+|+||.||+|.+. +|+.||||+++........                       ......+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999765321110                       0123456999999998887


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEccCCCeE
Q 013520           71 IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC-HSKGVYHRDLKPENLLLDSYGNLK  149 (441)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~L-H~~gi~HrDlkp~NILl~~~~~~k  149 (441)
                      +.....+...  ..++||||++|+++.......+.+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            7544433222  2389999999988776655567899999999999999999999 799999999999999998 48999


Q ss_pred             EeeccccccCCc
Q 013520          150 VSDFGLSALPQQ  161 (441)
Q Consensus       150 L~DFGls~~~~~  161 (441)
                      |+|||+|.....
T Consensus       158 LiDFG~a~~~~~  169 (190)
T cd05147         158 IIDVSQSVEHDH  169 (190)
T ss_pred             EEEccccccCCC
Confidence            999999875433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=1.7e-24  Score=199.21  Aligned_cols=173  Identities=16%  Similarity=0.209  Sum_probs=135.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHH------HHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ------IKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~------~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      .-++|++.+.||.|+||.||++.+  ++..+|+|++.............      +++|+..+.+++||+|..+.+++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            347899999999999999999765  46689999997655444444333      6899999999999999999988664


Q ss_pred             C--------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEee
Q 013520           81 R--------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (441)
Q Consensus        81 ~--------~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (441)
                      .        +..+++|||++|.+|.+..    .+++    ....++..++..||+.|++|||++|+||+++.+| ++|+|
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence            3        3588999999999998763    2333    2456999999999999999999999999999988 99999


Q ss_pred             ccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHH
Q 013520          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL  203 (441)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~l  203 (441)
                      ||.+........ .           ..++....|. .++|+||||+++..+
T Consensus       178 fg~~~~~~e~~a-~-----------d~~vler~y~-~~~di~~lg~~~~~~  215 (232)
T PRK10359        178 LSGKRCTAQRKA-K-----------DRIDLERHYG-IKNEIKDLGYYLLIY  215 (232)
T ss_pred             CCCcccccchhh-H-----------HHHHHHhHhc-ccccccceeEeehHH
Confidence            998765432111 0           1133445565 799999999988654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-23  Score=196.45  Aligned_cols=241  Identities=21%  Similarity=0.318  Sum_probs=191.7

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv   87 (441)
                      -.|.++++||+|+||..+.|.+.-++++||||.-....     ...+++.|....+.|. .++|...+.+...+.+-.+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            47999999999999999999999999999999754422     3567899999999984 79999999999999888999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-----CeEEeeccccccCCc
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-----NLKVSDFGLSALPQQ  161 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-----~~kL~DFGls~~~~~  161 (441)
                      +|+. |.+|.|+..-. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+     .+.++|||+|+....
T Consensus       103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9988 77887777654 4799999999999999999999999999999999999997544     489999999986654


Q ss_pred             ccc-------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC---CChHHHHHHhhcCcCCCCC
Q 013520          162 GVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPF  231 (441)
Q Consensus       162 ~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~~~  231 (441)
                      ...       ...+..||..||+--...+... +..-|+=|||-+++..|-|.+||.+   .+..+-|++|......-|.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence            221       2235569999999877766554 4789999999999999999999976   4456778888665554432


Q ss_pred             -----CCCHhHHHHHHHhcCCCCCCCCChH
Q 013520          232 -----WFSTGATSLIHKILDPNPKTRIRIE  256 (441)
Q Consensus       232 -----~~s~~~~~li~~~L~~dP~~R~t~~  256 (441)
                           .+|.++..-++-.-..+=.+-|..+
T Consensus       261 ~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd  290 (449)
T KOG1165|consen  261 EVLCEGFPEEFATYLRYVRRLDFFETPDYD  290 (449)
T ss_pred             HHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence                 3566655555544444444444443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=8.3e-24  Score=200.31  Aligned_cols=235  Identities=27%  Similarity=0.356  Sum_probs=152.9

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC----------CCcceeEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH----------PNIVRLHEVLA   79 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----------pnIv~l~~~~~   79 (441)
                      .+..++.||.|+++.||.+.+..||+.+|+|++...........+.+++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            45678899999999999999999999999999877664444456777777655544322          22333333321


Q ss_pred             ---------eC---C-----EEEEEEeccCCCChHHHHH---hcCCC---CHHHHHH-HHHHHHHHHHHHHHCCceecCC
Q 013520           80 ---------SR---T-----KVYIILEFVTGGELFDKIV---HQGRL---LENDCRR-YFQQLIDAVAHCHSKGVYHRDL  135 (441)
Q Consensus        80 ---------~~---~-----~~~lv~E~~~gg~L~~~i~---~~~~l---~e~~~~~-~~~qll~aL~~LH~~gi~HrDl  135 (441)
                               ..   +     +.+++|+-+ .++|.+.+.   .....   ....++. +..|++..+++||+.|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     236677766 457766653   23332   1223333 3489999999999999999999


Q ss_pred             CCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcCCccccccC-------CCCCCCcchhhHhHHHHHHhcCCC
Q 013520          136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-------GYDGSAADVWSCGVILFVLMAGYL  208 (441)
Q Consensus       136 kp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-------~~~~~~~DiwSlGvil~~ll~g~~  208 (441)
                      +|+|++++.+|.++|+||+.........   .....+..|.|||.....       ...+.+.|.|+||+++|.|.+|..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            9999999999999999998766443321   113455789999987432       123578899999999999999999


Q ss_pred             CCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCC
Q 013520          209 PFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTR  252 (441)
Q Consensus       209 Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  252 (441)
                      ||+..........    .+.....+|+.+++||+++|++||.+|
T Consensus       249 Pf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9987643221111    333333689999999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.8e-23  Score=189.73  Aligned_cols=145  Identities=19%  Similarity=0.283  Sum_probs=116.6

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch----------------------H-HHHHHHHHHHHHHhCCCC
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH----------------------R-MVDQIKREISIMKIVRHP   69 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~----------------------~-~~~~~~~Ei~il~~l~hp   69 (441)
                      +.+.||+|++|.||+|.+. +|+.||||+++.......                      . ......+|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 899999999987531100                      0 122356899999999999


Q ss_pred             CcceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCe
Q 013520           70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNL  148 (441)
Q Consensus        70 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~  148 (441)
                      ++.....+....  .|+||||++|+++.........+++..+..++.|++.++.++|+ .||+||||||+||+++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            886555444333  48999999988665443345678889999999999999999999 9999999999999999 7999


Q ss_pred             EEeeccccccCCc
Q 013520          149 KVSDFGLSALPQQ  161 (441)
Q Consensus       149 kL~DFGls~~~~~  161 (441)
                      +|+|||++.....
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.90  E-value=3.3e-24  Score=225.27  Aligned_cols=245  Identities=24%  Similarity=0.371  Sum_probs=182.1

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccc-ccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~-~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      .|...+.||.+.|=+|.+|++.+ |. |+||++-+.. ...-+...+...|++ ...+++||.+.+.-+.......|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            68899999999999999999863 54 9999986643 112222333444555 56669999999999988888899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC---Cccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP---QQGVEL  165 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~---~~~~~~  165 (441)
                      +|... +|+|.+....-+..-+-+.|+.||+.||.-||+.||+|||||.|||||+.-+-+.|+||..-+..   +.+...
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            99965 89999988777778888899999999999999999999999999999999889999999754321   111111


Q ss_pred             ----cccccCCCCcCCccccccCC----------CCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcCCC-
Q 013520          166 ----LHTTCGTPNYVAPEVLSNRG----------YDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSC-  229 (441)
Q Consensus       166 ----~~~~~gt~~Y~aPE~l~~~~----------~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~-  229 (441)
                          ..+..--.+|.|||.+....          ..+++.||||+||+++||++ |++||.-.   ++..-...+.... 
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGNADDPE  256 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccCccCHH
Confidence                12223345799999985421          12468899999999999998 89999422   2211111110000 


Q ss_pred             ---CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          230 ---PFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       230 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                         ..--+...+.+|..|++.||++|.++++.|+-
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence               00024578999999999999999999999874

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=4.2e-22  Score=179.78  Aligned_cols=189  Identities=16%  Similarity=0.185  Sum_probs=141.0

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHH-HHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-VDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~-~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ..+...|++|+||+|+++..  .+..++.+.+.....-.... ...+.+|+.+|++|+ |+++++++++    +..|++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45678999999999998865  56777766654433211111 125789999999995 5889999886    4579999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEccCCCeEEeeccccccCCccccc--
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL-KPENLLLDSYGNLKVSDFGLSALPQQGVEL--  165 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDl-kp~NILl~~~~~~kL~DFGls~~~~~~~~~--  165 (441)
                      ||+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++.........  
T Consensus        78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99999998754321      1 2357889999999999999999999 799999999999999999999855443211  


Q ss_pred             -----------cccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCC
Q 013520          166 -----------LHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGE  212 (441)
Q Consensus       166 -----------~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~  212 (441)
                                 ......++.|++|+.-.-.. ..-...++++.|.-+|.++|+..|+-+
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence                       11223678888888643221 111467999999999999999988643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.1e-23  Score=197.36  Aligned_cols=188  Identities=25%  Similarity=0.381  Sum_probs=141.1

Q ss_pred             CCCCcceeEEEEEe---------------------------CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 013520           67 RHPNIVRLHEVLAS---------------------------RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI  119 (441)
Q Consensus        67 ~hpnIv~l~~~~~~---------------------------~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll  119 (441)
                      +|||||++...|.+                           +..+|+||...+ .+|..++-. ...+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHH
Confidence            59999999877622                           346899998764 478888765 4567778888999999


Q ss_pred             HHHHHHHHCCceecCCCCCcEEEc--cCC--CeEEeeccccccCCcccc------ccccccCCCCcCCccccccCCC---
Q 013520          120 DAVAHCHSKGVYHRDLKPENLLLD--SYG--NLKVSDFGLSALPQQGVE------LLHTTCGTPNYVAPEVLSNRGY---  186 (441)
Q Consensus       120 ~aL~~LH~~gi~HrDlkp~NILl~--~~~--~~kL~DFGls~~~~~~~~------~~~~~~gt~~Y~aPE~l~~~~~---  186 (441)
                      +|+.|||++||+|||+|.+|||+.  +++  .+.++|||.+--.+...-      ..-..-|.-.-||||+....+-   
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999995  333  589999998643222100      1123347778999999854221   


Q ss_pred             --CCCCcchhhHhHHHHHHhcCCCCCCCCChHHHH-HHhh-cCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChH
Q 013520          187 --DGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-KKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE  256 (441)
Q Consensus       187 --~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~-~~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  256 (441)
                        +-.++|.|++|-+.||++....||.......+. +... ..-...|..+++.+++++..+|+.||++|++..
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence              125899999999999999999999874432211 1122 233456777999999999999999999999864

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=2.3e-21  Score=177.68  Aligned_cols=136  Identities=19%  Similarity=0.204  Sum_probs=109.1

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-----CCCCcceeEEEEEeCC---E
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-----RHPNIVRLHEVLASRT---K   83 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~---~   83 (441)
                      .-.+.||+|+||.||.  ++.++.. +||++.....   ...+.+.+|+.+++.+     +||||++++++++++.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            3357899999999995  7777665 6999876432   2346789999999999     5799999999999874   4


Q ss_pred             EE-EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCcEEEccC----CCeEEeeccc
Q 013520           84 VY-IILEF--VTGGELFDKIVHQGRLLENDCRRYFQQLIDAV-AHCHSKGVYHRDLKPENLLLDSY----GNLKVSDFGL  155 (441)
Q Consensus        84 ~~-lv~E~--~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL-~~LH~~gi~HrDlkp~NILl~~~----~~~kL~DFGl  155 (441)
                      ++ +|+||  +.+|+|.+++.. +.+++.  ..++.|++.++ +|||+++|+||||||+|||++.+    +.++|+||+.
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            34 78999  557999999976 456666  35678888777 99999999999999999999743    3799999554


Q ss_pred             c
Q 013520          156 S  156 (441)
Q Consensus       156 s  156 (441)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            4

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.5e-22  Score=182.63  Aligned_cols=245  Identities=20%  Similarity=0.311  Sum_probs=197.4

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++..++.+|.+.-.|+.|+++..  |..+++|++....... +....+..|.-.|+.+.||||+.+++.+.++.++
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            345666778889999999999999986  5567778886654432 2345688899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCC-cee-cCCCCCcEEEccCCCeEEe--ecccccc
Q 013520           85 YIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKG-VYH-RDLKPENLLLDSYGNLKVS--DFGLSAL  158 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~~LH~~g-i~H-rDlkp~NILl~~~~~~kL~--DFGls~~  158 (441)
                      .++..|++.|+|+..+.....  ++..++.+++.+++.|+.|||+.. ++- --|....++||++-..+|+  |--++..
T Consensus       263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq  342 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ  342 (448)
T ss_pred             eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence            999999999999999976543  577889999999999999999973 433 3688999999988766553  4333221


Q ss_pred             CCccccccccccCCCCcCCccccccCCCC--CCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh--hcCcCCCCCCCC
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFS  234 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~--~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s  234 (441)
                        .     ....-+|.|++||.++..+.+  -.++|+|||++++|||.|...||.+....+.--+|  ...+..+|+.++
T Consensus       343 --e-----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis  415 (448)
T KOG0195|consen  343 --E-----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS  415 (448)
T ss_pred             --c-----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence              1     122347899999999876554  34799999999999999999999987777665554  345668999999


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHh
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIR  259 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil  259 (441)
                      .....|+.-|+..||.+||.++.|.
T Consensus       416 ~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  416 RHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999999998763

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=3.5e-21  Score=180.35  Aligned_cols=146  Identities=17%  Similarity=0.223  Sum_probs=116.5

Q ss_pred             CeEEEeeeeecCcEEEEEEE-ECCCCcEEEEEEeecccccc---------------------hHHHHHHHHHHHHHHhCC
Q 013520           10 KYEVGRTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILK---------------------HRMVDQIKREISIMKIVR   67 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~-~~~~~~~vavK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~   67 (441)
                      .|++.+.||+|++|.||+|. +..+|+.||+|++.......                     ......+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999999 66789999999997643210                     001134678999999997


Q ss_pred             CC--CcceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEcc
Q 013520           68 HP--NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG-VYHRDLKPENLLLDS  144 (441)
Q Consensus        68 hp--nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~g-i~HrDlkp~NILl~~  144 (441)
                      +.  .+.++++.    ...|+||||+.|++|..............+..++.|++.++.+||+.| |+||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            53  34444442    235899999999888776544556677778899999999999999999 99999999999999 


Q ss_pred             CCCeEEeeccccccCC
Q 013520          145 YGNLKVSDFGLSALPQ  160 (441)
Q Consensus       145 ~~~~kL~DFGls~~~~  160 (441)
                      ++.++|+|||.+....
T Consensus       184 ~~~i~LiDFg~a~~~~  199 (237)
T smart00090      184 DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCCEEEEEChhhhccC
Confidence            8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=3.5e-19  Score=164.03  Aligned_cols=138  Identities=22%  Similarity=0.322  Sum_probs=116.2

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++.||+|++|.||+|..  .|..+++|+.........     .....+.+|+.++..+.|+++.....++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  677899998654332211     12245788999999999999988888877788899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                      ||++|++|.+.+.....    ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998865332    7788999999999999999999999999999999 78999999998864

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=5e-20  Score=197.24  Aligned_cols=232  Identities=22%  Similarity=0.322  Sum_probs=172.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~   84 (441)
                      -..|.|-+.||+|+||+||.|...+ |+.||+|+=.....=.--...+      ++.+|+   -+.|..+.....-.+.-
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q------~~~RLk~~~~~~~~~~~~a~~~~~~S  769 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQ------VMERLKPQMLPSIMHISSAHVFQNAS  769 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHH------HHHhhchhhhcchHHHHHHHccCCcc
Confidence            4579999999999999999999876 9999999854432111111222      233333   34566666666667788


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-------CCCeEEeeccccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-------YGNLKVSDFGLSA  157 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-------~~~~kL~DFGls~  157 (441)
                      ++|+||.+.|+|.+++...+.+++..+..+..|++..|++||..||||+||||+|.||..       +--++|+|||.|.
T Consensus       770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            999999999999999999899999999999999999999999999999999999999942       2359999999986


Q ss_pred             cCCc--cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CC----CC
Q 013520          158 LPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FS----CP  230 (441)
Q Consensus       158 ~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~----~~  230 (441)
                      .+.-  ........++|-.+-.+|+..+.++. +.+|.|.++-+++.||.|..-=           ...+. +.    ++
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~~~  917 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTNFP  917 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceeccccch
Confidence            4432  22355677899999999999998885 9999999999999999996321           11111 11    11


Q ss_pred             C-CCCHhHHHHHHHhcCCCCCCCCChHhH
Q 013520          231 F-WFSTGATSLIHKILDPNPKTRIRIEGI  258 (441)
Q Consensus       231 ~-~~s~~~~~li~~~L~~dP~~R~t~~ei  258 (441)
                      . |--.-..+++..+|..|-..=|...+|
T Consensus       918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l  946 (974)
T KOG1166|consen  918 RYWKRDMWNKFFDLLLNPDCDTLPNLQEL  946 (974)
T ss_pred             hhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence            1 122335578888888554444444444

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=3.5e-19  Score=162.63  Aligned_cols=140  Identities=19%  Similarity=0.310  Sum_probs=110.8

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch-------------------HHHHHHHHHHHHHHhCCCCC-
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-------------------RMVDQIKREISIMKIVRHPN-   70 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~hpn-   70 (441)
                      |.+.+.||+|+||.||++... +|+.||||++........                   .......+|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999875 799999999865431000                   01123678899999998774 


Q ss_pred             -cceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeE
Q 013520           71 -IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK  149 (441)
Q Consensus        71 -Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~k  149 (441)
                       ++..++    ....+++|||++|++|......      .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2455899999999998765321      45667889999999999999999999999999999999999


Q ss_pred             EeeccccccCCc
Q 013520          150 VSDFGLSALPQQ  161 (441)
Q Consensus       150 L~DFGls~~~~~  161 (441)
                      |+|||++.....
T Consensus       166 liDfg~~~~~~~  177 (198)
T cd05144         166 IIDWPQMVSTDH  177 (198)
T ss_pred             EEECCccccCCC
Confidence            999999865544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=1.1e-18  Score=159.36  Aligned_cols=134  Identities=19%  Similarity=0.275  Sum_probs=109.1

Q ss_pred             eeeecCcEEEEEEEECCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEec
Q 013520           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      .||+|+||.||+|..  +|..+++|..........     .....+.+|+.+++.++|+++....-++...+..+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  578899998654322211     1235678899999999988766655556667778999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      ++|++|.+.+.....       .++.|++.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999988754321       7899999999999999999999999999999 799999999998653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=6.2e-19  Score=177.35  Aligned_cols=198  Identities=23%  Similarity=0.338  Sum_probs=156.6

Q ss_pred             HHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCCCCCcE
Q 013520           63 MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGV-YHRDLKPENL  140 (441)
Q Consensus        63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi-~HrDlkp~NI  140 (441)
                      |+.+.|.|+.++++.+.++...++|.+||+.|+|.|.+.. ...++......++++|+.|+.|+|+..| .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3567899999999999999999999999999999999987 4467777777889999999999999866 9999999999


Q ss_pred             EEccCCCeEEeeccccccCCc--cccccccccCCCCcCCccccccCCC------CCCCcchhhHhHHHHHHhcCCCCCCC
Q 013520          141 LLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGY------DGSAADVWSCGVILFVLMAGYLPFGE  212 (441)
Q Consensus       141 Ll~~~~~~kL~DFGls~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~------~~~~~DiwSlGvil~~ll~g~~Pf~~  212 (441)
                      ++|....+||+|||+......  .........-..-|.|||.+.....      .+.+.||||+|++++|+++...||+.
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999876642  1111122224456999999976422      24679999999999999999999976


Q ss_pred             CCh----HHHHHHhhc-CcCCCCC------CCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          213 TDL----PTLYKKINA-AEFSCPF------WFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       213 ~~~----~~~~~~i~~-~~~~~~~------~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ...    .+....+.. +...+-+      .+.+++..++++|+..+|.+||+++++..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            322    234444444 3222212      24557999999999999999999999854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.78  E-value=4.6e-20  Score=182.43  Aligned_cols=206  Identities=23%  Similarity=0.353  Sum_probs=150.8

Q ss_pred             HHHHHHHHHHHHhCCCCCcceeEE-------EE-----EeCCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHH
Q 013520           53 VDQIKREISIMKIVRHPNIVRLHE-------VL-----ASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQ  117 (441)
Q Consensus        53 ~~~~~~Ei~il~~l~hpnIv~l~~-------~~-----~~~~~~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~q  117 (441)
                      .....+++..+....|.+..-+.+       .+     .....+||.|++|...+|.++|....   ..+......++.|
T Consensus       288 ~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q  367 (516)
T KOG1033|consen  288 CKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQ  367 (516)
T ss_pred             hhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHh
Confidence            344556666665554433333222       11     11335899999999999999997543   3556678899999


Q ss_pred             HHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc------cccccccCCCCcCCccccccCCCCCCCc
Q 013520          118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV------ELLHTTCGTPNYVAPEVLSNRGYDGSAA  191 (441)
Q Consensus       118 ll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~  191 (441)
                      +..|++|   +|.+|||+||.||+...++.+||.|||+.+......      .......||..||+||.+.+..|. .++
T Consensus       368 ~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kv  443 (516)
T KOG1033|consen  368 IAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKV  443 (516)
T ss_pred             hccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhc
Confidence            9999999   999999999999999999999999999987654432      123566799999999999988875 999


Q ss_pred             chhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcCCCCCCC-CHhHHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFWF-STGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       192 DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      ||||||+||+||+. =..+|..   ......+..+.++...+. -+.-..|+.+||.+.|.+||++.+.-.|+|.+
T Consensus       444 dIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  444 DIYALGLILAELLIQFSTQFER---IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             chhhHHHHHHHHHHHhccHHHH---HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            99999999999997 3333321   122223344444322332 34556899999999999999888888887753

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=4e-18  Score=178.64  Aligned_cols=139  Identities=18%  Similarity=0.272  Sum_probs=112.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      .|...+.||+|+||.||++....  ..+++|+.......     .....+.+.+|+.+++.++|++++....+..+....
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34567899999999999998754  34455443222111     111235688999999999999999888887777788


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      ++||||++|++|.+.+.        ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||++...
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            99999999999998875        456789999999999999999999999999999 6789999999998753

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=3e-18  Score=154.69  Aligned_cols=139  Identities=22%  Similarity=0.343  Sum_probs=101.5

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHH---------------------HHHHHHHHHHhCCCC--C
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---------------------QIKREISIMKIVRHP--N   70 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~hp--n   70 (441)
                      ++.||+|+||.||+|.+. +|+.||||++............                     ....|...+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999986 8999999998764322111111                     124566677666543  3


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCe
Q 013520           71 IVRLHEVLASRTKVYIILEFVTGGELFD-KIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNL  148 (441)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~-~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~  148 (441)
                      +.+.++.    ...+++|||++|+.+.. .+.. ... ...+..++.+++.++.++|+ .||+||||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD-VRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhh-hhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            4555543    24589999999954322 1111 111 16788999999999999999 9999999999999999 8999


Q ss_pred             EEeeccccccCC
Q 013520          149 KVSDFGLSALPQ  160 (441)
Q Consensus       149 kL~DFGls~~~~  160 (441)
                      +|+|||.+....
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.75  E-value=3.7e-19  Score=187.42  Aligned_cols=261  Identities=27%  Similarity=0.452  Sum_probs=215.8

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...+.+.+.+-+-+|+++.++.+.-..+|...+.|+..+.........+.+..+-.++-...+|.++.....+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            35678899999999999999999988888777887765543333333444555555555556777777666667778899


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC-----
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-----  160 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~-----  160 (441)
                      ++++|+.|++|...+...+..+++.++.++..+..+++|||+..+.|||++|.|+++..+|+.+++|||......     
T Consensus       881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            999999999999999998889999999999999999999999999999999999999999999999998322100     


Q ss_pred             ----------------cc----------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC
Q 013520          161 ----------------QG----------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD  214 (441)
Q Consensus       161 ----------------~~----------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~  214 (441)
                                      ..          ........||+.|.+||.+.+... +..+|+|+.|+++++.++|.+||+..+
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence                            00          011234469999999999987654 589999999999999999999999999


Q ss_pred             hHHHHHHhhcCcCCCCCC---CCHhHHHHHHHhcCCCCCCCCChH---hHhcCCCcccc
Q 013520          215 LPTLYKKINAAEFSCPFW---FSTGATSLIHKILDPNPKTRIRIE---GIRKHPWFRKN  267 (441)
Q Consensus       215 ~~~~~~~i~~~~~~~~~~---~s~~~~~li~~~L~~dP~~R~t~~---eil~hp~f~~~  267 (441)
                      .....+.|.....+.|..   .+.++++++.++|..+|.+|.++.   +...||||+..
T Consensus      1040 pq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1040 PQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             hhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            999999998888776654   799999999999999999999988   99999999863

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=1.5e-16  Score=149.29  Aligned_cols=137  Identities=23%  Similarity=0.352  Sum_probs=104.3

Q ss_pred             eeee-ecCcEEEEEEEECCCCcEEEEEEeecccc----c------chHHHHHHHHHHHHHHhCCCCCc--ceeEEEEEeC
Q 013520           15 RTIG-EGTFAKVRFAQNRETGESVAMKVLAKSTI----L------KHRMVDQIKREISIMKIVRHPNI--VRLHEVLASR   81 (441)
Q Consensus        15 ~~LG-~G~~g~V~~a~~~~~~~~vavK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~   81 (441)
                      ..|| .|+.|+||.+...  +..+++|.+.....    .      .......+.+|+.++..++|++|  ++.+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4566 7777778877663  77899998865321    0      01123567889999999998775  6777664432


Q ss_pred             C----EEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           82 T----KVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        82 ~----~~~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      .    ..++|||+++| .+|.+.+.. ..+++..    +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence            2    23599999997 688888764 4555543    578999999999999999999999999999899999999987


Q ss_pred             cc
Q 013520          157 AL  158 (441)
Q Consensus       157 ~~  158 (441)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            64

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.68  E-value=2.9e-16  Score=135.39  Aligned_cols=133  Identities=20%  Similarity=0.300  Sum_probs=113.3

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCEEEEEEec
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      +++.||+|.++.||++....  ..+++|.......     ...+.+|+.+++.++|  .++++++.+....+..|++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46889999999999999753  7899998865432     3568889999999976  5899999998888899999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK---GVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~---gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      +.|+.+...       +......++.+++.++.++|..   +++|+|++|+||+++..+.++++|||.+...
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            998877543       5566778899999999999985   7999999999999999899999999988643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=1e-15  Score=154.29  Aligned_cols=251  Identities=20%  Similarity=0.214  Sum_probs=191.5

Q ss_pred             CeEEEeeeee--cCcEEEEEEEE--CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520           10 KYEVGRTIGE--GTFAKVRFAQN--RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus        10 ~y~i~~~LG~--G~~g~V~~a~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      .+.+...+|.  |.+|.||.+..  ..++..+|+|.-+....... ....=.+|+.-.+.+ .|+|.++.+..+...+..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~-~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL-DSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc-ccccccchhhcccccCccccccccCcccccCCcc
Confidence            4567888999  99999999998  88999999997433221111 112234567777777 499999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCcEEEccC-CCeEEeecccccc
Q 013520           85 YIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLID----AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSAL  158 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~----aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~  158 (441)
                      |+-+|+|. .+|..+...-.. +++..++..+.+...    ||.++|+.+++|-|+||.||++..+ ...+++|||+...
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~  272 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK  272 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence            99999995 677777765444 889999999999999    9999999999999999999999998 8899999999876


Q ss_pred             CCcccccc-----ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC---ChHHHHHHhhcCcCCCC
Q 013520          159 PQQGVELL-----HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAAEFSCP  230 (441)
Q Consensus       159 ~~~~~~~~-----~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~  230 (441)
                      +..+.-..     ...-|...|++||.+.+  ..+...||+|+|.+..+-.+|..+....   .+.......  ....+.
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e~~  348 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY--IPLEFC  348 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc--Cchhhh
Confidence            65543221     22257888999999864  3458999999999999888776555322   222211111  111122


Q ss_pred             CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ...+.++...+..|++.+|..|++.+.++.|++...
T Consensus       349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             cCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            234667777999999999999999999999999863

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=2.2e-15  Score=155.35  Aligned_cols=147  Identities=20%  Similarity=0.388  Sum_probs=102.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc---------------------------ch----HHHHH
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---------------------------KH----RMVDQ   55 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~---------------------------~~----~~~~~   55 (441)
                      .+..|+. +.||+|++|+||+|+.+.+|+.||||+.+.....                           ..    +..+.
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3556777 8999999999999999988999999999754200                           00    11222


Q ss_pred             H------HHHHHHHHhC----CCCCcceeEEEEEe-CCEEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHH
Q 013520           56 I------KREISIMKIV----RHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDK--IVHQG----RLLENDCRRYFQQL  118 (441)
Q Consensus        56 ~------~~Ei~il~~l----~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~--i~~~~----~l~e~~~~~~~~ql  118 (441)
                      +      .+|+..+.++    .+.+.+.+-.++.+ .+..++||||++|+.+.+.  +...+    .+.+..+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence            3      3344444444    23444444444433 4567899999999999764  33333    24455566666666


Q ss_pred             HHHHHHHHHCCceecCCCCCcEEEccCC----CeEEeeccccccCCc
Q 013520          119 IDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQ  161 (441)
Q Consensus       119 l~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~~~~~  161 (441)
                      +       ..|++|+|+||.||+++.+|    .++++|||++.....
T Consensus       277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            5       58999999999999999888    999999999876544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=5e-14  Score=143.44  Aligned_cols=143  Identities=22%  Similarity=0.327  Sum_probs=97.8

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccc---------------------------hH----HHH------HHH
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK---------------------------HR----MVD------QIK   57 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~---------------------------~~----~~~------~~~   57 (441)
                      +.||.|++|.||+|+.+ +|+.||||+.+......                           ..    ...      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999975 78999999985431000                           00    001      234


Q ss_pred             HHHHHHHhC----CCCCcceeEEEE-EeCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 013520           58 REISIMKIV----RHPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLID-AVAHCHSKGV  130 (441)
Q Consensus        58 ~Ei~il~~l----~hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~-aL~~LH~~gi  130 (441)
                      +|...+.++    +|.+-+.+-.++ ...+..++||||++|++|.+..... ...   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            455555554    233223332333 2234578999999999998876432 122   22345555555 4678899999


Q ss_pred             eecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520          131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus       131 ~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      +|+|++|.||+++.+|.++++|||++.....
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999876543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.55  E-value=1.2e-13  Score=140.96  Aligned_cols=238  Identities=17%  Similarity=0.221  Sum_probs=163.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...--|++ ....-++.+..-.|..+.++.+|.|.+.+...-   .....+++-++-|+.++||||+++++.++..+.+|
T Consensus        10 ~~~fpY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~y   85 (690)
T KOG1243|consen   10 SSQFPYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLY   85 (690)
T ss_pred             cccCCccc-ccccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceE
Confidence            33445666 333333333332466678899999998876542   44567888899999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH-~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +|+|.+.  .|-.++...+   ......-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++........
T Consensus        86 lvTErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~  160 (690)
T KOG1243|consen   86 LVTERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA  160 (690)
T ss_pred             EEeeccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc
Confidence            9999884  4555565433   6677778899999999998 56899999999999999999999999998764433221


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      ......---.|..|+.+....   -..|.|-|||++++++.|..+  ..+           ....+..++.....+..+-
T Consensus       161 ~~~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~--~~~-----------~~~~~~~ipk~~~~~~~k~  224 (690)
T KOG1243|consen  161 PAKSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLL--TKT-----------DLSNTGKIPKALIELYCKK  224 (690)
T ss_pred             ccccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccC--cch-----------hhhccCccchhHHHHHHHH
Confidence            122222233466777653222   357999999999999999322  211           1122222343444455445


Q ss_pred             cCCCCCCCCChH-----hHhcCCCccccC
Q 013520          245 LDPNPKTRIRIE-----GIRKHPWFRKNY  268 (441)
Q Consensus       245 L~~dP~~R~t~~-----eil~hp~f~~~~  268 (441)
                      +.-.+..||...     -.+-|+||++.+
T Consensus       225 ~~~~~~~r~n~~~~~~~~~~~~gff~n~f  253 (690)
T KOG1243|consen  225 LGATELKRPNKLRFILECRLLGGFFRNDF  253 (690)
T ss_pred             hccccccccchhhHHHHHHhccccccchH
Confidence            555566666532     234599998764

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.53  E-value=1.7e-13  Score=123.71  Aligned_cols=143  Identities=16%  Similarity=0.215  Sum_probs=105.9

Q ss_pred             EeeeeecCcEEEEEEEECC------CCcEEEEEEeecccc-------------------cchHHHH----HHHHHHHHHH
Q 013520           14 GRTIGEGTFAKVRFAQNRE------TGESVAMKVLAKSTI-------------------LKHRMVD----QIKREISIMK   64 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~------~~~~vavK~i~~~~~-------------------~~~~~~~----~~~~Ei~il~   64 (441)
                      ...||.|.-+.||.|....      .+..+|||+.+....                   .+.+...    ..++|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998653      357999999754211                   0011122    3448999999


Q ss_pred             hCCC--CCcceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEE
Q 013520           65 IVRH--PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC-HSKGVYHRDLKPENLL  141 (441)
Q Consensus        65 ~l~h--pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~L-H~~gi~HrDlkp~NIL  141 (441)
                      ++..  -++..++++    ..-++||||+.++.+......+..+++..+..++.|++.++..| |+.|++|+||+|.||+
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            9953  566777764    45689999998754433222334566677788899999999998 8999999999999999


Q ss_pred             EccCCCeEEeeccccccCCc
Q 013520          142 LDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~  161 (441)
                      ++ +|.+.|+|||.+-...+
T Consensus       158 ~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             EE-CCcEEEEECCCceeCCC
Confidence            97 47899999998865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1.7e-14  Score=145.51  Aligned_cols=253  Identities=21%  Similarity=0.180  Sum_probs=194.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEEC-CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNR-ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      ....++|.++..||.|.|+.|+..... .++..|++|...+........+. -..|+.+...+ .|.++++++..+....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence            345788999999999999999988755 57788999988665544433222 23567776666 5999999999998888


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-CCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~~~~  161 (441)
                      +.|+-.|||+++++...+.-...+.+...++...|++.++.++|+..++|+|+||+||++..+ +..++.|||..+...-
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence            889999999999988777666678889999999999999999999999999999999999986 7889999998864222


Q ss_pred             cccccccccCCCCcC-CccccccCCCCCCCcchhhHhHHHHHHhcCCCC-CCCCChHHHHHHhhcCcCCCCCCCCHhHHH
Q 013520          162 GVELLHTTCGTPNYV-APEVLSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKINAAEFSCPFWFSTGATS  239 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~-aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  239 (441)
                      ...   .....-.+. .+|++.....+..++|++|||.-+.+..+|..- +.+.    ....|..+..+..+..+..+..
T Consensus       420 ~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  420 SSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQLQV  492 (524)
T ss_pred             ecc---cccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhhhh
Confidence            111   111222334 355655544556899999999999999988642 2222    2334555666666666688999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      +.+.++.+++..|+.+.++..|+-|-
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhh
Confidence            99999999999999999998887663

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.45  E-value=4.3e-13  Score=118.83  Aligned_cols=127  Identities=20%  Similarity=0.272  Sum_probs=96.7

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEeccC
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~   92 (441)
                      ++.|+.|.++.||++...  +..|++|+......    ......+|+.+++.+.+.++ .+++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            567899999999999864  77899998755421    11245789999998865444 45555433  33579999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCcEEEccCCCeEEeeccccc
Q 013520           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV-----YHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi-----~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      |.++.+.        ......++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887543        11123457899999999999985     9999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs)

Probab=99.44  E-value=1.9e-13  Score=97.99  Aligned_cols=61  Identities=41%  Similarity=0.795  Sum_probs=48.9

Q ss_pred             CCccchhhhhhcCCCCCccccCccccc-cccccceEEeCCCHHHHHHHHHHHHHHcCcEEEe
Q 013520          305 PLLMNAFEMITLSQGLNLAALFDRRQD-YVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHT  365 (441)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~  365 (441)
                      |..+|||++|++|+++||++||+..+. ..++.+||+|+.||+.|+++||++++.+|+.|++
T Consensus         2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K   63 (63)
T PF03822_consen    2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK   63 (63)
T ss_dssp             -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred             CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence            678999999999999999999987654 3578999999999999999999999999999875

Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=6.1e-13  Score=124.87  Aligned_cols=203  Identities=16%  Similarity=0.265  Sum_probs=144.2

Q ss_pred             HHHHHhCCCCCcceeEEEEEeC-----CEEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--
Q 013520           60 ISIMKIVRHPNIVRLHEVLASR-----TKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSK--  128 (441)
Q Consensus        60 i~il~~l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~--  128 (441)
                      ..-+-.+-|.||++++.++.+.     ....++.||++.|++..++++.    ..+.....++|+-||++||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3345556799999999998643     4588999999999999999763    4688889999999999999999987  


Q ss_pred             CceecCCCCCcEEEccCCCeEEeeccccccCCc----cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHh
Q 013520          129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM  204 (441)
Q Consensus       129 gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~----~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll  204 (441)
                      -|+|+++.-.-|++..+|-+|+.--........    .........+-+.|.|||.=..... +.++|||++|....+|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHH
Confidence            699999999999999999888853222111100    0011123346788999996433222 46899999999999998


Q ss_pred             cCCCC-CCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          205 AGYLP-FGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       205 ~g~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .|..- -.+.........+...-+...   ..--++++.+||+..|..||++.+++.||-.-+
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            87654 222222222222322222111   122357899999999999999999999998743

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=4e-11  Score=105.10  Aligned_cols=135  Identities=20%  Similarity=0.290  Sum_probs=100.3

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH-----HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----MVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      ..+++|+-+.++.+...  |..+++|.=.+......+     ......+|+.++..+.--.|.-..=+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            45789999999999663  445666653332222222     12456789999998876566555556667777889999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      |++|-.|.+.+...       ...++..+=.-+.-||..||+|+||.++||++.. +++.++|||++...
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~-~~i~~IDfGLg~~s  141 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG-GRIYFIDFGLGEFS  141 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC-CcEEEEECCccccc
Confidence            99999999888764       2445566666777899999999999999999987 44999999998754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=9.6e-11  Score=102.28  Aligned_cols=145  Identities=22%  Similarity=0.277  Sum_probs=108.5

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeeccc-----ccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-----ILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~-----~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .+..|-+|+-+.|+++..  .|+...||.=....     +...-...+..+|++++.++.--.|.-..=++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            678899999999999986  48888887532222     11111234578899999998766666666677777788899


Q ss_pred             EeccCC-CChHHHHHhcC-CCCHHHH-HHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEEeeccccccC
Q 013520           88 LEFVTG-GELFDKIVHQG-RLLENDC-RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALP  159 (441)
Q Consensus        88 ~E~~~g-g~L~~~i~~~~-~l~e~~~-~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~  159 (441)
                      |||++| .++.+++.... .-.++.. ..++++|=+.+.-||.++|+|+||..+||+|..+|   .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999988 46777776532 2223333 67888999999999999999999999999997665   3589999998754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.23  E-value=1.1e-11  Score=127.20  Aligned_cols=150  Identities=22%  Similarity=0.370  Sum_probs=114.9

Q ss_pred             HHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCcccc---------ccccccCCCCcCCccccccCCC
Q 013520          117 QLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---------LLHTTCGTPNYVAPEVLSNRGY  186 (441)
Q Consensus       117 qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~---------~~~~~~gt~~Y~aPE~l~~~~~  186 (441)
                      +...|+.|+|.. +++|++|.|++|.++.+|.+||+.|+++.....+.+         ......-...|.|||++.. ..
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence            344899999976 999999999999999999999999998764433111         1111224567999999977 34


Q ss_pred             CCCCcchhhHhHHHHHHh-cCCCCCCCCChHHHHHH----hhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          187 DGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKK----INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       187 ~~~~~DiwSlGvil~~ll-~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+.++|++|+||++|.+. .|..-+...+....+..    ...+.+..+..+++++++=+.++|..++..||++.+++.-
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence            468999999999999999 56666655443332222    2223344556789999999999999999999999999999


Q ss_pred             CCcccc
Q 013520          262 PWFRKN  267 (441)
Q Consensus       262 p~f~~~  267 (441)
                      |||+..
T Consensus       266 ~ff~D~  271 (700)
T KOG2137|consen  266 PFFSDP  271 (700)
T ss_pred             cccCCc
Confidence            999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=6.2e-11  Score=109.45  Aligned_cols=140  Identities=19%  Similarity=0.321  Sum_probs=106.5

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceeEEEEEeC---CEEEEEEe
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASR---TKVYIILE   89 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~---~~~~lv~E   89 (441)
                      +.||.|..+.||++...+ |+.+++|+.......  .....+.+|..+++.+.+  .++.+++.+....   +..|++||
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            678999999999998753 688999987654321  123567899999999975  4467777776654   36789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS------------------------------------------  127 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~------------------------------------------  127 (441)
                      |++|.++.+.+.. ..+++.+...++.+++.+|..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9999888765432 346666777777777777777773                                          


Q ss_pred             --------------CCceecCCCCCcEEEcc--CCCeEEeecccccc
Q 013520          128 --------------KGVYHRDLKPENLLLDS--YGNLKVSDFGLSAL  158 (441)
Q Consensus       128 --------------~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~  158 (441)
                                    ..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          24699999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.19  E-value=5.1e-10  Score=111.40  Aligned_cols=211  Identities=18%  Similarity=0.229  Sum_probs=156.7

Q ss_pred             cEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE----eCCEEEEEEeccCC-CCh
Q 013520           22 FAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA----SRTKVYIILEFVTG-GEL   96 (441)
Q Consensus        22 ~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~~~lv~E~~~g-g~L   96 (441)
                      -.+.|++....+|..|++|.++-......   ...-.-++.++++.|+|+|++.++|.    ....+++|++|.++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            35689999999999999999854332221   22334578899999999999999987    34579999999875 677


Q ss_pred             HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           97 FDKIVH---------------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        97 ~~~i~~---------------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      .++.-.               ..+.+|...|.|+.||..||.++|+.|.+-+-|.|.+||++.+.+++|+..|.......
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            665521               23578899999999999999999999999999999999999988999988777655443


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCC-CCCCChHHH-HHHhhcCcCCCCCCCCHhHHH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTL-YKKINAAEFSCPFWFSTGATS  239 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~~~~  239 (441)
                      ..            .  |-+..    -.+-|.=.||.+++.|.+|..- +........ .+.|.       ..+|.++++
T Consensus       446 d~------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D~rn  500 (655)
T KOG3741|consen  446 DP------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTDLRN  500 (655)
T ss_pred             CC------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHHHHH
Confidence            21            0  11211    1467899999999999999643 211111111 22222       236889999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +|.-+...++++ -++.+++.|
T Consensus       501 ~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  501 VVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHhcCccc-ccHHHHHHH
Confidence            999999999887 788888765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=1.9e-09  Score=97.00  Aligned_cols=129  Identities=20%  Similarity=0.301  Sum_probs=84.8

Q ss_pred             EEEEEEECCCCcEEEEEEeecccc----------------------cc-hHHHHHHHHHHHHHHhCCCC--CcceeEEEE
Q 013520           24 KVRFAQNRETGESVAMKVLAKSTI----------------------LK-HRMVDQIKREISIMKIVRHP--NIVRLHEVL   78 (441)
Q Consensus        24 ~V~~a~~~~~~~~vavK~i~~~~~----------------------~~-~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~   78 (441)
                      .||.|... .|+.+|+|+......                      .. .-.....++|...|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999874 578999999754210                      00 11224578899999999765  566776552


Q ss_pred             EeCCEEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           79 ASRTKVYIILEFVT--GGELFDKIVHQGRLLENDCRRYFQQLIDAVAH-CHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        79 ~~~~~~~lv~E~~~--gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~-LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                          .-++||||++  |..+..+. . ..++.+....++.+++..+.. +|+.||+|+||.+.||+++++ .+.++|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~-~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLK-D-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHH-H-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHH-h-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                2369999998  65554333 2 222255677788888886665 579999999999999999986 999999998


Q ss_pred             cccCC
Q 013520          156 SALPQ  160 (441)
Q Consensus       156 s~~~~  160 (441)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            76543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.03  E-value=2.5e-09  Score=99.30  Aligned_cols=138  Identities=20%  Similarity=0.304  Sum_probs=106.7

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-----------------c--hHHHHHHHHHHHHHHhCCCC--
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----------------K--HRMVDQIKREISIMKIVRHP--   69 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-----------------~--~~~~~~~~~Ei~il~~l~hp--   69 (441)
                      +.++..||-|.-|.||.|.+. .|..+|||.-......                 .  .-.....++|..+|.+|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            357789999999999999986 6899999975321100                 0  00124578899999999655  


Q ss_pred             CcceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeE
Q 013520           70 NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK  149 (441)
Q Consensus        70 nIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~k  149 (441)
                      .+.+.+++    +.-.+||||++|-.|...     +++.+.+..++..|+.-+..+-..||+|+|+++-||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            77777765    566899999999777542     234666777778888888877799999999999999999999999


Q ss_pred             Eeecccccc
Q 013520          150 VSDFGLSAL  158 (441)
Q Consensus       150 L~DFGls~~  158 (441)
                      ++||-.+..
T Consensus       243 vIDwPQ~v~  251 (304)
T COG0478         243 VIDWPQAVP  251 (304)
T ss_pred             EEeCccccc
Confidence            999976553

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.02  E-value=1.5e-08  Score=96.56  Aligned_cols=132  Identities=18%  Similarity=0.084  Sum_probs=93.4

Q ss_pred             EEEEEEECCCCcEEEEEEeeccccc---ch-----HHHHHHHHHHHHHHhCCCCC--cceeEEEEEe-----CCEEEEEE
Q 013520           24 KVRFAQNRETGESVAMKVLAKSTIL---KH-----RMVDQIKREISIMKIVRHPN--IVRLHEVLAS-----RTKVYIIL   88 (441)
Q Consensus        24 ~V~~a~~~~~~~~vavK~i~~~~~~---~~-----~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~-----~~~~~lv~   88 (441)
                      .|..+..  .|+.|.||........   +.     .-.....+|...+.+|..-+  .+.++.+...     ...-++|+
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555543  4678999966332210   00     00113678999888884333  3344445443     23578999


Q ss_pred             eccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-------CCCeEEeeccccc
Q 013520           89 EFVTGG-ELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-------YGNLKVSDFGLSA  157 (441)
Q Consensus        89 E~~~gg-~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-------~~~~kL~DFGls~  157 (441)
                      |++++. +|.+++..  ....++.....++.++...+.-||+.||+|+|++|.|||++.       ++.+.|+||+.+.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999886 78888753  345667778899999999999999999999999999999985       4679999999875

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.97  E-value=1.4e-08  Score=99.07  Aligned_cols=237  Identities=16%  Similarity=0.209  Sum_probs=152.8

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEE------EEeC-CE
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEV------LASR-TK   83 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~------~~~~-~~   83 (441)
                      ..++.||+|+-+.+|..-.-  +.. +.|+.++......   .   +.+..|... .||-+-.=+.+      ..+. ..
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecchh--hch-hheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            35678999999999966432  223 4588877653211   1   122333333 45533321111      1122 23


Q ss_pred             EEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           84 VYIILEFVTGGELFDKIVH-------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      +-+.|..++|..--..+.+       ........+.+..+.|+.+...||..|..-+|+.++|+|+++++.+.|.|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            7788888887533222211       123556778889999999999999999999999999999999999999875533


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCC----CCCCcchhhHhHHHHHHhcC-CCCCCCCC----hHHHHH-HhhcCc
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGY----DGSAADVWSCGVILFVLMAG-YLPFGETD----LPTLYK-KINAAE  226 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~----~~~~~DiwSlGvil~~ll~g-~~Pf~~~~----~~~~~~-~i~~~~  226 (441)
                      .+. .+.......+|.+.|.+||.-.-...    .+...|-|.||+++|+||.| +.||.+-.    ....++ .|..+.
T Consensus       165 qi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~  243 (637)
T COG4248         165 QIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR  243 (637)
T ss_pred             eec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence            222 23344556789999999997642211    14679999999999999886 99996521    111111 232222


Q ss_pred             C-----------CCC---CC--CCHhHHHHHHHhcCC--CCCCCCChHhH
Q 013520          227 F-----------SCP---FW--FSTGATSLIHKILDP--NPKTRIRIEGI  258 (441)
Q Consensus       227 ~-----------~~~---~~--~s~~~~~li~~~L~~--dP~~R~t~~ei  258 (441)
                      +           +.|   +|  +++++..|..+|+..  ++.-|||++..
T Consensus       244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW  293 (637)
T COG4248         244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW  293 (637)
T ss_pred             eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence            2           111   12  789999999999975  46789998653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.85  E-value=5.9e-08  Score=89.11  Aligned_cols=105  Identities=25%  Similarity=0.367  Sum_probs=84.8

Q ss_pred             HHHHHHHHHHHhCCC--CCcceeEEEEEeC----CEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013520           54 DQIKREISIMKIVRH--PNIVRLHEVLASR----TKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH  126 (441)
Q Consensus        54 ~~~~~Ei~il~~l~h--pnIv~l~~~~~~~----~~~~lv~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH  126 (441)
                      ....+|...+..|..  =...+.+.+....    ...++|+|+++|. +|.+++......+......++.++...+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            457788888887743  3345556665542    2468999999984 78888877555777888899999999999999


Q ss_pred             HCCceecCCCCCcEEEccCC---CeEEeecccccc
Q 013520          127 SKGVYHRDLKPENLLLDSYG---NLKVSDFGLSAL  158 (441)
Q Consensus       127 ~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~  158 (441)
                      +.||+|+|++|.|||++.++   .+.|+||+.+..
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.68  E-value=2.5e-07  Score=84.38  Aligned_cols=139  Identities=17%  Similarity=0.255  Sum_probs=91.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHH------HHHHHHHHHHhCCC---CCcceeEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD------QIKREISIMKIVRH---PNIVRLHEVL   78 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~------~~~~Ei~il~~l~h---pnIv~l~~~~   78 (441)
                      -++|.+.+.+-......|.+..-  .|..+++|.........++...      ...+++..+..+..   .....++-+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            35788888888888777777654  5788999987654322222211      12344444444432   2223322222


Q ss_pred             -----EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeec
Q 013520           79 -----ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDF  153 (441)
Q Consensus        79 -----~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (441)
                           .-....+++|||++|.+|.+...    +++    .+...+..++.-+|+.|++|+|..|.|++++. +.++++||
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~-~~i~iID~  178 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN-NGIRIIDT  178 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC-CcEEEEEC
Confidence                 12234568999999988866432    233    24456778899999999999999999999986 55999999


Q ss_pred             cccc
Q 013520          154 GLSA  157 (441)
Q Consensus       154 Gls~  157 (441)
                      +...
T Consensus       179 ~~k~  182 (229)
T PF06176_consen  179 QGKR  182 (229)
T ss_pred             cccc
Confidence            8654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.66  E-value=2.4e-09  Score=109.08  Aligned_cols=239  Identities=19%  Similarity=0.191  Sum_probs=166.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv~   88 (441)
                      -|....-+++|+++++++.+...+...+ .+++...        ....-++++|.+++||| .+..++-++.+...++.+
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            4566777899999999999877665544 6665443        34556899999999999 777777777888999999


Q ss_pred             eccCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           89 EFVTGG-ELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        89 E~~~gg-~L~~~i-~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      +++.++ +-...+ ...-.+.+-+.....+.-+.+++++|+.-=+|||    ||+..+ +..++.||+......... ..
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~  387 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KP  387 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-cc
Confidence            999887 221111 1111233334445566677889999998778998    777765 789999999877655432 35


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC------CCCCCHhHHHH
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC------PFWFSTGATSL  240 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~------~~~~s~~~~~l  240 (441)
                      .+..+++.++|||+.....+. ...|.|++|+--.++.-|.+|-..+-.  ....+..+ ...      ..|-+..-.++
T Consensus       388 ~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~--~~~~~g~~-p~s~~L~~~~aw~~~~~~~~  463 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPA--VLPMIGNG-PNSPMLTDKSAWSPVFHRDF  463 (829)
T ss_pred             ccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCcc--ccCCCCCC-CCccccchhhhcCcccccCC
Confidence            677899999999999887776 789999999877777778777543211  00000000 000      11111122347


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ...|+..-|..|+...+.+.|.+|..-
T Consensus       464 ~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  464 PAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccccCCCCCCCcchhhHHHHHHhccC
Confidence            788999999999999999999888653

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=7.3e-07  Score=80.99  Aligned_cols=138  Identities=13%  Similarity=0.121  Sum_probs=98.0

Q ss_pred             eecCcEEEEEEEECCCCcEEEEEEeecccccc---hHHHHHHHHHHHHHHhCCCC--CcceeEEEEEe----CCEEEEEE
Q 013520           18 GEGTFAKVRFAQNRETGESVAMKVLAKSTILK---HRMVDQIKREISIMKIVRHP--NIVRLHEVLAS----RTKVYIIL   88 (441)
Q Consensus        18 G~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~----~~~~~lv~   88 (441)
                      |+|+-+.|+.....  |..+-+|.-.......   ..-...+.+|+..+..|..-  .+.++...-..    .-.-+||+
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            67899999987653  4467788653111000   11236788999999988532  24444422111    22467999


Q ss_pred             eccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC--eEEeeccccc
Q 013520           89 EFVTG-GELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGLSA  157 (441)
Q Consensus        89 E~~~g-g~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~--~kL~DFGls~  157 (441)
                      |-+.| -+|.+++...  .+.++.....++.++..++.-||+.|+.|+|+.+.||+++.+|.  ++++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97754 5787777552  34577777899999999999999999999999999999987777  9999998665

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.61  E-value=7.4e-07  Score=82.21  Aligned_cols=141  Identities=18%  Similarity=0.231  Sum_probs=100.3

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch--------------------H-HHHHHHHHHHHHHhCC--CCC
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--------------------R-MVDQIKREISIMKIVR--HPN   70 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~--------------------~-~~~~~~~Ei~il~~l~--hpn   70 (441)
                      ...|+.|.-+.||+|.. .++..+|+|++......-.                    . ......+|...|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            44677788888999986 4688999999865332111                    1 1134667888888884  445


Q ss_pred             cceeEEEEEeCCEEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCe
Q 013520           71 IVRLHEVLASRTKVYIILEFVTGGEL-FDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNL  148 (441)
Q Consensus        71 Iv~l~~~~~~~~~~~lv~E~~~gg~L-~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~  148 (441)
                      +.+.+.+..    -.+||||+..... .-.+. +.++..+++..+..+++..+.-|-. .|++|+||+.=|||+. +|.+
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            566666543    3699999854311 11111 2334444788999999999998877 8999999999999999 7999


Q ss_pred             EEeeccccccCCc
Q 013520          149 KVSDFGLSALPQQ  161 (441)
Q Consensus       149 kL~DFGls~~~~~  161 (441)
                      .++|||-|....+
T Consensus       206 ~iID~~QaV~~~h  218 (268)
T COG1718         206 YIIDVSQAVTIDH  218 (268)
T ss_pred             EEEECccccccCC
Confidence            9999998876554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.57  E-value=1.1e-06  Score=81.91  Aligned_cols=134  Identities=15%  Similarity=0.131  Sum_probs=85.2

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeEEEEEeCCEEEEEEeccC
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      ..||+|..+.||+.    .|..+++|......     ....+.+|.++++.+..-  .+.+.+.+....+..+++||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            56899999999973    25567889875422     234578999999998643  35778888888888899999999


Q ss_pred             CCC-hH--------------HHHHh------c---CCCCHHH-HHHHHHH----------HHHH-HHHHHH----CCcee
Q 013520           93 GGE-LF--------------DKIVH------Q---GRLLEND-CRRYFQQ----------LIDA-VAHCHS----KGVYH  132 (441)
Q Consensus        93 gg~-L~--------------~~i~~------~---~~l~e~~-~~~~~~q----------ll~a-L~~LH~----~gi~H  132 (441)
                      |.+ +.              ..+..      .   ...+... ...+..+          +... ..+|.+    ..++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            963 11              11110      0   0011000 1111111          1111 122221    24789


Q ss_pred             cCCCCCcEEEccCCCeEEeecccccc
Q 013520          133 RDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus       133 rDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                      +|+.|.||++++++ +.++||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999878 99999998763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.54  E-value=3.4e-07  Score=94.45  Aligned_cols=137  Identities=24%  Similarity=0.391  Sum_probs=90.8

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeeccc---------------------------ccchH----HHH------HHH
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKST---------------------------ILKHR----MVD------QIK   57 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~---------------------------~~~~~----~~~------~~~   57 (441)
                      ..|+.++-|+||.|+.+. |+.||||+.+..-                           ..-.+    ..+      .+.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            568899999999999974 9999999964421                           00001    111      134


Q ss_pred             HHHHHHHhCC-----CCCcceeEEEE-EeCCEEEEEEeccCCCChHHHH--HhcCCCCHHH-----HHHHHHHHHHHHHH
Q 013520           58 REISIMKIVR-----HPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKI--VHQGRLLEND-----CRRYFQQLIDAVAH  124 (441)
Q Consensus        58 ~Ei~il~~l~-----hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i--~~~~~l~e~~-----~~~~~~qll~aL~~  124 (441)
                      +|...+.++.     .|++ .+=.++ +-.+.-.++|||++|-.+.+..  .. .+++.+.     +..++.|+      
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f~~q~------  281 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAFLRQL------  281 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHHHHHH------
Confidence            5555555542     2332 222333 3345678999999998887764  33 3444222     22333333      


Q ss_pred             HHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520          125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus       125 LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                       -..|++|.|..|.||+++.+|++.+.|||+......
T Consensus       282 -~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         282 -LRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -HhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             348999999999999999999999999999876554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=2.2e-06  Score=79.38  Aligned_cols=137  Identities=18%  Similarity=0.329  Sum_probs=83.5

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeEEEE---EeCCEEEEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHEVL---ASRTKVYIIL   88 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~~---~~~~~~~lv~   88 (441)
                      ++.|+.|..+.||++....  ..+++|.....     .....+.+|..+++.+...  .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5789999999999998764  48999986543     2456788999999888533  356666644   2344589999


Q ss_pred             eccCCCChHH----------------HHH---hc----CCCCHHH---HH---H---H------------HHHHHH-HHH
Q 013520           89 EFVTGGELFD----------------KIV---HQ----GRLLEND---CR---R---Y------------FQQLID-AVA  123 (441)
Q Consensus        89 E~~~gg~L~~----------------~i~---~~----~~l~e~~---~~---~---~------------~~qll~-aL~  123 (441)
                      ++++|..+..                .+.   ..    ..+....   ..   .   .            ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987776                111   00    0111000   00   0   0            111222 233


Q ss_pred             HHHH-------CCceecCCCCCcEEEc-cCCCeEEeeccccc
Q 013520          124 HCHS-------KGVYHRDLKPENLLLD-SYGNLKVSDFGLSA  157 (441)
Q Consensus       124 ~LH~-------~gi~HrDlkp~NILl~-~~~~~kL~DFGls~  157 (441)
                      .+++       ..++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3332       3699999999999999 66777899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.45  E-value=8.9e-07  Score=96.25  Aligned_cols=203  Identities=19%  Similarity=0.200  Sum_probs=145.1

Q ss_pred             HHHHHHHHHHHhCCCCCcceeEEEEEeCCEE----EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 013520           54 DQIKREISIMKIVRHPNIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG  129 (441)
Q Consensus        54 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~----~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~g  129 (441)
                      ...+-|+..+....|+|++.++.+-......    .+..|++++-++...++.-+.++.+..+.+..+++.|+.|+|+..
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            3445566677888999999999887544332    344579999999999999999999999999999999999999996


Q ss_pred             ceecCCCCC---cEEEccCCCeEEe--eccccccCCccccccccccCCCCcCCccccccCCCC-CCCcchhhHhHHHHHH
Q 013520          130 VYHRDLKPE---NLLLDSYGNLKVS--DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD-GSAADVWSCGVILFVL  203 (441)
Q Consensus       130 i~HrDlkp~---NILl~~~~~~kL~--DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~~DiwSlGvil~~l  203 (441)
                      ..|.-+...   +-..+..+....+  ||+.+...... .......-+..+.|||......+. +...|+|.+|..+..+
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~-~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN-EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCc-ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            655555444   3334455666666  88887765443 222344456678889888655443 2246999999999999


Q ss_pred             hcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          204 MAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       204 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ..|..+-.....   ...+.      +........+.+.+|+..++++|+++.+++.|||.+.
T Consensus       386 ~~~~~i~~~~~~---~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  386 SQGEDISEKSAV---PVSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hhcCcccccccc---hhhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            988655321111   11111      1111226788999999999999999999999999864

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.25  E-value=2.8e-08  Score=109.53  Aligned_cols=257  Identities=14%  Similarity=0.067  Sum_probs=174.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCCcceeEEEEE--eC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIVRHPNIVRLHEVLA--SR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~   81 (441)
                      +.+.+|++.=.+|.|.++.-..-+.+..  -+.+|+...-.+..  +-..+....|..-++...|+++.....-..  +.
T Consensus      1226 s~~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1226 SAMEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred             HHhhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence            4566777777777777665433332222  23344432211111  112233445666666778998887766553  33


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-C----ceecCCCCCcEEEccCCCeEEee
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSK-G----VYHRDLKPENLLLDSYGNLKVSD  152 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~-g----i~HrDlkp~NILl~~~~~~kL~D  152 (441)
                      ...|..++|+.+|.+++.|-+.    ....+.-+....++.+.+..-+|+. |    .+|+++|+-|.+|..+-++|+.+
T Consensus      1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred             hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence            4578999999999999999653    3445555666666668888888865 2    68999999999999999999999


Q ss_pred             ccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCC
Q 013520          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPF  231 (441)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~  231 (441)
                      +|+.++..+.........+++.|++|++...-.+. .++|+|..|+-+|.+..|..+|.......+...+.++. .+.+.
T Consensus      1384 ~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~ 1462 (2724)
T KOG1826|consen 1384 GGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEK 1462 (2724)
T ss_pred             cccccccCchHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCcccccccccccc
Confidence            99998655544445667788999999988665553 56999999999999999998885443333333333332 34444


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      ..|.++......+|-..-..||.-..++.-+.|-
T Consensus      1463 l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1463 LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            4566666666666666677899988888877774

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.25  E-value=1.2e-05  Score=75.59  Aligned_cols=135  Identities=14%  Similarity=0.131  Sum_probs=84.0

Q ss_pred             eeeecCc-EEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEEEeccCC
Q 013520           16 TIGEGTF-AKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYIILEFVTG   93 (441)
Q Consensus        16 ~LG~G~~-g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~g   93 (441)
                      .|..|.. +.||++...  +..+.+|+.....      ...+.+|+.+++.+. +--+.+++++....+..++|||+++|
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3445555 789998653  4678888875432      235678999998883 44566788877777778999999999


Q ss_pred             CChHHHHH----------------hcCCCCH-----H-HHHHHHHH-----------------------HHHHHHHHH--
Q 013520           94 GELFDKIV----------------HQGRLLE-----N-DCRRYFQQ-----------------------LIDAVAHCH--  126 (441)
Q Consensus        94 g~L~~~i~----------------~~~~l~e-----~-~~~~~~~q-----------------------ll~aL~~LH--  126 (441)
                      ..+.....                .-..++.     . .......+                       +...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            77653310                0000100     0 00000000                       111122221  


Q ss_pred             -----HCCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520          127 -----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus       127 -----~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                           ...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence                 23489999999999999977788999997753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=2.1e-05  Score=86.95  Aligned_cols=146  Identities=16%  Similarity=0.361  Sum_probs=92.0

Q ss_pred             EEeeeeecCcEEEEEEEECCCC--cEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCc--ceeEEEEEeC---CEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRETG--ESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNI--VRLHEVLASR---TKV   84 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~--~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnI--v~l~~~~~~~---~~~   84 (441)
                      -++.++.|.++.+|+......+  ..+++|+........  ....+.+|+.+++.+. |+++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3678899999999998765432  467777654432211  1346889999999995 6665  7777777654   467


Q ss_pred             EEEEeccCCCChHH--------------------HHH---h-c-C--CC---------CHHHHHHHHHH-----------
Q 013520           85 YIILEFVTGGELFD--------------------KIV---H-Q-G--RL---------LENDCRRYFQQ-----------  117 (441)
Q Consensus        85 ~lv~E~~~gg~L~~--------------------~i~---~-~-~--~l---------~e~~~~~~~~q-----------  117 (441)
                      |+||||++|..+.+                    .+.   . . .  .+         ...++..+..|           
T Consensus       120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~  199 (822)
T PLN02876        120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP  199 (822)
T ss_pred             eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence            89999999864321                    110   0 0 0  00         01222222222           


Q ss_pred             ----HHHHHHHHHH-----------CCceecCCCCCcEEEccC-CC-eEEeeccccccCC
Q 013520          118 ----LIDAVAHCHS-----------KGVYHRDLKPENLLLDSY-GN-LKVSDFGLSALPQ  160 (441)
Q Consensus       118 ----ll~aL~~LH~-----------~gi~HrDlkp~NILl~~~-~~-~kL~DFGls~~~~  160 (441)
                          +...+.+|..           ..++|+|++|.||+++.+ +. .-|.||++++.-.
T Consensus       200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence                2233456632           249999999999999853 34 5799999987543

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.10  E-value=6.7e-05  Score=67.77  Aligned_cols=128  Identities=23%  Similarity=0.267  Sum_probs=91.1

Q ss_pred             cCeEEEeeeeecCc-EEEEEEEECCCCcEEEEEEeeccc----------ccch--------HHHHHHHHHHHHHHhC---
Q 013520            9 AKYEVGRTIGEGTF-AKVRFAQNRETGESVAMKVLAKST----------ILKH--------RMVDQIKREISIMKIV---   66 (441)
Q Consensus         9 ~~y~i~~~LG~G~~-g~V~~a~~~~~~~~vavK~i~~~~----------~~~~--------~~~~~~~~Ei~il~~l---   66 (441)
                      .+++.++.||.|+- |.||+++..  |+.||+|++..-.          ....        ....-+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68999999999999 999999874  7899999942211          1100        1223567787776666   


Q ss_pred             CCCCc--ceeEEEEEeC------------------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 013520           67 RHPNI--VRLHEVLASR------------------TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH  126 (441)
Q Consensus        67 ~hpnI--v~l~~~~~~~------------------~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH  126 (441)
                      .+.++  ++.++++.-.                  ...-||.||++...         .+...    =+.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence            45566  8999987322                  12457888876643         22223    3456777788899


Q ss_pred             HCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520          127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus       127 ~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      +.||+-+|+++.|..     .-||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999986     4589999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.07  E-value=1.8e-05  Score=81.60  Aligned_cols=142  Identities=23%  Similarity=0.339  Sum_probs=86.6

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeeccccc----------------------------chHHHHH------HHHHH
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL----------------------------KHRMVDQ------IKREI   60 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~----------------------------~~~~~~~------~~~Ei   60 (441)
                      +.||..+.|.|++|+.+. |+.||||+-+..--.                            -.+..+.      +.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            578999999999999976 999999985431100                            0011122      23333


Q ss_pred             HHHHh----CCCCCc---ceeEEEEE-eCCEEEEEEeccCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCC
Q 013520           61 SIMKI----VRHPNI---VRLHEVLA-SRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAH-CHSKG  129 (441)
Q Consensus        61 ~il~~----l~hpnI---v~l~~~~~-~~~~~~lv~E~~~gg~L~~--~i~~~~~l~e~~~~~~~~qll~aL~~-LH~~g  129 (441)
                      +...+    +.|-+.   |.+=.++. -.+.-.++|||++|..+.|  .|.+. +++...+   ...+.++... +=..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i---~~~l~~~~~~qIf~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDI---LNKLVEAYLEQIFKTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHHHH---HHHHHHHHHHHHHhcC
Confidence            33332    334441   11223332 2345679999999976644  44443 3444432   2223332222 23578


Q ss_pred             ceecCCCCCcEEEcc----CCCeEEeeccccccCCc
Q 013520          130 VYHRDLKPENLLLDS----YGNLKVSDFGLSALPQQ  161 (441)
Q Consensus       130 i~HrDlkp~NILl~~----~~~~kL~DFGls~~~~~  161 (441)
                      ++|+|-.|.||+++.    ++.+.+-|||+......
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999999984    56899999999876544

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.00  E-value=0.00017  Score=65.54  Aligned_cols=131  Identities=19%  Similarity=0.230  Sum_probs=92.8

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccc-------------cchHHHHHHHHHHHHHHhCC------CCCccee
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-------------LKHRMVDQIKREISIMKIVR------HPNIVRL   74 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------hpnIv~l   74 (441)
                      ...||+|+.=.||.  ++ ......||++.....             ......++..+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35789999999984  33 345578899877650             01112455667777666555      7899999


Q ss_pred             EEEEEeCCEEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC--
Q 013520           75 HEVLASRTKVYIILEFVTG------GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG--  146 (441)
Q Consensus        75 ~~~~~~~~~~~lv~E~~~g------g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~--  146 (441)
                      +|+.+++...-+|+|.+..      -+|.+++.. +.+++ ..   ...+-.-..||-+.+|+.+|++|.||++..++  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999997643      357777754 45655 33   33344456688999999999999999997432  


Q ss_pred             --CeEEee
Q 013520          147 --NLKVSD  152 (441)
Q Consensus       147 --~~kL~D  152 (441)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              477776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.98  E-value=2.5e-05  Score=53.16  Aligned_cols=44  Identities=20%  Similarity=0.422  Sum_probs=38.3

Q ss_pred             CccEEEEEEEEEEc-CceEEEEEEecCCCchHHHHHHHHHHHhcc
Q 013520          380 TGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKNFCAKLE  423 (441)
Q Consensus       380 ~~~l~~~~~i~~~~-~~~~~v~f~~~~Gd~le~~~~~~~~~~~l~  423 (441)
                      +..+.|.++|+++. ++++.|+|+|.+||.+.|++++.+|...|+
T Consensus         2 ~~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~   46 (47)
T PF02149_consen    2 KEVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELR   46 (47)
T ss_dssp             CC-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT
T ss_pred             CcceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHcc
Confidence            34588999999998 899999999999999999999999988774

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.96  E-value=5.8e-05  Score=66.22  Aligned_cols=130  Identities=19%  Similarity=0.297  Sum_probs=91.7

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEec
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~   90 (441)
                      +..+.||+|.+|.||++...  |..+|+|+-..+.     ....+..|+++|..++-.++ .+++.+..    .++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence            34678999999999999875  5689999865543     24568899999999987665 44555533    3455999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CCcEEEccCCCeEEeeccccccC
Q 013520           91 VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK-PENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        91 ~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlk-p~NILl~~~~~~kL~DFGls~~~  159 (441)
                      +.|-.|.+.-...   .    +.-+..++.+-.-|-..||-|+.|. |...+|..++.+.|+||.-|+.-
T Consensus        94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            9998776544211   1    2223345555455677899999986 55555555569999999988743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.96  E-value=6.5e-05  Score=70.30  Aligned_cols=73  Identities=7%  Similarity=0.096  Sum_probs=45.9

Q ss_pred             EeeeeecCcE-EEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---CcceeEEEEEeC---CEEEE
Q 013520           14 GRTIGEGTFA-KVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP---NIVRLHEVLASR---TKVYI   86 (441)
Q Consensus        14 ~~~LG~G~~g-~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~~~---~~~~l   86 (441)
                      ++.++.|+.. .||..     +..+++|+.....     ....+.+|..+++.+...   .+.++++.....   ...|+
T Consensus         2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            3567766666 48876     2357778654321     235788999999888532   344445443332   24588


Q ss_pred             EEeccCCCCh
Q 013520           87 ILEFVTGGEL   96 (441)
Q Consensus        87 v~E~~~gg~L   96 (441)
                      +|++++|.++
T Consensus        72 l~~~i~G~~l   81 (235)
T cd05155          72 VYRWLEGETA   81 (235)
T ss_pred             EEEeecCCCC
Confidence            9999998765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.88  E-value=0.0001  Score=66.47  Aligned_cols=100  Identities=16%  Similarity=0.253  Sum_probs=79.3

Q ss_pred             HHHHHHHHhCCC-CCcceeEEEEEeCCEEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 013520           57 KREISIMKIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDK---IVHQGRLLENDCRRYFQQLIDAVAHCHS---KG  129 (441)
Q Consensus        57 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~---i~~~~~l~e~~~~~~~~qll~aL~~LH~---~g  129 (441)
                      ..|.-+++.+++ +++++++|++-    -+++.||...+++...   +..-...+......++.+++..+.+++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358889999975 69999999873    2568899987766421   1111345788899999999999999997   35


Q ss_pred             ceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520          130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus       130 i~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      +.-.|++|+|+-++++|++|++|...+....
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            7889999999999999999999999776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.84  E-value=0.00031  Score=65.47  Aligned_cols=75  Identities=23%  Similarity=0.346  Sum_probs=49.4

Q ss_pred             EeeeeecCcEEEEEEEECC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEEEEEEecc
Q 013520           14 GRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVYIILEFV   91 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv~E~~   91 (441)
                      ++.|+.|-...+|++.... .++.|++|+......    ..-...+|+.+++.+...+ ..+++....  +  .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            5678889999999997543 357889997654321    1123457899998885333 444544332  2  3799999


Q ss_pred             CCCCh
Q 013520           92 TGGEL   96 (441)
Q Consensus        92 ~gg~L   96 (441)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.78  E-value=2.9e-05  Score=74.28  Aligned_cols=137  Identities=17%  Similarity=0.259  Sum_probs=99.1

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-----------------chHHH--HHHHHHHHHHHhCC-C-
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----------------KHRMV--DQIKREISIMKIVR-H-   68 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-----------------~~~~~--~~~~~Ei~il~~l~-h-   68 (441)
                      -|.+++.||-|.-+.||.+-+. .|++.++|+-......                 ..-..  -...+|...|+.|. | 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            4678899999999999999885 5889999975332110                 00011  12457888998884 3 


Q ss_pred             CCcceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCe
Q 013520           69 PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL  148 (441)
Q Consensus        69 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~  148 (441)
                      --+.+.+++    +.-++|||++.|..|...-.      ...+..+...++.-+.-|-.+|+||+|..-=||++++++.+
T Consensus       172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence            234555554    56789999999987754321      23345566677777778999999999999999999999999


Q ss_pred             EEeeccccc
Q 013520          149 KVSDFGLSA  157 (441)
Q Consensus       149 kL~DFGls~  157 (441)
                      +++||--+.
T Consensus       242 ~vIDFPQmv  250 (465)
T KOG2268|consen  242 VVIDFPQMV  250 (465)
T ss_pred             EEeechHhh
Confidence            999996543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.76  E-value=0.00089  Score=67.34  Aligned_cols=80  Identities=19%  Similarity=0.208  Sum_probs=54.6

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccc--cc--hHHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LK--HRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~--~~--~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~l   86 (441)
                      .+.||.|.+..||++.+...++.++||.-.....  ..  .-..++...|...|+.+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            5789999999999999865446899997431100  00  112456677888888763   3467777776  4455789


Q ss_pred             EEeccCCCC
Q 013520           87 ILEFVTGGE   95 (441)
Q Consensus        87 v~E~~~gg~   95 (441)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.70  E-value=0.00017  Score=68.31  Aligned_cols=134  Identities=17%  Similarity=0.205  Sum_probs=78.6

Q ss_pred             eeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEeccCCC
Q 013520           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~~gg   94 (441)
                      .+..|-.+.+|+..  .+++.+++|.......   ...-...+|..+++.+....+ .+++...  .  -++|+||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence            45678888999887  3567888897544221   110124678999988854333 3444433  2  26899999986


Q ss_pred             ChHH----------HH----Hh---c----CCCC-HHHHHHHHHHHH---------HHHHHHHH--------CCceecCC
Q 013520           95 ELFD----------KI----VH---Q----GRLL-ENDCRRYFQQLI---------DAVAHCHS--------KGVYHRDL  135 (441)
Q Consensus        95 ~L~~----------~i----~~---~----~~l~-e~~~~~~~~qll---------~aL~~LH~--------~gi~HrDl  135 (441)
                      .+..          .+    .+   .    .+++ ...+..+..++-         ..+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5431          11    10   0    0111 112223332221         11222221        25899999


Q ss_pred             CCCcEEEccCCCeEEeeccccccC
Q 013520          136 KPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus       136 kp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      .|.||++++++ +.|+||..+..-
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCcC
Confidence            99999999877 889999987643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.67  E-value=0.00038  Score=67.38  Aligned_cols=137  Identities=19%  Similarity=0.204  Sum_probs=83.6

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeEE------EEEeCCEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHE------VLASRTKV   84 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~   84 (441)
                      -++.|..|....+|++...  +..+++|+....      ....+..|+.++..+.+.  .+.+++.      +....+..
T Consensus        18 ~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          18 SFEGISAGIENTNYFVTTD--SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             heecccCccccceEEEEeC--CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            3667888888899998643  457889987541      124577788888887432  2444443      22345677


Q ss_pred             EEEEeccCCCChHH-------HH-------Hh-cCCCCH--------HHHH------------HHHHHHHHHHHHHHH--
Q 013520           85 YIILEFVTGGELFD-------KI-------VH-QGRLLE--------NDCR------------RYFQQLIDAVAHCHS--  127 (441)
Q Consensus        85 ~lv~E~~~gg~L~~-------~i-------~~-~~~l~e--------~~~~------------~~~~qll~aL~~LH~--  127 (441)
                      ++++++++|..+..       .+       .. ...+..        ....            .....+..++.++.+  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            89999999866421       00       00 000000        0000            011112233444443  


Q ss_pred             -----CCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          128 -----KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       128 -----~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                           .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence                 479999999999999987777899999765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10593 hypothetical protein; Provisional

Probab=97.67  E-value=0.00086  Score=65.13  Aligned_cols=78  Identities=13%  Similarity=0.118  Sum_probs=55.9

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC---CCcceeEEEEEe---CCEEE
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH---PNIVRLHEVLAS---RTKVY   85 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~---~~~~~   85 (441)
                      .-.+.||.|..+.||...... + .+.+|.. +...    ....+..|...|+.+..   -.+.++++++..   .+..+
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~   89 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMA-RSFS----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV   89 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEe-cccc----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence            346689999999999986532 3 4667774 3210    12468899999998853   367888887754   36689


Q ss_pred             EEEeccCCCCh
Q 013520           86 IILEFVTGGEL   96 (441)
Q Consensus        86 lv~E~~~gg~L   96 (441)
                      +|||+++|+++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999998754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.64  E-value=0.00091  Score=65.23  Aligned_cols=139  Identities=16%  Similarity=0.183  Sum_probs=81.9

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeEEE------EEeCCE
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHEV------LASRTK   83 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~------~~~~~~   83 (441)
                      .-++.++.|....+|++.. .+| .+++|+.....     ..+.+..|..++..|...  .+.+++..      ....+.
T Consensus        25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~   97 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGK   97 (307)
T ss_pred             eeccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCe
Confidence            3366788888889998864 334 57889775421     123455677777777422  23444332      123466


Q ss_pred             EEEEEeccCCCChH-----------HHH---Hh-cCCCC--------HHHH-----H----------HHHHHHHHHHHHH
Q 013520           84 VYIILEFVTGGELF-----------DKI---VH-QGRLL--------ENDC-----R----------RYFQQLIDAVAHC  125 (441)
Q Consensus        84 ~~lv~E~~~gg~L~-----------~~i---~~-~~~l~--------e~~~-----~----------~~~~qll~aL~~L  125 (441)
                      .++++||++|..+.           ..+   .. ...++        ....     .          .....+...++++
T Consensus        98 ~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l  177 (307)
T TIGR00938        98 PACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYL  177 (307)
T ss_pred             EEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHH
Confidence            78999999985431           011   00 01110        0000     0          0011223345555


Q ss_pred             HH-------CCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          126 HS-------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       126 H~-------~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      ..       .+++|+|+.+.||+++.++...|+||+.+.
T Consensus       178 ~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       178 DKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            32       589999999999999988877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.61  E-value=0.00077  Score=65.80  Aligned_cols=146  Identities=21%  Similarity=0.293  Sum_probs=101.1

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccc----------------------cchHHH-HHHHHHHHHHHhCCC
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI----------------------LKHRMV-DQIKREISIMKIVRH   68 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~----------------------~~~~~~-~~~~~Ei~il~~l~h   68 (441)
                      ++-..|..|.-+.||.|... +|..+|||+++..-+                      ....++ -..+.|++-|++++.
T Consensus       147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            45567889999999999864 688899999754211                      011122 246778999999875


Q ss_pred             CCcceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEccCCC
Q 013520           69 PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYGN  147 (441)
Q Consensus        69 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH-~~gi~HrDlkp~NILl~~~~~  147 (441)
                      -.|.-.--+ .-. .-.|||+++.+...-.-...+..++...+..+.+|++.-+.-|- ..+.+|.||.-=|+|+-. |.
T Consensus       226 aGIP~PePI-lLk-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~  302 (520)
T KOG2270|consen  226 AGIPCPEPI-LLK-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK  302 (520)
T ss_pred             cCCCCCCce-eee-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE
Confidence            553322111 111 23589999964222111223457888889999999999988875 559999999999999976 99


Q ss_pred             eEEeeccccccCCc
Q 013520          148 LKVSDFGLSALPQQ  161 (441)
Q Consensus       148 ~kL~DFGls~~~~~  161 (441)
                      +.++|.+-|-...+
T Consensus       303 lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  303 LYIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEEccccccCCC
Confidence            99999998765444

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.44  E-value=0.0012  Score=64.18  Aligned_cols=76  Identities=18%  Similarity=0.187  Sum_probs=50.0

Q ss_pred             EeeeeecCcEEEEEEEECC------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRE------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVYI   86 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~l   86 (441)
                      ++.|..|-...+|++....      +++.+++|+......    ......+|..+++.+...+ ..+++..+..    .+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence            4667788888999987643      367899999755321    1234678888888885333 3455555432    35


Q ss_pred             EEeccCCCChH
Q 013520           87 ILEFVTGGELF   97 (441)
Q Consensus        87 v~E~~~gg~L~   97 (441)
                      |+||++|..+.
T Consensus        75 v~e~i~G~~l~   85 (302)
T cd05156          75 IEEFIPSRTLT   85 (302)
T ss_pred             hhheeCCCcCC
Confidence            89999887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.44  E-value=0.0038  Score=61.13  Aligned_cols=136  Identities=14%  Similarity=0.150  Sum_probs=75.8

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeEE------EEEeCCEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHE------VLASRTKVY   85 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~------~~~~~~~~~   85 (441)
                      .+.|+.|....+|.+...  +..+++|++..  . .   .+.+..|+.+++.|...  .+.+++.      +....+..+
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~   98 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA   98 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence            455777888899998753  33688998752  1 1   23444566666666321  2333332      123356789


Q ss_pred             EEEeccCCCChH-----------HHHHh----cCCC--------CH----HHHH-----------HHHHHHH-HHHHHHH
Q 013520           86 IILEFVTGGELF-----------DKIVH----QGRL--------LE----NDCR-----------RYFQQLI-DAVAHCH  126 (441)
Q Consensus        86 lv~E~~~gg~L~-----------~~i~~----~~~l--------~e----~~~~-----------~~~~qll-~aL~~LH  126 (441)
                      +++||++|..+.           ..+.+    ...+        ..    ....           ..+.+.+ ..+..+.
T Consensus        99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  178 (319)
T PRK05231         99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA  178 (319)
T ss_pred             EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence            999999986431           11110    0001        00    0000           0111111 1122222


Q ss_pred             -------HCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          127 -------SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       127 -------~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                             ..|++|+|+.|.||+++.+...-++||+.+.
T Consensus       179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                   2389999999999999965556899999875

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.38  E-value=0.00061  Score=69.04  Aligned_cols=162  Identities=20%  Similarity=0.219  Sum_probs=104.9

Q ss_pred             HHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 013520           54 DQIKREISIMKIVRHPNIVRLHEVLAS-RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH  132 (441)
Q Consensus        54 ~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~H  132 (441)
                      .++.-....++.+.|+|...++++... .....+|||++ +.+|.+.+.... +-....       +           +|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~-------~-----------~~   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESL-------L-----------AH   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhh-------c-----------cc
Confidence            446667888999999999999988753 34588999998 558888776532 211110       0           22


Q ss_pred             cCCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC
Q 013520          133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  212 (441)
Q Consensus       133 rDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~  212 (441)
                      |= -+.       +.++.+| -+++   .             |  |-.      .++++||||+|.++.++..|...|..
T Consensus        87 ~~-~~~-------~~~~~td-~~~t---~-------------~--~~~------~~pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   87 GV-LHL-------NIIYITD-HFLT---K-------------Y--PSP------IGPKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             cc-cee-------hhhhccc-cccc---c-------------C--CCC------CCcchhhhhHHHHHHHHHHhhHHHHH
Confidence            21 111       2233333 0000   0             0  111      12599999999999999999888766


Q ss_pred             CChHHHHHHhhcCcCCCC------------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          213 TDLPTLYKKINAAEFSCP------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       213 ~~~~~~~~~i~~~~~~~~------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ....+....+.+-.....            ..++....++..+|+-..|..||...++.+|+-|...+
T Consensus       134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~  201 (725)
T KOG1093|consen  134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVY  201 (725)
T ss_pred             HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHH
Confidence            555544444433221111            12567788999999999999999999999999997654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.20  E-value=0.0042  Score=60.47  Aligned_cols=143  Identities=19%  Similarity=0.231  Sum_probs=86.6

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceeEEEEEeCC--EEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASRT--KVY   85 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~--~~~   85 (441)
                      ...+++....|....+|.....  ++.+++. ... ............+|..+++.+.-  --+...++.+.++.  ..|
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf  101 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF  101 (321)
T ss_pred             CCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence            3455555555555556666654  7788888 321 11222345667789999988753  23344455555444  679


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHH-HHHHHHHHHHH-------------------------------------
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QLIDAVAHCHS-------------------------------------  127 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~-qll~aL~~LH~-------------------------------------  127 (441)
                      .||+|++|..+.+...     +.....++.. .+...|.-||+                                     
T Consensus       102 ~v~~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~  176 (321)
T COG3173         102 YVMEWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGR  176 (321)
T ss_pred             EEEEEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCC
Confidence            9999999854322111     0111111111 33333333333                                     


Q ss_pred             ---------------------CCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520          128 ---------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus       128 ---------------------~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                                           ..++|+|+.+.|++++.++-+=+.||+++..-+.
T Consensus       177 ~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         177 IPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             CchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence                                 2589999999999999988899999999876544

>PLN02236 choline kinase

Probab=97.01  E-value=0.0078  Score=59.72  Aligned_cols=138  Identities=17%  Similarity=0.248  Sum_probs=80.8

Q ss_pred             EEeeeeecCcEEEEEEEECC----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRE----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYII   87 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv   87 (441)
                      -+..|..|-...+|++....    +++.|++|+.....   ...++ -.+|..+++.+..-++ .++++.+...    .|
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v  111 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV  111 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence            34566668888999987432    34689999876532   11222 2678999988854333 4556665332    57


Q ss_pred             EeccCCCChHHH----------H----Hh----c--C---CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 013520           88 LEFVTGGELFDK----------I----VH----Q--G---RLLENDCRRYFQQL-----------------IDAVAHC--  125 (441)
Q Consensus        88 ~E~~~gg~L~~~----------i----~~----~--~---~l~e~~~~~~~~ql-----------------l~aL~~L--  125 (441)
                      .||++|.++...          +    .+    .  +   ....+.+..++.++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            888877665311          1    00    0  0   01112233333222                 1111122  


Q ss_pred             --H----HCCceecCCCCCcEEEcc-CCCeEEeecccccc
Q 013520          126 --H----SKGVYHRDLKPENLLLDS-YGNLKVSDFGLSAL  158 (441)
Q Consensus       126 --H----~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~  158 (441)
                        .    ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence              1    225899999999999986 46899999988753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.99  E-value=0.0075  Score=57.91  Aligned_cols=31  Identities=23%  Similarity=0.379  Sum_probs=25.9

Q ss_pred             CceecCCCCCcEEEccCCC-eEEeeccccccC
Q 013520          129 GVYHRDLKPENLLLDSYGN-LKVSDFGLSALP  159 (441)
Q Consensus       129 gi~HrDlkp~NILl~~~~~-~kL~DFGls~~~  159 (441)
                      .++|+|+.|.||++++++. .-|+||+.+..-
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997565 469999987653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.76  E-value=0.019  Score=56.78  Aligned_cols=77  Identities=14%  Similarity=0.131  Sum_probs=47.8

Q ss_pred             eeeecCcEEEEEEEECCCCcEEEEEEeecccc--c--chHHHHHHHHHHHHHHhCC--CC-CcceeEEEEEeCCEEEEEE
Q 013520           16 TIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--L--KHRMVDQIKREISIMKIVR--HP-NIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        16 ~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~--~--~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv~   88 (441)
                      .||.|...-||++.+...++.++||--..-..  .  -.-..++..-|...|+...  -| .+.+++.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            47999999999999864446899985321000  0  0112345567888887763  34 45555543  444556999


Q ss_pred             eccCCC
Q 013520           89 EFVTGG   94 (441)
Q Consensus        89 E~~~gg   94 (441)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.75  E-value=0.021  Score=57.49  Aligned_cols=77  Identities=10%  Similarity=0.069  Sum_probs=50.9

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-ch---HHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-KH---RMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVY   85 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-~~---~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+.||.|....||++.+.  +..++||.-...... ..   -...+...|...|+.+.   ..++.+++.+..  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4678899999999999873  456889865421110 00   02344455677776663   347888888776  3457


Q ss_pred             EEEeccCC
Q 013520           86 IILEFVTG   93 (441)
Q Consensus        86 lv~E~~~g   93 (441)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.70  E-value=0.027  Score=54.70  Aligned_cols=29  Identities=31%  Similarity=0.560  Sum_probs=25.7

Q ss_pred             CCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       128 ~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999988 778999999754

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.49  E-value=0.023  Score=56.11  Aligned_cols=137  Identities=23%  Similarity=0.307  Sum_probs=78.6

Q ss_pred             EeeeeecCcEEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEe
Q 013520           14 GRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILE   89 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E   89 (441)
                      ++.|..|-...+|++.....   +..|++|+.....-   . .-.-.+|..+++.+..-++ .++++++. ++   ++.+
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~   90 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQS   90 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeeh
Confidence            44555588888998875432   34789998755321   1 1123578888888865444 45566553 22   4889


Q ss_pred             ccCCCChHH----------HHH----h--cCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 013520           90 FVTGGELFD----------KIV----H--QGR------L-LENDCRRYFQQL----------------------IDAVAH  124 (441)
Q Consensus        90 ~~~gg~L~~----------~i~----~--~~~------l-~e~~~~~~~~ql----------------------l~aL~~  124 (441)
                      |++|..|..          .+.    +  ...      . ....+..|+.++                      ..-+..
T Consensus        91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  170 (330)
T PLN02421         91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE  170 (330)
T ss_pred             hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence            987765421          110    0  001      1 122233333322                      111222


Q ss_pred             HH----HCC----ceecCCCCCcEEEcc-CCCeEEeecccccc
Q 013520          125 CH----SKG----VYHRDLKPENLLLDS-YGNLKVSDFGLSAL  158 (441)
Q Consensus       125 LH----~~g----i~HrDlkp~NILl~~-~~~~kL~DFGls~~  158 (441)
                      +.    +.+    .+|.|+.|.|||+++ ++.++++||..|..
T Consensus       171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            21    122    699999999999975 57899999998753

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.04  E-value=0.025  Score=55.49  Aligned_cols=87  Identities=24%  Similarity=0.282  Sum_probs=61.5

Q ss_pred             CCCcceeEEEE-EeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccC
Q 013520           68 HPNIVRLHEVL-ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSY  145 (441)
Q Consensus        68 hpnIv~l~~~~-~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~  145 (441)
                      .++..+.+-+- ......|++|++- |+.+. .+   .--..+++..++++.+..+.-+..+ ..-|||+...||||+ +
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~  357 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E  357 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence            34444433333 3345677888864 44442 22   2234567888899998888888766 789999999999999 8


Q ss_pred             CCeEEeeccccccCC
Q 013520          146 GNLKVSDFGLSALPQ  160 (441)
Q Consensus       146 ~~~kL~DFGls~~~~  160 (441)
                      |++.|+||-+|+...
T Consensus       358 GnvtLIDfklsRl~~  372 (488)
T COG5072         358 GNVTLIDFKLSRLSY  372 (488)
T ss_pred             CceEEEEeeeeeccc
Confidence            999999999988443

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.95  E-value=0.18  Score=49.20  Aligned_cols=30  Identities=17%  Similarity=0.189  Sum_probs=27.6

Q ss_pred             CceecCCCCCcEEEccCCCeEEeecccccc
Q 013520          129 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus       129 gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                      +++|+|+.+.|+|++.++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999988753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.92  E-value=0.021  Score=52.30  Aligned_cols=30  Identities=33%  Similarity=0.632  Sum_probs=21.5

Q ss_pred             CceecCCCCCcEEE-ccCCCeEEeecccccc
Q 013520          129 GVYHRDLKPENLLL-DSYGNLKVSDFGLSAL  158 (441)
Q Consensus       129 gi~HrDlkp~NILl-~~~~~~kL~DFGls~~  158 (441)
                      .++|+|+.|.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58999999999999 7889999999998764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.91  E-value=0.093  Score=50.60  Aligned_cols=75  Identities=17%  Similarity=0.185  Sum_probs=49.1

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEE
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +-.+.||.|....+|...  .+++.+.||+-...      ....+..|..-|+.|.   .-.+.+++.+....+.-|++|
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            446789999999999887  56788999986522      1245778888888883   446788999888877789999


Q ss_pred             eccCCC
Q 013520           89 EFVTGG   94 (441)
Q Consensus        89 E~~~gg   94 (441)
                      ||++.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=95.85  E-value=0.077  Score=53.35  Aligned_cols=76  Identities=16%  Similarity=0.187  Sum_probs=45.4

Q ss_pred             EEeeeeecCcEEEEEEEECCC-CcE-----EEEEEeecccccchHHHHHHHHHHHHHHhCCCC-CcceeEEEEEeCCEEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRET-GES-----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP-NIVRLHEVLASRTKVY   85 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~-~~~-----vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~   85 (441)
                      .++.|..|-...+|++..... +..     |.+++....    .+..-.-.+|+.+++.+... .-.++++.+..    +
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g  125 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F  125 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence            345666688899999875432 222     344432111    11111235689999999644 44566666643    5


Q ss_pred             EEEeccCCCCh
Q 013520           86 IILEFVTGGEL   96 (441)
Q Consensus        86 lv~E~~~gg~L   96 (441)
                      ++.||++|..|
T Consensus       126 ~l~efIeGr~l  136 (383)
T PTZ00384        126 TIQEWVEGNTM  136 (383)
T ss_pred             EEEEEeccccC
Confidence            89999998765

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.58  E-value=0.051  Score=49.83  Aligned_cols=100  Identities=20%  Similarity=0.254  Sum_probs=62.5

Q ss_pred             EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHH
Q 013520           37 VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ  116 (441)
Q Consensus        37 vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~  116 (441)
                      ..+|.+..-.+.-.  ...+..+.+++.++.  .|+++..-  +.-.+.+++|+|-....         .+   . .++.
T Consensus        88 L~lKKi~slp~~~~--~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~~---~-N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCIN--DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------NF---S-NFIT  148 (308)
T ss_pred             hhhhhccCCCcccc--hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------ch---h-HHHH
Confidence            34555544333211  134567788877653  46666632  44567799999843211         01   1 1111


Q ss_pred             HHHHHHHHHHHC--CceecCCCCCcEEEccCCCeEEeeccc
Q 013520          117 QLIDAVAHCHSK--GVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus       117 qll~aL~~LH~~--gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                      -=+.+|.-.|+.  +.+|+|..|+||+-|..|.+||.|=+.
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            114567778843  799999999999999999999999764

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.54  E-value=0.05  Score=54.20  Aligned_cols=62  Identities=15%  Similarity=0.198  Sum_probs=44.3

Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEccC
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH-~~gi~HrDlkp~NILl~~~  145 (441)
                      ...++-+|..|-.+...+.. ...+|+..+.+..--..|+--|- -.+.+|.|+.|.||++--+
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            34566678888888877765 34556666666666666655443 4589999999999999643

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.36  E-value=0.12  Score=51.82  Aligned_cols=78  Identities=15%  Similarity=0.215  Sum_probs=50.4

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeeccc-cc--chHHHHHHHHHHHHHHhCC--CC-CcceeEEEEEeCCEEEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-IL--KHRMVDQIKREISIMKIVR--HP-NIVRLHEVLASRTKVYII   87 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~-~~--~~~~~~~~~~Ei~il~~l~--hp-nIv~l~~~~~~~~~~~lv   87 (441)
                      .+.||.|.-.-||++.+...++.|+||--..-. ..  -.-..++..-|...|+...  .| ++++++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            678999999999999985445678888532110 00  0112456677888888763  34 45556554  44456688


Q ss_pred             EeccCC
Q 013520           88 LEFVTG   93 (441)
Q Consensus        88 ~E~~~g   93 (441)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998864

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.26  E-value=0.74  Score=45.26  Aligned_cols=70  Identities=14%  Similarity=0.055  Sum_probs=42.3

Q ss_pred             CcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeE---E--EEEeCCEEEEEEeccCC
Q 013520           21 TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLH---E--VLASRTKVYIILEFVTG   93 (441)
Q Consensus        21 ~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~---~--~~~~~~~~~lv~E~~~g   93 (441)
                      .-..||++.. .+|..+++|+......    ....+..|+..+..|...  .++...   +  +...++..+.++++++|
T Consensus        37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G  111 (325)
T PRK11768         37 YENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG  111 (325)
T ss_pred             ccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence            4456888865 3466799998754321    235577788888777321  122211   1  22335678889999987


Q ss_pred             CC
Q 013520           94 GE   95 (441)
Q Consensus        94 g~   95 (441)
                      ..
T Consensus       112 ~~  113 (325)
T PRK11768        112 RA  113 (325)
T ss_pred             CC
Confidence            54

>PRK06148 hypothetical protein; Provisional

Probab=94.77  E-value=0.3  Score=55.46  Aligned_cols=31  Identities=29%  Similarity=0.440  Sum_probs=26.5

Q ss_pred             CCceecCCCCCcEEEccCC--CeE-Eeecccccc
Q 013520          128 KGVYHRDLKPENLLLDSYG--NLK-VSDFGLSAL  158 (441)
Q Consensus       128 ~gi~HrDlkp~NILl~~~~--~~k-L~DFGls~~  158 (441)
                      .++||+|+.+.|||++.++  ++. |+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999999775  565 999998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	441
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-69
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-69
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-68
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-67
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-67
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-67
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-67
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-67
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-64
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-58
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-58
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-58
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-58
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		8e-58
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-58
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-57
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-57
2ehb_D	143	The Structure Of The C-Terminal Domain Of The Prote		3e-57
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-56
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-55
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-52
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-51
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-51
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-51
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-51
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-51
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-51
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-51
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-51
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-51
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-50
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-50
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-49
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-49
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-49
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-48
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-48
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-48
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-48
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-48
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-48
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-48
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-48
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-48
3soa_A	444	Full-Length Human Camkii Length = 444		2e-48
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-48
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-48
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-48
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-48
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-48
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-48
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-48
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-48
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-48
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-48
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-48
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-48
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-47
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-47
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-47
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-47
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-47
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-47
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-47
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-47
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-47
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-47
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-47
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-47
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-47
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-47
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-47
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-47
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-47
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-47
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-47
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-47
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-47
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-47
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-47
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-47
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-47
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-47
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		9e-47
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-46
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-46
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-46
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-46
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-46
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-46
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-46
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-46
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-46
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		9e-46
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-46
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-46
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-45
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-45
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-45
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-45
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-45
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-44
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-44
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-44
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-44
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-44
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-44
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-44
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-44
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-44
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-44
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-44
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-44
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-42
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-42
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-42
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-42
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-42
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-42
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-42
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-42
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-42
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-42
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-42
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-42
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-42
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-41
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-41
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-41
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-41
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-41
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-41
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-41
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-41
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-41
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-41
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-41
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-41
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-41
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-41
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-41
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-41
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-41
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-41
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-41
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-41
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-41
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-41
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-41
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-41
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-41
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-41
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-41
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-41
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-41
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-41
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-40
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-40
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-40
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-40
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-40
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-40
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-40
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-40
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-40
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-40
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-40
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-40
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-40
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-40
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-40
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-40
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-40
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-40
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-40
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-40
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-40
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-40
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-40
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-40
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-40
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-40
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-40
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-40
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-40
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-40
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-40
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-40
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-40
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-40
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-40
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-40
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-40
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-40
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-40
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-40
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		6e-40
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-40
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-39
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-39
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-39
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-39
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-39
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-39
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-38
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-38
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-38
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-38
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-38
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-38
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-38
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-38
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-38
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-38
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-38
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-38
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-38
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		9e-38
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-37
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-37
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-37
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-37
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-37
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-37
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-37
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-37
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-37
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-37
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-37
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-37
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-37
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-37
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-37
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-36
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-36
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-36
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-35
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-35
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-35
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-35
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-35
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-35
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-35
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-35
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-35
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-34
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-34
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-34
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-34
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-34
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-34
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-34
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-34
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-34
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-34
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-34
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-34
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-34
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-34
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-34
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-34
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-34
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-34
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-34
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-34
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		7e-34
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-34
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-34
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-33
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-33
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-33
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-33
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-33
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-33
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-32
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-32
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-32
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-31
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-31
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-31
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-31
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-31
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-31
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-30
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-30
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-30
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-29
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-29
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-28
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-28
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-28
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-28
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-28
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-28
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-28
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-28
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-28
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-28
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-28
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-28
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-28
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-28
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-28
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-28
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-28
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-28
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-27
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-27
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-27
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-27
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-27
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-27
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-27
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-27
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-27
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-27
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-27
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-27
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-27
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-27
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-27
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-27
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-27
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-27
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-27
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-27
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-27
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-27
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-27
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-27
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-27
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-27
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-27
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-27
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-27
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-27
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-27
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-27
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-26
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-26
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-26
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-26
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-26
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-26
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-26
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-26
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-26
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-25
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-25
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-25
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-25
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-25
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-25
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-25
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-25
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-25
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-24
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-24
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-24
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-24
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-24
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-24
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-24
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-24
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-24
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-24
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-24
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		6e-24
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-24
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-24
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-24
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-24
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-24
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-24
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		7e-24
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-24
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-24
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-24
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-24
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-24
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-24
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		9e-24
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-23
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-23
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-23
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-23
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-23
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-23
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-23
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-23
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-23
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-23
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-23
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-23
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-23
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-23
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-23
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-23
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-23
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-23
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-23
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		8e-23
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-23
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-22
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-22
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-22
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-22
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-22
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-22
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-21
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-21
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-21
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-21
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-20
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-20
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-20
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-20
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-20
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		6e-20
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-20
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-19
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-19
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-19
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-19
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-19
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		8e-19
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-19
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-18
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-18
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-18
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-18
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-18
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-18
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-18
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-18
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-18
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-18
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-18
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-18
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-18
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-18
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-18
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-18
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-18
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-18
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-18
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-18
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-18
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-18
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-18
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-18
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-18
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-18
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-18
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-18
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-18
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-18
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-18
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-18
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-18
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-18
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-18
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-18
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-18
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-18
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-18
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-18
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-18
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-18
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-18
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-18
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-17
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-17
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-17
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-17
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-17
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-17
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-17
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-17
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-17
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-17
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-17
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		7e-17
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-17
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-17
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-17
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-17
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		8e-17
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-17
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-17
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-17
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-17
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-17
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-17
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-17
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-17
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-17
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-17
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		9e-17
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-16
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-16
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-16
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-16
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-16
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-16
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-16
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-16
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-16
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-16
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-16
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-16
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-16
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-16
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-16
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-16
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-16
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-16
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-16
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-16
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-16
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-16
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-16
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-16
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-16
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-16
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-16
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-16
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-16
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-16
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-16
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-15
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-15
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		8e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-15
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		9e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-15
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-14
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-14
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-14
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-14
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-14
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		6e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-13
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-13
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-13
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-13
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		5e-13
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		5e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		9e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		9e-13
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-12
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-12
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-12
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-12
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-12
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-12
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		8e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-11
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-11
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-11
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-11
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-11
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-11
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-11
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-11
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-11
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-11
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-11
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-11
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-11
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		5e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-11
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-11
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-11
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		7e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		9e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-10
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		5e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		7e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		8e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		9e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-09
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		9e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		9e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-08
2zfd_B	123	The Crystal Structure Of Plant Specific Calcium Bin		4e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-08
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		5e-08
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-08

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  258 bits (660), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 118/261 (45%), Positives = 178/261 (68%), Gaps = 1/261 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  Y +G T+G GTF KV+  +++ TG  VA+K+L +  I    +V +IKREI  +K+ 
Sbjct: 9   KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ AV +CH
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+S R Y
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLY 187
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+  +L 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247
Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            +P  R  I+ IR+H WF+++
Sbjct: 248 VDPLKRATIKDIREHEWFKQD 268

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  257 bits (657), Expect = 7e-69,   Method: Compositional matrix adjust.
 Identities = 116/267 (43%), Positives = 183/267 (68%), Gaps = 2/267 (0%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M    R +  Y +  T+GEG+F KV+ A + +T + VA+K +++  + K  M  +++REI
Sbjct: 1   MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           S +K++RHP+I++L++V+ + T + +++E+  GGELFD IV + R+ E++ RR+FQQ+I 
Sbjct: 61  SYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH   + HRDLKPENLLLD   N+K++DFGLS +   G   L T+CG+PNY APEV
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEV 178
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           ++ + Y G   DVWSCG++L+V++ G LPF +  +P L+KK+N+  +  P + S GA SL
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL 238
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I +++  +P  RI I+ IR+ PWF  N
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFNVN 265

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  256 bits (654), Expect = 2e-68,   Method: Compositional matrix adjust.
 Identities = 117/261 (44%), Positives = 177/261 (67%), Gaps = 1/261 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  Y +G T+G GTF KV+  +++ TG  VA+K+L +  I    +V +IKREI  +K+ 
Sbjct: 9   KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ AV +CH
Sbjct: 69  RHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              V HRDLKPEN+LLD++ N K++DFGLS +   G E L  +CG+PNY APEV+S R Y
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRDSCGSPNYAAPEVISGRLY 187
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+  +L 
Sbjct: 188 AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQ 247
Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            +P  R  I+ IR+H WF+++
Sbjct: 248 VDPLKRATIKDIREHEWFKQD 268

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  253 bits (646), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 177/258 (68%), Gaps = 2/258 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y++ +T+GEG+F KV+ A +  TG+ VA+K++ K  + K  M  +I+REIS ++++R
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV +CH 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S + Y 
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYA 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI ++L  
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 250
Query: 248 NPKTRIRIEGIRKHPWFR 265
           NP  RI I  I +  WF+
Sbjct: 251 NPLNRISIHEIMQDDWFK 268

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  253 bits (645), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 177/258 (68%), Gaps = 2/258 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y++ +T+GEG+F KV+ A +  TG+ VA+K++ K  + K  M  +I+REIS ++++R
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV +CH 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S + Y 
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYA 189
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI ++L  
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 249
Query: 248 NPKTRIRIEGIRKHPWFR 265
           NP  RI I  I +  WF+
Sbjct: 250 NPLNRISIHEIMQDDWFK 267

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  252 bits (644), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 177/258 (68%), Gaps = 2/258 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y++ +T+GEG+F KV+ A +  TG+ VA+K++ K  + K  M  +I+REIS ++++R
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV +CH 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S + Y 
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYA 180
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI ++L  
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 240
Query: 248 NPKTRIRIEGIRKHPWFR 265
           NP  RI I  I +  WF+
Sbjct: 241 NPLNRISIHEIMQDDWFK 258

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  252 bits (643), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 177/258 (68%), Gaps = 2/258 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y++ +T+GEG+F KV+ A +  TG+ VA+K++ K  + K  M  +I+REIS ++++R
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP+I++L++V+ S+ ++ +++E+  G ELFD IV + ++ E + RR+FQQ+I AV +CH 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLKPENLLLD + N+K++DFGLS +   G   L T+CG+PNY APEV+S + Y 
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEVISGKLYA 184
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWSCGVIL+V++   LPF +  +P L+K I+   ++ P + S GA  LI ++L  
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV 244
Query: 248 NPKTRIRIEGIRKHPWFR 265
           NP  RI I  I +  WF+
Sbjct: 245 NPLNRISIHEIMQDDWFK 262

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  251 bits (640), Expect = 8e-67,   Method: Compositional matrix adjust.
 Identities = 115/261 (44%), Positives = 175/261 (67%), Gaps = 1/261 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  Y +G T+G GTF KV+  ++  TG  VA+K+L +  I    +V +I+REI  +K+ 
Sbjct: 14  KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHP+I++L++V+++ + +++++E+V+GGELFD I   GRL E + RR FQQ++  V +CH
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              V HRDLKPEN+LLD++ N K++DFGLS +   G E L  +CG+PNY APEV+S R Y
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRXSCGSPNYAAPEVISGRLY 192
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G   D+WS GVIL+ L+ G LPF +  +PTL+KKI    F  P + +    SL+  +L 
Sbjct: 193 AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQ 252
Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            +P  R  I+ IR+H WF+++
Sbjct: 253 VDPMKRATIKDIREHEWFKQD 273

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  223 bits (569), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 114/278 (41%), Positives = 174/278 (62%), Gaps = 4/278 (1%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG  VA+K++ K T L    + ++ RE+ IMKI+ 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILN 69
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDTFCGSPPYAAPELFQGKKYD 188
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ + L  
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 248
Query: 248 NPKTRIRIEGIRKHPWFRKNY--NPVKCSEEEEVNLDD 283
           NP  R  +E I K  W    +  + +K   E E+++ D
Sbjct: 249 NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 286

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  223 bits (568), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 109/257 (42%), Positives = 165/257 (64%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  223 bits (568), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 109/257 (42%), Positives = 165/257 (64%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  222 bits (566), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 108/257 (42%), Positives = 165/257 (64%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA++++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  221 bits (562), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 113/278 (40%), Positives = 172/278 (61%), Gaps = 4/278 (1%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG  VA+K++ K T L    + ++ RE+ IMKI+ 
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILN 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+   + YD
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAAPELFQGKKYD 191
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ + L  
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVL 251
Query: 248 NPKTRIRIEGIRKHPWFRKNY--NPVKCSEEEEVNLDD 283
           NP  R  +E I K  W    +  + +K   E E+++ D
Sbjct: 252 NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISD 289

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  221 bits (562), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 108/257 (42%), Positives = 163/257 (63%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  219 bits (559), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 107/257 (41%), Positives = 164/257 (63%), Gaps = 2/257 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA++++ K T L    + ++ RE+ IMK++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDK-TQLNSSSLQKLFREVRIMKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG+P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDEFCGSPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPWF 264
           NP  R  +E I K  W 
Sbjct: 251 NPSKRGTLEQIMKDRWM 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  219 bits (558), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 108/256 (42%), Positives = 164/256 (64%), Gaps = 2/256 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ IMK++ 
Sbjct: 6   IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIMKVLN 64
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  G + E + R  F+Q++ AV +CH 
Sbjct: 65  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQ 124
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTFCGSPPYAAPELFQGKKYD 183
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLIL 243
Query: 248 NPKTRIRIEGIRKHPW 263
           NP  R  +E I K  W
Sbjct: 244 NPSKRGTLEQIMKDRW 259

>pdb|2EHB|D Chain D, The Structure Of The C-Terminal Domain Of The Protein Kinase Atsos2 Bound To The Calcium Sensor Atsos3 Length = 143

Iteration: 1
 Score =  219 bits (558), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 103/140 (73%), Positives = 122/140 (87%), Gaps = 3/140 (2%)
Query: 304 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 363
           GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S+  K 
Sbjct: 3   GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKS 62
Query: 364 HTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLE 423
           HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  C+KLE
Sbjct: 63  HTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLE 122
Query: 424 NIIWKPTEG---SSLLRTMS 440
           NIIW+ TEG   S +LRT++
Sbjct: 123 NIIWRATEGIPKSEILRTIT 142

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  214 bits (546), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 107/256 (41%), Positives = 160/256 (62%), Gaps = 2/256 (0%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG+ VA+K++ K T L    + ++ RE+ I K++ 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDK-TQLNSSSLQKLFREVRIXKVLN 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y++ E+ +GGE+FD +V  GR  E + R  F+Q++ AV +CH 
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD+  N+K++DFG S     G + L   CG P Y APE+   + YD
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK-LDAFCGAPPYAAPELFQGKKYD 190
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K L  
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLIL 250
Query: 248 NPKTRIRIEGIRKHPW 263
           NP  R  +E I K  W
Sbjct: 251 NPSKRGTLEQIXKDRW 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  213 bits (542), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 114/272 (41%), Positives = 170/272 (62%), Gaps = 8/272 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  Y + +TIG+G FAKV+ A++  TG  VA+K++ K T L    + ++ RE+ IMKI+ 
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDK-TQLNPTSLQKLFREVRIMKILN 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNIV+L EV+ +   +Y+++E+ +GGE+FD +V  GR+ E + R  F+Q++ AV +CH 
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K + HRDLK ENLLLD   N+K++DFG S     G + L T CG+P Y APE+   + YD
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK-LDTFCGSPPYAAPELFQGKKYD 191
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           G   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L+ K+L  
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVL 251
Query: 248 NPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
           NP  R  +E I K  W    +      EEEE+
Sbjct: 252 NPIKRGSLEQIMKDRWMNVGH------EEEEL 277

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  201 bits (510), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 160/270 (59%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  +++++ E VA+K + +      ++ + +KREI   + +RHP
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLRHP 74
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++CH+  
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APEVL  
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLK 189
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 249
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 250 RHLISRIFVADPAKRISIPEIRNHEWFLKN 279

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 159/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  +++++ E VA+K + +      ++   +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIAANVKREIINHRSLRHP 75
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APEVL  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLK 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 250
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  200 bits (509), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 103/270 (38%), Positives = 159/270 (58%), Gaps = 12/270 (4%)
Query: 2   KKQTRRVAK-YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           KKQ   + K +E   T+G G F++V  A+ + TG+  A+K + K  +        I+ EI
Sbjct: 14  KKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE--SSIENEI 71
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           ++++ ++H NIV L ++  S   +Y++++ V+GGELFD+IV +G   E D     +Q++D
Sbjct: 72  AVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD 131
Query: 121 AVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           AV + H  G+ HRDLKPENLL    D    + +SDFGLS +  +G +++ T CGTP YVA
Sbjct: 132 AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG-DVMSTACGTPGYVA 190
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
           PEVL+ + Y   A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   
Sbjct: 191 PEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDI 249
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPW 263
           S  A   I  +++ +P  R   E   +HPW
Sbjct: 250 SDSAKDFIRNLMEKDPNKRYTCEQAARHPW 279

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 11/260 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 131 YHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY- 195
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
             A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A   I  
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 244 ILDPNPKTRIRIEGIRKHPW 263
           +++ +P+ R   E   +HPW
Sbjct: 256 LMEKDPEKRFTCEQALQHPW 275

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 11/260 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 131 YHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY- 195
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
             A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A   I  
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 244 ILDPNPKTRIRIEGIRKHPW 263
           +++ +P+ R   E   +HPW
Sbjct: 256 LMEKDPEKRFTCEQALQHPW 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 11/260 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 131 YHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY- 195
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
             A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A   I  
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 244 ILDPNPKTRIRIEGIRKHPW 263
           +++ +P+ R   E   +HPW
Sbjct: 256 LMEKDPEKRFTCEQALQHPW 275

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  198 bits (503), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 109/270 (40%), Positives = 158/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G F   R  +++ T E VA+K + +   +     + ++REI   + +RHP
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHP 76
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + II+E+ +GGEL+++I + GR  E++ R +FQQL+  V++CHS  
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           + HRDLK EN LLD      LK+ DFG S        +LH    +T GTP Y+APEVL  
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLR 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCP--FWFSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  Y+K    I + ++S P     S   
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P TRI I  I+ H WF KN
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKN 281

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  197 bits (502), Expect = 7e-51,   Method: Compositional matrix adjust.
 Identities = 103/260 (39%), Positives = 155/260 (59%), Gaps = 11/260 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 131 YHRDLKPENLL---LDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLL   LD    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y 
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY- 195
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
             A D WS GVI ++L+ GY PF + +   L+++I  A  EF  P+W   S  A   I  
Sbjct: 196 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 244 ILDPNPKTRIRIEGIRKHPW 263
           +++ +P+ R   E   +HPW
Sbjct: 256 LMEKDPEKRFTCEQALQHPW 275

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  197 bits (501), Expect = 9e-51,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 159/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  +++++ E VA+K + +      ++ + +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLRHP 75
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK+  FG S        +LH    +T GTP Y+APEVL  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLK 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 250
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  197 bits (501), Expect = 9e-51,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 159/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  +++++ E VA+K + +      ++ + +KREI   + +RHP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERG----EKIDENVKREIINHRSLRHP 75
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++CH+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 130 VYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLHT----TCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK+  FG S        +LH+    T GTP Y+APEVL  
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKDTVGTPAYIAPEVLLK 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 250
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  197 bits (500), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 107/270 (39%), Positives = 158/270 (58%), Gaps = 21/270 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+ + IG G F   R  ++++  E VA+K + +      ++ + +KREI   + +RHP
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERG----EKIDENVKREIINHRSLRHP 75
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVR  EV+ + T + I++E+ +GGELF++I + GR  E++ R +FQQLI  V++ H+  
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 130 VYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLH----TTCGTPNYVAPEVLSN 183
           V HRDLK EN LLD      LK++DFG S        +LH    +  GTP Y+APEVL  
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSK-----ASVLHSQPKSAVGTPAYIAPEVLLK 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCPFW--FSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  ++K    I   +++ P +   S   
Sbjct: 191 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 250
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI +I   +P  RI I  IR H WF KN
Sbjct: 251 RHLISRIFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  195 bits (496), Expect = 4e-50,   Method: Compositional matrix adjust.
 Identities = 101/258 (39%), Positives = 147/258 (56%), Gaps = 13/258 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G F++V   + R TG+  A+K + KS   +      ++ EI+++K ++H NIV L +
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD---SSLENEIAVLKKIKHENIVTLED 73
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
           +  S T  Y++++ V+GGELFD+I+ +G   E D     QQ++ AV + H  G+ HRDLK
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 137 PENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           PENLL    +    + ++DFGLS + Q G+  + T CGTP YVAPEVL+ + Y   A D 
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPEVLAQKPY-SKAVDC 190
Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHKILDPNP 249
           WS GVI ++L+ GY PF E     L++KI     EF  PFW   S  A   I  +L+ +P
Sbjct: 191 WSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDP 250
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R   E    HPW   N
Sbjct: 251 NERYTCEKALSHPWIDGN 268

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  193 bits (491), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 100/280 (35%), Positives = 159/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   GE++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 183
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 184 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  191 bits (486), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 103/262 (39%), Positives = 152/262 (58%), Gaps = 9/262 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   +G+G F+ VR      TG+  A K++  +  L  R   +++RE  I ++++HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHP 63
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ++++V HCH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEVL    Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
            G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A  LI+
Sbjct: 184 -GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 243 KILDPNPKTRIRIEGIRKHPWF 264
           K+L  NP  RI      KHPW 
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  191 bits (485), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 106/276 (38%), Positives = 153/276 (55%), Gaps = 9/276 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y++   +G+G F+ VR       G+  A K++  +  L  R   +++RE  I ++++HPN
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHPN 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV HCH  GV
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 131 YHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLLL S      +K++DFGL+   +   +      GTP Y++PEVL    Y 
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY- 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIHK 243
           G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A  LI+K
Sbjct: 202 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 261
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
           +L  NP  RI      KHPW         C   +E 
Sbjct: 262 MLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 297

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 103/262 (39%), Positives = 152/262 (58%), Gaps = 9/262 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   +G+G F+ VR      TG+  A K++  +  L  R   +++RE  I ++++HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKII-NTKKLSARDHQKLEREARICRLLKHP 63
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ++++V HCH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEVL    Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
            G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A  LI+
Sbjct: 184 -GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 243 KILDPNPKTRIRIEGIRKHPWF 264
           K+L  NP  RI      KHPW 
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 77
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 78  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 138 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 195
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 196 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 254
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 255 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 294

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 183
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 184 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 243 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  190 bits (483), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 182 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 280

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 105/271 (38%), Positives = 155/271 (57%), Gaps = 10/271 (3%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M   T+    Y+V   +G+G F+ VR   ++ TG   A K++  +  L  R   +++RE 
Sbjct: 21  MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREA 79
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I + ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           ++A+CHS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLS 198
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
           PEVL    Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   
Sbjct: 199 PEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
           +  A SLI  +L  NPK RI  +   K PW 
Sbjct: 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  190 bits (482), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 204
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 205 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 263
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 303

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  190 bits (482), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 157/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE +
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEXI 183
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 184 EGRXHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 242
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 243 SRLLKHNPSQRPXLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 99/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPEMI 179
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 180 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/261 (39%), Positives = 151/261 (57%), Gaps = 9/261 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   IG+G F+ VR      TG   A K++  +  L  R   +++RE  I ++++H 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKII-NTKKLSARDHQKLEREARICRLLKHS 63
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ ++     Y++ + VTGGELF+ IV +    E D     QQ+++AV HCH  G
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           V HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++PEVL    Y
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
            G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A +LI+
Sbjct: 184 -GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 242
Query: 243 KILDPNPKTRIRIEGIRKHPW 263
           ++L  NP  RI      KHPW
Sbjct: 243 QMLTINPAKRITAHEALKHPW 263

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 106/282 (37%), Positives = 155/282 (54%), Gaps = 9/282 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           TR   +Y++   +G+G F+ VR       G+  A  ++  +  L  R   +++RE  I +
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARICR 65
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           +++HPNIVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV H
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 125 CHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CH  GV HR+LKPENLLL S      +K++DFGL+   +   +      GTP Y++PEVL
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGA 237
               Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A
Sbjct: 186 RKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
             LI+K+L  NP  RI      KHPW         C   +E 
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 286

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 159/281 (56%), Gaps = 6/281 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 180
           +++CHSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE+
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEM 179
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  L
Sbjct: 180 IEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 238
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           I ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 279

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  188 bits (478), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 100/282 (35%), Positives = 161/282 (57%), Gaps = 8/282 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 179
           +++CHSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPE 181
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           ++  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  
Sbjct: 182 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           LI ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 241 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  188 bits (478), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 160/281 (56%), Gaps = 6/281 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 180
           +++CHSK V HRD+KPENLLL S G LK++DFG S   P    + L   CGT +Y+ PE+
Sbjct: 147 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL---CGTLDYLPPEM 203
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  L
Sbjct: 204 IEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 262
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           I ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 303

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  188 bits (477), Expect = 5e-48,   Method: Compositional matrix adjust.
 Identities = 98/280 (35%), Positives = 158/280 (56%), Gaps = 4/280 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK+++FG S           T CGT +Y+ PE++
Sbjct: 123 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT--TLCGTLDYLPPEMI 180
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 181 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 239
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 240 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 279

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 154/271 (56%), Gaps = 4/271 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D   
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHD-EK 186
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 251 TRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            R  +  + +HPW   N + P  C  +E  +
Sbjct: 247 QRPMLREVLEHPWITANSSKPSNCQNKESAS 277

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 160/279 (57%), Gaps = 8/279 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 179
           +++CHSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPE 176
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           ++  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  
Sbjct: 177 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 235
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEE 277
           LI ++L  NP  R  +  + +HPW   N + P  C  +E
Sbjct: 236 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 100/282 (35%), Positives = 161/282 (57%), Gaps = 8/282 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 179
           +++CHSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPE 177
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           ++  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           LI ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 99/273 (36%), Positives = 157/273 (57%), Gaps = 8/273 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRD+KPENLLL S G LK++DFG S  A   +  EL    CGT +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL----CGTLDYLPPEMIEGRMHD- 184
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
              D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  N
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 249 PKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           P  R  +  + +HPW   N + P  C  +E  +
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPSNCQNKESAS 277

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 154/267 (57%), Gaps = 10/267 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    Y+V   +G+G F+ VR   ++ TG   A K++  +  L  R   +++RE  I +
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICR 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CHS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVL 178
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGA 237
               Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A
Sbjct: 179 KKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 237
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWF 264
            SLI  +L  NPK RI  +   K PW 
Sbjct: 238 KSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  188 bits (477), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 154/267 (57%), Gaps = 10/267 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    Y+V   +G+G F+ VR   ++ TG   A K++  +  L  R   +++RE  I +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICR 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CHS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGA 237
               Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A
Sbjct: 180 KKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWF 264
            SLI  +L  NPK RI  +   K PW 
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  188 bits (477), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 154/266 (57%), Gaps = 10/266 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    Y+V   +G+G F+ VR   ++ TG   A K++  +  L  R   +++RE  I +
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII-NTKKLSARDFQKLEREARICR 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CHS G+ HR+LKPENLLL S      +K++DFGL A+     E  H   GTP Y++PEVL
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVL 179
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGA 237
               Y     D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A
Sbjct: 180 KKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA 238
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPW 263
            SLI  +L  NPK RI  +   K PW
Sbjct: 239 KSLIDSMLTVNPKKRITADQALKVPW 264

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  187 bits (476), Expect = 7e-48,   Method: Compositional matrix adjust.
 Identities = 100/281 (35%), Positives = 159/281 (56%), Gaps = 6/281 (2%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   GE++ ++    +  E     Y  +L +A
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 180
           +++CHSK V HRD+KPENLLL S G LK++DFG S   P      L    GT +Y+ PE+
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---XGTLDYLPPEM 182
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  L
Sbjct: 183 IEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 241
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
           I ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 282

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 96/266 (36%), Positives = 152/266 (57%), Gaps = 3/266 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 182 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
            ++L  NP  R  +  + +HPW   N
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 101/280 (36%), Positives = 161/280 (57%), Gaps = 9/280 (3%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           MK+Q   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+
Sbjct: 1   MKRQWA-LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAP 178
           A+++CHSK V HRD+KPENLLL S G LK++DFG S  A   +  +L    CGT +Y+ P
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPP 175
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT 238
           E++  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA 
Sbjct: 176 EMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEE 277
            LI ++L  NP  R  +  + +HPW   N + P  C  +E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  187 bits (474), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 98/272 (36%), Positives = 155/272 (56%), Gaps = 6/272 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGRMHD-E 188
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 248
Query: 250 KTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
             R  +  + +HPW   N + P  C  +E  +
Sbjct: 249 SQRPMLREVLEHPWITANSSKPSNCQNKESAS 280

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  186 bits (471), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 153/267 (57%), Gaps = 5/267 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEV 180
           +++CHSK V HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE+
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEM 180
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  L
Sbjct: 181 IEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 239
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I ++L  NP  R  +  + +HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 148/257 (57%), Gaps = 3/257 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 128
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D   
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHD-EK 185
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP 
Sbjct: 186 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 245
Query: 251 TRIRIEGIRKHPWFRKN 267
            R  +  + +HPW   N
Sbjct: 246 QRPMLREVLEHPWITAN 262

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  185 bits (470), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 148/257 (57%), Gaps = 3/257 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D   
Sbjct: 134 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHD-EK 190
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP 
Sbjct: 191 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 250
Query: 251 TRIRIEGIRKHPWFRKN 267
            R  +  + +HPW   N
Sbjct: 251 QRPMLREVLEHPWITAN 267

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 152/266 (57%), Gaps = 3/266 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK+++FG S           T CGT +Y+ PE++
Sbjct: 124 LSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT--TLCGTLDYLPPEMI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 182 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 240
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
            ++L  NP  R  +  + +HPW   N
Sbjct: 241 SRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  185 bits (469), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEIXINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  185 bits (469), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  184 bits (468), Expect = 6e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 58
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNK 265

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 152/265 (57%), Gaps = 3/265 (1%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+   +  +++GR +G+G F  V  A+ R++   +A+KVL K+ + K  +  Q++RE+ I
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
              +RHPNI+RL+      T+VY+ILE+   G ++ ++    R  E     Y  +L +A+
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           ++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++ 
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIE 183
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
            R +D    D+WS GV+ +  + G  PF        Y++I+  EF+ P + + GA  LI 
Sbjct: 184 GRMHD-EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242
Query: 243 KILDPNPKTRIRIEGIRKHPWFRKN 267
           ++L  N   R+ +  + +HPW + N
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 97/277 (35%), Positives = 156/277 (56%), Gaps = 3/277 (1%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S           T  GT +Y+ PE++
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT--TLSGTLDYLPPEMI 179
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 180 EGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 278
            ++L  NP  R  +  + +HPW   N +    S+ +E
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKE 275

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  184 bits (468), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 152/265 (57%), Gaps = 3/265 (1%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+   +  +++GR +G+G F  V  A+ R++   +A+KVL K+ + K  +  Q++RE+ I
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
              +RHPNI+RL+      T+VY+ILE+   G ++ ++    R  E     Y  +L +A+
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           ++CHSK V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++ 
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR--DTLCGTLDYLPPEMIE 183
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
            R +D    D+WS GV+ +  + G  PF        Y++I+  EF+ P + + GA  LI 
Sbjct: 184 GRMHD-EKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLIS 242
Query: 243 KILDPNPKTRIRIEGIRKHPWFRKN 267
           ++L  N   R+ +  + +HPW + N
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  184 bits (467), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 150/267 (56%), Gaps = 3/267 (1%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M K+   +  +++GR +G+G F  V  A+ ++    +A+KVL KS + K  +  Q++REI
Sbjct: 7   MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 66
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I   +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L D
Sbjct: 67  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 126
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH + V HRD+KPENLL+   G LK++DFG S             CGT +Y+ PE+
Sbjct: 127 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRXMCGTLDYLPPEM 184
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  + +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  L
Sbjct: 185 IEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 243
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I K+L  +P  R+ ++G+ +HPW + N
Sbjct: 244 ISKLLRYHPPQRLPLKGVMEHPWVKAN 270

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 153/267 (57%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 147/257 (57%), Gaps = 3/257 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ ++    +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 126
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D   
Sbjct: 127 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--TLCGTLDYLPPEMIEGRMHD-EK 183
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP 
Sbjct: 184 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 243
Query: 251 TRIRIEGIRKHPWFRKN 267
            R  +  + +HPW   N
Sbjct: 244 QRPMLREVLEHPWITAN 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 149/258 (57%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL---CGTLDYLPPEMIEGRMHD-E 185
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 245
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 246 SQRPMLREVLEHPWITAN 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  184 bits (466), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 149/258 (57%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGRMHD-E 185
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 245
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 246 SQRPMLREVLEHPWITAN 263

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 149/258 (57%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL---CGTLDYLPPEMIEGRMHD-E 185
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 245
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 246 SQRPMLREVLEHPWITAN 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 148/258 (57%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ + +   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P      L   CGT +Y+ PE++  R +D  
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL---CGTLDYLPPEMIEGRMHD-E 185
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 186 KVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHNP 245
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 246 SQRPMLREVLEHPWITAN 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  183 bits (464), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 150/258 (58%), Gaps = 5/258 (1%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KPENLLL S G LK++DFG S   P    + L   CGT +Y+ PE++  R +D  
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDL---CGTLDYLPPEMIEGRMHD-E 188
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 189 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 248
Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 249 SQRPMLREVLEHPWITAN 266

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  182 bits (463), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 104/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG   +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  182 bits (463), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I  
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINA 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  181 bits (459), Expect = 8e-46,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 106/264 (40%), Positives = 151/264 (57%), Gaps = 13/264 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y +  TIG G++ +V+ A  + T    A K + K  +     VD+ K+EI IMK + HPN
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPN 67
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AVA+CH   V
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 131 YHRDLKPENLLL--DSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPEN L   DS  + LK+ DFGL+A  + G +++ T  GTP YV+P+VL   G  
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLE--GLY 184
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--FWF--STGATSLIHK 243
           G   D WS GV+++VL+ GY PF       +  KI    F+ P   W   S  A SLI +
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKN 267
           +L  +PK RI      +H WF K 
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQ 268

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 100/270 (37%), Positives = 152/270 (56%), Gaps = 9/270 (3%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M   TR    Y++   +G+G F+ VR    +   +  A K++  +  L  R   +++RE 
Sbjct: 23  MATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKII-NTKKLSARDHQKLEREA 81
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I ++++HPNIVRLH+ ++     Y++ + VTGGELF+ IV +    E D      Q+++
Sbjct: 82  RICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE 141
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           +V H H   + HRDLKPENLLL S      +K++DFGL+   Q   +      GTP Y++
Sbjct: 142 SVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLS 201
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
           PEVL    Y G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   
Sbjct: 202 PEVLRKDPY-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTV 260
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPW 263
           +  A +LI+++L  NP  RI  +   KHPW
Sbjct: 261 TPEAKNLINQMLTINPAKRITADQALKHPW 290

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 106/264 (40%), Positives = 151/264 (57%), Gaps = 13/264 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y +  TIG G++ +V+ A  + T    A K + K  +     VD+ K+EI IMK + HPN
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPN 84
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AVA+CH   V
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 131 YHRDLKPENLLL--DSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPEN L   DS  + LK+ DFGL+A  + G +++ T  GTP YV+P+VL   G  
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLE--GLY 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--FWF--STGATSLIHK 243
           G   D WS GV+++VL+ GY PF       +  KI    F+ P   W   S  A SLI +
Sbjct: 202 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 261
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKN 267
           +L  +PK RI      +H WF K 
Sbjct: 262 LLTKSPKQRITSLQALEHEWFEKQ 285

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  181 bits (458), Expect = 9e-46,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEIXINK 60
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNK 267

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  181 bits (458), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 149/267 (55%), Gaps = 3/267 (1%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M K+   +  +++ R +G+G F  V  A+ ++    +A+KVL KS + K  +  Q++REI
Sbjct: 6   MPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I   +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L D
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 125
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH + V HRD+KPENLL+   G LK++DFG S             CGT +Y+ PE+
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRXMCGTLDYLPPEM 183
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  + +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  L
Sbjct: 184 IEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242
Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I K+L  +P  R+ ++G+ +HPW + N
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEIXINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  180 bits (457), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 103/267 (38%), Positives = 152/267 (56%), Gaps = 13/267 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMK 64
           V  +++ +T+GEG + +V+ A NR T E+VA+K++        R VD    IK+EI I K
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-----RAVDCPENIKKEICINK 59
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+   GT  YVAPE+L 
Sbjct: 120 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+ + +D    Y      +     W    +   +
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           L+HKIL  NP  RI I  I+K  W+ K
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNK 266

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  177 bits (449), Expect = 9e-45,   Method: Compositional matrix adjust.
 Identities = 112/326 (34%), Positives = 177/326 (54%), Gaps = 20/326 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 130 VYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APEVL  RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVL--RGT 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
                DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S  A  LI 
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV-NLDDVHAVFDDIEYVAEQSENK 301
           K+L  +P  RI      +HPW +K       SE   + +L  + +   +I     Q+E K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK-----YSSETPTISDLPSLESAMTNIRQF--QAEKK 311
Query: 302 VG-GPLLMNAFEMITLSQGLNLAALF 326
           +    LL  A ++ TL +   L  +F
Sbjct: 312 LAQAALLYMASKLTTLDETKQLTEIF 337

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 162/297 (54%), Gaps = 22/297 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 71  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 188
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 286
             A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 162/297 (54%), Gaps = 22/297 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 71  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 188
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 286
             A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 305

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 105/271 (38%), Positives = 154/271 (56%), Gaps = 17/271 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 71  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 188
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             A  L+ K+L  +PK R   E   +HPW +
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 105/271 (38%), Positives = 154/271 (56%), Gaps = 17/271 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 70  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 187
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 247
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             A  L+ K+L  +PK R   E   +HPW +
Sbjct: 248 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  176 bits (447), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 162/297 (54%), Gaps = 22/297 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K    I   R  D    ++ EI I+K
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 77  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 194
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAE--FSCPFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +  F    W   S
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 254
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWF-----RKNYNPVKCSEEEEVNLDDVHA 286
             A  L+ K+L  +PK R   E   +HPW      ++ +  +   E E   L  V A
Sbjct: 255 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQVLA 311

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  175 bits (443), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 156/265 (58%), Gaps = 11/265 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  +++ RT+G G+F +V   ++R  G   AMKVL K  +++ + V+    E  ++ IV 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HP I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+ + HS
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           K + +RDLKPEN+LLD  G++K++DFG +  +P    ++ +  CGTP+Y+APEV+S + Y
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYXLCGTPDYIAPEVVSTKPY 180
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
           + S  D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+ +++ 
Sbjct: 181 NKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239
Query: 247 PNPKTRI-----RIEGIRKHPWFRK 266
            +   R+       E ++ HPWF++
Sbjct: 240 RDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 99/263 (37%), Positives = 153/263 (58%), Gaps = 19/263 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ--IKREISIMKIVRH 68
           +EV   +G G  + V   + + T +  A+KVL K+       VD+  ++ EI ++  + H
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-------VDKKIVRTEIGVLLRLSH 107
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI++L E+  + T++ ++LE VTGGELFD+IV +G   E D     +Q+++AVA+ H  
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 129 GVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           G+ HRDLKPENLL  +      LK++DFGLS + +  V L+ T CGTP Y APE+L    
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILRGCA 226
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAE--FSCPFW--FSTGATSL 240
           Y G   D+WS G+I ++L+ G+ PF  E     ++++I   E  F  P+W   S  A  L
Sbjct: 227 Y-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285
Query: 241 IHKILDPNPKTRIRIEGIRKHPW 263
           + K++  +PK R+      +HPW
Sbjct: 286 VRKLIVLDPKKRLTTFQALQHPW 308

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 152/264 (57%), Gaps = 11/264 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APEVL  RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVL--RGT 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
                DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S  A  LI 
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
           K+L  +P  RI      +HPW +K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  174 bits (442), Expect = 7e-44,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 152/264 (57%), Gaps = 11/264 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ  + +    GT  Y+APEVL  RG 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVL--RGT 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
                DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S  A  LI 
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
           K+L  +P  RI      +HPW +K
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  174 bits (442), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 155/271 (57%), Gaps = 17/271 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+++++K    I   R  D    ++ EI I+K
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 210 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 327
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSC--PFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +++     W   S
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 387
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             A  L+ K+L  +PK R   E   +HPW +
Sbjct: 388 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  174 bits (441), Expect = 8e-44,   Method: Compositional matrix adjust.
 Identities = 87/262 (33%), Positives = 148/262 (56%), Gaps = 2/262 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  ++VG  +G+G+FA V  A++  TG  VA+K++ K  + K  MV +++ E+ I   +
Sbjct: 9   KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHC 125
           +HP+I+ L+        VY++LE    GE+   + ++ +   EN+ R +  Q+I  + + 
Sbjct: 69  KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS G+ HRDL   NLLL    N+K++DFGL+   +   E  +T CGTPNY++PE+ + R 
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI-ATRS 187
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
             G  +DVWS G + + L+ G  PF    +     K+  A++  P + S  A  LIH++L
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 246 DPNPKTRIRIEGIRKHPWFRKN 267
             NP  R+ +  +  HP+  +N
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRN 269

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  174 bits (441), Expect = 9e-44,   Method: Compositional matrix adjust.
 Identities = 103/271 (38%), Positives = 155/271 (57%), Gaps = 17/271 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKS--TILKHRMVD---QIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+++++K    I   R  D    ++ EI I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE-TSLMRTLCGTPTYLAPEVL 313
Query: 182 SNRGYDG--SAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSC--PFW--FS 234
            + G  G   A D WS GVILF+ ++GY PF E     +L  +I + +++     W   S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             A  L+ K+L  +PK R   E   +HPW +
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 12/265 (4%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMK 64
           +++E+ + +G+G+F KV F   + +G       AMKVL K+T LK R   + K E  I+ 
Sbjct: 24  SQFELLKVLGQGSFGKV-FLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILV 81
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ R
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           G+  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +
Sbjct: 202 GHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260
Query: 245 LDPNPKTRI-----RIEGIRKHPWF 264
              NP  R+      +E I++H +F
Sbjct: 261 FKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 12/265 (4%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMK 64
           +++E+ + +G+G+F KV F   + +G       AMKVL K+T LK R   + K E  I+ 
Sbjct: 25  SQFELLKVLGQGSFGKV-FLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILV 82
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ R
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           G+  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +
Sbjct: 203 GHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 261
Query: 245 LDPNPKTRI-----RIEGIRKHPWF 264
              NP  R+      +E I++H +F
Sbjct: 262 FKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 100/265 (37%), Positives = 153/265 (57%), Gaps = 12/265 (4%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMK 64
           +++E+ + +G+G+F KV F   + +G       AMKVL K+T LK R   + K E  I+ 
Sbjct: 24  SQFELLKVLGQGSFGKV-FLVKKISGSDARQLYAMKVLKKAT-LKVRDRVRTKMERDILV 81
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            V HP IV+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ R
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           G+  S AD WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +
Sbjct: 202 GHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260
Query: 245 LDPNPKTRI-----RIEGIRKHPWF 264
              NP  R+      +E I++H +F
Sbjct: 261 FKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 146/264 (55%), Gaps = 10/264 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + +G G + +V   +++ TG   A+K++ KS++        +  E++++K + HP
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y+++E   GGELFD+I+ + +  E D     +Q++    + H   
Sbjct: 65  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 124
Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S      +K+ DFGLSA  + G + +    GT  Y+APEVL  + Y
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAPEVLRKK-Y 182
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFW--FSTGATSLIH 242
           D    DVWSCGVIL++L+ GY PFG      + K++   +FS   P W   S  A  L+ 
Sbjct: 183 D-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVK 241
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
            +L   P  RI  E    HPW  K
Sbjct: 242 LMLTYEPSKRISAEEALNHPWIVK 265

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 157/267 (58%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIVR 67
           YE+G  +G G FA VR  + + TG+  A K + K  +   R     ++I+RE++I++ +R
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V + HS
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           K + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAPE+++ 
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 206
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTG--AT 238
               G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ +T   A 
Sbjct: 207 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFSNTSELAK 264
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I    +H W +
Sbjct: 265 DFIRRLLVKDPKRRMXIAQSLEHSWIK 291

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 146/264 (55%), Gaps = 10/264 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + +G G + +V   +++ TG   A+K++ KS++        +  E++++K + HP
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y+++E   GGELFD+I+ + +  E D     +Q++    + H   
Sbjct: 82  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 141
Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S      +K+ DFGLSA  + G + +    GT  Y+APEVL  + Y
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK-MKERLGTAYYIAPEVLRKK-Y 199
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFW--FSTGATSLIH 242
           D    DVWSCGVIL++L+ GY PFG      + K++   +FS   P W   S  A  L+ 
Sbjct: 200 D-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVK 258
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
            +L   P  RI  E    HPW  K
Sbjct: 259 LMLTYEPSKRISAEEALNHPWIVK 282

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APEVL    Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT-Y 204
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 205 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K+L   P  RI       H W +
Sbjct: 264 KMLTYVPSMRISARDALDHEWIQ 286

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 50  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APEVL    Y
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT-Y 227
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 228 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 286
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K+L   P  RI       H W +
Sbjct: 287 KMLTYVPSMRISARDALDHEWIQ 309

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 157/267 (58%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           YE+G  +G G FA VR  + + TG+  A K + K  +   R     ++I+RE++I++ +R
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V + HS
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           K + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAPE+++ 
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 192
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTG--AT 238
               G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ +T   A 
Sbjct: 193 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFSNTSELAK 250
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I    +H W +
Sbjct: 251 DFIRRLLVKDPKRRMXIAQSLEHSWIK 277

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 95/260 (36%), Positives = 142/260 (54%), Gaps = 3/260 (1%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  +E+GR +G+G F  V  A+ +++   VA+KVL KS I K  +  Q++REI I   + 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+RL+     R ++Y+ILE+   GEL+ ++       E       ++L DA+ +CH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           K V HRD+KPENLLL   G LK++DFG S           T CGT +Y+ PE++  R ++
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSV--HAPSLRRKTMCGTLDYLPPEMIEGRMHN 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
               D+W  GV+ + L+ G  PF        Y++I   +   P    TGA  LI K+L  
Sbjct: 200 -EKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRH 258
Query: 248 NPKTRIRIEGIRKHPWFRKN 267
           NP  R+ +  +  HPW R N
Sbjct: 259 NPSERLPLAQVSAHPWVRAN 278

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 51  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APEVL    Y
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT-Y 228
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 229 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 287
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K+L   P  RI       H W +
Sbjct: 288 KMLTYVPSMRISARDALDHEWIQ 310

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  168 bits (425), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 151/264 (57%), Gaps = 10/264 (3%)
Query: 9   AKYEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           + +E+ + +G+G+F KV   R     ++G   AMKVL K+T LK R   + K E  I+  
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKAT-LKVRDRVRTKMERDILAD 86
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           V HP +V+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L   + H 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS G+ +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ +G
Sbjct: 147 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +  S AD WS GV++F ++ G LPF   D       I  A+   P + ST A SL+  + 
Sbjct: 207 HSHS-ADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALF 265
Query: 246 DPNPKTRI-----RIEGIRKHPWF 264
             NP  R+       E I++H ++
Sbjct: 266 KRNPANRLGSGPDGAEEIKRHVFY 289

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  167 bits (424), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 157/267 (58%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIVR 67
           YE+G  +G G FA VR  + + TG+  A K + K  +   R     ++I+RE++I++ +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V + HS
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           K + H DLKPEN++L         +K+ DFG++   + G E      GTP +VAPE+++ 
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVAPEIVNY 185
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTG--AT 238
               G  AD+WS GVI ++L++G  PF GET   TL   I+A   +F   ++ +T   A 
Sbjct: 186 EPL-GLEADMWSIGVITYILLSGASPFLGETKQETL-TNISAVNYDFDEEYFSNTSELAK 243
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I    +H W +
Sbjct: 244 DFIRRLLVKDPKRRMTIAQSLEHSWIK 270

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 157/274 (57%), Gaps = 16/274 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y+  + +G G + +V   +++ T    A+K++ K+++       ++  E++++K++ HPN
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHPN 97
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I++L++    +   Y+++E   GGELFD+I+H+ +  E D     +Q++  V + H   +
Sbjct: 98  IMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 131 YHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            HRDLKPENLLL+S      +K+ DFGLSA+ +   + +    GT  Y+APEVL  + YD
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPEVLRKK-YD 215
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIHK 243
               DVWS GVILF+L+AGY PFG      + +K+   +  F  P W   S GA  LI +
Sbjct: 216 -EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
           +L  + + RI  +   +HPW ++      CS++E
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKE-----MCSKKE 303

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 147/263 (55%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  + +    GT  Y+APEVL    Y
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT-Y 210
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 211 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 269
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K+L   P  RI       H W +
Sbjct: 270 KMLTYVPSMRISARDALDHEWIQ 292

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 151/266 (56%), Gaps = 22/266 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVR 73
           + +GEG+F+  R   ++++ ++ A+K+++K      RM    ++EI+ +K+   HPNIV+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LHEV   +   ++++E + GGELF++I  +    E +     ++L+ AV+H H  GV HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 134 DLKPENLLL-DSYGNL--KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
           DLKPENLL  D   NL  K+ DFG + L     + L T C T +Y APE+L+  GYD S 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES- 189
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLP-------TLYKKINAAEFS--CPFW--FSTGATS 239
            D+WS GVIL+ +++G +PF   D          + KKI   +FS     W   S  A  
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFR 265
           LI  +L  +P  R+++ G+R + W +
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 104/273 (38%), Positives = 155/273 (56%), Gaps = 15/273 (5%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V HPNI+ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW 232
           VAPE++ N    G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+
Sbjct: 185 VAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFF 242
Query: 233 FSTG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
             T   A   I K+L    + R+ I+   +HPW
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +TIG G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 145/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  RT+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
            + V  P +V+L       + +Y++LE+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 147
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 204
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 205 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 263
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  166 bits (419), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 147
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 204
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 205 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 263
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 264 NLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  165 bits (418), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGAT---WTLCGTPEYLAPEIIL 232
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 56  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 232
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 144/263 (54%), Gaps = 10/263 (3%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE+ ++K + HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI +L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++  + + H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 130 VYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLLL+S     N+++ DFGLS    +  +      GT  Y+APEVL    Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKXKDKIGTAYYIAPEVLHGT-Y 204
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
           D    DVWS GVIL++L++G  PF   +   + KK+   +  F  P W   S  A  LI 
Sbjct: 205 D-EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIR 263
Query: 243 KILDPNPKTRIRIEGIRKHPWFR 265
           K L   P  RI       H W +
Sbjct: 264 KXLTYVPSXRISARDALDHEWIQ 286

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 149/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF   +   +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 21  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 80
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 140
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +       T CGTP Y+APE++ 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WTLCGTPEYLAPEIIL 197
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 198 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 256
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 257 NLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 30  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 89
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 149
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 150 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 206
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 207 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 265
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 266 NLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   +++ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I  H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 175
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 232
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 233 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 291
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 292 NLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +TIG G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E++ GG++F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +TIG G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E++ GG++F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 22  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 81
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 141
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 142 EYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 198
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 199 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 257
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 258 NLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFGL+   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 145/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIII 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 145/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 191 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 248
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE++ N
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPAFVAPEIV-N 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 190
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 191 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 248
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 151/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 146/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G ++V+DFGL+   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 144/267 (53%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  162 bits (410), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 154/272 (56%), Gaps = 13/272 (4%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWF 233
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+ 
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 234 STG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
            T   A   I K+L    + R+ I+   +HPW
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 154/273 (56%), Gaps = 15/273 (5%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW 232
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFF 242
Query: 233 FSTG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
             T   A   I K+L    + R+ I+   +HPW
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 154/273 (56%), Gaps = 15/273 (5%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW 232
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T   TL   I A   +F   F+
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANITAVSYDFDEEFF 242
Query: 233 FSTG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
             T   A   I K+L    + R+ I+   +HPW
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 148/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPN-----PKTRIRIEGIRKHPWF 264
            +L  +        +  +  I+ H WF
Sbjct: 271 NLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 99/272 (36%), Positives = 154/272 (56%), Gaps = 13/272 (4%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWF 233
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+ 
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 234 STG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
            T   A   I K+L    + R+ I+   +HPW
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 100/272 (36%), Positives = 154/272 (56%), Gaps = 13/272 (4%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 120 DAVAHCHSKGVYHRDLKPEN-LLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN +LLD      ++K+ DFGL+   + GVE      GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEF 184
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFWF 233
           VAPE++ N    G  AD+WS GVI ++L++G  PF G+T   TL    + + +F   F+ 
Sbjct: 185 VAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243
Query: 234 STG--ATSLIHKILDPNPKTRIRIEGIRKHPW 263
            T   A   I K+L    + R+ I+   +HPW
Sbjct: 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 145/267 (54%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G ++V+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP Y+AP ++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEYLAPAIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 144/267 (53%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 144/267 (53%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T  + ++E  +T+G G+F +V   ++ ETG   AMK+L K  ++K + ++    E  I
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P + +L       + +Y+++E+  GGE+F  +   GR  E   R Y  Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENL++D  G +KV+DFG +   +     L   CGTP Y+APE++ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXL---CGTPEYLAPEIIL 212
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 213 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 271
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 272 NLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L   CGTP  +APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---CGTPEALAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L    GTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---AGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 147/267 (55%), Gaps = 9/267 (3%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  I
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           ++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + HS  + +RDLKPENLL+D  G ++V+DFG +   +     L    GTP Y+APE++ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXL---XGTPEYLAPEIIL 211
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
           ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+ 
Sbjct: 212 SKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270
Query: 243 KILDPNPKTRI-----RIEGIRKHPWF 264
            +L  +   R       +  I+ H WF
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/293 (32%), Positives = 151/293 (51%), Gaps = 20/293 (6%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD------- 54
           KK+ +    Y   R +G G + +V   + +      A+KV+ KS   K R  D       
Sbjct: 29  KKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEK 88
Query: 55  ---QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDC 111
              +I  EIS++K + HPNI++L +V   +   Y++ EF  GGELF++I+++ +  E D 
Sbjct: 89  FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148
Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQQGVELLHT 168
               +Q++  + + H   + HRD+KPEN+LL+   S  N+K+ DFGLS+   +  + L  
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRD 207
Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
             GT  Y+APEVL  +       DVWSCGVI+++L+ GY PFG  +   + KK+   ++ 
Sbjct: 208 RLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 229 CPF--W--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
             F  W   S  A  LI  +L  +   R   E      W +K  N +  S+++
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 150/267 (56%), Gaps = 15/267 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR 67
           Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPN++ LHEV  ++T V +I E V GGELFD +  +  L E +   + +Q+++ V + HS
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 128 KGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
             + H DLKPEN++L         +K+ DFGL+     G E      GTP +VAPE+++ 
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 191
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATS- 239
               G  AD+WS GVI ++L++G  PF G+T   TL   ++A   EF   ++ +T A + 
Sbjct: 192 EPL-GLEADMWSIGVITYILLSGASPFLGDTKQETL-ANVSAVNYEFEDEYFSNTSALAK 249
Query: 240 -LIHKILDPNPKTRIRIEGIRKHPWFR 265
             I ++L  +PK R+ I+   +HPW +
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  159 bits (402), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 142/266 (53%), Gaps = 8/266 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +  +E  R +G+G+F KV  A+ +ETG+  A+KVL K  IL+   V+    E  I+ + R
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 68  -HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP + +L     +  +++ ++EFV GG+L   I    R  E   R Y  ++I A+   H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            KG+ +RDLK +N+LLD  G+ K++DFG+            T CGTP+Y+APE+L    Y
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            G A D W+ GV+L+ ++ G+ PF   +   L++ I   E   P W    AT ++   + 
Sbjct: 202 -GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT 260
Query: 247 PNPKTRIRI------EGIRKHPWFRK 266
            NP  R+          I +HP+F++
Sbjct: 261 KNPTMRLGSLTQGGEHAILRHPFFKE 286

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 151/272 (55%), Gaps = 21/272 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--AKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G F+ VR   NRETG+  A+K++  AK T       + +KRE SI  +++H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAH 124
           P+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CH   + HRD+KPEN+LL S  N   +K+ DFG++    +   +     GTP+++APEV+
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCPFWFS 234
               Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S     S
Sbjct: 206 KREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS---HIS 260
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             A  L+ ++L  +P  RI +     HPW ++
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  157 bits (396), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 149/264 (56%), Gaps = 10/264 (3%)
Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKH-RMVDQIKREISIMKIV 66
           +E+ R +G+G + KV   R      TG+  AMKVL K+ I+++ +     K E +I++ V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HP IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+ H H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            KG+ +RDLKPEN++L+  G++K++DFGL         + HT CGT  Y+APE+L   G+
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
           +  A D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L 
Sbjct: 199 N-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLK 257
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            N  +R+         ++ HP+FR
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 133
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 134 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 192
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 193 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 251

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/347 (29%), Positives = 178/347 (51%), Gaps = 41/347 (11%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIV 66
           +  +++ R IG G++AKV   + ++T    AM+V+ K  +     +D ++ E  +  +  
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            +G+ +RDLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L    Y
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 187 DGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFSTGA 237
            G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S  A
Sbjct: 231 -GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289
Query: 238 TSLIHKILDPNPKTRI------RIEGIRKHPWFRK-NYN---------PVKCSEEEEVNL 281
            S++   L+ +PK R+          I+ HP+FR  +++         P K +   E  L
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 349
Query: 282 DDVHAVF-----------DDIEYVAEQSE---NKVGGPLLMNAFEMI 314
           D+  + F           DDI    +QSE    +   PLLM+A E +
Sbjct: 350 DNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINPLLMSAEECV 396

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 150/273 (54%), Gaps = 18/273 (6%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL-AKSTILKHRMVDQIK----REISIMK 64
           KY+    IG G  + VR   +R TG   A+K++   +  L    +++++    RE  I++
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 65  -IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            +  HP+I+ L +   S + ++++ + +  GELFD +  +  L E + R   + L++AV+
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 181
             H+  + HRDLKPEN+LLD    +++SDFG S   + G E L   CGTP Y+APE+L  
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKC 273
Query: 182 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFWFST 235
               ++ GY G   D+W+CGVILF L+AG  PF       + + I     +FS P W   
Sbjct: 274 SMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 236 GAT--SLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            +T   LI ++L  +P+ R+  E   +HP+F +
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 107/350 (30%), Positives = 181/350 (51%), Gaps = 47/350 (13%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIV 66
           +  +++ R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +  
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 183
            +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L  
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFS 234
             Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S
Sbjct: 196 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMS 254
Query: 235 TGATSLIHKILDPNPKTRI------RIEGIRKHPWFRK-NYN---------PVKCSEEEE 278
             A S++   L+ +PK R+          I+ HP+FR  +++         P K +   E
Sbjct: 255 VKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGE 314
Query: 279 VNLDDVHAVF-----------DDIEYVAEQSE---NKVGGPLLMNAFEMI 314
             LD+  + F           DDI    +QSE    +   PLLM+A E +
Sbjct: 315 FGLDNFDSQFTNERVQLXPDDDDIVRKIDQSEFEGFEYINPLLMSAEECV 364

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 83/239 (34%), Positives = 128/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 107/350 (30%), Positives = 181/350 (51%), Gaps = 47/350 (13%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIV 66
           +  +++ R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 183
            +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L  
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFS 234
             Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S
Sbjct: 181 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 239
Query: 235 TGATSLIHKILDPNPKTRI------RIEGIRKHPWFRK-NYN---------PVKCSEEEE 278
             A S++   L+ +PK R+          I+ HP+FR  +++         P K +   E
Sbjct: 240 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGE 299
Query: 279 VNLDDVHAVF-----------DDIEYVAEQSE---NKVGGPLLMNAFEMI 314
             LD+  + F           DDI    +QSE    +   PLLM+A E +
Sbjct: 300 FGLDNFDSQFTNEPVQLXPDDDDIVRKIDQSEFEGFEYINPLLMSAEESV 349

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 93/286 (32%), Positives = 151/286 (52%), Gaps = 30/286 (10%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--------------- 51
           ++ +Y +   IG+G++  V+ A N       AMKVL+K  +++                 
Sbjct: 11  QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 52  --------MVDQIKREISIMKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGELFDKIV 101
                    ++Q+ +EI+I+K + HPN+V+L EVL   +   +Y++ E V  G + + + 
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VP 129
Query: 102 HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ 161
               L E+  R YFQ LI  + + H + + HRD+KP NLL+   G++K++DFG+S   + 
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 162 GVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY 219
              LL  T GTP ++APE LS   + + G A DVW+ GV L+  + G  PF +  +  L+
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLH 249
Query: 220 KKI--NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW 263
            KI   A EF      +     LI ++LD NP++RI +  I+ HPW
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 148/264 (56%), Gaps = 10/264 (3%)
Query: 11  YEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKH-RMVDQIKREISIMKIV 66
           +E+ R +G+G + KV   R      TG+  AMKVL K+ I+++ +     K E +I++ V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HP IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+ H H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            KG+ +RDLKPEN++L+  G++K++DFGL         + H  CGT  Y+APE+L   G+
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
           +  A D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L 
Sbjct: 199 N-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLK 257
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            N  +R+         ++ HP+FR
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPFFR 281

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 135
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  Y G A D W
Sbjct: 136 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 194
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 195 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 253

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 82/239 (34%), Positives = 127/239 (53%), Gaps = 1/239 (0%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          +   CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVDWW 189
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 147/265 (55%), Gaps = 18/265 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV   IG G+++  +   ++ T    A+K++ KS   K    ++I  EI +++  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS---KRDPTEEI--EI-LLRYGQHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V + H++GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 131 YHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            HRDLKP N+L +D  GN   +++ DFG +   +    LL T C T N+VAPEVL  +GY
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEFSCP--FWFSTGATS-- 239
           D +A D+WS GV+L+ ++ GY PF  G  D P  +  +I + +FS    +W S   T+  
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWF 264
           L+ K+L  +P  R+    + +HPW 
Sbjct: 257 LVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 141/267 (52%), Gaps = 1/267 (0%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R + +Y  GR +G+G FAK     + +T E  A KV+ KS +LK    +++  EI+I K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V + 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H+  V HRDLK  NL L+   ++K+ DFGL+   +   E   T CGTPNY+APEVL  +G
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI ++L
Sbjct: 219 H-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVK 272
             +P  R  +  +    +F   Y P++
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/245 (34%), Positives = 132/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 152 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 212 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  Y G
Sbjct: 272 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-G 330
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 331 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 390
Query: 249 PKTRI 253
           PK R+
Sbjct: 391 PKQRL 395

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/245 (34%), Positives = 132/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  Y G
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-G 327
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 387
Query: 249 PKTRI 253
           PK R+
Sbjct: 388 PKQRL 392

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 147/264 (55%), Gaps = 18/264 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y V  TIG G++++ +   ++ T    A+KV+ KS   K    ++I  EI +++  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKS---KRDPSEEI--EI-LLRYGQHPN 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V + HS+GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 131 YHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            HRDLKP N+L +D  GN   L++ DFG +   +    LL T C T N+VAPEVL  +GY
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEF--SCPFW--FSTGATS 239
           D    D+WS G++L+ ++AGY PF  G +D P  +  +I + +F  S   W   S  A  
Sbjct: 203 D-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 240 LIHKILDPNPKTRIRIEGIRKHPW 263
           L+ K+L  +P  R+  + + +HPW
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 147/264 (55%), Gaps = 18/264 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y V  TIG G++++ +   ++ T    A+KV+ KS   K    ++I  EI +++  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKS---KRDPSEEI--EI-LLRYGQHPN 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+ L +V      VY++ E + GGEL DKI+ Q    E +       +   V + HS+GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 131 YHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            HRDLKP N+L +D  GN   L++ DFG +   +    LL T C T N+VAPEVL  +GY
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGY 202
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEF--SCPFW--FSTGATS 239
           D    D+WS G++L+ ++AGY PF  G +D P  +  +I + +F  S   W   S  A  
Sbjct: 203 D-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 240 LIHKILDPNPKTRIRIEGIRKHPW 263
           L+ K+L  +P  R+  + + +HPW
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/277 (32%), Positives = 153/277 (55%), Gaps = 23/277 (8%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIV 66
           +  +++ R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            HP +V LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 183
            +G+ +RDLK +N+LLDS G++K++D+G+    ++G+    TT   CGTPNY+APE+L  
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC---KEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT------LYKKINAAEFSCPFWFS 234
             Y G + D W+ GV++F +MAG  PF   G +D P       L++ I   +   P   S
Sbjct: 185 EDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243
Query: 235 TGATSLIHKILDPNPKTRI------RIEGIRKHPWFR 265
             A S++   L+ +PK R+          I+ HP+FR
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 1/267 (0%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R + +Y  GR +G+G FAK     + +T E  A KV+ KS +LK    +++  EI+I K 
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V + 
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 142
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  +G
Sbjct: 143 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI ++L
Sbjct: 203 H-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 261
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVK 272
             +P  R  +  +    +F   Y P++
Sbjct: 262 HADPTLRPSVAELLTDEFFTSGYAPMR 288

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 1/267 (0%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R + +Y  GR +G+G FAK     + +T E  A KV+ KS +LK    +++  EI+I K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V + 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  +G
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI ++L
Sbjct: 219 H-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVK 272
             +P  R  +  +    +F   Y P++
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 140/267 (52%), Gaps = 1/267 (0%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R + +Y  GR +G+G FAK     + +T E  A KV+ KS +LK    +++  EI+I K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + +P++V  H        VY++LE      L +    +  + E + R + +Q I  V + 
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYL 158
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H+  V HRDLK  NL L+   ++K+ DFGL+   +   E     CGTPNY+APEVL  +G
Sbjct: 159 HNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           +     D+WS G IL+ L+ G  PF  + L   Y +I   E+S P   +  A++LI ++L
Sbjct: 219 H-SFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVK 272
             +P  R  +  +    +F   Y P++
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAPMR 304

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  151 bits (382), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 144/265 (54%), Gaps = 18/265 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV   IG G+++  +   ++ T    A+K++ KS   K    ++I  EI +++  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKS---KRDPTEEI--EI-LLRYGQHPN 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+ L +V      VY++ E   GGEL DKI+ Q    E +       +   V + H++GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 131 YHRDLKPENLL-LDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            HRDLKP N+L +D  GN   +++ DFG +   +    LL T C T N+VAPEVL  +GY
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGY 197
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLP-TLYKKINAAEFSCP--FWFSTGATS-- 239
           D +A D+WS GV+L+  + GY PF  G  D P  +  +I + +FS    +W S   T+  
Sbjct: 198 D-AACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256
Query: 240 LIHKILDPNPKTRIRIEGIRKHPWF 264
           L+ K L  +P  R+    + +HPW 
Sbjct: 257 LVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 131/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 9   EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 128
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  Y G
Sbjct: 129 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-G 187
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 188 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 247
Query: 249 PKTRI 253
           PK R+
Sbjct: 248 PKQRL 252

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 131/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 10  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 129
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  Y G
Sbjct: 130 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-G 188
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 248
Query: 249 PKTRI 253
           PK R+
Sbjct: 249 PKQRL 253

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 131/245 (53%), Gaps = 2/245 (0%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++E  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 11  EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-K 128
            +  L     +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K
Sbjct: 71  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 130
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V +RDLK ENL+LD  G++K++DFGL     +    +   CGTP Y+APEVL +  Y G
Sbjct: 131 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-G 189
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            A D W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +
Sbjct: 190 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD 249
Query: 249 PKTRI 253
           PK R+
Sbjct: 250 PKQRL 254

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  148 bits (373), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 148/272 (54%), Gaps = 21/272 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--AKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G F+ VR   NRETG+  A+K++  AK T       + +KRE SI  +++H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAH 124
           P+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++A+ +
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP+++APEV+
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCPFWFS 234
               Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S     S
Sbjct: 206 KREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS---HIS 260
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             A  L+ ++L  +P  RI +     HPW ++
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  148 bits (373), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 93/272 (34%), Positives = 148/272 (54%), Gaps = 21/272 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--AKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G F+ VR   NRETG+  A+K++  AK T       + +KRE SI  +++H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAH 124
           P+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++A+ +
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 125 CHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP+++APEV+
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 207
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK-------KINAAEFSCPFWFS 234
               Y G   DVW CGVILF+L++G LPF  T    L++       K+N  ++S     S
Sbjct: 208 KREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS---HIS 262
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             A  L+ ++L  +P  RI +     HPW ++
Sbjct: 263 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  147 bits (372), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 131/256 (51%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+     DVWS 
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDVWSI 203
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 263
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 264 ELLNDEFFTSGYIPAR 279

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  147 bits (372), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 131/256 (51%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+     DVWS 
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDVWSI 203
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 263
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 264 ELLNDEFFTSGYIPAR 279

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 131/256 (51%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E   T CGTPNY+APEVLS +G+     DVWS 
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH-SFEVDVWSI 207
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 208 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 267
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 268 ELLNDEFFTSGYIPAR 283

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  146 bits (369), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/313 (28%), Positives = 161/313 (51%), Gaps = 8/313 (2%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  +E+ + +G+G+F KV  A+ ++T +  A+K L K  +L    V+    E  ++ + 
Sbjct: 16  KIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 75
Query: 67  -RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             HP +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   
Sbjct: 76  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKG+ +RDLK +N+LLD  G++K++DFG+      G    +  CGTP+Y+APE+L  + 
Sbjct: 136 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           Y+ S  D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+ 
Sbjct: 196 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 254
Query: 246 DPNPKTRIRIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD----DIEYVAEQSE 299
              P+ R+ + G IR+HP FR+ N+  ++  E +      V + FD    D E++ E+  
Sbjct: 255 VREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPR 314
Query: 300 NKVGGPLLMNAFE 312
                  L+N+ +
Sbjct: 315 LXFADRALINSMD 327

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  145 bits (367), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+     DVWS 
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSI 201
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 202 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 261
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 262 ELLNDEFFTSGYIPAR 277

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+     DVWS 
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSI 225
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 226 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 285
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 286 ELLNDEFFTSGYIPAR 301

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  145 bits (365), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 1/256 (0%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G FAK     + +T E  A K++ KS +LK    +++  EISI + + H ++V  H 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                  V+++LE      L +    +  L E + R Y +Q++    + H   V HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +G+     DVWS 
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSI 227
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
           G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+L  +P  R  I 
Sbjct: 228 GCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTIN 287
Query: 257 GIRKHPWFRKNYNPVK 272
            +    +F   Y P +
Sbjct: 288 ELLNDEFFTSGYIPAR 303

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 9/269 (3%)
Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 183 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241
Query: 242 HKILDPNPKTRI---RIEG---IRKHPWF 264
            K+L  +   R+    +EG   ++ HP+F
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 9/269 (3%)
Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 2   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 61
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 121
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L
Sbjct: 122 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 182 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 240
Query: 242 HKILDPNPKTRI---RIEG---IRKHPWF 264
            K+L  +   R+    +EG   ++ HP+F
Sbjct: 241 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  144 bits (364), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 9/269 (3%)
Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 4   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 63
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 123
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L
Sbjct: 124 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 184 TEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 242
Query: 242 HKILDPNPKTRI---RIEG---IRKHPWF 264
            K+L  +   R+    +EG   ++ HP+F
Sbjct: 243 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 142/267 (53%), Gaps = 9/267 (3%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 66
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + 
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 126
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSN 183
           H KG+ HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ 
Sbjct: 127 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 243
           +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K
Sbjct: 187 KS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 245
Query: 244 ILDPNPKTRI---RIEG---IRKHPWF 264
           +L  +   R+    +EG   ++ HP+F
Sbjct: 246 LLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/296 (31%), Positives = 163/296 (55%), Gaps = 30/296 (10%)
Query: 8   VAKYEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIM 63
           +  +E+ + +G G + KV   R     +TG+  AMKVL K+TI+ K +  +  + E  ++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 64  KIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           + +R  P +V LH    + TK+++IL+++ GGELF  +  + R  E++ + Y  +++ A+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVL 181
            H H  G+ +RD+K EN+LLDS G++ ++DFGLS        E  +  CGT  Y+AP+++
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 182 --SNRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPT-LYKKINAAEFSCPFWFST 235
              + G+D  A D WS GV+++ L+ G  PF   GE +    + ++I  +E   P   S 
Sbjct: 233 RGGDSGHD-KAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291
Query: 236 GATSLIHKILDPNPKTRI-----RIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHA 286
            A  LI ++L  +PK R+       + I++H +F+K            +N DD+ A
Sbjct: 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK------------INWDDLAA 335

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  144 bits (362), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 141/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+L+ +    
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 209
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 270 ATKRLGCEEMEGYGPLKAHPFF 291

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/313 (28%), Positives = 160/313 (51%), Gaps = 8/313 (2%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++  + + + +G+G+F KV  A+ ++T +  A+K L K  +L    V+    E  ++ + 
Sbjct: 15  KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 67  -RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             HP +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   
Sbjct: 75  WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HSKG+ +RDLK +N+LLD  G++K++DFG+      G    +  CGTP+Y+APE+L  + 
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           Y+ S  D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+ 
Sbjct: 195 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 253
Query: 246 DPNPKTRIRIEG-IRKHPWFRK-NYNPVKCSEEEEVNLDDVHAVFD----DIEYVAEQSE 299
              P+ R+ + G IR+HP FR+ N+  ++  E +      V + FD    D E++ E+  
Sbjct: 254 VREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPR 313
Query: 300 NKVGGPLLMNAFE 312
                  L+N+ +
Sbjct: 314 LSFADRALINSMD 326

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 209
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 270 ATKRLGCEEMEGYGPLKAHPFF 291

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   ++ KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 141/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+L+ +    
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 214
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 215 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 274 ATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACK 211
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 216
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 217 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLD 275
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 276 ATKRLGCEEMEGYGPLKAHPFF 297

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 194
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 254
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 255 ATKRLGCEEMEGYGPLKAHPFF 276

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  142 bits (359), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 214
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 215 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 274 ATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  142 bits (358), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 218
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 219 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 277
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 278 ATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   ++ KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 142/278 (51%), Gaps = 24/278 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-VDQIKREISIMKIVRHP 69
           Y++   +G G F  V     R TG + A    AK  +  H    + +++EI  M ++RHP
Sbjct: 53  YDIHEELGTGAFGVVHRVTERATGNNFA----AKFVMTPHESDKETVRKEIQTMSVLRHP 108
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK 128
            +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   + H H  
Sbjct: 109 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 129 GVYHRDLKPENLLLDS--YGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNR 184
              H DLKPEN++  +     LK+ DFGL+A   P+Q V++   T GT  + APEV   +
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK 225
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFWFSTGA 237
              G   D+WS GV+ ++L++G  PF GE D  TL         ++ + FS     S   
Sbjct: 226 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG---ISEDG 281
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              I K+L  +P TR+ I    +HPW      P + S+
Sbjct: 282 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 319

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  142 bits (357), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 122/217 (56%), Gaps = 2/217 (0%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KI 65
           + + +   + IG+G+F KV  A+++      A+KVL K  ILK +    I  E +++ K 
Sbjct: 36  KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN 95
Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           V+HP +V LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+ + 
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYL 155
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS  + +RDLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL  + 
Sbjct: 156 HSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP 215
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           YD +  D W  G +L+ ++ G  PF   +   +Y  I
Sbjct: 216 YDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 142/278 (51%), Gaps = 24/278 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-VDQIKREISIMKIVRHP 69
           Y++   +G G F  V     R TG + A    AK  +  H    + +++EI  M ++RHP
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFA----AKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK 128
            +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   + H H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 129 GVYHRDLKPENLLLDS--YGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNR 184
              H DLKPEN++  +     LK+ DFGL+A   P+Q V++   T GT  + APEV   +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGK 331
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFWFSTGA 237
              G   D+WS GV+ ++L++G  PF GE D  TL         ++ + FS     S   
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG---ISEDG 387
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              I K+L  +P TR+ I    +HPW      P + S+
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ 425

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  141 bits (355), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 139/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+    A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      +   GT  YV+PE+L+ +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  141 bits (355), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 140/262 (53%), Gaps = 9/262 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M  + HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
            V+L+       K+Y  L +   G L   I   G   E   R Y  +++ A+ + H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            HRDLKPEN+LL+   +++++DFG + +  P+      ++  GT  YV+PE+L+ +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASK 213
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           S +D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+ K+L  +
Sbjct: 214 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 249 PKTRI---RIEG---IRKHPWF 264
              R+    +EG   ++ HP+F
Sbjct: 273 ATKRLGCEEMEGYGPLKAHPFF 294

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 143/273 (52%), Gaps = 19/273 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL------AKSTILKHRMVDQIKREISIM- 63
           YE    +G G  + VR   ++ T +  A+K++      + S      + +   +E+ I+ 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 181
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L + CGTP+Y+APE++  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLRSVCGTPSYLAPEIIEC 197
Query: 182 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 198 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 142/273 (52%), Gaps = 19/273 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL------AKSTILKHRMVDQIKREISIM- 63
           YE    +G G  + VR   ++ T +  A+K++      + S      + +   +E+ I+ 
Sbjct: 6   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 65
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 125
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 181
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++  
Sbjct: 126 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIEC 184
Query: 182 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 185 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 243
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 244 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 142/273 (52%), Gaps = 19/273 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVL------AKSTILKHRMVDQIKREISIM- 63
           YE    +G G  + VR   ++ T +  A+K++      + S      + +   +E+ I+ 
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           K+  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ + 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 138
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-- 181
             H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++  
Sbjct: 139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIEC 197
Query: 182 ----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
               ++ GY G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 198 SMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 289

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 150/276 (54%), Gaps = 9/276 (3%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-QIKREISIM 63
            + + KY +G  +GEG++ KV+   + ET    A+K+L K  + +    +  +K+EI ++
Sbjct: 1   AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 64  KIVRHPNIVRLHEVLAS--RTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLI 119
           + +RH N+++L +VL +  + K+Y+++E+   G  E+ D +  + R        YF QLI
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLI 119
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVA 177
           D + + HS+G+ H+D+KP NLLL + G LK+S  G++    P    +   T+ G+P +  
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 178 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTG 236
           PE+ +    + G   D+WS GV L+ +  G  PF   ++  L++ I    ++ P      
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPP 239
Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
            + L+  +L+  P  R  I  IR+H WFRK + P +
Sbjct: 240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  139 bits (349), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 158/302 (52%), Gaps = 17/302 (5%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   Y+V + IG G F +V+  +++ + +  AMK+L+K  ++K         E  IM   
Sbjct: 73  KAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 132
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   + Y  +++ A+   H
Sbjct: 133 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G+ HRD+KP+N+LLD +G+LK++DFG    + + G+    T  GTP+Y++PEVL ++ 
Sbjct: 192 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQG 251
Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV LF ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 252 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAK 311
Query: 239 SLIHKILDPNPK--TRIRIEGIRKHPWFRK---NYNPVKCSEE---EEVNLDDVHAVFDD 290
           +LI   L        R  +E I++HP+F+    N++ ++ +      E++ D   + FDD
Sbjct: 312 NLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFDD 371
Query: 291 IE 292
           IE
Sbjct: 372 IE 373

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 139/257 (54%), Gaps = 7/257 (2%)
Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRL 74
            +G+G+F KV  A  + T E  A+K+L K  +++   V+    E  ++ ++ + P + +L
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           H    +  ++Y ++E+V GG+L   I   G+  E     Y  ++   +   H +G+ +RD
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRD 145
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LK +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y G + D W
Sbjct: 146 LKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY-GKSVDWW 204
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR 254
           + GV+L+ ++AG  PF   D   L++ I     S P   S  A S+   ++  +P  R+ 
Sbjct: 205 AYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPAKRLG 264
Query: 255 I--EG---IRKHPWFRK 266
              EG   +R+H +FR+
Sbjct: 265 CGPEGERDVREHAFFRR 281

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 141/271 (52%), Gaps = 11/271 (4%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM   
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 131
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++ 
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 310
Query: 239 SLIHKILDPNPK--TRIRIEGIRKHPWFRKN 267
           +LI   L        R  +E I++H +F+ +
Sbjct: 311 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  135 bits (340), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 141/271 (52%), Gaps = 11/271 (4%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM   
Sbjct: 67  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++ 
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305
Query: 239 SLIHKILDPNPK--TRIRIEGIRKHPWFRKN 267
           +LI   L        R  +E I++H +F+ +
Sbjct: 306 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 336

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 141/271 (52%), Gaps = 11/271 (4%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           +   YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM   
Sbjct: 72  KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 131
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
             P +V+L         +Y+++E++ GG+L + ++    + E   R Y  +++ A+   H
Sbjct: 132 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIH 190
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNR- 184
           S G  HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++ 
Sbjct: 191 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 185 --GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI----NAAEFSCPFWFSTGAT 238
             GY G   D WS GV L+ ++ G  PF    L   Y KI    N+  F      S  A 
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 310
Query: 239 SLIHKILDPNPK--TRIRIEGIRKHPWFRKN 267
           +LI   L        R  +E I++H +F+ +
Sbjct: 311 NLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  134 bits (337), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/264 (32%), Positives = 136/264 (51%), Gaps = 19/264 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F  V   + R +G    +K + K        ++QI+ EI ++K + HPNI+++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGR---LLENDCRRYFQQLIDAVAHCHSKGV 130
            EV      +YI++E   GGEL ++IV  Q R   L E       +Q+++A+A+ HS+ V
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 131 YHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            H+DLKPEN+L      +  +K+ DFGL+ L +   E      GT  Y+APEV       
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKRDV-- 202
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL-----YKKINAAEFSCPFWFSTGATSLIH 242
               D+WS GV+++ L+ G LPF  T L  +     YK+ N A    P   +  A  L+ 
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP--LTPQAVDLLK 260
Query: 243 KILDPNPKTRIRIEGIRKHPWFRK 266
           ++L  +P+ R     +  H WF++
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 138/256 (53%), Gaps = 7/256 (2%)
Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRL 74
            +G+G+F KV  ++ + T E  A+K+L K  +++   V+    E  ++ +  + P + +L
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           H    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    SKG+ +RD
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LK +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y G + D W
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDWW 205
Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIR 254
           + GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+ 
Sbjct: 206 AFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLG 265
Query: 255 I--EG---IRKHPWFR 265
              EG   I++H +FR
Sbjct: 266 CGPEGERDIKEHAFFR 281

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 139/266 (52%), Gaps = 20/266 (7%)
Query: 11  YEVGRT--IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           Y V +T  +G G F +V   +   TG  +A K++ K+  +K +  +++K EIS+M  + H
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTRGMKDK--EEVKNEISVMNQLDH 145
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHS 127
            N+++L++   S+  + +++E+V GGELFD+I+ +   L E D   + +Q+ + + H H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 128 KGVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
             + H DLKPEN+L        +K+ DFGL A   +  E L    GTP ++APEV+ N  
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGL-ARRYKPREKLKVNFGTPEFLAPEVV-NYD 263
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFWFSTGAT 238
           +     D+WS GVI ++L++G  PF G+ D  TL         +   EF      S  A 
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQD---ISEEAK 320
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWF 264
             I K+L      RI      KHPW 
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWL 346

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/277 (30%), Positives = 139/277 (50%), Gaps = 18/277 (6%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           KQ      Y++   +G G F  V     + TG     K +     L    V   K EISI
Sbjct: 45  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISI 101
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 121
           M  + HP ++ LH+    + ++ +ILEF++GGELFD+I  +  ++ E +   Y +Q  + 
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 122 VAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           + H H   + H D+KPEN++ ++    ++K+ DFGL A      E++  T  T  + APE
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL-ATKLNPDEIVKVTTATAEFAAPE 220
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK------KINAAEFSCPFW 232
           ++ +R   G   D+W+ GV+ +VL++G  PF GE DL TL        + +   FS    
Sbjct: 221 IV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS--- 276
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
            S  A   I  +L   P+ R+ +    +HPW + +++
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 138/255 (54%), Gaps = 7/255 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLH 75
           +G+G+F KV  ++ + T E  A+K+L K  +++   V+    E  ++ +  + P + +LH
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
               +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    SKG+ +RDL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           K +N++LDS G++K++DFG+              CGTP+Y+APE+++ + Y G + D W+
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY-GKSVDWWA 527
Query: 196 CGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRI 255
            GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+  
Sbjct: 528 FGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGC 587
Query: 256 --EG---IRKHPWFR 265
             EG   I++H +FR
Sbjct: 588 GPEGERDIKEHAFFR 602

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 73/254 (28%), Positives = 134/254 (52%), Gaps = 5/254 (1%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY   + IGEG+F K    ++ E G    +K +  S  +  +  ++ +RE++++  ++
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMK 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHC 125
           HPNIV+  E       +YI++++  GG+LF +I  Q  +L  E+    +F Q+  A+ H 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H + + HRD+K +N+ L   G +++ DFG++ +    VEL     GTP Y++PE+  N+ 
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHKI 244
           Y+ + +D+W+ G +L+ L      F    +  L  KI +  F      +S    SL+ ++
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 245 LDPNPKTRIRIEGI 258
              NP+ R  +  I
Sbjct: 261 FKRNPRDRPSVNSI 274

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 141/269 (52%), Gaps = 23/269 (8%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKIVRH- 68
             + +G G FA VR   ++ TG+  A K L K    + R  D   +I  EI+++++ +  
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKK----RRRGQDCRAEILHEIAVLELAKSC 88
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH 126
           P ++ LHEV  + +++ +ILE+  GGE+F   + +    + END  R  +Q+++ V + H
Sbjct: 89  PRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 127 SKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
              + H DLKP+N+LL S    G++K+ DFG+S       E L    GTP Y+APE+L+ 
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILN- 206
Query: 184 RGYD--GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA--AEFSCPFWFSTG--A 237
             YD   +A D+W+ G+I ++L+    PF   D    Y  I+    ++S   + S    A
Sbjct: 207 --YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA 264
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           T  I  +L  NP+ R   E    H W ++
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  129 bits (325), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 137/260 (52%), Gaps = 9/260 (3%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ R IG+G+F KV   Q  +T +  AMK + K   ++   V  + +E+ IM+ + HP 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V L         ++++++ + GG+L   +       E   + +  +L+ A+ +  ++ +
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GYD 187
            HRD+KP+N+LLD +G++ ++DF ++A+  +  ++  T  GT  Y+APE+ S+R   GY 
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT-TMAGTKPYMAPEMFSSRKGAGY- 194
Query: 188 GSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
             A D WS GV  + L+ G  P+     T    +         + P  +S    SL+ K+
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKL 254
Query: 245 LDPNPKTRI-RIEGIRKHPW 263
           L+PNP  R  ++  ++  P+
Sbjct: 255 LEPNPDQRFSQLSDVQNFPY 274

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 138/267 (51%), Gaps = 19/267 (7%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGE-SVAMKVLAKSTILKHR-MVDQIKREISIMKIV 66
           A+Y +G  +G+G F  V FA +R T    VA+KV+ ++ +L    + D +   + +  + 
Sbjct: 31  AEYRLGPLLGKGGFGTV-FAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 67  R------HPNIVRLHEVLASRTKVYIILE-FVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +      HP ++RL +   ++    ++LE  +   +LFD I  +G L E   R +F Q++
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 120 DAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
            A+ HCHS+GV HRD+K EN+L+D   G  K+ DFG  AL     E      GT  Y  P
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDFDGTRVYSPP 207
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT 238
           E +S   Y    A VWS G++L+ ++ G +PF E D     ++I  AE   P   S    
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIPF-ERD-----QEILEAELHFPAHVSPDCC 261
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
           +LI + L P P +R  +E I   PW +
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 139/274 (50%), Gaps = 13/274 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-----QIKREISIMK 64
           KY     +G G F  V  A ++E  + V +K + K  +L+   ++     ++  EI+I+ 
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 65  IVRHPNIVRLHEVLASRTKVYIILE-FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            V H NI+++ ++  ++    +++E   +G +LF  I    RL E      F+QL+ AV 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           +   K + HRD+K EN+++     +K+ DFG +A  ++G +L +T CGT  Y APEVL  
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMG 203
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK 243
             Y G   ++WS GV L+ L+    PF E     L + + AA    P+  S    SL+  
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPFCE-----LEETVEAA-IHPPYLVSKELMSLVSG 257
Query: 244 ILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
           +L P P+ R  +E +   PW  +  N    + EE
Sbjct: 258 LLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNI 71
             + +G G   KV    N+ T E  A+K+L            + +RE+ +  +  + P+I
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHI 117
Query: 72  VRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHC 125
           VR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+ + 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 126 HSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPEVL 
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLG 236
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW--FS 234
              YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W   S
Sbjct: 237 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                LI  +L   P  R+ I     HPW  ++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 61  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 112
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 113 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 172
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 173 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 231
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 232 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 290
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 291 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 334

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 62
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 181
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 182 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 240
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 241 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/315 (29%), Positives = 146/315 (46%), Gaps = 63/315 (20%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVR 67
           KY +   IG+G++  VR A   +T    A+K++ K+ I  +  + V++IK E+ +MK + 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKI--------------------------- 100
           HPNI RL+EV      + +++E   GG L DK+                           
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 101 -----------------VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD 143
                            V + +L+ N  R    Q+  A+ + H++G+ HRD+KPEN L  
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMR----QIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 144 SYGN--LKVSDFGLS----ALPQQGVELLHTTCGTPNYVAPEVL--SNRGYDGSAADVWS 195
           +  +  +K+ DFGLS     L       + T  GTP +VAPEVL  +N  Y G   D WS
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWS 261
Query: 196 CGVILFVLMAGYLPF-GETDLPTLYKKINAAE-FSCPFW--FSTGATSLIHKILDPNPKT 251
            GV+L +L+ G +PF G  D  T+ + +N    F  P +   S  A  L+  +L+ N   
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321
Query: 252 RIRIEGIRKHPWFRK 266
           R       +HPW  +
Sbjct: 322 RFDAMRALQHPWISQ 336

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 17  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 68
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 69  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 128
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 129 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 187
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 188 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 246
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 247 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 290

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 132/273 (48%), Gaps = 28/273 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNI 71
             + +G G   KV    N+ T E  A+K+L            + +RE+ +  +  + P+I
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHI 73
Query: 72  VRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHC 125
           VR+ +V     A R  + I++E + GGELF +I  +G     E +     + + +A+ + 
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 126 HSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPEVL 
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLG 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW--FS 234
              YD S  D+WS GVI+++L+ GY PF    G    P +  +I     EF  P W   S
Sbjct: 193 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 251
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                LI  +L   P  R+ I     HPW  ++
Sbjct: 252 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 284

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 16  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 67
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 68  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 127
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 128 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 186
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 187 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 245
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 246 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 289

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 15  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 66
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 67  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 126
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 127 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 185
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 186 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 244
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 245 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 288

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 10  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 61
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 62  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 121
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 122 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 180
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 181 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 239
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 240 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 283

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 60
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 61  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 121 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 179
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 180 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 238
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 239 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 134/268 (50%), Gaps = 14/268 (5%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   ++ +      +  E+++++ +
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 62
Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +         T  GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHP 262
                +I ++L+     R  +E I ++P
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 94/284 (33%), Positives = 138/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 25  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVE 76
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 77  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 136
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L T C 
Sbjct: 137 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCY 195
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 196 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 254
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 255 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 298

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 131/254 (51%), Gaps = 11/254 (4%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +A + + + IG G F++V  A     G  VA+K +    ++  +      +EI ++K + 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDAVA 123
           HPN+++ +       ++ I+LE    G+L   I H   Q RL+ E    +YF QL  A+ 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKINAAEFSCPF---WFSTGAT 238
            GY+   +D+WS G +L+ + A   PF   + +L +L KKI   ++  P     +S    
Sbjct: 211 NGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELR 268
Query: 239 SLIHKILDPNPKTR 252
            L++  ++P+P+ R
Sbjct: 269 QLVNMCINPDPEKR 282

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 133/268 (49%), Gaps = 14/268 (5%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   ++ +      +  E+++++ +
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 62
Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +            GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 182
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHP 262
                +I ++L+     R  +E I ++P
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 93/284 (32%), Positives = 137/284 (48%), Gaps = 29/284 (10%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 60
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 61  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG  A        L   C 
Sbjct: 121 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTEPCY 179
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 180 TPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 238
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 239 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G   KV    +R TG+  A+K+L  S   +  +    +           P+IV +
Sbjct: 16  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG-------PHIVCI 68
Query: 75  HEVLAS----RTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSK 128
            +V  +    +  + II+E + GGELF +I  +G     E +     + +  A+   HS 
Sbjct: 69  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 128
Query: 129 GVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            + HRD+KPENLL  S      LK++DFG +    Q    L T C TP YVAPEVL    
Sbjct: 129 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEK 186
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAE--FSCPFW--FSTGA 237
           YD S  D+WS GVI+++L+ G+ PF    G+   P + ++I   +  F  P W   S  A
Sbjct: 187 YDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 245
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI  +L  +P  R+ I     HPW  ++
Sbjct: 246 KQLIRLLLKTDPTERLTITQFMNHPWINQS 275

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G   KV    +R TG+  A+K+L  S   +  +    +           P+IV +
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG-------PHIVCI 87
Query: 75  HEVLAS----RTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSK 128
            +V  +    +  + II+E + GGELF +I  +G     E +     + +  A+   HS 
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 129 GVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            + HRD+KPENLL  S      LK++DFG +    Q    L T C TP YVAPEVL    
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEVLGPEK 205
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAE--FSCPFW--FSTGA 237
           YD S  D+WS GVI+++L+ G+ PF    G+   P + ++I   +  F  P W   S  A
Sbjct: 206 YDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             LI  +L  +P  R+ I     HPW  ++
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 14/268 (5%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   ++ +      +  E+++++ +
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 62
Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +     +      GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYY 182
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHP 262
                +I ++L+     R  +E I ++P
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENP 269

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 139/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 139/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 139/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 71
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 72  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 250
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 251 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 90/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 71
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKPENLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 131 LKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 250
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 251 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 139/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF++    +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 76
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 136 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIW 195
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 196 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 255
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 256 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 71
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 250
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 251 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 71
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 130
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 131 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 190
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 191 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 250
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 251 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 296

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 115/216 (53%), Gaps = 4/216 (1%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-REISIMK 64
           + + KYE    +GEG++  V   +N++TG  VA+K   +S     +MV +I  REI ++K
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLK 79
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            +RH N+V L EV   + + Y++ EFV    L D  +    L     ++Y  Q+I+ +  
Sbjct: 80  QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           CHS  + HRD+KPEN+L+   G +K+ DFG +       E+      T  Y APE+L   
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD 199
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
              G A DVW+ G ++  +  G   F G++D+  LY
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY 235

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 137/272 (50%), Gaps = 14/272 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  AQN+ET    A KV+   +      ++    EI I+    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 95
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNR 184
           + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+      +R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+     +
Sbjct: 216 PYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 272
            K L+ N   R     + +HP+   + N P++
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 73
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 133 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 192
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 193 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 252
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 253 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 129
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 130 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 189
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 190 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 249
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 250 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 295

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 73
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 132
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 133 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 192
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 193 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 252
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 253 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 298

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 137/272 (50%), Gaps = 14/272 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  AQN+ET    A KV+   +      ++    EI I+    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 95
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNR 184
           + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+      +R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+     +
Sbjct: 216 PYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 272
            K L+ N   R     + +HP+   + N P++
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 76
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 135
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 136 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 195
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 196 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 255
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 256 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 301

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 136/272 (50%), Gaps = 14/272 (5%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  AQN+ET    A KV+   +      ++    EI I+    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPN 95
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNR 184
           + HRDLK  N+L    G++K++DFG+SA   + ++      GTP ++APEV+      +R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+     +
Sbjct: 216 PYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVK 272
            K L+ N   R     + +HP+   + N P++
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIR 306

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  117 bits (294), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+        D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  ++ CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLSFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 91/273 (33%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNI 71
             + +G G   KV    N+ T E  A+K L            + +RE+ +  +  + P+I
Sbjct: 66  TSQVLGLGINGKVLQIFNKRTQEKFALKXLQD--------CPKARREVELHWRASQCPHI 117
Query: 72  VRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHC 125
           VR+ +V     A R  + I+ E + GGELF +I  +G     E +     + + +A+ + 
Sbjct: 118 VRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 126 HSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS  + HRD+KPENLL  S      LK++DFG  A        L T C TP YVAPEVL 
Sbjct: 178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLG 236
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFSCPFW--FS 234
              YD S  D WS GVI ++L+ GY PF    G    P    +I     EF  P W   S
Sbjct: 237 PEKYDKS-CDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVS 295
Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                LI  +L   P  R  I     HPW  ++
Sbjct: 296 EEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQS 328

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 72
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ E V     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 131
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 132 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 191
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 192 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 251
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 252 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 297

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 87/280 (31%), Positives = 136/280 (48%), Gaps = 33/280 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
                        SL+ ++L  +P  RI  +    HP+F+
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+  +   T  +      I REIS++K + HPNIV+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 69
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 128
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 129 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 188
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 189 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 248
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 249 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 137/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+  +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ EF+     +  D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/286 (31%), Positives = 136/286 (47%), Gaps = 33/286 (11%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEGT+  V  A+N+ TGE VA+K +   T  +      I REIS++K + HPNIV+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 68
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
           V+ +  K+Y++ E V        D     G  L    + Y  QL+  +A CHS  V HRD
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPL-IKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           LKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  +A D+W
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIW 187
Query: 195 SCGVILFVLMAGYLPF-GETDLPTLYK-----------------KINAAEFSCPFW---- 232
           S G I   ++     F G++++  L++                  +   + S P W    
Sbjct: 188 SLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQD 247
Query: 233 -------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                        SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 248 FSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 134/297 (45%), Gaps = 51/297 (17%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REI 60
           + KYE    IGEGT+  V  A+NRET E VA+K        + R+ D  +       REI
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREI 52
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
            ++K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  QL
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +  CHS+ V HRDLKP+NLL++  G LK++DFGL+      V        T  Y  P
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKI--------------- 222
           +VL       ++ D+WS G I   L     P F   D+    K+I               
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 223 -NAAEFSCPFWFSTGATSLIH--------------KILDPNPKTRIRIEGIRKHPWF 264
               ++  P+      TSL++               +L  NP  RI  E   +HP+F
Sbjct: 231 TKLPDYK-PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 134/294 (45%), Gaps = 45/294 (15%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G GT+A V    N+ TG  VA+K +   +  +        REIS+MK ++H NIVRL++
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 77  VLASRTKVYIILEFVTGG--ELFDK--IVHQGRLLENDCRRYFQ-QLIDAVAHCHSKGVY 131
           V+ +  K+ ++ EF+     +  D   + +  R LE +  +YFQ QL+  +A CH   + 
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDLKP+NLL++  G LK+ DFGL+      V    +   T  Y AP+VL       ++ 
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 192 DVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFST------------ 235
           D+WSCG IL  ++ G   F  T+    L  ++  +     S   W S             
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES--LWPSVTKLPKYNPNIQQ 248
Query: 236 --------------------GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
                                    +H +L  NP  R+  +    HPWF + Y+
Sbjct: 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 24/302 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVR 67
           + V R IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL      
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 188 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 428
Query: 245 LDPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--F 288
           L  +   R+   G     +++ P+FR         + Y P       EVN  D   +  F
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 488
Query: 289 DD 290
           D+
Sbjct: 489 DE 490

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 24/302 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVR 67
           + V R IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++    
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 249
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 250 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 309
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL      
Sbjct: 310 RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAY 367
Query: 188 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 368 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 427
Query: 245 LDPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--F 288
           L  +   R+   G     +++ P+FR         + Y P       EVN  D   +  F
Sbjct: 428 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 487
Query: 289 DD 290
           D+
Sbjct: 488 DE 489

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 126/275 (45%), Gaps = 29/275 (10%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + +   +  AMK+L K  +LK       + E  ++       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E   R Y  +++ A+   H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 184
             HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+L      +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHK 243
           G  G   D WS GV ++ ++ G  PF    L   Y KI N  E    F F T  T     
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---RFQFPTQVTD---- 308
Query: 244 ILDPNPKTRIR--------------IEGIRKHPWF 264
            +  N K  IR              IE  +KHP+F
Sbjct: 309 -VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 24/302 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVR 67
           + V R IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL      
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 188 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 428
Query: 245 LDPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--F 288
           L  +   R+   G     +++ P+FR         + Y P       EVN  D   +  F
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 488
Query: 289 DD 290
           D+
Sbjct: 489 DE 490

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 141/302 (46%), Gaps = 24/302 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREI--SIMKIVR 67
           + V R IG G F +V   +  +TG+  AMK L K  I +K      +   I  S++    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+       +  H + GT  Y+APEVL      
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLAC--DFSKKKPHASVGTHGYMAPEVLQKGVAY 368
Query: 188 GSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF +    D   + +         P  FS    SL+  +
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 428
Query: 245 LDPNPKTRIRIEG-----IRKHPWFR---------KNYNPVKCSEEEEVNLDDVHAV--F 288
           L  +   R+   G     +++ P+FR         + Y P       EVN  D   +  F
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 488
Query: 289 DD 290
           D+
Sbjct: 489 DE 490

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 135/297 (45%), Gaps = 51/297 (17%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REI 60
           + KYE    IGEGT+  V  A+NRET E VA+K        + R+ D  +       REI
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREI 52
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
            ++K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  QL
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQL 110
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +  CHS+ V HRDLKP+NLL++  G LK+++FGL+      V        T  Y  P
Sbjct: 111 LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLM-AGYLPFGETDLPTLYKKI--------------- 222
           +VL       ++ D+WS G I   L  AG   F   D+    K+I               
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 223 -NAAEFSCPFWFSTGATSLIH--------------KILDPNPKTRIRIEGIRKHPWF 264
               ++  P+      TSL++               +L  NP  RI  E   +HP+F
Sbjct: 231 TKLPDYK-PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 137/284 (48%), Gaps = 39/284 (13%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI-SIMKIVRHPNIVRLH 75
           +GEG +AKV+ A + + G+  A+K++ K          ++ RE+ ++ +   + NI+ L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQA---GHSRSRVFREVETLYQCQGNKNILELI 77
Query: 76  EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
           E     T+ Y++ E + GG +   I  Q    E +  R  + +  A+   H+KG+ HRDL
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 136 KPENLLLDS---YGNLKVSDFGL--------SALPQQGVELLHTTCGTPNYVAPEVL--- 181
           KPEN+L +S      +K+ DF L        S  P    EL  T CG+  Y+APEV+   
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT-TPCGSAEYMAPEVVEVF 196
Query: 182 -SNRGYDGSAADVWSCGVILFVLMAGYLPF------------GE---TDLPTLYKKINAA 225
                +     D+WS GV+L+++++GY PF            GE        L++ I   
Sbjct: 197 TDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG 256
Query: 226 EFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
           ++  P   W   S+ A  LI K+L  + K R+    + +HPW +
Sbjct: 257 KYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 135/262 (51%), Gaps = 13/262 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  A+N+ETG   A KV+   +  +  + D I  EI I+    HP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDHPY 77
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+   HSK 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----LSNR 184
           + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV     + + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   AD+WS G+ L  +     P  E +   +  KI  ++      P  +S      +
Sbjct: 198 PYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256
Query: 242 HKILDPNPKTRIRIEGIRKHPW 263
              LD NP+TR     + +HP+
Sbjct: 257 KIALDKNPETRPSAAQLLEHPF 278

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 135/262 (51%), Gaps = 13/262 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  A+N+ETG   A KV+   +  +  + D I  EI I+    HP 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDHPY 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKG 129
           IV+L        K++I++EF  GG +   ++   R L E   +   +Q+++A+   HSK 
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 129
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----LSNR 184
           + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV     + + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLI 241
            YD   AD+WS G+ L  +     P  E +   +  KI  ++      P  +S      +
Sbjct: 190 PYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 248
Query: 242 HKILDPNPKTRIRIEGIRKHPW 263
              LD NP+TR     + +HP+
Sbjct: 249 KIALDKNPETRPSAAQLLEHPF 270

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 134/257 (52%), Gaps = 8/257 (3%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A+ + +G  VA+K++    + K +  + +  E+ IM+  +H N+V +++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D IV Q RL E       + ++ A+A+ H++GV HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APEV+S   Y  +  D+WS 
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLY-ATEVDIWSL 227
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIHKILDPNPKTRI 253
           G+++  ++ G  P+         K++  +   +       S      + ++L  +P+ R 
Sbjct: 228 GIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287
Query: 254 RIEGIRKHPWFRKNYNP 270
             + +  HP+  +   P
Sbjct: 288 TAQELLDHPFLLQTGLP 304

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 110/194 (56%), Gaps = 5/194 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  + TG+ VA+K   K  + K +  + +  E+ IM+   H N+V ++ 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A+++ H++GV HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL S G +K+SDFG  A   + V       GTP ++APEV+S   Y G+  D+WS 
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIWSL 227
Query: 197 GVILFVLMAGYLPF 210
           G+++  ++ G  P+
Sbjct: 228 GIMVIEMIDGEPPY 241

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 135/282 (47%), Gaps = 15/282 (5%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIK 57
           MK++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++ 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 58  REISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRY 114
            E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 178
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 233
            Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----V 232
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           S+    LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 137/277 (49%), Gaps = 28/277 (10%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           + KQ   V  ++V   +GEG++  V  A ++ETG+ VA+K +   + L+     +I +EI
Sbjct: 23  LTKQPEEV--FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKEI 75
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLI 119
           SIM+    P++V+ +      T ++I++E+   G + D I +    L E++     Q  +
Sbjct: 76  SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTL 135
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
             + + H     HRD+K  N+LL++ G+ K++DFG++      +   +   GTP ++APE
Sbjct: 136 KGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPE 195
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-----------TDLPTLYKKINAAEFS 228
           V+   GY+   AD+WS G+    +  G  P+ +           T+ P  ++K       
Sbjct: 196 VIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK------- 247
Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
            P  +S   T  + + L  +P+ R     + +HP+ R
Sbjct: 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 135/282 (47%), Gaps = 15/282 (5%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIK 57
           MK++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++ 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 58  REISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRY 114
            E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 178
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 233
            Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----V 232
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           S+    LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 132/273 (48%), Gaps = 21/273 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQI--KREISIMKIVR 67
           KY +   +G G F  V    +R    S     +AK   +K +  DQ+  K+EISI+ I R
Sbjct: 6   KYMIAEDLGRGEFGIV----HRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIAR 59
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCH 126
           H NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A+   H
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 127 SKGVYHRDLKPENLLLDS--YGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVLS 182
           S  + H D++PEN++  +     +K+ +FG +    P     LL T    P Y APEV  
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEV-H 175
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGAT 238
                 +A D+WS G +++VL++G  PF       + + I  AE++         S  A 
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             + ++L    K+R+      +HPW ++    V
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 135/282 (47%), Gaps = 15/282 (5%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIK 57
           MK++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++ 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 58  REISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRY 114
            E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 178
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 233
            Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----V 232
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           S+    LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 233 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 127/270 (47%), Gaps = 17/270 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F++V   + ++TG+  AMK++ K  +LK   V   + E  ++       
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKG 129
           I +LH        +Y+++E+  GG+L   +   G R+     R Y  +++ A+   H  G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLS------ 182
             HRD+KP+N+LLD  G+++++DFG    L   G        GTP+Y++PE+L       
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPF---WFSTGA 237
             G  G   D W+ GV  + +  G  PF        Y KI       S P         A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302
Query: 238 TSLIHKILDPNPKTRIRIEG---IRKHPWF 264
              I ++L P P+TR+   G    R HP+F
Sbjct: 303 RDFIQRLLCP-PETRLGRGGAGDFRTHPFF 331

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE +    +LFD I  +G L E   R +F Q+++AV
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 185
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 239
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 132/285 (46%), Gaps = 31/285 (10%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+   IG G  A V+ A      E VA+K +          +D++ +EI  M    HPN
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 74
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH--------QGRLLENDCRRYFQQLIDAV 122
           IV  +     + +++++++ ++GG + D I H         G L E+      +++++ +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TTCGTPNYVA 177
            + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T  GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 178 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLPTLYKKINA 224
           PEV+   RGYD   AD+WS G+    L  G  P+             + D P+L   +  
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 253
Query: 225 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
            E      +      +I   L  +P+ R     + +H +F+K  N
Sbjct: 254 KEMLKK--YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/282 (30%), Positives = 134/282 (47%), Gaps = 15/282 (5%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIK 57
           MK++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++ 
Sbjct: 23  MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 58  REISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRY 114
            E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +
Sbjct: 83  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 142
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT 
Sbjct: 143 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 200
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF 233
            Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----V 254
Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           S     LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 255 SXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 296

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 185
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 239
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 126
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 184
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 238
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 239 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 272

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 235
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 235
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 181
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 235
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 268
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 267
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 268
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 267
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S+    LI
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSSECQHLI 267
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 143
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 255
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 256 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 142
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 254
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 255 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 288

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 170
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 228
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 282
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 37/295 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY+    +GEGT+  V  A++ + G  VA+K + +       +     REIS++K + 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRI-RLDAEDEGIPSTAIREISLLKELH 77
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHC 125
           HPNIV L +V+ S   + ++ EF+       K++ + +  L ++  + Y  QL+  VAHC
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H   + HRDLKP+NLL++S G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETD---LPTLYKKI---NAAEF----SCPFW-- 232
              ++ D+WS G I   ++ G   F G TD   LP ++  +   N  E+      P W  
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 233 -----------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                            F      L+  +L  +P  RI       HP+F K+ +P
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-KDLDP 309

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 88/295 (29%), Positives = 139/295 (47%), Gaps = 37/295 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY+    +GEGT+  V  A++ + G  VA+K + +       +     REIS++K + 
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRI-RLDAEDEGIPSTAIREISLLKELH 77
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHC 125
           HPNIV L +V+ S   + ++ EF+       K++ + +  L ++  + Y  QL+  VAHC
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H   + HRDLKP+NLL++S G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETD---LPTLYKKI---NAAEF----SCPFW-- 232
              ++ D+WS G I   ++ G   F G TD   LP ++  +   N  E+      P W  
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 233 -----------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                            F      L+  +L  +P  RI       HP+F K+ +P
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-KDLDP 309

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 202
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 254
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 255 VRDPAQRATAAELLKHPFLAKAGPP 279

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 220
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S+    LI
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSSECQHLI 274
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 275 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+   IG G  A V+ A      E VA+K +          +D++ +EI  M    HPN
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPN 69
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH--------QGRLLENDCRRYFQQLIDAV 122
           IV  +     + +++++++ ++GG + D I H         G L E+      +++++ +
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TTCGTPNYVA 177
            + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T  GTP ++A
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 178 PEVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFG------------ETDLPTLYKKINA 224
           PEV+   RGYD   AD+WS G+    L  G  P+             + D P+L   +  
Sbjct: 190 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQD 248
Query: 225 AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            E    +  S     +I   L  +P+ R     + +H +F+K
Sbjct: 249 KEMLKKYGKSF--RKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 213
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 214 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 265
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 266 VRDPAQRATAAELLKHPFLAKAGPP 290

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 13/267 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + + T    AMK+L K  +LK       + E  ++       
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 151
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + +L E+  R Y  +++ A+   H   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 184
             HRD+KP+N+LLD  G+++++DFG    +   G        GTP+Y++PE+L       
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 271
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGATS 239
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 272 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 331
Query: 240 LIHKILDPNPK--TRIRIEGIRKHPWF 264
           LI +++    +   +  IE  +KH +F
Sbjct: 332 LIQRLICSRERRLGQNGIEDFKKHAFF 358

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 211
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 212 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 263
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 264 VRDPAQRATAAELLKHPFLAKAGPP 288

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 36  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 95
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 96  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 155
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 156 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S     LI
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSXECQHLI 267
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 13/267 (4%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + + T    AMK+L K  +LK       + E  ++       
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQW 135
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + +L E+  R Y  +++ A+   H   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVL----SNR 184
             HRD+KP+N+LLD  G+++++DFG    +   G        GTP+Y++PE+L       
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGM 255
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW---FSTGATS 239
           G  G   D WS GV ++ ++ G  PF    L   Y KI   E  F  P      S  A  
Sbjct: 256 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKD 315
Query: 240 LIHKILDPNPK--TRIRIEGIRKHPWF 264
           LI +++    +   +  IE  +KH +F
Sbjct: 316 LIQRLICSRERRLGQNGIEDFKKHAFF 342

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S     LI
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSXECQHLI 268
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 206
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 207 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 258
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 259 VRDPAQRATAAELLKHPFLAKAGPP 283

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 37  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 96
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 97  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 156
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 157 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D     ++I   +       S     LI
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHD-----EEIIGGQVFFRQRVSXECQHLI 268
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 143
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 255
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 256 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 23  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 82
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 83  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 142
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 143 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 254
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 255 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 288

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 51  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 110
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 111 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 170
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 171 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 228
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 282
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 56  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 115
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 116 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 175
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 176 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 233
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 287
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 288 RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 321

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 130/274 (47%), Gaps = 15/274 (5%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKI 65
           ++Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K 
Sbjct: 24  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 83
Query: 66  VRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           V      ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV
Sbjct: 84  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 143
Query: 123 AHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V       GT  Y  PE +
Sbjct: 144 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWI 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
               Y G +A VWS G++L+ ++ G +PF E D   +  ++   +       S     LI
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-----VSXECQHLI 255
Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
              L   P  R   E I+ HPW +    P + +E
Sbjct: 256 RWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 256
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 257 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKV--------SPSLKGFLDRLL 308
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 309 VRDPAQRATAAELLKHPFLAKAGPP 333

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 130/265 (49%), Gaps = 24/265 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IGEG+   V  A  R +G+ VA+K   K  + K +  + +  E+ IM+  +H N+V ++ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                 ++++++EF+ GG L D + H  R+ E         ++ A++  H++GV HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
            +++LL   G +K+SDFG  A   + V       GTP ++APE++S   Y G   D+WS 
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWSL 333
Query: 197 GVILFVLMAGYLP-FGET----------DLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
           G+++  ++ G  P F E           +LP   K ++          S      + ++L
Sbjct: 334 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK--------VSPSLKGFLDRLL 385
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNP 270
             +P  R     + KHP+  K   P
Sbjct: 386 VRDPAQRATAAELLKHPFLAKAGPP 410

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 114/215 (53%), Gaps = 6/215 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-REISIMKIV 66
           + KYE    IGEG++  V   +NR+TG+ VA+K   +S      ++ +I  REI ++K +
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQL 59
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HPN+V L EV   + +++++ E+     L +   +Q  + E+  +    Q + AV  CH
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
                HRD+KPEN+L+  +  +K+ DFG + L     +       T  Y +PE+L     
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179
Query: 187 DGSAADVWSCGVILFVLMAGYLPF--GETDLPTLY 219
            G   DVW+ G +   L++G +P   G++D+  LY
Sbjct: 180 YGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLY 213

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 135/286 (47%), Gaps = 41/286 (14%)
Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRL 74
            +GEG  A+V+   N  T +  A+K++ K       +  ++ RE+ ++ +   H N++ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
            E      + Y++ E + GG +   I  +    E +     Q +  A+   H+KG+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 135 LKPENLLLD---SYGNLKVSDFGLSA--------LPQQGVELLHTTCGTPNYVAPEVLSN 183
           LKPEN+L +       +K+ DFGL +         P    ELL T CG+  Y+APEV+  
Sbjct: 137 LKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL-TPCGSAEYMAPEVVEA 195
Query: 184 RGYDGSA----ADVWSCGVILFVLMAGYLPF------------GETDLPT----LYKKIN 223
              + S      D+WS GVIL++L++GY PF            GE   P     L++ I 
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CPACQNMLFESIQ 254
Query: 224 AAEFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             ++  P   W   S  A  LI K+L  + K R+    + +HPW +
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 137/293 (46%), Gaps = 39/293 (13%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY     IGEGT+  V  AQN   GE+ A+K + +       +     REISI+K ++
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++ +A+C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------------GETDLP---- 216
              +  D+WS G I   ++ G   F                           T+LP    
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 217 --TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             T+Y+ +    F            L+ K+L  +P  RI  +   +H +F++N
Sbjct: 237 NFTVYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 137/293 (46%), Gaps = 39/293 (13%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY     IGEGT+  V  AQN   GE+ A+K + +       +     REISI+K ++
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++ +A+C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------------GETDLP---- 216
              +  D+WS G I   ++ G   F                           T+LP    
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 217 --TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             T+Y+ +    F            L+ K+L  +P  RI  +   +H +F++N
Sbjct: 237 NFTVYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 119/262 (45%), Gaps = 22/262 (8%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +   IG G+F  V  A+    G  VA+K+L +      R V++  RE++IMK +RHPNIV
Sbjct: 41  IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNIV 97
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA-----HCHS 127
                +     + I+ E+++ G L+  +   G   + D RR      D        H  +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HRDLK  NLL+D    +KV DFGLS L            GTP ++APEVL +   +
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
              +DV+S GVIL+ L     P+G          +N A+      F      +   +   
Sbjct: 218 -EKSDVYSFGVILWELATLQQPWG---------NLNPAQVVAAVGFKCKRLEIPRNL--- 264
Query: 248 NPKTRIRIEGI-RKHPWFRKNY 268
           NP+    IEG     PW R ++
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSF 286

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 137/293 (46%), Gaps = 39/293 (13%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + KY     IGEGT+  V  AQN   GE+ A+K + +       +     REISI+K ++
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           H NIV+L++V+ ++ ++ ++ E +     +L D  V +G L     + +  QL++ +A+C
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           H + V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL    
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------------GETDLP---- 216
              +  D+WS G I   ++ G   F                           T+LP    
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 217 --TLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             T+Y+ +    F            L+ K+L  +P  RI  +   +H +F++N
Sbjct: 237 NFTVYEPLPWESFLKG--LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 129/261 (49%), Gaps = 12/261 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 193
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           LD + + R   + + +H + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 120/262 (45%), Gaps = 22/262 (8%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +   IG G+F  V  A+    G  VA+K+L +      R V++  RE++IMK +RHPNIV
Sbjct: 41  IKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNIV 97
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA-----HCHS 127
                +     + I+ E+++ G L+  +   G   + D RR      D        H  +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
             + HR+LK  NLL+D    +KV DFGLS L         +  GTP ++APEVL +   +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
              +DV+S GVIL+ L     P+G          +N A+      F      +   +   
Sbjct: 218 -EKSDVYSFGVILWELATLQQPWG---------NLNPAQVVAAVGFKCKRLEIPRNL--- 264
Query: 248 NPKTRIRIEGI-RKHPWFRKNY 268
           NP+    IEG     PW R ++
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSF 286

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 134/286 (46%), Gaps = 41/286 (14%)
Query: 16  TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRL 74
            +GEG  A+V+   N  T +  A+K++ K       +  ++ RE+ ++ +   H N++ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
            E      + Y++ E + GG +   I  +    E +     Q +  A+   H+KG+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 135 LKPENLLLD---SYGNLKVSDFGLSA--------LPQQGVELLHTTCGTPNYVAPEVLSN 183
           LKPEN+L +       +K+ DF L +         P    ELL T CG+  Y+APEV+  
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL-TPCGSAEYMAPEVVEA 195
Query: 184 RGYDGSA----ADVWSCGVILFVLMAGYLPF------------GETDLPT----LYKKIN 223
              + S      D+WS GVIL++L++GY PF            GE   P     L++ I 
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-CPACQNMLFESIQ 254
Query: 224 AAEFSCP--FW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
             ++  P   W   S  A  LI K+L  + K R+    + +HPW +
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 108/215 (50%), Gaps = 3/215 (1%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   +G G  + V  A++      VA+K +      K   + + +RE+     + H 
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV + +V       Y+++E++ G  L + I   G L  +    +  Q++D + H H   
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
           + HRD+KP+N+L+DS   LK+ DFG++ AL +  +   +   GT  Y +PE       D 
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD- 190
Query: 189 SAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI 222
              D++S G++L+ ++ G  PF GET +    K I
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    YD S 
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS- 369
Query: 191 ADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    YD S 
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS- 369
Query: 191 ADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    YD S 
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS- 369
Query: 191 ADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 126/264 (47%), Gaps = 14/264 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    YD S 
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFS- 369
Query: 191 ADVWSCGVILFVLMAGYLPF---GE-TDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF   GE  +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429
Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 19/266 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I H G+    + R  F   ++   +   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  S  D
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFS-PD 367
Query: 193 VWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
            W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL  ++L
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYS--ERFSPQARSLCSQLL 424
Query: 246 DPNPKTRIRIEG-----IRKHPWFRK 266
             +P  R+   G     +++HP F+K
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 19/266 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF--QQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I H G+    + R  F   ++   +   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y  S  D
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFS-PD 367
Query: 193 VWSCGVILFVLMAGYLPFGE-------TDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
            W+ G +L+ ++AG  PF +        ++  L K++   E+S    FS  A SL  ++L
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-PEEYS--ERFSPQARSLCSQLL 424
Query: 246 DPNPKTRIRIEG-----IRKHPWFRK 266
             +P  R+   G     +++HP F+K
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 128/261 (49%), Gaps = 12/261 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV++ + Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAY- 193
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY--KKINAAEFSCPFWFSTGATSLIHKI 244
           G   D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           LD + + R   + + +H + +
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV++ + Y 
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAY- 193
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
           G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 112/213 (52%), Gaps = 10/213 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 78
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HR++K +N+LL   G++K++DFG  A   P+Q      T  GTP ++APEV++ + Y 
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAY- 194
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
           G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 227

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 111/213 (52%), Gaps = 10/213 (4%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      K  +   I  EI +M+  ++P
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 78
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 79  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA--LPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           V HRD+K +N+LL   G++K++DFG  A   P+Q         GTP ++APEV++ + Y 
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAY- 194
Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
           G   D+WS G++   ++ G  P+  E  L  LY
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 227

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 4/196 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++     P + + + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 190
Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 191 GITAIELARGEPPHSE 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 4/196 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++     P + + + 
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 92
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 152 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSL 210
Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 211 GITAIELARGEPPHSE 226

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 108/226 (47%), Gaps = 30/226 (13%)
Query: 51  RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND 110
           R++D  +R  S + I+  P  V+                     +LFD I  +G L E  
Sbjct: 120 RLLDWFERPDSFVLILERPEPVQ---------------------DLFDFITERGALQEEL 158
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTT 169
            R +F Q+++AV HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +  V      
Sbjct: 159 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDF 216
Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC 229
            GT  Y  PE +    Y G +A VWS G++L+ ++ G +PF E D   +  ++   +   
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-EHDEEIIRGQVFFRQR-- 273
Query: 230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
               S+    LI   L   P  R   E I+ HPW +    P + +E
Sbjct: 274 ---VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 4/196 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++     P + + + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +   GTP ++APEV+    YD S AD+WS 
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADIWSL 190
Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 191 GITAIELARGEPPHSE 206

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 100/196 (51%), Gaps = 4/196 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++     P + + + 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 87
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL  +G +K++DFG++          +   GTP ++APEV+    YD S AD+WS 
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADIWSL 205
Query: 197 GVILFVLMAGYLPFGE 212
           G+    L  G  P  E
Sbjct: 206 GITAIELARGEPPHSE 221

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 128/284 (45%), Gaps = 50/284 (17%)
Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVE 62
Query: 62  I-MKIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG +               
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------- 167
Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
                  +  +   YD S  D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 168 -------KETTGEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 219
Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+L+ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 136/305 (44%), Gaps = 47/305 (15%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R  + +E    +G+G F +V  A+N       A+K +  +       +  I  E+ ++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLAS 58
Query: 66  VRHPNIVRLHEVLASR-------------TKVYIILEFVTGGELFDKIVHQGRLLE--ND 110
           + H  +VR +     R             + ++I +E+   G L+D ++H   L +  ++
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDE 117
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--- 167
             R F+Q+++A+++ HS+G+ HRDLKP N+ +D   N+K+ DFGL+    + +++L    
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 168 -----------TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDL 215
                      +  GT  YVA EVL   G+     D++S G+I F ++    PF    + 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMER 234
Query: 216 PTLYKKINAAEFSCPFWFSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             + KK+ +     P  F      +  KI    +D +P  R     +    W      PV
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PV 289
Query: 272 KCSEE 276
           K  +E
Sbjct: 290 KHQDE 294

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 114/235 (48%), Gaps = 39/235 (16%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--MVDQIKR----EI 60
           R  +YE    +GEG FA V  A+++ T + VA+K +     L HR    D I R    EI
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK----LGHRSEAKDGINRTALREI 63
Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQL 118
            +++ + HPNI+ L +    ++ + ++ +F+      + I+    L+   +  + Y    
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---- 174
           +  + + H   + HRDLKP NLLLD  G LK++DFGL+            + G+PN    
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-----------KSFGSPNRAYX 170
Query: 175 -------YVAPEVLSNRGYDGSAADVWSCGVIL--FVLMAGYLPFGETDLPTLYK 220
                  Y APE+L      G   D+W+ G IL   +L   +LP G++DL  L +
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP-GDSDLDQLTR 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 4/193 (2%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T E VA+K++            Q  +EI+++     P I R   
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYITRYFG 84
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                TK++II+E++ GG   D ++  G L E       ++++  + + HS+   HRD+K
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL   G++K++DFG++          +   GTP ++APEV+    YD   AD+WS 
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-FKADIWSL 202
Query: 197 GVILFVLMAGYLP 209
           G+    L  G  P
Sbjct: 203 GITAIELAKGEPP 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 125/271 (46%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 89
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 90  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 149
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 150 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 210 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 266
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 267 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 297

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 120/245 (48%), Gaps = 13/245 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+GT+  V   ++      +A+K + +      R    +  EI++ K ++H NIV+   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND--CRRYFQQLIDAVAHCHSKGVYHR 133
             +    + I +E V GG L   +  + G L +N+     Y +Q+++ + + H   + HR
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 134 DLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSA 190
           D+K +N+L+++Y G LK+SDFG S           T  GT  Y+APE++    RGY G A
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKA 205
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLP--TLYK-KINAAEFSCPFWFSTGATSLIHKILDP 247
           AD+WS G  +  +  G  PF E   P   ++K  +       P   S  A + I K  +P
Sbjct: 206 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 265
Query: 248 NPKTR 252
           +P  R
Sbjct: 266 DPDKR 270

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 120/245 (48%), Gaps = 13/245 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+GT+  V   ++      +A+K + +      R    +  EI++ K ++H NIV+   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQ-GRLLEND--CRRYFQQLIDAVAHCHSKGVYHR 133
             +    + I +E V GG L   +  + G L +N+     Y +Q+++ + + H   + HR
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 132
Query: 134 DLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSA 190
           D+K +N+L+++Y G LK+SDFG S           T  GT  Y+APE++    RGY G A
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKA 191
Query: 191 ADVWSCGVILFVLMAGYLPFGETDLP--TLYK-KINAAEFSCPFWFSTGATSLIHKILDP 247
           AD+WS G  +  +  G  PF E   P   ++K  +       P   S  A + I K  +P
Sbjct: 192 ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEP 251
Query: 248 NPKTR 252
           +P  R
Sbjct: 252 DPDKR 256

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV ++    + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D   +DV+S G +L+ ++ G  PF G++ +   Y+ +   E   P        S  
Sbjct: 193 GDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 22/271 (8%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF-----WFSTG 236
               D + +DV+S G +L+ ++ G  PF G++     Y+ +   E   P        S  
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHVR--EDPIPPSARHEGLSAD 249
Query: 237 ATSLIHKILDPNPKTR------IRIEGIRKH 261
             +++ K L  NP+ R      +R + +R H
Sbjct: 250 LDAVVLKALAKNPENRYQTAAEMRADLVRVH 280

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 131/287 (45%), Gaps = 50/287 (17%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRL 74
           +GEGT+A V   +++ T   VA+K +     L+H         RE+S++K ++H NIV L
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 65
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQ-----GRLLE-NDCRRYFQQLIDAVAHCHSK 128
           H+++ +   + ++ E++      DK + Q     G ++  ++ + +  QL+  +A+CH +
Sbjct: 66  HDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRDLKP+NLL++  G LK++DFGL+       +       T  Y  P++L       
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 189 SAADVWSCGVILFVLMAGYLPF-------------------GETDLPTL-----YKKINA 224
           +  D+W  G I + +  G   F                    E   P +     +K  N 
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239
Query: 225 AEF-------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            ++         P   S GA  L+ K+L    + RI  E   KHP+F
Sbjct: 240 PKYRAEALLSHAPRLDSDGA-DLLTKLLQFEGRNRISAEDAMKHPFF 285

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 45/303 (14%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+  TIG G +  V  A+ R TG+ VA+K +  +  +      +  RE+ I+K  +H 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN-AKRTLRELKILKHFKHD 113
Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAV 122
           NI+ + ++L           VY++L+ +       +I+H  + L  +  RYF  QL+  +
Sbjct: 114 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS----ALPQQGVELLHTTCGTPNYVAP 178
            + HS  V HRDLKP NLL++    LK+ DFG++      P +    +     T  Y AP
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 231
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG---------------ETDLPTLYKKIN 223
           E++ +      A D+WS G I   ++A    F                 T  P + + + 
Sbjct: 232 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291
Query: 224 AAEFSC---------PFWFST-------GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           A              P  + T        A SL+ ++L   P  RI      +HP+  K 
Sbjct: 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351
Query: 268 YNP 270
           ++P
Sbjct: 352 HDP 354

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 45/303 (14%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+  TIG G +  V  A+ R TG+ VA+K +  +  +      +  RE+ I+K  +H 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN-AKRTLRELKILKHFKHD 114
Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAV 122
           NI+ + ++L           VY++L+ +       +I+H  + L  +  RYF  QL+  +
Sbjct: 115 NIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS----ALPQQGVELLHTTCGTPNYVAP 178
            + HS  V HRDLKP NLL++    LK+ DFG++      P +    +     T  Y AP
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAP 232
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFG---------------ETDLPTLYKKIN 223
           E++ +      A D+WS G I   ++A    F                 T  P + + + 
Sbjct: 233 ELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 292
Query: 224 AAEFSC---------PFWFST-------GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           A              P  + T        A SL+ ++L   P  RI      +HP+  K 
Sbjct: 293 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 352
Query: 268 YNP 270
           ++P
Sbjct: 353 HDP 355

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 74/305 (24%), Positives = 135/305 (44%), Gaps = 47/305 (15%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R  + +E    +G+G F +V  A+N       A+K +  +       +  I  E+ ++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLAS 58
Query: 66  VRHPNIVRLHEVLASR-------------TKVYIILEFVTGGELFDKIVHQGRLLE--ND 110
           + H  +VR +     R             + ++I +E+     L+D ++H   L +  ++
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQRDE 117
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--- 167
             R F+Q+++A+++ HS+G+ HRDLKP N+ +D   N+K+ DFGL+    + +++L    
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 168 -----------TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDL 215
                      +  GT  YVA EVL   G+     D++S G+I F ++    PF    + 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMER 234
Query: 216 PTLYKKINAAEFSCPFWFSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             + KK+ +     P  F      +  KI    +D +P  R     +    W      PV
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PV 289
Query: 272 KCSEE 276
           K  +E
Sbjct: 290 KHQDE 294

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/308 (23%), Positives = 132/308 (42%), Gaps = 50/308 (16%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--------- 51
           +K++ + +  Y + RT+ +G F K+   +  +  +  A+K   KS + K R         
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 52  -----MVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL 106
                  D  K E+ I+  +++   +    ++ +  +VYII E++    +  K      +
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL-KFDEYFFV 139
Query: 107 LENDCRRYF---------QQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
           L+ +   +          + ++++ ++ H+ K + HRD+KP N+L+D  G +K+SDFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 157 ALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFG-ETD 214
                  + +  + GT  ++ PE  SN   Y+G+  D+WS G+ L+V+    +PF  +  
Sbjct: 200 EYMVD--KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 215 LPTLYKKINAAEFSCPF-------------------WFSTGATSLIHKILDPNPKTRIRI 255
           L  L+  I       P                    + S      +   L  NP  RI  
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 256 EGIRKHPW 263
           E   KH W
Sbjct: 318 EDALKHEW 325

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    +E+   +G G F  V    +++TGE VA+K   +    K+R  ++   EI IMK
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMK 67
Query: 65  IVRHPNIVRLHEV------LASRTKVYIILEFVTGGEL---FDKIVHQGRLLENDCRRYF 115
            + HPN+V   EV      LA      + +E+  GG+L    ++  +   L E   R   
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL---KVSDFGLSALPQQGVELLHTTCGT 172
             +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL     GT
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGT 186
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
             Y+APE+L  + Y     D WS G + F  + G+ PF
Sbjct: 187 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           T+    +E+   +G G F  V    +++TGE VA+K   +    K+R  ++   EI IMK
Sbjct: 11  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLEIQIMK 68
Query: 65  IVRHPNIVRLHEV------LASRTKVYIILEFVTGGEL---FDKIVHQGRLLENDCRRYF 115
            + HPN+V   EV      LA      + +E+  GG+L    ++  +   L E   R   
Sbjct: 69  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 128
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL---KVSDFGLSALPQQGVELLHTTCGT 172
             +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL     GT
Sbjct: 129 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGT 187
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
             Y+APE+L  + Y     D WS G + F  + G+ PF
Sbjct: 188 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 224

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 120/254 (47%), Gaps = 9/254 (3%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG+G+F +V    +  T + VA+K++            Q  +EI+++       + + + 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSSYVTKYYG 88
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
                +K++II+E++ GG   D ++  G   E       ++++  + + HS+   HRD+K
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 137 PENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSC 196
             N+LL   G++K++DFG++          +T  GTP ++APEV+    YD S AD+WS 
Sbjct: 148 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADIWSL 206
Query: 197 GVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---FSTGATSLIHKILDPNPKTRI 253
           G+    L  G  P   +D+  +       + + P     F+      I   L+ +P  R 
Sbjct: 207 GITAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRP 264
Query: 254 RIEGIRKHPWFRKN 267
             + + KH +  KN
Sbjct: 265 TAKELLKHKFIVKN 278

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 138/319 (43%), Gaps = 53/319 (16%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           + +++   +GEG +  V  A ++ TGE VA+K +      K     +  REI I+K  +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 69  PNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            NI+ +  +       +  +VYII E +       +++    L ++  + +  Q + AV 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV----ELLHTTCGTPNYV--- 176
             H   V HRDLKP NLL++S  +LKV DFGL+ +  +      E      G   YV   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 177 ---APEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL--PFGET 213
              APEV+        A DVWSCG IL                   +L+ G +  P  + 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 214 DLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRK 260
           DL  + +   A E+  S P +            +     L+ ++L  +P  RI  +   +
Sbjct: 247 DLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 261 HPWFRKNYNPVKCSEEEEV 279
           HP+ +  ++P    E E +
Sbjct: 306 HPYLQTYHDPNDEPEGEPI 324

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 137/319 (42%), Gaps = 53/319 (16%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           + +++   +GEG +  V  A ++ TGE VA+K +      K     +  REI I+K  +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 69  PNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            NI+ +  +       +  +VYII E +       +++    L ++  + +  Q + AV 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL----------PQQGVELLHTTCGTP 173
             H   V HRDLKP NLL++S  +LKV DFGL+ +          P      +     T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL--PFGET 213
            Y APEV+        A DVWSCG IL                   +L+ G +  P  + 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 214 DLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRK 260
           DL  + +   A E+  S P +            +     L+ ++L  +P  RI  +   +
Sbjct: 247 DLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 261 HPWFRKNYNPVKCSEEEEV 279
           HP+ +  ++P    E E +
Sbjct: 306 HPYLQTYHDPNDEPEGEPI 324

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 134/277 (48%), Gaps = 25/277 (9%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+   +G GT+ +V   ++ +TG+  A+KV+  +   +    ++IK+EI+++K    H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 81
Query: 70  NIVRLHEVLASRT------KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYF-QQLIDA 121
           NI   +     +       ++++++EF   G + D I + +G  L+ +   Y  ++++  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           ++H H   V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP ++APEV+
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 182 S-----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFW 232
           +     +  YD   +D+WS G+    +  G  P  +   P     L  +  A       W
Sbjct: 202 ACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW 259
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
            S    S I   L  N   R   E + KHP+ R   N
Sbjct: 260 -SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 91/322 (28%), Positives = 141/322 (43%), Gaps = 54/322 (16%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRH 68
           +Y   + IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIK---KISPFEHQTYCQRTLREIQILLRFRH 100
Query: 69  PNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAV 122
            N++ + ++L + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  +
Sbjct: 101 ENVIGIRDILRASTLEAMRDVYIVQDLMET-DLYKLLKSQQ--LSNDHICYFLYQILRGL 157
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPE 179
            + HS  V HRDLKP NLL+++  +LK+ DFGL+  A P+      L     T  Y APE
Sbjct: 158 KYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 180 VLSN-RGYDGSAADVWSCGVILFVLMAGYLPF---------------------------- 210
           ++ N +GY  S  D+WS G IL  +++    F                            
Sbjct: 218 IMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 276
Query: 211 ---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                  L +L  K   A         + A  L+ ++L  NP  RI +E    HP+  + 
Sbjct: 277 NMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQY 336
Query: 268 YNPVKCSEEEE-----VNLDDV 284
           Y+P      EE     + LDD+
Sbjct: 337 YDPTDEPVAEEPFTFAMELDDL 358

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 63
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   N     +   Q+  
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 184 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII+EF+T G L D +    R   N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 83/319 (26%), Positives = 137/319 (42%), Gaps = 53/319 (16%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           + +++   +GEG +  V  A ++ TGE VA+K +      K     +  REI I+K  +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKH 68
Query: 69  PNIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
            NI+ +  +       +  +VYII E +       +++    L ++  + +  Q + AV 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG----------TP 173
             H   V HRDLKP NLL++S  +LKV DFGL+ +  +         G          T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVIL------------------FVLMAGYL--PFGET 213
            Y APEV+        A DVWSCG IL                   +L+ G +  P  + 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 214 DLPTLYKKINAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRK 260
           DL  + +   A E+  S P +            +     L+ ++L  +P  RI  +   +
Sbjct: 247 DLRCI-ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 261 HPWFRKNYNPVKCSEEEEV 279
           HP+ +  ++P    E E +
Sbjct: 306 HPYLQTYHDPNDEPEGEPI 324

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VY++   + G +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 164
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 225 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 284 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 339

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 48/308 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +   G +VA+K L++          +  RE+ ++K V H 
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHK 83
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAHCH 126
           NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H H
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 143
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   GY
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPYVVTRYYRAPEVILGMGY 202
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC----------- 229
             +  D+WS G I+  L+ G + F  TD    + K+       +AEF             
Sbjct: 203 -AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 230 --------------PFWF-----------STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                         P W            ++ A  L+ K+L  +P  RI ++   +HP+ 
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 265 RKNYNPVK 272
              Y+P +
Sbjct: 322 TVWYDPAE 329

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 130/308 (42%), Gaps = 48/308 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +   G +VA+K L++          +  RE+ ++K V H 
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHK 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAHCH 126
           NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H H
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 141
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   GY
Sbjct: 142 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF-MMTPYVVTRYYRAPEVILGMGY 200
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI------NAAEFSC----------- 229
             +  D+WS G I+  L+ G + F  TD    + K+       +AEF             
Sbjct: 201 KEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 230 --------------PFWF-----------STGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                         P W            ++ A  L+ K+L  +P  RI ++   +HP+ 
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319
Query: 265 RKNYNPVK 272
              Y+P +
Sbjct: 320 TVWYDPAE 327

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 146
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 186 YDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYKKINAAE--- 226
           Y  S  D+WS G IL  +++         YL          G      L   IN      
Sbjct: 207 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNY 265
Query: 227 -FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 147/343 (42%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T      I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII EF+T G L D +    R   N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 135/281 (48%), Gaps = 33/281 (11%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K   +R   Y   + IG G+F  V  A+  E+ E VA+K + +    K+R       E+ 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR-------ELQ 84
Query: 62  IMKIVRHPNIVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEND----C 111
           IM+IV+HPN+V L     S    + +V++  +LE+V    ++    H  +L +       
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLI 143
Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTC 170
           + Y  QL+ ++A+ HS G+ HRD+KP+NLLLD   G LK+ DFG + +   G   +   C
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSC 229
               Y APE++       +  D+WS G ++  LM G   F GE+ +  L + I       
Sbjct: 204 SR-YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV----- 257
Query: 230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                T +   I K ++PN     +   IR HP F K + P
Sbjct: 258 ---LGTPSREQI-KTMNPN-YMEHKFPQIRPHP-FSKVFRP 292

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 93
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 94  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 153 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 211
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 212 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 260
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 261 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 320
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 321 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 362

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK+V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS GVI+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                     ++++E+  G       VH+  L E +        +  +A+ HS  + HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAA 191
           +K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV   +    YDG   
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGK-V 195
Query: 192 DVWSCGVILFVLMAGYLP-FGETDLPTLY 219
           DVWS G+    L     P F    +  LY
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALY 224

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 9/209 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHPN ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                     ++++E+  G       VH+  L E +        +  +A+ HS  + HRD
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV---LSNRGYDGSAA 191
           +K  N+LL   G +K+ DFG +++    +   +   GTP ++APEV   +    YDG   
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASI----MAPANXFVGTPYWMAPEVILAMDEGQYDGK-V 234
Query: 192 DVWSCGVILFVLMAGYLP-FGETDLPTLY 219
           DVWS G+    L     P F    +  LY
Sbjct: 235 DVWSLGITCIELAERKPPLFNMNAMSALY 263

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 82
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 83  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 142 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 200
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 201 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 249
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 250 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 309
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 310 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 351

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 108
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 226
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 275
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 336 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 377

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 75
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 76  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 135 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 193
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 242
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 243 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 302
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 303 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 344

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYKKINAAE--- 226
           Y  S  D+WS G IL  +++         YL          G      L   IN      
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNY 263
Query: 227 -FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYKKINAAE--- 226
           Y  S  D+WS G IL  +++         YL          G      L   IN      
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNY 263
Query: 227 -FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII EF+T G L D +    R   N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 86
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 204
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 253
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 314 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 355

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 86
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 87  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 146 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 204
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 205 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 253
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 254 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 313
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 314 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 355

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 78
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 79  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 138 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 196
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 245
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 246 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 305
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 306 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 347

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 132/305 (43%), Gaps = 47/305 (15%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R  + +E    +G+G F +V  A+N       A+K +  +       +  I  E+ ++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVXLLAS 58
Query: 66  VRHPNIVRLHEVLASR-------------TKVYIILEFVTGGELFDKIVHQGRLLE--ND 110
           + H  +VR +     R             + ++I  E+     L+D ++H   L +  ++
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQRDE 117
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--- 167
             R F+Q+++A+++ HS+G+ HR+LKP N+ +D   N+K+ DFGL+    + +++L    
Sbjct: 118 YWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 168 -----------TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDL 215
                      +  GT  YVA EVL   G+     D +S G+I F  +    PF    + 
Sbjct: 178 QNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXER 234
Query: 216 PTLYKKINAAEFSCPFWFSTGATSLIHKI----LDPNPKTRIRIEGIRKHPWFRKNYNPV 271
             + KK+ +     P  F      +  KI    +D +P  R     +    W      PV
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL-----PV 289
Query: 272 KCSEE 276
           K  +E
Sbjct: 290 KHQDE 294

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 108
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 226
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 275
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 336 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 377

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK+V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS GVI+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGVIMGEMIKGGVLFPGTD 229

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 87
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 88  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 147 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 205
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 206 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 254
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 255 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 314
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 315 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 356

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII EF+T G L D +    R   N    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 102
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 162 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 220
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 221 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 269
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 270 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 329
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 330 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 371

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 20  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 75
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 135
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 136 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 195
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 196 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 236

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 91/296 (30%), Positives = 135/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 142
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 186 YDGSAADVWSCGVILFVLMAG--------YLP--------FGETDLPTLYKKINAAE--- 226
           Y  S  D+WS G IL  +++         YL          G  +   L   IN      
Sbjct: 203 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNY 261
Query: 227 -FSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 262 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 317

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 66
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 187 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 227

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 64
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 79
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 80  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 139 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 197
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 198 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 246
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 247 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 306
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 307 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 348

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 64
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLAFRHENIIGIN 89
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 146
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 207 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 149
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 210 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 269 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 324

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 95
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 152
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 213 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 271
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 272 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 327

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 87
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 205 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 263
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 264 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 319

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 110
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 170 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 228
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 229 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 277
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 278 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 337
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 338 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 379

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 153
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 213 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 271
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 320
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 321 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 380
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 381 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 422

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 89
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 146
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 207 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 265
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 266 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 321

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 148/343 (43%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 112
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 172 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 230
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 279
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 280 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 339
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 340 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 381

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 85
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 86  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 142
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 203 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 261
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 262 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 317

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 92
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 93  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 149
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 210 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 269 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 324

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 93
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 94  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 150
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 211 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 269
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 270 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 325

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 84
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 85  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 141
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 202 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 260
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 261 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 316

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 147/343 (42%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    + +VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T      I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 98/343 (28%), Positives = 147/343 (42%), Gaps = 48/343 (13%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K+R       E+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 71  IVRLHEVLAS----RTKVYI--ILEFVTGGELFDKIVHQGRLLEN----DCRRYFQQLID 120
           IVRL     S    +  VY+  +L++V    ++    H  R  +       + Y  QL  
Sbjct: 75  IVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 121 AVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C    Y APE
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPE 192
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGAT 238
           ++       S+ DVWS G +L  L+ G   F G++ +  L + I               T
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----------GT 241
Query: 239 SLIHKILDPNPK-TRIRIEGIRKHPW---FRKNYNP---VKCSEEEEVNLDD-------- 283
               +I + NP  T  +   I+ HPW   FR    P     CS   E             
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
Query: 284 VHAVFDDIEYVAEQSENKVGGPLLMNAFEMITLSQGLNLAALF 326
            H+ FD++     +  N    P L N F    LS    LA + 
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFN-FTTQELSSNPPLATIL 343

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 107
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 108 DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 164
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 225 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 283
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 284 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 339

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           G  +G+G F +     +RETGE + MK L +      R      +E+ +M+ + HPN+++
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR---TFLKEVKVMRCLEHPNVLK 71
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGVYH 132
              VL    ++  I E++ GG L   I           R  F + +   +A+ HS  + H
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIH 131
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSAL------PQQGVELL--------HTTCGTPNYVAP 178
           RDL   N L+    N+ V+DFGL+ L        +G+  L        +T  G P ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           E+++ R YD    DV+S G++L
Sbjct: 192 EMINGRSYD-EKVDVFSFGIVL 212

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKCQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 134/296 (45%), Gaps = 49/296 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRHPNIVRLH 75
           IGEG +  V  A +      VA++   K +  +H+   Q   REI I+   RH NI+ ++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIR---KISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 76  EVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           +++ + T      VYI+ + +   +L+  +  Q   L ND   YF  Q++  + + HS  
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH--LSNDHICYFLYQILRGLKYIHSAN 148
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQG-VELLHTTCGTPNYVAPEVLSN-RG 185
           V HRDLKP NLLL++  +LK+ DFGL+  A P       L     T  Y APE++ N +G
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-------------------GETDLPTLYK-KINAA 225
           Y  S  D+WS G IL  +++    F                    + DL  +   K    
Sbjct: 209 YTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 226 EFSCPF-----W------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             S P      W        + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 268 LLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-P 69
           Y++ R +G G +++V  A N    E V +K      ILK    ++IKREI I++ +R  P
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKNKIKREIKILENLRGGP 92
Query: 70  NIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           NI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +CH
Sbjct: 93  NIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYCH 148
Query: 127 SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           S G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L +  
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQ 207
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
               + D+WS G +L  ++    PF
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK+V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 16/231 (6%)
Query: 1   MKKQTRRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV 53
           M   +    K+E+ RT       +G G + +V     ++   +VA+K L + T+     V
Sbjct: 3   MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 58
Query: 54  DQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           ++  +E ++MK ++HPN+V+L  V       YII EF+T G L D +    R   +    
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 118
Query: 114 YFQ--QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG 171
            +   Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H    
Sbjct: 119 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 172 TP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            P  + APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 179 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 228

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK+V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKVVN 81
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQL 118
           H NI+ L  V   +        VYI++E      L D  + Q   +E D  R      Q+
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVME------LMDANLSQVIQMELDHERMSYLLYQM 135
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVA 177
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y A
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           PEV+   GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 194 PEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/233 (30%), Positives = 110/233 (47%), Gaps = 18/233 (7%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ R IG G F +V   + +  G+   +VA+K L      K R       E SIM    H
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRR--DFLCEASIMGQFDH 103
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCH 126
           PN+V L  V+     V I++EF+  G L D  +  H G+          + +   + +  
Sbjct: 104 PNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLA 162
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSN 183
             G  HRDL   N+L++S    KVSDFGLS + +   E ++TT G      + APE +  
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 184 RGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 230
           R +  SA+DVWS G++++ +M+ G  P+ +     + K I       A   CP
Sbjct: 223 RKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPMDCP 274

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/321 (24%), Positives = 134/321 (41%), Gaps = 48/321 (14%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           A Y   + +G G +  V  A +  TG  VA+K L +          +  RE+ ++K +RH
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRH 83
Query: 69  PNIVRL------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
            N++ L       E L   T  Y+++ F+  G    K++   +L E+  +    Q++  +
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y APEV+ 
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMXGXVVTRWYRAPEVIL 198
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF--------- 233
           N        D+WS G I+  ++ G   F  +D     K+I     + P  F         
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 234 ----------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                                 S  A +L+ K+L  + + R+       HP+F   ++  
Sbjct: 259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD-- 316
Query: 272 KCSEEEEVNLDDVHAVFDDIE 292
               E+E  +      FDD++
Sbjct: 317 ---TEDEPQVQKYDDSFDDVD 334

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 62
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 183 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 223

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVRHPNIV 72
           R +G G +  V  A +    + VA+K L++   +++  R   +  RE+ ++K ++H N++
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVI 90
Query: 73  RLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            L +V    T      +VY++   +  G   + IV    L +   +    QL+  + + H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y APE++ N  +
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
                D+WS G I+  L+ G   F  +D     K+I
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 308
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HR+L   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 429 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 469

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQILRG 133
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 190
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G F +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 5   KWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 60
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +G  IG G F +V   + R     VA+K   ++  L   +  +  +E  I+K   HPNIV
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIV 175
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---HCHSKG 129
           RL  V   +  +YI++E V GG+    +  +G  L    +   Q + DA A   +  SK 
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR--VKTLLQMVGDAAAGMEYLESKC 233
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG----TP-NYVAPEVLSNR 184
             HRDL   N L+     LK+SDFG+S     GV   +   G     P  + APE L N 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEAL-NY 289
Query: 185 GYDGSAADVWSCGVILF 201
           G   S +DVWS G++L+
Sbjct: 290 GRYSSESDVWSFGILLW 306

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 60
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII+EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 80  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 197
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 198 ASDTWMFGVTLW 209

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTF-SH 203
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 204 ASDTWMFGVTLW 215

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTF-SH 193
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 194 ASDTWMFGVTLW 205

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 193
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 194 ASDTWMFGVTLW 205

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 86  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 203
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 204 ASDTWMFGVTLW 215

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 93/194 (47%), Gaps = 10/194 (5%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           +G  IG G F +V   + R     VA+K   ++  L   +  +  +E  I+K   HPNIV
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIV 175
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---HCHSKG 129
           RL  V   +  +YI++E V GG+    +  +G  L    +   Q + DA A   +  SK 
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLR--VKTLLQMVGDAAAGMEYLESKC 233
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-GTP-NYVAPEVLSNRGYD 187
             HRDL   N L+     LK+SDFG+S     GV          P  + APE L N G  
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEAL-NYGRY 292
Query: 188 GSAADVWSCGVILF 201
            S +DVWS G++L+
Sbjct: 293 SSESDVWSFGILLW 306

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMXGXVATRWYRAPEIM 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 80  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 197
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 198 ASDTWMFGVTLW 209

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 17  IGEGTFAKVRFAQ-NRETGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G+G+F  VR  + +  +G+  SVA+K L    + +   +D   RE++ M  + H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           L+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK   H
Sbjct: 76  LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 133 RDLKPENLLLDSYGNLKVSDFGL-SALPQQGVE-LLHTTCGTP-NYVAPEVLSNRGYDGS 189
           RDL   NLLL +   +K+ DFGL  ALPQ     ++      P  + APE L  R +   
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SH 193
Query: 190 AADVWSCGVILF 201
           A+D W  GV L+
Sbjct: 194 ASDTWMFGVTLW 205

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVRHPNIV 72
           R +G G +  V  A +    + VA+K L++   +++  R   +  RE+ ++K ++H N++
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVI 90
Query: 73  RLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            L +V    T      +VY++   +  G   + IV    L +   +    QL+  + + H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y APE++ N  +
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
                D+WS G I+  L+ G   F  +D     K+I
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 241

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIM 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIM 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 50/312 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVKC 273
           P+    Y+P + 
Sbjct: 319 PYINVWYDPAEV 330

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL    +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLC---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIM 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 190
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 64
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L              P  + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 185 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 225

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 117/257 (45%), Gaps = 18/257 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G++ +V   +++E G   A+K              ++    S  K+ +HP  VRL +
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
                  +Y+  E + G  L       G  L E     Y +  + A+AH HS+G+ H D+
Sbjct: 125 AWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV 183
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-----GTPNYVAPEVLSNRGYDGSA 190
           KP N+ L   G  K+ DFGL       VEL          G P Y+APE+L  +G  G+A
Sbjct: 184 KPANIFLGPRGRCKLGDFGLL------VELGTAGAGEVQEGDPRYMAPELL--QGSYGTA 235
Query: 191 ADVWSCGV-ILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
           ADV+S G+ IL V     LP G      L +     EF+     S+   S++  +L+P+P
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA--GLSSELRSVLVMMLEPDP 293
Query: 250 KTRIRIEGIRKHPWFRK 266
           K R   E +   P  R+
Sbjct: 294 KLRATAEALLALPVLRQ 310

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 63
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   N     +   Q+  
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L              P  + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 184 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 224

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L+K   +I+  +   +  RE+ ++K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAK---RTYRELRLLKHMK 91
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 206
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 86/355 (24%), Positives = 156/355 (43%), Gaps = 67/355 (18%)
Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           ++  + + +++V R  G+GTF  V+  + + TG SVA+K + +    ++R + QI ++++
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLA 74
Query: 62  IMKIVRHPNIVRLHE---VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-- 116
           ++    HPNIV+L      L  R +  I L  V   E     +H+       CR Y++  
Sbjct: 75  VL---HHPNIVQLQSYFYTLGERDRRDIYLNVVM--EYVPDTLHRC------CRNYYRRQ 123
Query: 117 -------------QLIDAVA--HCHSKGVYHRDLKPENLLL-DSYGNLKVSDFGLSALPQ 160
                        QLI ++   H  S  V HRD+KP N+L+ ++ G LK+ DFG +    
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLY 219
                +   C    Y APE++    +  +A D+WS G I   +M G   F G+     L+
Sbjct: 184 PSEPNVAYICSR-YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 220 --------------KKINAAEFSCPFWFSTG-----------------ATSLIHKILDPN 248
                         +K+N +      + S G                 A  L+  +L   
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 249 PKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDDIEYVAEQSENKV 302
           P+ R++      HP+F + ++P  K    +++  D    + ++IE ++E  + K+
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKL 357

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 50/312 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVKC 273
           P+    Y+P + 
Sbjct: 319 PYINVWYDPAEV 330

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRWYRAPEIM 190
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    IG G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 199
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 129/317 (40%), Gaps = 50/317 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVKCSEEEE 278
           P+    Y+P      +E
Sbjct: 319 PYINVWYDPAXXXXXDE 335

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 196
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 89
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 204
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 237

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 128/312 (41%), Gaps = 50/312 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKH 134
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 193 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 262 PWFRKNYNPVKC 273
           P+    Y+P + 
Sbjct: 312 PYINVWYDPAEV 323

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 98
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 16/216 (7%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVRHPNIV 72
           R +G G +  V  A +    + VA+K L++   +++  R   +  RE+ ++K ++H N++
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHAR---RTYRELRLLKHLKHENVI 82
Query: 73  RLHEVLASRT------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            L +V    T      +VY++   +  G   + IV    L +   +    QL+  + + H
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           S G+ HRDLKP N+ ++    L++ DFGL+   +Q  E +     T  Y APE++ N  +
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLA---RQADEEMTGYVATRWYRAPEIMLNWMH 197
Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
                D+WS G I+  L+ G   F  +D     K+I
Sbjct: 198 YNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRI 233

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGXVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 137 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 197 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 247

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 269
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HR+L   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y+
Sbjct: 390 SLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 430

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 37  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 94
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 153
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 154 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 214 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 264

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 199
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+EF+  G L + +  H+ R+      +Y  Q+   + +  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 196 KF-SVASDVWSFGVVLYELFT 215

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 90
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 205
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 199
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 102
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMXGYVATRWYRAPEIM 217
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 196
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 78
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 193
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 226

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 201
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 234

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 75
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 190
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLIDAVA 123
            HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL  A+A
Sbjct: 69  DHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALA 125
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++
Sbjct: 126 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESIN 185
Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 186 FRRFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 47  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 104
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 163
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 164 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 224 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 274

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 196
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 90
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 205
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 238

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 76
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 191
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 81
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 196
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 229

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 84
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 199
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 76
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 191
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 224

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 91
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 206
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 91
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 206
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 102
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 217
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 250

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 77
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 135
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 192
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIV 66
           V+KYE    IG+GTF +V  A++R+TG+ VA+K VL ++   K        REI I++++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 74
Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ +R  
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
           Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +   PN 
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS--QPNR 185
Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVIL 200
                    Y  PE+L      G   D+W  G I+
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         +   + APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 193 KF-SVASDVWSFGVVLYELFT 212

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 99
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 214
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 247

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 98
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 213
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 246

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 128/272 (47%), Gaps = 19/272 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 90
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  + HRD+
Sbjct: 91  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 150
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y    +D+WS
Sbjct: 151 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWS 207
Query: 196 CGVILFVLMAGYLPFGE-TDLPTLYKKINAAEFSCPFWFSTGATSL-----IHKILDPNP 249
            G+ L  +  G  P G  +    +++ ++      P    +G  SL     ++K L  NP
Sbjct: 208 MGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 267
Query: 250 KTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
             R  ++ +  H + ++       S+ EEV+ 
Sbjct: 268 AERADLKQLMVHAFIKR-------SDAEEVDF 292

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 85
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 200
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 233

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 86/275 (31%), Positives = 124/275 (45%), Gaps = 36/275 (13%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRH 68
           +  V R + EG FA V  AQ+  +G   A+K L  +   K+R + Q   E+  MK +  H
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGH 85
Query: 69  PNIVRL--------HEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
           PNIV+          E    + +  ++ E   G   E   K+  +G L  +   + F Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 119 IDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFG------------LSALPQQGVE 164
             AV H H +   + HRDLK ENLLL + G +K+ DFG             SA  +  VE
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 165 LLHTTCGTPNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
              T   TP Y  PE+  L +    G   D+W+ G IL++L     PF   D   L  +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF--EDGAKL--RI 261
Query: 223 NAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRI 255
              ++S P   +  T   SLI  +L  NP+ R+ I
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSI 296

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 229

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 8/211 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 201 MGYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 230

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIV 66
           V+KYE    IG+GTF +V  A++R+TG+ VA+K VL ++   K        REI I++++
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 73
Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ +R  
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 130
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
           Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +   PN 
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS--QPNR 184
Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVIL 200
                    Y  PE+L      G   D+W  G I+
Sbjct: 185 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  + + ++G  +A+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 108
Query: 68  HPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V    T       VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DFGL+   +   + +     T  Y APE++
Sbjct: 167 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYRAPEIM 223
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTD 256

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 16/222 (7%)
Query: 10  KYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +E ++
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAV 60
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLID 120
           MK ++HPN+V+L  V       YII EF+T G L D +    R   +     +   Q+  
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
           A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            L+   +    +DVW+ GV+L+ +   G  P+   D   +Y+
Sbjct: 181 SLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 201 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 259
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 260 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 319
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 320 PYINVWYDPAE 330

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIV 66
           V+KYE    IG+GTF +V  A++R+TG+ VA+K VL ++   K        REI I++++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 74
Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ +R  
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
           Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +   PN 
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS--QPNR 185
Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVIL 200
                    Y  PE+L      G   D+W  G I+
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 448
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLIDAVA 123
            HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL  A+A
Sbjct: 449 DHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +  SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 566 FRRFT-SASDVWMFGVCMWEILMHGVKPF 593

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 119
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 238 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 357 PYINVWYDPAE 367

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 108/215 (50%), Gaps = 33/215 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVDQIKREISIMKIV 66
           V+KYE    IG+GTF +V  A++R+TG+ VA+K VL ++   K        REI I++++
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLL 74
Query: 67  RHPNIVRLHEVLASRTK--------VYIILEFVT---GGELFDKIVHQGRLLENDCRRYF 115
           +H N+V L E+  ++          +Y++ +F      G L + +V   +   ++ +R  
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVM 131
Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
           Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+    +   L   +   PN 
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA----RAFSLAKNS--QPNR 185
Query: 175 ---------YVAPEVLSNRGYDGSAADVWSCGVIL 200
                    Y  PE+L      G   D+W  G I+
Sbjct: 186 YXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 319 PYINVWYDPAE 329

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 82
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 83  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 142
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 200
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 201 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 259
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 260 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 319
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 320 PYINVWYDPAE 330

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 75
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 135
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 193
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 194 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 252
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 253 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 312
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 313 PYINVWYDPAE 323

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 50/239 (20%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISI 62
           RR+ K      +GEGT+ +V  A +  T E+VA+K +     L+H    +     RE+S+
Sbjct: 37  RRITK------LGEGTYGEVYKAIDTVTNETVAIKRIR----LEHEEEGVPGTAIREVSL 86
Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ------ 116
           +K ++H NI+ L  V+    ++++I E+                 END ++Y        
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYA----------------ENDLKKYMDKNPDVS 130
Query: 117 ---------QLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQG 162
                    QLI+ V  CHS+   HRDLKP+NLLL          LK+ DFGL+      
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
           +        T  Y  PE+L    +  ++ D+WS   I   +LM   L  G++++  L+K
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 74
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 193 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 312 PYINVWYDPAE 322

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 77/231 (33%), Positives = 114/231 (49%), Gaps = 18/231 (7%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           R   +YE    IGEG + KV  A++ +  G  VA+K +   T  +   +  I RE+++++
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLR 66
Query: 65  ---IVRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRY 114
                 HPN+VRL +V   SRT    K+ ++ E V        DK+   G   E      
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
           FQ L+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  
Sbjct: 127 FQ-LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLW 184
Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 223
           Y APEVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 185 YRAPEVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 80
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 81  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 140
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 141 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 198
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 199 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 257
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 258 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 317
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 318 PYINVWYDPAE 328

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 111/227 (48%), Gaps = 18/227 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           +YE    IGEG + KV  A++ +  G  VA+K +   T  +   +  I RE+++++    
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLET 70
Query: 66  VRHPNIVRLHEVLA-----SRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V         TK+ ++ E V        DK+   G   E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAP 188
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 223
           EVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 319 PYINVWYDPAE 329

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 75
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 76  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 135
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 193
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 194 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 252
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 253 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 312
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 313 PYINVWYDPAE 323

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/227 (32%), Positives = 111/227 (48%), Gaps = 18/227 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           +YE    IGEG + KV  A++ +  G  VA+K +   T  +   +  I RE+++++    
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-REVAVLRHLET 70
Query: 66  VRHPNIVRLHEVLA-----SRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V         TK+ ++ E V        DK+   G   E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-TLWYRAP 188
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKKIN 223
           EVL    Y  +  D+WS G I F  M    P   G +D+  L K ++
Sbjct: 189 EVLLQSSY-ATPVDLWSVGCI-FAEMFRRKPLFRGSSDVDQLGKILD 233

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 69  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 188 RFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/311 (25%), Positives = 128/311 (41%), Gaps = 50/311 (16%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 119
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 179
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 238 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356
Query: 262 PWFRKNYNPVK 272
           P+    Y+P +
Sbjct: 357 PYINVWYDPAE 367

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 96
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 97  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 155
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 156 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 215
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 216 RFT-SASDVWMFGVCMWEILMHGVKPF 241

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 71
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 72  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 132 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 191
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 192 KF-SVASDVWSFGVVLYELFT 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 70
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 71  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 129
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 130 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 189
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 190 RFT-SASDVWMFGVCMWEILMHGVKPF 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 77
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 78  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 138 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 197
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 198 KF-SVASDVWSFGVVLYELFT 217

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 70
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 71  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 131 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 190
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 191 KF-SVASDVWSFGVVLYELFT 210

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGL+ + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 69  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 127
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 128 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 187
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 188 RFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 193 KF-SVASDVWSFGVVLYELFT 212

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 65
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 185 RFT-SASDVWMFGVCMWEILMHGVKPF 210

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 14  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 71
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 72  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 130
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 131 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 190
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 191 RFT-SASDVWMFGVCMWEILMHGVKPF 216

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 103/207 (49%), Gaps = 10/207 (4%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 73
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 74  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 193 RFT-SASDVWMFGVCMWEILMHGVKPF 218

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E +  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 78
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 79  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 139 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 198
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 199 KF-SVASDVWSFGVVLYELFT 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 72
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 192
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 193 KF-SVASDVWSFGVVLYELFT 212

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 103
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 223
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 224 KF-SVASDVWSFGVVLYELFT 243

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H  R+      +Y  Q+   + +  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 196 KF-SVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 79
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 80  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 140 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 199
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 200 KF-SVASDVWSFGVVLYELFT 219

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ D+GL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 76
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 77  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 137 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 196
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 197 KF-SVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 75
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 76  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 136 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 195
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 196 KF-SVASDVWSFGVVLYELFT 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 68
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLIDAVA 123
            HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL  A+A
Sbjct: 69  DHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALA 125
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +  SK   HRD+   N+L+ +   +K+ DFGLS   +       +    P  ++APE ++
Sbjct: 126 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 185
Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 186 FRRFT-SASDVWMFGVCMWEILMHGVKPF 213

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E +  G L D  +  H  +          + +   + +   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 136
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 137 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 197 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 247

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E++  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGL  + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 6/210 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 83
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 84  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 143
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   
Sbjct: 144 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV-TRYYRAPEVILGM 202
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           GY  +  D+WS G I+  ++ G + F  TD
Sbjct: 203 GYKEN-VDIWSVGCIMGEMIKGGVLFPGTD 231

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 10  KYEVGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V    +        +VA+K     T    R  ++  +E   M+  
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQF 448
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLIDAVA 123
            HP+IV+L  V+ +   V+II+E  T GEL  +   Q R    D      Y  QL  A+A
Sbjct: 449 DHPHIVKLIGVI-TENPVWIIMELCTLGEL--RSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +  SK   HRD+   N+L+ +   +K+ DFGLS   +       +    P  ++APE ++
Sbjct: 506 YLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPF 210
            R +  SA+DVW  GV ++ +LM G  PF
Sbjct: 566 FRRFT-SASDVWMFGVCMWEILMHGVKPF 593

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 90
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 211 KF-SVASDVWSFGVVLYELFT 230

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 96/380 (25%), Positives = 158/380 (41%), Gaps = 83/380 (21%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRH 68
           KYE+ + +G+G +  V  + +R TGE VA+K +  +         +  REI I+ ++  H
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGH 68
Query: 69  PNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHC 125
            NIV L  VL +     VY++ +++   E     V +  +LE   ++Y   QLI  + + 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANILEPVHKQYVVYQLIKVIKYL 125
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-----------ALPQQGVE---------- 164
           HS G+ HRD+KP N+LL++  ++KV+DFGLS            +P    E          
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG------------------ 206
           +L     T  Y APE+L          D+WS G IL  ++ G                  
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 207 -------------YLPFGETDLPTLYKKINAAEFSCPFWFSTG----------------A 237
                          PF +T + +L +K+   + +    F+                  A
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHA--VFDDIEYVA 295
             L+ K+L  NP  RI      KHP+    +NP      EE N D +    + D++++  
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNP-----NEEPNCDHIITIPINDNVKHSI 360
Query: 296 EQSENKVGGPLLMNAFEMIT 315
           +   N V   +     E+I+
Sbjct: 361 DDYRNLVYSEISRRKRELIS 380

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 14/201 (6%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 90
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 91  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 150
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN--YVAPEVLSNR 184
           K   HRDL   N+L+++   +K+ DFGL+  LPQ          G     + APE L+  
Sbjct: 151 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTES 210
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV+L+ L  
Sbjct: 211 KF-SVASDVWSFGVVLYELFT 230

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 105/232 (45%), Gaps = 18/232 (7%)
Query: 13  VGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   R     +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 106
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHCHS 127
           NI+RL  V+     V I+ E +  G L D  +  H  +          + +   + +   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEVLSNR 184
            G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + +PE ++ R
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCP 230
            +  SA+DVWS G++L+ +M+ G  P+ E     + K ++          CP
Sbjct: 226 KFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP 276

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 11/211 (5%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMK 64
            ++  + + IG G   +V + + R  G+    VA+K L      + R       E SIM 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMG 105
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
              HPNI+RL  V+       I+ E++  G L   +  H G+          + +   + 
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEV 180
           +    G  HRDL   N+L+DS    KVSDFGLS + +   +  +TT G      + APE 
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  SA+DVWS GV+++ VL  G  P+
Sbjct: 226 IAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 16/225 (7%)
Query: 6   RRVAKYEVGRT-------IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR 58
           + + K+E+ RT       +G G + +V     ++   +VA+K L + T+     V++  +
Sbjct: 22  QSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTM----EVEEFLK 77
Query: 59  EISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-- 116
           E ++MK ++HPN+V+L  V       YI+ E++  G L D +    R         +   
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NY 175
           Q+  A+ +   K   HRDL   N L+     +KV+DFGLS L        H     P  +
Sbjct: 138 QISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKW 197
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLY 219
            APE L+   +    +DVW+ GV+L+ +   G  P+   DL  +Y
Sbjct: 198 TAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 241

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 125/274 (45%), Gaps = 27/274 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 74
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  + HRD+
Sbjct: 75  AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 134
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q   E+ +   GT +Y++PE L    Y    +D+WS
Sbjct: 135 KPSNILVNSRGEIKLCDFGVSG--QLIDEMANEFVGTRSYMSPERLQGTHYS-VQSDIWS 191
Query: 196 CGVILFVLMAGYLPFGETDLPTLYK--------KINAAEFSCPFWFSTGATSLIHKILDP 247
            G+ L  +  G  P     +  L          K+ +A FS  F         ++K L  
Sbjct: 192 MGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEF------QDFVNKCLIK 245
Query: 248 NPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
           NP  R  ++ +  H + ++       S+ EEV+ 
Sbjct: 246 NPAERADLKQLMVHAFIKR-------SDAEEVDF 272

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ DF L+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 81/322 (25%), Positives = 131/322 (40%), Gaps = 50/322 (15%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKXVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 199
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------PTLYKKINA---- 224
            GY  +  D+WS G I+  ++   + F   D                P   KK+      
Sbjct: 200 MGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 258
Query: 225 --------AEFSCPFWF---------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                   A  + P  F               ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 259 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318
Query: 262 PWFRKNYNPVKCSEEEEVNLDD 283
           P+    Y      +E E  +++
Sbjct: 319 PYINVWYXXXXXXDEREHTIEE 340

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 6/199 (3%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G    V   Q+R +G  +A K++     +K  + +QI RE+ ++     P IV  + 
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 81
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDL 135
              S  ++ I +E + GG L   +    R+ E    +    ++  +A+   K  + HRD+
Sbjct: 82  AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 141
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWS 195
           KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y+APE L    Y    +D+WS
Sbjct: 142 KPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMAPERLQGTHYS-VQSDIWS 198
Query: 196 CGVILFVLMAGYLPFGETD 214
            G+ L  L  G  P    D
Sbjct: 199 MGLSLVELAVGRYPIPPPD 217

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           ++YE    IG G +  V  A++  +G  VA+K +      +   +  + RE+++++    
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEA 62
Query: 66  VRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-TLWYRAP 180
Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           EVL    Y  +  D+WS G I 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIF 201

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 11/211 (5%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMK 64
            ++  + + IG G   +V + + R  G+    VA+K L      + R       E SIM 
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR--DFLSEASIMG 105
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
              HPNI+RL  V+       I+ E++  G L   +  H G+          + +   + 
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEV 180
           +    G  HRDL   N+L+DS    KVSDFGLS + +   +   TT G      + APE 
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  SA+DVWS GV+++ VL  G  P+
Sbjct: 226 IAFRTFS-SASDVWSFGVVMWEVLAYGERPY 255

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+  FGL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 129/284 (45%), Gaps = 25/284 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLP-------TLYKKINAAEFSCPFWFSTGATSL-- 240
            +D+WS G+ L  +  G  P    D          +++ ++      P    +G  SL  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 242
Query: 241 ---IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
              ++K L  NP  R  ++ +  H + ++       S+ EEV+ 
Sbjct: 243 QDFVNKCLIKNPAERADLKQLMVHAFIKR-------SDAEEVDF 279

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L      +HR     K+EI I++ + H +
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEH 94
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           I++       A    + +++E+V  G L D +      L      + QQ+ + +A+ H++
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICEGMAYLHAQ 153
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTPNY-VAPEVLSNRG 185
              HRDL   N+LLD+   +K+ DFGL+    +G E   +     +P +  APE L    
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 186 YDGSAADVWSCGVILFVLM 204
           +   A+DVWS GV L+ L+
Sbjct: 214 FY-YASDVWSFGVTLYELL 231

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + R IG G F +V   + +  G+    VA+K L      K R       E SIM    HP
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHP 83
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AV 122
           NI+ L  V+     V I+ E++  G L         L +ND +    QL+         +
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSL------DTFLKKNDGQFTVIQLVGMLRGISAGM 137
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPE 179
            +    G  HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE
Sbjct: 138 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 197
Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGE 212
            ++ R +  SA+DVWS G++++ V+  G  P+ E
Sbjct: 198 AIAFRKFT-SASDVWSYGIVMWEVVSYGERPYWE 230

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ + IG G F +V   + +  G+    VA+K L      K R       E SIM    H
Sbjct: 17  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDH 74
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S 
Sbjct: 75  PNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSG 128
Query: 129 GVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAP 178
             Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + AP
Sbjct: 129 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 188
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCPF 231
           E ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I           CP 
Sbjct: 189 EAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 246

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 18/203 (8%)
Query: 15  RTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G+G F  V   +       TGE VA+K L  ST      +   +REI I+K ++H N
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDN 73
Query: 71  IVRLHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   V   A R  + +I+E++  G L D +  H+ R+      +Y  Q+   + +  +
Sbjct: 74  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-----YVAPEVLS 182
           K   HR+L   N+L+++   +K+ DFGL+ +  Q  E  +     P      + APE L+
Sbjct: 134 KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE--YYKVKEPGESPIFWYAPESLT 191
Query: 183 NRGYDGSAADVWSCGVILFVLMA 205
              +   A+DVWS GV+L+ L  
Sbjct: 192 ESKF-SVASDVWSFGVVLYELFT 213

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ + IG G F +V   + +  G+    VA+K L      K R       E SIM    H
Sbjct: 32  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDH 89
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S 
Sbjct: 90  PNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSG 143
Query: 129 GVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAP 178
             Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + AP
Sbjct: 144 MKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 203
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCPF 231
           E ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I           CP 
Sbjct: 204 EAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 261

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 108/239 (45%), Gaps = 28/239 (11%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ + IG G F +V   + +  G+    VA+K L      K R       E SIM    H
Sbjct: 11  KIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDH 68
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI+ L  V+     V II E++  G L         L +ND R    QL+  +    S 
Sbjct: 69  PNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGSG 122
Query: 129 GVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAP 178
             Y       HRDL   N+L++S    KVSDFG+S + +   E  +TT G      + AP
Sbjct: 123 MKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-----EFSCPF 231
           E ++ R +  SA+DVWS G++++ +M+ G  P+ +     + K I           CP 
Sbjct: 183 EAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPI 240

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           ++YE    IG G +  V  A++  +G  VA+K +      +   +  + RE+++++    
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEA 62
Query: 66  VRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y AP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV-TLWYRAP 180
Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           EVL    Y  +  D+WS G I 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIF 201

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMK-- 64
           ++YE    IG G +  V  A++  +G  VA+K +             I   RE+++++  
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 65  -IVRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQ 116
               HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   +
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 127
Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    + L      T  Y 
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV-TLWYR 186
Query: 177 APEVLSNRGYDGSAADVWSCGVIL 200
           APEVL    Y  +  D+WS G I 
Sbjct: 187 APEVLLQSTY-ATPVDMWSVGCIF 209

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 16/213 (7%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVR 67
           +Y+    +G G +  V  A + +TG  VA+K L++   +I+  +   +  RE+ ++K ++
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 79
Query: 68  HPNIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           H N++ L +V      L     VY++   +  G   + IV   +L ++  +    Q++  
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           + + HS  + HRDLKP NL ++    LK+ D GL+   +   + +     T  Y APE++
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLA---RHTDDEMTGYVATRWYRAPEIM 194
Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
            N  +     D+WS G I+  L+ G   F  TD
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 227

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 6/218 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPEVVTRYYRAPEVILGM 200
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 201 GYKEN-VDIWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +TIG+G F  V     R  G  VA+K +      +  +      E S+M  +RH N+V+L
Sbjct: 27  QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 79
Query: 75  HEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGVY 131
             V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +       
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDL   N+L+      KVSDFGL+   ++      T      + APE L  + +  + +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS-TKS 195
Query: 192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 230
           DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 240

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +TIG+G F  V     R  G  VA+K +      +  +      E S+M  +RH N+V+L
Sbjct: 12  QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 64
Query: 75  HEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGVY 131
             V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +       
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 124
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDL   N+L+      KVSDFGL+   ++      T      + APE L  + +  + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF-STKS 180
Query: 192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 230
           DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 225

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F +V       + + VA+K L   T+     V     E ++MK ++H  +VRL
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRL 73
Query: 75  HEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           + V+     +YII E++  G L D  K    G++L      +  Q+ + +A+   K   H
Sbjct: 74  YAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 133
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAA 191
           RDL+  N+L+      K++DFGL+ + +            P  + APE + N G     +
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGCFTIKS 192
Query: 192 DVWSCGVILF-VLMAGYLPF 210
           DVWS G++L+ ++  G +P+
Sbjct: 193 DVWSFGILLYEIVTYGKIPY 212

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK---I 65
           ++YE    IG G +  V  A++  +G  VA+K +      +   +  + RE+++++    
Sbjct: 4   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRLEA 62
Query: 66  VRHPNIVRLHEVLA-SRT----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQL 118
             HPN+VRL +V A SRT    KV ++ E V        DK    G L     +   +Q 
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMRQF 121
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+ +    +  L     T  Y AP
Sbjct: 122 LRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LDPVVVTLWYRAP 180
Query: 179 EVLSNRGYDGSAADVWSCGVIL 200
           EVL    Y  +  D+WS G I 
Sbjct: 181 EVLLQSTY-ATPVDMWSVGCIF 201

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 10/200 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F +V       + + VA+K L   T+     V     E ++MK ++H  +VRL
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRL 72
Query: 75  HEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           + V+     +YII EF+  G L D  K    G++L      +  Q+ + +A+   K   H
Sbjct: 73  YAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 132
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAA 191
           RDL+  N+L+      K++DFGL+ + +            P  + APE + N G     +
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGCFTIKS 191
Query: 192 DVWSCGVILF-VLMAGYLPF 210
           +VWS G++L+ ++  G +P+
Sbjct: 192 NVWSFGILLYEIVTYGKIPY 211

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 20/225 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +TIG+G F  V     R  G  VA+K +      +  +      E S+M  +RH N+V+L
Sbjct: 199 QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 251
Query: 75  HEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGVY 131
             V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +       
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDL   N+L+      KVSDFGL+   ++      T      + APE L  + +  + +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS-TKS 367
Query: 192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 230
           DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 412

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 109/236 (46%), Gaps = 29/236 (12%)
Query: 15  RTIGEGTFAKV-RFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + IG G F +V +      +G+    VA+K L      K R VD +  E  IM    H N
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLG-EAGIMGQFSHHN 107
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVA 123
           I+RL  V++    + II E++  G L DK      L E D      QL+         + 
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGAL-DKF-----LREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP---NYVAPEV 180
           +  +    HRDL   N+L++S    KVSDFGLS + +   E  +TT G      + APE 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 181 LSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN-----AAEFSCP 230
           +S R +  SA+DVWS G++++ +M  G  P+ E     + K IN          CP
Sbjct: 222 ISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 6/218 (2%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 82  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 141
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+   
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPEVVTRYYRAPEVILGM 200
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 201 GYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 237

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 120/258 (46%), Gaps = 20/258 (7%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVR 67
           A+  +   IG G F KV  A     G+ VA+K           + ++ +++E  +  +++
Sbjct: 7   AELTLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           HPNI+ L  V      + +++EF  GG L ++++   R+  +    +  Q+   + + H 
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 128 KG---VYHRDLKPENLLL--------DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           +    + HRDLK  N+L+         S   LK++DFGL+    +  ++  +  G   ++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWM 181
Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYK-KINAAEFSCPFWFS 234
           APEV+    +    +DVWS GV+L+ L+ G +PF G   L   Y   +N      P    
Sbjct: 182 APEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240
Query: 235 TGATSLIHKILDPNPKTR 252
                L+    +P+P +R
Sbjct: 241 EPFAKLMEDCWNPDPHSR 258

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 8/219 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 75
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 76  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 135
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 193
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
            GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 194 MGYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 231

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 8/219 (3%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           + +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V 
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVN 86
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLIDAVAH 124
           H NI+ L  V   +  +    +     EL D  + Q   +E D  R      Q++  + H
Sbjct: 87  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 146
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSN 183
            HS G+ HRDLKP N+++ S   LK+ DFGL+     G   + T    T  Y APEV+  
Sbjct: 147 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 204
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
            GY  +  D+WS G I+  ++   + F   D    + K+
Sbjct: 205 MGYKEN-VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKV 242

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +TIG+G F  V     R  G  VA+K +      +  +      E S+M  +RH N+V+L
Sbjct: 18  QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 70
Query: 75  HEVLAS-RTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQ-QLIDAVAHCHSKGVY 131
             V+   +  +YI+ E++  G L D +  +GR +L  DC   F   + +A+ +       
Sbjct: 71  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 130
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           HRDL   N+L+      KVSDFGL+   ++      T      + APE L    +  + +
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREAAFS-TKS 186
Query: 192 DVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-----AEFSCP 230
           DVWS G++L+ + + G +P+    L  +  ++       A   CP
Sbjct: 187 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 231

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           EV   +G G F  V  A+ R   + VA+K +   +  K  +V     E+  +  V HPNI
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIV-----ELRQLSRVNHPNI 63
Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE----NDCRRYFQQLIDAVAHCHS 127
           V+L+   A    V +++E+  GG L++ ++H    L          +  Q    VA+ HS
Sbjct: 64  VKLYG--ACLNPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 128 ---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
              K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  ++APEV   
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEG 177
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
             Y     DV+S G+IL+ ++    PF E   P  
Sbjct: 178 SNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           EV   +G G F  V  A+ R   + VA+K +   +  K  +V     E+  +  V HPNI
Sbjct: 12  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIV-----ELRQLSRVNHPNI 64
Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE----NDCRRYFQQLIDAVAHCHS 127
           V+L+   A    V +++E+  GG L++ ++H    L          +  Q    VA+ HS
Sbjct: 65  VKLYG--ACLNPVCLVMEYAEGGSLYN-VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 128 ---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
              K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  ++APEV   
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEG 178
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
             Y     DV+S G+IL+ ++    PF E   P  
Sbjct: 179 SNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF 212

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 30  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 88  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMS 204
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YEV + IG+G+F +V  A + +  + VA+K++        R   Q   EI I++ +R  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 70  ------NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDA 121
                 N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQC 212
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +T   +  Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTXIQSRFYRAPE 269
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGY 207
           V+    Y G   D+WS G IL  L+ GY
Sbjct: 270 VILGARY-GMPIDMWSLGCILAELLTGY 296

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L      +HR     K+EI I++ + H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEH 77
Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           I++       + +  + +++E+V  G L D +      L      + QQ+ + +A+ HS+
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICEGMAYLHSQ 136
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTP-NYVAPEVLSNRG 185
              HR+L   N+LLD+   +K+ DFGL+    +G E   +     +P  + APE L    
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 186 YDGSAADVWSCGVILFVLMA 205
           +   A+DVWS GV L+ L+ 
Sbjct: 197 F-YYASDVWSFGVTLYELLT 215

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 127
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 244
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 245 QSDIWSMGLSLVEMAVGRYPIPPPD 269

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YEV + IG+G+F +V  A + +  + VA+K++        R   Q   EI I++ +R  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 70  ------NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDA 121
                 N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQC 212
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +T   +  Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTXIQSRFYRAPE 269
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGY 207
           V+    Y G   D+WS G IL  L+ GY
Sbjct: 270 VILGARY-GMPIDMWSLGCILAELLTGY 296

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G G +  V  A ++ +GE VA+K L++   S I   R      RE+ ++K ++H N++ 
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 87
Query: 74  LHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           L +V    + +      Y+++ F+       KI+   +  E   +    Q++  + + HS
Sbjct: 88  LLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHS 144
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            GV HRDLKP NL ++    LK+ DFGL+   +     +     T  Y APEV+ +  + 
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILSWMHY 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETD 214
               D+WS G I+  ++ G   F   D
Sbjct: 202 NQTVDIWSVGCIMAEMLTGKTLFKGKD 228

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 30  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 88  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIVRHPNIVR 73
           +G G +  V  A ++ +GE VA+K L++   S I   R      RE+ ++K ++H N++ 
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKHMQHENVIG 105
Query: 74  LHEVLASRTKV------YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           L +V    + +      Y+++ F+       KI+      E   +    Q++  + + HS
Sbjct: 106 LLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHS 162
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
            GV HRDLKP NL ++    LK+ DFGL+   +     +     T  Y APEV+ +  + 
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILSWMHY 219
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETD 214
               D+WS G I+  ++ G   F   D
Sbjct: 220 NQTVDIWSVGCIMAEMLTGKTLFKGKD 246

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 6/209 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 209
Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTL 218
            +D+WS G+ L  +  G  P    D   L
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 11  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 68
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 69  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 10  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 67
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 68  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 125
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 126 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 184
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 185 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 244
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 245 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 283

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 115
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 14  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 71
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 72  DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 129
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 130 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 188
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 189 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 248
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 249 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 287

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 6/205 (2%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 182
Query: 190 AADVWSCGVILFVLMAGYLPFGETD 214
            +D+WS G+ L  +  G  P    D
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPD 207

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 133/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 115
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  GT NY+ PE    +S
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 232
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L      +HR     K+EI I++ + H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHR--SGWKQEIDILRTLYHEH 77
Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           I++       + +  + +++E+V  G L D +      L      + QQ+ + +A+ H++
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQ-LLLFAQQICEGMAYLHAQ 136
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTP-NYVAPEVLSNRG 185
              HR+L   N+LLD+   +K+ DFGL+    +G E   +     +P  + APE L    
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 186 YDGSAADVWSCGVILFVLMA 205
           +   A+DVWS GV L+ L+ 
Sbjct: 197 F-YYASDVWSFGVTLYELLT 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL-- 74
           +G+G  A V   ++++TG+  A+KV    + L  R VD   RE  ++K + H NIV+L  
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 75  -HEVLASRTKVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKGV 130
             E   +R KV +I+EF   G L+  +        L E++     + ++  + H    G+
Sbjct: 75  IEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 131 YHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----- 181
            HR++KP N++     D     K++DFG +A   +  E   +  GT  Y+ P++      
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFG-AARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 182 --SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
              ++   G+  D+WS GV  +    G LPF   + P   K++
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 111/239 (46%), Gaps = 21/239 (8%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M  Q+     + +   +G+G  A V   ++++TG+  A+KV    + L  R VD   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREF 58
Query: 61  SIMKIVRHPNIVRL---HEVLASRTKVYIILEFVTGGELFDKIVHQGR---LLENDCRRY 114
            ++K + H NIV+L    E   +R KV +I+EF   G L+  +        L E++    
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTC 170
            + ++  + H    G+ HR++KP N++     D     K++DFG +A   +  E      
Sbjct: 118 LRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG-AARELEDDEQFVXLY 176
Query: 171 GTPNYVAPEVL-------SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
           GT  Y+ P++         ++   G+  D+WS GV  +    G LPF   + P   K++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 16  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 71
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAHC 125
            L    +++ ++ I+ ++  G  L+        L  ++ +   ++LID        + + 
Sbjct: 72  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSN 183
           H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV+  
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 184 RGYDGSA--ADVWSCGVILFVLMAGYLPF 210
           +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 185 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 213

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 112/256 (43%), Gaps = 51/256 (19%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +G+T+G G+F  V    + E+G+  A+K + +    K+R       E+ IMK++ H 
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-------ELDIMKVLDHV 60
Query: 70  NIVRL--------------------HEVLASRTK------------------VYIILEFV 91
           NI++L                    H  L  +                    + +I+E+V
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 92  --TGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN- 147
             T  ++    +  GR +  N    Y  QL  AV   HS G+ HRD+KP+NLL++S  N 
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 148 LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY 207
           LK+ DFG +         +   C    Y APE++        + D+WS G +   L+ G 
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAXICSR-FYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 208 LPF-GETDLPTLYKKI 222
             F GET +  L + I
Sbjct: 240 PLFSGETSIDQLVRII 255

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 35/222 (15%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK--VLAKSTILKHRMVDQIKREISIMKIV 66
           ++Y   + +G G    V  A + +  + VA+K  VL     +KH +     REI I++ +
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-----REIKIIRRL 65
Query: 67  RHPNIVRLHEVLASR--------------TKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
            H NIV++ E+L                   VYI+ E++        ++ QG LLE   R
Sbjct: 66  DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEEHAR 123
Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSAL-----PQQGVELL 166
            +  QL+  + + HS  V HRDLKP NL +++    LK+ DFGL+ +       +G    
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG---- 179
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
           H + G  T  Y +P +L +      A D+W+ G I   ++ G
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YEV + IG+G F +V  A + +  + VA+K++        R   Q   EI I++ +R  
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQ 153
Query: 70  ------NIVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDA 121
                 N++ + E    R  + +  E ++    EL  K   QG  L    R++   ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL-VRKFAHSILQC 212
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +    +  Y APE
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YXXIQSRFYRAPE 269
Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGY 207
           V+    Y G   D+WS G IL  L+ GY
Sbjct: 270 VILGARY-GMPIDMWSLGCILAELLTGY 296

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 132/279 (47%), Gaps = 23/279 (8%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
           Y + + IG G  +KV F    E  +  A+K +       ++ +D  + EI+ + K+ +H 
Sbjct: 58  YSILKQIGSGGSSKV-FQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHS 115
Query: 70  N-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR-YFQQLIDAVAHCHS 127
           + I+RL++   +   +Y+++E   G    +  + + + ++   R+ Y++ +++AV   H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVME--CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEV---LS 182
            G+ H DLKP N L+   G LK+ DFG++    P     +  +  G  NY+ PE    +S
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 183 NRGYDG-------SAADVWSCGVILFVLMAGYLPFGE--TDLPTLYKKINAA-EFSCPFW 232
           +   +G         +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
                  ++   L  +PK RI I  +  HP+ +   +PV
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLYG 133
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   +  QG L E+    Y  Q ++ + + HS+ + H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G +LL      GT  ++APEV+  R  D + 
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD-AK 252
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            DVWS   ++  ++ G  P+
Sbjct: 253 VDVWSSCCMMLHMLNGCHPW 272

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 122/274 (44%), Gaps = 25/274 (9%)
Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R  K+++   IG G+F  V    + ET   VA   L    + K     + K E   +K +
Sbjct: 26  RFLKFDI--EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEXLKGL 82
Query: 67  RHPNIVRLHEVLASRTK----VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQL 118
           +HPNIVR ++   S  K    + ++ E  T G L   +    V + ++L + CR+  + L
Sbjct: 83  QHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGL 142
Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
                H  +  + HRDLK +N+ +    G++K+ D GL+ L +          GTP + A
Sbjct: 143 --QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFXA 198
Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET-DLPTLYKKINAAEFSCPFWFSTG 236
           PE    + YD S  DV++ G           P+ E  +   +Y+++ +     P  F   
Sbjct: 199 PEXYEEK-YDES-VDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSG--VKPASFDKV 254
Query: 237 ATSLIHKILD----PNPKTRIRIEGIRKHPWFRK 266
           A   + +I++     N   R  I+ +  H +F++
Sbjct: 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 28  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAHC 125
            L    +++ ++ I+ ++  G  L+        L  ++ +   ++LID        + + 
Sbjct: 84  -LFMGYSTKPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSN 183
           H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV+  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 184 RGYDGSA--ADVWSCGVILFVLMAGYLPF 210
           +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK--------KVRLEVFRAEELMACAGLTSPRIVPLYG 152
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   +  QG L E+    Y  Q ++ + + HS+ + H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+  R  D + 
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD-AK 271
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            DVWS   ++  ++ G  P+
Sbjct: 272 VDVWSSCCMMLHMLNGCHPW 291

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 14  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 69
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 70  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 121
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 122 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 28/300 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G GT  +V   + R+TG  +A+K + +S   +      +  ++ ++K    P IV+   
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV-VLKSHDCPYIVQCFG 91
Query: 77  VLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRD 134
              + T V+I +E + T  E   K + QG + E    +    ++ A+ +   K GV HRD
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 150
Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-----SNRGYDGS 189
           +KP N+LLD  G +K+ DFG+S       +    + G   Y+APE +     +   YD  
Sbjct: 151 VKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYD-I 208
Query: 190 AADVWSCGVILFVLMAGYLPFG--ETDLPTLYKKINAAEFSCP--FWFSTGATSLIHKIL 245
            ADVWS G+ L  L  G  P+   +TD   L K +       P    FS    S +   L
Sbjct: 209 RADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCL 268
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGP 305
             + + R +   + +H  F K Y      E  EV   DV + F D   V  ++E+   GP
Sbjct: 269 TKDHRKRPKYNKLLEHS-FIKRY------ETLEV---DVASWFKD---VMAKTESPRSGP 315

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 17  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 124
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 17  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 72
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 73  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 124
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 117/259 (45%), Gaps = 14/259 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G +  V   ++  +G+ +A+K +  +   + +    +  +IS M+ V  P  V  + 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPFTVTFYG 117
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDC-RRYFQQLIDAVAHCHSK-GVYH 132
            L     V+I +E +     + + +++ +G+ +  D   +    ++ A+ H HSK  V H
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 177
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE----VLSNRGYDG 188
           RD+KP N+L+++ G +K+ DFG+S      V       G   Y+APE     L+ +GY  
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISGYLVDSVAKT-IDAGCKPYMAPERINPELNQKGY-S 235
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAAEFSCPF-WFSTGATSLIHKIL 245
             +D+WS G+ +  L     P+     P   L + +       P   FS        + L
Sbjct: 236 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 295
Query: 246 DPNPKTRIRIEGIRKHPWF 264
             N K R     + +HP+F
Sbjct: 296 KKNSKERPTYPELMQHPFF 314

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 117/259 (45%), Gaps = 14/259 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G +  V   ++  +G+ +A+K +  +   + +    +  +IS M+ V  P  V  + 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPFTVTFYG 73
Query: 77  VLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCR-RYFQQLIDAVAHCHSK-GVYH 132
            L     V+I +E +     + + +++ +G+ +  D   +    ++ A+ H HSK  V H
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 133
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE----VLSNRGYDG 188
           RD+KP N+L+++ G +K+ DFG+S      V       G   Y+APE     L+ +GY  
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVA-KDIDAGCKPYMAPERINPELNQKGY-S 191
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAAEFSCPF-WFSTGATSLIHKIL 245
             +D+WS G+ +  L     P+     P   L + +       P   FS        + L
Sbjct: 192 VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 251
Query: 246 DPNPKTRIRIEGIRKHPWF 264
             N K R     + +HP+F
Sbjct: 252 KKNSKERPTYPELMQHPFF 270

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 12  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 39  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 94
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 95  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 146
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 147 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           + ++      +DV++ G++L+ LM G LP+
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 236

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           ++  ++ + IG G F +V     +  G+    VA+K L      K R       E SIM 
Sbjct: 32  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMG 89
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
              HPN++ L  V+   T V II EF+  G L D  + Q     ND +    QL+  +  
Sbjct: 90  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQ-----NDGQFTVIQLVGMLRG 143
Query: 125 CHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY-- 175
             +   Y       HRDL   N+L++S    KVSDFGLS         L      P Y  
Sbjct: 144 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS-------RFLEDDTSDPTYTS 196
Query: 176 ----------VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA 224
                      APE +  R +  SA+DVWS G++++ +M+ G  P+ +    T    INA
Sbjct: 197 ALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINA 252
Query: 225 AE 226
            E
Sbjct: 253 IE 254

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L +    + R     +REI I++ + H +
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--SGWQREIEILRTLYHEH 72
Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDAVAH 124
           IV+       + +  V +++E+V  G L D +    V   +LL      + QQ+ + +A+
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-----LFAQQICEGMAY 127
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTP-NYVAPEVL 181
            H++   HR L   N+LLD+   +K+ DFGL+    +G E   +     +P  + APE L
Sbjct: 128 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 182 SNRGYDGSAADVWSCGVILFVLMA 205
               +   A+DVWS GV L+ L+ 
Sbjct: 188 KECKFY-YASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 15  RTIGEGTFAKVRF----AQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV        N  TGE VA+K L +    + R     +REI I++ + H +
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--SGWQREIEILRTLYHEH 71
Query: 71  IVRLHEVLASRTK--VYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDAVAH 124
           IV+       + +  V +++E+V  G L D +    V   +LL      + QQ+ + +A+
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL-----LFAQQICEGMAY 126
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL--LHTTCGTP-NYVAPEVL 181
            H++   HR L   N+LLD+   +K+ DFGL+    +G E   +     +P  + APE L
Sbjct: 127 LHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 182 SNRGYDGSAADVWSCGVILFVLMA 205
               +   A+DVWS GV L+ L+ 
Sbjct: 187 KECKFY-YASDVWSFGVTLYELLT 209

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 40  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 96  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 147
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           + ++      +DV++ G++L+ LM G LP+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G +  V    ++ +G+ +A+K + +ST+ +      +     +M+    P IV+ + 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 77  VLASRTKVYIILEFVTGGELFDKI------VHQGRLLENDCRRYFQQLIDAVAHCHSK-G 129
            L      +I +E ++    FDK       V    + E    +     + A+ H      
Sbjct: 89  ALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVL----SN 183
           + HRD+KP N+LLD  GN+K+ DFG+S    Q V+ +  T   G   Y+APE +    S 
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF 210
           +GYD   +DVWS G+ L+ L  G  P+
Sbjct: 204 QGYD-VRSDVWSLGITLYELATGRFPY 229

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           V+  ++   IG G F +V   + +  G+    VA+K L      + R   +   E SIM 
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMG 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
              HPNI+RL  V+ +   V I+ EF+  G L         L  ND +    QL+  +  
Sbjct: 71  QFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRG 124
Query: 125 CHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTC---GTP 173
             S   Y       HRDL   N+L++S    KVSDFGLS  L +   +  +T+      P
Sbjct: 125 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIP 184
Query: 174 -NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
             + APE ++ R +  SA+D WS G++++ +M+    FGE
Sbjct: 185 IRWTAPEAIAFRKFT-SASDAWSYGIVMWEVMS----FGE 219

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V+  + +   + VA+K++ + ++ +    D+  +E   M  + HP +V+ 
Sbjct: 14  KELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKF 68
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V +    +YI+ E+++ G L + +   G+ LE +        + + +A   S    HR
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 134 DLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           DL   N L+D    +KVSDFG++   L  Q V    ++ GT     + APEV     Y  
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPEVFHYFKY-S 183
Query: 189 SAADVWSCGVILF-VLMAGYLPF 210
           S +DVW+ G++++ V   G +P+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPY 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMK 64
           V+  ++   IG G F +V   + +  G+    VA+K L      + R   +   E SIM 
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMG 72
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
              HPNI+RL  V+ +   V I+ EF+  G L         L  ND +    QL+  +  
Sbjct: 73  QFEHPNIIRLEGVVTNSMPVMILTEFMENGAL------DSFLRLNDGQFTVIQLVGMLRG 126
Query: 125 CHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN--- 174
             S   Y       HRDL   N+L++S    KVSDFGLS   ++       T        
Sbjct: 127 IASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 175 --YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
             + APE ++ R +  SA+D WS G++++ +M+    FGE
Sbjct: 187 IRWTAPEAIAFRKFT-SASDAWSYGIVMWEVMS----FGE 221

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 28  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAHC 125
            L    ++  ++ I+ ++  G  L+        L  ++ +   ++LID        + + 
Sbjct: 84  -LFMGYSTAPQLAIVTQWCEGSSLYH------HLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSN 183
           H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV+  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 184 RGYDGSA--ADVWSCGVILFVLMAGYLPF 210
           +  +  +  +DV++ G++L+ LM G LP+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPY 225

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 15  RTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V  A  N+ T   VA+K +   ++     V+    E ++MK ++H  +V+
Sbjct: 21  KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 74
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID-------AVAH 124
           LH V+ ++  +YII EF+  G L D        L++D   ++   +LID        +A 
Sbjct: 75  LHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLIDFSAQIAEGMAF 126
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSN 183
              +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE + N
Sbjct: 127 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-N 185
Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
            G     +DVWS G++L  ++  G +P+     P + + +
Sbjct: 186 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 100/197 (50%), Gaps = 12/197 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVRHPNIVR 73
           +G+G F  V   +    G++    V  K   L+H   DQ    +REI I+K +    IV+
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 74  LHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
              V     R ++ +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+  
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 132
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
            HRDL   N+L++S  ++K++DFGL+  LP  +   ++     +P  + APE LS+  + 
Sbjct: 133 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF- 191
Query: 188 GSAADVWSCGVILFVLM 204
              +DVWS GV+L+ L 
Sbjct: 192 SRQSDVWSFGVVLYELF 208

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV--DQIKREISIM 63
           R +  +E  + +G G F  V  A+N+    + A+K +     L +R +  +++ RE+  +
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR----LPNRELAREKVMREVKAL 57
Query: 64  KIVRHPNIVRL----------HEVLASRTKVY--IILEFVTGGELFDKIVHQGRLLEND- 110
             + HP IVR            ++  S  KVY  I ++      L D +  +  + E + 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 111 --CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELL- 166
             C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL +A+ Q   E   
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 167 ---------HT-TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP 216
                    HT   GT  Y++PE +    Y     D++S G+ILF L+    PF  T + 
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELL---YPFS-TQME 232
Query: 217 TLYKKINAAEFSCPFWFSTGATS---LIHKILDPNPKTR 252
            +    +      P  F+        ++  +L P+P  R
Sbjct: 233 RVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMER 271

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 32  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 87
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 88  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 139
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV  
Sbjct: 140 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 12  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    ++  ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 68  -LFMGYSTAPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+ +  +  G        G+  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 24/214 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 12  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 68  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 119
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
           + ++      +DV++ G++L+ LM G LP+   +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           VG+ IG G+F  V   + +  G+ VA+K+L   T    + +   K E+ +++  RH NI+
Sbjct: 40  VGQRIGSGSFGTV--YKGKWHGD-VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNIL 95
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN--------DCRRYFQQLIDAVAH 124
            L    +++ ++ I+ ++  G  L+    H   ++E         D  R   Q +D   +
Sbjct: 96  -LFMGYSTKPQLAIVTQWCEGSSLY----HHLHIIETKFEMIKLIDIARQTAQGMD---Y 147
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEV-- 180
            H+K + HRDLK  N+ L     +K+ DFGL+    +  G        G+  ++APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           + ++      +DV++ G++L+ LM G LP+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPY 237

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +   +++ K    +M  + H  +V+L
Sbjct: 30  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 84
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS       E        P  +  PEVL    +  S +D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKF-SSKSD 203
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 204 IWAFGVLMWEIYSLGKMPY 222

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 15  RTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V  A  N+ T   VA+K +   ++     V+    E ++MK ++H  +V+
Sbjct: 194 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 247
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID-------AVAH 124
           LH V+ ++  +YII EF+  G L D        L++D   ++   +LID        +A 
Sbjct: 248 LHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSN 183
              +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE + N
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-N 358
Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPF 210
            G     +DVWS G++L  ++  G +P+
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPY 386

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/341 (24%), Positives = 141/341 (41%), Gaps = 70/341 (20%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---------QIKRE 59
           + Y V R I  G++  V    + E G  VA+K +  +T+   R V+         ++ RE
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVF-NTVSDGRTVNILSDSFLCKRVLRE 79
Query: 60  ISIMKIVRHPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-R 113
           I ++    HPNI+ L ++       +  K+Y++ E +       +++H  R++ +    +
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQ 137
Query: 114 YFQQLIDAVAHC-HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT 172
           YF   I    H  H  GV HRDL P N+LL    ++ + DF L+          H     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 173 PNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN-------- 223
             Y APE V+  +G+     D+WS G ++  +      F  +   T Y ++N        
Sbjct: 198 -WYRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRKALFRGS---TFYNQLNKIVEVVGT 252
Query: 224 -----AAEFSCP----------------FWFSTGATS------LIHKILDPNPKTRIRIE 256
                   FS P                 W +   T+      LI K+L+ NP+ RI  E
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 257 GIRKHPWFRKNYNPVKCSE---------EEEVNLDDVHAVF 288
              +HP+F   ++P+  +E         E   ++ D+H +F
Sbjct: 313 QALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIF 353

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/341 (24%), Positives = 141/341 (41%), Gaps = 70/341 (20%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---------QIKRE 59
           + Y V R I  G++  V    + E G  VA+K +  +T+   R V+         ++ RE
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVF-NTVSDGRTVNILSDSFLCKRVLRE 79
Query: 60  ISIMKIVRHPNIVRLHEVLA-----SRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-R 113
           I ++    HPNI+ L ++       +  K+Y++ E +       +++H  R++ +    +
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD--LAQVIHDQRIVISPQHIQ 137
Query: 114 YFQQLIDAVAHC-HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT 172
           YF   I    H  H  GV HRDL P N+LL    ++ + DF L+          H     
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 173 PNYVAPE-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKIN-------- 223
             Y APE V+  +G+     D+WS G ++  +      F  +   T Y ++N        
Sbjct: 198 -WYRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRKALFRGS---TFYNQLNKIVEVVGT 252
Query: 224 -----AAEFSCP----------------FWFSTGATS------LIHKILDPNPKTRIRIE 256
                   FS P                 W +   T+      LI K+L+ NP+ RI  E
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312
Query: 257 GIRKHPWFRKNYNPVKCSE---------EEEVNLDDVHAVF 288
              +HP+F   ++P+  +E         E   ++ D+H +F
Sbjct: 313 QALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIF 353

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 15  RTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV       +   TGE VA+K L   +   H  +  +K+EI I++ + H N
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 84
Query: 71  IVRLHEVLASR--TKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +  S
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YVAPEVLSNR 184
           +   HRDL   N+L++S   +K+ DFGL+   +   E         +   + APE L   
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV L  L+ 
Sbjct: 205 KF-YIASDVWSFGVTLHELLT 224

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 58  REISIMKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRY 114
           RE+ +++    HPN++R       R   YI +E         + V Q     L  +    
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA--TLQEYVEQKDFAHLGLEPITL 123
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLK--VSDFGLS---ALPQQGVELL 166
            QQ    +AH HS  + HRDLKP N+L+   +++G +K  +SDFGL    A+ +      
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 167 HTTCGTPNYVAPEVLSNRGYDGS--AADVWSCGVIL-FVLMAGYLPFGETDLPTLYKKIN 223
               GT  ++APE+LS    +      D++S G +  +V+  G  PFG+    +L ++ N
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK----SLQRQAN 239
Query: 224 AAEFSCPF-------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
               +C              A  LI K++  +P+ R   + + KHP+F
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 15  RTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           R +GEG F KV       +   TGE VA+K L   +   H  +  +K+EI I++ + H N
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 72
Query: 71  IVRLHEVLASR--TKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +  S
Sbjct: 73  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS 132
Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---YVAPEVLSNR 184
           +   HRDL   N+L++S   +K+ DFGL+   +   E         +   + APE L   
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 185 GYDGSAADVWSCGVILFVLMA 205
            +   A+DVWS GV L  L+ 
Sbjct: 193 KF-YIASDVWSFGVTLHELLT 212

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVRHPNIVR 73
           +G+G F  V   +    G++    V  K   L+H   DQ    +REI I+K +    IV+
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 74  LHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
              V     R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+  
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 135
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
            HRDL   N+L++S  ++K++DFGL+  LP  +   ++     +P  + APE LS+  + 
Sbjct: 136 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF- 194
Query: 188 GSAADVWSCGVILFVLM 204
              +DVWS GV+L+ L 
Sbjct: 195 SRQSDVWSFGVVLYELF 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVRHPNIVR 73
           +G+G F  V   +    G++    V  K   L+H   DQ    +REI I+K +    IV+
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 74  LHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
              V     R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+  
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 136
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
            HRDL   N+L++S  ++K++DFGL+  LP  +   ++     +P  + APE LS+  + 
Sbjct: 137 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 196
Query: 188 GSAADVWSCGVILFVLM 204
              +DVWS GV+L+ L 
Sbjct: 197 -RQSDVWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKREISIMKIVRHPNIVR 73
           +G+G F  V   +    G++    V  K   L+H   DQ    +REI I+K +    IV+
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ--LQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 74  LHEVL--ASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
              V     R  + +++E++  G L D +  H+ RL  +    Y  Q+   + +  S+  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LP-QQGVELLHTTCGTP-NYVAPEVLSNRGYD 187
            HRDL   N+L++S  ++K++DFGL+  LP  +   ++     +P  + APE LS+  + 
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208
Query: 188 GSAADVWSCGVILFVLM 204
              +DVWS GV+L+ L 
Sbjct: 209 -RQSDVWSFGVVLYELF 224

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 25/218 (11%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIV 66
           + E+G  IG+G F +V     R  GE VA++++     ++    DQ+K   RE+   +  
Sbjct: 34  QLEIGELIGKGRFGQV--YHGRWHGE-VAIRLID----IERDNEDQLKAFKREVMAYRQT 86
Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHC 125
           RH N+V       S   + II     G  L+  +     +L+ N  R+  Q+++  + + 
Sbjct: 87  RHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGL---SALPQQG--VELLHTTCGTPNYVAPEV 180
           H+KG+ H+DLK +N+  D+ G + ++DFGL   S + Q G   + L    G   ++APE+
Sbjct: 147 HAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 181 LSNRGYD--------GSAADVWSCGVILFVLMAGYLPF 210
           +     D           +DV++ G I + L A   PF
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 133/282 (47%), Gaps = 36/282 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F KV     R+ G  VA+K   + T    + +++ + EI  +   RHP++V L  
Sbjct: 47  IGHGVFGKVYKGVLRD-GAKVALK---RRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA------HCHSKGV 130
               R ++ +I +++  G L   +   G  L      + Q+L   +       + H++ +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-----GTPNYVAPEVLSNRG 185
            HRD+K  N+LLD     K++DFG+S   ++G EL  T       GT  Y+ PE    +G
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGIS---KKGTELGQTHLXXVVKGTLGYIDPEYFI-KG 216
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
                +DV+S GV+LF ++       ++ LP   + +N AE++      +     + +I+
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQS-LPR--EMVNLAEWAV----ESHNNGQLEQIV 269
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKC---SEEEEVNLDDV 284
           DPN   +IR E +RK          VKC   S E+  ++ DV
Sbjct: 270 DPNLADKIRPESLRKF-----GDTAVKCLALSSEDRPSMGDV 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 133/282 (47%), Gaps = 36/282 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F KV     R+ G  VA+K   + T    + +++ + EI  +   RHP++V L  
Sbjct: 47  IGHGVFGKVYKGVLRD-GAKVALK---RRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA------HCHSKGV 130
               R ++ +I +++  G L   +   G  L      + Q+L   +       + H++ +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC-----GTPNYVAPEVLSNRG 185
            HRD+K  N+LLD     K++DFG+S   ++G EL  T       GT  Y+ PE    +G
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGIS---KKGTELDQTHLXXVVKGTLGYIDPEYFI-KG 216
Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL 245
                +DV+S GV+LF ++       ++ LP   + +N AE++      +     + +I+
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQS-LPR--EMVNLAEWAV----ESHNNGQLEQIV 269
Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKC---SEEEEVNLDDV 284
           DPN   +IR E +RK          VKC   S E+  ++ DV
Sbjct: 270 DPNLADKIRPESLRKF-----GDTAVKCLALSSEDRPSMGDV 306

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 10/211 (4%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIV 72
           G  +GEG F  V       T  +VA+K LA    I    +  Q  +EI +M   +H N+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLIDAVAHCHSKG 129
            L    +    + ++  ++  G L D++  +     L    R +  Q   + +   H   
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVLSNRGYD 187
             HRD+K  N+LLD     K+SDFGL+   ++  + +  +   GT  Y+APE L  RG  
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL--RGEI 211
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
              +D++S GV+L  ++ G     E   P L
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     
Sbjct: 168 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAF 226
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 227 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETG 274
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +   
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 335 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     
Sbjct: 168 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAF 226
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 227 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETG 274
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +   
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 335 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     
Sbjct: 251 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAF 309
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 310 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETG 357
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +   
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 418 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 465

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 102/238 (42%), Gaps = 42/238 (17%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           ++ + IG G F +V     +  G+    VA+K L      K R       E SIM    H
Sbjct: 10  KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDH 67
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PN++ L  V+   T V II EF+  G L D  + Q     ND +    QL+  +    + 
Sbjct: 68  PNVIHLEGVVTKSTPVMIITEFMENGSL-DSFLRQ-----NDGQFTVIQLVGMLRGIAAG 121
Query: 129 GVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY------ 175
             Y       HR L   N+L++S    KVSDFGLS         L      P Y      
Sbjct: 122 MKYLADMNYVHRALAARNILVNSNLVCKVSDFGLS-------RFLEDDTSDPTYTSALGG 174
Query: 176 ------VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE 226
                  APE +  R +  SA+DVWS G++++ +M+ G  P+ +    T    INA E
Sbjct: 175 KIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIE 228

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 10/211 (4%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIV 72
           G  +GEG F  V       T  +VA+K LA    I    +  Q  +EI +M   +H N+V
Sbjct: 36  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLIDAVAHCHSKG 129
            L    +    + ++  ++  G L D++  +     L    R +  Q   + +   H   
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYD 187
             HRD+K  N+LLD     K+SDFGL+   ++  +  +     GT  Y+APE L  RG  
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL--RGEI 211
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
              +D++S GV+L  ++ G     E   P L
Sbjct: 212 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 10/211 (4%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIV 72
           G  +GEG F  V       T  +VA+K LA    I    +  Q  +EI +M   +H N+V
Sbjct: 30  GNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLIDAVAHCHSKG 129
            L    +    + ++  ++  G L D++  +     L    R +  Q   + +   H   
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 147
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYD 187
             HRD+K  N+LLD     K+SDFGL+   ++  +  +     GT  Y+APE L  RG  
Sbjct: 148 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL--RGEI 205
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
              +D++S GV+L  ++ G     E   P L
Sbjct: 206 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 236

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 27  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 80
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 198
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 199 VWSFGILLTEIVTHGRIPY 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 29  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 82
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 83  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 200
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 201 VWSFGILLTEIVTHGRIPY 219

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLA-KSTILKHRMVD---QIKREISIMKIVR 67
           E  + IG+G F  V   +  +    VA+K L    +  +  M++   + +RE+ IM  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDAVAHCH 126
           HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   + +  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++   + HRDL+  N+ L S         KV+DFGLS   QQ V  +    G   ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNFQWMAPE 196
Query: 180 VLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
            +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 197 TIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 123/271 (45%), Gaps = 25/271 (9%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           ++ +GR +G+G F  VR AQ ++   S   VA+K+L K+ I+    +++  RE + MK  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 67  RHPNIVRLHEV-LASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            HP++ +L  V L SR K       +IL F+  G+L   ++   R+ EN      Q L+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVR 141
Query: 121 -------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
                   + +  S+   HRDL   N +L     + V+DFGLS     G +     C + 
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG-DYYRQGCASK 200
Query: 174 ---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKK-INAAEFS 228
               ++A E L++  Y    +DVW+ GV ++ +M  G  P+   +   +Y   I      
Sbjct: 201 LPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLK 259
Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIR 259
            P         L+++    +PK R     +R
Sbjct: 260 QPPECMEEVYDLMYQCWSADPKQRPSFTCLR 290

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 22  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 75
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 76  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 193
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 194 VWSFGILLTEIVTHGRIPY 212

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 74
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 192
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 193 VWSFGILLTEIVTHGRIPY 211

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +   +++ K    +M  + H  +V+L
Sbjct: 14  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 68
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 69  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 187
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 188 IWAFGVLMWEIYSLGKMPY 206

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 23  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 76
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 77  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 194
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 195 VWSFGILLTEIVTHGRIPY 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 30  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 83
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 84  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 201
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 202 VWSFGILLTEIVTHGRIPY 220

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 74
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAI-NYGTFTIKSD 192
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 193 VWSFGILLTEIVTHGRIPY 211

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     
Sbjct: 168 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAF 226
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 227 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVGEYMSKGSLLD-------FLKGETG 274
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +   
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 335 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 382

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +V+L
Sbjct: 10  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 64
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 183
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 184 IWAFGVLMWEIYSLGKMPY 202

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +   +++ K    +M  + H  +V+L
Sbjct: 30  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 84
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 203
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 204 IWAFGVLMWEIYSLGKMPY 222

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +V+L
Sbjct: 15  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 69
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 188
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 189 IWAFGVLMWEIYSLGKMPY 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +   +++ K    +M  + H  +V+L
Sbjct: 21  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAK----VMMNLSHEKLVQL 75
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 76  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 135
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSD 194
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 195 IWAFGVLMWEIYSLGKMPY 213

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y++ R +G G +++V  A N    E VA+K+L      K       +    +  +   PN
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKK-----IKREIKILENLRGGPN 93
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           I+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +CHS
Sbjct: 94  IITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYCHS 149
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            G+ HRD+KP N+L+D  +  L++ D+GL+     G E  +    +  +  PE+L +   
Sbjct: 150 MGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDYQM 208
Query: 187 DGSAADVWSCGVILFVLMAGYLPF 210
              + D+WS G +L  ++    PF
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKIRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 21  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 74
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 192
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 193 VWSFGILLTEIVTHGRIPY 211

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 26  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 79
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 80  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 197
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 198 VWSFGILLTEIVTHGRIPY 216

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G+F  V   + +  G+ VA+K+L K            + E+++++  RH NI+ L  
Sbjct: 44  IGSGSFGTV--YKGKWHGD-VAVKIL-KVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFM 98
Query: 77  VLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDL 135
              ++  + I+ ++  G  L+  + V + +          +Q    + + H+K + HRD+
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 136 KPENLLLDSYGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSA--- 190
           K  N+ L     +K+ DFGL+ +  +  G + +    G+  ++APEV+  R  D +    
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI--RMQDNNPFSF 216
Query: 191 -ADVWSCGVILFVLMAGYLPFGETD 214
            +DV+S G++L+ LM G LP+   +
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 35/207 (16%)
Query: 15  RTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
           + +G G F +V  A  N+ T   VA+K +   ++     V+    E ++MK ++H  +V+
Sbjct: 188 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 241
Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--CRRYFQQLID-------AVAH 124
           LH V+ ++  +YII EF+  G L D        L++D   ++   +LID        +A 
Sbjct: 242 LHAVV-TKEPIYIITEFMAKGSLLD-------FLKSDEGSKQPLPKLIDFSAQIAEGMAF 293
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
              +   HRDL+  N+L+ +    K++DFGL+ +   G +          + APE + N 
Sbjct: 294 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV---GAKF------PIKWTAPEAI-NF 343
Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
           G     +DVWS G++L  ++  G +P+
Sbjct: 344 GSFTIKSDVWSFGILLMEIVTYGRIPY 370

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 31  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 84
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 85  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 202
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 203 VWSFGILLTEIVTHGRIPY 221

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 27  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 80
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 198
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 199 VWSFGILLTEIVTHGRIPY 217

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVRHPNIV 72
           + +GEG F+ V   +    G   A+K      IL H   D  + +RE  + ++  HPNI+
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALK-----RILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 73  RLHEVL----ASRTKVYIILEFVTGGELFDKIVH---QGRLL-ENDCRRYFQQLIDAVAH 124
           RL         ++ + +++L F   G L+++I     +G  L E+        +   +  
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFG------------LSALPQQGVELLHTTCGT 172
            H+KG  HRDLKP N+LL   G   + D G              AL  Q  +     C T
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ--DWAAQRC-T 206
Query: 173 PNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPF 210
            +Y APE+ S + +       DVWS G +L+ +M G  P+
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 98/199 (49%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +V+L
Sbjct: 15  KELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 69
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  ++II E++  G L + +   + R          + + +A+ +  SK   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L++  G +KVSDFGLS                P  +  PEVL    +  S +D
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKF-SSKSD 188
Query: 193 VWSCGVILFVLMA-GYLPF 210
           +W+ GV+++ + + G +P+
Sbjct: 189 IWAFGVLMWEIYSLGKMPY 207

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++ + H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+  +  D + 
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AK 236
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            D+WS   ++  ++ G  P+
Sbjct: 237 VDIWSSCCMMLHMLNGCHPW 256

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 85/175 (48%), Gaps = 6/175 (3%)
Query: 40  KVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD- 98
           KV  KS        D    E ++MK ++H  +VRL+ V+ ++  +YII E++  G L D 
Sbjct: 39  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDF 97
Query: 99  -KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA 157
            K     +L  N       Q+ + +A    +   HRDL+  N+L+    + K++DFGL+ 
Sbjct: 98  LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157
Query: 158 LPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           L +            P  + APE + N G     +DVWS G++L  ++  G +P+
Sbjct: 158 LIEDAEXTAREGAKFPIKWTAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVCEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 103/236 (43%), Gaps = 40/236 (16%)
Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREI 60
           K  +    YE+   IG G++  V  A ++   ++VA+K   K   +   ++D  +I REI
Sbjct: 22  KNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIK---KVNRMFEDLIDCKRILREI 78
Query: 61  SIMKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRR 113
           +I+  ++   I+RLH+++         ++YI+LE       +LF   +    L E   + 
Sbjct: 79  TILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEQHVKT 135
Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL-------- 165
               L+      H  G+ HRDLKP N LL+   ++K+ DFGL+       ++        
Sbjct: 136 ILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEE 195
Query: 166 -----------------LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
                            L +   T  Y APE++  +    ++ D+WS G I   L+
Sbjct: 196 KEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI++E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVMEYMSKGCLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 16  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 69
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 70  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 187
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 188 VWSFGILLTEIVTHGRIPY 206

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 133
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++ + H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+  +  D + 
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AK 252
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            D+WS   ++  ++ G  P+
Sbjct: 253 VDIWSSCCMMLHMLNGCHPW 272

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G+F +V   ++++TG   A+K        K R+      E+     +  P IV L+ 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYG 131
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK 136
            +     V I +E + GG L   I   G L E+    Y  Q ++ + + H++ + H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 137 PENLLLDSYGN-LKVSDFGLSALPQQ---GVELLHT--TCGTPNYVAPEVLSNRGYDGSA 190
            +N+LL S G+   + DFG +   Q    G  LL      GT  ++APEV+  +  D + 
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AK 250
Query: 191 ADVWSCGVILFVLMAGYLPF 210
            D+WS   ++  ++ G  P+
Sbjct: 251 VDIWSSCCMMLHMLNGCHPW 270

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +V+L+ 
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 73
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY--- 131
           V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y   
Sbjct: 74  VV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVER 125
Query: 132 ----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G 
Sbjct: 126 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYGR 184
Query: 187 DGSAADVWSCGVILFVLMA-GYLPF 210
               +DVWS G++L  L   G +P+
Sbjct: 185 FTIKSDVWSFGILLTELTTKGRVPY 209

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  ++  PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLMGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 31/208 (14%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F +V  A++R  G++  +K +  +        ++ +RE+  +  + H NIV  + 
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNG 71
Query: 77  VL-------------ASRTK---VYIILEFVTGGELFDKIVHQGRLLEND---CRRYFQQ 117
                          +SR+K   ++I +EF   G L ++ + + R  + D       F+Q
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL-EQWIEKRRGEKLDKVLALELFEQ 130
Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYV 176
           +   V + HSK + +RDLKP N+ L     +K+ DFGL ++L   G      + GT  Y+
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX--RSKGTLRYM 188
Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLM 204
           +PE +S++ Y G   D+++ G+IL  L+
Sbjct: 189 SPEQISSQDY-GKEVDLYALGLILAELL 215

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 58
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E++  G L D        L+ +  +Y
Sbjct: 59  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLD-------FLKGETGKY 107
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 108 LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWT 167
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                  P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 168 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +V+L+ 
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 71
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY--- 131
           V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y   
Sbjct: 72  VV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVER 123
Query: 132 ----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G 
Sbjct: 124 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYGR 182
Query: 187 DGSAADVWSCGVILFVLMA-GYLPF 210
               +DVWS G++L  L   G +P+
Sbjct: 183 FTIKSDVWSFGILLTELTTKGRVPY 207

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +V+L+ 
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 69
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY--- 131
           V+ S   +YI+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y   
Sbjct: 70  VV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVER 121
Query: 132 ----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G 
Sbjct: 122 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA-ALYGR 180
Query: 187 DGSAADVWSCGVILFVLMA-GYLPF 210
               +DVWS G++L  L   G +P+
Sbjct: 181 FTIKSDVWSFGILLTELTTKGRVPY 205

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 20/215 (9%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLA-KSTILKHRMVD---QIKREISIMKIVR 67
           E  + IG+G F  V   +  +    VA+K L    +  +  M++   + +RE+ IM  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDAVAHCH 126
           HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   + +  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++   + HRDL+  N+ L S         KV+DFG S   QQ V  +    G   ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS---QQSVHSVSGLLGNFQWMAPE 196
Query: 180 VLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
            +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 197 TIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 105/227 (46%), Gaps = 34/227 (14%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 58
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E++  G L D        L+ +  +Y
Sbjct: 59  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLD-------FLKGETGKY 107
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 108 LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 167
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                  P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 168 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 213

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 88
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 89  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 144
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 203
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 204 YDYS-LDMWSLGCMFAGMIFRKEPF 227

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 87
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL   N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 34/229 (14%)
Query: 2   KKQTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM 52
           K QT+ +AK  +E+ R        +G+G F +V       T   VA+K L    +     
Sbjct: 169 KPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGNMSPEAF 227
Query: 53  VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
           +    +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  
Sbjct: 228 L----QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGEMG 275
Query: 113 RYFQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
           +Y +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL  L +   
Sbjct: 276 KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNE 335
Query: 164 ELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
                    P  + APE  +  G     +DVWS G++L  L   G +P+
Sbjct: 336 YTARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPY 383

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 34  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 88
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 89  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 144
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 145 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 203
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 204 YDYS-LDMWSLGCMFAGMIFRKEPF 227

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 35  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 89
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 90  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 145
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 146 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 204
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 205 YDYS-LDMWSLGCMFAGMIFRKEPF 228

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 33  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 87
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 88  IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 143
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 144 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 202
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 203 YDYS-LDMWSLGCMFAGMIFRKEPF 226

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 107/215 (49%), Gaps = 20/215 (9%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMK-VLAKSTILKHRMVD---QIKREISIMKIVR 67
           E  + IG+G F  V   +  +    VA+K ++   +  +  M++   + +RE+ IM  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR-RYFQQLIDAVAHCH 126
           HPNIV+L+ ++ +  +  +++EFV  G+L+ +++ +   ++   + R    +   + +  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 127 SKG--VYHRDLKPENLLLDSYGN-----LKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++   + HRDL+  N+ L S         KV+DF LS   QQ V  +    G   ++APE
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS---QQSVHSVSGLLGNFQWMAPE 196
Query: 180 VLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
            +      Y    AD +S  +IL+ ++ G  PF E
Sbjct: 197 TIGAEEESYT-EKADTYSFAMILYTILTGEGPFDE 230

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 118/287 (41%), Gaps = 58/287 (20%)
Query: 9   AKYEVGRTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           A+YE+  T+GEG F KV     ++  G  VA+K++        R  +  + EI +++ + 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 68  --HPN----IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRYFQQLI 119
              PN     V++ E       + I+ E + G   +D I   G L    +  R+   Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 120 DAVAHCHSKGVYHRDLKPENLLL------DSYG-------------NLKVSDFGLSALPQ 160
            +V   HS  + H DLKPEN+L       ++Y              ++KV DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK 220
              E   T   T +Y APEV+   G+     DVWS G IL     G+  F   D      
Sbjct: 189 ---EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHD------ 238
Query: 221 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                        S    +++ +IL P PK    I+  RK  +F  +
Sbjct: 239 -------------SKEHLAMMERILGPLPKH--MIQKTRKRKYFHHD 270

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 87
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV R +G G +++V    N    E   +K+L      K       +    +  +   PN
Sbjct: 54  YEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKK-----IKREIKILQNLXGGPN 108
Query: 71  IVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           IV+L +++    S+T   +I E+V   +   K+++   L + D R Y  +L+ A+ +CHS
Sbjct: 109 IVKLLDIVRDQHSKTPS-LIFEYVNNTDF--KVLYPT-LTDYDIRYYIYELLKALDYCHS 164
Query: 128 KGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-RG 185
           +G+ HRD+KP N+++D     L++ D+GL+     G E  +    +  +  PE+L + + 
Sbjct: 165 QGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD 223
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
           YD S  D+WS G +   ++    PF
Sbjct: 224 YDYS-LDMWSLGCMFAGMIFRKEPF 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 80
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 81  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 141 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 200
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 256

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 76
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 77  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 137 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 196
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 252

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 4   QTRRVAK--YEVGR-------TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD 54
           QT+ +AK  +E+ R        +G+G F +V       T   VA+K L   T+     + 
Sbjct: 4   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL- 61
Query: 55  QIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
              +E  +MK +RH  +V+L+ V+ S   +YI+ E+++ G L D        L+ +  +Y
Sbjct: 62  ---QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGCLLD-------FLKGEMGKY 110
Query: 115 FQ--QLIDAVAHCHSKGVY-------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
            +  QL+D  A   S   Y       HRDL+  N+L+      KV+DFGL+ L +     
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 170
Query: 166 LHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKI 222
                  P  + APE  +  G     +DVWS G++L  L   G +P+ G  +   L +  
Sbjct: 171 ARQGAKFPIKWTAPEA-ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIE 256
                 CP         L+ +    +P+ R   E
Sbjct: 230 RGYRMPCPPECPESLHDLMCQCWRKDPEERPTFE 263

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 42/231 (18%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVR 67
           +YE+   IG G++  V  A ++     VA+K + +   +   ++D  +I REI+I+  + 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLN 110
Query: 68  HPNIVRLHEVLASRT-----KVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 120
           H ++V++ +++  +      ++Y++LE       +LF   V+   L E   +     L+ 
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVY---LTELHIKTLLYNLLV 167
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQG--------------- 162
            V + HS G+ HRDLKP N L++   ++KV DFGL+     P+ G               
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 163 VELLHTT---------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
           V   HT            T  Y APE++  +     A DVWS G I   L+
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 87
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 72
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 79
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 80  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 140 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 199
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 255

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 87
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 207
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 108/238 (45%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            +TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KNTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXX 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 97/199 (48%), Gaps = 13/199 (6%)
Query: 17  IGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           +G G F +V     N  T   VA+K L + ++      D    E ++MK ++H  +VRL+
Sbjct: 17  LGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLY 70
Query: 76  EVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            V+ ++  +YII E++  G L D  K     +L  N       Q+ + +A    +   HR
Sbjct: 71  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           +L+  N+L+    + K++DFGL+ L +            P  + APE + N G     +D
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGTFTIKSD 188
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS G++L  ++  G +P+
Sbjct: 189 VWSFGILLTEIVTHGRIPY 207

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 34/237 (14%)
Query: 13  VGRTIGEGTFAKVRFAQ---------NRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           +G+ +GEG F +V  A+         NR T   VA+K+L KS   +  + D I  E+ +M
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVT--KVAVKML-KSDATEKDLSDLIS-EMEMM 128
Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVH----------------QGRL 106
           K++ +H NI+ L         +Y+I+E+ + G L + +                  + +L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
              D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+          
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 167 HTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
            TT G     ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + + ++ +    D    E  +M  + HP +V+L
Sbjct: 33  QEIGSGQFGLVHLGYWLNK-DKVAIKTIKEGSMSE----DDFIEEAEVMMKLSHPKLVQL 87
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 147
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 206
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 207 VWSFGVLMWEVFSEGKIPY 225

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 28  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 85
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 86  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 205
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 206 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 262

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 25  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 82
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 83  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 202
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 203 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 259

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 91  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 146
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 205
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 23  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 80
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 81  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYY 200
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 201 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 90  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 145
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 204
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 91  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 146
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 205
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 82  KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 139
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 10/211 (4%)
Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-ILKHRMVDQIKREISIMKIVRHPNIV 72
           G   GEG F  V       T  +VA+K LA    I    +  Q  +EI +    +H N+V
Sbjct: 27  GNKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLV 84
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI--VHQGRLLENDCR-RYFQQLIDAVAHCHSKG 129
            L    +    + ++  +   G L D++  +     L    R +  Q   + +   H   
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENH 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVLSNRGYD 187
             HRD+K  N+LLD     K+SDFGL+   ++  + +  +   GT  Y APE L  RG  
Sbjct: 145 HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL--RGEI 202
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
              +D++S GV+L  ++ G     E   P L
Sbjct: 203 TPKSDIYSFGVVLLEIITGLPAVDEHREPQL 233

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +V+L+ 
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKLVQLYA 70
Query: 77  VLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ--QLIDAVAHCHSKGVY--- 131
           V+ S   + I+ E+++ G L D        L+ +  +Y +  QL+D  A   S   Y   
Sbjct: 71  VV-SEEPIXIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVER 122
Query: 132 ----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+ L +            P  + APE  +  G 
Sbjct: 123 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEA-ALYGR 181
Query: 187 DGSAADVWSCGVILFVLMA-GYLPF 210
               +DVWS G++L  L   G +P+
Sbjct: 182 FTIKSDVWSFGILLTELTTKGRVPY 206

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 109/238 (45%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L K    +  + D +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSDLVS-EMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 13  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 67
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 186
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 187 VWSFGVLMWEVFSEGKIPY 205

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 97  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLYQT-LTDYDIRFYMYEILKALDYC 152
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 211
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 212 QMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 12/222 (5%)
Query: 17  IGEGTFAKVR--FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR    + R+    VA+KVL + T  +    +++ RE  IM  + +P IVRL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHR 133
             V  +   + +++E   GG L   +V +   +  ++      Q+   + +   K   HR
Sbjct: 76  IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP--NYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS AL          + G     + APE ++ R +  S 
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 193
Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 230
           +DVWS GV ++  L  G  P+ +   P +   I   +   CP
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 235

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 58  REISIMKIVRHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQG--------RLL 107
           REI++++ ++HPN++ L +V  S    KV+++ ++           H+         +L 
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 108 ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSAL---PQ 160
               +    Q++D + + H+  V HRDLKP N+L+       G +K++D G + L   P 
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 186
Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
           + +  L     T  Y APE+L    +   A D+W+ G I   L+  
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 109/259 (42%), Gaps = 14/259 (5%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G +  V   ++  +G+  A+K +  +   + +       +IS  + V  P  V  + 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDIS-XRTVDCPFTVTFYG 100
Query: 77  VLASRTKVYIILEF--VTGGELFDKIVHQGRLLENDC-RRYFQQLIDAVAHCHSK-GVYH 132
            L     V+I  E    +  + + +++ +G+ +  D   +    ++ A+ H HSK  V H
Sbjct: 101 ALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH 160
Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE----VLSNRGYDG 188
           RD+KP N+L+++ G +K  DFG+S      V       G   Y APE     L+ +GY  
Sbjct: 161 RDVKPSNVLINALGQVKXCDFGISGYLVDDVA-KDIDAGCKPYXAPERINPELNQKGY-S 218
Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF---WFSTGATSLIHKIL 245
             +D+WS G+    L     P+     P    K    E S       FS        + L
Sbjct: 219 VKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCL 278
Query: 246 DPNPKTRIRIEGIRKHPWF 264
             N K R     + +HP+F
Sbjct: 279 KKNSKERPTYPELXQHPFF 297

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 11  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 65
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSD 184
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 185 VWSFGVLMWEVFSEGKIPY 203

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+E+ + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     ++++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 16  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 70
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 189
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 190 VWSFGVLMWEVFSEGKIPY 208

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 13  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 67
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 127
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 186
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 187 VWSFGVLMWEVFSEGKIPY 205

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 77/146 (52%), Gaps = 9/146 (6%)
Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   ++ E V   +   K + Q  L + D R Y  +++ A+ +C
Sbjct: 92  PNIITLADIVKDPVSRTPA-LVFEHVNNTDF--KQLRQT-LTDYDIRFYMYEILKALDYC 147
Query: 126 HSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E  +    +  +  PE+L + 
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLVDY 206
Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF 210
                + D+WS G +L  ++    PF
Sbjct: 207 QMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 11  YEVGRTIGEGTFAKVRFAQNR-ETG--ESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +++   IGEGTF+ V  A  + + G  E +A+K L  ++   H +  +I  E+  + +  
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPI--RIAAELQCLTVAG 77
Query: 68  -HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
              N++ +         V I + ++      D +     L   + R Y   L  A+   H
Sbjct: 78  GQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIH 134
Query: 127 SKGVYHRDLKPENLLLDS-YGNLKVSDFGLS-ALPQQGVELLH----------------T 168
             G+ HRD+KP N L +       + DFGL+       +ELL                 +
Sbjct: 135 QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCS 194
Query: 169 TC-----------GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
            C           GTP + APEVL+      +A D+WS GVI   L++G  PF
Sbjct: 195 ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 104/221 (47%), Gaps = 44/221 (19%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           IG G F +V  A++R  G++  ++ +  +        ++ +RE+  +  + H NIV  + 
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN-------EKAEREVKALAKLDHVNIVHYNG 72
Query: 77  VL--------------------------ASRTK---VYIILEFVTGGELFDKIVHQGRLL 107
                                       +SR+K   ++I +EF   G L ++ + + R  
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL-EQWIEKRRGE 131
Query: 108 END---CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGV 163
           + D       F+Q+   V + HSK + HRDLKP N+ L     +K+ DFGL ++L   G 
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
                + GT  Y++PE +S++ Y G   D+++ G+IL  L+
Sbjct: 192 RT--RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELL 229

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 13  VGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + R +GEG F +V    +  ++    +VA+K   K   L ++  ++   E  IMK + HP
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 69
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------YFQQLIDA 121
           +IV+L  ++      +II+E    GEL       G  LE +           Y  Q+  A
Sbjct: 70  HIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYSLQICKA 121
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 180
           +A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P  +++PE 
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 181
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 182 INFRRF-TTASDVWMFAVCMWEILSFGKQPF 211

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 117/287 (40%), Gaps = 58/287 (20%)
Query: 9   AKYEVGRTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           A+YE+  T+GEG F KV     ++  G  VA+K++        R  +  + EI +++ + 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 68  --HPN----IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL--LENDCRRYFQQLI 119
              PN     V++ E       + I+ E + G   +D I   G L    +  R+   Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 120 DAVAHCHSKGVYHRDLKPENLLL------DSYG-------------NLKVSDFGLSALPQ 160
            +V   HS  + H DLKPEN+L       ++Y              ++KV DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK 220
           +      T     +Y APEV+   G+     DVWS G IL     G+  F   D      
Sbjct: 189 EHHS---TLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHD------ 238
Query: 221 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                        S    +++ +IL P PK    I+  RK  +F  +
Sbjct: 239 -------------SKEHLAMMERILGPLPKH--MIQKTRKRKYFHHD 270

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 13  VGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + R +GEG F +V    +  ++    +VA+K   K   L ++  ++   E  IMK + HP
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 73
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------YFQQLIDA 121
           +IV+L  ++      +II+E    GEL       G  LE +           Y  Q+  A
Sbjct: 74  HIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 180
           +A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P  +++PE 
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 185
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 186 INFRRF-TTASDVWMFAVCMWEILSFGKQPF 215

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 24/211 (11%)
Query: 13  VGRTIGEGTFAKVR---FAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + R +GEG F +V    +  ++    +VA+K   K   L ++  ++   E  IMK + HP
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 85
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR--------YFQQLIDA 121
           +IV+L  ++      +II+E    GEL       G  LE +           Y  Q+  A
Sbjct: 86  HIVKLIGIIEEEP-TWIIMELYPYGEL-------GHYLERNKNSLKVLTLVLYSLQICKA 137
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEV 180
           +A+  S    HRD+   N+L+ S   +K+ DFGLS   +       +    P  +++PE 
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPES 197
Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 198 INFRRF-TTASDVWMFAVCMWEILSFGKQPF 227

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 9/199 (4%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + IG G F  V         + VA+K + +  + +   ++    E  +M  + HP +V+L
Sbjct: 14  QEIGSGQFGLVHLGYWLNK-DKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQL 68
Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           + V   +  + ++ EF+  G L D +   +G             + + +A+     V HR
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGSAAD 192
           DL   N L+     +KVSDFG++           T    P  + +PEV S   Y  S +D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSD 187
Query: 193 VWSCGVILF-VLMAGYLPF 210
           VWS GV+++ V   G +P+
Sbjct: 188 VWSFGVLMWEVFSEGKIPY 206

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           +K   + + +YE+   IG+G+F +V  A +R   E VA+K++      K   ++Q + E+
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEV 101
Query: 61  SIMKIVRHPN------IVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCR 112
            +++++   +      IV L      R  + ++ E ++    +L      +G  L N  R
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSL-NLTR 160
Query: 113 RYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHT 168
           ++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  + ++ 
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQ 217
Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
              +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 218 XIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 254

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           +K   + + +YE+   IG+G+F +V  A +R   E VA+K++      K   ++Q + E+
Sbjct: 27  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEV 82
Query: 61  SIMKIVRHPN------IVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCR 112
            +++++   +      IV L      R  + ++ E ++    +L      +G  L N  R
Sbjct: 83  RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSL-NLTR 141
Query: 113 RYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHT 168
           ++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  + ++ 
Sbjct: 142 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLGQRIYQ 198
Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
              +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 199 XIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 235

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 106/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+ + + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           +K   + + +YE+   IG+G+F +V  A +R   E VA+K++      K   ++Q + E+
Sbjct: 46  VKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEV 101
Query: 61  SIMKIVRHPN------IVRLHEVLASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCR 112
            +++++   +      IV L      R  + ++ E ++    +L      +G  L N  R
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSL-NLTR 160
Query: 113 RYFQQLIDAVAHCHSK--GVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGVELLHT 168
           ++ QQ+  A+    +    + H DLKPEN+LL       +K+ DFG S    Q  + ++ 
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSC---QLGQRIYQ 217
Query: 169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
              +  Y +PEVL    YD  A D+WS G IL  +  G
Sbjct: 218 XIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTG 254

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 24/227 (10%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G G F +V +         VA+K L   T+     ++    E  IMK ++H  +V+L
Sbjct: 15  KRLGNGQFGEV-WMGTWNGNTKVAIKTLKPGTMSPESFLE----EAQIMKKLKHDKLVQL 69
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVY-- 131
           + V+ S   +YI+ E++  G L D +   +GR L+         L+D  A   +   Y  
Sbjct: 70  YAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALK------LPNLVDMAAQVAAGMAYIE 122
Query: 132 -----HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRG 185
                HRDL+  N+L+ +    K++DFGL+ L +            P  + APE  +  G
Sbjct: 123 RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEA-ALYG 181
Query: 186 YDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 230
                +DVWS G++L  L+  G +P+ G  +   L +        CP
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP 228

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 106/238 (44%), Gaps = 30/238 (12%)
Query: 10  KYEVGRTIGEGTFAKVRFAQ-------NRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           K  +G+ +GEG F +V  A+         +   +VA+K+L      K   +  +  E+ +
Sbjct: 36  KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD--LSDLVSEMEM 93
Query: 63  MKIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI----------------VHQGR 105
           MK++ +H NI+ L         +Y+I+ + + G L + +                V + +
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           +   D      QL   + +  S+   HRDL   N+L+     +K++DFGL+         
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 166 LHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYK 220
             TT G     ++APE L +R Y    +DVWS GV+++ +   G  P+    +  L+K
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD--QIKREISIMKIVRH 68
           Y +   IG G++  V  A ++ T ++VA+K   K   +   ++D  +I REI+I+  ++ 
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRLKS 84
Query: 69  PNIVRLHEV-----LASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLIDA 121
             I+RL+++     L    ++YI+LE       +LF   +    L E   +     L+  
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIF---LTEEHIKTILYNLLLG 141
Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL---------------- 165
               H  G+ HRDLKP N LL+   ++KV DFGL+       +                 
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 166 ------LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLM 204
                 L +   T  Y APE++  +     + D+WS G I   L+
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 119
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 165
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 166 ---LHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCG-VILFVLMAGYLPFGET---DLP 216
              L+   GT  + APE+L  S +     + D++S G V  ++L  G  PFG+    +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 217 TLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 119
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 165
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 166 ---LHTTCGTPNYVAPEVL--SNRGYDGSAADVWSCG-VILFVLMAGYLPFGET---DLP 216
              L+   GT  + APE+L  S +     + D++S G V  ++L  G  PFG+    +  
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 217 TLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 104/222 (46%), Gaps = 12/222 (5%)
Query: 17  IGEGTFAKVRFA--QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR    + R+    VA+KVL + T  +    +++ RE  IM  + +P IVRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE-NDCRRYFQQLIDAVAHCHSKGVYHR 133
             V  +   + +++E   GG L   +V +   +  ++      Q+   + +   K   HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSA 190
           +L   N+LL +    K+SDFGLS AL          + G  P  + APE ++ R +  S 
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 519
Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINAAE-FSCP 230
           +DVWS GV ++  L  G  P+ +   P +   I   +   CP
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 561

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 39/237 (16%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--- 57
            K +  + A+Y + R +G G F+ V  A++      VAMK++    +      D+IK   
Sbjct: 11  FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 58  --------REIS-----IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGE----LFDKI 100
                   +E S     I+K++ H N    H+       V++++ F   GE    L  K 
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFN----HK---GPNGVHVVMVFEVLGENLLALIKKY 123
Query: 101 VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLL---DSYGNL---KVSDF 153
            H+G  L    ++  +QL+  + + H + G+ H D+KPEN+L+   DS  NL   K++D 
Sbjct: 124 EHRGIPLIY-VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           G +       E    +  T  Y +PEVL    + G  AD+WS   ++F L+ G   F
Sbjct: 183 GNACWYD---EHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLF 235

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--------------CRR 113
           H NIV L         V +I E+   G+L + +  + R+LE D                 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT 172
           +  Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 173 P-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           P  ++APE + +  Y    +DVWS G++L+ +   G  P+
Sbjct: 229 PVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 267

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 139/310 (44%), Gaps = 49/310 (15%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL------SALPQQGVELLHTTCGTP 173
           D +A+ ++K   HRDL   N ++     +K+ DFG+      +A  ++G + L       
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV---- 196
Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCPF 231
            ++APE L + G   +++D+WS GV+L+ + +    P+ G ++   L   ++      P 
Sbjct: 197 RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD 255
Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDI 291
                 T L+      NPK R         P F +  N +K         DD+H  F ++
Sbjct: 256 NCPERVTDLMRMCWQFNPKMR---------PTFLEIVNLLK---------DDLHPSFPEV 297
Query: 292 EYVAEQSENK 301
            +   + ENK
Sbjct: 298 SFFHSE-ENK 306

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 22/220 (10%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND--------------CRR 113
           H NIV L         V +I E+   G+L + +  + R+LE D                 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLH 168
Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT 172
           +  Q+   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 173 P-NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           P  ++APE + +  Y    +DVWS G++L+ +   G  P+
Sbjct: 229 PVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 267

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 39/237 (16%)
Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--- 57
            K +  + A+Y + R +G G F+ V  A++      VAMK++    +      D+IK   
Sbjct: 11  FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 58  --------REIS-----IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGE----LFDKI 100
                   +E S     I+K++ H N    H+       V++++ F   GE    L  K 
Sbjct: 71  RVNDADNTKEDSMGANHILKLLDHFN----HK---GPNGVHVVMVFEVLGENLLALIKKY 123
Query: 101 VHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLL---DSYGNL---KVSDF 153
            H+G  L    ++  +QL+  + + H + G+ H D+KPEN+L+   DS  NL   K++D 
Sbjct: 124 EHRGIPLIY-VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
Query: 154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           G +       E    +  T  Y +PEVL    + G  AD+WS   ++F L+ G   F
Sbjct: 183 GNACWYD---EHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLF 235

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 51/311 (16%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 77
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 138 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 193
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 230
             ++APE L + G   +++D+WS GV+L+ + +    P+ G ++   L   ++      P
Sbjct: 194 -RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 251
Query: 231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDD 290
                  T L+      NPK R         P F +  N +K         DD+H  F +
Sbjct: 252 DNCPERVTDLMRMCWQFNPKMR---------PTFLEIVNLLK---------DDLHPSFPE 293
Query: 291 IEYVAEQSENK 301
           + +   + ENK
Sbjct: 294 VSFFHSE-ENK 303

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE+V    A+KVL ++T  K     +I  E  +M  V  P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPY 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V ++ + +  G L D +  ++GRL   D   +  Q+   +++     
Sbjct: 81  VSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ S  ++K++DFGL+ L        H   G  P  ++A E +  R + 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 188 GSAADVWSCGVILFVLMA-GYLPFG---ETDLPTLYKK 221
              +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 200 -HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 236

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 69/157 (43%), Gaps = 20/157 (12%)
Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTT 169
           C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL +A+ Q   E    T
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 170 -----------CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
                       GT  Y++PE +    Y     D++S G+ILF L+  +     T +  +
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSF----STQMERV 280
Query: 219 YKKINAAEFSCPFWFSTGATS---LIHKILDPNPKTR 252
               +      P  F+        ++  +L P+P  R
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER 317

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 51/311 (16%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 196
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 230
             ++APE L + G   +++D+WS GV+L+ + +    P+ G ++   L   ++      P
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDD 290
                  T L+      NPK R         P F +  N +K         DD+H  F +
Sbjct: 255 DNCPERVTDLMRMCWQFNPKMR---------PTFLEIVNLLK---------DDLHPSFPE 296
Query: 291 IEYVAEQSENK 301
           + +   + ENK
Sbjct: 297 VSFFHSE-ENK 306

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 17  IGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIV 72
           IGEG F +V  A+ ++ G   ++   ++   ++   HR       E+ ++ K+  HPNI+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 89
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRRYFQQLIDAV 122
            L      R  +Y+ +E+   G L D  + + R+LE D               QQL+   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 123 A-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 174
           A       +   K   HRDL   N+L+      K++DFGLS    Q V +  T    P  
Sbjct: 149 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 206
Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
           ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 207 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 11  YEVGRTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G      V  A+ + TGE V ++ +       + MV  ++ E+ + K+  H
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 85
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH 126
           PNIV       +  +++++  F+  G   D I       + E       Q ++ A+ + H
Sbjct: 86  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 127 SKGVYHRDLKPENLLLDSYG---------NLKVSDFG-----LSALPQQGVELLHTTCGT 172
             G  HR +K  ++L+   G         NL +   G     +   P+  V++L      
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL------ 199
Query: 173 PNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAA 225
             +++PEVL    +GYD + +D++S G+    L  G++PF   D+P    L +K+N  
Sbjct: 200 -PWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPATQMLLEKLNGT 253

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 11  YEVGRTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG+G      V  A+ + TGE V ++ +       + MV  ++ E+ + K+  H
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNH 69
Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH 126
           PNIV       +  +++++  F+  G   D I       + E       Q ++ A+ + H
Sbjct: 70  PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 129
Query: 127 SKGVYHRDLKPENLLLDSYG---------NLKVSDFG-----LSALPQQGVELLHTTCGT 172
             G  HR +K  ++L+   G         NL +   G     +   P+  V++L      
Sbjct: 130 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL------ 183
Query: 173 PNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAA 225
             +++PEVL    +GYD + +D++S G+    L  G++PF   D+P    L +K+N  
Sbjct: 184 -PWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPF--KDMPATQMLLEKLNGT 237

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 77/312 (24%), Positives = 137/312 (43%), Gaps = 51/312 (16%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 79
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 195
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 230
             ++APE L + G   +++D+WS GV+L+ + +    P+ G ++   L   ++      P
Sbjct: 196 -RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 253
Query: 231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDD 290
                  T L+      NPK R         P F +  N +K         DD+H  F +
Sbjct: 254 DNCPERVTDLMRMCWQFNPKMR---------PTFLEIVNLLK---------DDLHPSFPE 295
Query: 291 IEYVAEQSENKV 302
           + +   + ENK 
Sbjct: 296 VSFFHSE-ENKA 306

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 17  IGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIV 72
           IGEG F +V  A+ ++ G   ++   ++   ++   HR       E+ ++ K+  HPNI+
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 79
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRRYFQQLIDAV 122
            L      R  +Y+ +E+   G L D  + + R+LE D               QQL+   
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 123 A-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 174
           A       +   K   HRDL   N+L+      K++DFGLS    Q V +  T    P  
Sbjct: 139 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 196
Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
           ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 197 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 244

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 86/335 (25%), Positives = 133/335 (39%), Gaps = 83/335 (24%)
Query: 10  KYEVGRTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+  T+GEGTF +V +   +R  G  VA+K++      K    +  + EI++++ +  
Sbjct: 34  RYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYK----EAARLEINVLEKINE 89
Query: 69  PN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE--NDCRRYFQQLID 120
            +       V++ +       + I  E + G   FD +     L    +  R    QL  
Sbjct: 90  KDPDNKNLCVQMFDWFDYHGHMCISFELL-GLSTFDFLKDNNYLPYPIHQVRHMAFQLCQ 148
Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYG-----NL--------------KVSDFGLSALPQQ 161
           AV   H   + H DLKPEN+L  +       NL              +V DFG +     
Sbjct: 149 AVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDH- 207
Query: 162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK 221
             E   T   T +Y APEV+   G+     DVWS G I+F    G+         TL++ 
Sbjct: 208 --EHHSTIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGF---------TLFQT 255
Query: 222 INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWF----------------- 264
            +  E            +++ +IL P P   IR    RK  +F                 
Sbjct: 256 HDNRE----------HLAMMERILGPIPSRMIR--KTRKQKYFYRGRLDWDENTSAGRYV 303
Query: 265 RKNYNPVK---CSEEEEVNLDDVHAVFDDIEYVAE 296
           R+N  P++    SE EE      H +FD IE + E
Sbjct: 304 RENCKPLRRYLTSEAEE-----HHQLFDLIESMLE 333

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 70  NIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           NI++L + +    S+T   ++ E++   +   K ++Q  L + D R Y  +L+ A+ +CH
Sbjct: 94  NIIKLIDTVKDPVSKTPA-LVFEYINNTDF--KQLYQ-ILTDFDIRFYMYELLKALDYCH 149
Query: 127 SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           SKG+ HRD+KP N+++D     L++ D+GL+       E  +    +  +  PE+L +  
Sbjct: 150 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE-YNVRVASRYFKGPELLVDYQ 208
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
               + D+WS G +L  ++    PF
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 137/311 (44%), Gaps = 51/311 (16%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 196
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF-GETDLPTLYKKINAAEFSCP 230
             ++APE L + G   +++D+WS GV+L+ + +    P+ G ++   L   ++      P
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 254
Query: 231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDD 290
                  T L+      NPK R         P F +  N +K         DD+H  F +
Sbjct: 255 DNCPERVTDLMRMCWQFNPKMR---------PTFLEIVNLLK---------DDLHPSFPE 296
Query: 291 IEYVAEQSENK 301
           + +   + ENK
Sbjct: 297 VSFFHSE-ENK 306

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 70  NIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           NI++L + +    S+T   ++ E++   +   K ++Q  L + D R Y  +L+ A+ +CH
Sbjct: 99  NIIKLIDTVKDPVSKTPA-LVFEYINNTDF--KQLYQ-ILTDFDIRFYMYELLKALDYCH 154
Query: 127 SKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           SKG+ HRD+KP N+++D     L++ D+GL+       E  +    +  +  PE+L +  
Sbjct: 155 SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE-YNVRVASRYFKGPELLVDYQ 213
Query: 186 YDGSAADVWSCGVILFVLMAGYLPF 210
               + D+WS G +L  ++    PF
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 11/216 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIVRHPNIV 72
           + +G G F  V        GES+ + V  K    K   +    +   +  +  + H +IV
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           RL   L   + + ++ +++  G L D +  H+G L       +  Q+   + +    G+ 
Sbjct: 97  RLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 155
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
           HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E +    Y   
Sbjct: 156 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-H 214
Query: 190 AADVWSCGVILFVLMA-GYLPFGE---TDLPTLYKK 221
            +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 215 QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 250

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 27/252 (10%)
Query: 9   AKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
            +YEV   I  G    +  A +R   G  V +K L  S   + + +   +R+   +  V 
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF--LAEVV 137
Query: 68  HPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           HP+IV++   +    +      YI++E+V GG+   +   Q +L   +   Y  +++ A+
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRSKGQ-KLPVAEAIAYLLEILPAL 195
Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           ++ HS G+ + DLKPEN++L +   LK+ D G  +     +       GTP + APE++ 
Sbjct: 196 SYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSR----INSFGYLYGTPGFQAPEIV- 249
Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK-INAAEFSCPFWFSTGATS-L 240
            R     A D+++ G  L  L          DLPT   + ++      P   +  +   L
Sbjct: 250 -RTGPTVATDIYTVGRTLAALT--------LDLPTRNGRYVDGLPEDDPVLKTYDSYGRL 300
Query: 241 IHKILDPNPKTR 252
           + + +DP+P+ R
Sbjct: 301 LRRAIDPDPRQR 312

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 101/216 (46%), Gaps = 11/216 (5%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIVRHPNIV 72
           + +G G F  V        GES+ + V  K    K   +    +   +  +  + H +IV
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           RL   L   + + ++ +++  G L D +  H+G L       +  Q+   + +    G+ 
Sbjct: 79  RLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 132 HRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
           HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E +    Y   
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-H 196
Query: 190 AADVWSCGVILFVLMA-GYLPFGE---TDLPTLYKK 221
            +DVWS GV ++ LM  G  P+      ++P L +K
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 18/216 (8%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF---------DKIVHQGRLLE-NDCRRYFQQ 117
           H NIV L         V +I E+   G+L          D     GR LE  D   +  Q
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NY 175
           +   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      P  +
Sbjct: 169 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPF 210
           +APE + +  Y    +DVWS G++L+ + + G  P+
Sbjct: 229 MAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 263

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV----R 67
           + G+T+G G F KV  A     G+  A+  +A   +      D+ +  +S +KI+    +
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 100
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF---------DKIVHQGRLLE-NDCRRYFQQ 117
           H NIV L         V +I E+   G+L          D     GR LE  D   +  Q
Sbjct: 101 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NY 175
           +   +A   SK   HRD+   N+LL +    K+ DFGL+  +      ++      P  +
Sbjct: 161 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           +APE + +  Y    +DVWS G++L+ +   G  P+
Sbjct: 221 MAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY 255

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLHTTCGT 172
           D +A+ ++K   HRDL   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPV---- 196
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 2   KKQTRRVAKYEVGRT--IGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQ 55
           + Q R + + E+ R   +G G F  V        GE+V    A+K+L ++T  K  +  +
Sbjct: 6   QAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--E 63
Query: 56  IKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLEN 109
              E  IM  + HP++VRL  V  S T + ++ + +  G L +  VH+       +LL N
Sbjct: 64  FMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLE-YVHEHKDNIGSQLLLN 121
Query: 110 DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
            C     Q+   + +   + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +  
Sbjct: 122 WC----VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNA 176
Query: 170 CGTP---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA 205
            G      ++A E +  R +    +DVWS GV ++ LM 
Sbjct: 177 DGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMT 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 17  IGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIV 72
           IGEG F +V  A+ ++ G   ++   ++   ++   HR       E+ ++ K+  HPNI+
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 86
Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND----------CRRYFQQLIDAV 122
            L      R  +Y+ +E+   G L D  + + R+LE D               QQL+   
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLD-FLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 123 A-------HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-N 174
           A       +   K   HR+L   N+L+      K++DFGLS    Q V +  T    P  
Sbjct: 146 ADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVR 203
Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI 222
           ++A E L+   Y  + +DVWS GV+L+ +++ G  P+       LY+K+
Sbjct: 204 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 251

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 39/234 (16%)
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 119
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVELL 166
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 167 HTT----CGTPNYVAPEVLSNRGYDGS------AADVWSCG-VILFVLMAGYLPFGET-- 213
            T      GT  + APE+L       +      + D++S G V  ++L  G  PFG+   
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 214 -DLPTLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            +   +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 2   KKQTRRVAKYEVGRT--IGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQ 55
           + Q R + + E+ R   +G G F  V        GE+V    A+K+L ++T  K  +  +
Sbjct: 29  QAQLRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--E 86
Query: 56  IKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ------GRLLEN 109
              E  IM  + HP++VRL  V  S T + ++ + +  G L +  VH+       +LL N
Sbjct: 87  FMDEALIMASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLE-YVHEHKDNIGSQLLLN 144
Query: 110 DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
            C     Q+   + +   + + HRDL   N+L+ S  ++K++DFGL+ L  +G E  +  
Sbjct: 145 WC----VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNA 199
Query: 170 CGTP---NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA 205
            G      ++A E +  R +    +DVWS GV ++ LM 
Sbjct: 200 DGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMT 237

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR--------RYFQQLI 119
           HPN++R +    +   +YI LE          +V    + + + +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYG-----------NLK--VSDFGLSALPQQGVEL- 165
             VAH HS  + HRDLKP+N+L+ +             NL+  +SDFGL      G    
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 166 ---LHTTCGTPNYVAPEVLSNRGYDGS------AADVWSCG-VILFVLMAGYLPFGET-- 213
              L+   GT  + APE+L       +      + D++S G V  ++L  G  PFG+   
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 214 -DLPTLYKKINAAEFSCPFWFS--TGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            +   +    +  E  C    S    AT LI +++D +P  R     + +HP F
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 79
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 80  VCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 199 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 230

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---KHRMVDQIKREISIMKIVRHP 69
           +G+ +GEG F  V    N +  +  ++KV  K+  L     R +++   E + MK   HP
Sbjct: 38  LGKILGEGEFGSV-MEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 70  NIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID---- 120
           N++RL  V    +     K  +IL F+  G+L   +++  RL         Q L+     
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMVD 155
Query: 121 ---AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG--TPNY 175
               + +  ++   HRDL   N +L     + V+DFGLS     G              +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 176 VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
           +A E L++R Y  S +DVW+ GV ++ +   G  P+
Sbjct: 216 IAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPY 250

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RHPNIVR- 73
           +G+G + +V   +    GE+VA+K+ +       R      RE  +   V  RH NI+  
Sbjct: 16  VGKGRYGEV--WRGSWQGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGF 67
Query: 74  LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDAVAHCH--- 126
           +   + SR   T++++I  +   G L+D +  Q   L+   C R    +   +AH H   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 127 -----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNYVA 177
                   + HRDLK +N+L+   G   ++D GL+ +  Q    L    +   GT  Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 178 PEVLSNR----GYDG-SAADVWSCGVILF 201
           PEVL        +D     D+W+ G++L+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RHPNIVR- 73
           +G+G + +V   +    GE+VA+K+ +       R      RE  +   V  RH NI+  
Sbjct: 16  VGKGRYGEV--WRGSWQGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGF 67
Query: 74  LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDAVAHCH--- 126
           +   + SR   T++++I  +   G L+D +  Q   L+   C R    +   +AH H   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 127 -----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNYVA 177
                   + HRDLK +N+L+   G   ++D GL+ +  Q    L    +   GT  Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 178 PEVLSNR----GYDG-SAADVWSCGVILF 201
           PEVL        +D     D+W+ G++L+
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLW 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE     VA+K L ++T  K     +I  E  +M  V +P+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 83  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 202 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 233

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 81
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 82  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 201 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RHPNIVR- 73
           +G+G + +V   +    GE+VA+K+ +       R      RE  +   V  RH NI+  
Sbjct: 45  VGKGRYGEV--WRGSWQGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGF 96
Query: 74  LHEVLASR---TKVYIILEFVTGGELFDKIVHQGRLLEN-DCRRYFQQLIDAVAHCH--- 126
           +   + SR   T++++I  +   G L+D +  Q   L+   C R    +   +AH H   
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 127 -----SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNYVA 177
                   + HRDLK +N+L+   G   ++D GL+ +  Q    L    +   GT  Y+A
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 178 PEVLSNR----GYDG-SAADVWSCGVILF 201
           PEVL        +D     D+W+ G++L+
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLW 243

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 81  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 78
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 79  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 198 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 79
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 80  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 199 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 230

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 78
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 79  VCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 198 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 80
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 172
           D +A+ ++K   HR+L   N ++     +K+ DFG++          + G  LL      
Sbjct: 141 DGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 196
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 197 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 101/209 (48%), Gaps = 30/209 (14%)
Query: 15  RTIGEGTFAKVRFAQNRET--GES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           R +G+G+F  V     R+   GE+   VA+K + +S  L+ R+  +   E S+MK     
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 81
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR---YFQQLI------- 119
           ++VRL  V++      +++E +  G+L   +       EN+  R     Q++I       
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLHTTCGT 172
           D +A+ ++K   HR+L   N ++     +K+ DFG++          + G  LL      
Sbjct: 142 DGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 197
Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             ++APE L + G   +++D+WS GV+L+
Sbjct: 198 -RWMAPESLKD-GVFTTSSDMWSFGVVLW 224

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 2/190 (1%)
Query: 37  VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGEL 96
           VA+K+ +++         + +RE      ++ P++V +H+      ++Y+    + G +L
Sbjct: 62  VALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDL 121
Query: 97  FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL- 155
              +  QG L         +Q+  A+   H+ G  HRD+KPEN+L+ +     + DFG+ 
Sbjct: 122 AAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA 181
Query: 156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL 215
           SA   + +  L  T GT  Y APE  S   +    AD+++   +L+  + G  P+    L
Sbjct: 182 SATTDEKLTQLGNTVGTLYYXAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQL 240
Query: 216 PTLYKKINAA 225
                 IN A
Sbjct: 241 SVXGAHINQA 250

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 75
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+ + + +   + 
Sbjct: 76  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR 134
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 135 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 194
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 195 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 226

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 103
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 104 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 162
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 163 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 222
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 223 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 254

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 84
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 85  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 143
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 144 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 203
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 204 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 235

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 78
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 79  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 198 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 103/244 (42%), Gaps = 38/244 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +GR IG G+F  +    N  +GE VA+K+    T  KH    Q+  E    K+++  
Sbjct: 10  KYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKT--KH---PQLHIESKFYKMMQGG 64
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF---------QQLID 120
             +   +   +     +++  + G  L D        L N C R F          Q+I 
Sbjct: 65  VGIPSIKWCGAEGDYNVMVMELLGPSLED--------LFNFCSRKFSLKTVLLLADQMIS 116
Query: 121 AVAHCHSKGVYHRDLKPENLL--LDSYGNL-KVSDFGLSALPQQGVELLH-------TTC 170
            + + HSK   HRD+KP+N L  L   GNL  + DFGL+   +      H          
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 171 GTPNYVAPEVLSNRGYDGSAA-DVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAAE 226
           GT  Y +  + ++ G + S   D+ S G +L     G LP+      T    Y++I+  +
Sbjct: 177 GTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234
Query: 227 FSCP 230
            S P
Sbjct: 235 MSTP 238

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 157 DLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFT-T 215
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 78
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 79  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 198 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 229

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 85
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 86  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 205 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 236

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 88
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 89  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 147
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 148 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 207
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 208 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 239

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 72
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 73  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 192 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 81
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 82  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 201 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 81  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 81
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 82  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 201 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 81
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 82  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 201 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 155
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 156 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 214
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 215 KSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 159 DLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 217
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 218 KSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 159 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 217
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 218 KSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 216
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 43/231 (18%)
Query: 13  VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI- 71
           V R +G+GTF +V   Q+ +  +  A+KV+        +     K E  I+K +++ +I 
Sbjct: 39  VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDIN 94
Query: 72  ----VRLHEVLASRTKVYIILEFVTGGELFDKIV---HQGRLLENDCRRYFQQLIDAVAH 124
               V+ H        + +I E + G  L++ I    + G  +E D + Y  +++ A+ +
Sbjct: 95  NNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIE-DIKLYCIEILKALNY 152
Query: 125 CHSKGVYHRDLKPENLLLDS-------------------------YGNLKVSDFGLSALP 159
                + H DLKPEN+LLD                             +K+ DFG +   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
               +   +   T  Y APEV+ N G+D S +D+WS G +L  L  G L F
Sbjct: 213 S---DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 162
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 163 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 221
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 222 KSDVWSFGVLLWELMTRGAPPYPDVN 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 13  VGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +G+T+GEG F KV  A     + R    +VA+K+L K       + D +  E +++K V 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVLKQVN 84
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF-----DKIVHQGRLLE-------------- 108
           HP++++L+   +    + +I+E+   G L       + V  G L                
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 109 -----NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQG 162
                 D   +  Q+   + +     + HRDL   N+L+     +K+SDFGLS  + ++ 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 163 VELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILF 201
             +  +    P  ++A E L +  Y  + +DVWS GV+L+
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 216
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK   HR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +  + +H   G      ++A E L  + +  +
Sbjct: 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-T 275
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVN 301

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 14/203 (6%)
Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G F KV +      G  VA+K L +       +  Q + E+ ++ +  H N++RL  
Sbjct: 46  LGRGGFGKV-YKGRLADGTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRNLLRLRG 102
Query: 77  VLASRTKVYIILEFVTGGE----LFDKIVHQGRLLENDCRRYFQQLIDAVA----HCHSK 128
              + T+  ++  ++  G     L ++   Q  L     +R        +A    HC  K
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 162
Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ-QGVELLHTTCGTPNYVAPEVLSNRGYD 187
            + HRD+K  N+LLD      V DFGL+ L   +   +     GT  ++APE LS  G  
Sbjct: 163 -IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLST-GKS 220
Query: 188 GSAADVWSCGVILFVLMAGYLPF 210
               DV+  GV+L  L+ G   F
Sbjct: 221 SEKTDVFGYGVMLLELITGQRAF 243

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 149
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 150 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 208
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 209 KSDVWSFGVLLWELMTRGAPPYPDVN 234

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 16  TIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
            IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 75  HEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYH 132
             + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   H
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151
Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           RDL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT- 210
Query: 189 SAADVWSCGVILFVLMA-GYLPFGETD 214
           + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 211 TKSDVWSFGVLLWELMTRGAPPYPDVN 237

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 216
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 16  TIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
            IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 75  HEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYH 132
             + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   H
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 154
Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           RDL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  
Sbjct: 155 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT- 213
Query: 189 SAADVWSCGVILFVLMA-GYLPFGETD 214
           + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 214 TKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 9/207 (4%)
Query: 16  TIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
            IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 75  HEV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYH 132
             + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   H
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 153
Query: 133 RDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDG 188
           RDL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  
Sbjct: 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT- 212
Query: 189 SAADVWSCGVILFVLMA-GYLPFGETD 214
           + +DVWS GV+L+ LM  G  P+ + +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVN 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 157 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 215
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+   +GEGTF KV    +   G+S VA+K++    + K+R  +  + EI+++K ++ 
Sbjct: 52  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYR--EAARLEINVLKKIKE 107
Query: 69  PN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY-------- 114
            +       V + +       + I  E + G   F+       L EN+ + Y        
Sbjct: 108 KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE------FLKENNFQPYPLPHVRHM 160
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGL 155
             QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG 
Sbjct: 161 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 220
Query: 156 SALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           +    +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 221 ATFDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 271

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 175
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 176 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 234
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 235 KSDVWSFGVLLWELMTRGAPPYPDVN 260

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+   +GEGTF KV    +   G+S VA+K++    + K+R   ++  EI+++K ++ 
Sbjct: 29  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYREAARL--EINVLKKIKE 84
Query: 69  PN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY-------- 114
            +       V + +       + I  E + G   F+       L EN+ + Y        
Sbjct: 85  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE------FLKENNFQPYPLPHVRHM 137
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGL 155
             QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG 
Sbjct: 138 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 197
Query: 156 SALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           +    +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 198 ATFDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 248

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 176
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 177 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 235
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 236 KSDVWSFGVLLWELMTRGAPPYPDVN 261

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 51/236 (21%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+   +GEGTF KV    +   G+S VA+K++    + K+R  +  + EI+++K ++ 
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKYR--EAARLEINVLKKIKE 75
Query: 69  PN------IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY-------- 114
            +       V + +       + I  E + G   F+       L EN+ + Y        
Sbjct: 76  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE------FLKENNFQPYPLPHVRHM 128
Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLL-----------------DSYGN--LKVSDFGL 155
             QL  A+   H   + H DLKPEN+L                   S  N  ++V+DFG 
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188
Query: 156 SALPQQGVELLHTT-CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           +    +     HTT   T +Y  PEV+   G+     DVWS G ILF    G+  F
Sbjct: 189 ATFDHEH----HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLF 239

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 34/220 (15%)
Query: 13  VGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +G+T+GEG F KV  A     + R    +VA+K+L K       + D +  E +++K V 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVLKQVN 84
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF-----DKIVHQGRLLE-------------- 108
           HP++++L+   +    + +I+E+   G L       + V  G L                
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 109 -----NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQG 162
                 D   +  Q+   + +     + HRDL   N+L+     +K+SDFGLS  + ++ 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 163 VELLHTTCGTP-NYVAPEVLSNRGYDGSAADVWSCGVILF 201
             +  +    P  ++A E L +  Y  + +DVWS GV+L+
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 9/206 (4%)
Query: 17  IGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLH 75
           IG G F  V      +  G+ +   V + + I     V Q   E  IMK   HPN++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 76  EV-LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHR 133
            + L S     ++L ++  G+L + I ++       D   +  Q+   + +  SK   HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 134 DLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NYVAPEVLSNRGYDGS 189
           DL   N +LD    +KV+DFGL+  +  +    +H   G      ++A E L  + +  +
Sbjct: 158 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-T 216
Query: 190 AADVWSCGVILFVLMA-GYLPFGETD 214
            +DVWS GV+L+ LM  G  P+ + +
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 20  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 77
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 78  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 137
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 138 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 197
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 198 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 225

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 11  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 68
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 69  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 128
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------ALPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 129 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 188
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 189 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 34/220 (15%)
Query: 13  VGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           +G+T+GEG F KV  A     + R    +VA+K+L K       + D +  E +++K V 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLS-EFNVLKQVN 84
Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELF-----DKIVHQGRLLE-------------- 108
           HP++++L+   +    + +I+E+   G L       + V  G L                
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 109 -----NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV 163
                 D   +  Q+   + +     + HRDL   N+L+     +K+SDFGLS    +  
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 164 ELLHTTCG--TPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
             +  + G     ++A E L +  Y  + +DVWS GV+L+
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +  G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 85
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 86  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 205 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 236

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 81  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E + +R Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 304 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 363
           G   MNAF++I+ S G NL+ LF   + Y  R  RFVS   A+ ++  +E +  + +L V
Sbjct: 2   GARRMNAFDIISGSPGFNLSGLFGDARKY-DRVERFVSAWTAERVVERLEEIVSAENLTV 60
Query: 364 HTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRK 403
             +  +  ++EG    + G FA+V+E+ ++   L M++VRK
Sbjct: 61  AKKETWGMKIEG----QKGNFAMVVEINQLTDELVMIEVRK 97

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 80
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 81  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E + +R Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 200 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 231

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V    A+K L ++T  K     +I  E  +M  V +P+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNPH 82
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I++ +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 83  VCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFG + L     +  H   G  P  ++A E + +R Y 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 202 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 233

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 6   RRVAK-YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           R +AK  ++ + IG+G + +V   + R  GE VA+KV   +         +I + +    
Sbjct: 33  RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTV---- 86
Query: 65  IVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           ++RH NI+           S T++Y+I ++   G L+D  +    L      +     + 
Sbjct: 87  LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVS 145
Query: 121 AVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLSA---LPQQGVEL-LHT 168
            + H H++         + HRDLK +N+L+   G   ++D GL+         V++  +T
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 169 TCGTPNYVAPEVLS---NRGYDGS--AADVWSCGVILF 201
             GT  Y+ PEVL    NR +  S   AD++S G+IL+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 19  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 76
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 77  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 137 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 197 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 224

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 38/244 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +GR IG G+F  +    +   GE VA+K+    T  KH    Q+  E  I K+++  
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KH---PQLHIESKIYKMMQGG 64
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF---------QQLID 120
             +       +     +++  + G  L D        L N C R F          Q+I 
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELLGPSLED--------LFNFCSRKFSLKTVLLLADQMIS 116
Query: 121 AVAHCHSKGVYHRDLKPENLL--LDSYGNL-KVSDFGLSALPQQGVELLH-------TTC 170
            + + HSK   HRD+KP+N L  L   GNL  + DFGL+   +      H          
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 171 GTPNYVAPEVLSNRGYDGSAA-DVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAAE 226
           GT  Y +  + ++ G + S   D+ S G +L     G LP+      T    Y++I+  +
Sbjct: 177 GTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234
Query: 227 FSCP 230
            S P
Sbjct: 235 MSTP 238

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 38/244 (15%)
Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +GR IG G+F  +    +   GE VA+K+    T  KH    Q+  E  I K+++  
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KH---PQLHIESKIYKMMQGG 62
Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF---------QQLID 120
             +       +     +++  + G  L D        L N C R F          Q+I 
Sbjct: 63  VGIPTIRWCGAEGDYNVMVMELLGPSLED--------LFNFCSRKFSLKTVLLLADQMIS 114
Query: 121 AVAHCHSKGVYHRDLKPENLL--LDSYGNL-KVSDFGLSALPQQGVELLH-------TTC 170
            + + HSK   HRD+KP+N L  L   GNL  + DFGL+   +      H          
Sbjct: 115 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 171 GTPNYVAPEVLSNRGYDGSAA-DVWSCGVILFVLMAGYLPFGETDLPT---LYKKINAAE 226
           GT  Y +  + ++ G + S   D+ S G +L     G LP+      T    Y++I+  +
Sbjct: 175 GTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232
Query: 227 FSCP 230
            S P
Sbjct: 233 MSTP 236

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 20  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 77
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 78  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 137
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 138 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 197
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 198 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 225

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 17  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 74
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 75  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 134
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 135 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 194
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 195 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 222

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 13  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 70
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 71  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 130
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 131 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 190
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 191 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 218

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 19/221 (8%)
Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKV----LAKSTILKHRMVDQIKREISIMKIVRHPN 70
           + +G G F  V        GE V + V    L ++T  K     +I  E  +M  V +P+
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKAN--KEILDEAYVMASVDNPH 112
Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           + RL  +  + T V +I + +  G L D +  H+  +       +  Q+   + +   + 
Sbjct: 113 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 171
Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGYD 187
           + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y 
Sbjct: 172 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 231
Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS 228
              +DVWS GV ++ LM     FG       Y  I A+E S
Sbjct: 232 -HQSDVWSYGVTVWELMT----FGSKP----YDGIPASEIS 263

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 26  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 83
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 84  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 143
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 203
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 204 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 231

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 10  KYEVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R+  +   E S+MK
Sbjct: 19  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 76
Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND-------CRRYFQ- 116
                ++VRL  V++      +I+E +T G+L   +      +EN+         +  Q 
Sbjct: 77  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQM 136
Query: 117 --QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-------LPQQGVELLH 167
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++          + G  LL 
Sbjct: 137 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 196
Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF 201
                  +++PE L + G   + +DVWS GV+L+
Sbjct: 197 V-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 224
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	441
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	0.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-170
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-169
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-167
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-167
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-166
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-165
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-165
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-165
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-164
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-163
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-159
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-157
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-156
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-154
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-149
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-145
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-144
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-141
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-112
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-110
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-109
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-108
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-108
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-106
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-106
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-106
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-105
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-105
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-105
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-104
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-103
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-103
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-102
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-101
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-101
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-101
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-100
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-99
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-99
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-99
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-99
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-99
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-98
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-98
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-96
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-94
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-93
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-92
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-92
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-92
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-88
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-87
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-85
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-83
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-83
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-83
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-82
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-82
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-81
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-80
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-79
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-77
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-77
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-77
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-77
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-76
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-75
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-74
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-73
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-73
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-73
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-73
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-72
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-72
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-72
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-71
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-71
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-71
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-71
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-71
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-71
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-70
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-69
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-68
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-67
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-66
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-58
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-55
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-54
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-54
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-53
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-53
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-53
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	2e-52
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-51
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-50
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-50
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-49
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-49
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-49
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-49
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-49
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-48
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-47
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-46
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-45
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-44
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-44
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-44
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-43
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-42
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-41
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-41
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-41
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-40
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-40
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-40
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	8e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-39
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-38
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-38
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-38
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-38
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-37
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-37
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-37
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-37
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-37
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-37
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-36
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-36
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-36
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-35
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-35
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-35
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-35
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-34
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-33
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-33
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-33
3soc_A	322	Activin receptor type-2A; structural genomics cons	7e-32
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-31
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-28
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-28
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-28
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-27
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-26
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-25
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-25
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-25
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-24
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-23
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-23
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-20
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-18
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-17
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-17
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-17
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-17
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-17
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-16
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-16
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-15
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	3e-05
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	7e-05

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  519 bits (1339), Expect = 0.0
 Identities = 137/468 (29%), Positives = 226/468 (48%), Gaps = 59/468 (12%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
                ++  Y +G T+G GTF KV+  ++  TG  VA+K+L +  I    +V +I+REI 
Sbjct: 9   HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
            +K+ RHP+I++L++V+++ + +++++E+V+GGELFD I   GRL E + RR FQQ++  
Sbjct: 69  NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           V +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVI 187

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           S R Y G   D+WS GVIL+ L+ G LPF +  +PTL+KKI    F  P + +    SL+
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL 247

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDV---------HAVFDDIE 292
             +L  +P  R  I+ IR+H WF+++       E+   +   +                E
Sbjct: 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEE 307

Query: 293 YVAEQSENKVGGPLLMNAFEMI-------------------------------------- 314
            V     N+     L  A+ +I                                      
Sbjct: 308 EVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVP 367

Query: 315 -------TLSQGLNLAALFDRRQDYVKRQTRFV---SRQPAQVILSNIEAVAESLSLKVH 364
                       L+       +   V++    +   S+     I++ +    + L  +  
Sbjct: 368 FLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWK 427

Query: 365 TRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEY 411
             N Y  R+   +   +    + L++++V    +++D R    + LE 
Sbjct: 428 VVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV 475

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  478 bits (1233), Expect = e-170
 Identities = 119/274 (43%), Positives = 179/274 (65%), Gaps = 1/274 (0%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
                ++  Y +G T+G GTF KV+  +++ TG  VA+K+L +  I    +V +IKREI 
Sbjct: 4   HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
            +K+ RHP+I++L++V+++ T  ++++E+V+GGELFD I   GR+ E + RR FQQ++ A
Sbjct: 64  NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           V +CH   V HRDLKPEN+LLD++ N K++DFGLS +   G E L T+CG+PNY APEV+
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVI 182

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           S R Y G   D+WSCGVIL+ L+ G LPF +  +PTL+KKI    F  P + +    +L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
             +L  +P  R  I+ IR+H WF+++       E
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  472 bits (1218), Expect = e-167
 Identities = 121/293 (41%), Positives = 193/293 (65%), Gaps = 3/293 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M    R +  Y +  T+GEG+F KV+ A + +T + VA+K +++  + K  M  +++REI
Sbjct: 1   MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
           S +K++RHP+I++L++V+ + T + +++E+  GGELFD IV + R+ E++ RR+FQQ+I 
Sbjct: 61  SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH   + HRDLKPENLLLD   N+K++DFGLS +   G   L T+CG+PNY APEV
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSCGSPNYAAPEV 178

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           ++ + Y G   DVWSCG++L+V++ G LPF +  +P L+KK+N+  +  P + S GA SL
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL 238

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNY-NPVKCSEEEEVNLDDVHAVFDDIE 292
           I +++  +P  RI I+ IR+ PWF  N  + ++  EE + +  D   V    E
Sbjct: 239 IRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGE 291

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  468 bits (1207), Expect = e-167
 Identities = 101/269 (37%), Positives = 151/269 (56%), Gaps = 7/269 (2%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
              V  +++ +T+GEG + +V+ A NR T E+VA+K++     +     + IK+EI I K
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINK 60

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+   +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNY 268
           L+HKIL  NP  RI I  I+K  W+ K  
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  467 bits (1205), Expect = e-166
 Identities = 90/268 (33%), Positives = 135/268 (50%), Gaps = 1/268 (0%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
            R   +Y  GR +G+G FAK     + +T E  A K++ KS +LK    +++  EISI +
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + H ++V  H        V+++LE      L +    +  L E + R Y +Q++    +
Sbjct: 71  SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            H   V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS +
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           G+     DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI K+
Sbjct: 191 GHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM 249

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           L  +P  R  I  +    +F   Y P +
Sbjct: 250 LQTDPTARPTINELLNDEFFTSGYIPAR 277

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  467 bits (1204), Expect = e-165
 Identities = 103/292 (35%), Positives = 156/292 (53%), Gaps = 8/292 (2%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
              V  +++ +T+GEG + +V+ A NR T E+VA+K++     +     + IK+EI I K
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINK 60

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++ H N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V +
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VELLHTTCGTPNYVAPEVLS 182
            H  G+ HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L 
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGATS 239
            R +     DVWSCG++L  ++AG LP+   +D    Y      +     W    +   +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDD 290
           L+HKIL  NP  RI I  I+K  W+ K      K        + +  + F  
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSK 292

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  467 bits (1204), Expect = e-165
 Identities = 90/270 (33%), Positives = 135/270 (50%), Gaps = 1/270 (0%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
              R   +Y  GR +G+G FAK     + +T E  A K++ KS +LK    +++  EISI
Sbjct: 35  VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 94

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
            + + H ++V  H        V+++LE      L +    +  L E + R Y +Q++   
Sbjct: 95  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 154

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
            + H   V HRDLK  NL L+    +K+ DFGL+   +   E     CGTPNY+APEVLS
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
            +G+     DVWS G I++ L+ G  PF  + L   Y +I   E+S P   +  A SLI 
Sbjct: 215 KKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           K+L  +P  R  I  +    +F   Y P +
Sbjct: 274 KMLQTDPTARPTINELLNDEFFTSGYIPAR 303

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  467 bits (1203), Expect = e-165
 Identities = 113/345 (32%), Positives = 173/345 (50%), Gaps = 17/345 (4%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
               +Y+  + IG G F   R  +++ T E VA+K + +       + + ++REI   + 
Sbjct: 17  HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRS 72

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           +RHPNIVR  EV+ + T + II+E+ +GGEL+++I + GR  E++ R +FQQL+  V++C
Sbjct: 73  LRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132

Query: 126 HSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           HS  + HRDLK EN LLD      LK+ DFG S           +T GTP Y+APEVL  
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLR 191

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----INAAEFSCP--FWFSTGA 237
           + YDG  ADVWSCGV L+V++ G  PF + + P  Y+K    I + ++S P     S   
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC 251

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP-VKCSEEEEVNLDDVHAVFDDIEYVAE 296
             LI +I   +P TRI I  I+ H WF KN    +           +       ++ + +
Sbjct: 252 CHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQ 311

Query: 297 QSENKVGGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVS 341
                   P + N      ++  L+L    D      + +    S
Sbjct: 312 IISEAT-IPAVRNRCLDDFMTDNLDLDDDMDDFDS--ESEIDIDS 353

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  463 bits (1193), Expect = e-164
 Identities = 84/287 (29%), Positives = 149/287 (51%), Gaps = 9/287 (3%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-QIKREISIMK 64
           + + KY +G  +GEG++ KV+   + ET    A+K+L K  + +    +  +K+EI +++
Sbjct: 2   KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61

Query: 65  IVRHPNIVRLHEVL--ASRTKVYIILEFVTGG--ELFDKIVHQGRLLENDCRRYFQQLID 120
            +RH N+++L +VL    + K+Y+++E+   G  E+ D +    R        YF QLID
Sbjct: 62  RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLID 120

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAP 178
            + + HS+G+ H+D+KP NLLL + G LK+S  G++         +   T+ G+P +  P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 179 EVLSN-RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 237
           E+ +    + G   D+WS GV L+ +  G  PF   ++  L++ I    ++ P       
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDV 284
           + L+  +L+  P  R  I  IR+H WFRK + P +       + D  
Sbjct: 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  459 bits (1184), Expect = e-163
 Identities = 87/271 (32%), Positives = 150/271 (55%), Gaps = 2/271 (0%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
            ++  ++VG  +G+G+FA V  A++  TG  VA+K++ K  + K  MV +++ E+ I   
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAH 124
           ++HP+I+ L+        VY++LE    GE+   + ++ +   EN+ R +  Q+I  + +
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
            HS G+ HRDL   NLLL    N+K++DFGL+   +   E  +T CGTPNY++PE+ +  
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            + G  +DVWS G + + L+ G  PF    +     K+  A++  P + S  A  LIH++
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQL 246

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
           L  NP  R+ +  +  HP+  +N +     E
Sbjct: 247 LRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  449 bits (1158), Expect = e-159
 Identities = 91/272 (33%), Positives = 152/272 (55%), Gaps = 3/272 (1%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M K+   +  +++GR +G+G F  V  A+ ++    +A+KVL KS + K  +  Q++REI
Sbjct: 6   MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            I   +RHPNI+R++     R ++Y++LEF   GEL+ ++   GR  E     + ++L D
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 125

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+ +CH + V HRD+KPENLL+   G LK++DFG S           T CGT +Y+ PE+
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEM 183

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
           +  + +D    D+W  GV+ +  + G  PF        +++I   +   P + S G+  L
Sbjct: 184 IEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL 242

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           I K+L  +P  R+ ++G+ +HPW + N   V 
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  443 bits (1142), Expect = e-157
 Identities = 98/280 (35%), Positives = 157/280 (56%), Gaps = 4/280 (1%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           KK+   +  +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I   +RHPNI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           +++CHSK V HRD+KPENLLL S G LK++DFG S             CGT +Y+ PE++
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMI 179

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
             R +D    D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI
Sbjct: 180 EGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 238

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYN-PVKCSEEEEVN 280
            ++L  NP  R  +  + +HPW   N + P  C  +E  +
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  442 bits (1140), Expect = e-156
 Identities = 91/294 (30%), Positives = 151/294 (51%), Gaps = 30/294 (10%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---------- 51
                ++ +Y +   IG+G++  V+ A N       AMKVL+K  +++            
Sbjct: 6   SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65

Query: 52  -------------MVDQIKREISIMKIVRHPNIVRLHEVL--ASRTKVYIILEFVTGGEL 96
                         ++Q+ +EI+I+K + HPN+V+L EVL   +   +Y++ E V  G +
Sbjct: 66  TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125

Query: 97  FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
            + +     L E+  R YFQ LI  + + H + + HRD+KP NLL+   G++K++DFG+S
Sbjct: 126 ME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

Query: 157 ALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETD 214
              +    LL  T GTP ++APE LS   + + G A DVW+ GV L+  + G  PF +  
Sbjct: 185 NEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

Query: 215 LPTLYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           +  L+ KI +     P     +     LI ++LD NP++RI +  I+ HPW  +
Sbjct: 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  438 bits (1129), Expect = e-154
 Identities = 112/291 (38%), Positives = 169/291 (58%), Gaps = 2/291 (0%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
              +   +  Y + +TIG+G FAKV+ A++  TG  VA+K++ K+ +     + ++ RE+
Sbjct: 7   CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREV 65

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID 120
            IMKI+ HPNIV+L EV+ +   +Y+I+E+ +GGE+FD +V  GR+ E + R  F+Q++ 
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           AV +CH K + HRDLK ENLLLD+  N+K++DFG S     G   L   CG P Y APE+
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPEL 184

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL 240
              + YDG   DVWS GVIL+ L++G LPF   +L  L +++   ++  PF+ ST   +L
Sbjct: 185 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDI 291
           + + L  NP  R  +E I K  W    +   +     E  LD       DI
Sbjct: 245 LKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDI 295

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  427 bits (1100), Expect = e-149
 Identities = 82/304 (26%), Positives = 144/304 (47%), Gaps = 13/304 (4%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-----QIK 57
            +     KY     +G G F  V  A ++E  + V +K + K  +L+   ++     ++ 
Sbjct: 18  CEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77

Query: 58  REISIMKIVRHPNIVRLHEVLASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRRYFQ 116
            EI+I+  V H NI+++ ++  ++    +++E   +G +LF  I    RL E      F+
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR 137

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           QL+ AV +   K + HRD+K EN+++     +K+ DFG +A  ++G +L +T CGT  Y 
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYC 196

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTG 236
           APEVL    Y G   ++WS GV L+ L+    PF E       ++   A    P+  S  
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKE 250

Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAE 296
             SL+  +L P P+ R  +E +   PW  +  N    + EE   ++   +       +  
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEM 310

Query: 297 QSEN 300
            + +
Sbjct: 311 GNRS 314

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  416 bits (1071), Expect = e-145
 Identities = 85/286 (29%), Positives = 135/286 (47%), Gaps = 17/286 (5%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ---IKR 58
           K +    A+Y +G  +G+G F  V           VA+KV+ ++ +L    +        
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83

Query: 59  EISIMKIVR----HPNIVRLHEVLASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRR 113
           E++++  V     HP ++RL +   ++    ++LE  +   +LFD I  +G L E   R 
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143

Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGT 172
           +F Q++ A+ HCHS+GV HRD+K EN+L+D   G  K+ DFG  AL            GT
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGT 201

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW 232
             Y  PE +S   Y    A VWS G++L+ ++ G +PF         ++I  AE   P  
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFPAH 255

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 278
            S    +LI + L P P +R  +E I   PW +     V  +  + 
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  412 bits (1061), Expect = e-144
 Identities = 85/289 (29%), Positives = 133/289 (46%), Gaps = 15/289 (5%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKR 58
           K++    ++Y+VG  +G G F  V           VA+K + K  I     +    ++  
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95

Query: 59  EISIMKIVRH--PNIVRLHEVLASRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYF 115
           E+ ++K V      ++RL +         +ILE      +LFD I  +G L E   R +F
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
            Q+++AV HCH+ GV HRD+K EN+L+D   G LK+ DFG  AL +    +     GT  
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRV 213

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFS 234
           Y  PE +    Y G +A VWS G++L+ ++ G +PF         ++I   +       S
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVS 267

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDD 283
           +    LI   L   P  R   E I+ HPW +    P + +E    +L  
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSP 316

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  406 bits (1044), Expect = e-141
 Identities = 71/323 (21%), Positives = 130/323 (40%), Gaps = 48/323 (14%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--------- 51
           +K++ + +  Y + RT+ +G F K+      +  +  A+K   KS + K R         
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 52  -----MVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRL 106
                  D  K E+ I+  +++   +    ++ +  +VYII E++    +     +   L
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 107 L--------ENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSA 157
                        +   + ++++ ++ H+ K + HRD+KP N+L+D  G +K+SDFG S 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200

Query: 158 LPQQGVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPF-GETDL 215
                   +  + GT  ++ PE  SN   Y+G+  D+WS G+ L+V+    +PF  +  L
Sbjct: 201 YMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258

Query: 216 PTLYKKINAAEFSCPF-------------------WFSTGATSLIHKILDPNPKTRIRIE 256
             L+  I       P                    + S      +   L  NP  RI  E
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 257 GIRKHPWFRKNYNPVKCSEEEEV 279
              KH W             +E+
Sbjct: 319 DALKHEWLADTNIEDLREFSKEL 341

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  332 bits (854), Expect = e-112
 Identities = 100/273 (36%), Positives = 149/273 (54%), Gaps = 17/273 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+K+++K         +      ++ EI I+K
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 71  KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 125 CHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL 188

Query: 182 SNRGYD--GSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWF--S 234
            + G      A D WS GVILF+ ++GY PF       +L  +I +    F    W   S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             A  L+ K+L  +PK R   E   +HPW +  
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  326 bits (837), Expect = e-110
 Identities = 67/295 (22%), Positives = 128/295 (43%), Gaps = 38/295 (12%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R  + +E    +G+G F +V  A+N       A+K +  +       +  I  E+ ++  
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLAS 58

Query: 66  VRHPNIVRLHEV-------------LASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDC 111
           + H  +VR +               +  ++ ++I +E+   G L+D I  +      ++ 
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 112 RRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-------- 163
            R F+Q+++A+++ HS+G+ HRDLKP N+ +D   N+K+ DFGL+    + +        
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 164 ------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT 217
                 + L +  GT  YVA EVL   G+     D++S G+I F ++  Y      +   
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236

Query: 218 LYKKINAAEFSCPFWF----STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 268
           + KK+ +     P  F          +I  ++D +P  R     +    W    +
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  323 bits (831), Expect = e-109
 Identities = 102/265 (38%), Positives = 150/265 (56%), Gaps = 10/265 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y+V   +G+G F+ VR   ++ TG   A K++     L  R   +++RE  I + ++HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ+++++A+CHS G
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HR+LKPENLLL S      +K++DFGL+       E  H   GTP Y++PEVL    Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPY 184

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
                D+W+CGVIL++L+ GY PF + D   LY +I A   ++  P W   +  A SLI 
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID 243

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKN 267
            +L  NPK RI  +   K PW    
Sbjct: 244 SMLTVNPKKRITADQALKVPWICNR 268

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  320 bits (822), Expect = e-108
 Identities = 105/267 (39%), Positives = 149/267 (55%), Gaps = 15/267 (5%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
             Y +  TIG G++ +V+ A  + T    A K + K  +     VD+ K+EI IMK + H
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           PNI+RL+E     T +Y+++E  TGGELF+++VH+    E+D  R  + ++ AVA+CH  
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 129 GVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            V HRDLKPEN L  +      LK+ DFGL+A  + G +++ T  GTP YV+P+VL    
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVL-EGL 183

Query: 186 YDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSL 240
           Y G   D WS GV+++VL+ GY PF   TD   +  KI      F    W   S  A SL
Sbjct: 184 Y-GPECDEWSAGVMMYVLLCGYPPFSAPTD-SEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRKN 267
           I ++L  +PK RI      +H WF K 
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQ 268

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  323 bits (831), Expect = e-108
 Identities = 100/274 (36%), Positives = 150/274 (54%), Gaps = 19/274 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMK 64
           +Y + +T+G G   +V+ A  R+T + VA+++++K         +      ++ EI I+K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
            + HP I+++     +    YI+LE + GGELFDK+V   RL E  C+ YF Q++ AV +
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 125 CHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
            H  G+ HRDLKPEN+LL S      +K++DFG S +  +   L+ T CGTP Y+APEVL
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVL 313

Query: 182 SN---RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWF-- 233
            +    GY   A D WS GVILF+ ++GY PF       +L  +I +    F    W   
Sbjct: 314 VSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372

Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           S  A  L+ K+L  +PK R   E   +HPW +  
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  318 bits (818), Expect = e-106
 Identities = 103/288 (35%), Positives = 154/288 (53%), Gaps = 13/288 (4%)

Query: 1   MKKQTRRV-AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           M   + +    Y+V   +G+G F+ VR   ++ TG   A K++     L  R   +++RE
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLERE 78

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
             I + ++HPNIVRLH+ +   +  Y++ + VTGGELF+ IV +    E D     QQ++
Sbjct: 79  ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL 138

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           +++A+CHS G+ HR+LKPENLLL S      +K++DFGL+       E  H   GTP Y+
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYL 197

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 232
           +PEVL    Y     D+W+CGVIL++L+ GY PF  E     LY +I A   ++  P W 
Sbjct: 198 SPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYDYPSPEWD 255

Query: 233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
             +  A SLI  +L  NPK RI  +   K PW             ++ 
Sbjct: 256 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 303

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  315 bits (809), Expect = e-106
 Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 21/276 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD------QIKREISIM 63
            YE    +G G  + VR   ++ T +  A+K++  +        +         +E+ I+
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 64  KIV-RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           + V  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL- 181
              H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++ 
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 196

Query: 182 -----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 232
                ++ GY G   D+WS GVI++ L+AG  PF        + + I +   +F  P W 
Sbjct: 197 CSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQFGSPEWD 254

Query: 233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            +S     L+ + L   P+ R   E    HP+F++ 
Sbjct: 255 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  317 bits (814), Expect = e-106
 Identities = 91/275 (33%), Positives = 147/275 (53%), Gaps = 20/275 (7%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-----LKHRMVDQIKREISIM 63
            KY+    IG G  + VR   +R TG   A+K++  +           + +  +RE  I+
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 64  K-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           + +  HP+I+ L +   S + ++++ + +  GELFD +  +  L E + R   + L++AV
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL- 181
           +  H+  + HRDLKPEN+LLD    +++SDFG S   + G E L   CGTP Y+APE+L 
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILK 272

Query: 182 -----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW- 232
                ++ GY G   D+W+CGVILF L+AG  PF        + + I     +FS P W 
Sbjct: 273 CSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQ-ILMLRMIMEGQYQFSSPEWD 330

Query: 233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             S+    LI ++L  +P+ R+  E   +HP+F +
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  314 bits (806), Expect = e-105
 Identities = 102/277 (36%), Positives = 151/277 (54%), Gaps = 13/277 (4%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           + T     +     +G G F++V   + R TG+  A+K + KS   +      ++ EI++
Sbjct: 3   QTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAV 59

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           +K ++H NIV L ++  S T  Y++++ V+GGELFD+I+ +G   E D     QQ++ AV
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAV 119

Query: 123 AHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
            + H  G+ HRDLKPENLL  +      + ++DFGLS + Q G+  + T CGTP YVAPE
Sbjct: 120 KYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPE 177

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FST 235
           VL+ + Y   A D WS GVI ++L+ GY PF E     L++KI     EF  PFW   S 
Sbjct: 178 VLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE 236

Query: 236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
            A   I  +L+ +P  R   E    HPW   N    +
Sbjct: 237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHR 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  312 bits (801), Expect = e-105
 Identities = 98/266 (36%), Positives = 151/266 (56%), Gaps = 13/266 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 130 VYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ    +    GT  Y+APEVL    Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVL-RGTY 199

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
                DVWS GVIL++L++G  PF G+ +   + K++      F  P W   S  A  LI
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDLPQWRTISDDAKDLI 257

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
            K+L  +P  RI      +HPW +K 
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKY 283

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  312 bits (801), Expect = e-105
 Identities = 81/268 (30%), Positives = 135/268 (50%), Gaps = 17/268 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +   R +G G F  V   + R +G    +K + K        ++QI+ EI ++K + HP
Sbjct: 23  LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHP 80

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHC 125
           NI+++ EV      +YI++E   GGEL ++IV        L E       +Q+++A+A+ 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 126 HSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HS+ V H+DLKPEN+L      +  +K+ DFGL+ L +   E      GT  Y+APEV  
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVF- 198

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAE--FSCPFWF-STGAT 238
            R       D+WS GV+++ L+ G LPF G +    + +K    E  ++      +  A 
Sbjct: 199 KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSL-EEVQQKATYKEPNYAVECRPLTPQAV 256

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            L+ ++L  +P+ R     +  H WF++
Sbjct: 257 DLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  315 bits (808), Expect = e-104
 Identities = 104/277 (37%), Positives = 152/277 (54%), Gaps = 9/277 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y++   +G+G F+ VR       G+  A  ++     L  R   +++RE  I ++++HP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRLLKHP 70

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+ ++     Y+I + VTGGELF+ IV +    E D     QQ+++AV HCH  G
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 130 VYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           V HR+LKPENLLL S      +K++DFGL+   +   +      GTP Y++PEVL    Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTGATSLIH 242
            G   D+W+CGVIL++L+ GY PF + D   LY++I A   +F  P W   +  A  LI+
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
           K+L  NP  RI      KHPW         C   +E 
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHRSTVASCMHRQET 286

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  308 bits (790), Expect = e-103
 Identities = 64/317 (20%), Positives = 117/317 (36%), Gaps = 48/317 (15%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M  Q+     + +   +G+G  A V   ++++TG+  A+KV    + L+   VD   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58

Query: 61  SIMKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR---LLENDCRRYF 115
            ++K + H NIV+L  +    T     +I+EF   G L+  +        L E++     
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCG 171
           + ++  + H    G+ HR++KP N++     D     K++DFG +   +   E   +  G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177

Query: 172 TPNYVAPEVLSNRGYD-------GSAADVWSCGVILFVLMAGYLPF-----GETDLPTLY 219
           T  Y+ P++              G+  D+WS GV  +    G LPF        +   +Y
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 220 KKINAA------------------EFSCPFW------FSTGATSLIHKILDPNPKTRIRI 255
           K I                         P             T ++  IL+ + +     
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 256 EGIRKHPWFRKNYNPVK 272
           +          +     
Sbjct: 298 DQFFAETSDILHRGNSH 314

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  307 bits (789), Expect = e-103
 Identities = 68/280 (24%), Positives = 126/280 (45%), Gaps = 21/280 (7%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y + + IG G  +KV    N E  +  A+K +       ++ +D  + EI+ +  ++  
Sbjct: 29  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 86

Query: 70  N--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++AV   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG 185
            G+ H DLKP N L+   G LK+ DFG++   Q      +  +  GT NY+ PE + +  
Sbjct: 146 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 186 YD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-AEFSCPFW 232
                          +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
                  ++   L  +PK RI I  +  HP+ +   +PV 
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  307 bits (788), Expect = e-102
 Identities = 94/266 (35%), Positives = 147/266 (55%), Gaps = 15/266 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +EV   +G G  + V   + + T +  A+KV     + K      ++ EI ++  + HP
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKV-----LKKTVDKKIVRTEIGVLLRLSHP 108

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+  + T++ ++LE VTGGELFD+IV +G   E D     +Q+++AVA+ H  G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168

Query: 130 VYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLL  +      LK++DFGLS + +    L+ T CGTP Y APE+L    Y
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAY 227

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
            G   D+WS G+I ++L+ G+ PF  E     ++++I      F  P+W   S  A  L+
Sbjct: 228 -GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLV 286

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
            K++  +PK R+      +HPW    
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWVTGK 312

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  306 bits (785), Expect = e-101
 Identities = 89/271 (32%), Positives = 144/271 (53%), Gaps = 15/271 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ--IKREISIMKIVR 67
            YE+   IG+G F+ VR   NRETG+  A+K++  +       +    +KRE SI  +++
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL----ENDCRRYFQQLIDAVA 123
           HP+IV L E  +S   +Y++ EF+ G +L  +IV +        E     Y +Q+++A+ 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 124 HCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           +CH   + HRD+KP  +LL S  N   +K+  FG++    +   +     GTP+++APEV
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEV 204

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--FSTG 236
           +    Y G   DVW CGVILF+L++G LPF  T    L++ I     + +   W   S  
Sbjct: 205 VKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISES 262

Query: 237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           A  L+ ++L  +P  RI +     HPW ++ 
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  303 bits (778), Expect = e-101
 Identities = 94/270 (34%), Positives = 153/270 (56%), Gaps = 15/270 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIV 66
            YE+G  +G G FA VR  + + TG+  A K + K  +   R     ++I+RE++I++ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           RHPNI+ LH++  ++T V +ILE V+GGELFD +  +  L E++  ++ +Q++D V + H
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 127 SKGVYHRDLKPENLLLDSY----GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           SK + H DLKPEN++L         +K+ DFG++   + G        GTP +VAPE+++
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVN 184

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGA 237
                G  AD+WS GVI ++L++G  PF GET        I+A   +F   ++   S  A
Sbjct: 185 YEPL-GLEADMWSIGVITYILLSGASPFLGETK-QETLTNISAVNYDFDEEYFSNTSELA 242

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
              I ++L  +PK R+ I    +H W +  
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  315 bits (809), Expect = e-101
 Identities = 72/304 (23%), Positives = 119/304 (39%), Gaps = 19/304 (6%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
              T+    +E+   +G G F  V    +++TGE VA+K   +   L  +  ++   EI 
Sbjct: 7   SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQ 64

Query: 62  IMKIVRHPNIVRLHEVLASRTKV------YIILEFVTGGELFDKIVHQGR---LLENDCR 112
           IMK + HPN+V   EV     K+       + +E+  GG+L   +        L E   R
Sbjct: 65  IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTT 169
                +  A+ + H   + HRDLKPEN++L         K+ D G +    QG EL    
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEF 183

Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFS 228
            GT  Y+APE+L  + Y     D WS G + F  + G+ PF         + K+      
Sbjct: 184 VGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242

Query: 229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK--NYNPVKCSEEEEVNLDDVHA 286
               +     ++    + P P     I   +   W +    ++  +   + +        
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302

Query: 287 VFDD 290
             D 
Sbjct: 303 ALDS 306

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  300 bits (770), Expect = e-100
 Identities = 94/270 (34%), Positives = 147/270 (54%), Gaps = 15/270 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIV 66
            Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 127 SKGVYHRDLKPENLLLDSY----GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           S  + H DLKPEN++L         +K+ DFGL+     G        GTP +VAPE+++
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN 190

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGA 237
                G  AD+WS GVI ++L++G  PF G+T   T    ++A   EF   ++   S  A
Sbjct: 191 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQET-LANVSAVNYEFEDEYFSNTSALA 248

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
              I ++L  +PK R+ I+   +HPW +  
Sbjct: 249 KDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  305 bits (783), Expect = 1e-99
 Identities = 97/278 (34%), Positives = 152/278 (54%), Gaps = 11/278 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y +   +G+G+F +V   ++R T +  A+KV+ K++  K++    I RE+ ++K + HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI++L E+L   +  YI+ E  TGGELFD+I+ + R  E+D  R  +Q+   + + H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 130 VYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPEN+LL+S     ++K+ DFGLS   QQ    +    GT  Y+APEVL    Y
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVL-RGTY 199

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
                DVWS GVIL++L++G  PF   +   + K++   +  F  P W   S  A  LI 
Sbjct: 200 -DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR 258

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN 280
           K+L  +P  RI      +HPW +K  +      +    
Sbjct: 259 KMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSL 296

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  299 bits (768), Expect = 2e-99
 Identities = 95/282 (33%), Positives = 149/282 (52%), Gaps = 15/282 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM---VDQIKREISIMKIV 66
            Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE+SI++ V
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
            H N++ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++D V + H
Sbjct: 73  LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 127 SKGVYHRDLKPENLLLDS----YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           +K + H DLKPEN++L        ++K+ DFGL+   + G        GTP +VAPE+++
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVN 191

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGA 237
                G  AD+WS GVI ++L++G  PF G+T        I +   +F   F+   S  A
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPFLGDTK-QETLANITSVSYDFDEEFFSHTSELA 249

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
              I K+L    + R+ I+   +HPW     N       E V
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV 291

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  299 bits (768), Expect = 5e-99
 Identities = 99/289 (34%), Positives = 152/289 (52%), Gaps = 15/289 (5%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKRE 59
           KQ +    Y++G  +G G FA V+  + + TG   A K + K      R     ++I+RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           +SI++ V HPNI+ LH+V  +RT V +ILE V+GGELFD +  +  L E +   + +Q++
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDS----YGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           D V + H+K + H DLKPEN++L        ++K+ DFGL+   + G        GTP +
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEF 184

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW 232
           VAPE+++     G  AD+WS GVI ++L++G  PF G+T        I A   +F   F+
Sbjct: 185 VAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTK-QETLANITAVSYDFDEEFF 242

Query: 233 --FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV 279
              S  A   I K+L    + R+ I+   +HPW             E V
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV 291

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  298 bits (766), Expect = 6e-99
 Identities = 72/310 (23%), Positives = 138/310 (44%), Gaps = 25/310 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y + + IG G  +KV    N E  +  A+K +       ++ +D  + EI+ +  ++  
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67

Query: 70  N--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++AV   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG 185
            G+ H DLKP N L+   G LK+ DFG++   Q      +  +  GT NY+ PE + +  
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 186 YD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-AEFSCPFW 232
                          +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE 292
                  ++   L  +PK RI I  +  HP+ +   +PV  ++  +   +++  V   + 
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV--NQMAKGTTEEMKYVLGQL- 302

Query: 293 YVAEQSENKV 302
            V   S N +
Sbjct: 303 -VGLNSPNSI 311

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  303 bits (778), Expect = 6e-99
 Identities = 93/275 (33%), Positives = 150/275 (54%), Gaps = 11/275 (4%)

Query: 1   MKKQTRRVAK-YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           ++  T   +  Y+  R +G+G+F +V   +++ TG+  A+KV++K  + +    + + RE
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           + ++K + HPNI++L+E    +   Y++ E  TGGELFD+I+ + R  E D  R  +Q++
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVL 136

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
             + + H   + HRDLKPENLLL+S     N+++ DFGLS   +   + +    GT  Y+
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYI 195

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW-- 232
           APEVL +  Y     DVWS GVIL++L++G  PF   +   + KK+   +  F  P W  
Sbjct: 196 APEVL-HGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKK 253

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            S  A  LI K+L   P  RI       H W +  
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  297 bits (763), Expect = 2e-98
 Identities = 87/281 (30%), Positives = 141/281 (50%), Gaps = 23/281 (8%)

Query: 1   MKKQTRRV-AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           + + + +    YEV   IG G+++  +   ++ T    A+K++ K         D    E
Sbjct: 13  LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRD-PTEE 65

Query: 60  ISIM-KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQL 118
           I I+ +  +HPNI+ L +V      VY++ E + GGEL DKI+ Q    E +       +
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI 125

Query: 119 IDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
              V + H++GV HRDLKP N+L      +  ++++ DFG +   +    LL T C T N
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTAN 185

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA--EFS 228
           +VAPEVL  +GYD +A D+WS GV+L+ ++ GY PF     +T    +  +I +     S
Sbjct: 186 FVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTP-EEILARIGSGKFSLS 243

Query: 229 CPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             +W   S  A  L+ K+L  +P  R+    + +HPW    
Sbjct: 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  300 bits (771), Expect = 9e-98
 Identities = 89/275 (32%), Positives = 156/275 (56%), Gaps = 12/275 (4%)

Query: 1   MKKQTRRVAK-YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           +  +   +++ Y+  + +G G + +V   +++ T    A+K++ K++ +      ++  E
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEE 86

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           ++++K++ HPNI++L++    +   Y+++E   GGELFD+I+H+ +  E D     +Q++
Sbjct: 87  VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVL 146

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
             V + H   + HRDLKPENLLL+S      +K+ DFGLSA+ +   + +    GT  Y+
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYI 205

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW-- 232
           APEVL  + Y     DVWS GVILF+L+AGY PFG      + +K+   +  F  P W  
Sbjct: 206 APEVL-RKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            S GA  LI ++L  + + RI  +   +HPW ++ 
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  295 bits (757), Expect = 1e-97
 Identities = 85/316 (26%), Positives = 135/316 (42%), Gaps = 53/316 (16%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ--IKREISIMKIV 66
            KY +   IG+G++  VR A   +T    A+K++ K+ I +    D   IK E+ +MK +
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL------------------- 107
            HPNI RL+EV      + +++E   GG L DK+                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 108 ---------------------ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG 146
                                E       +Q+  A+ + H++G+ HRD+KPEN L  +  
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 147 N--LKVSDFGLS----ALPQQGVELLHTTCGTPNYVAPEVLSNRGYD-GSAADVWSCGVI 199
           +  +K+ DFGLS     L       + T  GTP +VAPEVL+      G   D WS GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 200 LFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIHKILDPNPKTRIRI 255
           L +L+ G +PF   +      ++   +  F  P +   S  A  L+  +L+ N   R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 256 EGIRKHPWFRKNYNPV 271
               +HPW  +  + +
Sbjct: 326 MRALQHPWISQFSDKI 341

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  297 bits (761), Expect = 2e-97
 Identities = 64/317 (20%), Positives = 118/317 (37%), Gaps = 48/317 (15%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
           M  Q+     + +   +G+G  A V   ++++TG+  A+KV    + L+   VD   RE 
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREF 58

Query: 61  SIMKIVRHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGR---LLENDCRRYF 115
            ++K + H NIV+L  +    T     +I+EF   G L+  +        L E++     
Sbjct: 59  EVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVL 118

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVSDFGLSALPQQGVELLHTTCG 171
           + ++  + H    G+ HR++KP N++     D     K++DFG +   +   E   +  G
Sbjct: 119 RDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYG 177

Query: 172 TPNYVAPEVLSNRGYD-------GSAADVWSCGVILFVLMAGYLPF-----GETDLPTLY 219
           T  Y+ P++              G+  D+WS GV  +    G LPF        +   +Y
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237

Query: 220 KKINAA------------------EFSCPFW------FSTGATSLIHKILDPNPKTRIRI 255
           K I                         P             T ++  IL+ + +     
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

Query: 256 EGIRKHPWFRKNYNPVK 272
           +          +   + 
Sbjct: 298 DQFFAETSDILHRMVIH 314

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  296 bits (760), Expect = 2e-97
 Identities = 71/310 (22%), Positives = 137/310 (44%), Gaps = 25/310 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y + + IG G  +KV    N E  +  A+K +       ++ +D  + EI+ +  ++  
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 114

Query: 70  N--IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +  I+RL++   +   +Y+++E     +L   +  +  +   + + Y++ +++AV   H 
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRG 185
            G+ H DLKP N L+   G LK+ DFG++   Q      +  +  G  NY+ PE + +  
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 186 YD----------GSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINA-AEFSCPFW 232
                          +DVWS G IL+ +  G  PF +    +  L+  I+   E   P  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292

Query: 233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIE 292
                  ++   L  +PK RI I  +  HP+ +   +PV  ++  +   +++  V   + 
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV--NQMAKGTTEEMKYVLGQL- 349

Query: 293 YVAEQSENKV 302
            V   S N +
Sbjct: 350 -VGLNSPNSI 358

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  291 bits (748), Expect = 2e-96
 Identities = 90/276 (32%), Positives = 149/276 (53%), Gaps = 25/276 (9%)

Query: 10  KYEVG---RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            Y++    + +GEG+F+  R   ++++ ++ A+K+++K      RM    ++EI+ +K+ 
Sbjct: 9   HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLC 62

Query: 67  R-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
             HPNIV+LHEV   +   ++++E + GGELF++I  +    E +     ++L+ AV+H 
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 126 HSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           H  GV HRDLKPENLL         +K+ DFG + L     + L T C T +Y APE+L+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLN 182

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETD------LPTLYKKINAA--EFSCPFW- 232
             GYD  + D+WS GVIL+ +++G +PF              + KKI      F    W 
Sbjct: 183 QNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241

Query: 233 -FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             S  A  LI  +L  +P  R+++ G+R + W +  
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  291 bits (747), Expect = 2e-96
 Identities = 74/270 (27%), Positives = 130/270 (48%), Gaps = 15/270 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +   +G G F  V       + ++   K +      K      +K+EISI+ I RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSK 128
           NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A+   HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 129 GVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            + H D++PEN++  +  +  +K+ +FG +   + G +        P Y APEV  +   
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
             +A D+WS G +++VL++G  PF  ET+   + + I  A   F    +   S  A   +
Sbjct: 181 -STATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
            ++L    K+R+      +HPW ++    V
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLKQKIERV 268

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  297 bits (763), Expect = 2e-96
 Identities = 92/294 (31%), Positives = 151/294 (51%), Gaps = 21/294 (7%)

Query: 2   KKQTRRV-AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRM-------- 52
           +K+  ++   Y   R +G G + +V   + +      A+KV+ KS   K R         
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87

Query: 53  --VDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND 110
              ++I  EIS++K + HPNI++L +V   +   Y++ EF  GGELF++I+++ +  E D
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147

Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGVELLH 167
                +Q++  + + H   + HRD+KPEN+LL++     N+K+ DFGLS+   +    L 
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLR 206

Query: 168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE- 226
              GT  Y+APEVL  + Y     DVWSCGVI+++L+ GY PFG  +   + KK+   + 
Sbjct: 207 DRLGTAYYIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264

Query: 227 -FSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
            F    W   S  A  LI  +L  +   R   E      W +K  N +  S+++
Sbjct: 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  290 bits (744), Expect = 7e-96
 Identities = 84/285 (29%), Positives = 140/285 (49%), Gaps = 16/285 (5%)

Query: 10  KYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            Y +  + +G G FA VR   ++ TG+  A K L K          +I  EI+++++ + 
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87

Query: 69  -PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV--HQGRLLENDCRRYFQQLIDAVAHC 125
            P ++ LHEV  + +++ +ILE+  GGE+F   +      + END  R  +Q+++ V + 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 126 HSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           H   + H DLKP+N+LL      G++K+ DFG+S         L    GTP Y+APE+L+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILN 206

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGA 237
                 +A D+W+ G+I ++L+    PF GE +    Y  I+    ++S   +   S  A
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDN-QETYLNISQVNVDYSEETFSSVSQLA 264

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLD 282
           T  I  +L  NP+ R   E    H W ++         EE  +  
Sbjct: 265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSS 309

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  290 bits (743), Expect = 7e-95
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 14/266 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y++   +G G F  V     + TG     K +     L    V   K EISIM  + HP
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV---KNEISIMNQLHHP 108

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSK 128
            ++ LH+    + ++ +ILEF++GGELFD+I  +   + E +   Y +Q  + + H H  
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 129 GVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            + H D+KPEN++ ++     +K+ DFGL+       E++  T  T  + APE++     
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREPV 227

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
            G   D+W+ GV+ +VL++G  PF GE D     + +     EF    +   S  A   I
Sbjct: 228 -GFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKN 267
             +L   P+ R+ +    +HPW + +
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLKGD 311

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  287 bits (737), Expect = 3e-94
 Identities = 83/268 (30%), Positives = 136/268 (50%), Gaps = 16/268 (5%)

Query: 10  KYEVGRT--IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
            Y V +T  +G G F +V   +   TG  +A K++        +  +++K EIS+M  + 
Sbjct: 88  FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLD 144

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCH 126
           H N+++L++   S+  + +++E+V GGELFD+I+ +   L E D   + +Q+ + + H H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 127 SKGVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
              + H DLKPEN+L  +     +K+ DFGL+   +   E L    GTP ++APEV+ N 
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVV-NY 262

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATS 239
            +     D+WS GVI ++L++G  PF G+ D       I A   +     +   S  A  
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDLEDEEFQDISEEAKE 321

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            I K+L      RI      KHPW   +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPWLSDH 349

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  291 bits (746), Expect = 4e-93
 Identities = 81/280 (28%), Positives = 134/280 (47%), Gaps = 14/280 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y++   +G G F  V     R TG + A K +           + +++EI  M ++RHP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 214

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK 128
            +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   + H H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 129 GVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              H DLKPEN++  +     LK+ DFGL+A      + +  T GT  + APEV   +  
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPV 333

Query: 187 DGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFW--FSTGATSLI 241
            G   D+WS GV+ ++L++G  PF GE D  T  + + +         +   S      I
Sbjct: 334 -GYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWNMDDSAFSGISEDGKDFI 391

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
            K+L  +P TR+ I    +HPW      P + S+      
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 431

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  281 bits (721), Expect = 2e-92
 Identities = 88/277 (31%), Positives = 134/277 (48%), Gaps = 30/277 (10%)

Query: 10  KYEVGR-TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVR 67
            Y++ +  +G G   KV    +R TG+  A+K+L  S         + ++E+    +   
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASG 80

Query: 68  HPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDA 121
            P+IV + +V       +  + II+E + GGELF +I  +G     E +     + +  A
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +   HS  + HRD+KPENLL  S      LK++DFG +    Q    L T C TP YVAP
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAP 198

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDL---PTLYKKINAA--EFSCPFW 232
           EVL    YD  + D+WS GVI+++L+ G+ PF   T     P + ++I      F  P W
Sbjct: 199 EVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEW 257

Query: 233 --FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
              S  A  LI  +L  +P  R+ I     HPW  ++
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  282 bits (724), Expect = 7e-92
 Identities = 91/286 (31%), Positives = 136/286 (47%), Gaps = 29/286 (10%)

Query: 1   MKKQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
             K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE
Sbjct: 53  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARRE 104

Query: 60  ISIMK-IVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCR 112
           + +     + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +  
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTT 169
              + + +A+ + HS  + HRD+KPENLL  S      LK++DFG +         L T 
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTP 223

Query: 170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAA 225
           C TP YVAPEVL    YD  + D+WS GVI+++L+ GY PF     L     +  +I   
Sbjct: 224 CYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282

Query: 226 --EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
             EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  279 bits (716), Expect = 7e-92
 Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 40/294 (13%)

Query: 10  KYEVGR-TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR- 67
            Y++    +GEG  A+V+   N  T +  A+K++ K       +  ++ RE+ ++   + 
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQG 69

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           H N++ L E      + Y++ E + GG +   I  +    E +     Q +  A+   H+
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 128 KGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQG-------VELLHTTCGTPNYVA 177
           KG+ HRDLKPEN+L +       +K+ DF L +  +            L T CG+  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 178 PEVL-----SNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT-------------- 217
           PEV+         YD    D+WS GVIL++L++GY PF G                    
Sbjct: 190 PEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 218 LYKKINAA--EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
           L++ I     EF    W   S  A  LI K+L  + K R+    + +HPW +  
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  269 bits (691), Expect = 4e-88
 Identities = 81/273 (29%), Positives = 141/273 (51%), Gaps = 9/273 (3%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           + + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           +M  + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPE 179
           + + H KG+ HRDLKPEN+LL+   +++++DFG +    P+      ++  GT  YV+PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           +L+ +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261

Query: 240 LIHKILDPNPKTRI------RIEGIRKHPWFRK 266
           L+ K+L  +   R+          ++ HP+F  
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  270 bits (691), Expect = 2e-87
 Identities = 44/305 (14%), Positives = 96/305 (31%), Gaps = 51/305 (16%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
             R      G  +G+        A ++ETGES  + V   +       + Q+K E+  ++
Sbjct: 69  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128

Query: 65  IVR-------------------------HPNIVRLHEVLASRTKVYIILEF--------V 91
           ++R                            ++R+         +     +         
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188

Query: 92  TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS 151
            G  L         L+ +   +   Q+I  +A  H  G+ H  L+P +++LD  G + ++
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG----------YDGSAADVWSCGVILF 201
            F               +  +  +  PE+ + R               + D W+ G++++
Sbjct: 249 GFEHLVRDGA----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304

Query: 202 VLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
            +    LP  +       + I    F           +L+   L    + R+      + 
Sbjct: 305 WIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360

Query: 262 PWFRK 266
           P + +
Sbjct: 361 PEYEQ 365

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  261 bits (670), Expect = 2e-85
 Identities = 80/275 (29%), Positives = 137/275 (49%), Gaps = 14/275 (5%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   + +       +  E+++++ +
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLREL 62

Query: 67  RHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +         T  GTP Y
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 183 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
                +I ++L+     R  +E I ++P   ++++
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  259 bits (663), Expect = 2e-83
 Identities = 74/261 (28%), Positives = 136/261 (52%), Gaps = 5/261 (1%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY   + IGEG+F K    ++ E G    +K +  S  +  +  ++ +RE++++  ++HP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLL-ENDCRRYFQQLIDAVAHCHS 127
           NIV+  E       +YI++++  GG+LF +I   +G L  E+    +F Q+  A+ H H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + + HRD+K +N+ L   G +++ DFG++ +    VEL     GTP Y++PE+  N+ Y+
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFSTGATSLIHKILD 246
            + +D+W+ G +L+ L      F    +  L  KI +  F      +S    SL+ ++  
Sbjct: 204 -NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFK 262

Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            NP+ R  +  I +  +  K 
Sbjct: 263 RNPRDRPSVNSILEKGFIAKR 283

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  261 bits (668), Expect = 4e-83
 Identities = 68/295 (23%), Positives = 112/295 (37%), Gaps = 45/295 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRH 68
                + +G G+   V F      G  VA+K +           D    EI ++ +   H
Sbjct: 16  LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDH 68

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDA 121
           PN++R +    +   +YI LE      L D +  +           E +     +Q+   
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 122 VAHCHSKGVYHRDLKPENLLLDS-------------YGNLKVSDFGLSALPQQGVE---- 164
           VAH HS  + HRDLKP+N+L+ +                + +SDFGL      G      
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 165 LLHTTCGTPNYVAPEVLSNRGYD------GSAADVWSCGVILFVLM-AGYLPFG---ETD 214
            L+   GT  + APE+L              + D++S G + + ++  G  PFG     +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 215 LPTLYKKINAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
              +    +  E  C         AT LI +++D +P  R     + +HP F   
Sbjct: 248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  257 bits (658), Expect = 4e-83
 Identities = 62/285 (21%), Positives = 110/285 (38%), Gaps = 25/285 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y   + +GEG F+ V   +    G   A+K +      + +  ++ +RE  + ++  HP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHP 86

Query: 70  NIVRLHEVLASRT----KVYIILEFVTGGELFDKI----VHQGRLLENDCRRYFQQLIDA 121
           NI+RL            + +++L F   G L+++I         L E+        +   
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ---------QGVELLHTTCGT 172
           +   H+KG  HRDLKP N+LL   G   + D G                 ++       T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 173 PNYVAPEVLSNRGYD--GSAADVWSCGVILFVLMAGYLPFGETDLPT-LYKKINAAEFSC 229
            +Y APE+ S + +       DVWS G +L+ +M G  P+                + S 
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 230 PFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           P     S+    L++ ++  +P  R  I  +       +   P +
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  255 bits (655), Expect = 2e-82
 Identities = 84/260 (32%), Positives = 153/260 (58%), Gaps = 9/260 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +++ RT+G G+F +V   ++R  G   AMKVL K  +++ + V+    E  ++ IV HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+ + HSK +
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  G++K++DFG +   +   ++ +T CGTP+Y+APEV+S + Y   +
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPY-NKS 183

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+ +++  +  
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 243

Query: 251 TRI-----RIEGIRKHPWFR 265
            R+       E ++ HPWF+
Sbjct: 244 QRLGNLQNGTEDVKNHPWFK 263

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  256 bits (656), Expect = 3e-82
 Identities = 83/269 (30%), Positives = 147/269 (54%), Gaps = 9/269 (3%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
            + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
             + HS  + +RDLKPENLL+D  G ++V+DFG +   ++      T CGTP  +APE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEII 210

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
            ++GY   A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+
Sbjct: 211 LSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 242 HKILDPNPKTRI-----RIEGIRKHPWFR 265
             +L  +   R       +  I+ H WF 
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  252 bits (645), Expect = 7e-81
 Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 36/283 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-H 68
           +  V R + EG FA V  AQ+  +G   A+K L  +   +      I +E+  MK +  H
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85

Query: 69  PNIVRLH-------EVLASRTKVYIILEFVTGGELFDKIV---HQGRLLENDCRRYFQQL 118
           PNIV+         E   +    +++L  +  G+L + +     +G L  +   + F Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 119 IDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG------------VE 164
             AV H H +   + HRDLK ENLLL + G +K+ DFG +                  VE
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 165 LLHTTCGTPNYVAPEV--LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI 222
              T   TP Y  PE+  L +    G   D+W+ G IL++L     PF +        +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRI 261

Query: 223 NAAEFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPW 263
              ++S P      T   SLI  +L  NP+ R+ I  +     
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  249 bits (639), Expect = 1e-80
 Identities = 81/285 (28%), Positives = 126/285 (44%), Gaps = 50/285 (17%)

Query: 2   KKQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREI 60
            K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+
Sbjct: 10  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREV 61

Query: 61  SIM-KIVRHPNIVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRR 113
            +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +   
Sbjct: 62  ELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE 121

Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLHTTC 170
             + + +A+ + HS  + HRD+KPENLL  S      LK++DFG                
Sbjct: 122 IMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPT---LYKKINAA- 225
                 A E      YD  + D+WS GVI+++L+ GY PF     L     +  +I    
Sbjct: 167 ------AKETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218

Query: 226 -EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
            EF  P W   S     LI  +L   P  R+ I     HPW  ++
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  252 bits (644), Expect = 1e-79
 Identities = 63/275 (22%), Positives = 106/275 (38%), Gaps = 26/275 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRH 68
            +     +G G    + +         VA+K +               RE+ +++    H
Sbjct: 25  SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE------CFSFADREVQLLRESDEH 77

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHS 127
           PN++R       R   YI +E      L + +       L  +     QQ    +AH HS
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 128 KGVYHRDLKPENLLLDSYGN-----LKVSDFGLS---ALPQQGVELLHTTCGTPNYVAPE 179
             + HRDLKP N+L+            +SDFGL    A+ +          GT  ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 180 VLS---NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFWF-- 233
           +LS            D++S G + + +++ G  PFG++        + A    C      
Sbjct: 197 MLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 234 -STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
               A  LI K++  +P+ R   + + KHP+F   
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  244 bits (625), Expect = 2e-77
 Identities = 41/304 (13%), Positives = 88/304 (28%), Gaps = 45/304 (14%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           ++   K ++   +  G  + V   ++ E  E  A+KV           ++++        
Sbjct: 58  SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117

Query: 65  IVRHPNIVRLHEVL--------------------------ASRTKVYIILEFVTG----- 93
            +   +     +                             +     +++   +      
Sbjct: 118 RLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177

Query: 94  GELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD 152
               D +                 QLI   A+  SKG+ H    P+NL +   G L + D
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGD 237

Query: 153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD-GSAADVWSCGVILFVLMAGYLPFG 211
                           +     Y   E L+        A + W  G+ ++ +   +LPFG
Sbjct: 238 VSALWKVG---TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294

Query: 212 ETD--LPTLYKKINAAE-------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP 262
                +   +K+ +          F           +LI + L+ + + R+      + P
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354

Query: 263 WFRK 266
            F +
Sbjct: 355 EFLQ 358

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  242 bits (620), Expect = 2e-77
 Identities = 71/276 (25%), Positives = 128/276 (46%), Gaps = 9/276 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            + + + IG G F++V  A     G  VA+K +    ++  +      +EI ++K + HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLIDAVAHC 125
           N+++ +       ++ I+LE    G+L   I H  +    + E    +YF QL  A+ H 
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS+ V HRD+KP N+ + + G +K+ D GL           H+  GTP Y++PE +   G
Sbjct: 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 212

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFG--ETDLPTLYKKINAAEFSC--PFWFSTGATSLI 241
           Y+   +D+WS G +L+ + A   PF   + +L +L KKI   ++       +S     L+
Sbjct: 213 YN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLV 271

Query: 242 HKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
           +  ++P+P+ R  +  +                   
Sbjct: 272 NMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  243 bits (623), Expect = 5e-77
 Identities = 72/258 (27%), Positives = 133/258 (51%), Gaps = 9/258 (3%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R IG+G+F KV   Q  +T +  AMK + K   ++   V  + +E+ IM+ + HP +V L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                    ++++++ + GG+L   +       E   + +  +L+ A+ +  ++ + HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GYDGSAA 191
           +KP+N+LLD +G++ ++DF ++A+  +    + T  GT  Y+APE+ S+R   GY   A 
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTMAGTKPYMAPEMFSSRKGAGY-SFAV 198

Query: 192 DVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
           D WS GV  + L+ G  P+     T    +         + P  +S    SL+ K+L+PN
Sbjct: 199 DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPN 258

Query: 249 PKTRI-RIEGIRKHPWFR 265
           P  R  ++  ++  P+  
Sbjct: 259 PDQRFSQLSDVQNFPYMN 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  239 bits (613), Expect = 8e-77
 Identities = 63/281 (22%), Positives = 114/281 (40%), Gaps = 31/281 (11%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
            R    ++    IG G F +V  A++R  G++  +K +  +        ++ +RE+  + 
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59

Query: 65  IVRHPNIVRLHE----------------VLASRTKVYIILEFVTGGELFDKIVHQ--GRL 106
            + H NIV  +                   +    ++I +EF   G L   I  +   +L
Sbjct: 60  KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119

Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
            +      F+Q+   V + HSK + +RDLKP N+ L     +K+ DFGL    +      
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKR 178

Query: 167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE 226
             + GT  Y++PE +S++ Y     D+++ G+IL  L+       ET     +  +    
Sbjct: 179 TRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDGI 235

Query: 227 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN 267
                 F     +L+ K+L   P+ R     I +     K 
Sbjct: 236 I--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  240 bits (615), Expect = 1e-76
 Identities = 70/267 (26%), Positives = 114/267 (42%), Gaps = 8/267 (2%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           + ++     ++    +G G++ +V   +++E G   A+K              ++    S
Sbjct: 50  RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLID 120
             K+ +HP  VRL +       +Y+  E   G  L       G  L E     Y +  + 
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLL 168

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           A+AH HS+G+ H D+KP N+ L   G  K+ DFGL               G P Y+APE+
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPEL 227

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLPTLYKKINAAEFSCPFWFSTGATS 239
           L    Y  +AADV+S G+ +  +     LP G      L +     EF      S+   S
Sbjct: 228 LQG-SYG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRS 283

Query: 240 LIHKILDPNPKTRIRIEGIRKHPWFRK 266
           ++  +L+P+PK R   E +   P  R+
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  235 bits (602), Expect = 5e-75
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 33/295 (11%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           R +  +E  + +G G F  V  A+N+    + A+K +        R   ++ RE+  +  
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAK 59

Query: 66  VRHPNIVRLHEV------------LASRTKVYIILEFVTGGELFDKIVHQGRLL---END 110
           + HP IVR                 + +  +YI ++      L D +  +  +     + 
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 111 CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL------------ 158
           C   F Q+ +AV   HSKG+ HRDLKP N+       +KV DFGL               
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
           P           GT  Y++PE +    Y     D++S G+ILF L+  Y    + +    
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRT 236

Query: 219 YKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
              +   +F             ++  +L P+P  R     I ++  F     P K
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGK 291

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  235 bits (603), Expect = 1e-74
 Identities = 88/261 (33%), Positives = 143/261 (54%), Gaps = 10/261 (3%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIVRHPN 70
           R +G+G + KV   R      TG+  AMKVL K+ I+   +     K E +I++ V+HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV L     +  K+Y+ILE+++GGELF ++  +G  +E+    Y  ++  A+ H H KG+
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN++L+  G++K++DFGL         + HT CGT  Y+APE+L   G+   A
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRA 201

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D WS G +++ ++ G  PF   +      KI   + + P + +  A  L+ K+L  N  
Sbjct: 202 VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAA 261

Query: 251 TRI-----RIEGIRKHPWFRK 266
           +R+         ++ HP+FR 
Sbjct: 262 SRLGAGPGDAGEVQAHPFFRH 282

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  233 bits (597), Expect = 1e-73
 Identities = 85/256 (33%), Positives = 134/256 (52%), Gaps = 6/256 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD 134
                +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130

Query: 135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVW 194
           +K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y G A D W
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 189

Query: 195 SCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI- 253
             GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +PK R+ 
Sbjct: 190 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249

Query: 254 ----RIEGIRKHPWFR 265
                 + + +H +F 
Sbjct: 250 GGPSDAKEVMEHRFFL 265

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  234 bits (599), Expect = 2e-73
 Identities = 83/256 (32%), Positives = 131/256 (51%), Gaps = 6/256 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + IG+G+F KV  A+++      A+KVL K  ILK +    I  E +++ K V+HP +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  K+Y +L+++ GGELF  +  +   LE   R Y  ++  A+ + HS  + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLKPEN+LLDS G++ ++DFGL     +      T CGTP Y+APEVL  + Y     D 
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDW 222

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W  G +L+ ++ G  PF   +   +Y  I           +  A  L+  +L  +   R+
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 282

Query: 254 ----RIEGIRKHPWFR 265
                   I+ H +F 
Sbjct: 283 GAKDDFMEIKSHVFFS 298

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  235 bits (601), Expect = 2e-73
 Identities = 86/266 (32%), Positives = 140/266 (52%), Gaps = 13/266 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YEV + IG G F +V+  +++ T +  AMK+L+K  ++K         E  IM     P 
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           +V+L         +Y+++E++ GG+L   ++    + E   R Y  +++ A+   HS G 
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYD-- 187
            HRD+KP+N+LLD  G+LK++DFG    + ++G+    T  GTP+Y++PEVL ++G D  
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249

Query: 188 -GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIH 242
            G   D WS GV L+ ++ G  PF    L   Y KI   + S  F      S  A +LI 
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309

Query: 243 KILDPNPKTRIRIEG---IRKHPWFR 265
             L  + + R+   G   I++H +F+
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFK 334

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  232 bits (593), Expect = 3e-73
 Identities = 94/260 (36%), Positives = 145/260 (55%), Gaps = 10/260 (3%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + +G+G+F KV   +     +  +  AMKVL K+T+     V   K E  I+  V HP I
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           V+LH    +  K+Y+IL+F+ GG+LF ++  +    E D + Y  +L  A+ H HS G+ 
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAA 191
           +RDLKPEN+LLD  G++K++DFGLS       +  ++ CGT  Y+APEV++ RG+   +A
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSA 207

Query: 192 DVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKT 251
           D WS GV++F ++ G LPF   D       I  A+   P + S  A SL+  +   NP  
Sbjct: 208 DWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPAN 267

Query: 252 RI-----RIEGIRKHPWFRK 266
           R+      +E I++H +F  
Sbjct: 268 RLGAGPDGVEEIKRHSFFST 287

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  230 bits (589), Expect = 2e-72
 Identities = 78/253 (30%), Positives = 133/253 (52%), Gaps = 3/253 (1%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           + +G+G+F KV  A+ ++T +  A+K L K  +L    V+    E  ++     HP +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   HSKG+ +R
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD  G++K++DFG+      G    +T CGTP+Y+APE+L  + Y   + D 
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDW 201

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+    P+ R+
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 261

Query: 254 RIEG-IRKHPWFR 265
            + G IR+HP FR
Sbjct: 262 GVRGDIRQHPLFR 274

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  230 bits (588), Expect = 4e-72
 Identities = 87/258 (33%), Positives = 136/258 (52%), Gaps = 8/258 (3%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R +G+G+F KV  A+ +ETG+  A+KVL K  IL+   V+    E  I+     HP + +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           L     +  +++ ++EFV GG+L   I    R  E   R Y  ++I A+   H KG+ +R
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLD  G+ K++DFG+            T CGTP+Y+APE+L    Y G A D 
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDW 207

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+L+ ++ G+ PF   +   L++ I   E   P W    AT ++   +  NP  R+
Sbjct: 208 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRL 267

Query: 254 ------RIEGIRKHPWFR 265
                     I +HP+F+
Sbjct: 268 GSLTQGGEHAILRHPFFK 285

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  229 bits (586), Expect = 7e-72
 Identities = 75/257 (29%), Positives = 136/257 (52%), Gaps = 7/257 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
             +G+G+F KV  ++ + T E  A+K+L K  +++   V+    E  ++    + P + +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    SKG+ +R
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G + D 
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 204

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+
Sbjct: 205 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 264

Query: 254 -----RIEGIRKHPWFR 265
                    I++H +FR
Sbjct: 265 GCGPEGERDIKEHAFFR 281

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  231 bits (591), Expect = 1e-71
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 17/270 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F +V   + +   +  AMK+L K  +LK       + E  ++       
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           I  LH        +Y+++++  GG+L   +   + RL E   R Y  +++ A+   H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVL-----SN 183
             HRD+KP+N+L+D  G+++++DFG    L + G        GTP+Y++PE+L       
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-----WFSTGAT 238
             Y G   D WS GV ++ ++ G  PF    L   Y KI   +    F       S  A 
Sbjct: 256 GRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314

Query: 239 SLIHKILDPNPKTRIRIEG---IRKHPWFR 265
            LI +++      R+   G    +KHP+F 
Sbjct: 315 DLIRRLICSREH-RLGQNGIEDFKKHPFFS 343

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  228 bits (583), Expect = 1e-71
 Identities = 84/267 (31%), Positives = 142/267 (53%), Gaps = 17/267 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R IG G++AKV   + ++T    AMKV+ K  +     +D ++ E  +  +   HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H +G+ +R
Sbjct: 75  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L    Y G + D 
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 193

Query: 194 WSCGVILFVLMAGYLPFGETDLPT---------LYKKINAAEFSCPFWFSTGATSLIHKI 244
           W+ GV++F +MAG  PF                L++ I   +   P   S  A S++   
Sbjct: 194 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 253

Query: 245 LDPNPKTRI------RIEGIRKHPWFR 265
           L+ +PK R+          I+ HP+FR
Sbjct: 254 LNKDPKERLGCHPQTGFADIQGHPFFR 280

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  230 bits (587), Expect = 2e-71
 Identities = 48/300 (16%), Positives = 98/300 (32%), Gaps = 42/300 (14%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
             R      G  +G+        A ++ETGES  + V   +       + Q+K E+  ++
Sbjct: 74  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133

Query: 65  ----------------------IVRHPNIVRLHEVLASRTKVYIILEFVT---------- 92
                                 +V+ P   ++  V      ++++  F            
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193

Query: 93  -GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS 151
            G  L         L+ +   +   Q+I  +A  H  G+ H  L+P +++LD  G + ++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253

Query: 152 DFGLSALPQQ-GVELLHTTCGTPNYVAPEVLSNRGYDGS----AADVWSCGVILFVLMAG 206
            F          V  +      P   A  +L    +  +    A D W+ G+ ++ +   
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 207 YLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            LP  +       + I    F           +L+   L    + R+      + P + +
Sbjct: 314 DLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  228 bits (583), Expect = 2e-71
 Identities = 42/287 (14%), Positives = 97/287 (33%), Gaps = 36/287 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
              V   +GEG FA+V  A        +  +   +KV   +   +  +     + +  +K
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI---GTQLMERLK 122

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR-----LLENDCRRYFQQLI 119
                  ++ +     +    ++ E  + G L + I          + +     +  +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 120 DAVAHCHSKGVYHRDLKPENLLL-----------DSYGNLKVSDFGLSA--LPQQGVELL 166
             +   H   + H D+KP+N +L           D    L + D G S          + 
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242

Query: 167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAA 225
              C T  +   E+LSN+ ++    D +     ++ ++ G Y+           + +   
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

Query: 226 EFSCPFWFSTGATSLIHKILDPNPKTRI-RIEGIRK--HPWFRKNYN 269
                 W         H +L+      +  ++ +R+     F+++Y 
Sbjct: 302 LPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  230 bits (587), Expect = 7e-71
 Identities = 87/257 (33%), Positives = 135/257 (52%), Gaps = 7/257 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP +  L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHR 133
                +  ++  ++E+  GGELF  +  +    E+  R Y  +++ A+ + HS K V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK ENL+LD  G++K++DFGL     +    + T CGTP Y+APEVL +  Y G A D 
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 332

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W  GV+++ +M G LPF   D   L++ I   E   P      A SL+  +L  +PK R+
Sbjct: 333 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRL 392

Query: 254 -----RIEGIRKHPWFR 265
                  + I +H +F 
Sbjct: 393 GGGSEDAKEIMQHRFFA 409

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  228 bits (583), Expect = 8e-71
 Identities = 83/267 (31%), Positives = 142/267 (53%), Gaps = 17/267 (6%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVR 73
           R IG G++AKV   + ++T    AM+V+ K  +     +D ++ E  +  +   HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    + ++++ ++E+V GG+L   +  Q +L E   R Y  ++  A+ + H +G+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N+LLDS G++K++D+G+     +  +   T CGTPNY+APE+L    Y G + D 
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 236

Query: 194 WSCGVILFVLMAGYLPFGET---------DLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
           W+ GV++F +MAG  PF                L++ I   +   P   S  A S++   
Sbjct: 237 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 296

Query: 245 LDPNPKTRI------RIEGIRKHPWFR 265
           L+ +PK R+          I+ HP+FR
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFR 323

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  227 bits (581), Expect = 2e-70
 Identities = 76/271 (28%), Positives = 125/271 (46%), Gaps = 17/271 (6%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+ + IG G F++V   + ++TG+  AMK++ K  +LK   V   + E  ++       
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKG 129
           I +LH        +Y+++E+  GG+L   +   G R+     R Y  +++ A+   H  G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGYD- 187
             HRD+KP+N+LLD  G+++++DFG    L   G        GTP+Y++PE+L   G   
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242

Query: 188 -----GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF-----WFSTGA 237
                G   D W+ GV  + +  G  PF        Y KI   +               A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302

Query: 238 TSLIHKILDPNPKTRIRIEG---IRKHPWFR 265
              I ++L   P+TR+   G    R HP+F 
Sbjct: 303 RDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  221 bits (566), Expect = 6e-69
 Identities = 86/270 (31%), Positives = 151/270 (55%), Gaps = 20/270 (7%)

Query: 15  RTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTIL-KHRMVDQIKREISIM-KIVRHP 69
           + +G G + KV   R     +TG+  AMKVL K+TI+ K +  +  + E  ++  I + P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            +V LH    + TK+++IL+++ GGELF  +  + R  E++ + Y  +++ A+ H H  G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS--ALPQQGVELLHTTCGTPNYVAPEVL--SNRG 185
           + +RD+K EN+LLDS G++ ++DFGLS   +  +  E  +  CGT  Y+AP+++   + G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSG 238

Query: 186 YDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           +   A D WS GV+++ L+ G  PF     +     + ++I  +E   P   S  A  LI
Sbjct: 239 H-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 297

Query: 242 HKILDPNPKTRI-----RIEGIRKHPWFRK 266
            ++L  +PK R+       + I++H +F+K
Sbjct: 298 QRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  227 bits (581), Expect = 6e-68
 Identities = 75/257 (29%), Positives = 137/257 (53%), Gaps = 7/257 (2%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVR 73
             +G+G+F KV  ++ + T E  A+K+L K  +++   V+    E  ++ +  + P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
           LH    +  ++Y ++E+V GG+L   I   GR  E     Y  ++   +    SKG+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADV 193
           DLK +N++LDS G++K++DFG+            T CGTP+Y+APE+++ + Y G + D 
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 525

Query: 194 WSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRI 253
           W+ GV+L+ ++AG  PF   D   L++ I     + P   S  A ++   ++  +P  R+
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRL 585

Query: 254 -----RIEGIRKHPWFR 265
                    I++H +FR
Sbjct: 586 GCGPEGERDIKEHAFFR 602

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  223 bits (569), Expect = 3e-67
 Identities = 73/264 (27%), Positives = 124/264 (46%), Gaps = 14/264 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G G F +V   Q + TG+  A K L K  + K +       E  I+  V    IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGV 130
                ++T + +++  + GG++   I +         E     Y  Q++  + H H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  GN+++SD GL+   + G        GTP ++APE+L    Y   +
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFS 369

Query: 191 ADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD 246
            D ++ GV L+ ++A   PF     + +   L +++     + P  FS  +      +L 
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQ 429

Query: 247 PNPKTRI-----RIEGIRKHPWFR 265
            +P+ R+       +G+R HP FR
Sbjct: 430 KDPEKRLGFRDGSCDGLRTHPLFR 453

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  223 bits (570), Expect = 3e-66
 Identities = 80/264 (30%), Positives = 127/264 (48%), Gaps = 15/264 (5%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNI 71
           R IG G F +V   +  +TG+  AMK L K  I   +       E  ++ +V     P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVY 131
           V +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H++ V 
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS-NRGYDGSA 190
           +RDLKP N+LLD +G++++SD GL+    +     H + GT  Y+APEVL     Y  S+
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKKP--HASVGTHGYMAPEVLQKGVAY-DSS 371

Query: 191 ADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP 247
           AD +S G +LF L+ G+ PF      D   + +         P  FS    SL+  +L  
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431

Query: 248 NPKTRIR-----IEGIRKHPWFRK 266
           +   R+       + +++ P+FR 
Sbjct: 432 DVNRRLGCLGRGAQEVKESPFFRS 455

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  220 bits (561), Expect = 7e-66
 Identities = 74/262 (28%), Positives = 126/262 (48%), Gaps = 13/262 (4%)

Query: 15  RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           R +G+G F +V   Q R TG+  A K L K  I K +       E  I++ V    +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLL--ENDCRRYFQQLIDAVAHCHSKGVYH 132
                ++  + ++L  + GG+L   I H G+    E     Y  ++   +   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAAD 192
           RDLKPEN+LLD +G++++SD GL+    +G + +    GT  Y+APEV+ N  Y   + D
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNERY-TFSPD 367

Query: 193 VWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFSCPFWFSTGATSLIHKILDPN 248
            W+ G +L+ ++AG  PF +         + + +          FS  A SL  ++L  +
Sbjct: 368 WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKD 427

Query: 249 PKTRI-----RIEGIRKHPWFR 265
           P  R+         +++HP F+
Sbjct: 428 PAERLGCRGGSAREVKEHPLFK 449

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  192 bits (490), Expect = 2e-58
 Identities = 54/288 (18%), Positives = 98/288 (34%), Gaps = 33/288 (11%)

Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           ++R   ++     IG G F  V     R  G   A+K   K         + ++   +  
Sbjct: 6   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 65

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL----ENDCRRYFQQLI 119
            + +H ++VR     A    + I  E+  GG L D I    R++    E + +    Q+ 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNL-------------------KVSDFGLSALPQ 160
             + + HS  + H D+KP N+ +                         K+ D G      
Sbjct: 126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183

Query: 161 QGVELLHTTCGTPNYVAPEVLS-NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY 219
             +       G   ++A EVL  N  +    AD+++  + +             D    +
Sbjct: 184 --ISSPQVEEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAEPLPRNGD---QW 237

Query: 220 KKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            +I        P   S   T L+  ++ P+P+ R     + KH     
Sbjct: 238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  185 bits (471), Expect = 4e-55
 Identities = 67/328 (20%), Positives = 110/328 (33%), Gaps = 74/328 (22%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAM-------------------KVLAK------ 44
            +E  + +G G F  V  A+N+    + A+                   K LAK      
Sbjct: 7   DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66

Query: 45  ------------------------------STILKHRMVDQIKREISIMKIVRHPNIVRL 74
                                           +     +D    +I  M      N V  
Sbjct: 67  VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEND---CRRYFQQLIDAVAHCHSKGVY 131
            +  + +  +YI ++      L D +  +  L + +   C   F Q+ +AV   HSKG+ 
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186

Query: 132 HRDLKPENLLLDSYGNLKVSDFGLSAL------------PQQGVELLHTTCGTPNYVAPE 179
           HRDLKP N+       +KV DFGL               P           GT  Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW-FSTGAT 238
            +    Y     D++S G+ILF L+  Y    + +   +   +   +F   F        
Sbjct: 247 QIHGNNYS-HKVDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH 303

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            ++  +L P+P  R     I ++  F  
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFEN 331

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  182 bits (463), Expect = 7e-54
 Identities = 81/321 (25%), Positives = 129/321 (40%), Gaps = 70/321 (21%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--------AKSTILKHRMVDQIK 57
           + + KYE    +GEG++  V   +N++TG  VA+K           K   +         
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM--------- 72

Query: 58  REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYF 115
           REI ++K +RH N+V L EV   + + Y++ EFV     +  +       L     ++Y 
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYL 130

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPN 174
            Q+I+ +  CHS  + HRD+KPEN+L+   G +K+ DFG +  L   G            
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD------- 183

Query: 175 YV------APEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI- 222
            V      APE+L  +  Y G A DVW+ G ++  +  G    P G++D+  LY      
Sbjct: 184 EVATRWYRAPELLVGDVKY-GKAVDVWAIGCLVTEMFMGEPLFP-GDSDIDQLYHIMMCL 241

Query: 223 ---------------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRI 255
                            A    P               S     L  K L  +P  R   
Sbjct: 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC 301

Query: 256 EGIRKHPWFRKNYNPVKCSEE 276
             +  H +F+ +    + S+E
Sbjct: 302 AELLHHDFFQMDGFAERFSQE 322

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  180 bits (459), Expect = 7e-54
 Identities = 69/264 (26%), Positives = 120/264 (45%), Gaps = 15/264 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
              +G+GT+  V   ++      +A+K +        R    +  EI++ K ++H NIV+
Sbjct: 27  RVVLGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEIALHKHLKHKNIVQ 83

Query: 74  LHEVLASRTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGV 130
                +    + I +E V GG L   +  +    +  E     Y +Q+++ + + H   +
Sbjct: 84  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143

Query: 131 YHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL--SNRGYD 187
            HRD+K +N+L+++Y G LK+SDFG S           T  GT  Y+APE++    RGY 
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY- 202

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPT--LYKKINAAEFSCPF--WFSTGATSLIHK 243
           G AAD+WS G  +  +  G  PF E   P   ++ K+   +         S  A + I K
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSAEAKAFILK 261

Query: 244 ILDPNPKTRIRIEGIRKHPWFRKN 267
             +P+P  R     +    + + +
Sbjct: 262 CFEPDPDKRACANDLLVDEFLKVS 285

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  181 bits (460), Expect = 1e-53
 Identities = 59/265 (22%), Positives = 107/265 (40%), Gaps = 18/265 (6%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
           V        +G G+F +V   ++++TG   A+K +        R+      E+     + 
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRVEELVACAGLS 108

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV L+  +     V I +E + GG L   I   G L E+    Y  Q ++ + + H+
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 128 KGVYHRDLKPENLLLDSYGNL-KVSDFGLSA-----LPQQGVELLHTTCGTPNYVAPEVL 181
           + + H D+K +N+LL S G+   + DFG +         + +       GT  ++APEV+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK--KINAAEFSCPFWFSTGAT 238
             +  D +  D+WS   ++  ++ G  P+ +    P   K           P   +    
Sbjct: 229 MGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPW 263
             I + L   P  R     +R+   
Sbjct: 288 QAIQEGLRKEPVHRASAMELRRKVG 312

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  180 bits (458), Expect = 2e-53
 Identities = 80/317 (25%), Positives = 131/317 (41%), Gaps = 70/317 (22%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL--------AKSTILKHRMVDQIKREIS 61
           KYE    IGEG++  V   +NR+TG+ VA+K           K   L         REI 
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL---------REIR 54

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQLI 119
           ++K ++HPN+V L EV   + +++++ E+         D+  +Q  + E+  +    Q +
Sbjct: 55  MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTL 112

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYV-- 176
            AV  CH     HRD+KPEN+L+  +  +K+ DFG +  L        +      + V  
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL---TGPSDYYD----DEVAT 165

Query: 177 ----APEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI----- 222
               +PE+L  +  Y G   DVW+ G +   L++G    P G++D+  LY   K      
Sbjct: 166 RWYRSPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWP-GKSDVDQLYLIRKTLGDLI 223

Query: 223 -----------NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIR 259
                        +    P               S  A  L+   L  +P  R+  E + 
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

Query: 260 KHPWFRKNYNPVKCSEE 276
            HP+F         ++E
Sbjct: 284 HHPYFENIREIEDLAKE 300

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  180 bits (458), Expect = 5e-53
 Identities = 79/314 (25%), Positives = 126/314 (40%), Gaps = 76/314 (24%)

Query: 5   TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK------- 57
             R  +YE    +GEG FA V  A+++ T + VA+K        K ++  + +       
Sbjct: 6   KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK--------KIKLGHRSEAKDGINR 57

Query: 58  ---REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCR 112
              REI +++ + HPNI+ L +    ++ + ++ +F+      +     +   L  +  +
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIK 115

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT 172
            Y    +  + + H   + HRDLKP NLLLD  G LK++DFGL+            + G+
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-----------KSFGS 164

Query: 173 PN-----------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL--- 215
           PN           Y APE+L   R Y G   D+W+ G IL  L+    +LP G++DL   
Sbjct: 165 PNRAYTHQVVTRWYRAPELLFGARMY-GVGVDMWAVGCILAELLLRVPFLP-GDSDLDQL 222

Query: 216 ---------PT--------------LYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKT 251
                    PT               +K          F         LI  +   NP  
Sbjct: 223 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 282

Query: 252 RIRIEGIRKHPWFR 265
           RI      K  +F 
Sbjct: 283 RITATQALKMKYFS 296

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143

 Score =  171 bits (435), Expect = 2e-52
 Identities = 103/141 (73%), Positives = 122/141 (86%), Gaps = 3/141 (2%)

Query: 303 GGPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLK 362
            GPL+MNAFEMITLSQGLNL+ALFDRRQD+VKRQTRFVSR+    I++NIEAVA S+  K
Sbjct: 2   EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFK 61

Query: 363 VHTRNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKL 422
            HTRN+KTRLEG+S+ K GQ AVV+E++EVAPSLFMVDVRKAAG+TLEYHKFYK  C+KL
Sbjct: 62  SHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKL 121

Query: 423 ENIIWKPTEG---SSLLRTMS 440
           ENIIW+ TEG   S +LRT++
Sbjct: 122 ENIIWRATEGIPKSEILRTIT 142

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  175 bits (445), Expect = 1e-51
 Identities = 91/307 (29%), Positives = 132/307 (42%), Gaps = 69/307 (22%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--------RE 59
           + KYE    IGEGT+  V  A+NRET E VA+K        + R+ D           RE
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRL-DDDDEGVPSSALRE 51

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQ 117
           I ++K ++H NIVRLH+VL S  K+ ++ EF      + FD     G L     + +  Q
Sbjct: 52  ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQ 109

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCGTPN 174
           L+  +  CHS+ V HRDLKP+NLL++  G LK+++FGL+    +P +        C +  
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--------CYSAE 161

Query: 175 -----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDL----------- 215
                Y  P+VL   + Y  ++ D+WS G I   L     P   G               
Sbjct: 162 VVTLWYRPPDVLFGAKLY-STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220

Query: 216 -PT-----------LYKKINAAEFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGI 258
            PT            YK       +          +     L+  +L  NP  RI  E  
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

Query: 259 RKHPWFR 265
            +HP+F 
Sbjct: 281 LQHPYFS 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  171 bits (435), Expect = 5e-50
 Identities = 86/313 (27%), Positives = 136/313 (43%), Gaps = 78/313 (24%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
             + KY+    +GEGT+  V  A++   G  VA+K        + R+ D           
Sbjct: 18  GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALK--------RIRL-DAEDEGIPSTAI 67

Query: 58  REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYF 115
           REIS++K + HPNIV L +V+ S   + ++ EF+     ++ D+  ++  L ++  + Y 
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN- 174
            QL+  VAHCH   + HRDLKP+NLL++S G LK++DFGL+              G P  
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA-----------RAFGIPVR 174

Query: 175 ----------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK- 220
                     Y AP+VL  ++ Y  ++ D+WS G I   ++ G    P G TD   L K 
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKY-STSVDIWSIGCIFAEMITGKPLFP-GVTDDDQLPKI 232

Query: 221 -KI----------------NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTR 252
             I                   + +   +           F      L+  +L  +P  R
Sbjct: 233 FSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292

Query: 253 IRIEGIRKHPWFR 265
           I       HP+F+
Sbjct: 293 ISARDAMNHPYFK 305

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  170 bits (433), Expect = 1e-49
 Identities = 72/321 (22%), Positives = 127/321 (39%), Gaps = 79/321 (24%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--- 57
                  + +Y     +GEGT+ +V  A +  T E+VA+K        + R+ +  +   
Sbjct: 26  AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK--------RIRL-EHEEEGV 76

Query: 58  -----REISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCR 112
                RE+S++K ++H NI+ L  V+    ++++I E+    +L   +     +     +
Sbjct: 77  PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK 135

Query: 113 RYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-----GNLKVSDFGLSALPQQGVELLH 167
            +  QLI+ V  CHS+   HRDLKP+NLLL          LK+ DFGL+           
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------- 184

Query: 168 TTCGTPN-----------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGET 213
              G P            Y  PE+L  +R Y  ++ D+WS   I   ++      P G++
Sbjct: 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKTPLFP-GDS 242

Query: 214 DLPTLYK-----------------------------KINAAEFSCPFWFSTGATSLIHKI 244
           ++  L+K                             +    +             L+  +
Sbjct: 243 EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAM 302

Query: 245 LDPNPKTRIRIEGIRKHPWFR 265
           L+ +P  RI  +   +HP+F 
Sbjct: 303 LEMDPVKRISAKNALEHPYFS 323

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  169 bits (430), Expect = 3e-49
 Identities = 83/317 (26%), Positives = 128/317 (40%), Gaps = 79/317 (24%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL-------AKSTILKHRMVDQIKRE 59
             ++++    +G GT+A V    N+ TG  VA+K +         ST +         RE
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI---------RE 53

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGG-----ELFDKIVHQGRLLENDCRRY 114
           IS+MK ++H NIVRL++V+ +  K+ ++ EF+        +          L  N  + +
Sbjct: 54  ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
             QL+  +A CH   + HRDLKP+NLL++  G LK+ DFGL+              G P 
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA-----------RAFGIPV 162

Query: 175 -----------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLP----------- 209
                      Y AP+VL  +R Y  ++ D+WSCG IL  ++ G    P           
Sbjct: 163 NTFSSEVVTLWYRAPDVLMGSRTY-STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

Query: 210 F------------GETDLP------TLYKKINAAEF---SCPFWFSTGATSLIHKILDPN 248
           F              T LP            +  +                 +H +L  N
Sbjct: 222 FDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281

Query: 249 PKTRIRIEGIRKHPWFR 265
           P  R+  +    HPWF 
Sbjct: 282 PDMRLSAKQALHHPWFA 298

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  168 bits (428), Expect = 3e-49
 Identities = 60/263 (22%), Positives = 116/263 (44%), Gaps = 15/263 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR 73
              IG G+F  V    + ET   VA   L    + K     + K E  ++K ++HPNIVR
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVR 89

Query: 74  LH----EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            +      +  +  + ++ E +T G L   +     +     R + +Q++  +   H++ 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 130 --VYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
             + HRDLK +N+ +    G++K+ D GL+ L +          GTP ++APE+     Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KY 206

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINAAE--FSCPFWFSTGATSLIHK 243
           D  + DV++ G+ +  +     P+ E  +   +Y+++ +     S           +I  
Sbjct: 207 D-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265

Query: 244 ILDPNPKTRIRIEGIRKHPWFRK 266
            +  N   R  I+ +  H +F++
Sbjct: 266 CIRQNKDERYSIKDLLNHAFFQE 288

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  168 bits (428), Expect = 3e-49
 Identities = 83/306 (27%), Positives = 138/306 (45%), Gaps = 69/306 (22%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--------RE 59
           + KY     IGEGT+  V  AQN   GE+ A+K        K R+ ++          RE
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALK--------KIRL-EKEDEGIPSTTIRE 50

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQ 117
           ISI+K ++H NIV+L++V+ ++ ++ ++ E +     +L D    +G L     + +  Q
Sbjct: 51  ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQ 108

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCGTPN 174
           L++ +A+CH + V HRDLKP+NLL++  G LK++DFGL+    +P +          T  
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHE 160

Query: 175 -----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLP-----------F----- 210
                Y AP+VL  ++ Y  +  D+WS G I   ++ G    P           F     
Sbjct: 161 IVTLWYRAPDVLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219

Query: 211 -------GETDLP---TLYKKINAAEFSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIR 259
                    T+LP     +       +             L+ K+L  +P  RI  +   
Sbjct: 220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

Query: 260 KHPWFR 265
           +H +F+
Sbjct: 280 EHAYFK 285

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  168 bits (428), Expect = 6e-49
 Identities = 73/310 (23%), Positives = 129/310 (41%), Gaps = 76/310 (24%)

Query: 8   VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL-------AKSTILKHRMVDQIKREI 60
           +  Y     +GEGT+A V   +++ T   VA+K +       A  T +         RE+
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI---------REV 51

Query: 61  SIMKIVRHPNIVRLHEVLASRTKVYIILEFVTG--GELFDKIVHQGRLLENDCRRYFQQL 118
           S++K ++H NIV LH+++ +   + ++ E++     +  D       +  ++ + +  QL
Sbjct: 52  SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQL 109

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN---- 174
           +  +A+CH + V HRDLKP+NLL++  G LK++DFGL+                P     
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA-----------RAKSIPTKTYD 158

Query: 175 -------YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--KI 222
                  Y  P++L  +  Y  +  D+W  G I + +  G    P G T    L+   +I
Sbjct: 159 NEVVTLWYRPPDILLGSTDY-STQIDMWGVGCIFYEMATGRPLFP-GSTVEEQLHFIFRI 216

Query: 223 ----------------NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRI 255
                               ++ P +             +    L+ K+L    + RI  
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA 276

Query: 256 EGIRKHPWFR 265
           E   KHP+F 
Sbjct: 277 EDAMKHPFFL 286

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  167 bits (425), Expect = 4e-48
 Identities = 80/319 (25%), Positives = 133/319 (41%), Gaps = 75/319 (23%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
             V+KYE    IG+GTF +V  A++R+TG+ VA+K        K  M +  K        
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK--------KVLM-ENEKEGFPITAL 64

Query: 58  REISIMKIVRHPNIVRLHEVLASR--------TKVYIILEFV----TGGELFDKIVHQGR 105
           REI I+++++H N+V L E+  ++          +Y++ +F      G  L        +
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSN--VLVK 120

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQG 162
              ++ +R  Q L++ + + H   + HRD+K  N+L+   G LK++DFGL+   +L +  
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180

Query: 163 VELLHTTC-GTPNYVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDL--- 215
               +T    T  Y  PE+L   R Y G   D+W  G I+  +      +  G T+    
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRSPIMQ-GNTEQHQL 238

Query: 216 ---------PT-----------LYKKIN---------AAEFSCPFWFSTGATSLIHKILD 246
                     T           LY+K+                 +     A  LI K+L 
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK-AYVRDPYALDLIDKLLV 297

Query: 247 PNPKTRIRIEGIRKHPWFR 265
            +P  RI  +    H +F 
Sbjct: 298 LDPAQRIDSDDALNHDFFW 316

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  163 bits (416), Expect = 3e-47
 Identities = 73/323 (22%), Positives = 115/323 (35%), Gaps = 86/323 (26%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------- 57
              ++YE    IG G +  V  A++  +G  VA+K          R+             
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--------SVRV-PNGGGGGGGLPI 56

Query: 58  ---REISIMK---IVRHPNIVRLHEVLASR-----TKVYIILEFVTG--GELFDKIVHQG 104
              RE+++++      HPN+VRL +V A+       KV ++ E V        DK    G
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116

Query: 105 RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE 164
            L     +   +Q +  +   H+  + HRDLKPEN+L+ S G +K++DFGL+        
Sbjct: 117 -LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA-------- 167

Query: 165 LLHTTCGTPN----------YVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGE 212
                               Y APEVL    Y  +  D+WS G I   +         G 
Sbjct: 168 ---RIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFC-GN 222

Query: 213 TDLPTLYK-----------------KINAAEFSCPFW-----------FSTGATSLIHKI 244
           ++   L K                  +    F  P                    L+ ++
Sbjct: 223 SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAF--PPRGPRPVQSVVPEMEESGAQLLLEM 280

Query: 245 LDPNPKTRIRIEGIRKHPWFRKN 267
           L  NP  RI      +H +  K+
Sbjct: 281 LTFNPHKRISAFRALQHSYLHKD 303

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  161 bits (410), Expect = 2e-46
 Identities = 69/207 (33%), Positives = 102/207 (49%), Gaps = 11/207 (5%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   IG G+F  V  A+    G  VA+K+L          V++  RE++IMK +RHPNI
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH--GSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA------HC 125
           V     +     + I+ E+++ G L+  +   G   + D RR      D VA      H 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD-VAKGMNYLHN 155

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            +  + HR+LK  NLL+D    +KV DFGLS L         +  GTP ++APEVL +  
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP 215

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGE 212
            +   +DV+S GVIL+ L     P+G 
Sbjct: 216 SN-EKSDVYSFGVILWELATLQQPWGN 241

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  160 bits (406), Expect = 7e-46
 Identities = 72/257 (28%), Positives = 108/257 (42%), Gaps = 35/257 (13%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           EV   +G G F  V  A+ R   + VA+K +   +  K         E+  +  V HPNI
Sbjct: 11  EVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID---AVAHCHS- 127
           V+L    A    V +++E+  GG L++ +     L            +     VA+ HS 
Sbjct: 64  VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 128 --KGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
             K + HRDLKP NLLL + G  LK+ DFG +   Q     +    G+  ++APEV    
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGS 178

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---------SCPFWFST 235
            Y     DV+S G+IL+ ++    PF E   P    +I  A           + P     
Sbjct: 179 NYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTRPPLIKNLPKPIE- 234

Query: 236 GATSLIHKILDPNPKTR 252
              SL+ +    +P  R
Sbjct: 235 ---SLMTRCWSKDPSQR 248

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  159 bits (404), Expect = 2e-45
 Identities = 79/310 (25%), Positives = 123/310 (39%), Gaps = 66/310 (21%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIK------- 57
           R   +YE    IGEG + KV  A++ +  G  VA+K        + R+    +       
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALK--------RVRV-QTGEEGMPLST 58

Query: 58  -REISIMK---IVRHPNIVRLHEVLASR-----TKVYIILEFVTG--GELFDKIVHQGRL 106
            RE+++++      HPN+VRL +V         TK+ ++ E V        DK+  +  +
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV-PEPGV 117

Query: 107 LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
                +    QL+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+       ++ 
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMA 175

Query: 167 HTTC-GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG--YLPFGETDLPTLYK--- 220
            T+   T  Y APEVL    Y  +  D+WS G I   +         G +D+  L K   
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFR-GSSDVDQLGKILD 233

Query: 221 --------------KINAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRI 255
                          +    F                       L+ K L  NP  RI  
Sbjct: 234 VIGLPGEEDWPRDVALPRQAF--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 291

Query: 256 EGIRKHPWFR 265
                HP+F+
Sbjct: 292 YSALSHPYFQ 301

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  157 bits (398), Expect = 1e-44
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
             G  +G+G F +     +RETGE + MK L +             +E+ +M+ + HPN+
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNV 69

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLID-------AVAH 124
           ++   VL    ++  I E++ GG L   I              + Q +         +A+
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYP------WSQRVSFAKDIASGMAY 123

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH--------------TTC 170
            HS  + HRDL   N L+    N+ V+DFGL+ L                       T  
Sbjct: 124 LHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           G P ++APE+++ R YD    DV+S G++L  ++      
Sbjct: 184 GNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNAD 222

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  159 bits (403), Expect = 3e-44
 Identities = 83/301 (27%), Positives = 130/301 (43%), Gaps = 49/301 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y   + IG G+F  V  A+  ++GE VA+K   K  +L+ +      RE+ IM+ + H 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---K--VLQDKR--FKNRELQIMRKLDHC 107

Query: 70  NIVRLHEVLASRT------KVYIILEFV--TGGELFDKIVHQGRLLEND-CRRYFQQLID 120
           NIVRL     S         + ++L++V  T   +        + L     + Y  QL  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G   +   C +  Y APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYYRAPE 226

Query: 180 V-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI--------------- 222
           +      Y  S+ DVWS G +L  L+ G   F G++ +  L + I               
Sbjct: 227 LIFGATDYT-SSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285

Query: 223 -NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN 269
            N  EF  P                  A +L  ++L+  P  R+       H +F +  +
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345

Query: 270 P 270
           P
Sbjct: 346 P 346

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  155 bits (394), Expect = 3e-44
 Identities = 69/275 (25%), Positives = 124/275 (45%), Gaps = 27/275 (9%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +     IG+G+F +V    +  T + VA+K++          ++ I++EI+++     P 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           + + +      TK++II+E++ GG   D ++  G L E       ++++  + + HS+  
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            HRD+K  N+LL  +G +K++DFG++          +T  GTP ++APEV+    YD S 
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SK 199

Query: 191 ADVWSCGVILFVLMAGYLPFGET------------DLPTLYKKINAAEFSCPFWFSTGAT 238
           AD+WS G+    L  G  P  E             + PTL        +S P        
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN-----YSKPL------K 248

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKC 273
             +   L+  P  R   + + KH +  +N      
Sbjct: 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  154 bits (392), Expect = 4e-44
 Identities = 66/266 (24%), Positives = 108/266 (40%), Gaps = 38/266 (14%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVL----AKSTILKHRMVDQIKREISIMKIVR 67
           E  + IG+G F  V   +  +    VA+K L    ++          + +RE+ IM  + 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA---- 123
           HPNIV+L           +++EFV  G+L+ +++ +   +        + ++D       
Sbjct: 82  HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSVKLRLMLDIALGIEY 137

Query: 124 -HCHSKGVYHRDLKPENLLLDSYG-----NLKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
               +  + HRDL+  N+ L S         KV+DFGLS   QQ V  +    G   ++A
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLLGNFQWMA 194

Query: 178 PEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------- 227
           PE +      Y    AD +S  +IL+ ++ G  PF E       K IN            
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREEGLRPTIP 252

Query: 228 -SCPFWFSTGATSLIHKILDPNPKTR 252
             CP        ++I      +PK R
Sbjct: 253 EDCPPRLR----NVIELCWSGDPKKR 274

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (382), Expect = 7e-43
 Identities = 42/211 (19%), Positives = 84/211 (39%), Gaps = 20/211 (9%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
                + E    ++   + +  G  + +KVL K      R       E   ++I  HPN+
Sbjct: 13  NFLTKLNENHSGELWKGRWQ--GNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 72  VRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA------ 123
           + +     S       +I  ++  G L++ ++H+G     D  +  +  +D +A      
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYN-VLHEGTNFVVDQSQAVKFALD-MARGMAFL 127

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H     +    L   ++++D     ++S   +    Q            P +VAPE L  
Sbjct: 128 HTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-----GRMYAPAWVAPEALQK 182

Query: 184 RGYDGS--AADVWSCGVILFVLMAGYLPFGE 212
           +  D +  +AD+WS  V+L+ L+   +PF +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  152 bits (387), Expect = 2e-42
 Identities = 84/295 (28%), Positives = 128/295 (43%), Gaps = 50/295 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y   + IG G+F  V  A+  E+ E VA+K   K  +L+ +      RE+ IM+IV+HP
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDE-VAIK---K--VLQDK--RFKNRELQIMRIVKHP 92

Query: 70  NIVRLHEVLASRT------KVYIILEFV--TGGELFDKIVHQGRLLEND-CRRYFQQLID 120
           N+V L     S         + ++LE+V  T            + +     + Y  QL+ 
Sbjct: 93  NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           ++A+ HS G+ HRD+KP+NLLLD   G LK+ DFG + +   G   +   C +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPE 211

Query: 180 V-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKI--------------- 222
           +      Y  +  D+WS G ++  LM G   F GE+ +  L + I               
Sbjct: 212 LIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270

Query: 223 -NAAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
            N  E   P                  A  LI ++L+  P  R+       HP+F
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  149 bits (377), Expect = 1e-41
 Identities = 70/260 (26%), Positives = 136/260 (52%), Gaps = 8/260 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             +    IGEG+   V  A+ + +G  VA+K++    + K +  + +  E+ IM+  +H 
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHF 102

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           N+V +++      ++++++EF+ GG L D IV Q RL E       + ++ A+A+ H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+K +++LL   G +K+SDFG  A   + V    +  GTP ++APEV+S   Y  +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA-T 220

Query: 190 AADVWSCGVILFVLMAGYLP-FGETDLPTLYK--KINAAEFSCPFWFSTGATSLIHKILD 246
             D+WS G+++  ++ G  P F ++ +  + +       +       S      + ++L 
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280

Query: 247 PNPKTRIRIEGIRKHPWFRK 266
            +P+ R   + +  HP+  +
Sbjct: 281 RDPQERATAQELLDHPFLLQ 300

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  147 bits (373), Expect = 3e-41
 Identities = 68/260 (26%), Positives = 125/260 (48%), Gaps = 8/260 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +    + +    + I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+K +N+LL   G++K++DFG  A          T  GTP ++APEV++ + Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 190 AADVWSCGVILFVLMAGYLP-FGETDLPTLYK--KINAAEFSCPFWFSTGATSLIHKILD 246
             D+WS G++   ++ G  P   E  L  LY        E   P   S      +++ L+
Sbjct: 197 -VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255

Query: 247 PNPKTRIRIEGIRKHPWFRK 266
            + + R   + + +H + + 
Sbjct: 256 MDVEKRGSAKELLQHQFLKI 275

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  149 bits (377), Expect = 3e-41
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 6/243 (2%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E    +G G    V    ++ +G  +A K++      K  + +QI RE+ ++     P 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPY 92

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG- 129
           IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRD+KP N+L++S G +K+ DFG+S   Q    + ++  GT +Y++PE L    Y   
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGTHYS-V 209

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
            +D+WS G+ L  +  G  P    D   L                    +    +     
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269

Query: 250 KTR 252
            +R
Sbjct: 270 DSR 272

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  147 bits (372), Expect = 4e-41
 Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 13/266 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +E+   +G+G F KV  A+N+ETG   A KV+   +  +   ++    EI I+    HP
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSK 128
            IV+L        K++I++EF  GG +   ++   R L     +   +Q+++A+   HSK
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-----LSN 183
            + HRDLK  N+L+   G+++++DFG+SA   + ++   +  GTP ++APEV     + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYK--KINAAEFSCPFWFSTGATSL 240
             YD   AD+WS G+ L  +     P  E + +  L K  K +      P  +S      
Sbjct: 197 TPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFRK 266
           +   LD NP+TR     + +HP+   
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSS 281

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  147 bits (374), Expect = 5e-41
 Identities = 76/299 (25%), Positives = 128/299 (42%), Gaps = 56/299 (18%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-H 68
            Y++ R +G G +++V  A N    E V +K      ILK     +IKREI I++ +R  
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 90

Query: 69  PNIVRLHEVL---ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           PNI+ L +++    SRT   +  E V   +   K ++Q  L + D R Y  +++ A+ +C
Sbjct: 91  PNIITLADIVKDPVSRTPALVF-EHVNNTDF--KQLYQ-TLTDYDIRFYMYEILKALDYC 146

Query: 126 HSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL-SN 183
           HS G+ HRD+KP N+++D  +  L++ D+GL+     G E       +  +  PE+L   
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV-RVASRYFKGPELLVDY 205

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF--------------------GETDLPTLYKKIN 223
           + YD  + D+WS G +L  ++    PF                       D    Y    
Sbjct: 206 QMYD-YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264

Query: 224 AAEF--SCPFW----------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
              F                        S  A   + K+L  + ++R+      +HP+F
Sbjct: 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  147 bits (372), Expect = 8e-41
 Identities = 54/261 (20%), Positives = 104/261 (39%), Gaps = 29/261 (11%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           E+G  IG+G F +V   +       VA++++          +   KRE+   +  RH N+
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE---VAIRLI-DIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGV 130
           V       S   + II     G  L+  +     +L+ +  R   Q+++  + + H+KG+
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS-----ALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
            H+DLK +N+  D+ G + ++DFGL          +  + L    G   ++APE++    
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 186 YDGS--------AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------AEFSCPF 231
            D           +DV++ G I + L A   PF       +  ++        ++     
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK 270

Query: 232 WFSTGATSLIHKILDPNPKTR 252
             S     ++        + R
Sbjct: 271 EIS----DILLFCWAFEQEER 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (368), Expect = 1e-40
 Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 10/204 (4%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            VG+ IG G+F  V   +       VA+K+L   T    + +   K E+ +++  RH NI
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGD---VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGV 130
           +      ++  ++ I+ ++  G  L+  +       E        +Q    + + H+K +
Sbjct: 83  LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVLSNRGYD- 187
            HRDLK  N+ L     +K+ DFGL+    +           G+  ++APEV+  +  + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 188 -GSAADVWSCGVILFVLMAGYLPF 210
               +DV++ G++L+ LM G LP+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPY 225

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  145 bits (369), Expect = 2e-40
 Identities = 71/262 (27%), Positives = 131/262 (50%), Gaps = 12/262 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            ++V   +GEG++  V  A ++ETG+ VA+K +     ++   + +I +EISIM+    P
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESD-LQEIIKEISIMQQCDSP 84

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           ++V+ +      T ++I++E+   G + D I +    L E++     Q  +  + + H  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
              HRD+K  N+LL++ G+ K++DFG++      +   +T  GTP ++APEV+   GY+ 
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204

Query: 189 SAADVWSCGVILFVLMAGYLP--FGETDLPTLYK--KINAAEFSCPFWFSTGATSLIHKI 244
             AD+WS G I  + MA   P       +  ++         F  P  +S   T  + + 
Sbjct: 205 V-ADIWSLG-ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262

Query: 245 LDPNPKTRIRIEGIRKHPWFRK 266
           L  +P+ R     + +HP+ R 
Sbjct: 263 LVKSPEQRATATQLLQHPFVRS 284

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  145 bits (367), Expect = 3e-40
 Identities = 71/287 (24%), Positives = 120/287 (41%), Gaps = 32/287 (11%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHP 69
            E    +G GT  +V   + R+TG  +A+K + +S         +I  ++ + +K    P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCP 84

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK- 128
            IV+      + T V+I +E +       K   QG + E    +    ++ A+ +   K 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH-----TTCGTPNYVAPEVL-- 181
           GV HRD+KP N+LLD  G +K+ DFG+S        L+       + G   Y+APE +  
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG------RLVDDKAKDRSAGCAAYMAPERIDP 198

Query: 182 ---SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKI---NAAEFSCPFWFS 234
              +   YD   ADVWS G+ L  L  G  P+        +  K+             FS
Sbjct: 199 PDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
               S +   L  + + R +   + +H + ++        E  EV++
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR-------YETLEVDV 297

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  143 bits (363), Expect = 6e-40
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 24/216 (11%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREISIMKIVRHPN 70
            +   IG G F KV  A     G+ VA+K           + ++ +++E  +  +++HPN
Sbjct: 10  TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA---VAHCHS 127
           I+ L  V      + +++EF  GG L   ++   R+            +     + + H 
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNR-VLSGKRI---PPDILVNWAVQIARGMNYLHD 123

Query: 128 KGVY---HRDLKPENLLLDSYG--------NLKVSDFGLSALPQQGVELLHTTCGTPNYV 176
           + +    HRDLK  N+L+             LK++DFGL+    +  ++  +  G   ++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWM 181

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE 212
           APEV+    +    +DVWS GV+L+ L+ G +PF  
Sbjct: 182 APEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG 216

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123

 Score =  138 bits (348), Expect = 8e-40
 Identities = 33/127 (25%), Positives = 61/127 (48%), Gaps = 7/127 (5%)

Query: 304 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKV 363
           G   MNAF++I+ S G NL+ LF   +    R  RFVS   A+ ++  +E +  + +L V
Sbjct: 2   GARRMNAFDIISGSPGFNLSGLFGDARK-YDRVERFVSAWTAERVVERLEEIVSAENLTV 60

Query: 364 HTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKN-FCAK 421
             +  +  ++EG      G FA+V+E+ ++   L M++VRK           + +     
Sbjct: 61  AKKETWGMKIEGQK----GNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116

Query: 422 LENIIWK 428
              ++ +
Sbjct: 117 FVELVHE 123

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  140 bits (355), Expect = 1e-38
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 3/215 (1%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y++   +G G  + V  A++      VA+K +      K   + + +RE+     + H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IV + +V       Y+++E++ G  L + I   G L  +    +  Q++D + H H   +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
            HRD+KP+N+L+DS   LK+ DFG++ AL +  +   +   GT  Y +PE  +       
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKGEATDE 191

Query: 190 AADVWSCGVILFVLMAGYLPF-GETDLPTLYKKIN 223
             D++S G++L+ ++ G  PF GET +    K I 
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ 226

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  140 bits (354), Expect = 2e-38
 Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 35/284 (12%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKIVRH 68
           YE+   IG G  A V+ A      E VA+K   L K        +D++ +EI  M    H
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT----SMDELLKEIQAMSQCHH 72

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV------ 122
           PNIV  +     + +++++++ ++GG + D I H     E+      +  I  +      
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 123 --AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL-----HTTCGTPNY 175
              + H  G  HRD+K  N+LL   G+++++DFG+SA    G ++       T  GTP +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 176 VAPEVLS-NRGYDGSAADVWSCGVILFVLMAGYLPFGET------------DLPTLYKKI 222
           +APEV+   RGYD   AD+WS G+    L  G  P+ +             D P+L  + 
Sbjct: 193 MAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL--ET 249

Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
              +      +      +I   L  +P+ R     + +H +F+K
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  141 bits (357), Expect = 3e-38
 Identities = 83/333 (24%), Positives = 129/333 (38%), Gaps = 81/333 (24%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +G+T+G G+F  V    + E+G+  A+K   K             RE+ IMK++ H 
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRY----KNRELDIMKVLDHV 60

Query: 70  NIVRLHEVLASRTK--------------------------------------VYIILEFV 91
           NI++L +   +                                         + +I+E+V
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 92  --TGGELFDKIVHQGRLLEND-CRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GN 147
             T  ++    +  GR +  +    Y  QL  AV   HS G+ HRD+KP+NLL++S    
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180

Query: 148 LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV-LSNRGYDGSAADVWSCGVILFVLMAG 206
           LK+ DFG +         +   C +  Y APE+ L    Y   + D+WS G +   L+ G
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGELILG 238

Query: 207 YLPF-GETDL------------PTL--YKKIN--AAEFSCPFW----FS--------TGA 237
              F GET +            PT     ++N    E   P      +         + A
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             L+ +IL   P  RI       HP+F    N 
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFFDHLRNS 331

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  140 bits (355), Expect = 3e-38
 Identities = 69/269 (25%), Positives = 119/269 (44%), Gaps = 24/269 (8%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +   R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHP
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           N ++           ++++E+  G       VH+  L E +        +  +A+ HS  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR---GY 186
           + HRD+K  N+LL   G +K+ DFG +++        ++  GTP ++APEV+       Y
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQY 230

Query: 187 DGSAADVWSCGVILFVLMAGYLP--FGETDLPTLYK-------KINAAEFSCPFWFSTGA 237
           DG   DVWS G I  + +A   P  F    +  LY         + +  +S  F      
Sbjct: 231 DGK-VDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF------ 282

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
            + +   L   P+ R   E + KH +  +
Sbjct: 283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  140 bits (355), Expect = 1e-37
 Identities = 67/334 (20%), Positives = 120/334 (35%), Gaps = 78/334 (23%)

Query: 2   KKQTRRVAKYEV-GRTIGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKR 58
            ++ R    +E  G  +G GT+  V  A+ ++    +  A+K +  + I          R
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACR 67

Query: 59  EISIMKIVRHPNIVRLHEVLASRT--KVYIILEFV--------TGGELFDKIVHQGRLLE 108
           EI++++ ++HPN++ L +V  S    KV+++ ++                      +L  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127

Query: 109 NDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN----LKVSDFGLSALPQQGVE 164
              +    Q++D + + H+  V HRDLKP N+L+   G     +K++D G + L      
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL--FNSP 185

Query: 165 LLHTTCGTPN-----YVAPEVL-SNRGYDGSAADVWSCGVILFVLMAG------------ 206
           L       P      Y APE+L   R Y   A D+W+ G I   L+              
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244

Query: 207 -----------------------------YLPFGETDLPTLYKKINAAEFSCPF------ 231
                                         +P   T +    +          +      
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304

Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
              + A  L+ K+L  +P  RI  E   + P+F 
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  138 bits (350), Expect = 1e-37
 Identities = 71/303 (23%), Positives = 124/303 (40%), Gaps = 55/303 (18%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHP 69
            +    IG G +  V    ++ +G+ +A+K +   + +  +   Q+  ++ + M+    P
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV------HQGRLLENDCRRYFQQLIDAVA 123
            IV+ +  L      +I +E ++    FDK            + E    +     + A+ 
Sbjct: 82  YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139

Query: 124 HCHSKG-VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-----TCGTPNYVA 177
           H      + HRD+KP N+LLD  GN+K+ DFG+S       +L+ +       G   Y+A
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG------QLVDSIAKTRDAGCRPYMA 193

Query: 178 PEVL----SNRGYDGSAADVWSCGVILFVLMAGYLPFGET-------------DLPTLYK 220
           PE +    S +GYD   +DVWS G+ L+ L  G  P+ +              D P L  
Sbjct: 194 PERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL-S 251

Query: 221 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN 280
                EFS  F       + ++  L  +   R + + + KHP+           EE  V 
Sbjct: 252 NSEEREFSPSF------INFVNLCLTKDESKRPKYKELLKHPFILM-------YEERAVE 298

Query: 281 LDD 283
           +  
Sbjct: 299 VAC 301

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  138 bits (350), Expect = 2e-37
 Identities = 89/335 (26%), Positives = 138/335 (41%), Gaps = 69/335 (20%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVRH 68
            +++   +GEG +  V  A ++ TGE VA+K   K       +      REI I+K  +H
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKH 68

Query: 69  PNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQ-QLI 119
            NI+ +  +    +      VYII E      L    +H+    ++L +D  +YF  Q +
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQE------LMQTDLHRVISTQMLSDDHIQYFIYQTL 122

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP---NY 175
            AV   H   V HRDLKP NLL++S  +LKV DFGL+  + +   +    T        +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182

Query: 176 V------APEV-LSNRGYDGSAADVWSCGVILFVLMAG--------YL------------ 208
           V      APEV L++  Y   A DVWSCG IL  L           Y             
Sbjct: 183 VATRWYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 209 PFGETDLPTLYKKINAAEF--SCPFW----FST-------GATSLIHKILDPNPKTRIRI 255
           P  + DL  +     A E+  S P +                  L+ ++L  +P  RI  
Sbjct: 242 PHSDNDLRCIESP-RAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA 300

Query: 256 EGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDD 290
           +   +HP+ +  ++P     +E        + F+ 
Sbjct: 301 KEALEHPYLQTYHDP----NDEPEGEPIPPSFFEF 331

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  137 bits (347), Expect = 3e-37
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 11/214 (5%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVL----AKSTILKHRMVDQIKREIS 61
            +   Y + R +G G    V  A++      VA+K++    +   + + RM    +RE  
Sbjct: 31  TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRM----QREAR 86

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
               ++ P++V +H+      ++Y+ +  + G +L   +  QG L         +Q+  A
Sbjct: 87  TAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSA 146

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEV 180
           +   H+ G  HRD+KPEN+L+ +     + DFG+ SA   + +  L  T GT  Y+APE 
Sbjct: 147 LDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPER 206

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GET 213
            S        AD+++   +L+  + G  P+ G+ 
Sbjct: 207 FSESHATY-RADIYALTCVLYECLTGSPPYQGDQ 239

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  137 bits (347), Expect = 3e-37
 Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 35/289 (12%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHP 69
           +E+   +G GT+ +V   ++ +TG+  A+KV+     +     ++IK+EI+++K    H 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 81

Query: 70  NIVRLHE------VLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDA 121
           NI   +             ++++++EF   G + D  K      L E       ++++  
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
           ++H H   V HRD+K +N+LL     +K+ DFG+SA   + V   +T  GTP ++APEV+
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 182 -----SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT--LYK-------KINAAEF 227
                 +  YD   +D+WS G+    +  G  P  +   P   L+        ++ + ++
Sbjct: 202 ACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW 259

Query: 228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEE 276
           S  F       S I   L  N   R   E + KHP+ R   N  +   +
Sbjct: 260 SKKF------QSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  138 bits (349), Expect = 5e-37
 Identities = 46/204 (22%), Positives = 91/204 (44%), Gaps = 19/204 (9%)

Query: 10  KYEVGRTIGEG--TFAKVRFAQNRETGESVAMKV--LAKSTILKHRMVDQIKREISIMKI 65
            YE+   IG+G      V  A+ + TGE V ++   L   +   + MV  ++ E+ + K+
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS---NEMVTFLQGELHVSKL 82

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVA 123
             HPNIV       +  +++++  F+  G   D         + E       Q ++ A+ 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQG------VELLHTTCGTPNYV 176
           + H  G  HR +K  ++L+   G + +S    +  +   G       +    +     ++
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 177 APEVL--SNRGYDGSAADVWSCGV 198
           +PEVL  + +GYD + +D++S G+
Sbjct: 203 SPEVLQQNLQGYD-AKSDIYSVGI 225

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  137 bits (348), Expect = 6e-37
 Identities = 86/341 (25%), Positives = 141/341 (41%), Gaps = 65/341 (19%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
            +Y+  + IG G    V  A +     +VA+K L++   +     R      RE+ +MK 
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY----RELVLMKC 80

Query: 66  VRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QL 118
           V H NI+ L  V   +        VYI++E +    L  +++     L+++   Y   Q+
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQME--LDHERMSYLLYQM 136

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
           +  + H HS G+ HRDLKP N+++ S   LK+ DFGL A       ++     T  Y AP
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAP 195

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT----LYKKIN 223
           EV+   GY     D+WS G I+  ++ G + F  TD           L T      KK+ 
Sbjct: 196 EVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254

Query: 224 --AAEF--SCPFW-----------------------FSTGATSLIHKILDPNPKTRIRIE 256
                +  + P +                        ++ A  L+ K+L  +   RI ++
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 314

Query: 257 GIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQ 297
              +HP+    Y+P   SE E           D+ E+  E+
Sbjct: 315 EALQHPYINVWYDP---SEAEAPPPKIPDKQLDEREHTIEE 352

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  136 bits (344), Expect = 7e-37
 Identities = 58/221 (26%), Positives = 105/221 (47%), Gaps = 9/221 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 71  IVRLHEV----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           IV +++       +    YI++E+V G  L D +  +G +              A+   H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC--GTPNYVAPEVLSN 183
             G+ HRD+KP N+++ +   +KV DFG++ A+   G  +  T    GT  Y++PE  + 
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE-QAR 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKIN 223
                + +DV+S G +L+ ++ G  PF G++ +   Y+ + 
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 233

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  137 bits (346), Expect = 8e-37
 Identities = 78/310 (25%), Positives = 132/310 (42%), Gaps = 58/310 (18%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI---V 66
           +++V R  G+GTF  V+  + + TG SVA+K   K  +++        RE+ IM+    +
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIK---K--VIQDPRFR--NRELQIMQDLAVL 76

Query: 67  RHPNIVRLHEVLASRTK-------VYIILEFV--TGGELFDKIVHQGRLLENDCRRYFQ- 116
            HPNIV+L     +  +       + +++E+V  T          +         + F  
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF 136

Query: 117 QLIDAVA--HCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           QLI ++   H  S  V HRD+KP N+L++ + G LK+ DFG +         +   C + 
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC-SR 195

Query: 174 NYVAPEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDL------------PTL- 218
            Y APE+   N+ Y  +A D+WS G I   +M G   F G+               P+  
Sbjct: 196 YYRAPELIFGNQHYT-TAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254

Query: 219 -YKKINA--AEFSCPFW--------FSTG-------ATSLIHKILDPNPKTRIRIEGIRK 260
             +K+N    +              FS         A  L+  +L   P+ R++      
Sbjct: 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314

Query: 261 HPWFRKNYNP 270
           HP+F + ++P
Sbjct: 315 HPYFDELHDP 324

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  134 bits (340), Expect = 1e-36
 Identities = 65/290 (22%), Positives = 118/290 (40%), Gaps = 37/290 (12%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHP 69
            E    +G G +  V   ++  +G+ +A+K +  +  +  +   ++  ++ I M+ V  P
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIV-----HQGRLLENDCRRYFQQLIDAVAH 124
             V  +  L     V+I +E +      DK           + E+   +    ++ A+ H
Sbjct: 67  FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 125 CHSKG-VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL-----HTTCGTPNYVAP 178
            HSK  V HRD+KP N+L+++ G +K+ DFG+S        L+         G   Y+AP
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------YLVDDVAKDIDAGCKPYMAP 178

Query: 179 EVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKINAAEFSCP-F 231
           E ++      GY    +D+WS G+ +  L     P+     P   L + +       P  
Sbjct: 179 ERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237

Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
            FS        + L  N K R     + +HP+F          E +  ++
Sbjct: 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL-------HESKGTDV 280

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  138 bits (349), Expect = 2e-36
 Identities = 57/234 (24%), Positives = 97/234 (41%), Gaps = 56/234 (23%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKREI 60
           +YE+   IG G++  V  A ++     VA+K         +  K  +          REI
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL----------REI 103

Query: 61  SIMKIVRHPNIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYF 115
           +I+  + H ++V++ +++  +      ++Y++LE     +   K+      L     +  
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTL 161

Query: 116 Q-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---ALPQQGVELLHTTCG 171
              L+  V + HS G+ HRDLKP N L++   ++KV DFGL+     P+ G   L  +  
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 172 TPN------------------YV------APEV-LSNRGYDGSAADVWSCGVIL 200
             +                  +V      APE+ L    Y   A DVWS G I 
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIF 274

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  138 bits (349), Expect = 2e-36
 Identities = 85/346 (24%), Positives = 140/346 (40%), Gaps = 77/346 (22%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y+  + IG G    V  A +     +VA+K L++   +     R      RE+ +MK V
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMKCV 118

Query: 67  RHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QLI 119
            H NI+ L  V   +        VY+++E +    L  +++     L+++   Y   Q++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQME--LDHERMSYLLYQML 174

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             + H HS G+ HRDLKP N+++ S   LK+ DFGL+        +      TP YV   
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM------TP-YVVTR 227

Query: 177 ---APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT----L 218
              APEV+   GY     D+WS G I+  ++   + F   D           L T     
Sbjct: 228 YYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286

Query: 219 YKKIN--AAEF--SCPFW----FST-------------------GATSLIHKILDPNPKT 251
            KK+      +  + P +    F                      A  L+ K+L  +P  
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346

Query: 252 RIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQ 297
           RI ++   +HP+    Y+P   +E E           D+ E+  E+
Sbjct: 347 RISVDDALQHPYINVWYDP---AEVEAPPPQIYDKQLDEREHTIEE 389

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  132 bits (334), Expect = 1e-35
 Identities = 51/224 (22%), Positives = 95/224 (42%), Gaps = 28/224 (12%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G+G + +V     +  GE+VA+K+ +     +       + E+    ++RH NI
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64

Query: 72  VRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +           S T++++I  +   G L+D  +    L    C R    +   +AH H 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAHLHI 123

Query: 128 K--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNY 175
           +         + HRDLK +N+L+   G   ++D GL+ +  Q    L    +   GT  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 176 VAPEVLSNRGYDGSA-----ADVWSCGVILFVLMAGYLPFGETD 214
           +APEVL               D+W+ G++L+ +    +  G  +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  132 bits (333), Expect = 3e-35
 Identities = 73/315 (23%), Positives = 119/315 (37%), Gaps = 65/315 (20%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA-KSTILKHRMVDQIKREISIMKIVRH 68
           +Y   + +G G    V  A + +  + VA+K +           +    REI I++ + H
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL----REIKIIRRLDH 67

Query: 69  PNIVRLHEVLASRTK--------------VYIILEFVTGGELFDKIVHQGRLLENDCRRY 114
            NIV++ E+L                   VYI+ E++   +L   ++ QG LLE   R +
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARLF 125

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLS-ALPQQGVELLHTTCGT 172
             QL+  + + HS  V HRDLKP NL +++    LK+ DFGL+  +        H +   
Sbjct: 126 MYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS--- 182

Query: 173 PNYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF--------------- 210
              +      +P + LS   Y   A D+W+ G I   ++ G   F               
Sbjct: 183 -EGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

Query: 211 ----GETDLPTLYKKINAAEFSCPFW----FST-------GATSLIHKILDPNPKTRIRI 255
                E D   L   I     +         +         A   + +IL  +P  R+  
Sbjct: 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 256 EGIRKHPWFRKNYNP 270
           E    HP+      P
Sbjct: 301 EEALSHPYMSIYSFP 315

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  132 bits (335), Expect = 3e-35
 Identities = 81/337 (24%), Positives = 139/337 (41%), Gaps = 70/337 (20%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
           A Y   + +G G +  V  A +  TG  VA+K L +   S +   R      RE+ ++K 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY----RELRLLKH 80

Query: 66  VRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QL 118
           +RH N++ L +V             Y+++ F+ G +L   + H+   L  D  ++   Q+
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQM 137

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV-- 176
           +  + + H+ G+ HRDLKP NL ++    LK+ DFGL+    +  +   T      YV  
Sbjct: 138 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADSEMT-----GYVVT 188

Query: 177 ----APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--------- 222
               APEV L+   Y     D+WS G I+  ++ G   F  +D     K+I         
Sbjct: 189 RWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247

Query: 223 ---------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRK 260
                     A  +    P              S  A +L+ K+L  + + R+       
Sbjct: 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307

Query: 261 HPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQ 297
           HP+F   ++      E+E  +      FDD++   ++
Sbjct: 308 HPYFESLHDT-----EDEPQVQKYDDSFDDVDRTLDE 339

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  131 bits (332), Expect = 8e-35
 Identities = 81/336 (24%), Positives = 134/336 (39%), Gaps = 68/336 (20%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKI 65
             Y     +G G +  V  A ++ +GE VA+K L++   S I   R      RE+ ++K 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY----RELLLLKH 79

Query: 66  VRHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI 119
           ++H N++ L +V    +        Y+++ F+   +L  KI+   +  E   +    Q++
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGL-KFSEEKIQYLVYQML 136

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             + + HS GV HRDLKP NL ++    LK+ DFGL+    +  +   T      YV   
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA----RHADAEMT-----GYVVTR 187

Query: 177 ---APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---------- 222
              APEV LS   Y+    D+WS G I+  ++ G   F   D      +I          
Sbjct: 188 WYRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246

Query: 223 --------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                    A  +  S P              S  A  L+ K+L+ +   R+       H
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

Query: 262 PWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQ 297
           P+F    +P    EEE           +  +   ++
Sbjct: 307 PFFEPFRDP----EEETEAQQPFDDSLEHEKLTVDE 338

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  132 bits (333), Expect = 8e-35
 Identities = 87/313 (27%), Positives = 137/313 (43%), Gaps = 67/313 (21%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQ-IKREISIMKIVR 67
            +Y     IGEG +  V  A +      VA+K   K +  +H+   Q   REI I+   R
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFR 83

Query: 68  HPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQ---GRLLENDCRRYFQ-QL 118
           H NI+ +++++ + T      VYI+ +      L +  +++    + L ND   YF  Q+
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQD------LMETDLYKLLKTQHLSNDHICYFLYQI 137

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL--SALPQQGVELLHTTCGTPNYV 176
           +  + + HS  V HRDLKP NLLL++  +LK+ DFGL   A P        T      YV
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYV 192

Query: 177 ------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPF------------------- 210
                 APE+ L+++GY   + D+WS G IL  +++    F                   
Sbjct: 193 ATRWYRAPEIMLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

Query: 211 GETDLPTLYKKINAAEF--SCPFW----FST-------GATSLIHKILDPNPKTRIRIEG 257
            + DL  +     A  +  S P      ++         A  L+ K+L  NP  RI +E 
Sbjct: 252 SQEDLNCIINL-KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310

Query: 258 IRKHPWFRKNYNP 270
              HP+  + Y+P
Sbjct: 311 ALAHPYLEQYYDP 323

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  131 bits (332), Expect = 1e-34
 Identities = 77/309 (24%), Positives = 128/309 (41%), Gaps = 65/309 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK---STILKHRMVDQIKREISIMKIV 66
           +Y+    +G G +  V  A + +TG  VA+K L++   S I   R      RE+ ++K +
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY----RELRLLKHM 85

Query: 67  RHPNIVRLHEVLASRTK------VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ-QLI 119
           +H N++ L +V            VY++   + G +L + +  Q   L +D  ++   Q++
Sbjct: 86  KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK--LTDDHVQFLIYQIL 142

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV--- 176
             + + HS  + HRDLKP NL ++    LK+ DFGL+          HT      YV   
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTADEMTGYVATR 193

Query: 177 ---APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI---------- 222
              APE+ L+   Y+    D+WS G I+  L+ G   F  TD     K I          
Sbjct: 194 WYRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252

Query: 223 --------NAAEF--SCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                   +A  +  S                +  A  L+ K+L  +   RI       H
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 262 PWFRKNYNP 270
            +F + ++P
Sbjct: 313 AYFAQYHDP 321

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 6e-34
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 28/224 (12%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++ + IG+G + +V   + R  GE VA+KV   +           + EI    ++RH NI
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENI 93

Query: 72  VRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +       +   S T++Y+I ++   G L+D  +    L      +     +  + H H+
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYD-YLKSTTLDAKSMLKLAYSSVSGLCHLHT 152

Query: 128 K--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNY 175
           +         + HRDLK +N+L+   G   ++D GL+         +    +T  GT  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 176 VAPEVLSNRGYDGS-----AADVWSCGVILFVLMAGYLPFGETD 214
           + PEVL              AD++S G+IL+ +    +  G  +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  133 bits (335), Expect = 9e-34
 Identities = 55/215 (25%), Positives = 85/215 (39%), Gaps = 19/215 (8%)

Query: 11  YEVGRTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           YEV   I  G    +  A      G  V +K L  S             E   +  V HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139

Query: 70  NIVRLHEV-----LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           +IV++               YI++E+V G  L        +L   +   Y  +++ A+++
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSY 197

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEVLSN 183
            HS G+ + DLKPEN++L     LK+ D G  S +   G        GTP + APE++  
Sbjct: 198 LHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINSFG-----YLYGTPGFQAPEIV-- 249

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL 218
           R     A D+++ G  L  L           +  L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  128 bits (323), Expect = 2e-33
 Identities = 73/341 (21%), Positives = 126/341 (36%), Gaps = 68/341 (19%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMK-------VLAKSTILKHRMVDQ-IKREIS 61
            Y V R I  G++  V    +   G  VA+K             IL    + + + REI 
Sbjct: 23  PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81

Query: 62  IMKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQ 116
           ++    HPNI+ L ++     +     +Y++ E +   +L   I  Q  ++     +YF 
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140

Query: 117 -QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
             ++  +   H  GV HRDL P N+LL    ++ + DF L+                 +Y
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-------THY 193

Query: 176 V------APEV-LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----------LPT 217
           V      APE+ +  +G+     D+WS G ++  +      F  +            + T
Sbjct: 194 VTHRWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252

Query: 218 ----LYKKI---NAAEF---SCPFW-----------FSTGATSLIHKILDPNPKTRIRIE 256
                       +A ++   S                   A  LI K+L+ NP+ RI  E
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312

Query: 257 GIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQ 297
              +HP+F   ++P    +  E   +  H  FD+       
Sbjct: 313 QALRHPYFESLFDP---LDLTEGLSERFH--FDESVTDVYD 348

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  129 bits (326), Expect = 2e-33
 Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 51/235 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKREI 60
            Y +   IG G++  V  A ++ T ++VA+K         +  K  +          REI
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL----------REI 76

Query: 61  SIMKIVRHPNIVRLHEVLASRTK-----VYIILEFVTGGELFDKIVHQGRLLENDCRRYF 115
           +I+  ++   I+RL++++          +YI+LE     +L  K+      L  +  +  
Sbjct: 77  TILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTI 134

Query: 116 Q-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------------ALPQQ 161
              L+      H  G+ HRDLKP N LL+   ++KV DFGL+              L + 
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 162 GVELLHTTCGTP---NYV------APEV-LSNRGYDGSAADVWSCGVILFVLMAG 206
                H         ++V      APE+ L    Y   + D+WS G I   L+  
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  126 bits (318), Expect = 6e-33
 Identities = 47/210 (22%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +  +IG+G F +V   + R  GE VA+K+ +             + EI    ++RH NI
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98

Query: 72  VRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +      ++   + T+++++ ++   G LFD  +++  +      +        +AH H 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHM 157

Query: 128 K--------GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL----HTTCGTPNY 175
           +         + HRDLK +N+L+   G   ++D GL+       + +    +   GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 176 VAPEVLSNRGYDGS-----AADVWSCGVIL 200
           +APEVL +            AD+++ G++ 
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVF 247

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  127 bits (320), Expect = 6e-33
 Identities = 82/347 (23%), Positives = 128/347 (36%), Gaps = 102/347 (29%)

Query: 9   AKYEVGRTIGEGTFAKVRFAQNRETGESVAMK---------VLAKSTILKHRMVDQIKRE 59
            KYE+ + +G+G +  V  + +R TGE VA+K           A+ T           RE
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF----------RE 58

Query: 60  ISIMKIVR-HPNIVRLHEVLA--SRTKVYIILEFVTGGELFDKIVHQ---GRLLENDCRR 113
           I I+  +  H NIV L  VL   +   VY++ +        +  +H      +LE   ++
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFD------YMETDLHAVIRANILEPVHKQ 112

Query: 114 YFQ-QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT 172
           Y   QLI  + + HS G+ HRD+KP N+LL++  ++KV+DFGLS        + +    +
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 173 PN---------------YV------APEV-LSNRGYDGSAADVWSCGVILFVLMAG---- 206
            N               YV      APE+ L +  Y     D+WS G IL  ++ G    
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIF 231

Query: 207 ----------------------------------YL---------PFGETDLPTLYKKIN 223
                                              +                     K  
Sbjct: 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291

Query: 224 AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             + +     +  A  L+ K+L  NP  RI      KHP+    +NP
Sbjct: 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  122 bits (309), Expect = 7e-32
 Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 27/224 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             ++      G F  V  AQ     E VA+K+         +   Q + E+  +  ++H 
Sbjct: 25  PLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHE 78

Query: 70  NIVRL----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           NI++         +    +++I  F   G L D  +    +  N+     + +   +A+ 
Sbjct: 79  NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSD-FLKANVVSWNELCHIAETMARGLAYL 137

Query: 126 HSKGVY----------HRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTP 173
           H               HRD+K +N+LL +     ++DFGL+   + G     T    GT 
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTR 197

Query: 174 NYVAPEVLSNRGYDGS----AADVWSCGVILFVLMAGYLPFGET 213
            Y+APEVL              D+++ G++L+ L +        
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  120 bits (302), Expect = 3e-31
 Identities = 30/207 (14%), Positives = 63/207 (30%), Gaps = 30/207 (14%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y +    G     +   A +      VA+  +    +L   ++ +       +  +  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           + R+ +V+ +R    ++ E++ GG L +  V           R  Q L  A    H  GV
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
                 P  + +   G++ ++                        +              
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA--------------------TMPDA--------NPQ 182

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPT 217
            D+   G  L+ L+    P  E  + +
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRS 209

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  117 bits (294), Expect = 2e-29
 Identities = 62/327 (18%), Positives = 122/327 (37%), Gaps = 79/327 (24%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-- 67
           +Y + R +G G F+ V  A++      VAMK++ +         +  + EI +++ V   
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RG---DKVYTEAAEDEIKLLQRVNDA 75

Query: 68  ---------HPNIVRLHE--VLASRTKVYIILEF-VTGGELFD--KIVHQGRLLENDCRR 113
                      +I++L +         V++++ F V G  L    K      +     ++
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135

Query: 114 YFQQLIDAVAHCHSK-GVYHRDLKPENLLLD------SYGNLKVSDFGLSALPQQGVELL 166
             +QL+  + + H + G+ H D+KPEN+L++      +   +K++D G +       E  
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHY 192

Query: 167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK----- 221
             +  T  Y +PEVL    +    AD+WS   ++F L+ G   F   +  +  K      
Sbjct: 193 TNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251

Query: 222 -------------INAAEFSCPFWFSTGAT------------------------------ 238
                        +   +++  F+ S G                                
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 311

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
             +  +L  +P+ R    G+  HPW +
Sbjct: 312 DFLSPMLQLDPRKRADAGGLVNHPWLK 338

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  116 bits (293), Expect = 3e-29
 Identities = 61/207 (29%), Positives = 89/207 (42%), Gaps = 15/207 (7%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +G  IG G F +V   + R     VA+K   ++     +   +  +E  I+K   HPNI
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNI 174

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF-QQLIDAVAHCHSKGV 130
           VRL  V   +  +YI++E V GG+    +  +G  L               + +  SK  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG------TPNYVAPEVLSNR 184
            HRDL   N L+     LK+SDFG+S     GV              T    APE L+  
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYG 290

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            Y  S +DVWS G++L+     G  P+
Sbjct: 291 RYS-SESDVWSFGILLWETFSLGASPY 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  114 bits (287), Expect = 1e-28
 Identities = 45/219 (20%), Positives = 76/219 (34%), Gaps = 39/219 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHP 69
           ++   IG G +  V           VA+K      +           E +I ++  + H 
Sbjct: 16  KLLELIGRGRYGAVYKGSLD--ERPVAVK------VFSFANRQNFINEKNIYRVPLMEHD 67

Query: 70  NIVRL-----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           NI R            R +  +++E+   G L    +           R    +   +A+
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLAY 126

Query: 125 CHS---------KGVYHRDLKPENLLLDSYGNLKVSDFGLS--------ALPQQGVELLH 167
            H+           + HRDL   N+L+ + G   +SDFGLS          P +      
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 168 TTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVIL 200
           +  GT  Y+APEVL                D+++ G+I 
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  114 bits (288), Expect = 3e-28
 Identities = 70/281 (24%), Positives = 115/281 (40%), Gaps = 43/281 (15%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
           +YEV + IG+G+F +V  A + +  + VA+K++      + R   Q   EI I++ +R  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQ 153

Query: 69  -----PNIVRLHEVLASRTKVYIILEFVTGGELFD---KIVHQGRLLENDCRRYFQQLID 120
                 N++ + E    R  + +  E +    L++   K   QG  L    R++   ++ 
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSL-PLVRKFAHSILQ 211

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQGVELLHTTCGTPNYVAP 178
            +   H   + H DLKPEN+LL   G   +KV DFG S    Q V   +T   +  Y AP
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV---YTYIQSRFYRAP 268

Query: 179 EVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFWFSTGA 237
           EV+    Y     D+WS G IL  L+ GY    GE +   L                   
Sbjct: 269 EVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQL------------------- 308

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEE 278
            + + ++L    +  +     R   +      P  C+    
Sbjct: 309 -ACMIELLGMPSQKLLD-ASKRAKNFVSSKGYPRYCTVTTL 347

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  112 bits (282), Expect = 9e-28
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)

Query: 13  VGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + + +G G F +V   + +   +   SVA+K L      K R       E SIM    HP
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NI+RL  V+     V I+ E++  G L   +  H  +          + +   + +    
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNRG 185
           G  HRDL   N+L++S    KVSDFGL  + +   E  +TT G    +   +PE ++ R 
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 186 YDGSAADVWSCGVILF-VLMAGYLPF 210
           +  SA+DVWS G++L+ V+  G  P+
Sbjct: 227 FT-SASDVWSYGIVLWEVMSYGERPY 251

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  111 bits (280), Expect = 1e-27
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 11/207 (5%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            + + IG G   +V + + R  G+    VA+K L      + R       E SIM    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           PNI+RL  V+       I+ E++  G L   +  H G+          + +   + +   
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNR 184
            G  HRDL   N+L+DS    KVSDFGLS + +   +  +TT G    +   APE ++ R
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVWS GV+++ VL  G  P+
Sbjct: 230 TFS-SASDVWSFGVVMWEVLAYGERPY 255

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  113 bits (284), Expect = 2e-27
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 19/220 (8%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G G + +V     ++   +VA+K L + T+     V++  +E ++MK ++HPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNL 278

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVAH 124
           V+L  V       YII EF+T G L D       + V    LL         Q+  A+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEY 333

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-YVAPEVLSN 183
              K   HR+L   N L+     +KV+DFGLS L        H     P  + APE L+ 
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393

Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +    +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 394 NKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  110 bits (276), Expect = 2e-27
 Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 9/218 (4%)

Query: 13  VGRTIGEGTFAKVRFA--QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
             + +G G F  V+    Q ++  ++VA+K+L K+      + D++  E ++M+ + +P 
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           IVR+  +        +++E    G L   +     + + +      Q+   + +      
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P-NYVAPEVLSNRGYD 187
            HRDL   N+LL +    K+SDFGLS   +              P  + APE ++   + 
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198

Query: 188 GSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 224
            S +DVWS GV+++     G  P+       +   +  
Sbjct: 199 -SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  110 bits (278), Expect = 2e-27
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 12/207 (5%)

Query: 13  VGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
             + IG G F +V     + +       VA+K L      K R       E  IM    H
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
            NI+RL  V++    + II E++  G L   +    G           + +   + +  +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNR 184
               HRDL   N+L++S    KVSDFGLS + +   E  +TT G    +   APE +S R
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVWS G++++ V+  G  P+
Sbjct: 226 KFT-SASDVWSFGIVMWEVMTYGERPY 251

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  109 bits (275), Expect = 2e-27
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 10/205 (4%)

Query: 14  GRTIGEGTFAKVRFAQ-NRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
              +G+G+F  VR  + +  +G++  VA+K L    + +   +D   RE++ M  + H N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           ++RL+ V      + ++ E    G L D++  HQG  L     RY  Q+ + + +  SK 
Sbjct: 83  LIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNRGY 186
             HRDL   NLLL +   +K+ DFGL     Q  +               APE L  R +
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201

Query: 187 DGSAADVWSCGVILF-VLMAGYLPF 210
              A+D W  GV L+ +   G  P+
Sbjct: 202 S-HASDTWMFGVTLWEMFTYGQEPW 225

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  109 bits (274), Expect = 4e-27
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)

Query: 14  GRTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            R +GEG F KV       +   TGE VA+K L   +   H     +K+EI I++ + H 
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHE 83

Query: 70  NIVRLHEV--LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 126
           NIV+   +        + +I+EF+  G L + +  ++ ++      +Y  Q+   + +  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSN 183
           S+   HRDL   N+L++S   +K+ DFGL+   +   E         + V   APE L  
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203

Query: 184 RGYDGSAADVWSCGVIL 200
             +   A+DVWS GV L
Sbjct: 204 SKFY-IASDVWSFGVTL 219

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  107 bits (269), Expect = 2e-26
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 20/200 (10%)

Query: 14  GRTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIV 66
            + +G+G F  V           TGE VA+K L      +H   + ++   REI I+K +
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILKSL 68

Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
           +H NIV+   V  S  +  + +I+E++  G L D +  H+ R+      +Y  Q+   + 
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEV 180
           +  +K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         + +   APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 181 LSNRGYDGSAADVWSCGVIL 200
           L+   +   A+DVWS GV+L
Sbjct: 189 LTESKFS-VASDVWSFGVVL 207

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  106 bits (266), Expect = 4e-26
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 9/215 (4%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G G + +V     ++   +VA+K L + T+     V++  +E ++MK ++HPN+
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNL 71

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFD--KIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           V+L  V       YII EF+T G L D  +  ++  +          Q+  A+ +   K 
Sbjct: 72  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDG 188
             HRDL   N L+     +KV+DFGLS L        H     P  + APE L+   +  
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS- 190

Query: 189 SAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +DVW+ GV+L+ +   G  P+   DL  +Y+ +
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  107 bits (268), Expect = 4e-26
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 20/200 (10%)

Query: 14  GRTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIV 66
            + +G+G F  V           TGE VA+K L      +H   + ++   REI I+K +
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL------QHSTEEHLRDFEREIEILKSL 99

Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
           +H NIV+   V  S  +  + +I+E++  G L D +  H+ R+      +Y  Q+   + 
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEV 180
           +  +K   HRDL   N+L+++   +K+ DFGL+ +  Q  E         + +   APE 
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 181 LSNRGYDGSAADVWSCGVIL 200
           L+   +   A+DVWS GV+L
Sbjct: 220 LTESKFS-VASDVWSFGVVL 238

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  106 bits (267), Expect = 5e-26
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            + +G G F  V        GE     VA+K L ++T  K     +I  E  +M  V +P
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           ++ RL  +    + V +I + +  G L D +  H+  +       +  Q+   + +   +
Sbjct: 78  HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGY 186
            + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
               +DVWS GV ++ ++  G  P+       +   +
Sbjct: 197 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  107 bits (269), Expect = 6e-26
 Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 21/213 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+   IG+G+F +V  A +R   E VA+K++ K+   K   ++Q + E+ +++++   
Sbjct: 55  RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNKH 110

Query: 70  ------NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDA 121
                  IV L      R  + ++ E +    L+D + +     +  N  R++ QQ+  A
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169

Query: 122 VAHCHSK--GVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGVELLHTTCGTPNYVA 177
           +    +    + H DLKPEN+LL +     +K+ DFG S+      + ++    +  Y +
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLG--QRIYQYIQSRFYRS 226

Query: 178 PEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
           PEVL    YD  A D+WS G IL  +  G   F
Sbjct: 227 PEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLF 258

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  105 bits (264), Expect = 1e-25
 Identities = 56/200 (28%), Positives = 93/200 (46%), Gaps = 20/200 (10%)

Query: 14  GRTIGEGTFAKVRFA----QNRETGESVAMKVLAKSTILKHRMVDQIK---REISIMKIV 66
              +G+G F  V           TG  VA+K L      +H   DQ +   REI I+K +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL------QHSGPDQQRDFQREIQILKAL 81

Query: 67  RHPNIVRLHEVLASRTK--VYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
               IV+   V     +  + +++E++  G L D +  H+ RL  +    Y  Q+   + 
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEV 180
           +  S+   HRDL   N+L++S  ++K++DFGL+ L     +         + +   APE 
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201

Query: 181 LSNRGYDGSAADVWSCGVIL 200
           LS+  +    +DVWS GV+L
Sbjct: 202 LSDNIFS-RQSDVWSFGVVL 220

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  105 bits (263), Expect = 1e-25
 Identities = 60/196 (30%), Positives = 94/196 (47%), Gaps = 13/196 (6%)

Query: 14  GRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            R +GEG F KV        N  TGE VA+K L      +HR     K+EI I++ + H 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHE 93

Query: 70  NIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
           +I++            + +++E+V  G L D  + +  +       + QQ+ + +A+ H+
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNR 184
           +   HRDL   N+LLD+   +K+ DFGL+    +G E         + V   APE L   
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 185 GYDGSAADVWSCGVIL 200
            +   A+DVWS GV L
Sbjct: 213 KFY-YASDVWSFGVTL 227

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  104 bits (262), Expect = 1e-25
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 11/215 (5%)

Query: 17  IGEGTFAKVRFAQ-NRETGE-SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR         +  VA+KVL + T       +++ RE  IM  + +P IVRL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75

Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             V      + +++E   GG L   +   +  +  ++      Q+   + +   K   HR
Sbjct: 76  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P-NYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS                  P  + APE ++ R +  S 
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 193

Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 224
           +DVWS GV ++  L  G  P+ +   P +   I  
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 228

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  103 bits (259), Expect = 3e-25
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 35/225 (15%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++ +TIG+G F  V     R  G  VA+K +                E S+M  +RH N+
Sbjct: 24  KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNL 76

Query: 72  VRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVA 123
           V+L  V +  +  +YI+ E++  G L D        ++    LL+     +   + +A+ 
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-----FSLDVCEAME 131

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--PNYV---AP 178
           +       HRDL   N+L+      KVSDFGL+       E   T      P  V   AP
Sbjct: 132 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLP--VKWTAP 183

Query: 179 EVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
           E L  + +  + +DVWS G++L+ +   G +P+    L  +  ++
Sbjct: 184 EALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  106 bits (266), Expect = 3e-25
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 21/220 (9%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKL 241

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVAH 124
           V+L+ V  S   +YI+ E+++ G L D       K +   +L++        Q+   +A+
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-----MAAQIASGMAY 295

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSN 183
                  HRDL+  N+L+      KV+DFGL+ L +            P  + APE    
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355

Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +    +DVWS G++L  +   G +P+       +  ++
Sbjct: 356 GRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  106 bits (267), Expect = 3e-25
 Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 23/221 (10%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
            +   +G+G F +V       T   VA+K L   T+     +    +E  +MK +RH  +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKL 324

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID-------AVA 123
           V+L+ V  S   +YI+ E+++ G L D +    G+ L         QL+D        +A
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR------LPQLVDMAAQIASGMA 377

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLS 182
           +       HRDL+  N+L+      KV+DFGL+ L +            P  + APE   
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437

Query: 183 NRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
              +    +DVWS G++L  +   G +P+       +  ++
Sbjct: 438 YGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (260), Expect = 5e-25
 Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 12/217 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            + +G G F  V        GE     VA+K L ++T  K     +I  E  +M  V +P
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVDNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           ++ RL  +    + V +I + +  G L D +  H+  +       +  Q+   + +   +
Sbjct: 78  HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCG-TP-NYVAPEVLSNRGY 186
            + HRDL   N+L+ +  ++K++DFGL+ L     +  H   G  P  ++A E + +R Y
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
               +DVWS GV ++ ++  G  P+       +   +
Sbjct: 197 T-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  104 bits (261), Expect = 5e-25
 Identities = 69/333 (20%), Positives = 120/333 (36%), Gaps = 87/333 (26%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
            + V R +G+GTF +V   Q+ +  +  A+KV+ ++     +     K E  I+K +++ 
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQND 91

Query: 69  ----PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAV 122
                NIV+ H        + +I E   G  L++ I           D + Y  +++ A+
Sbjct: 92  DINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150

Query: 123 AHCHSKGVYHRDLKPENLLLDSYG-------------------------NLKVSDFGLSA 157
            +     + H DLKPEN+LLD                             +K+ DFG  A
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CA 209

Query: 158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLP 216
             +   +   +   T  Y APEV+ N G+D  ++D+WS G +L  L  G L F     + 
Sbjct: 210 TFKS--DYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEHME 266

Query: 217 TL-----------YKKINAAEFSCPFWF-------------STGATS------------- 239
            L              +  A  +    +             ++   S             
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326

Query: 240 --------LIHKILDPNPKTRIRIEGIRKHPWF 264
                    ++ IL  +P  R     + KH + 
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (259), Expect = 6e-25
 Identities = 52/217 (23%), Positives = 99/217 (45%), Gaps = 12/217 (5%)

Query: 14  GRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            + +G G F  V        GES    V +KV+   +  +      +   +  +  + H 
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF--QAVTDHMLAIGSLDHA 75

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           +IVRL  +    + + ++ +++  G L D +  H+G L       +  Q+   + +    
Sbjct: 76  HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
           G+ HR+L   N+LL S   ++V+DFG++  LP    +LL++   TP  ++A E +    Y
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
               +DVWS GV ++ ++  G  P+    L  +   +
Sbjct: 195 T-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  102 bits (256), Expect = 6e-25
 Identities = 54/225 (24%), Positives = 95/225 (42%), Gaps = 16/225 (7%)

Query: 9   AKYEV-------GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
            K+ +        + IG G F  V         + VA+K + +  + +    +    E  
Sbjct: 1   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSE----EDFIEEAE 55

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 120
           +M  + HP +V+L+ V   +  + ++ EF+  G L D +   +G             + +
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPE 179
            +A+     V HRDL   N L+     +KVSDFG++           T    P  + +PE
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 175

Query: 180 VLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 223
           V S   Y  S +DVWS GV+++ V   G +P+       + + I+
Sbjct: 176 VFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  104 bits (262), Expect = 1e-24
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 31/223 (13%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++ +TIG+G F  V     R  G  VA+K +                E S+M  +RH N+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNL 248

Query: 72  VRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVA 123
           V+L  V +  +  +YI+ E++  G L D        ++    LL+     +   + +A+ 
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK-----FSLDVCEAME 303

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT--P-NYVAPEV 180
           +       HRDL   N+L+      KVSDFGL+       E   T      P  + APE 
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEA 357

Query: 181 LSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
           L  + +  + +DVWS G++L+ +   G +P+    L  +  ++
Sbjct: 358 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  101 bits (253), Expect = 2e-24
 Identities = 51/215 (23%), Positives = 99/215 (46%), Gaps = 11/215 (5%)

Query: 13  VGRTIGEGTFAKVRFAQ-NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           + + +G G F  V+  +   +    VA+K++ + ++ +    D+  +E   M  + HP +
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKL 65

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           V+ + V +    +YI+ E+++ G L + +  H   L  +        + + +A   S   
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
            HRDL   N L+D    +KVSDFG++        +       P  + APEV     Y  S
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS-S 184

Query: 190 AADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 223
            +DVW+ G++++ V   G +P+       +  K++
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  104 bits (261), Expect = 3e-24
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 11/215 (5%)

Query: 17  IGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR    R   +   VA+KVL + T       +++ RE  IM  + +P IVRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401

Query: 75  HEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             V      + +++E   GG L   +   +  +  ++      Q+   + +   K   HR
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSA 190
           +L   N+LL +    K+SDFGLS                   +   APE ++ R +  S 
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 519

Query: 191 ADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA 224
           +DVWS GV ++  L  G  P+ +   P +   I  
Sbjct: 520 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 554

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (251), Expect = 3e-24
 Identities = 69/207 (33%), Positives = 103/207 (49%), Gaps = 14/207 (6%)

Query: 12  EVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           E+GR IGEG F  V        +N     +VA+K     T    R  ++  +E   M+  
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVR--EKFLQEALTMRQF 73

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+ 
Sbjct: 74  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPF 210
            +  SA+DVW  GV ++ +LM G  PF
Sbjct: 193 RFT-SASDVWMFGVCMWEILMHGVKPF 218

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =   99 bits (250), Expect = 5e-24
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 39/225 (17%)

Query: 10  KYEVGRT-------IGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           +Y + R        +GEG F +V    +  ++    +VA+K   K   L ++  ++   E
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSE 63

Query: 60  ISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQL 118
             IMK + HP+IV+L  ++      +II+E    GEL   +  ++  L       Y  Q+
Sbjct: 64  AVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122

Query: 119 IDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYV-- 176
             A+A+  S    HRD+   N+L+ S   +K+ DFGLS   +             +Y   
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----------DYYKA 171

Query: 177 ----------APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
                     +PE ++ R +  +A+DVW   V ++ +L  G  PF
Sbjct: 172 SVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPF 215

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 99.2 bits (248), Expect = 9e-24
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 11/215 (5%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++   +G G F +V         + VA+K L + ++     +     E ++MK ++H  +
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFL----AEANLMKQLQHQRL 70

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYF-QQLIDAVAHCHSKG 129
           VRL+ V  ++  +YII E++  G L D +    G  L  +       Q+ + +A    + 
Sbjct: 71  VRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDG 188
             HRDL+  N+L+    + K++DFGL+ L +            P  + APE ++   +  
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT- 188

Query: 189 SAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +DVWS G++L  ++  G +P+     P + + +
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  103 bits (257), Expect = 1e-23
 Identities = 68/205 (33%), Positives = 101/205 (49%), Gaps = 14/205 (6%)

Query: 14  GRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           GR IGEG F  V        +N     +VA+K     T    R  ++  +E   M+   H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHS 127
           P+IV+L  V+ +   V+II+E  T GEL   + V +  L       Y  QL  A+A+  S
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGY 186
           K   HRD+   N+L+ S   +K+ DFGLS   +       +    P  ++APE ++ R +
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569

Query: 187 DGSAADVWSCGVILF-VLMAGYLPF 210
             SA+DVW  GV ++ +LM G  PF
Sbjct: 570 T-SASDVWMFGVCMWEILMHGVKPF 593

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 9/215 (4%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
              + +G G F  V++ + R   + VA+K++ + ++ +    D+   E  +M  + H  +
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKL 81

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           V+L+ V   +  ++II E++  G L + +   + R          + + +A+ +  SK  
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSNRGYDGS 189
            HRDL   N L++  G +KVSDFGLS                P  +  PEVL    +  S
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-S 200

Query: 190 AADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 223
            +D+W+ GV+++ +   G +P+         + I 
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 68/331 (20%), Positives = 112/331 (33%), Gaps = 81/331 (24%)

Query: 10  KYEVGRTIGEGTFAKV-RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+   +GEGTF KV     +      VA+K++ ++     +  +  + EI+++K ++ 
Sbjct: 20  RYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIKE 75

Query: 69  P------NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLID 120
                    V + +       + I  E + G   F+ +             R    QL  
Sbjct: 76  KDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCH 134

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGN-------------------LKVSDFGLSALPQQ 161
           A+   H   + H DLKPEN+L  +                      ++V+DFG SA    
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFDH 193

Query: 162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTL-- 218
             E   T   T +Y  PEV+   G+     DVWS G ILF    G+  F    +   L  
Sbjct: 194 --EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250

Query: 219 ---------YKKINAAEFSCPFW--------------------------------FSTGA 237
                       I+       F+                                     
Sbjct: 251 MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL 310

Query: 238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY 268
             L+ ++L+ +P  RI +     HP+F    
Sbjct: 311 FDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 98.5 bits (246), Expect = 5e-23
 Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 37/229 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETG-ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           +YE+  T+GEG F KV    + + G   VA+K++ K+     R  +  + EI +++ +  
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLNT 70

Query: 69  P------NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLID 120
                    V++ E       + I+ E + G   +D I   G      +  R+   Q+  
Sbjct: 71  TDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICK 129

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGN-------------------LKVSDFGLSALPQQ 161
           +V   HS  + H DLKPEN+L                         +KV DFG SA    
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYDD 188

Query: 162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF 210
             E   T   T +Y APEV+   G+     DVWS G IL     G+  F
Sbjct: 189 --EHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVF 234

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.0 bits (242), Expect = 7e-23
 Identities = 47/223 (21%), Positives = 81/223 (36%), Gaps = 38/223 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES-------VAMKVLAKSTILKHRMVDQIKREISIMK 64
               ++G+GTF K+     RE G+        V +KVL K+        +      S+M 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVA 123
            + H ++V  + V     +  ++ EFV  G L   +  ++  +         +QL  A+ 
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNL--------KVSDFGLSALPQQGVELLHTTCGTPNY 175
                 + H ++  +N+LL    +         K+SD G+S                 + 
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-----------DI 176

Query: 176 -------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
                  V PE + N      A D WS G  L+ +   G  P 
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 51/220 (23%), Positives = 104/220 (47%), Gaps = 21/220 (9%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI 71
           ++ + +G G F +V  A   +  + VA+K +   ++     +     E ++MK ++H  +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFL----AEANVMKTLQHDKL 245

Query: 72  VRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLIDAVAH 124
           V+LH V  ++  +YII EF+  G L D             +L++     +  Q+ + +A 
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID-----FSAQIAEGMAF 299

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP-NYVAPEVLSN 183
              +   HRDL+  N+L+ +    K++DFGL+ + +            P  + APE ++ 
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359

Query: 184 RGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             +    +DVWS G++L  ++  G +P+     P + + +
Sbjct: 360 GSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 17/230 (7%)

Query: 6   RRVAKYEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
                      IG G F  V       N       A+K L + T +      Q   E  I
Sbjct: 86  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGII 143

Query: 63  MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 120
           MK   HPN++ L  + L S     ++L ++  G+L + I          D   +  Q+  
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT--PNYV- 176
            +    SK   HRDL   N +LD    +KV+DFGL+  +  +  + +H   G   P  V 
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP--VK 261

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKIN 223
             A E L  + +  + +DVWS GV+L+ ++  G  P+ + +   +   + 
Sbjct: 262 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 17/229 (7%)

Query: 6   RRVAKYEVGRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
                      IG G F  V       N       A+K L + T +      Q   E  I
Sbjct: 22  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGII 79

Query: 63  MKIVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLID 120
           MK   HPN++ L  + L S     ++L ++  G+L + I          D   +  Q+  
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139

Query: 121 AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT--PNYV- 176
            + +  SK   HRDL   N +LD    +KV+DFGL+  +  +    +H   G   P  V 
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP--VK 197

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             A E L  + +  + +DVWS GV+L+ ++  G  P+ + +   +   +
Sbjct: 198 WMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 94.6 bits (236), Expect = 6e-22
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 29/229 (12%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
              R IG+G F  V   +  +  ++    A+K L++ T ++    +   RE  +M+ + H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV--EAFLREGLLMRGLNH 81

Query: 69  PNIVRLHEV-LASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCH 126
           PN++ L  + L      +++L ++  G+L   I   Q      D   +  Q+   + +  
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLS---------ALPQQGVELLHTTCGTPNYV- 176
            +   HRDL   N +LD    +KV+DFGL+         ++ Q     L      P  V 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P--VK 193

Query: 177 --APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             A E L    +  + +DVWS GV+L+ +L  G  P+   D   L   +
Sbjct: 194 WTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 44/241 (18%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            +GR +G+G F  VR AQ ++   S   VA+K+L K+ I+    +++  RE + MK   H
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84

Query: 69  PNIVRL------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI--- 119
           P++ +L                 +IL F+  G+L   ++   R+ EN      Q L+   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVRFM 143

Query: 120 ----DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
                 + +  S+   HRDL   N +L     + V+DFGLS         +++     +Y
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-------RKIYSG----DY 192

Query: 176 -------------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKK 221
                        +A E L++  Y    +DVW+ GV ++ ++  G  P+   +   +Y  
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251

Query: 222 I 222
           +
Sbjct: 252 L 252

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 33/218 (15%)

Query: 12  EVGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-I 65
             G+T+G G F KV  A        +   +VA+K+L  S  L  R  + +  E+ ++  +
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLSYL 83

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGEL-----------FDKIVHQGRLLENDCRRY 114
             H NIV L           +I E+   G+L                    + +++    
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 115 FQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
            + L+         +A   SK   HRDL   N+LL      K+ DFGL+   +     + 
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 168 TTCGT-PNYV---APEVLSNRGYDGSAADVWSCGVILF 201
                 P  V   APE + N  Y    +DVWS G+ L+
Sbjct: 204 KGNARLP--VKWMAPESIFNCVYT-FESDVWSYGIFLW 238

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 43/240 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
            +G+ +GEG F  V     ++   +   VA+K + K      R +++   E + MK   H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95

Query: 69  PNIVRL-----HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI---- 119
           PN++RL             K  +IL F+  G+L   +++  RL         Q L+    
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154

Query: 120 ---DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY- 175
                + +  ++   HRDL   N +L     + V+DFGLS       + +++     +Y 
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS-------KKIYSG----DYY 203

Query: 176 ------------VAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
                       +A E L++R Y  S +DVW+ GV ++ +   G  P+       +Y  +
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 52/220 (23%), Positives = 84/220 (38%), Gaps = 45/220 (20%)

Query: 14  GRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVR 67
           G+T+G G F KV  A        +    VA+K+L  +        + +  E+ IM  + +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQ 108

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYFQQLID 120
           H NIV L         V +I E+   G+L +        +         +     + L+ 
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 121 -------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
                   +A   SK   HRD+   N+LL +    K+ DFGL+                 
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA----------RDIMNDS 218

Query: 174 NYV------------APEVLSNRGYDGSAADVWSCGVILF 201
           NY+            APE + +  Y    +DVWS G++L+
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 55/219 (25%), Positives = 83/219 (37%), Gaps = 47/219 (21%)

Query: 14  GRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMK-IVRHPN 70
              IGEG F +V  A+ ++ G     A+K + +              E+ ++  +  HPN
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPN 87

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRYF--QQLIDA 121
           I+ L      R  +Y+ +E+   G L D               + N        QQL+  
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 122 ---VA----HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPN 174
              VA    +   K   HRDL   N+L+      K++DFGLS              G   
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------------GQEV 194

Query: 175 YV------------APEVLSNRGYDGSAADVWSCGVILF 201
           YV            A E L+   Y  + +DVWS GV+L+
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLW 232

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 50/233 (21%), Positives = 95/233 (40%), Gaps = 53/233 (22%)

Query: 12  EVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            + R +G+G+F  V           E    VA+K + ++  ++ R+  +   E S+MK  
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRY---FQQLI---- 119
              ++VRL  V++      +I+E +T G+L   +      + N+         ++I    
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 120 ---DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS---------------ALPQQ 161
              D +A+ ++    HRDL   N ++     +K+ DFG++                LP  
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP-- 203

Query: 162 GVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPF 210
                         V   +PE L +  +  + +DVWS GV+L+ +      P+
Sbjct: 204 --------------VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPY 241

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 44/216 (20%), Positives = 74/216 (34%), Gaps = 34/216 (15%)

Query: 12  EVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
                +GE  F KV           E  ++VA+K L        R   + + E  +   +
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE--EFRHEAMLRARL 69

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRRYFQQ 117
           +HPN+V L  V+     + +I  + + G+L +          +                 
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129

Query: 118 LIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC 170
            +  V        +  S  V H+DL   N+L+    N+K+SD GL               
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189

Query: 171 G------TPNYVAPEVLSNRGYDGSAADVWSCGVIL 200
                       APE +    +    +D+WS GV+L
Sbjct: 190 SLLPIRWM----APEAIMYGKFS-IDSDIWSYGVVL 220

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 48/214 (22%), Positives = 73/214 (34%), Gaps = 36/214 (16%)

Query: 12  EVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            + R +G G F +V         N  +   VA+K L +    +  +      E  I+   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI------- 119
            H NIVR   V       +I++E + GG+L   +                 L+       
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL-------PQQGVELLHTT 169
               +       HRD+   N LL   G     K+ DFG++          + G  +L   
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML--- 207

Query: 170 CGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
              P  V    PE      +  S  D WS GV+L
Sbjct: 208 ---P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 235

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 49/214 (22%), Positives = 73/214 (34%), Gaps = 36/214 (16%)

Query: 12  EVGRTIGEGTFAKV-----RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            + R +G G F +V         N  +   VA+K L +    +  +      E  I+   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 131

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLI------- 119
            H NIVR   V       +I+LE + GG+L   +                 L+       
Sbjct: 132 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 191

Query: 120 DAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL-------PQQGVELLHTT 169
               +       HRD+   N LL   G     K+ DFG++          + G  +L   
Sbjct: 192 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML--- 248

Query: 170 CGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
              P  V    PE      +  S  D WS GV+L
Sbjct: 249 ---P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 276

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 55/223 (24%), Positives = 85/223 (38%), Gaps = 38/223 (17%)

Query: 12  EVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-I 65
           E G+ +G G F KV  A             VA+K+L +      R    +  E+ +M  +
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKMMTQL 105

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGEL----------------FDKIVHQGRLLEN 109
             H NIV L         +Y+I E+   G+L                  +   +    E+
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 110 DCRRYFQQLIDA---VA----HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQ 161
                F+ L+     VA        K   HRDL   N+L+     +K+ DFGL+  +   
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 162 GVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVILF 201
              ++      P  V   APE L    Y    +DVWS G++L+
Sbjct: 226 SNYVVRGNARLP--VKWMAPESLFEGIYT-IKSDVWSYGILLW 265

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 53/230 (23%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
            + VG+ IG G F ++R  +N  T E VA+K+    +  +     Q+  E    K +   
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAP---QLHLEYRFYKQLGSG 64

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE---NDCRRYF---------Q 116
             I +++          ++LE              G  LE   + C R F          
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLEL------------LGPSLEDLFDLCDRTFSLKTVLMIAI 112

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS-----DFGLS-----------ALPQ 160
           QLI  + + HSK + +RD+KPEN L+   GN         DF L+              +
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172

Query: 161 QGVELLHTTCGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
           +   L     GT  Y++  + ++ G + S   D+ + G +    + G LP
Sbjct: 173 EHKSL----TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 51/236 (21%), Positives = 91/236 (38%), Gaps = 46/236 (19%)

Query: 1   MKKQTRRVA-KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE 59
           M  Q   V   Y+VGR IGEG+F  +    N    + VA+K   + +        Q++ E
Sbjct: 1   MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAP---QLRDE 55

Query: 60  ISIMKIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE---NDCRRYF 115
               K++     I  ++          ++++              G  LE   + C R F
Sbjct: 56  YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL------------LGPSLEDLLDLCGRKF 103

Query: 116 ---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLK-----VSDFGLSAL--- 158
                    +Q++  V   H K + +RD+KP+N L+    +       V DFG+      
Sbjct: 104 SVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163

Query: 159 PQQGVELLHTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
           P     + +       GT  Y++  + ++ G + S   D+ + G +    + G LP
Sbjct: 164 PVTKQHIPYREKKNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 63/228 (27%)

Query: 14  GRTIGEGTFAKVR--FAQNRETGES---VAMKVLAKSTILKHRMVDQIK--REISIMKIV 66
            R +GEG F KV      N    +    VA+K L   T     +  +    RE  ++  +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-----LAARKDFQREAELLTNL 74

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRRYFQQ 117
           +H +IV+ + V      + ++ E++  G+L            I+  G+  +        Q
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 118 LI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-------------- 156
           ++         + +  S+   HRDL   N L+ +   +K+ DFG+S              
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 194

Query: 157 -ALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
             LP                +    PE +  R +  + +DVWS GVIL
Sbjct: 195 TMLP----------------IRWMPPESIMYRKFT-TESDVWSFGVIL 225

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 80.7 bits (200), Expect = 4e-17
 Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 54/229 (23%)

Query: 14  GRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH 68
           G+T+GEG F KV  A       R    +VA+K+L ++       +  +  E +++K V H
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNH 85

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGEL-----------------FDKIVHQGRLLENDC 111
           P++++L+   +    + +I+E+   G L                             ++ 
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 112 RRYFQQLI-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE 164
                 LI         + +     + HRDL   N+L+     +K+SDFGLS        
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-------- 197

Query: 165 LLHTTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 201
                    +YV            A E L +  Y  + +DVWS GV+L+
Sbjct: 198 --RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 82.4 bits (203), Expect = 4e-17
 Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 44/228 (19%)

Query: 7   RVA-KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           RV  K+ +GR IG G+F ++    N +T E VA+K+    T  KH    Q+  E  I +I
Sbjct: 4   RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHP---QLLYESKIYRI 58

Query: 66  VR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE---NDCRRYF------ 115
           ++    I  +           ++++              G  LE   N C R        
Sbjct: 59  LQGGTGIPNVRWFGVEGDYNVLVMDL------------LGPSLEDLFNFCSRKLSLKTVL 106

Query: 116 ---QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSAL---PQQGVELL 166
               Q+I+ V   HSK   HRD+KP+N L+        + + DFGL+           + 
Sbjct: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP 166

Query: 167 HTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
           +       GT  Y +  V ++ G + S   D+ S G +L   + G LP
Sbjct: 167 YRENKNLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 32/215 (14%)

Query: 14  GRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVR 67
           G+ +G G F +V  A         T  +VA+K+L +     H     +  E+ I+  I  
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGH 89

Query: 68  HPNIVRLHEV-LASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY--FQQ 117
           H N+V L          + +I+EF   G L         + V      E+  + +   + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 118 LID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC 170
           LI         +    S+   HRDL   N+LL     +K+ DFGL+    +  + +    
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 171 GT-PNYV---APEVLSNRGYDGSAADVWSCGVILF 201
              P  +   APE + +R Y    +DVWS GV+L+
Sbjct: 210 ARLP--LKWMAPETIFDRVYT-IQSDVWSFGVLLW 241

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 49/224 (21%)

Query: 14  GRTIGEGTFAKVRFA-------QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-I 65
           G+ +GEG F +V  A               VA+K+L        + +  +  E+ +MK I
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMI 131

Query: 66  VRHPNIVRLHEVLASRTKVYIILEFVTGGELFD---------KIVHQGRLLENDCRRYFQ 116
            +H NI+ L         +Y+I+E+ + G L +                    + +   +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 117 QLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT 169
            L+         + +  SK   HRDL   N+L+     +K++DFGL+         +H  
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA-------RDIHH- 243

Query: 170 CGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 201
                Y             APE L +R Y    +DVWS GV+L+
Sbjct: 244 --IDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLW 284

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 47/213 (22%), Positives = 83/213 (38%), Gaps = 30/213 (14%)

Query: 12  EVGRTIGEGTFAKVR--FAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIV 66
            +   +GEG F KV      N    +    VA+K L +++          +RE  ++ ++
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTML 100

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGEL--------FDKIVHQGRLLENDCRRYFQQL 118
           +H +IVR   V      + ++ E++  G+L         D  +  G            QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 119 I-------DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTC 170
           +         + +       HRDL   N L+     +K+ DFG+S  +       +    
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 171 GTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
             P  +    PE +  R +  + +DVWS GV+L
Sbjct: 221 MLP--IRWMPPESILYRKFT-TESDVWSFGVVL 250

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 44/263 (16%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL-- 74
           IG G F KV +      G  VA+K     +        + + EI  +   RHP++V L  
Sbjct: 47  IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102

Query: 75  ------HEVLASRTKVYIILEFVTGGE----LFDKIVHQGRLLENDCRRYFQQLIDA--- 121
                   +L     +Y   +++  G     L+   +    +      +  +  I A   
Sbjct: 103 FCDERNEMIL-----IY---KYMENGNLKRHLYGSDLPTMSM---SWEQRLEICIGAARG 151

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAP 178
           + + H++ + HRD+K  N+LLD     K++DFG+S    +  +  H +    GT  Y+ P
Sbjct: 152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL-DQTHLSTVVKGTLGYIDP 210

Query: 179 E-VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA 237
           E  +  R  + S  DV+S GV+LF ++          LP   + +N AE++     + G 
Sbjct: 211 EYFIKGRLTEKS--DVYSFGVVLFEVLCARSAI-VQSLPR--EMVNLAEWAVE-SHNNGQ 264

Query: 238 TSLIHKILDPNPKTRIRIEGIRK 260
              + +I+DPN   +IR E +RK
Sbjct: 265 ---LEQIVDPNLADKIRPESLRK 284

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 43/224 (19%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
           +Y +GR IG G+F  +    +   GE VA+K+    T  KH    Q+  E  I K+++  
Sbjct: 10  RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHP---QLHIESKIYKMMQGG 64

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLE---NDCRRYF---------Q 116
             I  +    A      +++E              G  LE   N C R F          
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMEL------------LGPSLEDLFNFCSRKFSLKTVLLLAD 112

Query: 117 QLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQGVELLHTT---- 169
           Q+I  + + HSK   HRD+KP+N L+        + + DFGL+   +      H      
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 170 ---CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
               GT  Y +  + ++ G + S   D+ S G +L     G LP
Sbjct: 173 KNLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 71/377 (18%), Positives = 117/377 (31%), Gaps = 139/377 (36%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-- 67
           +Y V R +G G F+ V  + + +  + VAMKV+ KS        +    EI ++K VR  
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSA---EHYTETALDEIRLLKSVRNS 93

Query: 68  ---HPN---IVRL------------HEVLASRTKVYIILEFVTGGELFD--KIVHQGRLL 107
               PN   +V+L            H  +     V+ +L    G  L       +   L 
Sbjct: 94  DPNDPNREMVVQLLDDFKISGVNGTHICM-----VFEVL----GHHLLKWIIKSNYQGLP 144

Query: 108 ENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLL------------------------ 142
               ++  QQ++  + + H+K  + H D+KPEN+LL                        
Sbjct: 145 LPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204

Query: 143 -------------------------DSYGNLKVSDFGLSALPQQGVELLHTTCGTPN-YV 176
                                         +K++D G +    +      T       Y 
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYR 260

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK--------------- 221
           + EVL   GY+ + AD+WS   + F L  G   F         +                
Sbjct: 261 SLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319

Query: 222 ---INAAEFSCPFWFSTG------------------------------ATSLIHKILDPN 248
              I A ++S  F+   G                               T  +  +L+  
Sbjct: 320 RKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELI 379

Query: 249 PKTRIRIEGIRKHPWFR 265
           P+ R       +HPW  
Sbjct: 380 PEKRATAAECLRHPWLN 396

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 49/226 (21%)

Query: 12  EVGRTIGEGTFAKVRFA-------QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
            +G+ +GEG F +V  A          +   +VA+K+L      K    D +  E+ +MK
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLV-SEMEMMK 95

Query: 65  -IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY-- 114
            I +H NI+ L         +Y+I+E+ + G L +         +     +         
Sbjct: 96  MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155

Query: 115 FQQLIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
           F+ L+           +  S+   HRDL   N+L+     +K++DFGL+           
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA----------R 205

Query: 168 TTCGTPNYV------------APEVLSNRGYDGSAADVWSCGVILF 201
                  Y             APE L +R Y    +DVWS GV+++
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMW 250

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 52/236 (22%), Positives = 84/236 (35%), Gaps = 66/236 (27%)

Query: 12  EVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           E  R IGEG F +V  A+       E    VA+K+L +      +     +RE ++M   
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMAEF 107

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGEL-----------------FDKIVHQGRLLEN 109
            +PNIV+L  V A    + ++ E++  G+L                  D           
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167

Query: 110 DCRRYFQQLIDAV-------AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS------ 156
                  + +          A+   +   HRDL   N L+     +K++DFGLS      
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

Query: 157 ---------ALPQQGVELLHTTCGTPNYV---APEVLSNRGYDGSAADVWSCGVIL 200
                    A+P                +    PE +    Y  + +DVW+ GV+L
Sbjct: 228 DYYKADGNDAIP----------------IRWMPPESIFYNRYT-TESDVWAYGVVL 266

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 33/218 (15%)

Query: 12  EVGRTIGEGTFAKVRFA-------QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
            +G+ +GEG F +V  A          +   +VA+K+L        + +  +  E+ +MK
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMK 141

Query: 65  -IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFD-------KIVHQGRLLENDCRRY-- 114
            I +H NI+ L         +Y+I+E+ + G L +         +     +         
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201

Query: 115 FQQLID-------AVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
           F+ L+         + +  S+   HRDL   N+L+     +K++DFGL+           
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261

Query: 168 TTCGT-PNYV---APEVLSNRGYDGSAADVWSCGVILF 201
           TT G  P  V   APE L +R Y    +DVWS GV+++
Sbjct: 262 TTNGRLP--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 74.1 bits (181), Expect = 9e-15
 Identities = 38/192 (19%), Positives = 63/192 (32%), Gaps = 48/192 (25%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA-----KSTILKHRMVDQIKREISIMK 64
           K +    IGEG F +V F Q       VA+K++A            +  ++I  EI I K
Sbjct: 21  KLQRCEKIGEGVFGEV-F-QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 65  IV---------RHPNIVRLHEV------------------------------LASRTKVY 85
            +         R    + L+ V                                   +++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 86  IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDS 144
           I+LEF  GG   +++  +        +    QL  ++A   +     HRDL   N+LL  
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197

Query: 145 YGNLKVSDFGLS 156
               K+      
Sbjct: 198 TSLKKLHYTLNG 209

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 26/205 (12%)

Query: 17  IGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHE 76
           +G G F KV +      G  VA+K L            Q + E+ ++ +  H N++RL  
Sbjct: 38  LGRGGFGKV-YKGRLADGTLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94

Query: 77  VLASRTKVYIILEFVTGG----ELFDKIVHQGRLLENDCRRYFQQLIDAVA--------H 124
              + T+  ++  ++  G     L ++   Q  L   D  +  +  + + A        H
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPL---DWPKRQRIALGS-ARGLAYLHDH 150

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVL 181
           C  K + HRD+K  N+LLD      V DFGL+ L        H T    GT  ++APE L
Sbjct: 151 CDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--HVTTAVRGTIGHIAPEYL 207

Query: 182 SNRGYDGSAADVWSCGVILFVLMAG 206
           S  G      DV+  GV+L  L+ G
Sbjct: 208 S-TGKSSEKTDVFGYGVMLLELITG 231

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 57/227 (25%), Positives = 86/227 (37%), Gaps = 50/227 (22%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK----HRMVDQIKREIS 61
                   G  +GEG F  V   +      +VA+K LA    +      +   Q  +EI 
Sbjct: 28  DERPISVGGNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQ---QFDQEIK 82

Query: 62  IMKIVRHPNIVRL--------HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
           +M   +H N+V L           L     VY    ++  G L    +         C  
Sbjct: 83  VMAKCQHENLVELLGFSSDGDDLCL-----VY---VYMPNGSL-LDRLS--------CLD 125

Query: 114 YFQQL---------IDA---VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ 161
               L           A   +   H     HRD+K  N+LLD     K+SDFGL+   ++
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 185

Query: 162 GVELLHTT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG 206
             + + T+   GT  Y+APE L       S  D++S GV+L  ++ G
Sbjct: 186 FAQTVMTSRIVGTTAYMAPEALRGEITPKS--DIYSFGVVLLEIITG 230

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 31/167 (18%), Positives = 60/167 (35%), Gaps = 24/167 (14%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           ++ +G+ IG G F  +  A      E  A  V+     ++++    +  E+   + V   
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRVAKK 93

Query: 70  NIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQ--GRLLEN--DCRRYF----- 115
           + ++                Y        G  +  +V +  G  L+        F     
Sbjct: 94  DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV 153

Query: 116 ----QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV--SDFGLS 156
                +++D + + H     H D+K  NLLL      +V  +D+GLS
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 39/229 (17%), Positives = 77/229 (33%), Gaps = 33/229 (14%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            ++VG  IG+G F  +  A +  + ESV         +        +  E+   +    P
Sbjct: 36  AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAKP 93

Query: 70  NIVRLHEVLASRT-----KVYIILEFVTGGELFDKIVHQ--GRLLE---NDCRRYF---- 115
             ++              K +        G+ +  ++    G  L+       + F    
Sbjct: 94  EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKT 153

Query: 116 -----QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV--SDFGLS---ALPQQGVEL 165
                 +++D + + H     H D+K  NLLL+     +V   D+GL+            
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213

Query: 166 LHTT----CGTPNYVAPEVLSNRGYDGS-AADVWSCGVILFVLMAGYLP 209
                    GT  + +  + ++ G   S   D+   G  +   + G+LP
Sbjct: 214 AADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 27/174 (15%), Positives = 59/174 (33%), Gaps = 35/174 (20%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETG--------ESVAMKVLAKSTILKHRMVDQIKREIS 61
           ++++           +  A    T         +  ++K+ AK   L +        E +
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFN--------EQN 94

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYI--ILEFVTGGELFDKIVHQ--GRLLE---NDC-RR 113
             +    P  V   + L S   + I   + F    + +  +V    GR L+   +   + 
Sbjct: 95  FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKH 154

Query: 114 YF---------QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV--SDFGLS 156
                       +L+DA+   H     H ++  EN+ +D     +V  + +G +
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 4/116 (3%)

Query: 97  FDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS 156
             + +++  L       Y  Q+   +    S+   HRDL   N+LL     +K+ DFGL+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

Query: 157 ALPQQGVELLHTTCGT-P-NYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLP 209
               +  + +       P  ++APE + +R Y    +DVWS GV+L+ + + G  P
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 37/183 (20%), Positives = 62/183 (33%), Gaps = 13/183 (7%)

Query: 12  EVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-I 65
           ++G+ +G G F +V  A         T  +VA+K+L +     H     +  E+ I+  I
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHI 82

Query: 66  VRHPNIVRLH-EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
             H N+V L          + +I+EF   G L   +    R   N+   Y  +       
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138

Query: 125 CHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR 184
               G    DLK     + S  +   S F          E         +++  E L   
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICY 198

Query: 185 GYD 187
            + 
Sbjct: 199 SFQ 201

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 8e-07
 Identities = 56/314 (17%), Positives = 102/314 (32%), Gaps = 87/314 (27%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFA-QNRETGESVA---MK-----VLAKSTILKHRMVDQI 56
           +  AKY V R      + K+R A       ++V    +       +A    L +++  ++
Sbjct: 124 QVFAKYNVSR---LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180

Query: 57  KREISIMKIVRHPNIVRLHEVLASRTKVYIILE--FVTGGELFDKIVHQGRLLENDCRRY 114
             +I  + +    N      VL    K+   ++  + +  +    I  +   ++ + RR 
Sbjct: 181 DFKIFWLNL---KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237

Query: 115 FQQ-------LI-DAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL 166
            +        L+   V   ++K     +L  + LL   +    V+DF LSA     + L 
Sbjct: 238 LKSKPYENCLLVLLNV--QNAKAWNAFNLSCKILLTTRFKQ--VTDF-LSAATTTHISLD 292

Query: 167 HTTCG-TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA 225
           H +   TP     EV S                    L+  YL     DLP      N  
Sbjct: 293 HHSMTLTP----DEVKS--------------------LLLKYLDCRPQDLPREVLTTN-- 326

Query: 226 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEV------ 279
               P        S+I + +     T           W   N+  V C +   +      
Sbjct: 327 ----PR-----RLSIIAESIRDGLAT-----------W--DNWKHVNCDKLTTIIESSLN 364

Query: 280 NLD--DVHAVFDDI 291
            L+  +   +FD +
Sbjct: 365 VLEPAEYRKMFDRL 378

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 2e-05
 Identities = 55/435 (12%), Positives = 115/435 (26%), Gaps = 134/435 (30%)

Query: 35  ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV-------YII 87
             +  +    S + +   ++Q  R  +  ++    N+ RL   L  R  +        ++
Sbjct: 96  SPIKTEQRQPSMMTR-MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVL 154

Query: 88  LEFVTGGELFDKIVHQGRLLENDCRRY-FQQLID------AVAHCHSKGVYHRDLKP-EN 139
           ++ V G     K      +  + C  Y  Q  +D       + +C+S       L+  + 
Sbjct: 155 IDGVLG---SGKTW----VALDVCLSYKVQCKMDFKIFWLNLKNCNSP---ETVLEMLQK 204

Query: 140 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY-------DGSAAD 192
           LL     N        S +  +   +              +L ++ Y            +
Sbjct: 205 LLYQIDPNWTSRSDHSSNIKLRIHSI--------QAELRRLLKSKPYENCLLVLL----N 252

Query: 193 VWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTR 252
           V +                           NA   SC    +T    +    L     T 
Sbjct: 253 VQNAKA-----------------------WNAFNLSCKILLTTRFKQVT-DFLSAATTTH 288

Query: 253 IRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKVGGPLLMNAFE 312
           I ++             P    E + + L  +     D+       E     P  ++   
Sbjct: 289 ISLDH------HSMTLTP---DEVKSLLLKYLDCRPQDL-----PREVLTTNPRRLS--- 331

Query: 313 MITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSN-IEAVAESLSLKVHTRNYKTR 371
           +I        A      +D +     +  +      L+  IE+    L    + + +   
Sbjct: 332 II--------AESI---RDGLATWDNW--KHVNCDKLTTIIESSLNVLEPAEYRKMFD-- 376

Query: 372 LEGVSANKTGQFAV----------VLEVF-----EVAPSLFMVDVRK---AAGD----TL 409
                     + +V          +L +      +    + +  + K           T+
Sbjct: 377 ----------RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426

Query: 410 EYHKFYKNFCAKLEN 424
                Y     KLEN
Sbjct: 427 SIPSIYLELKVKLEN 441

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 24/178 (13%), Positives = 63/178 (35%), Gaps = 26/178 (14%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD-QIKRE 59
           + +  R      +G+ +GEG  + V    + +      +K          ++ + +   +
Sbjct: 82  LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGD 140

Query: 60  ISIMKIVR------HPNIVRLHEVLASRTKVY----IILEFVTGGELFDKIVHQGRLLEN 109
           +    +           + +L  +   +   +    +++E +   EL+        +   
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYR-------VRVE 193

Query: 110 DCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
           +       +++ VA  + +G+ H DL   N+L+     + + DF       Q VE+  
Sbjct: 194 NPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP------QSVEVGE 244

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 43.1 bits (101), Expect = 7e-05
 Identities = 38/191 (19%), Positives = 66/191 (34%), Gaps = 32/191 (16%)

Query: 1   MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNR--ETGESVAMKV-------LAKSTILKHR 51
           + K + +     +G  I  G  A V +A         ++A+K+         K     + 
Sbjct: 39  LYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYG 98

Query: 52  MVDQIKREISIMKIVR------HPNIVRLHEVLASRTKVY------IILEFVTGGELFDK 99
                 R IS  + V         N+ R  E   S  + Y      +++EF+   EL   
Sbjct: 99  DERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAP 158

Query: 100 IVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLS 156
            + +    L E D    F  +++ V   + +  + H DL   N++      +   D G  
Sbjct: 159 TLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG-- 214

Query: 157 ALPQQGVELLH 167
               Q V L H
Sbjct: 215 ----QAVTLRH 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	441
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	100.0
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.43
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
3ose_A	120	Serine/threonine-protein kinase MARK1; kinase asso	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.9
1v5s_A	126	MAP/microtubule affinity-regulating kinase 3; Ka1	98.77
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.65
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.64
4eai_A	106	5'-AMP-activated protein kinase catalytic subunit	98.47
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.34
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.28
2v8q_A	157	5'-AMP-activated protein kinase catalytic subunit;	98.28
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.12
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.11
2y8l_A	173	5'-AMP-activated protein kinase catalytic subunit;	98.06
4eag_A	130	EG:132E8.2 protein; AMPK, transferase; HET: ATP TA	98.06
2qrd_A	137	SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind	98.0
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.8
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.76
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.71
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.65
3t4n_A	179	Carbon catabolite-derepressing protein kinase; CBS	97.65
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.4
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.32
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.31
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.22
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.19
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.18
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.0
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.89
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.85
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.73
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.8
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.5
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.45
3ost_A	128	Serine/threonine-protein kinase KCC4; kinase assoc	82.23

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.3e-69  Score=519.87  Aligned_cols=261  Identities=31%  Similarity=0.563  Sum_probs=242.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ..+.++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus        28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            34567899999999999999999999999999999999887665555678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (441)
                      |+|||||+||+|++++...+.++|..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....  
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999876432  


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH  242 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  242 (441)
                      .....+.|||+.|+|||++.+.+| +.++|||||||+||+|++|.+||.+.+..+++.+|..+.+.+|..+|+++++||+
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~  266 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE  266 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHH
Confidence            234567899999999999988777 4899999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCChHh------HhcCCCccc
Q 013520          243 KILDPNPKTRIRIEG------IRKHPWFRK  266 (441)
Q Consensus       243 ~~L~~dP~~R~t~~e------il~hp~f~~  266 (441)
                      +||+.||++|||++|      |++||||+.
T Consensus       267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          267 KLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            999999999999988      589999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-68  Score=510.58  Aligned_cols=261  Identities=44%  Similarity=0.866  Sum_probs=224.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|++++.||+|+||+||+|+++.+|+.||||++++....+....+.+.+|+.+|+.++|||||++++++.+++.+
T Consensus         9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~   88 (275)
T 3hyh_A            9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI   88 (275)
T ss_dssp             -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            34678999999999999999999999999999999999987766666667899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||| +|+|++++...+++++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+..... .
T Consensus        89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~  166 (275)
T 3hyh_A           89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-N  166 (275)
T ss_dssp             EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-C
Confidence            9999999 7899999999999999999999999999999999999999999999999999999999999999865443 3


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      ...+.+||+.|+|||++.+..|++.++|||||||++|+|++|++||.+.+...+.+.+..+.+.+|.++|+++++||++|
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  246 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM  246 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            45678999999999999988888889999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCcccc
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      |+.||++|||++|+++||||+..
T Consensus       247 L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          247 LIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             SCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             ccCChhHCcCHHHHHcCcccccC
Confidence            99999999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-66  Score=511.15  Aligned_cols=259  Identities=28%  Similarity=0.568  Sum_probs=231.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|+.+|+.++|||||++++++.+++.+||
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            5689999999999999999999999999999999998866543 346789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |||||+||+|+++|...  ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+.......
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999999999999754  3578999999999999999999999999999999999999999999999999987765545


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCCCHhHHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFSTGATSLIHK  243 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~  243 (441)
                      ...+.|||+.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+..+...++..+.+ +.+..+|+++.+||.+
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~  259 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQ  259 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence            55678999999999999888775 899999999999999999999999998888888877766 4566799999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCcccc
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ||+.||++|||++|+++||||++.
T Consensus       260 ~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          260 LFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             HTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HccCChhHCcCHHHHhcCHHhhcC
Confidence            999999999999999999999764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9.1e-66  Score=504.88  Aligned_cols=257  Identities=27%  Similarity=0.443  Sum_probs=232.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ...|++++.||+|+||+||+|+++.+|+.||||++++.....   .+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            357999999999999999999999999999999998754332   35678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||||+||+|.+++.. +++++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..........
T Consensus       150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            999999999998876 6899999999999999999999999999999999999999999999999999987766555667


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCCCCCCHhHHHHHHHh
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATSLIHKI  244 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~  244 (441)
                      +.|||+.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+..+....+.....   ..+..+|+++++||.+|
T Consensus       229 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHH
Confidence            8899999999999988777 5999999999999999999999999888888887766533   23345899999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCccccCC
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      |+.||++|||++|+++||||++...
T Consensus       308 L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          308 LVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             cCCChhHCcCHHHHhcCHhhcCCCC
Confidence            9999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.2e-66  Score=501.66  Aligned_cols=258  Identities=36%  Similarity=0.634  Sum_probs=229.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ..++|++++.||+|+||+||+|++.   .+++.||||++++....... ...+.+|+.+|+.++|||||++++++.+++.
T Consensus        22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            3468999999999999999999884   47889999999876543322 2357889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+|||||+||+|++++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998765555


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ....+.|||+.|+|||++.+.+|+ .++|||||||+||+|++|.+||.+.+..+...++....+.+|..+|+++.+||++
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  259 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM  259 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence            556788999999999999887775 8999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          244 ILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ||+.||++|||     ++|+++||||+.
T Consensus       260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          260 LFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            99999999998     479999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.6e-64  Score=505.34  Aligned_cols=256  Identities=27%  Similarity=0.454  Sum_probs=232.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+.....   .+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            357999999999999999999999999999999998754332   35688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||||+||+|.+++.. +++++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+..........
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999999998865 6799999999999999999999999999999999999999999999999999987766555667


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc---CCCCCCCCHhHHHHHHHh
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~~  244 (441)
                      +.|||+.|||||++.+..| +.++|||||||++|+|++|.+||.+.+..+....+....   +..+..+|+++++||.+|
T Consensus       306 ~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~  384 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRL  384 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHH
Confidence            8899999999999988777 599999999999999999999999988888888776653   234456899999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCccccC
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      |+.||++|||++|+++||||++..
T Consensus       385 L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          385 LVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             cCCChhHCcCHHHHhcCHHhcCCC
Confidence            999999999999999999998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.6e-63  Score=475.98  Aligned_cols=253  Identities=23%  Similarity=0.447  Sum_probs=221.8

Q ss_pred             cCe-EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCE
Q 013520            9 AKY-EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----RTK   83 (441)
Q Consensus         9 ~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~   83 (441)
                      ++| ++.+.||+|+||+||+|.++.++..||+|++.+..... ...+.+.+|+.+|+.++|||||++++++.+    +..
T Consensus        25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            466 78889999999999999999999999999998765443 345779999999999999999999999875    456


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEcc-CCCeEEeeccccccCC
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDS-YGNLKVSDFGLSALPQ  160 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~~-~~~~kL~DFGls~~~~  160 (441)
                      +|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++|  |+||||||+||||+. +|.+||+|||+|+...
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            8999999999999999999999999999999999999999999998  999999999999984 7999999999998644


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-hHHHHHHhhcCcCC--CCCCCCHhH
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKINAAEFS--CPFWFSTGA  237 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~--~~~~~s~~~  237 (441)
                      .  ....+.+|||.|||||++.+ .| +.++|||||||+||+|++|.+||.+.+ ...+++.+..+..+  .+...++++
T Consensus       184 ~--~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (290)
T 3fpq_A          184 A--SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             T--TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             C--CccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence            3  34567899999999999864 45 589999999999999999999997644 45566666655432  445689999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .+||.+||+.||++|||++|+++||||++
T Consensus       260 ~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          260 KEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999985

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.2e-63  Score=483.31  Aligned_cols=255  Identities=25%  Similarity=0.346  Sum_probs=225.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..+.|++.++||+|+||.||+|+++.+|+.||||+++++...        .+|+.+|+.++|||||++++++.+++.+||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            356799999999999999999999999999999999875432        369999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeeccccccCCcccc-
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQGVE-  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~~~-  164 (441)
                      |||||+||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+| ++||+|||+|+....... 
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999999999999999999999999999999999999999999999988 699999999986643211 


Q ss_pred             ----ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCCCCCCHhH
Q 013520          165 ----LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGA  237 (441)
Q Consensus       165 ----~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~  237 (441)
                          .....|||+.|||||++.+.+|+ .++|||||||+||+|++|.+||.+.+...+..++.....   ..|+.+|+++
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  286 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT  286 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence                22356899999999999987775 899999999999999999999998877777777766554   3567899999


Q ss_pred             HHHHHHhcCCCCCCCCChHhH-------------hcCCCccccCCC
Q 013520          238 TSLIHKILDPNPKTRIRIEGI-------------RKHPWFRKNYNP  270 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~ei-------------l~hp~f~~~~~~  270 (441)
                      .+||.+||+.||++|||+.|+             ++|||+++...|
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            999999999999999999997             579999765443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-61  Score=497.45  Aligned_cols=408  Identities=33%  Similarity=0.613  Sum_probs=314.1

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .+...+++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            35678899999999999999999999999999999999998765443344578999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++......
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999866543


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH  242 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  242 (441)
                       ....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+......++..+.+..|..+++++.+||+
T Consensus       170 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~  248 (476)
T 2y94_A          170 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK  248 (476)
T ss_dssp             -CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred             -ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence             3456779999999999998877777899999999999999999999999988899999999888899999999999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCccccCCCCCCcccccCC---c--ccccccccch--------------------------
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVN---L--DDVHAVFDDI--------------------------  291 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~~~~~~~~~~~~~---~--~~~~~~~~~~--------------------------  291 (441)
                      +||+.||++|||++++++||||+...............   .  +.........                          
T Consensus       249 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l  328 (476)
T 2y94_A          249 HMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHL  328 (476)
T ss_dssp             HHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC---------------------------
T ss_pred             HHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHH
Confidence            99999999999999999999998754321110000000   0  0000000000                          


Q ss_pred             ------------hh-hhhhccc--------cCCCCCccchhhhhhcCCCCCcccc-----CccccccccccceEEeCCCH
Q 013520          292 ------------EY-VAEQSEN--------KVGGPLLMNAFEMITLSQGLNLAAL-----FDRRQDYVKRQTRFVSRQPA  345 (441)
Q Consensus       292 ------------~~-~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~trf~s~~~~  345 (441)
                                  ++ ....+..        ....|.........+.+....+...     -...+...+++.++.|+.+|
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~~~p  408 (476)
T 2y94_A          329 IIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRP  408 (476)
T ss_dssp             ----CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEECSCH
T ss_pred             HHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccCCCH
Confidence                        00 0000000        0000000000000000000000000     00112235778889999999


Q ss_pred             HHHHHHHHHHHHHcCcEEEe-ecceEEEEeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchHH
Q 013520          346 QVILSNIEAVAESLSLKVHT-RNYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEY  411 (441)
Q Consensus       346 ~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~f~~~~Gd~le~  411 (441)
                      .+|+..|..+++.+|+.|+. +.+.++++.........+.|.+++|++.++.++|||++..|+.++|
T Consensus       409 ~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~  475 (476)
T 2y94_A          409 NDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEILEV  475 (476)
T ss_dssp             HHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred             HHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCCcccc
Confidence            99999999999999999976 4578888754333345567999999999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-61  Score=483.54  Aligned_cols=259  Identities=28%  Similarity=0.392  Sum_probs=225.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------CC
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------RT   82 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------~~   82 (441)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            579999999999999999999999999999999976543 23345678899999999999999999999864      36


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .+|||||||+ |+|++++...+++++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7999999995 689999999899999999999999999999999999999999999999999999999999999865332


Q ss_pred             ----ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC---------
Q 013520          163 ----VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC---------  229 (441)
Q Consensus       163 ----~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---------  229 (441)
                          .....+.+||+.|+|||++.+..+++.++||||+|||+|+|++|.+||.+.+..+....|.......         
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                2345678999999999999887777899999999999999999999999988877776664321111         


Q ss_pred             ----------------------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          230 ----------------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       230 ----------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                            .+.+|+++.+||.+||+.||++|||++|+|+||||++...
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                                  1236899999999999999999999999999999987543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.5e-61  Score=504.82  Aligned_cols=261  Identities=31%  Similarity=0.468  Sum_probs=231.9

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHH---HHHHHhCCCCCcceeEEEEEe
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKRE---ISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~E---i~il~~l~hpnIv~l~~~~~~   80 (441)
                      ....+++|+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+|   +.+++.++|||||+++++|.+
T Consensus       184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~  263 (689)
T 3v5w_A          184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT  263 (689)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred             CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence            36788999999999999999999999999999999999988655433333334444   566677799999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      .+.+|+|||||+||+|+++|...+.+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|....
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC---ChHHHHHHhhcCcCCCCCCCCHhH
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAAEFSCPFWFSTGA  237 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~  237 (441)
                      .  ....+.|||+.|+|||++.+...++.++|||||||+||+|++|.+||.+.   +...+.+.+....+.+|..+|+++
T Consensus       344 ~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a  421 (689)
T 3v5w_A          344 K--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL  421 (689)
T ss_dssp             S--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             C--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHH
Confidence            4  33467899999999999975444469999999999999999999999764   334566778888889999999999


Q ss_pred             HHHHHHhcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          238 TSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ++||.+||+.||++|++     ++||++||||+.
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999999999999998     699999999975

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.1e-60  Score=456.91  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=203.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   82 (441)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++....  .....+.+.+|+.+|+.++|||||++++++.+.+    
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~   80 (299)
T 4g31_A            3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK   80 (299)
T ss_dssp             HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred             cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence            3578999999999999999999999999999999997654  3334577899999999999999999999987544    


Q ss_pred             --------EEEEEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEe
Q 013520           83 --------KVYIILEFVTGGELFDKIVHQGRL---LENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS  151 (441)
Q Consensus        83 --------~~~lv~E~~~gg~L~~~i~~~~~l---~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  151 (441)
                              .+|+|||||+||+|.+++...+.+   ++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+
T Consensus        81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence                    479999999999999999876654   345688999999999999999999999999999999999999999


Q ss_pred             eccccccCCcccc------------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHH
Q 013520          152 DFGLSALPQQGVE------------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTL  218 (441)
Q Consensus       152 DFGls~~~~~~~~------------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~  218 (441)
                      |||+|+.......            ...+.|||+.|||||++.+..|+ .++|||||||++|+|++   ||..... ...
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~  236 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRT  236 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence            9999986544211            12456899999999999887774 89999999999999996   7764321 122


Q ss_pred             HHHhhcCcCC-CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          219 YKKINAAEFS-CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       219 ~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ...+....++ .+...++.+.+||++||++||++|||++|+++||||++-
T Consensus       237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            3333333322 112256778999999999999999999999999999753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.3e-59  Score=460.65  Aligned_cols=252  Identities=28%  Similarity=0.465  Sum_probs=208.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      .-++|++.+.||+|+||+||+|+++   .+++.||+|.+.+..     ....+.+|+.+|+.+ +||||+++++++.+++
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~   93 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND   93 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence            4468999999999999999999875   467899999986543     235678999999998 6999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-CCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls~~~~~  161 (441)
                      .+|+||||++||+|.+++   +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+....
T Consensus        94 ~~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A           94 HVVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             EEEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             EEEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999999999998   469999999999999999999999999999999999999876 8999999999974432


Q ss_pred             c----------------------------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC
Q 013520          162 G----------------------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (441)
Q Consensus       162 ~----------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~  213 (441)
                      .                            .....+.+||+.|+|||++.+..+++.++||||+|||+|+|++|++||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            1                            112345689999999999988776679999999999999999999999543


Q ss_pred             C-hHHHHHHhhc--------------------------------------CcCC----------------CCCCCCHhHH
Q 013520          214 D-LPTLYKKINA--------------------------------------AEFS----------------CPFWFSTGAT  238 (441)
Q Consensus       214 ~-~~~~~~~i~~--------------------------------------~~~~----------------~~~~~s~~~~  238 (441)
                      + ..+....|..                                      ....                ....+|++++
T Consensus       251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~  330 (361)
T 4f9c_A          251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY  330 (361)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred             CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence            3 2222222110                                      0000                1123789999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      |||++||+.||++|+|++|+|+||||++
T Consensus       331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          331 DLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999975

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-58  Score=484.72  Aligned_cols=261  Identities=30%  Similarity=0.612  Sum_probs=236.0

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||.||+|+++.+|+.||+|++.+..   ....+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            34689999999999999999999999999999999997754   223567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC--CCeEEeeccccccCCcc
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQG  162 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~--~~~kL~DFGls~~~~~~  162 (441)
                      +|||||+||+|+++|.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.+  |.+||+|||+|+.....
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999999999964 4689999999999999999999999999999999999999854  89999999999876543


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHhHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGAT  238 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~  238 (441)
                       ....+.|||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+..+....+.++    ..+|++++
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             -CceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence             34567899999999999988877 4899999999999999999999999999999999888776654    34899999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccccCCCC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV  271 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~~  271 (441)
                      +||++||+.||++|||++|+++||||+....+.
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            999999999999999999999999999766543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.6e-59  Score=448.88  Aligned_cols=256  Identities=23%  Similarity=0.339  Sum_probs=222.4

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA   79 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   79 (441)
                      ....++|.+.+.||+|+||+||+|++.     .++..||||+++..   .....+.+.+|+.+|++++|||||++++++.
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~   85 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCV   85 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            345578999999999999999999875     36789999999754   2345678999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQ-------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~-------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~  146 (441)
                      +++.+|+|||||+||+|.+++...             ..+++..+..++.||+.||.|||+++|+||||||+||||+.++
T Consensus        86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence            999999999999999999999764             3699999999999999999999999999999999999999999


Q ss_pred             CeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhh
Q 013520          147 NLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKIN  223 (441)
Q Consensus       147 ~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~  223 (441)
                      .+||+|||+|+.......  .....+||+.|+|||++.+..|+ .++|||||||+||||+| |..||.+.+..+....+.
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~  244 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  244 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            999999999976543222  23345799999999999887774 89999999999999998 999999988888888887


Q ss_pred             cCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          224 AAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       224 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .+. .+.|..+|+++.+|+.+||+.||++|||+++|  |+|+++
T Consensus       245 ~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          245 QGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            665 46778899999999999999999999999999  567753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.8e-56  Score=439.42  Aligned_cols=263  Identities=41%  Similarity=0.760  Sum_probs=243.6

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....+++|++++.||+|+||.||+|++..+|+.||||++.+.... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   88 (328)
T 3fe3_A           10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT   88 (328)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence            356688999999999999999999999999999999999876543 3346778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      .|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++...... 
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             EEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            9999999999999999999899999999999999999999999999999999999999999999999999999765543 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ......+||+.|+|||++.+..+++.++|||||||++|+|++|.+||.+.+.......+..+.+..|..+|+++.+||++
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR  247 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            34567889999999999988888778999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCccccC
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ||+.||.+|||++|+++||||+...
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HCCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999999999999999998654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.2e-57  Score=442.80  Aligned_cols=252  Identities=21%  Similarity=0.323  Sum_probs=214.7

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ....+|.+.+.||+|+||+||+|+.+     .++..||||+++..   .....+.+.+|+.+|++++|||||++++++.+
T Consensus        38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            34568999999999999999999865     36889999999753   23446789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ---------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~---------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~  145 (441)
                      .+.+|||||||++|+|.+++...               +++++.++..++.|++.||.|||+++|+||||||+||||+.+
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence            99999999999999999999753               358999999999999999999999999999999999999999


Q ss_pred             CCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHh
Q 013520          146 GNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI  222 (441)
Q Consensus       146 ~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i  222 (441)
                      +.+||+|||+|+......  ......+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..+....+
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  273 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI  273 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998654322  233456899999999999887774 89999999999999998 99999998888888777


Q ss_pred             hcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          223 NAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       223 ~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..+ .++.|..+|+++.+|+.+||+.||++|||++||+++
T Consensus       274 ~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            665 467788899999999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.4e-57  Score=438.72  Aligned_cols=254  Identities=23%  Similarity=0.359  Sum_probs=221.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA   79 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   79 (441)
                      ....+++++.+.||+|+||+||+|+..     .+++.||||+++...  .....+.+.+|+.+|++++|||||++++++.
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            355678999999999999999999853     467899999997543  2234577999999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~  143 (441)
                      +++.+|+|||||++|+|.++|...                ..+++..+..++.||+.||.|||+++|+||||||+||||+
T Consensus       100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            999999999999999999999643                3589999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHH
Q 013520          144 SYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  220 (441)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~  220 (441)
                      +++++||+|||+|+......  ......+||+.|+|||++.+..|+ .++|||||||+||||+| |..||.+.+..+...
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~  258 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE  258 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998654322  234567899999999999887764 89999999999999998 899999998888888


Q ss_pred             HhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          221 KINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       221 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+..+. .+.|..+|+++.+|+.+||+.||++|||+.||+++
T Consensus       259 ~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            877654 46777899999999999999999999999999875

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=7.8e-57  Score=435.76  Aligned_cols=250  Identities=20%  Similarity=0.315  Sum_probs=205.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..+++++.+.||+|+||+||+|+...   .||||+++.... .....+.+.+|+.+|++++|||||++++++.+ +.+||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            35688999999999999999998653   599999875443 33456789999999999999999999998754 56899


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--c
Q 013520           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--V  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--~  163 (441)
                      |||||+||+|.+++... +++++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|+.....  .
T Consensus       109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            99999999999999754 57999999999999999999999999999999999999999999999999999865432  2


Q ss_pred             cccccccCCCCcCCccccccCC--CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHH-HHhhcCcC-----CCCCCCCH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY-KKINAAEF-----SCPFWFST  235 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~-~~i~~~~~-----~~~~~~s~  235 (441)
                      ....+.+||+.|||||++.+..  .++.++|||||||+||||++|+.||.+.+..... ..+..+..     ..+..+|+
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  268 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK  268 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence            3455779999999999996432  2358999999999999999999999886654433 33333321     23456899


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++.+|+.+||+.||++|||+.||+++
T Consensus       269 ~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          269 AMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999987543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.7e-56  Score=436.13  Aligned_cols=260  Identities=33%  Similarity=0.587  Sum_probs=240.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            45789999999999999999999999999999999998765433444677889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.........
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999865444445


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhc
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (441)
                      ..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+......+|..+|+++.+||.+||
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL  240 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  240 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            667899999999999987766 5899999999999999999999999888888888888888899999999999999999


Q ss_pred             CCCCCCCC-----ChHhHhcCCCccc
Q 013520          246 DPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       246 ~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +.||++||     +++++++||||+.
T Consensus       241 ~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          241 KKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            99999999     8999999999975

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-56  Score=443.20  Aligned_cols=261  Identities=34%  Similarity=0.620  Sum_probs=233.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   83 (441)
                      ...+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~   98 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR   98 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence            45678999999999999999999999999999999999876554444567788999999988 79999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998655444


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+..+......+|.++++++.+||++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  257 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKS  257 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            55667899999999999987666 48999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCCCCCCCh------HhHhcCCCccc
Q 013520          244 ILDPNPKTRIRI------EGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t~------~eil~hp~f~~  266 (441)
                      ||+.||++||++      +++++||||+.
T Consensus       258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          258 FMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            999999999999      89999999975

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.3e-55  Score=436.20  Aligned_cols=261  Identities=30%  Similarity=0.581  Sum_probs=238.3

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   83 (441)
                      ...+++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+..|..+++.+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            46788999999999999999999999999999999999876543333456788899999877 99999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999998654444


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+..+.+..+......+|.++|+++.+||.+
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  251 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK  251 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHH
Confidence            45567899999999999987766 58999999999999999999999999988999999888889999999999999999


Q ss_pred             hcCCCCCCCCChH-hHhcCCCccc
Q 013520          244 ILDPNPKTRIRIE-GIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t~~-eil~hp~f~~  266 (441)
                      ||+.||++||++. +|++||||+.
T Consensus       252 lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          252 LFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             HSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HhcCCHhHcCCChHHHHcCccccC
Confidence            9999999999998 9999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.6e-56  Score=439.59  Aligned_cols=266  Identities=44%  Similarity=0.862  Sum_probs=240.3

Q ss_pred             CCcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      |.-....+++|++.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+
T Consensus         1 M~i~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   80 (336)
T 3h4j_B            1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT   80 (336)
T ss_dssp             ---CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCcCccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            44566789999999999999999999999999999999999987554433344678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      .+..|+||||+ +|+|++++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           81 PTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             SSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             CCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999999999 78999999988999999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHH
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (441)
                      .. ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.....+.+....+..|..+|+++.+|
T Consensus       160 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          160 DG-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL  238 (336)
T ss_dssp             TS-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHH
T ss_pred             CC-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            43 34567789999999999988877778999999999999999999999988777777777777788888999999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      |++||+.||.+|||++|+++||||+...
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhccCC
Confidence            9999999999999999999999998654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-55  Score=426.70  Aligned_cols=258  Identities=33%  Similarity=0.689  Sum_probs=237.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            35688999999999999999999999999999999999876544334467788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....   
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999976543   


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+....+..+......+|..+++++.++|++|
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l  237 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL  237 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            2356789999999999987766 489999999999999999999999988888889998888899999999999999999


Q ss_pred             cCCCCCCCC-----ChHhHhcCCCccc
Q 013520          245 LDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       245 L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      |..||++||     +++++++||||+.
T Consensus       238 L~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          238 ITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             hccCHHHcCCCcCCCHHHHhcCccccC
Confidence            999999999     9999999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.2e-55  Score=439.16  Aligned_cols=261  Identities=32%  Similarity=0.596  Sum_probs=234.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~   83 (441)
                      ...+++|++++.||+|+||+||+|+++.+++.||+|++.+.........+.+.+|..++..+ +||||+++++++.+.+.
T Consensus        48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~  127 (396)
T 4dc2_A           48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR  127 (396)
T ss_dssp             -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence            45678999999999999999999999999999999999987665555556788999999877 89999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.......
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998644444


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC---------ChHHHHHHhhcCcCCCCCCCC
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET---------DLPTLYKKINAAEFSCPFWFS  234 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s  234 (441)
                      ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||...         .....++.+......+|..+|
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s  286 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS  286 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSC
T ss_pred             CccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCC
Confidence            55678899999999999988776 58999999999999999999999642         234467778888889999999


Q ss_pred             HhHHHHHHHhcCCCCCCCCCh------HhHhcCCCccc
Q 013520          235 TGATSLIHKILDPNPKTRIRI------EGIRKHPWFRK  266 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~------~eil~hp~f~~  266 (441)
                      +++.+||++||+.||++||++      +||++||||+.
T Consensus       287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            999999999999999999995      79999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-54  Score=428.70  Aligned_cols=262  Identities=32%  Similarity=0.595  Sum_probs=237.9

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      ....+++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            346788999999999999999999999999999999999987766666678899999999988 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999865444


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC---------CChHHHHHHhhcCcCCCCCCC
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE---------TDLPTLYKKINAAEFSCPFWF  233 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~  233 (441)
                      .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||..         .+....++.+......+|..+
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~  242 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL  242 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred             CCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence            445567899999999999987766 5899999999999999999999965         233456677778888889999


Q ss_pred             CHhHHHHHHHhcCCCCCCCCCh------HhHhcCCCccc
Q 013520          234 STGATSLIHKILDPNPKTRIRI------EGIRKHPWFRK  266 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~------~eil~hp~f~~  266 (441)
                      |+++.+||++||+.||++||++      +++++||||+.
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            9999999999999999999996      79999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.5e-55  Score=433.03  Aligned_cols=262  Identities=29%  Similarity=0.560  Sum_probs=238.3

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      ....+++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|..++..+ +||||+++++++.+.+
T Consensus        15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            356789999999999999999999999999999999999876544444567788999999988 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999999865444


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH  242 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  242 (441)
                      .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+..+.++.+......+|..+|+++.+||+
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  253 (353)
T 2i0e_A          175 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK  253 (353)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            445667899999999999987776 5899999999999999999999999998899999999999999999999999999


Q ss_pred             HhcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          243 KILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       243 ~~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      +||..||++||+     +++|++||||+.
T Consensus       254 ~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          254 GLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            999999999995     699999999974

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.5e-54  Score=427.99  Aligned_cols=258  Identities=32%  Similarity=0.645  Sum_probs=239.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|++++.||+|+||.||+|+++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            46789999999999999999999999999999999999876544444567788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++......  
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            999999999999999999899999999999999999999999999999999999999999999999999999865432  


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                       ..+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+....+..+..+...+|..+++++.++|++|
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l  272 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred             -cccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence             346789999999999987766 489999999999999999999999999889999999999999999999999999999


Q ss_pred             cCCCCCCCCC-----hHhHhcCCCccc
Q 013520          245 LDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       245 L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      |+.||++||+     +++|++||||+.
T Consensus       273 L~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          273 LQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             hhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            9999999998     999999999974

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.4e-55  Score=432.05  Aligned_cols=252  Identities=22%  Similarity=0.360  Sum_probs=216.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCC-----CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~   80 (441)
                      ..++|++++.||+|+||+||+|.+..+     ++.||||.+.....  ....+.+.+|+.+|+.++| ||||++++++..
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~  139 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK  139 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence            346899999999999999999997654     36899999876542  2345678999999999965 999999999866


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 013520           81 -RTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (441)
Q Consensus        81 -~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~  143 (441)
                       ++.+|+|||||++|+|.++|...                ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus       140 ~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~  219 (353)
T 4ase_A          140 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS  219 (353)
T ss_dssp             TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC
Confidence             46799999999999999999753                3488999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCCh-HHHH
Q 013520          144 SYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL-PTLY  219 (441)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~-~~~~  219 (441)
                      .++.+||+|||+|+.......  ...+.+||+.|||||++.+..|+ .++|||||||+||||+| |.+||.+.+. ....
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~  298 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC  298 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            999999999999986544322  23456899999999999887764 89999999999999998 9999988654 4445


Q ss_pred             HHhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          220 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       220 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.+..+ .+..|..+|+++.+++.+||+.||++|||+.||++|
T Consensus       299 ~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          299 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            555544 467788899999999999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1e-53  Score=425.22  Aligned_cols=260  Identities=35%  Similarity=0.599  Sum_probs=234.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....++|++++.||+|+||.||+|+++.+|+.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            4456789999999999999999999999999999999987654321   1246789999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC----CeEEeeccccc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSA  157 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~  157 (441)
                      +.+|+||||++||+|++++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            99999999999999999999888999999999999999999999999999999999999998777    79999999998


Q ss_pred             cCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCC
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWF  233 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~  233 (441)
                      ..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+..+....+....+.++    ..+
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          168 EIEDG-VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             ECCTT-CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             EcCCC-CccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            66543 33456789999999999987666 5899999999999999999999999988888888888777665    358


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      |+++.+||++||..||++|||++|+++||||+.
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            999999999999999999999999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-54  Score=430.13  Aligned_cols=261  Identities=32%  Similarity=0.557  Sum_probs=230.0

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI-MKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|..+ ++.++||||+++++++.+.+.
T Consensus        34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            4567899999999999999999999999999999999988776555555667778777 567899999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            99999999999999999998999999999999999999999999999999999999999999999999999998644444


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.++.+.......|..+++++.+||++
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  272 (373)
T 2r5t_A          194 STTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEG  272 (373)
T ss_dssp             CCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHH
T ss_pred             CccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Confidence            45667899999999999987766 48999999999999999999999999988999999888888899999999999999


Q ss_pred             hcCCCCCCCCCh----HhHhcCCCccc
Q 013520          244 ILDPNPKTRIRI----EGIRKHPWFRK  266 (441)
Q Consensus       244 ~L~~dP~~R~t~----~eil~hp~f~~  266 (441)
                      ||+.||.+||++    ++|++||||+.
T Consensus       273 lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          273 LLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HcccCHHhCCCCCCCHHHHhCCccccC
Confidence            999999999997    69999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.8e-53  Score=426.46  Aligned_cols=262  Identities=27%  Similarity=0.519  Sum_probs=235.8

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~   89 (384)
T 4fr4_A           10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED   89 (384)
T ss_dssp             CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            45678899999999999999999999999999999999987665444456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... 
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            9999999999999999999889999999999999999999999999999999999999999999999999999865443 


Q ss_pred             cccccccCCCCcCCccccccC--CCCCCCcchhhHhHHHHHHhcCCCCCCCC---ChHHHHHHhhcCcCCCCCCCCHhHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGET---DLPTLYKKINAAEFSCPFWFSTGAT  238 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~  238 (441)
                      ....+.+||+.|+|||++.+.  ..++.++|||||||++|+|++|..||...   ........+.......|..+|+++.
T Consensus       169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~  248 (384)
T 4fr4_A          169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMV  248 (384)
T ss_dssp             CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHH
Confidence            345678899999999999642  22458999999999999999999999753   3455666777788888999999999


Q ss_pred             HHHHHhcCCCCCCCCC-hHhHhcCCCccc
Q 013520          239 SLIHKILDPNPKTRIR-IEGIRKHPWFRK  266 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t-~~eil~hp~f~~  266 (441)
                      +||++||+.||++||+ ++++++||||+.
T Consensus       249 ~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          249 SLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            9999999999999998 899999999975

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.6e-53  Score=432.26  Aligned_cols=260  Identities=38%  Similarity=0.709  Sum_probs=233.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||.||+|.++.+|+.||+|++.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            44578999999999999999999999999999999998765433 34567899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---cCCCeEEeeccccccCCcc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~---~~~~~kL~DFGls~~~~~~  162 (441)
                      +||||+.||+|++.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            9999999999999999999999999999999999999999999999999999999998   4578999999999877655


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGAT  238 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~  238 (441)
                      .......+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+.......+..+.+..|.    .+|+++.
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             CceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            455567889999999999987666 58999999999999999999999999888888888887765543    4799999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +||.+||+.||++|||++|+++||||+..
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999999999999999999999753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.6e-53  Score=414.85  Aligned_cols=262  Identities=34%  Similarity=0.612  Sum_probs=225.3

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRHPNIVRLHEVLA   79 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   79 (441)
                      .....++|++++.||+|+||.||+|++.   .+|+.||+|++.+..... ......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            3566789999999999999999999985   689999999998764322 223456788999999999999999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      +.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999998765


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHH
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS  239 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  239 (441)
                      ..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..+++++.+
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  250 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARD  250 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            444444567789999999999987666 5899999999999999999999999888888888888888899999999999


Q ss_pred             HHHHhcCCCCCCCC-----ChHhHhcCCCccc
Q 013520          240 LIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       240 li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +|.+||..||++||     +++++++||||+.
T Consensus       251 li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          251 LLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            99999999999999     8899999999974

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.1e-53  Score=405.78  Aligned_cols=260  Identities=33%  Similarity=0.457  Sum_probs=220.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++++.||+|+||.||+|.++.+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            47899999999999999999999999999999999876533 33457788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |||++++.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            99998744444444467899999999999999999999999999999999999999999999999999987655545556


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCC-CCCCChHHHHHHhhcCc--------------------
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLP-FGETDLPTLYKKINAAE--------------------  226 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~P-f~~~~~~~~~~~i~~~~--------------------  226 (441)
                      ..+||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+.......+....                    
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            778999999999998776567999999999999999987776 55555555544442210                    


Q ss_pred             ---------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          227 ---------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       227 ---------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                               ....+.+++++++||++||+.||++|||++|+++||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                     011224788999999999999999999999999999998653

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-53  Score=434.54  Aligned_cols=260  Identities=34%  Similarity=0.589  Sum_probs=228.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence            45689999999999999999999999999999999998765444445567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++........
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            999999999999999998999999999999999999999998 9999999999999999999999999999986554445


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      .....+||+.|+|||++.+..| +.++|||||||++|+|++|..||.+.+.......+......+|..+++++.+||.+|
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~  383 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL  383 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            5667899999999999987666 589999999999999999999999999888999998888899999999999999999


Q ss_pred             cCCCCCCCC-----ChHhHhcCCCccc
Q 013520          245 LDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       245 L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      |+.||++||     |++|+++||||+.
T Consensus       384 L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          384 LKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             TCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             cccCHHHhCCCCCCCHHHHHhCccccC
Confidence            999999999     9999999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-53  Score=430.53  Aligned_cols=261  Identities=32%  Similarity=0.554  Sum_probs=229.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45679999999999999999999999999999999998754333323345789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-c
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (441)
                      +||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|....... .
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            99999999999999876 579999999999999999999999999999999999999999999999999997654432 2


Q ss_pred             ccccccCCCCcCCccccccCC---CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCC--CCCCHhH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRG---YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCP--FWFSTGA  237 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~---~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~  237 (441)
                      ...+.+||+.|+|||++.+.+   +++.++|||||||++|+|++|.+||.+.+....+.++....  +.+|  ..+|+++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence            345789999999999997654   24589999999999999999999999999888888876542  3444  4689999


Q ss_pred             HHHHHHhcCCCCCC--CCChHhHhcCCCcccc
Q 013520          238 TSLIHKILDPNPKT--RIRIEGIRKHPWFRKN  267 (441)
Q Consensus       238 ~~li~~~L~~dP~~--R~t~~eil~hp~f~~~  267 (441)
                      ++||++||..+|.+  |++++||++||||+..
T Consensus       305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            99999999999988  9999999999999863

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.5e-53  Score=419.25  Aligned_cols=259  Identities=39%  Similarity=0.722  Sum_probs=232.4

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  103 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH  103 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            34456899999999999999999999999999999999876543 33457789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEEeeccccccCCc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQ  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~~~  161 (441)
                      |+||||+.||+|++.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++.....
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~  183 (362)
T 2bdw_A          104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  183 (362)
T ss_dssp             EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence            99999999999999999888999999999999999999999999999999999999998654   599999999986654


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGA  237 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~  237 (441)
                      . ......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+..+.+.+|.    .+++++
T Consensus       184 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (362)
T 2bdw_A          184 S-EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  261 (362)
T ss_dssp             C-CSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHH
T ss_pred             C-cccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence            3 33456789999999999987666 48999999999999999999999998888888888877766553    379999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .+||.+||+.||++|||++++++||||+.
T Consensus       262 ~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          262 KSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            99999999999999999999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-52  Score=405.97  Aligned_cols=258  Identities=26%  Similarity=0.430  Sum_probs=228.4

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++.......   .+.+.+|+.+++.++||||+++++++...+..
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   92 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence            345678999999999999999999999999999999997654332   45688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||++||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        93 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           93 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             EEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999999999976 4799999999999999999999999999999999999999999999999999887665444


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---cCCCCCCCCHhHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLI  241 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li  241 (441)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+...   ....|..+++.+.++|
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  250 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL  250 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHH
T ss_pred             ccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHH
Confidence            5567789999999999987766 58999999999999999999999887766554444322   3345566899999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+||+.||++|||++|+++||||+..
T Consensus       251 ~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          251 NRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8e-53  Score=402.96  Aligned_cols=264  Identities=36%  Similarity=0.665  Sum_probs=236.6

Q ss_pred             CcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         2 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      |+....+++|++++.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||+++++++.+.
T Consensus         2 k~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             --CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CcceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            45678899999999999999999999999999999999999776544444456789999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      +..|+||||+++|+|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999865433


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI  241 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li  241 (441)
                      .  .....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..+++++.+||
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          162 S--RRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI  238 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             c--cccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence            2  2345679999999999977655 589999999999999999999999999888888888888889999999999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .+||+.||++|||++|+++||||+...
T Consensus       239 ~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          239 SRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHhccChhhCCCHHHHhhCccccCCc
Confidence            999999999999999999999998654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-52  Score=408.79  Aligned_cols=262  Identities=34%  Similarity=0.597  Sum_probs=232.3

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      +....++|++.+.||+|+||.||+|.++.+|+.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   85 (326)
T 2y0a_A            6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN   85 (326)
T ss_dssp             CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            34456789999999999999999999999999999999987543321   124678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC----CeEEeecccc
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLS  156 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls  156 (441)
                      ....|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998888999999999999999999999999999999999999999887    8999999999


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CC
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FW  232 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~  232 (441)
                      ...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+    ..
T Consensus       166 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (326)
T 2y0a_A          166 HKIDFG-NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN  243 (326)
T ss_dssp             EECCTT-SCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eECCCC-CccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccccc
Confidence            866543 23456789999999999977665 5899999999999999999999998888777777776665554    35


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +|+.+.+||++||+.||++|||++++++||||+..
T Consensus       244 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            79999999999999999999999999999999753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.2e-53  Score=429.87  Aligned_cols=261  Identities=28%  Similarity=0.523  Sum_probs=228.7

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            34679999999999999999999999999999999998754333333345889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc-c
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-V  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~  163 (441)
                      +||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...... .
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999999987 578999999999999999999999999999999999999999999999999999765443 2


Q ss_pred             cccccccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCCCC---CC
Q 013520          164 ELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW---FS  234 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~---~s  234 (441)
                      ......+||+.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+..+.+.++...  .+.+|..   +|
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s  310 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS  310 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence            23345789999999999862    333468999999999999999999999999888888877543  3455543   89


Q ss_pred             HhHHHHHHHhcCCCCCC--CCChHhHhcCCCccc
Q 013520          235 TGATSLIHKILDPNPKT--RIRIEGIRKHPWFRK  266 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~--R~t~~eil~hp~f~~  266 (441)
                      +++++||++||..+|++  |++++|+++||||+.
T Consensus       311 ~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          311 ENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             HHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             HHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            99999999999998888  999999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-52  Score=411.02  Aligned_cols=255  Identities=27%  Similarity=0.507  Sum_probs=229.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            4679999999999999999999999999999999987532    234668899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc--CCCeEEeeccccccCCccc
Q 013520           87 ILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~~~~~~  163 (441)
                      ||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++...... 
T Consensus        79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-  157 (321)
T 1tki_A           79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence            999999999999997654 7999999999999999999999999999999999999997  789999999999876543 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~  239 (441)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+....+..+.    .+|+++.+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            33456789999999999976554 58999999999999999999999998888888888877776553    58999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ||.+||..||++|||++|+++||||++.
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            9999999999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.1e-52  Score=411.53  Aligned_cols=261  Identities=38%  Similarity=0.664  Sum_probs=224.7

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||.||+|+++.+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            35689999999999999999999999999999999997654322  2356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--c
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--V  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--~  163 (441)
                      +||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999999765432  2


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhcCcCCCC--CCCCHhHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP--FWFSTGATSL  240 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~l  240 (441)
                      ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+  ..+++.+.+|
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            33456789999999999988777668899999999999999999999876543 33333333333333  3489999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      |.+||+.||++|||++|+++||||++..
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999998653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=405.88  Aligned_cols=261  Identities=35%  Similarity=0.636  Sum_probs=223.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch-----------------------HHHHHHHHHHH
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----------------------RMVDQIKREIS   61 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~-----------------------~~~~~~~~Ei~   61 (441)
                      ...+++|++.+.||+|+||.||+|++..+|+.||||++.+......                       ...+.+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            3567899999999999999999999999999999999977543221                       12356889999


Q ss_pred             HHHhCCCCCcceeEEEEEe--CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 013520           62 IMKIVRHPNIVRLHEVLAS--RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPEN  139 (441)
Q Consensus        62 il~~l~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~N  139 (441)
                      +++.++||||+++++++.+  ...+|+||||+++++|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            9999999999999999986  678999999999999987653 4679999999999999999999999999999999999


Q ss_pred             EEEccCCCeEEeeccccccCCccccccccccCCCCcCCccccccCCC--CCCCcchhhHhHHHHHHhcCCCCCCCCChHH
Q 013520          140 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETDLPT  217 (441)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~  217 (441)
                      ||++.++.+||+|||++.............+||+.|+|||++.+...  .+.++|||||||++|+|++|..||...+...
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999999876554444566789999999999976542  3578999999999999999999999888777


Q ss_pred             HHHHhhcCcCCCC--CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          218 LYKKINAAEFSCP--FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       218 ~~~~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ....+.......|  ..+++++.++|.+||+.||++|||++|+++||||++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            7777766655544  458999999999999999999999999999999963

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.3e-52  Score=449.00  Aligned_cols=260  Identities=29%  Similarity=0.565  Sum_probs=239.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      ..+++|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..+ +||||+++++++.+.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            4678999999999999999999999999999999999876544444456788899999988 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||++||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++........
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999986544444


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      ...+.+||+.|+|||++.+..| +.++|||||||+||+|++|.+||.+.+..++++.|......+|..+|+++.+||++|
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~l  576 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGL  576 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHH
Confidence            5667899999999999987777 589999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCh-----HhHhcCCCccc
Q 013520          245 LDPNPKTRIRI-----EGIRKHPWFRK  266 (441)
Q Consensus       245 L~~dP~~R~t~-----~eil~hp~f~~  266 (441)
                      |+.||++|+++     ++|++||||+.
T Consensus       577 L~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          577 MTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             SCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             ccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            99999999998     99999999975

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-53  Score=427.17  Aligned_cols=261  Identities=29%  Similarity=0.515  Sum_probs=227.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++..++||||+++++++.+.+.+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            45578999999999999999999999999999999999875443333445688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||++||+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998754 79999999999999999999999999999999999999999999999999997654432


Q ss_pred             c-ccccccCCCCcCCcccccc------CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCC---C
Q 013520          164 E-LLHTTCGTPNYVAPEVLSN------RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCP---F  231 (441)
Q Consensus       164 ~-~~~~~~gt~~Y~aPE~l~~------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~---~  231 (441)
                      . .....+||+.|+|||++..      ...++.++|||||||++|+|++|.+||.+.+..+.+.++...  ....|   .
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  296 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE  296 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcccc
Confidence            2 2345789999999999963      223468999999999999999999999998888888777643  23344   4


Q ss_pred             CCCHhHHHHHHHhcCCCCCCC---CChHhHhcCCCccc
Q 013520          232 WFSTGATSLIHKILDPNPKTR---IRIEGIRKHPWFRK  266 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R---~t~~eil~hp~f~~  266 (441)
                      .+|+++++||++||. +|.+|   ++++||++||||+.
T Consensus       297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            699999999999999 99998   59999999999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.2e-52  Score=398.77  Aligned_cols=265  Identities=45%  Similarity=0.857  Sum_probs=231.5

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .+....++|++++.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            45677899999999999999999999999999999999997754433344567899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ..|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999999999998889999999999999999999999999999999999999999999999999998766543


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH  242 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~  242 (441)
                       ......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.....+.+.......|..+++++.++|.
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          165 -EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM  243 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             -cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHH
Confidence             2334667999999999998776656799999999999999999999999888888888888888888889999999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCccccC
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      +||+.||++|||++++++||||++..
T Consensus       244 ~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHccCChhhCCCHHHHHhChhhccCc
Confidence            99999999999999999999998754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.8e-52  Score=414.94  Aligned_cols=258  Identities=40%  Similarity=0.728  Sum_probs=216.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||.||+|+++.+|+.||+|++.......    +.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            34679999999999999999999999999999999997654332    45789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC--eEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~--~kL~DFGls~~~~~~~  163 (441)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...... 
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            99999999999999998899999999999999999999999999999999999999987765  999999998744332 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh----HHHHHHhhcCcCCCCC--CCCHhH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYKKINAAEFSCPF--WFSTGA  237 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~~i~~~~~~~~~--~~s~~~  237 (441)
                      ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.+.+.    ....+.+....+..|.  .+++++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  251 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPEC  251 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHH
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHH
Confidence            2335668999999999998888776669999999999999999999987543    3444555555555555  479999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .+||++||+.||++|||++|+++||||.+..
T Consensus       252 ~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          252 CHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            9999999999999999999999999997654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-52  Score=399.58  Aligned_cols=265  Identities=34%  Similarity=0.679  Sum_probs=238.2

Q ss_pred             CCcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      |.+....+++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+
T Consensus         6 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A            6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             ----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            45667788999999999999999999999999999999999977544333345678999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      .+..|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999986544


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHH
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (441)
                      ..  .....+|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......|..+++++.++
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (284)
T 2vgo_A          166 SL--RRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDL  242 (284)
T ss_dssp             SS--CBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred             cc--ccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHH
Confidence            32  2345689999999999987665 58999999999999999999999998888888888888888889999999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      |.+||..||.+|||++++++||||+...
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            9999999999999999999999998643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-52  Score=434.54  Aligned_cols=262  Identities=28%  Similarity=0.459  Sum_probs=235.5

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      +....++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            45677899999999999999999999999999999999987655444445778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           84 VYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      +|+||||++||+|.+++...    ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++...
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999999763    36999999999999999999999999999999999999999999999999999876


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC----ChHHHHHHhhcCcCCCCCCCCH
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET----DLPTLYKKINAAEFSCPFWFST  235 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~  235 (441)
                      ..........+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.    +...+.+.+......+|..+|+
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  418 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP  418 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cCCCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence            554444456799999999999988766 48999999999999999999999775    3456777787888888899999


Q ss_pred             hHHHHHHHhcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          236 GATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ++.+||++||+.||++||+     +++|++||||+.
T Consensus       419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            9999999999999999996     489999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-51  Score=396.84  Aligned_cols=265  Identities=34%  Similarity=0.557  Sum_probs=242.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            35667999999999999999999999999999999999887665556677899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999987654434


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      .....+||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+.......|..+++.+.++|.+|
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  249 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM  249 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHH
Confidence            4556789999999999977655 589999999999999999999999988888888888888888889999999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCccccCCC
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      |+.||++|||++++++||||+..+.+
T Consensus       250 l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          250 LQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             cccChhhCcCHHHHhhChheecCCcC
Confidence            99999999999999999999876544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.7e-52  Score=412.46  Aligned_cols=258  Identities=34%  Similarity=0.630  Sum_probs=224.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ..++|++.+.||+|+||.||+|.++.+|+.||||++........  ...+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            34689999999999999999999999999999999976432211  1246789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC---eEEeeccccc
Q 013520           85 YIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSA  157 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGls~  157 (441)
                      |+||||++||+|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999999888643    35899999999999999999999999999999999999987655   9999999998


Q ss_pred             cCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCC
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWF  233 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~  233 (441)
                      ............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+ ......+..+.+..+    ..+
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~~  259 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI  259 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccccC
Confidence            76654444566789999999999987666 589999999999999999999998753 455666666665544    358


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ++++.+||++||..||++|||+.++++||||+.
T Consensus       260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            999999999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-52  Score=397.63  Aligned_cols=262  Identities=33%  Similarity=0.625  Sum_probs=209.5

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|++.+.||+|+||.||+|++..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   86 (278)
T 3cok_A            7 GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYV   86 (278)
T ss_dssp             CSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEE
T ss_pred             ccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeE
Confidence            34678999999999999999999999999999999999775543334457789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999999875 579999999999999999999999999999999999999999999999999998665443


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~  243 (441)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+....+..|..++.++.++|.+
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQ  245 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHH
T ss_pred             CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHH
Confidence            34456789999999999976655 58999999999999999999999887766666666666777788899999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCcccc
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ||+.||++|||++++++||||+..
T Consensus       246 ~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          246 LLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HcccCHhhCCCHHHHhcCccccCC
Confidence            999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.7e-52  Score=435.58  Aligned_cols=261  Identities=29%  Similarity=0.475  Sum_probs=233.7

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      .....++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus       179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            45677899999999999999999999999999999999987655444445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           84 VYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      +|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999999998754  399999999999999999999999999999999999999999999999999986644


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC----hHHHHHHhhcCcCCCCCCCCHhH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFSTGA  237 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~  237 (441)
                      . ......+||+.|+|||++.+..| +.++|||||||++|+|++|.+||...+    .......+......+|..+|+++
T Consensus       339 ~-~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~  416 (576)
T 2acx_A          339 G-QTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA  416 (576)
T ss_dssp             T-CCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             C-ccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence            3 23456789999999999987666 489999999999999999999998753    34566677777777888899999


Q ss_pred             HHHHHHhcCCCCCCCC-----ChHhHhcCCCccc
Q 013520          238 TSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      .+||++||+.||++||     +++|+++||||+.
T Consensus       417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            9999999999999999     7899999999985

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.9e-52  Score=404.08  Aligned_cols=260  Identities=31%  Similarity=0.458  Sum_probs=217.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||.||+|++. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++..
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            456789999999999999999999995 589999999976532 223456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999999985 777777654 459999999999999999999999999999999999999999999999999998765544


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cC--------------
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EF--------------  227 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~--------------  227 (441)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+...  ..              
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            45566789999999999977555578999999999999999999999887655544443210  00              


Q ss_pred             --------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          228 --------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       228 --------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                    ...+.+++++.+||++||+.||++|||++|+++||||++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                          0112367899999999999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-52  Score=406.68  Aligned_cols=261  Identities=31%  Similarity=0.473  Sum_probs=209.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++......  ...+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            457899999999999999999999999999999999765422  223567899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           87 ILEFVTGGELFDKIVHQ------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      ||||++ |+|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999998 5999988754      358999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--c------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--E------------  226 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~------------  226 (441)
                      .........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+...  .            
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            44444556789999999999976555568999999999999999999999988776655544221  0            


Q ss_pred             --------------------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          227 --------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       227 --------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                                          ...+..+++++.+||.+||+.||++|||++|+++||||++.+.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                01122478899999999999999999999999999999876643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-51  Score=404.67  Aligned_cols=264  Identities=34%  Similarity=0.559  Sum_probs=242.7

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ....+|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            45678999999999999999999999999999999998876656566778999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999876544444


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhc
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (441)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..+.+..+....+..|..+++.+.++|.+||
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  276 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML  276 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHc
Confidence            556789999999999977665 5899999999999999999999999888888888888888888899999999999999


Q ss_pred             CCCCCCCCChHhHhcCCCccccCCC
Q 013520          246 DPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      +.||++|||++++++||||+..+.+
T Consensus       277 ~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          277 QTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             CSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             cCChhHCcCHHHHhcCccccCCCcc
Confidence            9999999999999999999887654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=6.4e-52  Score=398.89  Aligned_cols=257  Identities=30%  Similarity=0.458  Sum_probs=214.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++++.||+|+||.||+|++ .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999999 67899999999765432 22346678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+++ +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999976 898888764 679999999999999999999999999999999999999999999999999997655433344


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cC-----------------
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EF-----------------  227 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~-----------------  227 (441)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+...  ..                 
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            56689999999999976555568999999999999999999999887766554443211  00                 


Q ss_pred             ----------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          228 ----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       228 ----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                .....+++++.+||++||+.||++|||++|+++||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                      0113478999999999999999999999999999999753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.4e-52  Score=409.96  Aligned_cols=254  Identities=34%  Similarity=0.613  Sum_probs=224.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.+....       ..+|+.++.++ +||||+++++++.+.+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            4467899999999999999999999999999999999875422       34688888887 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-C---CeEEeeccccccCC
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-G---NLKVSDFGLSALPQ  160 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-~---~~kL~DFGls~~~~  160 (441)
                      |+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +   .+||+|||++....
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999999999998899999999999999999999999999999999999998543 3   49999999998765


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC---CChHHHHHHhhcCcCCCC----CCC
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE---TDLPTLYKKINAAEFSCP----FWF  233 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~---~~~~~~~~~i~~~~~~~~----~~~  233 (441)
                      .......+.+||+.|+|||++.+..|. .++|||||||++|+|++|.+||..   .+..+....+..+.+..+    ..+
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CCCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            554556678999999999999776664 899999999999999999999976   345567777877776654    358


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      |+++.+||++||..||++|||++++++||||...
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            9999999999999999999999999999999754

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-51  Score=397.54  Aligned_cols=259  Identities=28%  Similarity=0.431  Sum_probs=217.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            5799999999999999999999999999999999866542 333456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            99999999999998888899999999999999999999999999999999999999999999999999987665444556


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---------------------c
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------------------E  226 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------------------~  226 (441)
                      ..+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+...                     .
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            7789999999999976555579999999999999999999999887765544333211                     0


Q ss_pred             CCCC----------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          227 FSCP----------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       227 ~~~~----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+.+          +.+++++.+||++||+.||++|||++|+++||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  291 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI  291 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence            1111          3478889999999999999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.7e-51  Score=410.54  Aligned_cols=262  Identities=21%  Similarity=0.332  Sum_probs=220.3

Q ss_pred             ccccCeEEEeeeeec--CcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            6 RRVAKYEVGRTIGEG--TFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G--~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ...++|++++.||+|  +||.||+|+++.+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            356799999999999  9999999999999999999999876543 3456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           84 VYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      +|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||.+.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999999875  6799999999999999999999999999999999999999999999999998764322


Q ss_pred             c-------ccccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC------
Q 013520          162 G-------VELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF------  227 (441)
Q Consensus       162 ~-------~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~------  227 (441)
                      .       .......+||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.......+..+..      
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            1       1122345799999999999763 2345899999999999999999999987655443333221111      


Q ss_pred             ----------------------------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          228 ----------------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       228 ----------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                                              +.+..+++++.+||++||+.||++|||++|+++||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                                                    1334578999999999999999999999999999999864


Q ss_pred             C
Q 013520          268 Y  268 (441)
Q Consensus       268 ~  268 (441)
                      .
T Consensus       341 ~  341 (389)
T 3gni_B          341 K  341 (389)
T ss_dssp             -
T ss_pred             h
Confidence            3

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.7e-52  Score=404.05  Aligned_cols=246  Identities=21%  Similarity=0.322  Sum_probs=193.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----KV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~   84 (441)
                      .+|.+.+.||+|+||+||+|++  +|+.||||+++...    ......+.|+..+..++|||||++++++.+++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4799999999999999999987  58999999996542    11223445677777899999999999997653    68


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEccCCCeEEeecccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~--------gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      |||||||+||+|.+++.. .+++++.+.+++.|++.||.|||++        ||+||||||+||||+.++++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999999976 5799999999999999999999987        9999999999999999999999999999


Q ss_pred             ccCCcccc----ccccccCCCCcCCccccccCCC-----CCCCcchhhHhHHHHHHhcCCCCCCCC--------------
Q 013520          157 ALPQQGVE----LLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILFVLMAGYLPFGET--------------  213 (441)
Q Consensus       157 ~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~--------------  213 (441)
                      +.......    .....+||+.|+|||++.+...     ++.++|||||||+||||++|.+||...              
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            76544322    2235689999999999975421     246899999999999999998776422              


Q ss_pred             -ChHHHHHHhhcCcC--CCCCC-----CCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          214 -DLPTLYKKINAAEF--SCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       214 -~~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                       ......+.+.....  ..|..     .+..+.+|+.+||+.||++|||+.||++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             12233333333322  23322     23467899999999999999999999764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-51  Score=403.39  Aligned_cols=256  Identities=35%  Similarity=0.699  Sum_probs=206.4

Q ss_pred             ccccCeEEE---eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeC
Q 013520            6 RRVAKYEVG---RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~---~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~   81 (441)
                      ....+|++.   +.||+|+||.||+|.++.+|+.||||++.+.      ....+.+|+.+++.+. ||||+++++++.+.
T Consensus         5 ~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~   78 (325)
T 3kn6_A            5 PFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQ   78 (325)
T ss_dssp             HHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC
Confidence            335778886   8899999999999999999999999999653      2356778999999996 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEEeecccccc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSAL  158 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~  158 (441)
                      ...|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++..
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999999999999989999999999999999999999999999999999999998766   799999999987


Q ss_pred             CCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-------hHHHHHHhhcCcCCCCC
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-------LPTLYKKINAAEFSCPF  231 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------~~~~~~~i~~~~~~~~~  231 (441)
                      ...........+||+.|+|||++.+..+. .++|||||||++|+|++|..||...+       ..+....+..+.+..+.
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          159 KPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             CCC----------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             cCCCCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            66555556678899999999999877664 89999999999999999999997643       34566777777766553


Q ss_pred             ----CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          232 ----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       232 ----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                          .+|+++.+||++||+.||++|||++++++||||+...
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence                4899999999999999999999999999999998653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.3e-51  Score=389.90  Aligned_cols=260  Identities=39%  Similarity=0.721  Sum_probs=232.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      +...++|++.+.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (284)
T 3kk8_A            2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH   80 (284)
T ss_dssp             CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence            34568999999999999999999999999999999999876543 33457788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC---eEEeeccccccCCc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQ  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGls~~~~~  161 (441)
                      |+||||++|++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.   +||+|||++.....
T Consensus        81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999999999998899999999999999999999999999999999999999987665   99999999976554


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGA  237 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~  237 (441)
                      . .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..+....|.    .+++++
T Consensus       161 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          161 S-EAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             S-CBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             C-ccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            3 33346789999999999987665 58999999999999999999999998888888887776665443    479999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .++|.+||++||++|||++|+++||||++.
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            999999999999999999999999999764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-51  Score=405.13  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=213.0

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....+++|++++.||+|+||.||+|++..+|+.||||++...... ....+.+.+|+.+++.++||||+++++++.+++.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            456788999999999999999999999999999999999765432 2334667899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-----cCCCeEEeecccccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-----SYGNLKVSDFGLSAL  158 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~-----~~~~~kL~DFGls~~  158 (441)
                      .|+||||++| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||++..
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            9999999975 9999999988999999999999999999999999999999999999995     445599999999986


Q ss_pred             CCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-cCC---------
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-EFS---------  228 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-~~~---------  228 (441)
                      ...........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+... ..+         
T Consensus       187 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (329)
T 3gbz_A          187 FGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT  266 (329)
T ss_dssp             HC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence            6544444566789999999999987665579999999999999999999999988776555544321 000         


Q ss_pred             -CC-------------------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          229 -CP-------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       229 -~~-------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                       .+                   ..+++++.+||.+||+.||++|||++|+++||||+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence             00                   1167899999999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.6e-51  Score=423.12  Aligned_cols=262  Identities=33%  Similarity=0.616  Sum_probs=230.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch----------HHHHHHHHHHHHHHhCCCCCccee
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH----------RMVDQIKREISIMKIVRHPNIVRL   74 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~hpnIv~l   74 (441)
                      ....++|++++.||+|+||.||+|.++.+++.||+|++.+......          ...+.+.+|+.+++.++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            4456789999999999999999999999999999999987654321          234678999999999999999999


Q ss_pred             EEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEEe
Q 013520           75 HEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVS  151 (441)
Q Consensus        75 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~  151 (441)
                      ++++.+...+|+||||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence            999999999999999999999999999889999999999999999999999999999999999999999776   69999


Q ss_pred             eccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC-
Q 013520          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP-  230 (441)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~-  230 (441)
                      |||++...... ......+||+.|+|||++.+ .+ +.++||||+||++|+|++|.+||.+.+..+....+..+.+..+ 
T Consensus       192 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          192 DFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             CCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             ECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            99999866543 33456789999999999864 34 5899999999999999999999999998888888888877655 


Q ss_pred             ---CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          231 ---FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       231 ---~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                         ..+|+++.+||++||++||.+|||++|+++||||++...
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence               458999999999999999999999999999999987543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-51  Score=411.75  Aligned_cols=261  Identities=30%  Similarity=0.420  Sum_probs=211.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCC-
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRT-   82 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~-   82 (441)
                      ....++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+++.+. ||||+++++++...+ 
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            345789999999999999999999999999999999986543 33445677889999999997 999999999997544 


Q ss_pred             -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 -KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 -~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                       .+|+||||++ |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             CEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence             7999999997 589888876 6899999999999999999999999999999999999999999999999999975432


Q ss_pred             ---------------------cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHH
Q 013520          162 ---------------------GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  220 (441)
Q Consensus       162 ---------------------~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~  220 (441)
                                           ........+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  241 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE  241 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence                                 11224557899999999999875555699999999999999999999999887766555


Q ss_pred             HhhcC-cC----------------------------------------------CCCCCCCHhHHHHHHHhcCCCCCCCC
Q 013520          221 KINAA-EF----------------------------------------------SCPFWFSTGATSLIHKILDPNPKTRI  253 (441)
Q Consensus       221 ~i~~~-~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~  253 (441)
                      .+... ..                                              ..+..+++++.+||++||+.||++||
T Consensus       242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~  321 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI  321 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence            54311 00                                              01125789999999999999999999


Q ss_pred             ChHhHhcCCCccccC
Q 013520          254 RIEGIRKHPWFRKNY  268 (441)
Q Consensus       254 t~~eil~hp~f~~~~  268 (441)
                      |++|+++||||+...
T Consensus       322 t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          322 SANDALKHPFVSIFH  336 (388)
T ss_dssp             CHHHHTTSTTTTTTC
T ss_pred             CHHHHhCCHHHHHhc
Confidence            999999999998654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.3e-51  Score=388.36  Aligned_cols=257  Identities=40%  Similarity=0.681  Sum_probs=231.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|.++.++..||+|++.......   .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            345678999999999999999999999999999999997754332   46788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---ccCCCeEEeeccccccCCc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~  161 (441)
                      |+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999999999999999988999999999999999999999999999999999999999   7889999999999976554


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGA  237 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~  237 (441)
                      . ......+||+.|+|||++.+.  .+.++||||||+++|+|++|..||...+..+....+..+....|.    .+++.+
T Consensus       162 ~-~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          162 G-KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             T-SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             c-cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence            3 334567899999999998653  468999999999999999999999998888888888887777664    589999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .++|.+||+.||++|||+.++++||||++.
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999999764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-51  Score=408.48  Aligned_cols=259  Identities=27%  Similarity=0.563  Sum_probs=228.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||.||+|.++.+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+....
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  123 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  123 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence            345678999999999999999999999999999999997653   22345788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc--CCCeEEeeccccccCCc
Q 013520           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~~~~  161 (441)
                      |+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++.....
T Consensus       124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            99999999999999997654 7999999999999999999999999999999999999974  47899999999986654


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHhH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (441)
                      . ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....+..+    ..+|+++
T Consensus       204 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          204 D-EIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             T-SCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             C-cceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            3 33445689999999999987665 5899999999999999999999999888777777776655443    3479999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .+||.+||+.||++|||++++++||||+...
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999999998754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.3e-51  Score=425.69  Aligned_cols=260  Identities=34%  Similarity=0.614  Sum_probs=233.4

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++.+.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34568999999999999999999999999999999998766554445678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---ccCCCeEEeeccccccCCcc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~~  162 (441)
                      +||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999998999999999999999999999999999999999999999   46789999999999765543


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC--C--CCCHhHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--F--WFSTGAT  238 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~~~~  238 (441)
                       ......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..+....+..+.+..+  .  .+|+++.
T Consensus       183 -~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          183 -KKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             -CSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             -cccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence             33456789999999999965 44 5899999999999999999999999998888888887765443  2  3899999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      +||++||+.||++|||++++++||||+...
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            999999999999999999999999998653

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-50  Score=396.69  Aligned_cols=260  Identities=33%  Similarity=0.587  Sum_probs=231.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....++|++.+.||+|+||.||+|.++.+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            4456789999999999999999999999999999999987543321   1246789999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC----CeEEeeccccc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSA  157 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~  157 (441)
                      +..|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999999999888899999999999999999999999999999999999999888    79999999997


Q ss_pred             cCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCC
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWF  233 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~  233 (441)
                      ..... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+    ..+
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          168 EIEDG-VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             ECCTT-CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ecCcc-ccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence            65543 23346679999999999977665 5899999999999999999999999888888887777666554    458


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ++.+.++|.+||..||++|||++++++||||+.
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            999999999999999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.9e-51  Score=421.69  Aligned_cols=261  Identities=36%  Similarity=0.624  Sum_probs=230.2

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      +....++|++++.||+|+||.||+|.++.+|+.||||++.+...... ....+.+|+.+++.++||||+++++++.+...
T Consensus        17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   95 (486)
T 3mwu_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (486)
T ss_dssp             CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence            34556799999999999999999999999999999999976543322 35678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---cCCCeEEeeccccccCC
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~---~~~~~kL~DFGls~~~~  160 (441)
                      +|+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999999999999889999999999999999999999999999999999999995   45679999999998665


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC--C--CCCHh
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--F--WFSTG  236 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--~--~~s~~  236 (441)
                      .. ......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..+....+..+.+..+  .  .+|++
T Consensus       176 ~~-~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          176 QN-TKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             CC-----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             CC-CccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            43 33456789999999999975 34 5899999999999999999999999988888888877765543  2  38999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      +.+||++||+.||++|||+.++++||||++..
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999999998754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.8e-51  Score=419.90  Aligned_cols=257  Identities=28%  Similarity=0.452  Sum_probs=212.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   81 (441)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.+.. ......+.+.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            4678999999999999999999999999999999998753 3344567888999999999999999999999654     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ..+|+||||+++ +|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             468999999976 4666664  359999999999999999999999999999999999999999999999999998654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------  226 (441)
                      .. ......+||+.|+|||++.+..|. .++|||||||++|+|++|.+||.+.+..+.+..+....              
T Consensus       216 ~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~  293 (464)
T 3ttj_A          216 TS-FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  293 (464)
T ss_dssp             -C-CCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHH
T ss_pred             CC-cccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchh
Confidence            43 334567899999999999887765 89999999999999999999999888666555543210              


Q ss_pred             -------------CCC----CCC-----------CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          227 -------------FSC----PFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       227 -------------~~~----~~~-----------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                   ..+    |..           .++++.+||++||+.||++|||++|+++||||+..+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                         000    000           1567999999999999999999999999999987654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.4e-51  Score=421.20  Aligned_cols=257  Identities=33%  Similarity=0.648  Sum_probs=224.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||.||+|+++.++..||+|++.+...... ....+.+|+.+++.++||||+++++++.+...+|
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            344579999999999999999999999999999999987553322 2467889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC---CCeEEeeccccccCCcc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQG  162 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFGls~~~~~~  162 (441)
                      +||||++||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++......
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            999999999999999988999999999999999999999999999999999999999764   45999999999876543


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGAT  238 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~  238 (441)
                       ......+||+.|+|||++.+ .| +.++||||+||++|+|++|.+||.+.+..+....+..+.+..+.    .+|+++.
T Consensus       193 -~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          193 -KKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             -BCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             -ccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence             33456789999999999863 44 58999999999999999999999999988888888877665442    3899999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +||++||+.||.+|||++++++||||+.
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHHHCCCChhhCccHHHHhcCccccc
Confidence            9999999999999999999999999976

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-50  Score=387.41  Aligned_cols=258  Identities=32%  Similarity=0.574  Sum_probs=220.6

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      +....++|++.+.||+|+||.||+|.++.+|..+|+|++.......  ..+.+.+|+.+++.++||||+++++++.+...
T Consensus        17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            3455679999999999999999999999999999999998765322  35678999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---ccCCCeEEeecccc
Q 013520           84 VYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLS  156 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls  156 (441)
                      .|+||||+++|+|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+||++   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999999988543    679999999999999999999999999999999999999   45678999999999


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC---CCC
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP---FWF  233 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~  233 (441)
                      ...... ......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.......+   ..+
T Consensus       175 ~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (285)
T 3is5_A          175 ELFKSD-EHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPL  251 (285)
T ss_dssp             CC-----------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCC
T ss_pred             eecCCc-ccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcC
Confidence            765443 33456779999999999853 33 5899999999999999999999999888777776655544333   237


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ++++.+||.+||+.||++|||++|+++||||++
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            899999999999999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-51  Score=400.91  Aligned_cols=258  Identities=26%  Similarity=0.416  Sum_probs=211.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++......  .....+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            47899999999999999999999999999999999654321  1112345799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||++ |+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..........
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            99997 48888887654 58999999999999999999999999999999999999999999999999998665544455


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--C-----------------
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--F-----------------  227 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~-----------------  227 (441)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+....  .                 
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            667899999999999775555789999999999999999999999888766555443210  0                 


Q ss_pred             -----------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          228 -----------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       228 -----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                                 ..++.+++++.+||.+||+.||++|||++|+++||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                       01124688999999999999999999999999999998654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-50  Score=392.36  Aligned_cols=260  Identities=27%  Similarity=0.385  Sum_probs=213.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhC---CCCCcceeEEEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIV---RHPNIVRLHEVLA   79 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~   79 (441)
                      ....++|++++.||+|+||.||+|++..+|+.||+|++.......  ......+.+|+.+++.+   +||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            455689999999999999999999999999999999997543211  11224566788887776   4999999999998


Q ss_pred             eCC-----EEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEee
Q 013520           80 SRT-----KVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (441)
Q Consensus        80 ~~~-----~~~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (441)
                      ...     .+|++|||+. |+|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            765     5899999997 599999987654  99999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CC--
Q 013520          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FS--  228 (441)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~--  228 (441)
                      ||++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+....  .+  
T Consensus       164 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          164 FGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccccCCC-cccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999866543 33456789999999999987666 589999999999999999999999888766665543210  00  


Q ss_pred             -----------------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          229 -----------------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       229 -----------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                             ..+.+++++.+||.+||+.||++|||+.|+++||||++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                                   112478899999999999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.4e-50  Score=399.18  Aligned_cols=255  Identities=36%  Similarity=0.649  Sum_probs=208.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|+++.+++.||||++....     ..+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            4467999999999999999999999999999999997643     23567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CCCeEEeeccccccCCccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DFGls~~~~~~~  163 (441)
                      ||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...... 
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            9999999999999998888999999999999999999999999999999999999975   889999999999865443 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhcCcCCCC----CCCCHhHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP----FWFSTGAT  238 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~----~~~s~~~~  238 (441)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...... .....+.......+    ..++.++.
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  283 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAK  283 (349)
T ss_dssp             --------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             cccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHH
Confidence            23456789999999999987665 58999999999999999999999775544 35666665554432    34799999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      +||++||+.||++|||+.++++||||+...
T Consensus       284 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          284 DLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999999998643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.4e-50  Score=384.51  Aligned_cols=260  Identities=38%  Similarity=0.667  Sum_probs=226.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++......  ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            467899999999999999999999999999999999765432  245778999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--cc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--~~  164 (441)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......  ..
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999999999988788999999999999999999999999999999999999999999999999998765432  22


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhcCcCCCC--CCCCHhHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP--FWFSTGATSLI  241 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li  241 (441)
                      .....+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+  ..+++.+.++|
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence            3456789999999999987776667899999999999999999999876543 33333333322222  34899999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .+||+.||++|||++++++||||++..
T Consensus       243 ~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          243 HKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHCCCCchhCCCHHHHhcCccccChh
Confidence            999999999999999999999998654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=7.4e-50  Score=391.08  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=224.0

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      .|+..+.||+|+||.||+|+++.+|+.||||++......   ..+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            488899999999999999999999999999999765422   34668899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      |++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            9999999998865 579999999999999999999999999999999999999999999999999988665543444567


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCCCCCCHhHHHHHHHhcC
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~li~~~L~  246 (441)
                      +||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.....   ..+..+++.+.++|.+||+
T Consensus       202 ~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  280 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV  280 (321)
T ss_dssp             CSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSC
T ss_pred             cCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHcc
Confidence            89999999999977655 5899999999999999999999998877766666654432   2233478999999999999


Q ss_pred             CCCCCCCChHhHhcCCCccccC
Q 013520          247 PNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .||++|||++++++||||+...
T Consensus       281 ~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          281 RDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SSTTTSCCHHHHHTSGGGGGCC
T ss_pred             CChhhCcCHHHHhcChhhccCC
Confidence            9999999999999999997643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.9e-51  Score=403.54  Aligned_cols=254  Identities=31%  Similarity=0.530  Sum_probs=224.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----RMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++.+......     ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45689999999999999999999999999999999987653221     1234567899999999999999999999999


Q ss_pred             CEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg-~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      +..|+||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            9999999998766 999999998899999999999999999999999999999999999999999999999999998665


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHH
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (441)
                      .. ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||....      .........|..+++++.+|
T Consensus       182 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          182 RG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKELMSL  254 (335)
T ss_dssp             TT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHHHHH
T ss_pred             CC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHHHHH
Confidence            43 334567899999999999888776789999999999999999999997532      22334455667789999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      |.+||++||++|||++++++||||+..
T Consensus       255 i~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          255 VSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHccCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.6e-50  Score=397.11  Aligned_cols=261  Identities=29%  Similarity=0.420  Sum_probs=219.7

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            467899999999999999999999999999999999876542 3334567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999999999998887888999999999999999999999999999999999999999999999999999876554455


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------------------c
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------------------E  226 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------------------~  226 (441)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+...                   .
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            567789999999999977655578999999999999999999999887765444332210                   0


Q ss_pred             CCC------------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          227 FSC------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       227 ~~~------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ...            .+.+++.+.+||.+||+.||++|||++|+++||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            011            12468999999999999999999999999999999753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.1e-50  Score=399.18  Aligned_cols=263  Identities=26%  Similarity=0.371  Sum_probs=220.0

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-----   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----   80 (441)
                      ..+++|++++.||+|+||.||+|+++.+|+.||+|++....... .....+.+|+.+++.++||||+++++++..     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            45789999999999999999999999999999999987654322 234567789999999999999999999987     


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           81 ---RTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        81 ---~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                         .+.+|+||||+++ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence               4578999999986 67666654 367999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCc----cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCC
Q 013520          157 ALPQQ----GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW  232 (441)
Q Consensus       157 ~~~~~----~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  232 (441)
                      .....    ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.......++.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            76542    12233566799999999999776555799999999999999999999999888766665554322111111


Q ss_pred             --------------------------------CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          233 --------------------------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       233 --------------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                                                      .++.+.+||.+||+.||++|||++|+++||||+....+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence                                            26779999999999999999999999999999875443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-50  Score=414.41  Aligned_cols=259  Identities=27%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----CC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-----RT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~   82 (441)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            478999999999999999999999999999999996643 334456788999999999999999999999843     35


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .+|+||||+ +|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            799999998 5799999998888999999999999999999999999999999999999999999999999999865421


Q ss_pred             c---------------------------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc----------
Q 013520          163 V---------------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA----------  205 (441)
Q Consensus       163 ~---------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~----------  205 (441)
                      .                           ......+||+.|+|||++.....++.++|||||||+||+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                           124566899999999987555545699999999999999998          


Q ss_pred             -CCCCCCCCCh--------------------HHHHHHhhc--C--------------------c---------CCCCCCC
Q 013520          206 -GYLPFGETDL--------------------PTLYKKINA--A--------------------E---------FSCPFWF  233 (441)
Q Consensus       206 -g~~Pf~~~~~--------------------~~~~~~i~~--~--------------------~---------~~~~~~~  233 (441)
                       |.+||.+.+.                    ......+..  +                    .         ....+..
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7777765431                    011111100  0                    0         0011346


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ++++.+||++||..||++|||++|+++||||+...
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            89999999999999999999999999999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.1e-50  Score=397.42  Aligned_cols=258  Identities=33%  Similarity=0.607  Sum_probs=227.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   81 (441)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++......     .....+.+.+|+.+++.+ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            35799999999999999999999999999999999765321     122346688999999999 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      +..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999876654


Q ss_pred             cccccccccCCCCcCCccccccC-----CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CC
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FW  232 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~-----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~  232 (441)
                      . ......+||+.|+|||++.+.     ...+.++|||||||++|+|++|..||...+.......+..+.+..+    ..
T Consensus       253 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  331 (365)
T 2y7j_A          253 G-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD  331 (365)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred             C-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            3 334567899999999998632     2345899999999999999999999998887777777776665543    34


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +++.+.++|.+||+.||++|||++++++||||++
T Consensus       332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            7899999999999999999999999999999973

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-50  Score=405.95  Aligned_cols=254  Identities=33%  Similarity=0.593  Sum_probs=210.6

Q ss_pred             cccccCeEEE-eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHH-hCCCCCcceeEEEEEe--
Q 013520            5 TRRVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHPNIVRLHEVLAS--   80 (441)
Q Consensus         5 ~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~--   80 (441)
                      ...+++|.+. +.||+|+||+||+|.++.+|+.||||++...        ..+.+|+.++. ..+||||+++++++..  
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3456789887 7899999999999999999999999998642        34667888874 4589999999999876  


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CCCeEEeec
Q 013520           81 --RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDF  153 (441)
Q Consensus        81 --~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DF  153 (441)
                        ...+|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              667999999999999999998643  5999999999999999999999999999999999999997   789999999


Q ss_pred             cccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH----HHHHHhhcCcCCC
Q 013520          154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAAEFSC  229 (441)
Q Consensus       154 Gls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~  229 (441)
                      |++...... ....+.+||+.|+|||++.+..|. .++|||||||++|+|++|..||.+.+..    .....+..+.+..
T Consensus       209 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~  286 (400)
T 1nxk_A          209 GFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF  286 (400)
T ss_dssp             TTCEECC------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred             ccccccCCC-CccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence            999865432 334577899999999999776664 8999999999999999999999765432    2455565565554


Q ss_pred             C----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          230 P----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       230 ~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      |    ..+++++.+||++||+.||++|||++++++||||....
T Consensus       287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            4    34899999999999999999999999999999997643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.6e-50  Score=406.05  Aligned_cols=261  Identities=26%  Similarity=0.389  Sum_probs=212.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC----
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR----   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~----   81 (441)
                      ...++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+++.++||||+++++++...    
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            34679999999999999999999999999999999997643 3344567889999999999999999999999766    


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ..+|+||||+. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence             57999999986 5999999988889999999999999999999999999999999999999999999999999998654


Q ss_pred             ccc----------------------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcC-----------C
Q 013520          161 QGV----------------------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-----------Y  207 (441)
Q Consensus       161 ~~~----------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-----------~  207 (441)
                      ...                      ......+||+.|+|||++.....++.++||||+||++|+|++|           .
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            321                      1246778999999999975555556999999999999999984           4


Q ss_pred             CCCCCCCh-----------------HHH------------------------HHHhhcCcCCCC-------CCCCHhHHH
Q 013520          208 LPFGETDL-----------------PTL------------------------YKKINAAEFSCP-------FWFSTGATS  239 (441)
Q Consensus       208 ~Pf~~~~~-----------------~~~------------------------~~~i~~~~~~~~-------~~~s~~~~~  239 (441)
                      ++|.+.+.                 ...                        ...+.......+       +.+++++.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            44444321                 011                        111111111111       347999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ||++||+.||++|||++|+++||||+...
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            99999999999999999999999998754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.5e-50  Score=396.43  Aligned_cols=254  Identities=26%  Similarity=0.397  Sum_probs=218.0

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----CCCcceeEEE
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----HPNIVRLHEV   77 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----hpnIv~l~~~   77 (441)
                      ++...-++|++++.||+|+||.||+|++..+|+.||||++...    .........|+.+++.++     ||||++++++
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            4456678999999999999999999999999999999998642    233466788999999996     9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-----------
Q 013520           78 LASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-----------  144 (441)
Q Consensus        78 ~~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-----------  144 (441)
                      +...+..|+||||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.           
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence            99999999999999 999999998754  5999999999999999999999999999999999999975           


Q ss_pred             --------------CCCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCC
Q 013520          145 --------------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF  210 (441)
Q Consensus       145 --------------~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf  210 (441)
                                    ++.+||+|||++.....   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCC
Confidence                          78999999999975443   2346689999999999987776 48999999999999999999999


Q ss_pred             CCCChHHHHHHhhcCcCCCCC----------------------------------------------CCCHhHHHHHHHh
Q 013520          211 GETDLPTLYKKINAAEFSCPF----------------------------------------------WFSTGATSLIHKI  244 (441)
Q Consensus       211 ~~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~s~~~~~li~~~  244 (441)
                      ...+..+....+.....+.|.                                              ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            887766555544332222110                                              1236788999999


Q ss_pred             cCCCCCCCCChHhHhcCCCcc
Q 013520          245 LDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~  265 (441)
                      |+.||++|||++|+++||||+
T Consensus       340 L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGGGC
T ss_pred             hcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999996

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.1e-50  Score=390.18  Aligned_cols=258  Identities=29%  Similarity=0.531  Sum_probs=216.5

Q ss_pred             cccCeEEE-eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520            7 RVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         7 ~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      ..++|++. +.||+|+||.||+|.+..+|+.||||++.+...   ...+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~   86 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF   86 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            45689995 789999999999999999999999999976532   2346788999999885 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC---eEEeeccccccCCc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSALPQQ  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGls~~~~~  161 (441)
                      |+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.....
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999999999998889999999999999999999999999999999999999998776   99999999875432


Q ss_pred             c-------ccccccccCCCCcCCccccccC----CCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---------------
Q 013520          162 G-------VELLHTTCGTPNYVAPEVLSNR----GYDGSAADVWSCGVILFVLMAGYLPFGETDL---------------  215 (441)
Q Consensus       162 ~-------~~~~~~~~gt~~Y~aPE~l~~~----~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---------------  215 (441)
                      .       .......+||+.|+|||++.+.    ...+.++|||||||++|+|++|..||.+.+.               
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            1       1123456799999999998641    2235899999999999999999999976542               


Q ss_pred             HHHHHHhhcCcCCCC----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          216 PTLYKKINAAEFSCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       216 ~~~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ......+..+.+..|    ..+++++.+||++||+.||++|||++|+++||||+..
T Consensus       247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            335566666666665    3589999999999999999999999999999999853

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-50  Score=398.01  Aligned_cols=264  Identities=26%  Similarity=0.343  Sum_probs=216.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK--HRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++.......  ......+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            456789999999999999999999999999999999997643322  112346789999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..|+||||+++ +|.+.+... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  164 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC
Confidence            99999999986 888888764 3689999999999999999999999999999999999999999999999999987655


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCC---------C-
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFS---------C-  229 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~---------~-  229 (441)
                      ........+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+...  ...         . 
T Consensus       165 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred             CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCc
Confidence            5455567789999999999976555568999999999999999999999988776665554321  000         0 


Q ss_pred             ----------------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          230 ----------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       230 ----------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                      ...+++++.+||++||+.||++|||++|+++||||++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~  300 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG  300 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSC
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCC
Confidence                            1335789999999999999999999999999999987543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-50  Score=399.63  Aligned_cols=257  Identities=28%  Similarity=0.403  Sum_probs=214.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   81 (441)
                      ..++|++++.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            3578999999999999999999999999999999996643 2344567789999999999999999999999765     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ..+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence             3469999999 8899998876 689999999999999999999999999999999999999999999999999998654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------------  227 (441)
                      .   .....+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+.......+.....             
T Consensus       180 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  256 (367)
T 1cm8_A          180 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  256 (367)
T ss_dssp             S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             c---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence            3   234678999999999997744456999999999999999999999998876655544422100             


Q ss_pred             ------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                        ...+..++.+.+||.+||+.||++|||++++++||||+....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                              112346899999999999999999999999999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.7e-50  Score=387.19  Aligned_cols=258  Identities=37%  Similarity=0.682  Sum_probs=226.9

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      .....++|++.+.||+|+||.||+|++..+|+.||+|++......   ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (304)
T 2jam_A            4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTH   80 (304)
T ss_dssp             --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence            345567999999999999999999999999999999999864322   23568899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---ccCCCeEEeeccccccCC
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~  160 (441)
                      .|+||||++|++|.+.+...+.+++..+..++.|++.||.|||++||+||||||+||++   +.++.+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999999999999988899999999999999999999999999999999999999   778899999999987654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHh
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTG  236 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~  236 (441)
                      .  ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+.+..+    ..++++
T Consensus       161 ~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (304)
T 2jam_A          161 N--GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES  237 (304)
T ss_dssp             C--BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHH
T ss_pred             C--CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHH
Confidence            3  23345679999999999987665 4899999999999999999999999888888887777655433    357999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +.++|.+||..||++|||++++++||||+..
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          238 AKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.6e-51  Score=396.31  Aligned_cols=266  Identities=23%  Similarity=0.374  Sum_probs=224.8

Q ss_pred             CCcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      |..+....++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A            4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            45667778899999999999999999999999999999999988765555667789999999999999999999999876


Q ss_pred             CC----EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           81 RT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        81 ~~----~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      ..    ..|+||||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence            54    35999999999999999998899999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCccc---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC----
Q 013520          157 ALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC----  229 (441)
Q Consensus       157 ~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----  229 (441)
                      .......   ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......    
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            7654321   12334679999999999987665 489999999999999999999999888766655544443332    


Q ss_pred             CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +..+++++.++|.+||+.||++||+..+++.|+|++..
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            23489999999999999999999999999999999753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.7e-49  Score=379.95  Aligned_cols=256  Identities=21%  Similarity=0.284  Sum_probs=217.8

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      +....++|++.+.||+|+||.||+|.+..+++.||+|++........ ....+.+|+..+..+ +||||+++++++.+.+
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~   84 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDD   84 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            44556899999999999999999999999999999999987544333 356788899999999 9999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-------------
Q 013520           83 KVYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-------------  145 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-------------  145 (441)
                      ..|+||||++|++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+||+++.+             
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred             eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            999999999999999999765    679999999999999999999999999999999999999844             


Q ss_pred             ------CCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHH
Q 013520          146 ------GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLY  219 (441)
Q Consensus       146 ------~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~  219 (441)
                            ..+||+|||.+......    ....||+.|+|||++.+....+.++|||||||++|+|++|.+|+....   ..
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~  237 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QW  237 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HH
T ss_pred             cccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HH
Confidence                  47999999998765442    345699999999999766455579999999999999999998875442   23


Q ss_pred             HHhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          220 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       220 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ..+..+. ...|..+++++.++|.+||+.||++|||+.++++||||+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            3333333 35667799999999999999999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.2e-50  Score=382.42  Aligned_cols=258  Identities=34%  Similarity=0.627  Sum_probs=225.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            4689999999999999999999999999999999987644321   1256789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC----CeEEeeccccccCC
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQ  160 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~~~~  160 (441)
                      |+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999999888999999999999999999999999999999999999999877    89999999997654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHh
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTG  236 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~  236 (441)
                      .. .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+    ..+++.
T Consensus       164 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          164 AG-NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             CC-CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            43 22345679999999999976665 5899999999999999999999999888777777766655544    457899


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +.++|.+||..||++|||++++++||||+..
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9999999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.2e-49  Score=382.27  Aligned_cols=262  Identities=30%  Similarity=0.545  Sum_probs=228.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc------chHHHHHHHHHHHHHHhCC-CCCcceeEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL------KHRMVDQIKREISIMKIVR-HPNIVRLHEV   77 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~------~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~   77 (441)
                      ....++|++.+.||+|+||.||+|.++.+|+.||||++......      .....+.+.+|+.+++.+. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            34578999999999999999999999999999999999765321      1223467889999999995 9999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           78 LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        78 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      +...+..|+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence            99999999999999999999999988899999999999999999999999999999999999999999999999999987


Q ss_pred             cCCccccccccccCCCCcCCcccccc-----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC--
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--  230 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~--  230 (441)
                      ..... ......+||+.|+|||++.+     ....+.++||||||+++|+|++|..||...+.......+..+....+  
T Consensus       173 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (298)
T 1phk_A          173 QLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  251 (298)
T ss_dssp             ECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             hcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc
Confidence            65443 23456789999999999852     23345899999999999999999999998888777777776655443  


Q ss_pred             --CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          231 --FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       231 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                        ..+++.+.++|.+||+.||++|||++++++||||++.
T Consensus       252 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          252 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence              2378999999999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.9e-50  Score=399.96  Aligned_cols=253  Identities=31%  Similarity=0.550  Sum_probs=217.7

Q ss_pred             cCeEE--EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            9 AKYEV--GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         9 ~~y~i--~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      +.|.+  .+.||+|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            34555  6789999999999999999999999999977542   335678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE--ccCCCeEEeeccccccCCccc
Q 013520           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL--DSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl--~~~~~~kL~DFGls~~~~~~~  163 (441)
                      ||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||++...... 
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-  242 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-  242 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence            99999999999988654 469999999999999999999999999999999999999  56678999999999866543 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~~  239 (441)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+..+    ..+++++.+
T Consensus       243 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  321 (373)
T 2x4f_A          243 EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKE  321 (373)
T ss_dssp             CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHH
T ss_pred             cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHH
Confidence            23446679999999999976554 5899999999999999999999999888888777776665544    358999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ||.+||+.||++|||++|+++||||+.
T Consensus       322 li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          322 FISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             HHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            999999999999999999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-50  Score=396.12  Aligned_cols=261  Identities=32%  Similarity=0.582  Sum_probs=225.0

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTIL-KHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   80 (441)
                      ..+++|++++.||+|+||.||+|++.   .+|+.||||++.+.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            44679999999999999999999984   58999999999765432 112234567899999999 69999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      .+..|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999997654


Q ss_pred             cc-ccccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCC----hHHHHHHhhcCcCCCCCCCC
Q 013520          161 QG-VELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEFSCPFWFS  234 (441)
Q Consensus       161 ~~-~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s  234 (441)
                      .. .......+||+.|+|||++.+. ...+.++|||||||++|+|++|..||...+    .....+.+.......|..++
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  290 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccC
Confidence            32 2334466899999999999753 334589999999999999999999996532    34555566667777888899


Q ss_pred             HhHHHHHHHhcCCCCCCCC-----ChHhHhcCCCccc
Q 013520          235 TGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +.+.+||.+||..||++||     |++++++||||++
T Consensus       291 ~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            9999999999999999999     9999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-49  Score=382.24  Aligned_cols=260  Identities=22%  Similarity=0.366  Sum_probs=221.0

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||.||+|++..++..||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred             hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence            44567899999999999999999999999999999999776666666678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      |+||||++|++|.+++...+++++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            9999999999999999998999999999999999999999999999999999999999999999999999998654422 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-----CCCCCCHhHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-----CPFWFSTGAT  238 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~~~  238 (441)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.............+     .+..+++.+.
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             --------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             cccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            22345679999999999987665 58999999999999999999999988776554443333222     3455899999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      ++|.+||..||++||+..+.+.++|..
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            999999999999999666666666653

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.8e-49  Score=393.52  Aligned_cols=257  Identities=27%  Similarity=0.428  Sum_probs=219.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----CE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----TK   83 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~   83 (441)
                      ++|++++.||+|+||.||+|.+..+++.||||++....  .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            58999999999999999999999999999999997533  334457788999999999999999999999765     46


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      .|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            999999997 489998876 679999999999999999999999999999999999999999999999999998665422


Q ss_pred             c---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-------------
Q 013520          164 E---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-------------  227 (441)
Q Consensus       164 ~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-------------  227 (441)
                      .   .....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+.....             
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            1   234568999999999986655556899999999999999999999988776655554421100             


Q ss_pred             ------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          228 ------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       228 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                        ...+.+++++.+||.+||+.||++|||++|+++||||++.+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                              011347899999999999999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-50  Score=395.41  Aligned_cols=260  Identities=32%  Similarity=0.517  Sum_probs=219.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--KHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+....  .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            46899999999999999999999999999999999775432  1234577999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 013520           86 IILEFVTGGELFDKIVH----------------------------------------QGRLLENDCRRYFQQLIDAVAHC  125 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~----------------------------------------~~~l~e~~~~~~~~qll~aL~~L  125 (441)
                      +||||++||+|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998852                                        11235778889999999999999


Q ss_pred             HHCCceecCCCCCcEEEccCC--CeEEeeccccccCCcc----ccccccccCCCCcCCccccccC-CCCCCCcchhhHhH
Q 013520          126 HSKGVYHRDLKPENLLLDSYG--NLKVSDFGLSALPQQG----VELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGV  198 (441)
Q Consensus       126 H~~gi~HrDlkp~NILl~~~~--~~kL~DFGls~~~~~~----~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGv  198 (441)
                      |++||+||||||+|||++.++  .+||+|||++......    .......+||+.|+|||++.+. ...+.++|||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  8999999999754331    1123566799999999999642 34468999999999


Q ss_pred             HHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          199 ILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       199 il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++|+|++|..||.+.+..+....+.......+.    .+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            999999999999998887777776665544332    279999999999999999999999999999999764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1e-49  Score=404.34  Aligned_cols=257  Identities=38%  Similarity=0.678  Sum_probs=211.3

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH-----RMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.+......     .....+.+|+.+++.++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            5789999999999999999999999999999999987643211     122357899999999999999999999854 5


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEEeeccccccC
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALP  159 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL~DFGls~~~  159 (441)
                      ..|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++...
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999998888999999999999999999999999999999999999997654   5999999999876


Q ss_pred             CccccccccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCcCCCC----CC
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEFSCP----FW  232 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~~~----~~  232 (441)
                      ... ......+||+.|+|||++.+  ...++.++|||||||++|+|++|.+||..... ......+..+.+..+    ..
T Consensus       293 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  371 (419)
T 3i6u_A          293 GET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE  371 (419)
T ss_dssp             C------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred             CCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence            543 34456789999999999853  22334799999999999999999999976543 344555655555443    34


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +++.+.+||.+||+.||++|||++++++||||+.
T Consensus       372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            7999999999999999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.2e-49  Score=392.18  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=221.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      .+|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            46999999999999999999999999999999998765444455678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||+. |+|.+.+. ....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......    .
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----~  208 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----N  208 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----C
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----C
Confidence            9997 57877775 4567999999999999999999999999999999999999999999999999999765432    3


Q ss_pred             cccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC--CCCCCCHhHHHHHHH
Q 013520          168 TTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CPFWFSTGATSLIHK  243 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~li~~  243 (441)
                      ..+||+.|+|||++..  ....+.++|||||||++|+|++|.+||...+.......+.....+  .+..+++.+.++|.+
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  288 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  288 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHH
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            5689999999999852  233458999999999999999999999887766655555444332  234589999999999


Q ss_pred             hcCCCCCCCCChHhHhcCCCccccC
Q 013520          244 ILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ||+.||++|||++++++||||....
T Consensus       289 ~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          289 CLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HcccChhhCcCHHHHhhChhhhccC
Confidence            9999999999999999999997653

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8e-50  Score=386.64  Aligned_cols=263  Identities=31%  Similarity=0.602  Sum_probs=227.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceeEEEE--EeCCE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRHPNIVRLHEVL--ASRTK   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~--~~~~~   83 (441)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++.+..... ....+.+.+|+.+++.++||||+++++++  .+...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            5689999999999999999999999999999999997754322 23456789999999999999999999998  45568


Q ss_pred             EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           84 VYIILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      .|+||||+.++ |.+.+..  ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999999877 7777765  45799999999999999999999999999999999999999999999999999976543


Q ss_pred             --cccccccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHH
Q 013520          162 --GVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT  238 (441)
Q Consensus       162 --~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~  238 (441)
                        .........||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+....+..|..+++.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~  241 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS  241 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence              222344667999999999987533 33578999999999999999999999988888888888888888889999999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      ++|.+||+.||++|||++++++||||++...+
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             HHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            99999999999999999999999999876543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.5e-50  Score=381.90  Aligned_cols=260  Identities=30%  Similarity=0.548  Sum_probs=227.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTK   83 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~   83 (441)
                      ...++|++++.||+|+||.||+|.++.+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+  ...
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            4678999999999999999999999999999999999875543 3346778999999999999999999998854  678


Q ss_pred             EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEccCCCeEEeecc
Q 013520           84 VYIILEFVTGGELFDKIVHQ----GRLLENDCRRYFQQLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFG  154 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~----~~l~e~~~~~~~~qll~aL~~LH~~g-----i~HrDlkp~NILl~~~~~~kL~DFG  154 (441)
                      .|+||||++|++|.+++...    ..+++..++.++.|++.||.|||++|     |+||||||+||+++.++.+||+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999999753    34999999999999999999999999     9999999999999999999999999


Q ss_pred             ccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC-CCCCCC
Q 013520          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWF  233 (441)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~  233 (441)
                      ++..............||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+.. ..|..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  240 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY  240 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred             hheeeccccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCccc
Confidence            98766544333445679999999999977665 4899999999999999999999999887777777776655 566678


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++++.++|.+||+.||++|||++++++|||+...
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            9999999999999999999999999999999764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=386.53  Aligned_cols=250  Identities=25%  Similarity=0.375  Sum_probs=205.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceeEEEEEeCCEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI-VRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ++|++++.||+|+||+||+|+++.+|+.||||++......... ......|+..+.. .+||||+++++++.+.+..|+|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            6799999999999999999999999999999998665433333 3344455555544 4999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+ +++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  213 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAG  213 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCC
Confidence            9999 67888888764 46999999999999999999999999999999999999999999999999998765443 234


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC--CCCCCCCHhHHHHHHHh
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF--SCPFWFSTGATSLIHKI  244 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~~~li~~~  244 (441)
                      ...+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+...   .....+..+..  ..+..+++++.++|.+|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence            45679999999999875 44 58999999999999999997665432   22233333322  23455899999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCccc
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      |++||++|||++++++||||++
T Consensus       289 L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          289 LEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGSC
T ss_pred             cCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.3e-49  Score=377.58  Aligned_cols=254  Identities=23%  Similarity=0.414  Sum_probs=218.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CCEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----RTKV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~   84 (441)
                      ..|++.+.||+|+||.||+|.+..++..||+|++...... ....+.+.+|+.+++.++||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            3589999999999999999999999999999999875543 3346778999999999999999999999875    4669


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc-cCCCeEEeeccccccCCc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~  161 (441)
                      |+||||+++|+|.+++.....+++..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999998889999999999999999999999999  99999999999998 789999999999975443


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCcC--CCCCCCCHhHH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEF--SCPFWFSTGAT  238 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~--~~~~~~s~~~~  238 (441)
                        ......+||+.|+|||++.+ . .+.++|||||||++|+|++|..||..... ......+..+..  ..+...++++.
T Consensus       185 --~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  260 (290)
T 1t4h_A          185 --SFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  260 (290)
T ss_dssp             --TSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             --cccccccCCcCcCCHHHHhc-c-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence              23346679999999999864 3 45899999999999999999999987444 444444444322  23445789999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++|.+||+.||++|||++++++||||++.
T Consensus       261 ~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999753

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.4e-50  Score=393.15  Aligned_cols=256  Identities=25%  Similarity=0.400  Sum_probs=210.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT---   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---   82 (441)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+..   
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   80 (332)
T 3qd2_B            3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK   80 (332)
T ss_dssp             HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred             hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence            45689999999999999999999999999999999997654  2334577999999999999999999999986543   


Q ss_pred             ------------------------------------------------------EEEEEEeccCCCChHHHHHhcCC---
Q 013520           83 ------------------------------------------------------KVYIILEFVTGGELFDKIVHQGR---  105 (441)
Q Consensus        83 ------------------------------------------------------~~~lv~E~~~gg~L~~~i~~~~~---  105 (441)
                                                                            ..|+||||++||+|.+++.....   
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~  160 (332)
T 3qd2_B           81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED  160 (332)
T ss_dssp             HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred             hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence                                                                  38999999999999999987543   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc------------cccccccCCC
Q 013520          106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV------------ELLHTTCGTP  173 (441)
Q Consensus       106 l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~------------~~~~~~~gt~  173 (441)
                      .++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......            ......+||+
T Consensus       161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            4556789999999999999999999999999999999999999999999998665431            1234567999


Q ss_pred             CcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC-CCCCCHhHHHHHHHhcCCCCCCC
Q 013520          174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-PFWFSTGATSLIHKILDPNPKTR  252 (441)
Q Consensus       174 ~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-~~~~s~~~~~li~~~L~~dP~~R  252 (441)
                      .|+|||++.+..+ +.++|||||||++|+|++|..|+..  .......+.....+. +...++++.++|.+||+.||++|
T Consensus       241 ~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          241 LYMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             GGSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             CccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence            9999999987666 5899999999999999999877532  122223333332221 12357889999999999999999


Q ss_pred             CChHhHhcCCCccc
Q 013520          253 IRIEGIRKHPWFRK  266 (441)
Q Consensus       253 ~t~~eil~hp~f~~  266 (441)
                      ||++|+++||||++
T Consensus       318 ps~~~~l~~~~f~~  331 (332)
T 3qd2_B          318 PEATDIIENAIFEN  331 (332)
T ss_dssp             CCHHHHHHSTTCCC
T ss_pred             CCHHHHhhchhhhc
Confidence            99999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-49  Score=397.14  Aligned_cols=252  Identities=29%  Similarity=0.403  Sum_probs=211.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------   80 (441)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++..+...       ..+|+.+++.++||||+++++++..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            457899999999999999999999999999999998765322       2379999999999999999999843      


Q ss_pred             --------------------------------CCEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 013520           81 --------------------------------RTKVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAH  124 (441)
Q Consensus        81 --------------------------------~~~~~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~aL~~  124 (441)
                                                      ...+|+||||++| +|.+.+.    ....+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458999999985 6665554    45789999999999999999999


Q ss_pred             HHHCCceecCCCCCcEEEc-cCCCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHH
Q 013520          125 CHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVL  203 (441)
Q Consensus       125 LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~l  203 (441)
                      ||++||+||||||+|||++ .++.+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            9999999999999999998 6889999999999865443 3345678999999999998766557999999999999999


Q ss_pred             hcCCCCCCCCChHHHHHHhhcC-----------------cC------------CCCCCCCHhHHHHHHHhcCCCCCCCCC
Q 013520          204 MAGYLPFGETDLPTLYKKINAA-----------------EF------------SCPFWFSTGATSLIHKILDPNPKTRIR  254 (441)
Q Consensus       204 l~g~~Pf~~~~~~~~~~~i~~~-----------------~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t  254 (441)
                      ++|.+||.+.+..+....+...                 ..            ..|..+|+++.+||.+||+.||++|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999999988766555444210                 00            134457899999999999999999999


Q ss_pred             hHhHhcCCCcccc
Q 013520          255 IEGIRKHPWFRKN  267 (441)
Q Consensus       255 ~~eil~hp~f~~~  267 (441)
                      +.|+++||||+..
T Consensus       316 ~~e~l~hp~f~~~  328 (383)
T 3eb0_A          316 PYEAMAHPFFDHL  328 (383)
T ss_dssp             HHHHHTSGGGHHH
T ss_pred             HHHHhcCHHHHHH
Confidence            9999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.4e-50  Score=395.88  Aligned_cols=261  Identities=26%  Similarity=0.502  Sum_probs=228.7

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH--------------HHHHHHHHHHHHHhCCC
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR--------------MVDQIKREISIMKIVRH   68 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~--------------~~~~~~~Ei~il~~l~h   68 (441)
                      ......++|++++.||+|+||.||+|.+  +|+.||+|++.........              ..+.+.+|+.+++.++|
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h  102 (348)
T 2pml_X           25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN  102 (348)
T ss_dssp             SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred             hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence            4456678999999999999999999999  8999999999765433221              12678999999999999


Q ss_pred             CCcceeEEEEEeCCEEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCc
Q 013520           69 PNIVRLHEVLASRTKVYIILEFVTGGELFDK------IVH--QGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPEN  139 (441)
Q Consensus        69 pnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~------i~~--~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~N  139 (441)
                      |||+++++++.+.+..|+||||+++|+|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999999999999999999999999999998      665  5789999999999999999999999 999999999999


Q ss_pred             EEEccCCCeEEeeccccccCCccccccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HH
Q 013520          140 LLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PT  217 (441)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~  217 (441)
                      |+++.++.+||+|||++......  ......||+.|+|||++.+. .+.+.++|||||||++|+|++|..||...+. .+
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            99999999999999999765432  34567899999999999876 4443389999999999999999999988766 67


Q ss_pred             HHHHhhcCcCCCC-------------------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          218 LYKKINAAEFSCP-------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       218 ~~~~i~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ....+..+....|                   ..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            7777777766666                   5689999999999999999999999999999999753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-49  Score=393.30  Aligned_cols=259  Identities=25%  Similarity=0.400  Sum_probs=221.5

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      +....++|++.+.||+|+||.||+|.+..+|+.||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            3456789999999999999999999999999999999997753  33456789999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .|+||||++|++|.+++...+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++..... 
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            999999999999999999988999999999999999999999996 999999999999999999999999999865432 


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHH---------------------
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK---------------------  221 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~---------------------  221 (441)
                       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......                     
T Consensus       185 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          185 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             -HC----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             -ccccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence             23345689999999999987665 4899999999999999999999987665433221                     


Q ss_pred             ---------------------hhcCcC-CCC-CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          222 ---------------------INAAEF-SCP-FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       222 ---------------------i~~~~~-~~~-~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                           +..... ..+ ..++.++.+||++||+.||++|||++++++||||+..
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                 111111 111 2378899999999999999999999999999999764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-49  Score=395.38  Aligned_cols=258  Identities=29%  Similarity=0.442  Sum_probs=208.8

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT---   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---   82 (441)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++....   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence            346899999999999999999999999999999999976532 3345677889999999999999999999997655   


Q ss_pred             ---EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           83 ---KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        83 ---~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                         ..|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence               79999999975 7888875  46999999999999999999999999999999999999999999999999999765


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-----------
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-----------  228 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-----------  228 (441)
                      ... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+......           
T Consensus       178 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          178 GTS-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             -------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             ccc-cccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            432 23456789999999999987766 48999999999999999999999988776655554321100           


Q ss_pred             -------------------------CCC------CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          229 -------------------------CPF------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       229 -------------------------~~~------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                               .|.      ..++++.+||++||+.||++|||++|+++||||+..+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                                     000      01567899999999999999999999999999986543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.1e-49  Score=386.61  Aligned_cols=258  Identities=31%  Similarity=0.529  Sum_probs=221.3

Q ss_pred             cccCeEEE-eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEE
Q 013520            7 RVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         7 ~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~   84 (441)
                      .-++|.+. +.||+|+||.||+|.++.+|+.||+|++.+..... .....+.+|+.+++.+ +||||+++++++.+.+..
T Consensus        26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~  104 (327)
T 3lm5_A           26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI  104 (327)
T ss_dssp             HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence            34578887 89999999999999999999999999998754332 2356788999999999 569999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CCCeEEeeccccccC
Q 013520           85 YIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALP  159 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DFGls~~~  159 (441)
                      |+||||+.||+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++...
T Consensus       105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            9999999999999998553  67999999999999999999999999999999999999997   789999999999866


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCH
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFST  235 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~  235 (441)
                      ... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......+    ..+++
T Consensus       185 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          185 GHA-CELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             ----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             CCc-cccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence            443 23345689999999999987665 4899999999999999999999999888777777665544333    34789


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+.++|.+||+.||++|||++++++||||+..
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            99999999999999999999999999999764

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.4e-49  Score=380.92  Aligned_cols=260  Identities=29%  Similarity=0.441  Sum_probs=218.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   91 (302)
T 2j7t_A           15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKL   91 (302)
T ss_dssp             SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CE
T ss_pred             cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeE
Confidence            3456789999999999999999999999999999999876432   2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        92 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           92 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999999998875 4679999999999999999999999999999999999999999999999999876433222


Q ss_pred             cccccccCCCCcCCccccc----cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCCCCCCHh
Q 013520          164 ELLHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTG  236 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~  236 (441)
                      ......+||+.|+|||++.    .....+.++|||||||++|+|++|..||...+.......+.....   ..+..++.+
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVE  251 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHH
Confidence            2334567999999999984    223345899999999999999999999998887766666554433   234558999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +.++|.+||..||++|||++++++||||+..
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            9999999999999999999999999999754

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-49  Score=394.71  Aligned_cols=257  Identities=26%  Similarity=0.379  Sum_probs=201.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----   81 (441)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...     
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            3479999999999999999999999999999999997643 2334457788999999999999999999999654     


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ...|+++||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence             5689999999 7899988876 689999999999999999999999999999999999999999999999999997644


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------  226 (441)
                      .   .....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+.......+....              
T Consensus       184 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          184 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             c---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            3   23456899999999999875555689999999999999999999999887655554432210              


Q ss_pred             ---------CCC--------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          227 ---------FSC--------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       227 ---------~~~--------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                               ...        .+..++.+.+||++||+.||++|||++++++||||+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                     000        1236889999999999999999999999999999987544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.3e-49  Score=385.21  Aligned_cols=259  Identities=38%  Similarity=0.682  Sum_probs=215.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++......     .......+.+|+.+++.++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            3457899999999999999999999999999999999765432     11223458899999999999999999999977


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC---eEEeeccccc
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSDFGLSA  157 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~DFGls~  157 (441)
                      +. .|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             Cc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            65 8999999999999999998889999999999999999999999999999999999999987665   9999999997


Q ss_pred             cCCccccccccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhcCcCCCC----
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP----  230 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~----  230 (441)
                      ..... ......+||+.|+|||++.+  ....+.++|||||||++|+|++|..||...... .....+..+.....    
T Consensus       166 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          166 ILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             ECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             ecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            65443 22345679999999999742  233458999999999999999999999765432 34444555544432    


Q ss_pred             CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ..+++++.++|.+||..||++|||++++++||||+.
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            357999999999999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.7e-49  Score=378.51  Aligned_cols=259  Identities=36%  Similarity=0.621  Sum_probs=228.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||.||+|.++.+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            445679999999999999999999999999999999997754432 2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC---CCeEEeeccccccCCc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQ  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFGls~~~~~  161 (441)
                      |+||||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.+   +.+||+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999999999999888899999999999999999999999999999999999999764   4699999999876544


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHhH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (441)
                      . .......||+.|+|||++.+.  .+.++||||||+++|+|++|..||.+.+.......+..+.+..+    ..+++++
T Consensus       177 ~-~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (287)
T 2wei_A          177 N-TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (287)
T ss_dssp             C-SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHH
T ss_pred             C-CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHH
Confidence            3 223455689999999998653  45899999999999999999999999888887777777665433    3589999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .++|++||..||++|||++++++||||++.
T Consensus       254 ~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          254 KDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-48  Score=380.84  Aligned_cols=258  Identities=28%  Similarity=0.444  Sum_probs=215.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|++  +|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            34567999999999999999999987  5889999999765443 34467789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           85 YIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      |+||||+++|+|.+++...+.   +++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||++...
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999987553   999999999999999999999999  999999999999999999999999999865


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHh--hcCcCCCCCCCCHhH
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI--NAAEFSCPFWFSTGA  237 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~s~~~  237 (441)
                      ..........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+  .......|..+++++
T Consensus       190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          190 ASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             ------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             cccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            544344556789999999999987666 58999999999999999999999988877766655  344556777899999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhc--CCCccc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRK--HPWFRK  266 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~--hp~f~~  266 (441)
                      .++|.+||+.||++|||++++++  +++++.
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999987  455543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.9e-49  Score=387.50  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=215.4

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CCcceeEEEEEeCCE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH--PNIVRLHEVLASRTK   83 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~   83 (441)
                      ..-.+|++++.||+|+||.||+|.+. +++.||||++..... .....+.+.+|+.+++.++|  |||+++++++.+.+.
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            34568999999999999999999984 689999999987543 33446788999999999976  999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +|+||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999999 56889999999989999999999999999999999999999999999999997 5889999999998765432


Q ss_pred             c--ccccccCCCCcCCcccccc----------CCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhh--cCcCC
Q 013520          164 E--LLHTTCGTPNYVAPEVLSN----------RGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKIN--AAEFS  228 (441)
Q Consensus       164 ~--~~~~~~gt~~Y~aPE~l~~----------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~--~~~~~  228 (441)
                      .  .....+||+.|+|||++.+          ....+.++|||||||++|+|++|..||..... ......+.  .....
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            2  2346689999999999854          13345799999999999999999999976433 23333332  23345


Q ss_pred             CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      .|...++++.+||.+||+.||++|||+.++++||||+....+
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            667788999999999999999999999999999999865443

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.6e-49  Score=393.82  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=216.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--HPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~l   86 (441)
                      .+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++.++  ||||+++++++...+.+|+
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            459999999999999999999865 89999999987654 3345678999999999996  5999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--  164 (441)
                      ||| +.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........  
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  211 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  211 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence            999 56889999999988999999999999999999999999999999999999996 58999999999987654321  


Q ss_pred             ccccccCCCCcCCccccccC----------CCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhc--CcCCCCC
Q 013520          165 LLHTTCGTPNYVAPEVLSNR----------GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINA--AEFSCPF  231 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~----------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~--~~~~~~~  231 (441)
                      .....+||+.|+|||++.+.          ..++.++|||||||++|+|++|.+||..... ......+..  .....|.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  291 (390)
T 2zmd_A          212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD  291 (390)
T ss_dssp             --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred             cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence            23567899999999998642          2345799999999999999999999987533 233344433  2345677


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      +.++++.+||.+||+.||++|||+.|+++||||+....
T Consensus       292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            78999999999999999999999999999999986543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.6e-49  Score=398.66  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=213.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC------CCCCcceeEEEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV------RHPNIVRLHEVLA   79 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l------~hpnIv~l~~~~~   79 (441)
                      ....+|++++.||+|+||.||+|.+..+++.||||++...    ......+.+|+.+++.+      +|+||+++++++.
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            3456899999999999999999999999999999999753    23346677888888877      5779999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC--eEEeeccc
Q 013520           80 SRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--LKVSDFGL  155 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~--~kL~DFGl  155 (441)
                      ..+.+|+||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999996 68999987754  4999999999999999999999999999999999999999887  99999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc---------
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---------  226 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------  226 (441)
                      +.....   ...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+..+....+....         
T Consensus       249 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          249 SCYEHQ---RVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             CEETTC---CCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ceecCC---cccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            875433   2346789999999999987766 589999999999999999999998887655444332110         


Q ss_pred             -------------CC-------------------------------------CCCCCCHhHHHHHHHhcCCCCCCCCChH
Q 013520          227 -------------FS-------------------------------------CPFWFSTGATSLIHKILDPNPKTRIRIE  256 (441)
Q Consensus       227 -------------~~-------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~  256 (441)
                                   ++                                     .+...++.+.+||++||+.||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                         00                                     0112378899999999999999999999


Q ss_pred             hHhcCCCccccC
Q 013520          257 GIRKHPWFRKNY  268 (441)
Q Consensus       257 eil~hp~f~~~~  268 (441)
                      |+++||||++..
T Consensus       405 e~L~Hpw~~~~~  416 (429)
T 3kvw_A          405 QALRHPWLRRRL  416 (429)
T ss_dssp             HHHTSTTTC---
T ss_pred             HHhCChhhccCC
Confidence            999999998754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6e-49  Score=384.94  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=211.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEe--CCE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLAS--RTK   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~   83 (441)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++....      .+.+.+|+.+++.++ ||||+++++++.+  ...
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            3578999999999999999999999999999999986432      356889999999997 9999999999988  678


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~  162 (441)
                      .++||||+.+++|.+++.   .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus       108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999998874   489999999999999999999999999999999999999777 8999999999765443


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-hHHHH-------------HHhhcCcCC
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLY-------------KKINAAEFS  228 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~-------------~~i~~~~~~  228 (441)
                       ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.... .....             ..+......
T Consensus       185 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          185 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             -CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence             234567899999999999775555689999999999999999999995432 21111             111111111


Q ss_pred             C------------------------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          229 C------------------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       229 ~------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .                        +..+++++.+||++||++||++|||++|+++||||+..
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            1                        12279999999999999999999999999999999854

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-48  Score=377.74  Aligned_cols=257  Identities=25%  Similarity=0.411  Sum_probs=227.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      -..|++++.||+|+||.||+|.+..+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            457999999999999999999999999999999998764332  357789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            999999999999875 6799999999999999999999999999999999999999999999999999976655433445


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHHHHHhcC
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~  246 (441)
                      ...||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.... ...+..++..+.++|.+||.
T Consensus       178 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  256 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  256 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCC
T ss_pred             ccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcC
Confidence            6789999999999987665 489999999999999999999998877766665554433 34556689999999999999


Q ss_pred             CCCCCCCChHhHhcCCCccccC
Q 013520          247 PNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .||++|||++++++||||....
T Consensus       257 ~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          257 KEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             SSGGGSCCHHHHTTCHHHHHHC
T ss_pred             CChhhCcCHHHHhhChhhhcCC
Confidence            9999999999999999997653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=379.82  Aligned_cols=255  Identities=27%  Similarity=0.473  Sum_probs=218.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|.+....     ..+.+.+|+.+++.++||||+++++++...+..|+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            3568999999999999999999999999999999997643     23567899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||||+++++|.+++. ....+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999999997 4568999999999999999999999999999999999999999999999999999766544344


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---cCCCCCCCCHhHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~  242 (441)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+...   .+..+..+++.+.++|.
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  260 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK  260 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence            456789999999999987665 48999999999999999999999887765554444333   23335557999999999


Q ss_pred             HhcCCCCCCCCChHhHhcCCCcccc
Q 013520          243 KILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +||..||.+|||++++++||||+..
T Consensus       261 ~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          261 QCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHccCChhhCcCHHHHHhCHHHhcC
Confidence            9999999999999999999999764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.7e-49  Score=377.66  Aligned_cols=259  Identities=23%  Similarity=0.334  Sum_probs=203.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||.||+|++..+|+.||+|++...... ....+.+.++...++.++||||+++++++.+++..|
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            4578999999999999999999999999999999999765322 223344555566678889999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           86 IILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      +||||++| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++....
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99999975 77666643    56899999999999999999999998 99999999999999999999999999997654


Q ss_pred             ccccccccccCCCCcCCccccc---cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-H-HHHHHhhcCcCCCC-CCCC
Q 013520          161 QGVELLHTTCGTPNYVAPEVLS---NRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-P-TLYKKINAAEFSCP-FWFS  234 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~---~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~-~~~~~i~~~~~~~~-~~~s  234 (441)
                      .. ......+||+.|+|||++.   .....+.++|||||||++|+|++|..||..... . .....+.......+ ..++
T Consensus       162 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          162 DD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred             cc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence            43 2234557999999999972   233345899999999999999999999986332 2 33333333333333 3589


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +++.++|.+||+.||++|||++++++||||+..
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            999999999999999999999999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.9e-50  Score=403.94  Aligned_cols=249  Identities=16%  Similarity=0.201  Sum_probs=207.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH---HHHhCCCCCcceeE-------EE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS---IMKIVRHPNIVRLH-------EV   77 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~---il~~l~hpnIv~l~-------~~   77 (441)
                      .++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            468999999999999999999999999999999998765555556788999995   45555899999998       77


Q ss_pred             EEeCCE-----------------EEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCceec
Q 013520           78 LASRTK-----------------VYIILEFVTGGELFDKIVHQGRLLE-------NDCRRYFQQLIDAVAHCHSKGVYHR  133 (441)
Q Consensus        78 ~~~~~~-----------------~~lv~E~~~gg~L~~~i~~~~~l~e-------~~~~~~~~qll~aL~~LH~~gi~Hr  133 (441)
                      +.+.+.                 .|++|||+ +|+|.+++...+.+++       ..+..++.||+.||.|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            776543                 89999999 6899999987666666       7778899999999999999999999


Q ss_pred             CCCCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcCCccccccC-----------CCCCCCcchhhHhHHHHH
Q 013520          134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-----------GYDGSAADVWSCGVILFV  202 (441)
Q Consensus       134 Dlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-----------~~~~~~~DiwSlGvil~~  202 (441)
                      ||||+|||++.+|.+||+|||++.....   .....+| +.|+|||++.+.           .+ +.++|||||||++|+
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHH
Confidence            9999999999999999999999985432   3456678 999999999766           44 589999999999999


Q ss_pred             HhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          203 LMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       203 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      |++|..||.+.+.......+.    ..+..+++++.+||.+||+.||++|||+.++++||||+.
T Consensus       306 lltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            999999997765433332222    234568999999999999999999999999999999964

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-49  Score=385.20  Aligned_cols=259  Identities=24%  Similarity=0.413  Sum_probs=215.1

Q ss_pred             CCcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      |..+...-++|++.+.||+|+||.||+|++..+|+.||||++.......  ..+.+.+|+.+++.++||||+++++++..
T Consensus         1 m~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   78 (319)
T 4euu_A            1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (319)
T ss_dssp             -CEEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCcccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence            5667778899999999999999999999999999999999997654332  24667899999999999999999999987


Q ss_pred             CC--EEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----ccCCCeEEe
Q 013520           81 RT--KVYIILEFVTGGELFDKIVHQGR---LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVS  151 (441)
Q Consensus        81 ~~--~~~lv~E~~~gg~L~~~i~~~~~---l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl----~~~~~~kL~  151 (441)
                      ..  ..|+||||++|++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence            65  78999999999999999976543   9999999999999999999999999999999999999    777889999


Q ss_pred             eccccccCCccccccccccCCCCcCCcccccc-------CCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh----HHHHH
Q 013520          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSN-------RGYDGSAADVWSCGVILFVLMAGYLPFGETDL----PTLYK  220 (441)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~-------~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~----~~~~~  220 (441)
                      |||++...... ......+||+.|+|||++..       ....+.++|||||||++|+|++|..||.....    .+...
T Consensus       159 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  237 (319)
T 4euu_A          159 DFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (319)
T ss_dssp             CCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred             cCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence            99999866543 23346679999999999852       23446899999999999999999999964332    23333


Q ss_pred             HhhcCcC---------------------CCC----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCC
Q 013520          221 KINAAEF---------------------SCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  262 (441)
Q Consensus       221 ~i~~~~~---------------------~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp  262 (441)
                      .+..+..                     +.+    ..+++.+.++|++||+.||++|||++|+++||
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            3332221                     111    12456788999999999999999999999995

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.1e-49  Score=394.94  Aligned_cols=255  Identities=30%  Similarity=0.407  Sum_probs=209.3

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--   82 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--   82 (441)
                      .....+|++++.||+|+||.||+|++..+++ +|+|.+......       ..+|+.+++.++||||+++++++...+  
T Consensus        36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            3456689999999999999999999987766 888877654322       236999999999999999999996543  


Q ss_pred             ----EEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-cCCCeEEeecc
Q 013520           83 ----KVYIILEFVTGGELFDKI---VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFG  154 (441)
Q Consensus        83 ----~~~lv~E~~~gg~L~~~i---~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFG  154 (441)
                          .+|+||||++++.+....   .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence                389999999875433222   2356899999999999999999999999999999999999999 78999999999


Q ss_pred             ccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC---------
Q 013520          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA---------  225 (441)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~---------  225 (441)
                      ++...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+...         
T Consensus       188 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  266 (394)
T 4e7w_A          188 SAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI  266 (394)
T ss_dssp             TCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             CcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865443 23346789999999999977665679999999999999999999999988765544433211         


Q ss_pred             --------cC------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          226 --------EF------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       226 --------~~------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                              ..            .++..+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence                    00            12334789999999999999999999999999999998643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-48  Score=378.79  Aligned_cols=258  Identities=26%  Similarity=0.396  Sum_probs=214.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe----
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS----   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~----   80 (441)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.....    ..+.+.+|+.+++.+ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            346799999999999999999999999999999999976432    235688999999999 79999999999987    


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           81 --RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        81 --~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                        .+..|+||||+++|+|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999864  57999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccccccccccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC--CC
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS--CP  230 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~--~~  230 (441)
                      .............+||+.|+|||++..    ....+.++|||||||++|+|++|..||...+.......+.....+  .+
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  256 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSC
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCc
Confidence            866544334456689999999999862    233458999999999999999999999887766555555443322  23


Q ss_pred             CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          231 FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       231 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ..+++.+.++|.+||..||++|||++++++||||+..
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            4589999999999999999999999999999999764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5e-48  Score=381.95  Aligned_cols=261  Identities=29%  Similarity=0.423  Sum_probs=217.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC---
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR---   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~---   81 (441)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++....  .......+.+|+.+++.++||||+++++++...   
T Consensus         7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   84 (353)
T 2b9h_A            7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE   84 (353)
T ss_dssp             CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred             cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence            345679999999999999999999999999999999996432  334456788999999999999999999988654   


Q ss_pred             --CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           82 --TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        82 --~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                        ...|+||||+. |+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        85 ~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           85 NFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             TCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence              67999999997 589888876 67999999999999999999999999999999999999999999999999999765


Q ss_pred             Ccccc----------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC----
Q 013520          160 QQGVE----------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----  225 (441)
Q Consensus       160 ~~~~~----------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----  225 (441)
                      .....          .....+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+...    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            43211          1234578999999999866555568999999999999999999999887755443332110    


Q ss_pred             --------------------c--C------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          226 --------------------E--F------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       226 --------------------~--~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                          .  .      ..++.+++++.+||.+||+.||++|||++++++||||+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence                                0  0      011357899999999999999999999999999999987543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.4e-48  Score=380.85  Aligned_cols=256  Identities=28%  Similarity=0.440  Sum_probs=215.8

Q ss_pred             CcccccccCeEEEeeeeecCcEEEEEEEE-CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC------Cccee
Q 013520            2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQN-RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP------NIVRL   74 (441)
Q Consensus         2 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp------nIv~l   74 (441)
                      +.+....++|++.+.||+|+||.||+|.+ ..+|+.||+|++...    ....+.+.+|+.+++.++|+      +++++
T Consensus         7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~   82 (339)
T 1z57_A            7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQM   82 (339)
T ss_dssp             STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred             ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence            44566678999999999999999999998 568899999998653    23456788999999988765      49999


Q ss_pred             EEEEEeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc--------
Q 013520           75 HEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS--------  144 (441)
Q Consensus        75 ~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~--------  144 (441)
                      ++++.+.+..|+||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.        
T Consensus        83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence            99999999999999999 889999998765  6889999999999999999999999999999999999987        


Q ss_pred             -----------CCCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC
Q 013520          145 -----------YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (441)
Q Consensus       145 -----------~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~  213 (441)
                                 ++.+||+|||++......   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CccccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                       678999999998764432   345689999999999987666 48999999999999999999999887


Q ss_pred             ChHHHHHHhhcCcCCC--------------------------------------------CCCCCHhHHHHHHHhcCCCC
Q 013520          214 DLPTLYKKINAAEFSC--------------------------------------------PFWFSTGATSLIHKILDPNP  249 (441)
Q Consensus       214 ~~~~~~~~i~~~~~~~--------------------------------------------~~~~s~~~~~li~~~L~~dP  249 (441)
                      +..+....+.....+.                                            +...++++.+||.+||+.||
T Consensus       238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  317 (339)
T 1z57_A          238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP  317 (339)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence            7655443332111111                                            11134678899999999999


Q ss_pred             CCCCChHhHhcCCCccc
Q 013520          250 KTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       250 ~~R~t~~eil~hp~f~~  266 (441)
                      ++|||++|+++||||+.
T Consensus       318 ~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          318 AKRITLREALKHPFFDL  334 (339)
T ss_dssp             TTSCCHHHHTTSGGGGG
T ss_pred             ccccCHHHHhcCHHHHH
Confidence            99999999999999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3e-48  Score=393.66  Aligned_cols=252  Identities=29%  Similarity=0.390  Sum_probs=208.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC------
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR------   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~------   81 (441)
                      ..+|++.+.||+|+||.||+|+++.+|+.||||++.....       ...+|+.+++.++||||+++++++...      
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            4479999999999999999999999999999999876432       134699999999999999999998542      


Q ss_pred             CEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-CCeEEeecccc
Q 013520           82 TKVYIILEFVTGGELFDKIV----HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-GNLKVSDFGLS  156 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~----~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-~~~kL~DFGls  156 (441)
                      ..+++||||+.+ +|.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus       126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            247799999986 5655553    35689999999999999999999999999999999999999965 56899999999


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc------------
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA------------  224 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~------------  224 (441)
                      ...... ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+....+..            
T Consensus       205 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          205 KQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             EECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            865443 2334678999999999997665556899999999999999999999998776544433321            


Q ss_pred             -----CcCC------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          225 -----AEFS------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       225 -----~~~~------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                           ..+.            ++..+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                 1111            2234689999999999999999999999999999997643

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4.3e-48  Score=386.04  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=213.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE--
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV--   84 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~--   84 (441)
                      ..++|.+.+.||+|+||.||+|.++.+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..  
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            34799999999999999999999999999999999976542 334567888999999999999999999999877654  


Q ss_pred             ----EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           85 ----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        85 ----~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                          |+||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence                99999997 58887773  459999999999999999999999999999999999999999999999999997554


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------  226 (441)
                      ..   ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....              
T Consensus       196 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          196 AE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             cC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            32   3466899999999999774555689999999999999999999999887665554432200              


Q ss_pred             -----------C------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          227 -----------F------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       227 -----------~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                                 .      ..++.+++++.+||++||+.||++|||++|+++||||+...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                       0      01234689999999999999999999999999999998643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.9e-49  Score=379.69  Aligned_cols=261  Identities=26%  Similarity=0.437  Sum_probs=198.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   88 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL   88 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence            45567999999999999999999999999999999998764322  2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           85 YIILEFVTGGELFDKIVH--------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~--------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      |+||||++|++|.+++..        .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            999999999999999974        456999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCccc-----cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC----
Q 013520          157 ALPQQGV-----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF----  227 (441)
Q Consensus       157 ~~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~----  227 (441)
                      .......     ......+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.............    
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  248 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE  248 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTT
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccc
Confidence            7554321     1234567999999999986533345899999999999999999999988766544433322221    


Q ss_pred             ------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          228 ------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       228 ------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                            .....+++++.++|.+||+.||.+|||++++++||||++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence                  1123478899999999999999999999999999999764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.5e-48  Score=384.69  Aligned_cols=262  Identities=24%  Similarity=0.374  Sum_probs=210.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc--------chHHHHHHHHHHHHHHhCCCCCcceeEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL--------KHRMVDQIKREISIMKIVRHPNIVRLHEV   77 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~--------~~~~~~~~~~Ei~il~~l~hpnIv~l~~~   77 (441)
                      ...++|++.+.||+|+||.||+|.+.. |..||||++......        .....+.+.+|+.+++.++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            345799999999999999999999865 899999998654321        22345789999999999999999999999


Q ss_pred             EEe-----CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEe
Q 013520           78 LAS-----RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS  151 (441)
Q Consensus        78 ~~~-----~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  151 (441)
                      +..     ...+|+||||+. |+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            853     347899999998 5787877654 479999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC------
Q 013520          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA------  225 (441)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------  225 (441)
                      |||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...      
T Consensus       177 Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          177 DFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             ecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999754432 23446679999999999977455568999999999999999999999988766555444210      


Q ss_pred             ------------------cC--------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          226 ------------------EF--------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       226 ------------------~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                                        ..        ..++.+++.+.+||.+||+.||++|||++++++||||+..+.+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                              00        1123468899999999999999999999999999999887654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.6e-48  Score=383.22  Aligned_cols=260  Identities=25%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE-
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK-   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-   83 (441)
                      ...+++|++.+.||+|+||.||+|+++.+|+.||||++.......    ....+++..++.++||||+++++++...+. 
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            356789999999999999999999999999999999986643322    345567888888999999999999975433 


Q ss_pred             ------EEEEEeccCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEcc-CCCeEE
Q 013520           84 ------VYIILEFVTGGELFD----KIVHQGRLLENDCRRYFQQLIDAVAHCH--SKGVYHRDLKPENLLLDS-YGNLKV  150 (441)
Q Consensus        84 ------~~lv~E~~~gg~L~~----~i~~~~~l~e~~~~~~~~qll~aL~~LH--~~gi~HrDlkp~NILl~~-~~~~kL  150 (441)
                            +|+||||+.++ |.+    .+.....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++.+||
T Consensus        95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl  173 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL  173 (360)
T ss_dssp             CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred             cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence                  89999999875 433    3345678999999999999999999999  999999999999999996 899999


Q ss_pred             eeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc----
Q 013520          151 SDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE----  226 (441)
Q Consensus       151 ~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~----  226 (441)
                      +|||++...... ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+....    
T Consensus       174 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          174 CDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             CCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            999999866543 233466799999999999776656799999999999999999999999887766555443210    


Q ss_pred             ----------------------------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          227 ----------------------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       227 ----------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                                                  ...+...++++.+||.+||+.||++|||+.|+++||||+....+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence                                        01111256789999999999999999999999999999876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.2e-48  Score=375.69  Aligned_cols=260  Identities=27%  Similarity=0.376  Sum_probs=212.9

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE----
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA----   79 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----   79 (441)
                      +....++|++++.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.    
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            345668999999999999999999999999999999998754   2345677889999999999999999999873    


Q ss_pred             ----------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-cCCCe
Q 013520           80 ----------SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNL  148 (441)
Q Consensus        80 ----------~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~-~~~~~  148 (441)
                                +....|+||||++ |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence                      4578999999997 599998865 6799999999999999999999999999999999999997 56799


Q ss_pred             EEeeccccccCCcc---ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC
Q 013520          149 KVSDFGLSALPQQG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA  225 (441)
Q Consensus       149 kL~DFGls~~~~~~---~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~  225 (441)
                      ||+|||++......   ........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999865432   122345568999999999876455568999999999999999999999987765555444321


Q ss_pred             cC------------------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          226 EF------------------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       226 ~~------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ..                              ..++.+++++.++|++||+.||++|||++++++||||+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS  313 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence            10                              01235799999999999999999999999999999998643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.5e-48  Score=389.46  Aligned_cols=253  Identities=25%  Similarity=0.412  Sum_probs=208.5

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--------CCCcceeE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--------HPNIVRLH   75 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------hpnIv~l~   75 (441)
                      +....++|++.+.||+|+||.||+|++..+|+.||||++...    ....+.+.+|+.+++.++        ||||++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            345568999999999999999999999999999999999753    234567889999999885        78899999


Q ss_pred             EEEE----eCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCC--
Q 013520           76 EVLA----SRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYG--  146 (441)
Q Consensus        76 ~~~~----~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~--  146 (441)
                      +++.    ....+|+||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++  
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred             cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence            9987    566899999999 66777777654  4699999999999999999999999 999999999999999775  


Q ss_pred             -----------------------------------------------CeEEeeccccccCCccccccccccCCCCcCCcc
Q 013520          147 -----------------------------------------------NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE  179 (441)
Q Consensus       147 -----------------------------------------------~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE  179 (441)
                                                                     .+||+|||++......   ....+||+.|+|||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE  263 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCCh
Confidence                                                           7999999999765432   34568999999999


Q ss_pred             ccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh------HHHHHHhhc------------Cc---------------
Q 013520          180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL------PTLYKKINA------------AE---------------  226 (441)
Q Consensus       180 ~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~------~~~~~~i~~------------~~---------------  226 (441)
                      ++.+..+ +.++|||||||++|+|++|..||...+.      ......+..            +.               
T Consensus       264 ~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          264 VLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            9987776 4899999999999999999999976442      111111110            00               


Q ss_pred             ---------------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          227 ---------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       227 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                                     +..+...++.+.+||.+||+.||++|||++|+++||||+
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                           011122346788999999999999999999999999996

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=8e-48  Score=371.20  Aligned_cols=254  Identities=26%  Similarity=0.479  Sum_probs=208.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------   80 (441)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++...    ....+.+.+|+.+++.++||||+++++++.+      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            356899999999999999999999999999999999653    3345778999999999999999999998865      


Q ss_pred             -------CCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEee
Q 013520           81 -------RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSD  152 (441)
Q Consensus        81 -------~~~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~D  152 (441)
                             .+..|+||||++||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                   467899999999999999998644 578899999999999999999999999999999999999999999999


Q ss_pred             ccccccCCcc--------------ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC-CChHH
Q 013520          153 FGLSALPQQG--------------VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPT  217 (441)
Q Consensus       153 FGls~~~~~~--------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~  217 (441)
                      ||++......              .......+||+.|+|||++.+.+..+.++|||||||++|+|++   ||.. .+...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765421              1223456799999999999766555689999999999999998   5543 22334


Q ss_pred             HHHHhhcCcCCCCC----CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          218 LYKKINAAEFSCPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       218 ~~~~i~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ....+.......|+    ..++.+.++|++||+.||++|||++++++||||+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            45555555444443    356779999999999999999999999999999753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.9e-48  Score=377.54  Aligned_cols=262  Identities=24%  Similarity=0.359  Sum_probs=202.9

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      .....++|++++.||+|+||.||+|.+..++.   .||+|++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            34456789999999999999999999887765   89999997654333 346788999999999999999999999987


Q ss_pred             CCEE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCe
Q 013520           81 RTKV------YIILEFVTGGELFDKIVHQG------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL  148 (441)
Q Consensus        81 ~~~~------~lv~E~~~gg~L~~~i~~~~------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~  148 (441)
                      ....      |+||||+.+|+|.+++....      .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence            7665      99999999999999996543      59999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC
Q 013520          149 KVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA  225 (441)
Q Consensus       149 kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~  225 (441)
                      ||+|||++.......  .......+++.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+..+....+...
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            999999997654322  12234457788999999977665 489999999999999999 99999998887777766554


Q ss_pred             -cCCCCCCCCHhHHHHHHHhcCCCCCCCCC-------hHhHhcCCCcccc
Q 013520          226 -EFSCPFWFSTGATSLIHKILDPNPKTRIR-------IEGIRKHPWFRKN  267 (441)
Q Consensus       226 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t-------~~eil~hp~f~~~  267 (441)
                       ....+..+++++.++|.+||+.||++|||       +++++.|||+...
T Consensus       256 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence             45667779999999999999999999999       7788899999754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.4e-49  Score=393.87  Aligned_cols=253  Identities=17%  Similarity=0.213  Sum_probs=195.8

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC--CCCCcceeE-------EEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV--RHPNIVRLH-------EVLA   79 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l--~hpnIv~l~-------~~~~   79 (441)
                      .+|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            3599999999999999999999999999999999887654555567788886555555  699988755       5554


Q ss_pred             eC-----------------CEEEEEEeccCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHCCceecCC
Q 013520           80 SR-----------------TKVYIILEFVTGGELFDKIVHQG-RLLENDC------RRYFQQLIDAVAHCHSKGVYHRDL  135 (441)
Q Consensus        80 ~~-----------------~~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~------~~~~~qll~aL~~LH~~gi~HrDl  135 (441)
                      ..                 ..+|+||||++ |+|.+++...+ .+++...      ..++.||+.||.|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            43                 34899999998 89999998743 3444444      466699999999999999999999


Q ss_pred             CCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCC
Q 013520          136 KPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGET  213 (441)
Q Consensus       136 kp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~  213 (441)
                      ||+|||++.+|.+||+|||++......   .....+|+.|+|||++.+  ..+ +.++|||||||++|+|++|..||...
T Consensus       221 kp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          221 TPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             SGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCCc
Confidence            999999999999999999999865432   224567799999999975  344 58999999999999999999999876


Q ss_pred             ChHH--HHHH-----hhcCcCCC--CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          214 DLPT--LYKK-----INAAEFSC--PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       214 ~~~~--~~~~-----i~~~~~~~--~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ....  .+..     .....+..  +..+++.+.+||.+||+.||++|||++++++||||++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            4321  1111     11112222  3468999999999999999999999999999999975

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6e-48  Score=374.94  Aligned_cols=254  Identities=24%  Similarity=0.396  Sum_probs=215.3

Q ss_pred             CCcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      |.......++|++++.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.+
T Consensus         2 ~p~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   78 (310)
T 3s95_A            2 MPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK   78 (310)
T ss_dssp             CCCEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             CcceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence            334456788999999999999999999999999999999988543   34456789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           81 RTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      .+..|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            9999999999999999999987 567999999999999999999999999999999999999999999999999999765


Q ss_pred             Cccccc--------------cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH-----HH
Q 013520          160 QQGVEL--------------LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL-----YK  220 (441)
Q Consensus       160 ~~~~~~--------------~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~-----~~  220 (441)
                      ......              ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........     ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~  237 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR  237 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh
Confidence            432111              125679999999999987666 4899999999999999999999865332110     01


Q ss_pred             HhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          221 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       221 ~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ..  .....|..+++.+.++|.+||+.||++|||++++++
T Consensus       238 ~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          238 GF--LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HH--HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cc--ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11  112346678999999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=393.51  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=195.9

Q ss_pred             cccCeEE-EeeeeecCcEEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--C
Q 013520            7 RVAKYEV-GRTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--R   81 (441)
Q Consensus         7 ~~~~y~i-~~~LG~G~~g~V~~a~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~   81 (441)
                      ..+.|++ +++||+|+||.||+|+++  .+++.||||++.....     ...+.+|+.+++.++||||+++++++..  .
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD   92 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence            3456887 568999999999999976  5788999999976432     2457789999999999999999999954  7


Q ss_pred             CEEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----ccCCCe
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ---------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNL  148 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~---------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl----~~~~~~  148 (441)
                      ..+|+||||+.+ +|.+.+...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            789999999964 888877532         249999999999999999999999999999999999999    677899


Q ss_pred             EEeeccccccCCccc---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH---------
Q 013520          149 KVSDFGLSALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------  216 (441)
Q Consensus       149 kL~DFGls~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------  216 (441)
                      ||+|||++.......   ......+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..         
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999999998664321   23456789999999999987665678999999999999999999999764421         


Q ss_pred             HHHHHhhc-CcCCC-------------------------------------CCCCCHhHHHHHHHhcCCCCCCCCChHhH
Q 013520          217 TLYKKINA-AEFSC-------------------------------------PFWFSTGATSLIHKILDPNPKTRIRIEGI  258 (441)
Q Consensus       217 ~~~~~i~~-~~~~~-------------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~ei  258 (441)
                      +....+.. ...+.                                     ....++.+.+||++||+.||++|||++|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            22222111 00000                                     01127789999999999999999999999


Q ss_pred             hcCCCccccCCC
Q 013520          259 RKHPWFRKNYNP  270 (441)
Q Consensus       259 l~hp~f~~~~~~  270 (441)
                      ++||||+....+
T Consensus       332 L~hp~f~~~~~~  343 (405)
T 3rgf_A          332 MQDPYFLEDPLP  343 (405)
T ss_dssp             HTSGGGTSSSCC
T ss_pred             hcChhhccCCCC
Confidence            999999876443

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.3e-48  Score=381.85  Aligned_cols=256  Identities=32%  Similarity=0.527  Sum_probs=222.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCC--CCCcceeEEEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVR--HPNIVRLHEVLA   79 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~   79 (441)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++........   ...+.+.+|+.+++.++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            4567799999999999999999999999999999999987643321   11234667999999996  599999999999


Q ss_pred             eCCEEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-cCCCeEEeeccccc
Q 013520           80 SRTKVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSA  157 (441)
Q Consensus        80 ~~~~~~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGls~  157 (441)
                      ..+..++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999999986 89999999889999999999999999999999999999999999999999 78999999999987


Q ss_pred             cCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhH
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGA  237 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~  237 (441)
                      .....  ......||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+      .+.......+..+++++
T Consensus       199 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~~  270 (320)
T 3a99_A          199 LLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSEC  270 (320)
T ss_dssp             ECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHH
T ss_pred             ccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCHHH
Confidence            65432  33456799999999999877776688999999999999999999996532      23344556677899999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .++|.+||+.||++|||++++++||||+...
T Consensus       271 ~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            9999999999999999999999999998653

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=379.56  Aligned_cols=254  Identities=26%  Similarity=0.398  Sum_probs=212.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE----
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK----   83 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~----   83 (441)
                      .++|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+.    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            478999999999999999999999999999999997643 233456778899999999999999999999987654    


Q ss_pred             --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           84 --VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        84 --~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                        .|+||||+. ++|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              599999997 58887764  4699999999999999999999999999999999999999999999999999976543


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC----------------
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------  225 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------  225 (441)
                      .   ....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...                
T Consensus       179 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          179 E---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             C---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence            2   345679999999999977455568999999999999999999999887765544433210                


Q ss_pred             ------------c---CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          226 ------------E---FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       226 ------------~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                                  .   ...++.+++++.+||.+||+.||++|||++++++||||+...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                        0   012235789999999999999999999999999999997643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-47  Score=382.41  Aligned_cols=253  Identities=23%  Similarity=0.392  Sum_probs=219.3

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEEC-------CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNR-------ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEV   77 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~   77 (441)
                      ...++|++++.||+|+||.||+|++.       .++..||+|++....  .....+.+.+|+.+++.+ +||||++++++
T Consensus        78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            34578999999999999999999874       345689999997653  334567899999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 013520           78 LASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (441)
Q Consensus        78 ~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NIL  141 (441)
                      +.+.+.+|+||||++||+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL  235 (370)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence            999999999999999999999998643                4789999999999999999999999999999999999


Q ss_pred             EccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHH
Q 013520          142 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  218 (441)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~  218 (441)
                      ++.+|.+||+|||++.......  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+.
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            9999999999999997554322  12234567889999999987665 489999999999999999 9999999888777


Q ss_pred             HHHhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          219 YKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       219 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ...+..+. ...|..+++++.++|.+||+.||++|||+.|++++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          315 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77766553 45667799999999999999999999999999875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.8e-47  Score=372.20  Aligned_cols=256  Identities=30%  Similarity=0.407  Sum_probs=214.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEEC-CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeEEEEE----
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNR-ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLA----   79 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~----   79 (441)
                      .++|++++.||+|+||.||+|++. .+|+.||+|++....... .....+.+|+.+++.+   +||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            479999999999999999999995 678999999997654321 1123456777777766   8999999999987    


Q ss_pred             -eCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           80 -SRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        80 -~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                       .....|+||||+. |+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5678999999998 59999997753  4999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC-------c---
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA-------E---  226 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~-------~---  226 (441)
                      ...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+...       .   
T Consensus       168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          168 RIYSFQ-MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCGG-GGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             ccccCC-CCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            866543 23456789999999999987665 58999999999999999999999988776655544321       0   


Q ss_pred             -----------------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          227 -----------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       227 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                       ...+..+++.+.+||.+||..||++|||+.++++||||+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                             01224578999999999999999999999999999999764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-47  Score=374.90  Aligned_cols=254  Identities=25%  Similarity=0.372  Sum_probs=218.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....++|++.+.||+|+||.||+|.+..+|+   .||||++....  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3456799999999999999999999986655   59999997643  233457789999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      +..|+||||++||+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999999654 579999999999999999999999999999999999999999999999999998664


Q ss_pred             cccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCH
Q 013520          161 QGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFST  235 (441)
Q Consensus       161 ~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~  235 (441)
                      ....   ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ..+.|..+++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH  281 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence            4322   2223446778999999977665 489999999999999999 99999998888777776654 4556677999


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+.++|.+||..||++|||+.++++.
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999998763

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-47  Score=363.62  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=218.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   82 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEE
Confidence            4579999999999999999999987 5778999999765432    2568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-c
Q 013520           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-E  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~  164 (441)
                      ||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           83 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            99999999999999653 468999999999999999999999999999999999999999999999999997654421 2


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (441)
                      ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+... ....|..+++++.+++.
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  241 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             cccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence            2344567888999999977665 489999999999999999 99999998888887777665 44556668999999999


Q ss_pred             HhcCCCCCCCCChHhHhcC
Q 013520          243 KILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~h  261 (441)
                      +||+.||++|||+.++++|
T Consensus       242 ~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          242 HCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCcccCcCHHHHHHH
Confidence            9999999999999999876

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-47  Score=383.21  Aligned_cols=255  Identities=29%  Similarity=0.404  Sum_probs=213.0

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CC-----CcceeEEE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HP-----NIVRLHEV   77 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hp-----nIv~l~~~   77 (441)
                      +....++|++.+.||+|+||.||+|.++.+|+.||||++...    ....+.+.+|+.+++.++ |+     +|++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~  124 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH  124 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence            445678999999999999999999999999999999999753    234567788999988885 55     49999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEc--cCCCeEEe
Q 013520           78 LASRTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCH--SKGVYHRDLKPENLLLD--SYGNLKVS  151 (441)
Q Consensus        78 ~~~~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH--~~gi~HrDlkp~NILl~--~~~~~kL~  151 (441)
                      +...+..|+||||+. |+|.+++...  ..+++..++.++.|++.||.|||  +.||+||||||+|||++  .++.+||+
T Consensus       125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999999996 5999999875  46999999999999999999999  57999999999999995  47789999


Q ss_pred             eccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC--
Q 013520          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--  229 (441)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--  229 (441)
                      |||++.....   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+..+....+.......  
T Consensus       204 DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          204 DFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             eccCceeccc---ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9999976543   2346789999999999987766 489999999999999999999999887766555443210000  


Q ss_pred             -----------------------------------CCC---------------------------CCHhHHHHHHHhcCC
Q 013520          230 -----------------------------------PFW---------------------------FSTGATSLIHKILDP  247 (441)
Q Consensus       230 -----------------------------------~~~---------------------------~s~~~~~li~~~L~~  247 (441)
                                                         |..                           .++++.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                                               000                           013689999999999


Q ss_pred             CCCCCCChHhHhcCCCcccc
Q 013520          248 NPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       248 dP~~R~t~~eil~hp~f~~~  267 (441)
                      ||++|||++|+++||||++.
T Consensus       360 dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC-
T ss_pred             ChhhCCCHHHHhcCcccccC
Confidence            99999999999999999764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.2e-47  Score=369.22  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=211.4

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++++...+.
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe
Confidence            45678999999999999999999999999999999999987665555566789999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      .|+||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999987654421


Q ss_pred             -cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCCCCCCHhHHH
Q 013520          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATS  239 (441)
Q Consensus       164 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~  239 (441)
                       .......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.....   ..++.+|+++.+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence             22345679999999999977655 5899999999999999999999988776655444443322   234568999999


Q ss_pred             HHHHhcCCCCCCCC-ChHhHhc
Q 013520          240 LIHKILDPNPKTRI-RIEGIRK  260 (441)
Q Consensus       240 li~~~L~~dP~~R~-t~~eil~  260 (441)
                      +|.+||+.||++|| |++++++
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999 7888765

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-47  Score=368.42  Aligned_cols=257  Identities=26%  Similarity=0.399  Sum_probs=213.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ..+|.....||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..|+|
T Consensus        21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            334444559999999999999999999999999997653   23456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEeeccccccCCccc
Q 013520           88 LEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~~~~  163 (441)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            99999999999998652   4678899999999999999999999999999999999987 8999999999998665433


Q ss_pred             cccccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCCCChHH--HHH-HhhcCcCCCCCCCCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLPT--LYK-KINAAEFSCPFWFSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~--~~~-~i~~~~~~~~~~~s~~~~~  239 (441)
                      .......||+.|+|||++.+.. ..+.++||||||+++|+|++|..||...+...  ... .........|..+++++.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA  257 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence            3445678999999999986542 23589999999999999999999997644322  111 1233344567779999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      +|.+||+.||++|||++++++||||+..
T Consensus       258 li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          258 FILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-48  Score=385.29  Aligned_cols=258  Identities=21%  Similarity=0.280  Sum_probs=220.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEE-----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ...++|++++.||+|+||.||+|+     +..++..||||++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            345789999999999999999999     44577899999986533  23345678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC---CeEE
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG---NLKV  150 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~---~~kL  150 (441)
                      ....|+||||++||+|.+++....       .+++..+..++.||+.||.|||++||+||||||+|||++.+|   .+||
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999999998753       589999999999999999999999999999999999999655   4999


Q ss_pred             eeccccccCCcc--ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-
Q 013520          151 SDFGLSALPQQG--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-  226 (441)
Q Consensus       151 ~DFGls~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-  226 (441)
                      +|||++......  ........||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+. 
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~  304 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  304 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            999998744221  122345668999999999977666 489999999999999998 999999988888877776654 


Q ss_pred             CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          227 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       227 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ...+..+++.+.+||.+||+.||++|||++++++|.|+-.
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            4566678999999999999999999999999999988743

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=376.85  Aligned_cols=255  Identities=33%  Similarity=0.568  Sum_probs=213.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH---HHHHHHHHHHHHHhC----CCCCcceeEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIV----RHPNIVRLHEV   77 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~---~~~~~~~Ei~il~~l----~hpnIv~l~~~   77 (441)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++.........   ....+.+|+.+++.+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44567899999999999999999999999999999999765433211   223456799999998    89999999999


Q ss_pred             EEeCCEEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc-cCCCeEEeeccc
Q 013520           78 LASRTKVYIILEF-VTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGL  155 (441)
Q Consensus        78 ~~~~~~~~lv~E~-~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~-~~~~~kL~DFGl  155 (441)
                      +...+..++|||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9999999999999 78999999999888999999999999999999999999999999999999999 889999999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCH
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFST  235 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~  235 (441)
                      +......  ......||+.|+|||++.+..+.+.++|||||||++|+|++|..||...      ..+.......+..+++
T Consensus       187 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~  258 (312)
T 2iwi_A          187 GALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSP  258 (312)
T ss_dssp             CEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTSCH
T ss_pred             hhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccCCH
Confidence            8765442  3346679999999999987776656899999999999999999999653      2234455667788999


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+.++|.+||+.||++|||++++++||||+..
T Consensus       259 ~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          259 DCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            99999999999999999999999999999864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.8e-47  Score=375.95  Aligned_cols=255  Identities=25%  Similarity=0.416  Sum_probs=212.5

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCC-cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC------cceeEE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETG-ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN------IVRLHE   76 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn------Iv~l~~   76 (441)
                      +....++|++.+.||+|+||.||+|.+..++ ..||+|++...    ....+.+.+|+.+++.++|++      ++.+++
T Consensus        14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            4456689999999999999999999998877 68999999653    234567888999999987655      999999


Q ss_pred             EEEeCCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE------------
Q 013520           77 VLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL------------  142 (441)
Q Consensus        77 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl------------  142 (441)
                      ++...+..|+||||+ +++|.+.+....  .+++..++.++.||+.||.|||++||+||||||+|||+            
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence            999999999999999 667777776653  69999999999999999999999999999999999999            


Q ss_pred             -------ccCCCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh
Q 013520          143 -------DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL  215 (441)
Q Consensus       143 -------~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~  215 (441)
                             +.++.+||+|||++......   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                   56789999999999764332   345689999999999987666 4899999999999999999999988776


Q ss_pred             HHHHHHhhcCcCCCC--------------------------------------------CCCCHhHHHHHHHhcCCCCCC
Q 013520          216 PTLYKKINAAEFSCP--------------------------------------------FWFSTGATSLIHKILDPNPKT  251 (441)
Q Consensus       216 ~~~~~~i~~~~~~~~--------------------------------------------~~~s~~~~~li~~~L~~dP~~  251 (441)
                      ......+.......|                                            ...++++.+||++||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            554433322111111                                            112457889999999999999


Q ss_pred             CCChHhHhcCCCcccc
Q 013520          252 RIRIEGIRKHPWFRKN  267 (441)
Q Consensus       252 R~t~~eil~hp~f~~~  267 (441)
                      |||++|+++||||+..
T Consensus       325 Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          325 RITLAEALLHPFFAGL  340 (355)
T ss_dssp             SCCHHHHTTSGGGGGC
T ss_pred             CcCHHHHhcChhhcCC
Confidence            9999999999999753

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.9e-47  Score=360.44  Aligned_cols=251  Identities=22%  Similarity=0.357  Sum_probs=218.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||.||+|.++ ++..||+|++......    .+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            456789999999999999999999886 5678999999765432    25688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998754 59999999999999999999999999999999999999999999999999997654432


Q ss_pred             -cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHH
Q 013520          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSL  240 (441)
Q Consensus       164 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l  240 (441)
                       .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+. ...|...++.+.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             hhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence             22234456778999999977665 489999999999999999 999999888877777666554 44566689999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcC
Q 013520          241 IHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~h  261 (441)
                      |.+||+.||++|||+.++++|
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999886

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-47  Score=366.10  Aligned_cols=249  Identities=22%  Similarity=0.270  Sum_probs=213.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCC-------cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETG-------ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEV   77 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~   77 (441)
                      ....++|++.+.||+|+||.||+|++..++       ..||+|++....   ....+.+.+|+.+++.++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            345689999999999999999999998877       469999986643   2345778999999999999999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC--------e
Q 013520           78 LASRTKVYIILEFVTGGELFDKIVHQGR-LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN--------L  148 (441)
Q Consensus        78 ~~~~~~~~lv~E~~~gg~L~~~i~~~~~-l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~--------~  148 (441)
                      +.+.+..|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987654 999999999999999999999999999999999999998887        9


Q ss_pred             EEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcC
Q 013520          149 KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF  227 (441)
Q Consensus       149 kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~  227 (441)
                      ||+|||++......    ....||+.|+|||++.+....+.++|||||||++|+|++ |.+||...+..... .......
T Consensus       161 kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~~  235 (289)
T 4fvq_A          161 KLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDRH  235 (289)
T ss_dssp             EECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTC
T ss_pred             eeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhccC
Confidence            99999998755432    345689999999999874555689999999999999999 45666555544333 3344455


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..|...++++.++|.+||+.||++|||++++++|
T Consensus       236 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          236 QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6667789999999999999999999999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6e-47  Score=362.73  Aligned_cols=250  Identities=22%  Similarity=0.358  Sum_probs=216.4

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            44669999999999999999999886 6778999999765433    256889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      +||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999999999976 5679999999999999999999999999999999999999999999999999997654421 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+... ....|...++.+.++|
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  254 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM  254 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHH
Confidence            22334457788999999987665 489999999999999998 99999998887777777655 3445666899999999


Q ss_pred             HHhcCCCCCCCCChHhHhcC
Q 013520          242 HKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+||+.||++|||++++++|
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2e-47  Score=378.47  Aligned_cols=253  Identities=23%  Similarity=0.363  Sum_probs=214.7

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEE-----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA   79 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~   79 (441)
                      ...++|++++.||+|+||.||+|+     +..+++.||||++....  .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            346799999999999999999999     55677999999997643  233456789999999999 7999999999998


Q ss_pred             eCC-EEEEEEeccCCCChHHHHHhcCC-----------------------------------------------------
Q 013520           80 SRT-KVYIILEFVTGGELFDKIVHQGR-----------------------------------------------------  105 (441)
Q Consensus        80 ~~~-~~~lv~E~~~gg~L~~~i~~~~~-----------------------------------------------------  105 (441)
                      +.+ ..|+||||++||+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            755 49999999999999999976543                                                     


Q ss_pred             -------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc--ccccccc
Q 013520          106 -------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTC  170 (441)
Q Consensus       106 -------------l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~  170 (441)
                                   +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  .......
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  256 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  256 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence                         8999999999999999999999999999999999999999999999999998654321  2334567


Q ss_pred             CCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHH-HHHHhhc-CcCCCCCCCCHhHHHHHHHhcCC
Q 013520          171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT-LYKKINA-AEFSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       171 gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~-~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~  247 (441)
                      ||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+... ....+.. .....|..+++++.++|.+||+.
T Consensus       257 ~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  335 (359)
T 3vhe_A          257 LPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG  335 (359)
T ss_dssp             ECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            8999999999987665 489999999999999998 999998866433 3333333 34566777999999999999999


Q ss_pred             CCCCCCChHhHhcC
Q 013520          248 NPKTRIRIEGIRKH  261 (441)
Q Consensus       248 dP~~R~t~~eil~h  261 (441)
                      ||++|||++++++|
T Consensus       336 dP~~Rps~~ell~~  349 (359)
T 3vhe_A          336 EPSQRPTFSELVEH  349 (359)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCCCHHHHHHH
Confidence            99999999999887

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-47  Score=374.35  Aligned_cols=253  Identities=24%  Similarity=0.325  Sum_probs=220.0

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ...++|++++.||+|+||.||+|++.     .+++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            45679999999999999999999987     455899999997653  23446789999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ------------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLK  136 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~------------------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlk  136 (441)
                      .+..|+||||+++|+|.+++...                        ..+++..++.++.||+.||.|||++||+|||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk  201 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  201 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            99999999999999999999763                        578999999999999999999999999999999


Q ss_pred             CCcEEEccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCC
Q 013520          137 PENLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGET  213 (441)
Q Consensus       137 p~NILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~  213 (441)
                      |+|||++.++.+||+|||++.......  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            999999999999999999987543321  22345568899999999987665 489999999999999999 99999998


Q ss_pred             ChHHHHHHhhcCcC-CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          214 DLPTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       214 ~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +..+....+..+.. ..|..+++++.++|.+||+.||++|||+.+++++
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            88777777766554 5677799999999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-47  Score=375.96  Aligned_cols=254  Identities=32%  Similarity=0.574  Sum_probs=185.5

Q ss_pred             cccccCeEEEe-eeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe---
Q 013520            5 TRRVAKYEVGR-TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS---   80 (441)
Q Consensus         5 ~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~---   80 (441)
                      ....++|++.+ .||+|+||.||+|.++.+|+.||||++....       ....+....++.++||||+++++++..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            45668999965 6999999999999999999999999986532       112223334567799999999999976   


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC---CCeEEeecc
Q 013520           81 -RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFG  154 (441)
Q Consensus        81 -~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL~DFG  154 (441)
                       ....|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             556899999999999999998754  69999999999999999999999999999999999999864   459999999


Q ss_pred             ccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH----HHHhhcCcCCCC
Q 013520          155 LSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL----YKKINAAEFSCP  230 (441)
Q Consensus       155 ls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~  230 (441)
                      ++.....  ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....    ...+.......+
T Consensus       177 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          177 FAKETTQ--NALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             TCEEC------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             cceeccc--cccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            9975543  23456789999999999976655 4799999999999999999999976554332    222333333322


Q ss_pred             ----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          231 ----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       231 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                          ..+++++.+||.+||+.||++|||++++++||||+...
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence                34899999999999999999999999999999998653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.2e-47  Score=368.82  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=219.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ...++|++.+.||+|+||.||+|.+     +.++..||+|++....  .....+.+.+|+.+++.++||||+++++++.+
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   97 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ   97 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence            3457999999999999999999998     3456899999997643  33456788999999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGR------------------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLK  136 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~------------------------l~e~~~~~~~~qll~aL~~LH~~gi~HrDlk  136 (441)
                      .+..|+||||++||+|.+++.....                        +++..++.++.||+.||.|||++||+|||||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik  177 (314)
T 2ivs_A           98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA  177 (314)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence            9999999999999999999987543                        8899999999999999999999999999999


Q ss_pred             CCcEEEccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCC
Q 013520          137 PENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGET  213 (441)
Q Consensus       137 p~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~  213 (441)
                      |+||+++.++.+||+|||++........  ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~  256 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGI  256 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999976543222  2334567889999999977655 489999999999999999 99999988


Q ss_pred             ChHHHHHHhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          214 DLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       214 ~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.......+..+. ...|..+++++.++|.+||+.||++|||+++++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8777777766543 45666799999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=376.03  Aligned_cols=253  Identities=23%  Similarity=0.389  Sum_probs=220.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEV   77 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~   77 (441)
                      ...++|++++.||+|+||.||+|++..       .+..||+|++....  .......+.+|+.+++.+ +||||++++++
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            445799999999999999999999753       33579999997653  334457789999999999 89999999999


Q ss_pred             EEeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 013520           78 LASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (441)
Q Consensus        78 ~~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NIL  141 (441)
                      +.+.+..|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  223 (382)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence            999999999999999999999998754                4999999999999999999999999999999999999


Q ss_pred             EccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHH
Q 013520          142 LDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTL  218 (441)
Q Consensus       142 l~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~  218 (441)
                      ++.++.+||+|||++.......  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+.
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999998665422  22344567889999999987665 489999999999999999 9999999888887


Q ss_pred             HHHhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          219 YKKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       219 ~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+.+..+ ....|..+++++.++|.+||+.||++|||+.+++++
T Consensus       303 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          303 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7777655 445667799999999999999999999999999886

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.7e-47  Score=362.40  Aligned_cols=253  Identities=28%  Similarity=0.390  Sum_probs=206.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....++|++.+.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.+++.++||||+++++++. .
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            34567999999999999999999998654   4579999886543  2344577899999999999999999999984 5


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      +..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence            67899999999999999998654 69999999999999999999999999999999999999999999999999997654


Q ss_pred             cccc-ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhH
Q 013520          161 QGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (441)
Q Consensus       161 ~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (441)
                      .... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+..+....+..+ ..+.+..+++.+
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l  246 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  246 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            4221 2234457789999999976665 489999999999999996 99999988877777766554 345677799999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .++|.+||+.||++|||+.+++++
T Consensus       247 ~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          247 YSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.1e-47  Score=378.80  Aligned_cols=255  Identities=23%  Similarity=0.434  Sum_probs=208.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCCcce
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----------HPNIVR   73 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~   73 (441)
                      ....++|++.+.||+|+||.||+|.+..+|+.||||++....    ...+.+.+|+.+++.++           ||||++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            445679999999999999999999999999999999997532    23466888999998886           899999


Q ss_pred             eEEEEEeCC----EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEcc--
Q 013520           74 LHEVLASRT----KVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDS--  144 (441)
Q Consensus        74 l~~~~~~~~----~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~--  144 (441)
                      +++++...+    .++++|||+ +++|.+++...  ..+++..+..++.||+.||.|||++ ||+||||||+|||++.  
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            999998654    799999999 89999999763  4599999999999999999999998 9999999999999953  


Q ss_pred             ----CCCeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-----
Q 013520          145 ----YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-----  215 (441)
Q Consensus       145 ----~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-----  215 (441)
                          .+.+||+|||++......   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.     
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence                347999999999765432   345689999999999987666 5899999999999999999999976441     


Q ss_pred             -HHHHHHhh------------------------------------------cCcCCCCCCCCHhHHHHHHHhcCCCCCCC
Q 013520          216 -PTLYKKIN------------------------------------------AAEFSCPFWFSTGATSLIHKILDPNPKTR  252 (441)
Q Consensus       216 -~~~~~~i~------------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R  252 (441)
                       ......+.                                          ...+..+..+++++.+||.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence             11111111                                          11122333356789999999999999999


Q ss_pred             CChHhHhcCCCccccC
Q 013520          253 IRIEGIRKHPWFRKNY  268 (441)
Q Consensus       253 ~t~~eil~hp~f~~~~  268 (441)
                      ||++|+++||||++..
T Consensus       326 pt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          326 ADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             BCHHHHHTCGGGTTCT
T ss_pred             CCHHHHhhChhhhccc
Confidence            9999999999998754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-46  Score=362.08  Aligned_cols=256  Identities=28%  Similarity=0.514  Sum_probs=207.5

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            34678999999999999999999999999999999999875555555667899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           85 YIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      |+||||+++++|.+++..    ...+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999999864    4568999999999999999999999999999999999999999999999999988665


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC--hHHHHHHhhcCcCCC--CCCCCHh
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD--LPTLYKKINAAEFSC--PFWFSTG  236 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~--~~~~s~~  236 (441)
                      ..........|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+..  .......+....++.  +..++++
T Consensus       188 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          188 SKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             CCCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            54444456679999999999977665 489999999999999999999997643  334455555544432  2458999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.++|.+||..||++|||+++++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.5e-47  Score=379.57  Aligned_cols=251  Identities=27%  Similarity=0.409  Sum_probs=217.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.++.+++.||||++....  .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            4568999999999999999999999999999999987542  23344568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           87 ILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      ||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            999999999999998654 6999999999999999999999999999999999999999999999999998754332111


Q ss_pred             --cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          166 --LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       166 --~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                        .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.++|
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence              112235678999999976665 489999999999999998 99999988877776666544 4566777999999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||+.||++|||++++++
T Consensus       349 ~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHH
Confidence            9999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=364.70  Aligned_cols=259  Identities=25%  Similarity=0.372  Sum_probs=199.0

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||.||+|.++.+|+.||||++...... ....+.+.++..+++.++||||+++++++.+.+..|
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            4578999999999999999999999999999999999775432 222344555566788889999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +||||+ ++.+...... ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++.+||+|||++...... 
T Consensus       101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-  178 (318)
T ss_dssp             EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC-
Confidence            999999 5555555443 46899999999999999999999996 9999999999999999999999999998765442 


Q ss_pred             cccccccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCC-ChHHHHHHhhcCcC-CCC--CCCCH
Q 013520          164 ELLHTTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGET-DLPTLYKKINAAEF-SCP--FWFST  235 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~-~~~~~~~~i~~~~~-~~~--~~~s~  235 (441)
                      ......+||+.|+|||++..    ....+.++|||||||++|+|++|..||... +.......+..... ..|  ..+++
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (318)
T 2dyl_A          179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG  258 (318)
T ss_dssp             --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred             ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence            23345679999999999852    233458999999999999999999999873 34444444444332 223  34799


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ++.++|.+||+.||.+|||++++++||||+..
T Consensus       259 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          259 DFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            99999999999999999999999999999753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-46  Score=357.24  Aligned_cols=250  Identities=18%  Similarity=0.273  Sum_probs=217.4

Q ss_pred             cccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-
Q 013520            3 KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-   81 (441)
Q Consensus         3 ~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-   81 (441)
                      ......++|++.+.||+|+||.||+|++.  |+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+. 
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            45677899999999999999999999985  889999999775433 33456799999999999999999999999877 


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEccCCCeEEeecccc
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                       ...|+||||++||+|.+++....  .+++..+..++.||+.||.|||++|  |+||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             78999999999999999998765  4899999999999999999999999  999999999999999999999999987


Q ss_pred             ccCCccccccccccCCCCcCCccccccCCCCCC--CcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC--cCCCCCC
Q 013520          157 ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS--AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW  232 (441)
Q Consensus       157 ~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~--~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~  232 (441)
                      .....     ....||+.|+|||++.+..+...  ++|||||||++|+|++|..||...+.......+...  ....|..
T Consensus       161 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3kmu_A          161 FSFQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG  235 (271)
T ss_dssp             CTTSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred             eeecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence            64332     34578999999999977655422  799999999999999999999988877665555433  4456677


Q ss_pred             CCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          233 FSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       233 ~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +++++.++|.+||+.||++|||++++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-46  Score=361.49  Aligned_cols=252  Identities=26%  Similarity=0.371  Sum_probs=222.0

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|.++.++..||+|++....    ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            456789999999999999999999999999999999997643    2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           85 YIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      |+||||++|++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999999999864  45899999999999999999999999999999999999999999999999999866543


Q ss_pred             c-cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHH
Q 013520          163 V-ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATS  239 (441)
Q Consensus       163 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~  239 (441)
                      . .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |.+||...+.......+... ....|..+++.+.+
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  243 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  243 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHH
Confidence            2 22334557889999999977665 489999999999999999 99999988877777766554 45566779999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcC
Q 013520          240 LIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +|++||..||++|||++++++.
T Consensus       244 li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          244 LMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhCCChhhCcCHHHHHHH
Confidence            9999999999999999999763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.1e-46  Score=364.54  Aligned_cols=261  Identities=25%  Similarity=0.411  Sum_probs=212.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--HPNIVRLHEVLASRTK   83 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~   83 (441)
                      ....+|++++.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.+++.++  ||||+++++++.+.+.
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            34567999999999999999999985 5899999999775433 345678899999999997  5999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      .|+||| +.+++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+++ +.+||+|||++.......
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence            999999 568899999999889999999999999999999999999999999999999965 899999999998654422


Q ss_pred             c--ccccccCCCCcCCccccccC----------CCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhc--CcCC
Q 013520          164 E--LLHTTCGTPNYVAPEVLSNR----------GYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINA--AEFS  228 (441)
Q Consensus       164 ~--~~~~~~gt~~Y~aPE~l~~~----------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~--~~~~  228 (441)
                      .  .....+||+.|+|||++.+.          ...+.++|||||||++|+|++|..||..... ......+..  ....
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  260 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  260 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence            1  23456799999999998652          2345789999999999999999999976543 223333322  2345


Q ss_pred             CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      .|...++++.++|.+||+.||++|||++++++||||+....+
T Consensus       261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            566789999999999999999999999999999999876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.9e-46  Score=356.68  Aligned_cols=250  Identities=25%  Similarity=0.427  Sum_probs=204.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...++|++.+.||+|+||.||+|.+.  |+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            35689999999999999999999975  8899999987654322 22356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEcc--------CCCeEEeec
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG---VYHRDLKPENLLLDS--------YGNLKVSDF  153 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~g---i~HrDlkp~NILl~~--------~~~~kL~DF  153 (441)
                      |+||||++|++|.+++. ...+++..+..++.|++.||.|||++|   |+||||||+||+++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999998885 468999999999999999999999999   999999999999986        678999999


Q ss_pred             cccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--CCCCC
Q 013520          154 GLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPF  231 (441)
Q Consensus       154 Gls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~  231 (441)
                      |++......  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+....  .+.|.
T Consensus       161 g~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (271)
T 3dtc_A          161 GLAREWHRT--TKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS  237 (271)
T ss_dssp             CC---------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred             Ccccccccc--cccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence            999765442  2235679999999999977665 489999999999999999999999887766655554443  45566


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+++.+.++|.+||+.||++|||+.++++|
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            789999999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-46  Score=368.34  Aligned_cols=252  Identities=23%  Similarity=0.339  Sum_probs=216.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEE--EEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESV--AMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v--avK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      ...++|++.+.||+|+||.||+|+++.+|..+  |+|.+....  .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~   99 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   99 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence            45689999999999999999999999888865  999886532  223346788999999999 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC
Q 013520           83 KVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~  146 (441)
                      ..|+||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence            9999999999999999997654                699999999999999999999999999999999999999999


Q ss_pred             CeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC
Q 013520          147 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA  225 (441)
Q Consensus       147 ~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~  225 (441)
                      .+||+|||++...... .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            9999999998744322 22234567889999999976655 489999999999999998 99999998888877777655


Q ss_pred             -cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          226 -EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       226 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                       ....|..+++++.++|.+||..||++|||+++++++
T Consensus       258 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          258 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             345666789999999999999999999999999886

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-46  Score=363.02  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=208.8

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA   79 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~   79 (441)
                      .....++|++++.||+|+||.||+|+    +..+|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            45567899999999999999999998    56789999999987542   344577899999999999999999999985


Q ss_pred             e--CCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           80 S--RTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        80 ~--~~~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      .  ...+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            4  456899999999999999997754 5999999999999999999999999999999999999999999999999999


Q ss_pred             ccCCccc---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH----------------H
Q 013520          157 ALPQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----------------T  217 (441)
Q Consensus       157 ~~~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----------------~  217 (441)
                      .......   .......|++.|+|||++.+..+ +.++|||||||++|+|++|..||......                .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            8664432   12234457778999999987766 48999999999999999999998653211                1


Q ss_pred             HHHHh-hcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          218 LYKKI-NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       218 ~~~~i-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ....+ .....+.|..+++++.++|.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            11222 23345667789999999999999999999999999875

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.2e-46  Score=354.16  Aligned_cols=249  Identities=23%  Similarity=0.367  Sum_probs=218.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL   80 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEE
Confidence            4578999999999999999999986 6788999999775432    2568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc-cc
Q 013520           87 ILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG-VE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~-~~  164 (441)
                      ||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            99999999999999875 56899999999999999999999999999999999999999999999999998765432 12


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (441)
                      ......|++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+..+ ....|..+++.+.+++.
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  239 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  239 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             ccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence            2334567889999999976665 489999999999999999 99999998887777777665 34456668999999999


Q ss_pred             HhcCCCCCCCCChHhHhcC
Q 013520          243 KILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~h  261 (441)
                      +||+.||++|||+.+++++
T Consensus       240 ~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          240 HCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCChhhCcCHHHHHHH
Confidence            9999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-46  Score=369.55  Aligned_cols=246  Identities=23%  Similarity=0.298  Sum_probs=209.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~   85 (441)
                      .-++|++.+.||+|+||.||+|++..+|+.||||++......     +.+.+|+.+++.+ +||||+++++++.+....|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   81 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA   81 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence            346899999999999999999999999999999998765322     3577899999999 9999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC-----eEEeeccccccC
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-----LKVSDFGLSALP  159 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~-----~kL~DFGls~~~  159 (441)
                      +||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++...
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999999 9999999986 468999999999999999999999999999999999999998887     999999999865


Q ss_pred             Ccccc-------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC---hHHHHHHhhcCcCCC
Q 013520          160 QQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKKINAAEFSC  229 (441)
Q Consensus       160 ~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~  229 (441)
                      .....       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+   ..+.+..+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            43221       1246789999999999987666 589999999999999999999998743   334455554433333


Q ss_pred             CC-----CCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          230 PF-----WFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       230 ~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +.     .++ ++.+++.+||+.||.+||++++|++
T Consensus       240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            31     244 9999999999999999999998876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.7e-46  Score=368.03  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=208.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----avK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ...++|++.+.||+|+||.||+|++..+|+.+    |+|.+....  .....+.+.+|+.+++.++||||+++++++.+.
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   89 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            45678999999999999999999998887765    666664432  222356789999999999999999999999876


Q ss_pred             CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      . .++++||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus        90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            5 7899999999999999987 4579999999999999999999999999999999999999999999999999997654


Q ss_pred             cccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHh
Q 013520          161 QGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (441)
Q Consensus       161 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (441)
                      ....  ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+ ....|..++.+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             CCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            3222  2234456889999999987666 489999999999999999 99999988877777666554 35667779999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.+++.+||+.||++|||+.+++++
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=369.69  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=212.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   80 (441)
                      ..++|++.+.||+|+||.||+|.+     ..++..||+|++.....  ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            457899999999999999999997     34667899999975432  22346789999999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQG-----------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKP  137 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~-----------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp  137 (441)
                      .+..|+||||+++|+|.+++....                       .+++..+..++.||+.||.|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            999999999999999999997643                       378999999999999999999999999999999


Q ss_pred             CcEEEccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCC
Q 013520          138 ENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETD  214 (441)
Q Consensus       138 ~NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~  214 (441)
                      +|||++.++.+||+|||++........  ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            999999999999999999976543221  2334567889999999977665 489999999999999998 999998866


Q ss_pred             hHHHHHH-hhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCC
Q 013520          215 LPTLYKK-INAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  262 (441)
Q Consensus       215 ~~~~~~~-i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp  262 (441)
                      ....... +..+ ....|..+++++.++|.+||..||.+|||+.++++|.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            5443333 3332 3456677899999999999999999999999999873

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.8e-47  Score=369.25  Aligned_cols=253  Identities=21%  Similarity=0.319  Sum_probs=213.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcE----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~----vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ....++|++++.||+|+||.||+|.+..+++.    ||+|.+.....  ......+.+|+.+++.++||||+++++++. 
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   85 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-   85 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence            34567999999999999999999999888876    66666643321  112245678999999999999999999986 


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      .+..|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++...
T Consensus        86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            45689999999999999999764 57999999999999999999999999999999999999999999999999999876


Q ss_pred             Cccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCH
Q 013520          160 QQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFST  235 (441)
Q Consensus       160 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~  235 (441)
                      ....  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTI  244 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCT
T ss_pred             CcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcH
Confidence            4422  22345668889999999977665 489999999999999999 99999988877777766654 4556677899


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++.++|.+||..||++|||+.++++|
T Consensus       245 ~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          245 DVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999887

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=8.3e-46  Score=357.01  Aligned_cols=251  Identities=20%  Similarity=0.272  Sum_probs=212.4

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      .....++|++.+.||+|+||.||+|.+..+|+.||+|++.....     .+.+.+|+.+++.+ +|+|++++++++.+..
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            34556789999999999999999999999999999999875432     23477899999999 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC-----eEEeecccc
Q 013520           83 KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN-----LKVSDFGLS  156 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~-----~kL~DFGls  156 (441)
                      ..|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 999999998754 5999999999999999999999999999999999999987776     999999999


Q ss_pred             ccCCcccc-------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC---hHHHHHHhhcCc
Q 013520          157 ALPQQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKKINAAE  226 (441)
Q Consensus       157 ~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~  226 (441)
                      ........       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+   .......+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            76544211       2346679999999999987665 589999999999999999999998743   333444443322


Q ss_pred             CC-----CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          227 FS-----CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       227 ~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..     .+..+++++.+++.+||+.||++|||+++|++.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            21     224689999999999999999999999998764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-46  Score=367.78  Aligned_cols=257  Identities=22%  Similarity=0.368  Sum_probs=192.4

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCCcceeEEEEEeCCEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS-IMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...++|++++.||+|+||.||+|.++.+|+.||||++.....  ......+.+|+. +++.++||||+++++++.+.+..
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~   96 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC   96 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence            456899999999999999999999999999999999976532  223345556666 67778999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEccCCCeEEeecccccc
Q 013520           85 YIILEFVTGGELFDKIVH-----QGRLLENDCRRYFQQLIDAVAHCHSK-GVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~aL~~LH~~-gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                      |+||||+.+ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||++..
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999999986 77777763     57899999999999999999999999 999999999999999999999999999976


Q ss_pred             CCccccccccccCCCCcCCccccc----cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh-HHHHHHhhcCcC-CC---
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLS----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDL-PTLYKKINAAEF-SC---  229 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~----~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~-~~~~~~i~~~~~-~~---  229 (441)
                      .... .......||+.|+|||++.    +..+ +.++|||||||++|+|++|..||...+. .+....+..+.. ..   
T Consensus       176 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          176 LVDS-IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             -------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred             cccc-cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence            5443 2233457999999999983    3333 5899999999999999999999976442 122222222221 11   


Q ss_pred             -CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          230 -PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       230 -~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                       +..+++.+.+||.+||+.||++|||++++++||||...
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence             13479999999999999999999999999999999753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.6e-46  Score=363.07  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=215.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   80 (441)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            357999999999999999999985     45788999999976532  23457789999999999 99999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQG------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl  142 (441)
                      .+..|+||||+++|+|.+++....                  .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            999999999999999999998654                  48999999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHH
Q 013520          143 DSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  219 (441)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~  219 (441)
                      +.++.+||+|||++........  ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.......
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            9999999999999986654322  2334567889999999977665 489999999999999998 99999876654333


Q ss_pred             H-HhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          220 K-KINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       220 ~-~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      . .+... ....+..+++++.++|.+||+.||.+|||+++++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            3 33322 334456789999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.2e-45  Score=354.38  Aligned_cols=251  Identities=25%  Similarity=0.366  Sum_probs=211.5

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHH----HHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMV----DQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~----~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ....++|++.+.||+|+||.||+|++..+++.||+|++...........    +.+.+|+.+++.++||||+++++++.+
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (287)
T 4f0f_A           15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN   94 (287)
T ss_dssp             BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred             hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence            4556899999999999999999999999999999999976544332221    678899999999999999999999977


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEccCCC-----eEEee
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGN-----LKVSD  152 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~~~~~-----~kL~D  152 (441)
                      ..  ++||||+++|+|.+.+... ..+++..+..++.|++.||.|||++|  |+||||||+||+++.++.     +||+|
T Consensus        95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            66  6999999999999888654 47999999999999999999999999  999999999999998776     99999


Q ss_pred             ccccccCCccccccccccCCCCcCCccccccC-CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH--HHHhhc--CcC
Q 013520          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL--YKKINA--AEF  227 (441)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~--~~~i~~--~~~  227 (441)
                      ||++.....   ......||+.|+|||++... ...+.++|||||||++|+|++|..||...+....  ...+..  ...
T Consensus       173 fg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  249 (287)
T 4f0f_A          173 FGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP  249 (287)
T ss_dssp             CTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred             CCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence            999875433   23467899999999998432 2335799999999999999999999987654332  333332  234


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ..+..+++++.++|.+||+.||++|||++++++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            566678999999999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.2e-46  Score=356.64  Aligned_cols=252  Identities=20%  Similarity=0.313  Sum_probs=214.5

Q ss_pred             ccccCeEEEe-eeeecCcEEEEEEE--ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            6 RRVAKYEVGR-TIGEGTFAKVRFAQ--NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         6 ~~~~~y~i~~-~LG~G~~g~V~~a~--~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ...++|++.+ .||+|+||.||+|.  +..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            3456899998 99999999999995  456788999999976542 233467899999999999999999999999 567


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ..|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            78999999999999999998888999999999999999999999999999999999999999999999999999765442


Q ss_pred             cc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhH
Q 013520          163 VE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGA  237 (441)
Q Consensus       163 ~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~  237 (441)
                      ..   ......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+. ...|..+++.+
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM  249 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            22   1223456788999999976665 489999999999999999 999999988877777666543 45667799999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .++|.+||+.||++|||+.++++
T Consensus       250 ~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          250 YDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-46  Score=356.46  Aligned_cols=255  Identities=24%  Similarity=0.347  Sum_probs=218.5

Q ss_pred             cccccCeEEEe-eeeecCcEEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            5 TRRVAKYEVGR-TIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         5 ~~~~~~y~i~~-~LG~G~~g~V~~a~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.++||||+++++++ ..
T Consensus         5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~   81 (287)
T 1u59_A            5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA   81 (287)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred             cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC
Confidence            45567899988 9999999999999864  467889999997653  334567899999999999999999999999 55


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      +..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            6799999999999999999654 569999999999999999999999999999999999999999999999999997654


Q ss_pred             cccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCH
Q 013520          161 QGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFST  235 (441)
Q Consensus       161 ~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~  235 (441)
                      ....   ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+. ...|..+++
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  240 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPP  240 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCH
Confidence            3221   1234457889999999976655 489999999999999998 999999888777777766553 456778999


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCC
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPW  263 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~  263 (441)
                      ++.++|.+||+.||++|||+.++++|.+
T Consensus       241 ~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          241 ELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            9999999999999999999999998743

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.9e-46  Score=364.03  Aligned_cols=252  Identities=23%  Similarity=0.399  Sum_probs=217.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEEC-------CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNR-------ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVL   78 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~-------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~   78 (441)
                      ..++|++.+.||+|+||.||+|.+.       .++..||+|++....  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            4579999999999999999999985       457789999997653  233467789999999999 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 013520           79 ASRTKVYIILEFVTGGELFDKIVHQG----------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (441)
Q Consensus        79 ~~~~~~~lv~E~~~gg~L~~~i~~~~----------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl  142 (441)
                      .+.+..|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            99999999999999999999998654                38999999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHH
Q 013520          143 DSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  219 (441)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~  219 (441)
                      +.++.+||+|||++.......  .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+..
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  269 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  269 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence            999999999999997654422  12234457889999999976655 489999999999999999 99999988887777


Q ss_pred             HHhhcCc-CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          220 KKINAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       220 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..+..+. ...+..+++++.++|.+||+.||.+|||+.+++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          270 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7665543 45666789999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.5e-46  Score=362.64  Aligned_cols=253  Identities=21%  Similarity=0.269  Sum_probs=219.0

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ...++|++.+.||+|+||.||+|.++     .+++.||+|++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            34578999999999999999999876     467899999997643  22345678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEE
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ----------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV  150 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL  150 (441)
                      .+..|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence            99999999999999999999753          45789999999999999999999999999999999999999999999


Q ss_pred             eeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-
Q 013520          151 SDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-  226 (441)
Q Consensus       151 ~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-  226 (441)
                      +|||++.......  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. 
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            9999987554322  12234567899999999977665 489999999999999999 899999988877777766554 


Q ss_pred             CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          227 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       227 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ...+..+++.+.++|.+||+.||++|||+.++++|
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            34567799999999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.8e-46  Score=372.38  Aligned_cols=252  Identities=25%  Similarity=0.377  Sum_probs=206.3

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEEC---CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNR---ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ...++|++.+.||+|+||.||+|+++   .++..||||++....  .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            34568999999999999999999986   467789999997643  2334577899999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            9999999999999999997654 699999999999999999999999999999999999999999999999999986654


Q ss_pred             cccc---cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHh
Q 013520          162 GVEL---LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (441)
Q Consensus       162 ~~~~---~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (441)
                      ....   .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ ..+.+..++..
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  278 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAA  278 (373)
T ss_dssp             --------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence            3221   122345778999999987666 489999999999999998 99999988877777766554 34556678999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +.+++.+||+.||++||+++++++
T Consensus       279 l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCcChhhCcCHHHHHH
Confidence            999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-46  Score=362.92  Aligned_cols=252  Identities=21%  Similarity=0.324  Sum_probs=209.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEE----EEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESV----AMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~v----avK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ...++|++++.||+|+||.||+|.+..+++.+    |+|.+....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            45679999999999999999999998888866    555554322  222457788999999999999999999999876


Q ss_pred             CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      . .++++||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            5 7899999999999999976 4579999999999999999999999999999999999999999999999999998654


Q ss_pred             cccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHh
Q 013520          161 QGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTG  236 (441)
Q Consensus       161 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~  236 (441)
                      ....  ......||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+... ..+.|..++++
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  247 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence            4222  2234457888999999987666 489999999999999999 99999998887777766554 35667779999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.++|++||..||.+|||+.++++.
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999874

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3.1e-46  Score=365.77  Aligned_cols=258  Identities=20%  Similarity=0.270  Sum_probs=216.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEE-----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~-----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ...++|++++.||+|+||.||+|+     +..++..||+|++....  .......+.+|+.+++.++||||+++++++.+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  104 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence            456799999999999999999999     55678899999996533  23345678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC---CCeEE
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQG-------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKV  150 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~-------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~---~~~kL  150 (441)
                      ....|+||||++||+|.+++....       .+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||
T Consensus       105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999999998753       48899999999999999999999999999999999999954   46999


Q ss_pred             eeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-c
Q 013520          151 SDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-E  226 (441)
Q Consensus       151 ~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~  226 (441)
                      +|||++.......  .......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  263 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  263 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence            9999986443221  12234568999999999977665 489999999999999998 99999988877777766554 3


Q ss_pred             CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          227 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       227 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ...+..+++.+.++|.+||+.||.+|||++++++|.|+-.
T Consensus       264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            4556678999999999999999999999999999988743

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.6e-46  Score=360.04  Aligned_cols=255  Identities=22%  Similarity=0.325  Sum_probs=207.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....++|++.+.||+|+||.||+|.+..   ++..||+|++...... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3456799999999999999999998765   5568999999765433 33457789999999999999999999999765


Q ss_pred             C-----EEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEE
Q 013520           82 T-----KVYIILEFVTGGELFDKIVH------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKV  150 (441)
Q Consensus        82 ~-----~~~lv~E~~~gg~L~~~i~~------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL  150 (441)
                      +     ..|+||||+++|+|.+++..      ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            5     35999999999999999843      356999999999999999999999999999999999999999999999


Q ss_pred             eeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-c
Q 013520          151 SDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-E  226 (441)
Q Consensus       151 ~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~  226 (441)
                      +|||++.......  .......+++.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+.......+..+ .
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            9999997654322  12234557889999999977665 489999999999999999 99999988877777766554 4


Q ss_pred             CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          227 FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       227 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ...|..+++++.++|.+||..||++|||+.+++++
T Consensus       268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            45667789999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-45  Score=353.57  Aligned_cols=253  Identities=24%  Similarity=0.305  Sum_probs=212.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECC---CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....++|++.+.||+|+||.||+|.+..   ++..||+|++....  .....+.+.+|+.+++.++||||+++++++.++
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   85 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE   85 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence            4556899999999999999999998653   34569999987653  233457789999999999999999999998754


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                       ..|+||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        86 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 -PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             -CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence             568999999999999999765 459999999999999999999999999999999999999999999999999998654


Q ss_pred             cccc-ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhH
Q 013520          161 QGVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (441)
Q Consensus       161 ~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (441)
                      .... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ..+.|..+++.+
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL  243 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred             cccccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence            4221 2334567889999999976665 489999999999999998 99999887776666665544 445667789999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .++|.+||..||++|||+.+++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          244 YTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCchhCcCHHHHHHH
Confidence            999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=377.59  Aligned_cols=258  Identities=24%  Similarity=0.414  Sum_probs=212.0

Q ss_pred             CCcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            1 MKKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      |..+...-++|++.+.||+|+||.||+|++..+|+.||||++.......  ..+.+.+|+.+++.++||||+++++++..
T Consensus         1 m~~~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   78 (396)
T 4eut_A            1 MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEE   78 (396)
T ss_dssp             -CEEECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             CCCCCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence            5667778889999999999999999999999999999999997654332  24667899999999999999999999987


Q ss_pred             CC--EEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE----ccCCCeEEe
Q 013520           81 RT--KVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL----DSYGNLKVS  151 (441)
Q Consensus        81 ~~--~~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl----~~~~~~kL~  151 (441)
                      .+  ..|+||||++||+|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence            65  7899999999999999997643   39999999999999999999999999999999999999    777789999


Q ss_pred             eccccccCCccccccccccCCCCcCCccccccC-------CCCCCCcchhhHhHHHHHHhcCCCCCCCCC----hHHHHH
Q 013520          152 DFGLSALPQQGVELLHTTCGTPNYVAPEVLSNR-------GYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYK  220 (441)
Q Consensus       152 DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~----~~~~~~  220 (441)
                      |||++...... ......+||+.|+|||++.+.       ...+.++|||||||++|+|++|..||....    ..+...
T Consensus       159 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~  237 (396)
T 4eut_A          159 DFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY  237 (396)
T ss_dssp             CGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred             cCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence            99999866543 334567899999999998641       223478999999999999999999996422    233344


Q ss_pred             HhhcCcCC---------------------CC----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          221 KINAAEFS---------------------CP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       221 ~i~~~~~~---------------------~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+..+...                     .+    ..+++.+.++|++||+.||++|||+++++++
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            44333221                     11    1135678899999999999999999998543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.4e-46  Score=361.32  Aligned_cols=253  Identities=23%  Similarity=0.368  Sum_probs=214.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEE-----CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQN-----RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLA   79 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~-----~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~   79 (441)
                      ...++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            3457999999999999999999985     4577899999997653  233456789999999999 7999999999987


Q ss_pred             eCC-EEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 013520           80 SRT-KVYIILEFVTGGELFDKIVHQGR----------------LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (441)
Q Consensus        80 ~~~-~~~lv~E~~~gg~L~~~i~~~~~----------------l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl  142 (441)
                      ..+ ..|+||||++||+|.+++.....                +++..+..++.||+.||.|||++||+||||||+||++
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  181 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence            754 59999999999999999987554                8899999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChH-HH
Q 013520          143 DSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP-TL  218 (441)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~-~~  218 (441)
                      +.++.+||+|||++........  ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.. ..
T Consensus       182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~  260 (316)
T 2xir_A          182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  260 (316)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence            9999999999999976543221  2335568899999999987665 489999999999999998 99999876643 33


Q ss_pred             HHHhhc-CcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          219 YKKINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       219 ~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ...+.. .....|..+++++.++|.+||+.||.+|||++++++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            344433 3455677799999999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8e-46  Score=358.03  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=209.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ....+|++++.||+|+||.||+|+    +..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTED   95 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence            345679999999999999999999    567899999999976542  22356789999999999999999999999876


Q ss_pred             --CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520           82 --TKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus        82 --~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                        ..+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence              679999999999999999954 46799999999999999999999999999999999999999999999999999986


Q ss_pred             CCccc---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC---------------hHHHHH
Q 013520          159 PQQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---------------LPTLYK  220 (441)
Q Consensus       159 ~~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---------------~~~~~~  220 (441)
                      .....   .......||+.|+|||++.+..+. .++|||||||++|+|++|..|+....               ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            65432   233456688899999999776664 89999999999999999999874321               112222


Q ss_pred             Hhh-cCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          221 KIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       221 ~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .+. ......|..+++++.++|.+||+.||++|||++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            222 2345567779999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-45  Score=375.97  Aligned_cols=244  Identities=25%  Similarity=0.444  Sum_probs=212.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC-EE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT-KV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-~~   84 (441)
                      ...++|++.+.||+|+||.||+|.+.  |+.||||+++...     ..+.+.+|+.+|+.++||||+++++++.... .+
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            44678999999999999999999885  7799999997643     2456889999999999999999999987655 79


Q ss_pred             EEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           85 YIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      |+||||+++|+|.+++...+.  +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  342 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence            999999999999999987654  799999999999999999999999999999999999999999999999998754332


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (441)
                         .....+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ ....|..+++++.++
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  418 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDV  418 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ---ccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence               223467889999999987665 489999999999999998 99999987777777666554 456777899999999


Q ss_pred             HHHhcCCCCCCCCChHhHhc
Q 013520          241 IHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (441)
                      |.+||+.||++|||+.++++
T Consensus       419 i~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          419 MKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=359.11  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=206.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE----eCCE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA----SRTK   83 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~----~~~~   83 (441)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.    ....
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            46899999999999999999999999999999998653   2344577899999999999999999999986    3457


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           84 VYIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      .|+||||+.+|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            8999999999999999976    467999999999999999999999999999999999999999999999999998754


Q ss_pred             Ccccc---------ccccccCCCCcCCccccccCCC--CCCCcchhhHhHHHHHHhcCCCCCCCCCh--HHHHHHhh-cC
Q 013520          160 QQGVE---------LLHTTCGTPNYVAPEVLSNRGY--DGSAADVWSCGVILFVLMAGYLPFGETDL--PTLYKKIN-AA  225 (441)
Q Consensus       160 ~~~~~---------~~~~~~gt~~Y~aPE~l~~~~~--~~~~~DiwSlGvil~~ll~g~~Pf~~~~~--~~~~~~i~-~~  225 (441)
                      .....         ......||+.|+|||++.+...  .+.++|||||||++|+|++|..||.....  ......+. ..
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  264 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL  264 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence            32111         1124468999999999875432  35899999999999999999999954111  11111222 22


Q ss_pred             cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          226 EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       226 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..+.+..+++++.++|.+||+.||.+|||+++++++
T Consensus       265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            334445689999999999999999999999999987

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=360.57  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=211.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETG----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ...++|++.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            45678999999999999999999987553    359999997643  233456788999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      +..|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999999999764 579999999999999999999999999999999999999999999999999998654


Q ss_pred             cccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCH
Q 013520          161 QGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFST  235 (441)
Q Consensus       161 ~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~  235 (441)
                      ....   ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ ..+.+..+++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  277 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             cccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCH
Confidence            4221   1223346788999999976665 489999999999999998 99999988877777776654 4556667899


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+.++|.+||+.||++||++.+++++
T Consensus       278 ~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          278 AIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.9e-46  Score=354.06  Aligned_cols=247  Identities=26%  Similarity=0.377  Sum_probs=212.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------   80 (441)
                      ...+|++++.||+|+||.||+|.+..+|+.||+|++....       +.+.+|+.+++.++||||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            3468999999999999999999999999999999997643       245689999999999999999998864      


Q ss_pred             ----------CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCe
Q 013520           81 ----------RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNL  148 (441)
Q Consensus        81 ----------~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~  148 (441)
                                ...+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                      45689999999999999999754  679999999999999999999999999999999999999999999


Q ss_pred             EEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC
Q 013520          149 KVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS  228 (441)
Q Consensus       149 kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~  228 (441)
                      ||+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...  ......+...  .
T Consensus       162 kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~  235 (284)
T 2a19_B          162 KIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--I  235 (284)
T ss_dssp             EECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--C
T ss_pred             EECcchhheecccc-ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--c
Confidence            99999998765543 23345679999999999987665 58999999999999999999987432  2333333333  3


Q ss_pred             CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          229 CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .+..+++.+.++|.+||..||++|||+.++++|+|.-.
T Consensus       236 ~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            45668999999999999999999999999999988744

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=9.7e-46  Score=362.79  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=214.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEe
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGE-----SVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLAS   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~   80 (441)
                      ..++|++.+.||+|+||.||+|.+..+++     .||+|++....  .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            45789999999999999999999977664     79999997643  233457789999999999 89999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ--------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~--------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~  146 (441)
                      .+..|+||||+++|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence            99999999999999999999753              3579999999999999999999999999999999999999999


Q ss_pred             CeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHh-
Q 013520          147 NLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-  222 (441)
Q Consensus       147 ~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i-  222 (441)
                      .+||+|||++........  ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+ 
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  280 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV  280 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence            999999999976543221  2234557889999999977665 489999999999999998 99999876654443333 


Q ss_pred             hc-CcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          223 NA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       223 ~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .. .....|...++.+.++|.+||+.||.+|||+.+++++
T Consensus       281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            22 2344566789999999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.6e-45  Score=351.48  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=207.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEE-EEeCCEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEV-LASRTKVY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~   85 (441)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++......     +.+.+|+.+++.++|++++..+.. .......|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            457899999999999999999999999999999998765422     357899999999998876665554 46778899


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---ccCCCeEEeeccccccCCc
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~  161 (441)
                      +||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999999 9999999974 4579999999999999999999999999999999999999   4889999999999976544


Q ss_pred             ccc-------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC---hHHHHHHhhcCcCCCC-
Q 013520          162 GVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD---LPTLYKKINAAEFSCP-  230 (441)
Q Consensus       162 ~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~-  230 (441)
                      ...       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+   ....+..+.......| 
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            321       2346679999999999987665 589999999999999999999997643   2233444433333333 


Q ss_pred             ----CCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          231 ----FWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       231 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                          ..+|+++.++|.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence                568999999999999999999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.2e-45  Score=382.16  Aligned_cols=249  Identities=26%  Similarity=0.382  Sum_probs=218.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...+|++.+.||+|+||.||+|.++.++..||||++.....    ..+.+.+|+.+|+.++||||+++++++.+...+|+
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            45689999999999999999999999999999999976432    24678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            99999999999999864  458999999999999999999999999999999999999999999999999998654322 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      .......+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+..+.+..+ ....|..+++++.+||
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  452 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  452 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            12234456788999999977665 489999999999999999 99999998877777766544 4456778999999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||+.||++|||+.+|++
T Consensus       453 ~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          453 RACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCcChhHCcCHHHHHH
Confidence            9999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.7e-45  Score=349.57  Aligned_cols=247  Identities=23%  Similarity=0.389  Sum_probs=213.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|.+. ++..||+|++.....    ..+.+.+|+.+++.++||||+++++++.+ +..|+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   84 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence            4578999999999999999999985 567899999976432    23578899999999999999999999864 56899


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           87 ILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... 
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            999999999999997543  79999999999999999999999999999999999999999999999999998654432 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....+..+++++.++|
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  243 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM  243 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHH
Confidence            22234557889999999976555 489999999999999999 99999988877777766554 3455667899999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||..||++|||++++++
T Consensus       244 ~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          244 RLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccChhhCCCHHHHHH
Confidence            9999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-45  Score=350.83  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=211.4

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE-
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV-   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~-   84 (441)
                      -.|++.+.||+|+||.||+|.+..++.   .||+|++....  .....+.+.+|+.+++.++||||+++++++.+.+.. 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            357788999999999999999765544   79999986533  334567889999999999999999999999876665 


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +++|||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999999999976 4568999999999999999999999999999999999999999999999999997554321


Q ss_pred             ----cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhH
Q 013520          164 ----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (441)
Q Consensus       164 ----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (441)
                          .......+|+.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+... ....+..+++.+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence                22345568899999999977665 489999999999999999 66667777766666665544 345667789999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .++|.+||+.||.+|||+.++++.
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999998763

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.1e-45  Score=359.80  Aligned_cols=251  Identities=24%  Similarity=0.373  Sum_probs=212.3

Q ss_pred             cccCeEEEeeeeecCcEEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE--e
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA--S   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~   80 (441)
                      ...+|++++.||+|+||.||+|+    +..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.  +
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            45799999999999999999999    56789999999997643   334567899999999999999999999986  5


Q ss_pred             CCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           81 RTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      ....|+||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            6679999999999999999977 456999999999999999999999999999999999999999999999999999865


Q ss_pred             Ccccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH---------------HHHHH
Q 013520          160 QQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------------TLYKK  221 (441)
Q Consensus       160 ~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------~~~~~  221 (441)
                      .....   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......               .....
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            44221   2334568888999999977665 48999999999999999999998654321               12222


Q ss_pred             hh-cCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          222 IN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       222 i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +. ......+..+++++.++|.+||+.||++|||+++++++
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22 23345667799999999999999999999999999765

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.3e-45  Score=360.85  Aligned_cols=249  Identities=21%  Similarity=0.236  Sum_probs=200.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC---
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT---   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~---   82 (441)
                      ...++|++++.||+|+||.||+|++.  ++.||||++....    .......+|+.+++.++||||+++++++....   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            34578999999999999999999875  7899999996542    22345667999999999999999999998743   


Q ss_pred             -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCcEEEccCCCeEEe
Q 013520           83 -KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK----------GVYHRDLKPENLLLDSYGNLKVS  151 (441)
Q Consensus        83 -~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~----------gi~HrDlkp~NILl~~~~~~kL~  151 (441)
                       .+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.          ||+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence             47999999999999999976 5699999999999999999999999          99999999999999999999999


Q ss_pred             eccccccCCcccc--ccccccCCCCcCCccccccCCC----CCCCcchhhHhHHHHHHhcCCCCCCCCC-----------
Q 013520          152 DFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGY----DGSAADVWSCGVILFVLMAGYLPFGETD-----------  214 (441)
Q Consensus       152 DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~----~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----------  214 (441)
                      |||++........  .....+||+.|+|||++.+...    .+.++|||||||++|+|++|..||.+..           
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999976543222  2345689999999999976322    2357899999999999999999997542           


Q ss_pred             -----hHHHHHHhhcCcCC--CCCC-----CCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          215 -----LPTLYKKINAAEFS--CPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       215 -----~~~~~~~i~~~~~~--~~~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                           .......+......  .+..     .++++.+||.+||+.||++|||+.++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 12222222222111  1111     23459999999999999999999999763

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.1e-45  Score=375.18  Aligned_cols=247  Identities=22%  Similarity=0.417  Sum_probs=214.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+. ++..||||++.....    ..+.+.+|+.+|+.++||||+++++++. ....|+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            4568999999999999999999986 467899999976432    2467889999999999999999999986 567899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~  339 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  339 (454)
T ss_dssp             EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence            99999999999999754  368999999999999999999999999999999999999999999999999998654421 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      .......+++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++++.++|
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  418 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  418 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             eccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            12234456788999999976665 489999999999999999 99999998887777776554 4566777999999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||+.||++|||+++|++
T Consensus       419 ~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          419 MRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHH
Confidence            9999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-45  Score=350.87  Aligned_cols=244  Identities=25%  Similarity=0.437  Sum_probs=205.8

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-CEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-TKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~   84 (441)
                      ...++|++.+.||+|+||.||+|.+.  |+.||+|++....     ..+.+.+|+.+++.++||||+++++++... +..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (278)
T 1byg_A           18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   90 (278)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence            45689999999999999999999874  8899999987543     346788999999999999999999997544 578


Q ss_pred             EEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           85 YIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~--l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      |+||||+++++|.+++...+.  +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            999999999999999976543  899999999999999999999999999999999999999999999999998754432


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (441)
                         .....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..+ ....+..+++.+.++
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred             ---ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHH
Confidence               234468899999999977665 489999999999999998 99999988877777766554 445667799999999


Q ss_pred             HHHhcCCCCCCCCChHhHhc
Q 013520          241 IHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~  260 (441)
                      |.+||..||++|||+.++++
T Consensus       247 i~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-45  Score=354.43  Aligned_cols=253  Identities=25%  Similarity=0.407  Sum_probs=206.2

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC-CCc--EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-TGE--SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ..++|++.+.||+|+||.||+|++.. +++  .||+|++...........+.+.+|+.+++.++||||+++++++.+.. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            45689999999999999999998643 333  68999998765545556788999999999999999999999998765 


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .++||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            89999999999999999764 57999999999999999999999999999999999999999999999999998765442


Q ss_pred             cc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc--CCCCCCCCHh
Q 013520          163 VE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE--FSCPFWFSTG  236 (441)
Q Consensus       163 ~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~  236 (441)
                      ..   ......+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.......+....  .+.+..++++
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  253 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHH
Confidence            21   2234567889999999977665 489999999999999999 999999988877777765543  3455678999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +.++|.+||..||++|||+.+++++
T Consensus       254 l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          254 IYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.4e-45  Score=351.72  Aligned_cols=251  Identities=24%  Similarity=0.289  Sum_probs=209.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEE-EeCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVL-ASRT   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~   82 (441)
                      ...+|++.+.||+|+||.||+|.+..++   ..+|+|.+....  .....+.+.+|+.+++.++||||+++++++ ..++
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  100 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence            4457999999999999999999976433   368999886533  334567889999999999999999999985 5567


Q ss_pred             EEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            88999999999999999976 34689999999999999999999999999999999999999999999999999986544


Q ss_pred             cc----cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCH
Q 013520          162 GV----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFST  235 (441)
Q Consensus       162 ~~----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~  235 (441)
                      ..    .......||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+.......+..+. ...|..+++
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD  259 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence            21    12334567889999999977665 489999999999999999 778888777666665555444 345667899


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .+.++|.+||+.||++|||+.++++
T Consensus       260 ~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          260 PLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=363.44  Aligned_cols=252  Identities=15%  Similarity=0.151  Sum_probs=200.8

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECC---CCcEEEEEEeecccccchH--------HHHHHHHHHHHHHhCCCCCcceeEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRE---TGESVAMKVLAKSTILKHR--------MVDQIKREISIMKIVRHPNIVRLHE   76 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~---~~~~vavK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~hpnIv~l~~   76 (441)
                      .++|++.+.||+|+||.||+|.+..   ++..+|+|++.........        ....+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3589999999999999999999987   7889999999765321111        1123667889999999999999999


Q ss_pred             EEEe----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC--CeEE
Q 013520           77 VLAS----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG--NLKV  150 (441)
Q Consensus        77 ~~~~----~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~--~~kL  150 (441)
                      ++..    ....|+||||+ |++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            9988    78899999999 999999998878999999999999999999999999999999999999999877  9999


Q ss_pred             eeccccccCCccc-------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCC--ChHHHHHH
Q 013520          151 SDFGLSALPQQGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGET--DLPTLYKK  221 (441)
Q Consensus       151 ~DFGls~~~~~~~-------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~--~~~~~~~~  221 (441)
                      +|||++.......       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...  +.......
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            9999997654321       12245689999999999987655 58999999999999999999999652  22222221


Q ss_pred             hhcCcCCCC---------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          222 INAAEFSCP---------FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       222 i~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ........|         ..+++++.++|.+||..||++|||++++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            111111122         2688999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6.5e-45  Score=350.18  Aligned_cols=247  Identities=21%  Similarity=0.286  Sum_probs=203.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEE-EEeCCEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEV-LASRTKVY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~-~~~~~~~~   85 (441)
                      .-++|++.+.||+|+||.||+|++..+++.||+|++......     +.+.+|+.+++.++|++++..+.. +...+..|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            346899999999999999999999999999999987654322     347789999999988776666555 47788899


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---ccCCCeEEeeccccccCCc
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~~  161 (441)
                      +||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999999 9999999975 4679999999999999999999999999999999999999   7889999999999976544


Q ss_pred             ccc-------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---HHHHHHhhcCcCCCC-
Q 013520          162 GVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEFSCP-  230 (441)
Q Consensus       162 ~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~~~-  230 (441)
                      ...       ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.   ......+.......| 
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            221       2345679999999999987665 5899999999999999999999976432   233333333333333 


Q ss_pred             ----CCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          231 ----FWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       231 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                          ..+|+++.++|.+||+.||++|||++++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence                557999999999999999999999999876

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=372.57  Aligned_cols=249  Identities=25%  Similarity=0.406  Sum_probs=196.7

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +|++.+.||+|+||+|+. ....+|+.||||++......      .+.+|+.+++.+ +||||+++++++.+....|+||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            599999999999999764 34467899999999764432      245799999999 7999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---C--CCeEEeeccccccCCcc
Q 013520           89 EFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---Y--GNLKVSDFGLSALPQQG  162 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~--~~~kL~DFGls~~~~~~  162 (441)
                      ||+. |+|.+++.... ..++..+..++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||++......
T Consensus        98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            9996 59999997654 4666678899999999999999999999999999999953   2  35889999999866432


Q ss_pred             c---cccccccCCCCcCCccccccC--CCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcCCC---CCCC
Q 013520          163 V---ELLHTTCGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSC---PFWF  233 (441)
Q Consensus       163 ~---~~~~~~~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~  233 (441)
                      .   ......+||+.|+|||++.+.  ...+.++|||||||++|+|++ |..||...........+.......   +...
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHE  256 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHH
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccc
Confidence            1   233457899999999999742  223568999999999999999 999997665444433332222211   1224


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      +..+.+||.+||+.||++|||++++++||||..
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            566899999999999999999999999999964

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6e-45  Score=352.26  Aligned_cols=234  Identities=31%  Similarity=0.575  Sum_probs=195.3

Q ss_pred             ccccccCeEEE-eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHH-HhCCCCCcceeEEEEEe-
Q 013520            4 QTRRVAKYEVG-RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHPNIVRLHEVLAS-   80 (441)
Q Consensus         4 ~~~~~~~y~i~-~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il-~~l~hpnIv~l~~~~~~-   80 (441)
                      ....+++|.+. +.||+|+||.||+|.++.+|+.||+|++...        ....+|+.++ +.++||||+++++++.. 
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            35567899998 7899999999999999999999999998642        3466888888 56699999999999987 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CCCeEEee
Q 013520           81 ---RTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSD  152 (441)
Q Consensus        81 ---~~~~~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~D  152 (441)
                         ....|+||||++||+|.+++....  .+++..++.++.||+.||.|||++||+||||||+||+++.   ++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               778999999999999999998754  6999999999999999999999999999999999999998   78999999


Q ss_pred             ccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHH----HhhcCcCC
Q 013520          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK----KINAAEFS  228 (441)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~  228 (441)
                      ||++.....                      ..+ +.++|||||||++|+|++|..||...+......    .+......
T Consensus       164 fg~a~~~~~----------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  220 (299)
T 3m2w_A          164 FGFAKETTG----------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  220 (299)
T ss_dssp             CTTCEECTT----------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCS
T ss_pred             ccccccccc----------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcccc
Confidence            999853321                      123 478999999999999999999997765433221    22223333


Q ss_pred             CC----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          229 CP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       229 ~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      .|    ..+++++.++|.+||+.||++|||++|+++||||++..
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          221 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            33    45899999999999999999999999999999998654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.7e-45  Score=351.16  Aligned_cols=251  Identities=22%  Similarity=0.368  Sum_probs=197.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...-++|++.+.||+|+||.||+|++..   .||+|++..... .....+.+.+|+.+++.++||||++++++. .....
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            4556799999999999999999998643   599999976543 334567899999999999999999999965 55678


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc--
Q 013520           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--  161 (441)
                      ++||||++|++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....  
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999999999954 45799999999999999999999999999999999999999999999999999875543  


Q ss_pred             cccccccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhcCcCCC-----CCCC
Q 013520          162 GVELLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSC-----PFWF  233 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~-----~~~~  233 (441)
                      .........||+.|+|||++..  ....+.++|||||||++|+|++|..||...+.. .....+..+....     +..+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence            2223345679999999999862  222347899999999999999999999875544 3444444443322     2357


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ++.+.++|.+||+.||++|||++++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            899999999999999999999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=9.2e-45  Score=369.53  Aligned_cols=248  Identities=28%  Similarity=0.404  Sum_probs=193.4

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +.|.+.+.||+|+||+||.+. ..+|+.||||.+..+.      .+.+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv   87 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA   87 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence            345667899999999998764 4579999999986532      34577899999876 899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC-------------CC
Q 013520           88 LEFVTGGELFDKIVHQGRLL-------ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY-------------GN  147 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~-------e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~-------------~~  147 (441)
                      |||+. |+|.+++.......       +..+..++.||+.||.|||++||+||||||+|||++.+             +.
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence            99996 59999998754332       23456799999999999999999999999999999754             48


Q ss_pred             eEEeeccccccCCcccc----ccccccCCCCcCCcccccc------CCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChH
Q 013520          148 LKVSDFGLSALPQQGVE----LLHTTCGTPNYVAPEVLSN------RGYDGSAADVWSCGVILFVLMA-GYLPFGETDLP  216 (441)
Q Consensus       148 ~kL~DFGls~~~~~~~~----~~~~~~gt~~Y~aPE~l~~------~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~  216 (441)
                      +||+|||++........    .....+||+.|+|||++.+      ....+.++|||||||++|+|++ |..||......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            99999999987654322    2345689999999999965      2334689999999999999999 99999765443


Q ss_pred             HHHHHhhcCcCCCCC-------CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          217 TLYKKINAAEFSCPF-------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       217 ~~~~~i~~~~~~~~~-------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .  ..+..+....+.       .+++++.++|.+||+.||++|||+.++++||||..
T Consensus       247 ~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            3  223333322221       24578999999999999999999999999999964

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.4e-46  Score=363.73  Aligned_cols=252  Identities=21%  Similarity=0.285  Sum_probs=207.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++.+.||+|+||.||+|.+. +|+.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            35679999999999999999999974 68999999886643   224567899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           86 IILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      +||||+++|+|.+++....    .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999999986543    589999999999999999999999999999999999999999999999999875433


Q ss_pred             c--ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHH---H----HHhhcCcC-----
Q 013520          162 G--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL---Y----KKINAAEF-----  227 (441)
Q Consensus       162 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~---~----~~i~~~~~-----  227 (441)
                      .  .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........   .    .....+.+     
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD  270 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence            1  122345569999999999977665 5899999999999999999999976432211   1    11111111     


Q ss_pred             -----CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCC
Q 013520          228 -----SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHP  262 (441)
Q Consensus       228 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp  262 (441)
                           ..++..+..+.+++.+||+.||++|||+.++++|.
T Consensus       271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                 11122456789999999999999999999999873

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.1e-45  Score=364.32  Aligned_cols=251  Identities=14%  Similarity=0.157  Sum_probs=199.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC-----CcEEEEEEeecccccchHHH--------HHHHHHHHHHHhCCCCCccee
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET-----GESVAMKVLAKSTILKHRMV--------DQIKREISIMKIVRHPNIVRL   74 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-----~~~vavK~i~~~~~~~~~~~--------~~~~~Ei~il~~l~hpnIv~l   74 (441)
                      .++|++++.||+|+||.||+|.+..+     ++.||||++...........        ....+|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            34899999999999999999998764     58899999876532111101        123456667778899999999


Q ss_pred             EEEEEeC----CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--cCCC
Q 013520           75 HEVLASR----TKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD--SYGN  147 (441)
Q Consensus        75 ~~~~~~~----~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~--~~~~  147 (441)
                      ++++...    ...|+||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++  .++.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            9998764    5689999999 99999999875 6799999999999999999999999999999999999999  8899


Q ss_pred             eEEeeccccccCCcccc-------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHH
Q 013520          148 LKVSDFGLSALPQQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLY  219 (441)
Q Consensus       148 ~kL~DFGls~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~  219 (441)
                      +||+|||++........       .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ...
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            99999999976543211       1234569999999999987665 58999999999999999999999863322 111


Q ss_pred             HHhhc---Cc-------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          220 KKINA---AE-------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       220 ~~i~~---~~-------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .....   ..       ...+..+++++.+++.+||..||++||++++|++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11100   00       0112457999999999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-44  Score=348.81  Aligned_cols=247  Identities=24%  Similarity=0.387  Sum_probs=197.6

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceeEEEEEe--
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHPNIVRLHEVLAS--   80 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~--   80 (441)
                      ....++|++++.||+|+||.||+|.+  +|+.||||++....      .....+|..++..  ++||||+++++++..  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            45578999999999999999999987  58999999986532      3445567777766  799999999998654  


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEEccCCCeEE
Q 013520           81 --RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH--------SKGVYHRDLKPENLLLDSYGNLKV  150 (441)
Q Consensus        81 --~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH--------~~gi~HrDlkp~NILl~~~~~~kL  150 (441)
                        ....|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||        ++||+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3568999999999999999964 67999999999999999999999        999999999999999999999999


Q ss_pred             eeccccccCCccccc----cccccCCCCcCCccccccCCCC-----CCCcchhhHhHHHHHHhcC----------CCCCC
Q 013520          151 SDFGLSALPQQGVEL----LHTTCGTPNYVAPEVLSNRGYD-----GSAADVWSCGVILFVLMAG----------YLPFG  211 (441)
Q Consensus       151 ~DFGls~~~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~~-----~~~~DiwSlGvil~~ll~g----------~~Pf~  211 (441)
                      +|||++.........    ....+||+.|+|||++.+....     +.++|||||||++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999998754432211    2345899999999999765322     2589999999999999999          88885


Q ss_pred             CCC-----hHHHHHHhhcC--cCCCCC-----CCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          212 ETD-----LPTLYKKINAA--EFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       212 ~~~-----~~~~~~~i~~~--~~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ...     .......+...  ....|.     ..++++.++|.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            532     12222222211  122221     13467999999999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.9e-45  Score=354.27  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=207.5

Q ss_pred             cccCe-EEEeeeeecCcEEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-
Q 013520            7 RVAKY-EVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-   80 (441)
Q Consensus         7 ~~~~y-~i~~~LG~G~~g~V~~a~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-   80 (441)
                      .-++| ++++.||+|+||.||++.    +..+|+.||||++....  .....+.+.+|+.+++.++||||+++++++.+ 
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            44556 999999999999998875    34578999999997653  23346778999999999999999999999987 


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           81 -RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        81 -~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                       ...+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence             4689999999999999999976 45999999999999999999999999999999999999999999999999999866


Q ss_pred             Cccc---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH---------------HHHHH
Q 013520          160 QQGV---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---------------TLYKK  221 (441)
Q Consensus       160 ~~~~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---------------~~~~~  221 (441)
                      ....   .......||+.|+|||++.+..+. .++|||||||++|+|++|..||......               .....
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            5432   123455688899999999876664 8999999999999999999999754321               11122


Q ss_pred             hh-cCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          222 IN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       222 i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +. ......+..+++++.++|++||+.||++|||++++++
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            22 2244566779999999999999999999999999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.4e-45  Score=371.34  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=209.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++......    .+.+.+|+.+|+.++||||+++++++.+ +..|+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            35689999999999999999999875 467999999765422    3568899999999999999999999876 67899


Q ss_pred             EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           87 ILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      ||||+++|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999999999974  3569999999999999999999999999999999999999999999999999998654321 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|..+++.+.++|
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  414 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  414 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             ecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            12234457788999999977665 489999999999999999 99999988877777776554 4566778999999999


Q ss_pred             HHhcCCCCCCCCChHhHhc
Q 013520          242 HKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||+.||++|||++++++
T Consensus       415 ~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          415 CQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHH
Confidence            9999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-45  Score=358.94  Aligned_cols=244  Identities=14%  Similarity=0.160  Sum_probs=202.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC--------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcce------
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET--------GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVR------   73 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~------   73 (441)
                      .++|++.+.||+|+||.||+|++..+        ++.||+|++...        +.+.+|+.+++.++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence            37999999999999999999999874        889999998764        34678999999999999887      


Q ss_pred             ---------eEEEEEe-CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 013520           74 ---------LHEVLAS-RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLL  141 (441)
Q Consensus        74 ---------l~~~~~~-~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NIL  141 (441)
                               +++++.. ....|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred             cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence                     6777776 78899999999 99999999876  78999999999999999999999999999999999999


Q ss_pred             EccCC--CeEEeeccccccCCcccc-------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC
Q 013520          142 LDSYG--NLKVSDFGLSALPQQGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE  212 (441)
Q Consensus       142 l~~~~--~~kL~DFGls~~~~~~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~  212 (441)
                      ++.++  .+||+|||++........       ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence            99988  999999999976544221       1234579999999999987665 5899999999999999999999977


Q ss_pred             CC--hHHHHHHh---hcCcCCCC------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          213 TD--LPTLYKKI---NAAEFSCP------FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       213 ~~--~~~~~~~i---~~~~~~~~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..  ........   .......+      ..+++++.++|.+||+.||++|||++++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            53  22222222   22211111      1368999999999999999999999998763

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=353.36  Aligned_cols=249  Identities=29%  Similarity=0.406  Sum_probs=188.3

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEE--------
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLA--------   79 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~--------   79 (441)
                      .+|++.+.||+|+||.||+|++..+|+.||+|++....   ....+.+.+|+.+++.+. ||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            48999999999999999999999999999999986542   334567889999999995 999999999984        


Q ss_pred             eCCEEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEccCCCeEEeecc
Q 013520           80 SRTKVYIILEFVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLDSYGNLKVSDFG  154 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~~~~~~kL~DFG  154 (441)
                      ....+|++|||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            4456899999996 688888865   567999999999999999999999999  9999999999999999999999999


Q ss_pred             ccccCCcccc------------ccccccCCCCcCCccccc--cCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHH
Q 013520          155 LSALPQQGVE------------LLHTTCGTPNYVAPEVLS--NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK  220 (441)
Q Consensus       155 ls~~~~~~~~------------~~~~~~gt~~Y~aPE~l~--~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~  220 (441)
                      ++........            .....+||+.|+|||++.  .....+.++|||||||++|+|++|..||..........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  263 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN  263 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence            9986544211            112556999999999983  22233579999999999999999999997654433222


Q ss_pred             HhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCC
Q 013520          221 KINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  263 (441)
Q Consensus       221 ~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  263 (441)
                      .  ......+...++.+.++|++||+.||++|||++++++|-+
T Consensus       264 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          264 G--KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             C--cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1  1223344557889999999999999999999999998843

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=348.82  Aligned_cols=243  Identities=29%  Similarity=0.430  Sum_probs=199.4

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++.+.||+|+||.||+|.+.  ++.||+|.+...     ...+.+.+|+.+++.++||||+++++++.+  ..|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence            45679999999999999999999875  789999998643     234678899999999999999999998774  478


Q ss_pred             EEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCcEEEccCCC-eEEeecccccc
Q 013520           86 IILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHS---KGVYHRDLKPENLLLDSYGN-LKVSDFGLSAL  158 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~~LH~---~gi~HrDlkp~NILl~~~~~-~kL~DFGls~~  158 (441)
                      +||||++||+|.+++....   .+++..+..++.|++.||.|||+   +||+||||||+||+++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998655   37889999999999999999999   89999999999999998887 79999999875


Q ss_pred             CCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH--HHHHHhh-cCcCCCCCCCCH
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP--TLYKKIN-AAEFSCPFWFST  235 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~--~~~~~i~-~~~~~~~~~~s~  235 (441)
                      ....   .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||......  .....+. ......+..+++
T Consensus       156 ~~~~---~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (307)
T 2eva_A          156 IQTH---MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPK  231 (307)
T ss_dssp             ------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCH
T ss_pred             cccc---cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCH
Confidence            4432   234569999999999987665 48999999999999999999999764432  2222222 333445567899


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+.++|.+||+.||++|||+++++++
T Consensus       232 ~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          232 PIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.4e-44  Score=380.50  Aligned_cols=247  Identities=20%  Similarity=0.333  Sum_probs=209.5

Q ss_pred             eEE-EeeeeecCcEEEEEEEE--CCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520           11 YEV-GRTIGEGTFAKVRFAQN--RETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        11 y~i-~~~LG~G~~g~V~~a~~--~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +.+ .+.||+|+||.||+|.+  +.+++.||||++..... .....+.+.+|+.+|+.++||||+++++++.. ...|+|
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv  447 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV  447 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence            444 34899999999999954  56778999999976533 23346789999999999999999999999975 458999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc---
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---  164 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~---  164 (441)
                      |||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........   
T Consensus       448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999999999999888999999999999999999999999999999999999999999999999999976544221   


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (441)
                      ......||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+ ....|..+++++.++|.
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  606 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  606 (635)
T ss_dssp             -------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            2234457788999999977666 489999999999999998 99999998888877777655 35567789999999999


Q ss_pred             HhcCCCCCCCCChHhHhc
Q 013520          243 KILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (441)
                      +||+.||++|||++++++
T Consensus       607 ~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          607 LCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHTCSSTTTSCCHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHH
Confidence            999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=359.50  Aligned_cols=243  Identities=15%  Similarity=0.211  Sum_probs=199.3

Q ss_pred             ccCeEEEeeeeecCcEEEEEE-----EECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFA-----QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLA   79 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a-----~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~   79 (441)
                      -++|++.+.||+|+||.||+|     .+..+++.||+|++....      ...+.+|+.+++.++   |+||+++++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            467999999999999999999     467789999999986542      345778888888886   899999999999


Q ss_pred             eCCEEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc----------
Q 013520           80 SRTKVYIILEFVTGGELFDKIVH-----QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS----------  144 (441)
Q Consensus        80 ~~~~~~lv~E~~~gg~L~~~i~~-----~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~----------  144 (441)
                      ..+..|+||||++||+|.+++..     ...+++..+..++.||+.||.|||++||+||||||+|||++.          
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence            99999999999999999999974     467999999999999999999999999999999999999998          


Q ss_pred             -CCCeEEeeccccccCCc--cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHH
Q 013520          145 -YGNLKVSDFGLSALPQQ--GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK  221 (441)
Q Consensus       145 -~~~~kL~DFGls~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~  221 (441)
                       ++.+||+|||+|.....  ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......    
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence             89999999999965432  2234567789999999999988776 489999999999999999999995432210    


Q ss_pred             hhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          222 INAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       222 i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..........+.++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            0001111122457789999999999999999765554443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-45  Score=362.29  Aligned_cols=250  Identities=24%  Similarity=0.296  Sum_probs=201.9

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEE-eCCEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLA-SRTKV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~   84 (441)
                      ..|++.+.||+|+||.||+|.+..++   ..||+|.+....  .....+.+.+|+.+++.++||||+++++++. .++..
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            36899999999999999999875432   468999886532  3345678999999999999999999999864 45688


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999999764 458899999999999999999999999999999999999999999999999997553321


Q ss_pred             ----cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhH
Q 013520          164 ----ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGA  237 (441)
Q Consensus       164 ----~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~  237 (441)
                          .......+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+..+....+..+ ....|..+++.+
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence                11234457889999999987665 489999999999999999 78999877666555555444 345566789999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+++.+||..||++|||+.+++++
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.5e-45  Score=356.34  Aligned_cols=253  Identities=21%  Similarity=0.265  Sum_probs=204.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++........  ...+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            4578999999999999999999864 689999999976543221  2358899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           87 ILEFVTGGELFDKIVHQG----RLLENDCRRYFQQLIDAVAHCHSK---GVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~----~l~e~~~~~~~~qll~aL~~LH~~---gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      ||||+++|+|.+++....    .+++..+..++.|++.||.|||++   ||+||||||+|||++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            999999999999997643    489999999999999999999999   9999999999999999999999999999866


Q ss_pred             Ccc-ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-----hHHHHHHhh----cCcC--
Q 013520          160 QQG-VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-----LPTLYKKIN----AAEF--  227 (441)
Q Consensus       160 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-----~~~~~~~i~----~~~~--  227 (441)
                      ... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....     .......+.    ....  
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (326)
T 3uim_A          185 DYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA  263 (326)
T ss_dssp             CSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTT
T ss_pred             CcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhh
Confidence            442 223445669999999999976665 589999999999999999999995211     111111111    0000  


Q ss_pred             --------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCC
Q 013520          228 --------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPW  263 (441)
Q Consensus       228 --------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~  263 (441)
                              ..+...++.+.+++.+||+.||++|||+.++++|-+
T Consensus       264 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             SSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                    111113467999999999999999999999998854

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=348.40  Aligned_cols=247  Identities=25%  Similarity=0.387  Sum_probs=196.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceeEEEEEeC--
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHPNIVRLHEVLASR--   81 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~--   81 (441)
                      ...++|++++.||+|+||.||+|++.  |+.||||++....      .....+|..++..  ++||||+++++++...  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            34578999999999999999999885  8999999986532      2334455555554  4899999999999887  


Q ss_pred             --CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEccCCCeEEe
Q 013520           82 --TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK--------GVYHRDLKPENLLLDSYGNLKVS  151 (441)
Q Consensus        82 --~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~--------gi~HrDlkp~NILl~~~~~~kL~  151 (441)
                        ...|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++        ||+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              789999999999999999976 5799999999999999999999999        99999999999999999999999


Q ss_pred             eccccccCCccccc----cccccCCCCcCCccccccCCCCCC-----CcchhhHhHHHHHHhcC----------CCCCCC
Q 013520          152 DFGLSALPQQGVEL----LHTTCGTPNYVAPEVLSNRGYDGS-----AADVWSCGVILFVLMAG----------YLPFGE  212 (441)
Q Consensus       152 DFGls~~~~~~~~~----~~~~~gt~~Y~aPE~l~~~~~~~~-----~~DiwSlGvil~~ll~g----------~~Pf~~  212 (441)
                      |||++.........    ....+||+.|+|||++.+..+...     ++|||||||++|+|++|          ..||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            99999755432221    235689999999999976655422     38999999999999999          777754


Q ss_pred             CC-----hHHHHHHhhcC--cCCCCC-----CCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          213 TD-----LPTLYKKINAA--EFSCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       213 ~~-----~~~~~~~i~~~--~~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ..     .......+...  ....|.     .+++++.++|.+||+.||++|||+.++++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            32     12222222222  222232     245679999999999999999999999876

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=377.11  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=208.7

Q ss_pred             ccCeEEEe-eeeecCcEEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGR-TIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~-~LG~G~~g~V~~a~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      .+++.+.+ .||+|+||.||+|.++  .++..||||+++....  ....+.+.+|+.+|+.++||||+++++++.. +.+
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            34566666 8999999999999875  3566899999976532  2245778999999999999999999999976 569


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999999999999999754 469999999999999999999999999999999999999999999999999998654322


Q ss_pred             c---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHH
Q 013520          164 E---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGAT  238 (441)
Q Consensus       164 ~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~  238 (441)
                      .   ......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+....+..+. ...|..+++++.
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  569 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  569 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence            1   1123346689999999977666 489999999999999998 999999988888777776553 566778999999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ++|.+||..||++|||++++++
T Consensus       570 ~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          570 ALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999853

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-44  Score=349.73  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=209.7

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEE----ECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQ----NRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~----~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ....++|++++.||+|+||.||+|+    +..+|+.||+|++...   .....+.+.+|+.+++.++||||+++++++..
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            3456789999999999999999998    4668999999998764   23446789999999999999999999999865


Q ss_pred             CC--EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           81 RT--KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        81 ~~--~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      .+  ..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            44  789999999999999999875 469999999999999999999999999999999999999999999999999998


Q ss_pred             cCCcccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH----------------HH
Q 013520          158 LPQQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP----------------TL  218 (441)
Q Consensus       158 ~~~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----------------~~  218 (441)
                      .......   ......+++.|+|||++.+..+ +.++|||||||++|+|++|..||......                ..
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            6654322   1234457788999999977665 48999999999999999999998643110                11


Q ss_pred             HHHhh-cCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          219 YKKIN-AAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       219 ~~~i~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      ...+. ....+.|..+++++.++|.+||+.||++|||+.++++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            12222 2345566779999999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.1e-44  Score=347.93  Aligned_cols=247  Identities=24%  Similarity=0.343  Sum_probs=203.0

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccc-cchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      |..++.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44568999999999999986  588999999876432 233456789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc--c
Q 013520           90 FVTGGELFDKIVH---QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV--E  164 (441)
Q Consensus        90 ~~~gg~L~~~i~~---~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~--~  164 (441)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......  .
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999999874   3469999999999999999999999999999999999999999999999999987654321  2


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHH----HHHHhhcCcC-----------CC
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEF-----------SC  229 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~-----------~~  229 (441)
                      .....+||+.|+|||++.+.  .+.++|||||||++|+|++|.+||.......    ....+.....           ..
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             cccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence            23456799999999998653  3589999999999999999999997654322    2222221111           11


Q ss_pred             CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          230 PFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       230 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +...++.+.+++.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22245678999999999999999999999864

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-45  Score=386.84  Aligned_cols=258  Identities=27%  Similarity=0.400  Sum_probs=208.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----   80 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----   80 (441)
                      +...++|++.+.||+|+||.||+|.+..+|+.||||++....  .....+.+.+|+.+++.++||||+++++++..    
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~   87 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL   87 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence            456789999999999999999999999999999999987643  33445778999999999999999999998765    


Q ss_pred             --CCEEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC---eEEee
Q 013520           81 --RTKVYIILEFVTGGELFDKIVHQG---RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN---LKVSD  152 (441)
Q Consensus        81 --~~~~~lv~E~~~gg~L~~~i~~~~---~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~---~kL~D  152 (441)
                        .+..|+||||++||+|.+++....   .+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|
T Consensus        88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              677899999999999999998754   6999999999999999999999999999999999999997775   99999


Q ss_pred             ccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHH---------Hh-
Q 013520          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---------KI-  222 (441)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---------~i-  222 (441)
                      ||++...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........+.         .+ 
T Consensus       168 FG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          168 LGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             CCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccc-cccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            9999876543 33456789999999999987666 489999999999999999999997643322110         00 


Q ss_pred             ----hcCcC------CCC----CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          223 ----NAAEF------SCP----FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       223 ----~~~~~------~~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                          ..+..      +.|    ..+++.+.++|.+||.+||++|||++++++||||+.
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence                01111      111    125678999999999999999999999999999964

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.8e-44  Score=372.88  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=214.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++.+.||+|+||.||+|.+.. +..||||++......    .+.+.+|+.+|+.++||||+++++++.+ ..+|+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            45689999999999999999999875 467999999765422    3568899999999999999999999876 67899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      ||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            99999999999999753  569999999999999999999999999999999999999999999999999998664321 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      .......++..|+|||++....+ +.++|||||||+||+|++ |..||.+.+..+....+..+ ....|..+++.+.+||
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  497 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM  497 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            12234456788999999977665 489999999999999999 99999988887777776554 4556778999999999


Q ss_pred             HHhcCCCCCCCCChHhHhcC
Q 013520          242 HKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+||+.||++|||+++|++.
T Consensus       498 ~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          498 CQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999763

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.8e-44  Score=351.72  Aligned_cols=256  Identities=20%  Similarity=0.265  Sum_probs=194.2

Q ss_pred             ccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHH--HHHHHHHhCCCCCcceeEEEEEe-
Q 013520            4 QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK--REISIMKIVRHPNIVRLHEVLAS-   80 (441)
Q Consensus         4 ~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~--~Ei~il~~l~hpnIv~l~~~~~~-   80 (441)
                      ....+++|++++.||+|+||.||+|++  +++.||||++....      .....  .|+..+..++||||+++++.+.. 
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            456789999999999999999999976  68999999997543      12233  34444556899999999986542 


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcEEEccCCC
Q 013520           81 ----RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK---------GVYHRDLKPENLLLDSYGN  147 (441)
Q Consensus        81 ----~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~---------gi~HrDlkp~NILl~~~~~  147 (441)
                          ...+|+||||+++|+|.+++.. ...++..+..++.||+.||.|||++         ||+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence                3468999999999999999976 4568999999999999999999999         9999999999999999999


Q ss_pred             eEEeeccccccCCcc--------ccccccccCCCCcCCccccccC------CCCCCCcchhhHhHHHHHHhcCCCCCCC-
Q 013520          148 LKVSDFGLSALPQQG--------VELLHTTCGTPNYVAPEVLSNR------GYDGSAADVWSCGVILFVLMAGYLPFGE-  212 (441)
Q Consensus       148 ~kL~DFGls~~~~~~--------~~~~~~~~gt~~Y~aPE~l~~~------~~~~~~~DiwSlGvil~~ll~g~~Pf~~-  212 (441)
                      +||+|||++......        .......+||+.|+|||++.+.      ...+.++|||||||++|+|++|..||.. 
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            999999999765431        1223356799999999999752      1224689999999999999999766532 


Q ss_pred             CCh-----------------HHHHHHhh--cCcCCCCCC------CCHhHHHHHHHhcCCCCCCCCChHhH------hcC
Q 013520          213 TDL-----------------PTLYKKIN--AAEFSCPFW------FSTGATSLIHKILDPNPKTRIRIEGI------RKH  261 (441)
Q Consensus       213 ~~~-----------------~~~~~~i~--~~~~~~~~~------~s~~~~~li~~~L~~dP~~R~t~~ei------l~h  261 (441)
                      ...                 ......+.  ......|..      +++++.++|.+||+.||++|||+.|+      +.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            111                 11111111  112223322      33479999999999999999999999      457


Q ss_pred             CCccccC
Q 013520          262 PWFRKNY  268 (441)
Q Consensus       262 p~f~~~~  268 (441)
                      +|-++..
T Consensus       319 ~~~~~~~  325 (336)
T 3g2f_A          319 IWERNKS  325 (336)
T ss_dssp             CCCC---
T ss_pred             HHHhccc
Confidence            7776653

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=351.02  Aligned_cols=252  Identities=21%  Similarity=0.312  Sum_probs=209.3

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++.+.||+|+||.||+|.+..   .+|+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  104 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL  104 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence            4557899999999999999999999864   49999987653222 2234577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc--
Q 013520           85 YIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ--  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~--  161 (441)
                      |+||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.....  
T Consensus       105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            99999999999999997754 699999999999999999999999999999999999998 68999999999875432  


Q ss_pred             ---cccccccccCCCCcCCccccccC--------CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC
Q 013520          162 ---GVELLHTTCGTPNYVAPEVLSNR--------GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP  230 (441)
Q Consensus       162 ---~~~~~~~~~gt~~Y~aPE~l~~~--------~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  230 (441)
                         .........||+.|+|||++...        ...+.++|||||||++|+|++|..||...+.......+..+..+..
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  263 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL  263 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence               11233455699999999998642        2235789999999999999999999998887777776665543322


Q ss_pred             --CCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          231 --FWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       231 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                        ..+++++.++|.+||..||++|||+.++++.
T Consensus       264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence              3478999999999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.6e-43  Score=375.92  Aligned_cols=252  Identities=28%  Similarity=0.393  Sum_probs=213.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCC---CcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ...++|++.+.||+|+||.||+|.+..+   +..||+|.+....  .....+.+.+|+.+++.++||||+++++++. .+
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            3457899999999999999999998654   4579999886533  3344577899999999999999999999985 46


Q ss_pred             EEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            6899999999999999998654 689999999999999999999999999999999999999999999999999986644


Q ss_pred             ccc-ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHH
Q 013520          162 GVE-LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGAT  238 (441)
Q Consensus       162 ~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~  238 (441)
                      ... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+..+....+..+ ..+.|..+++.+.
T Consensus       544 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  622 (656)
T 2j0j_A          544 STYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY  622 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             CcceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            321 2234457789999999977665 489999999999999997 99999998887777776554 4567788999999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++|.+||..||++|||+.+++++
T Consensus       623 ~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999998763

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9.9e-46  Score=363.66  Aligned_cols=244  Identities=20%  Similarity=0.262  Sum_probs=196.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-----chHHHHHHHHHHHHHHhCC---------CCCcc
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-----KHRMVDQIKREISIMKIVR---------HPNIV   72 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------hpnIv   72 (441)
                      ..++|++++.||+|+||.||+|++  +|+.||||++......     .....+.+.+|+.+++.++         ||||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            357899999999999999999998  6899999999876432     2223467889999998885         78888


Q ss_pred             eeEEEEE------------------------------eCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 013520           73 RLHEVLA------------------------------SRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV  122 (441)
Q Consensus        73 ~l~~~~~------------------------------~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL  122 (441)
                      ++.+++.                              ..+.+|+||||+++|++.+.+.. ..+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            7777643                              26889999999999988777754 6789999999999999999


Q ss_pred             HHHH-HCCceecCCCCCcEEEccCC--------------------CeEEeeccccccCCccccccccccCCCCcCCcccc
Q 013520          123 AHCH-SKGVYHRDLKPENLLLDSYG--------------------NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL  181 (441)
Q Consensus       123 ~~LH-~~gi~HrDlkp~NILl~~~~--------------------~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l  181 (441)
                      .||| ++||+||||||+|||++.+|                    .+||+|||+|+.....     ..+||+.|+|||++
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGG
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhh
Confidence            9999 99999999999999999887                    8999999999865432     45899999999999


Q ss_pred             ccCCCCCCCcchhhHhHH-HHHHhcCCCCCCCCCh-HHHHHHhh-cCcCCC------CCCCCHhHHHHHHHhcCCCCCCC
Q 013520          182 SNRGYDGSAADVWSCGVI-LFVLMAGYLPFGETDL-PTLYKKIN-AAEFSC------PFWFSTGATSLIHKILDPNPKTR  252 (441)
Q Consensus       182 ~~~~~~~~~~DiwSlGvi-l~~ll~g~~Pf~~~~~-~~~~~~i~-~~~~~~------~~~~s~~~~~li~~~L~~dP~~R  252 (441)
                      .+..  +.++||||+|++ .++++.|..||.+... ......+. ......      +..+|+++.+||++||+.|    
T Consensus       250 ~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             CCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             cCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            8655  589999998777 7889999999954322 11222222 111111      1136889999999999976    


Q ss_pred             CChHhHh-cCCCcc
Q 013520          253 IRIEGIR-KHPWFR  265 (441)
Q Consensus       253 ~t~~eil-~hp~f~  265 (441)
                       |++|++ +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999995

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-44  Score=364.37  Aligned_cols=249  Identities=17%  Similarity=0.195  Sum_probs=194.7

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCc---------ce-----
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNI---------VR-----   73 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnI---------v~-----   73 (441)
                      ..|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.++| +|.         +.     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            358899999999999999999999999999999875443333345779999999999977 221         11     


Q ss_pred             -------eEEEEEe-----CCEEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 013520           74 -------LHEVLAS-----RTKVYIILEFVTGGELFDKIVH-------QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRD  134 (441)
Q Consensus        74 -------l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~~-------~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrD  134 (441)
                             +..++..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||.|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                   1111111     22467778766 6799988842       23467778888999999999999999999999


Q ss_pred             CCCCcEEEccCCCeEEeeccccccCCccccccccccCCCCcCCccccc---------cCCCCCCCcchhhHhHHHHHHhc
Q 013520          135 LKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS---------NRGYDGSAADVWSCGVILFVLMA  205 (441)
Q Consensus       135 lkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~---------~~~~~~~~~DiwSlGvil~~ll~  205 (441)
                      |||+|||++.+|.+||+|||++......   ....+| +.|+|||++.         .....+.++|||||||++|+|++
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            9999999999999999999998765432   456788 9999999993         22223479999999999999999


Q ss_pred             CCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          206 GYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       206 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      |..||...+.......+.    .....+|+++.+||.+||+.||++|||+.++++||||+.
T Consensus       313 g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             SSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            999998766544333332    223457899999999999999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.4e-43  Score=358.52  Aligned_cols=248  Identities=23%  Similarity=0.314  Sum_probs=207.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLASRTKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~   84 (441)
                      ...++|++++.||+|+||.||+|++..+++.||||++......     ..+.+|+.+++.++| ++|..+..++......
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4567999999999999999999999999999999998765432     247789999999976 5666777777888999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---ccCCCeEEeeccccccCC
Q 013520           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL---DSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl---~~~~~~kL~DFGls~~~~  160 (441)
                      |+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 9999999975 5679999999999999999999999999999999999999   688999999999997654


Q ss_pred             cccc-------ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---HHHHHHhhcCcC---
Q 013520          161 QGVE-------LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEF---  227 (441)
Q Consensus       161 ~~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~---  227 (441)
                      ....       .....+||+.|+|||++.+..+ +.++|||||||+||+|++|..||.+...   ...+..+.....   
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            4221       1236689999999999987665 4899999999999999999999987443   333333332222   


Q ss_pred             --CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          228 --SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       228 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                        ..+..+++++.++|.+||+.||++||++++|++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence              122457899999999999999999999998764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.9e-43  Score=342.57  Aligned_cols=245  Identities=22%  Similarity=0.353  Sum_probs=202.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh--CCCCCcceeEEEEEeCC---
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI--VRHPNIVRLHEVLASRT---   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~---   82 (441)
                      .++|++.+.||+|+||.||+|.+  +|+.||||++....      ...+.+|+.+++.  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            46899999999999999999998  48999999986532      3557788999887  68999999999998876   


Q ss_pred             -EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEEccCCCeEEeec
Q 013520           83 -KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH--------SKGVYHRDLKPENLLLDSYGNLKVSDF  153 (441)
Q Consensus        83 -~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH--------~~gi~HrDlkp~NILl~~~~~~kL~DF  153 (441)
                       ..|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||        ++||+||||||+|||++.++.+||+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             89999999999999999976 57999999999999999999999        899999999999999999999999999


Q ss_pred             cccccCCcccc----ccccccCCCCcCCccccccCCCC-----CCCcchhhHhHHHHHHhcC----------CCCCCCCC
Q 013520          154 GLSALPQQGVE----LLHTTCGTPNYVAPEVLSNRGYD-----GSAADVWSCGVILFVLMAG----------YLPFGETD  214 (441)
Q Consensus       154 Gls~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~~~~-----~~~~DiwSlGvil~~ll~g----------~~Pf~~~~  214 (441)
                      |++........    .....+||+.|+|||++.+....     +.++|||||||++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99976544321    23456799999999999764322     1579999999999999999          78986542


Q ss_pred             -----hHHHHHHhhcCcC--CCCC-----CCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          215 -----LPTLYKKINAAEF--SCPF-----WFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       215 -----~~~~~~~i~~~~~--~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                           .......+.....  ..|.     ..+..+.++|.+||+.||++|||++++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                 2334444433322  2222     123578899999999999999999999876

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-42  Score=332.97  Aligned_cols=225  Identities=14%  Similarity=0.160  Sum_probs=191.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..-++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999999999999999998876655566688999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||++|++|.+++..  ......+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|           
T Consensus       108 lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            99999999999999954  34666788999999999999999999999999999999999999998543           


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHH---HhhcCcCC----CCCCCCHhHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---KINAAEFS----CPFWFSTGAT  238 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~----~~~~~s~~~~  238 (441)
                               |++|        .+.++|||||||++|+|++|..||.+.+......   +.......    .+..+++++.
T Consensus       175 ---------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 ---------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             ---------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             ---------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                     3333        3589999999999999999999998765432110   11111111    2346899999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      ++|.+||+.||++| |++++++.
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHcccCCccC-CHHHHHHH
Confidence            99999999999999 99999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.2e-43  Score=375.31  Aligned_cols=244  Identities=24%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECC-CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRE-TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ....++|++.+.||+|+||.||+|.+.. +|+.||||++....  .......+.+|+.+++.++||||+++++++...+.
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            3455899999999999999999999976 78999999986532  23445678899999999999999999999987665


Q ss_pred             -----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520           84 -----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus        84 -----~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                           .|+||||++|++|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||++. +.+||+|||++..
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~-~~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SCEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC-CcEEEEecccchh
Confidence                 7999999999999988754  7999999999999999999999999999999999999998 4999999999976


Q ss_pred             CCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHH
Q 013520          159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGAT  238 (441)
Q Consensus       159 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~  238 (441)
                      ....    ...+||+.|+|||++.+. + +.++|||||||++|+|++|.+||.+......    .  ........++.+.
T Consensus       231 ~~~~----~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--~~~~~~~~~~~l~  298 (681)
T 2pzi_A          231 INSF----GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--EDDPVLKTYDSYG  298 (681)
T ss_dssp             TTCC----SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C--TTCHHHHHCHHHH
T ss_pred             cccC----CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc----c--ccccccccCHHHH
Confidence            5432    456799999999998654 3 5899999999999999999999865321100    0  0000011467899


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      ++|.+||++||++||+..+.+.|+|+.
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999999999999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=9.5e-37  Score=319.85  Aligned_cols=233  Identities=13%  Similarity=0.105  Sum_probs=165.5

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeeccccc-------chHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCCEEEE
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL-------KHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~-------~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ...+.|++|.+..++....|+.||+|++.+....       .....+.+.+|+.+|+++ .|+||+++++++++++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3467788888888888888999999999875321       122345699999999999 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      ||||++|++|.++|...+++++.   .++.||+.||+|+|++||+||||||+||||+.+|++||+|||+|+.........
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999999998888765   488999999999999999999999999999999999999999998776655556


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcC
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (441)
                      .+.+||+.|+|||++.+..  ..++|+||+|+++++|.++..|+.        ..+..    .|.. ...+..+...+..
T Consensus       397 ~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~--------~~l~~----~~~~-~~~~~~l~~~l~~  461 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL--------YAVWQ----EPVE-RWNFVLLLALFEK  461 (569)
T ss_dssp             HHHHHHHHHHHHHHC-------------------CCCCTTHHHHH--------HHHHT----SCGG-GCSHHHHHHHHHT
T ss_pred             cCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH--------HHhhc----CCCC-CCcHHHHHHHHhC
Confidence            7889999999999997642  468999999999998877655431        11111    1110 1124567777778


Q ss_pred             CCCCCCCChHhHhcCCCcc
Q 013520          247 PNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       247 ~dP~~R~t~~eil~hp~f~  265 (441)
                      .+|..|+.......|+|..
T Consensus       462 ~~~~~~~~~~~~~~~~~~~  480 (569)
T 4azs_A          462 KAKLPSAEQQRGATEQWII  480 (569)
T ss_dssp             GGGSCCGGGSSCCHHHHHH
T ss_pred             CCCCCCCChhhhccchhHH
Confidence            8888888877777777764

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana}

Probab=100.00  E-value=8.3e-34  Score=239.93  Aligned_cols=136  Identities=76%  Similarity=1.188  Sum_probs=119.5

Q ss_pred             CCCccchhhhhhcCCCCCccccCccccccccccceEEeCCCHHHHHHHHHHHHHHcCcEEEeecceEEEEeeccCCCccE
Q 013520          304 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQF  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  383 (441)
                      .|..+|||++|++|+++|||+||+..+.+++|+|||+|+.||++|+++|+++++.+|+.|++++++++++++.+|++|.|
T Consensus         3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~~~vkl~~~~~grkG~l   82 (143)
T 2ehb_D            3 GPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRNFKTRLEGLSSIKAGQL   82 (143)
T ss_dssp             CCEECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESSSEEEEEECCSSGGGCC
T ss_pred             CccccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcCcEEEEEEecCCCcceE
Confidence            57789999999999999999999865555788999999999999999999999999999999888999999999999999


Q ss_pred             EEEEEEEEEcCceEEEEEEecCCCchHHHHHHHHHHHhcccceeccCCc---ccchhhc
Q 013520          384 AVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFYKNFCAKLENIIWKPTEG---SSLLRTM  439 (441)
Q Consensus       384 ~~~~~i~~~~~~~~~v~f~~~~Gd~le~~~~~~~~~~~l~~~v~~~~~~---~~~~~~~  439 (441)
                      ++.+|||||+|+++||||||++||++||+++|++|++.|+||||+|++.   +.++|++
T Consensus        83 ~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~diV~~~~~~~~~~~~~~~~  141 (143)
T 2ehb_D           83 AVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLENIIWRATEGIPKSEILRTI  141 (143)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHSTTTBCC--------------
T ss_pred             EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhhcceecCCCCCchhhhhhhh
Confidence            9999999999999999999999999999999999999999999999874   6667665

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana}

Probab=99.96  E-value=2e-30  Score=214.02  Aligned_cols=121  Identities=26%  Similarity=0.410  Sum_probs=106.0

Q ss_pred             CCCccchhhhhhcCCCCCccccCccccccccccceEEeCCCHHHHHHHHHHHHHHcCcEEEeecceEEEEeeccCCCccE
Q 013520          304 GPLLMNAFEMITLSQGLNLAALFDRRQDYVKRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRNYKTRLEGVSANKTGQF  383 (441)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  383 (441)
                      +|..+|||++|++|+++|||+||+.. ...+++|||+|+.||++|+++|+++++++|+.|++++++   +++.++++|.|
T Consensus         2 ~~~~lNAFdiIs~S~g~dLSgLFe~~-~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~~---~~~~~g~kG~l   77 (123)
T 2zfd_B            2 GARRMNAFDIISGSPGFNLSGLFGDA-RKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKETW---GMKIEGQKGNF   77 (123)
T ss_dssp             --CCCCHHHHHHTSTTSSSGGGGGGG-CSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEETT---EEEEEEGGGTE
T ss_pred             CcccccHHHHHHHCcCCCchHhcCcc-cccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCCc---cccccCCCccE
Confidence            56779999999999999999999753 234789999999999999999999999999999988876   66678999999


Q ss_pred             EEEEEEEEEcCceEEEEEEecCCCchHHHHHH-HHHHHhcccceec
Q 013520          384 AVVLEVFEVAPSLFMVDVRKAAGDTLEYHKFY-KNFCAKLENIIWK  428 (441)
Q Consensus       384 ~~~~~i~~~~~~~~~v~f~~~~Gd~le~~~~~-~~~~~~l~~~v~~  428 (441)
                      ++.+|||||+|+++||||+|++||++||++|| ++|++.|+||||.
T Consensus        78 ~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~diV~~  123 (123)
T 2zfd_B           78 AMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFVELVHE  123 (123)
T ss_dssp             EEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHHHTBC-
T ss_pred             EEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHhhhhcC
Confidence            99999999999999999999999999999966 5899999999984

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.2e-29  Score=264.46  Aligned_cols=185  Identities=20%  Similarity=0.247  Sum_probs=145.7

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH-----HHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR-----MVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      ..+.||+|+||.||+|.  ..+..+++|...........     ..+.+.+|+.+++.++||||+++..+....+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            45689999999999994  45788999987554332221     235589999999999999999666666677778999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc---
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE---  164 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~---  164 (441)
                      |||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.  ++||+|||+++.......   
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999999865        6689999999999999999999999999999998  999999999987655322   


Q ss_pred             ----ccccccCCCCcCCcccccc--CCCCCCCcchhhHhHHHHHHhcCCCCC
Q 013520          165 ----LLHTTCGTPNYVAPEVLSN--RGYDGSAADVWSCGVILFVLMAGYLPF  210 (441)
Q Consensus       165 ----~~~~~~gt~~Y~aPE~l~~--~~~~~~~~DiwSlGvil~~ll~g~~Pf  210 (441)
                          ...+.+||+.|+|||++..  .+|. ..+|+||..+-..+-..++-+|
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence                1246789999999999975  4554 6789999988888777766665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.1e-26  Score=220.62  Aligned_cols=146  Identities=18%  Similarity=0.250  Sum_probs=117.4

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch---------------HHHHHHHHHHHHHHhCCCCCcceeE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---------------RMVDQIKREISIMKIVRHPNIVRLH   75 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~hpnIv~l~   75 (441)
                      |.+++.||+|+||.||+|.+ .+|+.||+|++........               .....+.+|+.+++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            34449999999999999999 8899999999965332111               13467889999999998  4 5666


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           76 EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        76 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                      +++.. +..|+||||++||+|.+ +.      ......++.|++.||.|||++||+||||||+|||++ +|.+||+|||+
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~  238 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ  238 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence            65544 45699999999999987 42      234567999999999999999999999999999999 99999999999


Q ss_pred             cccCCccccccccccCCCCcCCccccc
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLS  182 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~  182 (441)
                      |.             .+..|.|||++.
T Consensus       239 a~-------------~~~~~~a~e~l~  252 (282)
T 1zar_A          239 SV-------------EVGEEGWREILE  252 (282)
T ss_dssp             CE-------------ETTSTTHHHHHH
T ss_pred             Ce-------------ECCCCCHHHHHH
Confidence            86             244678999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=2.3e-22  Score=189.96  Aligned_cols=140  Identities=19%  Similarity=0.240  Sum_probs=110.1

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcE--EEEEEeecccccc---------------------hHHHHHHHHHHHHHHhCC
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILK---------------------HRMVDQIKREISIMKIVR   67 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~--vavK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~   67 (441)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++......-                     ......+.+|+.+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999999778999  9999975532110                     011246889999999998


Q ss_pred             CCCc--ceeEEEEEeCCEEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCc
Q 013520           68 HPNI--VRLHEVLASRTKVYIILEFVTG-G----ELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPEN  139 (441)
Q Consensus        68 hpnI--v~l~~~~~~~~~~~lv~E~~~g-g----~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH-~~gi~HrDlkp~N  139 (441)
                      |+++  ..+++.    +..|+||||+.+ |    .|.+....   .++..+..++.|++.||.||| +.||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8764  444432    356899999942 3    66665432   345678899999999999999 9999999999999


Q ss_pred             EEEccCCCeEEeeccccccC
Q 013520          140 LLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus       140 ILl~~~~~~kL~DFGls~~~  159 (441)
                      ||++.  .++|+|||+|...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99998  9999999998644

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=6e-19  Score=174.40  Aligned_cols=139  Identities=18%  Similarity=0.239  Sum_probs=102.8

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc---------------chHHH----HHHHHHHHHHHhCCCCCc
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---------------KHRMV----DQIKREISIMKIVRHPNI   71 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~---------------~~~~~----~~~~~Ei~il~~l~hpnI   71 (441)
                      |++++.||.|++|.||+|.+. +|+.||||+++.....               .....    -...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999985 6999999997643211               00001    123467888888855544


Q ss_pred             ceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCC----
Q 013520           72 VRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGN----  147 (441)
Q Consensus        72 v~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~----  147 (441)
                      .-..-+....  .++||||++|++|..+.      ..+.+..++.||+.+|.+||+.||+||||||.|||++++|.    
T Consensus       176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            3222222222  37999999999886532      22345678999999999999999999999999999998773    


Q ss_pred             ------eEEeecccccc
Q 013520          148 ------LKVSDFGLSAL  158 (441)
Q Consensus       148 ------~kL~DFGls~~  158 (441)
                            +.|+||+-+-.
T Consensus       248 ~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECCCTTCEE
T ss_pred             cccccceEEEEeCCccc
Confidence                  89999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.43  E-value=7.7e-13  Score=124.33  Aligned_cols=141  Identities=15%  Similarity=0.108  Sum_probs=114.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~   85 (441)
                      .++.|++...+|.|+.+.||++...  +..+++|+........   ...+.+|+.+++.+. +..+.+++++..+.+..|
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            4678999999999999999999753  6889999986532111   235889999999984 678889999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS--------------------------------------  127 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~--------------------------------------  127 (441)
                      +||||++|.+|.+.+.     +......++.++..+|..||+                                      
T Consensus        87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999999876531     223345788899999999998                                      


Q ss_pred             ---------------------CCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          128 ---------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       128 ---------------------~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                                           .+++|+|++|.||++++++.+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 458999999999999875556799999765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.29  E-value=1.2e-11  Score=115.35  Aligned_cols=136  Identities=15%  Similarity=0.164  Sum_probs=101.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC--cceeEEEEEeCCEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN--IVRLHEVLASRTKV   84 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~   84 (441)
                      .+..|.+....+.|..+.||++.. .+|..+++|+.....      ...+.+|+.+++.+.+.+  +.+++.+....+..
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            355677766556777799999964 467789999875531      134778999999885434  56789988888889


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG-----------------------------------  129 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~g-----------------------------------  129 (441)
                      |+||||++|.+|.  .   ....   ...++.++...|..||+..                                   
T Consensus        91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999999998883  1   1111   2356677777778887643                                   


Q ss_pred             -----------------------ceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          130 -----------------------VYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       130 -----------------------i~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                                             ++|+|++|.||+++.++.+.|+|||.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   9999999999999876666799999875

>3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A

Probab=99.20  E-value=1.7e-10  Score=94.57  Aligned_cols=84  Identities=13%  Similarity=0.187  Sum_probs=75.3

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEEeeccCCCccEEEEEEEEEEc-CceEEEEEEecCCCchHHHHHHHH
Q 013520          340 VSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  417 (441)
Q Consensus       340 ~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~f~~~~Gd~le~~~~~~~  417 (441)
                      +|+.+|++|+..|++++..+|+.++.++ |.++.........+.+.|.+||+++. +++++|+|+|.+||.+.|++++.+
T Consensus        34 TS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~~  113 (120)
T 3ose_A           34 TSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK  113 (120)
T ss_dssp             EECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHHH
Confidence            7889999999999999999999998766 78888765444567899999999996 899999999999999999999999


Q ss_pred             HHHhcc
Q 013520          418 FCAKLE  423 (441)
Q Consensus       418 ~~~~l~  423 (441)
                      |.+.|+
T Consensus       114 il~~L~  119 (120)
T 3ose_A          114 IANELK  119 (120)
T ss_dssp             HHHHCC
T ss_pred             HHHHhc
Confidence            998875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.18  E-value=7.6e-11  Score=116.02  Aligned_cols=143  Identities=20%  Similarity=0.322  Sum_probs=108.1

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEee--cccccchHHHHHHHHHHHHHHhCC--CCCcceeEEEEEeC---CE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLA--KSTILKHRMVDQIKREISIMKIVR--HPNIVRLHEVLASR---TK   83 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~---~~   83 (441)
                      ..-++.|+.|.++.||++...  +..+++|+..  .....  .....+.+|+.+++.+.  +..+.+++.++.+.   +.
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            345778999999999998864  4678888775  32211  12346888999999996  45688899888776   45


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS------------------------------------  127 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~------------------------------------  127 (441)
                      .|+||||++|..+.+..  ...++......++.++..+|..||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            89999999998775421  1346788888999999999999997                                    


Q ss_pred             ----------------------CCceecCCCCCcEEEccCCC--eEEeeccccccC
Q 013520          128 ----------------------KGVYHRDLKPENLLLDSYGN--LKVSDFGLSALP  159 (441)
Q Consensus       128 ----------------------~gi~HrDlkp~NILl~~~~~--~kL~DFGls~~~  159 (441)
                                            .+++|+|++|.||+++.++.  +.|+||+.+..-
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                  36899999999999997764  689999988643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=1.2e-10  Score=112.04  Aligned_cols=184  Identities=17%  Similarity=0.222  Sum_probs=123.1

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCC--cceeEEEEEeCC---EEEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPN--IVRLHEVLASRT---KVYII   87 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpn--Iv~l~~~~~~~~---~~~lv   87 (441)
                      ++.++.|....||++.     ..+++|+....     .....+.+|..+++.+ .+..  +.+++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4569999999999863     46889986432     2356789999999988 3333  445554443333   35899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS----------------------------------------  127 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~----------------------------------------  127 (441)
                      ||+++|..|.+...  ..++.++...++.|+...+..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988875433  356777888888888888888886                                        


Q ss_pred             ------------------CCceecCCCCCcEEEcc--CCCeEEeeccccccCCccccccccccCCCCcCCcccccc--CC
Q 013520          128 ------------------KGVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN--RG  185 (441)
Q Consensus       128 ------------------~gi~HrDlkp~NILl~~--~~~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~--~~  185 (441)
                                        ..++|+|++|.||+++.  .+.+.|+||+.+..-....+........ .-.+|+....  ..
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHH
Confidence                              13699999999999998  4568899999886533221111110000 0022332110  11


Q ss_pred             CCC-----------CCcchhhHhHHHHHHhcCCCCC
Q 013520          186 YDG-----------SAADVWSCGVILFVLMAGYLPF  210 (441)
Q Consensus       186 ~~~-----------~~~DiwSlGvil~~ll~g~~Pf  210 (441)
                      |..           ...+.|++|.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            111           1258999999999999998876

>1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1

Probab=98.77  E-value=1.5e-08  Score=82.92  Aligned_cols=84  Identities=12%  Similarity=0.138  Sum_probs=73.3

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEe-ecceEEEEeeccCCCccEEEEEEEEEEc-CceEEEEEEecCCCchHHHHHHHH
Q 013520          340 VSRQPAQVILSNIEAVAESLSLKVHT-RNYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  417 (441)
Q Consensus       340 ~s~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~f~~~~Gd~le~~~~~~~  417 (441)
                      +|+.+|++|+..|..+++++|+.++. +.|.++........+..+.|.+||+++. .+++.|+|+|.+||.+.|++++.+
T Consensus        34 TSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~  113 (126)
T 1v5s_A           34 GSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK  113 (126)
T ss_dssp             CCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHHHHHHH
T ss_pred             ecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHHHHHHH
Confidence            67889999999999999999999986 4577777644333456799999999994 689999999999999999999999


Q ss_pred             HHHhcc
Q 013520          418 FCAKLE  423 (441)
Q Consensus       418 ~~~~l~  423 (441)
                      |...|+
T Consensus       114 IL~eLk  119 (126)
T 1v5s_A          114 IANELK  119 (126)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            999988

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.65  E-value=5.5e-07  Score=86.41  Aligned_cols=134  Identities=19%  Similarity=0.245  Sum_probs=95.5

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---CcceeEEEEE-eCCEEEEEEe
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP---NIVRLHEVLA-SRTKVYIILE   89 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp---nIv~l~~~~~-~~~~~~lv~E   89 (441)
                      ++.++.|....||++     |..+++|+...     ......+.+|..+|+.+.+.   .+.+++.+.. ..+..|++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            566899999999988     56788898422     23456789999999999642   3566666664 4556789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK-----------------------------------------  128 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~-----------------------------------------  128 (441)
                      +++|..+.+..-  ..++......+..|+...|..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988865321  2344555555555555555555542                                         


Q ss_pred             -------------------CceecCCCCCcEEEcc---CCCe-EEeeccccccC
Q 013520          129 -------------------GVYHRDLKPENLLLDS---YGNL-KVSDFGLSALP  159 (441)
Q Consensus       129 -------------------gi~HrDlkp~NILl~~---~~~~-kL~DFGls~~~  159 (441)
                                         .++|+|++|.||+++.   ++.+ .|+||+.+..-
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                               3599999999999987   4665 89999987653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.64  E-value=4.8e-07  Score=84.75  Aligned_cols=138  Identities=13%  Similarity=0.192  Sum_probs=100.2

Q ss_pred             CeEEEeeeeecCcE-EEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEEEE
Q 013520           10 KYEVGRTIGEGTFA-KVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus        10 ~y~i~~~LG~G~~g-~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .|+.. .+..|..| .||+......+..+.+|+-...      ....+.+|...|+.+. +--+.+++.+..+.+..|+|
T Consensus        26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv   98 (272)
T 4gkh_A           26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL   98 (272)
T ss_dssp             TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence            34433 34445444 7999888777788999976432      3456889999999884 44477889999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS----------------------------------------  127 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~----------------------------------------  127 (441)
                      ||+++|.++.+.....    ......+..++...|.-||+                                        
T Consensus        99 me~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A           99 TTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             EECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             EEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            9999998887665431    22233455666666666664                                        


Q ss_pred             ------------------CCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520          128 ------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus       128 ------------------~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                                        ..++|+|+.|.||+++.++.+-|+||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              1279999999999999876677999998753

>4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A*

Probab=98.47  E-value=1.9e-06  Score=67.97  Aligned_cols=85  Identities=15%  Similarity=0.274  Sum_probs=72.3

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEee-cceEEEEeeccCCCccEEEEEEEEEEcCceEEEEEEecCCC--------ch
Q 013520          339 FVSRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGD--------TL  409 (441)
Q Consensus       339 f~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~f~~~~Gd--------~l  409 (441)
                      .-|...|.+++..|..|++.+|+.|+.- .|.+++..........+.+.+++|++.++.+++||++..||        .+
T Consensus        12 IrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~   91 (106)
T 4eai_A           12 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTI   91 (106)
T ss_dssp             EEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHH
T ss_pred             ceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcE
Confidence            4678889999999999999999999875 58888875533334568899999999999999999999995        89


Q ss_pred             HHHHHHHHHHHhcc
Q 013520          410 EYHKFYKNFCAKLE  423 (441)
Q Consensus       410 e~~~~~~~~~~~l~  423 (441)
                      +|-++|.++...|.
T Consensus        92 ~F~d~ca~li~~la  105 (106)
T 4eai_A           92 EFFEMCANLIKILA  105 (106)
T ss_dssp             HHHHHHHHHHHHCC
T ss_pred             eHHHHHHHHHHHHh
Confidence            99999998877764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.34  E-value=1.3e-06  Score=86.80  Aligned_cols=81  Identities=15%  Similarity=0.191  Sum_probs=51.1

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccc-cch---HHHHHHHHHHHHHHhCCC--CC-cceeEEEEEeCCEEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI-LKH---RMVDQIKREISIMKIVRH--PN-IVRLHEVLASRTKVY   85 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~h--pn-Iv~l~~~~~~~~~~~   85 (441)
                      -.+.||.|..+.||++....++..+++|....... ...   ...+.+..|..+++.+..  |. +.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            46789999999999998766678899998643211 000   012456779999888742  33 4455543  344568


Q ss_pred             EEEeccCCCC
Q 013520           86 IILEFVTGGE   95 (441)
Q Consensus        86 lv~E~~~gg~   95 (441)
                      +|||+++|..
T Consensus       112 lvmE~l~g~~  121 (397)
T 2olc_A          112 TVMEDLSHLK  121 (397)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEEeCCCcc
Confidence            9999998743

>2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C*

Probab=98.28  E-value=1.1e-05  Score=67.32  Aligned_cols=73  Identities=15%  Similarity=0.255  Sum_probs=59.1

Q ss_pred             eEEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEEeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchH
Q 013520          338 RFVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  410 (441)
Q Consensus       338 rf~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~f~~~~Gd~le  410 (441)
                      ..-|..+|.+|+..|..|++.+|+.|++.+ |.+++..........+.|.+++|++.++.+||||++..||+.|
T Consensus         8 GIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e   81 (157)
T 2v8q_A            8 GIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   81 (157)
T ss_dssp             SEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             ecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence            345778899999999999999999999765 8888876543323357899999999999999999999999865

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.12  E-value=4.1e-05  Score=73.79  Aligned_cols=135  Identities=12%  Similarity=0.116  Sum_probs=78.1

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceeEE------EEEeCCEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--HPNIVRLHE------VLASRTKVY   85 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~------~~~~~~~~~   85 (441)
                      ++.|+.|..+.||++...  +..+++|+.....       ..+..|..+++.+.  .-.+.+++.      +....+..|
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~  107 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF  107 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence            455677788999998763  3458999886521       23445566665552  112333332      123567889


Q ss_pred             EEEeccCCCChH--------------HHHHh-cCCC--C-----------HH--------H-------------------
Q 013520           86 IILEFVTGGELF--------------DKIVH-QGRL--L-----------EN--------D-------------------  110 (441)
Q Consensus        86 lv~E~~~gg~L~--------------~~i~~-~~~l--~-----------e~--------~-------------------  110 (441)
                      ++|||++|..+.              ..+.. ...+  +           ..        .                   
T Consensus       108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  187 (346)
T 2q83_A          108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL  187 (346)
T ss_dssp             EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred             EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence            999999986431              11111 1111  1           00        0                   


Q ss_pred             ----HHHHHHHHHHHHHHHH-------------HCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          111 ----CRRYFQQLIDAVAHCH-------------SKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       111 ----~~~~~~qll~aL~~LH-------------~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                          ...+..++-.++.+|+             ..+++|+|++|.||+++.++.+.|+||+.+.
T Consensus       188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                1111223334566665             2579999999999999888899999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.11  E-value=3.5e-06  Score=82.25  Aligned_cols=85  Identities=9%  Similarity=0.196  Sum_probs=56.4

Q ss_pred             EEEeee-eecCcEEEEEEEEC--C----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C--CCcceeEEEEEeC
Q 013520           12 EVGRTI-GEGTFAKVRFAQNR--E----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-H--PNIVRLHEVLASR   81 (441)
Q Consensus        12 ~i~~~L-G~G~~g~V~~a~~~--~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~   81 (441)
                      ...+.| +.|....+|++...  .    ++..+++|+..............+.+|+.+++.+. +  -.+.+++.+..+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345778 89999999988653  1    15678999865432000000134678999998884 3  3577788877655


Q ss_pred             ---CEEEEEEeccCCCCh
Q 013520           82 ---TKVYIILEFVTGGEL   96 (441)
Q Consensus        82 ---~~~~lv~E~~~gg~L   96 (441)
                         +..|+||||++|..+
T Consensus       103 ~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTTSSCEEEEECCCCBCC
T ss_pred             CccCCceEEEEecCCCCh
Confidence               356899999998654

>2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A*

Probab=98.06  E-value=2.5e-05  Score=66.11  Aligned_cols=77  Identities=14%  Similarity=0.233  Sum_probs=61.2

Q ss_pred             cccceEEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEEeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchH
Q 013520          334 KRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  410 (441)
Q Consensus       334 ~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~f~~~~Gd~le  410 (441)
                      +..-..-|..+|.+|+..|..|++.+|+.|++.+ |.++++.........+.|.+++|++.++.+||||++..||+-|
T Consensus        18 kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e   95 (173)
T 2y8l_A           18 AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   95 (173)
T ss_dssp             EEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             eeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCccc
Confidence            3444457888999999999999999999999765 7888876533223357899999999999999999999999866

>4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster}

Probab=98.06  E-value=5.4e-05  Score=61.27  Aligned_cols=73  Identities=15%  Similarity=0.253  Sum_probs=55.7

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEee-cceEEEEeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchHHH
Q 013520          340 VSRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLEYH  412 (441)
Q Consensus       340 ~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~f~~~~Gd~le~~  412 (441)
                      -|...|.+|+..|..|++.+|+.|+.- .|.+++..........+.+.+++|++.++.+++||++..||..|..
T Consensus        13 rS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~   86 (130)
T 4eag_A           13 RSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQG   86 (130)
T ss_dssp             CCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC-------
T ss_pred             ecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcchhhcc
Confidence            456779999999999999999999876 4888887554443445779999999999999999999999976644

>2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A*

Probab=98.00  E-value=1.8e-05  Score=65.58  Aligned_cols=90  Identities=18%  Similarity=0.214  Sum_probs=71.2

Q ss_pred             cccceEEeCCCHHHHHHHHHHHHHHcCcEEEee---------c-ceEEEEeeccCC-----CccEEEEEEEEEEcCceEE
Q 013520          334 KRQTRFVSRQPAQVILSNIEAVAESLSLKVHTR---------N-YKTRLEGVSANK-----TGQFAVVLEVFEVAPSLFM  398 (441)
Q Consensus       334 ~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~---------~-~~~~~~~~~~~~-----~~~l~~~~~i~~~~~~~~~  398 (441)
                      +..-..-|..+|.+|+..|..|++.+|+.|+.-         + |.|++....+..     ...+.|.+++|++.++.+|
T Consensus        12 kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YL   91 (137)
T 2qrd_A           12 KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFM   91 (137)
T ss_dssp             CCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEE
T ss_pred             ccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEE
Confidence            333344677899999999999999999999865         4 678877543321     2347799999999999999


Q ss_pred             EEEEecCCC---------------c----hHHHHHHHHHHHhcc
Q 013520          399 VDVRKAAGD---------------T----LEYHKFYKNFCAKLE  423 (441)
Q Consensus       399 v~f~~~~Gd---------------~----le~~~~~~~~~~~l~  423 (441)
                      |||++..|+               .    ++|-.+|.+|...|.
T Consensus        92 lDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa  135 (137)
T 2qrd_A           92 LDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  135 (137)
T ss_dssp             EEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             EEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHh
Confidence            999999999               5    889999888877664

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.80  E-value=0.00026  Score=67.81  Aligned_cols=76  Identities=12%  Similarity=0.200  Sum_probs=61.1

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCCcceeEEEEEeCCEEEEEEe
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR---HPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      -.+.|+.|....+|++..  ++..+++|+....      ....+..|...|+.+.   ...+.+++.+....+..|+|||
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme  111 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE  111 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence            357799999999999975  4678889987542      2456888999998883   3678889998888889999999


Q ss_pred             ccCCCCh
Q 013520           90 FVTGGEL   96 (441)
Q Consensus        90 ~~~gg~L   96 (441)
                      |++|..+
T Consensus       112 ~l~G~~~  118 (312)
T 3jr1_A          112 ALNKSKN  118 (312)
T ss_dssp             CCCCCCC
T ss_pred             eccCCCC
Confidence            9998754

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.76  E-value=0.00015  Score=72.42  Aligned_cols=77  Identities=13%  Similarity=0.116  Sum_probs=45.7

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeeccc--ccch----HHHHHHHHHHHHHH-hCCCCCcceeEEEEEeCCEEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKST--ILKH----RMVDQIKREISIMK-IVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~--~~~~----~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      -++.||.|..+.||++..  ++..++||......  ....    .....++.|+..+. ......+.+++.+.  ....+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            467899999999999964  46789999422110  0000    01122333333322 22334567777665  56678


Q ss_pred             EEEecc-CC
Q 013520           86 IILEFV-TG   93 (441)
Q Consensus        86 lv~E~~-~g   93 (441)
                      +||||+ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 77

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.71  E-value=0.00028  Score=63.33  Aligned_cols=121  Identities=14%  Similarity=0.075  Sum_probs=81.3

Q ss_pred             ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccccCC
Q 013520           95 ELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCH-SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGT  172 (441)
Q Consensus        95 ~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH-~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~~gt  172 (441)
                      +|.+.+.. +.+++|+++|.++.|.+.+|.-+- ++.-..+=+.|..|++..+|++-+.+ +.+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            67888865 568999999999999999987762 22222444567999999999988864 1111            123


Q ss_pred             CCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcCC
Q 013520          173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       173 ~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~  247 (441)
                      ..+.|||...  ...+.+.=|+|||+++|.-+--..|=                 .-+..+|+++.+||..|...
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence            3577888863  22346778999999999887644331                 22345899999999999866

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.65  E-value=0.00016  Score=68.82  Aligned_cols=135  Identities=13%  Similarity=0.110  Sum_probs=76.4

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEe
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILE   89 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E   89 (441)
                      +.-++.|+.|....+|++      ..+++|+.......    .-...+|+.+++.+...++ .+++..  +...-++++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            333788999999999998      45888987643111    1123468888877743222 455554  3334578999


Q ss_pred             cc-CCCChHHHH------------------HhcC-CCC-----HHHHHHHHHH--------------HHHHHHHHH----
Q 013520           90 FV-TGGELFDKI------------------VHQG-RLL-----ENDCRRYFQQ--------------LIDAVAHCH----  126 (441)
Q Consensus        90 ~~-~gg~L~~~i------------------~~~~-~l~-----e~~~~~~~~q--------------ll~aL~~LH----  126 (441)
                      |+ +|.++....                  .... .++     ......+..+              +...+..+.    
T Consensus        88 ~i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~  167 (301)
T 3dxq_A           88 YIAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALA  167 (301)
T ss_dssp             CCTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHH
T ss_pred             ecCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHH
Confidence            99 664442110                  0000 010     1111111111              111122111    


Q ss_pred             H----CCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520          127 S----KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus       127 ~----~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                      .    ..++|+|+.|.||+ ..++.+.++||..+..
T Consensus       168 ~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          168 AHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             SSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             hcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            1    24799999999999 5667899999998764

>3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A

Probab=97.65  E-value=0.00033  Score=59.93  Aligned_cols=84  Identities=13%  Similarity=0.228  Sum_probs=67.7

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEee----cceEEEEeeccC---------CCccEEEEEEEEEEcCceEEEEEEecC
Q 013520          339 FVSRQPAQVILSNIEAVAESLSLKVHTR----NYKTRLEGVSAN---------KTGQFAVVLEVFEVAPSLFMVDVRKAA  405 (441)
Q Consensus       339 f~s~~~~~~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~~~---------~~~~l~~~~~i~~~~~~~~~v~f~~~~  405 (441)
                      .-|...|.+|+..|..|++.+|+.|++-    .|.++++...+.         ....+.|.+++|++.++.+||||+ ..
T Consensus        55 IrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDfk-~~  133 (179)
T 3t4n_A           55 IRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDFK-FD  133 (179)
T ss_dssp             EEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEEE-EE
T ss_pred             cccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEEE-ec
Confidence            4678899999999999999999999874    467888743111         113478999999999999999999 78


Q ss_pred             C----------------------CchHHHHHHHHHHHhcc
Q 013520          406 G----------------------DTLEYHKFYKNFCAKLE  423 (441)
Q Consensus       406 G----------------------d~le~~~~~~~~~~~l~  423 (441)
                      |                      .++.|-.++.+|...|.
T Consensus       134 G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa  173 (179)
T 3t4n_A          134 GWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELA  173 (179)
T ss_dssp             EEECC----------------CCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccCCccHHHHHHHHHHHHH
Confidence            8                      67889999888877664

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.40  E-value=0.0017  Score=61.10  Aligned_cols=79  Identities=9%  Similarity=0.027  Sum_probs=55.5

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC---CCcceeEEEEEeCCEEEE
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH---PNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h---pnIv~l~~~~~~~~~~~l   86 (441)
                      +..-++.+|.|..+.||++... +|+.|.+|+-.......   ...+..|...|+.+..   -.+.+++.+  +.  -++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l   87 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL   87 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence            4566788999999999999864 68899999865432211   2357789999998842   234555554  22  378


Q ss_pred             EEeccCCCCh
Q 013520           87 ILEFVTGGEL   96 (441)
Q Consensus        87 v~E~~~gg~L   96 (441)
                      +|||..++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.32  E-value=0.00073  Score=65.00  Aligned_cols=136  Identities=15%  Similarity=0.161  Sum_probs=72.2

Q ss_pred             EeeeeecCcEE-EEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-CCcceeEEEEEeCCEEEEEEec
Q 013520           14 GRTIGEGTFAK-VRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-H-PNIVRLHEVLASRTKVYIILEF   90 (441)
Q Consensus        14 ~~~LG~G~~g~-V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-pnIv~l~~~~~~~~~~~lv~E~   90 (441)
                      ++.|+.|+... +|+... .+|..+++|.......      ..+..|+.+++.+. + -.+.+++.+....+  +++||+
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~   93 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED   93 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence            45676665555 666653 2356777775433210      23456778777774 2 23566666533333  789999


Q ss_pred             cCCCChHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHH
Q 013520           91 VTGGELFDKIVHQ--------------------------GRLLENDCR-------R-YF------------QQLIDAVAH  124 (441)
Q Consensus        91 ~~gg~L~~~i~~~--------------------------~~l~e~~~~-------~-~~------------~qll~aL~~  124 (441)
                      +.+..+.+.+...                          ..+......       . +.            ..+...+..
T Consensus        94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  173 (333)
T 3csv_A           94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ  173 (333)
T ss_dssp             CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred             CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            9876665444211                          011121110       0 00            011112222


Q ss_pred             H------HHCCceecCCCCCcEEEccC----CCeEEeecccccc
Q 013520          125 C------HSKGVYHRDLKPENLLLDSY----GNLKVSDFGLSAL  158 (441)
Q Consensus       125 L------H~~gi~HrDlkp~NILl~~~----~~~kL~DFGls~~  158 (441)
                      +      +...++|||+.|.||+++.+    +.+.|+||+.+..
T Consensus       174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3      23479999999999999874    6799999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.31  E-value=0.0015  Score=62.35  Aligned_cols=139  Identities=12%  Similarity=0.111  Sum_probs=78.3

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC--cceeEE------EEEeCCE
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN--IVRLHE------VLASRTK   83 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn--Iv~l~~------~~~~~~~   83 (441)
                      .-++.|+.|....+|++... +| .+++|+.....     ..+.+..|..+++.+...+  +.+++.      +....+.
T Consensus        25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~   97 (322)
T 2ppq_A           25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR   97 (322)
T ss_dssp             EEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred             eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence            34567888998999999764 33 68899886521     1234567888877763211  233331      1223467


Q ss_pred             EEEEEeccCCCChH--------------HHHHhc-CCC--------CHHHHHHHH---------------HHHHHHHHHH
Q 013520           84 VYIILEFVTGGELF--------------DKIVHQ-GRL--------LENDCRRYF---------------QQLIDAVAHC  125 (441)
Q Consensus        84 ~~lv~E~~~gg~L~--------------~~i~~~-~~l--------~e~~~~~~~---------------~qll~aL~~L  125 (441)
                      .+++++|++|..+.              ..+... ..+        ........+               ..+...+..+
T Consensus        98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l  177 (322)
T 2ppq_A           98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL  177 (322)
T ss_dssp             EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred             EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence            89999999986431              011110 011        101001100               1133445555


Q ss_pred             HH-------CCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          126 HS-------KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       126 H~-------~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      ++       .+++|+|+.|.|||++.++.+.++||+.+.
T Consensus       178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            52       369999999999999876556899998765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.22  E-value=0.0006  Score=67.15  Aligned_cols=136  Identities=19%  Similarity=0.200  Sum_probs=82.3

Q ss_pred             EeeeeecCcEEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVY   85 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~   85 (441)
                      ++.|..|....+|++....       ++..+++|+.....    .....+.+|..+++.+. +.-..++++.+.+    .
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g  126 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G  126 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence            4567788888999998642       35789999863311    12345668999998884 3334667666543    2


Q ss_pred             EEEeccCCCChHH----------HH----H---hc----C-CC--CHHHHHHHHHHHHH-------------------HH
Q 013520           86 IILEFVTGGELFD----------KI----V---HQ----G-RL--LENDCRRYFQQLID-------------------AV  122 (441)
Q Consensus        86 lv~E~~~gg~L~~----------~i----~---~~----~-~l--~e~~~~~~~~qll~-------------------aL  122 (441)
                      +||||++|..|..          .+    .   ..    + ..  ...++.+|..++-.                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            8999999855421          11    1   00    1 11  13455666655422                   23


Q ss_pred             HHHH----H----CCceecCCCCCcEEEccC----CCeEEeeccccc
Q 013520          123 AHCH----S----KGVYHRDLKPENLLLDSY----GNLKVSDFGLSA  157 (441)
Q Consensus       123 ~~LH----~----~gi~HrDlkp~NILl~~~----~~~kL~DFGls~  157 (441)
                      ..|.    .    ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            3332    2    258999999999999876    789999998875

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.19  E-value=0.0012  Score=66.12  Aligned_cols=74  Identities=12%  Similarity=0.127  Sum_probs=50.1

Q ss_pred             EEeeeeecCcEEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKV   84 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~   84 (441)
                      -++.|+.|....||++....       .+..+++|+.....  .   ...+.+|..+++.+...+ ..++++.+.  +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            35678899999999998653       25789999874321  1   134457999998884333 366776554  2  


Q ss_pred             EEEEeccCCCC
Q 013520           85 YIILEFVTGGE   95 (441)
Q Consensus        85 ~lv~E~~~gg~   95 (441)
                      .+|+||++|..
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            28999998743

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.18  E-value=0.0018  Score=61.93  Aligned_cols=75  Identities=15%  Similarity=0.121  Sum_probs=47.6

Q ss_pred             eeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--CcceeEEE-----EEeCCEEEEE
Q 013520           15 RTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP--NIVRLHEV-----LASRTKVYII   87 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hp--nIv~l~~~-----~~~~~~~~lv   87 (441)
                      ..|+ |....||++.. .+|+.+++|+......    ....+..|..+++.+...  .+++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 78889998764 3466799999864321    124566788888777321  23334332     2335677899


Q ss_pred             EeccCCCC
Q 013520           88 LEFVTGGE   95 (441)
Q Consensus        88 ~E~~~gg~   95 (441)
                      |++++|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998854

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.00  E-value=0.0011  Score=64.72  Aligned_cols=74  Identities=15%  Similarity=0.121  Sum_probs=45.1

Q ss_pred             EeeeeecCcEEEEEEEECC--------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEE
Q 013520           14 GRTIGEGTFAKVRFAQNRE--------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKV   84 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~   84 (441)
                      ++.|+.|....+|++....        .+..+++|+......   . ......|..+++.+...+ ..++++..  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            5678888889999998653        136889998754321   1 112357888888884333 45666554  22  


Q ss_pred             EEEEeccCCCC
Q 013520           85 YIILEFVTGGE   95 (441)
Q Consensus        85 ~lv~E~~~gg~   95 (441)
                      +++|||++|..
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            68999998854

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.89  E-value=0.006  Score=58.91  Aligned_cols=31  Identities=19%  Similarity=0.328  Sum_probs=27.5

Q ss_pred             CCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520          128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus       128 ~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                      .+++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3689999999999999888999999987764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.85  E-value=0.01  Score=59.85  Aligned_cols=76  Identities=18%  Similarity=0.191  Sum_probs=49.5

Q ss_pred             EEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc-ceeEEEEEeCCEEEEEEecc
Q 013520           13 VGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI-VRLHEVLASRTKVYIILEFV   91 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~lv~E~~   91 (441)
                      -++.|+.|....+|++.....+..+++|+......   ... ...+|..+++.+...++ .++++.+.  +.  .||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEee
Confidence            35678899999999998765457889998744211   011 12579999999865444 56777663  32  499999


Q ss_pred             CCCCh
Q 013520           92 TGGEL   96 (441)
Q Consensus        92 ~gg~L   96 (441)
                      +|..|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.80  E-value=0.027  Score=56.06  Aligned_cols=76  Identities=13%  Similarity=0.129  Sum_probs=49.5

Q ss_pred             EEeeeeecCcEEEEEEEECCC-------CcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEE
Q 013520           13 VGRTIGEGTFAKVRFAQNRET-------GESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKV   84 (441)
Q Consensus        13 i~~~LG~G~~g~V~~a~~~~~-------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~   84 (441)
                      -++.|..|....+|++.....       +..+++++.....   .. .-...+|..+++.+. +.-..++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            356778888899999987521       5789999864422   11 112357888888884 33345666543  22  


Q ss_pred             EEEEeccCCCCh
Q 013520           85 YIILEFVTGGEL   96 (441)
Q Consensus        85 ~lv~E~~~gg~L   96 (441)
                      +.|+||++|..|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            689999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.50  E-value=0.35  Score=47.49  Aligned_cols=29  Identities=31%  Similarity=0.450  Sum_probs=24.9

Q ss_pred             ceecCCCCCcEEE------ccCCCeEEeecccccc
Q 013520          130 VYHRDLKPENLLL------DSYGNLKVSDFGLSAL  158 (441)
Q Consensus       130 i~HrDlkp~NILl------~~~~~~kL~DFGls~~  158 (441)
                      ++|+|+.+.|||+      ++++.+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3457799999998764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.45  E-value=2.2  Score=38.00  Aligned_cols=82  Identities=18%  Similarity=0.152  Sum_probs=63.6

Q ss_pred             CCCCcceeEEEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCceecCCCCCcEEEccC
Q 013520           67 RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA-HCHSKGVYHRDLKPENLLLDSY  145 (441)
Q Consensus        67 ~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~-~LH~~gi~HrDlkp~NILl~~~  145 (441)
                      .||++  -..+-.+++.+.+.++.-+++.-+..++   .++....++++.+|+.... ++  ..-+|--+.|+||++|.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            68888  4555578888888888776766677663   5778888888888877555 33  445777899999999999


Q ss_pred             CCeEEeeccc
Q 013520          146 GNLKVSDFGL  155 (441)
Q Consensus       146 ~~~kL~DFGl  155 (441)
                      +.+++.-.|+
T Consensus       121 ~~p~i~hRGi  130 (219)
T 4ano_A          121 LEPFFLHVGV  130 (219)
T ss_dssp             CCEEESCCEE
T ss_pred             CcEEEEEcCC
Confidence            9999987776

>3ost_A Serine/threonine-protein kinase KCC4; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.69A {Saccharomyces cerevisiae} PDB: 3osm_A

Probab=82.23  E-value=18  Score=28.95  Aligned_cols=85  Identities=14%  Similarity=0.171  Sum_probs=60.6

Q ss_pred             eEEeCCCHHHHHHHHHHHHH---HcCcE-EEeecceEEEEeeccCCC----ccEEEEEEEEEEcCce-EEEEEEecCCCc
Q 013520          338 RFVSRQPAQVILSNIEAVAE---SLSLK-VHTRNYKTRLEGVSANKT----GQFAVVLEVFEVAPSL-FMVDVRKAAGDT  408 (441)
Q Consensus       338 rf~s~~~~~~~~~~l~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~----~~l~~~~~i~~~~~~~-~~v~f~~~~Gd~  408 (441)
                      -+++..+..++...|...++   ..|+. ++.......+.+.....|    ....|.|+|++=. +. .+|-|++.+|-.
T Consensus        28 ~l~t~v~k~~~~~~L~~LL~~Wk~yGlkdv~~D~~~~~ItGrvs~~N~L~LRsv~F~i~i~~~g-n~~Slv~f~q~rGSs  106 (128)
T 3ost_A           28 EIHAKIPEKRLYEGLHKLLEGWKQYGLKNLVFNITNMIITGKLVNDSILFLRSTLFEIMVLPNG-DGRSLIKFNKKTGST  106 (128)
T ss_dssp             CEEESSCHHHHHHHHHHHHHTCGGGTEEEEEEETTTTEEEEEECCCCSSSCCCEEEEEEEEECS-TTCEEEEEEESSSCH
T ss_pred             EEEEecCHHHHHHHHHHHHHHHHHhCccceEecCCCCEEEEEEccccccccceeEEEEEEeecC-CceEEEEEEEeeccH
Confidence            46888999999999988885   66653 444433323333212212    4468999999755 66 999999999999


Q ss_pred             hHHHHHHHHHHHhcc
Q 013520          409 LEYHKFYKNFCAKLE  423 (441)
Q Consensus       409 le~~~~~~~~~~~l~  423 (441)
                      --|++++..|..-|+
T Consensus       107 stf~klv~eiEkVL~  121 (128)
T 3ost_A          107 KTLTKLATEIQIILQ  121 (128)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHH
Confidence            999999988776553

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	441
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-89
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-85
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-83
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-81
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-80
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-79
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-79
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-79
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-78
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-77
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-77
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-76
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-75
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-75
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-74
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-74
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-72
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-72
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-72
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-71
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-70
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-69
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-66
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-65
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-65
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-65
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-64
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-62
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-62
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-61
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-60
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-60
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-60
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-59
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-58
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	8e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-57
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-56
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-55
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-53
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-45
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-39
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-22
d1ul7a_	102	d.129.6.1 (A:) Map/microtubule affinity-regulating	1e-13

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  269 bits (690), Expect = 4e-89
 Identities = 94/258 (36%), Positives = 148/258 (57%), Gaps = 3/258 (1%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +E+GR +G+G F  V  A+ +++   +A+KVL K+ + K  +  Q++RE+ I   +RHP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI+RL+      T+VY+ILE+   G ++ ++    +  E     Y  +L +A+++CHSK 
Sbjct: 67  NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+KPENLLL S G LK++DFG S           T CGT +Y+ PE++  R +D  
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRMHD-E 183

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
             D+WS GV+ +  + G  PF        YK+I+  EF+ P + + GA  LI ++L  NP
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 243

Query: 250 KTRIRIEGIRKHPWFRKN 267
             R  +  + +HPW   N
Sbjct: 244 SQRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  260 bits (666), Expect = 2e-85
 Identities = 100/265 (37%), Positives = 150/265 (56%), Gaps = 7/265 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +++ +T+GEG + +V+ A NR T E+VA+K++     +     + IK+EI I K++ H 
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHE 63

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           N+V+ +         Y+ LE+ +GGELFD+I     + E D +R+F QL+  V + H  G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYD 187
           + HRD+KPENLLLD   NLK+SDFGL+ + +      LL+  CGT  YVAPE+L  R + 
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 188 GSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKI 244
               DVWSCG++L  ++AG LP+   +D    Y      +     W    +   +L+HKI
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYN 269
           L  NP  RI I  I+K  W+ K   
Sbjct: 244 LVENPSARITIPDIKKDRWYNKPLK 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  254 bits (650), Expect = 7e-83
 Identities = 81/270 (30%), Positives = 139/270 (51%), Gaps = 9/270 (3%)

Query: 4   QTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM 63
           + +R   ++ G+ +GEG+F+ V  A+   T    A+K+L K  I+K   V  + RE  +M
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
             + HP  V+L+       K+Y  L +   GEL   I   G   E   R Y  +++ A+ 
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALE 122

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGTPNYVAPEVL 181
           + H KG+ HRDLKPEN+LL+   +++++DFG + +     +        GT  YV+PE+L
Sbjct: 123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
           + +     ++D+W+ G I++ L+AG  PF   +   +++KI   E+  P  F   A  L+
Sbjct: 183 TEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241

Query: 242 HKILDPNPKTRIRIE------GIRKHPWFR 265
            K+L  +   R+  E       ++ HP+F 
Sbjct: 242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  252 bits (644), Expect = 1e-81
 Identities = 69/288 (23%), Positives = 123/288 (42%), Gaps = 9/288 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +   R IG G+F  V FA++    E VA+K ++ S    +     I +E+  ++ +RHP
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           N ++           ++++E+  G       VH+  L E +        +  +A+ HS  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL--SNRGYD 187
           + HRD+K  N+LL   G +K+ DFG +++        ++  GTP ++APEV+   + G  
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQY 191

Query: 188 GSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW--FSTGATSLIHKIL 245
               DVWS G+    L     P    +  +    I   E        +S    + +   L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251

Query: 246 DPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEY 293
              P+ R   E + KH +  +   P    +  +   D V    D+++Y
Sbjct: 252 QKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE-LDNLQY 298

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  248 bits (635), Expect = 1e-80
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 11/267 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +E+   +G+G F KV  AQN+ET    A KV+          ++    EI I+    HPN
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPN 70

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSKG 129
           IV+L +       ++I++EF  GG +   ++   R L E+  +   +Q +DA+ + H   
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL----SNRG 185
           + HRDLK  N+L    G++K++DFG+SA   + ++   +  GTP ++APEV+    S   
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---FSCPFWFSTGATSLIH 242
                ADVWS G+ L  +     P  E +   +  KI  +E    + P  +S+     + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYN 269
           K L+ N   R     + +HP+   + N
Sbjct: 251 KCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  248 bits (633), Expect = 2e-79
 Identities = 82/331 (24%), Positives = 151/331 (45%), Gaps = 18/331 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y++   +G G F  V     R TG + A K +           + +++EI  M ++RHP
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHP 83

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSK 128
            +V LH+      ++ +I EF++GGELF+K+  +  ++ E++   Y +Q+   + H H  
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143

Query: 129 GVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
              H DLKPEN++  +     LK+ DFGL+A      + +  T GT  + APEV   +  
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIH 242
            G   D+WS GV+ ++L++G  PFG  +     + + + +++         S      I 
Sbjct: 203 -GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 261

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQSENKV 302
           K+L  +P TR+ I    +HPW      P     + ++       + D I+   +     +
Sbjct: 262 KLLLADPNTRMTIHQALEHPWLTPGNAP---GRDSQIPSSRYTKIRDSIKTKYDAWPEPL 318

Query: 303 GGPLLMNAFEMITLSQGLNLA---ALFDRRQ 330
                ++ +  +   +    +   A +DR +
Sbjct: 319 PPLGRISNYSSLRKHRPQEYSIRDAFWDRSE 349

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  246 bits (628), Expect = 2e-79
 Identities = 69/261 (26%), Positives = 125/261 (47%), Gaps = 8/261 (3%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IG+G    V  A +  TG+ VA++ +      +    + I  EI +M+  ++P
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKNP 77

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV   +      ++++++E++ GG L D +V +  + E       ++ + A+   HS  
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRD+K +N+LL   G++K++DFG  A          T  GTP ++APEV++ + Y   
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-P 195

Query: 190 AADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA--EFSCPFWFSTGATSLIHKILD 246
             D+WS G++   ++ G  P+  E  L  LY        E   P   S      +++ LD
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 247 PNPKTRIRIEGIRKHPWFRKN 267
            + + R   + + +H + +  
Sbjct: 256 MDVEKRGSAKELLQHQFLKIA 276

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  246 bits (630), Expect = 6e-79
 Identities = 73/276 (26%), Positives = 132/276 (47%), Gaps = 12/276 (4%)

Query: 3   KQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISI 62
           KQ      Y++   +G G F  V     + TG     K +     L       +K EISI
Sbjct: 23  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISI 79

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDA 121
           M  + HP ++ LH+    + ++ +ILEF++GGELFD+I  +  ++ E +   Y +Q  + 
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 122 VAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPE 179
           + H H   + H D+KPEN++ ++    ++K+ DFGL+       E++  T  T  + APE
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPE 198

Query: 180 VLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFST 235
           ++          D+W+ GV+ +VL++G  PF   D     + +   ++          S 
Sbjct: 199 IVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257

Query: 236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
            A   I  +L   P+ R+ +    +HPW + +++ +
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (621), Expect = 5e-78
 Identities = 78/258 (30%), Positives = 138/258 (53%), Gaps = 3/258 (1%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHP 69
           + + + +G+G+F KV  A+ ++T +  A+K L K  +L    V+    E  ++ +   HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            +  +     ++  ++ ++E++ GG+L   I    +   +    Y  ++I  +   HSKG
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + +RDLK +N+LLD  G++K++DFG+      G    +T CGTP+Y+APE+L  + Y+  
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-H 182

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
           + D WS GV+L+ ++ G  PF   D   L+  I       P W    A  L+ K+    P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 242

Query: 250 KTRIRIEG-IRKHPWFRK 266
           + R+ + G IR+HP FR+
Sbjct: 243 EKRLGVRGDIRQHPLFRE 260

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (611), Expect = 3e-77
 Identities = 79/269 (29%), Positives = 133/269 (49%), Gaps = 14/269 (5%)

Query: 7   RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           R   YEV  TIG G++ + +  + +  G+ +  K L   ++ +      +  E+++++ +
Sbjct: 2   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLREL 60

Query: 67  RHPNIVRLHEVLASRT--KVYIILEFVTGGELFDKIVHQGR----LLENDCRRYFQQLID 120
           +HPNIVR ++ +  RT   +YI++E+  GG+L   I    +    L E    R   QL  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 121 AVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
           A+  CH +      V HRDLKP N+ LD   N+K+ DFGL+ +            GTP Y
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYY 180

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF-SCPFWFS 234
           ++PE ++   Y+   +D+WS G +L+ L A   PF       L  KI   +F   P+ +S
Sbjct: 181 MSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239

Query: 235 TGATSLIHKILDPNPKTRIRIEGIRKHPW 263
                +I ++L+     R  +E I ++P 
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  239 bits (612), Expect = 7e-77
 Identities = 103/275 (37%), Positives = 157/275 (57%), Gaps = 11/275 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y+    +G G F++V  A+++ T + VA+K +AK  +        ++ EI+++  ++HP
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHP 67

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV L ++  S   +Y+I++ V+GGELFD+IV +G   E D  R   Q++DAV + H  G
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 130 VYHRDLKPENLLL---DSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           + HRDLKPENLL    D    + +SDFGLS +   G  +L T CGTP YVAPEVL+ + Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVLSTACGTPGYVAPEVLAQKPY 186

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--FSCPFW--FSTGATSLIH 242
              A D WS GVI ++L+ GY PF + +   L+++I  AE  F  P+W   S  A   I 
Sbjct: 187 S-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEE 277
            +++ +P+ R   E   +HPW   +    K   + 
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQS 280

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  236 bits (604), Expect = 4e-76
 Identities = 82/273 (30%), Positives = 138/273 (50%), Gaps = 17/273 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH------RMVDQIKREISIM 63
            YE    +G G  + VR   ++ T +  A+K++  +            + +   +E+ I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 64  KIVR-HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAV 122
           + V  HPNI++L +   + T  +++ + +  GELFD +  +  L E + R+  + L++ +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 123 AHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
              H   + HRDLKPEN+LLD   N+K++DFG S     G E L   CGTP+Y+APE++ 
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIE 182

Query: 183 -----NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--F 233
                N    G   D+WS GVI++ L+AG  PF       + + I +   +F  P W  +
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
           S     L+ + L   P+ R   E    HP+F++
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  235 bits (601), Expect = 4e-75
 Identities = 84/261 (32%), Positives = 155/261 (59%), Gaps = 9/261 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           +++ RT+G G+F +V   ++R  G   AMKVL K  +++ + V+    E  ++ IV HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGV 130
           I+R+        ++++I++++ GGELF  +    R      + Y  ++  A+ + HSK +
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125

Query: 131 YHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSA 190
            +RDLKPEN+LLD  G++K++DFG +   +   ++ +T CGTP+Y+APEV+S + Y+  +
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLCGTPDYIAPEVVSTKPYN-KS 181

Query: 191 ADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNPK 250
            D WS G++++ ++AGY PF +++    Y+KI  AE   P +F+     L+ +++  +  
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 241

Query: 251 TRIR-----IEGIRKHPWFRK 266
            R+       E ++ HPWF++
Sbjct: 242 QRLGNLQNGTEDVKNHPWFKE 262

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (601), Expect = 4e-75
 Identities = 72/270 (26%), Positives = 127/270 (47%), Gaps = 13/270 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY +   +G G F  V       + ++   K +      K      +K+EISI+ I RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSK 128
           NI+ LHE   S  ++ +I EF++G ++F++I      L E +   Y  Q+ +A+   HS 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 129 GVYHRDLKPENLLLDS--YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
            + H D++PEN++  +     +K+ +FG +   + G +        P Y APEV  +   
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAPEVHQHDVV 180

Query: 187 DGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATSLIH 242
             +A D+WS G +++VL++G  PF       + + I  AE++         S  A   + 
Sbjct: 181 S-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
           ++L    K+R+      +HPW ++    V 
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVS 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 3e-74
 Identities = 68/317 (21%), Positives = 121/317 (38%), Gaps = 57/317 (17%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            +E    +G G    V    ++ +G  +A K++     +K  + +QI RE+ ++     P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK- 128
            IV  +    S  ++ I +E + GG L   +   GR+ E    +    +I  + +   K 
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            + HRD+KP N+L++S G +K+ DFG+S      +   ++  GT +Y++PE L    Y  
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTHYS- 181

Query: 189 SAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW---------------- 232
             +D+WS G+ L  +  G  P    D   L                              
Sbjct: 182 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 233 ----------------------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWF 264
                                       FS      ++K L  NP  R  ++ +  H + 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 265 RKNYNPVKCSEEEEVNL 281
           ++       S+ EEV+ 
Sbjct: 302 KR-------SDAEEVDF 311

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (596), Expect = 4e-74
 Identities = 84/261 (32%), Positives = 135/261 (51%), Gaps = 6/261 (2%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            ++  + +G+GTF KV   + + TG   AMK+L K  I+    V     E  +++  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
            +  L     +  ++  ++E+  GGELF  +  +    E   R Y  +++ A+ + HS+ 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V +RD+K ENL+LD  G++K++DFGL          + T CGTP Y+APEVL +  Y   
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-R 184

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILDPNP 249
           A D W  GV+++ +M G LPF   D   L++ I   E   P   S  A SL+  +L  +P
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244

Query: 250 KTRIR-----IEGIRKHPWFR 265
           K R+       + + +H +F 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL 265

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (579), Expect = 2e-72
 Identities = 85/279 (30%), Positives = 130/279 (46%), Gaps = 18/279 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVD---QIKREISIMKIV 66
           +Y+VG  +G G F  V           VA+K + K  I     +    ++  E+ ++K V
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 67  R--HPNIVRLHEVLASRTKVYIILEFVTGG-ELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
                 ++RL +         +ILE      +LFD I  +G L E   R +F Q+++AV 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 124 HCHSKGVYHRDLKPENLLLD-SYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           HCH+ GV HRD+K EN+L+D + G LK+ DFG  AL +    +     GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIR 182

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIH 242
              Y G +A VWS G++L+ ++ G +PF   +      +I   +       S+    LI 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIR 236

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
             L   P  R   E I+ HPW +    P    E  E++L
Sbjct: 237 WCLALRPSDRPTFEEIQNHPWMQDVLLP---QETAEIHL 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  228 bits (583), Expect = 7e-72
 Identities = 81/266 (30%), Positives = 128/266 (48%), Gaps = 13/266 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--- 67
           + V R IG G F +V   +  +TG+  AMK L K  I   +       E  ++ +V    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS 127
            P IV +     +  K+  IL+ + GG+L   +   G   E D R Y  ++I  + H H+
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYD 187
           + V +RDLKP N+LLD +G++++SD GL+    +     H + GT  Y+APEVL      
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAY 183

Query: 188 GSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI 244
            S+AD +S G +LF L+ G+ PF      D   + +         P  FS    SL+  +
Sbjct: 184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 243

Query: 245 LDPNPKTRIRIEG-----IRKHPWFR 265
           L  +   R+   G     +++ P+FR
Sbjct: 244 LQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 8e-72
 Identities = 88/268 (32%), Positives = 140/268 (52%), Gaps = 13/268 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIV 66
            Y+ G  +G G FA V+  + + TG   A K + K      R     + I+RE+SI+K +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           +HPN++ LHEV  ++T V +ILE V GGELFD +  +  L E +   + +Q+++ V + H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 127 SKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLS 182
           S  + H DLKPEN++L         +K+ DFGL+     G        GTP +VAPE+++
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVN 189

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF----STGAT 238
                   AD+WS GVI ++L++G  PF           ++A  +     +    S  A 
Sbjct: 190 YEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFRK 266
             I ++L  +PK R+ I+   +HPW + 
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 6e-71
 Identities = 61/265 (23%), Positives = 117/265 (44%), Gaps = 15/265 (5%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
            +    IG G+F  V    + ET   VA   L    + K     + K E  ++K ++HPN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-ERQRFKEEAEMLKGLQHPN 69

Query: 71  IVRLHEVLASRTK----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           IVR ++   S  K    + ++ E +T G L   +     +     R + +Q++  +   H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 127 SKG--VYHRDLKPENLLLDS-YGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           ++   + HRDLK +N+ +    G++K+ D GL+ L +          GTP ++APE+   
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE 187

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPFW--FSTGATSL 240
           + YD  + DV++ G+ +  +     P+    +   +Y+++ +      F          +
Sbjct: 188 K-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245

Query: 241 IHKILDPNPKTRIRIEGIRKHPWFR 265
           I   +  N   R  I+ +  H +F+
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 8e-70
 Identities = 94/309 (30%), Positives = 146/309 (47%), Gaps = 29/309 (9%)

Query: 3   KQTRRVAKYEV-GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
           K+   +  Y+V  + +G G   KV    N+ T E  A+K+L            + +RE+ 
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVE 56

Query: 62  IM-KIVRHPNIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRY 114
           +  +  + P+IVR+ +V     A R  + I++E + GGELF +I  +G     E +    
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSY---GNLKVSDFGLSALPQQGVELLHTTCG 171
            + + +A+ + HS  + HRD+KPENLL  S      LK++DFG +         L T C 
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCY 175

Query: 172 TPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF----GETDLPTLYKKINAA-- 225
           TP YVAPEVL    YD  + D+WS GVI+++L+ GY PF    G    P +  +I     
Sbjct: 176 TPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234

Query: 226 EFSCPFW--FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNLDD 283
           EF  P W   S     LI  +L   P  R+ I     HPW  ++    +        L +
Sbjct: 235 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKE 294

Query: 284 VHAVFDDIE 292
               ++D++
Sbjct: 295 DKERWEDVK 303

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  221 bits (563), Expect = 5e-69
 Identities = 83/270 (30%), Positives = 148/270 (54%), Gaps = 9/270 (3%)

Query: 2   KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREIS 61
            + T ++ +++  +T+G G+F +V   +++E+G   AMK+L K  ++K + ++    E  
Sbjct: 34  SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR 93

Query: 62  IMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDA 121
           I++ V  P +V+L       + +Y+++E+V GGE+F  +   GR  E   R Y  Q++  
Sbjct: 94  ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVL 181
             + HS  + +RDLKPENLL+D  G ++V+DFG +   ++      T CGTP  +APE++
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEII 210

Query: 182 SNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLI 241
            ++GY+  A D W+ GV+++ + AGY PF       +Y+KI + +   P  FS+    L+
Sbjct: 211 LSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 242 HKILDPNPKTRIR-----IEGIRKHPWFRK 266
             +L  +   R       +  I+ H WF  
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  211 bits (538), Expect = 3e-66
 Identities = 64/267 (23%), Positives = 114/267 (42%), Gaps = 12/267 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +YE+G  +G G  ++V  A++      VA+KVL            + +RE      + HP
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 70  NIVRLHEVLASRTK----VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
            IV +++   + T      YI++E+V G  L D +  +G +              A+   
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL---PQQGVELLHTTCGTPNYVAPEVLS 182
           H  G+ HRD+KP N+++ +   +KV DFG++         V       GT  Y++PE   
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGAT 238
               D + +DV+S G +L+ ++ G  PF      ++  +    +   P       S    
Sbjct: 188 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD 246

Query: 239 SLIHKILDPNPKTRIRIEGIRKHPWFR 265
           +++ K L  NP+ R +     +    R
Sbjct: 247 AVVLKALAKNPENRYQTAAEMRADLVR 273

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 3e-65
 Identities = 55/263 (20%), Positives = 109/263 (41%), Gaps = 16/263 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +  VG+ IG G+F  V   +       VA+K+L  +     + +   K E+ +++  RH 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 64

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NI+      ++  ++ I+ ++  G  L+  + + + +          +Q    + + H+K
Sbjct: 65  NILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL--PQQGVELLHTTCGTPNYVAPEVL--SNR 184
            + HRDLK  N+ L     +K+ DFGL+ +     G        G+  ++APEV+   ++
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 185 GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFW------FSTGAT 238
                 +DV++ G++L+ LM G LP+   +       +    +  P              
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243

Query: 239 SLIHKILDPNPKTRIRIEGIRKH 261
            L+ + L      R     I   
Sbjct: 244 RLMAECLKKKRDERPLFPQILAS 266

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 4e-65
 Identities = 73/299 (24%), Positives = 121/299 (40%), Gaps = 41/299 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y     IGEG +  V  A +      VA+K ++           +  REI I+   RH 
Sbjct: 9   RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 66

Query: 70  NIVRLHEVLASRT----KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           NI+ +++++ + T    K   ++  + G +L+  ++    L  +    +  Q++  + + 
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL---PQQGVELLHTTCGTPNYVAPEVLS 182
           HS  V HRDLKP NLLL++  +LK+ DFGL+ +          L     T  Y APE++ 
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 183 NRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-------------------- 222
           N      + D+WS G IL  +++    F           I                    
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 223 NAAEFSCPFW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                S P               + A  L+ K+L  NP  RI +E    HP+  + Y+P
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 5e-65
 Identities = 86/292 (29%), Positives = 137/292 (46%), Gaps = 31/292 (10%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            ++    IGEGT+  V  A+N+ TGE VA+K +   T     +     REIS++K + HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHP 61

Query: 70  NIVRLHEVLASRTKVYIILEFV-TGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           NIV+L +V+ +  K+Y++ EF+    + F        +     + Y  QL+  +A CHS 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
            V HRDLKP+NLL+++ G +K++DFGL+      V        T  Y APE+L    Y  
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 189 SAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-----------------EFSCP 230
           +A D+WS G I   ++     F G++++  L++                      + S P
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 231 FW-----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPV 271
            W                 SL+ ++L  +P  RI  +    HP+F+    PV
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 2e-64
 Identities = 70/294 (23%), Positives = 112/294 (38%), Gaps = 30/294 (10%)

Query: 12  EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI--LKHRMVDQIKREISIMKIVRHP 69
           E    +GEG FA V  A+++ T + VA+K +        K  +     REI +++ + HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NI+ L +    ++ + ++ +F+          +   L  +  + Y    +  + + H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           + HRDLKP NLLLD  G LK++DFGL+               T  Y APE+L      G 
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 190 AADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA-EFSCPFW--------------- 232
             D+W+ G IL  L+       G++DL  L +        +   W               
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 233 -----------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVKCSE 275
                             LI  +   NP  RI      K  +F     P    +
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 6e-64
 Identities = 69/309 (22%), Positives = 117/309 (37%), Gaps = 45/309 (14%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
             V+KYE    IG+GTF +V  A++R+TG+ VA+K +      K        REI I+++
Sbjct: 7   DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQL 65

Query: 66  VRHPNIVRLHEVLASRT--------KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQ 117
           ++H N+V L E+  ++          +Y++ +F              +   ++ +R  Q 
Sbjct: 66  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 118 LIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL----PQQGVELLHTTCGTP 173
           L++ + + H   + HRD+K  N+L+   G LK++DFGL+                   T 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP--- 230
            Y  PE+L      G   D+W  G I+  +                  I+    S     
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 231 -----------------------------FWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                                        +     A  LI K+L  +P  RI  +    H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 262 PWFRKNYNP 270
            +F  +  P
Sbjct: 306 DFFWSDPMP 314

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (514), Expect = 1e-62
 Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 31/286 (10%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KY     IGEGT+  V  AQN   GE+ A+K +         +     REISI+K ++H 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIV+L++V+ ++ ++ ++ E +         V +G L     + +  QL++ +A+CH + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRDLKP+NLL++  G LK++DFGL+      V        T  Y AP+VL       +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 190 AADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA--EFSCPFW--------------- 232
             D+WS G I   ++ G   F          +I       +   W               
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 233 ------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK 266
                              L+ K+L  +P  RI  +   +H +F++
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (513), Expect = 2e-62
 Identities = 86/291 (29%), Positives = 123/291 (42%), Gaps = 31/291 (10%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           KYE    IGEGT+  V  A+NRET E VA+K +         +     REI ++K ++H 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHK 61

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG 129
           NIVRLH+VL S  K+ ++ EF             G L     + +  QL+  +  CHS+ 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGS 189
           V HRDLKP+NLL++  G LK+++FGL+      V        T  Y  P+VL       +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 190 AADVWSCGVILFVLMAGYLP-FGETDLPTLYKKINAAEFSCPF----------------- 231
           + D+WS G I   L     P F   D+    K+I     +                    
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 232 ------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                         +     L+  +L  NP  RI  E   +HP+F     P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 2e-62
 Identities = 78/325 (24%), Positives = 136/325 (41%), Gaps = 48/325 (14%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
            Y   + +G G +  V  A +  TG  VA+K L +          +  RE+ ++K +RH 
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHE 77

Query: 70  NIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           N++ L +V      L   T  Y+++ F+  G    K++   +L E+  +    Q++  + 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           + H+ G+ HRDLKP NL ++    LK+ DFGL+   +Q    +     T  Y APEV+ N
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRWYRAPEVILN 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF---------- 233
                   D+WS G I+  ++ G   F  +D     K+I     + P  F          
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252

Query: 234 ---------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNPVK 272
                                S  A +L+ K+L  + + R+       HP+F   ++   
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT-- 310

Query: 273 CSEEEEVNLDDVHAVFDDIEYVAEQ 297
              E+E  +      FDD++   ++
Sbjct: 311 ---EDEPQVQKYDDSFDDVDRTLDE 332

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-61
 Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 16/257 (6%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           + ++ +TIG+G F  V     R  G  VA+K +                E S+M  +RH 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60

Query: 70  NIVRLHEVLA-SRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCH 126
           N+V+L  V+   +  +YI+ E++  G L D +  +GR  L  +   ++   + +A+ +  
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
                HRDL   N+L+      KVSDFGL+   ++      T      + APE L  + +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKF 177

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKI 244
             + +DVWS G++L+ + + G +P+    L  +  ++        P         ++   
Sbjct: 178 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNC 236

Query: 245 LDPNPKTRIRIEGIRKH 261
              +   R     +R+ 
Sbjct: 237 WHLDAAMRPSFLQLREQ 253

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 1e-60
 Identities = 86/284 (30%), Positives = 152/284 (53%), Gaps = 18/284 (6%)

Query: 1   MKKQTRRVA--KYEVGRTIGEGTFAKVRFAQ---NRETGESVAMKVLAKSTIL-KHRMVD 54
           +     +V    +E+ + +G G + KV   +     +TG+  AMKVL K+TI+ K +  +
Sbjct: 14  LTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE 73

Query: 55  QIKREISIMKIVRH-PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRR 113
             + E  +++ +R  P +V LH    + TK+++IL+++ GGELF  +  + R  E++ + 
Sbjct: 74  HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI 133

Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGT 172
           Y  +++ A+ H H  G+ +RD+K EN+LLDS G++ ++DFGLS        E  +  CGT
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193

Query: 173 PNYVAPEVL-SNRGYDGSAADVWSCGVILFVLMAGYLPFGETD----LPTLYKKINAAEF 227
             Y+AP+++         A D WS GV+++ L+ G  PF           + ++I  +E 
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253

Query: 228 SCPFWFSTGATSLIHKILDPNPKTRIR-----IEGIRKHPWFRK 266
             P   S  A  LI ++L  +PK R+       + I++H +F+K
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-60
 Identities = 52/260 (20%), Positives = 107/260 (41%), Gaps = 13/260 (5%)

Query: 15  RTIGEGTFAKVRFA--QNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIV 72
           + +G G F  V+    Q ++  ++VA+K+L K+      + D++  E ++M+ + +P IV
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 73  RLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYH 132
           R+  +        +++E    G L   +     + + +      Q+   + +       H
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 133 RDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGS 189
           RDL   N+LL +    K+SDFGLS   +                 + APE ++   +  S
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189

Query: 190 AADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDP 247
            +DVWS GV+++   + G  P+       +   +   E   CP         L++     
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249

Query: 248 NPKTRIRIEGIR---KHPWF 264
           + + R     +    ++ ++
Sbjct: 250 DVENRPGFAAVELRLRNYYY 269

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 3e-60
 Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 39/296 (13%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+    +G G +  V  A + +TG  VA+K L++          +  RE+ ++K ++H 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRLLKHMKHE 77

Query: 70  NIVRLHEVLASRTKV----YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           N++ L +V      +     + L     G   + IV   +L ++  +    Q++  + + 
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           HS  + HRDLKP NL ++    LK+ DFGL+      +        T  Y APE++ N  
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGYVATRWYRAPEIMLNWM 194

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF------------ 233
           +     D+WS G I+  L+ G   F  TD     K I     +                 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254

Query: 234 -------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
                              +  A  L+ K+L  +   RI       H +F + ++P
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 4e-60
 Identities = 54/255 (21%), Positives = 110/255 (43%), Gaps = 10/255 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
               + +G G F  V++ + R     VA+K++ + ++ +    D+   E  +M  + H  
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKG 129
           +V+L+ V   +  ++II E++  G L + +   + R          + + +A+ +  SK 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
             HRDL   N L++  G +KVSDFGLS  +          +     +  PEVL    +  
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS- 179

Query: 189 SAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKILD 246
           S +D+W+ GV+++ + + G +P+         + I        P   S    ++++    
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239

Query: 247 PNPKTRIRIEGIRKH 261
                R   + +  +
Sbjct: 240 EKADERPTFKILLSN 254

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-59
 Identities = 78/299 (26%), Positives = 121/299 (40%), Gaps = 47/299 (15%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
           Y   + IG G+F  V  A+  ++GE VA+K + +    K        RE+ IM+ + H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCN 74

Query: 71  IVRLHEVLAS------RTKVYIILEFVTGG---ELFDKIVHQGRLLENDCRRYFQQLIDA 121
           IVRL     S         + ++L++V              +  L     + Y  QL  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 122 VAHCHSKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEV 180
           +A+ HS G+ HRD+KP+NLLLD     LK+ DFG +    +G E   +   +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPEL 193

Query: 181 LSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKI-----------------N 223
           +       S+ DVWS G +L  L+ G   F          +I                 N
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 224 AAEFSCPFW------------FSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP 270
             EF  P                  A +L  ++L+  P  R+       H +F +  +P
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (491), Expect = 3e-59
 Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 12/277 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
              +   +G G + +V     ++   +VA+K L + T+     V++  +E ++MK ++HP
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 73

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHS 127
           N+V+L  V       YII EF+T G L D +    R  +          Q+  A+ +   
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT-TCGTPNYVAPEVLSNRGY 186
           K   HRDL   N L+     +KV+DFGLS L        H        + APE L+   +
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKINA-AEFSCPFWFSTGATSLIHKI 244
               +DVW+ GV+L+ +   G  P+   DL  +Y+ +        P         L+   
Sbjct: 194 S-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 252

Query: 245 LDPNPKTRIRIEGIRKHPWFRKNYNPVKCSEEEEVNL 281
              NP  R     I +   F   +     S+E E  L
Sbjct: 253 WQWNPSDRPSFAEIHQ--AFETMFQESSISDEVEKEL 287

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 4e-59
 Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 12/261 (4%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRET---GESVAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
             +   +G+G+F  VR  +         SVA+K L    + +   +D   RE++ M  + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCH 126
           H N++RL+ V+ +   + ++ E    G L D++  HQG  L     RY  Q+ + + +  
Sbjct: 70  HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSN 183
           SK   HRDL   NLLL +   +K+ DFGL     Q  +             + APE L  
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 184 RGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEFSCPFW--FSTGATSL 240
           R +   A+D W  GV L+ +   G  P+   +   +  KI+      P          ++
Sbjct: 189 RTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247

Query: 241 IHKILDPNPKTRIRIEGIRKH 261
           + +     P+ R     +R  
Sbjct: 248 MVQCWAHKPEDRPTFVALRDF 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-58
 Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 15/259 (5%)

Query: 17  IGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRL 74
           +G G F  VR    R   +   VA+KVL + T  +    +++ RE  IM  + +P IVRL
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 75  HEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHR 133
             V      + +++E   GG L   +V  +  +  ++      Q+   + +   K   HR
Sbjct: 75  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133

Query: 134 DLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT---CGTPNYVAPEVLSNRGYDGSA 190
           DL   N+LL +    K+SDFGLS                     + APE ++ R +  S 
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SR 192

Query: 191 ADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKILDPN 248
           +DVWS GV ++  ++ G  P+ +   P +   I   +   CP        +L+       
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252

Query: 249 PKTRIRIEGIR---KHPWF 264
            + R     +    +  ++
Sbjct: 253 WEDRPDFLTVEQRMRACYY 271

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 9e-58
 Identities = 79/297 (26%), Positives = 123/297 (41%), Gaps = 40/297 (13%)

Query: 6   RRVAKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           R   +YE    IGEG + KV  A++ +  G  VA+K +   T  +  M     RE+++++
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLR 62

Query: 65  I---VRHPNIVRLHEVLAS-----RTKVYIILEFVTGGEL-FDKIVHQGRLLENDCRRYF 115
                 HPN+VRL +V         TK+ ++ E V      +   V +  +     +   
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
            QL+  +   HS  V HRDLKP+N+L+ S G +K++DFGL+ +    +  L +   T  Y
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTLWY 181

Query: 176 VAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAAEFSCPF--- 231
            APEVL    Y  +  D+WS G I   +      F G +D+  L K ++           
Sbjct: 182 RAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240

Query: 232 -----------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
                                          L+ K L  NP  RI       HP+F+
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 2e-57
 Identities = 59/262 (22%), Positives = 110/262 (41%), Gaps = 14/262 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
             ++   +G G F +V           VA+K L + ++      D    E ++MK ++H 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHS 127
            +VRL+ V+ ++  +YII E++  G L D +      +L  N       Q+ + +A    
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLSA-LPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
           +   HRDL+  N+L+    + K++DFGL+  +                + APE + N G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI-NYGT 186

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKI 244
               +DVWS G++L  ++  G +P+     P + + +        P         L+   
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLC 246

Query: 245 LDPNPKTRIRIEGIRK--HPWF 264
               P+ R   + +R     +F
Sbjct: 247 WKERPEDRPTFDYLRSVLEDFF 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 8e-57
 Identities = 57/255 (22%), Positives = 102/255 (40%), Gaps = 10/255 (3%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
               + IG G F  V         + VA+K + +  + +    +    E  +M  + HP 
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61

Query: 71  IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSKG 129
           +V+L+ V   +  + ++ EF+  G L D +  Q  L            + + +A+     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 130 VYHRDLKPENLLLDSYGNLKVSDFGL-SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDG 188
           V HRDL   N L+     +KVSDFG+   +          T     + +PEV S   Y  
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS- 180

Query: 189 SAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKILD 246
           S +DVWS GV+++ + + G +P+       + + I        P   ST    +++    
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240

Query: 247 PNPKTRIRIEGIRKH 261
             P+ R     + + 
Sbjct: 241 ERPEDRPAFSRLLRQ 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 8e-57
 Identities = 58/265 (21%), Positives = 105/265 (39%), Gaps = 14/265 (5%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
              +   +G+G F +V       T   VA+K L   T+      +   +E  +MK +RH 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR--LLENDCRRYFQQLIDAVAHCHS 127
            +V+L+ V+ S   +YI+ E+++ G L D +  +    L          Q+   +A+   
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 128 KGVYHRDLKPENLLLDSYGNLKVSDFGLS-ALPQQGVELLHTTCGTPNYVAPEVLSNRGY 186
               HRDL+  N+L+      KV+DFGL+  +                + APE      +
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 187 DGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIHKI 244
               +DVWS G++L  +   G +P+       +  ++       CP         L+ + 
Sbjct: 192 T-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC 250

Query: 245 LDPNPKTRIRIEGIRK--HPWFRKN 267
               P+ R   E ++     +F   
Sbjct: 251 WRKEPEERPTFEYLQAFLEDYFTST 275

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 8e-57
 Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 37/286 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-----VAMKVLAKSTILKHRMVDQIKREISIM- 63
             E G+ +G G F KV  A      ++     VA+K+L +      R  + +  E+ +M 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER--EALMSELKMMT 95

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ-------------------- 103
           ++  H NIV L         +Y+I E+   G+L + +  +                    
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 104 ---GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-- 158
                L   D   +  Q+   +     K   HRDL   N+L+     +K+ DFGL+    
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPT 217
                 +         ++APE L    Y    +DVWS G++L+ + + G  P+    +  
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 218 LYKKI--NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
            + K+  N  +   PF+ +     ++      + + R     +   
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 1e-56
 Identities = 74/259 (28%), Positives = 113/259 (43%), Gaps = 11/259 (4%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIV 66
           + E+GR IGEG F  V              VA+K     T     + ++  +E   M+  
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFD-KIVHQGRLLENDCRRYFQQLIDAVAHC 125
            HP+IV+L  V+ +   V+II+E  T GEL     V +  L       Y  QL  A+A+ 
Sbjct: 66  DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-CGTPNYVAPEVLSNR 184
            SK   HRD+   N+L+ S   +K+ DFGLS   +       +       ++APE ++ R
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 185 GYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIH 242
            +   A+DVW  GV ++ +LM G  PF       +  +I N      P        SL+ 
Sbjct: 185 RFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMT 243

Query: 243 KILDPNPKTRIRIEGIRKH 261
           K    +P  R R   ++  
Sbjct: 244 KCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (475), Expect = 1e-56
 Identities = 64/271 (23%), Positives = 106/271 (39%), Gaps = 21/271 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGES---VAMKVLAKSTILKHRMVDQIKREISIMKIVR 67
            ++ + IG G F +V     +  G+    VA+K L      K R       E SIM    
Sbjct: 28  VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFD 85

Query: 68  HPNIVRLHEVLASRTKVYIILEFVTGGELFD-KIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           HPN++ L  V+   T V II EF+  G L      + G+          + +   + +  
Sbjct: 86  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145

Query: 127 SKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT-----CGTPNYVAPEVL 181
                HRDL   N+L++S    KVSDFGLS   +        T          + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205

Query: 182 SNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATS 239
             R +   A+DVWS G++++ +M+ G  P+ +     +   I        P    +    
Sbjct: 206 QYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264

Query: 240 LIHKILDPNPKTRI-------RIEGIRKHPW 263
           L+      +   R         ++ + ++P 
Sbjct: 265 LMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  187 bits (476), Expect = 2e-56
 Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 52/298 (17%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRH 68
            Y++ R +G G +++V  A N    E V +K      ILK     +IKREI I++ +   
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVK------ILKPVKKKKIKREIKILENLRGG 89

Query: 69  PNIVRLHEVLASRTK--VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCH 126
           PNI+ L +++         ++ E V   +          L + D R Y  +++ A+ +CH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146

Query: 127 SKGVYHRDLKPENLLLDSYGN-LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRG 185
           S G+ HRD+KP N+++D     L++ D+GL+     G +  +    +  +  PE+L +  
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQ 205

Query: 186 YDGSAADVWSCGVILFVLMAGYLPFGETD--------------LPTLYKKINAAEFSCPF 231
               + D+WS G +L  ++    PF                     LY  I+        
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265

Query: 232 WF------------------------STGATSLIHKILDPNPKTRIRIEGIRKHPWFR 265
            F                        S  A   + K+L  + ++R+      +HP+F 
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 3e-56
 Identities = 57/270 (21%), Positives = 97/270 (35%), Gaps = 21/270 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIM-KIVRHP 69
            +    IGEG F +V  A+ ++ G  +   +                 E+ ++ K+  HP
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 70  NIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRR 113
           NI+ L      R  +Y+ +E+   G L D +                     L       
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 114 YFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTP 173
           +   +   + +   K   HRDL   N+L+      K++DFGLS   +  V+         
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPV 190

Query: 174 NYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI-NAAEFSCPF 231
            ++A E L N     + +DVWS GV+L+ ++  G  P+       LY+K+        P 
Sbjct: 191 RWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 249

Query: 232 WFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                   L+ +     P  R     I   
Sbjct: 250 NCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 1e-55
 Identities = 53/257 (20%), Positives = 100/257 (38%), Gaps = 7/257 (2%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAK--STILKHRMVDQIKREISIMKIVRH 68
           ++  + +G G F  V        GE V + V  K        +   +I  E  +M  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
           P++ RL  +  + T   I      G  L     H+  +       +  Q+   + +   +
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC--GTPNYVAPEVLSNRGY 186
            + HRDL   N+L+ +  ++K++DFGL+ L     +  H         ++A E + +R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 187 DGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSLIHKI 244
               +DVWS GV ++ LM  G  P+       +   +   E    P   +     ++ K 
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 245 LDPNPKTRIRIEGIRKH 261
              +  +R +   +   
Sbjct: 250 WMIDADSRPKFRELIIE 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (462), Expect = 8e-55
 Identities = 55/287 (19%), Positives = 103/287 (35%), Gaps = 29/287 (10%)

Query: 7   RVA-KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI 65
           RV  +Y +GR IG G+F  +    +   GE VA+K+    T        Q+  E  I K+
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKM 58

Query: 66  VRHPN-IVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAH 124
           ++    I  +    A      +++E +             +           Q+I  + +
Sbjct: 59  MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118

Query: 125 CHSKGVYHRDLKPENLLLDSYG---NLKVSDFGLSALPQQGVELLH-------TTCGTPN 174
            HSK   HRD+KP+N L+        + + DFGL+   +      H          GT  
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178

Query: 175 YVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF---GETDLPTLYKKINAAEFSCPF 231
           Y +              D+ S G +L     G LP+           Y++I+  + S P 
Sbjct: 179 YASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 232 W-----FSTGATSLIHKILDPNPKTRIRIEGIR---KHPWFRKNYNP 270
                 + +   + ++         +     +R   ++ + R+ ++ 
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-53
 Identities = 67/269 (24%), Positives = 109/269 (40%), Gaps = 20/269 (7%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGES----VAMKVLAKSTILKHRMVDQIKREISIMKIV 66
               + IG G F +V     + +       VA+K L      K R+      E  IM   
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQF 66

Query: 67  RHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHC 125
            H NI+RL  V++    + II E++  G L   +    G           + +   + + 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 126 HSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTC---GTPNYVAPEVLS 182
            +    HRDL   N+L++S    KVSDFGLS + +   E  +TT        + APE +S
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186

Query: 183 NRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL 240
            R +  SA+DVWS G++++ +M  G  P+ E     + K IN       P    +    L
Sbjct: 187 YRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245

Query: 241 IHKILDPNPKTRI-------RIEGIRKHP 262
           + +        R         ++ + + P
Sbjct: 246 MMQCWQQERARRPKFADIVSILDKLIRAP 274

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-52
 Identities = 79/336 (23%), Positives = 129/336 (38%), Gaps = 57/336 (16%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
           +Y+  + IG G    V  A +     +VA+K L++          +  RE+ +MK V H 
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHK 76

Query: 70  NIVRLHEV------LASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVA 123
           NI+ L  V      L     VY+++E +         V Q  L          Q++  + 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIK 133

Query: 124 HCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSN 183
           H HS G+ HRDLKP N+++ S   LK+ DFGL+        ++     T  Y APEV+  
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILG 192

Query: 184 RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWF---------- 233
            GY     D+WS G I+  ++   + F   D    + K+     +    F          
Sbjct: 193 MGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 234 --------------------------------STGATSLIHKILDPNPKTRIRIEGIRKH 261
                                           ++ A  L+ K+L  +P  RI ++   +H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 262 PWFRKNYNPVKCSEEEEVNLDDVHAVFDDIEYVAEQ 297
           P+    Y+P   +E E           D+ E+  E+
Sbjct: 312 PYINVWYDP---AEVEAPPPQIYDKQLDEREHTIEE 344

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-50
 Identities = 63/280 (22%), Positives = 102/280 (36%), Gaps = 32/280 (11%)

Query: 10  KYEVGRTIGEGTFAKVRFAQ-----NRETGESVAMKVLAKSTILKHRMVDQIKREISIM- 63
           +   G+T+G G F KV  A        +   +VA+K+L  S  L  R  + +  E+ ++ 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81

Query: 64  KIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKI------------------VHQGR 105
            +  H NIV L           +I E+   G+L + +                    +  
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           L   D   +  Q+   +A   SK   HRDL   N+LL      K+ DFGL+   +     
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 166 LHTT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF--GETDLPTLYKK 221
           +          ++APE + N       +DVWS G+ L+ L +       G       YK 
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 222 INAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK 260
           I        P         ++    D +P  R   + I +
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (432), Expect = 2e-50
 Identities = 60/284 (21%), Positives = 106/284 (37%), Gaps = 36/284 (12%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
             E  R IGEG F +V  A+       E    VA+K+L +       M    +RE ++M 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGR------------------- 105
              +PNIV+L  V A    + ++ E++  G+L + +                        
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 106 -----LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSAL-- 158
                L   +     +Q+   +A+   +   HRDL   N L+     +K++DFGLS    
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 159 PQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYL-PFGETDLPT 217
                +          ++ PE +    Y  + +DVW+ GV+L+ + +  L P+       
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 218 LYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK 260
           +   +      +CP        +L+       P  R     I +
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  169 bits (430), Expect = 4e-50
 Identities = 48/272 (17%), Positives = 94/272 (34%), Gaps = 27/272 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH- 68
            Y+VGR IGEG+F  +    N    + VA+K   + +        Q++ E    K++   
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGC 60

Query: 69  PNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSK 128
             I  ++          ++++ +         +   +          +Q++  V   H K
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120

Query: 129 GVYHRDLKPENLLLDSY-----GNLKVSDFGLSALPQQGVE-------LLHTTCGTPNYV 176
            + +RD+KP+N L+          + V DFG+    +  V              GT  Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 177 APEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTL---YKKINAAEFSCPFW- 232
           +      R       D+ + G +    + G LP+      T    Y++I   + S P   
Sbjct: 181 SINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239

Query: 233 ----FSTGATSLIHKILDPNPKTRIRIEGIRK 260
               F       +H   +         + ++ 
Sbjct: 240 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 5e-49
 Identities = 64/278 (23%), Positives = 106/278 (38%), Gaps = 20/278 (7%)

Query: 14  GRTIGEGTFAKV---RFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN 70
              IG G F  V       N       A+K L + T      V Q   E  IMK   HPN
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPN 89

Query: 71  IVRLHEV-LASRTKVYIILEFVTGGELFDKIVHQGRLL-ENDCRRYFQQLIDAVAHCHSK 128
           ++ L  + L S     ++L ++  G+L + I ++       D   +  Q+   +    SK
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 129 GVYHRDLKPENLLLDSYGNLKVSDFGLSAL----PQQGVELLHTTCGTPNYVAPEVLSNR 184
              HRDL   N +LD    +KV+DFGL+          V           ++A E L  +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 185 GYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKI-NAAEFSCPFWFSTGATSLIH 242
            +  + +DVWS GV+L+ LM  G  P+ + +   +   +        P +       ++ 
Sbjct: 210 KFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268

Query: 243 KILDPNPKTRIRIEGIRKH------PWFRKNYNPVKCS 274
           K   P  + R     +          +  ++Y  V  +
Sbjct: 269 KCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNAT 306

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 9e-49
 Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 28/282 (9%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           K  + R +G+G+F  V     +     E    VA+K + ++  ++ R   +   E S+MK
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78

Query: 65  IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLEN----------DCRRY 114
                ++VRL  V++      +I+E +T G+L   +      + N             + 
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 115 FQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT--CGT 172
             ++ D +A+ ++    HRDL   N ++     +K+ DFG++    +             
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 173 PNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAE-FSCP 230
             +++PE L +  +    +DVWS GV+L+ +      P+       + + +        P
Sbjct: 199 VRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 231 FWFSTGATSLIHKILDPNPKTRIRIEGIRK------HPWFRK 266
                    L+      NPK R     I         P FR+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-48
 Identities = 61/280 (21%), Positives = 112/280 (40%), Gaps = 31/280 (11%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGES-------VAMKVLAKSTILKHRMVDQIKREISI 62
           +  +G+ +GEG F +V  A+     +        VA+K+L        + +  +  E+ +
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71

Query: 63  MK-IVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQG----------------R 105
           MK I +H NI+ L         +Y+I+E+ + G L + +  +                 +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 106 LLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL 165
           L   D      Q+   + +  SK   HRDL   N+L+     +K++DFGL+         
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 166 LHT--TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILF-VLMAGYLPFGETDLPTLYKKI 222
             T        ++APE L +R Y    +DVWS GV+L+ +   G  P+    +  L+K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 223 NAAE-FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                   P   +     ++       P  R   + + + 
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 9e-46
 Identities = 57/294 (19%), Positives = 111/294 (37%), Gaps = 50/294 (17%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHP 69
              +  +IG+G F +V     +  GE VA+K+ +     +       + EI    ++RH 
Sbjct: 4   TIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS----REERSWFREAEIYQTVMLRHE 57

Query: 70  NIVRLHEVL----ASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHC 125
           NI+           + T+++++ ++   G LFD + ++  +      +        +AH 
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHL 116

Query: 126 HS--------KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT----CGTP 173
           H           + HRDLK +N+L+   G   ++D GL+       + +        GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 174 NYVAPEVLSNR-----GYDGSAADVWSCGVILFVLMAGYLPFG---------------ET 213
            Y+APEVL +            AD+++ G++ + +       G               + 
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 214 DLPTLYKKINAAEFSCPF---WFSTGATSLIHKI----LDPNPKTRIRIEGIRK 260
            +  + K +   +        W S  A  ++ KI       N   R+    I+K
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-45
 Identities = 54/279 (19%), Positives = 103/279 (36%), Gaps = 29/279 (10%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMK 64
           + ++G+ +G G F +V  A         T  +VA+K+L +           +     ++ 
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR-ALMSELKILIH 72

Query: 65  IVRHPNIVRLHEV-LASRTKVYIILEFVTGGELFDKI----------------VHQGRLL 107
           I  H N+V L          + +I+EF   G L   +                +++  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 108 ENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH 167
                 Y  Q+   +    S+   HRDL   N+LL     +K+ DFGL+    +  + + 
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 168 TT--CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLPTLYKKI-- 222
                    ++APE + +R Y    +DVWS GV+L+ + +    P+    +   + +   
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 223 NAAEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH 261
                  P + +      +       P  R     + +H
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  142 bits (358), Expect = 4e-39
 Identities = 54/328 (16%), Positives = 112/328 (34%), Gaps = 71/328 (21%)

Query: 10  KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIK-------REISI 62
           +Y + R +G G F+ V  A++      VAMK++    +      D+IK        + + 
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 63  MKIVRHPNIVRLHEVLASRTKVYIILEFVT-----GGELFDKIVHQGRLLENDCRRYFQQ 117
              +   +I++L +    +    + +  V            K      +     ++  +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 118 LIDAVAHCHSK-GVYHRDLKPENLLLDSYG------NLKVSDFGLSALPQQGVELLHTTC 170
           L+  + + H + G+ H D+KPEN+L++          +K++D G +    +       + 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSI 190

Query: 171 GTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---------- 220
            T  Y +PEVL    +    AD+WS   ++F L+ G   F   +  +  K          
Sbjct: 191 QTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 221 --------------------------------------KINAAEFSCPFWFSTGATSLIH 242
                                                  +   ++      +   +  + 
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 243 KILDPNPKTRIRIEGIRKHPWFRKNYNP 270
            +L  +P+ R    G+  HPW +     
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGM 337

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 90.6 bits (224), Expect = 7e-22
 Identities = 31/213 (14%), Positives = 71/213 (33%), Gaps = 44/213 (20%)

Query: 11  YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTI---------------LKHRMVDQ 55
             +G+ +GEG  + V    + E      +K                           +  
Sbjct: 2   DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 56  IKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYF 115
            + E   ++ ++   + +++          +++E +             R+   +     
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAK-------ELYRVRVENPDEVL 109

Query: 116 QQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTTCGTPNY 175
             +++ VA  + +G+ H DL   N+L+   G + + DF  S      VE+          
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS------VEVGEEGW--REI 160

Query: 176 VAPEVLS-----NRGYDGSAADVWSCGVILFVL 203
           +  +V +     +R Y  +  D+ S   I  +L
Sbjct: 161 LERDVRNIITYFSRTY-RTEKDINS--AIDRIL 190

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 64.4 bits (157), Expect = 1e-13
 Identities = 11/85 (12%), Positives = 28/85 (32%), Gaps = 2/85 (2%)

Query: 341 SRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFM 398
           S      ++  I  V  + +     R  +         +        +EV ++   SL  
Sbjct: 17  SSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNG 76

Query: 399 VDVRKAAGDTLEYHKFYKNFCAKLE 423
           V  ++ +G ++ +         +L+
Sbjct: 77  VRFKRISGTSIAFKNIASKIANELK 101

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	441
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1ul7a_	102	Map/microtubule affinity-regulating kinase 3 {Mous	99.41
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.61
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.11
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.06
d2v8qa1	153	5'-AMP-activated protein kinase catalytic subunit	98.04
d2qrda1	127	Snf1-like protein kinase ssp2 {Schizosaccharomyces	97.47
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.1
d2qlva1	171	Carbon catabolite-derepressing protein kinase SNF1	97.04
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.04
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.33

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-66  Score=487.19  Aligned_cols=260  Identities=36%  Similarity=0.671  Sum_probs=241.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      .+.+++|++++.||+|+||.||+|+++.+|+.||+|++.+....+....+.+.+|+.+++.++||||+++++++.+++.+
T Consensus         2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            35689999999999999999999999999999999999876655555567889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|......  
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            999999999999999999899999999999999999999999999999999999999999999999999999765442  


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                      .....+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+.++....+..|..+|+++.+||.+|
T Consensus       160 ~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  238 (263)
T d2j4za1         160 RRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL  238 (263)
T ss_dssp             CCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence            3456789999999999988776 489999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCCCCCChHhHhcCCCcccc
Q 013520          245 LDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       245 L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      |++||++|||++|+++||||+.+
T Consensus       239 L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         239 LKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             TCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             ccCCHhHCcCHHHHHcCcCcCCc
Confidence            99999999999999999999754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-64  Score=491.05  Aligned_cols=260  Identities=33%  Similarity=0.586  Sum_probs=244.4

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+++.+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            46889999999999999999999999999999999998876555555678899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVEL  165 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~  165 (441)
                      +||||++||+|++++...+.++++.++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876655556


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhc
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L  245 (441)
                      ..+.+||+.|+|||++.+.+| +.++|||||||++|+|++|.+||.+.+..++.+.+....+.+|..+|+++++||++||
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L  240 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  240 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhc
Confidence            678899999999999998887 5899999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCC-----hHhHhcCCCccc
Q 013520          246 DPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       246 ~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ++||++|++     ++|+++||||+.
T Consensus       241 ~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         241 KKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             cCCchhhcccccccHHHHHcCccccc
Confidence            999999994     899999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-64  Score=485.66  Aligned_cols=264  Identities=31%  Similarity=0.560  Sum_probs=238.8

Q ss_pred             CcccccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            2 KKQTRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         2 ~~~~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ++...+.++|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|++++||||+++++++.++
T Consensus         1 ~P~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~   80 (288)
T d1uu3a_           1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD   80 (288)
T ss_dssp             CCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred             CCCCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence            34556778999999999999999999999999999999999876655555567899999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      +.+|+||||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+|.....
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999987643


Q ss_pred             c--ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHH
Q 013520          162 G--VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATS  239 (441)
Q Consensus       162 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~  239 (441)
                      .  .....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+.++....+.+|..+|+++++
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  239 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD  239 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred             CCcccccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            2  233456789999999999988776 4899999999999999999999999998899999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCChHh------HhcCCCccc
Q 013520          240 LIHKILDPNPKTRIRIEG------IRKHPWFRK  266 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~e------il~hp~f~~  266 (441)
                      ||++||+.||++|||++|      |++||||+.
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            999999999999999998      578999964

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-64  Score=480.93  Aligned_cols=260  Identities=38%  Similarity=0.668  Sum_probs=225.8

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++.....  ..+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i   80 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   80 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence            3678999999999999999999999999999999998764322  34568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--cc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--VE  164 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--~~  164 (441)
                      ||||++||+|++++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|......  ..
T Consensus        81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999999866432  23


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhhcCcCCCC--CCCCHhHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKINAAEFSCP--FWFSTGATSLI  241 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~s~~~~~li  241 (441)
                      ...+.+||+.|+|||++.+..+++.++|||||||++|+|++|++||...+.. ..+..+.......+  ..+|+++.+||
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  240 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence            4567789999999999988888778899999999999999999999775543 33333333333332  34899999999


Q ss_pred             HHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          242 HKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      ++||+.||++|||++|+++||||++..
T Consensus       241 ~~~L~~dP~~R~t~~eil~hpwf~~~l  267 (271)
T d1nvra_         241 HKILVENPSARITIPDIKKDRWYNKPL  267 (271)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHhhCcCC
Confidence            999999999999999999999998643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-63  Score=473.87  Aligned_cols=253  Identities=26%  Similarity=0.448  Sum_probs=227.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.....   .+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            47999999999999999999999999999999998754332   467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccccc
Q 013520           89 EFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHT  168 (441)
Q Consensus        89 E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~  168 (441)
                      |||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|............
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999988765 67999999999999999999999999999999999999999999999999999877655555677


Q ss_pred             ccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc-C--cCCCCCCCCHhHHHHHHHhc
Q 013520          169 TCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA-A--EFSCPFWFSTGATSLIHKIL  245 (441)
Q Consensus       169 ~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li~~~L  245 (441)
                      .+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+.......+.. .  .+..|..+|+++++||.+||
T Consensus       176 ~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  254 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHT
T ss_pred             cccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHc
Confidence            889999999999988776 4899999999999999999999988776655554433 3  33455679999999999999


Q ss_pred             CCCCCCCCChHhHhcCCCccc
Q 013520          246 DPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ++||++|||++|+++||||+.
T Consensus       255 ~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         255 DMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             CSSTTTSCCHHHHTTCGGGGG
T ss_pred             cCChhHCcCHHHHhcCHhhCC
Confidence            999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-62  Score=476.50  Aligned_cols=256  Identities=33%  Similarity=0.692  Sum_probs=239.5

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ++++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            57899999999999999999999999999999999987665444556789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      ||||++||+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|......   .
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~  158 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T  158 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876442   3


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcC
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (441)
                      .+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+...++..+....|+.+|+++.++|.+||.
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  237 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT  237 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            567899999999999887775 8999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCC-----ChHhHhcCCCccc
Q 013520          247 PNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       247 ~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +||.+|+     |++++++||||++
T Consensus       238 ~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         238 RDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             SCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             hCHHhccccchhhHHHHHcCccccc
Confidence            9999996     9999999999976

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-62  Score=473.38  Aligned_cols=259  Identities=38%  Similarity=0.703  Sum_probs=215.9

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ....++|++++.||+|+||+||+|+++.+|+.||||++.+.....  ....+.+|+.+|+.++||||+++++++.+++.+
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   82 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHL   82 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            344567999999999999999999999999999999998765433  235688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc---cCCCeEEeeccccccCCc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD---SYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~---~~~~~kL~DFGls~~~~~  161 (441)
                      |+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+.   .+|.+||+|||+|.....
T Consensus        83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999999999989999999999999999999999999999999999999995   578999999999986554


Q ss_pred             cccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHhH
Q 013520          162 GVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGA  237 (441)
Q Consensus       162 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~  237 (441)
                      . ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+....+.......+    +.+|+++
T Consensus       163 ~-~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         163 G-SVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             C-CeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            3 345678899999999999887774 899999999999999999999999888888888877766543    3589999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      .+||.+||++||++|||++|+++||||+..
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-62  Score=468.73  Aligned_cols=256  Identities=29%  Similarity=0.455  Sum_probs=227.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIIL   88 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~   88 (441)
                      +.|++++.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46999999999999999999999999999999997653   223467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           89 EFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        89 E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      ||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...........
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            99999999998765 45799999999999999999999999999999999999999999999999999976554434456


Q ss_pred             cccCCCCcCCcccccc----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC---CCCCCCCHhHHHH
Q 013520          168 TTCGTPNYVAPEVLSN----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF---SCPFWFSTGATSL  240 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~l  240 (441)
                      +.+||+.|+|||++..    ...++.++|||||||++|+|++|.+||.+.+..+...++..+..   ..|..+|+++.+|
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l  248 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF  248 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            7889999999999842    22235899999999999999999999999888877777766543   3455689999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      |++||++||++|||++|+++||||+..
T Consensus       249 i~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         249 LKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-62  Score=465.49  Aligned_cols=256  Identities=30%  Similarity=0.558  Sum_probs=218.0

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe--CCEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS--RTKV   84 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~   84 (441)
                      +.++|++++.||+|+||+||+|+++.+|+.||+|++++.... ....+.+.+|+.+|++++|||||++++++.+  .+.+
T Consensus         2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            468999999999999999999999999999999999876553 3346778999999999999999999999864  4568


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEccCCCeEEeeccc
Q 013520           85 YIILEFVTGGELFDKIVH----QGRLLENDCRRYFQQLIDAVAHCHSKG-----VYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~----~~~l~e~~~~~~~~qll~aL~~LH~~g-----i~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                      |+|||||+||+|.+++..    ...+++..++.++.||+.||.|||++|     |+||||||+|||++.+|.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999999864    467999999999999999999999976     99999999999999999999999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCC-CCCCCC
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFS-CPFWFS  234 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s  234 (441)
                      |...........+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+...++..+.+. .|..+|
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s  239 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS  239 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccC
Confidence            9877665555667899999999999987776 48999999999999999999999999888888888777654 566799


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhcCCCc
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRKHPWF  264 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~hp~f  264 (441)
                      +++.+||++||+.||++|||++|+++|||+
T Consensus       240 ~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         240 DELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999999999999999999999999995

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-61  Score=476.64  Aligned_cols=258  Identities=32%  Similarity=0.647  Sum_probs=240.2

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      ...+++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+...+
T Consensus        37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            45578999999999999999999999999999999999876655555567889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      |+||||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....  
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999866532  


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHh
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKI  244 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~  244 (441)
                       ..+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+......++..+.+..|..+|+++.+||++|
T Consensus       195 -~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  272 (350)
T d1rdqe_         195 -TWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL  272 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred             -cccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence             3467899999999999887774 89999999999999999999999999889999999999999999999999999999


Q ss_pred             cCCCCCCCC-----ChHhHhcCCCccc
Q 013520          245 LDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       245 L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      |++||.+|+     |++++++||||+.
T Consensus       273 L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         273 LQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             hhhCHHhccccccccHHHHHcCccccC
Confidence            999999995     9999999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=471.22  Aligned_cols=258  Identities=30%  Similarity=0.581  Sum_probs=237.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHH-hCCCCCcceeEEEEEeCCEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMK-IVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+.+|+.++. .++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            478999999999999999999999999999999998765444444566667777765 6899999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           87 ILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      ||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++..........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998766555556


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHHHHHhcC
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSLIHKILD  246 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~  246 (441)
                      ...+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||.+.+..++..++..+.+.+|..+|+++.+||++||+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~  239 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV  239 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSC
T ss_pred             cccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcc
Confidence            678999999999999887775 8999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCChH-hHhcCCCccc
Q 013520          247 PNPKTRIRIE-GIRKHPWFRK  266 (441)
Q Consensus       247 ~dP~~R~t~~-eil~hp~f~~  266 (441)
                      .||++|||+. ++++||||++
T Consensus       240 ~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         240 REPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             SSGGGSBTTBSCGGGSGGGTT
T ss_pred             cCCCCCcCHHHHHHhCchhcc
Confidence            9999999995 8999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-61  Score=468.17  Aligned_cols=255  Identities=25%  Similarity=0.373  Sum_probs=228.8

Q ss_pred             CeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           10 KYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        10 ~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      .|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999988766666667789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      ||.||+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|.....    ....
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~~  171 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANSF  171 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CCcc
Confidence            999999988888888999999999999999999999999999999999999999999999999999986543    2467


Q ss_pred             cCCCCcCCccccccC--CCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC--CCCCCHhHHHHHHHhc
Q 013520          170 CGTPNYVAPEVLSNR--GYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC--PFWFSTGATSLIHKIL  245 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~--~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~s~~~~~li~~~L  245 (441)
                      +||+.|+|||++.+.  +.++.++|||||||++|+|++|..||.+.+..+....+.....+.  +..+|+++.+||++||
T Consensus       172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L  251 (309)
T d1u5ra_         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL  251 (309)
T ss_dssp             CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred             ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence            899999999998642  234589999999999999999999999888777766665554432  3458999999999999


Q ss_pred             CCCCCCCCChHhHhcCCCccccC
Q 013520          246 DPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       246 ~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      +.||++|||++|+++||||++..
T Consensus       252 ~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         252 QKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             CSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             cCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999998653

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-61  Score=461.14  Aligned_cols=258  Identities=34%  Similarity=0.602  Sum_probs=233.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch---HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH---RMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      .-++|++++.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+.+|+.++|||||++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            34679999999999999999999999999999999987654322   235779999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC----CeEEeeccccccC
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG----NLKVSDFGLSALP  159 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~----~~kL~DFGls~~~  159 (441)
                      +|+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|    .+||+|||+|...
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~  167 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  167 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence            999999999999999999989999999999999999999999999999999999999998776    5999999999876


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCH
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFST  235 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~  235 (441)
                      ... ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+    +.+|+
T Consensus       168 ~~~-~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (293)
T d1jksa_         168 DFG-NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA  245 (293)
T ss_dssp             TTS-CBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred             CCC-ccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence            543 33456789999999999987666 5999999999999999999999999998888888888776654    45899


Q ss_pred             hHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          236 GATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       236 ~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      ++++||++||+.||++|||++|+++||||+.
T Consensus       246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            9999999999999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.3e-61  Score=471.10  Aligned_cols=260  Identities=29%  Similarity=0.606  Sum_probs=233.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++.+..   ....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            45679999999999999999999999999999999997653   233567899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--cCCCeEEeeccccccCCcc
Q 013520           86 IILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD--SYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~--~~~~~kL~DFGls~~~~~~  162 (441)
                      +||||++||+|.+++.. .+++++..++.++.||+.||.|||++||+||||||+|||++  .+|.+||+|||+|......
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999999999954 46799999999999999999999999999999999999996  4678999999999866543


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGAT  238 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~  238 (441)
                       ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+....+....+..+.    .+|++++
T Consensus       180 -~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         180 -QSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             -SCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             -cccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence             334577899999999999887774 8999999999999999999999999888888888877765543    4899999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      +||++||++||++|||++|+++||||+....+
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            99999999999999999999999999876543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-60  Score=470.00  Aligned_cols=259  Identities=27%  Similarity=0.562  Sum_probs=232.9

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||.||+|+++.+|+.||||++++...   ...+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~  102 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV  102 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            446789999999999999999999999999999999987542   23457889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc--cCCCeEEeeccccccCCcc
Q 013520           86 IILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD--SYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~--~~~~~kL~DFGls~~~~~~  162 (441)
                      +|||||+||+|++.+...+ ++++.+++.++.||+.||.|||++||+||||||+||||+  .+|.+||+|||+|......
T Consensus       103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999999999999886644 699999999999999999999999999999999999998  5789999999999876543


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCC----CCCCHhHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCP----FWFSTGAT  238 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~s~~~~  238 (441)
                       ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+....+....+.+|    ..+|+++.
T Consensus       183 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         183 -EIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             -SCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             -CceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence             34567789999999999988776 4899999999999999999999999998888888887776554    35899999


Q ss_pred             HHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          239 SLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       239 ~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                      +||.+||++||.+|||++|+++||||+....
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~  291 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  291 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence            9999999999999999999999999987543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-60  Score=451.65  Aligned_cols=253  Identities=23%  Similarity=0.442  Sum_probs=220.6

Q ss_pred             ccCe-EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe----CC
Q 013520            8 VAKY-EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS----RT   82 (441)
Q Consensus         8 ~~~y-~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~   82 (441)
                      -++| ++.+.||+|+||+||+|+++.++..||+|.+....... ...+.+.+|+.+|++++|||||++++++.+    +.
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   85 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK   85 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence            3456 78889999999999999999999999999998765433 345779999999999999999999999875    45


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEc-cCCCeEEeeccccccC
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKG--VYHRDLKPENLLLD-SYGNLKVSDFGLSALP  159 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~g--i~HrDlkp~NILl~-~~~~~kL~DFGls~~~  159 (441)
                      .+|+||||++||+|.+++.....+++..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+..
T Consensus        86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            68999999999999999999899999999999999999999999998  99999999999997 5789999999999864


Q ss_pred             CccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCC-hHHHHHHhhcCcCC--CCCCCCHh
Q 013520          160 QQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETD-LPTLYKKINAAEFS--CPFWFSTG  236 (441)
Q Consensus       160 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~--~~~~~s~~  236 (441)
                      ..  ....+.+||+.|+|||++.+ .| +.++|||||||++|+|++|+.||.+.+ ....++.+..+..+  .+...+++
T Consensus       166 ~~--~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         166 RA--SFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             CT--TSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             cC--CccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence            43  23457789999999999865 45 589999999999999999999997654 45566666655432  34458999


Q ss_pred             HHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          237 ATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       237 ~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      +.+||.+||++||++|||++|+++||||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-61  Score=470.48  Aligned_cols=257  Identities=25%  Similarity=0.404  Sum_probs=219.4

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ..-++|++++.||+|+||.||+|+++.+|+.||+|++++..  .....+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            34578999999999999999999999999999999998753  2334578899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCCeEEeeccccccCCcccc
Q 013520           86 IILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE  164 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~  164 (441)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|.....  .
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~  158 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--S  158 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--H
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--C
Confidence            999999999999999998999999999999999999999997 5999999999999999999999999999985433  3


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHH-----------------------
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKK-----------------------  221 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~-----------------------  221 (441)
                      ...+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.......                       
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence            34577999999999999887764 899999999999999999999976543221110                       


Q ss_pred             -------------------hhcCc-CCCCC-CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          222 -------------------INAAE-FSCPF-WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       222 -------------------i~~~~-~~~~~-~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                         +.... ...|. .+|+++.+||.+||+.||++|||++|+++||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                               00000 01111 258899999999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5e-60  Score=451.08  Aligned_cols=258  Identities=30%  Similarity=0.565  Sum_probs=231.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccc------hHHHHHHHHHHHHHHhCC-CCCcceeEEEEEe
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILK------HRMVDQIKREISIMKIVR-HPNIVRLHEVLAS   80 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~------~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~   80 (441)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++++.....      ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999998765432      223456889999999996 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      ++.+|+||||++||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999998765


Q ss_pred             ccccccccccCCCCcCCcccccc-----CCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSN-----RGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----  231 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~-----~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----  231 (441)
                      .. ......+||+.|+|||++.+     ...++.++||||+||++|+|++|..||.+.+.....+.+..+....+.    
T Consensus       162 ~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         162 PG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            43 33456789999999999863     233468999999999999999999999999888888888777654433    


Q ss_pred             CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          232 WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       232 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                      .+|+++++||.+||++||++|||++|+++||||++
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            48999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-60  Score=471.09  Aligned_cols=259  Identities=30%  Similarity=0.461  Sum_probs=226.5

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHH---HHHHHHhCCCCCcceeEEEEEeCC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKR---EISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~---Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .++++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+   |+.+++.++|||||++++++.+++
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            36789999999999999999999999999999999998755433322233334   466777778999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      .+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999865542


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH---HHHHHhhcCcCCCCCCCCHhHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP---TLYKKINAAEFSCPFWFSTGATS  239 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~~s~~~~~  239 (441)
                        .....+||+.|+|||++.+...++.++|||||||+||+|++|..||.+.+..   ...+.+.......|..+|+++++
T Consensus       161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  238 (364)
T d1omwa3         161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS  238 (364)
T ss_dssp             --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred             --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence              3456789999999999976555568999999999999999999999875433   34445556666777889999999


Q ss_pred             HHHHhcCCCCCCCCC-----hHhHhcCCCccc
Q 013520          240 LIHKILDPNPKTRIR-----IEGIRKHPWFRK  266 (441)
Q Consensus       240 li~~~L~~dP~~R~t-----~~eil~hp~f~~  266 (441)
                      ||.+||+.||++|||     ++|+++||||+.
T Consensus       239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            999999999999999     799999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-60  Score=458.76  Aligned_cols=255  Identities=27%  Similarity=0.507  Sum_probs=231.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++++...    ....+.+|+.+|+.++||||+++++++.+++.+|+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            56899999999999999999999999999999999977532    23467899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccC--CCeEEeeccccccCCccc
Q 013520           87 ILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSY--GNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~--~~~kL~DFGls~~~~~~~  163 (441)
                      |||||+||+|++++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||++...... 
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-  157 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence            999999999999998765 79999999999999999999999999999999999999854  48999999999866543 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC----CCCHhHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF----WFSTGATS  239 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~~~~  239 (441)
                      ....+.+||+.|+|||++.+..| +.++|||||||++|+|++|.+||.+.+..+.+..+....+.++.    .+|+++.+
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            33456789999999999987766 48999999999999999999999999998999999888777664    58999999


Q ss_pred             HHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          240 LIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       240 li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                      ||++||+.||++|||++|+++||||++.
T Consensus       237 li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            9999999999999999999999999754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-60  Score=454.47  Aligned_cols=259  Identities=25%  Similarity=0.315  Sum_probs=220.4

Q ss_pred             EEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccch--HHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEe
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKH--RMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILE   89 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~--~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E   89 (441)
                      +.++.||+|+||+||+|+++.+|+.||||++++......  ...+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            357899999999999999999999999999976543221  223568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccccc
Q 013520           90 FVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLHTT  169 (441)
Q Consensus        90 ~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~~~  169 (441)
                      |+.|+++.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|...........+.
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            99999888877777889999999999999999999999999999999999999999999999999998776655556678


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcC--------------------C-
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEF--------------------S-  228 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--------------------~-  228 (441)
                      +||+.|+|||++....+++.++||||+||++|+|++|.+||.+.+..+...++.....                    . 
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            9999999999997666667899999999999999999999998887766655532100                    0 


Q ss_pred             -------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          229 -------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       229 -------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                             ....+|+++.+||++||+.||++|||++|+++||||++...|
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence                   012368899999999999999999999999999999875443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-59  Score=447.70  Aligned_cols=253  Identities=32%  Similarity=0.533  Sum_probs=224.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchH---HHHHHHHHHHHHHhCC--CCCcceeEEEEEeCC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHR---MVDQIKREISIMKIVR--HPNIVRLHEVLASRT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~---~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~   82 (441)
                      -++|++.+.||+|+||.||+|+++.+|+.||||++.+.......   ....+.+|+.+|+.++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46899999999999999999999999999999999876543221   1234668999999996  899999999999999


Q ss_pred             EEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-CCCeEEeeccccccCC
Q 013520           83 KVYIILEFVTG-GELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-YGNLKVSDFGLSALPQ  160 (441)
Q Consensus        83 ~~~lv~E~~~g-g~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-~~~~kL~DFGls~~~~  160 (441)
                      ..|+||||+.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|....
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence            99999999986 688899988899999999999999999999999999999999999999985 4799999999997654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCCCCCHhHHHH
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPFWFSTGATSL  240 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l  240 (441)
                      .  ....+.+||+.|+|||++.+..+++.++|||||||++|+|++|..||...      ..+..+...++..+|+++.+|
T Consensus       163 ~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         163 D--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHL  234 (273)
T ss_dssp             S--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHHH
T ss_pred             c--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHHH
Confidence            3  33457789999999999988887778899999999999999999999753      235566778888999999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          241 IHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      |++||+.||++|||++|+++||||++..
T Consensus       235 i~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999998643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=445.85  Aligned_cols=262  Identities=31%  Similarity=0.442  Sum_probs=221.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++..... ....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            47999999999999999999999999999999999765432 23356788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccccc
Q 013520           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELL  166 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~  166 (441)
                      |||+.++.+...... ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|..........
T Consensus        80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            999976544433333 4579999999999999999999999999999999999999999999999999998766555566


Q ss_pred             ccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc------------------CC
Q 013520          167 HTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE------------------FS  228 (441)
Q Consensus       167 ~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~------------------~~  228 (441)
                      ...+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+..+...++....                  ..
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            777899999999999888888899999999999999999999998877655444432110                  00


Q ss_pred             C-----------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          229 C-----------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       229 ~-----------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                      .           .+.+|+++.+||++||++||++|||++|+++||||++-..|
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            1           12367899999999999999999999999999999876555

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=450.90  Aligned_cols=255  Identities=33%  Similarity=0.580  Sum_probs=217.5

Q ss_pred             ccccccCeEEEe-eeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCCcceeEEEEEe-
Q 013520            4 QTRRVAKYEVGR-TIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKI-VRHPNIVRLHEVLAS-   80 (441)
Q Consensus         4 ~~~~~~~y~i~~-~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~-l~hpnIv~l~~~~~~-   80 (441)
                      +...+++|+++. .||+|+||+||+|+++.+|+.||||++++.        ..+.+|+.++.+ .+|||||+++++|.+ 
T Consensus         6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            445688999975 699999999999999999999999998652        346789998765 489999999999976 


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CCCeEEee
Q 013520           81 ---RTKVYIILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSD  152 (441)
Q Consensus        81 ---~~~~~lv~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~D  152 (441)
                         ...+|+|||||+||+|++++...  .++++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence               46799999999999999999864  46999999999999999999999999999999999999985   46799999


Q ss_pred             ccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHH----HHHHhhcCcCC
Q 013520          153 FGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPT----LYKKINAAEFS  228 (441)
Q Consensus       153 FGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~  228 (441)
                      ||+|+..... ......+||+.|+|||++.+..|+ .++|||||||+||+|++|.+||.+.+...    +...+....+.
T Consensus       158 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~  235 (335)
T d2ozaa1         158 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE  235 (335)
T ss_dssp             CTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred             cceeeeccCC-CccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence            9999866543 344677899999999999887775 89999999999999999999997765433    33445555555


Q ss_pred             CCC----CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          229 CPF----WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       229 ~~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                      +|.    .+|+++.+||++||+.||++|||++|+++||||++..
T Consensus       236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            553    3899999999999999999999999999999997653

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.5e-58  Score=438.84  Aligned_cols=257  Identities=30%  Similarity=0.434  Sum_probs=220.2

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++++.||+|+||+||+|+++ +|+.||||+++..... ....+.+.+|+.+|+.++||||+++++++.+++..|++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            479999999999999999999996 7899999999776533 23357788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      |||+.++.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|...........
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            99999988888888888999999999999999999999999999999999999999999999999999987655444456


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc---------------------
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE---------------------  226 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~---------------------  226 (441)
                      ...|++.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+...++....                     
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            66799999999999887777899999999999999999999999887665554432100                     


Q ss_pred             --------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          227 --------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       227 --------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                              ...+..+|+++.+||++||++||++|||++|+++||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                    0112346889999999999999999999999999999974

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-56  Score=427.96  Aligned_cols=260  Identities=24%  Similarity=0.391  Sum_probs=218.4

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC--
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT--   82 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--   82 (441)
                      ...-++|++.+.||+|+||.||+|+++.+|+.||||++++.........+.+.+|+.+++.++||||+++++++...+  
T Consensus         3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred             cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence            344567999999999999999999999999999999998877666666788999999999999999999999997654  


Q ss_pred             --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           83 --KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        83 --~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                        .+|+||||++||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+....
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence              489999999999999999999999999999999999999999999999999999999999999999999999886543


Q ss_pred             cc---ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC----CCCC
Q 013520          161 QG---VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC----PFWF  233 (441)
Q Consensus       161 ~~---~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~----~~~~  233 (441)
                      ..   .....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+...++.......    +..+
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             cccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            32   2234567899999999999877664 89999999999999999999999888777766655544433    3458


Q ss_pred             CHhHHHHHHHhcCCCCCCCCChHhHhcCCCcc
Q 013520          234 STGATSLIHKILDPNPKTRIRIEGIRKHPWFR  265 (441)
Q Consensus       234 s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~  265 (441)
                      |+++.++|.+||++||++||+..+.+.|+|.+
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            99999999999999999999544445566664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-56  Score=425.32  Aligned_cols=260  Identities=32%  Similarity=0.457  Sum_probs=227.6

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            4789999999999999999999999999999999977653 334568899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccccccc
Q 013520           88 LEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVELLH  167 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~~~~  167 (441)
                      +|++.|++|...+...+.+++..++.++.|++.||+|||++||+||||||+|||++.++++||+|||.|...........
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            99999999999999889999999999999999999999999999999999999999999999999999987766555556


Q ss_pred             cccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCC-CCCChHHHHHHhhcC---------------------
Q 013520          168 TTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPF-GETDLPTLYKKINAA---------------------  225 (441)
Q Consensus       168 ~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~---------------------  225 (441)
                      ...+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+..+...++...                     
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            6678899999999988777779999999999999999999885 445555554443211                     


Q ss_pred             --------cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          226 --------EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       226 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                              ....+..+++.+.+||++||++||++|||++|+|+||||++..
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                    0112234688999999999999999999999999999998643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=433.88  Aligned_cols=263  Identities=25%  Similarity=0.331  Sum_probs=218.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-----   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----   80 (441)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||++.++... ......+.+|+.+|+.++||||+++++++..     
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~   85 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPY   85 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence            3579999999999999999999999999999999999776543 2344678899999999999999999999854     


Q ss_pred             ---CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           81 ---RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        81 ---~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                         ++.+|++|||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence               45689999999988777666667789999999999999999999999999999999999999999999999999997


Q ss_pred             cCCcc----ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCCCC--
Q 013520          158 LPQQG----VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSCPF--  231 (441)
Q Consensus       158 ~~~~~----~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~--  231 (441)
                      .....    .....+.+||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+.......++  
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            55431    223455689999999999987666679999999999999999999999887766555544322111110  


Q ss_pred             ------------------------------CCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          232 ------------------------------WFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       232 ------------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                                    ..++++.+||.+||++||++|||++|+++||||+..+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence                                          03678899999999999999999999999999986543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=430.45  Aligned_cols=257  Identities=29%  Similarity=0.376  Sum_probs=213.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCC-CcEEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCCcceeEEEEEe---
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRET-GESVAMKVLAKSTILKHRMVDQIKREISIMKIV---RHPNIVRLHEVLAS---   80 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~---   80 (441)
                      -++|++++.||+|+||+||+|++..+ ++.||||++........ ....+.+|+.+++.+   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            46899999999999999999999765 67899999976543221 223456788877766   79999999999853   


Q ss_pred             --CCEEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520           81 --RTKVYIILEFVTGGELFDKIV-HQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus        81 --~~~~~lv~E~~~gg~L~~~i~-~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                        ...+|++|||+.++.+..... ....+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              357899999999887754443 34579999999999999999999999999999999999999999999999999988


Q ss_pred             cCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc-----------
Q 013520          158 LPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE-----------  226 (441)
Q Consensus       158 ~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~-----------  226 (441)
                      ..... ......+||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+..+...++....           
T Consensus       165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (305)
T d1blxa_         165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  242 (305)
T ss_dssp             CCCGG-GGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             hhccc-ccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccc
Confidence            65443 345678899999999999887774 89999999999999999999999888766655542110           


Q ss_pred             ----------------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCcccc
Q 013520          227 ----------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKN  267 (441)
Q Consensus       227 ----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~  267 (441)
                                      ...+..+|+.+.+||++||++||++|||++|+++||||++-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                            01233478999999999999999999999999999999853

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-55  Score=423.39  Aligned_cols=248  Identities=26%  Similarity=0.362  Sum_probs=217.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|++.+.||+|+||+||+|+++.+|+.||||+++.+...    .+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   91 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence            45789999999999999999999999999999999765432    45688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc-
Q 013520           88 LEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE-  164 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~-  164 (441)
                      |||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....... 
T Consensus        92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            9999999999999764  5789999999999999999999999999999999999999999999999999987654322 


Q ss_pred             ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCC-CCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHH
Q 013520          165 LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIH  242 (441)
Q Consensus       165 ~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~-~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~  242 (441)
                      ......||+.|+|||++.+..|+ .++||||+||++|+|++|. +||.+.+.....+.+..+ ....|..+|+++.+||.
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  250 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR  250 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence            23344589999999999887764 8999999999999999955 556666666666666544 45677789999999999


Q ss_pred             HhcCCCCCCCCChHhHhc
Q 013520          243 KILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       243 ~~L~~dP~~R~t~~eil~  260 (441)
                      +||+.||++|||++++++
T Consensus       251 ~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         251 ACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHH
Confidence            999999999999999965

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=432.60  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=213.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----   82 (441)
                      .-++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||++++++...+    
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            45799999999999999999999999999999999976543 3445678999999999999999999999997654    


Q ss_pred             --EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           83 --KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        83 --~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                        .+|+||||+ |++|...+. .+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  172 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence              579999999 566766654 5789999999999999999999999999999999999999999999999999998654


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCc--------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAE--------------  226 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~--------------  226 (441)
                      .   .....+||+.|+|||++.+..+.+.++||||+||++|+|++|.+||.+.+.......+....              
T Consensus       173 ~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         173 S---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             S---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             C---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            3   24567899999999999877777899999999999999999999998877554433322110              


Q ss_pred             -----------------CCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          227 -----------------FSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       227 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                                       ......+++++.+||++||..||++|||++|+|+||||+.-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                             012234789999999999999999999999999999998643

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=428.07  Aligned_cols=261  Identities=32%  Similarity=0.586  Sum_probs=226.3

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEE---CCCCcEEEEEEeecccccc-hHHHHHHHHHHHHHHhCCC-CCcceeEEEEEe
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQN---RETGESVAMKVLAKSTILK-HRMVDQIKREISIMKIVRH-PNIVRLHEVLAS   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~---~~~~~~vavK~i~~~~~~~-~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~   80 (441)
                      ..+++|++++.||+|+||+||+|++   +.+|+.||||++++..... ....+.+.+|+.+|++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            3568999999999999999999987   4478999999997754322 2234567899999999976 899999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      ...+|++|||+.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999997654


Q ss_pred             c-cccccccccCCCCcCCccccccCC-CCCCCcchhhHhHHHHHHhcCCCCCCCCChH----HHHHHhhcCcCCCCCCCC
Q 013520          161 Q-GVELLHTTCGTPNYVAPEVLSNRG-YDGSAADVWSCGVILFVLMAGYLPFGETDLP----TLYKKINAAEFSCPFWFS  234 (441)
Q Consensus       161 ~-~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~~s  234 (441)
                      . ......+.+|++.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+..    ...+.......+.|..+|
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s  260 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS  260 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence            3 333456778999999999997544 4567999999999999999999999775543    334444556677778899


Q ss_pred             HhHHHHHHHhcCCCCCCCC-----ChHhHhcCCCccc
Q 013520          235 TGATSLIHKILDPNPKTRI-----RIEGIRKHPWFRK  266 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~-----t~~eil~hp~f~~  266 (441)
                      +++.+||++||++||++||     |++|+++||||++
T Consensus       261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            9999999999999999999     5899999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-55  Score=430.07  Aligned_cols=255  Identities=29%  Similarity=0.368  Sum_probs=212.6

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-----
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-----   80 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----   80 (441)
                      ....+|+.++.||+|+||+||+|+++.+|+.||||++.++...       ..+|+.+|+.++||||+++++++..     
T Consensus        17 ~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~   89 (350)
T d1q5ka_          17 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKK   89 (350)
T ss_dssp             CEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CC
T ss_pred             cccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccC
Confidence            3344799999999999999999999999999999999775422       2379999999999999999999854     


Q ss_pred             -CCEEEEEEeccCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeeccc
Q 013520           81 -RTKVYIILEFVTGGELFD---KIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGL  155 (441)
Q Consensus        81 -~~~~~lv~E~~~gg~L~~---~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGl  155 (441)
                       ..++|+||||++++.+..   .......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+
T Consensus        90 ~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          90 DEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             SCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             CceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccc
Confidence             345899999998764333   234456899999999999999999999999999999999999999775 899999999


Q ss_pred             cccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC----------
Q 013520          156 SALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------  225 (441)
Q Consensus       156 s~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------  225 (441)
                      +...... ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|.+||...+..+....+...          
T Consensus       170 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         170 AKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            9866543 33456789999999999877666679999999999999999999999887765554443210          


Q ss_pred             -------cCC------------CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          226 -------EFS------------CPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       226 -------~~~------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                             ...            ..+.+++++.+||++||+.||++|||+.|+++||||++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence                   001            1234789999999999999999999999999999998654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=415.44  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=208.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|++++.||+|+||.||+|+++ +++.||||++++....    .+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            468999999999999999999986 5678999999765432    35688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-cc
Q 013520           88 LEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-EL  165 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~  165 (441)
                      |||+++|+|.+++... ..++++.+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++...... ..
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999999998754 568899999999999999999999999999999999999999999999999998665432 23


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (441)
                      .....||+.|+|||++.+..|+ .++|||||||++|||++ |.+||...+..+..+.+..+ ....|..+++++.+++.+
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            3456799999999999887764 89999999999999998 67888888877787777665 445667789999999999


Q ss_pred             hcCCCCCCCCChHhHhcC
Q 013520          244 ILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (441)
                      ||+.||++|||+++|++|
T Consensus       238 cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHH
Confidence            999999999999999886

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-55  Score=420.37  Aligned_cols=247  Identities=20%  Similarity=0.343  Sum_probs=211.0

Q ss_pred             eeeeecCcEEEEEEEEC--CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEEEeccC
Q 013520           15 RTIGEGTFAKVRFAQNR--ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYIILEFVT   92 (441)
Q Consensus        15 ~~LG~G~~g~V~~a~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   92 (441)
                      +.||+|+||+||+|.+.  .+++.||||++..... .....+.+.+|+.+|++++|||||++++++.++ ..|+||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            47999999999999764  4567899999976543 334567899999999999999999999998654 5789999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc---cccccc
Q 013520           93 GGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV---ELLHTT  169 (441)
Q Consensus        93 gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~---~~~~~~  169 (441)
                      +|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......   ......
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            99999999998999999999999999999999999999999999999999999999999999998654321   123345


Q ss_pred             cCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHHhcCC
Q 013520          170 CGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHKILDP  247 (441)
Q Consensus       170 ~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~  247 (441)
                      .||+.|+|||++.+..+ +.++|||||||++|||++ |.+||.+.+..+....+..+ .++.|..+|+++.+||.+||+.
T Consensus       171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence            79999999999987666 489999999999999997 99999998888887777665 4567788999999999999999


Q ss_pred             CCCCCCChHhH---hcCCCc
Q 013520          248 NPKTRIRIEGI---RKHPWF  264 (441)
Q Consensus       248 dP~~R~t~~ei---l~hp~f  264 (441)
                      ||++|||+++|   |+|+|+
T Consensus       250 dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHh
Confidence            99999999998   466665

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.5e-55  Score=421.44  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=209.1

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCc---EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGE---SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~---~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      ...++|++.+.||+|+||+||+|+++.+|+   .||||.+....  .....+.+.+|+.+|+.++|||||++++++.+++
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~  100 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST  100 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            346789999999999999999999987765   58889876543  2334577999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      .+|+||||++||+|.+++... +.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999999988774 4699999999999999999999999999999999999999999999999999986644


Q ss_pred             cccc-----cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCC
Q 013520          162 GVEL-----LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFS  234 (441)
Q Consensus       162 ~~~~-----~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s  234 (441)
                      ....     .....||+.|+|||++.+..|. .++|||||||++|||++ |.+||.+.+..+....+..+ ..+.|..++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP  259 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence            2111     1234578999999999876664 89999999999999998 89999998888887777654 456677799


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +++.+|+.+||+.||++|||+.||+++
T Consensus       260 ~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         260 SALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999998765

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-55  Score=427.80  Aligned_cols=259  Identities=27%  Similarity=0.429  Sum_probs=214.0

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----KV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~   84 (441)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..  .....+.+.+|+.+|+.++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            67999999999999999999999999999999997643  3445677889999999999999999999997653    23


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (441)
                      +++++|+.||+|++++.. .++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|......  
T Consensus        86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            444456679999999976 57999999999999999999999999999999999999999999999999999765442  


Q ss_pred             -ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcC----------------
Q 013520          163 -VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAA----------------  225 (441)
Q Consensus       163 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~----------------  225 (441)
                       .......+||+.|+|||++.....++.++||||+||++|+|++|.+||.+.+...........                
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence             123456789999999999977666678999999999999999999999887654433322110                


Q ss_pred             ---------cC------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCCC
Q 013520          226 ---------EF------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYNP  270 (441)
Q Consensus       226 ---------~~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~~  270 (441)
                               ..      ...+.+|+++++||.+||+.||++|||++|+++||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                     00      0123478899999999999999999999999999999876544

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-55  Score=428.19  Aligned_cols=251  Identities=22%  Similarity=0.366  Sum_probs=212.5

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCc-----EEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGE-----SVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~-----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   81 (441)
                      .++|++++.||+|+||+||+|++..+++     .||+|.+.....  ......+.+|+.+|+.+ +|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            4689999999999999999999876544     689998865432  22346788999999988 899999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ-----------------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE  138 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~-----------------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~  138 (441)
                      +.+|+|||||+||+|.++|...                       ..+++..+..++.||+.||.|||++||+||||||+
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~  193 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR  193 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchh
Confidence            9999999999999999999754                       24889999999999999999999999999999999


Q ss_pred             cEEEccCCCeEEeeccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCCh
Q 013520          139 NLLLDSYGNLKVSDFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDL  215 (441)
Q Consensus       139 NILl~~~~~~kL~DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~  215 (441)
                      |||++.++++||+|||+|+.......  ...+.+||+.|+|||++.+..| +.++|||||||++|+|++ |.+||.+.+.
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999986554322  2345678999999999987766 489999999999999997 8999988665


Q ss_pred             HHHHHHh-hcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          216 PTLYKKI-NAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       216 ~~~~~~i-~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .....++ ..+ .++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus       273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5444443 332 456677899999999999999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=418.06  Aligned_cols=255  Identities=24%  Similarity=0.359  Sum_probs=219.6

Q ss_pred             cccCeEEEee-eeecCcEEEEEEEECC--CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCE
Q 013520            7 RVAKYEVGRT-IGEGTFAKVRFAQNRE--TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTK   83 (441)
Q Consensus         7 ~~~~y~i~~~-LG~G~~g~V~~a~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~   83 (441)
                      ..++|.+.+. ||+|+||.||+|.++.  ++..||||+++...  .....+.+.+|+.+|++++|||||++++++.+ +.
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            3467888885 9999999999998764  45589999997643  33446789999999999999999999999875 45


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      +|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            8999999999999998865 457999999999999999999999999999999999999999999999999999866442


Q ss_pred             c---cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhH
Q 013520          163 V---ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGA  237 (441)
Q Consensus       163 ~---~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~  237 (441)
                      .   ......+||+.|+|||++.+..+ +.++|||||||++|||++ |..||.+.+..+....+..+. .+.|+.+|+++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  241 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL  241 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence            2   22345578999999999987666 489999999999999998 999999988888888776654 56778899999


Q ss_pred             HHHHHHhcCCCCCCCCChHhH---hcCCCcc
Q 013520          238 TSLIHKILDPNPKTRIRIEGI---RKHPWFR  265 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~ei---l~hp~f~  265 (441)
                      .+||.+||+.||++|||+.+|   |+|+|+.
T Consensus       242 ~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            999999999999999999888   6788774

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=418.58  Aligned_cols=251  Identities=21%  Similarity=0.335  Sum_probs=207.3

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++++.||+|+||+||+|+.+   ..||||+++...... ...+.+.+|+.+|++++|||||++++++. .+.+|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEE
Confidence            34578999999999999999999754   359999997655433 34678999999999999999999999865 45689


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc--
Q 013520           86 IILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG--  162 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~--  162 (441)
                      +||||++||+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|......  
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999999754 56999999999999999999999999999999999999999999999999999876442  


Q ss_pred             ccccccccCCCCcCCccccccCC--CCCCCcchhhHhHHHHHHhcCCCCCCCCChHH-HHHHhhcCcC-----CCCCCCC
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRG--YDGSAADVWSCGVILFVLMAGYLPFGETDLPT-LYKKINAAEF-----SCPFWFS  234 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~--~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~-----~~~~~~s  234 (441)
                      .....+.+||+.|+|||++.+..  .++.++|||||||+||||++|+.||.+.+... ....+..+..     ..+..+|
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence            22345678999999999996432  23579999999999999999999998866543 3334433322     2345689


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      +++.+||.+||+.||++|||+++|+++
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999887

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-55  Score=416.78  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=218.4

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~l   86 (441)
                      ..++|++++.||+|+||.||+|+++ ++..||||+++.....    .+.+.+|+.++++++|||||++++++.+ +..|+
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i   84 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI   84 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence            3479999999999999999999986 5788999999765432    3568999999999999999999998754 56799


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-
Q 013520           87 ILEFVTGGELFDKIVHQ--GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-  163 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~--~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-  163 (441)
                      ||||+++|+|.+++...  .++++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... 
T Consensus        85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            99999999999977543  369999999999999999999999999999999999999999999999999998765432 


Q ss_pred             cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHH
Q 013520          164 ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLI  241 (441)
Q Consensus       164 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li  241 (441)
                      .......||+.|+|||++.+..+ +.++|||||||++|||++ |.+||...+..+..+.+..+ ....|..+|+++.+|+
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  243 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM  243 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHH
Confidence            23445679999999999987666 489999999999999999 56777777777777777654 4566778999999999


Q ss_pred             HHhcCCCCCCCCChHhHhc--CCCcc
Q 013520          242 HKILDPNPKTRIRIEGIRK--HPWFR  265 (441)
Q Consensus       242 ~~~L~~dP~~R~t~~eil~--hp~f~  265 (441)
                      .+||+.||++|||+++|++  |+||.
T Consensus       244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         244 RLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999988  78885

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-55  Score=410.42  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=221.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVYII   87 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~lv   87 (441)
                      .++|++++.||+|+||+||+|+++ ++..||||++++....    .+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            368999999999999999999985 7789999999876543    35688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc-cc
Q 013520           88 LEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV-EL  165 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~-~~  165 (441)
                      |||+++|+|.+++.. ...+++..+.+++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999998655 4578999999999999999999999999999999999999999999999999997654432 23


Q ss_pred             cccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHHHHH
Q 013520          166 LHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSLIHK  243 (441)
Q Consensus       166 ~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~  243 (441)
                      .....||+.|+|||++.+..++ .++|||||||++|||++ |+.||.+.+..+...++..+ ....|...++++.+||++
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence            3356799999999999887775 89999999999999998 89999999988888888765 445667789999999999


Q ss_pred             hcCCCCCCCCChHhHhcC
Q 013520          244 ILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       244 ~L~~dP~~R~t~~eil~h  261 (441)
                      ||+.||++|||+++|++|
T Consensus       237 cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         237 CWHEKADERPTFKILLSN  254 (258)
T ss_dssp             TTCSSGGGSCCHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHH
Confidence            999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=426.58  Aligned_cols=257  Identities=25%  Similarity=0.350  Sum_probs=216.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC-----C
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR-----T   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~   82 (441)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            3689999999999999999999999999999999987543 333456788999999999999999999999643     3


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           83 KVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      ..+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++..... 
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence            34666777889999998865 6799999999999999999999999999999999999999999999999999876543 


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhcCcCCC-------------
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINAAEFSC-------------  229 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-------------  229 (441)
                        ...+.+||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+.......+.......             
T Consensus       174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence              34567899999999998887777899999999999999999999999887665555443211110             


Q ss_pred             ------------------CCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccCC
Q 013520          230 ------------------PFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNYN  269 (441)
Q Consensus       230 ------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~~  269 (441)
                                        ...+|+++++||++||+.||++|||++|+++||||++...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                              1247899999999999999999999999999999987544

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.5e-54  Score=419.40  Aligned_cols=250  Identities=26%  Similarity=0.456  Sum_probs=210.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEe--CCE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLAS--RTK   83 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~--~~~   83 (441)
                      ..++|++++.||+|+||+||+|+++.+|+.||||++++..      .+.+.+|+.+|+.++ ||||+++++++..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            4578999999999999999999999999999999986532      356889999999995 9999999999974  456


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC-CeEEeeccccccCCcc
Q 013520           84 VYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG-NLKVSDFGLSALPQQG  162 (441)
Q Consensus        84 ~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~-~~kL~DFGls~~~~~~  162 (441)
                      +|+||||+++++|....   +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|......
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999999997764   5799999999999999999999999999999999999999655 5999999999866543


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH-HHHHHhh-------------cCcC-
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP-TLYKKIN-------------AAEF-  227 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~-~~~~~i~-------------~~~~-  227 (441)
                       ......+||+.|+|||++.+...++.++||||+||++|+|++|..||...... .....+.             .... 
T Consensus       184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  262 (328)
T d3bqca1         184 -QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  262 (328)
T ss_dssp             -CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             -CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence             33467789999999999887666679999999999999999999999764422 1111110             0000 


Q ss_pred             -----------------------CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccc
Q 013520          228 -----------------------SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRK  266 (441)
Q Consensus       228 -----------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~  266 (441)
                                             .....+|+++.+||++||+.||++|||++|+|+||||+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                                   011226899999999999999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-54  Score=408.69  Aligned_cols=250  Identities=29%  Similarity=0.396  Sum_probs=207.0

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      .++|++++.||+|+||.||+|++..++   ..||||.++...  .....+.+.+|+.+|+.++||||+++++++. .+.+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            468999999999999999999987543   468888875433  3444577999999999999999999999985 4678


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVH-QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~-~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+......
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~  162 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  162 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence            999999999999998765 4579999999999999999999999999999999999999999999999999998655422


Q ss_pred             -cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhHHHH
Q 013520          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGATSL  240 (441)
Q Consensus       164 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l  240 (441)
                       ......+||+.|+|||++.+..|. .++|||||||++|+|++ |.+||.+.+..+....+..+. .+.|+.+|+++.+|
T Consensus       163 ~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  241 (273)
T d1mp8a_         163 YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  241 (273)
T ss_dssp             --------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence             233456789999999999877664 89999999999999997 999999988888888877654 56778899999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcC
Q 013520          241 IHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~h  261 (441)
                      |.+||+.||++|||++||++|
T Consensus       242 i~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         242 MTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999876

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-54  Score=423.12  Aligned_cols=256  Identities=28%  Similarity=0.438  Sum_probs=204.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe------
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS------   80 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~------   80 (441)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+++.++||||++++++|..      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            45789999999999999999999999999999999987654 34456778999999999999999999999963      


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQ  160 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~  160 (441)
                      .+.+|+||||+.++. ++.+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++....
T Consensus        94 ~~~~~iv~Ey~~~~l-~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDANL-CQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEEH-HHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccchHH-HHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            478999999997654 4444  3579999999999999999999999999999999999999999999999999987655


Q ss_pred             ccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHHHhhc----------------
Q 013520          161 QGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYKKINA----------------  224 (441)
Q Consensus       161 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~~i~~----------------  224 (441)
                      .. ......+||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+......++..                
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         171 TS-FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             -----------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cc-cccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            43 33456789999999999988766 5899999999999999999999988775554443321                


Q ss_pred             ------CcCCC--------------C------CCCCHhHHHHHHHhcCCCCCCCCChHhHhcCCCccccC
Q 013520          225 ------AEFSC--------------P------FWFSTGATSLIHKILDPNPKTRIRIEGIRKHPWFRKNY  268 (441)
Q Consensus       225 ------~~~~~--------------~------~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~f~~~~  268 (441)
                            .....              +      ...|+++.+||++||..||++|||++|+|+||||+...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                  00000              0      01367899999999999999999999999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=405.95  Aligned_cols=255  Identities=23%  Similarity=0.362  Sum_probs=213.8

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~   85 (441)
                      ...++|++.+.||+|+||+||+|+++.+ +.||||+++.....    .+.+.+|+.+|++++|||||++++++.+ +..|
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            3458999999999999999999999755 57999999765432    3568899999999999999999999854 5689


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           86 IILEFVTGGELFDKIVH--QGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        86 lv~E~~~gg~L~~~i~~--~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      +||||+++|+|..++..  ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+......
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999999988854  4579999999999999999999999999999999999999999999999999998654332


Q ss_pred             -cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCCHhHHHH
Q 013520          164 -ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFSTGATSL  240 (441)
Q Consensus       164 -~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l  240 (441)
                       ......+||+.|+|||++.+..+ +.++||||+||++|+|++ |.+|+...+..+....+..+ ..+.|..+|+++.++
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  246 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  246 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             ceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHH
Confidence             23345679999999999987766 489999999999999999 56666777777777776554 456788899999999


Q ss_pred             HHHhcCCCCCCCCChHhHhc--CCCcccc
Q 013520          241 IHKILDPNPKTRIRIEGIRK--HPWFRKN  267 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~--hp~f~~~  267 (441)
                      |.+||+.||++|||+++|++  |+||...
T Consensus       247 i~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         247 MCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999999999999999988  8898754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=402.80  Aligned_cols=253  Identities=25%  Similarity=0.341  Sum_probs=209.8

Q ss_pred             cccccCeEEEeeeeecCcEEEEEEEECCCC----cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe
Q 013520            5 TRRVAKYEVGRTIGEGTFAKVRFAQNRETG----ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS   80 (441)
Q Consensus         5 ~~~~~~y~i~~~LG~G~~g~V~~a~~~~~~----~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~   80 (441)
                      ....+.|++.+.||+|+||.||+|.++.++    ..||||.+.....  ......+.+|+.+++.++|||||++++++.+
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~   80 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISK   80 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence            445678999999999999999999987654    4799999976442  2335678899999999999999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccC
Q 013520           81 RTKVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALP  159 (441)
Q Consensus        81 ~~~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~  159 (441)
                      .+..++||||+.+|++.+.+... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999999999988754 57999999999999999999999999999999999999999999999999999875


Q ss_pred             Ccccc---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcC-cCCCCCCCC
Q 013520          160 QQGVE---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAA-EFSCPFWFS  234 (441)
Q Consensus       160 ~~~~~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s  234 (441)
                      .....   ......||+.|+|||++.+..+. .++|||||||++|||++ |.+||...+..+..+.+..+ ..+.|..++
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  239 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence            44222   23345689999999999877664 89999999999999998 56666767777777776654 446667799


Q ss_pred             HhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          235 TGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       235 ~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +++.+||.+||+.||++|||+.||++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-53  Score=409.32  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=211.9

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCCc----EEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETGE----SVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      +-++|++++.||+|+||+||+|.+..+|+    .||+|.+.....  ....+.+.+|+.++++++|||||++++++.++ 
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            34689999999999999999999988876    477777754332  22457789999999999999999999999875 


Q ss_pred             EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCc
Q 013520           83 KVYIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQ  161 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~  161 (441)
                      ..++++||+.+|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            567888999999999888764 5799999999999999999999999999999999999999999999999999987654


Q ss_pred             ccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCc-CCCCCCCCHhH
Q 013520          162 GVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAE-FSCPFWFSTGA  237 (441)
Q Consensus       162 ~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~  237 (441)
                      ...  ......||+.|+|||++.+..| +.++|||||||++|||++ |.+||.+.+..+....+..+. ++.|..+++++
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred             ccccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            322  2334568999999999987766 489999999999999998 899999988888877776654 56777899999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhcCC
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRKHP  262 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~hp  262 (441)
                      .+|+.+||+.||++|||+.||++|.
T Consensus       243 ~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999883

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=406.38  Aligned_cols=252  Identities=22%  Similarity=0.324  Sum_probs=216.2

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcE--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeCC
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGES--VAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASRT   82 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~--vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~   82 (441)
                      ...++|++.+.||+|+||.||+|+++.+|..  ||||.+....  .....+.+.+|+.+|+++ +|||||++++++.+++
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~   84 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG   84 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence            4567999999999999999999999888875  5677665432  223456789999999998 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCC
Q 013520           83 KVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYG  146 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~  146 (441)
                      .+|+||||++||+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence            999999999999999999654                5789999999999999999999999999999999999999999


Q ss_pred             CeEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcC-CCCCCCCChHHHHHHhhcC
Q 013520          147 NLKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAA  225 (441)
Q Consensus       147 ~~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~  225 (441)
                      .+||+|||+|...... ......+||+.|+|||.+.+..| +.++|||||||++|+|++| .+||.+.+..++.+.+..+
T Consensus       165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~  242 (309)
T d1fvra_         165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  242 (309)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             ceEEcccccccccccc-ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence            9999999999765443 23346679999999999987776 4899999999999999996 5789988888888887654


Q ss_pred             -cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          226 -EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       226 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                       .+..|..+++++.+||.+||+.||++|||+++|++|
T Consensus       243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             556677899999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-53  Score=400.32  Aligned_cols=251  Identities=25%  Similarity=0.400  Sum_probs=205.4

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECC-CC--cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCCEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRE-TG--ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRTKV   84 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-~~--~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~   84 (441)
                      .++|++++.||+|+||.||+|+... ++  ..||||++.+.........+.+.+|+.+|+.++||||+++++++.+ ...
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4689999999999999999998643 33  3689999988766666667889999999999999999999999976 467


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCccc
Q 013520           85 YIILEFVTGGELFDKIVHQ-GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~-~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~  163 (441)
                      |+||||+++|++.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~  165 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND  165 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred             heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence            8999999999999877654 579999999999999999999999999999999999999999999999999998764422


Q ss_pred             c---ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhcCcC--CCCCCCCHhH
Q 013520          164 E---LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINAAEF--SCPFWFSTGA  237 (441)
Q Consensus       164 ~---~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~~~~--~~~~~~s~~~  237 (441)
                      .   ......|++.|+|||++.+..+ +.++|||||||++|||++ |.+||.+.+..+...++.....  +.|..+|+++
T Consensus       166 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l  244 (273)
T d1u46a_         166 DHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI  244 (273)
T ss_dssp             CEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred             CcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence            2   2334568889999999987665 488999999999999998 8999999998888888765543  4556789999


Q ss_pred             HHHHHHhcCCCCCCCCChHhHhc
Q 013520          238 TSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       238 ~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .+||.+||+.||++|||+++|++
T Consensus       245 ~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         245 YNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999863

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-52  Score=402.02  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=217.1

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT   82 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~   82 (441)
                      .++|++++.||+|+||+||+|+.+     .+++.||||+++...  .....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~   89 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK   89 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence            457999999999999999999875     356789999997644  2334577999999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 013520           83 KVYIILEFVTGGELFDKIVHQG------------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPE  138 (441)
Q Consensus        83 ~~~lv~E~~~gg~L~~~i~~~~------------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~  138 (441)
                      ..+++|||+++|+|.+++....                        .+++..+..++.||+.||+|||++||+||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999996532                        4888999999999999999999999999999999


Q ss_pred             cEEEccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCC-CCCCCCCh
Q 013520          139 NLLLDSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGY-LPFGETDL  215 (441)
Q Consensus       139 NILl~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~-~Pf~~~~~  215 (441)
                      |||++.++++||+|||+|+......  ....+.+||+.|+|||.+.+..|+ .++|||||||++|||++|. +||.+.+.
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            9999999999999999997554322  233467899999999999887765 8999999999999999984 78998888


Q ss_pred             HHHHHHhhcCcC-CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          216 PTLYKKINAAEF-SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       216 ~~~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      .+....+..+.. +.|..+++++.+||.+||+.||++|||+.||++
T Consensus       249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888888877654 457779999999999999999999999999854

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=395.62  Aligned_cols=245  Identities=24%  Similarity=0.427  Sum_probs=208.3

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RTKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~   84 (441)
                      ..+++|++++.||+|+||.||+|+++  |..||||+++++.     ..+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            45789999999999999999999984  7799999997643     34678899999999999999999999854 5678


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcc
Q 013520           85 YIILEFVTGGELFDKIVHQG--RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQG  162 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~--~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~  162 (441)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||++..... 
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence            99999999999999996543  589999999999999999999999999999999999999999999999999986443 


Q ss_pred             ccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHHHhhc-CcCCCCCCCCHhHHHH
Q 013520          163 VELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYKKINA-AEFSCPFWFSTGATSL  240 (441)
Q Consensus       163 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~s~~~~~l  240 (441)
                        ......+|+.|+|||++.+..+ +.++|||||||++|||++ |.+||...+..+....+.. ..++.|..+++++.+|
T Consensus       156 --~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l  232 (262)
T d1byga_         156 --TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV  232 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred             --CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence              2345678999999999987766 589999999999999998 8999999888888888765 4566778899999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcC
Q 013520          241 IHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~h  261 (441)
                      |.+||+.||++|||+.+++++
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999774

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=400.75  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=201.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   81 (441)
                      .++|++++.||+|+||.||+|++..     +++.||||+++....  ....+.+.+|..++.++ +||||+.+++++...
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            4789999999999999999999754     456899999875442  23346677788887776 689999999987654


Q ss_pred             -CEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc
Q 013520           82 -TKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS  144 (441)
Q Consensus        82 -~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~  144 (441)
                       ..+|+|||||++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence             5689999999999999999653                34889999999999999999999999999999999999999


Q ss_pred             CCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcC-CCCCCCCChHH-HHH
Q 013520          145 YGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPT-LYK  220 (441)
Q Consensus       145 ~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~-~~~  220 (441)
                      ++++||+|||+|+......  ......+||+.|+|||++.+..+ +.++|||||||++|+|++| .+||.+.+... ...
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~  248 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR  248 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            9999999999997654422  23345679999999999987666 5899999999999999986 57887765443 344


Q ss_pred             Hhhc-CcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          221 KINA-AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       221 ~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                      .+.. ..+..|..+++++.++|.+||+.||++|||++||++|
T Consensus       249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4443 3456677899999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-52  Score=399.92  Aligned_cols=251  Identities=24%  Similarity=0.398  Sum_probs=214.7

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECCCC-------cEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEE
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRETG-------ESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVL   78 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~~~-------~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~   78 (441)
                      ..++|++++.||+|+||.||+|++..++       ..||||+++++..  ......+.+|...+.++ +|||||++++++
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3589999999999999999999976554       4799999977542  33456788898888888 899999999999


Q ss_pred             EeCCEEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 013520           79 ASRTKVYIILEFVTGGELFDKIVHQ----------------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLL  142 (441)
Q Consensus        79 ~~~~~~~lv~E~~~gg~L~~~i~~~----------------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl  142 (441)
                      .+++.+|+||||+++|+|.++|...                ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  168 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence            9999999999999999999999754                358999999999999999999999999999999999999


Q ss_pred             ccCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHH
Q 013520          143 DSYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLY  219 (441)
Q Consensus       143 ~~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~  219 (441)
                      +.++.+||+|||++.......  ......+||+.|+|||.+.+..|+ .++|||||||++|+|++ |.+||.+.+....+
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~  247 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  247 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence            999999999999998665422  234556799999999999887764 89999999999999997 79999998888888


Q ss_pred             HHhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          220 KKINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       220 ~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                      +.+..+ .+..|.++|+++.+||.+||+.||++|||+.||++
T Consensus       248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            877654 45677889999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-51  Score=393.87  Aligned_cols=257  Identities=21%  Similarity=0.275  Sum_probs=222.1

Q ss_pred             cccCeEEEeeeeecCcEEEEEEEECC-----CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeC
Q 013520            7 RVAKYEVGRTIGEGTFAKVRFAQNRE-----TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASR   81 (441)
Q Consensus         7 ~~~~y~i~~~LG~G~~g~V~~a~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~   81 (441)
                      ..++|++++.||+|+||.||+|.++.     ++..||||++++..  .......+.+|+.++++++||||+++++++..+
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            34799999999999999999998753     45789999997643  333456789999999999999999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEe
Q 013520           82 TKVYIILEFVTGGELFDKIVHQ----------GRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVS  151 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~----------~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~  151 (441)
                      ...++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+
T Consensus        96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEe
Confidence            9999999999999999988643          246888999999999999999999999999999999999999999999


Q ss_pred             eccccccCCcccc--ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcC-CCCCCCCChHHHHHHhhcCc-C
Q 013520          152 DFGLSALPQQGVE--LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAG-YLPFGETDLPTLYKKINAAE-F  227 (441)
Q Consensus       152 DFGls~~~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g-~~Pf~~~~~~~~~~~i~~~~-~  227 (441)
                      |||+|........  .....+||+.|+|||.+.+..+. .++|||||||++|+|++| .+||.+.+..+....+..+. .
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~  254 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL  254 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence            9999986644322  23455789999999999877664 899999999999999998 68999988888888776654 4


Q ss_pred             CCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc------CCCccc
Q 013520          228 SCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK------HPWFRK  266 (441)
Q Consensus       228 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~------hp~f~~  266 (441)
                      ..|..+|+.+.++|.+||+.||++|||+++|++      +|+|++
T Consensus       255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            567789999999999999999999999999987      666643

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=391.72  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=213.7

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEEC-----CCCcEEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCCcceeEEEEEeC
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNR-----ETGESVAMKVLAKSTILKHRMVDQIKREISIMKIV-RHPNIVRLHEVLASR   81 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~   81 (441)
                      .++|++++.||+|+||.||+|+..     .+++.||||+++....  ......+.+|+.+++.+ +|||||++++++.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            479999999999999999999863     4677999999976542  33456788999999999 799999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEc
Q 013520           82 TKVYIILEFVTGGELFDKIVHQG------------------RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLD  143 (441)
Q Consensus        82 ~~~~lv~E~~~gg~L~~~i~~~~------------------~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~  143 (441)
                      ...|+||||+++|+|.+++....                  .+++..+..++.||+.||+|||++||+||||||+||+++
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT  179 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence            99999999999999999997643                  589999999999999999999999999999999999999


Q ss_pred             cCCCeEEeeccccccCCccc--cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhc-CCCCCCCCChHHHHH
Q 013520          144 SYGNLKVSDFGLSALPQQGV--ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMA-GYLPFGETDLPTLYK  220 (441)
Q Consensus       144 ~~~~~kL~DFGls~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~-g~~Pf~~~~~~~~~~  220 (441)
                      .++.+|++|||+++......  ......+||+.|+|||++.+..+ +.++|||||||++|+|++ |.+||...+..+...
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998765432  23345689999999999977655 589999999999999998 777787766544443


Q ss_pred             -HhhcC-cCCCCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          221 -KINAA-EFSCPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       221 -~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                       .+..+ ....|..+|+++.+||.+||+.||++|||+++|++
T Consensus       259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             33333 34456678999999999999999999999999985

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-49  Score=381.94  Aligned_cols=247  Identities=23%  Similarity=0.265  Sum_probs=203.6

Q ss_pred             EEEeeeeecCcEEEEEEEECCCC---cEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEe-CCEEEEE
Q 013520           12 EVGRTIGEGTFAKVRFAQNRETG---ESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLAS-RTKVYII   87 (441)
Q Consensus        12 ~i~~~LG~G~~g~V~~a~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~lv   87 (441)
                      .+.++||+|+||+||+|++..++   ..||||.+++..  .....+.+.+|+.+|++++||||+++++++.+ ++..|+|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            34678999999999999987643   368999986532  34456789999999999999999999999765 5689999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccccccCCcccc--
Q 013520           88 LEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGLSALPQQGVE--  164 (441)
Q Consensus        88 ~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGls~~~~~~~~--  164 (441)
                      ||||++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++.......  
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            99999999999887543 577888999999999999999999999999999999999999999999999986544211  


Q ss_pred             --ccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCC-CChHHHHHHhhc-CcCCCCCCCCHhHHHH
Q 013520          165 --LLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGE-TDLPTLYKKINA-AEFSCPFWFSTGATSL  240 (441)
Q Consensus       165 --~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~-~~~~~~~~~i~~-~~~~~~~~~s~~~~~l  240 (441)
                        ......||+.|+|||++.+..+ +.++|||||||++|||++|..||.. .+..+....+.. ..+..|..+++++.+|
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence              2234568999999999987666 5899999999999999997666644 333444444443 3456677899999999


Q ss_pred             HHHhcCCCCCCCCChHhHhcC
Q 013520          241 IHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       241 i~~~L~~dP~~R~t~~eil~h  261 (441)
                      |.+||+.||++|||+.||++|
T Consensus       267 i~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         267 MLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-49  Score=379.44  Aligned_cols=253  Identities=20%  Similarity=0.269  Sum_probs=202.6

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCC-cceeEEEEEeCCEEEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPN-IVRLHEVLASRTKVYII   87 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~lv   87 (441)
                      ++|++++.||+|+||.||+|++..+|+.||||++..+...     +.+.+|+.+++.++|+| |+.+..++.+.+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4799999999999999999999999999999998765422     34778999999998765 55566777888999999


Q ss_pred             EeccCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc---CCCeEEeeccccccCCccc
Q 013520           88 LEFVTGGELFDKI-VHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS---YGNLKVSDFGLSALPQQGV  163 (441)
Q Consensus        88 ~E~~~gg~L~~~i-~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~---~~~~kL~DFGls~~~~~~~  163 (441)
                      |||+.+ +|.+.+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|.......
T Consensus        82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            999955 555554 44568999999999999999999999999999999999999863   4579999999998654321


Q ss_pred             -------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChHHHHH---HhhcCcC-----C
Q 013520          164 -------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLPTLYK---KINAAEF-----S  228 (441)
Q Consensus       164 -------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~~~~~---~i~~~~~-----~  228 (441)
                             ....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..........   +......     .
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  239 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence                   12345689999999999988776 489999999999999999999998755433222   2211111     1


Q ss_pred             CCCCCCHhHHHHHHHhcCCCCCCCCChHh---HhcCCCccccC
Q 013520          229 CPFWFSTGATSLIHKILDPNPKTRIRIEG---IRKHPWFRKNY  268 (441)
Q Consensus       229 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e---il~hp~f~~~~  268 (441)
                      .+..+|+++.++|.+||+.||++||++++   +++|+|.+..+
T Consensus       240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~  282 (299)
T d1ckia_         240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  282 (299)
T ss_dssp             HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence            23468999999999999999999999874   57888776544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-47  Score=367.22  Aligned_cols=246  Identities=20%  Similarity=0.285  Sum_probs=205.9

Q ss_pred             ccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CCcceeEEEEEeCCEEEE
Q 013520            8 VAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-PNIVRLHEVLASRTKVYI   86 (441)
Q Consensus         8 ~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~l   86 (441)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.....     ...+.+|+.+++.++| +|++.+++++......|+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            4689999999999999999999999999999999866432     2346789999999965 899999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEcc-----CCCeEEeeccccccCC
Q 013520           87 ILEFVTGGELFDKIVHQG-RLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDS-----YGNLKVSDFGLSALPQ  160 (441)
Q Consensus        87 v~E~~~gg~L~~~i~~~~-~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~-----~~~~kL~DFGls~~~~  160 (441)
                      ||||+ |++|.+.+...+ .+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+...
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 789999887654 6999999999999999999999999999999999999974     5789999999998654


Q ss_pred             ccc-------cccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCCh---HHHHHHhhcCcCC--
Q 013520          161 QGV-------ELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDL---PTLYKKINAAEFS--  228 (441)
Q Consensus       161 ~~~-------~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~---~~~~~~i~~~~~~--  228 (441)
                      ...       ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.   .....++......  
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            321       12345689999999999988766 4899999999999999999999976443   2333333322211  


Q ss_pred             ---CCCCCCHhHHHHHHHhcCCCCCCCCChHhHhc
Q 013520          229 ---CPFWFSTGATSLIHKILDPNPKTRIRIEGIRK  260 (441)
Q Consensus       229 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  260 (441)
                         .+..+|+++.+++..|+..+|++||+.+.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence               23458899999999999999999999887654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=370.59  Aligned_cols=246  Identities=21%  Similarity=0.322  Sum_probs=192.2

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCcceeEEEEEeCC----EE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNIVRLHEVLASRT----KV   84 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~----~~   84 (441)
                      .+|.+.+.||+|+||.||+|+.  +|+.||||+++.+.    ......+.|+..+..++||||+++++++.+++    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            4789999999999999999986  58899999986542    11122334556667789999999999997654    68


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCcEEEccCCCeEEeecccc
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS--------KGVYHRDLKPENLLLDSYGNLKVSDFGLS  156 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~--------~gi~HrDlkp~NILl~~~~~~kL~DFGls  156 (441)
                      |+||||+++|+|.+++.. .+++++....++.|++.||.|||+        +||+||||||+||||+.+|++||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999999986 479999999999999999999996        59999999999999999999999999999


Q ss_pred             ccCCcccc----ccccccCCCCcCCccccccCCC-----CCCCcchhhHhHHHHHHhcCCCCCCCCC-------------
Q 013520          157 ALPQQGVE----LLHTTCGTPNYVAPEVLSNRGY-----DGSAADVWSCGVILFVLMAGYLPFGETD-------------  214 (441)
Q Consensus       157 ~~~~~~~~----~~~~~~gt~~Y~aPE~l~~~~~-----~~~~~DiwSlGvil~~ll~g~~Pf~~~~-------------  214 (441)
                      ........    .....+||+.|+|||++.+...     .+.++|||||||+||||++|.+||....             
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            86544221    2346789999999999865421     2468999999999999999998874321             


Q ss_pred             --hHHHHHHhhcCcC--CCCCC-----CCHhHHHHHHHhcCCCCCCCCChHhHhcC
Q 013520          215 --LPTLYKKINAAEF--SCPFW-----FSTGATSLIHKILDPNPKTRIRIEGIRKH  261 (441)
Q Consensus       215 --~~~~~~~i~~~~~--~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h  261 (441)
                        .....+.......  ..|..     .+..+.+|+.+||+.||++|||+.||+++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence              1222333322222  12221     12358899999999999999999999764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-46  Score=371.04  Aligned_cols=251  Identities=23%  Similarity=0.415  Sum_probs=197.1

Q ss_pred             cCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-----------CCCcceeEEE
Q 013520            9 AKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-----------HPNIVRLHEV   77 (441)
Q Consensus         9 ~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------hpnIv~l~~~   77 (441)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++++.    ...+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            47999999999999999999999999999999997643    23456778999888775           5789999988


Q ss_pred             EE--eCCEEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEccCCC----
Q 013520           78 LA--SRTKVYIILEFVTGGELFDKI---VHQGRLLENDCRRYFQQLIDAVAHCHS-KGVYHRDLKPENLLLDSYGN----  147 (441)
Q Consensus        78 ~~--~~~~~~lv~E~~~gg~L~~~i---~~~~~l~e~~~~~~~~qll~aL~~LH~-~gi~HrDlkp~NILl~~~~~----  147 (441)
                      +.  .....+++++++..+......   .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.    
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            75  456777788777665443332   234578999999999999999999998 89999999999999987654    


Q ss_pred             --eEEeeccccccCCccccccccccCCCCcCCccccccCCCCCCCcchhhHhHHHHHHhcCCCCCCCCChH------HHH
Q 013520          148 --LKVSDFGLSALPQQGVELLHTTCGTPNYVAPEVLSNRGYDGSAADVWSCGVILFVLMAGYLPFGETDLP------TLY  219 (441)
Q Consensus       148 --~kL~DFGls~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~~DiwSlGvil~~ll~g~~Pf~~~~~~------~~~  219 (441)
                        ++++|||.+.....   .....+||+.|+|||++.+..|+ .++||||+||++++|++|+.||...+..      ...
T Consensus       169 ~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ceeeEeeccccccccc---ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence              99999999875443   23567899999999999887774 8999999999999999999999653311      000


Q ss_pred             -HHhh-----------c------------------------------CcCCCCCCCCHhHHHHHHHhcCCCCCCCCChHh
Q 013520          220 -KKIN-----------A------------------------------AEFSCPFWFSTGATSLIHKILDPNPKTRIRIEG  257 (441)
Q Consensus       220 -~~i~-----------~------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e  257 (441)
                       ..+.           .                              .....+...++++.+||.+||+.||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence             0000           0                              000111124678999999999999999999999


Q ss_pred             HhcCCCcccc
Q 013520          258 IRKHPWFRKN  267 (441)
Q Consensus       258 il~hp~f~~~  267 (441)
                      +|+||||++.
T Consensus       325 ~L~Hp~f~~~  334 (362)
T d1q8ya_         325 LVNHPWLKDT  334 (362)
T ss_dssp             HHTCGGGTTC
T ss_pred             HhcCcccCCC
Confidence            9999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=5.2e-26  Score=203.12  Aligned_cols=138  Identities=16%  Similarity=0.238  Sum_probs=110.1

Q ss_pred             eEEEeeeeecCcEEEEEEEECCCCcEEEEEEeeccccc---------------chHHHHHHHHHHHHHHhCCCCCcceeE
Q 013520           11 YEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTIL---------------KHRMVDQIKREISIMKIVRHPNIVRLH   75 (441)
Q Consensus        11 y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~---------------~~~~~~~~~~Ei~il~~l~hpnIv~l~   75 (441)
                      |.+++.||+|+||.||+|++. +|+.||||+++.....               .........+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999985 6899999987542211               011123456789999999999999988


Q ss_pred             EEEEeCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEccCCCeEEeeccc
Q 013520           76 EVLASRTKVYIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHSKGVYHRDLKPENLLLDSYGNLKVSDFGL  155 (441)
Q Consensus        76 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~~gi~HrDlkp~NILl~~~~~~kL~DFGl  155 (441)
                      ++..    .+++|||+++..+.       .+++..+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||.
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            6632    27999999886653       35667778899999999999999999999999999999964 599999999


Q ss_pred             cccCCc
Q 013520          156 SALPQQ  161 (441)
Q Consensus       156 s~~~~~  161 (441)
                      |.....
T Consensus       149 a~~~~~  154 (191)
T d1zara2         149 SVEVGE  154 (191)
T ss_dssp             CEETTS
T ss_pred             cccCCC
Confidence            875543

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.41  E-value=6e-13  Score=103.66  Aligned_cols=84  Identities=13%  Similarity=0.165  Sum_probs=77.9

Q ss_pred             EeCCCHHHHHHHHHHHHHHcCcEEEee-cceEEEEeeccCCCccEEEEEEEEEEc-CceEEEEEEecCCCchHHHHHHHH
Q 013520          340 VSRQPAQVILSNIEAVAESLSLKVHTR-NYKTRLEGVSANKTGQFAVVLEVFEVA-PSLFMVDVRKAAGDTLEYHKFYKN  417 (441)
Q Consensus       340 ~s~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~i~~~~-~~~~~v~f~~~~Gd~le~~~~~~~  417 (441)
                      +|+.||++|+..|+++|+.+|+.++.+ .|.++.+...+++++.+.|.+||+++. +++++|+|+|.+||.++|++++.+
T Consensus        16 TS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~~   95 (102)
T d1ul7a_          16 TSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASK   95 (102)
T ss_dssp             CBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHHH
T ss_pred             CcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHHH
Confidence            788999999999999999999999765 488999988888889999999999995 799999999999999999999999


Q ss_pred             HHHhcc
Q 013520          418 FCAKLE  423 (441)
Q Consensus       418 ~~~~l~  423 (441)
                      |...|+
T Consensus        96 il~~l~  101 (102)
T d1ul7a_          96 IANELK  101 (102)
T ss_dssp             HHHHCC
T ss_pred             HHHhcc
Confidence            988875

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.61  E-value=7.9e-08  Score=87.48  Aligned_cols=143  Identities=15%  Similarity=0.112  Sum_probs=99.3

Q ss_pred             ccccCeEEEeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEE
Q 013520            6 RRVAKYEVGRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKV   84 (441)
Q Consensus         6 ~~~~~y~i~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~   84 (441)
                      ..++.|+..+..+.++.+.||++.  ..+..+.+|+.......   ....+.+|...++.+. +--+.+++.+..+++..
T Consensus        11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_          11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            346788888887777778999886  34667788887654322   1234678888888774 44467888888899999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 013520           85 YIILEFVTGGELFDKIVHQGRLLENDCRRYFQQLIDAVAHCHS-------------------------------------  127 (441)
Q Consensus        85 ~lv~E~~~gg~L~~~i~~~~~l~e~~~~~~~~qll~aL~~LH~-------------------------------------  127 (441)
                      |+||++++|..+.+....     ......+..++...+..||+                                     
T Consensus        86 ~lv~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred             EEEEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence            999999999887554321     11122233344444444442                                     


Q ss_pred             ----------------------CCceecCCCCCcEEEccCCCeEEeecccccc
Q 013520          128 ----------------------KGVYHRDLKPENLLLDSYGNLKVSDFGLSAL  158 (441)
Q Consensus       128 ----------------------~gi~HrDlkp~NILl~~~~~~kL~DFGls~~  158 (441)
                                            ..++|+|+.|.||++++++..-|+||+.+..
T Consensus       161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  1379999999999999766667999998753

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.11  E-value=4.7e-06  Score=74.86  Aligned_cols=80  Identities=14%  Similarity=0.159  Sum_probs=55.5

Q ss_pred             cCeEEEeeeeecC-cEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC--CCCcceeEEEEEeCCEEE
Q 013520            9 AKYEVGRTIGEGT-FAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR--HPNIVRLHEVLASRTKVY   85 (441)
Q Consensus         9 ~~y~i~~~LG~G~-~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~   85 (441)
                      ..++... +..|. .+.||++.. ..+..+.+|......      ...+..|...++.+.  .-.+.+++.+..+++..+
T Consensus        11 ~g~~~~~-~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~   82 (255)
T d1nd4a_          11 FGYDWAQ-QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   82 (255)
T ss_dssp             TTCEEEE-CSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             cCCceEE-cCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceE
Confidence            4455543 34444 478998875 356678889764432      234678888888774  334677888888889999


Q ss_pred             EEEeccCCCCh
Q 013520           86 IILEFVTGGEL   96 (441)
Q Consensus        86 lv~E~~~gg~L   96 (441)
                      ++|++++|.++
T Consensus        83 ~v~~~i~G~~~   93 (255)
T d1nd4a_          83 LLLGEVPGQDL   93 (255)
T ss_dssp             EEEECCSSEET
T ss_pred             EEEEeeecccc
Confidence            99999988655

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.06  E-value=6.5e-06  Score=79.39  Aligned_cols=81  Identities=15%  Similarity=0.171  Sum_probs=50.2

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeeccc-c-cc--hHHHHHHHHHHHHHHhCC-C--CCcceeEEEEEeCCEEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKST-I-LK--HRMVDQIKREISIMKIVR-H--PNIVRLHEVLASRTKVYI   86 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~-~-~~--~~~~~~~~~Ei~il~~l~-h--pnIv~l~~~~~~~~~~~l   86 (441)
                      .+.||.|....||++.+..+++.+++|.-.... . ..  ....++...|...|+.+. +  ..+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            567899999999999988788899999643210 0 00  011234567888887763 3  345566554  4445678


Q ss_pred             EEeccCCCCh
Q 013520           87 ILEFVTGGEL   96 (441)
Q Consensus        87 v~E~~~gg~L   96 (441)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987544

>d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.04  E-value=1.6e-05  Score=63.95  Aligned_cols=72  Identities=15%  Similarity=0.263  Sum_probs=59.7

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEeec-ceEEEEeeccCCCccEEEEEEEEEEcCceEEEEEEecCCCchH
Q 013520          339 FVSRQPAQVILSNIEAVAESLSLKVHTRN-YKTRLEGVSANKTGQFAVVLEVFEVAPSLFMVDVRKAAGDTLE  410 (441)
Q Consensus       339 f~s~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~~i~~~~~~~~~v~f~~~~Gd~le  410 (441)
                      .-|+..|.+|+..|..|++.||+.|++-+ |.++++.........+.+.+++|++.++.+||||+...|+-.|
T Consensus         5 IrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~~~e   77 (153)
T d2v8qa1           5 IRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE   77 (153)
T ss_dssp             EEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred             cccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcchhc
Confidence            35778999999999999999999998755 8888886644445567899999999999999999999998765

>d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Snf1-like protein kinase ssp2
species: Schizosaccharomyces pombe [TaxId: 4896]

Probab=97.47  E-value=0.0003  Score=55.15  Aligned_cols=85  Identities=19%  Similarity=0.244  Sum_probs=62.6

Q ss_pred             EEeCCCHHHHHHHHHHHHHHcCcEEEeec----------ceEEEEeec-----cCCCccEEEEEEEEEEcCceEEEEEE-
Q 013520          339 FVSRQPAQVILSNIEAVAESLSLKVHTRN----------YKTRLEGVS-----ANKTGQFAVVLEVFEVAPSLFMVDVR-  402 (441)
Q Consensus       339 f~s~~~~~~~~~~l~~~~~~~~~~~~~~~----------~~~~~~~~~-----~~~~~~l~~~~~i~~~~~~~~~v~f~-  402 (441)
                      .-|+-.|.+|+-.|-.|++.+|+.|++-+          +.|+++...     .....-+.+.+++|++.++.+||||+ 
T Consensus         7 IRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLlDFK~   86 (127)
T d2qrda1           7 VRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKS   86 (127)
T ss_dssp             EEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEEEEE
T ss_pred             cccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEEEEcc
Confidence            35778899999999999999999997633          567776421     12233467899999999999999998 


Q ss_pred             -----ecCC-------------CchHHHHHHHHHHHhcc
Q 013520          403 -----KAAG-------------DTLEYHKFYKNFCAKLE  423 (441)
Q Consensus       403 -----~~~G-------------d~le~~~~~~~~~~~l~  423 (441)
                           ...|             .+.+|-.++.+|...|.
T Consensus        87 dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~  125 (127)
T d2qrda1          87 NGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLF  125 (127)
T ss_dssp             EEEEESCC-------------CCCTTHHHHHHHHHHHHH
T ss_pred             CCcccccCCccccccCccccccCCccHHHHHHHHHHHHh
Confidence                 2222             24668888877766654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.10  E-value=0.0011  Score=63.23  Aligned_cols=74  Identities=14%  Similarity=0.141  Sum_probs=50.8

Q ss_pred             EeeeeecCcEEEEEEEECC-------CCcEEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCCcceeEEEEEeCCEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRE-------TGESVAMKVLAKSTILKHRMVDQIKREISIMKIVR-HPNIVRLHEVLASRTKVY   85 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~   85 (441)
                      ++.|+.|-.-.+|++....       .++.|.+++.-...    . .-...+|..+++.+. +.-..++++++.+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence            4678999999999998653       34567888765321    1 224568999999884 4444577777643    5


Q ss_pred             EEEeccCCCCh
Q 013520           86 IILEFVTGGEL   96 (441)
Q Consensus        86 lv~E~~~gg~L   96 (441)
                      +|+||++|..+
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             eEEEEeccccC
Confidence            78999987543

>d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Carbon catabolite-derepressing protein kinase SNF1
species: Saccharomyces cerevisiae [TaxId: 4932]

Probab=97.04  E-value=0.0012  Score=54.30  Aligned_cols=70  Identities=13%  Similarity=0.219  Sum_probs=50.2

Q ss_pred             cccceEEeCCCHHHHHHHHHHHHHHcCcEEEeec----ceEEEEeecc---------CCCccEEEEEEEEEEcCceEEEE
Q 013520          334 KRQTRFVSRQPAQVILSNIEAVAESLSLKVHTRN----YKTRLEGVSA---------NKTGQFAVVLEVFEVAPSLFMVD  400 (441)
Q Consensus       334 ~~~trf~s~~~~~~~~~~l~~~~~~~~~~~~~~~----~~~~~~~~~~---------~~~~~l~~~~~i~~~~~~~~~v~  400 (441)
                      +..-..-|+.+|-+++-.|..|++.+|+.|++-+    |.|+++...+         .....+.+.+++|++.++.+|||
T Consensus        45 kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlD  124 (171)
T d2qlva1          45 RWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVD  124 (171)
T ss_dssp             CCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEE
T ss_pred             eeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEE
Confidence            3444557899999999999999999999997643    6677764211         11123679999999999999999


Q ss_pred             EEe
Q 013520          401 VRK  403 (441)
Q Consensus       401 f~~  403 (441)
                      |+-
T Consensus       125 FK~  127 (171)
T d2qlva1         125 FKF  127 (171)
T ss_dssp             EEE
T ss_pred             Eec
Confidence            974

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.04  E-value=0.001  Score=61.67  Aligned_cols=68  Identities=16%  Similarity=0.133  Sum_probs=44.9

Q ss_pred             cEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCCCCc--ceeE-----EEEEeCCEEEEEEeccCCC
Q 013520           22 FAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRHPNI--VRLH-----EVLASRTKVYIILEFVTGG   94 (441)
Q Consensus        22 ~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~hpnI--v~l~-----~~~~~~~~~~lv~E~~~gg   94 (441)
                      --.||++.. .+|+.|++|+.+....    ..+++..|...+..|...++  +...     ..+...+..+.+++++.|.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            357999987 4688899999865432    23567789988887742211  1111     2235577889999999874

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.33  E-value=0.0084  Score=54.64  Aligned_cols=137  Identities=16%  Similarity=0.150  Sum_probs=72.8

Q ss_pred             EeeeeecCcEEEEEEEECCCCcEEEEEEeecccccchHHHHHHHHHHHHHHhCCC-----CCcceeE---EEEEeCCEEE
Q 013520           14 GRTIGEGTFAKVRFAQNRETGESVAMKVLAKSTILKHRMVDQIKREISIMKIVRH-----PNIVRLH---EVLASRTKVY   85 (441)
Q Consensus        14 ~~~LG~G~~g~V~~a~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-----pnIv~l~---~~~~~~~~~~   85 (441)
                      .+.|..|.--+.|++... +| .+++|++....     ..+.+..|+.++..|..     |..+...   .+........
T Consensus        23 ~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~   95 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA   95 (316)
T ss_dssp             EEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred             eecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccc
Confidence            444557777888998754 34 58999986532     12346667777777732     2222211   1123345666


Q ss_pred             EEEeccCCCChH--------------HHHHh---c------CCCCHH------------------HHHHHHHHHHHHHHH
Q 013520           86 IILEFVTGGELF--------------DKIVH---Q------GRLLEN------------------DCRRYFQQLIDAVAH  124 (441)
Q Consensus        86 lv~E~~~gg~L~--------------~~i~~---~------~~l~e~------------------~~~~~~~qll~aL~~  124 (441)
                      .++.+..|....              ..+..   .      ......                  .....+..+...+.-
T Consensus        96 ~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  175 (316)
T d2ppqa1          96 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA  175 (316)
T ss_dssp             EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred             eeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhc
Confidence            777776654321              00000   0      000111                  111222223333333


Q ss_pred             HHH----CCceecCCCCCcEEEccCCCeEEeeccccc
Q 013520          125 CHS----KGVYHRDLKPENLLLDSYGNLKVSDFGLSA  157 (441)
Q Consensus       125 LH~----~gi~HrDlkp~NILl~~~~~~kL~DFGls~  157 (441)
                      .+.    .|++|+|+.+.||+++.++..-+.||+.+.
T Consensus       176 ~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         176 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            222    479999999999999987777899999875